Citrus Sinensis ID: 018630

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350---
Protein Sequence
MVILETVRLPNFLPMNFSRTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHcccccccccEEEEEEEcccccEEEEEEEEccccHHHHHHHHHHHHHHHccccccEEEEEEEEEEccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEccccccHHHHHHHccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccccccccHHHHHHHcccccccccccccccHHHHHHHHHHHcccccccccHHHHHccHHHHHcccccccHHHHHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
ccEcccccccccccccHHcccccccccccccccccccccccccccccccccccccccccHHHHHEEEEEccccccEEEEEEEcccccEEHHHHHHHHccHHHHHHHHHHHHHHHHcccccEEEEEEEEccccccEEEEEcccccEHHHHccHcccccHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccccccEcccHHHccHHHHHcccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHcccHHHcccHHHHHcccHHHcccHHHHHHcccccccccccccccccccc
Coil and Loop (DISEMBL)
mviletvrlpnflpmnfsrtksgtfmdgdllvnkdgvrivsqteteapplikpsdnqlnledidtikvvgkgsggIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKinqssqcpyvVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYlhhekhiihrdlkpsnllinhrgevkitdfGVSAIMAstsgqantfvgtynymsperisggkygyksDIWSLGLVLLEcatgqfpysppeqqdgWTSFYELMEAivdqpppsapsdqfspeFCSFISACvqkepqqrlsaqelmthpflkmygdlnvdlseyftdagsplatlsnlsgf
Flexible Loop (DISEMBL)
mviletvrlpnflpmnfsrtksgtfmdgdlLVNKDGVRIVSQteteapplikpsdnqlnlEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELkinqssqcPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIhrdlkpsnllINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAgsplatlsnlsgf
Low Complexity Region (SEG)
MVILETVRLPNFLPMNFSRTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTikvvgkgsggivQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF
Disordered region (IsUnstruct)
**ILETVRLPNFLPMNFSRTKSGTFMDGDLLVNKDGVRIV*****************LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV**************EFCSFISACVQ*********QELMTHPFLKMYGDLNVDLSEYFTDA*************
Disordered Region (DISOPRED)
*********************************************************LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA***QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLA********
Disordered Region (DISEMBL)
MVILETVRLPNFLPMNFSRTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF
Disordered Region (DISPRO)
*****T*R************************************************QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLA********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVILETVRLPNFLPMNFSRTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	353	2.2.26 [Sep-21-2011]
Q9S7U9	363	Mitogen-activated protein	yes	no	0.943	0.917	0.738	1e-150
Q94A06	354	Mitogen-activated protein	no	no	0.934	0.932	0.7	1e-138
Q5QN75	355	Mitogen-activated protein	no	no	0.903	0.898	0.636	1e-127
Q9FJV0	356	Mitogen-activated protein	no	no	0.906	0.898	0.632	1e-124
Q63932	401	Dual specificity mitogen-	yes	no	0.790	0.695	0.380	1e-62
Q01986	393	Dual specificity mitogen-	yes	no	0.790	0.709	0.395	2e-62
Q02750	393	Dual specificity mitogen-	yes	no	0.790	0.709	0.395	2e-62
P31938	393	Dual specificity mitogen-	no	no	0.790	0.709	0.395	2e-62
P29678	393	Dual specificity mitogen-	yes	no	0.790	0.709	0.395	2e-62
Q90891	398	Dual specificity mitogen-	yes	no	0.790	0.701	0.387	3e-62

>sp|Q9S7U9|M2K2_ARATH Mitogen-activated protein kinase kinase 2 OS=Arabidopsis thaliana GN=MKK2 PE=1 SV=2

 Score =  530 bits (1365), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 246/333 (73%), Positives = 284/333 (85%)

Query: 20  TKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQL 79
           T+SGTF DGDL VNKDGVRI+SQ E E    IKP+D+QL+L D+D +KV+GKGS G+VQL
Sbjct: 27  TQSGTFKDGDLRVNKDGVRIISQLEPEVLSPIKPADDQLSLSDLDMVKVIGKGSSGVVQL 86

Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           VQHKWTGQFFALKVIQ+N++E+ R+ IAQELKINQSSQCP +V  YQSFY NGAIS+ILE
Sbjct: 87  VQHKWTGQFFALKVIQLNIDEAIRKAIAQELKINQSSQCPNLVTSYQSFYDNGAISLILE 146

Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           YMDGGSLADFLK VK IP+ YL+AI  QVL+GL+YLHH++HIIHRDLKPSNLLINHRGEV
Sbjct: 147 YMDGGSLADFLKSVKAIPDSYLSAIFRQVLQGLIYLHHDRHIIHRDLKPSNLLINHRGEV 206

Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           KITDFGVS +M +T+G ANTFVGTYNYMSPERI G KYG KSDIWSLGLV+LECATG+FP
Sbjct: 207 KITDFGVSTVMTNTAGLANTFVGTYNYMSPERIVGNKYGNKSDIWSLGLVVLECATGKFP 266

Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           Y+PP Q++ WTS +ELMEAIVDQPPP+ PS  FSPE  SFIS C+QK+P  R SA+ELM 
Sbjct: 267 YAPPNQEETWTSVFELMEAIVDQPPPALPSGNFSPELSSFISTCLQKDPNSRSSAKELME 326

Query: 320 HPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSG 352
           HPFL  Y    ++L+ YFTDAGSPLATL NLSG
Sbjct: 327 HPFLNKYDYSGINLASYFTDAGSPLATLGNLSG 359

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates by phosphorylation the downstream MPK4 and MPK6.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2

>sp|Q94A06|M2K1_ARATH Mitogen-activated protein kinase kinase 1 OS=Arabidopsis thaliana GN=MKK1 PE=1 SV=2

 Score =  490 bits (1261), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 231/330 (70%), Positives = 274/330 (83%)

Query: 20  TKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQL 79
           T+SGTF DGDL VNKDG++ VS +E  APP I+P DNQL+L D++ IKV+GKGS G VQL
Sbjct: 25  TQSGTFKDGDLRVNKDGIQTVSLSEPGAPPPIEPLDNQLSLADLEVIKVIGKGSSGNVQL 84

Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V+HK T QFFALKVIQ+N EES  R I+QEL+IN SSQCPY+V CYQSFY NG +SIILE
Sbjct: 85  VKHKLTQQFFALKVIQLNTEESTCRAISQELRINLSSQCPYLVSCYQSFYHNGLVSIILE 144

Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +MDGGSLAD LKKV  +PE  L+AIC++VL+GL Y+HHE+ IIHRDLKPSNLLINHRGEV
Sbjct: 145 FMDGGSLADLLKKVGKVPENMLSAICKRVLRGLCYIHHERRIIHRDLKPSNLLINHRGEV 204

Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           KITDFGVS I+ STS  AN+FVGTY YMSPERISG  Y  KSDIWSLGLVLLECATG+FP
Sbjct: 205 KITDFGVSKILTSTSSLANSFVGTYPYMSPERISGSLYSNKSDIWSLGLVLLECATGKFP 264

Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           Y+PPE + GW+S YEL++AIV+ PPP APS+ FSPEFCSFIS CVQK+P+ R SA+EL+ 
Sbjct: 265 YTPPEHKKGWSSVYELVDAIVENPPPCAPSNLFSPEFCSFISQCVQKDPRDRKSAKELLE 324

Query: 320 HPFLKMYGDLNVDLSEYFTDAGSPLATLSN 349
           H F+KM+ D + +LS YFTDAGS +  L+N
Sbjct: 325 HKFVKMFEDSDTNLSAYFTDAGSLIPPLAN 354

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Phosphorylates MPK4 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q5QN75|M2K1_ORYSJ Mitogen-activated protein kinase kinase 1 OS=Oryza sativa subsp. japonica GN=MEK1 PE=1 SV=1

 Score =  454 bits (1168), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 205/322 (63%), Positives = 269/322 (83%), Gaps = 3/322 (0%)

Query: 14  PMNFSRTKSGTFMDGDLLVNKDGVRIVSQTETEAPPL--IKPSDNQLNLEDIDTIKVVGK 71
           P++   T SGTF DG+L +N+ G++++S+   + P    +K  D QL+++D++ I+V+GK
Sbjct: 20  PVDKFLTASGTFKDGELRLNQRGLQLISEETADEPQSTNLKVEDVQLSMDDLEMIQVIGK 79

Query: 72  GSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN 131
           GSGGIVQLV+HKW G  +ALK IQMN++E+ R+QI QELKINQ++Q  ++V+C+QSFY N
Sbjct: 80  GSGGIVQLVRHKWVGTLYALKGIQMNIQEAVRKQIVQELKINQATQNAHIVLCHQSFYHN 139

Query: 132 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           G I ++LEYMD GSLAD +K+VKTI E YLA +C+QVL+GLLYLHHE+H+IHRD+KPSNL
Sbjct: 140 GVIYLVLEYMDRGSLADIIKQVKTILEPYLAVLCKQVLEGLLYLHHERHVIHRDIKPSNL 199

Query: 192 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           L+N +GEVKITDFGVSA++AS+ GQ +TFVGTYNYM+PERISG  Y YKSDIWSLGLV+L
Sbjct: 200 LVNRKGEVKITDFGVSAVLASSMGQRDTFVGTYNYMAPERISGSSYDYKSDIWSLGLVIL 259

Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
           ECA G+FPY P E + GW SFYEL+EAIVDQPPPSAP+DQFSPEFC+FIS+C+QK+P +R
Sbjct: 260 ECAIGRFPYIPSEGE-GWLSFYELLEAIVDQPPPSAPADQFSPEFCAFISSCIQKDPAER 318

Query: 312 LSAQELMTHPFLKMYGDLNVDL 333
           +SA EL+ HPF+K + D ++DL
Sbjct: 319 MSASELLNHPFIKKFEDKDLDL 340

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9FJV0|M2K6_ARATH Mitogen-activated protein kinase kinase 6 OS=Arabidopsis thaliana GN=MKK6 PE=1 SV=1

 Score =  444 bits (1143), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 203/321 (63%), Positives = 259/321 (80%), Gaps = 1/321 (0%)

Query: 14  PMNFSRTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGS 73
           P++   T SGTF DGD L+N+ G+R+ S  +       K  D ++  ED++T+KV+GKGS
Sbjct: 21  PISSFLTASGTFHDGDFLLNQKGLRLTSDEKQSRQSDSKELDFEITAEDLETVKVIGKGS 80

Query: 74  GGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNG 132
           GG+VQLV+HKW G+FFA+KVIQMN++E  R+QI QELKINQ SSQCP+VVVCY SFY NG
Sbjct: 81  GGVVQLVRHKWVGKFFAMKVIQMNIQEEIRKQIVQELKINQASSQCPHVVVCYHSFYHNG 140

Query: 133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           A S++LEYMD GSLAD +++VKTI E YLA +C+QVL GL+YLH+E+H+IHRD+KPSNLL
Sbjct: 141 AFSLVLEYMDRGSLADVIRQVKTILEPYLAVVCKQVLLGLVYLHNERHVIHRDIKPSNLL 200

Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +NH+GEVKI+DFGVSA +AS+ GQ +TFVGTYNYMSPERISG  Y Y SDIWSLG+ +LE
Sbjct: 201 VNHKGEVKISDFGVSASLASSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGMSVLE 260

Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 312
           CA G+FPY   E Q    SFYEL+ AIV+ PPP+APSDQFSPEFCSF+SAC+QK+P  R 
Sbjct: 261 CAIGRFPYLESEDQQNPPSFYELLAAIVENPPPTAPSDQFSPEFCSFVSACIQKDPPARA 320

Query: 313 SAQELMTHPFLKMYGDLNVDL 333
           S+ +L++HPF+K + D ++DL
Sbjct: 321 SSLDLLSHPFIKKFEDKDIDL 341

Involved in the regulation of plant cytokinesis during meiosis and mitosis. Activates MPK13 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q63932|MP2K2_MOUSE Dual specificity mitogen-activated protein kinase kinase 2 OS=Mus musculus GN=Map2k2 PE=1 SV=2

 Score =  240 bits (612), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 122/321 (38%), Positives = 182/321 (56%), Gaps = 42/321 (13%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
           +L  +D + I  +G G+GG+V   +H+ +G   A K+I + ++ + R QI +EL++    
Sbjct: 66  ELKDDDFERISELGAGNGGVVTKARHRPSGLIMARKLIHLEIKPAVRNQIIRELQVLHEC 125

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             PY+V  Y +FYS+G ISI +E+MDGGSL   LK+ K IPE+ L  +   VL+GL YL 
Sbjct: 126 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEDILGKVSIAVLRGLAYLR 185

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 186 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 243

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF------------------------ 272
           Y  +SDIWS+GL L+E A G++P  PP+ ++   SF                        
Sbjct: 244 YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEASFGRPVVDGADGEPHSVSPRPRPPGR 303

Query: 273 ----------------YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
                           +EL++ IV++PPP  PS  FS +F  F++ C+ K P +R   + 
Sbjct: 304 PISVGHGMDSRPAMAIFELLDYIVNEPPPKLPSGVFSSDFQEFVNKCLIKNPAERADLKL 363

Query: 317 LMTHPFLKMYGDLNVDLSEYF 337
           LM H F+K      VD + + 
Sbjct: 364 LMNHAFIKRSEGEEVDFAGWL 384

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q01986|MP2K1_RAT Dual specificity mitogen-activated protein kinase kinase 1 OS=Rattus norvegicus GN=Map2k1 PE=1 SV=2

 Score =  239 bits (611), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 125/316 (39%), Positives = 182/316 (57%), Gaps = 37/316 (11%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
           +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL++    
Sbjct: 62  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 121

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+KGL YL 
Sbjct: 122 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 181

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 182 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 239

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQD----------------------------- 267
           Y  +SDIWS+GL L+E A G++P  PP+ ++                             
Sbjct: 240 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLFGCQVEGDAAETPPRPRTPGRPLSS 299

Query: 268 -GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 321
            G  S      +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H 
Sbjct: 300 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 359

Query: 322 FLKMYGDLNVDLSEYF 337
           F+K      VD + + 
Sbjct: 360 FIKRSDAEEVDFAGWL 375

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q02750|MP2K1_HUMAN Dual specificity mitogen-activated protein kinase kinase 1 OS=Homo sapiens GN=MAP2K1 PE=1 SV=2

 Score =  239 bits (611), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 125/316 (39%), Positives = 182/316 (57%), Gaps = 37/316 (11%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
           +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL++    
Sbjct: 62  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 121

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+KGL YL 
Sbjct: 122 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 181

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 182 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 239

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQD----------------------------- 267
           Y  +SDIWS+GL L+E A G++P  PP+ ++                             
Sbjct: 240 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 299

Query: 268 -GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 321
            G  S      +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H 
Sbjct: 300 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 359

Query: 322 FLKMYGDLNVDLSEYF 337
           F+K      VD + + 
Sbjct: 360 FIKRSDAEEVDFAGWL 375

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P31938|MP2K1_MOUSE Dual specificity mitogen-activated protein kinase kinase 1 OS=Mus musculus GN=Map2k1 PE=1 SV=2

 Score =  239 bits (610), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 125/316 (39%), Positives = 182/316 (57%), Gaps = 37/316 (11%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
           +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL++    
Sbjct: 62  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 121

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+KGL YL 
Sbjct: 122 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 181

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 182 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 239

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQD----------------------------- 267
           Y  +SDIWS+GL L+E A G++P  PP+ ++                             
Sbjct: 240 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLFGCHVEGDAAETPPRPRTPGRPLSS 299

Query: 268 -GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 321
            G  S      +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H 
Sbjct: 300 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 359

Query: 322 FLKMYGDLNVDLSEYF 337
           F+K      VD + + 
Sbjct: 360 FIKRSDAEEVDFAGWL 375

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P29678|MP2K1_RABIT Dual specificity mitogen-activated protein kinase kinase 1 OS=Oryctolagus cuniculus GN=MAP2K1 PE=1 SV=2

 Score =  239 bits (610), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 125/316 (39%), Positives = 182/316 (57%), Gaps = 37/316 (11%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
           +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL++    
Sbjct: 62  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 121

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+KGL YL 
Sbjct: 122 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 181

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 182 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 239

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQD----------------------------- 267
           Y  +SDIWS+GL L+E A G++P  PP+ ++                             
Sbjct: 240 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 299

Query: 268 -GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 321
            G  S      +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H 
Sbjct: 300 YGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 359

Query: 322 FLKMYGDLNVDLSEYF 337
           F+K      VD + + 
Sbjct: 360 FIKRSDAEEVDFAGWL 375

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q90891|MP2K2_CHICK Dual specificity mitogen-activated protein kinase kinase 2 OS=Gallus gallus GN=MAP2K2 PE=2 SV=1

 Score =  239 bits (609), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 124/320 (38%), Positives = 184/320 (57%), Gaps = 41/320 (12%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
           +L  +D + I  +G G+GG+V  VQHK +G   A K+I + ++ + R QI +EL++    
Sbjct: 64  ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 123

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             PY+V  Y +FYS+G ISI +E+MDGGSL   LK+ K IPEE L  +   VL+GL YL 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 183

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 184 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 241

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQ-----------DG----------WT----- 270
           Y  +SDIWS+GL L+E + G++P  PP+ +           DG          W      
Sbjct: 242 YSVQSDIWSMGLSLVELSIGRYPIPPPDSKELEAIFGRPVVDGAEGESHSVSPWARPPGR 301

Query: 271 -------------SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
                        + +EL++ IV++PPP  P+  F+ +F  F++ C+ K P +R   + L
Sbjct: 302 PISGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTQDFQEFVNKCLIKNPAERADLKML 361

Query: 318 MTHPFLKMYGDLNVDLSEYF 337
           M H F+K      VD + + 
Sbjct: 362 MNHTFIKRSEVEEVDFAGWL 381

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	353
225444840	354	PREDICTED: mitogen-activated protein kin	0.929	0.926	0.847	1e-167
224142910	364	predicted protein [Populus trichocarpa]	0.929	0.901	0.838	1e-165
7682432	357	MAP kinase kinase [Nicotiana tabacum]	0.963	0.952	0.771	1e-158
267881840	354	mitogen-activated protein kinase kinase	0.929	0.926	0.798	1e-158
42601214	354	mitogen-activated protein kinase kinase	0.929	0.926	0.810	1e-158
51471926	357	MAPKK [Solanum lycopersicum]	0.963	0.952	0.763	1e-157
350536161	357	MAP kinase kinase [Solanum lycopersicum]	0.963	0.952	0.763	1e-157
449452534	355	PREDICTED: mitogen-activated protein kin	0.929	0.923	0.795	1e-156
449525237	355	PREDICTED: LOW QUALITY PROTEIN: mitogen-	0.929	0.923	0.795	1e-156
315258241	331	MAP kinase kinase, partial [Nicotiana at	0.934	0.996	0.782	1e-155

>gi|225444840|ref|XP_002280877.1| PREDICTED: mitogen-activated protein kinase kinase 2 [Vitis vinifera] gi|37625027|gb|AAQ96337.1| putative mitogen-activated protein kinase kinase [Vitis aestivalis] gi|297738625|emb|CBI27870.3| unnamed protein product [Vitis vinifera]

 Score =  593 bits (1530), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 278/328 (84%), Positives = 301/328 (91%)

Query: 20  TKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQL 79
           T+SGTFMDGDLLVN+DGVRIVS++E E PPLIKPSDNQL+L DIDTIKV+GKG+GG VQL
Sbjct: 27  TQSGTFMDGDLLVNRDGVRIVSKSEAEVPPLIKPSDNQLSLADIDTIKVIGKGAGGTVQL 86

Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           VQHKWTGQFFALKVIQMN++E+A + IAQELKINQSSQCPYVVVCY+SFY NGA SIILE
Sbjct: 87  VQHKWTGQFFALKVIQMNIQEAALKHIAQELKINQSSQCPYVVVCYKSFYDNGAFSIILE 146

Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           YMDGGSL DFLKKVK+IPE YLAAIC QVLKGL YLHHE+HIIHRDLKPSNLLINHRGEV
Sbjct: 147 YMDGGSLLDFLKKVKSIPEPYLAAICNQVLKGLSYLHHERHIIHRDLKPSNLLINHRGEV 206

Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           KITDFGVSAI+ STSGQANTFVGTYNYMSPERISGGKYG KSDIWSLGLVLLECATGQFP
Sbjct: 207 KITDFGVSAILTSTSGQANTFVGTYNYMSPERISGGKYGSKSDIWSLGLVLLECATGQFP 266

Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           YSPPEQ +GWTSFYELMEAIVDQPPP A ++QFS EFCSFISAC+QK+P  R SA ELM 
Sbjct: 267 YSPPEQGEGWTSFYELMEAIVDQPPPCASTNQFSAEFCSFISACIQKDPNDRKSAHELMA 326

Query: 320 HPFLKMYGDLNVDLSEYFTDAGSPLATL 347
           HPF+ MY DLNVDL+ YFT+AGSPLAT 
Sbjct: 327 HPFISMYRDLNVDLATYFTNAGSPLATF 354

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224142910|ref|XP_002324775.1| predicted protein [Populus trichocarpa] gi|222866209|gb|EEF03340.1| predicted protein [Populus trichocarpa]

 Score =  587 bits (1514), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 275/328 (83%), Positives = 300/328 (91%)

Query: 20  TKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQL 79
           T+SGTF DGDLLVN+DGVR+VSQTE+E PP I PSDNQL+L D+D +KV+GKGS GIVQL
Sbjct: 29  TQSGTFKDGDLLVNRDGVRVVSQTESEPPPPITPSDNQLSLADMDMVKVIGKGSSGIVQL 88

Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           VQHKWT QFFALKVIQMN+EE AR+ IAQELKINQSSQCPYVV+ YQSFY NGAISIILE
Sbjct: 89  VQHKWTSQFFALKVIQMNIEEPARKAIAQELKINQSSQCPYVVMSYQSFYDNGAISIILE 148

Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           YMDGGSLADFLK VKTIPE YLAAIC+QVLKGLLYLHHEKHIIHRDLKPSNLL+NHRGEV
Sbjct: 149 YMDGGSLADFLKSVKTIPEPYLAAICKQVLKGLLYLHHEKHIIHRDLKPSNLLVNHRGEV 208

Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           KITDFGVSAIM STSGQAN+FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP
Sbjct: 209 KITDFGVSAIMQSTSGQANSFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268

Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           +SPPE  +GWT+ YELMEAIVD PPPSA SD FSPEFCSFISACVQK+P+ R +A ELM 
Sbjct: 269 FSPPELDEGWTNVYELMEAIVDHPPPSASSDHFSPEFCSFISACVQKDPKDRQAAHELMA 328

Query: 320 HPFLKMYGDLNVDLSEYFTDAGSPLATL 347
           HPF+ +Y DL+VDL+ YFT+AGSPLATL
Sbjct: 329 HPFMNLYEDLHVDLATYFTNAGSPLATL 356

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7682432|gb|AAF67262.1|AF165186_1 MAP kinase kinase [Nicotiana tabacum]

 Score =  563 bits (1451), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 267/346 (77%), Positives = 298/346 (86%), Gaps = 6/346 (1%)

Query: 5   ETVRLPNFLPMNFSRTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDID 64
           + V L  FL      T+SGTF DGDLLVN+DGVRIVSQ+E EAP +I+PSDNQL L D +
Sbjct: 18  DEVNLSKFL------TESGTFKDGDLLVNRDGVRIVSQSEVEAPSVIQPSDNQLCLADFE 71

Query: 65  TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVC 124
            +KV+GKG+GGIV+LVQHKWTGQFFALK IQMN+EES R+ IAQEL+INQSSQ PYVV+ 
Sbjct: 72  AVKVIGKGNGGIVRLVQHKWTGQFFALKAIQMNIEESMRKHIAQELRINQSSQVPYVVIS 131

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 184
           YQSF+ NGAISIILEYMDGGSLADFLKKVKTIPE YLAAIC+QVLKGL YLHHEKHIIHR
Sbjct: 132 YQSFFDNGAISIILEYMDGGSLADFLKKVKTIPERYLAAICKQVLKGLWYLHHEKHIIHR 191

Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 244
           DLKPSNLLINH G+VKITDFGVSA++ASTSG ANTFVGTYNYMSPERI GG YGY+SDIW
Sbjct: 192 DLKPSNLLINHIGDVKITDFGVSAVLASTSGLANTFVGTYNYMSPERILGGAYGYRSDIW 251

Query: 245 SLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
           SLGLVLLECATG FPYSPP+  +GW + YELME IVDQP PSAP DQFSP+FCSFISACV
Sbjct: 252 SLGLVLLECATGVFPYSPPQADEGWVNVYELMETIVDQPAPSAPPDQFSPQFCSFISACV 311

Query: 305 QKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNL 350
           QK+ + RLSA ELM HPF+ MY DL++DL  YFT AG PLATL+ L
Sbjct: 312 QKDQKDRLSANELMRHPFITMYDDLDIDLGSYFTSAGPPLATLTEL 357

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|267881840|gb|ACY82515.1| mitogen-activated protein kinase kinase [Malus x domestica]

 Score =  563 bits (1450), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 262/328 (79%), Positives = 293/328 (89%)

Query: 20  TKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQL 79
           T+SGTFMDGDLLVN++GVRIVS  E E PP I+ SDNQ+ L D+D IKV+GKG+GG+VQL
Sbjct: 27  TQSGTFMDGDLLVNREGVRIVSHREVEVPPPIQASDNQMILADLDAIKVIGKGNGGVVQL 86

Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           VQHKWT QFFALKVIQMN+EES R+QIAQELKI+QSSQCP +VVCYQSFY NGAISIILE
Sbjct: 87  VQHKWTHQFFALKVIQMNIEESIRKQIAQELKIDQSSQCPNIVVCYQSFYENGAISIILE 146

Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           YMDGGSLAD LKKVKTIPE YLAAIC+QVL+GL YLHHEKHIIHRD KPSNLLINHRGE+
Sbjct: 147 YMDGGSLADLLKKVKTIPEFYLAAICKQVLQGLCYLHHEKHIIHRDFKPSNLLINHRGEI 206

Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           KITDFGVSAI ASTS QANTFVGTYNYMSPERI G  Y YKSDIWSLGLVLLECATGQFP
Sbjct: 207 KITDFGVSAIKASTSEQANTFVGTYNYMSPERIVGSNYSYKSDIWSLGLVLLECATGQFP 266

Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           Y+PP+Q + W +F+ELM AIV+QPP  APSDQFSPEFCSFISACVQK+P+ RLSAQ+L+ 
Sbjct: 267 YTPPDQSEAWDNFFELMSAIVEQPPSCAPSDQFSPEFCSFISACVQKDPKDRLSAQDLLR 326

Query: 320 HPFLKMYGDLNVDLSEYFTDAGSPLATL 347
           HPF+ MY D+++DLS YFT+AGSPLAT 
Sbjct: 327 HPFISMYDDVHIDLSPYFTEAGSPLATF 354

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42601214|gb|AAS21304.1| mitogen-activated protein kinase kinase 2 [Petroselinum crispum]

 Score =  563 bits (1450), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 266/328 (81%), Positives = 298/328 (90%)

Query: 20  TKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQL 79
           T+SGTFMDGDLLVN+DGVRIVSQT+ +A P I+ +DNQL+L D D IKVVGKGSGGIV+L
Sbjct: 27  TQSGTFMDGDLLVNRDGVRIVSQTDVQAAPPIQATDNQLSLADFDAIKVVGKGSGGIVRL 86

Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           VQHKWTGQFFALKVIQMN++ESAR+QIAQELKINQSSQC  VVVCYQSFY NGAISIILE
Sbjct: 87  VQHKWTGQFFALKVIQMNIQESARKQIAQELKINQSSQCLNVVVCYQSFYDNGAISIILE 146

Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           YMDGGSLADFLK VK IPE YLAAI +QVLKGL YLHHEKHIIHRDLKPSNLLINHRGEV
Sbjct: 147 YMDGGSLADFLKIVKNIPEPYLAAIFKQVLKGLWYLHHEKHIIHRDLKPSNLLINHRGEV 206

Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           KITDFGVSAI+A+TSGQANTFVGTYNYMSPERISGG++GY SDIWSLGLVLLECATG FP
Sbjct: 207 KITDFGVSAILATTSGQANTFVGTYNYMSPERISGGQHGYSSDIWSLGLVLLECATGYFP 266

Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           YSPPEQ +GW++ +ELM+ IV+Q PP AP D+FSPEFCSF+SACVQK+P++R SA EL+ 
Sbjct: 267 YSPPEQDEGWSNVFELMDTIVNQAPPCAPPDEFSPEFCSFVSACVQKDPRKRPSANELLR 326

Query: 320 HPFLKMYGDLNVDLSEYFTDAGSPLATL 347
           HPF+ MY  LN+DL+ YFT+AGSPLATL
Sbjct: 327 HPFINMYEHLNIDLAGYFTEAGSPLATL 354

Source: Petroselinum crispum

Species: Petroselinum crispum

Genus: Petroselinum

Family: Apiaceae

Order: Apiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|51471926|gb|AAU04433.1| MAPKK [Solanum lycopersicum]

 Score =  561 bits (1446), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 264/346 (76%), Positives = 298/346 (86%), Gaps = 6/346 (1%)

Query: 5   ETVRLPNFLPMNFSRTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDID 64
           + V L  FL      T+SGTF DGDLLVN+DGVRIVSQ+E  AP +I+PSDNQL L D +
Sbjct: 18  DEVALSKFL------TESGTFKDGDLLVNRDGVRIVSQSEVAAPSVIQPSDNQLCLADFE 71

Query: 65  TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVC 124
            +KV+GKG+GGIV+LVQHKWTGQFFALKVIQMN++ES R+ IAQEL+INQSSQCPYVV+C
Sbjct: 72  AVKVIGKGNGGIVRLVQHKWTGQFFALKVIQMNIDESMRKHIAQELRINQSSQCPYVVIC 131

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 184
           YQSF+ NGAIS+ILEYMDGGSLADFLKKVKTIPE +LA IC+QVLKGL YLHHEKHIIHR
Sbjct: 132 YQSFFDNGAISLILEYMDGGSLADFLKKVKTIPERFLAVICKQVLKGLWYLHHEKHIIHR 191

Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 244
           DLKPSNLLINHRG+VKITDFGVSA++ASTSG ANTFVGTYNYMSPERISGG Y YKSDIW
Sbjct: 192 DLKPSNLLINHRGDVKITDFGVSAVLASTSGLANTFVGTYNYMSPERISGGAYDYKSDIW 251

Query: 245 SLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
           SLGLVLLECATG FPY+PPE  +GW + YELME IVDQP P AP DQFSP+FCSFISACV
Sbjct: 252 SLGLVLLECATGHFPYNPPEGDEGWVNVYELMETIVDQPEPCAPPDQFSPQFCSFISACV 311

Query: 305 QKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNL 350
           QK  + RLSA +LM+HPF+ MY D ++DL  YFT AG PLATL+ L
Sbjct: 312 QKHQKDRLSANDLMSHPFITMYDDQDIDLGSYFTSAGPPLATLTEL 357

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350536161|ref|NP_001234744.1| MAP kinase kinase [Solanum lycopersicum] gi|9843771|emb|CAA04261.2| MAP kinase kinase [Solanum lycopersicum]

 Score =  561 bits (1446), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 264/346 (76%), Positives = 297/346 (85%), Gaps = 6/346 (1%)

Query: 5   ETVRLPNFLPMNFSRTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDID 64
           + V L  FL      T+SGTF DGDLLVN+DGVRIVSQ+E  AP +I+PSDNQL L D +
Sbjct: 18  DEVALSKFL------TESGTFKDGDLLVNRDGVRIVSQSEVAAPSVIQPSDNQLCLADFE 71

Query: 65  TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVC 124
            +KV+GKG+GGIV+LVQHKWTGQFFALKVIQMN++ES R+ IAQEL+INQSSQCPYVV+C
Sbjct: 72  AVKVIGKGNGGIVRLVQHKWTGQFFALKVIQMNIDESMRKHIAQELRINQSSQCPYVVIC 131

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 184
           YQSF+ NGAIS+ILEYMDGGSLADFLKKVKTIPE +LA IC+QVLKGL YLHHEKHIIHR
Sbjct: 132 YQSFFDNGAISLILEYMDGGSLADFLKKVKTIPERFLAVICKQVLKGLWYLHHEKHIIHR 191

Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 244
           DLKPSNLLINHRG+VKITDFGVSA++ASTSG ANTFVGTYNYMSPERISGG Y YKSDIW
Sbjct: 192 DLKPSNLLINHRGDVKITDFGVSAVLASTSGLANTFVGTYNYMSPERISGGAYDYKSDIW 251

Query: 245 SLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
           SLGLVLLECATG FPY PPE  +GW + YELME IVDQP P AP DQFSP+FCSFISACV
Sbjct: 252 SLGLVLLECATGHFPYKPPEGDEGWVNVYELMETIVDQPEPCAPPDQFSPQFCSFISACV 311

Query: 305 QKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNL 350
           QK  + RLSA +LM+HPF+ MY D ++DL  YFT AG PLATL+ L
Sbjct: 312 QKHQKDRLSANDLMSHPFITMYDDQDIDLGSYFTSAGPPLATLTEL 357

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452534|ref|XP_004144014.1| PREDICTED: mitogen-activated protein kinase kinase 2-like [Cucumis sativus]

 Score =  556 bits (1433), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 261/328 (79%), Positives = 291/328 (88%)

Query: 20  TKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQL 79
           T+SGTF DGDLLVN+DGVRIVSQ+E EAPP IKP+D+QL+L DID IKV+GKG+GG VQL
Sbjct: 28  TQSGTFKDGDLLVNRDGVRIVSQSEVEAPPPIKPTDDQLSLADIDIIKVIGKGNGGTVQL 87

Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           VQHKWT QFFALKVIQM +EES R+QIAQELKINQS+QCPYVVVCYQSFY NG+I IILE
Sbjct: 88  VQHKWTAQFFALKVIQMKIEESHRKQIAQELKINQSAQCPYVVVCYQSFYDNGSIYIILE 147

Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           YMDGGSLADFLKKVK I E YLAA+C+QVLKGL YLHHE+HIIHRDLKPSNLLINHRGEV
Sbjct: 148 YMDGGSLADFLKKVKKIEEPYLAALCKQVLKGLSYLHHERHIIHRDLKPSNLLINHRGEV 207

Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           KITDFGVSAIM +T  +ANTFVGTYNYMSPERI G  Y  KSDIWSLGL+LLECATG+FP
Sbjct: 208 KITDFGVSAIMENTYEEANTFVGTYNYMSPERIVGEGYDNKSDIWSLGLILLECATGKFP 267

Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           YSPP Q  GW +FYELMEAIV+  PPSAP+DQF+PEFCSFISACVQ +P+ RLSA+EL+ 
Sbjct: 268 YSPPGQDGGWVNFYELMEAIVEGEPPSAPADQFTPEFCSFISACVQTDPKNRLSARELLE 327

Query: 320 HPFLKMYGDLNVDLSEYFTDAGSPLATL 347
           HPF+KMY D ++DLS YF DAGSPLAT 
Sbjct: 328 HPFIKMYEDKDIDLSSYFNDAGSPLATF 355

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449525237|ref|XP_004169624.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase kinase 2-like [Cucumis sativus]

 Score =  556 bits (1432), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 261/328 (79%), Positives = 291/328 (88%)

Query: 20  TKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQL 79
           T+SGTF DGDLLVN+DGVRIVSQ+E EAPP IKP+D+QL+L DID IKV+GKG+GG VQL
Sbjct: 28  TQSGTFKDGDLLVNRDGVRIVSQSEVEAPPPIKPTDDQLSLADIDIIKVIGKGNGGTVQL 87

Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           VQHKWT QFFALKVIQM +EES R+QIAQELKINQS+QCPYVVVCYQSFY NG+I IILE
Sbjct: 88  VQHKWTAQFFALKVIQMKIEESHRKQIAQELKINQSAQCPYVVVCYQSFYDNGSIYIILE 147

Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           YMDGGSLADFLKKVK I E YLAA+C+QVLKGL YLHHE+HIIHRDLKPSNLLINHRGEV
Sbjct: 148 YMDGGSLADFLKKVKXIEEPYLAALCKQVLKGLSYLHHERHIIHRDLKPSNLLINHRGEV 207

Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           KITDFGVSAIM +T  +ANTFVGTYNYMSPERI G  Y  KSDIWSLGL+LLECATG+FP
Sbjct: 208 KITDFGVSAIMENTYEEANTFVGTYNYMSPERIVGEGYDNKSDIWSLGLILLECATGKFP 267

Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           YSPP Q  GW +FYELMEAIV+  PPSAP+DQF+PEFCSFISACVQ +P+ RLSA+EL+ 
Sbjct: 268 YSPPGQDGGWVNFYELMEAIVEGEPPSAPADQFTPEFCSFISACVQTDPKNRLSARELLE 327

Query: 320 HPFLKMYGDLNVDLSEYFTDAGSPLATL 347
           HPF+KMY D ++DLS YF DAGSPLAT 
Sbjct: 328 HPFIKMYEDKDIDLSSYFNDAGSPLATF 355

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|315258241|gb|ADT91699.1| MAP kinase kinase, partial [Nicotiana attenuata]

 Score =  553 bits (1426), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 263/336 (78%), Positives = 292/336 (86%), Gaps = 6/336 (1%)

Query: 5   ETVRLPNFLPMNFSRTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDID 64
           + V L  FL      T+SGTF DGDLLVN+DGVRIVSQ+E EAP +I+PSDNQL L D +
Sbjct: 2   DEVNLSKFL------TESGTFKDGDLLVNRDGVRIVSQSEVEAPSVIQPSDNQLCLADFE 55

Query: 65  TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVC 124
            +KV+GKG+GGIV+LVQHKWTGQFFALKVIQMN+EES R+ IAQEL+INQSSQCPYVVV 
Sbjct: 56  AVKVIGKGNGGIVRLVQHKWTGQFFALKVIQMNIEESMRKHIAQELRINQSSQCPYVVVS 115

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 184
           YQSF+ NGAISIILEYMDGGSLADFLKKVKTIPE YLAAIC+QVLKGL YLHHEKHIIHR
Sbjct: 116 YQSFFDNGAISIILEYMDGGSLADFLKKVKTIPERYLAAICKQVLKGLWYLHHEKHIIHR 175

Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 244
           DLKPSNLLINH G+VKITDFGVSA++ASTSG ANTFVGTYNYMSPERI GG YGY+SDIW
Sbjct: 176 DLKPSNLLINHIGDVKITDFGVSAVLASTSGLANTFVGTYNYMSPERILGGAYGYRSDIW 235

Query: 245 SLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
           SLGLVLLECATG FPYSPP+  +GW + YELME IVDQP PSAP DQFSP+FCSFISACV
Sbjct: 236 SLGLVLLECATGVFPYSPPQADEGWVNVYELMETIVDQPAPSAPPDQFSPQFCSFISACV 295

Query: 305 QKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 340
           QK+ + RLSA ELM HPF+ MY DL++DL  YFT A
Sbjct: 296 QKDQKDRLSANELMRHPFVTMYDDLDIDLGPYFTSA 331

Source: Nicotiana attenuata

Species: Nicotiana attenuata

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	353
TAIR|locus:2120855	354	MEK1 "MAP kinase/ ERK kinase 1	0.934	0.932	0.672	7.7e-119
TAIR|locus:2164981	356	MKK6 "MAP kinase kinase 6" [Ar	0.906	0.898	0.604	1.2e-106
DICTYBASE|DDB_G0269152	660	mekA "MAP kinase kinase (MAP2K	0.589	0.315	0.490	4.7e-71
TAIR|locus:2170578	520	MKK3 "AT5G40440" [Arabidopsis	0.730	0.496	0.462	2.5e-58
UNIPROTKB|F1PJI7	380	MAP2K1 "Uncharacterized protei	0.575	0.534	0.473	4.8e-58
UNIPROTKB|J9P5W6	393	MAP2K1 "Uncharacterized protei	0.575	0.516	0.473	4.8e-58
UNIPROTKB|Q0VD16	393	MAP2K1 "MAP2K1 protein" [Bos t	0.575	0.516	0.468	1.6e-57
UNIPROTKB|Q02750	393	MAP2K1 "Dual specificity mitog	0.575	0.516	0.468	1.6e-57
RGD|70495	393	Map2k1 "mitogen activated prot	0.575	0.516	0.468	2e-57
MGI|MGI:1346866	393	Map2k1 "mitogen-activated prot	0.575	0.516	0.468	2.6e-57

TAIR|locus:2120855 MEK1 "MAP kinase/ ERK kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1170 (416.9 bits), Expect = 7.7e-119, P = 7.7e-119
 Identities = 222/330 (67%), Positives = 264/330 (80%)

Query:    20 TKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTXXXXXXXXXXXXQL 79
             T+SGTF DGDL VNKDG++ VS +E  APP I+P DNQL+L D++             QL
Sbjct:    25 TQSGTFKDGDLRVNKDGIQTVSLSEPGAPPPIEPLDNQLSLADLEVIKVIGKGSSGNVQL 84

Query:    80 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
             V+HK T QFFALKVIQ+N EES  R I+QEL+IN SSQCPY+V CYQSFY NG +SIILE
Sbjct:    85 VKHKLTQQFFALKVIQLNTEESTCRAISQELRINLSSQCPYLVSCYQSFYHNGLVSIILE 144

Query:   140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
             +MDGGSLAD LKKV  +PE  L+AIC++VL+GL Y+HHE+ IIHRDLKPSNLLINHRGEV
Sbjct:   145 FMDGGSLADLLKKVGKVPENMLSAICKRVLRGLCYIHHERRIIHRDLKPSNLLINHRGEV 204

Query:   200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
             KITDFGVS I+ STS  AN+FVGTY YMSPERISG  Y  KSDIWSLGLVLLECATG+FP
Sbjct:   205 KITDFGVSKILTSTSSLANSFVGTYPYMSPERISGSLYSNKSDIWSLGLVLLECATGKFP 264

Query:   260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
             Y+PPE + GW+S YEL++AIV+ PPP APS+ FSPEFCSFIS CVQK+P+ R SA+EL+ 
Sbjct:   265 YTPPEHKKGWSSVYELVDAIVENPPPCAPSNLFSPEFCSFISQCVQKDPRDRKSAKELLE 324

Query:   320 HPFLKMYGDLNVDLSEYFTDAGSPLATLSN 349
             H F+KM+ D + +LS YFTDAGS +  L+N
Sbjct:   325 HKFVKMFEDSDTNLSAYFTDAGSLIPPLAN 354

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0042542 "response to hydrogen peroxide" evidence=IEP;IDA

GO:0000165 "MAPK cascade" evidence=IC;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA;IDA

GO:0009414 "response to water deprivation" evidence=IMP

GO:0009814 "defense response, incompatible interaction" evidence=IGI;RCA

GO:0000023 "maltose metabolic process" evidence=RCA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0019252 "starch biosynthetic process" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0009611 "response to wounding" evidence=IEP

TAIR|locus:2164981 MKK6 "MAP kinase kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1055 (376.4 bits), Expect = 1.2e-106, P = 1.2e-106
 Identities = 194/321 (60%), Positives = 247/321 (76%)

Query:    14 PMNFSRTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTXXXXXXXX 73
             P++   T SGTF DGD L+N+ G+R+ S  +       K  D ++  ED++T        
Sbjct:    21 PISSFLTASGTFHDGDFLLNQKGLRLTSDEKQSRQSDSKELDFEITAEDLETVKVIGKGS 80

Query:    74 XXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNG 132
                 QLV+HKW G+FFA+KVIQMN++E  R+QI QELKINQ SSQCP+VVVCY SFY NG
Sbjct:    81 GGVVQLVRHKWVGKFFAMKVIQMNIQEEIRKQIVQELKINQASSQCPHVVVCYHSFYHNG 140

Query:   133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
             A S++LEYMD GSLAD +++VKTI E YLA +C+QVL GL+YLH+E+H+IHRD+KPSNLL
Sbjct:   141 AFSLVLEYMDRGSLADVIRQVKTILEPYLAVVCKQVLLGLVYLHNERHVIHRDIKPSNLL 200

Query:   193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
             +NH+GEVKI+DFGVSA +AS+ GQ +TFVGTYNYMSPERISG  Y Y SDIWSLG+ +LE
Sbjct:   201 VNHKGEVKISDFGVSASLASSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGMSVLE 260

Query:   253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 312
             CA G+FPY   E Q    SFYEL+ AIV+ PPP+APSDQFSPEFCSF+SAC+QK+P  R 
Sbjct:   261 CAIGRFPYLESEDQQNPPSFYELLAAIVENPPPTAPSDQFSPEFCSFVSACIQKDPPARA 320

Query:   313 SAQELMTHPFLKMYGDLNVDL 333
             S+ +L++HPF+K + D ++DL
Sbjct:   321 SSLDLLSHPFIKKFEDKDIDL 341

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

DICTYBASE|DDB_G0269152 mekA "MAP kinase kinase (MAP2K)" [Dictyostelium discoideum (taxid:44689)]

 Score = 532 (192.3 bits), Expect = 4.7e-71, Sum P(3) = 4.7e-71
 Identities = 103/210 (49%), Positives = 141/210 (67%)

Query:    59 NLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC 118
             +L+D+              +L  H+ +G + ALKVI ++++E+ R+QI  ELK    +  
Sbjct:   288 DLKDLKIIRVLGRGAGGVVKLAYHETSGTYIALKVITLDIQENIRKQIILELKTLHKTSY 347

Query:   119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
             PY+V  Y +FY+ G+I I LE+M+ GSL+D +KK  TIPE  L  I  QVL+GL+YLH +
Sbjct:   348 PYIVSFYDAFYTEGSIFIALEFMELGSLSDIMKKTSTIPEPVLGKIAFQVLQGLVYLHRK 407

Query:   179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 238
              H+IHRD+KPSN+L+N++GE KI DFGVS  +  T  +A T+VGT  YMSPERISG  Y 
Sbjct:   408 LHLIHRDIKPSNILVNNKGEAKIADFGVSGQLQHTLSKAVTWVGTVTYMSPERISGRSYS 467

Query:   239 YKSDIWSLGLVLLECATGQFPYSP--PEQQ 266
             + S+IWSLGL +LECA G+FPY    P QQ
Sbjct:   468 FDSEIWSLGLTILECAIGKFPYGSNLPHQQ 497

GO:0030587 "sorocarp development" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0016020 "membrane" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0031152 "aggregation involved in sorocarp development" evidence=TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0006935 "chemotaxis" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2170578 MKK3 "AT5G40440" [Arabidopsis thaliana (taxid:3702)]

 Score = 599 (215.9 bits), Expect = 2.5e-58, P = 2.5e-58
 Identities = 124/268 (46%), Positives = 169/268 (63%)

Query:    87 QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ-SFYS--NGAISIILEYMDG 143
             +  ALK I +  E   R+Q+  E++    + C   +V +  +FYS  +G ISI LEYM+G
Sbjct:   107 RILALKKINI-FEREKRQQLLTEIRTLCEAPCHEGLVDFHGAFYSPDSGQISIALEYMNG 165

Query:   144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
             GSLAD LK  K IPE  L+++  ++L+GL YLH  +H++HRD+KP+NLLIN +GE KITD
Sbjct:   166 GSLADILKVTKKIPEPVLSSLFHKLLQGLSYLHGVRHLVHRDIKPANLLINLKGEPKITD 225

Query:   204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 263
             FG+SA + ++     TFVGT  YMSPERI    Y Y +DIWSLGL L EC TG+FPY   
Sbjct:   226 FGISAGLENSMAMCATFVGTVTYMSPERIRNDSYSYPADIWSLGLALFECGTGEFPYIAN 285

Query:   264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
             E          LM  I+D P P+ P  +FSPEFCSFI AC+QK+P  R +A +L++HPF+
Sbjct:   286 EGP------VNLMLQILDDPSPTPPKQEFSPEFCSFIDACLQKDPDARPTADQLLSHPFI 339

Query:   324 KMYGDLNVDLSEYFTDAGSPLATLSNLS 351
               +    VDL+ +      P   L +L+
Sbjct:   340 TKHEKERVDLATFVQSIFDPTQRLKDLA 367

GO:0000165 "MAPK cascade" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IEP

GO:0009866 "induced systemic resistance, ethylene mediated signaling pathway" evidence=IEP

GO:0009814 "defense response, incompatible interaction" evidence=IMP

GO:0004707 "MAP kinase activity" evidence=IDA

UNIPROTKB|F1PJI7 MAP2K1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 478 (173.3 bits), Expect = 4.8e-58, Sum P(2) = 4.8e-58
 Identities = 98/207 (47%), Positives = 136/207 (65%)

Query:    80 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
             V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct:    85 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 144

Query:   140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE 198
             +MDGGSL   LKK   IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE
Sbjct:   145 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGE 203

Query:   199 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 258
             +K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++
Sbjct:   204 IKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 261

Query:   259 PYSPPEQQDGWTSFYELMEAIVDQPPP 285
             P  PP+ ++    F   +E  V + PP
Sbjct:   262 PIPPPDAKELELMFGCQVEGDVAETPP 288

GO:0090398 "cellular senescence" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|J9P5W6 MAP2K1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 478 (173.3 bits), Expect = 4.8e-58, Sum P(2) = 4.8e-58
 Identities = 98/207 (47%), Positives = 136/207 (65%)

Query:    80 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
             V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct:    85 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 144

Query:   140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE 198
             +MDGGSL   LKK   IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE
Sbjct:   145 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGE 203

Query:   199 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 258
             +K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++
Sbjct:   204 IKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 261

Query:   259 PYSPPEQQDGWTSFYELMEAIVDQPPP 285
             P  PP+ ++    F   +E  V + PP
Sbjct:   262 PIPPPDAKELELMFGCQVEGDVAETPP 288

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q0VD16 MAP2K1 "MAP2K1 protein" [Bos taurus (taxid:9913)]

 Score = 474 (171.9 bits), Expect = 1.6e-57, Sum P(2) = 1.6e-57
 Identities = 97/207 (46%), Positives = 135/207 (65%)

Query:    80 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
             V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct:    85 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 144

Query:   140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE 198
             +MDGGSL   LKK   IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE
Sbjct:   145 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGE 203

Query:   199 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 258
             +K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++
Sbjct:   204 IKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 261

Query:   259 PYSPPEQQDGWTSFYELMEAIVDQPPP 285
             P  PP+ ++    F   +E    + PP
Sbjct:   262 PIPPPDAKELELMFGCQVEGDAAETPP 288

GO:0090398 "cellular senescence" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q02750 MAP2K1 "Dual specificity mitogen-activated protein kinase kinase 1" [Homo sapiens (taxid:9606)]

 Score = 474 (171.9 bits), Expect = 1.6e-57, Sum P(2) = 1.6e-57
 Identities = 97/207 (46%), Positives = 135/207 (65%)

Query:    80 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
             V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct:    85 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 144

Query:   140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE 198
             +MDGGSL   LKK   IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE
Sbjct:   145 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGE 203

Query:   199 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 258
             +K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++
Sbjct:   204 IKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 261

Query:   259 PYSPPEQQDGWTSFYELMEAIVDQPPP 285
             P  PP+ ++    F   +E    + PP
Sbjct:   262 PIPPPDAKELELMFGCQVEGDAAETPP 288

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005938 "cell cortex" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0008283 "cell proliferation" evidence=IEA

GO:0017016 "Ras GTPase binding" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030335 "positive regulation of cell migration" evidence=IEA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IEA

GO:0032320 "positive regulation of Ras GTPase activity" evidence=IEA

GO:0032402 "melanosome transport" evidence=IEA

GO:0032839 "dendrite cytoplasm" evidence=IEA

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=IEA

GO:0033267 "axon part" evidence=IEA

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=IEA

GO:0043204 "perikaryon" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=IEA

GO:0047496 "vesicle transport along microtubule" evidence=IEA

GO:0048313 "Golgi inheritance" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0048678 "response to axon injury" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0051291 "protein heterooligomerization" evidence=IEA

GO:0051384 "response to glucocorticoid stimulus" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0005816 "spindle pole body" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=TAS

GO:0005634 "nucleus" evidence=TAS

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=TAS

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0005739 "mitochondrion" evidence=TAS

GO:0005925 "focal adhesion" evidence=TAS

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=IDA

GO:0004708 "MAP kinase kinase activity" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IDA

GO:0004672 "protein kinase activity" evidence=TAS

GO:0006928 "cellular component movement" evidence=TAS

GO:0006935 "chemotaxis" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0000165 "MAPK cascade" evidence=TAS

GO:0000186 "activation of MAPKK activity" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007264 "small GTPase mediated signal transduction" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0051403 "stress-activated MAPK cascade" evidence=TAS

GO:0007050 "cell cycle arrest" evidence=IMP

GO:0008285 "negative regulation of cell proliferation" evidence=IDA

GO:0090398 "cellular senescence" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

RGD|70495 Map2k1 "mitogen activated protein kinase kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 473 (171.6 bits), Expect = 2.0e-57, Sum P(2) = 2.0e-57
 Identities = 97/207 (46%), Positives = 135/207 (65%)

Query:    80 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
             V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct:    85 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 144

Query:   140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE 198
             +MDGGSL   LKK   IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE
Sbjct:   145 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGE 203

Query:   199 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 258
             +K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++
Sbjct:   204 IKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 261

Query:   259 PYSPPEQQDGWTSFYELMEAIVDQPPP 285
             P  PP+ ++    F   +E    + PP
Sbjct:   262 PIPPPDAKELELLFGCQVEGDAAETPP 288

GO:0000165 "MAPK cascade" evidence=IMP

GO:0000187 "activation of MAPK activity" evidence=ISO;IDA;TAS

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IMP;IDA;TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA;ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IDA

GO:0005634 "nucleus" evidence=TAS

GO:0005737 "cytoplasm" evidence=ISO

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=IDA;TAS

GO:0005816 "spindle pole body" evidence=IEA

GO:0005829 "cytosol" evidence=IDA;TAS

GO:0005886 "plasma membrane" evidence=ISO;IDA

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISO;IDA;TAS

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0007050 "cell cycle arrest" evidence=IEA;ISO

GO:0007067 "mitosis" evidence=IDA

GO:0007243 "intracellular protein kinase cascade" evidence=TAS

GO:0008283 "cell proliferation" evidence=IDA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA;ISO

GO:0017016 "Ras GTPase binding" evidence=IPI

GO:0019901 "protein kinase binding" evidence=IPI

GO:0030182 "neuron differentiation" evidence=ISO;IMP

GO:0030216 "keratinocyte differentiation" evidence=IEA;ISO

GO:0030335 "positive regulation of cell migration" evidence=IMP

GO:0030425 "dendrite" evidence=IDA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IDA;IPI

GO:0032320 "positive regulation of Ras GTPase activity" evidence=IMP

GO:0032402 "melanosome transport" evidence=IDA

GO:0032839 "dendrite cytoplasm" evidence=IDA

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=IMP

GO:0033267 "axon part" evidence=IDA

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=IMP

GO:0043204 "perikaryon" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA;ISO

GO:0045597 "positive regulation of cell differentiation" evidence=IEA;ISO

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=IMP

GO:0047496 "vesicle transport along microtubule" evidence=IDA

GO:0048313 "Golgi inheritance" evidence=IMP

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0048678 "response to axon injury" evidence=IMP

GO:0048812 "neuron projection morphogenesis" evidence=IMP

GO:0048870 "cell motility" evidence=IEA;ISO

GO:0051291 "protein heterooligomerization" evidence=IPI

GO:0051384 "response to glucocorticoid stimulus" evidence=IDA

GO:0060674 "placenta blood vessel development" evidence=IEA;ISO

GO:0060711 "labyrinthine layer development" evidence=IEA;ISO

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0090398 "cellular senescence" evidence=IEA;ISO

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005874 "microtubule" evidence=IDA

MGI|MGI:1346866 Map2k1 "mitogen-activated protein kinase kinase 1" [Mus musculus (taxid:10090)]

 Score = 472 (171.2 bits), Expect = 2.6e-57, Sum P(2) = 2.6e-57
 Identities = 97/207 (46%), Positives = 135/207 (65%)

Query:    80 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
             V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct:    85 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 144

Query:   140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE 198
             +MDGGSL   LKK   IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE
Sbjct:   145 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGE 203

Query:   199 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 258
             +K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++
Sbjct:   204 IKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 261

Query:   259 PYSPPEQQDGWTSFYELMEAIVDQPPP 285
             P  PP+ ++    F   +E    + PP
Sbjct:   262 PIPPPDAKELELLFGCHVEGDAAETPP 288

GO:0000165 "MAPK cascade" evidence=ISO

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000187 "activation of MAPK activity" evidence=ISO;IMP;TAS

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IMP

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IMP

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=TAS

GO:0005737 "cytoplasm" evidence=IEA

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=ISO;TAS

GO:0005829 "cytosol" evidence=ISO;TAS

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005874 "microtubule" evidence=ISO

GO:0005886 "plasma membrane" evidence=ISO

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IMP

GO:0006979 "response to oxidative stress" evidence=ISO

GO:0007050 "cell cycle arrest" evidence=ISO

GO:0007067 "mitosis" evidence=ISO

GO:0008283 "cell proliferation" evidence=ISO

GO:0008285 "negative regulation of cell proliferation" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017016 "Ras GTPase binding" evidence=ISO

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030182 "neuron differentiation" evidence=ISO;IMP

GO:0030216 "keratinocyte differentiation" evidence=IMP

GO:0030335 "positive regulation of cell migration" evidence=ISO

GO:0030425 "dendrite" evidence=ISO

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=ISO

GO:0032320 "positive regulation of Ras GTPase activity" evidence=ISO

GO:0032402 "melanosome transport" evidence=ISO

GO:0032839 "dendrite cytoplasm" evidence=ISO

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=ISO

GO:0033267 "axon part" evidence=ISO

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=ISO

GO:0043204 "perikaryon" evidence=ISO

GO:0043539 "protein serine/threonine kinase activator activity" evidence=ISO

GO:0045597 "positive regulation of cell differentiation" evidence=IDA

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=ISO

GO:0047496 "vesicle transport along microtubule" evidence=ISO

GO:0048313 "Golgi inheritance" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0048678 "response to axon injury" evidence=ISO

GO:0048812 "neuron projection morphogenesis" evidence=ISO

GO:0048870 "cell motility" evidence=IMP

GO:0051291 "protein heterooligomerization" evidence=ISO

GO:0051384 "response to glucocorticoid stimulus" evidence=ISO

GO:0060674 "placenta blood vessel development" evidence=IMP

GO:0060711 "labyrinthine layer development" evidence=IMP

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0090398 "cellular senescence" evidence=ISO

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9S7U9	M2K2_ARATH	2, ., 7, ., 1, 2, ., 2	0.7387	0.9433	0.9173	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.12.2	0.991
3rd Layer	2.7.12	0.976
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	GSVIVG00016514001	SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (354 aa)
		(Vitis vinifera)
Predicted Functional Partners:
	GSVIVG00002553001	SubName- Full=Chromosome chr2 scaffold_132, whole genome shotgun sequence; (373 aa)			•			•		•	0.818
	GSVIVG00015318001	SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (563 aa)			•			•		•	0.815
	GSVIVG00026919001	SubName- Full=Putative uncharacterized protein (Chromosome chr15 scaffold_40, whole genome shot [...] (375 aa)			•			•		•	0.814
	GSVIVG00034702001	SubName- Full=Chromosome chr5 scaffold_72, whole genome shotgun sequence; (398 aa)			•			•		•	0.814
	GSVIVG00014559001	SubName- Full=Putative uncharacterized protein (Chromosome chr18 scaffold_1, whole genome shotg [...] (371 aa)			•			•		•	0.812
	GSVIVG00024447001	SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (371 aa)			•			•		•	0.811
	GSVIVG00024457001	SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (375 aa)			•			•		•	0.809
	GSVIVG00005840001	SubName- Full=Chromosome chr12 scaffold_159, whole genome shotgun sequence; (552 aa)						•		•	0.800

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	353
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-157
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-136
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-99
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-94
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-91
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-88
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-87
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-83
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-79
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-78
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-78
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-78
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-77
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-76
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-76
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-76
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-74
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-74
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-71
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-67
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-66
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-64
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-64
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-62
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-60
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-59
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-59
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-57
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-57
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-56
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-53
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-53
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-51
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-50
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-49
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-49
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-49
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-48
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-47
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-47
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-47
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-47
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-46
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-46
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-46
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-45
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-45
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-45
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-45
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-44
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-44
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-44
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-44
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-44
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-43
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-42
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-42
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-42
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-41
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-41
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-40
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-40
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-40
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-40
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-39
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-39
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-39
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-39
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-39
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-38
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-38
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-37
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-37
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-37
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-37
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-37
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-37
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-37
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-36
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-36
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-36
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-36
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-36
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-36
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-35
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-35
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-35
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-35
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-35
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-35
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-35
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-35
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-34
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-34
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-34
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-34
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-33
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-33
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-33
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-32
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-32
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-32
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-32
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-32
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-32
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-32
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-31
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-31
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-31
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-31
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-31
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-31
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-31
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-31
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-31
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-31
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-31
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-30
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-30
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-30
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-30
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-30
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-30
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-30
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-30
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-30
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-29
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-29
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-29
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-29
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-28
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-28
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-28
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-28
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-28
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-28
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-28
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-28
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-27
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-27
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-27
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-27
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-27
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-27
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-27
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-26
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-26
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-26
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-26
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-25
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-25
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-25
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-25
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-24
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-24
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-24
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-24
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-24
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-24
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-23
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-23
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-23
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-23
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-23
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-23
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-23
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-22
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-22
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-22
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-22
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-22
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-21
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-21
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-21
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-20
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-20
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-20
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-19
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-19
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-19
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-19
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-19
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-19
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-19
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-19
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-18
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-18
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-18
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-18
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-18
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-18
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-18
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-18
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	9e-18
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-16
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-16
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-16
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-16
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-16
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-15
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-12
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-09
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	1e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	9e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	6e-05
cd05145	190	cd05145, RIO1_like, RIO kinase family; RIO1, RIO3	7e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-04
cd05119	187	cd05119, RIO, RIO kinase family, catalytic domain	2e-04
cd05144	198	cd05144, RIO2_C, RIO kinase family; RIO2, C-termin	3e-04
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	3e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	6e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	7e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-04
COG1718	268	COG1718, RIO1, Serine/threonine protein kinase inv	0.003

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  440 bits (1135), Expect = e-157
 Identities = 159/266 (59%), Positives = 201/266 (75%), Gaps = 4/266 (1%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
            D++ +KV+G+GS G+V  V+HK TG+ +ALK I ++ +E  R+Q+ +ELK  +S + PY
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
           VV CY +FY  G ISI+LEYMDGGSLAD LKKV  IPE  LA I  Q+LKGL YLH ++H
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 240
           IIHRD+KPSNLLIN +GEVKI DFG+S ++ +T  Q NTFVGT  YMSPERI G  Y Y 
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 241 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           +DIWSLGL LLECA G+FP+ PP Q     SF+ELM+AI D PPPS P+++FSPEF  FI
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236

Query: 301 SACVQKEPQQRLSAQELMTHPFLKMY 326
           SAC+QK+P++R SA EL+ HPF+K  
Sbjct: 237 SACLQKDPKKRPSAAELLQHPFIKKA 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  387 bits (995), Expect = e-136
 Identities = 131/267 (49%), Positives = 182/267 (68%), Gaps = 5/267 (1%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
           +D++ +  +G G+ G+V  V H+ TG+  A+K I++ + E+ ++QI +EL I      PY
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK 179
           +V  Y +FY+NG ISI +EYMDGGSL   LK+V   IPE  L  I   VLKGL YLH + 
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
            IIHRD+KPSN+L+N RG++K+ DFGVS  +   +  A TFVGT +YM+PERI G  Y  
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 240 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 299
           KSDIWSLGL L+E ATG+FPY P    D     +EL++ IV++PPP  PS +FSP+F  F
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPE--NDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236

Query: 300 ISACVQKEPQQRLSAQELMTHPFLKMY 326
           ++ C+ K+P++R S +EL+ HPF+K Y
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  296 bits (759), Expect = 1e-99
 Identities = 125/305 (40%), Positives = 179/305 (58%), Gaps = 31/305 (10%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
           +D + +  +G G+GG+V  V H+ +G   A K+I + ++ + R QI +ELK+      PY
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
           +V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE  L  I   VL+GL YL  +  
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK 120

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 240
           I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYTVQ 178

Query: 241 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSF---------------------------- 272
           SDIWSLGL L+E A G++P  PP+ ++    F                            
Sbjct: 179 SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238

Query: 273 -YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 331
            +EL++ IV++PPP  PS  FS EF  F+  C++K P++R   +EL  HPF+K      V
Sbjct: 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEV 298

Query: 332 DLSEY 336
           D + +
Sbjct: 299 DFAGW 303

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  279 bits (716), Expect = 9e-94
 Identities = 97/261 (37%), Positives = 146/261 (55%), Gaps = 9/261 (3%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 123
           + ++ +G+GS G V L + K TG+  A+KVI+    +  R +I +E+KI +  + P +V 
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            Y  F     + +++EY +GG L D LKK   + E+       Q+L  L YL H K I+H
Sbjct: 62  LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL-HSKGIVH 120

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLKP N+L++  G VK+ DFG++  +     +  TFVGT  YM+PE + G  YG   DI
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV-DQPPPSAPSDQFSPEFCSFISA 302
           WSLG++L E  TG+ P+   +Q        EL + I   +PP   P    SPE    I  
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLL------ELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Query: 303 CVQKEPQQRLSAQELMTHPFL 323
            + K+P++RL+A+E + HPF 
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  275 bits (704), Expect = 2e-91
 Identities = 120/284 (42%), Positives = 174/284 (61%), Gaps = 7/284 (2%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
           L  ED++TI  +G G+GG V  V+H  TG   A KV+ +  + S R+QI +EL+I    +
Sbjct: 2   LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR 61

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
            PY+V  Y +F +   I + +E+MD GSL    KK   IP E L  I   V++GL YL++
Sbjct: 62  SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 237
              I+HRD+KPSN+L+N RG++K+ DFGVS  + ++   A+TFVGT  YMSPERI GGKY
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPERIQGGKY 179

Query: 238 GYKSDIWSLGLVLLECATGQFPYSPPEQ----QDGWTSFYELMEAIVDQPPPSAPSDQFS 293
             KSD+WSLG+ ++E A G+FP++        QD      +L++ IV +PPP  PS  F 
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239

Query: 294 PEFCSFISACVQKEPQQRLSAQELM-THPFLKMYGDLNVDLSEY 336
            +   F+ AC+ K+P +R + Q+L    PF++     NVDL  +
Sbjct: 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQAW 283

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  269 bits (688), Expect = 4e-88
 Identities = 128/288 (44%), Positives = 174/288 (60%), Gaps = 15/288 (5%)

Query: 41  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE 100
           S + + +           +L +++ +  +G G+GG V  V H+ TG+ +ALKVI  N E+
Sbjct: 54  SSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED 113

Query: 101 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY 160
           + RRQI +E++I +    P VV C+  F  NG I ++LE+MDGGS    L+      E++
Sbjct: 114 TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS----LEGTHIADEQF 169

Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 220
           LA +  Q+L G+ YL H +HI+HRD+KPSNLLIN    VKI DFGVS I+A T    N+ 
Sbjct: 170 LADVARQILSGIAYL-HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228

Query: 221 VGTYNYMSPERISG----GKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 275
           VGT  YMSPERI+     G Y GY  DIWSLG+ +LE   G+FP+    Q D W S   L
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WAS---L 284

Query: 276 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           M AI    PP AP+   S EF  FIS C+Q+EP +R SA +L+ HPF+
Sbjct: 285 MCAICMSQPPEAPATA-SREFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  263 bits (674), Expect = 2e-87
 Identities = 101/261 (38%), Positives = 158/261 (60%), Gaps = 12/261 (4%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 123
           + ++ +GKG  G V   +HK TG+  A+KVI++  +E  + +I  E++I +  + P +V 
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK-KEKIINEIQILKKCKHPNIVK 61

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
            Y S+     + I++E+  GGSL D LK   +T+ E  +A +C+++LKGL YLH    II
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH-SNGII 120

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           HRD+K +N+L+   GEVK+ DFG+SA ++ T    NT VGT  +M+PE I+G  Y YK+D
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDT-KARNTMVGTPYWMAPEVINGKPYDYKAD 179

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD-QFSPEFCSFIS 301
           IWSLG+  +E A G+ PYS            + +  I    PP   +  ++S EF  F+ 
Sbjct: 180 IWSLGITAIELAEGKPPYSELP-------PMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232

Query: 302 ACVQKEPQQRLSAQELMTHPF 322
            C+QK P++R +A++L+ HPF
Sbjct: 233 KCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  254 bits (650), Expect = 1e-83
 Identities = 87/261 (33%), Positives = 141/261 (54%), Gaps = 5/261 (1%)

Query: 65  TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVV 123
            ++ +G GS G V   +HK TG+  A+K+++  + +    +   +E++I +    P +V 
Sbjct: 3   LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
              +F     + +++EY +GG L D+L +   + E+    I  Q+L+GL YLH    IIH
Sbjct: 63  LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH-SNGIIH 121

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSD 242
           RDLKP N+L++  G VKI DFG++  +  +S    TFVGT  YM+PE + GG  YG K D
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVD 181

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
           +WSLG++L E  TG+ P+S     D       ++   +            S E    I  
Sbjct: 182 VWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL--EFDEPKWSSGSEEAKDLIKK 239

Query: 303 CVQKEPQQRLSAQELMTHPFL 323
           C+ K+P +R +A+E++ HP+ 
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  243 bits (621), Expect = 5e-79
 Identities = 118/273 (43%), Positives = 172/273 (63%), Gaps = 7/273 (2%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
           +DI   +++G G+GG V    H  T +  A+KVI +++    ++QI  EL+I      PY
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
           ++  Y +F+    ISI  E+MDGGSL D  +K   IPE  L  I   V+KGL YL   K 
Sbjct: 61  IIGFYGAFFVENRISICTEFMDGGSL-DVYRK---IPEHVLGRIAVAVVKGLTYLWSLK- 115

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 240
           I+HRD+KPSN+L+N RG+VK+ DFGVS  + ++   A T+VGT  YM+PERISG +YG  
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERISGEQYGIH 173

Query: 241 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           SD+WSLG+  +E A G+FPY   ++  G     +L++ IVD+ PP  P  QFS +F  FI
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233

Query: 301 SACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
           + C++K+P++R + + LM HPF+  Y D N ++
Sbjct: 234 TQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV 266

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  240 bits (614), Expect = 2e-78
 Identities = 106/268 (39%), Positives = 157/268 (58%), Gaps = 19/268 (7%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
           E  D ++ +G+GS G V    HK TGQ  A+KV+ +  +     +I +E+ I +    PY
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPY 59

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK 179
           +V  Y S++ N  + I++EY   GS++D +K   KT+ EE +AAI  Q LKGL YLH   
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH-SN 118

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
             IHRD+K  N+L+N  G+ K+ DFGVS  +  T  + NT +GT  +M+PE I    Y  
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 240 KSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSPE 295
           K+DIWSLG+  +E A G+ PYS   P +          +  I ++PPP  S P  ++SPE
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRA---------IFMIPNKPPPTLSDPE-KWSPE 228

Query: 296 FCSFISACVQKEPQQRLSAQELMTHPFL 323
           F  F+  C+ K+P++R SA +L+ HPF+
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  241 bits (616), Expect = 4e-78
 Identities = 118/287 (41%), Positives = 171/287 (59%), Gaps = 16/287 (5%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
           E I  +  +G+G+GG V   + K TG  FALK I  +     ++QI +EL+IN+S + PY
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 121 VVVCYQSFYSN--GAISIILEYMDGGSLADFLKKVKT----IPEEYLAAICEQVLKGLLY 174
           +V  Y +F      +I I +EY +GGSL    KKVK     I E+ L  I E VLKGL Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           LH  + IIHRD+KPSN+L+  +G+VK+ DFGVS  + ++   A TF GT  YM+PERI G
Sbjct: 121 LH-SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--LAGTFTGTSFYMAPERIQG 177

Query: 235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD---- 290
             Y   SD+WSLGL LLE A  +FP+ PPE +       EL+  IV+ P P    +    
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPF-PPEGEPPLGPI-ELLSYIVNMPNPELKDEPGNG 235

Query: 291 -QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY 336
            ++S EF  FI  C++K+P +R +  +++ HP++K      V+++++
Sbjct: 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAKF 282

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  238 bits (611), Expect = 9e-78
 Identities = 92/263 (34%), Positives = 142/263 (53%), Gaps = 14/263 (5%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCY 125
           +++G+GS G V L   K TG+  A+K +++    E     + +E++I  S Q P +V  Y
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 126 QSFYSNGA--ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            S        ++I LEY+ GGSL+  LKK   +PE  +     Q+L+GL YLH    I+H
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH-SNGIVH 124

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMAS--TSGQANTFVGTYNYMSPERISGGKYGYKS 241
           RD+K +N+L++  G VK+ DFG +  +    T     +  GT  +M+PE I G +YG  +
Sbjct: 125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAA 184

Query: 242 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV-DQPPPSAPSDQFSPEFCSFI 300
           DIWSLG  ++E ATG+ P+S              +  I     PP  P    S E   F+
Sbjct: 185 DIWSLGCTVIEMATGKPPWSELGNP------MAALYKIGSSGEPPEIPEH-LSEEAKDFL 237

Query: 301 SACVQKEPQQRLSAQELMTHPFL 323
             C++++P++R +A EL+ HPFL
Sbjct: 238 RKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  236 bits (605), Expect = 9e-77
 Identities = 107/263 (40%), Positives = 147/263 (55%), Gaps = 19/263 (7%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVC 124
           + +GKGS G V     K T Q  A+KVI  ++EE+      I QE++     + PY+   
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 184
           Y SF     + II+EY  GGS  D LK  K + E Y+A I  +VL GL YLH E  I HR
Sbjct: 65  YGSFLKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEGKI-HR 122

Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 244
           D+K +N+L++  G+VK+ DFGVS  + ST  + NTFVGT  +M+PE I    Y  K+DIW
Sbjct: 123 DIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIW 182

Query: 245 SLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA---IVDQPPPSAPSDQFSPEFCSFIS 301
           SLG+  +E A G+ P S              M     I    PPS   ++FS  F  F+S
Sbjct: 183 SLGITAIELAKGEPPLSD----------LHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVS 232

Query: 302 ACVQKEPQQRLSAQELMTHPFLK 324
            C+ K+P++R SA+EL+ H F+K
Sbjct: 233 LCLNKDPKERPSAKELLKHKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  238 bits (607), Expect = 2e-76
 Identities = 122/307 (39%), Positives = 179/307 (58%), Gaps = 41/307 (13%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
           +L  +D + I  +G G+GG+V  VQHK +G   A K+I + ++ + R QI +EL++    
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             PY+V  Y +FYS+G ISI +E+MDGGSL   LK+ K IPEE L  +   VL+GL YL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 178

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF------------------------ 272
           Y  +SDIWS+GL L+E A G++P  PP+ ++    F                        
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238

Query: 273 ---------------YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
                          +EL++ IV++PPP  P+  F+P+F  F++ C+ K P +R   + L
Sbjct: 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML 298

Query: 318 MTHPFLK 324
           M H F+K
Sbjct: 299 MNHTFIK 305

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  235 bits (602), Expect = 4e-76
 Identities = 113/289 (39%), Positives = 175/289 (60%), Gaps = 16/289 (5%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
           ++I+ +  +GKG+ G V  V H+ TG   A+K I++ ++ES   QI  EL I   +  PY
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60

Query: 121 VVVCYQSFYSNGAISIILEYMDGGS---LADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
           +V  Y +F+  GA+ + +EYMD GS   L       + IPE+ L  I   V+KGL +L  
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-- 235
           E +IIHRD+KP+N+L+N  G+VK+ DFGVS  + ++  + N  +G  +YM+PERI  G  
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGP 178

Query: 236 ----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 291
                Y  +SD+WSLGL +LE A G++PY PPE    + + +  + AIVD  PP+ PS  
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPY-PPET---YANIFAQLSAIVDGDPPTLPSG- 233

Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 340
           +S +   F++ C+ K P +R +  +L+ HP+L  Y + +VD++E+ T A
Sbjct: 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVTGA 282

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  236 bits (604), Expect = 6e-76
 Identities = 123/318 (38%), Positives = 180/318 (56%), Gaps = 39/318 (12%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
           +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL++    
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+KGL YL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 178

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF------------------------ 272
           Y  +SDIWS+GL L+E A G++P  PP+ ++    F                        
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238

Query: 273 -------------YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
                        +EL++ IV++PPP  PS  F  EF  F++ C+ K P +R   ++LM 
Sbjct: 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298

Query: 320 HPFLKMYGDLNVDLSEYF 337
           H F+K      VD + + 
Sbjct: 299 HAFIKRSEAEEVDFAGWL 316

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  230 bits (590), Expect = 1e-74
 Identities = 102/263 (38%), Positives = 148/263 (56%), Gaps = 14/263 (5%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVC 124
           IK +GKGS G V LV+ K  G+ + LK I + N+ E  R     E+KI +    P ++  
Sbjct: 5   IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKH 180
           Y+SF   G + I++EY DGG L+  +KK     K  PEE +     Q+   L YLH  + 
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-SRK 123

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 240
           I+HRD+KP N+ +   G VK+ DFG+S +++ST   A T VGT  Y+SPE      Y YK
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYK 183

Query: 241 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           SDIWSLG VL E  T + P+      +G  +  EL   I+    P  PS Q+S E  + +
Sbjct: 184 SDIWSLGCVLYELCTLKHPF------EG-ENLLELALKILKGQYPPIPS-QYSSELRNLV 235

Query: 301 SACVQKEPQQRLSAQELMTHPFL 323
           S+ +QK+P++R S  +++  PF+
Sbjct: 236 SSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  231 bits (591), Expect = 2e-74
 Identities = 99/277 (35%), Positives = 157/277 (56%), Gaps = 22/277 (7%)

Query: 53  PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI 112
           P +   NLE I      G+G+ G V     + TG+  A+K  +M + +  +  I  E+ I
Sbjct: 17  PRELYKNLEKI------GEGASGEVYKATDRATGKEVAIK--KMRLRKQNKELIINEILI 68

Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKG 171
            +  + P +V  Y S+     + +++EYMDGGSL D + +    + E  +A +C +VL+G
Sbjct: 69  MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQG 128

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           L YLH  +++IHRD+K  N+L++  G VK+ DFG +A +     + N+ VGT  +M+PE 
Sbjct: 129 LEYLH-SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEV 187

Query: 232 ISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGWTSFYELMEAIVDQ-PPPSAP 288
           I    YG K DIWSLG++ +E A G+ PY   PP +          +  I  +  PP   
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---------ALFLITTKGIPPLKN 238

Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 325
            +++SPEF  F++ C+ K+P++R SA+EL+ HPFLK 
Sbjct: 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  223 bits (569), Expect = 3e-71
 Identities = 107/286 (37%), Positives = 173/286 (60%), Gaps = 19/286 (6%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCP 119
           +D++ I+ +G+G+ G+V  ++H  TG   A+K I+  V    ++++  +L I+ +S  CP
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYL 175
           Y V  Y + +  G + I +E MD  SL  F KKV     TIPE+ L  I   ++K L YL
Sbjct: 61  YTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-VGTYNYMSPERISG 234
           H +  +IHRD+KPSN+LIN  G+VK+ DFG+S  +      A T   G   YM+PERI+ 
Sbjct: 120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPERINP 177

Query: 235 GK----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
                 Y  KSD+WSLG+ ++E ATG+FPY      D W + ++ ++ +V++P P  P++
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPY------DSWKTPFQQLKQVVEEPSPQLPAE 231

Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY 336
           +FSPEF  F++ C++K  ++R +  EL+ HPF +++   N D++ +
Sbjct: 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASF 277

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  211 bits (540), Expect = 1e-67
 Identities = 86/256 (33%), Positives = 130/256 (50%), Gaps = 44/256 (17%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 128
           +G+G  G V L + K TG+  A+K+I+     S   ++ +E++I +    P +V  Y  F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 129 YSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 187
                + +++EY +GGSL D LK+    + E+ +  I  Q+L+GL YL H   IIHRDLK
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYL-HSNGIIHRDLK 119

Query: 188 PSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWS 245
           P N+L++   G+VK+ DFG+S ++ S      T VGT  YM+PE + G G Y  KSDIWS
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 246 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 305
           LG++L E                                         PE    I   +Q
Sbjct: 180 LGVILYEL----------------------------------------PELKDLIRKMLQ 199

Query: 306 KEPQQRLSAQELMTHP 321
           K+P++R SA+E++ H 
Sbjct: 200 KDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  208 bits (531), Expect = 6e-66
 Identities = 93/263 (35%), Positives = 138/263 (52%), Gaps = 23/263 (8%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQ 126
           +GKGS G V LV+ K TG+ +A+KV+  +  ++         E  I      P++V  + 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 127 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGLLYLHHEKHII 182
           +F +   + ++LEY  GG L   L K     EE    Y A I       L YLH    II
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVL----ALEYLH-SLGII 115

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           +RDLKP N+L++  G +K+TDFG++  ++S   + NTF GT  Y++PE + G  YG   D
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVD 175

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
            WSLG++L E  TG+ P+   +++       E+ E I+   P   P    SPE    IS 
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRK-------EIYEKILKD-PLRFPEF-LSPEARDLISG 226

Query: 303 CVQKEPQQRL---SAQELMTHPF 322
            +QK+P +RL    A+E+  HPF
Sbjct: 227 LLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  206 bits (526), Expect = 1e-64
 Identities = 109/292 (37%), Positives = 168/292 (57%), Gaps = 25/292 (8%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQ 117
           L D++ +  +G G+ G V  ++ K TG   A+K ++   N EE+ R  I  +L +   S 
Sbjct: 14  LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKR--ILMDLDVVLKSH 71

Query: 118 -CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLY 174
            CPY+V CY  F ++  + I +E M   +  D L K     IPE+ L  +   ++K L Y
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129

Query: 175 LHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERI 232
           L  EKH +IHRD+KPSN+L++  G VK+ DFG+S  +     +A T   G   YM+PERI
Sbjct: 130 LK-EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAYMAPERI 186

Query: 233 ----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
                  KY  ++D+WSLG+ L+E ATGQFPY          + +E++  I+ + PPS P
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPY------KNCKTEFEVLTKILQEEPPSLP 240

Query: 289 SDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 339
            ++ FSP+FCSF+  C+ K+ ++R   +EL+ HPF++ Y    VD++ +F D
Sbjct: 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVAGWFQD 292

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  204 bits (522), Expect = 4e-64
 Identities = 108/294 (36%), Positives = 163/294 (55%), Gaps = 23/294 (7%)

Query: 59  NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK-INQSSQ 117
           +L+D+  I   G+G+ G V  + HK +G   A+K I+  V+E  ++++  +L  + +SS 
Sbjct: 5   DLKDLGEI---GRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSD 61

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGL 172
           CPY+V  Y + +  G   I +E MD  SL  F K V       IPEE L  I    +K L
Sbjct: 62  CPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 232
            YL  E  IIHRD+KPSN+L++  G +K+ DFG+S  +  +  +     G   YM+PERI
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERI 179

Query: 233 -SGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 289
               + GY  +SD+WSLG+ L E ATG+FPY        W S ++ +  +V   PP   +
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPY------PKWNSVFDQLTQVVKGDPPILSN 233

Query: 290 D---QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 340
               +FSP F +FI+ C+ K+  +R   +EL+ HPF+K Y + NVD++ Y    
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAYVQRI 287

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  197 bits (504), Expect = 8e-62
 Identities = 91/262 (34%), Positives = 139/262 (53%), Gaps = 20/262 (7%)

Query: 68  VVGKGSGGIVQLVQHKWTGQFFALK-VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 126
           ++G+G+ G+V    +  TG F A+K +    ++E A + I QE+ + ++ + P +V    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 127 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 186
           S  ++ ++ IILEY + GSL   +KK    PE  +A    QVL+GL YLH +  +IHRD+
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG-VIHRDI 125

Query: 187 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 246
           K +N+L    G VK+ DFGV+  +   S    + VGT  +M+PE I        SDIWSL
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSL 185

Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYEL-----MEAIVDQPPPSAPSDQFSPEFCSFIS 301
           G  ++E  TG  PY            Y+L     +  IV    P  P    SPE   F+ 
Sbjct: 186 GCTVIELLTGNPPY------------YDLNPMAALFRIVQDDHPPLPEG-ISPELKDFLM 232

Query: 302 ACVQKEPQQRLSAQELMTHPFL 323
            C QK+P  R +A++L+ HP++
Sbjct: 233 QCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  195 bits (498), Expect = 1e-60
 Identities = 92/275 (33%), Positives = 146/275 (53%), Gaps = 26/275 (9%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
            ED + I+ +G G+ G V   +   TG+  A+KVI++         I QE+ + +  + P
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKL-EPGDDFEIIQQEISMLKECRHP 60

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHE 178
            +V  + S+     + I++EY  GGSL D  +  +  + E  +A +C + LKGL YLH E
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH-E 119

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI---SGG 235
              IHRD+K +N+L+   G+VK+ DFGVSA + +T  +  +F+GT  +M+PE       G
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179

Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--MEAI------VDQPPPSA 287
            Y  K DIW+LG+  +E A  Q P             ++L  M A+         PP   
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPM------------FDLHPMRALFLISKSNFPPPKLK 227

Query: 288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
             +++SP F  FI  C+ K+P++R +A +L+ HPF
Sbjct: 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  193 bits (492), Expect = 1e-59
 Identities = 96/270 (35%), Positives = 155/270 (57%), Gaps = 13/270 (4%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS---SQCPYVV 122
           ++++G+G+ G V   +H  TG+  ALK+I ++  +     I +E+ +      SQ P + 
Sbjct: 6   LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
             Y S+     + II+EY +GGS+   L K   I E+Y++ I  +VL  L Y+H    +I
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKVG-VI 123

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKS 241
           HRD+K +N+L+ + G VK+ DFGV+A++   S + +TFVGT  +M+PE I+ GK Y  K+
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183

Query: 242 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 301
           DIWSLG+ + E ATG  PYS  +        +  M  I    PP    + +S     F++
Sbjct: 184 DIWSLGITIYEMATGNPPYSDVDA-------FRAMMLIPKSKPPRLEDNGYSKLLREFVA 236

Query: 302 ACVQKEPQQRLSAQELMTHPFLKMYGDLNV 331
           AC+ +EP++RLSA+EL+   ++K +    V
Sbjct: 237 ACLDEEPKERLSAEELLKSKWIKAHSKTPV 266

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  190 bits (486), Expect = 7e-59
 Identities = 99/280 (35%), Positives = 152/280 (54%), Gaps = 37/280 (13%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS-SQCPYVVVC 124
           ++V+G+G+ G V   +HK TGQ  A+K+  M++ E    +I +E  I +  S  P +   
Sbjct: 11  VEVIGEGTYGKVYKARHKKTGQLVAIKI--MDIIEDEEEEIKEEYNILRKYSNHPNIATF 68

Query: 125 YQSFYSNGA------ISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLY 174
           Y +F           + +++E   GGS+ D +K +    K + EE++A I  + L+GL Y
Sbjct: 69  YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           LH E  +IHRD+K  N+L+    EVK+ DFGVSA + ST G+ NTF+GT  +M+PE I+ 
Sbjct: 129 LH-ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIAC 187

Query: 235 GK-----YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA---IVDQPP 284
            +     Y  +SD+WSLG+  +E A G+ P     P            M A   I   PP
Sbjct: 188 DEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP------------MRALFKIPRNPP 235

Query: 285 PS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           P+    + +S +F  FIS C+ K  +QR   +EL+ HPF+
Sbjct: 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  186 bits (475), Expect = 4e-57
 Identities = 92/267 (34%), Positives = 147/267 (55%), Gaps = 18/267 (6%)

Query: 70  GKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY 129
           G G+ G V   QHK TG F A K+IQ+  EE     +  E+ I    + P +V  Y++++
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV-EIDILSECKHPNIVGLYEAYF 72

Query: 130 SNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
               + I++E+ DGG+L   + ++ + + E  +  +C Q+L+ L +LH    +IHRDLK 
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH-SHKVIHRDLKA 131

Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDI 243
            N+L+   G+VK+ DFGVSA   ST  + +TF+GT  +M+PE +         Y YK+DI
Sbjct: 132 GNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADI 191

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSPEFCSFIS 301
           WSLG+ L+E A  + P+          +   ++  I+   PP    PS ++S  F  F+ 
Sbjct: 192 WSLGITLIELAQMEPPHHE-------LNPMRVLLKILKSEPPTLDQPS-KWSSSFNDFLK 243

Query: 302 ACVQKEPQQRLSAQELMTHPFLKMYGD 328
           +C+ K+P  R +A EL+ HPF+    D
Sbjct: 244 SCLVKDPDDRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  186 bits (474), Expect = 5e-57
 Identities = 93/272 (34%), Positives = 151/272 (55%), Gaps = 17/272 (6%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCP 119
             +D    +G+GS GIV +   K TG+  A+K  +M++ +  RR++   E+ I +  Q P
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVK--KMDLRKQQRRELLFNEVVIMRDYQHP 76

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            +V  Y S+     + +++E+++GG+L D +   + + EE +A +C  VLK L +LH + 
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHAQG 135

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
            +IHRD+K  ++L+   G VK++DFG  A ++    +  + VGT  +M+PE IS   YG 
Sbjct: 136 -VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194

Query: 240 KSDIWSLGLVLLECATGQFPY--SPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEF 296
           + DIWSLG++++E   G+ PY   PP Q          M+ I D  PP      + SP  
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQA---------MKRIRDNLPPKLKNLHKVSPRL 245

Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
            SF+   + ++P QR +A EL+ HPFL   G 
Sbjct: 246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  183 bits (467), Expect = 4e-56
 Identities = 93/276 (33%), Positives = 145/276 (52%), Gaps = 24/276 (8%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
           +D + I+V+G G+  +V         +  A+K I +   +++  ++ +E++       P 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLK---KVKTIPEEYLAAICEQVLKGLLYLHH 177
           VV  Y SF     + +++ Y+ GGSL D +K       + E  +A + ++VLKGL YLH 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA----STSGQANTFVGTYNYMSPERIS 233
              I HRD+K  N+L+   G VKI DFGVSA +A     T     TFVGT  +M+PE + 
Sbjct: 121 NGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 234 GGK-YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
               Y +K+DIWS G+  +E ATG  PYS  PP          +++   +   PPS  + 
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPP---------MKVLMLTLQNDPPSLETG 230

Query: 291 ----QFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
               ++S  F   IS C+QK+P +R +A+EL+ H F
Sbjct: 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  177 bits (451), Expect = 1e-53
 Identities = 88/264 (33%), Positives = 148/264 (56%), Gaps = 16/264 (6%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-SARRQIAQELKINQSSQCPYVVVCYQS 127
           +G G+ G V    +  TG+  A+K I++   +    ++IA E+K+ +  + P +V  Y  
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 128 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 187
                 + I +EY  GG+L + L+  + + E  +     Q+L+GL YLH    I+HRD+K
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH-SHGIVHRDIK 126

Query: 188 PSNLLINHRGEVKITDFGVSAIMASTS----GQANTFVGTYNYMSPERISGGK---YGYK 240
           P+N+ ++H G +K+ DFG +  + + +     +  +  GT  YM+PE I+GGK   +G  
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRA 186

Query: 241 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP-SDQFSPEFCSF 299
           +DIWSLG V+LE ATG+ P+S  E  + +    ++M  +     P  P S Q SPE   F
Sbjct: 187 ADIWSLGCVVLEMATGKRPWS--ELDNEF----QIMFHVGAGHKPPIPDSLQLSPEGKDF 240

Query: 300 ISACVQKEPQQRLSAQELMTHPFL 323
           +  C++ +P++R +A EL+ HPF+
Sbjct: 241 LDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  175 bits (446), Expect = 5e-53
 Identities = 88/275 (32%), Positives = 141/275 (51%), Gaps = 23/275 (8%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKINQSSQC 118
           D + ++ +GKGS G V+ V+ K  G+    K I    M  +E  ++Q+  E+ I +  + 
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE--KQQLVSEVNILRELKH 58

Query: 119 PYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAICEQVLKGL 172
           P +V  Y      SN  + I++EY +GG LA  ++K K     I EE++  I  Q+L  L
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 173 LYLHHEKH----IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
              H+       ++HRDLKP+N+ ++    VK+ DFG++ I+   S  A T+VGT  YMS
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           PE+++   Y  KSDIWSLG ++ E        SPP       +  +L   I +      P
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCAL----SPPFTA---RNQLQLASKIKEGKFRRIP 231

Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
             ++S E    I + +  +P +R S +EL+  P +
Sbjct: 232 Y-RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  171 bits (434), Expect = 4e-51
 Identities = 97/260 (37%), Positives = 143/260 (55%), Gaps = 14/260 (5%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 128
           +GKGS G V       T +  A+K+I +   E     I QE+ +      PY+   Y S+
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 129 YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
                + II+EY+ GGS  D LK    + E Y+A I  ++LKGL YLH E+ I HRD+K 
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKI-HRDIKA 129

Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
           +N+L++ +G+VK+ DFGV+  +  T  + NTFVGT  +M+PE I    Y +K+DIWSLG+
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGI 189

Query: 249 VLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQK 306
             +E A G+ P S              M  +   P  S P+   Q+S  F  F+ AC+ K
Sbjct: 190 TAIELAKGEPPNSD----------LHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239

Query: 307 EPQQRLSAQELMTHPFLKMY 326
           +P+ R +A+EL+ H F+  Y
Sbjct: 240 DPRFRPTAKELLKHKFITRY 259

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  169 bits (430), Expect = 1e-50
 Identities = 91/262 (34%), Positives = 144/262 (54%), Gaps = 14/262 (5%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE----ESARRQIAQELKINQSSQCPYVV 122
           +++G GS G V    +   G FFA+K + +  +    + A +Q+ QE+ +    Q P +V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
               +      + I LE + GGSLA  LKK  + PE  +     Q+L GL YL H+++ +
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYL-HDRNTV 124

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKS 241
           HRD+K +N+L++  G VK+ DFG++  +      A +F G+  +M+PE I   G YG  +
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 242 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 301
           DIWSLG  +LE ATG+ P+S   Q +G  + +++  +    P P    D  S E   FI 
Sbjct: 184 DIWSLGCTVLEMATGKPPWS---QLEGVAAVFKIGRSKELPPIP----DHLSDEAKDFIL 236

Query: 302 ACVQKEPQQRLSAQELMTHPFL 323
            C+Q++P  R +A EL+ HPF+
Sbjct: 237 KCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  166 bits (423), Expect = 1e-49
 Identities = 84/263 (31%), Positives = 132/263 (50%), Gaps = 14/263 (5%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVV 123
           ++V+GKG+ G V +VQ + T + FA+K +  Q  VE+ + R +  E +I Q    P++V 
Sbjct: 5   LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAA-ICEQVLKGLLYLHHEKHII 182
            + SF     + ++++ + GG L   L +     EE +   ICE VL  L YLH  K II
Sbjct: 65  LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVL-ALEYLH-SKGII 122

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           HRD+KP N+L++ +G V ITDF + A   +      +  GT  YM+PE +    Y    D
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNI-ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVD 181

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
            WSLG+   EC  G+ PY                +   D   P+     +S E    I+ 
Sbjct: 182 WWSLGVTAYECLRGKRPY--RGHSRTIRDQIRAKQETADVLYPAT----WSTEAIDAINK 235

Query: 303 CVQKEPQQRLS--AQELMTHPFL 323
            ++++PQ+RL    ++L  HP+ 
Sbjct: 236 LLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  166 bits (424), Expect = 2e-49
 Identities = 81/300 (27%), Positives = 134/300 (44%), Gaps = 59/300 (19%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ------ 114
           +D    K++G+GS   V L + K T + +A+K++        +RQ+ +E K+        
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKE 53

Query: 115 ----SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
                +  P ++  Y +F     +  +LEY   G L  +++K  ++ E+       ++L 
Sbjct: 54  VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL 113

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---------------- 214
            L YLH  K IIHRDLKP N+L++    +KITDFG + ++   S                
Sbjct: 114 ALEYLH-SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 215 ----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 270
                +  +FVGT  Y+SPE ++    G  SD+W+LG ++ +  TG+ P+    +     
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----- 227

Query: 271 SFYELMEAIV----DQPPPSAPSDQFSPEFCSFISACVQKEPQQRL----SAQELMTHPF 322
             Y   + I+      PP       F P+    I   +  +PQ RL       EL  HPF
Sbjct: 228 --YLTFQKILKLEYSFPP------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  164 bits (418), Expect = 8e-49
 Identities = 75/261 (28%), Positives = 123/261 (47%), Gaps = 14/261 (5%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQ 126
           +G G  G V+LV+ K   + FALK ++    VE   +  I  E +I +    P++V  Y+
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 127 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 186
           +F     I +++EY  GG L   L+      E         V+    YLH+ + II+RDL
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDL 119

Query: 187 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 246
           KP NLL++  G VK+ DFG +  + S   +  TF GT  Y++PE I    Y +  D WSL
Sbjct: 120 KPENLLLDSNGYVKLVDFGFAKKLKS-GQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSL 178

Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G++L E  TG+ P+   ++        E+   I+         +         I   +++
Sbjct: 179 GILLYELLTGRPPFGEDDEDP-----MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233

Query: 307 EPQQRL-----SAQELMTHPF 322
            P++RL       +++  H +
Sbjct: 234 NPEERLGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  162 bits (413), Expect = 5e-48
 Identities = 88/276 (31%), Positives = 133/276 (48%), Gaps = 33/276 (11%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVI------QMNVEESARRQIAQELKINQSSQCPYVV 122
           + KG+ G V L + K TG  +A+KVI      + N  +    Q+  E  I   +Q PYVV
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD----QVLTERDILSQAQSPYVV 56

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
             Y SF     + +++EY+ GG LA  L+ V ++ E+       +++  L YLH    II
Sbjct: 57  KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG-II 115

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAI--------MASTSGQANTFVGTYNYMSPERISG 234
           HRDLKP N+LI+  G +K+TDFG+S +        +     +    VGT +Y++PE I G
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQF 292
             +    D WSLG +L E   G  P+     +       E+ + I+      P       
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------EIFQNILNGKIEWPEDVEV-- 226

Query: 293 SPEFCSFISACVQKEPQQRL---SAQELMTHPFLKM 325
           S E    IS  +  +P++RL   S +E+  HPF K 
Sbjct: 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  162 bits (410), Expect = 1e-47
 Identities = 96/277 (34%), Positives = 148/277 (53%), Gaps = 30/277 (10%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK-INQSSQCPYVV 122
           + ++VVG G+ G V   +H  TGQ  A+KV  M+V E    +I  E+  + + S    + 
Sbjct: 19  ELVEVVGNGTYGQVYKGRHVKTGQLAAIKV--MDVTEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 123 VCYQSFYS------NGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLY 174
             Y +F        +  + +++E+   GS+ D +K  K   + E+++A IC ++L+GL +
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS- 233
           LH    +IHRD+K  N+L+    EVK+ DFGVSA +  T G+ NTF+GT  +M+PE I+ 
Sbjct: 137 LH-AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 234 ----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA---IVDQPPPS 286
                  Y Y+SDIWSLG+  +E A G    +PP            M A   I   PPP 
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEG----APP------LCDMHPMRALFLIPRNPPPK 245

Query: 287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
             S ++S +F  FI  C+ K    R S ++L+ HPF+
Sbjct: 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  162 bits (411), Expect = 1e-47
 Identities = 95/276 (34%), Positives = 161/276 (58%), Gaps = 16/276 (5%)

Query: 50  LIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-Q 108
           ++   D +  LE+   IK+ G+GS GIV + + K +G+  A+K+  M++ +  RR++   
Sbjct: 13  VVDQGDPRSLLENY--IKI-GEGSTGIVCIAREKHSGRQVAVKM--MDLRKQQRRELLFN 67

Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 168
           E+ I +  Q   VV  Y+S+     + +++E++ GG+L D + + + + EE +A +CE V
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESV 126

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
           L+ L YLH +  +IHRD+K  ++L+   G VK++DFG  A ++    +  + VGT  +M+
Sbjct: 127 LQALCYLHSQG-VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 185

Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           PE IS   YG + DIWSLG++++E   G+ PY          S  + M+ + D PPP   
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-------DSPVQAMKRLRDSPPPKLK 238

Query: 289 -SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
            + + SP    F+   + +EPQ+R +AQEL+ HPFL
Sbjct: 239 NAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  164 bits (415), Expect = 3e-47
 Identities = 93/309 (30%), Positives = 147/309 (47%), Gaps = 30/309 (9%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQS-SQCPYVV 122
           ++ +G+GS G V L + +   +  ALKV+  ++  +     +  +E++I  S +  P +V
Sbjct: 5   LRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKK---VKTIPEEYLAAICEQVLKGLLYLHHEK 179
             Y  F   G++ +++EY+DGGSL D LKK      + E     I  Q+L  L YLH  K
Sbjct: 62  KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH-SK 120

Query: 180 HIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSG------QANTFVGTYNYMSPERI 232
            IIHRD+KP N+L++  G  VK+ DFG++ ++             +T VGT  YM+PE +
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 233 SG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 289
            G         SDIWSLG+ L E  TG  P+         ++  + ++ I++ P PS  S
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE---KNSSATSQTLKIILELPTPSLAS 237

Query: 290 D-------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGS 342
                     S      +   + K+P+ RLS+   ++H  L        DLS+      S
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297

Query: 343 PLATLSNLS 351
               LS   
Sbjct: 298 APLRLSLPP 306

Length = 384

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  159 bits (404), Expect = 9e-47
 Identities = 86/261 (32%), Positives = 131/261 (50%), Gaps = 12/261 (4%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQ 117
           L +    K +GKG   +V        G+  ALK +Q+   ++  AR+   +E+ + +   
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLL 173
            P V+    SF  N  ++I+LE  D G L+  +K  K     IPE  +     Q+   L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           ++H  K I+HRD+KP+N+ I   G VK+ D G+    +S +  A++ VGT  YMSPERI 
Sbjct: 121 HMH-SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
              Y +KSDIWSLG +L E A  Q P+      D   + Y L + I     P  P+D +S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDK-MNLYSLCKKIEKCDYPPLPADHYS 234

Query: 294 PEFCSFISACVQKEPQQRLSA 314
            E    +S C+  +P++R   
Sbjct: 235 EELRDLVSRCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  159 bits (403), Expect = 1e-46
 Identities = 96/255 (37%), Positives = 139/255 (54%), Gaps = 10/255 (3%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 128
           +GKGS G V       T Q  A+K+I +   E     I QE+ +      PYV   Y S+
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 129 YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
                + II+EY+ GGS  D L+      E  +A + +++LKGL YLH EK I HRD+K 
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKI-HRDIKA 129

Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
           +N+L++ +G+VK+ DFGV+  +  T  + NTFVGT  +M+PE I    Y  K+DIWSLG+
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGI 189

Query: 249 VLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 308
             +E A G+ P S             ++  I    PP+   + FS  F  FI AC+ K+P
Sbjct: 190 TAIELAKGEPPNSDMHPM-------RVLFLIPKNNPPTLTGE-FSKPFKEFIDACLNKDP 241

Query: 309 QQRLSAQELMTHPFL 323
             R +A+EL+ H F+
Sbjct: 242 SFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  157 bits (398), Expect = 6e-46
 Identities = 95/274 (34%), Positives = 149/274 (54%), Gaps = 24/274 (8%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK-INQSSQCPYVV 122
           + +++VG G+ G V   +H  TGQ  A+KV  M+V      +I QE+  + + S    + 
Sbjct: 9   ELVELVGNGTYGQVYKGRHVKTGQLAAIKV--MDVTGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 123 VCYQSFYS------NGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLY 174
             Y +F        +  + +++E+   GS+ D +K  K  T+ EE++A IC ++L+GL +
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS- 233
           LH  K +IHRD+K  N+L+    EVK+ DFGVSA +  T G+ NTF+GT  +M+PE I+ 
Sbjct: 127 LHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 234 ----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 289
                  Y +KSD+WSLG+  +E A G  P                +  I   P P   S
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFLIPRNPAPRLKS 238

Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
            ++S +F SFI +C+ K   QR + ++LM HPF+
Sbjct: 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  157 bits (400), Expect = 6e-46
 Identities = 90/278 (32%), Positives = 140/278 (50%), Gaps = 34/278 (12%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR-RQIAQ---ELKINQSS 116
           +D + IK +G GS G V LV+HK +G+++ALK+  ++  +  + +Q+     E +I QS 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI--LSKAKIVKLKQVEHVLNEKRILQSI 58

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGL 172
           + P++V  Y SF  +  + +++EY+ GG L   L+K    PE     Y A    QV+  L
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA----QVVLAL 114

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 232
            YLH    I++RDLKP NLL++  G +KITDFG +  +    G+  T  GT  Y++PE I
Sbjct: 115 EYLHS-LDIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYTLCGTPEYLAPEII 170

Query: 233 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL-MEAIVDQPPPSAPSDQ 291
               YG   D W+LG+++ E   G  P+            YE  +E  V  P        
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEKILEGKVRFPSF------ 220

Query: 292 FSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
           FSP+    I   +Q +  +RL        ++  HP+  
Sbjct: 221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  156 bits (396), Expect = 1e-45
 Identities = 83/263 (31%), Positives = 131/263 (49%), Gaps = 16/263 (6%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVC 124
           I+V+GKG+ G   L +          K + +  + E  RR    E+ I    Q P ++  
Sbjct: 5   IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 125 YQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
           Y  F  +  + I +EY +GG+L D +  +K +   EE +     Q++  + Y+H +  I+
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH-KAGIL 123

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           HRD+K  N+ +   G +K+ DFG+S I+ S    A T VGT  YMSPE   G KY +KSD
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSD 183

Query: 243 IWSLGLVLLE--CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           IW+LG VL E       F  + P           L+  IV Q   +     +S E  S +
Sbjct: 184 IWALGCVLYELLTLKRTFDATNP---------LNLVVKIV-QGNYTPVVSVYSSELISLV 233

Query: 301 SACVQKEPQQRLSAQELMTHPFL 323
            + +Q++P++R +A E++  P L
Sbjct: 234 HSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  156 bits (395), Expect = 1e-45
 Identities = 88/269 (32%), Positives = 143/269 (53%), Gaps = 20/269 (7%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQC 118
           D + +  +GKGS G+V  V  K   + +A+K  Q+++ +  RR+  +   E ++      
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMK--QIDLSKMNRREREEAIDEARVLAKLDS 58

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH 176
            Y++  Y+SF   G ++I++EY + G L   LK    + +PE+ +     Q+L GL +LH
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
            +K I+HRD+K  NL ++    VKI D GV+ +++  +  ANT VGT  Y+SPE      
Sbjct: 119 SKK-ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--PPPSAPSDQFSP 294
           Y  KSD+W+LG+VL EC TG+ P+    Q         L+  I+    PP S     +S 
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIRGVFPPVSQM---YSQ 227

Query: 295 EFCSFISACVQKEPQQRLSAQELMTHPFL 323
           +    I  C+ K+ +QR    +L+ +P L
Sbjct: 228 QLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  156 bits (396), Expect = 1e-45
 Identities = 95/258 (36%), Positives = 142/258 (55%), Gaps = 10/258 (3%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
           ++ +GKGS G V       T +  A+K+I +   E     I QE+ +      PYV   Y
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
            S+  +  + II+EY+ GGS  D L+    + E  +A I  ++LKGL YLH EK I HRD
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI-HRD 126

Query: 186 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWS 245
           +K +N+L++  GEVK+ DFGV+  +  T  + NTFVGT  +M+PE I    Y  K+DIWS
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 186

Query: 246 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 305
           LG+  +E A G+ P+S            +++  I    PP+   + +S     F+ AC+ 
Sbjct: 187 LGITAIELAKGEPPHSELHPM-------KVLFLIPKNNPPTLEGN-YSKPLKEFVEACLN 238

Query: 306 KEPQQRLSAQELMTHPFL 323
           KEP  R +A+EL+ H F+
Sbjct: 239 KEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  155 bits (392), Expect = 7e-45
 Identities = 96/282 (34%), Positives = 158/282 (56%), Gaps = 20/282 (7%)

Query: 50  LIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-Q 108
           ++ P D +   E +D+   +G+GS GIV +   K TG+  A+K  +M++ +  RR++   
Sbjct: 14  VVSPGDPR---EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVK--KMDLRKQQRRELLFN 68

Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 168
           E+ I +      VV  Y S+     + +++E+++GG+L D +   + + EE +A +C  V
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSV 127

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
           L+ L YLH++  +IHRD+K  ++L+   G +K++DFG  A ++    +  + VGT  +M+
Sbjct: 128 LRALSYLHNQG-VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186

Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGWTSFYELMEAIVDQPPPS 286
           PE IS   YG + DIWSLG++++E   G+ PY   PP Q          M  I D  PP 
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---------MRRIRDNLPPR 237

Query: 287 AP-SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 327
              S + S     F+   + +EP QR +AQEL+ HPFLK+ G
Sbjct: 238 VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  153 bits (389), Expect = 1e-44
 Identities = 90/268 (33%), Positives = 139/268 (51%), Gaps = 25/268 (9%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR----QIAQELKINQSSQCPYVV 122
           K++G+G+ G V L     TG+  A+K +  + +    +     +  E+++ ++ Q   +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
             Y     +  +SI +EYM GGS+ D LK    + E        Q+L+G+ YLH    I+
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH-SNMIV 126

Query: 183 HRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGKYG 238
           HRD+K +N+L +  G VK+ DFG S     I +S +G   +  GT  +MSPE ISG  YG
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM-KSVTGTPYWMSPEVISGEGYG 185

Query: 239 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA---IVDQPP-PSAPSDQFSP 294
            K+D+WS+G  ++E  T +    PP     W  F E M A   I  QP  P  PS   SP
Sbjct: 186 RKADVWSVGCTVVEMLTEK----PP-----WAEF-EAMAAIFKIATQPTNPQLPSH-VSP 234

Query: 295 EFCSFISACVQKEPQQRLSAQELMTHPF 322
           +  +F+     +  ++R SA+EL+ H F
Sbjct: 235 DARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  152 bits (386), Expect = 2e-44
 Identities = 89/267 (33%), Positives = 138/267 (51%), Gaps = 16/267 (5%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPY 120
           D   +K +GKGS G V  V+     QF+ALK + +       R+ A  E++I  S   P 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAICEQVLKGLLYLH 176
           ++   ++F     + I++EY   G L+  + K K     IPE+ +  I  Q+L+GL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
            +K I+HRDLK +N+L+     VKI D G+S ++      A T +GT +YM+PE   G  
Sbjct: 121 EQK-ILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQIGTPHYMAPEVWKGRP 177

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 296
           Y YKSDIWSLG +L E AT   P+     QD     Y++        PP      +S + 
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKVQRGKYPPIPPI-----YSQDL 229

Query: 297 CSFISACVQKEPQQRLSAQELMTHPFL 323
            +FI + +Q +P+ R +  +++  P +
Sbjct: 230 QNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  153 bits (387), Expect = 4e-44
 Identities = 96/282 (34%), Positives = 159/282 (56%), Gaps = 20/282 (7%)

Query: 50  LIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-Q 108
           ++ P D +  L++   IK+ G+GS GIV +   K +G+  A+K  +M++ +  RR++   
Sbjct: 12  VVDPGDPRTYLDNF--IKI-GEGSTGIVCIATVKSSGKLVAVK--KMDLRKQQRRELLFN 66

Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 168
           E+ I +  Q   VV  Y S+     + +++E+++GG+L D +   + + EE +AA+C  V
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAV 125

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
           LK L  LH +  +IHRD+K  ++L+ H G VK++DFG  A ++    +  + VGT  +M+
Sbjct: 126 LKALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184

Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGWTSFYELMEAIVDQPPPS 286
           PE IS   YG + DIWSLG++++E   G+ PY   PP          + M+ I D  PP 
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---------LKAMKMIRDNLPPK 235

Query: 287 APS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 327
             +  + SP    F+   + ++P QR +A EL+ HPFL   G
Sbjct: 236 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  154 bits (392), Expect = 4e-44
 Identities = 96/307 (31%), Positives = 146/307 (47%), Gaps = 61/307 (19%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR-QIA---QELKINQSS 116
           +D + IKV+G+G+ G V LV+ K TGQ +A+KV  +   +  +R QIA    E  I   +
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKV--LRKSDMIKRNQIAHVRAERDILADA 58

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGL 172
             P++V  Y SF     + +++EYM GG L + L +    PEE    Y+A +        
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV------- 111

Query: 173 LYLH--HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-------------- 216
           L L   H+   IHRD+KP N+LI+  G +K+ DFG+   M     +              
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 217 ---------------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS 261
                          AN+ VGT +Y++PE + G  YG + D WSLG++L E   G  P+ 
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231

Query: 262 PPEQQDGW---TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-SAQEL 317
               Q+ +    ++ E +       PP  P    SPE    I   +  +P+ RL S +E+
Sbjct: 232 SDTLQETYNKIINWKESLRF-----PPDPP---VSPEAIDLICRLLC-DPEDRLGSFEEI 282

Query: 318 MTHPFLK 324
            +HPF K
Sbjct: 283 KSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  152 bits (386), Expect = 5e-44
 Identities = 91/262 (34%), Positives = 143/262 (54%), Gaps = 14/262 (5%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 128
           +G G+ G V   ++K TG   A KVI+   EE     +  E++I  +   PY+V    +F
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-EIEILATCNHPYIVKLLGAF 78

Query: 129 YSNGAISIILEYMDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 187
           Y +G + I++E+  GG++ A  L+  + + E  +  IC Q+L+ L YLH  K IIHRDLK
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK-IIHRDLK 137

Query: 188 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSD 242
             N+L+   G++K+ DFGVSA    T  + ++F+GT  +M+PE +         Y YK+D
Sbjct: 138 AGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 197

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
           IWSLG+ L+E A       PP  +        L++    +PP  +   ++S EF  F+  
Sbjct: 198 IWSLGITLIEMAQ----IEPPHHE--LNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKT 251

Query: 303 CVQKEPQQRLSAQELMTHPFLK 324
            + K P+ R SA +L+ HPF+ 
Sbjct: 252 ALDKHPETRPSAAQLLEHPFVS 273

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  149 bits (377), Expect = 9e-43
 Identities = 77/251 (30%), Positives = 131/251 (52%), Gaps = 23/251 (9%)

Query: 85  TGQFFALKVI---------QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           TG   A+K +         Q  V E+ R++I    ++N     P+++    +   +   +
Sbjct: 24  TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH----PHIIRMLGATCEDSHFN 79

Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           + +E+M GGS++  L K     E  +    EQ+L+GL YLH E  IIHRD+K +NLLI+ 
Sbjct: 80  LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH-ENQIIHRDVKGANLLIDS 138

Query: 196 RGE-VKITDFGVSAIMASTSGQANTF----VGTYNYMSPERISGGKYGYKSDIWSLGLVL 250
            G+ ++I DFG +A +A+    A  F    +GT  +M+PE + G +YG   D+WS+G V+
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVI 198

Query: 251 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 310
           +E AT + P++  +  +     +++  A      PS P    SP        C++ +P+ 
Sbjct: 199 IEMATAKPPWNAEKHSNHLALIFKIASAT---TAPSIPE-HLSPGLRDVTLRCLELQPED 254

Query: 311 RLSAQELMTHP 321
           R  ++EL+ HP
Sbjct: 255 RPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  147 bits (373), Expect = 3e-42
 Identities = 88/269 (32%), Positives = 133/269 (49%), Gaps = 17/269 (6%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ---------IAQELKINQSSQ 117
           +++GKG+ G V L  +  TG+  A+K +++    + R           +  E++  +   
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
              +V       +   +SI LEY+ GGS+   L+      E+ +    EQVL+GL YLH 
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH- 125

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS--TSGQANTFVGTYNYMSPERISGG 235
            K I+HRDLK  NLL++  G  KI+DFG+S        + Q  +  G+  +M+PE I   
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 236 KYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
             GY  K DIWSLG V+LE   G+ P+S  E      + ++L       P P   S   S
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNKRSAPPIPPDVSMNLS 242

Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPF 322
           P    F++AC    P  R +A+EL+ HPF
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  148 bits (374), Expect = 4e-42
 Identities = 83/258 (32%), Positives = 146/258 (56%), Gaps = 11/258 (4%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQS 127
           +G+G+ G V       TGQ  A+K  QMN+++  +++ I  E+ + + ++ P +V    S
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIK--QMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 128 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 187
           +     + +++EY+ GGSL D + +   + E  +AA+C + L+ L +LH    +IHRD+K
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH-SNQVIHRDIK 142

Query: 188 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 247
             N+L+   G VK+TDFG  A +     + +T VGT  +M+PE ++   YG K DIWSLG
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 248 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 307
           ++ +E   G+ PY     ++   + Y +     +  P     ++ S  F  F++ C++ +
Sbjct: 203 IMAIEMVEGEPPYL---NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLEMD 256

Query: 308 PQQRLSAQELMTHPFLKM 325
            ++R SA+EL+ HPFLK+
Sbjct: 257 VEKRGSAKELLQHPFLKI 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  148 bits (374), Expect = 7e-42
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 21/262 (8%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVCYQ 126
           +G GS G V   +   T +  A+K +  + ++S  +   I +E++  Q  + P  +    
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 127 SFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLH-HEKHIIHR 184
            +       +++EY  G S +D L+   K + E  +AAIC   L+GL YLH HE+  IHR
Sbjct: 83  CYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER--IHR 139

Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGYKS 241
           D+K  N+L+   G VK+ DFG +++++     AN+FVGT  +M+PE I     G+Y  K 
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASLVSP----ANSFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 242 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 301
           D+WSLG+  +E A  + P       +  ++ Y     I     P+  S+ +S  F +F+ 
Sbjct: 196 DVWSLGITCIELAERKPPLF---NMNAMSALYH----IAQNDSPTLSSNDWSDYFRNFVD 248

Query: 302 ACVQKEPQQRLSAQELMTHPFL 323
           +C+QK PQ R S++EL+ H F+
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  146 bits (369), Expect = 2e-41
 Identities = 95/290 (32%), Positives = 149/290 (51%), Gaps = 17/290 (5%)

Query: 58  LNLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
           LN E+  + I  +G G+ G V   Q+K TG   A KVI    EE     +  E+ I  S 
Sbjct: 1   LNPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-EIDILASC 59

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYL 175
             P +V    +FY    + I++E+  GG++ A  L+  + + E  +  +C+Q L+ L YL
Sbjct: 60  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI--- 232
           H  K IIHRDLK  N+L    G++K+ DFGVSA    T  + ++F+GT  +M+PE +   
Sbjct: 120 HENK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 233 --SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
                 Y YK+D+WSLG+ L+E A       PP  +        L++    +PP  A   
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQ----IEPPHHE--LNPMRVLLKIAKSEPPTLAQPS 232

Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 340
           ++S EF  F+  C++K    R +  +L+ HPF+ +  + N  + E   +A
Sbjct: 233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV--NSNKPIRELIAEA 280

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  144 bits (366), Expect = 2e-41
 Identities = 89/265 (33%), Positives = 144/265 (54%), Gaps = 24/265 (9%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKINQSSQCPYVV 122
           I+VVG+G+ GIV L + K   +   +K I   QM  +E  R     E ++ +    P ++
Sbjct: 5   IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE--RLAAQNECQVLKLLSHPNII 62

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKH 180
             Y++F  + A+ I++EY  GG+LA++++K     + E+ +     Q+L  L ++H  K 
Sbjct: 63  EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH-TKL 121

Query: 181 IIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
           I+HRDLK  N+L++ H+  VKI DFG+S I++S S +A T VGT  Y+SPE   G  Y  
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKPYNQ 180

Query: 240 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--AP-SDQFSPEF 296
           KSDIW+LG VL E A+ +  +               + A+V +      AP SD++SP+ 
Sbjct: 181 KSDIWALGCVLYELASLKRAFEA-----------ANLPALVLKIMSGTFAPISDRYSPDL 229

Query: 297 CSFISACVQKEPQQRLSAQELMTHP 321
              I + +  +P +R    ++M  P
Sbjct: 230 RQLILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  143 bits (362), Expect = 1e-40
 Identities = 90/277 (32%), Positives = 141/277 (50%), Gaps = 40/277 (14%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQI----AQELKINQSSQCPYV 121
           +K + KG+ G V L + + TG +FA+KV++ + +  A+ Q+    A+   +    + PYV
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKS-DMIAKNQVTNVKAERAIMMIQGESPYV 59

Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
              Y SF S   + +++EY++GG  A  +K +  +PE++      +V+ G+  LH ++ I
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH-QRGI 118

Query: 182 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGGKYGYK 240
           IHRD+KP NLLI+  G +K+TDFG+S       G  N  FVGT +Y++PE I G      
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKM 173

Query: 241 SDIWSLGLVLLECATGQFPYSP--PEQ--------QDGWTSFYELMEAIVDQPPPSAPSD 290
           SD WSLG V+ E   G  P+    P+         +  W    +  E             
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVK--EFC----------- 220

Query: 291 QFSPEFCSFISACVQKEPQQRLSA---QELMTHPFLK 324
             SPE    I+  +  +P +RL A   QE+ +HPF K
Sbjct: 221 --SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  142 bits (360), Expect = 2e-40
 Identities = 84/262 (32%), Positives = 141/262 (53%), Gaps = 13/262 (4%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVC 124
           ++VVGKGS G V LV+H+  G+ + +K + + N     R+   QE ++    + P +V  
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 125 YQSFY-SNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
            +S+   +G + I++ + +GG L   LK  K K +PE  +     Q+   L YLH EKHI
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH-EKHI 123

Query: 182 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKS 241
           +HRDLK  N+ +     +K+ D G++ ++ +    A+T +GT  YMSPE  S   Y YKS
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKS 183

Query: 242 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 301
           D+W+LG  + E AT +  ++  +          L+  I++   P  P D +SPE    I+
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMN-------SLVYRIIEGKLPPMPKD-YSPELGELIA 235

Query: 302 ACVQKEPQQRLSAQELMTHPFL 323
             + K P++R S + ++  P++
Sbjct: 236 TMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  142 bits (359), Expect = 7e-40
 Identities = 83/258 (32%), Positives = 146/258 (56%), Gaps = 11/258 (4%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQS 127
           +G+G+ G V       TGQ  A+K  QMN+++  +++ I  E+ + + ++ P +V    S
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIK--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 128 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 187
           +     + +++EY+ GGSL D + +   + E  +AA+C + L+ L +LH  + +IHRD+K
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ-VIHRDIK 142

Query: 188 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 247
             N+L+   G VK+TDFG  A +     + +T VGT  +M+PE ++   YG K DIWSLG
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 248 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 307
           ++ +E   G+ PY     ++   + Y +     +  P     ++ S  F  F++ C++ +
Sbjct: 203 IMAIEMVEGEPPYL---NENPLRALYLIA---TNGTPELQNPERLSAVFRDFLNRCLEMD 256

Query: 308 PQQRLSAQELMTHPFLKM 325
             +R SA+EL+ HPFLK+
Sbjct: 257 VDRRGSAKELLQHPFLKL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  141 bits (357), Expect = 8e-40
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 42/275 (15%)

Query: 63  IDTIKVVGKGSGGIVQL----VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC 118
           +   K +G+G+ G V       +        A+K ++ +  E    +  +E +I +    
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 119 PYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLL 173
           P VV    VC +       + I++EYM+GG L  +L+K +  +    L +   Q+ +G+ 
Sbjct: 61  PNVVKLLGVCTEE----EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS------AIMASTSGQANTFVGTYNYM 227
           YL   K+ IHRDL   N L+     VKI+DFG+S             G+         +M
Sbjct: 117 YLE-SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-----PIRWM 170

Query: 228 SPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----Q 282
           +PE +  GK+  KSD+WS G++L E  T G+ PY          S  E++E + +     
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY-------PGMSNEEVLEYLKNGYRLP 223

Query: 283 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
            PP+ P     PE    +  C  ++P+ R +  EL
Sbjct: 224 QPPNCP-----PELYDLMLQCWAEDPEDRPTFSEL 253

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  141 bits (355), Expect = 2e-39
 Identities = 84/258 (32%), Positives = 146/258 (56%), Gaps = 11/258 (4%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQS 127
           +G+G+ G V       TGQ  A+K  Q+N+++  +++ I  E+ + +  + P +V    S
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIK--QINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 128 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 187
           F     + +++EY+ GGSL D + +   + E  +AA+C + L+ L +LH    +IHRD+K
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLH-ANQVIHRDIK 142

Query: 188 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 247
             N+L+   G VK+TDFG  A +     + +T VGT  +M+PE ++   YG K DIWSLG
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 248 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 307
           ++ +E   G+ PY     ++   + Y +     +  P     ++ SP F  F++ C++ +
Sbjct: 203 IMAIEMVEGEPPYL---NENPLRALYLIA---TNGTPELQNPEKLSPIFRDFLNRCLEMD 256

Query: 308 PQQRLSAQELMTHPFLKM 325
            ++R SA+EL+ HPFLK+
Sbjct: 257 VEKRGSAKELLQHPFLKL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  141 bits (357), Expect = 4e-39
 Identities = 82/270 (30%), Positives = 132/270 (48%), Gaps = 17/270 (6%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA--RRQIAQELKINQSSQCP 119
           D   +  VG+G  G V L + K TG+  ALK ++ ++       R +  E  I  +++  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGLLYL 175
           ++V    +F  +  + + +EY+ GG     L  +  + E+    Y+A + E V   L   
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV-DAL--- 117

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 235
            HE   IHRDLKP N LI+  G +K+TDFG+S  + +    AN+ VG+ +YM+PE + G 
Sbjct: 118 -HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGK 173

Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 295
            Y +  D WSLG +L E   G  P+S     + W +     E  + +P    P    S E
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-TLQRPVYDDPRFNLSDE 232

Query: 296 FCSFISACVQKEPQQRL-SAQELMTHPFLK 324
               I+  +  +P +R  S +++  HPF K
Sbjct: 233 AWDLITKLIN-DPSRRFGSLEDIKNHPFFK 261

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 6e-39
 Identities = 86/294 (29%), Positives = 137/294 (46%), Gaps = 51/294 (17%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIA--QELKINQSSQC 118
           ++ +G+G+ G+V   + K TG+  ALK I+++ EE     +A R+I+  +ELK       
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK------H 57

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHH 177
           P +V      ++   + ++ EY D   L  +L K    +    + +I  Q+L+GL Y H 
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH- 115

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVS-----AIMASTSGQANTFVGTYNYMSPERI 232
              I+HRDLKP N+LIN  G +K+ DFG++      +   T       V T  Y +PE +
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE-----VVTLWYRAPEIL 170

Query: 233 SGGK-YGYKSDIWSLGLVLLECATGQ--FPY---------------SPPEQQDGWTSFYE 274
            G K Y    DIWS+G +  E  TG+  FP                +P E+   W    +
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES--WPGVTK 228

Query: 275 LME--AIVDQPPPSAPSDQFS---PEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           L +      + PP           PE    +S  +Q  P +R+SA+E + HP+ 
Sbjct: 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  140 bits (353), Expect = 8e-39
 Identities = 87/267 (32%), Positives = 145/267 (54%), Gaps = 22/267 (8%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN---QSSQCPYVVV 123
           K++GKG+ G V LV+ K TG+++A+K+++  V   A+ ++A  L  N   Q+S+ P++  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
              SF ++  +  ++EY +GG L   L + +   E+       +++  L YLH EK++++
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLK  NL+++  G +KITDFG+            TF GT  Y++PE +    YG   D 
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFIS 301
           W LG+V+ E   G+ P+   + +      +E  LME I  + P +      SPE  S +S
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEI--RFPRT-----LSPEAKSLLS 228

Query: 302 ACVQKEPQQRL-----SAQELMTHPFL 323
             ++K+P+QRL      A+E+M H F 
Sbjct: 229 GLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  139 bits (352), Expect = 9e-39
 Identities = 95/290 (32%), Positives = 144/290 (49%), Gaps = 39/290 (13%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQC 118
           ED +TIK++  G+ G V LV+HK T Q FA+K I  Q  +  +  +Q+  E  I   ++ 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGLLY 174
           P+VV  + SF +   + +++EY++GG  A  LK +  +P +    Y A   E VL  L Y
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA---ETVL-ALEY 116

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI--MASTSG--------QANTFV--- 221
           LH+   I+HRDLKP NLLI   G +K+TDFG+S I  M+ T+             F+   
Sbjct: 117 LHNYG-IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 222 --GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGWTSFYELME 277
             GT  Y++PE I    YG   D W++G++L E   G  P+    PE+  G     ++  
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235

Query: 278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLK 324
              D+  P         +    IS  +++ P +RL    A E+  H F  
Sbjct: 236 PEGDEALP--------ADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 2e-38
 Identities = 82/289 (28%), Positives = 136/289 (47%), Gaps = 38/289 (13%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVC 124
           I  +G+G+ G V   ++K TG+  ALK I+M N +E       +E+K+ Q  + P +V  
Sbjct: 4   IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 125 YQSFYS--NGAISIILEYMDGGSLADFL--KKVK-TIPEEYLAAICEQVLKGLLYLHHEK 179
            +   S   G+I ++ EYMD   L   L   +VK T  +  +    +Q+L+GL YLH   
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQ--IKCYMKQLLEGLQYLHS-N 119

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-VGTYNYMSPERISGG-KY 237
            I+HRD+K SN+LIN+ G +K+ DFG++      +    T  V T  Y  PE + G  +Y
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY 179

Query: 238 GYKSDIWSLGLVLLECATGQFPY-----------------SPPEQQDGWTSFYELMEAIV 280
           G + D+WS+G +L E   G+  +                 SP ++   W    +L     
Sbjct: 180 GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN--WPGVSKLPWFEN 237

Query: 281 DQPPPSAPS---DQF----SPEFCSFISACVQKEPQQRLSAQELMTHPF 322
            +P         + F     P     +   +  +P++R+SA + + H +
Sbjct: 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  136 bits (345), Expect = 3e-38
 Identities = 77/276 (27%), Positives = 124/276 (44%), Gaps = 43/276 (15%)

Query: 63  IDTIKVVGKGSGGIV---QLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQSSQC 118
           +   K +G+G+ G V    L       +   A+K ++ +  E    +  +E +I +    
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 119 PYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGL 172
           P +V    VC +       + I++EYM GG L D+L+K   K +    L +   Q+ +G+
Sbjct: 61  PNIVKLLGVCTEE----EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS------AIMASTSGQANTFVGTYNY 226
            YL   K+ IHRDL   N L+     VKI+DFG+S             G+         +
Sbjct: 117 EYLE-SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-----PIRW 170

Query: 227 MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD---- 281
           M+PE +  GK+  KSD+WS G++L E  T G+ PY          S  E++E +      
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPG-------MSNAEVLEYLKKGYRL 223

Query: 282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
             PP+ P     PE    +  C  ++P+ R +  EL
Sbjct: 224 PKPPNCP-----PELYKLMLQCWAEDPEDRPTFSEL 254

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  135 bits (341), Expect = 3e-37
 Identities = 81/258 (31%), Positives = 145/258 (56%), Gaps = 11/258 (4%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQS 127
           +G+G+ G V       TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V    S
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 128 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 187
           +     + +++EY+ GGSL D + +   + E  +AA+C + L+ L +LH  + +IHRD+K
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIK 143

Query: 188 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 247
             N+L+   G VK+TDFG  A +     + +T VGT  +M+PE ++   YG K DIWSLG
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203

Query: 248 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 307
           ++ +E   G+ PY     ++   + Y +     +  P     ++ S  F  F++ C+  +
Sbjct: 204 IMAIEMIEGEPPYL---NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLDMD 257

Query: 308 PQQRLSAQELMTHPFLKM 325
            ++R SA+EL+ H FLK+
Sbjct: 258 VEKRGSAKELLQHQFLKI 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  134 bits (339), Expect = 3e-37
 Identities = 83/265 (31%), Positives = 137/265 (51%), Gaps = 9/265 (3%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
           ED + I+ +G G+ G V   ++  TG+  A+KVI++   E     + QE+ + +  +   
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA-VVQQEIIMMKDCKHSN 67

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
           +V  + S+     + I +E+  GGSL D       + E  +A +  + L+GL YLH  K 
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS-KG 126

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKY 237
            +HRD+K +N+L+   G VK+ DFGVSA + +T  +  +F+GT  +M+PE  +    G Y
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186

Query: 238 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 297
               DIW++G+  +E A  Q    PP           LM     QPP      ++S  F 
Sbjct: 187 NQLCDIWAVGITAIELAELQ----PPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242

Query: 298 SFISACVQKEPQQRLSAQELMTHPF 322
            F+   + K P++R +A++L+ HPF
Sbjct: 243 HFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  134 bits (339), Expect = 3e-37
 Identities = 70/257 (27%), Positives = 114/257 (44%), Gaps = 55/257 (21%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++ +  E  R+   +E ++ +    P VV    VC +       + ++LEYM+GG 
Sbjct: 27  AVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE----EEPLYLVLEYMEGGD 82

Query: 146 LADFLKKVK---------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           L D+L+K +         T+  + L +   Q+ KG+ YL   K  +HRDL   N L+   
Sbjct: 83  LLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA-SKKFVHRDLAARNCLVGED 141

Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNY-----------MSPERISGGKYGYKSDIWS 245
             VKI+DFG+S          + +   Y             M+PE +  G +  KSD+WS
Sbjct: 142 LVVKISDFGLS---------RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWS 192

Query: 246 LGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFI 300
            G++L E  T G  PY       G ++  E++E +        P   P      E    +
Sbjct: 193 FGVLLWEIFTLGATPYP------GLSNE-EVLEYLRKGYRLPKPEYCP-----DELYELM 240

Query: 301 SACVQKEPQQRLSAQEL 317
            +C Q +P+ R +  EL
Sbjct: 241 LSCWQLDPEDRPTFSEL 257

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  133 bits (337), Expect = 3e-37
 Identities = 84/260 (32%), Positives = 137/260 (52%), Gaps = 11/260 (4%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV 121
             + ++VVG+GS G   LVQH  + Q +A+K I++    SA     +E  +    + P +
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEK 179
           V   +SF ++G + I++EY DGG L   +K  + K  PE+ +     Q+  G+ ++H EK
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH-EK 119

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
            ++HRD+K  N+ +   G+VK+ DFG + ++ S    A T+VGT  Y+ PE      Y  
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179

Query: 240 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 299
           KSDIWSLG +L E  T + P+    Q + W +    +     +P PS     +S E  S 
Sbjct: 180 KSDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYKPLPS----HYSYELRSL 231

Query: 300 ISACVQKEPQQRLSAQELMT 319
           I    ++ P+ R SA  +++
Sbjct: 232 IKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  134 bits (340), Expect = 4e-37
 Identities = 83/281 (29%), Positives = 146/281 (51%), Gaps = 29/281 (10%)

Query: 62  DIDTIKVVGKGSGGIVQLVQH---KWTGQFFALKVI--------QMNVEES-ARRQIAQE 109
           + + ++V+G G+ G V LV+       G+ +A+KV+            E +   RQ+ + 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 110 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 169
           ++     +CP++V  + +F ++  + +IL+Y++GG L   L + +   E  +     +++
Sbjct: 61  VR-----RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIV 115

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMS 228
             L +LH    II+RD+K  N+L++  G V +TDFG+S    +    +A +F GT  YM+
Sbjct: 116 LALDHLHQLG-IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 229 PERISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 286
           PE I GG  G+    D WSLG++  E  TG  P++   +Q+   S  E+   I+   PP 
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKSKPPF 231

Query: 287 APSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLK 324
             +   S E   FI   ++K+P++RL    A E+  HPF +
Sbjct: 232 PKT--MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  133 bits (337), Expect = 6e-37
 Identities = 81/251 (32%), Positives = 129/251 (51%), Gaps = 12/251 (4%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVC 124
           K +G+G    V        G   ALK +Q+   ++  AR    +E+ + +    P V+  
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67

Query: 125 YQSFYSNGAISIILEYMDGGSLAD----FLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
           Y SF  +  ++I+LE  D G L+     F K+ + IPE+ +     Q+   L ++H  + 
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH-SRR 126

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 240
           ++HRD+KP+N+ I   G VK+ D G+    +S +  A++ VGT  YMSPERI    Y +K
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186

Query: 241 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           SDIWSLG +L E A  Q P+   +      + Y L + I     P  PSD +S E    +
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241

Query: 301 SACVQKEPQQR 311
           + C+  +P++R
Sbjct: 242 NMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  133 bits (338), Expect = 7e-37
 Identities = 78/288 (27%), Positives = 132/288 (45%), Gaps = 36/288 (12%)

Query: 65  TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVV 123
            +  +G+G+ G+V   + K TG+  A+K I++  E     + A +E+K+ +    P ++ 
Sbjct: 3   KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIK 62

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAICEQVLKGLLYLHHEK 179
               F   G + ++ E+MD     D  K +K     +PE  + +   Q+L+GL + H   
Sbjct: 63  LLDVFRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH--S 116

Query: 180 H-IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-Y 237
           H I+HRDLKP NLLIN  G +K+ DFG++    S       +V T  Y +PE + G K Y
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 238 GYKSDIWSLGLVLLECATGQ--FP--------------YSPPEQQDGWTSFYELMEAIV- 280
               DIWS+G +  E  + +  FP                 P+ +  W  F  L      
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV-WPKFTSLARNYKF 235

Query: 281 --DQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
              +         F   SP+    +S  +  +P +R++A++ + HP+ 
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  134 bits (338), Expect = 1e-36
 Identities = 78/311 (25%), Positives = 126/311 (40%), Gaps = 46/311 (14%)

Query: 68  VVGKG--SGGIVQLVQHKWTGQFFALKVIQMNVEESAR-RQIAQELKINQSSQCPYVVVC 124
           ++GK      IV L +HK T    A+K I ++       + + QE+  ++  Q P ++  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHII 182
             SF  +  + ++   M  GS  D LK      +PE  +A I + VL  L Y+H  K  I
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS-KGFI 123

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--------NYMSPE---- 230
           HR +K S++L++  G+V ++    S  M    G+    V  +         ++SPE    
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIK-HGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182

Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPYS-------------------------PPEQ 265
            + G  Y  KSDI+S+G+   E A G  P+                          P  +
Sbjct: 183 NLQG--YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240

Query: 266 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 325
                S                 +  FS  F  F+  C+Q++P+ R SA +L+ H F K 
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300

Query: 326 YGDLNVDLSEY 336
               N  L + 
Sbjct: 301 CKRRNTSLLDL 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  132 bits (333), Expect = 2e-36
 Identities = 84/265 (31%), Positives = 139/265 (52%), Gaps = 9/265 (3%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
            D + I+ VG G+ G V   ++  TG+  A+K+I++   +     I QE+ + +  +   
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS-LIQQEIFMVKECKHCN 67

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
           +V  + S+ S   + I +EY  GGSL D       + E  +A +C + L+GL YLH  K 
Sbjct: 68  IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH-SKG 126

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKY 237
            +HRD+K +N+L+   G+VK+ DFGV+A + +T  +  +F+GT  +M+PE  +    G Y
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186

Query: 238 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 297
               DIW++G+  +E A  Q    PP           LM     QPP      ++S  F 
Sbjct: 187 NQLCDIWAVGITAIELAELQ----PPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242

Query: 298 SFISACVQKEPQQRLSAQELMTHPF 322
           +F+   + K P++R +A+ L+TH F
Sbjct: 243 NFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  132 bits (335), Expect = 2e-36
 Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 33/283 (11%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCYQS 127
           +G+G+ GIV   + + TG+  ALK + +  +E     Q  +E+K  Q+ Q PYVV     
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 128 FYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 186
           F       +++EYM    L++ L+   + +PE  + +    +LKG+ Y+H    I+HRDL
Sbjct: 68  FPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG-IMHRDL 125

Query: 187 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-VGTYNYMSPERISGG-KYGYKSDIW 244
           KP+NLLI+  G +KI DFG++ + +    +  +  V T  Y +PE + G  KY    D+W
Sbjct: 126 KPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLW 185

Query: 245 SLGLVLLECATGQ--FPY---------------SPPEQQDGWTSFYEL--MEAIVDQPPP 285
           ++G +  E   G   FP                +P E+   W     L     I      
Sbjct: 186 AVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEET--WPGLTSLPDYNKITFPESK 243

Query: 286 SAPSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
             P ++  P+  S      +   +  +P +RLSA E + HP+ 
Sbjct: 244 PIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  131 bits (332), Expect = 4e-36
 Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 33/271 (12%)

Query: 63  IDTIKVVGKGSGGIVQLVQHKWTGQFF------ALKVIQMNVEESARRQIAQELKINQSS 116
           ++  K +G+G+ G V   +    G         A+K ++    E  R +  +E  I +  
Sbjct: 1   LELGKKLGEGAFGEV--YKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL 58

Query: 117 QCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKG 171
             P +V    VC Q       + I+ EYM GG L DFL+K    +  + L  +  Q+ KG
Sbjct: 59  SHPNIVRLLGVCTQG----EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTY---NYM 227
           + YL   K+ +HRDL   N L+     VKI+DFG+S  I      +     G      +M
Sbjct: 115 MEYL-ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWM 171

Query: 228 SPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 286
           +PE +  GK+  KSD+WS G++L E  T G+ PY       G ++  E++E + D     
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP------GMSN-EEVLELLEDGYRLP 224

Query: 287 APSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
            P +    E    +  C   +P+ R +  EL
Sbjct: 225 RP-ENCPDELYELMLQCWAYDPEDRPTFSEL 254

Length = 258

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  132 bits (335), Expect = 4e-36
 Identities = 76/266 (28%), Positives = 138/266 (51%), Gaps = 18/266 (6%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 123
           KV+GKGS G V L + K T + +A+KV++ +V   ++     + ++  +  + + P++  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            +  F +   +  ++EY++GG L   +++     E        +++ GL +LH E+ II+
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH-ERGIIY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLK  N+L++  G +KI DFG+           +TF GT +Y++PE +S   YG   D 
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDW 179

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
           W+LG++L E   GQ P+   + +D      EL ++I++           S E  S + + 
Sbjct: 180 WALGVLLYEMLAGQSPF-EGDDED------ELFQSILEDEVRYPRW--LSKEAKSILKSF 230

Query: 304 VQKEPQQRLSA-----QELMTHPFLK 324
           + K P++RL       Q++  HPF +
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 6e-36
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 53/304 (17%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCP 119
               IK++GKG  G V LV+ K TG+ FALKV+  +  ++ +  +++  E +I  +   P
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEE----YLAAICEQVLKGLL 173
           ++   Y SF +   + ++++Y  GG L   L++   K + EE    Y A    +VL  L 
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA----EVLLALE 117

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-------------------------- 207
           YLH    I++RDLKP N+L++  G + ++DF +S                          
Sbjct: 118 YLHLLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 208 ---AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 264
                    S ++N+FVGT  Y++PE ISG  +G   D W+LG++L E   G  P+    
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 265 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL----SAQELMTH 320
           +        E    I+ +      S   S      I   + K+P +RL     A E+  H
Sbjct: 237 RD-------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289

Query: 321 PFLK 324
           PF +
Sbjct: 290 PFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  132 bits (333), Expect = 8e-36
 Identities = 80/264 (30%), Positives = 140/264 (53%), Gaps = 18/264 (6%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 123
           KV+GKGS G V L + K T +FFA+K ++ +V   ++     + +   +  + + P++  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            + +F +   +  ++EY++GG L   ++      E        +++ GL +LH +K II+
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH-KKGIIY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLK  N+L++  G +KI DFG+     +  G+A+TF GT +Y++PE + G KY    D 
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFIS 301
           WS G++L E   GQ P+   E +D      EL ++I++  P  P       S E    +S
Sbjct: 180 WSFGVLLYEMLIGQSPFH-GEDED------ELFDSILNDRPHFPR----WISKEAKDCLS 228

Query: 302 ACVQKEPQQRL-SAQELMTHPFLK 324
              +++P +RL    ++  HPF +
Sbjct: 229 KLFERDPTKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  131 bits (331), Expect = 1e-35
 Identities = 84/266 (31%), Positives = 144/266 (54%), Gaps = 21/266 (7%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVV 123
           K++GKG+ G V LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
              +F ++  +  ++EY +GG L   L + +   EE       +++  L YLH  + +++
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVY 118

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RD+K  NL+++  G +KITDFG+     S      TF GT  Y++PE +    YG   D 
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYE-LMEAIVDQPPPSAPSDQFSPEFCSFISA 302
           W LG+V+ E   G+ P+     QD    F   LME I  + P +      SPE  S ++ 
Sbjct: 179 WGLGVVMYEMMCGRLPFY---NQDHERLFELILMEEI--RFPRT-----LSPEAKSLLAG 228

Query: 303 CVQKEPQQRL-----SAQELMTHPFL 323
            ++K+P+QRL      A+E+M H F 
Sbjct: 229 LLKKDPKQRLGGGPSDAKEVMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  129 bits (327), Expect = 2e-35
 Identities = 80/272 (29%), Positives = 139/272 (51%), Gaps = 27/272 (9%)

Query: 68  VVGKGSGGIVQLVQHKWTGQFFALKVIQM---NVEESARRQ-----IAQELKINQSSQCP 119
           ++G GS G V L  +  +G+  A+K +++   +     R++     +A+E+ + +  Q  
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            +V    S      ++I LEY+ GGS+A  L       E  +     Q+LKGL YLH+  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVS------AIMASTSGQANTFVGTYNYMSPERIS 233
            IIHRD+K +N+L++++G +KI+DFG+S      ++   T+G   +  G+  +M+PE + 
Sbjct: 127 -IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185

Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI--VDQPPPSAPSDQ 291
              Y  K+DIWSLG +++E  TG+ P+    Q          ++AI  + +         
Sbjct: 186 QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----------LQAIFKIGENASPEIPSN 235

Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
            S E   F+    + +  +R +A EL+ HPFL
Sbjct: 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  129 bits (326), Expect = 2e-35
 Identities = 77/258 (29%), Positives = 129/258 (50%), Gaps = 12/258 (4%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQ 117
           L +    K +G+G    V         +  ALK +Q+   ++  AR+   +E+ + +   
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLAD----FLKKVKTIPEEYLAAICEQVLKGLL 173
            P V+    SF  +  ++I+LE  D G L+     F K+ + IPE  +     Q+   + 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           ++H  + ++HRD+KP+N+ I   G VK+ D G+    +S +  A++ VGT  YMSPERI 
Sbjct: 121 HMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
              Y +KSDIWSLG +L E A  Q P+   +      + + L + I     P  P++ +S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQKIEQCDYPPLPTEHYS 234

Query: 294 PEFCSFISACVQKEPQQR 311
            +    +S C+  +P QR
Sbjct: 235 EKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  129 bits (325), Expect = 2e-35
 Identities = 91/267 (34%), Positives = 136/267 (50%), Gaps = 26/267 (9%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQ------MNVEESARRQIAQELKINQSSQCPYVV 122
           +GKGS G V LV+ K       LKV++      +N  E+   Q  QE ++      P +V
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV--QANQEAQLLSKLDHPAIV 65

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHE 178
             + SF    A  II EY +G  L   L+++K    T+ E  +     Q+L G+ Y+H +
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-Q 124

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 238
           + I+HRDLK  N+ +     +KI DFGVS ++  +   A TF GT  YMSPE +    Y 
Sbjct: 125 RRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYD 183

Query: 239 YKSDIWSLGLVLLE--CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 296
            KSDIWSLG +L E  C    F            +F  ++  IV+ P PS P + +S + 
Sbjct: 184 SKSDIWSLGCILYEMCCLAHAFEGQ---------NFLSVVLRIVEGPTPSLP-ETYSRQL 233

Query: 297 CSFISACVQKEPQQRLSAQELMTHPFL 323
            S + + + K+P  R SA E++ +PF+
Sbjct: 234 NSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  129 bits (325), Expect = 3e-35
 Identities = 93/271 (34%), Positives = 138/271 (50%), Gaps = 32/271 (11%)

Query: 68  VVGKGSGGIVQLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQ 126
           V+GKG+ GIV   +   T    A+K I + +      + + +E+ ++   +   +V    
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV--QPLHEEIALHSYLKHRNIVQYLG 72

Query: 127 SFYSNGAISIILEYMDGGSLADFLKKVKTIP----EEYLAAICEQVLKGLLYLHHEKHII 182
           S   NG   I +E + GGSL+  L+  K  P    E+ +    +Q+L+GL YLH +  I+
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIIFYTKQILEGLKYLH-DNQIV 130

Query: 183 HRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY-- 239
           HRD+K  N+L+N + G VKI+DFG S  +A  +    TF GT  YM+PE I  G  GY  
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190

Query: 240 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-------QPPPSAPSDQF 292
            +DIWSLG  ++E ATG+    PP        F EL E           +  P  P +  
Sbjct: 191 PADIWSLGCTIVEMATGK----PP--------FIELGEPQAAMFKVGMFKIHPEIP-ESL 237

Query: 293 SPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           S E  +FI  C + +P +R SA +L+  PFL
Sbjct: 238 SAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  129 bits (325), Expect = 4e-35
 Identities = 79/267 (29%), Positives = 130/267 (48%), Gaps = 20/267 (7%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ----ELKINQSSQCPYVVVC 124
           +GKG  G V   Q K TG+ +A K  +++ +   +R+  Q    E KI +     ++V  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACK--KLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL 58

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHII 182
             +F +   + +++  M+GG L   +  V     PE        Q++ GL +LH ++ I+
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH-QRRIV 117

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           +RDLKP N+L++  G V+I+D G+ A+      +     GT  YM+PE + G  Y +  D
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGL-AVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
            ++LG  L E   G+ P+    Q+       EL    ++        D+FSPE      A
Sbjct: 177 WFALGCTLYEMIAGRSPF---RQRKEKVEKEELKRRTLEM--AVEYPDKFSPEAKDLCEA 231

Query: 303 CVQKEPQQRL-----SAQELMTHPFLK 324
            +QK+P++RL     SA E+  HP  K
Sbjct: 232 LLQKDPEKRLGCRGGSADEVREHPLFK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  129 bits (325), Expect = 5e-35
 Identities = 97/293 (33%), Positives = 149/293 (50%), Gaps = 36/293 (12%)

Query: 50  LIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEESARRQIA 107
           L  P+D        + I+ +GKG+ G V  V +K  G   A+K++    +V+E    +I 
Sbjct: 17  LGDPTDTW------EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE----EIE 66

Query: 108 QELKINQS-SQCPYVVVCYQSFY-----SNGAISIILEYMDGGSLADFLKKV----KTIP 157
            E  I QS    P VV  Y  FY       G + ++LE  +GGS+ + +K +    + + 
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126

Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 217
           E  ++ I    L GL +LH+ + IIHRD+K +N+L+   G VK+ DFGVSA + ST  + 
Sbjct: 127 EAMISYILYGALLGLQHLHNNR-IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185

Query: 218 NTFVGTYNYMSPERISGGK-----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 272
           NT VGT  +M+PE I+  +     Y  + D+WSLG+  +E   G  P    +     T F
Sbjct: 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF--DMHPVKTLF 243

Query: 273 YELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                 I   PPP+    +++   F  FIS C+ K+ + R S   L+ HPF+K
Sbjct: 244 -----KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  129 bits (327), Expect = 6e-35
 Identities = 83/268 (30%), Positives = 137/268 (51%), Gaps = 27/268 (10%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 123
           KV+GKGS G V L +HK  G+F+A+KV+Q      ++  +  +A+   + ++ + P++V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            + SF +   +  +L+Y++GG L   L++ ++ PE        ++   L YLH   +II+
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH-SLNIIY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLKP N+L++ +G V +TDFG+       S   +TF GT  Y++PE +    Y    D 
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPPPSAPSDQFSPEFCS 298
           W LG VL E   G     PP        FY     E+ + I+++P    P+   S     
Sbjct: 180 WCLGAVLYEMLYGL----PP--------FYSRDTAEMYDNILNKPLRLKPN--ISVSARH 225

Query: 299 FISACVQKEPQQRLSAQ----ELMTHPF 322
            +   +QK+  +RL A+    E+  H F
Sbjct: 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  127 bits (319), Expect = 2e-34
 Identities = 90/271 (33%), Positives = 136/271 (50%), Gaps = 24/271 (8%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKIN--QSSQCPYVV 122
           K++G+G+ G V L     TG+  A K +Q + E  E+++   A E +I   ++ Q   +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 123 VCYQSFYSNG--AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
             Y          ++I +EYM GGS+ D LK    + E        Q+L+G+ YLH    
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH-SNM 126

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGK 236
           I+HRD+K +N+L +  G VK+ DFG S     I  S +G   +  GT  +MSPE ISG  
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG-IRSVTGTPYWMSPEVISGEG 185

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI--VDQPPPSAPSDQFSP 294
           YG K+D+WSLG  ++E  T + P++           YE M AI  +   P +        
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPPWAE----------YEAMAAIFKIATQPTNPQLPSHIS 235

Query: 295 EFCSFISACVQKEPQQRLSAQELMTHPFLKM 325
           E       C+  E + R SA+EL+ HPF ++
Sbjct: 236 EHARDFLGCIFVEARHRPSAEELLRHPFAQL 266

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  128 bits (323), Expect = 2e-34
 Identities = 81/264 (30%), Positives = 140/264 (53%), Gaps = 19/264 (7%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVV 123
           K++GKG+ G V LV+ K TG+++A+K+++  V   A+ ++A  L   ++ Q+++ P++  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTA 59

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
              SF ++  +  ++EY +GG L   L + +   E+       +++  L YLH    +++
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH-SCDVVY 118

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLK  NL+++  G +KITDFG+     S      TF GT  Y++PE +    YG   D 
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
           W LG+V+ E   G+ P+     QD    F  ++   +  P         SPE  S ++  
Sbjct: 179 WGLGVVMYEMMCGRLPFY---NQDHEKLFELILMEEIRFP------RTLSPEAKSLLAGL 229

Query: 304 VQKEPQQRL-----SAQELMTHPF 322
           ++K+P+QRL      A+E+M H F
Sbjct: 230 LKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  128 bits (323), Expect = 3e-34
 Identities = 84/301 (27%), Positives = 141/301 (46%), Gaps = 46/301 (15%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES---ARRQIAQELKINQSSQCPYVV 122
           +K +G G+ G+V     K TG+  A+K I  NV +    A+R I +E+K+ +  +   ++
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKI-SNVFDDLIDAKR-ILREIKLLRHLRHENII 62

Query: 123 VCYQSFYSN-----GAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLL 173
                           + I+ E M+     D L KV    + + ++++     Q+L+GL 
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTELME----TD-LHKVIKSPQPLTDDHIQYFLYQILRGLK 117

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM---ASTSGQANTFVGTYNYMSPE 230
           YLH   ++IHRDLKPSN+L+N   ++KI DFG++  +       G    +V T  Y +PE
Sbjct: 118 YLH-SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176

Query: 231 RI-SGGKYGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQQDGWTSF 272
            + S  +Y    DIWS+G +  E  T +  FP   Y            +P E+   + + 
Sbjct: 177 LLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236

Query: 273 YELMEAIVDQPP-PSAP-SDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 327
            +    +   P  P  P S  F   SPE    +   +  +P++R++A E + HP+L    
Sbjct: 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296

Query: 328 D 328
           D
Sbjct: 297 D 297

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  126 bits (317), Expect = 4e-34
 Identities = 81/272 (29%), Positives = 137/272 (50%), Gaps = 27/272 (9%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-----ESARRQIAQELKINQSSQCPYV 121
           +V+GKG+ G V        GQ  A+K ++++       E    ++ +E+ + +S +   +
Sbjct: 6   EVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
           V    +   +  ISI +E++ GGS++  L +   +PE       +Q+L G+ YLH    +
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH-NNCV 123

Query: 182 IHRDLKPSNLLINHRGEVKITDFGVSAIMA------STSGQANTFVGTYNYMSPERISGG 235
           +HRD+K +N+++   G +K+ DFG +  +A      + S    +  GT  +M+PE I+  
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--MEAIVDQ--PPPSAPSDQ 291
            YG KSDIWS+G  + E ATG+    PP       S   L  M  I       P  P D 
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGK----PP-----LASMDRLAAMFYIGAHRGLMPRLP-DS 233

Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           FS     F+++C+ ++  +R SA +L+ H FL
Sbjct: 234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  125 bits (317), Expect = 1e-33
 Identities = 85/300 (28%), Positives = 134/300 (44%), Gaps = 64/300 (21%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVV- 122
           +G+G+ G V   +   TG+F ALK +++ + E     S  R+IA  LK  +S + P +V 
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFEHPNIVR 65

Query: 123 ---VCYQSFYSNG-AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH 176
              VC+         ++++ E++D   LA +L K     +P E +  +  Q+L+G+ +LH
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI----MASTSGQANTFVGTYNYMSPERI 232
             + I+HRDLKP N+L+   G+VKI DFG++ I    MA TS      V T  Y +PE +
Sbjct: 125 SHR-IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS-----VVVTLWYRAPEVL 178

Query: 233 SGGKYGYKSDIWSLGLVLLE--------CATG---------QFPYSPPEQQ------DGW 269
               Y    D+WS+G +  E          T               P E++         
Sbjct: 179 LQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238

Query: 270 TSFYELMEAIVDQPPPSAPSD--QFSPEFCS----FISACVQKEPQQRLSAQELMTHPFL 323
           +SF           P   P     F PE C      +   +   P +R+SA E + HP+ 
Sbjct: 239 SSF-----------PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  125 bits (315), Expect = 2e-33
 Identities = 75/288 (26%), Positives = 141/288 (48%), Gaps = 31/288 (10%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVV 122
           + + VVG+G+ G+V   ++K TG+  A+K  + + + E  ++   +E+K+ +  +   +V
Sbjct: 4   EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
              ++F   G + ++ EY++   L         +P + + +   Q+L+ + Y H   +II
Sbjct: 64  NLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH-SHNII 122

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISG-GKYGYK 240
           HRD+KP N+L++  G +K+ DFG +  + +      T +V T  Y +PE + G   YG  
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182

Query: 241 SDIWSLGLVLLECATGQ--FP--------YS--------PPEQQDGWTSFYELMEAIVDQ 282
            D+W++G ++ E   G+  FP        Y         PP  Q+ ++S           
Sbjct: 183 VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF-- 240

Query: 283 PPPSAP-------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           P PS P         + S     F+ AC++ +P++RL+  EL+ HP+ 
Sbjct: 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 7e-33
 Identities = 90/295 (30%), Positives = 141/295 (47%), Gaps = 50/295 (16%)

Query: 65  TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-----NVEESAR-RQIAQELKINQSSQC 118
            IK +G G+ G V L ++K TG+  A+K  +M     + EE    R++    K+N+    
Sbjct: 3   VIKQLGDGTFGSVYLARNKETGELVAIK--KMKKKFYSWEECMNLREVKSLRKLNEH--- 57

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLH 176
           P +V   + F  N  +  + EYM+G +L   +K  K K   E  + +I  Q+L+GL ++H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 177 HEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMAS----TSGQANTFVGTYNYMSPER 231
             KH   HRDLKP NLL++    VKI DFG++  + S    T      +V T  Y +PE 
Sbjct: 117 --KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT-----DYVSTRWYRAPEI 169

Query: 232 I-SGGKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWTSFYE 274
           +     Y    DIW+LG ++ E  T +  FP S               P +QD W   Y+
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD-WPEGYK 228

Query: 275 LMEAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           L   +  + P  AP+         SPE    I   ++ +P++R +A + + HP+ 
Sbjct: 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 1e-32
 Identities = 81/276 (29%), Positives = 134/276 (48%), Gaps = 24/276 (8%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSS---QCPYVV 122
           +GKG+ G V  V+ K T + +A+KV+    E  A++++A    E  I   +   + P++V
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKK-EIVAKKEVAHTIGERNILVRTLLDESPFIV 59

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
               SF ++  + ++ +YM GG L   L+K     E+       +++  L +LH +  I+
Sbjct: 60  GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH-KYDIV 118

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKS 241
           +RDLKP N+L++  G + + DFG+S    + +   NTF GT  Y++PE +   K Y    
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178

Query: 242 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 301
           D WSLG+++ E   G  P+   + Q         M   +       P +  S E   F+ 
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQ--------MYRNIAFGKVRFPKNVLSDEGRQFVK 230

Query: 302 ACVQKEPQQRLSA----QELMTHPFLKMYGDLNVDL 333
             + + PQ RL A     EL  HPF     D++ DL
Sbjct: 231 GLLNRNPQHRLGAHRDAVELKEHPFFA---DIDWDL 263

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  121 bits (306), Expect = 1e-32
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 12/261 (4%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVC 124
           +K +G+GS G   LV+ K  G+ + +K I ++      R+ + +E+ +  + + P +V  
Sbjct: 5   VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKTI--PEEYLAAICEQVLKGLLYLHHEKHII 182
            +SF  NG + I+++Y +GG L   +   + +  PE+ +     Q+   L ++H  K I+
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK-IL 123

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           HRD+K  N+ +   G +K+ DFG++ ++ ST   A T +GT  Y+SPE      Y  KSD
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSD 183

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
           IW+LG VL E  T +  +     ++       L+  I+    P   S  +S +  + +S 
Sbjct: 184 IWALGCVLYEMCTLKHAFEAGNMKN-------LVLKIIRGSYPPVSS-HYSYDLRNLVSQ 235

Query: 303 CVQKEPQQRLSAQELMTHPFL 323
             ++ P+ R S   ++   F+
Sbjct: 236 LFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  122 bits (308), Expect = 1e-32
 Identities = 90/278 (32%), Positives = 143/278 (51%), Gaps = 30/278 (10%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEESARRQIAQELKINQS-SQCPY 120
           + I+ +GKG+ G V  V +K  G   A+K++    +++E    +I  E  I ++ S  P 
Sbjct: 21  EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE----EIEAEYNILKALSDHPN 76

Query: 121 VVVCYQSFYSNGAIS-----IILEYMDGGSLAD----FLKKVKTIPEEYLAAICEQVLKG 171
           VV  Y  +Y     +     ++LE  +GGS+ D    FLK+ + + E  +A I  + L G
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           L +LH  K  IHRD+K +N+L+   G VK+ DFGVSA + ST  + NT VGT  +M+PE 
Sbjct: 137 LQHLHVNK-TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195

Query: 232 IS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 286
           I+        Y  + D+WSLG+  +E   G  P +              +  I   PPP+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LFKIPRNPPPT 248

Query: 287 APSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
               + +S EF  FI  C+ K+ ++R +  +L+ H F+
Sbjct: 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  123 bits (310), Expect = 1e-32
 Identities = 80/267 (29%), Positives = 143/267 (53%), Gaps = 23/267 (8%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVV 123
           K++GKG+ G V LV+ K +G+++A+K+++  V   A+ ++A  L   ++ ++++ P++  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
              SF +   +  ++EY++GG L   L + +   E+       +++  L YLH  K I++
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-IVY 118

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLK  NL+++  G +KITDFG+     + +    TF GT  Y++PE +    YG   D 
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFIS 301
           W LG+V+ E   G+ P+   + +      +E  LME I  + P +  +D       S +S
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEDI--KFPRTLSADA-----KSLLS 227

Query: 302 ACVQKEPQQRL-----SAQELMTHPFL 323
             + K+P +RL      A+E+M H F 
Sbjct: 228 GLLIKDPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  123 bits (309), Expect = 2e-32
 Identities = 80/281 (28%), Positives = 145/281 (51%), Gaps = 27/281 (9%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVVV 123
           +V+G+GS   V LV+ K T + +A+KV++   +N +E       ++    Q+S  P++V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L YLH E+ II+
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH-ERGIIY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLK  N+L++  G +K+TD+G+           +TF GT NY++PE + G  YG+  D 
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 244 WSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 297
           W+LG+++ E   G+ P+        P+Q      F  ++E  +  P         S +  
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP------RSLSVKAA 233

Query: 298 SFISACVQKEPQQRLSA------QELMTHPFLKMYGDLNVD 332
           S + + + K+P++RL         ++  HPF +     NVD
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR-----NVD 269

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  122 bits (307), Expect = 4e-32
 Identities = 72/267 (26%), Positives = 140/267 (52%), Gaps = 12/267 (4%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 123
           +V+G+GS   V LV+ K   Q +A+KV++  +   +E       ++    Q+S  P++V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            +  F +   + +++EY++GG L   +++ + +PEE+      ++   L +LH E+ II+
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH-ERGIIY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLK  N+L++  G +K+TD+G+           +TF GT NY++PE + G +YG+  D 
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
           W+LG+++ E   G+ P+          +   L + I+++P         S +    +   
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLKGF 237

Query: 304 VQKEPQQRLSAQ------ELMTHPFLK 324
           + K+P++RL  Q      ++ +H F +
Sbjct: 238 LNKDPKERLGCQPQTGFSDIKSHTFFR 264

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  121 bits (306), Expect = 6e-32
 Identities = 78/276 (28%), Positives = 144/276 (52%), Gaps = 28/276 (10%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVVV 123
           +V+G+GS   V LV+ K T + +A+KVI+   +N +E       ++     +S  P++V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            +  F +   +  ++E++ GG L   +++ + +PEE+      ++   L +LH E+ II+
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH-ERGIIY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLK  N+L++  G +K+TD+G+           +TF GT NY++PE + G  YG+  D 
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 244 WSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQP---PPSAPSDQFSP 294
           W+LG+++ E   G+ P+        P+Q    T  Y L + I+++    P S      S 
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQN---TEDY-LFQVILEKQIRIPRS-----LSV 230

Query: 295 EFCSFISACVQKEPQQRLSAQ------ELMTHPFLK 324
           +  S +   + K+P++RL         ++ +HPF +
Sbjct: 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  121 bits (304), Expect = 1e-31
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 6/211 (2%)

Query: 52  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQE 109
           KP  +   L D +  + +G GS G V++ +HK TG+++A+K +  +  ++    + +AQE
Sbjct: 9   KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQE 68

Query: 110 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 169
             I      P++V    SF     +  +LE++ GG L   L+K    P +       +++
Sbjct: 69  KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV 128

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 229
               YLH  K II+RDLKP NLL++++G VK+TDFG +        +  T  GT  Y++P
Sbjct: 129 LAFEYLH-SKDIIYRDLKPENLLLDNKGHVKVTDFGFA---KKVPDRTFTLCGTPEYLAP 184

Query: 230 ERISGGKYGYKSDIWSLGLVLLECATGQFPY 260
           E I    +G   D W++G++L E   G  P+
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 1e-31
 Identities = 71/270 (26%), Positives = 130/270 (48%), Gaps = 22/270 (8%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-----QCPYV 121
           +V+GKG  G V   Q + TG+ +A K ++   ++  +++  + + +N+          +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILEKVNSRFV 62

Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEK 179
           V    ++ +  A+ ++L  M+GG L   +  +      EE       ++  GL  LH E+
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
            I++RDLKP N+L++  G ++I+D G+ A+           VGT  YM+PE +   +Y +
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGL-AVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180

Query: 240 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 299
             D W LG ++ E   G+ P+   +++       E +E  V +      S++FS    S 
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKR----EEVERRVKEDQEEY-SEKFSEAARSI 235

Query: 300 ISACVQKEPQQRL-----SAQELMTHPFLK 324
               + K+P  RL      A+E+  HPF +
Sbjct: 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  120 bits (303), Expect = 1e-31
 Identities = 82/276 (29%), Positives = 141/276 (51%), Gaps = 33/276 (11%)

Query: 66  IKVVGKGSGGIVQLV---QHKWTGQFFALKVIQ-----MNVEESARRQIAQELKINQSSQ 117
           +KV+GKG  G V  V       TG+ FA+KV++      N +++A  +   E  I ++ +
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVK 58

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGLL 173
            P++V    +F + G + +ILEY+ GG L   L++     E+    YL+ I       L 
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI----SLALE 114

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           +LH  + II+RDLKP N+L++ +G VK+TDFG+           +TF GT  YM+PE + 
Sbjct: 115 HLHQ-QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
              +G   D WSLG ++ +  TG  P++   ++    +  ++++  ++ PP        +
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKILKGKLNLPP------YLT 224

Query: 294 PEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
           PE    +   +++ P  RL      A E+ +HPF +
Sbjct: 225 PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  120 bits (301), Expect = 2e-31
 Identities = 86/264 (32%), Positives = 142/264 (53%), Gaps = 19/264 (7%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVV 123
           ++ +G GS G V   +   T +  A+K +  + ++S  +   I +E+K  Q  + P  + 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
               +       +++EY  G S +D L+   K + E  +AAI    L+GL YLH   ++I
Sbjct: 90  YKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-SHNMI 147

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGY 239
           HRD+K  N+L+   G+VK+ DFG SA +AS    AN+FVGT  +M+PE I     G+Y  
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFG-SASIASP---ANSFVGTPYWMAPEVILAMDEGQYDG 203

Query: 240 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 299
           K D+WSLG+  +E A  +    P    +  ++ Y     I     P+  S+++S  F +F
Sbjct: 204 KVDVWSLGITCIELAERK---PPLFNMNAMSALYH----IAQNESPTLQSNEWSDYFRNF 256

Query: 300 ISACVQKEPQQRLSAQELMTHPFL 323
           + +C+QK PQ R +++EL+ H F+
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  119 bits (300), Expect = 3e-31
 Identities = 90/287 (31%), Positives = 145/287 (50%), Gaps = 21/287 (7%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVCYQ 126
           +G GS G V    +  T +  A+K +  + +++  +   I +E+K  Q  + P  +    
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 127 SFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
            +       +++EY  G S +D L+   K + E  +AAI    L+GL YLH   ++IHRD
Sbjct: 89  CYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-SHNMIHRD 146

Query: 186 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGYKSD 242
           +K  N+L+   G+VK+ DFG     AS S  AN+FVGT  +M+PE I     G+Y  K D
Sbjct: 147 IKAGNILLTEPGQVKLADFG----SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVD 202

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
           +WSLG+  +E A  +    P    +  ++ Y     I     P+  S++++  F  F+  
Sbjct: 203 VWSLGITCIELAERK---PPLFNMNAMSALYH----IAQNDSPTLQSNEWTDSFRGFVDY 255

Query: 303 CVQKEPQQRLSAQELMTHPFLKMYGDLNV--DLSEYFTDAGSPLATL 347
           C+QK PQ+R ++ EL+ H F++      V  DL +   DA   L  L
Sbjct: 256 CLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDNL 302

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 3e-31
 Identities = 76/260 (29%), Positives = 125/260 (48%), Gaps = 15/260 (5%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQ 126
           +GKGS G V  V+ + T + +ALK I+    V  S       E  +     CP++V    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 127 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 186
           SF S   + ++L +++GG L   L++              ++L  L  LH + ++I+RDL
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH-KFNVIYRDL 119

Query: 187 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 246
           KP N+L++++G + + DFG+  +      + NTF GT  Y++PE + G  Y    D W+L
Sbjct: 120 KPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTL 179

Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G++L E  TG  P+      +        M   + Q P   P D F  +    +   + +
Sbjct: 180 GVLLYEMLTGLPPFYDENVNE--------MYRKILQEPLRFP-DGFDRDAKDLLIGLLSR 230

Query: 307 EPQQRL---SAQELMTHPFL 323
           +P +RL    AQE+  HPF 
Sbjct: 231 DPTRRLGYNGAQEIKNHPFF 250

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  119 bits (300), Expect = 4e-31
 Identities = 89/273 (32%), Positives = 143/273 (52%), Gaps = 33/273 (12%)

Query: 66  IKVVGKGSGGIVQLVQHKW---TGQFFALKVIQ---MNVEESARRQIAQELKINQSSQCP 119
           +KV+G+GS G V LV+       GQ +A+KV++   + V +  R ++  E  I      P
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM--ERDILAEVNHP 58

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGLLYL 175
           ++V  + +F + G + +IL+++ GG L   L K     EE    YLA   E  L  L +L
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELAL-ALDHL 114

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 235
           H    II+RDLKP N+L++  G +K+TDFG+S        +A +F GT  YM+PE ++  
Sbjct: 115 H-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 173

Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF-SP 294
            +   +D WS G+++ E  TG  P+   ++++  T    +++A +  P       QF SP
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT---MILKAKLGMP-------QFLSP 223

Query: 295 EFCSFISACVQKEPQQRLSA-----QELMTHPF 322
           E  S + A  ++ P  RL A     +E+  HPF
Sbjct: 224 EAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  120 bits (302), Expect = 5e-31
 Identities = 80/276 (28%), Positives = 141/276 (51%), Gaps = 14/276 (5%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQ 114
           Q+  ED D +KV+G+G+ G VQLV+HK + + +A+K++     ++ S      +E  I  
Sbjct: 39  QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 174
            +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +V+  L  
Sbjct: 99  FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDA 157

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERIS 233
           + H   +IHRD+KP N+L++  G +K+ DFG    M  T   + +T VGT +Y+SPE + 
Sbjct: 158 I-HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216

Query: 234 G----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 289
                G YG + D WS+G+ L E   G  P+        ++   +   ++ + P     S
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL-NFPEDVEIS 275

Query: 290 DQFSPEFCSFISACVQKEPQ-QRLSAQELMTHPFLK 324
                  C+F++    +E +  R   +E+  HPF K
Sbjct: 276 KHAKNLICAFLT---DREVRLGRNGVEEIKQHPFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  119 bits (299), Expect = 6e-31
 Identities = 80/265 (30%), Positives = 136/265 (51%), Gaps = 17/265 (6%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ---IAQELKINQSSQCPYVVV 123
           KV+GKGS G V L + K  G+ +A+KV+Q  +  + + Q   +A+   + ++ + P++V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            + SF +   +  +L++++GG L   L++ ++ PE        ++   L YLH    I++
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN-IVY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLKP N+L++ +G V +TDFG+     + S    TF GT  Y++PE I    Y    D 
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
           W LG VL E   G  P+   +         E+ + I+ +P    P    S    S +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDV-------AEMYDNILHKPLVLRPG--ASLTAWSILEEL 230

Query: 304 VQKEPQQRLSAQ----ELMTHPFLK 324
           ++K+ Q+RL A+    E+  HPF +
Sbjct: 231 LEKDRQRRLGAKEDFLEIQEHPFFE 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  117 bits (295), Expect = 6e-31
 Identities = 75/259 (28%), Positives = 123/259 (47%), Gaps = 25/259 (9%)

Query: 69  VGKGSGGIVQLVQHKWTGQ-FFALKVIQMN---------VEESARRQIAQELK-INQSSQ 117
           +G G+ G V  V+ K  GQ   ALK I ++           + +   I  E+  I +  +
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLL 173
            P +V  Y++F  N  + I+++ ++G  L +    +K       EE +  I  Q++  L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           YLH EK I+HRDL P+N+++    +V ITDFG+ A       +  + VGT  Y  PE + 
Sbjct: 128 YLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL-AKQKQPESKLTSVVGTILYSCPEIVK 186

Query: 234 GGKYGYKSDIWSLGLVLLECATGQFP-YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
              YG K+D+W+ G +L +  T Q P YS        T+   L   IV+      P   +
Sbjct: 187 NEPYGEKADVWAFGCILYQMCTLQPPFYS--------TNMLSLATKIVEAVYEPLPEGMY 238

Query: 293 SPEFCSFISACVQKEPQQR 311
           S +    I++C+  + + R
Sbjct: 239 SEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 8e-31
 Identities = 89/321 (27%), Positives = 138/321 (42%), Gaps = 69/321 (21%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQ 117
           ED  T+KV+GKG+ G V+LVQ K TG+ +A+K + +  E   + Q+A    E  +   S 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE---YLAAICEQVLKGLLY 174
            P+VV  Y SF     + +I+E++ GG L   L K  T  E+   +  A C   ++ +  
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV-- 117

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-------------------------- 208
             H+   IHRD+KP N+LI+  G +K++DFG+S                           
Sbjct: 118 --HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175

Query: 209 ----------IMASTSGQANTF-----------VGTYNYMSPERISGGKYGYKSDIWSLG 247
                     +  S+  Q  T+           VGT +Y++PE      YG + D WSLG
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235

Query: 248 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD-QFSPEFCSFISACVQK 306
            ++ EC  G  P+      + +       E +        P D   S E    I   +  
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKIINWRETL------YFPDDIHLSVEAEDLIRRLIT- 288

Query: 307 EPQQRL---SAQELMTHPFLK 324
             + RL    A E+ +HPF +
Sbjct: 289 NAENRLGRGGAHEIKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  118 bits (296), Expect = 1e-30
 Identities = 74/268 (27%), Positives = 136/268 (50%), Gaps = 26/268 (9%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 123
           K++GKGS G V L + K T QFFA+K ++ +V   ++     + ++  ++ + + P++  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            Y +F +   +  ++EY++GG L   ++               +++ GL +LH  K I++
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH-SKGIVY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLK  N+L++  G +KI DFG+         +  TF GT +Y++PE + G KY    D 
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI-VDQPPPSAPSDQFSPEFCS---- 298
           WS G++L E   GQ P+   +++       EL ++I +D P          P + +    
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMDNP--------CYPRWLTREAK 224

Query: 299 -FISACVQKEPQQRLSAQ-ELMTHPFLK 324
             +     +EP++RL  + ++  HPF +
Sbjct: 225 DILVKLFVREPERRLGVKGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  116 bits (292), Expect = 1e-30
 Identities = 90/271 (33%), Positives = 134/271 (49%), Gaps = 28/271 (10%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQ-SSQCPYVVV 123
           K++G+G+ G V L     TG+  A+K +Q + E  E+++   A E +I    +     +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 124 CYQSFYSNG---AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
            Y     +     +SI +E+M GGS+ D LK    + E        Q+L+G+ YLH    
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH-SNM 126

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGK 236
           I+HRD+K +N+L +  G VK+ DFG S     I  S +G   +  GT  +MSPE ISG  
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM-KSVTGTPYWMSPEVISGEG 185

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPE 295
           YG K+DIWS+G  ++E  T +    PP     W  F E M AI      P+ P     P 
Sbjct: 186 YGRKADIWSVGCTVVEMLTEK----PP-----WAEF-EAMAAIFKIATQPTNP--VLPPH 233

Query: 296 FCSFISACVQK---EPQQRLSAQELMTHPFL 323
                   +++   E + R SA EL+ H F+
Sbjct: 234 VSDHCRDFLKRIFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  117 bits (294), Expect = 2e-30
 Identities = 81/264 (30%), Positives = 137/264 (51%), Gaps = 19/264 (7%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVV 123
           ++ +G GS G V   +     +  A+K +  + ++S  +   I +E++  Q  + P  + 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
               +       +++EY  G S +D L+   K + E  +AA+    L+GL YLH   ++I
Sbjct: 80  YRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-NMI 137

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGY 239
           HRD+K  N+L++  G VK+ DFG ++IMA     AN FVGT  +M+PE I     G+Y  
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVGTPYWMAPEVILAMDEGQYDG 193

Query: 240 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 299
           K D+WSLG+  +E A  +    P    +  ++ Y     I     P+  S  +S  F +F
Sbjct: 194 KVDVWSLGITCIELAERK---PPLFNMNAMSALYH----IAQNESPALQSGHWSEYFRNF 246

Query: 300 ISACVQKEPQQRLSAQELMTHPFL 323
           + +C+QK PQ R +++ L+ H F+
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  115 bits (290), Expect = 2e-30
 Identities = 79/264 (29%), Positives = 133/264 (50%), Gaps = 13/264 (4%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ-ELKINQSSQCPYVV 122
           + IK +G+GS G + L + K   +   +K I +       ++ ++ E+ +    + P +V
Sbjct: 3   EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI--PEEYLAAICEQVLKGLLYLHHEKH 180
             + SF  NG + I++EY DGG L   + + + +   E+ + +   Q+  GL ++H  K 
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK- 121

Query: 181 IIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
           I+HRD+K  N+ ++  G V K+ DFG++  +  +   A T VGT  Y+SPE      Y  
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181

Query: 240 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 299
           K+DIWSLG VL E  T + P+          + ++L+  I  Q   +  S  FS +  S 
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEG-------NNLHQLVLKIC-QGYFAPISPNFSRDLRSL 233

Query: 300 ISACVQKEPQQRLSAQELMTHPFL 323
           IS   +  P+ R S   ++  PFL
Sbjct: 234 ISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  117 bits (296), Expect = 3e-30
 Identities = 86/287 (29%), Positives = 138/287 (48%), Gaps = 36/287 (12%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA----QELKI 112
           ++  ED D IKV+G+G+ G VQLV+HK + Q +A+K   ++  E  +R  +    +E  I
Sbjct: 39  RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMK--LLSKFEMIKRSDSAFFWEERDI 96

Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 172
              +   ++V  + +F  +  + +++EYM GG L + +     IPE++      +V+  L
Sbjct: 97  MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLAL 155

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPE 230
             + H    IHRD+KP N+L++  G +K+ DFG    M +  G    +T VGT +Y+SPE
Sbjct: 156 DAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPDYISPE 213

Query: 231 RISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ---- 282
            +      G YG + D WS+G+ L E   G      P   D     Y     I+D     
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGD----TPFYADSLVGTY---SKIMDHKNSL 266

Query: 283 --PPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLK 324
             P     S Q     C+F++       + RL      E+ +HPF K
Sbjct: 267 TFPDDIEISKQAKDLICAFLTD-----REVRLGRNGVDEIKSHPFFK 308

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  117 bits (294), Expect = 4e-30
 Identities = 75/270 (27%), Positives = 135/270 (50%), Gaps = 23/270 (8%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQC---PY 120
           + V+G+G  G V L ++K TG+ +A+K ++    +       +  E +I +++     P+
Sbjct: 4   LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
           +V  +  F +   +  ++EY  GG L   +   V + P     A C  V+ GL YLH E 
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC--VVLGLQYLH-EN 120

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
            I++RDLK  NLL++  G VKI DFG+         + +TF GT  +++PE ++   Y  
Sbjct: 121 KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180

Query: 240 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 299
             D W LG+++ E   G+ P+ P + ++      E+ ++IV+      P    S E  S 
Sbjct: 181 AVDWWGLGVLIYEMLVGESPF-PGDDEE------EVFDSIVNDEVRY-PR-FLSREAISI 231

Query: 300 ISACVQKEPQQRL-----SAQELMTHPFLK 324
           +   +++ P++RL      A+++   PF +
Sbjct: 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  115 bits (291), Expect = 4e-30
 Identities = 79/287 (27%), Positives = 139/287 (48%), Gaps = 27/287 (9%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCP 119
           E  + +  +G+GS G+V   +++ TGQ  A+K    + ++   ++IA +E+++ +  + P
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            +V   + F     + ++ EY D   L +  K  + +PE  +  I  Q L+ + + H   
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYG 238
             IHRD+KP N+LI  +G++K+ DFG + I+         +V T  Y +PE + G  +YG
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179

Query: 239 YKSDIWSLGLVLLECATGQFPYSP-------------------PEQQDGWTSFYELMEAI 279
              D+W++G V  E  TGQ P  P                   P  Q  +++        
Sbjct: 180 PPVDVWAIGCVFAELLTGQ-PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238

Query: 280 VDQPPPSAP-SDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPF 322
           + +P    P   +F   S    SF+  C+Q +P +RLS +EL+ HP+
Sbjct: 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  116 bits (291), Expect = 8e-30
 Identities = 74/271 (27%), Positives = 134/271 (49%), Gaps = 18/271 (6%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQC 118
           D + + V+GKGS G V L + K T + +A+K+++ +V   ++     + ++  +    + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
           P++   +  F +   +  ++EY++GG L   +++V    E +      ++  GL +LH  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH-S 119

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 238
           K II+RDLK  N++++  G +KI DFG+            TF GT +Y++PE I+   YG
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179

Query: 239 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 298
              D W+ G++L E   GQ P+   E +D      EL ++I++       S   S E  S
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFD-GEDED------ELFQSIMEHNVSYPKS--LSKEAVS 230

Query: 299 FISACVQKEPQQRLSA-----QELMTHPFLK 324
                + K P +RL       +++  H F +
Sbjct: 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  115 bits (289), Expect = 8e-30
 Identities = 81/284 (28%), Positives = 148/284 (52%), Gaps = 33/284 (11%)

Query: 62  DIDTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQ-------MNVEESAR--RQIAQ 108
           + + +KV+G G+ G V LV+    H  +G+ +A+KV++           E  R  RQ+ +
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHD-SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59

Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 168
            ++     Q P++V  + +F ++  + +IL+Y++GG L   L + +   E+ +     ++
Sbjct: 60  HIR-----QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEI 114

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTSGQANTFVGTYNYM 227
           +  L +LH +  II+RD+K  N+L++  G V +TDFG+S         +A +F GT  YM
Sbjct: 115 VLALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 228 SPERISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP 285
           +P+ + GG  G+    D WS+G+++ E  TG  P++   +++   S  E+   I+   PP
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPP 230

Query: 286 SAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
             P +  S      I   + K+P++RL      A E+  HPF +
Sbjct: 231 -YPQE-MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  116 bits (292), Expect = 1e-29
 Identities = 79/281 (28%), Positives = 140/281 (49%), Gaps = 14/281 (4%)

Query: 52  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM--NVEESARRQIAQE 109
           K  D ++  ED + +KV+G+G+ G VQLV+HK T + +A+K++     ++ S      +E
Sbjct: 34  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 110 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 169
             I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +V+
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVV 152

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMS 228
             L  + H    IHRD+KP N+L++  G +K+ DFG    M      + +T VGT +Y+S
Sbjct: 153 LALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211

Query: 229 PERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 284
           PE +      G YG + D WS+G+ L E   G  P+        ++       ++   P 
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-FPD 270

Query: 285 PSAPSDQFSPEFCSFISACVQKEPQ-QRLSAQELMTHPFLK 324
            +  S +     C+F++    +E +  R   +E+  H F K
Sbjct: 271 DNDISKEAKNLICAFLT---DREVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  114 bits (287), Expect = 3e-29
 Identities = 76/293 (25%), Positives = 132/293 (45%), Gaps = 41/293 (13%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ----ELKINQSSQCP 119
           +  K +G+G+  +V   + K TG+  A+K I++   + A+  I      E+K+ Q  + P
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KTIP--EEYLAAICEQVLKGLLY 174
            ++     F     I+++ E+M+     D L+KV   K+I      + +     L+GL Y
Sbjct: 63  NIIGLLDVFGHKSNINLVFEFMET----D-LEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           LH    I+HRDLKP+NLLI   G +K+ DFG++    S + +    V T  Y +PE + G
Sbjct: 118 LH-SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176

Query: 235 GK-YGYKSDIWSLGLVLLECATGQFPYSP-----------------PEQQDGWTSFYELM 276
            + YG   D+WS+G +  E    + P+ P                 P  ++ W     L 
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPT-EENWPGVTSLP 234

Query: 277 E--AIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
           +       PP       F   S +    +   +   P +R++A++ + HP+  
Sbjct: 235 DYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  112 bits (283), Expect = 6e-29
 Identities = 79/292 (27%), Positives = 139/292 (47%), Gaps = 37/292 (12%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCP 119
           E  + + +VG+GS G+V   +HK TGQ  A+K    + ++   ++IA +E+++ +  +  
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            +V   + F     + ++ E++D   L D  K    + E  +     Q+L+G+ + H   
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH- 119

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGG-KY 237
           +IIHRD+KP N+L++  G VK+ DFG +  +A+  G+  T +V T  Y +PE + G  KY
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVATRWYRAPELLVGDTKY 178

Query: 238 GYKSDIWSLGLVLLECATGQ--FPYSPPEQQDGWTSFYELM----------EAIVDQPPP 285
           G   DIW++G ++ E  TG+  FP      Q      Y ++          + I  + P 
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-----LYHIIKCLGNLIPRHQEIFQKNPL 233

Query: 286 SA----PSDQ-----------FSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
            A    P  +            S         C++ +P  R S+ +L+ H F
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  113 bits (284), Expect = 7e-29
 Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 19/265 (7%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ---IAQELKINQSSQCPYVVV 123
           KV+GKGS G V L + K  G F+A+KV+Q       + Q   +A+   + ++ + P++V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            + SF +   +  +L+Y++GG L   L++ +   E        +V   + YLH   +II+
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH-SLNIIY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLKP N+L++ +G V +TDFG+           +TF GT  Y++PE +    Y    D 
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179

Query: 244 WSLGLVLLECATGQFP-YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
           W LG VL E   G  P YS    Q        + + I+ +P         +   C  +  
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQ--------MYDNILHKPLQLPGGK--TVAACDLLVG 229

Query: 303 CVQKEPQQRLSA----QELMTHPFL 323
            + K+ ++RL A     E+  H F 
Sbjct: 230 LLHKDQRRRLGAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  113 bits (284), Expect = 7e-29
 Identities = 78/263 (29%), Positives = 137/263 (52%), Gaps = 16/263 (6%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 123
           KV+GKGS G V L + K  G++FA+K ++ +V   ++     + ++  +  + + P++  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI-CEQVLKGLLYLHHEKHII 182
            Y +F +   +  ++E+++GG L  F  + K   + Y A     +++ GL +LH  K II
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLM-FHIQDKGRFDLYRATFYAAEIVCGLQFLH-SKGII 118

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           +RDLK  N++++  G +KI DFG+         +A+TF GT +Y++PE + G KY +  D
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVD 178

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
            WS G++L E   GQ P+   ++        EL E+I     P  P    + E    +  
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDED-------ELFESI-RVDTPHYPR-WITKESKDILEK 229

Query: 303 CVQKEPQQRLSAQ-ELMTHPFLK 324
             +++P +RL     +  HPF K
Sbjct: 230 LFERDPTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  112 bits (281), Expect = 1e-28
 Identities = 80/281 (28%), Positives = 132/281 (46%), Gaps = 42/281 (14%)

Query: 66  IKVVGKGSGGIVQLVQHKW----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV 121
           IK +G+G  G V+L ++      TG+  A+K +  + EE  R    +E++I ++     +
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 122 V----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLH 176
           V    VC +    +  + +I+EY+  GSL D+L++ +  I  + L     Q+ KG+ YL 
Sbjct: 69  VKYKGVCEKPGGRS--LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--------GQANTFVGTYNYMS 228
             +  IHRDL   N+L+     VKI+DFG++ ++            G++  F     + +
Sbjct: 127 -SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF-----WYA 180

Query: 229 PERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ----------QDGWTSFYELME 277
           PE +   K+   SD+WS G+ L E  T G    SPP +          Q   T   EL++
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240

Query: 278 AIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
                P PPS P + +       +  C + EPQ R S  +L
Sbjct: 241 EGERLPRPPSCPDEVY-----DLMKLCWEAEPQDRPSFADL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 1e-28
 Identities = 59/204 (28%), Positives = 106/204 (51%), Gaps = 10/204 (4%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR-RQIAQ---ELKINQSS 116
           +D++ IK VG G+ G V LV+ + +  ++ALKV  M + E  R +Q      E ++ +  
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKV--MAIPEVIRLKQEQHVHNEKRVLKEV 58

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             P+++  + + +    + +++EY+ GG L  +L+               +++  L YLH
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH 118

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
             K I++RDLKP N+L++  G +K+TDFG +        +  T  GT  Y++PE I    
Sbjct: 119 -SKEIVYRDLKPENILLDKEGHIKLTDFGFA---KKLRDRTWTLCGTPEYLAPEVIQSKG 174

Query: 237 YGYKSDIWSLGLVLLECATGQFPY 260
           +    D W+LG+++ E   G  P+
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  112 bits (281), Expect = 3e-28
 Identities = 81/282 (28%), Positives = 134/282 (47%), Gaps = 37/282 (13%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQC 118
           +D D   +VG+G  G VQ+V+ K TG  +A+KV++ +V   +       +E  I   S  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE-----YLAAICEQVLKGLL 173
           P++     +F     + +++EY  GG L   L + +   +E     YLA +       +L
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAEL-------VL 113

Query: 174 YLH--HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF--VGTYNYMSP 229
            +H  H+   +HRD+KP N+LI+  G +K+ DFG +A + + +   N+   VGT +Y++P
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAP 172

Query: 230 ERI------SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP 283
           E +        G YG + D WSLG++  E   G+ P+        + +       +    
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL---- 228

Query: 284 PPSAPSD-QFSPEFCSFISA--CVQKEPQQRLSAQELMTHPF 322
               P D + S +F   I +  C QKE   RL  + L  HPF
Sbjct: 229 --KFPEDPKVSSDFLDLIQSLLCGQKE---RLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  111 bits (279), Expect = 3e-28
 Identities = 75/271 (27%), Positives = 133/271 (49%), Gaps = 18/271 (6%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQC 118
           D + + V+GKGS G V L + K T + +A+K+++ +V   ++     + ++  +  S + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
           P++   +  F +   +  ++EY++GG L   +++V    E +      ++  GL +LH  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH-S 119

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 238
           K II+RDLK  N++++  G +KI DFG+            TF GT +Y++PE I+   YG
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179

Query: 239 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 298
              D W+ G++L E   GQ P+   E +D    F  +ME  V  P         S E  +
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPF---EGEDEDELFQSIMEHNVAYP------KSMSKEAVA 230

Query: 299 FISACVQKEPQQRLSA-----QELMTHPFLK 324
                + K P +RL       +++  H F +
Sbjct: 231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  110 bits (275), Expect = 6e-28
 Identities = 76/287 (26%), Positives = 139/287 (48%), Gaps = 25/287 (8%)

Query: 68  VVGKGSGGIVQLVQHKWTGQFFALKV-----IQMNVEESARRQIAQELKINQSSQCPYVV 122
           ++G+G  G V   +   TG+ +A+K      I+M   E+        L +  +  CP++V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
               +F++   +  IL+ M+GG L   L +     E+ +     +++ GL ++H+ + ++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN-RFVV 119

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKS 241
           +RDLKP+N+L++  G V+I+D G++   +     A+  VGT+ YM+PE +  G  Y   +
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGTAYDSSA 177

Query: 242 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 301
           D +SLG +L +   G  P+   + +D        +   V+ P      D FSPE  S + 
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP------DSFSPELKSLLE 231

Query: 302 ACVQKEPQQRL-----SAQELMTHPFLKMYGDLNVDLSEYFTDAGSP 343
             +Q++  +RL      AQE+  H F K      +D  + +     P
Sbjct: 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFK-----GIDWQQVYLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  110 bits (277), Expect = 8e-28
 Identities = 79/289 (27%), Positives = 146/289 (50%), Gaps = 24/289 (8%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKW---TGQFFALKVIQ----MNVEESARRQIAQELKINQ 114
           + + +KV+G G+ G V LV+      TG+ +A+KV+Q    +   ++      +   +  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 174
             Q P++V  + +F +   + +IL+Y+ GG +   L +     E+ +     +++  L +
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTSGQANTFVGTYNYMSPERIS 233
           LH +  I++RD+K  N+L++  G V +TDFG+S   ++    +  +F GT  YM+PE I 
Sbjct: 121 LH-KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179

Query: 234 G-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
           G G +G   D WSLG+++ E  TG  P++   +++   +  E+   I+   PP       
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN---TQSEVSRRILKCDPPFPS--FI 234

Query: 293 SPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLN-VDLSE 335
            PE    +   ++K+P++RL      A E+  HPF K    L+   L+ 
Sbjct: 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK---GLDWEALAL 280

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  110 bits (277), Expect = 8e-28
 Identities = 73/267 (27%), Positives = 135/267 (50%), Gaps = 19/267 (7%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 123
           +V+GKGS G V L + K +G+ +A+KV++ +V   ++     + ++  ++ +   P++  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            Y  F +   +  ++E+++GG L   ++K +   E        ++   L++LH +K II+
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH-DKGIIY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLK  N+L++H G  K+ DFG+           +TF GT +Y++PE +    YG   D 
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
           W++G++L E   G  P+   E +D      +L EAI++           S +    + A 
Sbjct: 180 WAMGVLLYEMLCGHAPFE-AENED------DLFEAILND--EVVYPTWLSQDAVDILKAF 230

Query: 304 VQKEPQQRLSA------QELMTHPFLK 324
           + K P  RL +      + ++ HPF K
Sbjct: 231 MTKNPTMRLGSLTLGGEEAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  110 bits (276), Expect = 9e-28
 Identities = 70/254 (27%), Positives = 125/254 (49%), Gaps = 13/254 (5%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQC 118
           D + + V+GKGS G V L + K T + +A+K+++ +V   ++     + ++  +    + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
           P++   +  F +   +  ++EY++GG L   +++V    E        ++  GL +LH  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH-R 119

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 238
           + II+RDLK  N++++  G +KI DFG+            TF GT +Y++PE I+   YG
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG 179

Query: 239 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 298
              D W+ G++L E   GQ P+   ++ +    F  +ME  V  P         S E  S
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIMEHNVSYP------KSLSKEAVS 230

Query: 299 FISACVQKEPQQRL 312
                + K P +RL
Sbjct: 231 ICKGLMTKHPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  108 bits (272), Expect = 2e-27
 Identities = 77/267 (28%), Positives = 132/267 (49%), Gaps = 16/267 (5%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIA-QELKINQSSQCPYVVVC 124
           +V+GKG  G V   Q + TG+ +A K ++   +++     +A  E +I +     +VV  
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHII 182
             ++ +  A+ ++L  M+GG L   +  +      E        ++  GL  LH E+ I+
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER-IV 124

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           +RDLKP N+L++  G ++I+D G+ A+           VGT  YM+PE +   +Y +  D
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 183

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
            W+LG +L E   GQ P+    QQ       E +E +V +      S++FSP+  S    
Sbjct: 184 WWALGCLLYEMIAGQSPF----QQRKKKIKREEVERLVKEVQEEY-SEKFSPDARSLCKM 238

Query: 303 CVQKEPQQRL-----SAQELMTHPFLK 324
            + K+P++RL      A+E+  HP  K
Sbjct: 239 LLCKDPKERLGCQGGGAREVKEHPLFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 2e-27
 Identities = 91/312 (29%), Positives = 143/312 (45%), Gaps = 60/312 (19%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQ 117
           +D ++IKV+G+G+ G V+LVQ K TG  +A+K ++ + E   + Q+A    E  I   + 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS-EMLEKEQVAHVRAERDILAEAD 59

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGLL 173
            P+VV  Y SF     + +I+EY+ GG +   L K  T  EE    Y+A   E +L   +
Sbjct: 60  NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA---ETILA--I 114

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV--------------------------- 206
              H+   IHRD+KP NLL++ +G +K++DFG+                           
Sbjct: 115 DSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 207 SAIMASTSGQANTF-----------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            +   S+  +A T+           VGT +Y++PE      Y  + D WSLG+++ E   
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234

Query: 256 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL--- 312
           G  P+     Q+ +       E +  Q P   P    SPE    I      E ++RL   
Sbjct: 235 GYPPFCSDNPQETYRKIINWKETL--QFPDEVP---LSPEAKDLIKRLCC-EAERRLGNN 288

Query: 313 SAQELMTHPFLK 324
              E+ +HPF K
Sbjct: 289 GVNEIKSHPFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  108 bits (271), Expect = 2e-27
 Identities = 73/269 (27%), Positives = 133/269 (49%), Gaps = 21/269 (7%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ----ELKINQSSQCPYVVVC 124
           +GKG  G V   Q + TG+ +A K  ++N +   +R+  +    E +I       ++V  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACK--KLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAICEQVLKGLLYLHHEKH 180
             +F +   + +++  M+GG L   +  V       PE        Q++ GL +LH ++ 
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH-QRR 117

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 240
           II+RDLKP N+L+++ G V+I+D G++  +     +   + GT  +M+PE + G +Y + 
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS 177

Query: 241 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
            D ++LG+ L E    + P+    ++       EL + I++        D+FSP   SF 
Sbjct: 178 VDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRILND--SVTYPDKFSPASKSFC 232

Query: 301 SACVQKEPQQRL-----SAQELMTHPFLK 324
            A + K+P++RL     +   L THP  +
Sbjct: 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFR 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 4e-27
 Identities = 83/300 (27%), Positives = 134/300 (44%), Gaps = 48/300 (16%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           LE    +  +G+GS   V   + K TGQ  ALK I++  EE A     +E  + +  +  
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE--------QVLKG 171
            +V  +   ++   ++++ EY+D          +K   ++    +          Q+L+G
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYLD--------TDLKQYMDDCGGGLSMHNVRLFLFQLLRG 115

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGTYNYMS 228
           L Y H  + ++HRDLKP NLLI+ RGE+K+ DFG++    + S  + T+   V T  Y  
Sbjct: 116 LAYCHQ-RRVLHRDLKPQNLLISERGELKLADFGLA---RAKSVPSKTYSNEVVTLWYRP 171

Query: 229 PERISGG-KYGYKSDIWSLGLVLLECATGQ--FP-YSPPEQQ-------------DGW-- 269
           P+ + G  +Y    D+W +G +  E ATG+  FP  +  E Q             + W  
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231

Query: 270 -TSFYELMEAIVDQPPPS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
            +S  E         PP      AP     P         +Q EP++R+SA E M HP+ 
Sbjct: 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  107 bits (269), Expect = 6e-27
 Identities = 81/285 (28%), Positives = 131/285 (45%), Gaps = 40/285 (14%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 128
           +G+G+   V   +++ TG+  ALK I ++ EE       +E+ + +  +   +V  +   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 129 YSNGAISIILEYMDGGSLADFLKKVKT------IPEEYLAAICEQVLKGLLYLHHEKHII 182
           ++   + ++ EYMD     D  K + T      +    + +   Q+LKG+ + H E  ++
Sbjct: 68  HTENKLMLVFEYMDK----DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH-ENRVL 122

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTF---VGTYNYMSPERISGGK-Y 237
           HRDLKP NLLIN RGE+K+ DFG    +A   G   NTF   V T  Y +P+ + G + Y
Sbjct: 123 HRDLKPQNLLINKRGELKLADFG----LARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178

Query: 238 GYKSDIWSLGLVLLECATGQ--FPYSPPEQQ-------------DGWTSFYELMEAIVDQ 282
               DIWS+G ++ E  TG+  FP +  E Q               W    +L E     
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238

Query: 283 PP-PSAPSDQFSPEF----CSFISACVQKEPQQRLSAQELMTHPF 322
           P  P     Q  P         +   +Q  P+ R+SA + + HP+
Sbjct: 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  108 bits (271), Expect = 6e-27
 Identities = 74/270 (27%), Positives = 131/270 (48%), Gaps = 24/270 (8%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 123
           KV+GKGS G V L + K T + +A+KV++ +V   ++     + ++  +  +++ P++  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            +  F +   +  ++EY++GG L   +++ +   E        +V   L++LH    +I+
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG-VIY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLK  N+L++  G  K+ DFG+            TF GT +Y++PE +   +YG   D 
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQFSPEFCSFIS 301
           W+LG+++ E   GQ P+    + D       L E+I+  D   P       S E  S + 
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDD-------LFESILHDDVLYPV----WLSKEAVSILK 228

Query: 302 ACVQKEPQQRLSA-------QELMTHPFLK 324
           A + K P +RL           +  HPF K
Sbjct: 229 AFMTKNPNKRLGCVASQGGEDAIKQHPFFK 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  108 bits (270), Expect = 8e-27
 Identities = 79/273 (28%), Positives = 136/273 (49%), Gaps = 19/273 (6%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKIN-QSSQCPYVVV 123
           KV+GKGS G V L +HK   +F+A+KV+Q    +++   + I  E  +  ++ + P++V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            + SF +   +  +L+Y++GG L   L++ +   E        ++   L YLH   +I++
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH-SLNIVY 119

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           RDLKP N+L++ +G + +TDFG+       +G  +TF GT  Y++PE +    Y    D 
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
           W LG VL E   G  P+             E+ + I+++P    P+   S      +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNKPLQLKPNITNSAR--HLLEGL 230

Query: 304 VQKEPQQRLSAQ----ELMTHPFLKM--YGDLN 330
           +QK+  +RL A+    E+  H F     + DL 
Sbjct: 231 LQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLI 263

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  106 bits (266), Expect = 1e-26
 Identities = 75/268 (27%), Positives = 135/268 (50%), Gaps = 20/268 (7%)

Query: 68  VVGKGSGGIVQLVQHKWTGQFFALKV-----IQMNVEESARRQIAQELKINQSSQCPYVV 122
           ++G+G  G V   +   TG+ +A+K      I+M   E+        L +  +  CP++V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
               +F++   +S IL+ M+GG L   L +     E  +     +++ GL ++H+ + ++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN-RFVV 119

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKS 241
           +RDLKP+N+L++  G V+I+D G++   +     A+  VGT+ YM+PE +  G  Y   +
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSA 177

Query: 242 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 301
           D +SLG +L +   G  P+   + +D        +   V+ P      D FSPE  S + 
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP------DSFSPELRSLLE 231

Query: 302 ACVQKEPQQRL-----SAQELMTHPFLK 324
             +Q++  +RL      AQE+  HPF +
Sbjct: 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFR 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 1e-26
 Identities = 86/269 (31%), Positives = 134/269 (49%), Gaps = 26/269 (9%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKIN--QSSQCPYVV 122
           K++G+G+ G V L     TG+  A+K +  +   +E+++   A E +I   ++ +   +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 123 VCYQSF--YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
             Y          +SI +EYM GGS+ D LK    + E        Q+L+G+ YLH    
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH-SNM 126

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGK 236
           I+HRD+K +N+L +  G VK+ DFG S     I  S +G   +  GT  +MSPE ISG  
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG-IKSVTGTPYWMSPEVISGEG 185

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA---IVDQPPPSAPSDQFS 293
           YG K+D+WS+   ++E  T + P++           YE M A   I  QP      D  S
Sbjct: 186 YGRKADVWSVACTVVEMLTEKPPWAE----------YEAMAAIFKIATQPTKPMLPDGVS 235

Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPF 322
                F+     +E ++R +A+ L+ HPF
Sbjct: 236 DACRDFLKQIFVEE-KRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  106 bits (265), Expect = 6e-26
 Identities = 82/305 (26%), Positives = 140/305 (45%), Gaps = 49/305 (16%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQC 118
           +D +++KV+G+G+ G V+LVQ K TG  +A+K+++    +E+     I  E  I   +  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA-AICEQVLKGLLYLHH 177
            +VV  + SF     + +I+E++ GG +   L K  T+ EE     I E VL   +   H
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA--IDAIH 118

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA------------------------ST 213
           +   IHRD+KP NLL++ +G VK++DFG+   +                         ++
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 214 SGQANTF-----------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
             +A T+           VGT +Y++PE      Y    D WSLG+++ E   G  P+  
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMT 319
              Q+ +       E +V   PP  P  + + +    +  C   E   R+     +E+ +
Sbjct: 239 ETPQETYRKVMNWKETLVF--PPEVPISEKAKDL--ILRFCTDSE--NRIGSNGVEEIKS 292

Query: 320 HPFLK 324
           HPF +
Sbjct: 293 HPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  104 bits (261), Expect = 7e-26
 Identities = 75/267 (28%), Positives = 129/267 (48%), Gaps = 16/267 (5%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIA-QELKINQSSQCPYVVVC 124
           +V+GKG  G V   Q + TG+ +A K ++   +++     +A  E +I +     +VV  
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHII 182
             ++ +  A+ ++L  M+GG L   +  +      EE       ++L GL  LH E + +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-NTV 124

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           +RDLKP N+L++  G ++I+D G+ A+           VGT  YM+PE ++  +Y    D
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGL-AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPD 183

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
            W LG ++ E   GQ P+   +++       E ++  V        S +FS E  S    
Sbjct: 184 YWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRV-LETEEVYSAKFSEEAKSICKM 238

Query: 303 CVQKEPQQRLSAQ-----ELMTHPFLK 324
            + K+P+QRL  Q     E+  HPF +
Sbjct: 239 LLTKDPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  104 bits (260), Expect = 2e-25
 Identities = 66/215 (30%), Positives = 116/215 (53%), Gaps = 22/215 (10%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ----IAQELKINQSS 116
           +D + +KV+G+G+ G V +V+ K TGQ +A+K+  +N  E  +R       +E  +  + 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKI--LNKWEMLKRAETACFREERDVLVNG 58

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEE----YLAAICEQVLKG 171
              ++   + +F     + ++++Y  GG L   L K    +PE+    YLA   E VL  
Sbjct: 59  DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA---EMVLA- 114

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTYNYMSPE 230
            +   H+   +HRD+KP N+L++  G +++ DFG    ++A  + Q+N  VGT +Y+SPE
Sbjct: 115 -IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 231 RISG-----GKYGYKSDIWSLGLVLLECATGQFPY 260
            +       G+YG + D WSLG+ + E   G+ P+
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  103 bits (259), Expect = 2e-25
 Identities = 65/215 (30%), Positives = 117/215 (54%), Gaps = 22/215 (10%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ----IAQELKINQSS 116
           +D + IKV+G+G+ G V +V+ K T + +A+K+  +N  E  +R       +E  +  + 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKI--LNKWEMLKRAETACFREERNVLVNG 58

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEE----YLAAICEQVLKG 171
            C ++   + +F     + ++++Y  GG L   L K +  +PE+    Y+A   E VL  
Sbjct: 59  DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA---EMVLA- 114

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTYNYMSPE 230
            ++  H+ H +HRD+KP N+L++  G +++ DFG    +    + Q++  VGT +Y+SPE
Sbjct: 115 -IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 231 RISG-----GKYGYKSDIWSLGLVLLECATGQFPY 260
            +       GKYG + D WSLG+ + E   G+ P+
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  105 bits (264), Expect = 3e-25
 Identities = 85/285 (29%), Positives = 140/285 (49%), Gaps = 44/285 (15%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQSSQCPY--V 121
           +V+G G+ G V   +    G+ FA+KV+    M+  +  R Q      +N    C +  +
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN----CDFFSI 93

Query: 122 VVCYQSF-YSNGA-------ISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVL 169
           V C++ F   +         I+++L+Y + G L   +K      +T  E     +  QVL
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 170 KGLLYLHH--EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYN 225
              L +HH   KH+IHRD+K +N+L+   G VK+ DFG S + A+T       TF GT  
Sbjct: 154 ---LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 226 YMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV----D 281
           Y++PE      Y  K+D++SLG++L E  T + P+      DG  +  E+M   +    D
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF------DG-ENMEEVMHKTLAGRYD 263

Query: 282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
             PPS      SPE    ++A +  +P++R S+ +L+  P  K++
Sbjct: 264 PLPPS-----ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303

Length = 496

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  102 bits (255), Expect = 5e-25
 Identities = 78/284 (27%), Positives = 128/284 (45%), Gaps = 28/284 (9%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
           ++ +G+GS   V     +  GQ  ALKVI M  EE       +E  + +  +   +V+ +
Sbjct: 10  LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKHIIHR 184
              ++   ++ + EYM    LA ++ +       Y +     Q+L+GL Y+H  +HI+HR
Sbjct: 70  DIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHR 127

Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDI 243
           DLKP NLLI++ GE+K+ DFG++   +  S   ++ V T  Y  P+ + G   Y    DI
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187

Query: 244 WSLGLVLLECATGQ--FP--YSPPEQ------------QDGWTSFYELMEAIVD-QPPPS 286
           W  G + +E   GQ  FP      EQ            +D W    +L     +   P  
Sbjct: 188 WGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCK 247

Query: 287 APS-----DQFS--PEFCSFISACVQKEPQQRLSAQELMTHPFL 323
                    + S  P+     S  +   P+ R+SAQ+ + HP+ 
Sbjct: 248 PQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 5e-25
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 26/211 (12%)

Query: 66  IKVVGKGSGGIVQLVQHK--WTGQF------FALKVIQMNVEESARRQIAQELKINQSSQ 117
           IKV+G G+ G V    +K  W  +        A+KV++      A ++I  E  +  S  
Sbjct: 12  IKVLGSGAFGTV----YKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67

Query: 118 CPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGL 172
            P+VV    +C  S      + +I + M  G L D+++  K  I  +YL   C Q+ KG+
Sbjct: 68  HPHVVRLLGICLSS-----QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGM 122

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPE 230
            YL  EK ++HRDL   N+L+     VKITDFG++ ++     + +   G     +M+ E
Sbjct: 123 SYLE-EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181

Query: 231 RISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
            I    Y +KSD+WS G+ + E  T G  PY
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  101 bits (254), Expect = 8e-25
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 54/297 (18%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-----VEESARRQIA--QELKINQSS 116
           + ++ +G+G+ G V   +++ T +  ALK ++++     V  SA R+I   +ELK     
Sbjct: 3   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN-- 60

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE----QVLKGL 172
               +V  Y   +S+  ++++ EY D     D  K   +   +    I +    Q+LKGL
Sbjct: 61  ----IVRLYDVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 232
            + H   +++HRDLKP NLLIN  GE+K+ DFG++          +  V T  Y  P+ +
Sbjct: 113 AFCH-SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 171

Query: 233 SGGK-YGYKSDIWSLGLVLLECATGQFPY------------------SPPEQQDGWTSFY 273
            G K Y    D+WS G +  E A    P                   +P E+   W    
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES--WPGVS 229

Query: 274 ELMEAIVDQPPPSAPS--------DQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
           +L +    +P P  P+         + +      +   +   P QR+SA+E + HP+
Sbjct: 230 KLPD---YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 9e-25
 Identities = 69/267 (25%), Positives = 126/267 (47%), Gaps = 37/267 (13%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQF-FALKVIQ---MNVEESARRQIAQELKINQSSQCPYV 121
           +K +G G  G+V L   KW G+   A+K+I+   M+ ++       +E K+      P +
Sbjct: 9   LKELGSGQFGVVHL--GKWRGKIDVAIKMIREGAMSEDD-----FIEEAKVMMKLSHPNL 61

Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEKH 180
           V  Y        I I+ EYM  G L ++L++ K     E+L  +C  V + + YL     
Sbjct: 62  VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE-SNG 120

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKY 237
            IHRDL   N L+     VK++DFG++  +     TS Q   F     +  PE     ++
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDYSRF 178

Query: 238 GYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI-----VDQPPPSAPSDQ 291
             KSD+WS G+++ E  + G+ PY      + +++  E++E++     + +P        
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPY------ERFSN-SEVVESVSAGYRLYRP------KL 225

Query: 292 FSPEFCSFISACVQKEPQQRLSAQELM 318
              E  + + +C  ++P+ R + ++L+
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 1e-24
 Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 53/292 (18%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQ--LVQHKWTGQFF---ALKVIQMNVEESARRQIAQELK 111
           +L  E I  I+ +G+GS G+V   L +    G+     A+K +  N     R +   E  
Sbjct: 2   ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61

Query: 112 INQSSQCPYVVVCYQSFYSNGAIS------IILEYMDGGSLADFLKK----------VKT 155
           + +   C +VV         G +S      +++E M  G L  +L+           +  
Sbjct: 62  VMKEFNCHHVVRLL------GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115

Query: 156 IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-- 213
              +    +  ++  G+ YL   K  +HRDL   N ++     VKI DFG++  +  T  
Sbjct: 116 PTLQKFIQMAAEIADGMAYLA-AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY 174

Query: 214 ---SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 269
               G+    V    +M+PE +  G +  KSD+WS G+VL E AT  + PY         
Sbjct: 175 YRKGGKGLLPV---RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG------- 224

Query: 270 TSFYELMEAIVDQ---PPPSAPSDQFSPEFC-SFISACVQKEPQQRLSAQEL 317
            S  E+++ ++D      P        P+     +  C Q  P+ R +  E+
Sbjct: 225 LSNEEVLKFVIDGGHLDLPENC-----PDKLLELMRMCWQYNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  101 bits (252), Expect = 1e-24
 Identities = 78/292 (26%), Positives = 135/292 (46%), Gaps = 25/292 (8%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           LE    +  +G+G+   V   + K T    ALK I++  EE A     +E+ + +  +  
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE 178
            +V  +   ++  +++++ EY+D   L  +L     +I    +     Q+L+GL Y H  
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KY 237
           K ++HRDLKP NLLIN RGE+K+ DFG++   +  +   +  V T  Y  P+ + G   Y
Sbjct: 124 K-VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 238 GYKSDIWSLGLVLLECATGQ--FPYSPPEQQ-------------DGWTSFYELMEAIVDQ 282
             + D+W +G +  E +TG+  FP S  E+Q             + W       E     
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242

Query: 283 PPPSAP------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
            P          + +   +    +S  +Q E ++R+SA+E M HP+    G+
Sbjct: 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  102 bits (255), Expect = 2e-24
 Identities = 84/307 (27%), Positives = 140/307 (45%), Gaps = 53/307 (17%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQC 118
           ED +++KV+G+G+ G V+LVQ K TG  +A+K+++    +E+     I  E  I   +  
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA-AICEQVLKGLLYLHH 177
            +VV  + SF     + +I+E++ GG +   L K  T+ EE     I E VL   +   H
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLA--IDSIH 118

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA------------------------ST 213
           +   IHRD+KP NLL++ +G VK++DFG+   +                         ++
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 214 SGQANTF-----------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
             +A T+           VGT +Y++PE      Y    D WSLG+++ E   G  P+  
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 263 PEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSA---QEL 317
              Q+ +       E ++  P  P S  +      FC         E + R+ A   +E+
Sbjct: 239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC--------EWEHRIGAPGVEEI 290

Query: 318 MTHPFLK 324
            T+PF +
Sbjct: 291 KTNPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  100 bits (250), Expect = 2e-24
 Identities = 76/271 (28%), Positives = 130/271 (47%), Gaps = 24/271 (8%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIA-QELKINQSSQCPYVVVC 124
           +V+GKG  G V   Q + TG+ +A K ++   +++     +A  E +I +     +VV  
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEE----YLAAICEQVLKGLLYLHHE 178
             ++ +  A+ ++L  M+GG L   +  +      E+    Y A +C     GL  L  E
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELC----CGLEDLQRE 121

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 238
           + I++RDLKP N+L++ RG ++I+D G+ A+           VGT  YM+PE I+  KY 
Sbjct: 122 R-IVYRDLKPENILLDDRGHIRISDLGL-AVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179

Query: 239 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 298
           +  D W LG ++ E   GQ P+   +++         ++   DQ      S++FS +  S
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQ---EEYSEKFSEDAKS 234

Query: 299 FISACVQKEPQQRL-----SAQELMTHPFLK 324
                + K P++RL      A  +  HP  K
Sbjct: 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  101 bits (253), Expect = 2e-24
 Identities = 81/298 (27%), Positives = 144/298 (48%), Gaps = 40/298 (13%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVV 123
           I+ +G G+ G+V       +G+  A+K I    +V   A+R + +ELKI +  +   ++ 
Sbjct: 10  IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDNIIA 68

Query: 124 CYQSFYSNGA----ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
                   GA    + ++++ M    L   +   + + EE++     Q+L+GL Y+H   
Sbjct: 69  IRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN 127

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF----VGTYNYMSPE-RISG 234
            +IHRDLKPSNLL+N   E++I DFG++  ++S+  +   F    V T  Y +PE  +S 
Sbjct: 128 -VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL 186

Query: 235 GKYGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQ---QDGWTSFYE 274
            +Y    D+WS+G +  E    +  FP   Y            SP E+   + G     +
Sbjct: 187 PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRK 246

Query: 275 LMEAIVDQPPPSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
            ++ +  + P   P  +     SPE    +S  +Q +P++R++ ++ + HPFL  Y D
Sbjct: 247 YIQNLPRKQP--VPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 99.3 bits (247), Expect = 8e-24
 Identities = 76/291 (26%), Positives = 137/291 (47%), Gaps = 25/291 (8%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +E    ++ +G+G+   V   + K T    ALK I++  EE A     +E+ + +  +  
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI-CEQVLKGLLYLHHE 178
            +V  +   +++ +++++ EY+D   L  ++     I   +   I   Q+L+GL Y H  
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKY 237
           K ++HRDLKP NLLIN RGE+K+ DFG++   +  +   +  V T  Y  P+ + G  +Y
Sbjct: 124 K-VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 238 GYKSDIWSLGLVLLECATGQ--FPYSPPEQ-------------QDGWTSFYELMEAIVDQ 282
             + D+W +G +  E A+G+  FP S  E              ++ W       E     
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242

Query: 283 PPPSAP------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 327
            P   P      + +   E    ++  +Q E ++R+SA+E M H + +  G
Sbjct: 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 99.0 bits (246), Expect = 1e-23
 Identities = 65/215 (30%), Positives = 119/215 (55%), Gaps = 22/215 (10%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ----MNVEESARRQIAQELKINQSS 116
           ED + +KV+G+G+ G V +V+ K   + FA+K++     +   E+A  +  +++ +N  +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEE----YLAAICEQVLKG 171
           Q  ++   + +F     + ++++Y  GG L   L K +  +PE+    YLA   E V+  
Sbjct: 61  Q--WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA---EMVIA- 114

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTYNYMSPE 230
            +   H+ H +HRD+KP N+L++  G +++ DFG    +M   + Q++  VGT +Y+SPE
Sbjct: 115 -IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173

Query: 231 RISG-----GKYGYKSDIWSLGLVLLECATGQFPY 260
            +       GKYG + D WSLG+ + E   G+ P+
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 97.8 bits (243), Expect = 2e-23
 Identities = 64/205 (31%), Positives = 112/205 (54%), Gaps = 4/205 (1%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVV 122
           + + VVG+G+ G+V   +HK T +  A+K  + + E E  +    +ELK+ ++ +   +V
Sbjct: 4   EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIV 63

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
              ++F   G + ++ EY++   L    +    +P E + +   Q++K + + H +  I+
Sbjct: 64  ELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH-KNDIV 122

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGGKYGYKS 241
           HRD+KP NLLI+H   +K+ DFG +  ++  S    T +V T  Y SPE + G  YG   
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182

Query: 242 DIWSLGLVLLECATGQFPYSPPEQQ 266
           D+WS+G +L E + GQ P  P E +
Sbjct: 183 DMWSVGCILGELSDGQ-PLFPGESE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 19/200 (9%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVV----V 123
           +G+G+ G V   +HK T Q  ALK + M  E+      A +E+KI Q  +   VV    +
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 124 CYQ--SFYSN--GAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHH 177
           C    + Y+   G+  ++ E+ +   LA  L  K VK    E +  + + +L GL Y+H 
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSE-IKKVMKMLLNGLYYIHR 137

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERIS 233
            K I+HRD+K +N+LI   G +K+ DFG++ A   S + + N +   V T  Y  PE + 
Sbjct: 138 NK-ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL 196

Query: 234 GGK-YGYKSDIWSLGLVLLE 252
           G + YG   D+W  G ++ E
Sbjct: 197 GERDYGPPIDMWGAGCIMAE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 97.2 bits (243), Expect = 2e-23
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 18/206 (8%)

Query: 59  NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM---NVEESARRQIAQELKINQS 115
           N E +  +K++  G  G V +++HK T + F  K+I+    N  E     + Q +K N  
Sbjct: 15  NCEIVKKLKLI-DGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPM---VHQLMKDN-- 68

Query: 116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL 175
              P  +  Y S  +     +I++Y+  G L D LKK   + E  +  I  Q+++ L  L
Sbjct: 69  ---PNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDL 125

Query: 176 HHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           H + +IIH D+K  N+L +  +  + + D+G+  I+ + S     + GT +Y SPE+I G
Sbjct: 126 H-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPEKIKG 180

Query: 235 GKYGYKSDIWSLGLVLLECATGQFPY 260
             Y    D W++G++  E  TG+ P+
Sbjct: 181 HNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 97.5 bits (243), Expect = 3e-23
 Identities = 83/286 (29%), Positives = 133/286 (46%), Gaps = 52/286 (18%)

Query: 66  IKVVGKGSGGIVQLVQHK----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV 121
           I+ +GKG+ G V+L ++      TG+  A+K +Q +  E  R    +E++I +S Q   +
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-DFEREIEILKSLQHDNI 67

Query: 122 V----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLH 176
           V    VCY +   N  + +++EY+  GSL D+L+K +  +    L     Q+ KG+ YL 
Sbjct: 68  VKYKGVCYSAGRRN--LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI--------MASTSGQANTFVGTYNYMS 228
             K  +HRDL   N+L+     VKI DFG++ +             G++  F     + +
Sbjct: 126 -SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-----WYA 179

Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPY-----SPPE--------QQDGWTSFYEL 275
           PE ++  K+   SD+WS G+VL E     F Y     SPP          + G    Y L
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYEL----FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235

Query: 276 MEAIVDQ----PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           +E + +      PP  P+     E  + +  C   +P QR S  EL
Sbjct: 236 IELLKNNGRLPAPPGCPA-----EIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  100 bits (249), Expect = 5e-23
 Identities = 86/308 (27%), Positives = 141/308 (45%), Gaps = 41/308 (13%)

Query: 52  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQEL 110
           K  D +  L + + IK +G G  G V LV+HK T +FF  K I    ++E  + Q+  E+
Sbjct: 4   KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEV 63

Query: 111 KINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAI 164
            + +  +   +V     F   +N  + I++E+ D G L+  ++K       I E  +  I
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123

Query: 165 CEQVLKGLLYLHHEK------HIIHRDLKPSNLL----INHRGEV-------------KI 201
             Q+L  L Y H+ K       ++HRDLKP N+     I H G++             KI
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 202 TDFGVSAIMASTSGQANTFVGTYNYMSPERI--SGGKYGYKSDIWSLGLVLLECATGQFP 259
            DFG+S  +   S  A++ VGT  Y SPE +      Y  KSD+W+LG ++ E  +G+ P
Sbjct: 184 GDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           +          +F +L+  +  +  P  P    S E    I   +    ++R SA + + 
Sbjct: 243 FHKA------NNFSQLISEL--KRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294

Query: 320 HPFLKMYG 327
           +  +K  G
Sbjct: 295 YQIIKNVG 302

Length = 1021

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 96.3 bits (240), Expect = 7e-23
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 5/198 (2%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPY 120
           D   I+ +G+G+ G+V   ++K TGQ  A+K I++  EE      A +E+ + +  Q P 
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 121 VVVCYQSFYSNGAISIILEY--MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
           +V           + +I E+  MD     D L K + +  E + +   Q+L+G+L+ H  
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH-S 119

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KY 237
           + ++HRDLKP NLLI+++G +K+ DFG++             V T  Y +PE + G  +Y
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 238 GYKSDIWSLGLVLLECAT 255
               DIWS+G +  E AT
Sbjct: 180 STPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 96.4 bits (240), Expect = 8e-23
 Identities = 76/293 (25%), Positives = 133/293 (45%), Gaps = 41/293 (13%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQS-SQCPYVV- 122
           ++ +G+G+ G V   + K TG+  ALK  ++ ++E      A +E+ + Q  S+  Y+V 
Sbjct: 6   LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVR 65

Query: 123 -VCYQSFYSNGA---ISIILEYMDGGSLADFL-----KKVKTIPEEYLAAICEQVLKGLL 173
            +  +          + ++ EY+D   L  F+        + +P + + +   Q+LKG+ 
Sbjct: 66  LLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 174 YLHHEKH-IIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           + H  KH ++HRDLKP NLL++ +  + KI D G+    +         + T  Y +PE 
Sbjct: 125 HCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182

Query: 232 ISGGK-YGYKSDIWSLGLVLLECATGQ--FP---------------YSPPEQQDGWTSFY 273
           + G   Y    DIWS+G +  E +  Q  FP                +P EQ   W    
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV--WPGVS 240

Query: 274 ELME-AIVDQPPP---SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
           +L +     Q  P   S      SPE    +   ++ +P +R+SA+  +THP+
Sbjct: 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 81/309 (26%), Positives = 145/309 (46%), Gaps = 55/309 (17%)

Query: 59  NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKIN 113
            ++  D I  +G+G+ G V   + K TG+  ALK ++++ E+     +A R+I    ++N
Sbjct: 5   CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN 64

Query: 114 QSSQCPYVVVCYQSFYSN-----------GAISIILEYMDGGSLADFLKKVKTIPEEYLA 162
             +     +V  +   ++           GA  ++ EYMD   +      +    E+++ 
Sbjct: 65  HRN-----IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119

Query: 163 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FV 221
           +  +Q+L+GL Y H +K+ +HRD+K SN+L+N++G++K+ DFG++ +  S   +  T  V
Sbjct: 120 SFMKQLLEGLNYCH-KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 222 GTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 280
            T  Y  PE + G  +YG   D+WS G +L E     F   P  Q +   +  EL+  + 
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGEL----FTKKPIFQANQELAQLELISRLC 234

Query: 281 DQPPPSA--------------PSDQFS----PEFCSFISA--------CVQKEPQQRLSA 314
             P P+               P  Q+      EF SFI           +  +P +R +A
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTA 293

Query: 315 QELMTHPFL 323
           +E +  P+L
Sbjct: 294 EEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 74/279 (26%), Positives = 131/279 (46%), Gaps = 32/279 (11%)

Query: 55  DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF--FALKVIQMN--VEESARRQIAQEL 110
            N++  ED + I+ +G GS G V L  +K    F   A+K  + +  +++     +  E 
Sbjct: 24  KNKMKYEDFNFIRTLGTGSFGRVILATYK-NEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82

Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           KI      P+ V  Y SF     + ++LE++ GG    FL++ K  P +       Q++ 
Sbjct: 83  KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YL    +I++RDLKP NLL++  G +K+TDFG + ++ +   +  T  GT  Y++PE
Sbjct: 143 IFEYLQ-SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---RTYTLCGTPEYIAPE 198

Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
            +    +G  +D W+LG+ + E   G  P+   E       + +++E I+  P       
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQKILEGIIYFP------- 248

Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 329
           +F    C  +              ++L++H   K YG+L
Sbjct: 249 KFLDNNCKHL-------------MKKLLSHDLTKRYGNL 274

Length = 340

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 82/321 (25%), Positives = 122/321 (38%), Gaps = 83/321 (25%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVV 122
           IK +G G+ G V LV+   T   +A+K ++   +   R Q A    E  I   +   +VV
Sbjct: 6   IKTIGIGAFGEVCLVRKVDTNALYAMKTLR-KADVLMRNQAAHVKAERDILAEADNEWVV 64

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYL 175
             Y SF     +  +++Y+ GG +   L ++    E+        L    E V       
Sbjct: 65  KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV------- 117

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFG------------------------------ 205
            H+   IHRD+KP N+LI+  G +K+TDFG                              
Sbjct: 118 -HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 206 VSAIMAS-------------TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
            S I                    A++ VGT NY++PE +    Y    D WS+G++L E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Query: 253 CATGQFPY---SPPEQQD---GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
              GQ P+   +P E Q     W +   +        P  A   + S E    I      
Sbjct: 237 MLVGQPPFLADTPAETQLKVINWETTLHI--------PSQA---KLSREASDLILRLC-C 284

Query: 307 EPQQRL---SAQELMTHPFLK 324
             + RL    A E+  HPF K
Sbjct: 285 GAEDRLGKNGADEIKAHPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 94.3 bits (234), Expect = 4e-22
 Identities = 73/278 (26%), Positives = 131/278 (47%), Gaps = 25/278 (8%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 128
           +G+G+   V   + K T    ALK I++  EE A     +E+ + ++ +   +V  +   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 129 YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE-QVLKGLLYLHHEKHIIHRDLK 187
           ++   ++++ EY+D   L  +L     +   +   I   Q+L+GL Y H  K I+HRDLK
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK-ILHRDLK 130

Query: 188 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSL 246
           P NLLIN +GE+K+ DFG++   +  +   +  V T  Y  P+ + G  +Y    D+W +
Sbjct: 131 PQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGV 190

Query: 247 GLVLLECATGQ--FPYSPPEQ-------------QDGW---TSFYELMEAIVDQPPPSA- 287
           G +L E ATG+  FP S  ++             ++ W   TS  E    +  Q      
Sbjct: 191 GCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPL 250

Query: 288 --PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
              + +   +    +S+ +  E + R+SA+  + H + 
Sbjct: 251 INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 94.0 bits (234), Expect = 4e-22
 Identities = 73/289 (25%), Positives = 126/289 (43%), Gaps = 45/289 (15%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQ--HKWTGQFF---ALKVIQMNVEESARRQIAQELKI 112
           +  + I   + +G+G+ G V L +  H          A+K ++      AR+   +E ++
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61

Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--------------KVKTIPE 158
             + Q   +V  Y          ++ EYM+ G L  FL+               +  +  
Sbjct: 62  LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST----- 213
             L  I  Q+  G++YL   +H +HRDL   N L+ +   VKI DFG+S  + +T     
Sbjct: 122 SQLLQIAVQIASGMVYLA-SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRV 180

Query: 214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSF 272
            G     +    +M PE I   K+  +SD+WS G+VL E  T G+ P+          S 
Sbjct: 181 GGHTMLPI---RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG-------LSN 230

Query: 273 YELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
            E++E I    + Q P + P      E    +  C +++PQQR++ +++
Sbjct: 231 EEVIECITQGRLLQRPRTCP-----SEVYDIMLGCWKRDPQQRINIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 5e-22
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 68/300 (22%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIA--QELKINQSSQCPYV 121
           +G+G+ G+V   + K TG+  ALK I++  E+     +A R+I+  +EL        P +
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNI 60

Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAA-----ICEQVLKGLLYLH 176
           V      +S   + ++ E++D     D  K + + P   L          Q+L+G+ Y H
Sbjct: 61  VRLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGTYN-------Y 226
             + ++HRDLKP NLLI+  G +K+ DFG+          A  F   V TY        Y
Sbjct: 117 SHR-VLHRDLKPQNLLIDREGALKLADFGL----------ARAFGVPVRTYTHEVVTLWY 165

Query: 227 MSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---------------YSPPEQQDG 268
            +PE + G + Y    DIWS+G +  E    +  FP                +P E  D 
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDE--DV 223

Query: 269 W---TSFYELMEAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           W   TS  +                      +    +S  +  +P +R+SA+  + HP+ 
Sbjct: 224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 82/308 (26%), Positives = 135/308 (43%), Gaps = 47/308 (15%)

Query: 59  NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKIN 113
            L D + +  +G+G+ G V   +   TG+  ALK I M+ E+     +A R+I    K+ 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 114 QSSQCPYVVVCY----QSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQ 167
             +  P + +      +S    G++ ++  YMD   L+  L+   VK + E  +     Q
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVK-LTESQIKCYMLQ 123

Query: 168 VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI------MASTSGQANT-- 219
           +L+G+ YLH E HI+HRD+K +N+LI+++G +KI DFG++             G   T  
Sbjct: 124 LLEGINYLH-ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182

Query: 220 ---FVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FPYS------------ 261
               V T  Y  PE + G + Y    DIW +G V  E  T +                  
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242

Query: 262 --PPEQQD--GWTSFYELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSA 314
              P ++   GW S             P    ++F    PE    +S  +  +P +RL+A
Sbjct: 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA 302

Query: 315 QELMTHPF 322
            + + HP+
Sbjct: 303 SDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 53/299 (17%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA-RRQIAQELKINQSSQCPYVVVC 124
           ++ VG G+ G+V   + + TGQ  A+K I          ++  +ELK+ +  +   ++  
Sbjct: 15  LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74

Query: 125 YQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
              F S    I  + E + G  L   L   + + ++++     Q+L+GL Y+H    ++H
Sbjct: 75  SDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVH-SAGVVH 131

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSD 242
           RDLKPSN+LIN   ++KI DFG++ I      Q   +V T  Y +PE  ++  KY  + D
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVD 188

Query: 243 IWSLGLVLLECATGQ--FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS-- 298
           IWS G +  E   G+  FP      Q     F  + + +        P D      CS  
Sbjct: 189 IWSAGCIFAEMLEGKPLFPGKDHVNQ-----FSIITDLL------GTPPDDVINTICSEN 237

Query: 299 ---FISACVQKE--------------------------PQQRLSAQELMTHPFLKMYGD 328
              F+ +  ++E                          PQ+R+SA E + HP+L  Y D
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 17/194 (8%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIA--QELKINQSSQCPYV 121
           +G+G+ GIV   +   +G+  ALK ++M+ E      S+ R+I     L+     +   V
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 122 VVCYQSFYSNGAISIILEY--MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
           VV         +I +++EY   D  SL D +    +  +  +  +  Q+L+GL YLH   
Sbjct: 75  VVGKHL----DSIFLVMEYCEQDLASLLDNMPTPFSESQ--VKCLMLQLLRGLQYLHEN- 127

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
            IIHRDLK SNLL+  +G +KI DFG++      +      V T  Y +PE + G     
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187

Query: 240 KS-DIWSLGLVLLE 252
            + D+W++G +L E
Sbjct: 188 TAIDMWAVGCILAE 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 91.0 bits (226), Expect = 3e-21
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 34/263 (12%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VC 124
           +GKG+ G V     K      A+K  +  +    +R+  QE +I +    P +V    VC
Sbjct: 3   IGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            Q       I I++E + GGSL  FL+K K  +  + L  +      G+ YL   K+ IH
Sbjct: 62  VQKQ----PIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE-SKNCIH 116

Query: 184 RDLKPSNLLINHRGEVKITDFGVS-----AIMASTSGQANTFVGTYNYMSPERISGGKYG 238
           RDL   N L+     +KI+DFG+S      I   + G     +    + +PE ++ G+Y 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI---KWTAPEALNYGRYT 173

Query: 239 YKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS--FYELMEAIVDQPPPSAPSDQFSPE 295
            +SD+WS G++L E  + G  PY       G ++    E +E+    P P     Q  PE
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYP------GMSNQQTRERIESGYRMPAP-----QLCPE 222

Query: 296 FCSFI-SACVQKEPQQRLSAQEL 317
               +   C   +P+ R S  E+
Sbjct: 223 EIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 90.3 bits (224), Expect = 6e-21
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 15/210 (7%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF-FALKVIQMNVEES-ARRQIAQELKINQS 115
           ++ +D+  +K +G G  G+V+    KW GQ+  A+K+I+   E S +  +  +E K+   
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKY--GKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMK 55

Query: 116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLY 174
                +V  Y        I I+ EYM  G L ++L++     +   L  +C+ V +G+ Y
Sbjct: 56  LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPER 231
           L   K  IHRDL   N L++ +G VK++DFG+S  +     +  + VG+     +  PE 
Sbjct: 116 LE-SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEV 172

Query: 232 ISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           +   K+  KSD+W+ G+++ E  + G+ PY
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 89.9 bits (223), Expect = 8e-21
 Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 31/272 (11%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF-FALKVIQMNVEESARRQIAQELKINQSS 116
           +N  ++  +K +G G  G+V L   KW  Q   A+K I  N    +     +E K+    
Sbjct: 1   INPSELTFMKELGSGQFGVVHL--GKWRAQIKVAIKAI--NEGAMSEEDFIEEAKVMMKL 56

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYL 175
             P +V  Y        + I+ E+M+ G L ++L++ +  + ++ L ++C+ V +G+ YL
Sbjct: 57  SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL 116

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERI 232
                 IHRDL   N L++  G VK++DFG++  +     TS     F     +  PE  
Sbjct: 117 E-RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--PVKWSPPEVF 173

Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 291
           +  KY  KSD+WS G+++ E  T G+ P+          S YE++E I      S     
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-------KSNYEVVEMI------SRGFRL 220

Query: 292 FSPEFCS-----FISACVQKEPQQRLSAQELM 318
           + P+  S      + +C  ++P+ R +  EL+
Sbjct: 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 90.0 bits (223), Expect = 9e-21
 Identities = 74/269 (27%), Positives = 136/269 (50%), Gaps = 33/269 (12%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA-RRQIAQELKINQSS 116
           LNL+ +   +++G+G  G V  +Q ++TGQ  A+K I+ +V   A   + A   K++  +
Sbjct: 3   LNLQKLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKN 60

Query: 117 QCPYV-VVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLL 173
               + V+ +   Y      I++E M  G+L +FL+      +    L      V +G+ 
Sbjct: 61  LVRLLGVILHNGLY------IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           YL  +K ++HRDL   N+L++  G  K++DFG++     + G  N+ +    + +PE + 
Sbjct: 115 YLESKK-LVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPV-KWTAPEALK 170

Query: 234 GGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAP 288
             K+  KSD+WS G++L E  + G+ PY  P+      S  E+ E +      +PP   P
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPY--PK-----MSLKEVKECVEKGYRMEPPEGCP 223

Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           +D +       +++C + EP++R S  +L
Sbjct: 224 ADVY-----VLMTSCWETEPKKRPSFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 83/288 (28%), Positives = 135/288 (46%), Gaps = 48/288 (16%)

Query: 72  GSGGIVQLVQHKWTGQFFALKVIQMNVEES-----ARRQIAQELKINQSS--QCPYVVVC 124
           G+ G+V   + K TG+  ALK ++M  E+      + R+I   LK+   +      VVV 
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV- 74

Query: 125 YQSFYSNGA----ISIILEYM--DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
                  G+    I +++EY+  D  SL + +K+     E  +  +  Q+L G+ +LH +
Sbjct: 75  -------GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE--VKCLMLQLLSGVAHLH-D 124

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-Y 237
             I+HRDLK SNLL+N+RG +KI DFG++    S        V T  Y +PE + G K Y
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEY 184

Query: 238 GYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWTSFYELMEA---I 279
               D+WS+G +  E  T +  FP  S  +Q            +  W  F EL  A    
Sbjct: 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKT 244

Query: 280 VDQPPPSAPSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPF 322
             + P +    +F     S      ++  +  +P +R+SA++ + HP+
Sbjct: 245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 88.5 bits (220), Expect = 4e-20
 Identities = 74/290 (25%), Positives = 134/290 (46%), Gaps = 44/290 (15%)

Query: 67  KVVGK-GSGGI--VQLVQHKWTGQFFALKVIQMN-----VEESAR-RQIAQELKINQSSQ 117
           K++GK G G    V   Q + TG+++A+K   M      +E+    R+I Q L+  + S 
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREI-QALR--RLSP 56

Query: 118 CPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLY 174
            P ++   +  +    G ++++ E MD  +L + +K  K  +PE+ + +   Q+LK L +
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-S 233
           +H    I HRD+KP N+LI     +K+ DFG S     +      ++ T  Y +PE + +
Sbjct: 116 MHR-NGIFHRDIKPENILI-KDDILKLADFG-SCRGIYSKPPYTEYISTRWYRAPECLLT 172

Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ-DGWTSFYELM-----EAIVDQPPPSA 287
            G YG K DIW++G V  E  +  FP  P   + D     ++++     E +        
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231

Query: 288 PSDQF---------------SPEFCSFISACVQKEPQQRLSAQELMTHPF 322
            +  F               S E    +   +  +P +R++A++ + HP+
Sbjct: 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 89.2 bits (222), Expect = 5e-20
 Identities = 86/314 (27%), Positives = 138/314 (43%), Gaps = 77/314 (24%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI----QMNVEESAR--RQIA--QELKINQS 115
           + ++ +GKG+ GIV     + T +  ALK I    + N  ++ R  R+I   QEL     
Sbjct: 10  EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELG---- 64

Query: 116 SQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKV--KTIPEE----YLAAICEQ 167
              P +V       +  +  I ++ EYM+     D L  V    I E+    Y   I  Q
Sbjct: 65  -DHPNIVKLLNVIKAENDKDIYLVFEYME----TD-LHAVIRANILEDVHKRY---IMYQ 115

Query: 168 VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG----VSAIMASTSGQANT-FVG 222
           +LK L Y+H   ++IHRDLKPSN+L+N    VK+ DFG    +S +  +      T +V 
Sbjct: 116 LLKALKYIH-SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 223 TYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQ 265
           T  Y +PE + G  +Y    D+WS+G +L E   G+  FP +              PP  
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234

Query: 266 QD--------GWTSFYELMEAIVDQPP-------PSAPSDQFSPEFCSFISACVQKEPQQ 310
           +D          T    +++++  +P        P A  D         +   +   P +
Sbjct: 235 EDIESIKSPFAAT----MLDSLPSRPRKPLDELLPKASDDAL-----DLLKKLLVFNPNK 285

Query: 311 RLSAQELMTHPFLK 324
           RL+A+E + HP++ 
Sbjct: 286 RLTAEEALEHPYVA 299

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 88.5 bits (219), Expect = 5e-20
 Identities = 77/285 (27%), Positives = 127/285 (44%), Gaps = 34/285 (11%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVV- 122
           +G G+ G V   +   +G F ALK +++   E     S  R++A  LK  ++   P +V 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL-LKRLEAFDHPNIVR 66

Query: 123 ---VCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLH 176
              VC  S       ++++ E++D   L  +L KV    +P E +  +  Q L+GL +LH
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
               I+HRDLKP N+L+   G+VK+ DFG++ I  S        V T  Y +PE +    
Sbjct: 126 ANC-IVHRDLKPENILVTSGGQVKLADFGLARIY-SCQMALTPVVVTLWYRAPEVLLQST 183

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP---SAPSDQFS 293
           Y    D+WS+G +  E    +  +    + D     ++L+    +   P   + P   FS
Sbjct: 184 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFS 243

Query: 294 PEFCSFISACVQK---------------EPQQRLSAQELMTHPFL 323
           P     + + V +                P +R+SA   + HPF 
Sbjct: 244 PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 88.3 bits (219), Expect = 5e-20
 Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 48/292 (16%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-----ESARRQIAQELKINQSSQCPY 120
           ++ +G+G+ G+V   ++K TG+  ALK I+++ E      +A R+I+   ++N     P 
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH----PN 60

Query: 121 VVVCYQSFYSNGAISIILE--------YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 172
           +V      ++   + ++ E        +MD   L+        IP   + +   Q+L+GL
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSG-------IPLPLIKSYLFQLLQGL 113

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 232
            + H  + ++HRDLKP NLLIN  G +K+ DFG++             V T  Y +PE +
Sbjct: 114 AFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172

Query: 233 SGGKYGYKS--DIWSLGLVLLECATGQ--FPY-SPPEQ------------QDGWTSFYEL 275
            G KY Y +  DIWSLG +  E  T +  FP  S  +Q            +  W     L
Sbjct: 173 LGCKY-YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231

Query: 276 MEAIVDQP--PPSAPSD---QFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
            +     P       S        +    +S  +  +P +R+SA+  + HPF
Sbjct: 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 5e-20
 Identities = 66/270 (24%), Positives = 121/270 (44%), Gaps = 31/270 (11%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
           +N +++     +GKG  G V  +   + GQ  A+K ++ +   +A +    E  +  + +
Sbjct: 3   INSKELKLGATIGKGEFGDV--MLGDYRGQKVAVKCLKDDS--TAAQAFLAEASVMTTLR 58

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYL 175
            P +V           + I+ EYM  GSL D+L+      I           V +G+ YL
Sbjct: 59  HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERIS 233
             EK+ +HRDL   N+L++     K++DFG++    ++ GQ     G     + +PE + 
Sbjct: 119 E-EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQD---SGKLPVKWTAPEALR 172

Query: 234 GGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAP 288
             K+  KSD+WS G++L E  + G+ PY P           +++  +      + P   P
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLK------DVVPHVEKGYRMEAPEGCP 225

Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQELM 318
                PE    +  C + +P +R + ++L 
Sbjct: 226 -----PEVYKVMKDCWELDPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 89.3 bits (221), Expect = 8e-20
 Identities = 90/328 (27%), Positives = 135/328 (41%), Gaps = 72/328 (21%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVV 122
           IK +G G+ G V L +   T   +A+K ++   +   R Q+A    E  I   +   +VV
Sbjct: 6   IKTLGIGAFGEVCLARKVDTKALYAMKTLRKK-DVLLRNQVAHVKAERDILAEADNEWVV 64

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
             Y SF     +  +++Y+ GG +   L ++   PE+ LA      L   +   H+   I
Sbjct: 65  RLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED-LARFYIAELTCAVESVHKMGFI 123

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMAST-------SGQ------------------- 216
           HRD+KP N+LI+  G +K+TDFG+      T       SG                    
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183

Query: 217 ---------------------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
                                A++ VGT NY++PE +    Y    D WS+G++L E   
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 243

Query: 256 GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD-QFSPEFCSFI-SACVQKEPQQ 310
           GQ P+   +P E Q         M+ I  Q     P   + SPE    I   C  + P+ 
Sbjct: 244 GQPPFLAQTPLETQ---------MKVINWQTSLHIPPQAKLSPEASDLIIKLC--RGPED 292

Query: 311 RL---SAQELMTHPFLKMYGDLNVDLSE 335
           RL    A E+  HPF K   D + DL +
Sbjct: 293 RLGKNGADEIKAHPFFKTI-DFSSDLRQ 319

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.9 bits (215), Expect = 9e-20
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 19/200 (9%)

Query: 77  VQLVQHKWTGQFFAL---------KVIQMNVEESA--RRQIAQELKINQSSQCPYVVVCY 125
           + LVQ   +GQF  +         KV    + E A       +E ++      P +V  Y
Sbjct: 6   LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHR 184
                   I ++ E+M+ G L+D+L+  +    +E L  +C  V +G+ YL    ++IHR
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE-SSNVIHR 124

Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKS 241
           DL   N L+     VK++DFG++  +     TS     F     + SPE  S  KY  KS
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYSSKS 182

Query: 242 DIWSLGLVLLEC-ATGQFPY 260
           D+WS G+++ E  + G+ PY
Sbjct: 183 DVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 86.7 bits (215), Expect = 1e-19
 Identities = 60/244 (24%), Positives = 110/244 (45%), Gaps = 14/244 (5%)

Query: 72  GSGGIVQLVQHKWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS 130
           GSG   ++ +  W  +   A+K+++ +     +    +E++  +  +  +++  +     
Sbjct: 15  GSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 131 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
              + II E M+ GSL  FL+    + +P   L  +  QV +G+ YL  E++ IHRDL  
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE-EQNSIHRDLAA 132

Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
            N+L+      K+ DFG++ ++      ++     Y + +PE  S G +  KSD+WS G+
Sbjct: 133 RNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGI 192

Query: 249 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 307
           +L E  T GQ PY      +    + ++        P   P      E    +  C   E
Sbjct: 193 LLYEMFTYGQVPYPGMNNHE---VYDQITAGYRMPCPAKCP-----QEIYKIMLECWAAE 244

Query: 308 PQQR 311
           P+ R
Sbjct: 245 PEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 86.3 bits (214), Expect = 1e-19
 Identities = 58/180 (32%), Positives = 93/180 (51%), Gaps = 16/180 (8%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++     + +++  +E  +      P +V    VC         + +++E    G 
Sbjct: 27  AVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-----PLMLVMELAPLGP 81

Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 205
           L  +LKK + IP   L  +  QV  G+ YL   KH +HRDL   N+L+ +R + KI+DFG
Sbjct: 82  LLKYLKKRREIPVSDLKELAHQVAMGMAYLE-SKHFVHRDLAARNVLLVNRHQAKISDFG 140

Query: 206 VS-AIMA-STSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           +S A+ A S   +A T  G +   + +PE I+ GK+  KSD+WS G+ L E  + G  PY
Sbjct: 141 MSRALGAGSDYYRATT-AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 61/189 (32%), Positives = 96/189 (50%), Gaps = 27/189 (14%)

Query: 134 ISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           I I+ EYM  GSL DFLK    K +    L  +  Q+ +G+ YL   ++ IHRDL   N+
Sbjct: 76  IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE-SRNYIHRDLAARNI 134

Query: 192 LINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
           L+      KI DFG++ ++     T+ +   F     + +PE  + G++  KSD+WS G+
Sbjct: 135 LVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIKSDVWSFGI 192

Query: 249 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ----P-PPSAPSDQFSPEFCSFISA 302
           +L E  T G+ PY       G T+  E++E  V++    P PP+ P      E    +  
Sbjct: 193 LLTEIVTYGRVPYP------GMTN-REVLEQ-VERGYRMPRPPNCP-----EELYDLMLQ 239

Query: 303 CVQKEPQQR 311
           C  K+P++R
Sbjct: 240 CWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 83/291 (28%), Positives = 134/291 (46%), Gaps = 49/291 (16%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA--RRQIAQELKINQSSQCPYV 121
           D I+++GKG  G V L       +  ALK I+ ++ E+   +++  +E KI      P +
Sbjct: 5   DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGI 64

Query: 122 VVCYQSFYSNG-AISIILEYMDGGSLADFLKKV---KTIPEEY--------LAAICEQVL 169
           V  Y S  S+G  +   + Y++G +L   LK V   +++ +E           +I  ++ 
Sbjct: 65  VPVY-SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG------------------VSAIMA 211
             + Y+H  K ++HRDLKP N+L+   GEV I D+G                     I  
Sbjct: 124 ATIEYVH-SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 271
           S+       VGT +YM+PER+ G      +DI++LG++L +  T  FPY    ++ G   
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY---RRKKGRKI 239

Query: 272 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK----EPQQRL-SAQEL 317
            Y   + I+  P   AP  +  P    F+S    K    +P +R  S QEL
Sbjct: 240 SYR--DVILS-PIEVAPYREIPP----FLSQIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 86.5 bits (214), Expect = 2e-19
 Identities = 66/258 (25%), Positives = 121/258 (46%), Gaps = 12/258 (4%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQ 126
           +GKG  G V  VQ K TG+ +A K +      ++S  +    E +I +    P++V    
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 127 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI--CEQVLKGLLYLHHEKHIIHR 184
           +F S   + +++  M+GG L   +  V     E    I    Q+  G+L+LH    I++R
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH-SMDIVYR 119

Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGGKYGYKSDI 243
           D+KP N+L++ +G  +++D G++  +    G+  T   GT  YM+PE +    Y Y  D 
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEILKEEPYSYPVDW 177

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
           +++G  + E   G+ P+   +++    +  EL    + +         F+ E        
Sbjct: 178 FAMGCSIYEMVAGRTPFKDHKEK---VAKEELKRRTL-EDEVKFEHQNFTEESKDICRLF 233

Query: 304 VQKEPQQRLSAQELMTHP 321
           + K+P+ RL ++E    P
Sbjct: 234 LAKKPEDRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 61/186 (32%), Positives = 89/186 (47%), Gaps = 29/186 (15%)

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 226
           Q+L+GL Y+H    IIHRDLKPSN+ +N   E+KI DFG++     T  +   +V T  Y
Sbjct: 126 QILRGLKYIH-SAGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMTGYVATRWY 181

Query: 227 MSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQ-------DGWTSFYELM 276
            +PE + +   Y    DIWS+G ++ E  TG+  FP S    Q        G T   EL+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG-TPDEELL 240

Query: 277 EAIVD-------QPPPSAPSDQF-------SPEFCSFISACVQKEPQQRLSAQELMTHPF 322
           + I         Q  P  P   F       +P     +   +  +P +R++A E + HP+
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300

Query: 323 LKMYGD 328
           L  Y D
Sbjct: 301 LAEYHD 306

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 86.3 bits (213), Expect = 4e-19
 Identities = 73/285 (25%), Positives = 125/285 (43%), Gaps = 26/285 (9%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 123
           + ++ +G+GS   V   + K  G+  ALKVI++  EE       +E  + +  +   +V+
Sbjct: 8   EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            +   ++   ++++ EY+         K    +  E +     Q+L+GL Y+H +++I+H
Sbjct: 68  LHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH-QRYILH 126

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSD 242
           RDLKP NLLI+  GE+K+ DFG++   +  S   +  V T  Y  P+ + G  +Y    D
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLD 186

Query: 243 IWSLGLVLLECATG--QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           +W +G + +E   G   FP     Q      F  L     D  P       F PE  +  
Sbjct: 187 MWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLY 246

Query: 301 SA----------------------CVQKEPQQRLSAQELMTHPFL 323
           S                        +Q  P+ RLSAQ  ++H + 
Sbjct: 247 SPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 85.0 bits (210), Expect = 4e-19
 Identities = 56/181 (30%), Positives = 94/181 (51%), Gaps = 17/181 (9%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+KV++   E+S R ++ +E +I      PY+V    VC        A+ +++E   GG 
Sbjct: 26  AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-----ALMLVMEMASGGP 80

Query: 146 LADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L  FL  K   I    +  +  QV  G+ YL   K+ +HRDL   N+L+ ++   KI+DF
Sbjct: 81  LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE-GKNFVHRDLAARNVLLVNQHYAKISDF 139

Query: 205 GVSAIMASTSG--QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFP 259
           G+S  + +     +A +  G +   + +PE I+  K+  +SD+WS G+ + E  + GQ P
Sbjct: 140 GLSKALGADDSYYKARSA-GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Query: 260 Y 260
           Y
Sbjct: 199 Y 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 84.5 bits (209), Expect = 5e-19
 Identities = 67/253 (26%), Positives = 111/253 (43%), Gaps = 32/253 (12%)

Query: 77  VQLVQHKWTGQFFALKVIQMNVEES-ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           V LV    T Q F LK ++ + E S  R  I            P +V  ++   S  ++ 
Sbjct: 9   VLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPH-------CVPNMVCLHKYIVSEDSVF 61

Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           ++L++ +GG L   + K   IPEE +     +++  L  LH E  I+ RDL P+N+L++ 
Sbjct: 62  LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG-IVCRDLNPNNILLDD 120

Query: 196 RGEVKITDFGV-SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
           RG +++T F   S +  S  G+A   +    Y +PE     +     D WSLG +L E  
Sbjct: 121 RGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPEVGGISEETEACDWWSLGAILFELL 176

Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
           TG              +  E   + ++        +  S E  S +   +Q  P +RL A
Sbjct: 177 TG-------------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223

Query: 315 -----QELMTHPF 322
                +++ +HPF
Sbjct: 224 GVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 86.0 bits (213), Expect = 6e-19
 Identities = 78/312 (25%), Positives = 134/312 (42%), Gaps = 59/312 (18%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFA---LKVIQMNVEESARRQ----------IAQELKIN 113
             +G+G+ G V+      TG+  A   +K+I+++ + +  RQ            +ELKI 
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KT-IPEEYLAAICEQVL 169
              +   ++     +     I+++++ M        LKKV   K  + E  +  I  Q+L
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMASD-----LKKVVDRKIRLTESQVKCILLQIL 129

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS------AIMASTSGQANTF--- 220
            GL  LH + + +HRDL P+N+ IN +G  KI DFG++          + S         
Sbjct: 130 NGLNVLH-KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 221 -----VGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQ-DGWTSFY 273
                V T  Y +PE + G  KY +  D+WS+G +  E  TG+ P  P E + D     +
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLGRIF 247

Query: 274 ELMEAIVDQPPPSAPS----DQFSP----------EFCS-----FISACVQKEPQQRLSA 314
           EL+    +   P A       +F+P             S      + + ++  P +R+SA
Sbjct: 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307

Query: 315 QELMTHPFLKMY 326
           +E + H + K  
Sbjct: 308 KEALKHEYFKSD 319

Length = 335

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 84.7 bits (209), Expect = 7e-19
 Identities = 77/271 (28%), Positives = 119/271 (43%), Gaps = 41/271 (15%)

Query: 69  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VC 124
           +G+G+ G V   + +      A+K  +  +    + +  QE +I +    P +V    VC
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLK------KVKTIPEEYLAAICEQVLKGLLYLHHE 178
            Q       I I++E + GG    FL+      KVK      L  + E    G+ YL   
Sbjct: 63  TQ----KQPIYIVMELVQGGDFLTFLRTEGPRLKVKE-----LIQMVENAAAGMEYLE-S 112

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVS-----AIMASTSGQANTFVGTYNYMSPERIS 233
           KH IHRDL   N L+  +  +KI+DFG+S      + AST G     V    + +PE ++
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV---KWTAPEALN 169

Query: 234 GGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
            G+Y  +SD+WS G++L E  + G  PY+    Q       E +E  V  P P    +  
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT----REAIEQGVRLPCP----ELC 221

Query: 293 SPEFCSFISACVQKEPQQRLS----AQELMT 319
                  +  C + +P QR S     QEL +
Sbjct: 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 84.5 bits (209), Expect = 7e-19
 Identities = 50/147 (34%), Positives = 80/147 (54%), Gaps = 15/147 (10%)

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK  +   +    L  +  Q+ +G+ ++  
Sbjct: 67  YAVVTQEPIY------IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE- 119

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 234
            K+ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 177

Query: 235 GKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G +  KSD+WS G++L E  T G+ PY
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 7e-19
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 28/217 (12%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI-----QMNVEESARRQIAQELKINQS 115
                +  +G+G+ G+V    HK TG   A+K I     Q   + + R     E+KI + 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-----EIKILRR 59

Query: 116 SQCPYV-----VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQV 168
            +   +     ++   SF S   + I+ E M+     D  K +KT  +  +++     Q+
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELME----TDLYKLIKTQHLSNDHIQYFLYQI 115

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST---SGQANTFVGTYN 225
           L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ I       +G    +V T  
Sbjct: 116 LRGLKYIH-SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 226 YMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FP 259
           Y +PE  ++   Y    DIWS+G +L E  + +  FP
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 84.6 bits (209), Expect = 8e-19
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 17/209 (8%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA---RRQIAQELKINQ 114
           LN++++  ++ +GKG  G V L  ++  G   A+K I+ +    A      +  +L+ + 
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSN 60

Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGL 172
             Q   V+V        G + I+ EYM  GSL D+L+      +  + L      V + +
Sbjct: 61  LVQLLGVIV-----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 232
            YL    + +HRDL   N+L++     K++DFG++   +ST       V    + +PE +
Sbjct: 116 EYLE-ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEAL 171

Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
              K+  KSD+WS G++L E  + G+ PY
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 85.0 bits (210), Expect = 8e-19
 Identities = 74/252 (29%), Positives = 114/252 (45%), Gaps = 40/252 (15%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K ++    ESAR+   +E ++    Q  ++V  Y        + ++ EYM  G L  F
Sbjct: 39  AVKALK-EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97

Query: 150 LKK----VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           L+      K +               + AI  Q+  G++YL    H +HRDL   N L+ 
Sbjct: 98  LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA-SLHFVHRDLATRNCLVG 156

Query: 195 HRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 249
               VKI DFG+S  + ST      G+    +    +M PE I   K+  +SDIWS G+V
Sbjct: 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI---RWMPPESILYRKFTTESDIWSFGVV 213

Query: 250 LLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 305
           L E  T G+ P+   S  E  +  T   EL      + P + P     PE  + +  C Q
Sbjct: 214 LWEIFTYGKQPWYQLSNTEAIECITQGREL------ERPRTCP-----PEVYAIMQGCWQ 262

Query: 306 KEPQQRLSAQEL 317
           +EPQQR+  +++
Sbjct: 263 REPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 73/319 (22%), Positives = 134/319 (42%), Gaps = 76/319 (23%)

Query: 69  VGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEE------SARRQIA--QELKINQSSQC 118
           +G+G+ G V   + K    G+ +A+K  + + E+      SA R+IA  +ELK       
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK------H 61

Query: 119 PYVVVCYQSFYSNGA--ISIILEYMDGGSLADFL--------KKVKTIPEEYLAAICEQV 168
             VV   + F  +    + ++ +Y +     D           K  +IP   + ++  Q+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMASTSGQ---ANTFV 221
           L G+ YLH    ++HRDLKP+N+L+      RG VKI D G++ +  +        +  V
Sbjct: 118 LNGVHYLH-SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 222 GTYNYMSPERISGGKYGYKS-DIWSLGLVLLE---------CATGQFPYSPPEQQDGWTS 271
            T  Y +PE + G ++  K+ DIW++G +  E             +   S P Q+D    
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236

Query: 272 FYELM--------EAIVDQPPPSAPSDQFSPEF--CSFISACVQK--------------- 306
            +E++          I   P        F  +    + ++  ++K               
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296

Query: 307 ---EPQQRLSAQELMTHPF 322
              +P +R++A+E + HP+
Sbjct: 297 LEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 22/209 (10%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQF------FALKVIQMNVEESARRQIAQELKINQSSQCP 119
           IKV+G G+ G V   +  W  +        A+K ++      A ++I  E  +  S   P
Sbjct: 12  IKVLGSGAFGTVY--KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 69

Query: 120 YVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLY 174
           +V     +C  S      + +I + M  G L D++++ K  I  +YL   C Q+ KG+ Y
Sbjct: 70  HVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  E+ ++HRDL   N+L+     VKITDFG++ ++ +   + +   G     +M+ E I
Sbjct: 125 LE-ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+ + E  T G  PY
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 84.1 bits (208), Expect = 1e-18
 Identities = 66/248 (26%), Positives = 112/248 (45%), Gaps = 42/248 (16%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++    +  +++  +E  +  +   P +V    VC      N    II+E M+GG 
Sbjct: 30  AVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL----NEPQYIIMELMEGGD 85

Query: 146 LADFLKKVK---------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           L  +L+  +         T+ E  L  IC  V KG +YL  + H IHRDL   N L++ +
Sbjct: 86  LLSYLRDARVERFGPPLLTLKE--LLDICLDVAKGCVYLE-QMHFIHRDLAARNCLVSEK 142

Query: 197 GE-----VKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSL 246
           G      VKI DFG++  +  +      G+    V    +M+PE +  GK+  +SD+WS 
Sbjct: 143 GYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV---RWMAPESLLDGKFTTQSDVWSF 199

Query: 247 GLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 305
           G+++ E  T GQ PY     Q+       +      Q P + P   +       ++ C  
Sbjct: 200 GVLMWEILTLGQQPYPALNNQE---VLQHVTAGGRLQKPENCPDKIY-----QLMTNCWA 251

Query: 306 KEPQQRLS 313
           ++P +R +
Sbjct: 252 QDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 2e-18
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 27/189 (14%)

Query: 134 ISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           I I+ E M  GSL ++L+    + +    L  +  QV  G+ YL   ++ IHRDL   N+
Sbjct: 76  IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE-AQNYIHRDLAARNV 134

Query: 192 LINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGL 248
           L+      K+ DFG++ ++     +A    G      + +PE     ++  KSD+WS G+
Sbjct: 135 LVGENNICKVADFGLARVIKEDIYEARE--GAKFPIKWTAPEAALYNRFSIKSDVWSFGI 192

Query: 249 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ-----PPPSAPSDQFSPEFCSFISA 302
           +L E  T G+ PY       G T+  E+++  VDQ      PP  P      E    +  
Sbjct: 193 LLTEIVTYGRMPYP------GMTN-AEVLQQ-VDQGYRMPCPPGCP-----KELYDIMLD 239

Query: 303 CVQKEPQQR 311
           C +++P  R
Sbjct: 240 CWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 76/308 (24%), Positives = 132/308 (42%), Gaps = 58/308 (18%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
           ++ +G GS G+V         +  A+K I +   +S +  + +E+KI +      +V  Y
Sbjct: 10  LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVY 68

Query: 126 QSFYSNG--------------AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 171
           +    +G              ++ I+ EYM+   LA+ L++   + EE+      Q+L+G
Sbjct: 69  EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRG 126

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMA---STSGQANTFVGTYNYM 227
           L Y+H   +++HRDLKP+N+ IN    V KI DFG++ I+    S  G  +  + T  Y 
Sbjct: 127 LKYIH-SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185

Query: 228 SPERI-SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-- 284
           SP  + S   Y    D+W+ G +  E  TG+  ++   +        E M+ I++  P  
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE-------LEQMQLILESVPVV 238

Query: 285 ----------------------PSAPSDQFSPEFCS----FISACVQKEPQQRLSAQELM 318
                                 P  P     P        F+   +   P  RL+A+E +
Sbjct: 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298

Query: 319 THPFLKMY 326
            HP++  Y
Sbjct: 299 MHPYMSCY 306

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 83.5 bits (206), Expect = 3e-18
 Identities = 75/291 (25%), Positives = 132/291 (45%), Gaps = 47/291 (16%)

Query: 69  VGKGS-GGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVV 122
           +G+G+ G + +    K  G+F ALK +++   E     S  R++A  L+  ++ + P VV
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVV 67

Query: 123 ----VCYQSFYS-NGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYL 175
               VC  S       ++++ E++D   L  +L KV    +P E +  +  Q+L+GL +L
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 235
           H  + ++HRDLKP N+L+   G++K+ DFG++ I  S      + V T  Y +PE +   
Sbjct: 127 HSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQS 184

Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSP--------------------PEQQDGWTSFYEL 275
            Y    D+WS+G +  E     F   P                    P ++D W     L
Sbjct: 185 SYATPVDLWSVGCIFAE----MFRRKPLFRGSSDVDQLGKILDVIGLPGEED-WPRDVAL 239

Query: 276 MEAIVDQPPPSAPSDQFSPEF----CSFISACVQKEPQQRLSAQELMTHPF 322
                     + P ++F  +        +  C+   P +R+SA   ++HP+
Sbjct: 240 PRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 85.7 bits (212), Expect = 3e-18
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 14/186 (7%)

Query: 85  TGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYM 141
           TG   A+K+++ +  E   +  +  +E  +      P +V    S  +  G +  + EY+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---E 198
            G +L + L     +P      +  QVL  L   H  + I+HRDLKP N++++  G    
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACAH-NQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 199 VKITDFGVSAIM-------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
            K+ DFG+  ++        +T  +    +GT  Y +PE++ G      SD+++ GL+ L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 252 ECATGQ 257
           EC TGQ
Sbjct: 181 ECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 83.5 bits (206), Expect = 4e-18
 Identities = 76/314 (24%), Positives = 135/314 (42%), Gaps = 56/314 (17%)

Query: 64  DTIKVVGKGSGGI--VQLVQHKWTGQFFALKVIQMNVEESARRQIAQ-ELKINQSSQCPY 120
           + + V+G+G   +  V L ++K TG++  ++ I +    +      Q EL +++    P 
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHE 178
           +V    +F ++  + ++  +M  GS  D +    +  + E  +A I + VLK L Y+HH 
Sbjct: 61  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYN--------YMSP 229
            ++ HR +K S++LI+  G+V ++  G+ + ++  + GQ    V  +         ++SP
Sbjct: 121 GYV-HRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177

Query: 230 ERISGGKYGY--KSDIWSLGLVLLECATGQFPYS-------------------------P 262
           E +     GY  KSDI+S+G+   E A G  P+                          P
Sbjct: 178 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237

Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSD------------QFSPEFCSFISACVQKEPQQ 310
            E+     S       + +    S P               FSP F  F+  C+Q+ P  
Sbjct: 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDA 297

Query: 311 RLSAQELMTHPFLK 324
           R SA  L+ H F K
Sbjct: 298 RPSASTLLNHSFFK 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 82.9 bits (205), Expect = 4e-18
 Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 35/298 (11%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQC 118
           ++  + ++ +G+G+ G+V   + + T +  ALK I++  E+      A +E+ + +  Q 
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 119 PYVVVCYQSFYSNGAISIILEYMD------GGSLADFLKKVKTIPEEYLAAICEQVLKGL 172
             +V      +S   + ++ EY+D        S  DF K  + I + YL     Q+L+G+
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI-KTYLY----QILRGI 115

Query: 173 LYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
            Y H  + ++HRDLKP NLLI+ R   +K+ DFG++             V T  Y +PE 
Sbjct: 116 AYCHSHR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEI 174

Query: 232 ISGGK-YGYKSDIWSLGLVLLECATGQ--FP---------------YSPPEQQ-DGWTSF 272
           + G + Y    DIWS+G +  E    +  FP                +P E+   G TS 
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234

Query: 273 YELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
            +   A    PP    +      P     +S  ++ +P +R++A+  + H + K  GD
Sbjct: 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Length = 294

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 82.4 bits (203), Expect = 5e-18
 Identities = 67/248 (27%), Positives = 114/248 (45%), Gaps = 25/248 (10%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+KV++ N    A ++I  E  +      PYV     +C  S      + ++ + M  G 
Sbjct: 40  AIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-----TVQLVTQLMPYGC 94

Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  + L   C Q+ KG+ YL  E  ++HRDL   N+L+     VKITDF
Sbjct: 95  LLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE-EVRLVHRDLAARNVLVKSPNHVKITDF 153

Query: 205 GVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 261
           G++ ++    T   A+       +M+ E I   ++ ++SD+WS G+ + E  T G  PY 
Sbjct: 154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213

Query: 262 PPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
               ++      +L+E     P PP    D +       +  C   + + R   +EL+  
Sbjct: 214 GIPARE----IPDLLEKGERLPQPPICTIDVY-----MIMVKCWMIDSECRPRFRELV-D 263

Query: 321 PFLKMYGD 328
            F +M  D
Sbjct: 264 EFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 21/208 (10%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES---ARRQIAQELKINQSSQCPYVV 122
           IK +G+G+ GIV   ++  T +  A+K I  N  ++   A+R + +E+K+ +      V+
Sbjct: 10  IKPIGRGAYGIVCSAKNSETNEKVAIKKIA-NAFDNRIDAKRTL-REIKLLRHLDHENVI 67

Query: 123 --------VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 174
                      ++F     + I+ E MD   L   ++  +T+ +++      Q+L+GL Y
Sbjct: 68  AIKDIMPPPHREAFND---VYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-S 233
           +H   +++HRDLKPSNLL+N   ++KI DFG++   +        +V T  Y +PE + +
Sbjct: 124 IH-SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN 182

Query: 234 GGKYGYKSDIWSLGLVLLECATGQ--FP 259
             +Y    D+WS+G +  E    +  FP
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRKPLFP 210

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 29/226 (12%)

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH---- 176
           +V  +  F S+  + +I+EY  GG   D  K++K   +E+L     +V  GLL+      
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGG---DLNKQIKQRLKEHLPFQEYEV--GLLFYQIVLA 181

Query: 177 ----HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPE 230
               H + ++HRDLK +N+ +   G +K+ DFG S   + +     A++F GT  Y++PE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---DQPPPSA 287
                +Y  K+D+WSLG++L E  T   P+  P Q+       E+M+ ++     P P  
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-------EIMQQVLYGKYDPFPCP 294

Query: 288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
            S        + +   + K P  R + Q+L+   FLK   +L  D+
Sbjct: 295 VSSGMK----ALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDI 336

Length = 478

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 84.2 bits (208), Expect = 9e-18
 Identities = 49/153 (32%), Positives = 83/153 (54%), Gaps = 5/153 (3%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQ 117
           +E+   +K + +G+ G V L + K   + +A+KV++    + ++   Q+  E      S+
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
            P++V  Y S  S   + +++EY+ GG +   L       EE       +V   L YLH 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH- 121

Query: 178 EKH-IIHRDLKPSNLLINHRGEVKITDFGVSAI 209
            +H IIHRDLKP N+LI++ G +K+TDFG+S +
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 79.4 bits (196), Expect = 9e-18
 Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 28/189 (14%)

Query: 144 GSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
            SLAD L+     + EE + A+C Q L  L  LH +        K  N+L+   G +K+ 
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA-------KSGNILLTWDGLLKL- 52

Query: 203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
             G  A          +    Y +M+PE I G  Y  K+DI+SLG+ L E    + PY+ 
Sbjct: 53  -DGSVAFK----TPEQSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106

Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-------FCSFISACVQKEPQQRLSAQ 315
             +         ++E +++  P   P D+ + E       F  F+  C  + PQ+R +A 
Sbjct: 107 ERE------LSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAAN 160

Query: 316 ELMTHPFLK 324
             + H    
Sbjct: 161 HYLAHCRAL 169

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 59/182 (32%), Positives = 88/182 (48%), Gaps = 26/182 (14%)

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-VGTYN 225
           Q+L+GL YLH    I+HRD+KP NLL+N    +KI DFG++ +      +  T  V T  
Sbjct: 111 QILRGLKYLH-SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169

Query: 226 YMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPY---SPPEQQD------GWTSFYEL 275
           Y +PE + G + Y    DIWS+G +  E    +  +   SP +Q D      G  S   +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229

Query: 276 MEA-------IVDQP--PPSAP-----SDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 321
             A       I+  P  PPS P     S Q + E    +   +  +P +R+SA + + HP
Sbjct: 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289

Query: 322 FL 323
           +L
Sbjct: 290 YL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 76/287 (26%), Positives = 126/287 (43%), Gaps = 40/287 (13%)

Query: 66  IKVVGKGSGGIVQLVQHK----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV 121
           I+V+G+G  G V L  +      TG+  A+K ++    +       +E+ I ++     +
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 122 VVCYQSFYSNGA---ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
           V  Y+   S      + +I+EY+  GSL D+L K K +    L    +Q+ +G+ YLH  
Sbjct: 69  VK-YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMAYLH-S 125

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIM--------ASTSGQANTFVGTYNYMSPE 230
           +H IHRDL   N+L+++   VKI DFG++  +            G +  F     + + E
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYAVE 180

Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY-SPPEQ----------QDGWTSFYELMEAI 279
            +   K+ Y SD+WS G+ L E  T      SPP++          Q       EL+E  
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240

Query: 280 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           +  P P         E    +  C + E + R + + L+  P LK  
Sbjct: 241 MRLPCP----KNCPQEVYILMKNCWETEAKFRPTFRSLI--PILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.9 bits (197), Expect = 3e-17
 Identities = 69/234 (29%), Positives = 106/234 (45%), Gaps = 22/234 (9%)

Query: 90  ALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 148
            LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D
Sbjct: 38  TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLD 91

Query: 149 FLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           +L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+
Sbjct: 92  YLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGL 150

Query: 207 SAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPE 264
           S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   +
Sbjct: 151 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210

Query: 265 QQDGWTSFYELME-AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
                   YEL+E     + P   P     P+    + AC Q  P  R S  E+
Sbjct: 211 LSQ----VYELLEKGYRMERPEGCP-----PKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 79.7 bits (197), Expect = 4e-17
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 123
           KV+G G  G V   + K  G+     A+K ++    +  R     E  I      P ++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHI 181
                  +  + II EYM+ GSL  FL++   K    + +  +   +  G+ YL  E + 
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLR-GIASGMKYLS-EMNY 127

Query: 182 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG--TYNYMSPERISGGKYGY 239
           +HRDL   N+L+N     K++DFG+S  +  +     T  G     + +PE I+  K+  
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS 187

Query: 240 KSDIWSLGLVLLE-CATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSP 294
            SD+WS G+V+ E  + G+ PY     QD       +++A+ D     PP   PS  +  
Sbjct: 188 ASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRLPPPMDCPSALY-- 238

Query: 295 EFCSFISACVQKEPQQRLSAQELMTH 320
                +  C QK+  +R +  ++++ 
Sbjct: 239 ---QLMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 79.7 bits (197), Expect = 6e-17
 Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 55/269 (20%)

Query: 89  FALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGG 144
            A+KV++ +  ++AR    +E+KI      P +     VC         + +I+EYM+ G
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD----PPLCMIMEYMENG 104

Query: 145 SLADFLKK-----------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
            L  FL+K            K++    L  +  Q+  G+ YL    + +HRDL   N L+
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-SLNFVHRDLATRNCLV 163

Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTY-----------NYMSPERISGGKYGYKSD 242
                +KI DFG+S          N +   Y            +M+ E +  GK+  KSD
Sbjct: 164 GKNYTIKIADFGMS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSD 214

Query: 243 IWSLGLVLLECAT--GQFPYSP-PEQQ--DGWTSFYEL--MEAIVDQPPPSAPSDQFSPE 295
           +W+ G+ L E  T   + PY    +QQ  +    F+     +  + +PP   P D +   
Sbjct: 215 VWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNC-PKDIY--- 270

Query: 296 FCSFISACVQKEPQQRLSAQELMTHPFLK 324
               +  C +++ + R + +E+  H FL+
Sbjct: 271 --ELMLECWRRDEEDRPTFREI--HLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 78.9 bits (194), Expect = 7e-17
 Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 30/230 (13%)

Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           QI ++L+ ++  Q  Y VV  +  Y      I+ EYM  GSL DFLK    +   +P   
Sbjct: 53  QIMKKLRHDKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKDGEGRALKLPN-- 103

Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  QV  G+ Y+    +I HRDL+ +N+L+      KI DFG++ ++     T+ Q 
Sbjct: 104 LVDMAAQVAAGMAYIERMNYI-HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162

Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     +       E++
Sbjct: 163 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------EVL 213

Query: 277 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           E +        P D         +  C +K+P++R + + L +  FL+ Y
Sbjct: 214 EQVERGYRMPCPQDC-PISLHELMLQCWKKDPEERPTFEYLQS--FLEDY 260

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 78.6 bits (194), Expect = 9e-17
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)

Query: 67  KVVGKGSGGIVQLVQHKWT---GQFF--ALKVIQMNVEESARRQIAQELKINQSSQCPYV 121
           K +G GS G+V+  + +W+   G+    A+K ++ +          +E  I  S     +
Sbjct: 1   KKLGDGSFGVVR--RGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEK 179
           +  Y    ++  + ++ E    GSL D L+K          L     Q+  G+ YL   K
Sbjct: 59  IRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE-SK 116

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN------YMSPERIS 233
             IHRDL   N+L+    +VKI DFG   +M +     + +V   +      + +PE + 
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFG---LMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 234 GGKYGYKSDIWSLGLVLLECAT-GQFPY 260
              + + SD+W  G+ L E  T G+ P+
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 32/216 (14%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQF-----FALKVIQ---MNVEESARRQIAQELKI 112
           E I  +K +G G  G V      W G +      A+K ++   M+V+        +E  +
Sbjct: 6   ESIKLVKKLGAGQFGEV------WMGYYNNSTKVAVKTLKPGTMSVQ-----AFLEEANL 54

Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQV 168
            ++ Q   +V  Y        I II EYM  GSL DFLK  +     +P+  L     Q+
Sbjct: 55  MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK--LIDFSAQI 112

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYN 225
            +G+ Y+   K+ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     
Sbjct: 113 AEGMAYIE-RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIK 169

Query: 226 YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           + +PE I+ G +  KSD+WS G++L E  T G+ PY
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 78.2 bits (192), Expect = 1e-16
 Identities = 65/230 (28%), Positives = 109/230 (47%), Gaps = 30/230 (13%)

Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 53  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 103

Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 104 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162

Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 163 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 216

Query: 277 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           E     P P    +      C     C +KEP++R + + L    FL+ Y
Sbjct: 217 ERGYRMPCPPECPESLHDLMCQ----CWRKEPEERPTFEYL--QAFLEDY 260

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 78.4 bits (193), Expect = 1e-16
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 123
           KV+G G  G V   + K  G+     A+K ++    E  RR    E  I      P ++ 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKH 180
                  +  + I+ EYM+ GSL  FL+K     T+ +  L  +   +  G+ YL    +
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMKYLSDMGY 127

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG---TYNYMSPERISGGKY 237
           + HRDL   N+L+N     K++DFG+S ++      A T  G      + +PE I+  K+
Sbjct: 128 V-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 238 GYKSDIWSLGLVLLECAT-GQFPYSPPEQQD 267
              SD+WS G+V+ E  + G+ PY     QD
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 39/206 (18%)

Query: 152 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 211
           K + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N   E+KI DFG++    
Sbjct: 113 KCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA---R 168

Query: 212 STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDG 268
            T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  TG+  FP +    Q  
Sbjct: 169 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-- 226

Query: 269 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ------------KEPQ------- 309
                +L+  +V  P         S    ++I +  Q              P        
Sbjct: 227 ----LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 282

Query: 310 -------QRLSAQELMTHPFLKMYGD 328
                  +R++A + + H +   Y D
Sbjct: 283 MLVLDSDKRITAAQALAHAYFAQYHD 308

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 40/229 (17%)

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYLHHEKHII 182
           +Q FY      +++ YM        L+K+   P  E+ +  +  Q+L GL Y+H    II
Sbjct: 92  FQDFY------LVMPYMQTD-----LQKIMGHPLSEDKVQYLVYQMLCGLKYIH-SAGII 139

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKS 241
           HRDLKP NL +N   E+KI DFG++        +   +V T  Y +PE I +   Y    
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILNWMHYNQTV 196

Query: 242 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--------ELMEAIVD-------QPPPS 286
           DIWS+G ++ E  TG+  +   +  D  T           E ++ + D       +  P 
Sbjct: 197 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPK 256

Query: 287 APSDQFS-------PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
            P   FS       P+    +   ++ +  +RL+A E + HP+   + D
Sbjct: 257 YPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 3/161 (1%)

Query: 98  VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 157
           ++   R   A E  I ++   P ++    +F  N    +IL       L  +L   + I 
Sbjct: 122 IKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIA 180

Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-TSGQ 216
              + AI   VL+ + YLH E  IIHRD+K  N+ INH G+V + DFG +       + +
Sbjct: 181 ICDILAIERSVLRAIQYLH-ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239

Query: 217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ 257
              + GT    +PE ++   YG   DIWS G+VL E AT  
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 46/126 (36%), Positives = 63/126 (50%), Gaps = 11/126 (8%)

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 226
           Q+L G+ +LH    IIHRDLKPSN+++     +KI DFG+ A  A TS     +V T  Y
Sbjct: 126 QMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYY 183

Query: 227 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 286
            +PE I G  Y    DIWS+G ++ E   G   +   +  D W    E +          
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL---------G 234

Query: 287 APSDQF 292
            PSD+F
Sbjct: 235 TPSDEF 240

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 40/229 (17%)

Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + +++E MD    A+  + +   +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 101 VYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 155

Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A T+     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 156 VKSDCTLKILDFGL-ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214

Query: 253 CATGQFPYSPPEQQDGWTSFYE------------LMEAIVD--QPPPSAPSDQFSPEFCS 298
              G   +   +  D W    E            L   + +  +  P  P   F   F  
Sbjct: 215 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPD 274

Query: 299 FI-------------------SACVQKEPQQRLSAQELMTHPFLKMYGD 328
           +I                   S  +  +P +R+S  E + HP++ ++ D
Sbjct: 275 WIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 77/300 (25%), Positives = 130/300 (43%), Gaps = 53/300 (17%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVV- 122
           +V+GKGS G+V       TG+  A+K I     +V ++ R  I +E+K+ +  + P +V 
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVE 63

Query: 123 ----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
               +   S      I ++ E M+   L   +K    +  E+      Q+L+ L Y+H  
Sbjct: 64  IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIH-T 121

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA---NTFVGTYNYMSPERISG- 234
            ++ HRDLKP N+L N   ++KI DFG++ +  + +  A     +V T  Y +PE + G 
Sbjct: 122 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGS 180

Query: 235 --GKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDGWTSFYELMEAIVDQPPPSA--- 287
              KY    DIWS+G +  E  TG+  FP      Q       +L+  ++  P P     
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ------LDLITDLLGTPSPETISR 234

Query: 288 ----------------PSDQFSPEF-------CSFISACVQKEPQQRLSAQELMTHPFLK 324
                               FS +F          +   +  +P+ R +A+E +  P+ K
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 76/298 (25%), Positives = 131/298 (43%), Gaps = 46/298 (15%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEESARRQIAQELKINQSSQCPYVVV 123
           +K VG G+ G V     + TG   A+K +      E  A+R   +EL++ +  +   V+ 
Sbjct: 20  LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIG 78

Query: 124 CYQSFYSNGAIS------IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
               F  + ++       +++ +M G  L   +K  K + E+ +  +  Q+LKGL Y+H 
Sbjct: 79  LLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK-LSEDRIQFLVYQMLKGLKYIH- 135

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGK 236
              IIHRDLKP NL +N   E+KI DFG++     T  +   +V T  Y +PE I +   
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYRAPEVILNWMH 192

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP------------ 284
           Y    DIWS+G ++ E  TG+  +   +  D      E+M+ +   P             
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLM---EIMK-VTGTPSKEFVQKLQSEDA 248

Query: 285 -------PSAPSDQF-------SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
                  P      F       +P   + +   +  + + R++A E + HP+ + + D
Sbjct: 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.0 bits (189), Expect = 4e-16
 Identities = 46/133 (34%), Positives = 76/133 (57%), Gaps = 9/133 (6%)

Query: 134 ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           I II E+M  GSL DFLK  +    P   L     Q+ +G+ ++  +++ IHRDL+ +N+
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANI 133

Query: 192 LINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
           L++     KI DFG++ ++     T+ +   F     + +PE I+ G +  KSD+WS G+
Sbjct: 134 LVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSDVWSFGI 191

Query: 249 VLLECAT-GQFPY 260
           +L+E  T G+ PY
Sbjct: 192 LLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 77.3 bits (190), Expect = 4e-16
 Identities = 64/274 (23%), Positives = 122/274 (44%), Gaps = 55/274 (20%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K+++ N   S  R +  E  + +    P+V+  Y +   +G + +I+EY   GSL  F
Sbjct: 34  AVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSF 93

Query: 150 LKKVKTIPEEYLAAICE------------------------QVLKGLLYLHHEKHIIHRD 185
           L++ + +   YL +                           Q+ +G+ YL  E  ++HRD
Sbjct: 94  LRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA-EMKLVHRD 152

Query: 186 LKPSNLLINHRGEVKITDFGVS-------AIMASTSGQANTFVGTYNYMSPERISGGKYG 238
           L   N+L+    ++KI+DFG+S       + +  + G+         +M+ E +    Y 
Sbjct: 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPV-----KWMAIESLFDHIYT 207

Query: 239 YKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEA--IVDQPPPSAPSDQFS 293
            +SD+WS G++L E  T G  PY    PE+       + L++    +++P      +  S
Sbjct: 208 TQSDVWSFGVLLWEIVTLGGNPYPGIAPER------LFNLLKTGYRMERP------ENCS 255

Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 327
            E  + +  C ++EP +R +  ++ +    KM  
Sbjct: 256 EEMYNLMLTCWKQEPDKRPTFADI-SKELEKMMV 288

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 76.6 bits (188), Expect = 6e-16
 Identities = 70/253 (27%), Positives = 118/253 (46%), Gaps = 40/253 (15%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K ++ +  ++AR+   +E ++  + Q  ++V  Y        + ++ EYM  G L  F
Sbjct: 39  AVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97

Query: 150 LKK-------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           L+                 + +  +  I +Q+  G++YL   +H +HRDL   N L+   
Sbjct: 98  LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVGEN 156

Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYN-----YMSPERISGGKYGYKSDIWSLGLVLL 251
             VKI DFG+S  + ST       VG +      +M PE I   K+  +SD+WSLG+VL 
Sbjct: 157 LLVKIGDFGMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 213

Query: 252 ECAT-GQFPYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQK 306
           E  T G+ P+          S  E++E I    V Q P + P + +       +  C Q+
Sbjct: 214 EIFTYGKQPWYQ-------LSNNEVIECITQGRVLQRPRTCPKEVY-----DLMLGCWQR 261

Query: 307 EPQQRLSAQELMT 319
           EP  RL+ +E+ +
Sbjct: 262 EPHMRLNIKEIHS 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.8 bits (189), Expect = 7e-16
 Identities = 70/237 (29%), Positives = 117/237 (49%), Gaps = 20/237 (8%)

Query: 90  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 148
           A+K+++     S R  +  ELKI +       +V    +    G I +I EY   G L +
Sbjct: 69  AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLN 128

Query: 149 FL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           FL  K+   +  E L +   QV KG+ +L   K+ IHRDL   N+L+ H   VKI DFG+
Sbjct: 129 FLRRKRESFLTLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNVLLTHGKIVKICDFGL 187

Query: 207 SAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           +  + + S    + N  +    +M+PE I    Y ++SD+WS G++L E  + G  PY P
Sbjct: 188 ARDIMNDSNYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY-P 245

Query: 263 PEQQDGWTSFYELMEA--IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
               D  + FY+L++    + Q P  AP++ +       +  C   +P +R + +++
Sbjct: 246 GMPVD--SKFYKLIKEGYRMAQ-PEHAPAEIY-----DIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 76.2 bits (187), Expect = 9e-16
 Identities = 68/240 (28%), Positives = 109/240 (45%), Gaps = 36/240 (15%)

Query: 101 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-------- 152
           +AR+   +E ++  + Q  ++V  Y        + ++ EYM  G L  FL+         
Sbjct: 49  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 108

Query: 153 VKTIPEE--------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           V   P +         +  I  Q+  G++YL   +H +HRDL   N L+     VKI DF
Sbjct: 109 VDGQPRQAKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGANLLVKIGDF 167

Query: 205 GVSAIMASTSGQANTFVGTYN-----YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 258
           G+S  + ST       VG +      +M PE I   K+  +SD+WS G++L E  T G+ 
Sbjct: 168 GMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Query: 259 PYSPPEQQDGWTSFYE-LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           P+     Q   T   E + +  V + P   P + +       +  C Q+EPQQRL+ +E+
Sbjct: 225 PWF----QLSNTEVIECITQGRVLERPRVCPKEVY-----DIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 52/190 (27%), Positives = 85/190 (44%), Gaps = 30/190 (15%)

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV----SAIMASTSGQANTFVG 222
           Q+L GL Y+H   +++HRDLKP NLL+N   E+KI DFG+    S      +G    +V 
Sbjct: 113 QILCGLKYIH-SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 223 TYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQFPY------------------SPP 263
           T  Y +PE  +S   Y    D+WS+G +L E    + P                   +P 
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGTPD 230

Query: 264 E---QQDGWTSFYELMEAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQRLSAQELM 318
           E    + G       + ++ + P     S     +P     +   +  +P +R+S +E +
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290

Query: 319 THPFLKMYGD 328
            HP+L ++ D
Sbjct: 291 EHPYLAIWHD 300

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 55/300 (18%)

Query: 77  VQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           V L +H  TG    +++  + N  E   + +  E+ ++   + P ++  +  F +   + 
Sbjct: 16  VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLW 75

Query: 136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           +I  +M  GS    LK    + + E  +  I    L+GL YLH   +I HR++K S++LI
Sbjct: 76  VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI-HRNIKASHILI 134

Query: 194 NHRGEVKITDFGVSAIMAST-SGQANTFVGTYN--------YMSPERISGGKYGY--KSD 242
           +  G V ++  G+S + +   +GQ    V  +         ++SPE +    YGY  KSD
Sbjct: 135 SGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSD 192

Query: 243 IWSLGLVLLECATGQFP------------------YSP-------------PEQQDGWTS 271
           I+S+G+   E ATG+ P                  YSP                Q G  S
Sbjct: 193 IYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDS 252

Query: 272 ------FYELMEAIVDQPPPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                     M   +       PS + FSP F + +  C+Q++P++R SA  L++H F K
Sbjct: 253 GIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 22/213 (10%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQF------FALKVIQMNVEESARRQIAQELKINQS 115
           ++  +KV+G G+ G V   +  W  +        A+K++       A  +   E  I  S
Sbjct: 8   ELKRVKVLGSGAFGTV--YKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 65

Query: 116 SQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLK 170
              P++V    VC         I ++ + M  G L D++ + K  I  + L   C Q+ K
Sbjct: 66  MDHPHLVRLLGVCLSP-----TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMS 228
           G++YL  E+ ++HRDL   N+L+     VKITDFG++ ++     + N   G     +M+
Sbjct: 121 GMMYLE-ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179

Query: 229 PERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
            E I   K+ ++SD+WS G+ + E  T G  PY
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 74.2 bits (182), Expect = 3e-15
 Identities = 57/204 (27%), Positives = 109/204 (53%), Gaps = 19/204 (9%)

Query: 69  VGKGSGGIVQ--LVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVV--- 122
           +G G+ G V+  + + K + +  A+K+++  N + + + ++ +E  + Q    PY+V   
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 123 -VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
            +C        +  +++E  + G L  FL+K K + E+ +  +  QV  G+ YL  E + 
Sbjct: 63  GICEAE-----SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE-ETNF 116

Query: 182 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTY--NYMSPERISGGKY 237
           +HRDL   N+L+  +   KI+DFG+S  + +     +A T  G +   + +PE ++  K+
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH-GKWPVKWYAPECMNYYKF 175

Query: 238 GYKSDIWSLGLVLLEC-ATGQFPY 260
             KSD+WS G+++ E  + GQ PY
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 74.1 bits (182), Expect = 3e-15
 Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 29/247 (11%)

Query: 62  DIDTIK---VVGKGSGGIVQLVQHKWTG---QFFALKVIQMNVEESARRQIAQELKINQS 115
           D+  +K   V+G G  G V   + K  G    F A+K ++    E  RR    E  I   
Sbjct: 2   DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 61

Query: 116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLY 174
              P ++        +  + II E+M+ G+L  FL+          L  +   +  G+ Y
Sbjct: 62  FDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 121

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN------YMS 228
           L  E + +HRDL   N+L+N     K++DFG+S  +   +    T+  +        + +
Sbjct: 122 LS-EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP-TYTSSLGGKIPIRWTA 179

Query: 229 PERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ----- 282
           PE I+  K+   SD+WS G+V+ E  + G+ PY     QD       ++ AI +Q     
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAI-EQDYRLP 231

Query: 283 PPPSAPS 289
           PP   P+
Sbjct: 232 PPMDCPT 238

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 74.3 bits (182), Expect = 3e-15
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 25/206 (12%)

Query: 130 SNGAISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
           S   I I+ E+M  GSL DFLK    K   +P+  L  +  Q+  G+ Y+    +I HRD
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ--LVDMAAQIADGMAYIERMNYI-HRD 127

Query: 186 LKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           L+ +N+L+      KI DFG++ ++     T+ Q   F     + +PE    G++  KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSD 185

Query: 243 IWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFI 300
           +WS G++L E  T G+ PY     +       E++E +  +     P  Q  PE     +
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNR-------EVLEQV--ERGYRMPCPQGCPESLHELM 236

Query: 301 SACVQKEPQQRLSAQELMTHPFLKMY 326
             C +K+P +R + + + +  FL+ Y
Sbjct: 237 KLCWKKDPDERPTFEYIQS--FLEDY 260

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 36/216 (16%)

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICE 166
           VC Q     G + +++EY   G+L DFL+  +   E                  L +   
Sbjct: 84  VCTQ----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG--TY 224
           QV +G+ +L  +K  IHRDL   N+L+     +KI DFG++  +        T  G    
Sbjct: 140 QVARGMEFLASKK-CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPV 198

Query: 225 NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVD 281
            +M+PE +    Y ++SD+WS G++L E  T G  PY   P E+      F  L E    
Sbjct: 199 KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-----FKLLKEGYRM 253

Query: 282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           + P +   + +       +  C  + P QR + ++L
Sbjct: 254 EKPQNCTQELY-----HLMRDCWHEVPSQRPTFKQL 284

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 15/161 (9%)

Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           II EYM+ G+L  +L+        Y L  +   +  G+ YL  + + +HRDL   N+L+N
Sbjct: 83  IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS-DMNYVHRDLAARNILVN 141

Query: 195 HRGEVKITDFGVSAIMASTSGQANTFVG---TYNYMSPERISGGKYGYKSDIWSLGLVLL 251
              E K++DFG+S ++        T  G      + +PE I+  K+   SD+WS G+V+ 
Sbjct: 142 SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201

Query: 252 ECAT-GQFPYSPPEQQDGW-TSFYELMEAIVDQPPPSAPSD 290
           E  + G+ PY        W  S +E+M+AI D     AP D
Sbjct: 202 EVMSFGERPY--------WDMSNHEVMKAINDGFRLPAPMD 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 84/312 (26%), Positives = 130/312 (41%), Gaps = 49/312 (15%)

Query: 61  EDIDTIKVVGKGSGG--IVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQ 117
           EDI    V+G+G+ G  I  +++        A+K+++    E+  R  A EL++  +   
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYL 161
            P ++    +  + G + I +EY   G+L DFL+K +                T+  + L
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 162 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQA 217
                 V  G+ YL  EK  IHRDL   N+L+      KI DFG+S      +  T G+ 
Sbjct: 122 LQFASDVATGMQYLS-EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180

Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT--SFYE 274
                   +M+ E ++   Y  KSD+WS G++L E  + G  PY       G T    YE
Sbjct: 181 PV-----RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC------GMTCAELYE 229

Query: 275 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR-----LSAQELMTHPFLKMYGDL 329
            +        P    D    E    +  C +  P +R     +S Q        K Y  +
Sbjct: 230 KLPQGYRMEKPRNCDD----EVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY--V 283

Query: 330 NVDLSEYFTDAG 341
           N+ L E FT AG
Sbjct: 284 NMALFENFTYAG 295

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 45/151 (29%), Positives = 65/151 (43%), Gaps = 28/151 (18%)

Query: 136 IILEYMDGGSLADFLK---------------KVKTIPEEYLA-------AICEQVLKGLL 173
           ++ EYM  G L +FL+                 +      L         I +QV  G+ 
Sbjct: 85  LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMA 144

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---GQANTFVGTYNYMSPE 230
           YL  E+  +HRDL   N L+     VKI DFG+S  + S        N  +    +M PE
Sbjct: 145 YLS-ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI-PIRWMPPE 202

Query: 231 RISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
            I   +Y  +SD+W+ G+VL E  + G  PY
Sbjct: 203 SIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 59/196 (30%), Positives = 84/196 (42%), Gaps = 36/196 (18%)

Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  PE         L      V KG  YL  E H IHRD+  
Sbjct: 86  ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE-ENHFIHRDIAA 144

Query: 189 SNLLINHRGE---VKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYK 240
            N L+  +G     KI DFG++  +   S     G+A   +    +M PE    G +  K
Sbjct: 145 RNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI---KWMPPEAFLDGIFTSK 201

Query: 241 SDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPE 295
           +D+WS G++L E  + G  PY     Q       E+ME +       PP   P   +   
Sbjct: 202 TDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVMEFVTGGGRLDPPKGCPGPVY--- 251

Query: 296 FCSFISACVQKEPQQR 311
               ++ C Q  P+ R
Sbjct: 252 --RIMTDCWQHTPEDR 265

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 56/201 (27%), Positives = 85/201 (42%), Gaps = 22/201 (10%)

Query: 87  QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL 146
           Q  A+K ++   E   R +   E  +    Q P +V           +S+I  Y     L
Sbjct: 36  QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95

Query: 147 ADFL---------------KKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 189
            +FL               K VK+   P +++  I  Q+  G+ +L    H++H+DL   
Sbjct: 96  HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH-IVTQIAAGMEFLS-SHHVVHKDLATR 153

Query: 190 NLLINHRGEVKITDFGV--SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 247
           N+L+  +  VKI+D G+      A         +    +MSPE I  GK+   SDIWS G
Sbjct: 154 NVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYG 213

Query: 248 LVLLEC-ATGQFPYSPPEQQD 267
           +VL E  + G  PY     QD
Sbjct: 214 VVLWEVFSYGLQPYCGYSNQD 234

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 58/225 (25%), Positives = 107/225 (47%), Gaps = 29/225 (12%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHK--WT--GQFFALKVIQMNVEESARRQIAQELKINQ--- 114
           ++  +K++G G  G V    HK  W   G    + V    +++ + RQ  QE+  +    
Sbjct: 8   ELRKLKLLGSGVFGTV----HKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63

Query: 115 -SSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQV 168
            S    Y+V    +C        ++ ++ +    GSL D +++ + ++  + L   C Q+
Sbjct: 64  GSLDHAYIVRLLGIC-----PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNY 226
            KG+ YL  E  ++HR+L   N+L+     V+I DFGV+ ++     +   +       +
Sbjct: 119 AKGMYYLE-EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177

Query: 227 MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS---PPEQQD 267
           M+ E I  G+Y ++SD+WS G+ + E  + G  PY+   P E  D
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 7/142 (4%)

Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158

Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

Query: 253 CATGQFPYSPPEQQDGWTSFYE 274
              G   +   +  D W    E
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIE 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 37/205 (18%)

Query: 152 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 211
           K + + +E++  +  Q+L+GL Y+H    IIHRDLKPSN+ +N   E++I DFG++    
Sbjct: 111 KCQKLSDEHVQFLIYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDCELRILDFGLA---R 166

Query: 212 STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDG 268
               +   +V T  Y +PE  ++   Y    DIWS+G ++ E   G+  FP +     D 
Sbjct: 167 QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN-----DY 221

Query: 269 WTSFYELMEAIVDQPP------------------PSAPSDQFSPEF-------CSFISAC 303
                 +ME +    P                  P  P       F          +   
Sbjct: 222 IDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKM 281

Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +  +  +R+SA E + HP+   Y D
Sbjct: 282 LVLDSDKRISASEALAHPYFSQYHD 306

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 59/194 (30%), Positives = 91/194 (46%), Gaps = 30/194 (15%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K+++ +  ++AR    +E+KI    + P ++    VC  S      + +I EYM+ G 
Sbjct: 50  AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITS----DPLCMITEYMENGD 105

Query: 146 LADFLKK-----------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           L  FL +           V TI    L  +  Q+  G+ YL    + +HRDL   N L+ 
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS-SLNFVHRDLATRNCLVG 164

Query: 195 HRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 249
               +KI DFG+S  + S       G+A   V    +MS E I  GK+   SD+W+ G+ 
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRA---VLPIRWMSWESILLGKFTTASDVWAFGVT 221

Query: 250 LLECAT--GQFPYS 261
           L E  T   + PYS
Sbjct: 222 LWEILTLCKEQPYS 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 46/206 (22%)

Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICE--------QVLKGLLYLHHEKHIIHRDLK 187
           ++  YM+ G+L  FL++ +        A+          Q+  G+ YLH ++ +IH+D+ 
Sbjct: 86  VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-KRGVIHKDIA 144

Query: 188 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN-----------YMSPERISGGK 236
             N +I+   +VKITD  +S          + F   Y+           +M+ E +   +
Sbjct: 145 ARNCVIDEELQVKITDNALSR---------DLFPMDYHCLGDNENRPVKWMALESLVNKE 195

Query: 237 YGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQ 291
           Y   SD+WS G++L E  T GQ PY    + D     +E+   + D      P + P   
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTPY---VEIDP----FEMAAYLKDGYRLAQPINCPD-- 246

Query: 292 FSPEFCSFISACVQKEPQQRLSAQEL 317
              E  + ++ C   +P++R S  +L
Sbjct: 247 ---ELFAVMACCWALDPEERPSFSQL 269

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 18/181 (9%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K  + ++ +  + +   E +I +    P +V    VC Q       I I++E + GG 
Sbjct: 23  AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ----RQPIYIVMELVPGGD 78

Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
              FL+K K  +  + L         G+ YL   K+ IHRDL   N L+     +KI+DF
Sbjct: 79  FLSFLRKKKDELKTKQLVKFALDAAAGMAYLE-SKNCIHRDLAARNCLVGENNVLKISDF 137

Query: 205 GVSAI----MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFP 259
           G+S      + S+SG     +    + +PE ++ G+Y  +SD+WS G++L E  + G  P
Sbjct: 138 GMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCP 194

Query: 260 Y 260
           Y
Sbjct: 195 Y 195

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 34/224 (15%)

Query: 57  QLNLEDIDTIKVVGKGSGGIV---QLVQ--HKWTGQFFALKVIQMNVEESARRQIAQELK 111
           ++ L  +  ++ +G+G+ G V   +L     + +    A+K ++ N E   +++  QE +
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 112 INQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFL---------------KK 152
           +    Q P +V    VC +         ++ EY+  G L +FL               + 
Sbjct: 61  LMSDLQHPNIVCLLGVCTKE----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 153 VKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 210
           VK+     ++L  I  Q+  G+ YL    H +HRDL   N L+     VKI+DFG+S  +
Sbjct: 117 VKSSLDCSDFLH-IAIQIAAGMEYLS-SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174

Query: 211 ASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
            S       +  +    +M PE I  GK+  +SDIWS G+VL E
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 67.5 bits (165), Expect = 7e-13
 Identities = 54/228 (23%), Positives = 102/228 (44%), Gaps = 31/228 (13%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTG-----QFFALKVIQMNVEESA----RRQIAQ 108
               ++  I  +G+G  G V L + K            +K +Q   +E+     RR++  
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 109 ELKINQSSQCPYVVVCYQS--FYSNGAISIILEYMDGGSLADFL----KKVKTIPEEYLA 162
             K++  +    + +C ++   Y      +ILEY D G L  FL     K + +    L+
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHY------MILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115

Query: 163 -----AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--G 215
                A+C Q+  G+ +L      +HRDL   N L++ + EVK++   +S  + ++    
Sbjct: 116 TKQKVALCTQIALGMDHLS-NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174

Query: 216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
             N  +    +++PE +    +  KSD+WS G+++ E  T G+ P+  
Sbjct: 175 LRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.4 bits (167), Expect = 8e-13
 Identities = 43/134 (32%), Positives = 67/134 (50%), Gaps = 2/134 (1%)

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
           P V+    +  S     ++L +          K+ + +P +    I +Q+L+GL YLH +
Sbjct: 117 PSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ 176

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 238
           + IIHRD+K  N+ IN   +V I D G +A     +       GT    +PE ++  KY 
Sbjct: 177 R-IIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDKYN 234

Query: 239 YKSDIWSLGLVLLE 252
            K+DIWS G+VL E
Sbjct: 235 SKADIWSAGIVLFE 248

Length = 357

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 68.2 bits (166), Expect = 8e-13
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 40/229 (17%)

Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 97  VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 151

Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 152 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210

Query: 253 CATGQFPYSPPEQQDGW--------TSFYELMEAI-------VDQPPPSA---------- 287
               +  +   +  D W        T   E M+ +       V+  P  A          
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270

Query: 288 ---PSDQ-----FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
              P+D       + +    +S  +  +P +R+S  E + HP++ ++ D
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 66/251 (26%), Positives = 105/251 (41%), Gaps = 49/251 (19%)

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLK-----------KVKTIPEEYLA-----AICE 166
           VC Q     G + +I+EY   G+L +FL+            +  +PEE L+     +   
Sbjct: 86  VCTQ----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY 141

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN- 225
           QV +G+ YL   +  IHRDL   N+L+     +KI DFG    +A      + +  T N 
Sbjct: 142 QVARGMEYLE-SRRCIHRDLAARNVLVTEDNVMKIADFG----LARGVHDIDYYKKTSNG 196

Query: 226 -----YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELME 277
                +M+PE +    Y ++SD+WS G+++ E  T G  PY   P E+      F  L E
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-----FKLLRE 251

Query: 278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 337
                 P +        E    +  C    P QR + ++L     ++    +   +SE +
Sbjct: 252 GHRMDKPSNCTH-----ELYMLMRECWHAVPTQRPTFKQL-----VEALDKVLAAVSEEY 301

Query: 338 TDAGSPLATLS 348
            D   P    S
Sbjct: 302 LDLSMPFEQYS 312

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 24/208 (11%)

Query: 123 VCYQSFYSNGAIS--IILEYMDGGSLADFLKKVKT------IPEEYLAAICEQVLKGLLY 174
           VC Q+  S G  S  +IL +M  G L  FL   +       +P + L      +  G+ Y
Sbjct: 68  VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEY 127

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERI 232
           L   K  IHRDL   N ++N    V + DFG+S  + +     Q         +++ E +
Sbjct: 128 LS-SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186

Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA--IVDQPPPSAPS 289
           +   Y  KSD+WS G+ + E AT GQ PY   E  +     Y+ +     + QPP     
Sbjct: 187 ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE----IYDYLRQGNRLKQPPDCLDG 242

Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQEL 317
                   S +S+C    P+ R S + L
Sbjct: 243 ------LYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 78/333 (23%), Positives = 136/333 (40%), Gaps = 77/333 (23%)

Query: 61  EDIDT-------IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE---SARRQIAQEL 110
           EDID        + ++G+G+ G V     +   ++ A+K+++ NV +    A+ +I    
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR-NVPKYTRDAKIEIQFME 180

Query: 111 KINQSSQCP-YVVVCYQSFYSN--GAISIIL-EYMDGGSLADFLKKVKTIPEEYLAAICE 166
           K+ Q+     + ++  Q ++ N  G + I++ +Y  G  L D++ K       +LA I  
Sbjct: 181 KVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIF 238

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLI----------NHRG------EVKITDFGVSAIM 210
           Q    L Y H E H++H DLKP N+L+           +R        V+I D G     
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--- 295

Query: 211 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 270
                     V T +Y SPE + G  + Y +D+WS+G ++ E  TG+  Y   +  D   
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY---DTHDNLE 352

Query: 271 SFYELMEAIVDQPP-----------------------PSAPSDQFS-------------- 293
             + LME  + + P                       P       +              
Sbjct: 353 HLH-LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRD 411

Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
              C  I   +  + Q+RL+A+++ THP++  Y
Sbjct: 412 DLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444

Length = 467

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 68/228 (29%), Positives = 112/228 (49%), Gaps = 35/228 (15%)

Query: 69  VGKGSGGIVQLVQHK--WTGQFFALKVIQ-MNVEESARRQIA--QELKINQSSQCPYVVV 123
           VG+G+ G V   + K     + +ALK I+   +  SA R+IA  +ELK       P V+ 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELK------HPNVIA 62

Query: 124 CYQSF--YSNGAISIILEYMDG----------GSLADFLKKVKTIPEEYLAAICEQVLKG 171
             + F  +S+  + ++ +Y +            S A+  KK   +P   + ++  Q+L G
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN--KKPMQLPRSMVKSLLYQILDG 120

Query: 172 LLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMAS---TSGQANTFVGTY 224
           + YLH    ++HRDLKP+N+L+      RG VKI D G + +  S        +  V T+
Sbjct: 121 IHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 225 NYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPPEQQDGWTS 271
            Y +PE + G ++  K+ DIW++G +  E  T + P     Q+D  TS
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTS 226

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 66/277 (23%), Positives = 122/277 (44%), Gaps = 32/277 (11%)

Query: 66  IKVVGKGSGGIVQLVQHK----WTGQFFALKVIQMNVEESARRQIAQELKI----NQSSQ 117
           I+ +G+G  G V+L ++      TG+  A+K ++     +    + +E++I       + 
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLH 176
             Y  +C +       I +I+E++  GSL ++L + K  I  +       Q+ KG+ YL 
Sbjct: 69  VKYKGICTED--GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERIS 233
             +++ HRDL   N+L+    +VKI DFG++  + +        +       + +PE + 
Sbjct: 127 SRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 234 GGKYGYKSDIWSLGLVLLE----CATGQFPYS-------PPEQQDGWTSFYELMEAIVDQ 282
             K+   SD+WS G+ L E    C +   P +       P   Q   T    ++E     
Sbjct: 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245

Query: 283 P-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
           P PP+ P      E    +  C + +P +R + Q L+
Sbjct: 246 PRPPNCPE-----EVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 65.9 bits (160), Expect = 2e-12
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 30/217 (13%)

Query: 68  VVGKGSGG--IVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVC 124
           V+G+G+ G  +   ++        A+K ++    +   R  A EL++  +    P ++  
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQV 168
             +    G + + +EY   G+L DFL+K +                T+  + L      V
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQANTFVGTY 224
            +G+ YL  +K  IHRDL   N+L+      KI DFG+S      +  T G+        
Sbjct: 122 ARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV----- 175

Query: 225 NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
            +M+ E ++   Y   SD+WS G++L E  + G  PY
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 67/277 (24%), Positives = 112/277 (40%), Gaps = 27/277 (9%)

Query: 61  EDIDTIKVVGKGSGGIV-----QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS 115
           E I   + +G+GS G+V     + V         A+K +        R +   E  + + 
Sbjct: 6   EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 65

Query: 116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE----------EYLAAIC 165
             C +VV             +I+E M  G L  +L+ ++   E          + +  + 
Sbjct: 66  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125

Query: 166 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY- 224
            ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  T        G   
Sbjct: 126 GEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 225 -NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ 282
             +MSPE +  G +   SD+WS G+VL E AT  + PY     +        +ME  +  
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFVMEGGLLD 241

Query: 283 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
            P + P   F       +  C Q  P+ R S  E+++
Sbjct: 242 KPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 31/195 (15%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K+++ +V ++AR    +E+KI    + P ++    VC         + +I EYM+ G 
Sbjct: 48  AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD----DPLCMITEYMENGD 103

Query: 146 LADFLKK------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           L  FL +            + ++    L  +  Q+  G+ YL    + +HRDL   N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL-ASLNFVHRDLATRNCLV 162

Query: 194 NHRGEVKITDFGVSAIMAST-----SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
            +   +KI DFG+S  + S       G+A   V    +M+ E I  GK+   SD+W+ G+
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRA---VLPIRWMAWESILLGKFTTASDVWAFGV 219

Query: 249 VLLECAT--GQFPYS 261
            L E  T   + PYS
Sbjct: 220 TLWEMFTLCKEQPYS 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 3/111 (2%)

Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 205
           L  ++ +   +P E    I  ++L+ L YLH  + IIHRD+K  N+ ++      + DFG
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRLLEALAYLH-GRGIIHRDVKTENIFLDEPENAVLGDFG 230

Query: 206 VSA--IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
            +        + Q   + GT    SPE ++   Y  K+DIWS GLVL E +
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 65.7 bits (160), Expect = 3e-12
 Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 36/274 (13%)

Query: 67  KVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESAR-----RQIAQELKINQSSQC 118
           +++GKG  G V   QL     + Q  A+K+++ ++  S+      R+ A   + +  +  
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 119 PYVVVCYQSFYSNGAISI---ILEYMDGGSLADFLKKVK------TIPEEYLAAICEQVL 169
             + V  +S  + G + I   IL +M  G L  FL   +      T+P + L      + 
Sbjct: 65  KLIGVSLRS-RAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS----TSGQANTFVGTYN 225
            G+ YL   K+ IHRDL   N ++N    V + DFG+S  + S      G A+       
Sbjct: 124 SGMEYLS-SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVK 180

Query: 226 YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE-LMEAIVDQP 283
           +++ E ++   Y   SD+W+ G+ + E  T GQ PY+  E  +     Y  L++    + 
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE----IYNYLIKGNRLKQ 236

Query: 284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           PP    D +       +  C   EP+ R S Q L
Sbjct: 237 PPDCLEDVY-----ELMCQCWSPEPKCRPSFQHL 265

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 65.2 bits (159), Expect = 4e-12
 Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 40/279 (14%)

Query: 67  KVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC----- 118
           K++G+G  G V   QL Q   +    A+K   M ++     +I + L     + C     
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKT--MKLDIHTYSEIEEFLS---EAACMKDFD 59

Query: 119 -PYVV----VCYQSFYSNGAIS--IILEYMDGGSLADFLKKVKT------IPEEYLAAIC 165
            P V+    VC+++          +IL +M  G L  FL   +       +P + L    
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 166 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY- 224
             +  G+ YL + ++ IHRDL   N ++     V + DFG+S  + S        +    
Sbjct: 120 VDIALGMEYLSN-RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 225 -NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE-LMEAIVD 281
             +++ E ++   Y  KSD+W+ G+ + E AT GQ PY   E  +     Y+ L      
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----IYDYLRHGNRL 234

Query: 282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
           + P          E    + +C + +P+ R +  +L   
Sbjct: 235 KQPEDCLD-----ELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 81/316 (25%), Positives = 120/316 (37%), Gaps = 71/316 (22%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVV 122
           IK +G G+ G V L     T   +A+K ++   +   R Q+A    E  I   +   +VV
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRKK-DVLNRNQVAHVKAERDILAEADNEWVV 64

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
             Y SF     +  +++Y+ GG +   L +++  PE  LA      L   +   H+   I
Sbjct: 65  KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPE-VLARFYIAELTLAIESVHKMGFI 123

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY---NYMSPERISGGKYGY 239
           HRD+KP N+LI+  G +K+TDFG+      T        G++   + M P          
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP---------- 173

Query: 240 KSDIWS------LG--LVLLE-------------CATGQFPYSPPEQQ---------DGW 269
            SD+W        G  L  LE                G   Y  PE           D W
Sbjct: 174 -SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232

Query: 270 TSFYELMEAIVDQPPPSAPSD--------------------QFSPEFCSFIS--ACVQKE 307
           +    L E +V QPP  AP+                     + SPE    I+   C  +E
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEE 292

Query: 308 PQQRLSAQELMTHPFL 323
              R  A ++  HPF 
Sbjct: 293 RLGRNGADDIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 65.5 bits (159), Expect = 6e-12
 Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 35/228 (15%)

Query: 69  VGKGSGGIVQLVQHK--WTGQFFALKVIQ-MNVEESARRQIA--QELKINQSSQCPYVVV 123
           VG+G+ G V   + K     + +ALK I+   +  SA R+IA  +ELK       P V+ 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELK------HPNVIS 62

Query: 124 CYQSFYSNG--AISIILEYMDG----------GSLADFLKKVKTIPEEYLAAICEQVLKG 171
             + F S+    + ++ +Y +            S A+  KK   +P   + ++  Q+L G
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN--KKPVQLPRGMVKSLLYQILDG 120

Query: 172 LLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMAS---TSGQANTFVGTY 224
           + YLH    ++HRDLKP+N+L+      RG VKI D G + +  S        +  V T+
Sbjct: 121 IHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 225 NYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPPEQQDGWTS 271
            Y +PE + G ++  K+ DIW++G +  E  T + P     Q+D  TS
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTS 226

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 84/315 (26%), Positives = 132/315 (41%), Gaps = 49/315 (15%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF--ALKVIQMNVEESARRQIAQELKI-NQ 114
           L   DI    V+G+G+ G V   + K  G     A+K ++    +   R  A EL++  +
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 63

Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPE 158
               P ++    +    G + + +EY   G+L DFL+K +                T+  
Sbjct: 64  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTS 214
           + L      V +G+ YL  +K  IHRDL   N+L+      KI DFG+S      +  T 
Sbjct: 124 QQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182

Query: 215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT--S 271
           G+         +M+ E ++   Y   SD+WS G++L E  + G  PY       G T   
Sbjct: 183 GRLPV-----RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTCAE 231

Query: 272 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-AQELMTHPFL----KMY 326
            YE +        P    D    E    +  C +++P +R S AQ L++   +    K Y
Sbjct: 232 LYEKLPQGYRLEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287

Query: 327 GDLNVDLSEYFTDAG 341
             +N  L E FT AG
Sbjct: 288 --VNTTLYEKFTYAG 300

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)

Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+            +  +P+E      L +   QV +G+ Y
Sbjct: 93  DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEY 152

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 153 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL 211

Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 212 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 39/234 (16%)

Query: 131 NGAISIILEYMDGGSLADFLKKVK-----------TIPEEYLA-----AICEQVLKGLLY 174
           +G + +++EY   G+L ++L+  +            +PEE L      +   QV +G+ Y
Sbjct: 90  DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEY 149

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 150 LASQK-CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL 208

Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 289
               Y ++SD+WS G++L E  T G  PY   P E+      F  L E      P +   
Sbjct: 209 FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-----FKLLKEGHRMDKPANCTH 263

Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQEL-------MTHPFLKMYGDLNVDLSEY 336
           + +       +  C    P QR + ++L       +T      Y DL+V   +Y
Sbjct: 264 ELY-----MIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQY 312

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 19/160 (11%)

Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---- 214
           E L +   QV KG+ +L   K+ IHRDL   N+L+ H    KI DFG++  + + S    
Sbjct: 214 EDLLSFSYQVAKGMSFLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272

Query: 215 -GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 272
            G A   V    +M+PE I    Y ++SD+WS G++L E  + G  PY P    D  + F
Sbjct: 273 KGNARLPV---KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-PGMPVD--SKF 326

Query: 273 YELM-EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
           Y+++ E      P  AP      E    + +C   +P +R
Sbjct: 327 YKMIKEGYRMLSPECAP-----SEMYDIMKSCWDADPLKR 361

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 63/276 (22%), Positives = 115/276 (41%), Gaps = 27/276 (9%)

Query: 61  EDIDTIKVVGKGSGGIV-QLVQHKWTGQFFALKVIQMNVEESA----RRQIAQELKINQS 115
           E I  ++ +G+GS G+V +             +V    V ESA    R +   E  + + 
Sbjct: 6   EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 65

Query: 116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE----------EYLAAIC 165
             C +VV             +++E M  G L  +L+ ++   E          + +  + 
Sbjct: 66  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125

Query: 166 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY- 224
            ++  G+ YL+ +K  +HRDL   N ++ H   VKI DFG++  +  T        G   
Sbjct: 126 AEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 225 -NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ 282
             +M+PE +  G +   SD+WS G+VL E  +  + PY     +       ++++ ++D 
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-------QVLKFVMDG 237

Query: 283 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
                P D         +  C Q  P+ R +  E++
Sbjct: 238 GYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 59/179 (32%), Positives = 82/179 (45%), Gaps = 19/179 (10%)

Query: 148 DFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           D  KKV T+  E L     QV KG+ +L   K  IHRDL   N+L++    VKI DFG++
Sbjct: 170 DLYKKVLTL--EDLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLA 226

Query: 208 AIMAST-----SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYS 261
             +         G A        +M+PE I    Y  +SD+WS G++L E  + G  PY 
Sbjct: 227 RDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY- 282

Query: 262 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
           P  + D      E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 283 PGVKID-----EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 62.2 bits (151), Expect = 4e-11
 Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 28/187 (14%)

Query: 136 IILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           I+ EYM  G+L  FL+K +  +    L  +   +  G+ YL  E   +H+ L    +L+N
Sbjct: 83  IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS-EMGYVHKGLAAHKVLVN 141

Query: 195 HRGEVKITDFG------VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
                KI+ F         AI  + SG++        + +PE I    +   SD+WS G+
Sbjct: 142 SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-----WAAPEAIQYHHFSSASDVWSFGI 196

Query: 249 VLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACV 304
           V+ E  + G+ PY     QD       +++A+ D    P P              +  C 
Sbjct: 197 VMWEVMSYGERPYWDMSGQD-------VIKAVEDGFRLPAPR----NCPNLLHQLMLDCW 245

Query: 305 QKEPQQR 311
           QKE  +R
Sbjct: 246 QKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 62/247 (25%), Positives = 99/247 (40%), Gaps = 31/247 (12%)

Query: 86  GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGS 145
            Q  A+K ++         +  QE  +      P +V           + ++ EY++ G 
Sbjct: 34  AQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD 93

Query: 146 LADFL----------------KKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           L +FL                  VK+ +       I  Q+  G+ YL      +H+DL  
Sbjct: 94  LHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS-SHFFVHKDLAA 152

Query: 189 SNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWS 245
            N+LI  +  VKI+D G+S  + S      Q  + +    +M PE I  GK+   SDIWS
Sbjct: 153 RNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL-PIRWMPPEAIMYGKFSSDSDIWS 211

Query: 246 LGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
            G+VL E  + G  PY     Q       E++E +  +       D   P   S ++ C 
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQ-------EVIEMVRKRQLLPCSED-CPPRMYSLMTECW 263

Query: 305 QKEPQQR 311
           Q+ P +R
Sbjct: 264 QEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 20/149 (13%)

Query: 131 NGAISIILEYMDGGSLADFLKKVK-----------TIPEEYLA-----AICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+  +            +PEE L+     +   QV +G+ Y
Sbjct: 96  DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEY 155

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 156 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 214

Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G++L E  T G  PY
Sbjct: 215 FDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 61/270 (22%), Positives = 105/270 (38%), Gaps = 53/270 (19%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K+++ +  ++AR    +E+KI    + P ++           + +I EYM+ G L  F
Sbjct: 50  AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109

Query: 150 LK-------------------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN 190
           L                     +  I    L  +  Q+  G+ YL    + +HRDL   N
Sbjct: 110 LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL-SSLNFVHRDLATRN 168

Query: 191 LLINHRGEVKITDFGVSAIMASTSGQANTFVGTY-----------NYMSPERISGGKYGY 239
            L+     +KI DFG+S          N + G Y            +M+ E I  GK+  
Sbjct: 169 CLVGENLTIKIADFGMS---------RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219

Query: 240 KSDIWSLGLVLLE----CATGQFPYSPPEQ--QDGWTSFYELMEAIVDQPPPSAPSDQFS 293
            SD+W+ G+ L E    C    +     EQ  ++    F +    +    PP  P   + 
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLY- 278

Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPFL 323
                 +  C  ++ ++R S  ++  H FL
Sbjct: 279 ----ELMLQCWSRDCRERPSFSDI--HAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 17/160 (10%)

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-----SGQANTFV 221
           QV +G+ +L   K  IHRDL   N+L++    VKI DFG++  +         G A    
Sbjct: 181 QVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237

Query: 222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIV 280
               +M+PE I    Y  +SD+WS G++L E  + G  PY P  Q D      E    + 
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-PGVQID-----EEFCRRLK 290

Query: 281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
           +     AP +  +PE  S +  C    P+ R +  EL+  
Sbjct: 291 EGTRMRAP-EYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 21/153 (13%)

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTS----GQANTFV 221
           QV +G+ +L   K+ IHRD+   N+L+      KI DFG++  IM  ++    G A   V
Sbjct: 220 QVAQGMDFLA-SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEA-- 278
               +M+PE I    Y  +SD+WS G++L E  + G+ PY P    +  + FY++++   
Sbjct: 279 ---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY-PGILVN--SKFYKMVKRGY 332

Query: 279 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
            + +P      D   PE  S +  C   EP +R
Sbjct: 333 QMSRP------DFAPPEIYSIMKMCWNLEPTER 359

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 5/97 (5%)

Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 220
           + A+  Q+L  + Y+H E  IIHRD+K  N+L+N   ++ + DFG +A  A  S      
Sbjct: 262 VTAVARQLLSAIDYIHGEG-IIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFH 319

Query: 221 ---VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
               GT +  +PE ++G  Y    DIWS GLV+ E A
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-----SGQANTFV 221
           QV +G+ +L   K  IHRDL   N+L++    VKI DFG++  +         G A    
Sbjct: 182 QVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-- 238

Query: 222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIV 280
               +M+PE I    Y  +SD+WS G++L E  + G  PY P  Q +      E  + + 
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-PGVQIN-----EEFCQRLK 291

Query: 281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 329
           D     AP +  +PE    + AC Q +P++R +   L     +++ GDL
Sbjct: 292 DGTRMRAP-ENATPEIYRIMLACWQGDPKERPTFSAL-----VEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 15/201 (7%)

Query: 61  EDIDTIKVVGKGSGGIV-QLVQHKWTGQFF--ALKVIQMNVEESARRQIAQELKINQSSQ 117
           EDI   + +G+G  G V Q V      +    A+K  +     S R +  QE  I +   
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 118 CPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGL 172
            P++V    V      +   + I++E    G L  +L+  K  +    L     Q+   L
Sbjct: 66  HPHIVKLIGVI-----TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTYNYMSPER 231
            YL   K  +HRD+   N+L++    VK+ DFG+S  +   +  +A+       +M+PE 
Sbjct: 121 AYLE-SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179

Query: 232 ISGGKYGYKSDIWSLGLVLLE 252
           I+  ++   SD+W  G+ + E
Sbjct: 180 INFRRFTSASDVWMFGVCMWE 200

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.1 bits (145), Expect = 6e-10
 Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 2/97 (2%)

Query: 163 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG-VSAIMASTSGQANTFV 221
           AI +Q+L  + Y+H +K +IHRD+K  N+ +N  G++ + DFG               +V
Sbjct: 271 AIMKQLLCAVEYIH-DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV 329

Query: 222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 258
           GT    SPE ++G  Y   +DIWS GL+LL+  +  F
Sbjct: 330 GTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366

Length = 501

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 13/161 (8%)

Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTS--GQA 217
           L +   QV +G+ +L   K+ +HRDL   N+L+     VKI DFG++  IM  ++   + 
Sbjct: 239 LLSFTYQVARGMEFLA-SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM 276
           +TF+    +M+PE I    Y   SD+WS G++L E  + G  PY P    D  ++FY  +
Sbjct: 298 STFLPV-KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY-PGMIVD--STFYNKI 353

Query: 277 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           ++      P    D  + E    +  C   EP++R S   L
Sbjct: 354 KSGYRMAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHL 390

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 7/138 (5%)

Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL   K  +HRDL  
Sbjct: 68  SEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA-SKKFVHRDLAA 126

Query: 189 SNLLINHRGEVKITDFGVSAIMAST---SGQANTFVG-TYNYMSPERISGGKYGYKSDIW 244
            N +++    VK+ DFG++  +      S   +T       +M+ E +   K+  KSD+W
Sbjct: 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVW 186

Query: 245 SLGLVLLECAT-GQFPYS 261
           S G++L E  T G  PY 
Sbjct: 187 SFGVLLWELMTRGAPPYP 204

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 24/192 (12%)

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE-VKITDFGVSAIMASTSGQANTFVGTYN 225
           Q+ + L Y+H  K I HRDLKP NLLI+     +K+ DFG SA       ++ +++ +  
Sbjct: 178 QLCRALAYIH-SKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVSYICSRF 235

Query: 226 YMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP- 283
           Y +PE + G   Y    D+WSLG ++ E   G   +S     D      +++    +   
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295

Query: 284 ------------PPSAPSD------QFSP-EFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                       P   P D      + +P +  +FIS  ++ EP +RL+  E +  PF  
Sbjct: 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355

Query: 325 MYGDLNVDLSEY 336
              D  + L +Y
Sbjct: 356 DLRDPCIKLPKY 367

Length = 440

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 31/191 (16%)

Query: 136 IILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           ++ E+++ G L   L+K K  +P  +   + +Q+   L YL  +K+++H ++   N+L+ 
Sbjct: 93  MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE-DKNLVHGNVCAKNILLA 151

Query: 195 HRGE-------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKSDIWSL 246
             G        +K++D GVS    S   +    V    +++PE +  G      +D WS 
Sbjct: 152 RLGLAEGTSPFIKLSDPGVSFTALSREER----VERIPWIAPECVPGGNSLSTAADKWSF 207

Query: 247 GLVLLE-CATGQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
           G  LLE C  G+ P    +P E++     FYE    +   P PS        E  + IS 
Sbjct: 208 GTTLLEICFDGEVPLKERTPSEKE----RFYEKKHRL---PEPSCK------ELATLISQ 254

Query: 303 CVQKEPQQRLS 313
           C+  EP QR S
Sbjct: 255 CLTYEPTQRPS 265

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 45/131 (34%), Positives = 67/131 (51%), Gaps = 13/131 (9%)

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTS--GQANTFVGT 223
           QV  G+ +L   K+ +HRDL   N+LI     VKI DFG++  IM  ++   + +TF+  
Sbjct: 247 QVANGMEFLA-SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL-P 304

Query: 224 YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIV 280
             +M+PE I    Y   SD+WS G++L E  T G  PY   P  +Q     FY  ++   
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-----FYNAIKRGY 359

Query: 281 DQPPPSAPSDQ 291
               P+  SD+
Sbjct: 360 RMAKPAHASDE 370

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 54.1 bits (131), Expect = 1e-08
 Identities = 27/90 (30%), Positives = 41/90 (45%), Gaps = 11/90 (12%)

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
            P V   Y     N    I++EY++G  L D +        E    I   V  G L   H
Sbjct: 63  VPAV---YFVDPENF--IIVMEYIEGEPLKDLINSNGMEELELSREIGRLV--GKL---H 112

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
              IIH DL  SN++++  G++ + DFG++
Sbjct: 113 SAGIIHGDLTTSNMILSG-GKIYLIDFGLA 141

Length = 211

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 53.2 bits (127), Expect = 9e-08
 Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 16/164 (9%)

Query: 144 GSLADFLKKVKTIPEE---------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           G L +F+   K IP+           +  +  QVL GL  LH    I+HRD+KP NLL+ 
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVT 343

Query: 195 HRGEVKITDFGVSAIMASTSGQANTFVGTYN--YMSPERISGGKYGYKSDIWSLGLVLLE 252
             G+VKI DFG +  M  T    N   G  +  Y  PE +   +   ++   ++  +L  
Sbjct: 344 VDGQVKIIDFGAAVDMC-TGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSP 402

Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 296
            A   + Y  P+  D +T+   LM+  V +  P A    F+ E 
Sbjct: 403 FA---WLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL 443

Length = 507

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 7/130 (5%)

Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           +S+ILEY   G L + L K K +  +    +     KGL  L+   +  +++L   + L+
Sbjct: 97  LSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV 156

Query: 194 NHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVL 250
               ++KI   G+  I++S      N  V    Y S + ++    +Y  K DI+SLG+VL
Sbjct: 157 TENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVL 212

Query: 251 LECATGQFPY 260
            E  TG+ P+
Sbjct: 213 WEIFTGKIPF 222

Length = 283

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 29/123 (23%), Positives = 59/123 (47%), Gaps = 8/123 (6%)

Query: 145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           +  +  K++K   ++ +  I + +L  L Y+H E  I H D+KP N++++      I D+
Sbjct: 112 NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH-EHGISHGDIKPENIMVDGNNRGYIIDY 170

Query: 205 GVSAI-------MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ 257
           G+++        +  +  Q +   GT  Y   +  +G     + D+ SLG  +L+ A  +
Sbjct: 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIK 230

Query: 258 FPY 260
            P+
Sbjct: 231 LPW 233

Length = 294

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)

Query: 136 IILEYMDGGSLADFLKKVKTI------PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 189
           ++LE+   G L ++L+  + +       +      CE V  GLL+LH +   IH DL   
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACE-VASGLLWLH-QADFIHSDLALR 129

Query: 190 NLLINHRGEVKITDFGV--SAIMASTSGQANTFVGTYNYMSPE-------RISGGKYGYK 240
           N  +     VKI D+G+             +       +++PE        +       K
Sbjct: 130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK 189

Query: 241 SDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP---SDQFSP-- 294
           S+IWSLG+ + E  T    PY  P+  D       + E  +  P P      SD++    
Sbjct: 190 SNIWSLGVTMWELFTAADQPY--PDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVM 247

Query: 295 EFCSFISACVQKEPQQRLSAQE---LMTH 320
           +FC         +P+ R +A+E   L+T+
Sbjct: 248 QFCWL-------DPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.5 bits (103), Expect = 3e-05
 Identities = 30/143 (20%), Positives = 62/143 (43%), Gaps = 23/143 (16%)

Query: 76  IVQLVQHKWTGQFFALK------VIQMNVEESARRQIAQELKI-----NQSSQCPYVVVC 124
            ++L++   T + + L       V+++N          +E+ I      +    P V+  
Sbjct: 2   SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH--EKHII 182
            +S   +G   +++E+++G +L +       + EE    I EQ+ + L  LH      + 
Sbjct: 62  GES---DGWSYLLMEWIEGETLDE-------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 183 HRDLKPSNLLINHRGEVKITDFG 205
           H DL P N+L++    + I D+ 
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 43.0 bits (102), Expect = 6e-05
 Identities = 23/73 (31%), Positives = 37/73 (50%), Gaps = 9/73 (12%)

Query: 135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           +I++EY++G  L D    ++   +E L  I   V  G L   H+  I+H DL  SN+++ 
Sbjct: 73  TIVMEYIEGKPLKD---VIEEGNDELLREIGRLV--GKL---HKAGIVHGDLTTSNIIVR 124

Query: 195 HRGEVKITDFGVS 207
                 I DFG+ 
Sbjct: 125 DDKLYLI-DFGLG 136

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

 Score = 42.9 bits (102), Expect = 7e-05
 Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 10/89 (11%)

Query: 118 CPYVVVCYQSFYSNGAISIILEYM-DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
            P  ++       N    +++E++ D GS A  LK V  + EE    + EQV++ +  L+
Sbjct: 83  VPEPIL----LKKN---VLVMEFIGDDGSPAPRLKDVP-LEEEEAEELYEQVVEQMRRLY 134

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFG 205
            E  ++H DL   N+L  H G+  I D  
Sbjct: 135 QEAGLVHGDLSEYNILY-HDGKPYIIDVS 162

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 32/192 (16%)

Query: 136 IILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           ++ EY+  G L  FL + K  +   +   + +Q+   L YL  +K ++H ++   N+L+ 
Sbjct: 77  MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-DKKLVHGNVCGKNILVA 135

Query: 195 HRGE-------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG--KYGYKSDIWS 245
             G        +K++D G+      T       V    +++PE I  G       +D WS
Sbjct: 136 RYGLNEGYVPFIKLSDPGIP----ITVLSREERVERIPWIAPECIRNGQASLTIAADKWS 191

Query: 246 LGLVLLE-CATGQFP---YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 301
            G  LLE C+ G+ P    S  E++     FY+      DQ     P      E  + I+
Sbjct: 192 FGTTLLEICSNGEEPLSTLSSSEKER----FYQ------DQHRLPMPD---CAELANLIN 238

Query: 302 ACVQKEPQQRLS 313
            C   +P +R S
Sbjct: 239 QCWTYDPTKRPS 250

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain

 Score = 41.3 bits (98), Expect = 2e-04
 Identities = 19/71 (26%), Positives = 37/71 (52%), Gaps = 4/71 (5%)

Query: 136 IILEYMDGGSLADF-LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           +++E++ G  +    LK V+    E    + +Q+L+ +  L+ E  ++H DL   N+L+ 
Sbjct: 92  LVMEFIGGDGIPAPRLKDVR--LLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV- 148

Query: 195 HRGEVKITDFG 205
             G+V I D  
Sbjct: 149 DDGKVYIIDVP 159

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187

>gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain

 Score = 41.0 bits (97), Expect = 3e-04
 Identities = 24/71 (33%), Positives = 40/71 (56%), Gaps = 11/71 (15%)

Query: 136 IILEYMDGGSLADFLKKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           +++EY+DG      L +V+ +  PEE L  I E+++K   Y H    IIH DL   N+L+
Sbjct: 108 VVMEYIDG----VELYRVRVLEDPEEVLDEILEEIVK--AYKHG---IIHGDLSEFNILV 158

Query: 194 NHRGEVKITDF 204
           +   ++ I D+
Sbjct: 159 DDDEKIYIIDW 169

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 20/79 (25%), Positives = 35/79 (44%), Gaps = 7/79 (8%)

Query: 129 YSNGAISIILEYMDGGSLADF--LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 186
           Y+   + + +E++DG  ++D   LK      +E    +    L+ LL         H D 
Sbjct: 237 YTTRRV-LTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL----RDGFFHADP 291

Query: 187 KPSNLLINHRGEVKITDFG 205
            P N+L+   G + + DFG
Sbjct: 292 HPGNILVRSDGRIVLLDFG 310

Length = 517

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.4 bits (98), Expect = 6e-04
 Identities = 22/71 (30%), Positives = 34/71 (47%), Gaps = 10/71 (14%)

Query: 135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           +I++EY+ G  L D L+       E +  + E V K    LH    I+H DL  SN ++ 
Sbjct: 412 TIVMEYIGGKDLKDVLEGN----PELVRKVGEIVAK----LHKAG-IVHGDLTTSNFIV- 461

Query: 195 HRGEVKITDFG 205
               + + DFG
Sbjct: 462 RDDRLYLIDFG 472

Length = 535

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 14/90 (15%)

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
            P V              I++EY++G  L D L+       + L  +   V  G L   H
Sbjct: 63  VPIVY-----DVDPDNGLIVMEYIEGELLKDALE---EARPDLLREVGRLV--GKL---H 109

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           +  I+H DL  SN++++  G +   DFG+ 
Sbjct: 110 KAGIVHGDLTTSNIILS-GGRIYFIDFGLG 138

Length = 204

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 40.2 bits (94), Expect = 9e-04
 Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 26/189 (13%)

Query: 136 IILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           ++ EY+  GSL  +LKK K  I   +   + +Q+   L +L  +K + H ++   N+L+ 
Sbjct: 76  MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE-DKGLTHGNVCAKNVLLI 134

Query: 195 HRGE--------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWS 245
              +        +K++D G+S  +          +    ++ PE I   +     +D WS
Sbjct: 135 REEDRKTGNPPFIKLSDPGISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWS 190

Query: 246 LGLVLLE-CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
            G  L E  + G  P S  + Q     FYE      D+    AP      E  + I+ C+
Sbjct: 191 FGTTLWEIFSGGDKPLSALDSQKK-LQFYE------DRHQLPAPK---WTELANLINQCM 240

Query: 305 QKEPQQRLS 313
             EP  R S
Sbjct: 241 DYEPDFRPS 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

 Score = 38.5 bits (90), Expect = 0.003
 Identities = 22/71 (30%), Positives = 37/71 (52%), Gaps = 3/71 (4%)

Query: 136 IILEYM-DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           +++E++ D G  A  LK V  +  E    + E V++ +  L+ E  ++H DL   N+L+ 
Sbjct: 143 LVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV- 200

Query: 195 HRGEVKITDFG 205
           H GE  I D  
Sbjct: 201 HDGEPYIIDVS 211

Length = 268

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	353
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
PRK10345	210	hypothetical protein; Provisional	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
smart00090	237	RIO RIO-like kinase.	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
KOG1243	690	consensus Protein kinase [General function predict	99.63
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.47
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.4
KOG3087	229	consensus Serine/threonine protein kinase [General	99.3
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.28
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.16
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.15
COG4248	637	Uncharacterized protein with protein kinase and he	99.14
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.14
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.12
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.99
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.96
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.79
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.78
PRK09902	216	hypothetical protein; Provisional	98.74
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.74
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.72
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.66
PF01636	239	APH: Phosphotransferase enzyme family This family	98.52
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.51
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.34
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.34
PLN02876	822	acyl-CoA dehydrogenase	98.33
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.13
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.13
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.11
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.99
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.97
KOG2270	520	consensus Serine/threonine protein kinase involved	97.92
PRK10593	297	hypothetical protein; Provisional	97.86
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.79
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.77
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.75
PRK05231	319	homoserine kinase; Provisional	97.71
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.67
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.66
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.51
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.47
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.3
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.09
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.04
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.92
PLN02236	344	choline kinase	96.84
PLN02756	418	S-methyl-5-thioribose kinase	96.74
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.66
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.65
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.62
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.6
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.56
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.31
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.24
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.97
PRK11768	325	serine/threonine protein kinase; Provisional	95.85
PRK12396	409	5-methylribose kinase; Reviewed	95.84
PRK06148	1013	hypothetical protein; Provisional	95.72
COG2334	331	Putative homoserine kinase type II (protein kinase	95.72
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.31
PTZ00384	383	choline kinase; Provisional	94.91
KOG2269	531	consensus Serine/threonine protein kinase [Signal	94.5

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-67  Score=465.30  Aligned_cols=288  Identities=56%  Similarity=0.956  Sum_probs=268.8

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC-eE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-AI  134 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~-~~  134 (353)
                      ..+..++++.++.||+|..|+||+|+|+.+++.+|+|++..+.+...++++.+|+++++..+|||||.+|++|..++ ..
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            44566789999999999999999999999999999999988888999999999999999999999999999999999 59


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +++||||++|||.+++...+++++.....++.++++||.|||+..+||||||||.|||++..|.+||||||.++.+... 
T Consensus       154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            9999999999999999998999999999999999999999996589999999999999999999999999999887654 


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                       ...+++||..|||||.+.+..|+.++||||||++++|+++|++||...  .+.+....+++..|....+|..+...+|+
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~  309 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYLDIFELLCAIVDEPPPRLPEGEFSP  309 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc--CCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence             567889999999999999999999999999999999999999999876  33456778999999999888877667999


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhhCCCcccc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATL  347 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (353)
                      ++++||..||++||.+|||+.|+++|||++++.+.++++..|+....++..++
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~~~~~~~~~~~~~~~  362 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDMASFVRKALSPPRSL  362 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccHHHHHHHhcccCCCC
Confidence            99999999999999999999999999999999999999999999888887665

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-60  Score=425.33  Aligned_cols=264  Identities=31%  Similarity=0.477  Sum_probs=229.7

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHH------HHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES------ARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||+++.+....      ....+.+|+++|++++|||||+++++|..+.
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4577899999999999999999999999999999997652211      2344679999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC---CcEEEeecccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAI  209 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~---~~~kl~DfG~a~~  209 (353)
                      ..|+||||++||+|.+.+-.++.+.++..+.+++|++.|+.|||+ +||+||||||+|||+..+   ..+||+|||+|+.
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            999999999999999999999999999999999999999999999 999999999999999876   6799999999998


Q ss_pred             ccccCCCCcccccCCcccCcceecCCC---CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-
Q 018630          210 MASTSGQANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-  285 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-  285 (353)
                      .. ......+.||||.|.|||++.++.   +..++|+||+||+||-+++|.+||++.....      .+.+.+..+... 
T Consensus       329 ~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------sl~eQI~~G~y~f  401 (475)
T KOG0615|consen  329 SG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------SLKEQILKGRYAF  401 (475)
T ss_pred             cc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------cHHHHHhcCcccc
Confidence            76 455678899999999999998765   3447899999999999999999998754332      234555555432 


Q ss_pred             -CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          286 -SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       286 -~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                       +..+..++.+..+||.+||..||++|||+.|+|+||||+......
T Consensus       402 ~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  402 GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS  447 (475)
T ss_pred             cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence             345678999999999999999999999999999999999766443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-58  Score=408.32  Aligned_cols=262  Identities=33%  Similarity=0.573  Sum_probs=237.3

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      ....++|+++++||+|+||+||+|+.+.+++.||+|++++.  ......+....|..++..++||+||+++-.|++...+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            46678999999999999999999999999999999999765  2334568899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |+|+||+.||.|+.+|++.+.++++.++.++.+|+.||.|||+ +|||||||||+|||++.+|+++|+|||+++.....+
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            9999999999999999999999999999999999999999998 999999999999999999999999999999776666


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ....+.|||+.|||||++.+..|+..+|.||||+++|||++|.+||.+.+.       .+..+++...+.+ ..+..+++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-------~~~~~~I~~~k~~-~~p~~ls~  251 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-------KKMYDKILKGKLP-LPPGYLSE  251 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-------HHHHHHHhcCcCC-CCCccCCH
Confidence            667778999999999999999999999999999999999999999988543       3556666666533 23456899


Q ss_pred             HHHHHHHHhhhhCcCCCC----CHHHHHcCCcccccC
Q 018630          295 EFCSFISACVQKEPQQRL----SAQELMTHPFLKMYG  327 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rp----t~~e~l~hp~~~~~~  327 (353)
                      +++++++++|+.||++|.    .+.++-+||||...-
T Consensus       252 ~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  252 EARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             HHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence            999999999999999996    788999999998754

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-58  Score=430.14  Aligned_cols=256  Identities=30%  Similarity=0.480  Sum_probs=234.9

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .+|+..+.||+|+|+.||.+++..+|+.||+|++...  .....+..+.+|+++.++++|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999999999999999999764  34556788999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      |+|..++|..++++.++++|.+++.++.||+.||.|||+ .+|+|||||..|++++.+.+|||+|||+|+.+....+...
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence            999999999999999999999999999999999999999 9999999999999999999999999999999988878889


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      +.||||.|.|||++....++..+||||+||++|.|++|++||...       ...+....+....-  ..+..++.++++
T Consensus       177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-------~vkety~~Ik~~~Y--~~P~~ls~~A~d  247 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-------TVKETYNKIKLNEY--SMPSHLSAEAKD  247 (592)
T ss_pred             eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-------hHHHHHHHHHhcCc--ccccccCHHHHH
Confidence            999999999999999989999999999999999999999999763       34555555554432  234588999999


Q ss_pred             HHHHhhhhCcCCCCCHHHHHcCCcc-ccc
Q 018630          299 FISACVQKEPQQRLSAQELMTHPFL-KMY  326 (353)
Q Consensus       299 li~~~L~~dp~~Rpt~~e~l~hp~~-~~~  326 (353)
                      ||.+||+.||.+|||+.+++.|+|| +.+
T Consensus       248 LI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence            9999999999999999999999999 444

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-56  Score=382.22  Aligned_cols=259  Identities=29%  Similarity=0.533  Sum_probs=235.3

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ..+++|++++.||.|+||.|.+++++.+|..+|+|++...  ..-........|..+++.+.||+++++++.|.+.+.+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            6779999999999999999999999999999999999765  23445677889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||++||.|+.++++.+++++..++.++.||+.|++|||+ ++|++|||||+|||+|.+|.+||+|||+|+.....  
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            999999999999999999999999999999999999999999 99999999999999999999999999999886533  


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                       .-+.||||.|+|||.+..++|+.++|.||||+++|||+.|.+||.+.+.       ..+.++|..+....  +..++++
T Consensus       198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~v~f--P~~fs~~  267 (355)
T KOG0616|consen  198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGKVKF--PSYFSSD  267 (355)
T ss_pred             -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCcccC--CcccCHH
Confidence             5678999999999999999999999999999999999999999987544       45667777766533  4678999


Q ss_pred             HHHHHHHhhhhCcCCCC-----CHHHHHcCCcccccCCC
Q 018630          296 FCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDL  329 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~  329 (353)
                      +++|+.++|+.|-.+|.     ...++.+||||+.....
T Consensus       268 ~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~  306 (355)
T KOG0616|consen  268 AKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE  306 (355)
T ss_pred             HHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence            99999999999999994     56799999999976544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.8e-57  Score=388.56  Aligned_cols=267  Identities=26%  Similarity=0.480  Sum_probs=226.9

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +++|+.+..+|+|+||+||+++++.+|+.||||.+..+. +....+-.++|+++++++.|+|+|.+.++|.....+++|+
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            367999999999999999999999999999999987664 3556677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |||+. ++.+.++. ...++...+.++++|++.|+.|+|+ +++|||||||+|||++.+|.+||||||+|+.+..++...
T Consensus        81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            99987 55555554 3568999999999999999999998 999999999999999999999999999999988777778


Q ss_pred             cccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHH-------HhcCC------
Q 018630          218 NTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA-------IVDQP------  283 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~-------~~~~~------  283 (353)
                      +.++.|.||+|||++.+ .+|...+||||+||++.||++|.+.|++.+.-+....+...+..       +....      
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            88999999999999988 57999999999999999999999999987765543333322211       11100      


Q ss_pred             -CC--------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          284 -PP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       284 -~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                       .|        ......++.-+.+|+..||+.||.+|++.+|++.||||..+-+
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE  292 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence             00        0112356677899999999999999999999999999977643

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.2e-55  Score=406.92  Aligned_cols=268  Identities=30%  Similarity=0.551  Sum_probs=236.2

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .+..++|+++++||+|+||.||+|+.+.+|..+|+|+++++  ........++.|-++|...++|+||++|-.|.+..++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            56789999999999999999999999999999999999876  3455667889999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc-
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-  213 (353)
                      ||||||++||++..+|.+.+.|+++.++.++.+++.|++.+|+ .|+|||||||+|+|||..|++||+|||++..+... 
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            9999999999999999999999999999999999999999998 99999999999999999999999999999543210 


Q ss_pred             -----------------------C----CC-------------------CcccccCCcccCcceecCCCCCccccHHHHH
Q 018630          214 -----------------------S----GQ-------------------ANTFVGTYNYMSPERISGGKYGYKSDIWSLG  247 (353)
Q Consensus       214 -----------------------~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  247 (353)
                                             .    ..                   ..+.+|||.|||||++.+..|+..+|+||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                                   0    00                   1134799999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCC---HHHHHcCCccc
Q 018630          248 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHPFLK  324 (353)
Q Consensus       248 ~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~  324 (353)
                      ||+||||.|.+||...+..+.|.++......+.     .+....+++++.+||.+||. ||++|..   ++||.+||||+
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-----fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~  449 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-----FPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFK  449 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-----CCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccc
Confidence            999999999999999888776666655544432     22335678999999999999 9999994   89999999999


Q ss_pred             ccCCCCc
Q 018630          325 MYGDLNV  331 (353)
Q Consensus       325 ~~~~~~~  331 (353)
                      .....++
T Consensus       450 ~v~W~~l  456 (550)
T KOG0605|consen  450 GVDWDHL  456 (550)
T ss_pred             cCCcchh
Confidence            9887764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-55  Score=406.79  Aligned_cols=264  Identities=30%  Similarity=0.524  Sum_probs=231.0

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~  133 (353)
                      .....+|.+.+.||.|+|++|++|+++.+++.||||++.+.  ..+.-..-+..|-..|..| .||.|+++|..|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34568999999999999999999999999999999998654  2222334566788888888 89999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+|+||+++|+|.++|++.+.+++..++.++.||+.||+|||+ +|||||||||+|||++.+++++|+|||.|+.+...
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999999999999999999999999999999999 99999999999999999999999999999887532


Q ss_pred             CCC-------------CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh
Q 018630          214 SGQ-------------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV  280 (353)
Q Consensus       214 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~  280 (353)
                      ...             ..+++||..|.+||++..+..+..+|+|+||||+|.|+.|.+||.+.++.       .+.++|.
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-------liFqkI~  300 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-------LIFQKIQ  300 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-------HHHHHHH
Confidence            211             14589999999999999999999999999999999999999999986553       3444444


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      .-.  ...+..+++.+.+||.++|..||++|+|+++|.+||||......+
T Consensus       301 ~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  301 ALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             Hhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            432  233567899999999999999999999999999999999887666

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-55  Score=391.49  Aligned_cols=262  Identities=29%  Similarity=0.511  Sum_probs=231.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .++|...+.||+|+||+||+++++.++..||||.+.+.. .......+..|+++++.++|||||.++++...++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            478999999999999999999999999999999987653 5667788899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC------CcEEEeeccccccccc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR------GEVKITDFGVSAIMAS  212 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~------~~~kl~DfG~a~~~~~  212 (353)
                      |||+||+|.+++++.+.+++..++.++.||+.||++||+ ++||||||||.|||++..      -.+||+|||+|+.+..
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            999999999999999999999999999999999999998 999999999999999864      3589999999998873


Q ss_pred             cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-CCCCCCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQ  291 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  291 (353)
                       +....+.||+|.|||||++....|+.|+|+||+|+++|++++|..||...+       ..++...+.++. ..+..+..
T Consensus       168 -~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t-------~~eL~~~~~k~~~~~~~~~~~  239 (429)
T KOG0595|consen  168 -GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET-------PKELLLYIKKGNEIVPVLPAE  239 (429)
T ss_pred             -hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC-------HHHHHHHHhccccccCchhhh
Confidence             445677899999999999999999999999999999999999999997643       344444444433 23344566


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      +++...+++...|+.+|.+|.+..+-+.|+++....-.+
T Consensus       240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~  278 (429)
T KOG0595|consen  240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDR  278 (429)
T ss_pred             ccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcccc
Confidence            777888999999999999999999999999998766433

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-56  Score=404.18  Aligned_cols=268  Identities=25%  Similarity=0.386  Sum_probs=228.0

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecC-eEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNG-AISI  136 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~-~~~l  136 (353)
                      ..++|.+++.||.|+||.||+|+.+.+|+.||||.++.........--.||++-+++++ ||||+++.+++.++. .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            45789999999999999999999999999999999887655555555678999999998 999999999999887 9999


Q ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          137 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |||||+. +|+++++.+ +.+++..++.|++||+.||+|+|. +|+.|||+||+|||+.....+||+|||+|+...+. .
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-p  164 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-P  164 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccceeEecccccccccccC-C
Confidence            9999986 999999754 679999999999999999999998 99999999999999998999999999999987754 4


Q ss_pred             CCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH---------------HHH
Q 018630          216 QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM---------------EAI  279 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~---------------~~~  279 (353)
                      ..+.++.|.||+|||++.. +-|+.+.|+||+|||++|+++-++.|++.++.|....+.+++               .++
T Consensus       165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m  244 (538)
T KOG0661|consen  165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM  244 (538)
T ss_pred             CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence            5778999999999998755 568999999999999999999999999987765433333332               222


Q ss_pred             hcCCCCC------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          280 VDQPPPS------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       280 ~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      .-..+..      ....+.++++.++|.+||.+||.+||||.|+++||||+.....
T Consensus       245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence            1111110      1123478899999999999999999999999999999976544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-56  Score=380.75  Aligned_cols=252  Identities=33%  Similarity=0.586  Sum_probs=227.4

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEee-EeEecCe
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQ-SFYSNGA  133 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~-~~~~~~~  133 (353)
                      .+..+.+|++.+.||+|+||.||+|.+..+|..+|.|.++.. .+...+..+..|+.++++++|||||++|+ .|.+++.
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            345568999999999999999999999999999999998755 45667788999999999999999999998 6666665


Q ss_pred             -EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--c-CCceecCCCCCcEEEcCCCcEEEeecc
Q 018630          134 -ISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHH--E-KHIIHRDLKPSNLLINHRGEVKITDFG  205 (353)
Q Consensus       134 -~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~--~-~~iiH~Dlkp~NIll~~~~~~kl~DfG  205 (353)
                       ++||||||.+|+|...++.    .+.+++..+++++.|+|.||..+|+  . .-|+||||||.||+++.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence             9999999999999998864    3679999999999999999999997  2 238999999999999999999999999


Q ss_pred             ccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018630          206 VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  285 (353)
Q Consensus       206 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  285 (353)
                      +++.+.+......+++|||.||+||.+.+.+|+.++||||+||++|||+.-+.||.+.       +..++-.+|.....+
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L~~KI~qgd~~  246 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSLCKKIEQGDYP  246 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHHHHHHHcCCCC
Confidence            9999988888888999999999999999999999999999999999999999999883       566777788887776


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCH
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSA  314 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  314 (353)
                      +.+...+|.++..+|..|+..||+.||+.
T Consensus       247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  247 PLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            66667899999999999999999999984

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-53  Score=395.04  Aligned_cols=259  Identities=30%  Similarity=0.550  Sum_probs=228.3

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc---c-HHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecC
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---E-ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNG  132 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~-~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~  132 (353)
                      ...++|++.+.||+|+||+|+.+.+..++..||+|++....   . ......+.+|+.+++.+. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            45689999999999999999999999999999999876531   1 134566779999999999 999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC-CcEEEeecccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~  211 (353)
                      .+|+||||+.||+|.+++...+++.+..+..+++|++.|++|+|+ +||+||||||+|||++.+ +++||+|||++....
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            999999999999999999999999999999999999999999999 999999999999999999 999999999998874


Q ss_pred             ccCCCCcccccCCcccCcceecCCC-CC-ccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGK-YG-YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||.+.       +...+...+..+...  .+
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-------~~~~l~~ki~~~~~~--~p  243 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-------NVPNLYRKIRKGEFK--IP  243 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-------cHHHHHHHHhcCCcc--CC
Confidence            3445677889999999999999977 85 7999999999999999999999873       233444445544432  23


Q ss_pred             CCC-CHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          290 DQF-SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       290 ~~~-~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      ..+ ++++.+|+++||..||.+|+|+.+++.||||+..
T Consensus       244 ~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  244 SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence            455 9999999999999999999999999999999974

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.6e-54  Score=398.87  Aligned_cols=254  Identities=33%  Similarity=0.569  Sum_probs=235.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ++|-+.+.||+|+||.||+++.+++.+.||+|.+.+. ..+...+.+.+|++|++.++||||+.+++.|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            5788889999999999999999999999999998654 455667889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      |+.| +|+.++...+.++++.+..++.|++.||.|||+ ++|+|||+||.|||++.+|.+|+||||+|+.+.....-..+
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            9987 999999999999999999999999999999999 99999999999999999999999999999998876655667


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (353)
                      ..|||.|||||+..+.+|+..+|+|||||++||++.|++||..       ..+.++...|...+.++  +...+..+.+|
T Consensus       160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~I~~d~v~~--p~~~S~~f~nf  230 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKSILKDPVKP--PSTASSSFVNF  230 (808)
T ss_pred             ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHHHhcCCCCC--cccccHHHHHH
Confidence            7899999999999999999999999999999999999999976       57778888888776544  35889999999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          300 ISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      +..+|++||.+|.|..+++.|||+++
T Consensus       231 l~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  231 LQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             HHHHhhcChhhcccHHHHhcChHHhh
Confidence            99999999999999999999999986

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.7e-54  Score=364.05  Aligned_cols=265  Identities=26%  Similarity=0.454  Sum_probs=222.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ++|...+.||+|+||.||+|++..+|+.||||.++..... .......+|++.++.++|+||+.+.++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            5788999999999999999999999999999999876333 334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      |++. +|...++.. ..++...++.++.++++|++|||+ +.|+||||||+|+|++++|.+||+|||+|+...+......
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            9985 999999764 578999999999999999999998 9999999999999999999999999999999887776666


Q ss_pred             ccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH---------------HHHH--Hh
Q 018630          219 TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------LMEA--IV  280 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---------------~~~~--~~  280 (353)
                      ..+-|.||+|||++.+. .|+..+|+||+|||++||+-|.+-|.+.+.-+....+..               +...  +.
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            66889999999999885 599999999999999999999988887554332211111               1111  11


Q ss_pred             cCCCCC--CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          281 DQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       281 ~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ..+.+.  ......+.++.+|+.+||.+||.+|+|+.|+++|+||+..+
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence            011110  11245677889999999999999999999999999999644

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-53  Score=400.38  Aligned_cols=264  Identities=32%  Similarity=0.550  Sum_probs=239.2

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      .+-|++.+.||.|+.|.|.+|++..||+.+|||++...  ........+.+|+.+|+.+.|||++.+|++|+++.++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            36788999999999999999999999999999999654  3445567899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      .||++||.|++++.+.+++++.++.++++||+.|+.|+|. .+|+||||||+|+|++..+++||+|||.|.... .+.-.
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gklL  168 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGKLL  168 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhcccCEeeeccceeeccc-CCccc
Confidence            9999999999999999999999999999999999999998 999999999999999999999999999997643 44567


Q ss_pred             cccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .+.||+|.|.|||++.+.+| ..++||||-|||||.|++|..||.+       .++..++.++..+...  .+..+++++
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-------dNir~LLlKV~~G~f~--MPs~Is~ea  239 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-------DNIRVLLLKVQRGVFE--MPSNISSEA  239 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-------ccHHHHHHHHHcCccc--CCCcCCHHH
Confidence            78899999999999999998 5799999999999999999999985       3556677777776653  347899999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHh
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  334 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~  334 (353)
                      ++||++||..||.+|+|.+||++|||++.+.+.....+
T Consensus       240 QdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~  277 (786)
T KOG0588|consen  240 QDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKS  277 (786)
T ss_pred             HHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhh
Confidence            99999999999999999999999999999988776533

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-52  Score=379.07  Aligned_cols=275  Identities=32%  Similarity=0.545  Sum_probs=234.4

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..+....++|++...||.|..++||+|+...+++.||||++...........+.+|+..++.++||||++.+..|..+..
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            34566779999999999999999999999999999999999877666668899999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      +++||.||.+||+.++++..  ..+++..+..+.+++++||.|||+ +|.||||||+.||||+++|.|||+|||.+..+.
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            99999999999999999865  458999999999999999999998 999999999999999999999999999998776


Q ss_pred             ccCCCC----cccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-
Q 018630          212 STSGQA----NTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-  284 (353)
Q Consensus       212 ~~~~~~----~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-  284 (353)
                      ..+.+.    .+.+||++|||||++..  ..|+.|+||||||++..||.+|..||....+.      .-++..+...++ 
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp~  251 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPPT  251 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCCC
Confidence            544322    45689999999999644  35999999999999999999999999875442      123334433333 


Q ss_pred             ------CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhH
Q 018630          285 ------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE  335 (353)
Q Consensus       285 ------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~  335 (353)
                            +......++..+..+|..||.+||.+|||++++++|+||+.......--.+
T Consensus       252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~  308 (516)
T KOG0582|consen  252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKK  308 (516)
T ss_pred             cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchh
Confidence                  112223466789999999999999999999999999999987655543333

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-53  Score=379.47  Aligned_cols=261  Identities=35%  Similarity=0.583  Sum_probs=218.8

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec-C-eEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-G-AISII  137 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~-~-~~~lv  137 (353)
                      ..++...+.||+|+||+||++.+..+|..+|||.+....... ...+.+|+.++++++|||||++++..... + .+++.
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            356888899999999999999999999999999987663333 67799999999999999999999974433 3 79999


Q ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-CCcEEEeeccccccccc---
Q 018630          138 LEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMAS---  212 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~---  212 (353)
                      |||+++|||.+++.+.+ .+++..++.+.+|++.||+|||+ +|++||||||+|||++. ++.+||+|||++.....   
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999999876 79999999999999999999998 99999999999999999 79999999999987663   


Q ss_pred             cCCCCcccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      .........||+.|||||++.++. ...++|||||||++.||+||..||...      ......+-.+......+..+..
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P~ip~~  247 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLPEIPDS  247 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCCCCCcc
Confidence            112234578999999999999643 345999999999999999999999763      0111222223322222355677


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      +|+++++|+.+||..||++||||+++|+|||.+....
T Consensus       248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999999999987554

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.5e-51  Score=380.57  Aligned_cols=285  Identities=43%  Similarity=0.792  Sum_probs=241.9

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +..++|++++.||+|+||.||++++..++..+|+|++...........+.+|+++++.++||||+++++++..++.+++|
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            34589999999999999999999999999999999998765556677899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+..+|+||||||+||+++.++.++|+|||++......  ..
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  159 (331)
T cd06649          82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA  159 (331)
T ss_pred             eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--cc
Confidence            9999999999999988889999999999999999999998446999999999999999999999999998765332  23


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc-----------------------------
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG-----------------------------  268 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----------------------------  268 (353)
                      ....|++.|+|||++.+..++.++|+|||||++|||++|..||...+..+.                             
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence            445799999999999988899999999999999999999999975432110                             


Q ss_pred             ----------hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhh
Q 018630          269 ----------WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFT  338 (353)
Q Consensus       269 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~  338 (353)
                                ..........+.....+......+++++.+||.+||++||++|||+.|+++||||+.......+...+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~  319 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEEVDFAGWLC  319 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccccccHHHHHH
Confidence                      0011222333333333333345678999999999999999999999999999999999888888888887


Q ss_pred             hhCCCc
Q 018630          339 DAGSPL  344 (353)
Q Consensus       339 ~~~~~~  344 (353)
                      ...+..
T Consensus       320 ~~~~~~  325 (331)
T cd06649         320 KTLRLN  325 (331)
T ss_pred             Hhhccc
Confidence            665543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-52  Score=370.94  Aligned_cols=269  Identities=27%  Similarity=0.433  Sum_probs=224.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-----cCeE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS-----NGAI  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-----~~~~  134 (353)
                      ..|..++.||.|+||.|+.|.++.+|+.||||.+... .......+..+|+++++.++|+||+.+++++..     -+..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            4566689999999999999999999999999988632 345567889999999999999999999998764     3679


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc--
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS--  212 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--  212 (353)
                      |+|+|+|+ -+|...++.+..++++.+..+++|+++||+|+|+ .+++||||||.|++++.++.+||||||+|+....  
T Consensus       102 YiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  102 YLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             EEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            99999996 4999999998889999999999999999999999 9999999999999999999999999999998753  


Q ss_pred             cCCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH----------------
Q 018630          213 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL----------------  275 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~----------------  275 (353)
                      .....+.++.|.||+|||++.. ..|+.+.||||+|||++||++|++.|.+.+..+....+.+.                
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence            2344567899999999998755 56999999999999999999999999987665432221111                


Q ss_pred             -HHHHhcCCCCC-----CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCc
Q 018630          276 -MEAIVDQPPPS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  331 (353)
Q Consensus       276 -~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  331 (353)
                       ...+...+..+     ....+.++.+.+|+.+||..||.+|+|++|+|.|||+..+.+..-
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d  321 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED  321 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence             11111111111     112478899999999999999999999999999999999876554

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-52  Score=392.55  Aligned_cols=261  Identities=29%  Similarity=0.534  Sum_probs=233.3

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecC
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNG  132 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~  132 (353)
                      ..+..++|.++++||+|+||+|+++..+.+++.+|||++++.  ...+....++.|.+++.... ||.++.++..|....
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            467889999999999999999999999999999999999876  34556678888888877664 999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ++|+||||+.||++..+ ...+.+++..+..++.+++.||.|||+ +|||+||||.+|||+|.+|++||+|||+++....
T Consensus       443 ~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             eEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccCcEEecccccccccCC
Confidence            99999999999994443 334789999999999999999999998 9999999999999999999999999999998766


Q ss_pred             cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      .+..+.+.||||.|||||++.+..|+.++|.|||||++|||+.|..||.+.++       .++.+.|......  .+..+
T Consensus       521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-------ee~FdsI~~d~~~--yP~~l  591 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-------EEVFDSIVNDEVR--YPRFL  591 (694)
T ss_pred             CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCCCC--CCCcc
Confidence            66778889999999999999999999999999999999999999999998654       3567777766553  45789


Q ss_pred             CHHHHHHHHHhhhhCcCCCCC-----HHHHHcCCcccccC
Q 018630          293 SPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  327 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~  327 (353)
                      |.++.++++++|+++|++|..     +.++..||||+...
T Consensus       592 s~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  592 SKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             cHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence            999999999999999999995     47999999998653

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-53  Score=384.87  Aligned_cols=264  Identities=25%  Similarity=0.432  Sum_probs=223.1

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec--CeEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAIS  135 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~--~~~~  135 (353)
                      ..+.|+.+.+||+|+||.||+|++..+|+.||+|.+.... .........+|+.|+++++||||+++.+...+.  +.+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            4567999999999999999999999999999999998774 344556788999999999999999999988766  7999


Q ss_pred             EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ||+|||+. +|.-++... -.+++.+++.++.||+.||+|+|+ +||+|||||..|||||.+|.+||+|||+|+.+....
T Consensus       195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            99999987 999988763 579999999999999999999998 999999999999999999999999999999765443


Q ss_pred             C-CCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-----CC-
Q 018630          215 G-QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-----PS-  286 (353)
Q Consensus       215 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~-  286 (353)
                      . ..+..+-|.||+|||++.+. .|+.++|+||.||||.||+.|++.|.+.++.+....+.++.........     |. 
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence            3 36677889999999999886 5999999999999999999999999987765544443333211111111     00 


Q ss_pred             -------C-------CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          287 -------A-------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       287 -------~-------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                             .       ....+++...+|+..||..||.+|.||.++|.++||.
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence                   0       0134678899999999999999999999999999994

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-52  Score=366.83  Aligned_cols=266  Identities=25%  Similarity=0.421  Sum_probs=225.9

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHH-HHHHHHHHHHhcCCCCceEEEeeEeEe--cCeEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR-RQIAQELKINQSSQCPYVVVCYQSFYS--NGAIS  135 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~~~~  135 (353)
                      ..++|+.+..|++|+||.||+|+++.+++.||+|.++........ -.-.+|+.++.+++|||||.+-.+...  -+.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            457899999999999999999999999999999999877543332 345789999999999999999987763  46799


Q ss_pred             EEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +|||||+. +|..++...+ +++..+++.++.|++.|++|||. +.|+||||||+|+|++..|.+||+|||+|+.++++.
T Consensus       154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            99999986 9999998765 89999999999999999999998 999999999999999999999999999999999887


Q ss_pred             CCCcccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--------
Q 018630          215 GQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--------  285 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------  285 (353)
                      ...+..+-|.||+|||++.+.+ |+.+.|+||+|||+.||+++.+.|.+..+.+....+...+..-.....+        
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            7788889999999999998864 9999999999999999999999999877665444333332211111100        


Q ss_pred             ---------------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          286 ---------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       286 ---------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                                     ......++....+|+..+|.+||.+|.||.|+|+|+||...
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                           01112256889999999999999999999999999999983

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-52  Score=387.80  Aligned_cols=257  Identities=34%  Similarity=0.614  Sum_probs=228.7

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ..|.....||+|+.|.||.|+...+++.||||.+.... ...+.-+..|+.+|+..+|+|||.+++.|.....+++||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            46788889999999999999999999999999987653 23456688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      ++||+|.+.+.. ..+++.++..++++++.||+|||. +||+|||||.+|||++.+|.+||+|||++..+........+.
T Consensus       352 m~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm  429 (550)
T KOG0578|consen  352 MEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM  429 (550)
T ss_pred             cCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence            999999998876 459999999999999999999998 999999999999999999999999999998887776667788


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc-CCCCCCCCCCCCHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  299 (353)
                      +|||.|||||++....|+.++||||||++++||+-|.+||-+.++       ...+..+.. +.+.-..+..+|+++++|
T Consensus       430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAlyLIa~ng~P~lk~~~klS~~~kdF  502 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGTPKLKNPEKLSPELKDF  502 (550)
T ss_pred             cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence            999999999999999999999999999999999999999976332       233344444 334445678899999999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          300 ISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +.+||+.|+++|+||.|+|+||||+..+
T Consensus       503 L~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  503 LDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             HHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence            9999999999999999999999997654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-51  Score=378.30  Aligned_cols=255  Identities=29%  Similarity=0.517  Sum_probs=220.7

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcE-EEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF-FALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ...+...+..+.+.||+|+||+||.+..+  |+. ||||++.... .......+.+|+.++.+++|||||++++++.++.
T Consensus        35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~  112 (362)
T KOG0192|consen   35 EEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP  112 (362)
T ss_pred             ceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34556677778888999999999988765  776 9999987542 2233789999999999999999999999999887


Q ss_pred             -eEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCC-ceecCCCCCcEEEcCCC-cEEEeecccc
Q 018630          133 -AISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRG-EVKITDFGVS  207 (353)
Q Consensus       133 -~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~-iiH~Dlkp~NIll~~~~-~~kl~DfG~a  207 (353)
                       .+++||||+++|+|.+++..  ...++...+..++.||++||.|||+ ++ ||||||||+|||++.++ ++||+|||++
T Consensus       113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence             79999999999999999987  5789999999999999999999998 88 99999999999999998 9999999999


Q ss_pred             ccccccCCCCcccccCCcccCcceec--CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERIS--GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  285 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  285 (353)
                      +.............||+.|||||++.  ...|+.++||||||+++|||+||..||.+...       ......+......
T Consensus       192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~~~~R  264 (362)
T KOG0192|consen  192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVVGGLR  264 (362)
T ss_pred             eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCC
Confidence            88765434444578999999999999  56899999999999999999999999987543       3555666555555


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +..+..+++.+..+|.+||..||++||++.+++.
T Consensus       265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            5555669999999999999999999999999865

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-52  Score=347.96  Aligned_cols=262  Identities=32%  Similarity=0.490  Sum_probs=232.0

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      ....+.+++|++.+.||+|.||.||+|+.+.++..||+|++..+.  ......++.+|+++...++||||+++|+.|.+.
T Consensus        15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            345677899999999999999999999999999999999987652  333457899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          132 GAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ...|+++||..+|+|+..+.  ...++++..+..++.|++.|+.|+|. +++|||||||+|+|++..|.+|++|||.+..
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            99999999999999999998  56789999999999999999999998 9999999999999999999999999999865


Q ss_pred             ccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          210 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      ..  .....+.|||..|.+||...+..++..+|+|++|++.||++.|.+||...+.       .+...++.+-...  .+
T Consensus       174 ~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-------~etYkrI~k~~~~--~p  242 (281)
T KOG0580|consen  174 AP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-------SETYKRIRKVDLK--FP  242 (281)
T ss_pred             cC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-------HHHHHHHHHcccc--CC
Confidence            33  4556778999999999999999999999999999999999999999987542       2344444443332  23


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ..++.++.++|.+||.++|.+|.+..|++.|||+....
T Consensus       243 ~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~~  280 (281)
T KOG0580|consen  243 STISGGAADLISRLLVKNPIERLALTEVMDHPWIVANG  280 (281)
T ss_pred             cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhcC
Confidence            78899999999999999999999999999999998653

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-52  Score=369.33  Aligned_cols=278  Identities=29%  Similarity=0.480  Sum_probs=230.4

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec--C---eEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN--G---AIS  135 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~--~---~~~  135 (353)
                      -.|...+.+|+|+||+||++....+++.||||.+-...     +--.+|+.+|+.++|||||++..+|...  +   ++.
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            35788899999999999999999999999999875442     2334789999999999999999888743  2   567


Q ss_pred             EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC-CcEEEeeccccccc
Q 018630          136 IILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIM  210 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~~~  210 (353)
                      +||||++. +|.+.++.    +..++.-.++-+.+||++||.|||+ .||+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            89999985 99999884    4778999999999999999999999 999999999999999976 89999999999987


Q ss_pred             cccCCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH-----HHHh----
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM-----EAIV----  280 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~-----~~~~----  280 (353)
                      ... ....++..|..|+|||++.+. .|+.+.||||.||++.||+-|++-|.+.+..+....+.+++     +.+.    
T Consensus       177 ~~~-epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  177 VKG-EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             ccC-CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence            644 445788899999999999886 59999999999999999999999999865544333222221     0111    


Q ss_pred             -----------cCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhhCCCcccccc
Q 018630          281 -----------DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSN  349 (353)
Q Consensus       281 -----------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (353)
                                 ............++++.+|+.++|+++|.+|.++.|++.||||....+.+..+.+     +.++++|+|
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~-----g~~lp~lf~  330 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPN-----GRPLPPLFN  330 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcC-----CCcCCCccC
Confidence                       0001111335678999999999999999999999999999999999999888876     779999999


Q ss_pred             cC
Q 018630          350 LS  351 (353)
Q Consensus       350 ~~  351 (353)
                      |.
T Consensus       331 f~  332 (364)
T KOG0658|consen  331 FK  332 (364)
T ss_pred             ch
Confidence            85

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-53  Score=354.29  Aligned_cols=259  Identities=29%  Similarity=0.461  Sum_probs=226.9

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ...+.|++...||+|.|+.|+++.+..+|+.+|+|++... ........+.+|+.|-+.++||||+.+.+.+.+.+..|+
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            3447899999999999999999999999999999988644 223356789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC---cEEEeecccccccccc
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMAST  213 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~a~~~~~~  213 (353)
                      |+|+++|++|..-+-..-.+++..+..+++||++||.|+|. +||||||+||+|+++.+..   -+||+|||+|..+. .
T Consensus        88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~  165 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D  165 (355)
T ss_pred             EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence            99999999998777665678999999999999999999998 9999999999999996543   59999999998877 4


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQ  291 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  291 (353)
                      +......+|||.|||||++...+|+..+|||+-|++||-|+.|.+||.+.++.       .+.+.|..+.  .+...++.
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~yd~~~~~w~~  238 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAYDYPSPEWDT  238 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccccCCCCcccCc
Confidence            44455689999999999999999999999999999999999999999985442       3444554433  34556789


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      +++++++|+++||..||.+|+|+.|+|+|||+..
T Consensus       239 is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  239 VTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             CCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            9999999999999999999999999999999965

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-51  Score=373.05  Aligned_cols=264  Identities=31%  Similarity=0.513  Sum_probs=223.2

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-------------HHHHHHHHHHHHHHhcCCCCceEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-------------ESARRQIAQELKINQSSQCPYVVVC  124 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~~~~l~hp~iv~~  124 (353)
                      ..+.+|++++.||+|+||.|-+|++..+++.||||++.....             ......+.+|+.+++++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            456789999999999999999999999999999999954311             1123578999999999999999999


Q ss_pred             eeEeEec--CeEEEEEEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEE
Q 018630          125 YQSFYSN--GAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI  201 (353)
Q Consensus       125 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  201 (353)
                      +++..+.  ..+|||+|||..|.+...- ..++ +++.++++++++++.||+|||. +|||||||||.|+|++++|++||
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEcCCCcEEe
Confidence            9988754  6899999999988875432 2344 9999999999999999999998 99999999999999999999999


Q ss_pred             eeccccccccccC-----CCCcccccCCcccCcceecCCC----CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhH
Q 018630          202 TDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF  272 (353)
Q Consensus       202 ~DfG~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~  272 (353)
                      +|||.+.......     ......+|||.|+|||++.++.    -+.+.||||+||+||.|+.|+.||.+       ...
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-------~~~  324 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-------DFE  324 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-------chH
Confidence            9999987653221     1122368999999999987733    35789999999999999999999977       355


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          273 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      .++..+|............+.+++++||.+||++||++|.+..++..|||....++..
T Consensus       325 ~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  325 LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            6777888887766655567899999999999999999999999999999998876544

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-50  Score=375.02  Aligned_cols=257  Identities=28%  Similarity=0.505  Sum_probs=223.9

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .+..++|++.+.||+|+||.||+|+++.+++.||+|+++...  .......+.+|+.+++.++||||+++++.+.+++.+
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            455689999999999999999999999999999999987542  223456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |+||||+.+++|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++...... 
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            9999999999999999988889999999999999999999998 99999999999999999999999999999765322 


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                        ....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.       .+....+......  .+..++.
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~~~--~p~~~~~  240 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILAGRLK--FPNWFDG  240 (329)
T ss_pred             --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCCcC--CCCCCCH
Confidence              2345799999999999998899999999999999999999999976432       2333444443322  2356889


Q ss_pred             HHHHHHHHhhhhCcCCCCC-----HHHHHcCCccccc
Q 018630          295 EFCSFISACVQKEPQQRLS-----AQELMTHPFLKMY  326 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~  326 (353)
                      .+.+||.+||+.||.+||+     ++++++||||+..
T Consensus       241 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        241 RARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            9999999999999999997     7999999999864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-50  Score=370.81  Aligned_cols=255  Identities=25%  Similarity=0.463  Sum_probs=221.0

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++....  .......+.+|+.+++.++||||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999999999999999987542  2234566889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||+++++|.+++...+.+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++......   ..
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---cc
Confidence            999999999999988889999999999999999999998 99999999999999999999999999998765422   23


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.       ......+.....  ..+..+++.+.+
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~  227 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEKILAGKL--EFPRHLDLYAKD  227 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCc--CCCccCCHHHHH
Confidence            45799999999999988899999999999999999999999976432       233344444332  223456899999


Q ss_pred             HHHHhhhhCcCCCCC-----HHHHHcCCcccccCC
Q 018630          299 FISACVQKEPQQRLS-----AQELMTHPFLKMYGD  328 (353)
Q Consensus       299 li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~  328 (353)
                      ||.+||+.||.+||+     ++|+++||||+....
T Consensus       228 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             HHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            999999999999995     999999999986543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-52  Score=378.92  Aligned_cols=259  Identities=36%  Similarity=0.593  Sum_probs=235.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ..|..+..||+|+||.||++.+..+++.||+|++.....+.....+.+|+.++.+++++||.++|+.|..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777799999999999999999999999999999887778888999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      |.||++.+.++....+++..+..++++++.|+.|||+ .+.+|||||+.||++..+|.+||+|||++..+........+.
T Consensus        93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence            9999999999987777999999999999999999998 999999999999999999999999999998887776666889


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      +|||.|||||++.+..|+.++||||||++.+||++|.+||....+..       .+..|.+..+|. ....+++.+++||
T Consensus       172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-------vlflIpk~~PP~-L~~~~S~~~kEFV  243 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-------VLFLIPKSAPPR-LDGDFSPPFKEFV  243 (467)
T ss_pred             cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-------EEEeccCCCCCc-cccccCHHHHHHH
Confidence            99999999999998899999999999999999999999998876632       222334444443 4458999999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      ..||++||+.||||.++++|+|++..+.
T Consensus       244 ~~CL~k~P~~RpsA~~LLKh~FIk~a~k  271 (467)
T KOG0201|consen  244 EACLDKNPEFRPSAKELLKHKFIKRAKK  271 (467)
T ss_pred             HHHhhcCcccCcCHHHHhhhHHHHhcCC
Confidence            9999999999999999999999998553

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.2e-50  Score=372.46  Aligned_cols=281  Identities=43%  Similarity=0.803  Sum_probs=235.6

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +..++|++.+.||+|+||.||++.+..++..+|+|++...........+.+|+++++.++||||+++++++..++.+++|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            34578999999999999999999999999999999987765555667899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+..+++||||||+||+++.++.+||+|||++......  ..
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~  159 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA  159 (333)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--cc
Confidence            9999999999999988889999999999999999999997457999999999999999999999999998755322  22


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch----------------------------
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW----------------------------  269 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----------------------------  269 (353)
                      ....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+..                            
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS  239 (333)
T ss_pred             ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence            3457899999999999888999999999999999999999999754321100                            


Q ss_pred             ---------hhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhh
Q 018630          270 ---------TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  340 (353)
Q Consensus       270 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~  340 (353)
                               .........+.....+......++.++.+||.+||++||++|||+.|++.||||+....+..++..|+.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~~~  319 (333)
T cd06650         240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAEEVDFAGWLCST  319 (333)
T ss_pred             hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCccccccHHHHHHHH
Confidence                     00111222233333333333457889999999999999999999999999999998877777888877443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2e-50  Score=374.18  Aligned_cols=250  Identities=31%  Similarity=0.566  Sum_probs=216.9

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      +.||+|+||.||+|+++.+|+.||+|+++...  .......+.+|+.+++.++||||+++++.+..++.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999987542  2334566788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCC
Q 018630          145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  224 (353)
Q Consensus       145 sL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  224 (353)
                      +|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+||+++.++.+||+|||+++............+||+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            999999988889999999999999999999998 9999999999999999999999999999876443333444568999


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018630          225 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  304 (353)
Q Consensus       225 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  304 (353)
                      .|+|||++.+..++.++||||+||++|||++|..||...+.       ......+.....  ..+..+++++.+||.+||
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L  230 (323)
T cd05571         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEI--RFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHHHHHHHHHHc
Confidence            99999999998999999999999999999999999976432       223333333322  234578999999999999


Q ss_pred             hhCcCCCC-----CHHHHHcCCccccc
Q 018630          305 QKEPQQRL-----SAQELMTHPFLKMY  326 (353)
Q Consensus       305 ~~dp~~Rp-----t~~e~l~hp~~~~~  326 (353)
                      +.||++||     ++.++++||||+..
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999     89999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.9e-50  Score=368.39  Aligned_cols=263  Identities=26%  Similarity=0.444  Sum_probs=213.5

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ..++|++.+.||.|+||.||++.++.+++.||+|+++..........+.+|+.+++.++||||+++++++..+...++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            45789999999999999999999999999999999875543334456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      ||+.+ +|.+++...+ .+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.........
T Consensus        83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            99985 9999887653 57899999999999999999998 999999999999999999999999999987654333333


Q ss_pred             cccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--------------HHHhcC
Q 018630          218 NTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------------EAIVDQ  282 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~--------------~~~~~~  282 (353)
                      ....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+.........              ..+...
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            44578999999999876 468999999999999999999999997654322111110000              000000


Q ss_pred             CCC-------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          283 PPP-------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       283 ~~~-------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ..+       ......+++++.+||.+||++||.+|||++|+++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            000       00123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-50  Score=359.17  Aligned_cols=267  Identities=30%  Similarity=0.492  Sum_probs=231.4

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ...+.+++|++++.||.|.-|+||+|+.+.++..+|+|++....  ......++..|.+||..++||.+..+|..|+.+.
T Consensus        71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            34677889999999999999999999999999999999997652  2334567788999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      ..|++||||+||+|..+++++  +.+++..++.++.+++.||+|||. .|||.|||||+||||..+|++.|+||.++...
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            999999999999999999876  679999999999999999999998 99999999999999999999999999998543


Q ss_pred             cc---------------------------------c-C----------------------CCCcccccCCcccCcceecC
Q 018630          211 AS---------------------------------T-S----------------------GQANTFVGTYNYMSPERISG  234 (353)
Q Consensus       211 ~~---------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~  234 (353)
                      ..                                 . .                      ....+.+||-.|.|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            10                                 0 0                      01123578999999999999


Q ss_pred             CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCC-
Q 018630          235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-  313 (353)
Q Consensus       235 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-  313 (353)
                      ...+.++|+|+||+.+|||+.|..||.+.+..       +.+..+............++..+++||+++|.+||++|.. 
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~-------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK-------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCch-------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcc
Confidence            99999999999999999999999999997654       3445555555544444578899999999999999999998 


Q ss_pred             ---HHHHHcCCcccccCCC
Q 018630          314 ---AQELMTHPFLKMYGDL  329 (353)
Q Consensus       314 ---~~e~l~hp~~~~~~~~  329 (353)
                         |+||-+||||+++.+.
T Consensus       383 ~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  383 KRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             ccchHHhhcCccccCCChh
Confidence               9999999999987654

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-50  Score=368.99  Aligned_cols=248  Identities=30%  Similarity=0.516  Sum_probs=215.4

Q ss_pred             ecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           69 VGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      ||+|+||.||++++..+++.||+|+++...  .......+.+|+.++..++||||+++++.+..++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999999999999999987542  234456778899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCCcc
Q 018630          147 ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY  226 (353)
Q Consensus       147 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y  226 (353)
                      .+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||+++............+||+.|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            9999888889999999999999999999998 999999999999999999999999999987644333334456899999


Q ss_pred             cCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhh
Q 018630          227 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK  306 (353)
Q Consensus       227 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  306 (353)
                      +|||++.+..++.++||||+||++|||++|..||...+.       .+....+.....  ..+..+++++.+||.+||+.
T Consensus       160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~  230 (312)
T cd05585         160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKILQEPL--RFPDGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcCC
Confidence            999999998999999999999999999999999976432       233344443322  23467899999999999999


Q ss_pred             CcCCCC---CHHHHHcCCccccc
Q 018630          307 EPQQRL---SAQELMTHPFLKMY  326 (353)
Q Consensus       307 dp~~Rp---t~~e~l~hp~~~~~  326 (353)
                      ||.+||   ++.++++||||...
T Consensus       231 dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         231 DPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CHHHcCCCCCHHHHHcCCCcCCC
Confidence            999997   57999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.3e-49  Score=372.89  Aligned_cols=258  Identities=29%  Similarity=0.462  Sum_probs=216.0

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|++++.||+|+||+||+|.++.+++.||+|+++...  .......+.+|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999987542  2334467888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC---
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---  215 (353)
                      ||++||+|.+++.+.+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++.......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            999999999999988899999999999999999999998 9999999999999999999999999999875432110   


Q ss_pred             --------------------------------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 018630          216 --------------------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP  263 (353)
Q Consensus       216 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  263 (353)
                                                      .....+||+.|+|||++.+..++.++|+|||||++|||++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                            012357999999999999989999999999999999999999999764


Q ss_pred             ccCCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhhCcC---CCCCHHHHHcCCcccccC
Q 018630          264 EQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQ---QRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~---~Rpt~~e~l~hp~~~~~~  327 (353)
                      +..       +....+....  ........+++++.++|.+|+. +|.   .||+++|+++||||+...
T Consensus       240 ~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~  300 (363)
T cd05628         240 TPQ-------ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD  300 (363)
T ss_pred             CHH-------HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence            332       2333333321  1111223578999999999875 444   468999999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-50  Score=372.05  Aligned_cols=262  Identities=29%  Similarity=0.504  Sum_probs=220.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|++++.||+|+||.||+|++..+++.||||+++...  .......+.+|+.++..++||||+++++.+...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999987542  2234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....   ...
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccC
Confidence            999999999999988889999999999999999999998 9999999999999999999999999999876543   234


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ..+||+.|+|||.+.+..++.++|||||||++|||++|..||...+..+.+........ .............+++++.+
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-TLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-cccCCCCCccccccCHHHHH
Confidence            56799999999999988999999999999999999999999976543221111110000 00111111112356899999


Q ss_pred             HHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          299 FISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       299 li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ||.+||+.+|.+|||+.++++||||+...
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~~  264 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEVD  264 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence            99999999999999999999999998753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-49  Score=369.50  Aligned_cols=260  Identities=26%  Similarity=0.433  Sum_probs=223.3

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCC-cEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTG-QFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      ...+..++|.+.+.||+|+||.||+|.++.++ ..||+|++....  .......+.+|+.+++.++||||+++++++.++
T Consensus        24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            34567789999999999999999999876554 689999986542  233456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      +.+|+||||+.+|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999999999988899999999999999999999998 999999999999999999999999999997653


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      .   .....+||+.|+|||++.+..++.++|+||+||++|||++|..||...+..       .....+.....  ..+..
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~--~~p~~  250 (340)
T PTZ00426        183 T---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGII--YFPKF  250 (340)
T ss_pred             C---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCC--CCCCC
Confidence            2   233567999999999999888999999999999999999999999864331       22333433332  22456


Q ss_pred             CCHHHHHHHHHhhhhCcCCCC-----CHHHHHcCCcccccC
Q 018630          292 FSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  327 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  327 (353)
                      +++++.++|++||+.||.+|+     |++++++||||+...
T Consensus       251 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        251 LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            789999999999999999995     899999999998654

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-49  Score=364.79  Aligned_cols=265  Identities=25%  Similarity=0.405  Sum_probs=213.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .++|++.+.||+|+||.||+|+++.+++.||||++...........+.+|+.+++.++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            37899999999999999999999999999999998755433334567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      |+. ++|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++...........
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence            996 5888877654 568999999999999999999998 9999999999999999999999999999876543333344


Q ss_pred             ccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-------------C
Q 018630          219 TFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-------------P  284 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------------~  284 (353)
                      ...+|+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.....  ..............             .
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhhccccc
Confidence            5678999999999865 458899999999999999999999997643210  11111111100000             0


Q ss_pred             CC-------------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          285 PS-------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       285 ~~-------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      +.             ......++++.+|+.+||+.||.+|||++|+++||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence            00             001124578999999999999999999999999999987654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.9e-49  Score=366.47  Aligned_cols=251  Identities=31%  Similarity=0.569  Sum_probs=215.9

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      +.||+|+||.||+++++.+|+.||+|+++...  .......+.+|+.+++.++||||+++++.+..++.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999999999999999987542  2334566788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCC
Q 018630          145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  224 (353)
Q Consensus       145 sL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  224 (353)
                      +|..++.....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..............||+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            999999888889999999999999999999998 9999999999999999999999999999875433333334567999


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018630          225 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  304 (353)
Q Consensus       225 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  304 (353)
                      .|+|||++.+..++.++|+|||||++|||++|..||...+.       ......+.....  ..+..+++++.++|.+||
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L  230 (323)
T cd05595         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEI--RFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence            99999999988999999999999999999999999976432       122333332222  223568999999999999


Q ss_pred             hhCcCCCC-----CHHHHHcCCcccccC
Q 018630          305 QKEPQQRL-----SAQELMTHPFLKMYG  327 (353)
Q Consensus       305 ~~dp~~Rp-----t~~e~l~hp~~~~~~  327 (353)
                      +.||.+||     ++.++++||||....
T Consensus       231 ~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         231 KKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             cCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            99999998     899999999998744

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3e-49  Score=368.62  Aligned_cols=261  Identities=31%  Similarity=0.529  Sum_probs=230.2

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~  135 (353)
                      ..+.|++.+.||+|.||.||.++++.+|+.+|+|++.....  ......+.+|+.+++++. ||||+.++++|++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34679999999999999999999999999999999976532  224578999999999998 999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC----CcEEEeecccccccc
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR----GEVKITDFGVSAIMA  211 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~----~~~kl~DfG~a~~~~  211 (353)
                      +|||++.||.|++.+... .+++..+..++.|++.|++|||+ .|++||||||+|+|+...    +.+|++|||+|....
T Consensus       113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            999999999999999876 49999999999999999999999 999999999999999643    479999999998877


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPS  289 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  289 (353)
                      . .......+||+.|+|||++....|+..+|+||+|+++|.|++|..||.+.+...       ....+....  .....+
T Consensus       191 ~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-------~~~~i~~~~~~f~~~~w  262 (382)
T KOG0032|consen  191 P-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-------IFLAILRGDFDFTSEPW  262 (382)
T ss_pred             C-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-------HHHHHHcCCCCCCCCCc
Confidence            6 556777899999999999999999999999999999999999999998865432       222444433  345567


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      ..++..++++|++||..||.+|+|+.++|+|||++.....
T Consensus       263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~  302 (382)
T KOG0032|consen  263 DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA  302 (382)
T ss_pred             cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence            7899999999999999999999999999999999986433

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-50  Score=343.31  Aligned_cols=277  Identities=34%  Similarity=0.688  Sum_probs=239.2

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~l  136 (353)
                      .+..+.+.+..||.|+.|+|++++.+.+|...|||.+..+.+.....++++.+++.... ++|+||+++++|..+...++
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I  168 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI  168 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence            34567778889999999999999999999999999998887777777888888876554 59999999999999999999


Q ss_pred             EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          137 ILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      .||.|. ..+..++++ .+++++..+-++...++.||.||..++||+|||+||.|||+|..|++||||||++..+.... 
T Consensus       169 cMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-  246 (391)
T KOG0983|consen  169 CMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-  246 (391)
T ss_pred             HHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence            999995 377777764 46899999999999999999999988999999999999999999999999999998876543 


Q ss_pred             CCcccccCCcccCcceecCC---CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC-CC
Q 018630          216 QANTFVGTYNYMSPERISGG---KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQ  291 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  291 (353)
                      ......|.+.|||||.+...   +|+.++||||||++++||.||+.||.+-+      ...+.+..+.+..+|.... ..
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~------tdFe~ltkvln~ePP~L~~~~g  320 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK------TDFEVLTKVLNEEPPLLPGHMG  320 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC------ccHHHHHHHHhcCCCCCCcccC
Confidence            23445899999999999654   59999999999999999999999998743      3345666666655554433 34


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhhCC
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGS  342 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~  342 (353)
                      +|+.+++|+..||++|+.+||.+.++++|||+..++.-.++..+||+|+-.
T Consensus       321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV~~  371 (391)
T KOG0983|consen  321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDVMA  371 (391)
T ss_pred             cCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHHHh
Confidence            999999999999999999999999999999999999999999999988643

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.5e-49  Score=358.18  Aligned_cols=258  Identities=27%  Similarity=0.451  Sum_probs=216.5

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      |+..+.||+|+||.||++.+..+++.||+|.+....  .......+.+|+.+++.++|+||+++++.+.+++.+++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            778899999999999999999999999999986542  223345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          141 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       141 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      +++|+|.+++...  ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||++...... ....
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR  159 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ceec
Confidence            9999999887643  468999999999999999999998 99999999999999999999999999998765322 2233


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ...||+.|+|||++.+..++.++||||+||++|||++|..||...+....   .......+...  ....+..+++++.+
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~--~~~~~~~~s~~~~~  234 (285)
T cd05631         160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKED--QEEYSEKFSEDAKS  234 (285)
T ss_pred             CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcc--cccCCccCCHHHHH
Confidence            45789999999999998999999999999999999999999987543221   11222222221  12234568999999


Q ss_pred             HHHHhhhhCcCCCCC-----HHHHHcCCcccccC
Q 018630          299 FISACVQKEPQQRLS-----AQELMTHPFLKMYG  327 (353)
Q Consensus       299 li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~  327 (353)
                      |+.+||+.||.+|||     ++++++||||+...
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            999999999999997     89999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.7e-50  Score=355.54  Aligned_cols=269  Identities=26%  Similarity=0.476  Sum_probs=222.9

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCc-eEEEeeEeEecC-----
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPY-VVVCYQSFYSNG-----  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~-iv~~~~~~~~~~-----  132 (353)
                      ...|+.++.||+|+||+||+|+++.+|+.||+|++..... +..-....+|+.+++.++|+| |+.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            5678888999999999999999999999999999987644 334456789999999999999 999999998776     


Q ss_pred             -eEEEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          133 -AISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       133 -~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                       .+++|+||++- +|..++....    .++...++.+++||+.||+|||+ ++|+||||||.|||++++|.+||+|||+|
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCCcEeeeccchH
Confidence             89999999975 9999998754    47888999999999999999999 99999999999999999999999999999


Q ss_pred             ccccccCCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-  285 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-  285 (353)
                      +............++|.+|+|||++.+. .|+...||||+|||++||+++++.|.+.++.+....+.+++..-.....| 
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            9877666667777899999999999887 59999999999999999999999998866533222222221110000000 


Q ss_pred             ----------CC----------CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          286 ----------SA----------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       286 ----------~~----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                                ..          .....+++..+++.+||+++|.+|.|++.++.||||+..+...
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence                      00          0122335899999999999999999999999999999886554

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.2e-49  Score=366.91  Aligned_cols=250  Identities=30%  Similarity=0.551  Sum_probs=215.4

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      +.||+|+||.||+++++.+++.||+|++....  .......+.+|+.+++.++||||+++++.+..++.+++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999987542  2334567788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCC
Q 018630          145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  224 (353)
Q Consensus       145 sL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  224 (353)
                      +|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            999999888889999999999999999999998 9999999999999999999999999999876433333334567999


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018630          225 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  304 (353)
Q Consensus       225 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  304 (353)
                      .|+|||++.+..++.++|||||||++|+|++|..||...+.       .+....+.....  ..+..+++++.+||.+||
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-------~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L  230 (328)
T cd05593         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEDI--KFPRTLSADAKSLLSGLL  230 (328)
T ss_pred             CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-------HHHHHHhccCCc--cCCCCCCHHHHHHHHHHc
Confidence            99999999988999999999999999999999999976432       222333332222  234568999999999999


Q ss_pred             hhCcCCCC-----CHHHHHcCCccccc
Q 018630          305 QKEPQQRL-----SAQELMTHPFLKMY  326 (353)
Q Consensus       305 ~~dp~~Rp-----t~~e~l~hp~~~~~  326 (353)
                      +.||++|+     ++.++++||||...
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999997     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-49  Score=371.80  Aligned_cols=258  Identities=31%  Similarity=0.529  Sum_probs=218.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|++++.||+|+||.||+|++..+++.||||++....  .......+.+|+.++..++||||+++++.+.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999997542  2334566788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC---
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---  215 (353)
                      ||+++|+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.++|+|||++........   
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            999999999999888889999999999999999999998 9999999999999999999999999999875432110   


Q ss_pred             -----------------------------------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCC
Q 018630          216 -----------------------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  260 (353)
Q Consensus       216 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf  260 (353)
                                                         ...+.+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence                                               011246999999999999889999999999999999999999999


Q ss_pred             CCCccCCchhhHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhhhCcCCCCC---HHHHHcCCcccccC
Q 018630          261 SPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMYG  327 (353)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~~  327 (353)
                      ...+..       +....+.....  .......+++++.+||.+||. +|.+|++   ++|+++||||+...
T Consensus       240 ~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~  303 (364)
T cd05599         240 CSDNPQ-------ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD  303 (364)
T ss_pred             CCCCHH-------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            764432       22233332221  112223578999999999997 9999998   99999999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-49  Score=371.12  Aligned_cols=258  Identities=34%  Similarity=0.590  Sum_probs=221.0

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|.+.+.||+|+||.||+|++..+++.||||+++...  .......+.+|+.++..++||||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999987542  2234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC----
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----  214 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~----  214 (353)
                      ||+++++|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++.......    
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            999999999999888889999999999999999999998 999999999999999999999999999997654333    


Q ss_pred             -------------------------CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch
Q 018630          215 -------------------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW  269 (353)
Q Consensus       215 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  269 (353)
                                               .......||+.|+|||.+.+..++.++|||||||++|||++|..||...+..   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~---  236 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ---  236 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH---
Confidence                                     1223457999999999999999999999999999999999999999875422   


Q ss_pred             hhHHHHHHHHhc--CCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCC-HHHHHcCCcccccC
Q 018630          270 TSFYELMEAIVD--QPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-AQELMTHPFLKMYG  327 (353)
Q Consensus       270 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-~~e~l~hp~~~~~~  327 (353)
                          .....+..  ..........+++++.+||.+||+ ||.+||+ ++++++||||+...
T Consensus       237 ----~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         237 ----ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             ----HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence                22233333  111122223479999999999998 9999999 99999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.5e-49  Score=366.36  Aligned_cols=251  Identities=29%  Similarity=0.537  Sum_probs=214.4

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||+|+++.+++.||||+++...  .......+..|..++..+ +||||+++++.+...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999999999999987542  223445667777777765 799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      |+|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++..............||
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            9999999888899999999999999999999998 999999999999999999999999999987643333334456799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      +.|+|||++.+..++.++|+|||||++|+|++|..||...+.       .+....+.....  ..+..+++++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (320)
T cd05590         160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDEV--VYPTWLSQDAVDILKAF  230 (320)
T ss_pred             ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence            999999999988899999999999999999999999976432       233444444332  22356899999999999


Q ss_pred             hhhCcCCCCCH------HHHHcCCcccccC
Q 018630          304 VQKEPQQRLSA------QELMTHPFLKMYG  327 (353)
Q Consensus       304 L~~dp~~Rpt~------~e~l~hp~~~~~~  327 (353)
                      |+.||.+||++      +++++||||+...
T Consensus       231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         231 MTKNPTMRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             cccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence            99999999998      9999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.8e-49  Score=361.36  Aligned_cols=262  Identities=25%  Similarity=0.439  Sum_probs=212.9

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.... .......+.+|+.+++.++||||+++++++..++.+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36999999999999999999999999999999987542 23345677899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CCc
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QAN  218 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~  218 (353)
                      |++++++..+......+++..++.++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++........ ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            99987776665555679999999999999999999998 9999999999999999999999999999977543221 223


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--------HHHhcC------CC
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------EAIVDQ------PP  284 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~------~~  284 (353)
                      ...|++.|+|||++.+..++.++|+||+||++|||++|..||...+..+.........        ......      ..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            4578999999999998889999999999999999999999998754322111111100        000000      00


Q ss_pred             CC---------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          285 PS---------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       285 ~~---------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +.         .....+++++.+||.+||++||++|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00         0012368889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.8e-49  Score=365.86  Aligned_cols=257  Identities=27%  Similarity=0.528  Sum_probs=214.9

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||+++++.+++.||+|+++...  .......+.+|..++..+ +||||+++++.+..++.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999999999999999997542  233456678899998887 799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      |+|.+++...+.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++............+||
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            9999999888899999999999999999999998 999999999999999999999999999987543333344456899


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC--chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS  301 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  301 (353)
                      +.|+|||++.+..++.++|+|||||++|+|++|..||......+  .........+.+.....  ..+..+++++.++|.
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~  237 (329)
T cd05588         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKASSVLK  237 (329)
T ss_pred             ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence            99999999999899999999999999999999999996432211  11111122233333322  234568999999999


Q ss_pred             HhhhhCcCCCCC------HHHHHcCCccccc
Q 018630          302 ACVQKEPQQRLS------AQELMTHPFLKMY  326 (353)
Q Consensus       302 ~~L~~dp~~Rpt------~~e~l~hp~~~~~  326 (353)
                      +||+.||.+|+|      ++++++||||+..
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999999997      7899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.3e-50  Score=357.23  Aligned_cols=253  Identities=27%  Similarity=0.501  Sum_probs=227.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      ..+|++.+.||+|+||.|-+|.+...|+.||||.++..  .++.....+++|++||..++||||+.+|++|++...+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            46899999999999999999999999999999998765  4566678899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |||..+|.|++++...+.+++.+++.+++||+.|+.|+|. ++++|||||.+|||+|.++++||+|||++..+.. ....
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-~kfL  209 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-KKFL  209 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCCCeeeeccchhhhhcc-ccHH
Confidence            9999999999999999999999999999999999999998 9999999999999999999999999999987653 3457


Q ss_pred             cccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .++||+|.|.+||.+.+.+| .+.+|.||||++||.|+.|..||.+.+       ...++.+|..+.....   .-+.++
T Consensus       210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-------hk~lvrQIs~GaYrEP---~~PSdA  279 (668)
T KOG0611|consen  210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-------HKRLVRQISRGAYREP---ETPSDA  279 (668)
T ss_pred             HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-------HHHHHHHhhcccccCC---CCCchH
Confidence            78999999999999999998 689999999999999999999998743       3455666665554322   235678


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                      .-||+.||-.||++|.|++|+.+|=|++
T Consensus       280 ~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  280 SGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHHHHHHhcCcccchhHHHHhhhheee
Confidence            8999999999999999999999997775

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.5e-49  Score=366.17  Aligned_cols=252  Identities=32%  Similarity=0.568  Sum_probs=215.5

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      +.||+|+||.||++++..+|+.||+|+++...  .......+.+|++++..++||||+++++.+..++.+|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997542  2334466778999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCC
Q 018630          145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  224 (353)
Q Consensus       145 sL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  224 (353)
                      +|.+++...+.+++..+..++.||+.||.|||+.+||+||||||+||+++.++.+||+|||+++.............||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            99999988888999999999999999999999647999999999999999999999999999875433333344567999


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018630          225 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  304 (353)
Q Consensus       225 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  304 (353)
                      .|+|||++.+..++.++|||||||++|||++|..||...+.       ......+.....  ..+..+++++.+||.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-------~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L  231 (325)
T cd05594         161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEI--RFPRTLSPEAKSLLSGLL  231 (325)
T ss_pred             ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-------HHHHHHHhcCCC--CCCCCCCHHHHHHHHHHh
Confidence            99999999988999999999999999999999999976432       223333332222  224568999999999999


Q ss_pred             hhCcCCCC-----CHHHHHcCCcccccC
Q 018630          305 QKEPQQRL-----SAQELMTHPFLKMYG  327 (353)
Q Consensus       305 ~~dp~~Rp-----t~~e~l~hp~~~~~~  327 (353)
                      +.||.+|+     ++.++++||||+...
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence            99999997     999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-48  Score=369.73  Aligned_cols=258  Identities=28%  Similarity=0.453  Sum_probs=215.3

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .|++++.||+|+||+||+|+++.+++.||+|++....  .......+.+|+.+++.++||||+++++.+.++..+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5889999999999999999999999999999987542  23445678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-----
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-----  214 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-----  214 (353)
                      |++||+|.+++.+...+++..++.++.|++.||.|||+ .||+||||||+|||++.++++||+|||++.......     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            99999999999888889999999999999999999998 999999999999999999999999999875321000     


Q ss_pred             ------------------------------------------CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHH
Q 018630          215 ------------------------------------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  252 (353)
Q Consensus       215 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  252 (353)
                                                                ....+.+||+.|+|||.+.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                      00123579999999999998889999999999999999


Q ss_pred             HHcCCCCCCCCccCCchhhHHHHHHHHhcC--CCCCCCCCCCCHHHHHHHHHhhh--hCcCCCCCHHHHHcCCcccccC
Q 018630          253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQ--PPPSAPSDQFSPEFCSFISACVQ--KEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       253 ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~--~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      |++|..||...+..       +....+...  .........+++++.+||.+|+.  .+|..|+++.++++||||+...
T Consensus       241 lltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         241 MLVGQPPFLAPTPT-------ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             HHhCCCCCcCCCHH-------HHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence            99999999765432       112222221  11222234689999999999665  4555599999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.1e-48  Score=360.85  Aligned_cols=256  Identities=28%  Similarity=0.505  Sum_probs=218.5

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCC-ceEEEeeEeEecCeEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCP-YVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp-~iv~~~~~~~~~~~~~lv~  138 (353)
                      +|++++.||+|+||.||+|+++.+++.||||+++...  .......+..|..++..+.|+ +|+.+++.+...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5889999999999999999999999999999987542  233456678888888888765 5888999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||+++|+|.+++.....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++...........
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            999999999999888889999999999999999999998 9999999999999999999999999999875433333344


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ..+||+.|+|||++.+..++.++|+||+||++|+|++|..||...+.       .+....+.....  ..+..+++++.+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~  230 (324)
T cd05587         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHNV--SYPKSLSKEAVS  230 (324)
T ss_pred             eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHHHHH
Confidence            56799999999999998999999999999999999999999976432       233344443332  234568999999


Q ss_pred             HHHHhhhhCcCCCCCH-----HHHHcCCcccccC
Q 018630          299 FISACVQKEPQQRLSA-----QELMTHPFLKMYG  327 (353)
Q Consensus       299 li~~~L~~dp~~Rpt~-----~e~l~hp~~~~~~  327 (353)
                      ++.+||+.||.+|+++     +++++||||+...
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999999986     8999999998753

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-48  Score=362.74  Aligned_cols=253  Identities=28%  Similarity=0.509  Sum_probs=214.4

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHH---hcCCCCceEEEeeEeEecCeEEEE
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKIN---QSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~---~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      |++++.||+|+||.||++.++.+++.||||+++...  .......+.+|++++   +.++||||+++++.+...+.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678999999999999999999999999999997542  222344566666554   567899999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |||+++++|..++.. ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999988865 579999999999999999999998 999999999999999999999999999987544333334


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  297 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ...+|++.|+|||.+.+..++.++|+|||||++|||++|..||...+.       .+....+......  .+..+++++.
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~~~--~p~~~~~~~~  229 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-------EEVFDSIVNDEVR--YPRFLSREAI  229 (324)
T ss_pred             cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC--CCCCCCHHHH
Confidence            456899999999999988899999999999999999999999976432       2333444443322  3456899999


Q ss_pred             HHHHHhhhhCcCCCC-----CHHHHHcCCccccc
Q 018630          298 SFISACVQKEPQQRL-----SAQELMTHPFLKMY  326 (353)
Q Consensus       298 ~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  326 (353)
                      ++|.+||+.||.+||     ++.++++||||+..
T Consensus       230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            999999999999999     79999999999864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-49  Score=366.04  Aligned_cols=255  Identities=27%  Similarity=0.405  Sum_probs=219.1

Q ss_pred             CCCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           53 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ...+.+..+.+.+++.||+|.||.|+.+.... ...||+|.++..  ......+.+|+++|++++|+|||++++++..+.
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            44556777888999999999999999998862 337999998764  223356779999999999999999999999988


Q ss_pred             eEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          133 AISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      .+|||||||+.|+|.++|+.  ...+.......++.|||+||+||++ +++|||||..+||||+++..+||+|||+|+..
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCceEEEccccccccc
Confidence            99999999999999999987  4678999999999999999999998 99999999999999999999999999999954


Q ss_pred             cccCCCCc-ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          211 ASTSGQAN-TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       211 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      .+...... ..--...|.|||++..+.++.+|||||||++||||+| |+.||.+.       ...++++.+..+...+. 
T Consensus       354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-------sn~ev~~~le~GyRlp~-  425 (468)
T KOG0197|consen  354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-------SNEEVLELLERGYRLPR-  425 (468)
T ss_pred             CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-------CHHHHHHHHhccCcCCC-
Confidence            43332211 1223568999999999999999999999999999999 99999875       44577788887776555 


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +..+|+++.++|..||+.+|++|||++.+..
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            4679999999999999999999999996644

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-48  Score=370.35  Aligned_cols=256  Identities=29%  Similarity=0.479  Sum_probs=215.5

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .|++++.||+|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5899999999999999999999999999999987542  23445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc------
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST------  213 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------  213 (353)
                      |+++|+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||++......      
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            99999999999888889999999999999999999998 99999999999999999999999999997532100      


Q ss_pred             -----------------------------------------CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHH
Q 018630          214 -----------------------------------------SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  252 (353)
Q Consensus       214 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  252 (353)
                                                               .....+.+||+.|+|||++.+..++.++||||+||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                     000123479999999999998899999999999999999


Q ss_pred             HHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhhCcCCCCC---HHHHHcCCccccc
Q 018630          253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMY  326 (353)
Q Consensus       253 ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~  326 (353)
                      |++|..||...+..       +....+....  ........+++++.++|.+|+ .+|.+|++   ++++++||||+..
T Consensus       241 lltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         241 MLVGQPPFLAQTPL-------ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHhCCCCCCCCCHH-------HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            99999999764321       1222222211  122223568999999999986 59999997   9999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-48  Score=370.03  Aligned_cols=257  Identities=31%  Similarity=0.520  Sum_probs=214.7

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|.+++.||+|+||.||++.++.+++.||||++....  .......+.+|+++++.++||||+++++.+.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999999999999999986542  2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC---
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---  215 (353)
                      ||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++.......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            999999999999888889999999999999999999998 9999999999999999999999999999863211000   


Q ss_pred             --------------------------------------------CCcccccCCcccCcceecCCCCCccccHHHHHHHHH
Q 018630          216 --------------------------------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  251 (353)
Q Consensus       216 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  251 (353)
                                                                  .....+||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                                                        001246999999999999889999999999999999


Q ss_pred             HHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhhCcCCC---CCHHHHHcCCccccc
Q 018630          252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQR---LSAQELMTHPFLKMY  326 (353)
Q Consensus       252 ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~R---pt~~e~l~hp~~~~~  326 (353)
                      ||++|..||...+..       +....+....  ........+++++.+||.+||+ +|.+|   +|+.|++.||||+..
T Consensus       240 elltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         240 ECLIGWPPFCSENSH-------ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhcCCCCCCCCCHH-------HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999999764432       2222332211  1111223578999999999998 77765   599999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.9e-49  Score=370.98  Aligned_cols=257  Identities=27%  Similarity=0.437  Sum_probs=215.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .+|++++.||+|+||.||+|++..+++.||||++....  .......+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            37999999999999999999999999999999986432  2233466789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc-----
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-----  213 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-----  213 (353)
                      ||+++|+|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+||+++.++.+||+|||++......     
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            999999999999988889999999999999999999998 99999999999999999999999999997532100     


Q ss_pred             --------------------------------------CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc
Q 018630          214 --------------------------------------SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  255 (353)
Q Consensus       214 --------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  255 (353)
                                                            .......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                                                  000123479999999999999899999999999999999999


Q ss_pred             CCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhhCcCCCC---CHHHHHcCCccccc
Q 018630          256 GQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKMY  326 (353)
Q Consensus       256 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~~  326 (353)
                      |..||...+..       +....+....  ........+++++.++|.+|+ .+|.+|+   |+.++++||||+..
T Consensus       240 G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         240 GQPPFLADTPA-------ETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             CCCCCCCCCHH-------HHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            99999875432       1222222211  111223468999999999976 5999999   99999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.1e-48  Score=367.16  Aligned_cols=261  Identities=30%  Similarity=0.505  Sum_probs=219.0

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .+..++|++.+.||+|+||.||+++++.+++.||+|++....  .......+.+|+.+++.++||||+++++.+.+++.+
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456789999999999999999999999999999999986431  223345578899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |+||||++||+|.+++.. ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999999876 468999999999999999999998 999999999999999999999999999987654322


Q ss_pred             C-CCcccccCCcccCcceecCC----CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCC
Q 018630          215 G-QANTFVGTYNYMSPERISGG----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSA  287 (353)
Q Consensus       215 ~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  287 (353)
                      . .....+||+.|+|||.+.+.    .++.++|+|||||++|||++|..||...+.       ......+.....  ...
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~  269 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMDHKNSLTFP  269 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCCCcCCCC
Confidence            1 22345799999999998653    378999999999999999999999976432       223334433221  112


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCC--CCCHHHHHcCCccccc
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMY  326 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~  326 (353)
                      ....++.++.+||.+||+.+|.+  |+|++|+++||||+..
T Consensus       270 ~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         270 DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            22357999999999999999988  9999999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-48  Score=362.36  Aligned_cols=257  Identities=28%  Similarity=0.532  Sum_probs=213.5

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||+++++.+++.||+|+++...  .......+.+|+.++..+ +||||+++++.+..++.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999997642  233445677888887665 899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      ++|..++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987543333334456899


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC--chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS  301 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  301 (353)
                      +.|+|||++.+..++.++|+|||||++|||++|..||.......  ...........+.....  ..+..++.++.++|.
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~  237 (329)
T cd05618         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKAASVLK  237 (329)
T ss_pred             ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCCCCCCHHHHHHHH
Confidence            99999999999899999999999999999999999996322111  11111222233333222  234578899999999


Q ss_pred             HhhhhCcCCCCC------HHHHHcCCccccc
Q 018630          302 ACVQKEPQQRLS------AQELMTHPFLKMY  326 (353)
Q Consensus       302 ~~L~~dp~~Rpt------~~e~l~hp~~~~~  326 (353)
                      +||+.||.+|||      ++++++||||+..
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999999998      5799999999865

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.2e-48  Score=363.80  Aligned_cols=260  Identities=46%  Similarity=0.776  Sum_probs=217.1

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      ...++|+.++.||+|+||.||++++..+++.||||++...........+.+|+++++.++|+||+++++++..++.+++|
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence            45678999999999999999999999999999999987665556677899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |||+++++|.+.    ...++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.........
T Consensus       151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            999999998653    345678888999999999999998 999999999999999999999999999998765433333


Q ss_pred             cccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          218 NTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      ....||..|+|||.+..     ...+.++|||||||++|||++|..||...... .+   ......+..... ......+
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~---~~~~~~~~~~~~-~~~~~~~  300 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DW---ASLMCAICMSQP-PEAPATA  300 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cH---HHHHHHHhccCC-CCCCCcc
Confidence            45689999999998743     22456899999999999999999999743322 12   222223322222 2234578


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +.++.+||.+||+.||++|||+.|+++||||....
T Consensus       301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            99999999999999999999999999999998753

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-48  Score=359.83  Aligned_cols=251  Identities=30%  Similarity=0.520  Sum_probs=214.8

Q ss_pred             eeeecccCCeEEEEEEec---cCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           66 IKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ++.||+|+||.||+|++.   .+++.||+|+++...   .......+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            367999999999999864   468899999987542   22334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT  159 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence            99999999999988889999999999999999999998 99999999999999999999999999998754433333445


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (353)
                      ..||+.|+|||++.+..++.++|||||||++|||++|..||...+.       ......+.....  ..+..+++++.+|
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~~~~~--~~~~~~~~~~~~l  230 (323)
T cd05584         160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKILKGKL--NLPPYLTPEARDL  230 (323)
T ss_pred             cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence            6799999999999988899999999999999999999999976432       223344443332  2345678999999


Q ss_pred             HHHhhhhCcCCCC-----CHHHHHcCCccccc
Q 018630          300 ISACVQKEPQQRL-----SAQELMTHPFLKMY  326 (353)
Q Consensus       300 i~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  326 (353)
                      |.+||+.||++||     +++++++||||+..
T Consensus       231 i~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-47  Score=353.37  Aligned_cols=276  Identities=45%  Similarity=0.821  Sum_probs=230.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|++.+.||+|+||.||++.+..++..+|+|.++.........++.+|++++++++||||+++++.+..++.+++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36899999999999999999999999999999987665555667789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++++|.+++...+.+++..+..++.|++.||.|||+..+++|+||||+||+++.++.++|+|||++......  .....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~  158 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF  158 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccccC
Confidence            9999999999988889999999999999999999997458999999999999999999999999998654322  23445


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch-----------------------------hh
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW-----------------------------TS  271 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-----------------------------~~  271 (353)
                      .|++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.....                             ..
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (308)
T cd06615         159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA  238 (308)
T ss_pred             CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence            7899999999998888999999999999999999999999653321100                             01


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhh
Q 018630          272 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFT  338 (353)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~  338 (353)
                      ..+....+.....+..+...++.++.+|+.+||+.||++|||+.++++||||+.+.-...+...|..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~  305 (308)
T cd06615         239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEVDFAGWVC  305 (308)
T ss_pred             HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccccchhhhhhh
Confidence            1112222222223333334578899999999999999999999999999999987766666666653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2e-48  Score=360.53  Aligned_cols=250  Identities=29%  Similarity=0.496  Sum_probs=214.3

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||+++++.+++.||+|+++...  .......+..|.+++..+ +||||+++++.+..++.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36899999999999999999999999987542  233445667788887754 799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      ++|..++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.............+||
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987644333334456799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      +.|+|||++.+..++.++|+|||||++|+|++|..||...+.       ......+......  .+..+++++.+++.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~~~~~~~ll~~~  230 (321)
T cd05591         160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-------DDLFESILHDDVL--YPVWLSKEAVSILKAF  230 (321)
T ss_pred             ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCC--CCCCCCHHHHHHHHHH
Confidence            999999999988999999999999999999999999976443       2333444443322  2346789999999999


Q ss_pred             hhhCcCCCC-------CHHHHHcCCccccc
Q 018630          304 VQKEPQQRL-------SAQELMTHPFLKMY  326 (353)
Q Consensus       304 L~~dp~~Rp-------t~~e~l~hp~~~~~  326 (353)
                      |+.||++||       +++++++||||...
T Consensus       231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             hccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            999999999       99999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-48  Score=360.74  Aligned_cols=250  Identities=30%  Similarity=0.516  Sum_probs=211.0

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhc-CCCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~-l~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||+++++.+|+.||+|+++....  .........|..++.. .+||||+++++.+.+.+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999875421  2233455667777654 5899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      |+|.+++.....+++..+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||+++............+||
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987543333334456799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      +.|+|||++.+..++.++|+||+||++|||++|..||...+.       .+..+.+....+  ..+..++.++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~  230 (316)
T cd05620         160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFESIRVDTP--HYPRWITKESKDILEKL  230 (316)
T ss_pred             cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC--CCCCCCCHHHHHHHHHH
Confidence            999999999998999999999999999999999999976432       233333333322  22356899999999999


Q ss_pred             hhhCcCCCCCH-HHHHcCCccccc
Q 018630          304 VQKEPQQRLSA-QELMTHPFLKMY  326 (353)
Q Consensus       304 L~~dp~~Rpt~-~e~l~hp~~~~~  326 (353)
                      |+.||++||++ +++++||||+..
T Consensus       231 l~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         231 FERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             ccCCHHHcCCChHHHHcCCCcCCC
Confidence            99999999998 588899999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.1e-48  Score=361.99  Aligned_cols=259  Identities=30%  Similarity=0.523  Sum_probs=215.9

Q ss_pred             CceeeeeecccCCeEEEEEEec---cCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV---EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~  134 (353)
                      +|++++.||+|+||.||++++.   .+++.||+|++....   .......+.+|+.+++.+ +||||+++++.+..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5889999999999999998874   468899999987532   223345678899999998 589999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ++||||+++|+|.+++.....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            9999999999999999888889999999999999999999998 999999999999999999999999999987653322


Q ss_pred             C-CCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          215 G-QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       215 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      . .....+||+.|+|||++.+. .++.++|||||||++|||++|..||........   .......+....+  ..+..+
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~~~--~~~~~~  234 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILKCDP--PFPSFI  234 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhcCCC--CCCCCC
Confidence            2 22346799999999999865 478999999999999999999999975433221   1223333333222  234568


Q ss_pred             CHHHHHHHHHhhhhCcCCCC-----CHHHHHcCCccccc
Q 018630          293 SPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMY  326 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  326 (353)
                      ++.+.+++.+||+.||++||     +++++++||||+..
T Consensus       235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999999999999     88899999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.4e-48  Score=359.16  Aligned_cols=257  Identities=26%  Similarity=0.525  Sum_probs=215.8

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||++++..+++.||+|+++...  .......+.+|+.++..+ +||||+.+++.+...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999997642  233456678888888777 699999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      |+|.+++...+.+++..+..++.||+.||+|||+ +|++||||||+||+++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987543333334456899


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      +.|+|||++.+..++.++|+|||||++|||++|..||..................+.....  ..+..++..+.+++.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~  237 (327)
T cd05617         160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--RIPRFLSVKASHVLKGF  237 (327)
T ss_pred             cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHH
Confidence            9999999999999999999999999999999999999654332222222223333333322  23456889999999999


Q ss_pred             hhhCcCCCCC------HHHHHcCCccccc
Q 018630          304 VQKEPQQRLS------AQELMTHPFLKMY  326 (353)
Q Consensus       304 L~~dp~~Rpt------~~e~l~hp~~~~~  326 (353)
                      |+.||.+|++      ++++++||||+..
T Consensus       238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         238 LNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             hccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            9999999998      5799999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-48  Score=361.03  Aligned_cols=265  Identities=25%  Similarity=0.380  Sum_probs=212.0

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec-----CeEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAIS  135 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~-----~~~~  135 (353)
                      +|++.+.||+|+||.||++.++.+++.||||++.... ......++.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5889999999999999999999999999999986432 223345788999999999999999999987543     3589


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||+. ++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            9999996 5999999888889999999999999999999998 9999999999999999999999999999876432221


Q ss_pred             ---CCcccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhh-------------------
Q 018630          216 ---QANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS-------------------  271 (353)
Q Consensus       216 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-------------------  271 (353)
                         ......||+.|+|||++.+  ..++.++|||||||++|||++|..||.+.+.......                   
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               1234579999999999866  5789999999999999999999999976432110000                   


Q ss_pred             -HHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          272 -FYELMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       272 -~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                       .......+....+..  .....+++++.+++.+||+.||++|||++|+++||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence             000111111111110  112356788999999999999999999999999999987554

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-48  Score=367.44  Aligned_cols=262  Identities=24%  Similarity=0.360  Sum_probs=212.0

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +...+|.+++.||+|+||.||+|.+..+++.||+|...       ...+.+|+.+++.++||||+++++++..+...++|
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            45578999999999999999999999999999999743       23467899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-CC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQ  216 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~  216 (353)
                      +|++. ++|..++.....+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++...... ..
T Consensus       162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            99996 6999999887889999999999999999999998 999999999999999999999999999986543221 22


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch----hhHHHHHH---------------
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW----TSFYELME---------------  277 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~~~~~~~---------------  277 (353)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..++.    .....+..               
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            33457999999999999889999999999999999999999887543221100    00000000               


Q ss_pred             -------HHhcCCC--CCC-----CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          278 -------AIVDQPP--PSA-----PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       278 -------~~~~~~~--~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                             .......  +..     ....++.++.+||.+||+.||++|||+.|+++||||+...+
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~  384 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD  384 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence                   0000000  000     01135678999999999999999999999999999987543

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.3e-48  Score=359.69  Aligned_cols=251  Identities=30%  Similarity=0.518  Sum_probs=214.5

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||++.++.+++.||||+++...  .......+.+|..++..+ +||||+++++.+...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999999999999997542  233445667888888776 799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      ++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||+++............+|+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987543333334446799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      +.|+|||++.+..++.++|+|||||++|+|++|..||...+.       ......+.....  ..+..+++++.+||.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (318)
T cd05570         160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILEDEV--RYPRWLSKEAKSILKSF  230 (318)
T ss_pred             ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCC--CCCCcCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999976432       223333333322  23356899999999999


Q ss_pred             hhhCcCCCCCH-----HHHHcCCcccccC
Q 018630          304 VQKEPQQRLSA-----QELMTHPFLKMYG  327 (353)
Q Consensus       304 L~~dp~~Rpt~-----~e~l~hp~~~~~~  327 (353)
                      |+.||++|||+     .++++||||+...
T Consensus       231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         231 LTKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             ccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            99999999999     9999999998753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3e-48  Score=359.63  Aligned_cols=251  Identities=32%  Similarity=0.536  Sum_probs=211.7

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHH-HHhcCCCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~-~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||+||+++++.+|+.||+|++....  .......+..|.. +++.++||||+++++.+...+.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999999999999999987542  1222344445544 56779999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      |+|.+++.....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.............+||
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987643333334456799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      +.|+|||++.+..++.++|+|||||++|||++|..||...+.       .+....+......  ....+++++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~--~~~~~~~~~~~li~~~  230 (323)
T cd05575         160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILNKPLR--LKPNISVSARHLLEGL  230 (323)
T ss_pred             hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCCC--CCCCCCHHHHHHHHHH
Confidence            999999999998999999999999999999999999976432       2333444443322  2346799999999999


Q ss_pred             hhhCcCCCCCH----HHHHcCCcccccC
Q 018630          304 VQKEPQQRLSA----QELMTHPFLKMYG  327 (353)
Q Consensus       304 L~~dp~~Rpt~----~e~l~hp~~~~~~  327 (353)
                      |+.||.+||++    .++++||||....
T Consensus       231 l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         231 LQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             hhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            99999999988    6999999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-47  Score=347.03  Aligned_cols=266  Identities=43%  Similarity=0.798  Sum_probs=225.7

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|++++.||+|+||.||++.+..+++.||+|++...........+.+|++++.+++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            46888999999999999999999999999999987654455567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++++|..+    ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++......  .....
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~  153 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTY  153 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCC
Confidence            999999754    357889999999999999999998 99999999999999999999999999998765322  23445


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      .|+..|+|||.+.+..++.++|+|||||++|+|++|..||......+...........+.....+.......++++.+++
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI  233 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence            78999999999998889999999999999999999999997644332222223334444444444434456789999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccCCCCcCH
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  333 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~  333 (353)
                      .+||+.||.+||+++|++.||||+...+...++
T Consensus       234 ~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~~~  266 (279)
T cd06619         234 TQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV  266 (279)
T ss_pred             HHHhhCChhhCCCHHHHhcCcccccccCccHHH
Confidence            999999999999999999999999887776655

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.2e-48  Score=357.53  Aligned_cols=255  Identities=29%  Similarity=0.511  Sum_probs=216.7

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +|.+++.||+|+||.||+++++.+++.||+|+++...  ..........|..++..+ +|++|+++++.+...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5889999999999999999999999999999987542  223334566677777665 5899999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||+++|+|.+++.....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++..........
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            999999999999888889999999999999999999998 9999999999999999999999999999875433333344


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ..+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+.       ......+.....  ..+..+++++.+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-------~~~~~~i~~~~~--~~p~~~s~~~~~  230 (323)
T cd05616         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHNV--AYPKSMSKEAVA  230 (323)
T ss_pred             cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC--CCCCcCCHHHHH
Confidence            56799999999999999999999999999999999999999976432       233344444332  233568999999


Q ss_pred             HHHHhhhhCcCCCCCH-----HHHHcCCccccc
Q 018630          299 FISACVQKEPQQRLSA-----QELMTHPFLKMY  326 (353)
Q Consensus       299 li~~~L~~dp~~Rpt~-----~e~l~hp~~~~~  326 (353)
                      ++.+||+.||++|+++     .++++||||+..
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999999984     899999999764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.7e-48  Score=365.20  Aligned_cols=258  Identities=29%  Similarity=0.501  Sum_probs=216.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|++++.||+|+||.||+|.++.+++.||+|+++...  .......+.+|+.++..++||||+++++.+.+++.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999999999999999987542  2334567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC---
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---  215 (353)
                      ||++||+|.+++.+.+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++.++|+|||++........   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            999999999999888889999999999999999999998 9999999999999999999999999999865421100   


Q ss_pred             --------------------------------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 018630          216 --------------------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP  263 (353)
Q Consensus       216 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  263 (353)
                                                      .....+||+.|+|||++.+..++.++|+|||||++|||++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence                                            012347999999999999999999999999999999999999999765


Q ss_pred             ccCCchhhHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhhhCcCCCC---CHHHHHcCCcccccC
Q 018630          264 EQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKMYG  327 (353)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~~~  327 (353)
                      +..       .....+.....  .......+++++++||.+|+ .||.+|+   +++++++||||+...
T Consensus       240 ~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  300 (360)
T cd05627         240 TPQ-------ETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVD  300 (360)
T ss_pred             CHH-------HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCC
Confidence            432       22233332211  11122347899999999987 4999999   479999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-48  Score=360.20  Aligned_cols=275  Identities=26%  Similarity=0.463  Sum_probs=220.7

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ..++|.+.+.||+|+||.||+++++.+++.||+|.++..........+.+|+.+++.++||||+++++.+..++..++||
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            45789999999999999999999999999999999876544444456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      ||+++ +|.+++... ..++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..........
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            99985 888888654 458899999999999999999998 999999999999999999999999999987654333333


Q ss_pred             cccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--------HHH------hcC
Q 018630          218 NTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------EAI------VDQ  282 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~--------~~~------~~~  282 (353)
                      ....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+..+.........        ..+      ...
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            34578999999998865 458999999999999999999999997754432211111100        000      000


Q ss_pred             CCCC-------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhH
Q 018630          283 PPPS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE  335 (353)
Q Consensus       283 ~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~  335 (353)
                      ..+.       .....+++++.+||.+||+.||.+|||++|+++||||+.......++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~  301 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPE  301 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccccccCCc
Confidence            0000       1113578899999999999999999999999999999987655554443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.9e-48  Score=357.17  Aligned_cols=251  Identities=31%  Similarity=0.558  Sum_probs=211.0

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHh-cCCCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||+|++..+++.||+|+++...  .......+..|..++. ..+||||+++++.+..++.+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999999999999999987542  2223344455666655 45899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      |+|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++............+||
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999997654333334456899


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      +.|+|||++.+..++.++|+|||||++|||++|..||.+.+.       .+....+....+  ..+..++.++.+++.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~  230 (316)
T cd05592         160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILNDRP--HFPRWISKEAKDCLSKL  230 (316)
T ss_pred             ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            999999999988899999999999999999999999976432       233333433322  23456899999999999


Q ss_pred             hhhCcCCCCCH-HHHHcCCcccccC
Q 018630          304 VQKEPQQRLSA-QELMTHPFLKMYG  327 (353)
Q Consensus       304 L~~dp~~Rpt~-~e~l~hp~~~~~~  327 (353)
                      |+.||++||++ .++++||||+...
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         231 FERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             ccCCHHHcCCChHHHHcCcccCCCC
Confidence            99999999986 5888999998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-49  Score=338.32  Aligned_cols=258  Identities=28%  Similarity=0.506  Sum_probs=223.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-------ccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEec
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-------VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSN  131 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~  131 (353)
                      ...|+-.+.||+|..++|.++.++.+|+.+|+|++...       .....+....+|+.|++++ .||+|+++.++|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            46788889999999999999999999999999998532       1233455677899999885 699999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ..+++|+|.|+.|.|+|++...-.+++...+.+++|+++|+.|||. ++|+||||||+|||++++-+++|+|||+|+.+.
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeeccccceEEeccceeeccC
Confidence            9999999999999999999998899999999999999999999998 999999999999999999999999999999876


Q ss_pred             ccCCCCcccccCCcccCcceecC------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-
Q 018630          212 STSGQANTFVGTYNYMSPERISG------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-  284 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-  284 (353)
                       .+......||||+|.|||.+..      ..|+..+|+||.|+++|.|+.|.+||....+       .-.+..+..+.. 
T Consensus       175 -~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~ImeGkyq  246 (411)
T KOG0599|consen  175 -PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMIMEGKYQ  246 (411)
T ss_pred             -CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHHHhcccc
Confidence             4456677899999999998743      4589999999999999999999999976332       222333443332 


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          285 -PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       285 -~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                       ....+.+++...++||++||+.||.+|.|++|+|.||||+..
T Consensus       247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence             345567899999999999999999999999999999999654

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-49  Score=363.39  Aligned_cols=259  Identities=34%  Similarity=0.546  Sum_probs=232.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe-EEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISII  137 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~-~~lv  137 (353)
                      .++|+.++++|+|+||.+++++++.+++.+++|.+.... ....++...+|+.+++++.|||||.+++.|..++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            478999999999999999999999999999999987663 33445578999999999999999999999999888 9999


Q ss_pred             EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |+||+||+|.+.+.+.  ..++++.+..|+.|++.|+.|||+ ++|+|||||+.||+++.++.|+|+|||+|+.+.....
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            9999999999999765  468999999999999999999997 9999999999999999999999999999999987766


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ...+.+||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+-       ..+..++...... +.+..++.+
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~ki~~~~~~-Plp~~ys~e  233 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELILKINRGLYS-PLPSMYSSE  233 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-------HHHHHHHhhccCC-CCCccccHH
Confidence            77788999999999999999999999999999999999999999987533       3455555555533 335678999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +..+|..||+.+|..||++.++|.+|.++.+.
T Consensus       234 l~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  234 LRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            99999999999999999999999999998765

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.2e-48  Score=350.38  Aligned_cols=253  Identities=28%  Similarity=0.497  Sum_probs=212.2

Q ss_pred             ecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           69 VGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      ||+|+||+||++.++.+++.||+|.+....  .......+..|+.+++.++||||+++.+++..+..+++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999999999999999986542  222345678899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccccc
Q 018630          147 ADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  222 (353)
Q Consensus       147 ~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  222 (353)
                      .+++..    ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++..............|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g  159 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG  159 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence            988743    3568999999999999999999998 99999999999999999999999999998765544333445678


Q ss_pred             CCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018630          223 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  302 (353)
Q Consensus       223 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  302 (353)
                      |+.|+|||.+.+..++.++|+||+||++|||++|..||.......   ........+....  ...+..+++++.+++.+
T Consensus       160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~  234 (280)
T cd05608         160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRILNDS--VTYPDKFSPASKSFCEA  234 (280)
T ss_pred             CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch---hHHHHHHhhcccC--CCCcccCCHHHHHHHHH
Confidence            999999999999999999999999999999999999997643321   1112222222221  22345689999999999


Q ss_pred             hhhhCcCCCC-----CHHHHHcCCcccccC
Q 018630          303 CVQKEPQQRL-----SAQELMTHPFLKMYG  327 (353)
Q Consensus       303 ~L~~dp~~Rp-----t~~e~l~hp~~~~~~  327 (353)
                      ||+.||++||     |++++++||||+...
T Consensus       235 ~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         235 LLAKDPEKRLGFRDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             HhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence            9999999999     889999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.1e-48  Score=355.68  Aligned_cols=251  Identities=29%  Similarity=0.515  Sum_probs=211.4

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhc-CCCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~-l~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||++++..+++.||||+++...  ..........|..++.. ++||||+++++.+.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999999999999999987652  12233445666667664 5899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      |+|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++..............||
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            9999999887889999999999999999999998 999999999999999999999999999987543333333456799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      +.|+|||++.+..++.++|+||+||++|||++|..||...+.       .+....+....+  ..+..++.++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (316)
T cd05619         160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-------EELFQSIRMDNP--CYPRWLTREAKDILVKL  230 (316)
T ss_pred             ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence            999999999988899999999999999999999999976432       223333333222  22346889999999999


Q ss_pred             hhhCcCCCCCHH-HHHcCCcccccC
Q 018630          304 VQKEPQQRLSAQ-ELMTHPFLKMYG  327 (353)
Q Consensus       304 L~~dp~~Rpt~~-e~l~hp~~~~~~  327 (353)
                      |+.||++||++. ++++||||+...
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         231 FVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             hccCHhhcCCChHHHHcCcccCCCC
Confidence            999999999996 899999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.6e-48  Score=363.53  Aligned_cols=261  Identities=30%  Similarity=0.528  Sum_probs=216.7

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      ....++|++.+.||+|+||.||+++++.+++.||+|++...  ........+.+|+.+++.++||||+++++.+.++..+
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            34568899999999999999999999999999999998643  1223345678899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence            999999999999999976 468999999999999999999998 999999999999999999999999999997654322


Q ss_pred             C-CCcccccCCcccCcceecCC----CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCC
Q 018630          215 G-QANTFVGTYNYMSPERISGG----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSA  287 (353)
Q Consensus       215 ~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  287 (353)
                      . .....+||+.|+|||++.+.    .++.++|+||+||++|||++|..||...+.       ......+.....  ...
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~p  269 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-------VGTYSKIMDHKNSLNFP  269 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCcccCCC
Confidence            1 22356799999999998754    378899999999999999999999976432       222333433221  112


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCC--CCCHHHHHcCCccccc
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMY  326 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~  326 (353)
                      ....++..+++++.+||+.++.+  |+|++|+++||||+..
T Consensus       270 ~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         270 EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            22357999999999999865543  8999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.9e-48  Score=359.85  Aligned_cols=258  Identities=27%  Similarity=0.502  Sum_probs=217.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|.+.+.||+|+||.||+++++.+++.||+|+++...  .......+.+|+.+++.++||||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46899999999999999999999999999999997552  2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC-
Q 018630          139 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  216 (353)
                      ||+++|+|.+++.+. ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++......... 
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            999999999999876 679999999999999999999998 99999999999999999999999999999765432221 


Q ss_pred             CcccccCCcccCcceec------CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCC
Q 018630          217 ANTFVGTYNYMSPERIS------GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAP  288 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  288 (353)
                      .....||+.|+|||++.      ...++.++|||||||++|||++|..||...+..       .....+.....  ....
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~  232 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------KTYNNIMNFQRFLKFPE  232 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------HHHHHHHcCCCccCCCC
Confidence            22347899999999986      456789999999999999999999999764321       22233322221  1112


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ...+++++.+||.+||+ +|.+|||++++++||||+...
T Consensus       233 ~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         233 DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence            23578999999999998 999999999999999998754

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.8e-48  Score=372.81  Aligned_cols=267  Identities=24%  Similarity=0.393  Sum_probs=210.9

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec-------
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-------  131 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~-------  131 (353)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++...       
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            4468999999999999999999999999999999875432     2234799999999999999998876432       


Q ss_pred             -CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-cEEEeecc
Q 018630          132 -GAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFG  205 (353)
Q Consensus       132 -~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG  205 (353)
                       ..+++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence             357799999985 78777653    4678999999999999999999998 9999999999999998665 79999999


Q ss_pred             ccccccccCCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc---
Q 018630          206 VSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD---  281 (353)
Q Consensus       206 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~---  281 (353)
                      +|+..... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+..   ......+..   
T Consensus       217 la~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~---~~i~~~~~~p~~  292 (440)
T PTZ00036        217 SAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL---VRIIQVLGTPTE  292 (440)
T ss_pred             cchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCH
Confidence            99865432 233456789999999998764 6899999999999999999999999875432211   111111100   


Q ss_pred             ------------CCCC--------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHH
Q 018630          282 ------------QPPP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY  336 (353)
Q Consensus       282 ------------~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~  336 (353)
                                  ...+        ...+...++++.+||.+||++||.+|||+.|+++||||+...+....+..+
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~  367 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKY  367 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCC
Confidence                        0000        011235678999999999999999999999999999999877665554443

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3e-48  Score=366.60  Aligned_cols=259  Identities=28%  Similarity=0.473  Sum_probs=213.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-C-----CceEEEeeEeEecCeE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-C-----PYVVVCYQSFYSNGAI  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h-----p~iv~~~~~~~~~~~~  134 (353)
                      .+|++++.||+|+||.|.+|.+..+++.||||+++..  .....+...|+.++..++ |     -|+|+++++|...+++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            3689999999999999999999999999999999754  456677888999998886 3     5799999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC--cEEEeeccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG--EVKITDFGVSAIM  210 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~--~~kl~DfG~a~~~  210 (353)
                      |||+|.++ .+|+++++.+  ..++...++.++.||+.||..||+ .||||+||||+||||...+  .+||+|||.|+..
T Consensus       264 ciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  264 CIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99999996 4999999876  568999999999999999999998 9999999999999997544  6999999999875


Q ss_pred             cccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH-------------
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME-------------  277 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~-------------  277 (353)
                      ....   -+++.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.++.+...-+.++..             
T Consensus       342 ~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~  418 (586)
T KOG0667|consen  342 SQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA  418 (586)
T ss_pred             CCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence            5332   378899999999999999999999999999999999999999988766543222222110             


Q ss_pred             -----H-----------------------------HhcCCCCCC-------CCCCCCHHHHHHHHHhhhhCcCCCCCHHH
Q 018630          278 -----A-----------------------------IVDQPPPSA-------PSDQFSPEFCSFISACVQKEPQQRLSAQE  316 (353)
Q Consensus       278 -----~-----------------------------~~~~~~~~~-------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  316 (353)
                           .                             ......|..       ....-...+.+||.+||++||.+|+|+.+
T Consensus       419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q  498 (586)
T KOG0667|consen  419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ  498 (586)
T ss_pred             ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence                 0                             000000000       00011235789999999999999999999


Q ss_pred             HHcCCccccc
Q 018630          317 LMTHPFLKMY  326 (353)
Q Consensus       317 ~l~hp~~~~~  326 (353)
                      +++||||...
T Consensus       499 al~Hpfl~~~  508 (586)
T KOG0667|consen  499 ALNHPFLTGT  508 (586)
T ss_pred             HhcCcccccc
Confidence            9999999854

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.7e-47  Score=353.21  Aligned_cols=256  Identities=28%  Similarity=0.508  Sum_probs=216.5

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +|+..+.||+|+||.||+|+++.+|+.||+|+++...  .......+..|..++..+. |++|+++++.+..++.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788899999999999999999999999999987542  2233456777888887775 577888999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||++||+|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||+++..........
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            999999999999888889999999999999999999998 9999999999999999999999999999876433333344


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ...||+.|+|||++.+..++.++|+||+||++|+|++|..||...+.       ......+.....  ..+..++.++.+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~--~~p~~~~~~~~~  230 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHNV--SYPKSLSKEAVS  230 (323)
T ss_pred             CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC--CCCccCCHHHHH
Confidence            56799999999999988899999999999999999999999976533       223334433322  233567899999


Q ss_pred             HHHHhhhhCcCCCCC-----HHHHHcCCcccccC
Q 018630          299 FISACVQKEPQQRLS-----AQELMTHPFLKMYG  327 (353)
Q Consensus       299 li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~  327 (353)
                      ++.+||+.||.+|++     .+++++||||+...
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            999999999999997     47999999998753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-47  Score=346.66  Aligned_cols=259  Identities=26%  Similarity=0.456  Sum_probs=217.1

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .|++.+.||+|+||.||++.+..+++.||+|++....  .......+.+|+.+++.++||||+++++.+..+..+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3788999999999999999999899999999986542  22234567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          140 YMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       140 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+ .|++||||||+||++++++.++|+|||++...... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Ccc
Confidence            99999999888653  468999999999999999999998 99999999999999999999999999998765322 223


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  297 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ....|++.|+|||++.+..++.++|+||+||++|||++|..||.+.+.....   ......+....  ...+..+++.+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~  233 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ--EEYSEKFSEAAR  233 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc--cccCcccCHHHH
Confidence            3457899999999999888999999999999999999999999875432211   12222222221  223456899999


Q ss_pred             HHHHHhhhhCcCCCC-----CHHHHHcCCcccccC
Q 018630          298 SFISACVQKEPQQRL-----SAQELMTHPFLKMYG  327 (353)
Q Consensus       298 ~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  327 (353)
                      +|+.+||+.||.+||     +++++++||||....
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05605         234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN  268 (285)
T ss_pred             HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence            999999999999999     899999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-47  Score=355.81  Aligned_cols=250  Identities=32%  Similarity=0.527  Sum_probs=210.7

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHH-HHhcCCCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~-~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||+++++.+|+.||+|++....  .......+..|.. +++.++||||+++++.+..++.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999999999999999987542  2223344555554 46779999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      |+|..++.....+++..+..++.||+.||+|||+ +||+||||||+||+++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987543333334456799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      +.|+|||++.+..++.++|||||||++|||++|..||...+.       .+....+......  .....+.++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~~~~~~~~--~~~~~~~~~~~ll~~l  230 (325)
T cd05604         160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-------AEMYDNILHKPLV--LRPGASLTAWSILEEL  230 (325)
T ss_pred             hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-------HHHHHHHHcCCcc--CCCCCCHHHHHHHHHH
Confidence            999999999998999999999999999999999999976432       2333444433322  2245789999999999


Q ss_pred             hhhCcCCCCCH----HHHHcCCccccc
Q 018630          304 VQKEPQQRLSA----QELMTHPFLKMY  326 (353)
Q Consensus       304 L~~dp~~Rpt~----~e~l~hp~~~~~  326 (353)
                      |+.||.+||++    .++++||||+..
T Consensus       231 l~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         231 LEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             hccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            99999999977    599999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.8e-48  Score=356.47  Aligned_cols=250  Identities=32%  Similarity=0.523  Sum_probs=213.7

Q ss_pred             eeecccCCeEEEEEEe---ccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecC
Q 018630           67 KVVGKGSGGIVQLVQH---KWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD  142 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  142 (353)
                      +.||+|+||.||++++   ..+|+.||+|++.... .......+.+|++++++++||||+++++.+..++.+|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999886   3578999999987542 22234567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccccc
Q 018630          143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  222 (353)
Q Consensus       143 ~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  222 (353)
                      +++|.+++.+...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..............|
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            99999999888889999999999999999999998 99999999999999999999999999998765444333445679


Q ss_pred             CCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018630          223 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  302 (353)
Q Consensus       223 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  302 (353)
                      ++.|+|||.+.+..++.++|+|||||++|||++|..||...+.       .+....+.....  ..+..+++++.+||.+
T Consensus       161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-------~~~~~~i~~~~~--~~p~~~~~~~~~li~~  231 (318)
T cd05582         161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-------KETMTMILKAKL--GMPQFLSPEAQSLLRA  231 (318)
T ss_pred             ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence            9999999999988899999999999999999999999976432       223333333322  2235689999999999


Q ss_pred             hhhhCcCCCCC-----HHHHHcCCccccc
Q 018630          303 CVQKEPQQRLS-----AQELMTHPFLKMY  326 (353)
Q Consensus       303 ~L~~dp~~Rpt-----~~e~l~hp~~~~~  326 (353)
                      ||+.||++|||     .++++.||||+..
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            99999999999     6779999999865

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.5e-47  Score=351.34  Aligned_cols=270  Identities=26%  Similarity=0.465  Sum_probs=218.3

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ..++|.+.+.||.|+||.||+++++.+++.||+|.++..........+.+|+.+++.++||||+++++++..++.+++||
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            45789999999999999999999999999999999876544444456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      ||+. ++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++..........
T Consensus        84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence            9997 4999888754 568999999999999999999998 999999999999999999999999999987654333333


Q ss_pred             cccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--------HHHh------cC
Q 018630          218 NTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------EAIV------DQ  282 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~--------~~~~------~~  282 (353)
                      ....+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||...+..+....+....        ..+.      ..
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence            344678999999988654 47889999999999999999999998654322111111000        0000      00


Q ss_pred             CCCC-------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          283 PPPS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       283 ~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      ..+.       .....+++++.+||.+||+.||.+|||++|+++||||+..++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~  296 (301)
T cd07873         242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI  296 (301)
T ss_pred             ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence            0000       11235788999999999999999999999999999999887654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-49  Score=341.51  Aligned_cols=265  Identities=30%  Similarity=0.554  Sum_probs=236.0

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ...+..++|+.+++||+|+||.|.+++.+.+++.+|+|++++.  ...+..+....|-++++..+||.+..+.-.|+.+.
T Consensus       162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d  241 (516)
T KOG0690|consen  162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD  241 (516)
T ss_pred             cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence            3456789999999999999999999999999999999999876  34556677888999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .+|+||||+.||.|+-++.+.+.++++.++.+-.+|+.||.|||+ ++||.||||.+|+|+|.+|++||+|||+++..-.
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence            999999999999999999998999999999999999999999999 9999999999999999999999999999987766


Q ss_pred             cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      .+....+.||||.|.|||++....|+.++|.|.+|+++|||+||+.||.+.+.+       .+.+-|.....  ..+..+
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-------kLFeLIl~ed~--kFPr~l  391 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-------KLFELILMEDL--KFPRTL  391 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-------HHHHHHHhhhc--cCCccC
Confidence            666778899999999999999999999999999999999999999999875542       23333333322  234678


Q ss_pred             CHHHHHHHHHhhhhCcCCCC-----CHHHHHcCCcccccCCC
Q 018630          293 SPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDL  329 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~  329 (353)
                      +++++.|+..+|.+||.+|.     .+.|+..|+||......
T Consensus       392 s~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~  433 (516)
T KOG0690|consen  392 SPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE  433 (516)
T ss_pred             CHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence            99999999999999999998     57899999999876543

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-47  Score=349.32  Aligned_cols=257  Identities=24%  Similarity=0.436  Sum_probs=202.4

Q ss_pred             cCceeeeeecccCCeEEEEEEecc-CCcEEEEEEeecccc-HHHHHHHHHHHHHHhc---CCCCceEEEeeEeE-----e
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKW-TGQFFALKVIQMNVE-ESARRQIAQELKINQS---SQCPYVVVCYQSFY-----S  130 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~---l~hp~iv~~~~~~~-----~  130 (353)
                      ++|++.+.||+|+||.||+|++.. +++.||+|.++.... ......+.+|+.+++.   +.||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            478999999999999999999854 467899999865422 2222344556666554   47999999999875     3


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          131 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      ...+++||||+. ++|.+++...  ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            457899999997 5999998754  458999999999999999999998 999999999999999999999999999997


Q ss_pred             cccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-----
Q 018630          209 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-----  283 (353)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----  283 (353)
                      ..... .......||+.|+|||.+.+..++.++|+||+||++|||++|.+||.+.+..+..   ..+........     
T Consensus       159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i~~~~~~~~~~~~~  234 (290)
T cd07862         159 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGEEDWP  234 (290)
T ss_pred             eccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhCCCChhhch
Confidence            65432 2334457899999999998888999999999999999999999999875432211   11111110000     


Q ss_pred             -------------CC---CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          284 -------------PP---SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       284 -------------~~---~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                                   ..   ......+++.+.+|+.+||+.||++|||+.|+++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                         00   00113467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-47  Score=354.20  Aligned_cols=250  Identities=30%  Similarity=0.519  Sum_probs=209.9

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHH-HHHhcCCCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQEL-KINQSSQCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~-~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||+|+++.+++.||+|++....  .......+..|. .+++.++||||+++++.+..++.+|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46899999999999999999999999987542  122223444444 456788999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      ++|.+++.....+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987654333344556899


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+.       .+....+.....  .....+++++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (325)
T cd05602         160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNKPL--QLKPNITNSARHLLEGL  230 (325)
T ss_pred             ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCCc--CCCCCCCHHHHHHHHHH
Confidence            999999999998999999999999999999999999976432       222333333322  22346899999999999


Q ss_pred             hhhCcCCCCCHH----HHHcCCccccc
Q 018630          304 VQKEPQQRLSAQ----ELMTHPFLKMY  326 (353)
Q Consensus       304 L~~dp~~Rpt~~----e~l~hp~~~~~  326 (353)
                      |+.||.+||++.    ++++|+||...
T Consensus       231 l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         231 LQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             cccCHHHCCCCCCCHHHHhcCcccCCC
Confidence            999999999876    89999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.3e-47  Score=344.40  Aligned_cols=271  Identities=40%  Similarity=0.731  Sum_probs=229.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|++++.||+|+||.||++.+..+++.||+|.++..........+.+|+.+++.++||||+++++.+..++.+++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            47889999999999999999999999999999987654555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          141 MDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       141 ~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      +++++|..++...   ..+++..+..++.|++.||.|||+..|++|+||||+||+++.++.++|+|||++......  ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~  158 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LA  158 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--cc
Confidence            9999999988763   378999999999999999999996469999999999999999999999999998765322  22


Q ss_pred             cccccCCcccCcceecCC------CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          218 NTFVGTYNYMSPERISGG------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      ....+++.|+|||.+.+.      .++.++|+||+||++|+|++|..||.....    .........+.....+. .+..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~-~~~~  233 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANIFAQLSAIVDGDPPT-LPSG  233 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhHHHHHHHHhhcCCCC-CCcc
Confidence            345688899999998553      358899999999999999999999965332    22223333444443333 3345


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhh
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFT  338 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~  338 (353)
                      +++++.++|.+||+.+|++||+++++++||||..+.....++.+|+.
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~~~~~~~~~  280 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVT  280 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCccchHHHHH
Confidence            89999999999999999999999999999999999999888888763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.1e-47  Score=357.89  Aligned_cols=264  Identities=25%  Similarity=0.435  Sum_probs=211.6

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------C
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~  132 (353)
                      .++|++.+.||+|+||.||++.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++...      .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            47899999999999999999999999999999998654 2334456788999999999999999999988644      3


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .+|+||||+.+ +|.+.+..  .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            57999999975 77776643  58899999999999999999998 9999999999999999999999999999876432


Q ss_pred             cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH---------------HHH
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------LME  277 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---------------~~~  277 (353)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+....+               ...
T Consensus       176 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (359)
T cd07876         176 N-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR  254 (359)
T ss_pred             C-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            2 223445789999999999998999999999999999999999999987654322211111               001


Q ss_pred             HHhcCCCCC------------------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          278 AIVDQPPPS------------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       278 ~~~~~~~~~------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      ......+..                  ......++++.+||.+||+.||++|||+.|+++||||+.+.+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence            111110000                  011124678999999999999999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.1e-47  Score=357.69  Aligned_cols=263  Identities=29%  Similarity=0.508  Sum_probs=217.5

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ...+..++|++.+.||+|+||.||+++++.+++.||+|++...  ........+.+|+.+++.++||||+++++.+..++
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            3455668999999999999999999999999999999998643  12333456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .+++||||++||+|.+++.. ..+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            99999999999999999876 468999999999999999999998 9999999999999999999999999999976543


Q ss_pred             cCC-CCcccccCCcccCcceecCC----CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CC
Q 018630          213 TSG-QANTFVGTYNYMSPERISGG----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PP  285 (353)
Q Consensus       213 ~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~  285 (353)
                      ... .....+||+.|+|||++.+.    .++.++|||||||++|||++|..||...+.       ......+....  ..
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~  267 (371)
T cd05622         195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMNHKNSLT  267 (371)
T ss_pred             CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCccc
Confidence            221 22356799999999998653    378999999999999999999999986433       22233333322  11


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCC--CCCHHHHHcCCccccc
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMY  326 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~  326 (353)
                      ......++.++.++|.+||+.++.+  |++++|+++||||+..
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         268 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            2223468999999999999844433  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-46  Score=336.28  Aligned_cols=255  Identities=31%  Similarity=0.503  Sum_probs=217.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc----HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE----ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      +.|++.+.||+|++|.||.+.+..+++.||+|.+.....    ......+.+|+.+++.++||||+++++.+..+...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            568899999999999999999998999999999865421    2234568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      |+||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||+++........
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            99999999999999888889999999999999999999998 99999999999999999999999999998765322111


Q ss_pred             C---cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          217 A---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       217 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .   ....++..|+|||.+.+..++.++|+||+|+++|||++|..||...+..       ...............+..++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  233 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPQLPSHVS  233 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhccCCCCCCCccCC
Confidence            1   2346788999999999988999999999999999999999999764321       11222222222333456789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .++.++|.+||+.+|++|||+.++++||||
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         234 PDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-47  Score=351.56  Aligned_cols=259  Identities=25%  Similarity=0.477  Sum_probs=213.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|++++.||+|+||.||++++..+++.||+|++...  ........+.+|+.++..++|+||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4799999999999999999999999999999998753  12233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-C
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-Q  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~  216 (353)
                      ||++||+|.+++.+ ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++........ .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            99999999999976 4579999999999999999999998 9999999999999999999999999999876543222 1


Q ss_pred             CcccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC---CCCCC
Q 018630          217 ANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP---PPSAP  288 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  288 (353)
                      ....+||+.|+|||++..     ..++.++|+||+||++|+|++|..||...+..       +....+....   ..+..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~  232 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKEHFQFPPD  232 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCcccCCCc
Confidence            223469999999999863     45788999999999999999999999764321       2222332211   11122


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCC--CCCHHHHHcCCcccccC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYG  327 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~~  327 (353)
                      ...++++++++|.+||+.++++  |++++++++||||....
T Consensus       233 ~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         233 VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence            2457999999999999765444  78999999999998653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.1e-47  Score=351.69  Aligned_cols=250  Identities=30%  Similarity=0.509  Sum_probs=209.9

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHH-HHhcCCCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~-~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||+|++..+++.||+|++....  .......+.+|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999999999999999987542  1222344555544 57889999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      ++|..++.....+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987543333334456799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      +.|+|||.+.+..++.++|+|||||++|||++|..||...+.       ......+.....  ..+...+.++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (321)
T cd05603         160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNILHKPL--QLPGGKTVAACDLLVGL  230 (321)
T ss_pred             cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence            999999999988899999999999999999999999976432       233344443322  22346788999999999


Q ss_pred             hhhCcCCCCCH----HHHHcCCccccc
Q 018630          304 VQKEPQQRLSA----QELMTHPFLKMY  326 (353)
Q Consensus       304 L~~dp~~Rpt~----~e~l~hp~~~~~  326 (353)
                      |+.||.+||++    .++++||||...
T Consensus       231 l~~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         231 LHKDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             ccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            99999999976    499999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-46  Score=340.48  Aligned_cols=261  Identities=40%  Similarity=0.637  Sum_probs=225.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|++.+.||.|++|.||++.+..+++.||+|++...........+.+|+++++.++||||+++++.+.++..+++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999999999999999987654445556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++++|.+++... ++++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||+++............
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF  158 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence            9999999999875 78999999999999999999998 999999999999999999999999999998776543344456


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      .+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..       .....+.....+......+++++.+++
T Consensus       159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l  231 (274)
T cd06609         159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLIPKNNPPSLEGNKFSKPFKDFV  231 (274)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHhhhcCCCCCcccccCHHHHHHH
Confidence            7889999999999888999999999999999999999999764421       222333333333333233889999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      .+||..||++|||++++++||||+...+.+
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  261 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAKKTS  261 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCCccc
Confidence            999999999999999999999999987774

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.8e-47  Score=340.99  Aligned_cols=264  Identities=49%  Similarity=0.903  Sum_probs=227.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|++.+.||.|++|.||++.++.+++.+|+|.+..........++.+|+++++.+.||||+++++.+..++.+++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36888899999999999999999999999999988765556677889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          141 MDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       141 ~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      +.+++|.+++... ..+++..+..++.|++.|++|||+..|++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~  158 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KT  158 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--hc
Confidence            9999999999876 78999999999999999999999647999999999999999999999999999876543222  12


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (353)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..  .....+....+.....+......+++++.++
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEPPPRLPSGKFSPDFQDF  236 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence            67888999999998888999999999999999999999999764321  1223344555555544444333488999999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          300 ISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      |.+||..||++|||+.+++.||||+.|++
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~~~  265 (265)
T cd06605         237 VNLCLIKDPRERPSYKELLEHPFIKKYES  265 (265)
T ss_pred             HHHHcCCCchhCcCHHHHhhCchhhcccC
Confidence            99999999999999999999999998864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.4e-47  Score=368.13  Aligned_cols=275  Identities=23%  Similarity=0.376  Sum_probs=208.3

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC------CCCceEEEeeEeEec-C
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS------QCPYVVVCYQSFYSN-G  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~hp~iv~~~~~~~~~-~  132 (353)
                      .++|++++.||+|+||+||+|.+..+++.||||+++...  ........|+.+++.+      .|++++++++++..+ +
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~  205 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG  205 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence            468999999999999999999999999999999986431  1223334455554444      456688998888754 5


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC---------------
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---------------  197 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---------------  197 (353)
                      ++|+|||++ |++|.+++.+.+.+++..+..++.||+.||.|||++.||+||||||+|||++.++               
T Consensus       206 ~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        206 HMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            789999998 6799999988888999999999999999999999735999999999999998765               


Q ss_pred             -cEEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH
Q 018630          198 -EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM  276 (353)
Q Consensus       198 -~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~  276 (353)
                       .+||+|||.+....   ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+....+....
T Consensus       285 ~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  361 (467)
T PTZ00284        285 CRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL  361 (467)
T ss_pred             ceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence             49999999875422   22345689999999999999999999999999999999999999997654322111111000


Q ss_pred             ----------------HHHhcCC---CCC--------------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          277 ----------------EAIVDQP---PPS--------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       277 ----------------~~~~~~~---~~~--------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                                      ..+....   .+.              ......++.+.+||.+||++||.+|||++|+++||||
T Consensus       362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~  441 (467)
T PTZ00284        362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV  441 (467)
T ss_pred             CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence                            0000000   000              0000124568899999999999999999999999999


Q ss_pred             cccCCCCcCHhHHhhhh
Q 018630          324 KMYGDLNVDLSEYFTDA  340 (353)
Q Consensus       324 ~~~~~~~~~~~~~~~~~  340 (353)
                      +.+-..-.....|+.+.
T Consensus       442 ~~~~~~~~~~~~~~~~~  458 (467)
T PTZ00284        442 LKYYPECRQHPNYPDNR  458 (467)
T ss_pred             cccCCccccCCCCCCcc
Confidence            98766555555555443

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-47  Score=355.61  Aligned_cols=249  Identities=29%  Similarity=0.483  Sum_probs=207.3

Q ss_pred             ecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC---CCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           69 VGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS---QCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l---~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      ||+|+||+||+|+++.+++.||||++....  ..........|..++...   +||||+.++..+.....+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999999999999999986431  122233445566665544   799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      |+|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+|||++.++.++|+|||++.............+||
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987644333334456899


Q ss_pred             CcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018630          224 YNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  302 (353)
Q Consensus       224 ~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  302 (353)
                      +.|+|||++.+. .++.++||||+||++|+|++|..||...+.       .+....+...... .....+++++.+||.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~-~~~~~~~~~~~~li~~  231 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAFGKVR-FPKNVLSDEGRQFVKG  231 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHcCCCC-CCCccCCHHHHHHHHH
Confidence            999999998765 489999999999999999999999976432       2333334333222 2234578999999999


Q ss_pred             hhhhCcCCCC----CHHHHHcCCccccc
Q 018630          303 CVQKEPQQRL----SAQELMTHPFLKMY  326 (353)
Q Consensus       303 ~L~~dp~~Rp----t~~e~l~hp~~~~~  326 (353)
                      ||+.||.+||    ++.++++||||+..
T Consensus       232 ~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         232 LLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             HcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence            9999999998    78999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-47  Score=341.49  Aligned_cols=256  Identities=40%  Similarity=0.669  Sum_probs=214.0

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHH-HHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA-RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      |++.+.||+|+||+||++++..+++.||+|++........ .....+|+.+++.++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            7889999999999999999999999999999987643333 334566999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccc
Q 018630          142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV  221 (353)
Q Consensus       142 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  221 (353)
                      .+++|.+++.....++...+..++.|++.||.+||+ .|++|+||||+||+++.++.++|+|||.+..............
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999977899999999999999999999999 9999999999999999999999999999875433333444567


Q ss_pred             cCCcccCcceec-CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CCCCCCCHHHHH
Q 018630          222 GTYNYMSPERIS-GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFSPEFCS  298 (353)
Q Consensus       222 gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  298 (353)
                      ++..|+|||++. +..++.++|+||+|+++|+|++|..||...+..+    ...............  ......++++.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD----QLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH----HHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchh----hhhhhhhcccccccccccccchhHHHHHH
Confidence            899999999998 7789999999999999999999999998752211    112222221111110  011122489999


Q ss_pred             HHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          299 FISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       299 li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +|.+||+.||++|||+.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.6e-47  Score=352.31  Aligned_cols=256  Identities=26%  Similarity=0.405  Sum_probs=208.5

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY  129 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~  129 (353)
                      +.+..++|++.+.||+|+||.||+|.+.     .+++.||+|+++..........+.+|+.++..+ +||||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            3455689999999999999999999752     345689999987654455567789999999998 8999999999887


Q ss_pred             ec-CeEEEEEEecCCCCHHHHHHhc-------------------------------------------------------
Q 018630          130 SN-GAISIILEYMDGGSLADFLKKV-------------------------------------------------------  153 (353)
Q Consensus       130 ~~-~~~~lv~e~~~~gsL~~~l~~~-------------------------------------------------------  153 (353)
                      .. +.+++||||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            54 4689999999999999998752                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CCcccccCC
Q 018630          154 -------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTY  224 (353)
Q Consensus       154 -------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~  224 (353)
                             .+++...+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.......  ......+++
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                   237788889999999999999998 9999999999999999999999999999976532211  112234567


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          225 NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       225 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      .|+|||++.+..++.++|||||||++|||++ |..||......+      .....+..... ...+..+++++.+++.+|
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~-~~~~~~~~~~l~~li~~c  313 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTR-MRAPENATPEIYRIMLAC  313 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCC-CCCCCCCCHHHHHHHHHH
Confidence            8999999998889999999999999999997 999997643321      22223333322 223457889999999999


Q ss_pred             hhhCcCCCCCHHHHHc
Q 018630          304 VQKEPQQRLSAQELMT  319 (353)
Q Consensus       304 L~~dp~~Rpt~~e~l~  319 (353)
                      |+.||++|||+.|+++
T Consensus       314 l~~dp~~RPs~~el~~  329 (338)
T cd05102         314 WQGDPKERPTFSALVE  329 (338)
T ss_pred             ccCChhhCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-46  Score=365.93  Aligned_cols=261  Identities=29%  Similarity=0.461  Sum_probs=220.3

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC-----
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----  132 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~-----  132 (353)
                      ..++|.+.+.||+|+||+||++++..+++.||||++... ........+.+|+.++..++|+|+++++..+....     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            347999999999999999999999999999999998654 23455667889999999999999999988765322     


Q ss_pred             ---eEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecc
Q 018630          133 ---AISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG  205 (353)
Q Consensus       133 ---~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  205 (353)
                         .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence               478999999999999998643    468999999999999999999998 999999999999999999999999999


Q ss_pred             ccccccccC--CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          206 VSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       206 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      +++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.       .+....+....
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~~~~~  261 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKTLAGR  261 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCC
Confidence            997654321  123346799999999999998999999999999999999999999976432       23444444433


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      ..+ .+..+++++.+++.+||+.||.+|||+.++++|||++.+..
T Consensus       262 ~~~-~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~  305 (496)
T PTZ00283        262 YDP-LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS  305 (496)
T ss_pred             CCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence            322 34678999999999999999999999999999999987544

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.3e-46  Score=340.99  Aligned_cols=258  Identities=28%  Similarity=0.483  Sum_probs=214.9

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .|+..+.||+|+||.||++.+..+++.||+|.+....  .......+.+|+.+++.++|++++.+++.+.+.+.+++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3678899999999999999999999999999986542  22334567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          140 YMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       140 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++...... ...
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-ccc
Confidence            99999999988643  358999999999999999999998 99999999999999999999999999998764322 222


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  297 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ....|+..|+|||.+.+..++.++|+||+||++|+|++|..||...........    ......... ......+++++.
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~  233 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE----VERLVKEVQ-EEYSEKFSPDAR  233 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH----HHhhhhhhh-hhcCccCCHHHH
Confidence            345789999999999988899999999999999999999999976433221111    111111111 123456889999


Q ss_pred             HHHHHhhhhCcCCCCC-----HHHHHcCCccccc
Q 018630          298 SFISACVQKEPQQRLS-----AQELMTHPFLKMY  326 (353)
Q Consensus       298 ~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~  326 (353)
                      +|+.+||+.||++|||     ++|+++||||+..
T Consensus       234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            9999999999999999     9999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.9e-46  Score=362.63  Aligned_cols=257  Identities=25%  Similarity=0.386  Sum_probs=218.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccC-CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWT-GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ...|.+.+.||+|++|.||+|.+..+ ++.||+|.+... .......+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            34599999999999999999998877 788999976544 3344466788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          139 EYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       139 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ||++||+|.+++..    ..++++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            99999999988754    3468999999999999999999998 999999999999999999999999999998654322


Q ss_pred             C--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          215 G--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       215 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      .  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.       .+....+......+ .+..+
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~~-~~~~~  295 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQVLYGKYDP-FPCPV  295 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCC-CCccC
Confidence            1  13345799999999999988999999999999999999999999976432       23344444333322 23568


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      ++++.++|.+||+.||++|||+++++.|||++..
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            8999999999999999999999999999999754

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-46  Score=355.94  Aligned_cols=263  Identities=25%  Similarity=0.397  Sum_probs=212.7

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC-----eEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----AIS  135 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~-----~~~  135 (353)
                      +|++.+.||+|+||.||++.+..+++.||||.+... .......++.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999999989999999998643 22334567889999999999999999999988766     789


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  214 (353)
                      +|+||+. ++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++...... 
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            9999997 5899988877889999999999999999999998 999999999999999999999999999997653222 


Q ss_pred             CCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH----------------HHH
Q 018630          215 GQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE----------------LME  277 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----------------~~~  277 (353)
                      .......+++.|+|||.+.+. .++.++||||+||++|||++|..||.+.+..+....+..                ...
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence            122334688999999998874 479999999999999999999999976543221111110                001


Q ss_pred             HHhcCCC-CC------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          278 AIVDQPP-PS------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       278 ~~~~~~~-~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      .+..... +.      ......++++.+||.+||+.||++|||+.|+++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            1111111 10      1123458899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.6e-46  Score=339.22  Aligned_cols=252  Identities=25%  Similarity=0.444  Sum_probs=208.4

Q ss_pred             ecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           69 VGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      ||+|+||.||+++++.+|+.||+|.+....  .......+..|+++++.++||||+++++.+..+..+++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999999999999999986432  122334566799999999999999999999999999999999999999


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCC
Q 018630          147 ADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  224 (353)
Q Consensus       147 ~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  224 (353)
                      .+++...  ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++....... ......|++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCC
Confidence            9888654  358889999999999999999998 999999999999999999999999999987654322 223457899


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018630          225 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  304 (353)
Q Consensus       225 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  304 (353)
                      .|+|||++.+..++.++|+||+||++|||++|..||.......   ..............+ .....+++++.+|+.+||
T Consensus       159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L  234 (277)
T cd05607         159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV---AKEELKRRTLEDEVK-FEHQNFTEESKDICRLFL  234 (277)
T ss_pred             CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh---hHHHHHHHhhccccc-cccccCCHHHHHHHHHHh
Confidence            9999999998889999999999999999999999997643211   122233333332222 223468999999999999


Q ss_pred             hhCcCCCCCH----HHHHcCCccccc
Q 018630          305 QKEPQQRLSA----QELMTHPFLKMY  326 (353)
Q Consensus       305 ~~dp~~Rpt~----~e~l~hp~~~~~  326 (353)
                      +.||++||++    ++++.||||+.+
T Consensus       235 ~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         235 AKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             ccCHhhCCCCccchhhhhcChhhcCC
Confidence            9999999999    678899999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.9e-46  Score=347.66  Aligned_cols=259  Identities=25%  Similarity=0.473  Sum_probs=213.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|++.+.||+|+||.||+++++.+++.+|+|++...  ........+.+|+.++..++|+||+++++.+.++..+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4799999999999999999999999999999998643  12233445788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-C
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-Q  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~  216 (353)
                      ||+++|+|.+++.+ ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++........ .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            99999999999986 4678999999999999999999998 9999999999999999999999999999876433222 2


Q ss_pred             CcccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC---CCCC
Q 018630          217 ANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP---PSAP  288 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  288 (353)
                      ....+||+.|+|||++.     ...++.++|+|||||++|||++|..||...+.       .+....+.....   .+..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~p~~  232 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKERFQFPAQ  232 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCccccCCCc
Confidence            22357999999999986     34588999999999999999999999976432       223333333221   1222


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCC--CCCHHHHHcCCcccccC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYG  327 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~~  327 (353)
                      ...+++++.+|+.+||..++++  |++++|+++||||+...
T Consensus       233 ~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         233 VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            3467999999999999765544  78999999999998743

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-46  Score=343.09  Aligned_cols=256  Identities=25%  Similarity=0.459  Sum_probs=202.0

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhc---CCCCceEEEeeEeEe-----cC
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQS---SQCPYVVVCYQSFYS-----NG  132 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~---l~hp~iv~~~~~~~~-----~~  132 (353)
                      +|++.+.||+|+||+||+|+++.+++.||+|.++.... ........+|+.+++.   ++||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            58899999999999999999999999999999875421 1112334456665544   579999999998764     34


Q ss_pred             eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      .++++|||+.+ +|.+++...  ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            68999999985 899988764  348999999999999999999998 99999999999999999999999999998765


Q ss_pred             cccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC---CC--
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP---PP--  285 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~--  285 (353)
                      .... ......||+.|+|||++.+..++.++||||+||++|+|++|.+||......+...   ..........   .+  
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         159 SCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG---KIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH---HHHHHhCCCChhhCccc
Confidence            4322 2234578999999999998889999999999999999999999997643322111   1111110000   00  


Q ss_pred             ----------------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          286 ----------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       286 ----------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                                      ......++.++.++|.+||++||++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                            00113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-46  Score=340.59  Aligned_cols=274  Identities=43%  Similarity=0.744  Sum_probs=228.6

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ..++|++++.||+|+||+||++.+..+++.||+|++...........+.+|+++++.++||||+++++.+...+.+++||
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            45789999999999999999999999999999999876655556778899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||+++++|.+++...+.++...+..++.|++.||.|||+..+++||||+|+||+++.++.++|+|||++......  ...
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~~  160 (284)
T cd06620          83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IAD  160 (284)
T ss_pred             ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--ccC
Confidence            999999999999888889999999999999999999997468999999999999999999999999998654322  223


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC----chhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----GWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ...|+..|+|||++.+..++.++|+||+||++|+|++|..||.......    ...........+.....+......++.
T Consensus       161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd06620         161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE  240 (284)
T ss_pred             ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence            4578999999999988889999999999999999999999998644321    111223344444444333333344788


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCccccc-CCCCcCHh
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMY-GDLNVDLS  334 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~-~~~~~~~~  334 (353)
                      ++.+|+.+||+.||++|||+.|+++||||... .....++.
T Consensus       241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~~~~~~  281 (284)
T cd06620         241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQ  281 (284)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhcCcccccccccccCCcc
Confidence            99999999999999999999999999988653 33334443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.5e-47  Score=354.06  Aligned_cols=265  Identities=25%  Similarity=0.426  Sum_probs=211.8

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------  131 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------  131 (353)
                      ..++|++.+.||+|+||.||++.+..+++.||||.+... ........+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            357899999999999999999999999999999998654 2334456788899999999999999999987643      


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ...|+||||+++ +|.+.+..  .++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            357999999975 77777754  58899999999999999999998 999999999999999999999999999997654


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH---------------HH
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------LM  276 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---------------~~  276 (353)
                      .. .......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+.+....+               ..
T Consensus       171 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         171 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             Cc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            32 223446789999999999988899999999999999999999999986543222111110               00


Q ss_pred             HHHhcCCCC------------------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          277 EAIVDQPPP------------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       277 ~~~~~~~~~------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      .......+.                  .......+.++.+||.+||+.||++|||+.|+++||||+.+.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~  319 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD  319 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence            001000000                  0011224567899999999999999999999999999987643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.5e-46  Score=353.99  Aligned_cols=267  Identities=25%  Similarity=0.423  Sum_probs=212.8

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------  131 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------  131 (353)
                      ..++|.+.+.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999999999999999986542 334456778899999999999999999887543      


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ..+|+||||+.+ +|.+.+..  .++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            467999999975 88887754  58889999999999999999998 999999999999999999999999999997654


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH---------------H
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL---------------M  276 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~---------------~  276 (353)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.+......               .
T Consensus       178 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (364)
T cd07875         178 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  256 (364)
T ss_pred             CC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence            32 2234457899999999999989999999999999999999999999875543222211110               0


Q ss_pred             HHHhcCCCC------------------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          277 EAIVDQPPP------------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       277 ~~~~~~~~~------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      .......+.                  .......+.++.+||.+||+.||.+|||+.|+++||||+.+.+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  328 (364)
T cd07875         257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS  328 (364)
T ss_pred             HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence            000000000                  001112356789999999999999999999999999998765443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-50  Score=344.33  Aligned_cols=257  Identities=35%  Similarity=0.618  Sum_probs=226.4

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +-|+++..||+|+||.||+|.++.+|..+|||.+...   ....++.+|+.++++++.|++|++|+.|..+..+++||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            4488999999999999999999999999999998754   4567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          141 MDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       141 ~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      |..||+.+.++ ++++++++++..+++..+.||+|||. ..-||||||..|||++.+|.+||+|||.|..+.......++
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            99999999987 45789999999999999999999998 88899999999999999999999999999888766666677


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (353)
                      ..|||.|||||++..-.|+.++||||||++..||..|++||.+..+...      +...-...++....+...|.++.+|
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------IFMIPT~PPPTF~KPE~WS~~F~DF  262 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA------IFMIPTKPPPTFKKPEEWSSEFNDF  262 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce------eEeccCCCCCCCCChHhhhhHHHHH
Confidence            8999999999999988899999999999999999999999988655321      1111112222233455678899999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          300 ISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +++||-++|++|-|+.++++|||++...
T Consensus       263 i~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  263 IRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             HHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            9999999999999999999999998764

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=349.77  Aligned_cols=256  Identities=30%  Similarity=0.506  Sum_probs=225.7

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      +-|++.+.||+|.|++|-+|++.-+|+.||||++.+. .+.....++.+|++.|+..+|||||++|++...+..+|+|+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            5588889999999999999999999999999999765 345556789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE-cCCCcEEEeeccccccccccCCCC
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI-NHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll-~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      .-++|+|++++-++ ..+.++.+++++.||+.|+.|+|+ ..+|||||||+|+.+ ..-|-|||+|||++..+. ++...
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~kL  175 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGKKL  175 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccCC-Ccchh
Confidence            99999999999765 569999999999999999999998 999999999999886 467899999999998765 45567


Q ss_pred             cccccCCcccCcceecCCCCC-ccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYG-YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .+.||+..|-|||.+.+..|+ +++||||||||||.|+||++||...+..+....       |.+-  ....+..++.++
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm-------ImDC--KYtvPshvS~eC  246 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM-------IMDC--KYTVPSHVSKEC  246 (864)
T ss_pred             hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh-------hhcc--cccCchhhhHHH
Confidence            788999999999999999986 678999999999999999999987665443322       2221  233456789999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ++||.+||..||.+|.|.++|.+|+|+|...
T Consensus       247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             HHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence            9999999999999999999999999999764

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-46  Score=353.60  Aligned_cols=266  Identities=19%  Similarity=0.304  Sum_probs=214.5

Q ss_pred             ccCceeeeeecccCCeEEEEEEec--cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      ..+|++++.||.|+||.||++...  .+++.||+|.+...      ....+|+++++.++||||+++++.+......++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            457999999999999999999764  35678999987643      2345799999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--  215 (353)
                      ||++. ++|.+++.....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++|+|||++........  
T Consensus       165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence            99996 5999999777889999999999999999999998 9999999999999999999999999999876543222  


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh---------------
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---------------  280 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~---------------  280 (353)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..||.+............+...+.               
T Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  322 (392)
T PHA03207        243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC  322 (392)
T ss_pred             cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence            12245799999999999988999999999999999999999999976543321111111111111               


Q ss_pred             -------cCCCC-CC-----CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCH
Q 018630          281 -------DQPPP-SA-----PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  333 (353)
Q Consensus       281 -------~~~~~-~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~  333 (353)
                             ....+ ..     ....++.++.++|.+||+.||++|||+.|+++||||+..+...+++
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~~~  388 (392)
T PHA03207        323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLLNI  388 (392)
T ss_pred             HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhhcC
Confidence                   00000 00     1124567899999999999999999999999999999876655543

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.6e-45  Score=329.32  Aligned_cols=253  Identities=34%  Similarity=0.615  Sum_probs=218.9

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|.+.+.||+|++|.||++.++.+++.|++|.+... ........+.+|+++++.++|||++++++.+..++.+++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            578899999999999999999999999999998654 2344567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          141 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       141 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      +++++|.+++...  ..++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            9999999999764  578999999999999999999998 9999999999999999999999999999887654443344


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ...|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.       ......+.....+. ....++.++.+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~  231 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-------GALILKIIRGVFPP-VSQMYSQQLAQ  231 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCC-CccccCHHHHH
Confidence            55788999999999988899999999999999999999999976542       12333344433333 23467899999


Q ss_pred             HHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          299 FISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       299 li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ++.+||+.+|++||++.+++.|||+
T Consensus       232 ~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         232 LIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHccCCcccCcCHHHHhhCCCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.7e-46  Score=347.73  Aligned_cols=259  Identities=25%  Similarity=0.491  Sum_probs=213.9

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|++.+.||+|+||.||+++++.+++.||+|++...  ........+.+|..++..++|+||+.+++.+.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4799999999999999999999999999999998653  12233455788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-C
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-Q  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~  216 (353)
                      ||++||+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++........ .
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            99999999999987 4678999999999999999999998 9999999999999999999999999999876543322 1


Q ss_pred             CcccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC---CCCC
Q 018630          217 ANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP---PSAP  288 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  288 (353)
                      ....+||+.|+|||++.+     +.++.++|+||+||++|||++|..||...+..       +....+.....   .+..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~  232 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHEERFQFPSH  232 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------HHHHHHHcCCCcccCCCc
Confidence            223579999999999875     46789999999999999999999999764321       22233332211   1122


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCC--CCCHHHHHcCCcccccC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYG  327 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~~  327 (353)
                      ...+++++.+++.+||+.++.+  |++++++++||||+...
T Consensus       233 ~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         233 ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence            2457899999999999976554  56999999999998743

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.2e-46  Score=336.68  Aligned_cols=271  Identities=39%  Similarity=0.742  Sum_probs=222.0

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHH-HhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ++|++.+.||+|+||.||++.++.+|+.||+|+++.........++..|+.+ ++..+||||+++++.+..++..|++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            4789999999999999999999999999999998766443344555566664 666789999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          140 YMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       140 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~-~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |++ ++|.+++...    ..+++..+..++.|++.||.|||+ + +++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            997 5888887642    468999999999999999999998 6 99999999999999999999999999987654322


Q ss_pred             CCCcccccCCcccCcceecC----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          215 GQANTFVGTYNYMSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                       ......++..|+|||.+.+    ..++.++|+||+||++|+|++|..||.....     .... .........+.....
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~-~~~~~~~~~~~~~~~  231 (283)
T cd06617         159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PFQQ-LKQVVEEPSPQLPAE  231 (283)
T ss_pred             -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CHHH-HHHHHhcCCCCCCcc
Confidence             1223468889999998865    4468899999999999999999999964321     1112 222233333333445


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhh
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  340 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~  340 (353)
                      .++.++.++|.+||+.+|.+|||+.++++||||+.....+.++.++++.+
T Consensus       232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~  281 (283)
T cd06617         232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASFVSLI  281 (283)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccccHHHHHHHHhc
Confidence            68999999999999999999999999999999999988888888877654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.6e-46  Score=335.25  Aligned_cols=256  Identities=30%  Similarity=0.526  Sum_probs=214.2

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.+++.++||||+++++.+...+.+++||
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            34689999999999999999999999999999999876532 33456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||+++++|.+++...+.+++..+..++.|++.|+.|||+ .|++|+||||+||+++.++.++|+|||++...........
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            999999999999888899999999999999999999998 9999999999999999999999999999876544333334


Q ss_pred             ccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CCCCCCC
Q 018630          219 TFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFS  293 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  293 (353)
                      ...|++.|+|||.+.   ...++.++|+|||||++|+|++|..||.......      ...........+.  .....++
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR------ALFLMTKSNFQPPKLKDKMKWS  238 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh------hHHhhhccCCCCCcccccCCCC
Confidence            567899999999874   4558899999999999999999999996543211      1111111111111  1123567


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPF  322 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  322 (353)
                      ..+.++|.+||+.||++|||++++++|||
T Consensus       239 ~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            89999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.5e-45  Score=328.34  Aligned_cols=253  Identities=31%  Similarity=0.583  Sum_probs=215.2

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-cCeEEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILE  139 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e  139 (353)
                      +|++++.||.|++|.||++.++.+++.||+|.+.... .......+.+|+++++.++|+|++++++.+.. +..++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4899999999999999999999899999999986542 33445678899999999999999999988764 457899999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          140 YMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       140 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |+++++|.+++...  ..+++..++.++.|++.|+.+||+ +|++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            99999999998763  458999999999999999999998 999999999999999999999999999998765444344


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  297 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ....+++.|+|||.+.+..++.++|+||+||++++|++|..||...+.       ......+.....+. .+..+++++.
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~  231 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRIIEGKLPP-MPKDYSPELG  231 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcCCCC-CccccCHHHH
Confidence            456789999999999988899999999999999999999999975332       12223333333322 3456889999


Q ss_pred             HHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          298 SFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       298 ~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +++.+||+.||++|||+.++++||||
T Consensus       232 ~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         232 ELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHhccCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-45  Score=338.43  Aligned_cols=260  Identities=30%  Similarity=0.573  Sum_probs=220.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      .+|++.+.||+|++|.||++.+..+++.||+|.+...... ....+.+|+.+++.+.|||++++++.+..+...++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            6899999999999999999999989999999998765332 346688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++++|.+++.. ..++...+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.............
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  176 (296)
T cd06654          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (296)
T ss_pred             cCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence            999999999865 468999999999999999999998 999999999999999999999999999987654333333345


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      .+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+...      ..........+....+..+++.+.+++
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTPELQNPEKLSAIFRDFL  250 (296)
T ss_pred             cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCCCCCCCccccCHHHHHHH
Confidence            78999999999988889999999999999999999999997654321      111111222222223456889999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      .+||..||++|||+.++++||||......
T Consensus       251 ~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  279 (296)
T cd06654         251 NRCLDMDVEKRGSAKELLQHQFLKIAKPL  279 (296)
T ss_pred             HHHCcCCcccCcCHHHHhhChhhhccCCc
Confidence            99999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-48  Score=359.20  Aligned_cols=267  Identities=31%  Similarity=0.555  Sum_probs=230.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +.|+++..||.|+||.||+|.++.++-..|.|++... .......+.-|++|+..++||+||++++.|..++.++++.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            5688999999999999999999988888889988644 455667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          141 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       141 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      |.||-+...+-. ...++++++..+++|+++||.|||+ ++|||||||..|||++-+|.++|+|||++...........+
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence            999999887654 4679999999999999999999999 99999999999999999999999999999776666666678


Q ss_pred             cccCCcccCccee-----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC-CCCCCCC
Q 018630          220 FVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFS  293 (353)
Q Consensus       220 ~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  293 (353)
                      +.|||+|||||+.     ...+|++++||||||++|.||.-+.+|-...+.       ..++-++.+..+|. ..+...+
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllKiaKSePPTLlqPS~Ws  262 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLLQPSHWS  262 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHHHhhcCCCcccCcchhh
Confidence            8999999999986     346799999999999999999999999876433       34444555544443 4566788


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHh
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF  337 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~  337 (353)
                      ..+.+|+.+||.+||..||+++++++||||+..... .-+.+.+
T Consensus       263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn-K~ireLl  305 (1187)
T KOG0579|consen  263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN-KMIRELL  305 (1187)
T ss_pred             hHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc-hHHHHHH
Confidence            999999999999999999999999999999987765 3344433

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.3e-45  Score=336.29  Aligned_cols=258  Identities=32%  Similarity=0.595  Sum_probs=220.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      .+|++.+.||.|++|.||++.+..+++.||+|.+..... .....+.+|+.+++.++|||++++++.+..+..+++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            579999999999999999999999999999999865432 2346678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++++|.+++.. ..+++..+..++.|++.|+.|||+ .|++|+||+|+||+++.++.++|+|||++.............
T Consensus        98 ~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  175 (296)
T cd06655          98 LAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (296)
T ss_pred             cCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence            999999998876 468999999999999999999998 999999999999999999999999999987654433333345


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh-cCCCCCCCCCCCCHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV-DQPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  299 (353)
                      .+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+...      . ...+. ........+..+++.+.++
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~-~~~~~~~~~~~~~~~~~~~~~~~~l  248 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------A-LYLIATNGTPELQNPEKLSPIFRDF  248 (296)
T ss_pred             CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHhcCCcccCCcccCCHHHHHH
Confidence            78899999999998889999999999999999999999997754321      1 11122 2222223345788999999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          300 ISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      |.+||..||++|||+.++++||||+...+
T Consensus       249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         249 LNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            99999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.9e-46  Score=334.12  Aligned_cols=254  Identities=31%  Similarity=0.535  Sum_probs=212.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .++|++.+.||+|+||.||++++..+++.||+|++..... .....+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            3689999999999999999999999999999999875422 234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      |+++++|.+++.....+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.++|+|||++............
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06646          87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS  165 (267)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence            99999999999887889999999999999999999998 99999999999999999999999999999876443333344


Q ss_pred             cccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC---CCCCCCCCCC
Q 018630          220 FVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP---PPSAPSDQFS  293 (353)
Q Consensus       220 ~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  293 (353)
                      ..|++.|+|||.+.   ...++.++|+||+||++|||++|..||...+..+.       ...+....   ........++
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFLMSKSNFQPPKLKDKTKWS  238 (267)
T ss_pred             cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-------heeeecCCCCCCCCccccccC
Confidence            57889999999884   34578899999999999999999999965432211       00111111   1111124578


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPF  322 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  322 (353)
                      .++.++|.+||+.||++|||++++++|+|
T Consensus       239 ~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         239 STFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            89999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=330.65  Aligned_cols=257  Identities=29%  Similarity=0.442  Sum_probs=216.1

Q ss_pred             ccCceee-eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHh-cCCCCceEEEeeEeEe----cCe
Q 018630           60 LEDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ-SSQCPYVVVCYQSFYS----NGA  133 (353)
Q Consensus        60 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~hp~iv~~~~~~~~----~~~  133 (353)
                      .++|.+- ++||-|-.|.|..+.++.+++.+|+|++..+      ...++|+++.. ...|||||.++++|.+    ...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            3566653 6899999999999999999999999998643      44567887744 4579999999998874    367


Q ss_pred             EEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC---CCcEEEeeccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSA  208 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~  208 (353)
                      +.+|||.|+||.|+..++.++.  +++.++..|+.||+.|+.|||+ .+|.||||||+|+|...   +..+||+|||+|+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEeccccccc
Confidence            8899999999999999987754  9999999999999999999999 99999999999999975   4469999999998


Q ss_pred             cccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh--cCCCCC
Q 018630          209 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPS  286 (353)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~  286 (353)
                      .-.. .....+.|-||.|.|||++...+|+...|+||+||++|-|+||.+||....-. ..+.  ....+|.  ....|.
T Consensus       213 ~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-aisp--gMk~rI~~gqy~FP~  288 (400)
T KOG0604|consen  213 ETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISP--GMKRRIRTGQYEFPE  288 (400)
T ss_pred             ccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-cCCh--hHHhHhhccCccCCC
Confidence            7543 45577789999999999999999999999999999999999999999764321 1111  1222332  333566


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ..+.++|.+.+++|+.+|..+|.+|.|+.++++|||+..+.
T Consensus       289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            67889999999999999999999999999999999998765

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.4e-45  Score=334.19  Aligned_cols=261  Identities=33%  Similarity=0.573  Sum_probs=219.0

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +.|++++.||.|+||.||++++..+++.+|+|.+... .......+.+|+.+++.++||||+++++.+..++.+++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            6799999999999999999999999999999998755 344466788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          141 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       141 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      +++++|..++.+ ...+++..+..++.|++.|+.|||+ .|++||||+|+||+++.++.++|+|||++............
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  169 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS  169 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCCCEEEccCccceeccccccccce
Confidence            999999888754 4568999999999999999999998 99999999999999999999999999998765433333345


Q ss_pred             cccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-CCCCCCCCC
Q 018630          220 FVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFS  293 (353)
Q Consensus       220 ~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  293 (353)
                      ..+++.|+|||.+.     ...++.++|+|||||++|||++|..||...+.       ......+..... ....+..++
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  242 (292)
T cd06644         170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLSQPSKWS  242 (292)
T ss_pred             ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHhcCCCccCCCCcccC
Confidence            57889999999985     34578899999999999999999999976432       112222222222 222345678


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      .++.++|.+||+.||++||+++++++||||......+
T Consensus       243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence            8999999999999999999999999999998765554

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.4e-45  Score=333.48  Aligned_cols=259  Identities=32%  Similarity=0.564  Sum_probs=216.6

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      .|++.+.||.|+||.||++.+..++..+|+|.+.... ......+.+|+++++.++|||++++++.+..++..++|+||+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            3688899999999999999999999999999986543 344567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          142 DGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       142 ~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      ++++|..++.+ ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.............
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            99999988765 4678999999999999999999998 999999999999999999999999999987654433334445


Q ss_pred             ccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-CCCCCCCCCCH
Q 018630          221 VGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSP  294 (353)
Q Consensus       221 ~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  294 (353)
                      .+++.|+|||++.     +..++.++|+||+||++|||++|..||...+..       +....+.... .....+..++.
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSEPPTLAQPSRWSS  236 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------HHHHHHhhcCCCCCCCccccCH
Confidence            7899999999984     345788999999999999999999999764321       1222222221 12223456789


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      ++.++|.+||+.||++|||+.++++||||+.....
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  271 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK  271 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCCCEeccCCC
Confidence            99999999999999999999999999999976543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-46  Score=336.63  Aligned_cols=260  Identities=35%  Similarity=0.626  Sum_probs=220.4

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|++++.||.|++|.||++.+..+++.+|+|++... .......+.+|+++++.++||||+++++.+..+...++||||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            6799999999999999999999889999999998755 334456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          141 MDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       141 ~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      +++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++............
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence            9999999998764 579999999999999999999998 99999999999999999999999999998765443333444


Q ss_pred             cccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-CCCCCCCC
Q 018630          220 FVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFS  293 (353)
Q Consensus       220 ~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  293 (353)
                      ..+++.|+|||.+.     ...++.++|+||+||++|+|++|..||...+..       .....+.....+ ...+..++
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  235 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------RVLLKILKSEPPTLDQPSKWS  235 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------HHHHHHhcCCCCCcCCcccCC
Confidence            57899999999874     345788999999999999999999999764321       222333333322 22345678


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      .++.++|.+||+.||.+|||+.++++||||....+.
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN  271 (280)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhcChhhcccchh
Confidence            999999999999999999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-45  Score=338.56  Aligned_cols=264  Identities=31%  Similarity=0.569  Sum_probs=222.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      .+|.+++.||+|++|.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++.+..+...++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            789999999999999999999999999999999875533 2345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++++|.+++.. ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.............
T Consensus        98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  175 (297)
T cd06656          98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (297)
T ss_pred             cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcc
Confidence            999999999865 568999999999999999999998 999999999999999999999999999987654333333345


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      .+++.|+|||.+.+..++.++|+||+||++|++++|..||...+....      .........+....+..+++.+.+++
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li  249 (297)
T cd06656         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGTPELQNPERLSAVFRDFL  249 (297)
T ss_pred             cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh------eeeeccCCCCCCCCccccCHHHHHHH
Confidence            788999999999988899999999999999999999999976543211      11111112222223456788999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccCCCCcCH
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  333 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~  333 (353)
                      .+||+.||++|||++++++||||+.......-.
T Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~  282 (297)
T cd06656         250 NRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLT  282 (297)
T ss_pred             HHHccCChhhCcCHHHHhcCchhcccccccccC
Confidence            999999999999999999999999877665433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.8e-45  Score=334.49  Aligned_cols=254  Identities=33%  Similarity=0.559  Sum_probs=220.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|.+.+.||+|++|.||++.+..+++.||+|+++...  .......+.+|+++++.++||||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46899999999999999999999999999999987542  2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ +|++|+||+|.||+++.++.++|+|||++......   ..
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CC
Confidence            999999999999988889999999999999999999998 99999999999999999999999999998775433   33


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.       ......+.....  ..+..+++.+.+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~--~~~~~~~~~l~~  227 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGKV--RFPSFFSPDAKD  227 (290)
T ss_pred             CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCc--cCCccCCHHHHH
Confidence            45789999999999888889999999999999999999999976432       122333333322  223467899999


Q ss_pred             HHHHhhhhCcCCCC-----CHHHHHcCCcccccC
Q 018630          299 FISACVQKEPQQRL-----SAQELMTHPFLKMYG  327 (353)
Q Consensus       299 li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  327 (353)
                      +|.+||+.||.+|+     +++|+++||||+...
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            99999999999999     999999999998765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.6e-45  Score=333.77  Aligned_cols=265  Identities=36%  Similarity=0.587  Sum_probs=225.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +.|+.++.||.|+||.||.+.+..+++.||+|++...........+.+|+.+++.+.||||+++++.+.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45778899999999999999999899999999987664455567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++++|.+++.. .++++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++.............
T Consensus        84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06640          84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence            999999999875 578999999999999999999998 999999999999999999999999999997654433333345


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      .++..|+|||.+.+..++.++|+|||||++|||++|..||...+..       .....+.... ++.....++..+.+++
T Consensus       162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~~~li  233 (277)
T cd06640         162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-------RVLFLIPKNN-PPTLTGEFSKPFKEFI  233 (277)
T ss_pred             cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-------hHhhhhhcCC-CCCCchhhhHHHHHHH
Confidence            6788999999998888999999999999999999999999764321       1112222222 2233456788999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhH
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE  335 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~  335 (353)
                      .+||+.+|++||++.++++||||...+.....+..
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~  268 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTE  268 (277)
T ss_pred             HHHcccCcccCcCHHHHHhChHhhhcchhhhHHHH
Confidence            99999999999999999999999988776554443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.5e-45  Score=328.34  Aligned_cols=263  Identities=60%  Similarity=1.042  Sum_probs=227.9

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      .+|++.+.||.|++|.||+|.+..+++.||+|++...........+.+|+..+..++|+|++++++.+..++.+++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36889999999999999999999999999999987664445567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++++|.+++.....+++..+..++.|++.|+.|||+..+++|+||+|+||+++.++.++|+|||.+.............
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~  160 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF  160 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence            99999999998888899999999999999999999954899999999999999999999999999988765444333355


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||....+.    ...+....+.....+......++..+.++|
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (264)
T cd06623         161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFELMQAICDGPPPSLPAEEFSPEFRDFI  236 (264)
T ss_pred             eecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence            7889999999998888999999999999999999999999776431    233444555544444433333889999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      .+||+.+|++|||+.++++||||+.+.
T Consensus       237 ~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         237 SACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-46  Score=350.37  Aligned_cols=264  Identities=25%  Similarity=0.417  Sum_probs=210.3

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------C
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~  132 (353)
                      .++|.+++.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            378999999999999999999999999999999986542 223345677899999999999999999877532      4


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ..|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            579999998 6799888764 579999999999999999999998 9999999999999999999999999999976532


Q ss_pred             cCCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH--------HH------
Q 018630          213 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--------ME------  277 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~--------~~------  277 (353)
                         ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+........        ..      
T Consensus       171 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07878         171 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH  247 (343)
T ss_pred             ---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence               2345678999999999877 46899999999999999999999999764332111111000        00      


Q ss_pred             --HHhcCCC--CC----CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          278 --AIVDQPP--PS----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       278 --~~~~~~~--~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                        ......+  +.    ......++.+.+||.+||+.||++|||+.|+++||||..+.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence              0000000  00    0012456789999999999999999999999999999886543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.8e-46  Score=336.79  Aligned_cols=260  Identities=26%  Similarity=0.466  Sum_probs=208.7

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|++++.||+|++|.||++.+..+++.||+|.++.... ......+.+|+.+++.++||||+++++.+.+++.+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            58899999999999999999998999999999865422 22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          141 MDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       141 ~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      +. ++|.+++...   ..+++..++.++.|++.||+|||+ +|++||||+|+||+++.++.++|+|||++..........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            97 5898888643   468999999999999999999998 999999999999999999999999999987654333333


Q ss_pred             cccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhH---------------HHH---HHH
Q 018630          218 NTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF---------------YEL---MEA  278 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---------------~~~---~~~  278 (353)
                      ....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||......+.....               ...   ...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            344678999999988654 4789999999999999999999999764321100000               000   000


Q ss_pred             HhcC--CCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          279 IVDQ--PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       279 ~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ....  .........+++++.++|.+||+.||.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            0000  00011123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1e-45  Score=335.97  Aligned_cols=259  Identities=29%  Similarity=0.539  Sum_probs=212.7

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ++|++.+.||+|++|.||++.++.+++.||+|++..... ......+.+|+.+++.++|||++++++.+.....+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            478999999999999999999998999999999865422 2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      |+++++|..++.....+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            99998888887776789999999999999999999998 99999999999999999999999999999876544333344


Q ss_pred             cccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc----------------C
Q 018630          220 FVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD----------------Q  282 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~----------------~  282 (353)
                      ..++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+.   ..........                .
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhccccccccc
Confidence            567889999999876 4578999999999999999999999976543221   1111110000                0


Q ss_pred             -CCCC--------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          283 -PPPS--------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       283 -~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                       ..+.        .....++..+.+|+.+||+.||++|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence             0000        0013467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-45  Score=337.28  Aligned_cols=265  Identities=31%  Similarity=0.516  Sum_probs=222.3

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE--SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|+..+.||+|++|.||++.+..+++.||+|.+......  .....+.+|+++++.++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            4789999999999999999999989999999998765322  35567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-
Q 018630          139 EYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-  215 (353)
                      ||+.+++|.+++...  ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            999999999998764  568999999999999999999998 9999999999999999999999999999865432111 


Q ss_pred             ----------------------------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC
Q 018630          216 ----------------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD  267 (353)
Q Consensus       216 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~  267 (353)
                                                  ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.. 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-  238 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD-  238 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH-
Confidence                                        111246788999999999888999999999999999999999999765432 


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCC----HHHHHcCCcccccCCCCcCH
Q 018630          268 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS----AQELMTHPFLKMYGDLNVDL  333 (353)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~~~~~~~~~~~~  333 (353)
                            .....+............+++++.++|.+||+.||++|||    ++++++||||+......+.+
T Consensus       239 ------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         239 ------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             ------HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhccc
Confidence                  1222233322222222347899999999999999999999    99999999999877666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.8e-45  Score=333.80  Aligned_cols=259  Identities=27%  Similarity=0.453  Sum_probs=216.1

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      |+..+.||.|+||+||++.+..+++.+|+|.+....  .......+.+|+.+++.++|+||+.+++.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            677899999999999999999999999999986542  222345577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          141 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       141 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++...... ....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIR  159 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cccc
Confidence            9999999888653  369999999999999999999998 99999999999999999999999999998764322 2223


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ...|+..|+|||.+.+..++.++|+||+||++|+|++|..||.......   ........+....  ......+++++.+
T Consensus       160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~~  234 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLETE--EVYSAKFSEEAKS  234 (285)
T ss_pred             CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhccc--cccCccCCHHHHH
Confidence            4578999999999988889999999999999999999999997643321   1112222222221  1234567899999


Q ss_pred             HHHHhhhhCcCCCCC-----HHHHHcCCcccccCC
Q 018630          299 FISACVQKEPQQRLS-----AQELMTHPFLKMYGD  328 (353)
Q Consensus       299 li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~  328 (353)
                      |+.+||+.||.+|||     +.+++.||||+....
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence            999999999999999     889999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.3e-45  Score=333.09  Aligned_cols=241  Identities=20%  Similarity=0.267  Sum_probs=203.5

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe----cCeEEEEEEe
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEY  140 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~----~~~~~lv~e~  140 (353)
                      ..||+|++|.||++..  +|+.||||.++...  .......+.+|+.++++++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6789999999999987  68999999987542  22335678899999999999999999999876    3578999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++|+|.+++...+.++......++.|++.||.|||+..+++||||||+||+++.++.+||+|||+++.....   ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~  180 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKN  180 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---cccc
Confidence            9999999999988889999999999999999999997458999999999999999999999999998765432   2234


Q ss_pred             ccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          221 VGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       221 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .|++.|+|||.+.+  ..++.++|||||||++|||++|..||.+.+.       .+....+.........+..+++++.+
T Consensus       181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~l~~  253 (283)
T PHA02988        181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-------KEIYDLIINKNNSLKLPLDCPLEIKC  253 (283)
T ss_pred             cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence            68899999999976  6799999999999999999999999986432       23334443333333334467999999


Q ss_pred             HHHHhhhhCcCCCCCHHHHHc
Q 018630          299 FISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       299 li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ++.+||+.||++|||++++++
T Consensus       254 li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        254 IVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHhcCCcccCcCHHHHHH
Confidence            999999999999999999986

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-45  Score=327.68  Aligned_cols=253  Identities=35%  Similarity=0.611  Sum_probs=215.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|++.+.||.|++|.||++.+..+++.+|+|++...... ....+.+|+.+++.++||||+++++.+.....++++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            6899999999999999999999989999999998765333 567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          141 MDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       141 ~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      +.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++............
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence            9999999999876 789999999999999999999998 99999999999999999999999999998766543333344


Q ss_pred             cccCCcccCcceecCC---CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC--C-CCCCCCCCCC
Q 018630          220 FVGTYNYMSPERISGG---KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--P-PPSAPSDQFS  293 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~  293 (353)
                      ..++..|+|||.+.+.   .++.++|+||+||++|+|++|..||...+...       ........  . .........+
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------ALFLISKSNFPPPKLKDKEKWS  233 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccCCCccccchhhhh
Confidence            5788899999998776   78999999999999999999999997644321       11111111  1 1111233567


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPF  322 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  322 (353)
                      .++.+++.+||+.+|.+|||+.+++.|||
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            88999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.5e-45  Score=331.22  Aligned_cols=253  Identities=36%  Similarity=0.645  Sum_probs=209.9

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEec------Ce
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSN------GA  133 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~------~~  133 (353)
                      +.|++.+.||+|+||.||++.+..+++.||+|++....  .....+.+|+.+++.+ +||||+++++.+...      ..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            56888899999999999999999999999999986542  2335678888888887 699999999988753      46


Q ss_pred             EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ++++|||+.+++|.+++...  ..+++..+..++.|++.|++|||+ ++++|+||+|+||+++.++.++|+|||++....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            89999999999999998864  468999999999999999999998 999999999999999999999999999987654


Q ss_pred             ccCCCCcccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      ..........|++.|+|||++.     +..++.++|+||+||++|||++|..||.......       ............
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~  235 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPRNPAPR  235 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHHHhcCCCCC
Confidence            3333444567899999999986     3358889999999999999999999996543211       111112222223


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .....++.++.+|+.+||..||.+|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            3345678999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.8e-45  Score=327.69  Aligned_cols=253  Identities=29%  Similarity=0.485  Sum_probs=216.6

Q ss_pred             ecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           69 VGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      ||.|++|.||++.+..+++.||+|++....  .......+.+|+.+++.++||||+++++.+.++..+++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999999899999999987542  234457789999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCCcc
Q 018630          147 ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY  226 (353)
Q Consensus       147 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y  226 (353)
                      .+++.+...+++..+..++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||++....... ......+++.|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCc
Confidence            9999887889999999999999999999998 999999999999999999999999999997765432 23345788999


Q ss_pred             cCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhh
Q 018630          227 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK  306 (353)
Q Consensus       227 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  306 (353)
                      +|||.+.+..++.++|+||+|+++|+|++|..||...+..     ..+....+.........+...++++.++|.+||+.
T Consensus       159 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-----PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             cChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-----HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence            9999998888999999999999999999999999875421     12333444432223333445589999999999999


Q ss_pred             CcCCCCC-----HHHHHcCCcccccCC
Q 018630          307 EPQQRLS-----AQELMTHPFLKMYGD  328 (353)
Q Consensus       307 dp~~Rpt-----~~e~l~hp~~~~~~~  328 (353)
                      ||++|||     ++|+++||||+.+..
T Consensus       234 ~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         234 NPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             ChhhCcCCcccCHHHHhcChhhhCCCC
Confidence            9999999     999999999997654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-44  Score=329.42  Aligned_cols=273  Identities=42%  Similarity=0.749  Sum_probs=223.9

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--cCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~  138 (353)
                      ++|+..+.||.|++|.||++.+..+++.+|+|.+..........++.+|+++++.++||||+++++.+..  .+.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4689999999999999999999989999999998766555566788999999999999999999998864  35789999


Q ss_pred             EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          139 EYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       139 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            99999999988753    3458999999999999999999998 999999999999999999999999999986544322


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC---CC--C
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS---AP--S  289 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--~  289 (353)
                        .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.......  ....+....+.....+.   ..  .
T Consensus       160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP--LGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC--CChHHHHHHHhcCCchhhccCCCCC
Confidence              223467889999999998889999999999999999999999998653211  11122233333211111   11  1


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhh
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFT  338 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~  338 (353)
                      ...++++.+++.+||+.+|++|||+.|++.||||+....++.....|+.
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~~~~~~  284 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAKFVA  284 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccchhhHHHHHH
Confidence            2356789999999999999999999999999999988888877666653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.6e-45  Score=328.64  Aligned_cols=258  Identities=27%  Similarity=0.527  Sum_probs=216.9

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-----cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      +|+..+.||+|++|.||++.+..+++.||+|+++...     .......+.+|+++++.++||||+++++.+.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4777889999999999999999999999999986432     12245778999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCC
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSG  215 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~  215 (353)
                      |+||+++++|.+++...+++++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            99999999999999888889999999999999999999998 9999999999999998776 599999999876643321


Q ss_pred             C----CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          216 Q----ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       216 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      .    .....++..|+|||.+.+..++.++|+||+||++|+|++|..||...+..    ..................+..
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS----NHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc----chHHHHHHHhccCCCCCCchh
Confidence            1    12346788999999998888999999999999999999999999754322    112222233322233334456


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                      +++++.+++.+||+.+|++|||+.++++||||+
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            889999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.3e-45  Score=339.87  Aligned_cols=259  Identities=27%  Similarity=0.461  Sum_probs=205.1

Q ss_pred             eeeeeccc--CCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           65 TIKVVGKG--SGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        65 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      ++++||+|  +||+||++.++.+|+.||+|.+.... .......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  67899999999999999999987653 2344567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC---
Q 018630          142 DGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---  216 (353)
Q Consensus       142 ~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~---  216 (353)
                      ++++|.+++...  ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.++++||+.+.........   
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            999999999653  458999999999999999999998 99999999999999999999999999865443221111   


Q ss_pred             ----CcccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH-------------
Q 018630          217 ----ANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME-------------  277 (353)
Q Consensus       217 ----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~-------------  277 (353)
                          .....++..|+|||++.+  ..++.++||||+||++|||++|..||........   ......             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCccccccccchh
Confidence                112356778999999976  3589999999999999999999999975432110   000000             


Q ss_pred             --HHhcCC-------------------------CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          278 --AIVDQP-------------------------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       278 --~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                        ......                         ........+++++.+|+.+||+.||++|||++|+++||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence              000000                         00001124577899999999999999999999999999998643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.9e-45  Score=333.80  Aligned_cols=271  Identities=38%  Similarity=0.699  Sum_probs=221.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .++|+..+.||+|+||.||++.+..+++.+|+|.+...........+.+|+.++.++. ||||+++++.+..++..+++|
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            3567788899999999999999999999999999876544456677889999998886 999999999999999999999


Q ss_pred             EecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          139 EYMDGGSLADFLK-----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       139 e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      ||+.. ++.++..     ....+++..+..++.|++.||+|||+..+++||||||+||+++.++.++|+|||++......
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            99964 7665432     23679999999999999999999997459999999999999999999999999998765432


Q ss_pred             CCCCcccccCCcccCcceecCC---CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC---
Q 018630          214 SGQANTFVGTYNYMSPERISGG---KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA---  287 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---  287 (353)
                      . ......|++.|+|||.+.+.   .++.++|+||+||++|+|++|..||...+      ...+..........+..   
T Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd06616         162 I-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKGDPPILSNS  234 (288)
T ss_pred             C-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCCCCCcCCCc
Confidence            2 22334688999999998776   68999999999999999999999997532      11222223322222221   


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhh
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFT  338 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~  338 (353)
                      ....+++++.+|+.+||+.||++|||++++++||||+.+...+....++.+
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~~~~~~~~~  285 (288)
T cd06616         235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAYVQ  285 (288)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcchhHHHHHH
Confidence            223588999999999999999999999999999999999988887776654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.8e-46  Score=336.16  Aligned_cols=265  Identities=37%  Similarity=0.624  Sum_probs=224.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +.|...+.||+|+||.||++.+..+++.||+|.+...........+.+|+.+++.++||||+++++.+..++..++|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45777889999999999999998889999999987654455567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++++|.+++.. ..+++..+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||++.............
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence            999999998865 578999999999999999999998 999999999999999999999999999987655433223335


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      .++..|+|||.+.+..++.++|+|||||++|||++|..||......       .....+..... ......++.++.+++
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~~~li  233 (277)
T cd06642         162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-------RVLFLIPKNSP-PTLEGQYSKPFKEFV  233 (277)
T ss_pred             cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-------hHHhhhhcCCC-CCCCcccCHHHHHHH
Confidence            6888999999999888999999999999999999999999754322       11222222222 223356788999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhH
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE  335 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~  335 (353)
                      .+||+.+|++|||+.++++||||+.+......+.+
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~  268 (277)
T cd06642         234 EACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTE  268 (277)
T ss_pred             HHHccCCcccCcCHHHHHHhHHHHHHhhhHHHHHH
Confidence            99999999999999999999999998877655543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.6e-45  Score=326.95  Aligned_cols=252  Identities=40%  Similarity=0.690  Sum_probs=215.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|++.+.||.|++|.||++.+..+++.+|+|.++....   ...+.+|+++++.++||||+++++.+..+..+|+++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            679999999999999999999998899999999875422   67889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          141 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       141 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      +.+++|.+++.. ...+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++............
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT  158 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence            999999999975 4578999999999999999999998 99999999999999999999999999998876544333344


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-CCCCCCCCCCHHHHH
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCS  298 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  298 (353)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+...       ....+.... .....+..++.++.+
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~  231 (256)
T cd06612         159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AIFMIPNKPPPTLSDPEKWSPEFND  231 (256)
T ss_pred             ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------hhhhhccCCCCCCCchhhcCHHHHH
Confidence            568889999999988889999999999999999999999997643321       111111111 111223457789999


Q ss_pred             HHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          299 FISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       299 li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ++.+||+.||++|||+.|++.||||
T Consensus       232 ~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         232 FVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.1e-45  Score=327.18  Aligned_cols=254  Identities=32%  Similarity=0.516  Sum_probs=211.1

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc----cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--cCeEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----EESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAIS  135 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~~~~  135 (353)
                      +|+..+.||+|+||.||++.+..++..||+|.+....    .......+.+|+.+++.++||||+++++.+..  ...++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            6888999999999999999999999999999886431    22344678899999999999999999998775  36789


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  214 (353)
                      +++||+++++|.+++.....+++..++.++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++....... 
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            999999999999999887889999999999999999999998 999999999999999999999999999987653211 


Q ss_pred             --CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          215 --GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       215 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                        .......++..|+|||.+.+..++.++|+||+||++|||++|..||...+..       ............+..+..+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~  234 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTNPQLPSHI  234 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcCCCCCCCchhc
Confidence              1122345788999999999888999999999999999999999999764321       1112222222222334567


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                      ++.+.+++ +||..+|++|||++|+++||||+
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            88899998 68889999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.1e-45  Score=330.66  Aligned_cols=254  Identities=35%  Similarity=0.646  Sum_probs=211.2

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEe------cC
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYS------NG  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~------~~  132 (353)
                      .+.|++.+.||.|+||.||++.+..+++.+|+|++...  ......+..|+.+++.+ +||||+++++.+..      ..
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   92 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD   92 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence            46899999999999999999999999999999998654  23345678888888887 79999999998853      46


Q ss_pred             eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      .++++|||+.+|+|.+++...  ..+++..+..++.|++.|+.|||+ .|++|+||+|+||+++.++.++|+|||++...
T Consensus        93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            789999999999999998753  458888999999999999999998 99999999999999999999999999998765


Q ss_pred             cccCCCCcccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018630          211 ASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  285 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  285 (353)
                      ...........|++.|+|||.+.     ...++.++|+|||||++|||++|..||....+.       .....+.....+
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------~~~~~~~~~~~~  244 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------RALFLIPRNPPP  244 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------hhhhhHhhCCCC
Confidence            43333344567899999999885     345888999999999999999999999764321       111122223333


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ......++.++.+||.+||+.||.+|||+.|+++||||
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            33445688999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.9e-45  Score=326.24  Aligned_cols=255  Identities=35%  Similarity=0.615  Sum_probs=215.7

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|++.+.||.|++|.||++....++..+|+|++...........+.+|+.+++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999998899999999987654444667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC-
Q 018630          141 MDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-  216 (353)
Q Consensus       141 ~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  216 (353)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+ .|++|+||+|+||++++++.++|+|||++......... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            9999999999764   458999999999999999999998 99999999999999999999999999998766543322 


Q ss_pred             ---CcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC----C
Q 018630          217 ---ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA----P  288 (353)
Q Consensus       217 ---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~  288 (353)
                         .....|+..|+|||.+... .++.++|+|||||++|+|++|..||...+...       ..........+..    .
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~  232 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQNDPPSLETGAD  232 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHhcCCCCCcCCccc
Confidence               1234688999999998776 68999999999999999999999997643321       1122222221111    1


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ...+++++.+++.+||+.||++|||+++++.||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            13678999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.9e-44  Score=322.54  Aligned_cols=253  Identities=32%  Similarity=0.531  Sum_probs=218.8

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|+.++.||.|+||.||.+++..+++.+++|.+... ........+.+|+.++++++|+||+++++.+.+++.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588999999999999999999999999999998654 2345566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          141 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       141 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      +++++|.+++...  ..+++..+..++.|++.|+.|||+ .|++|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            9999999999765  468999999999999999999998 9999999999999999999999999999876644433334


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ...+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.       .+....+....... ....++.++.+
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~  231 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKIVQGNYTP-VVSVYSSELIS  231 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCC-CccccCHHHHH
Confidence            56789999999999888889999999999999999999999976332       23333443333332 23667899999


Q ss_pred             HHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          299 FISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       299 li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ++.+||+.+|.+|||+.++++|||+
T Consensus       232 ~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         232 LVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHcccCcccCCCHHHHhhCcCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.4e-45  Score=342.38  Aligned_cols=257  Identities=25%  Similarity=0.349  Sum_probs=203.3

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ...+|++++.||+|+||.||++++..+++.||+|+....       ....|+.+++.++||||+++++.+...+..++|+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            445799999999999999999999999999999985432       2346888999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |++. ++|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||+++..... ...
T Consensus       137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~  213 (357)
T PHA03209        137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAF  213 (357)
T ss_pred             EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEecCccccccccC-ccc
Confidence            9996 588888765 4679999999999999999999998 99999999999999999999999999998753322 223


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCC-CCCCCCccC--Cchh----hHHHHHHHHhcCCC--C---
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ-FPYSPPEQQ--DGWT----SFYELMEAIVDQPP--P---  285 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~Pf~~~~~~--~~~~----~~~~~~~~~~~~~~--~---  285 (353)
                      ....||+.|+|||++.+..++.++|+|||||++|||+++. .+|......  ....    ..............  +   
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  293 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP  293 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence            3457899999999999989999999999999999999854 444432211  0000    00111111100000  0   


Q ss_pred             -----------------------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          286 -----------------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       286 -----------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                                             ......++.++.+||.+||+.||.+|||+.|+++||||+.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                   0011245677888999999999999999999999999985

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6e-45  Score=334.55  Aligned_cols=259  Identities=22%  Similarity=0.321  Sum_probs=205.8

Q ss_pred             CccCceeeeeecccCCeEEEEEEecc----------------CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKW----------------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV  122 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv  122 (353)
                      ..++|.+.+.||+|+||.||+|.+..                ++..||+|++...........+.+|+.++..++||||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            34789999999999999999997532                34479999988765566677899999999999999999


Q ss_pred             EEeeEeEecCeEEEEEEecCCCCHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCcee
Q 018630          123 VCYQSFYSNGAISIILEYMDGGSLADFLKKV-------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIH  183 (353)
Q Consensus       123 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH  183 (353)
                      ++++.+...+..++||||+++++|.+++...                   ..++...+..++.|++.||.|||+ .||+|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~ivH  161 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LNFVH  161 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence            9999999999999999999999999998653                   135778889999999999999998 99999


Q ss_pred             cCCCCCcEEEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc--CCCC
Q 018630          184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT--GQFP  259 (353)
Q Consensus       184 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~P  259 (353)
                      |||||+||+++.++.+||+|||+++.......  ......++..|+|||.+.++.++.++|+|||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999876533221  1122345788999999988889999999999999999986  6678


Q ss_pred             CCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       260 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      |...+..+............... .....+..++..+.+|+.+||+.||++|||+.++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQ-VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhcccc-ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            87644322111111111111111 111123467889999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-45  Score=329.27  Aligned_cols=263  Identities=35%  Similarity=0.632  Sum_probs=220.0

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC---CCceEEEeeEeEecCeEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ---CPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .|+..+.||+|+||.||++.+..+++.||+|.+..........++.+|+.+++.+.   |||++++++.+..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            47788999999999999999999999999999876545555667888999988886   999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||+++++|.++++. ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...........
T Consensus        82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06917          82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS  159 (277)
T ss_pred             ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence            99999999999876 478999999999999999999998 9999999999999999999999999999987654443344


Q ss_pred             ccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018630          219 TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  297 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ...|+..|+|||.+.++ .++.++|+|||||++|+|++|..||...+..       .....+.....+......++.++.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  232 (277)
T cd06917         160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RAMMLIPKSKPPRLEDNGYSKLLR  232 (277)
T ss_pred             cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hhhhccccCCCCCCCcccCCHHHH
Confidence            45789999999988754 4789999999999999999999999764321       111122222222233334788999


Q ss_pred             HHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCH
Q 018630          298 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  333 (353)
Q Consensus       298 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~  333 (353)
                      +++.+||+.||++|||+.+++.||||+.........
T Consensus       233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~~~~~  268 (277)
T cd06917         233 EFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSI  268 (277)
T ss_pred             HHHHHHcCCCcccCcCHHHHhhChHhhccccCchhh
Confidence            999999999999999999999999998766544433

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-44  Score=323.50  Aligned_cols=253  Identities=28%  Similarity=0.510  Sum_probs=216.7

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+... ........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588999999999999999999999999999998654 2334456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          141 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       141 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      +.+++|.+++...  ..+++..+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            9999999998764  357899999999999999999998 9999999999999999999999999999876544333233


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ...|++.|+|||.+.+..++.++|+||+||++++|++|..||...+.       .+....+.....+. .+..++.++.+
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~  231 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKIIRGSYPP-VSSHYSYDLRN  231 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHhcCCCCC-CcccCCHHHHH
Confidence            44688899999999888899999999999999999999999975322       23333443333322 34567899999


Q ss_pred             HHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          299 FISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       299 li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +|.+||+.+|++||++.+++.||||
T Consensus       232 li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         232 LVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHhhCChhhCcCHHHHhhCcCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-45  Score=335.18  Aligned_cols=258  Identities=26%  Similarity=0.460  Sum_probs=207.0

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|++.+.||+|++|.||+|+++.+|+.||+|.++... .......+.+|+.+++.++||||+++++.+.+...+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            5889999999999999999999999999999987542 222335677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          141 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       141 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      +.+ +|.+++.. ...+++..++.++.||+.||.|||+ +|++||||||+||+++.++.++|+|||++............
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            975 88888765 4679999999999999999999998 99999999999999999999999999998765433333344


Q ss_pred             cccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHH--------------hcCCC
Q 018630          220 FVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI--------------VDQPP  284 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~--------------~~~~~  284 (353)
                      ..+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.......  .....+....              .....
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            56789999999987654 7899999999999999999888864322111  0001110000              00000


Q ss_pred             C---------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          285 P---------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       285 ~---------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .         ......+++++.++|.+||+.||.+|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0         01113578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-47  Score=350.48  Aligned_cols=257  Identities=32%  Similarity=0.526  Sum_probs=226.4

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .|.-++.||.|+||.||-|++..+.+.||||.+..+  ........+.+|+..++++.|||++.+.++|..+...++|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            366678999999999999999999999999998655  234445789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||-| |-.|++.-. +++.+..+..|+.+.+.||.|||+ .+.||||||..|||+++.|.|||+|||.|....    ...
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----PAn  180 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA----PAN  180 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCCeeeeccccchhhcC----chh
Confidence            9975 999998754 689999999999999999999999 999999999999999999999999999886654    356


Q ss_pred             ccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          219 TFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      +++|||.|||||++..   +.|+-++||||||++..||...++|+.+.+.       ...+..|.....|.......|..
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSALYHIAQNesPtLqs~eWS~~  253 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPTLQSNEWSDY  253 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHHHHHHhcCCCCCCCchhHHH
Confidence            7899999999999854   6799999999999999999999999876433       34456667777777777788999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCc
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  331 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  331 (353)
                      +++|+..||++-|.+|||+++++.|+|+..-...++
T Consensus       254 F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tv  289 (948)
T KOG0577|consen  254 FRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTV  289 (948)
T ss_pred             HHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchH
Confidence            999999999999999999999999999998766554

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.4e-44  Score=327.56  Aligned_cols=264  Identities=36%  Similarity=0.589  Sum_probs=223.1

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      -|+..+.||.|+||.||++.+..+++.||+|++...........+.+|+.++..++||||+++++.+..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            46788899999999999999988999999999876544555678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccc
Q 018630          142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV  221 (353)
Q Consensus       142 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  221 (353)
                      ++++|.+++.. ..++...+..++.|++.|+.+||+ .|++|+||+|+||+++.++.++|+|||++..............
T Consensus        85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06641          85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence            99999999875 568999999999999999999998 9999999999999999999999999999876543332233456


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 018630          222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS  301 (353)
Q Consensus       222 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  301 (353)
                      ++..|+|||.+.+..++.++|+||+||++|+|++|..||.....       ......+..... ......++.++.+++.
T Consensus       163 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~~~~i~  234 (277)
T cd06641         163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------MKVLFLIPKNNP-PTLEGNYSKPLKEFVE  234 (277)
T ss_pred             CCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HHHHHHHhcCCC-CCCCcccCHHHHHHHH
Confidence            88899999999888889999999999999999999999975332       122222222222 2234567899999999


Q ss_pred             HhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhH
Q 018630          302 ACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE  335 (353)
Q Consensus       302 ~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~  335 (353)
                      +||+.+|.+||++.++++||||.........+.+
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~~~~~~~~~~~~~~~~  268 (277)
T cd06641         235 ACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTE  268 (277)
T ss_pred             HHccCChhhCcCHHHHHhCHHHhhhhhccchHHH
Confidence            9999999999999999999999988766544443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-44  Score=325.77  Aligned_cols=253  Identities=31%  Similarity=0.522  Sum_probs=213.9

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--------HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--------ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      +|.+...||.|++|.||+|.+..+++.+|+|.+.....        ......+.+|+.+++.++||||+++++.+..+..
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            36777899999999999999988899999998854311        1233568899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      .++|+||+++++|.+++...+.+++..+..++.|++.||.|||+ +|++||||+|+||++++++.++|+|||.++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            99999999999999999888889999999999999999999998 99999999999999999999999999998766422


Q ss_pred             CC------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          214 SG------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       214 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      ..      ......|+..|+|||.+.+..++.++|+||+||++|+|++|..||...+..       .....+.....+ .
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-~  231 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIFKIGENASP-E  231 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHHHHhccCCC-c
Confidence            11      112345788999999999888999999999999999999999999764321       122222222222 2


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .+..++..+.++|.+||+.||++||++.++++||||
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            345678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.5e-44  Score=325.00  Aligned_cols=254  Identities=29%  Similarity=0.529  Sum_probs=212.6

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-----cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      +|++.+.||.|+||.||++.+. +++.+|+|.+....     .......+.+|+.+++.++|+||+++++.+.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            4778899999999999999874 78899999886432     22334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--  214 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--  214 (353)
                      ++||+++++|.+++.+...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.......  
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            99999999999999887889999999999999999999998 999999999999999999999999999987643211  


Q ss_pred             ----CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          215 ----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       215 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                          .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+...      ............+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~  232 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------AMFYIGAHRGLMPRLPD  232 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH------HHHHhhhccCCCCCCCC
Confidence                11223468899999999998889999999999999999999999997643211      11111111122223345


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .++.++.++|.+||+.+|++|||+.++++||||
T Consensus       233 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         233 SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            689999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.6e-44  Score=330.56  Aligned_cols=259  Identities=32%  Similarity=0.512  Sum_probs=216.7

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+.....  ......+.+|+++++.++||||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            368999999999999999999999999999999875522  234467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC----
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----  214 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~----  214 (353)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||+++......    
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            999999999999888889999999999999999999998 999999999999999999999999999886321000    


Q ss_pred             -----------CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          215 -----------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       215 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                                 .......++..|+|||.+.+..++.++|+|||||++|||++|..||.+.+.       .+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~~~~~~~~~~  232 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQVISDD  232 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcc
Confidence                       001123578899999999888899999999999999999999999976432       23333333322


Q ss_pred             C-CCCCCCCCCHHHHHHHHHhhhhCcCCCCC---HHHHHcCCcccccC
Q 018630          284 P-PSAPSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMYG  327 (353)
Q Consensus       284 ~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~~  327 (353)
                      . .+.....+++++.++|.+||+.||++||+   +.++++||||...+
T Consensus       233 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         233 IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence            1 12222367899999999999999999998   79999999997654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.8e-44  Score=323.39  Aligned_cols=255  Identities=31%  Similarity=0.469  Sum_probs=212.3

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc----cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec--CeE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAI  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~--~~~  134 (353)
                      .+|++.+.||+|+||.||.+.+..+++.||+|.+....    .......+.+|+.+++.+.||||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57999999999999999999999999999999875431    223456788999999999999999999988753  578


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +++|||+++++|.+++.....+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            8999999999999999887789999999999999999999998 999999999999999999999999999987643211


Q ss_pred             ---CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          215 ---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       215 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                         .......++..|+|||++.+..++.++|+|||||++|+|++|..||...+.      .... ............+..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~-~~~~~~~~~~~~~~~  233 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAI-FKIATQPTNPVLPPH  233 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHH-HHHhcCCCCCCCchh
Confidence               112334688899999999888899999999999999999999999975422      1122 222222222333456


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                      ++..+.+++.+||. +|++|||++|+++|||+.
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            78889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-45  Score=351.51  Aligned_cols=257  Identities=21%  Similarity=0.297  Sum_probs=205.2

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ...|.+.+.||+|+||.||++.+..+++.||||....       ..+.+|+++++.++|+||+++++++..++..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            4579999999999999999999999999999996432       235689999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--C
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--Q  216 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~  216 (353)
                      ++. ++|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++.++|+|||+++.......  .
T Consensus       241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            996 5898888654 569999999999999999999998 9999999999999999999999999999976532211  1


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc----hhhHHHHHHHHhcC----------
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG----WTSFYELMEAIVDQ----------  282 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~~~~----------  282 (353)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..|+........    .......+......          
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            1235799999999999998999999999999999999998765533222111    11111111111000          


Q ss_pred             -------------CCCC------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          283 -------------PPPS------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       283 -------------~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                                   ..+.      .....+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                         0000      001135678999999999999999999999999999974

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=348.63  Aligned_cols=247  Identities=27%  Similarity=0.446  Sum_probs=215.0

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .|++.++...-++-||.|+.|.||+++.+  ++.||||.++..        -..+++-+++|+||||+.+.++|.....+
T Consensus       118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcy  187 (904)
T KOG4721|consen  118 LWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCY  187 (904)
T ss_pred             hccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence            45667777778899999999999999875  889999986522        23467889999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |||||||..|-|...|+....++......|..+|+.||.|||. +.|||||||.-||||+.+..|||+|||-++..... 
T Consensus       188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-  265 (904)
T KOG4721|consen  188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-  265 (904)
T ss_pred             EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence            9999999999999999999999999999999999999999999 88999999999999999999999999998876544 


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ....+++||..|||||++++.+.+.|+|||||||+||||+||..||.+.+..-       ++--+.........+..++.
T Consensus       266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------IIwGVGsNsL~LpvPstcP~  338 (904)
T KOG4721|consen  266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------IIWGVGSNSLHLPVPSTCPD  338 (904)
T ss_pred             hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-------eEEeccCCcccccCcccCch
Confidence            44567899999999999999999999999999999999999999998765421       11112222233344577899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .++-||++||+-.|..||++.+++.|
T Consensus       339 GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  339 GFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             HHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            99999999999999999999999998

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.2e-44  Score=327.86  Aligned_cols=259  Identities=34%  Similarity=0.625  Sum_probs=218.4

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      .|...+.||+|++|.||++.+..+++.+|+|.+... .......+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            455568999999999999999889999999988644 2334456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccc
Q 018630          142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV  221 (353)
Q Consensus       142 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  221 (353)
                      ++++|.+++.. .+++...+..++.|++.||+|||+ +|++||||+|+||+++.++.++|+|||.+..............
T Consensus        99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  176 (285)
T cd06648          99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV  176 (285)
T ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence            99999999987 678999999999999999999998 9999999999999999999999999998876543333333456


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHHH
Q 018630          222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSFI  300 (353)
Q Consensus       222 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li  300 (353)
                      |++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.       ......+.....+. .....++..+.+++
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIRDNLPPKLKNLHKVSPRLRSFL  249 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence            89999999999888899999999999999999999999976432       12223333332222 12234789999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      .+||+.+|++|||+.+++.||||+.+++..
T Consensus       250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         250 DRMLVRDPAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             HHHcccChhhCcCHHHHccCcccccCCCcc
Confidence            999999999999999999999999888643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.1e-45  Score=335.93  Aligned_cols=253  Identities=23%  Similarity=0.402  Sum_probs=194.3

Q ss_pred             eeeecccCCeEEEEEEec--cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--cCeEEEEEEec
Q 018630           66 IKVVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYM  141 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~  141 (353)
                      .+.||+|+||+||+|+++  .+++.||+|.+.....   ...+.+|+.+++.++||||+++++.+..  +...++++||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            357999999999999965  4678999999864421   2346789999999999999999998864  46789999999


Q ss_pred             CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE----cCCCcEEEeeccccc
Q 018630          142 DGGSLADFLKKV---------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSA  208 (353)
Q Consensus       142 ~~gsL~~~l~~~---------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll----~~~~~~kl~DfG~a~  208 (353)
                      .+ +|.+++...         ..+++..++.++.|++.||.|||+ +||+||||||+|||+    +.++.+||+|||+++
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            64 898887532         258999999999999999999998 999999999999999    456789999999997


Q ss_pred             cccccCC---CCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCch------hhHHHHHHH
Q 018630          209 IMASTSG---QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW------TSFYELMEA  278 (353)
Q Consensus       209 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~~~~~~~~  278 (353)
                      .......   ......||+.|+|||++.+. .++.++|+||+||++|+|++|.+||...+.....      .....+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            6543221   22345789999999998774 5899999999999999999999999754332110      000000000


Q ss_pred             ------------------------HhcCCCC--------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          279 ------------------------IVDQPPP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       279 ------------------------~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                                              .......        .......+.++.+||.+||+.||.+|||++|+++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                    0000000        00011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.5e-45  Score=329.77  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=214.7

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCC-----cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTG-----QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      +..++|++.+.||+|+||.||++.....+     +.||+|.+...........+.+|+.++..++||||+++++.+....
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            34578999999999999999999876554     6899999876655566678899999999999999999999999889


Q ss_pred             eEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC
Q 018630          133 AISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  196 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~  196 (353)
                      ..+++|||+++++|.+++...                ..++...+..++.|++.||.|||+ +|++||||||+||+++.+
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEcCC
Confidence            999999999999999999764                457888999999999999999998 999999999999999999


Q ss_pred             CcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHH
Q 018630          197 GEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY  273 (353)
Q Consensus       197 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~  273 (353)
                      +.++|+|||+++.......  ......+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+.+.       .
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-------~  233 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-------Q  233 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-------H
Confidence            9999999999876532221  1223456788999999988889999999999999999998 9999976433       2


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          274 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +....+.....+ ..+..+++++.+|+.+||+.||.+|||+.|++++
T Consensus       234 ~~~~~i~~~~~~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         234 EVIEMIRSRQLL-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCcC-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            334444444333 2346789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=370.76  Aligned_cols=266  Identities=28%  Similarity=0.508  Sum_probs=226.4

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .+..++|+++++||+|+||.|.+++++.+++.||+|++..-  .....-..|+.|-++|...+.+-|+.++-+|.++.++
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            45678999999999999999999999999999999998652  1223346789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc-c
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-T  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-~  213 (353)
                      |+|||||+||+|..++.+..+++++.++.++..++-||.-||+ .|+|||||||+|||+|..|++||+|||.+-.+.. .
T Consensus       151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence            9999999999999999998899999999999999999999998 9999999999999999999999999998877653 2


Q ss_pred             CCCCcccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CC
Q 018630          214 SGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PS  286 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  286 (353)
                      .-.....+|||.|.+||++..     +.|+..+|.||+||++|||+.|..||...+-       .+...+|.....  ..
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-------veTY~KIm~hk~~l~F  302 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-------VETYGKIMNHKESLSF  302 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-------HHHHHHHhchhhhcCC
Confidence            334455789999999999853     5689999999999999999999999987433       233333333211  11


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCC---HHHHHcCCcccccCCCCc
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMYGDLNV  331 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~~~~~~  331 (353)
                      +....+|.++++||+++++ +|+.|..   ++|+-+||||....+.++
T Consensus       303 P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~i  349 (1317)
T KOG0612|consen  303 PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNI  349 (1317)
T ss_pred             CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhh
Confidence            1234699999999999876 5889998   999999999999877443

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.4e-44  Score=328.31  Aligned_cols=255  Identities=35%  Similarity=0.567  Sum_probs=209.5

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEec-----Ce
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSN-----GA  133 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~-----~~  133 (353)
                      .++|.+.+.||+|+||.||++.+..+++.+|+|++....  .....+.+|+.+++.+ +|||++++++.+...     +.
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~   98 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ   98 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence            478999999999999999999999999999999986432  2235567888888888 799999999988753     46


Q ss_pred             EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          134 ISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      +++||||+++++|.++++.    ...+++..++.++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++..
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~~~kl~dfg~~~~  177 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence            8999999999999998863    3578999999999999999999998 9999999999999999999999999999876


Q ss_pred             ccccCCCCcccccCCcccCcceecCC-----CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018630          210 MASTSGQANTFVGTYNYMSPERISGG-----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  284 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  284 (353)
                      ............|+..|+|||.+...     .++.++|+||+||++|||++|..||...+..       .....+.....
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-------~~~~~~~~~~~  250 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------KTLFKIPRNPP  250 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-------HHHHHHhcCCC
Confidence            54333333345788999999987543     3688999999999999999999999764321       11122222222


Q ss_pred             C-CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          285 P-SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       285 ~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                      + ...+...+.++.++|.+||+.||++||++.++++||||+
T Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            1 122345678899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.7e-44  Score=325.32  Aligned_cols=253  Identities=21%  Similarity=0.279  Sum_probs=211.2

Q ss_pred             CCccCceeeeeecccCCeEEEEEEec---cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      +...+|++.+.||+|+||.||++..+   ..+..||+|.++..........+.+|+..++.++||||+++++.+..++..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            34578999999999999999999765   346689999988665555567789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      ++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++++|||.+......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999999764 578999999999999999999998 99999999999999999999999999987653222


Q ss_pred             CC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          214 SG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       214 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      .. ......++..|+|||.+.+..++.++||||+||++||+++ |..||...+.       ......+......+ .+..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~  232 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKAVEDGFRLP-APRN  232 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCCCCCC-CCCC
Confidence            11 1112345678999999998899999999999999999875 9999976432       23344444443332 3467


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ++..+.+++.+||+.+|++|||++++++
T Consensus       233 ~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         233 CPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            8999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.5e-45  Score=344.21  Aligned_cols=256  Identities=25%  Similarity=0.354  Sum_probs=208.8

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccC-----CcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY  129 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~  129 (353)
                      +.+..++|++.+.||+|+||.||++.+...     ++.||+|+++..........+.+|+.+++.+ +|+||+++++.+.
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            345567899999999999999999986443     3579999997665555567789999999998 8999999999999


Q ss_pred             ecCeEEEEEEecCCCCHHHHHHhc--------------------------------------------------------
Q 018630          130 SNGAISIILEYMDGGSLADFLKKV--------------------------------------------------------  153 (353)
Q Consensus       130 ~~~~~~lv~e~~~~gsL~~~l~~~--------------------------------------------------------  153 (353)
                      ..+..++||||+++|+|.+++...                                                        
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            999999999999999999998642                                                        


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC--C
Q 018630          154 --------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--A  217 (353)
Q Consensus       154 --------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~  217 (353)
                                    .++++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++........  .
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                          246788899999999999999998 99999999999999999999999999998765332211  1


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....+++.|+|||++.+..++.++|||||||++|||++ |..||.......      .....+. .......+...++++
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~l  344 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVK-RGYQMSRPDFAPPEI  344 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHH-cccCccCCCCCCHHH
Confidence            12234567999999988889999999999999999997 999997643221      1112222 222222335578999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHc
Q 018630          297 CSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+++.+||+.||.+|||+.++++
T Consensus       345 ~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         345 YSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.1e-45  Score=343.28  Aligned_cols=256  Identities=24%  Similarity=0.374  Sum_probs=208.1

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEe-----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQH-----KWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYS  130 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~  130 (353)
                      .+..++|++.+.||+|+||.||+|.+     ..++..||||+++..........+.+|+.++..+ +||||+++++.+..
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            44556899999999999999999974     3456789999987654445556788999999999 89999999999999


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhcC--------------------------------------------------------
Q 018630          131 NGAISIILEYMDGGSLADFLKKVK--------------------------------------------------------  154 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  154 (353)
                      .+..++||||+++|+|.+++....                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999999986421                                                        


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          155 -------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       155 -------------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                                         .+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++.......
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                               46788899999999999999998 9999999999999999999999999999976543221


Q ss_pred             C--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          216 Q--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       216 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      .  .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.......      .....+..... ...+...
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~-~~~~~~~  342 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYR-MLSPECA  342 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCcc-CCCCCCC
Confidence            1  112234567999999999899999999999999999998 899997643221      12222222222 2223456


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +.++.+|+.+||+.||++|||+.|+++.
T Consensus       343 ~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         343 PSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            8899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-45  Score=357.65  Aligned_cols=254  Identities=29%  Similarity=0.437  Sum_probs=222.7

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEecc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      .+...+.+..+.||+|+||+||+++...     ....||||.++...+...+.+|++|++++..++|||||++++++..+
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            4566788899999999999999998643     34589999999887777899999999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC
Q 018630          132 GAISIILEYMDGGSLADFLKKVK--------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG  197 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~--------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~  197 (353)
                      +.+|+|+|||..|+|.++|+...              +++..+...+|.||+.||.||-+ +.+|||||..+|+||+++-
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceeccce
Confidence            99999999999999999997531              28889999999999999999988 8999999999999999999


Q ss_pred             cEEEeeccccccccccCCCCc--ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHH
Q 018630          198 EVKITDFGVSAIMASTSGQAN--TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE  274 (353)
Q Consensus       198 ~~kl~DfG~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~  274 (353)
                      .|||+|||+++..-+..+...  ...-..+|||||.+..++|+.+|||||+||+|||+++ |..||.+.+       ..+
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-------n~E  713 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-------NQE  713 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-------hHH
Confidence            999999999987654433221  1234679999999999999999999999999999999 999998853       457


Q ss_pred             HHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          275 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +++.+..+...+ -+.++|.++++||..||+.+|.+||++.||=+
T Consensus       714 VIe~i~~g~lL~-~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  714 VIECIRAGQLLS-CPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             HHHHHHcCCccc-CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            788888877744 35789999999999999999999999999843

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.7e-44  Score=322.39  Aligned_cols=253  Identities=33%  Similarity=0.577  Sum_probs=216.5

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--cCeEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIIL  138 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~  138 (353)
                      +|++.+.||.|+||.||++.+..+++.||+|++... .......++.+|+++++.++||||+++++.+..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            588999999999999999999999999999998754 234456778899999999999999999997753  45789999


Q ss_pred             EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          139 EYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLH-----HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       139 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH-----~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||     + .+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            99999999999875    357899999999999999999999     7 8999999999999999999999999999987


Q ss_pred             ccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          210 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      ............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.       ......+..... ...+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~  231 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQLASKIKEGKF-RRIP  231 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHHHHHHhcCCC-CCCc
Confidence            65444323445789999999999988899999999999999999999999976432       233334444333 2334


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ..++.++.+++.+||+.+|++|||+.++++|||+
T Consensus       232 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            5788999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-44  Score=365.31  Aligned_cols=264  Identities=30%  Similarity=0.506  Sum_probs=216.6

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--cC
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NG  132 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~  132 (353)
                      .....++|++++.||.|+||.||+|++..++..||+|++... ........+..|+.+++.+.||||+++++.|..  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            345568999999999999999999999999999999998754 234456778999999999999999999998864  45


Q ss_pred             eEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhc------CCceecCCCCCcEEEcCC------
Q 018630          133 AISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHE------KHIIHRDLKPSNLLINHR------  196 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~------~~iiH~Dlkp~NIll~~~------  196 (353)
                      .+|+||||+++++|.+++...    ..+++..++.|+.||+.||.|||+.      .+|+||||||+||||+.+      
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            799999999999999998753    5799999999999999999999972      249999999999999642      


Q ss_pred             -----------CcEEEeeccccccccccCCCCcccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 018630          197 -----------GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPP  263 (353)
Q Consensus       197 -----------~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~  263 (353)
                                 +.+||+|||++....... .....+||+.|+|||++.+  ..++.++|||||||++|||++|..||...
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                       348999999997654322 2334579999999999864  45889999999999999999999999753


Q ss_pred             ccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      +.      ...++..+....  .......++++.+||.+||+.+|.+|||+.|+|.|||++....
T Consensus       247 ~~------~~qli~~lk~~p--~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        247 NN------FSQLISELKRGP--DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             Cc------HHHHHHHHhcCC--CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            22      223333333332  2223457899999999999999999999999999999986543

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3e-44  Score=321.23  Aligned_cols=250  Identities=32%  Similarity=0.513  Sum_probs=214.5

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      +|++.+.||.|+||.||++.+..+++.+|+|.++..........+.+|+.+++.++||||+++++.+..++.++++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            58899999999999999999999999999999876544556677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          142 DGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       142 ~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+............
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            999999988653  458999999999999999999998 99999999999999999999999999999776544433445


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (353)
                      ..|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+.       ......+...... ..+..++..+.++
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~~l  231 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLILKVCQGSYK-PLPSHYSYELRSL  231 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHHHHHhcCCCC-CCCcccCHHHHHH
Confidence            6789999999999888899999999999999999999999975322       2223333333322 2345678899999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcC
Q 018630          300 ISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      |.+||+.||++|||+.++++-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.4e-45  Score=333.78  Aligned_cols=262  Identities=26%  Similarity=0.465  Sum_probs=212.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ++|++.+.||+|+||.||++.++.+++.||+|.+..... ......+.+|+++++.++||||+++++.+..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            478999999999999999999998899999998765422 2345668889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      |+++++|.++......+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            99999998887766679999999999999999999998 99999999999999999999999999998765544433444


Q ss_pred             cccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH-------------HHhcCCC-
Q 018630          220 FVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME-------------AIVDQPP-  284 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~-------------~~~~~~~-  284 (353)
                      ..++..|+|||.+.+ ..++.++|+||+|+++|||++|.+||...+..+..........             .+..... 
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            578899999998865 3478899999999999999999999975432211111000000             0000000 


Q ss_pred             CC--------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          285 PS--------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       285 ~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +.        .....++..+.+|+.+||+.+|++|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            00        0123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.9e-44  Score=323.41  Aligned_cols=253  Identities=30%  Similarity=0.514  Sum_probs=214.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|++.+.||+|+||.||+++++.+++.||||.++..  ........+.+|+.+++.++||||+++++.+...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            6899999999999999999999999999999987643  23445567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          139 EYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       139 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            99999999988853    2458999999999999999999998 999999999999999999999999999987765433


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      .......+++.|+|||.+.+..++.++|+||+|+++|||++|..||.....     ........+.....++.....++.
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQKIEQCDYPPLPTEHYSE  235 (267)
T ss_pred             HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHHHhcCCCCCCChhhcCH
Confidence            333345788999999999888899999999999999999999999965432     112333444443344444456788


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+.+++.+||+.+|++|||++++++
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHH
Confidence            9999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.9e-44  Score=322.99  Aligned_cols=256  Identities=33%  Similarity=0.515  Sum_probs=209.5

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .+.......||+|+||.||++.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++.+..++..++|+|
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            344445568999999999999999889999999887553 3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-CCcEEEeeccccccccccCC
Q 018630          140 YMDGGSLADFLKKV-KTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l--~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |+++++|.+++... ..+  ++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++........
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            99999999999764 455  888899999999999999998 99999999999999976 67999999999876543333


Q ss_pred             CCcccccCCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          216 QANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ......|++.|+|||.+....  ++.++|+||+|+++|+|++|..||.......      ...............+..++
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ------AAMFKVGMFKIHPEIPESLS  238 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh------hhHhhhhhhccCCCCCcccC
Confidence            333456889999999986643  7899999999999999999999997532211      01111111111222345688


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +++.+++.+||+.+|.+|||+.|++.||||
T Consensus       239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3e-44  Score=321.19  Aligned_cols=253  Identities=35%  Similarity=0.545  Sum_probs=215.6

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc----cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +|+..+.||+|++|.||++.+..+++.||+|.+....    .......+.+|+.+++.++||||+++++.+..+..++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4667789999999999999998899999999986542    234557789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      +||+++++|.+++.+...+++..+..++.|++.|+.|||+ .|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccCccceeccccc-cc
Confidence            9999999999999888889999999999999999999998 999999999999999999999999999987654332 23


Q ss_pred             cccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....|+..|+|||.+.... ++.++|+||+||++|+|++|..||.....       ......+.........+..+++++
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  231 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPPIPDHLSDEA  231 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccCCCcCCCcCHHH
Confidence            4457889999999987766 89999999999999999999999976432       112222222122223345688999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .+++.+||+.+|++|||+.+++.|||+
T Consensus       232 ~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         232 KDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-45  Score=332.22  Aligned_cols=261  Identities=28%  Similarity=0.489  Sum_probs=207.7

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ..++|++.+.||+|++|.||++.++.+++.||+|.+...........+.+|+.+++.++||||+++++++..+...++||
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            35789999999999999999999998999999999875533333345678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      ||+.+ +|.+++... ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||+++.........
T Consensus        83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            99985 999988764 468999999999999999999998 999999999999999999999999999987543222222


Q ss_pred             cccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC--------------
Q 018630          218 NTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--------------  282 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--------------  282 (353)
                      ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.......  .............              
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            23356889999999875 458899999999999999999999997643110  0000000000000              


Q ss_pred             ---C----CCC---CCCCCCC--HHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          283 ---P----PPS---APSDQFS--PEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       283 ---~----~~~---~~~~~~~--~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                         .    .+.   .....++  .++.+++.+||+.||++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence               0    000   0001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=325.29  Aligned_cols=253  Identities=36%  Similarity=0.654  Sum_probs=210.4

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecC------e
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNG------A  133 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~------~  133 (353)
                      ++|++.+.||+|++|.||+|.++.+++.+|+|++.....  ....+.+|+.+++.+ .|+||+++++.+....      .
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            789999999999999999999998999999999875532  346788999999988 7999999999987644      4


Q ss_pred             EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          134 ISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      +++||||+++++|.+++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++..
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            8999999999999999865    3578999999999999999999998 9999999999999999999999999999876


Q ss_pred             ccccCCCCcccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018630          210 MASTSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  284 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  284 (353)
                      ............|+..|+|||.+..     ..++.++|+|||||++|+|++|..||...+..       .....+.....
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~  235 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------RALFKIPRNPP  235 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-------HHHHHhhccCC
Confidence            5443333445678999999998753     34678999999999999999999999753321       11222222222


Q ss_pred             CC-CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          285 PS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       285 ~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +. .....++.++.+||.+||..||++|||+.|+++|||+
T Consensus       236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            22 2223478899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.3e-44  Score=328.36  Aligned_cols=278  Identities=36%  Similarity=0.726  Sum_probs=226.8

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~  134 (353)
                      ..+..++|++.+.||+|++|.||++.+..+++.||||.++..........+.+|+.++... .||||+++++.+......
T Consensus        10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            3456789999999999999999999999889999999987654444455666677665555 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          135 SIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      |++|||+. ++|.+++.. ...+++..+..++.|++.||.|||+..|++||||+|+||+++.++.++|+|||++......
T Consensus        90 ~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          90 FICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99999996 488887765 4578999999999999999999997359999999999999999999999999998765432


Q ss_pred             CCCCcccccCCcccCcceecCCC----CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC-C
Q 018630          214 SGQANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA-P  288 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  288 (353)
                      .. .....++..|+|||.+.+..    ++.++|+||||+++|+|++|..||......      .+....+.....+.. .
T Consensus       169 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~  241 (296)
T cd06618         169 KA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEEPPSLPP  241 (296)
T ss_pred             Cc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCCCCCCCC
Confidence            22 22335788999999987553    788999999999999999999999653221      122333333332222 2


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhhC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAG  341 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~  341 (353)
                      ...++.++.+|+.+||+.||++|||+++++.||||+.++...-++..||.++.
T Consensus       242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~  294 (296)
T cd06618         242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVAGWFQDVM  294 (296)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHHHHHHHHHHHh
Confidence            23578999999999999999999999999999999999999999999987753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.2e-45  Score=333.24  Aligned_cols=260  Identities=34%  Similarity=0.620  Sum_probs=217.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +.|.....||+|+||.||++.+..+++.||||.+.... ......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            45566678999999999999999899999999986542 34456688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++++|.+++.. +.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++.............
T Consensus       101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            999999998865 568999999999999999999998 999999999999999999999999999987654333333446


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-CCCCCCCCHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSF  299 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  299 (353)
                      .|+..|+|||.+.+..++.++|+||+|+++|||++|..||...+..       .....+.....+ ......++..+.++
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l  251 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------QAMRRIRDNLPPRVKDSHKVSSVLRGF  251 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCccccccccCHHHHHH
Confidence            7899999999998888999999999999999999999999764321       111222221111 11223578899999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          300 ISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      +.+||..||++|||++++++||||+......
T Consensus       252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         252 LDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            9999999999999999999999999776554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=352.23  Aligned_cols=252  Identities=33%  Similarity=0.516  Sum_probs=222.6

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      -+||+|+||+||.++++.+....|||.+... ......-+.+|+.+.+.+.|.|||++++.+..++++-|.||-++||||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek-dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK-DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc-cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            3799999999999999999999999998755 334456789999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc-CCCcEEEeeccccccccccCCCCccccc
Q 018630          147 ADFLKKV-KTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVG  222 (353)
Q Consensus       147 ~~~l~~~-~~l--~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~g  222 (353)
                      .++++.. +++  .+..+..+..||+.||+|||. +.|||||||-+|+|++ -.|.+||+|||-++.+...+.-..++.|
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            9999865 777  888999999999999999998 9999999999999997 4789999999999999887777888999


Q ss_pred             CCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          223 TYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       223 t~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      |.-|||||++..++  |..++|||||||++.||.||++||.....      ....+-++...+..+..+..++.++++||
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs------pqAAMFkVGmyKvHP~iPeelsaeak~Fi  812 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS------PQAAMFKVGMYKVHPPIPEELSAEAKNFI  812 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC------hhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence            99999999997764  89999999999999999999999965321      12333344444445556788999999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      .+|+.+||.+||+|.++|..||++..
T Consensus       813 lrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  813 LRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHcCCCcccCccHHHhccCcccccC
Confidence            99999999999999999999999987

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=344.01  Aligned_cols=263  Identities=27%  Similarity=0.433  Sum_probs=225.2

Q ss_pred             CCCCCCCCCCCccCceeeeeecccCCeEEEEEEeccCCc---E-EEEEEeec--cccHHHHHHHHHHHHHHhcCCCCceE
Q 018630           49 PLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---F-FALKVIQM--NVEESARRQIAQELKINQSSQCPYVV  122 (353)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~hp~iv  122 (353)
                      ..+....|++..++..+.+.||+|+||.||+++.+..+.   . ||+|..+.  ......+.++.+|++++++++|||||
T Consensus       145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV  224 (474)
T KOG0194|consen  145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV  224 (474)
T ss_pred             ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence            345566788888999999999999999999998876433   3 89999875  35577789999999999999999999


Q ss_pred             EEeeEeEecCeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEE
Q 018630          123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI  201 (353)
Q Consensus       123 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  201 (353)
                      ++||+...+..+++|||+|+||+|.+++++.+ .++..+...++.+.++||+|||+ +++|||||..+|+|++.++.+||
T Consensus       225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCCeEEe
Confidence            99999999999999999999999999999876 49999999999999999999999 99999999999999999999999


Q ss_pred             eeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHh
Q 018630          202 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIV  280 (353)
Q Consensus       202 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~  280 (353)
                      +|||+++............--...|+|||.+..+.|+.++||||+||++||+++ |..||.+..       ..++...+.
T Consensus       304 SDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-------~~~v~~kI~  376 (474)
T KOG0194|consen  304 SDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK-------NYEVKAKIV  376 (474)
T ss_pred             CccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC-------HHHHHHHHH
Confidence            999998765311111111124578999999999999999999999999999999 888998753       346667775


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ....+...+...+.++..++.+||..||++|||+.++.+
T Consensus       377 ~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  377 KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            555445555688999999999999999999999999876

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.3e-44  Score=327.37  Aligned_cols=255  Identities=33%  Similarity=0.531  Sum_probs=208.3

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeE-----ecC
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY-----SNG  132 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~-----~~~  132 (353)
                      ..++|++.+.||+|+||.||++.+..+++.+|+|++....  .....+.+|+.+++.+ +||||+++++.+.     .++
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            4478999999999999999999999999999999876432  2235677888988888 6999999999874     346


Q ss_pred             eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          133 AISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      .+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~  172 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEGGVKLVDFGVSA  172 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCCCEEEccCCcee
Confidence            79999999999999998753    2568899999999999999999998 999999999999999999999999999987


Q ss_pred             cccccCCCCcccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          209 IMASTSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      .............|++.|+|||.+..     ..++.++|+||+||++|||++|..||...+...       .........
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-------~~~~~~~~~  245 (286)
T cd06638         173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-------ALFKIPRNP  245 (286)
T ss_pred             ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-------HHhhccccC
Confidence            66443333344578999999998753     447889999999999999999999997643211       111121221


Q ss_pred             C-CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          284 P-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       284 ~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      . ....+..++.++.++|.+||+.||++|||+.|+++|+||
T Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            1 112234467899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-44  Score=324.41  Aligned_cols=254  Identities=29%  Similarity=0.513  Sum_probs=218.3

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      +|++.+.||.|+||.||++.+..+++.||+|++....  .......+.+|++++++++||||+++++.+.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4889999999999999999999899999999987542  22456788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      |+.|++|.+++.....+++..+..++.|++.||.|||+ +|++|+||+|.||+++.++.++|+|||++....... ....
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccc
Confidence            99999999999887789999999999999999999998 999999999999999999999999999987654332 2334


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (353)
                      ..|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..    ...........  .....+...+.++.++
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~~~~~~~~~~~~~~~~  232 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--ADVLYPATWSTEAIDA  232 (258)
T ss_pred             cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--ccccCcccCcHHHHHH
Confidence            56888999999998888999999999999999999999999865432    11222222222  2223345678999999


Q ss_pred             HHHhhhhCcCCCCCH--HHHHcCCcc
Q 018630          300 ISACVQKEPQQRLSA--QELMTHPFL  323 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~--~e~l~hp~~  323 (353)
                      |.+||+.||.+||++  +|+++||||
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhcCCCC
Confidence            999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.9e-44  Score=329.95  Aligned_cols=264  Identities=25%  Similarity=0.401  Sum_probs=214.6

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc----HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE----ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +|++.+.||.|++|.||++.+..+++.||||.+.....    ......+..|+++++.++|+||+++++.+.+++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            47889999999999999999998999999999875532    22345677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          138 LEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      |||+ +++|.+++.... .+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence            9999 889999998765 79999999999999999999998 99999999999999999999999999999776544333


Q ss_pred             CcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-------------
Q 018630          217 ANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-------------  282 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------  282 (353)
                      .....+++.|+|||.+.+ ..++.++|+||+||++|||++|.+||...+..+   ............             
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhcccccc
Confidence            334467889999998865 457899999999999999999988887644321   111111111000             


Q ss_pred             -C-----C---CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          283 -P-----P---PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       283 -~-----~---~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                       .     .   ........+.++.++|.+||++||++|||+.|++.||||+.....+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence             0     0   0001134578899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.1e-44  Score=324.54  Aligned_cols=251  Identities=27%  Similarity=0.498  Sum_probs=202.8

Q ss_pred             eecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHH---HHHhcCCCCceEEEeeEeEecCeEEEEEEecC
Q 018630           68 VVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAISIILEYMD  142 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~---~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  142 (353)
                      .||+|+||.||++.+..+++.+|+|.+.....  ........+|.   .++...+||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999999999999998865421  11122223333   34445689999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccccc
Q 018630          143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  222 (353)
Q Consensus       143 ~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  222 (353)
                      +++|.+++...+.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.......  .....|
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVG  157 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcCC
Confidence            99999999888889999999999999999999998 999999999999999999999999999986543322  233478


Q ss_pred             CCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 018630          223 TYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS  301 (353)
Q Consensus       223 t~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  301 (353)
                      ++.|+|||.+.. ..++.++|+||+||++|+|++|..||.......    .... ...... .....+..+++++.++|.
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~-~~~~~~-~~~~~~~~~~~~~~~li~  231 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEI-DRMTLT-VNVELPDSFSPELKSLLE  231 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC----HHHH-HHHhhc-CCcCCccccCHHHHHHHH
Confidence            999999999864 458999999999999999999999997543321    1111 111111 122234568999999999


Q ss_pred             HhhhhCcCCCC-----CHHHHHcCCcccccC
Q 018630          302 ACVQKEPQQRL-----SAQELMTHPFLKMYG  327 (353)
Q Consensus       302 ~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  327 (353)
                      +||+.||.+||     |++++++||||+...
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            99999999999     699999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.1e-44  Score=325.68  Aligned_cols=259  Identities=27%  Similarity=0.410  Sum_probs=206.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++...........+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            68999999999999999999999999999999987553333344567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          141 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       141 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      +. ++|.+++.. ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.+++++|+|||+++...........
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence            96 578777654 3567888999999999999999998 99999999999999999999999999998765433333344


Q ss_pred             cccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh------------------
Q 018630          220 FVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV------------------  280 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~------------------  280 (353)
                      ..+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+...  ....+....+.                  
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            5678999999998764 47889999999999999999999997643210  11111100000                  


Q ss_pred             ---cCCCCCC-----CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          281 ---DQPPPSA-----PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       281 ---~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                         ....+..     .....++++.+++.+||+.||.+|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence               0000000     001236789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.4e-44  Score=328.99  Aligned_cols=258  Identities=31%  Similarity=0.586  Sum_probs=217.4

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            68999999999999999999998889999999986442 23346678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++++|.+++.+ ..++...+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||++.............
T Consensus        98 ~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~  175 (293)
T cd06647          98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (293)
T ss_pred             CCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccc
Confidence            999999999876 458899999999999999999998 999999999999999999999999999887655443333445


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      .+++.|+|||.+.+..++.++|+||+||++|++++|..||...+..+      ..........+....+..++..+.++|
T Consensus       176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (293)
T cd06647         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGTPELQNPEKLSAIFRDFL  249 (293)
T ss_pred             cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh------heeehhcCCCCCCCCccccCHHHHHHH
Confidence            78899999999988889999999999999999999999997643321      111111112222223445788999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      .+||..+|++||++.+++.||||+...
T Consensus       250 ~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         250 NRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-43  Score=318.90  Aligned_cols=255  Identities=34%  Similarity=0.602  Sum_probs=215.5

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|.+.+.||+|++|.||++.+..+++.||+|.++.... ......+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            58889999999999999999988999999999876633 34678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc--
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN--  218 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~--  218 (353)
                      +++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||++...........  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            9999999999887779999999999999999999998 9999999999999999999999999999877643332211  


Q ss_pred             --ccccCCcccCcceecCCC---CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC-CCCCCC
Q 018630          219 --TFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQF  292 (353)
Q Consensus       219 --~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  292 (353)
                        ...+++.|+|||.+.+..   ++.++|+||+|+++|++++|..||...+..  +    .....+.....+. .....+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~----~~~~~~~~~~~~~~~~~~~~  233 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--F----QIMFHVGAGHKPPIPDSLQL  233 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--H----HHHHHHhcCCCCCCCccccc
Confidence              246788999999998766   889999999999999999999999754321  1    1122222222221 222345


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ++.+.++|.+||+.+|++|||+.|++.|||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.7e-44  Score=330.04  Aligned_cols=263  Identities=24%  Similarity=0.409  Sum_probs=210.4

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEec--CeEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAIS  135 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~--~~~~  135 (353)
                      ..++|++.+.||+|+||.||++.++.+|+.||+|.++.... ......+.+|+.++++++|+||+++++.+...  +.++
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            35789999999999999999999999999999999875422 22233456799999999999999999988754  5689


Q ss_pred             EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +||||+.+ +|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            99999975 898888753 678999999999999999999998 999999999999999999999999999998765433


Q ss_pred             CCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-----------
Q 018630          215 GQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-----------  282 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-----------  282 (353)
                      .......+++.|+|||.+.+ ..++.++|+||+||++|||++|.+||...+..+...   .........           
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD---LIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCChhhchhhhcc
Confidence            33333456888999999865 457999999999999999999999998654322111   111110000           


Q ss_pred             ------CCCCC-------CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          283 ------PPPSA-------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       283 ------~~~~~-------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                            ..+..       .....++++.++|.+||+.||++|||+.|++.||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence                  00000       012358889999999999999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-44  Score=328.21  Aligned_cols=259  Identities=25%  Similarity=0.512  Sum_probs=213.0

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ++|++.+.||+|++|.||++.+..+++.||+|.++... .......+.+|+++++.++|+||+++++.+..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36999999999999999999999999999999886542 33445778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CCc
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QAN  218 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~  218 (353)
                      |++++.+..+......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            99987777766666779999999999999999999998 9999999999999999999999999999877654332 333


Q ss_pred             ccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc----------------
Q 018630          219 TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD----------------  281 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~----------------  281 (353)
                      ...++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+.   ..........                
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcccCcccc
Confidence            46788999999999887 789999999999999999999999976433211   1010000000                


Q ss_pred             C--CCC--------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          282 Q--PPP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       282 ~--~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .  .+.        ...+..+++++.+||.+||..+|++|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0  000        01122358899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.7e-44  Score=323.03  Aligned_cols=258  Identities=33%  Similarity=0.529  Sum_probs=210.4

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc---------HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---------ESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      +|...+.||.|++|.||++.+..+|+.+|+|.++....         ......+.+|+.+++.++|||++++++.+...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            57788999999999999999998999999998864311         112356788999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            999999999999999999888889999999999999999999998 9999999999999999999999999999876432


Q ss_pred             cCC--CCcccccCCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          213 TSG--QANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       213 ~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      ...  ......|+..|+|||.+....  ++.++|+||||+++|++++|..||...+...   ...+..........+...
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA---AMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH---HHHHhhccccCCcCCccc
Confidence            211  122346788999999987654  7899999999999999999999996532211   111111011111111222


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ...++.++.++|.+||+.||++|||++++++||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            23568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-46  Score=335.04  Aligned_cols=266  Identities=28%  Similarity=0.464  Sum_probs=225.9

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      +....|...++||+|+||.|+-++.+.+|+.+|+|.+...  .......-.+.|..++...+.+.||.+--+|+....+|
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            4456788899999999999999999999999999987433  12233445678889999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          136 IILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+..|.||+|.-+|.+.+  .+++..+..++.+|+.||++||+ .+||.|||||+|||+|+.|+++|+|+|+|..+...
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            9999999999998887665  79999999999999999999998 99999999999999999999999999999876543


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                       ......+||.+|||||++.+..|+...|.|||||++|||+.|+.||........+   .++-+.+....  ...+..+|
T Consensus       341 -~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~~~~--~ey~~kFS  414 (591)
T KOG0986|consen  341 -KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTLEDP--EEYSDKFS  414 (591)
T ss_pred             -CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHhcch--hhcccccC
Confidence             3455569999999999999999999999999999999999999999775443322   23333333322  23447899


Q ss_pred             HHHHHHHHHhhhhCcCCCC-----CHHHHHcCCcccccCCCC
Q 018630          294 PEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~~~  330 (353)
                      ++++++.+.+|++||++|.     +++++-+||||+.....+
T Consensus       415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence            9999999999999999998     567999999999865444

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3e-44  Score=326.37  Aligned_cols=258  Identities=29%  Similarity=0.502  Sum_probs=210.7

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|++.+.||.|++|.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+..+..+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5889999999999999999999899999999987653 234456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CCc
Q 018630          141 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QAN  218 (353)
Q Consensus       141 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~  218 (353)
                      + +++|.+++.. ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            9 8999999865 3668999999999999999999998 9999999999999999999999999999876643321 123


Q ss_pred             ccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC---------------
Q 018630          219 TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ---------------  282 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------  282 (353)
                      ...++..|+|||.+.+. .++.++||||+||++|||++|.+||........   ...........               
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcchhh
Confidence            45789999999998654 468999999999999999999888865433211   11111111000               


Q ss_pred             --CCC-------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          283 --PPP-------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       283 --~~~-------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                        ..+       .......+.++.++|.+||+.||++|||++++++||||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence              000       001134578999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-45  Score=340.80  Aligned_cols=254  Identities=23%  Similarity=0.376  Sum_probs=213.3

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      .++.+..++..+...||+|+||+||++++..   .||||++... ...+..+.|+.|+..+++-+|.||+-+.+++..++
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            3456677888899999999999999998853   5999999866 34456788999999999999999999999998877


Q ss_pred             eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      . .||+.||+|-+|+.+++.. ..+.....+.|++|++.||.|||. ++|||||||..||++.++++|||+|||++....
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            7 9999999999999999753 578999999999999999999998 999999999999999999999999999997643


Q ss_pred             c--cCCCCcccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC---C
Q 018630          212 S--TSGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ---P  283 (353)
Q Consensus       212 ~--~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---~  283 (353)
                      .  .........|...|||||+++.   .+|+..+|||||||++|||++|..||.....       ..++-.+..+   +
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-------dqIifmVGrG~l~p  612 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-------DQIIFMVGRGYLMP  612 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-------hheEEEecccccCc
Confidence            2  2223445678899999999965   4689999999999999999999999984322       1223333333   2


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .......+++.++++|+..||.+++++||++.+++.
T Consensus       613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            233445677889999999999999999999999987

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.3e-44  Score=325.29  Aligned_cols=257  Identities=26%  Similarity=0.492  Sum_probs=208.6

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|+.++.||.|++|.||+|++..+++.||||.++... .......+.+|+++++.++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4889999999999999999999999999999886542 222345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          141 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       141 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      +. ++|.+++...  ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            96 5899988653  568999999999999999999998 9999999999999999999999999999876543333333


Q ss_pred             ccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC---------------
Q 018630          219 TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ---------------  282 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------  282 (353)
                      ...+++.|+|||.+.+.. ++.++|+|||||++|+|+||..||...+..+   ............               
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            446788999999887654 6889999999999999999999997654321   111111110000               


Q ss_pred             ------CCC--CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          283 ------PPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       283 ------~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                            ...  ......+++++.++|.+||+.||.+|||+++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                  000  00113468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.4e-44  Score=326.86  Aligned_cols=260  Identities=26%  Similarity=0.477  Sum_probs=210.6

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      +|++.+.||.|++|.||++.+..+|+.||||+++..........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            58899999999999999999999999999999876544444566778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          142 DGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       142 ~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ++ +|.+++...   ..+++..+..++.|++.||.|||+ .|++||||+|+||++++++.++|+|||++...........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence            85 899888654   358999999999999999999998 9999999999999999999999999999876543333333


Q ss_pred             ccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH--------HHHHhcCC-----C
Q 018630          219 TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--------MEAIVDQP-----P  284 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~-----~  284 (353)
                      ...+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+..+......+.        ...+....     .
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF  238 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence            45678899999988664 5789999999999999999999999876543221111110        00000000     0


Q ss_pred             CC-------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          285 PS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       285 ~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +.       ......++++.+++.+||+.||.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            00       0012457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-43  Score=316.26  Aligned_cols=252  Identities=33%  Similarity=0.560  Sum_probs=213.6

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|+..+.||+|++|.||++.+..+++.+|+|.+... ........+.+|+.+++.++|||++++++.+...+.+++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588999999999999999999999999999998654 2334567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCCCC
Q 018630          141 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       141 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~  217 (353)
                      +++++|.+++...  ..+++..+..++.|++.|++|||+ +|++|+||+|+||+++.++ .++|+|||.+....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~  158 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KA  158 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-cc
Confidence            9999999999764  358999999999999999999998 9999999999999998654 68999999997664332 22


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  297 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..       .....+...... ..+..+++++.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~l~  230 (256)
T cd08220         159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-------ALVLKIMSGTFA-PISDRYSPDLR  230 (256)
T ss_pred             cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-------HHHHHHHhcCCC-CCCCCcCHHHH
Confidence            3356889999999998888899999999999999999999999764321       222233322222 23356889999


Q ss_pred             HHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          298 SFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       298 ~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +++.+||+.||++|||+.|+++||||
T Consensus       231 ~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         231 QLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.8e-44  Score=337.10  Aligned_cols=264  Identities=25%  Similarity=0.447  Sum_probs=210.9

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------C
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~  132 (353)
                      .++|+..+.||+|+||.||++.+..+++.||+|.+... ........+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            47899999999999999999999999999999998643 2334456677899999999999999999987643      3


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ..|+||||+.+ +|.+.+...  ++...+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++....
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            57999999975 898888653  8999999999999999999998 9999999999999999999999999999976543


Q ss_pred             cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH---------------HHH
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------LME  277 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---------------~~~  277 (353)
                      .. ......+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+..+.+.....               ...
T Consensus       171 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         171 SF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            22 23345688999999999998999999999999999999999999976543221111100               000


Q ss_pred             HHhcCCCC-------------------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          278 AIVDQPPP-------------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       278 ~~~~~~~~-------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      ........                   .......++++.++|.+||+.||++|||+.|++.||||+.+-+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence            00000000                   0001234667899999999999999999999999999986554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5e-44  Score=324.03  Aligned_cols=252  Identities=30%  Similarity=0.494  Sum_probs=210.4

Q ss_pred             ecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           69 VGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      ||+|+||+||+|.+..+|+.||+|.+....  .......+.+|+++++.++||||+++++.+...+.+|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999999999999999986542  223345567899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCC
Q 018630          147 ADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  224 (353)
Q Consensus       147 ~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  224 (353)
                      .+++....  .+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++..... ........++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCCC
Confidence            99997765  78999999999999999999998 9999999999999999999999999999876543 22233456788


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018630          225 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  304 (353)
Q Consensus       225 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  304 (353)
                      .|+|||.+.+..++.++|+||+||++|+|++|..||...+...   ....+.......  +...+..+++.+.++|.+||
T Consensus       159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l  233 (277)
T cd05577         159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV---EKEELKRRTLEM--AVEYPDKFSPEAKDLCEALL  233 (277)
T ss_pred             CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc---cHHHHHhccccc--cccCCccCCHHHHHHHHHHc
Confidence            9999999988889999999999999999999999997654321   111222222211  22234567999999999999


Q ss_pred             hhCcCCCC-----CHHHHHcCCcccccC
Q 018630          305 QKEPQQRL-----SAQELMTHPFLKMYG  327 (353)
Q Consensus       305 ~~dp~~Rp-----t~~e~l~hp~~~~~~  327 (353)
                      +.||.+||     ++.++++||||....
T Consensus       234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         234 QKDPEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             cCChhHccCCCcccHHHHHhChhhhcCC
Confidence            99999999     888999999998644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.2e-44  Score=328.04  Aligned_cols=257  Identities=34%  Similarity=0.635  Sum_probs=215.8

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      .|+....||+|+||.||++.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+..++..++|+||+
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            45555689999999999999998999999999865432 33466889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccc
Q 018630          142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV  221 (353)
Q Consensus       142 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  221 (353)
                      ++++|.+++.. ..+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++..............
T Consensus       101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence            99999997765 568999999999999999999998 9999999999999999999999999999876544333344567


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-CCCCCCCCCCHHHHHHH
Q 018630          222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       222 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  300 (353)
                      |+..|+|||.+.+..++.++|+||+||++|||++|..||...+..       +....+.... ........+++.+.++|
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~i  251 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAMKRLRDSPPPKLKNAHKISPVLRDFL  251 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhccCCCCccccCCCCHHHHHHH
Confidence            899999999998888999999999999999999999999754321       1222222221 11222346788999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      .+||+.+|++|||++++++||||....-
T Consensus       252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         252 ERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            9999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.4e-43  Score=322.96  Aligned_cols=261  Identities=23%  Similarity=0.379  Sum_probs=212.4

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEecc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      .+..++|++.+.||+|+||.||++.++.     .+..||+|.+...........+.+|+.+++.++||||+++++.+...
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4566899999999999999999987652     34589999987554444556678899999999999999999999988


Q ss_pred             CeEEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEE
Q 018630          132 GAISIILEYMDGGSLADFLKKV----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI  201 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  201 (353)
                      ...++||||+++|+|.+++...          ..++...+..++.|++.||.|||+ ++++||||||+||+++.++.++|
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999999753          234567888999999999999998 99999999999999999999999


Q ss_pred             eeccccccccccCCCC--cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHH
Q 018630          202 TDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA  278 (353)
Q Consensus       202 ~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~  278 (353)
                      +|||+++.........  ....++..|+|||.+.++.++.++|+|||||++|||++ |..||...+.       .+....
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~~~~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLKF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHH
Confidence            9999987653322111  12245678999999998889999999999999999998 7889976432       223333


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc------CCccccc
Q 018630          279 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT------HPFLKMY  326 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~------hp~~~~~  326 (353)
                      +....... .+...++.+.+++.+||+.||++|||+.++++      ||||+..
T Consensus       234 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         234 VMDGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             HHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            33332222 23466899999999999999999999999987      8888754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.7e-44  Score=326.89  Aligned_cols=263  Identities=24%  Similarity=0.448  Sum_probs=211.0

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ++|++.+.||+|++|.||++.++.+|+.||+|.+..... ......+.+|+++++.++||||+++++.+.....+++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            679999999999999999999999999999999865422 2334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-CCcEEEeeccccccccccCCC
Q 018630          140 YMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      |++ ++|.+++....  .+++..+..++.||+.||+|||+ ++++|+||+|+||+++. ++.+||+|||++.........
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence            996 48888876543  35788899999999999999998 99999999999999985 557999999999765433322


Q ss_pred             CcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-------------
Q 018630          217 ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-------------  282 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------  282 (353)
                      .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...++.+.   ..+........             
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhccccccchh
Confidence            3345678899999988764 578999999999999999999999976543221   11111111000             


Q ss_pred             ----CC--CC----CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          283 ----PP--PS----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       283 ----~~--~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                          .+  +.    .....+++++.+++.+||+.||++||++.+++.||||+.+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence                00  00    012356889999999999999999999999999999998765

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-43  Score=322.88  Aligned_cols=260  Identities=35%  Similarity=0.634  Sum_probs=220.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .+.|+..+.||+|++|.||++.+..+++.||+|++.....  ....+.+|+++++.++|+|++++++.+..+...++|+|
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3568888999999999999999998899999999876533  45678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          140 YMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      |+++++|.+++.... .++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...........
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence            999999999998876 89999999999999999999998 9999999999999999999999999998876543333333


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFC  297 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  297 (353)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..       .....+..... .......++.++.
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~  247 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RALFLITTKGIPPLKNPEKWSPEFK  247 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCCCcchhhCCHHHH
Confidence            446788999999998888999999999999999999999999754321       11222222222 2222334789999


Q ss_pred             HHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          298 SFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       298 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      ++|.+||+.+|.+|||+.+++.||||+..+..
T Consensus       248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  279 (286)
T cd06614         248 DFLNKCLVKDPEKRPSAEELLQHPFLKKACPK  279 (286)
T ss_pred             HHHHHHhccChhhCcCHHHHhhChHhhccCch
Confidence            99999999999999999999999999985543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8e-44  Score=320.54  Aligned_cols=253  Identities=32%  Similarity=0.543  Sum_probs=214.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|.+.+.||+|++|.||++.+..+++.+|||.+...  ........+.+|+.+++.++||||+++++.+..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            5788999999999999999999989999999987643  23344567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          139 EYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       139 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            99999999998864    3468999999999999999999998 999999999999999999999999999987665443


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      .......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.....     ........+.....+......+++
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPSDHYSE  235 (267)
T ss_pred             cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhhhcCCCCCCCcccccH
Confidence            333445789999999999888899999999999999999999999965432     122333333333334444456889


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ++.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.9e-45  Score=340.37  Aligned_cols=264  Identities=28%  Similarity=0.464  Sum_probs=233.8

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..+.....|.+.+.||+|.|+.|.++++..++..||||.+.+. .+...+..+.+|++++..++|||||+++++...+..
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            4455668899999999999999999999999999999999766 344455669999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+||||+.+|.+++++.+.++..+..+..++.|++.|++|||+ ++|+|||||++|||++.+-++||+|||++..+. .
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~  207 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENMNIKIADFGFSTFFD-Y  207 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhcccccccceeeeccccceeec-c
Confidence            99999999999999999999999999999999999999999998 999999999999999999999999999998876 4


Q ss_pred             CCCCcccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      +....+.||++.|.|||++.+..| .+.+|+||+|+++|-|++|..||.+.+-       .++.+....+..  ..+..+
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------k~Lr~rvl~gk~--rIp~~m  278 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------KELRPRVLRGKY--RIPFYM  278 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------ccccchheeeee--ccccee
Confidence            556778899999999999999887 5799999999999999999999987432       233333333332  234567


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      +.++.++|+++|-.+|.+|++.+++..|.|.....+.
T Consensus       279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             echhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            8899999999999999999999999999999877665

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.9e-44  Score=327.24  Aligned_cols=259  Identities=25%  Similarity=0.443  Sum_probs=209.8

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH-HHHHHHHHHHHHHhcCCCCceEEEeeEeEec--CeEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-SARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISI  136 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~--~~~~l  136 (353)
                      .++|++.+.||.|++|.||+|.++.+++.+|+|.++..... .....+.+|+.+++.+.||||+++++++...  +..|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            36899999999999999999999999999999998755322 2234567899999999999999999998877  89999


Q ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          137 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |+||+.+ +|.+++... ..+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++.++|+|||++........
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            9999975 999988764 458999999999999999999998 9999999999999999999999999999987654433


Q ss_pred             CCcccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh-----------c--
Q 018630          216 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV-----------D--  281 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~-----------~--  281 (353)
                      ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||......+.   ...+.....           .  
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHHHhhccc
Confidence            334456788999999987644 68999999999999999999999976543211   111111000           0  


Q ss_pred             ----CC--------CCCCCCCC-CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          282 ----QP--------PPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       282 ----~~--------~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                          ..        .....+.. +++.+.++|.+||+.||++|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                00        00011111 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.2e-44  Score=329.93  Aligned_cols=252  Identities=23%  Similarity=0.411  Sum_probs=193.0

Q ss_pred             eeecccCCeEEEEEEecc--CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--cCeEEEEEEecC
Q 018630           67 KVVGKGSGGIVQLVQHKW--TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMD  142 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~  142 (353)
                      ..||+|+||.||+|+++.  ++..||+|.+....   ....+.+|+.+++.++||||+++++++..  +..+++|+||+.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            579999999999999653  56789999886542   22356789999999999999999998853  567899999997


Q ss_pred             CCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE----cCCCcEEEeecccccc
Q 018630          143 GGSLADFLKKV---------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAI  209 (353)
Q Consensus       143 ~gsL~~~l~~~---------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll----~~~~~~kl~DfG~a~~  209 (353)
                      + +|.+++...         ..+++..+..++.|++.||.|||+ .|++||||||+||++    +.++.+||+|||+++.
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            5 888877532         258899999999999999999998 999999999999999    4567899999999976


Q ss_pred             ccccCC---CCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchh------hHHHHHHH-
Q 018630          210 MASTSG---QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT------SFYELMEA-  278 (353)
Q Consensus       210 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------~~~~~~~~-  278 (353)
                      ......   ......||+.|+|||.+.+. .++.++||||+||++|||++|.+||...+......      ........ 
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            543221   22345789999999998764 58999999999999999999999997543321100      00000000 


Q ss_pred             -----------------------HhcCCC--------CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          279 -----------------------IVDQPP--------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       279 -----------------------~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                                             ......        ........+..+.+|+.+||+.||.+|||++|+++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                                   000000        000112345678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-43  Score=321.48  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=207.7

Q ss_pred             CCccCceeeeeecccCCeEEEEEEecc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      +..++|++.+.||+|+||.||++.++.     ++..||+|.+..........++.+|+.+++.++||||+++++.+..++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            455789999999999999999998642     356899999865444445567889999999999999999999999899


Q ss_pred             eEEEEEEecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEe
Q 018630          133 AISIILEYMDGGSLADFLKKVK----------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT  202 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~  202 (353)
                      ..++||||+++++|.+++....          .++...+..++.|++.||.|||+ .|++||||||+||+++.++.++|+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCCCEEEC
Confidence            9999999999999999987532          35677889999999999999998 999999999999999999999999


Q ss_pred             eccccccccccCCCC--cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHH
Q 018630          203 DFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI  279 (353)
Q Consensus       203 DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~  279 (353)
                      |||+++.........  ....+++.|+|||.+.+..++.++|+|||||++|||++ |..||...+.       .+....+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~~~~~~  234 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLRFV  234 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHH
Confidence            999987543222111  12345778999999998889999999999999999999 7899976432       1222333


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          280 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .....+ ..+..++..+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         235 MEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333222 2345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1e-43  Score=324.63  Aligned_cols=259  Identities=25%  Similarity=0.454  Sum_probs=206.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCe-----
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGA-----  133 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~-----  133 (353)
                      ++|++.+.||+|+||.||++.+..+++.||+|.++.... ......+.+|+.+++.+. ||||+++++.+.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            468999999999999999999999999999998765422 223356788999999985 6999999998876655     


Q ss_pred             EEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-CCcEEEeecccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVS  207 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a  207 (353)
                      .|+||||+++ +|.+++...     ..+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence            8999999986 898887643     357999999999999999999998 99999999999999998 889999999998


Q ss_pred             ccccccCCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC---
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP---  283 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---  283 (353)
                      ..............+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+...   ........+....   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~  235 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ---QLLHIFKLLGTPTEQV  235 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHhCCCChhh
Confidence            765433333333467889999998865 457999999999999999999999997643321   1111111110000   


Q ss_pred             ----------------C---CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          284 ----------------P---PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       284 ----------------~---~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                                      .   .......+++++.+||.+||..||.+|||+.|++.||||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                            0   0001135788999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.8e-43  Score=318.90  Aligned_cols=248  Identities=27%  Similarity=0.481  Sum_probs=201.8

Q ss_pred             cCceeeeee--cccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHh-cCCCCceEEEeeEeEecCeEEEE
Q 018630           61 EDIDTIKVV--GKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        61 ~~~~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      ++|++.+.+  |+|+||.||++.++.++..+|+|.+........      |+.... ..+||||+++++.+..++.+++|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            456666555  999999999999999999999999865421111      111111 12799999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~  216 (353)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++ .++|+|||++......   
T Consensus        88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---  163 (267)
T PHA03390         88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---  163 (267)
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence            9999999999999887789999999999999999999998 9999999999999999988 9999999998765322   


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                       ....++..|+|||++.+..++.++|+||+|+++|+|++|..||......+  .......... .  ........+++.+
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~-~--~~~~~~~~~~~~~  237 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ-Q--KKLPFIKNVSKNA  237 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh-c--ccCCcccccCHHH
Confidence             23468899999999998889999999999999999999999998543322  1111222222 1  1112234689999


Q ss_pred             HHHHHHhhhhCcCCCCC-HHHHHcCCccc
Q 018630          297 CSFISACVQKEPQQRLS-AQELMTHPFLK  324 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt-~~e~l~hp~~~  324 (353)
                      .++|.+||+.||.+||+ ++++++||||+
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            99999999999999996 59999999996

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4e-43  Score=313.20  Aligned_cols=255  Identities=35%  Similarity=0.612  Sum_probs=219.5

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEec--CeEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIIL  138 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~  138 (353)
                      +|...+.||+|++|.||++.+..+++.|++|++..... ......+.+|+.++++++||||+++++.+...  ..+++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            47788999999999999999998999999999875532 34567889999999999999999999999988  8999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--C
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--Q  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~  216 (353)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            999999999999887789999999999999999999998 9999999999999999999999999999877654432  1


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .....++..|+|||.+....++.++|+||||+++|+|++|..||...+      ........+.........+...++++
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGEPPEIPEHLSEEA  233 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCCCcCCCcccCHHH
Confidence            334578899999999988889999999999999999999999997654      11222233333233334456679999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .+++.+||+.||++||++.|++.||||
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         234 KDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.1e-43  Score=320.91  Aligned_cols=254  Identities=25%  Similarity=0.388  Sum_probs=210.8

Q ss_pred             CCccCceeeeeecccCCeEEEEEEec----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHK----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      +.+++|++.+.||+|+||.||++...    .++..+|+|.+...........+.+|+.+++.++||||+++++.+..+..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            35578999999999999999999853    45678999998765555556778899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC
Q 018630          134 ISIILEYMDGGSLADFLKKV-----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  196 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~  196 (353)
                      .++||||+.+++|.+++...                 ..+++..+..++.|++.||.|||+ +|++||||||+||+++.+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~~~  160 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEcCC
Confidence            99999999999999998532                 247888899999999999999998 999999999999999999


Q ss_pred             CcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHH
Q 018630          197 GEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY  273 (353)
Q Consensus       197 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~  273 (353)
                      +.+||+|||+++.......  ......++..|+|||.+.+..++.++|+|||||++|||++ |..||...+.       .
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~  233 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------Q  233 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------H
Confidence            9999999999976532221  1223345678999999988889999999999999999998 9999976322       2


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          274 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ...+.+...... ..+..+++++.+++.+||+.||.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         234 EVIEMVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            333333333322 2346789999999999999999999999999774

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-43  Score=316.98  Aligned_cols=249  Identities=35%  Similarity=0.592  Sum_probs=204.8

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHH-HhcCCCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~-~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||.|++|.||+|.+..+++.||+|+++....  ......+..|..+ ....+|||++++++.+...+.+|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            568999999999999999999999999865421  2222334444443 4556899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccC
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  223 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  223 (353)
                      ++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|.||+++.++.++|+|||++.....    .....++
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~  156 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGT  156 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCC
Confidence            9999999888889999999999999999999998 9999999999999999999999999998865432    2334688


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHH
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFIS  301 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~  301 (353)
                      ..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..       .....+....  .+......+++++.+++.
T Consensus       157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  229 (260)
T cd05611         157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRINWPEEVKEFCSPEAVDLIN  229 (260)
T ss_pred             cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcccCCCCcccccCCHHHHHHHH
Confidence            8999999998888899999999999999999999999764321       2222222221  122233467899999999


Q ss_pred             HhhhhCcCCCCCH---HHHHcCCcccccC
Q 018630          302 ACVQKEPQQRLSA---QELMTHPFLKMYG  327 (353)
Q Consensus       302 ~~L~~dp~~Rpt~---~e~l~hp~~~~~~  327 (353)
                      +||+.||++|||+   +|+++||||+...
T Consensus       230 ~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         230 RLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence            9999999999954   7999999998643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8e-44  Score=331.93  Aligned_cols=269  Identities=23%  Similarity=0.384  Sum_probs=215.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec-----CeE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAI  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~-----~~~  134 (353)
                      .+|.+.+.||+|+||+||++.+..+++.||||.+.... .......+.+|+.+++.++||||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            57999999999999999999999999999999986532 223345677899999999999999999977643     358


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |+|+||+. ++|.+++...+.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            99999996 6999999888889999999999999999999998 999999999999999999999999999997664433


Q ss_pred             CCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH-------------------
Q 018630          215 GQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE-------------------  274 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~-------------------  274 (353)
                      .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..........                   
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence            33445678999999998865 4589999999999999999999999976432110000000                   


Q ss_pred             -HHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCc
Q 018630          275 -LMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  331 (353)
Q Consensus       275 -~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  331 (353)
                       ..........+  ......+++++.++|.+||+.||++|||++++++||||+...+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~  302 (337)
T cd07858         243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD  302 (337)
T ss_pred             HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence             00000000000  0112457899999999999999999999999999999988765543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3e-43  Score=323.80  Aligned_cols=254  Identities=32%  Similarity=0.544  Sum_probs=212.9

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +.|...+.||+|+||.||++.+..+++.||+|++...  ........+.+|+.+++.++||||+++++.+.+++..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            5699999999999999999999989999999998643  22344567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      ||+. |+|.+++.. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....    .
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----~  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----A  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCCCEEEeecCcceecCC----C
Confidence            9997 488777754 4578999999999999999999998 9999999999999999999999999998865432    2


Q ss_pred             cccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          218 NTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ....+++.|+|||.+.   ...++.++|+||+|+++|||++|..||...+..       .....+.....+......++.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  241 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNDSPTLSSNDWSD  241 (307)
T ss_pred             CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-------HHHHHHhcCCCCCCCchhhCH
Confidence            2346788999999884   356889999999999999999999999764321       122223333333333445788


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ++.++|.+||+.||++|||+.+++.||||....
T Consensus       242 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            999999999999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.2e-43  Score=315.53  Aligned_cols=253  Identities=33%  Similarity=0.559  Sum_probs=215.0

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|++.+.||+|++|.||++.+..+|+.||+|.++..  ........+.+|+++++.++|+|++++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5799999999999999999999989999999988643  23344677889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          139 EYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       139 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            99999999998864    2458999999999999999999998 999999999999999999999999999987655433


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      .......+++.|+|||.+.+..++.++|+||+||++|+|++|..||.....     ........+.....++.+...++.
T Consensus       161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08224         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEKCDYPPLPADHYSE  235 (267)
T ss_pred             cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHHHhhhhcCCCCCCChhhcCH
Confidence            333445788999999999888899999999999999999999999965431     222334444444444443447888


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ++.++|.+||..+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-43  Score=318.55  Aligned_cols=250  Identities=34%  Similarity=0.557  Sum_probs=212.0

Q ss_pred             ecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           69 VGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      ||.|+||.||++.+..+|+.+|+|++.....  ......+.+|+++++.+.||||+++++.+......|+++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999998899999999865422  24567788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--------CCc
Q 018630          147 ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--------QAN  218 (353)
Q Consensus       147 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--------~~~  218 (353)
                      .+++.+.+.+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........        ...
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            9999887889999999999999999999998 9999999999999999999999999999876443311        223


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ...++..|+|||......++.++|+||||+++|+|++|..||.....       ......+............+++.+.+
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (265)
T cd05579         160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQNILNGKIEWPEDVEVSDEAID  232 (265)
T ss_pred             CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCcCCCccccCCHHHHH
Confidence            34678899999999888899999999999999999999999976432       22333333333322222335899999


Q ss_pred             HHHHhhhhCcCCCCCH---HHHHcCCccccc
Q 018630          299 FISACVQKEPQQRLSA---QELMTHPFLKMY  326 (353)
Q Consensus       299 li~~~L~~dp~~Rpt~---~e~l~hp~~~~~  326 (353)
                      ++.+||+.+|.+|||+   .++++||||+..
T Consensus       233 ~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         233 LISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            9999999999999999   999999999854

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-43  Score=321.65  Aligned_cols=252  Identities=27%  Similarity=0.417  Sum_probs=211.5

Q ss_pred             CccCceeeeeecccCCeEEEEEEecc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..++|.+.+.||+|+||.||++.+..     +++.||+|.++..........+.+|+++++.+.||||+++++.+.....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            34679999999999999999998753     3578999998766555567889999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcE
Q 018630          134 ISIILEYMDGGSLADFLKKV--------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV  199 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  199 (353)
                      .++||||+++++|.+++...              ..+++..+..++.|++.|+.|||+ +|++||||||+||+++.++.+
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcCCCeE
Confidence            99999999999999999754              247888999999999999999998 999999999999999999999


Q ss_pred             EEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHH
Q 018630          200 KITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM  276 (353)
Q Consensus       200 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~  276 (353)
                      +|+|||++........  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...+.       ....
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-------~~~~  234 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-------EEVI  234 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHH
Confidence            9999999875432211  1122345788999999999999999999999999999998 9999976433       2233


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          277 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+.....+. .+..++..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         235 ECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3343333322 34568899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-43  Score=314.78  Aligned_cols=254  Identities=30%  Similarity=0.477  Sum_probs=214.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc----ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec--CeE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN----VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAI  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~--~~~  134 (353)
                      .+|.+.+.||+|++|.||++.+..+++.||+|.+...    ........+.+|+.+++.++||||+++++.+.+.  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5789999999999999999999999999999987532    1234456788999999999999999999988653  568


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ++++||+++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+++......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            9999999999999999887789999999999999999999998 999999999999999999999999999997653211


Q ss_pred             ---CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          215 ---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       215 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                         .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.....       ......+.........+..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~p~~  233 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------MAAIFKIATQPTKPMLPDG  233 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------HHHHHHHHcCCCCCCCCcc
Confidence               112235688999999999888899999999999999999999999976432       1222333333333445678


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +++++.+++.+||+ +|.+|||+.+++.|||+
T Consensus       234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         234 VSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             cCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            89999999999999 57999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.3e-44  Score=332.09  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=208.4

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY  129 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~  129 (353)
                      |++..++|++.+.||+|+||.||+|...     .+++.||+|+++..........+.+|+.++..+ +|+||+++++.+.
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            3455578999999999999999999753     345789999987654445556788899999998 8999999999876


Q ss_pred             e-cCeEEEEEEecCCCCHHHHHHhc-------------------------------------------------------
Q 018630          130 S-NGAISIILEYMDGGSLADFLKKV-------------------------------------------------------  153 (353)
Q Consensus       130 ~-~~~~~lv~e~~~~gsL~~~l~~~-------------------------------------------------------  153 (353)
                      . +..+++++||+++++|.+++...                                                       
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4 46789999999999999998542                                                       


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CCcccccCCc
Q 018630          154 ------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYN  225 (353)
Q Consensus       154 ------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~  225 (353)
                            ..++...+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||+++.......  ......++..
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                  257889999999999999999998 9999999999999999999999999999976532221  1122345678


Q ss_pred             ccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018630          226 YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  304 (353)
Q Consensus       226 y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  304 (353)
                      |+|||++.+..++.++|||||||++|||++ |..||.+....+      .....+...... ..+...++++.+++.+||
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl  313 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRM-RAPEYATPEIYSIMLDCW  313 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCC-CCCccCCHHHHHHHHHHc
Confidence            999999999999999999999999999998 999997643321      122223332222 223567899999999999


Q ss_pred             hhCcCCCCCHHHHHcC
Q 018630          305 QKEPQQRLSAQELMTH  320 (353)
Q Consensus       305 ~~dp~~Rpt~~e~l~h  320 (353)
                      +.+|++||++.|+++|
T Consensus       314 ~~~p~~RPs~~ell~~  329 (337)
T cd05054         314 HNNPEDRPTFSELVEI  329 (337)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.6e-43  Score=312.93  Aligned_cols=253  Identities=39%  Similarity=0.648  Sum_probs=219.0

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|.+.+.||.|++|.||++.+..+++.||+|++.... .......+.+|+++++.++|||++++.+.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5889999999999999999999899999999987553 235567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          141 MDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       141 ~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            9999999999764    679999999999999999999998 89999999999999999999999999998776544333


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .....|++.|+|||.+.+..++.++|+||+|+++++|++|..||...+.       ............+ ..+..++.++
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~  231 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKILKGQYP-PIPSQYSSEL  231 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHHhcCCCC-CCCCCCCHHH
Confidence            3445788999999999888899999999999999999999999976432       2333333333332 2345788999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .+++.+||..+|++|||+.++++||||
T Consensus       232 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         232 RNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-45  Score=294.34  Aligned_cols=265  Identities=24%  Similarity=0.441  Sum_probs=217.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .+|+..+.||+|+||+||+++++.+++.||+|.++...+ +..-....+|+-+++.+.|.|||+++++...++.+.+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            457778899999999999999999999999999986633 3334667899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          140 YMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       140 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||.. +|..+... ++.++.+.++.++.|+++|+.++|+ .++.|||+||.|++++.+|++||+|||+++..+.+..-..
T Consensus        82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence            9975 89888865 4789999999999999999999999 8999999999999999999999999999998765543334


Q ss_pred             ccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCC----------
Q 018630          219 TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS----------  286 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------  286 (353)
                      ..+-|.+|++|.++.+.+ |+...|+||.||++.|+.. |.+.|++.+-.+....+........+...|.          
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            456799999999998865 8999999999999999998 8888887665544333332222111111111          


Q ss_pred             -CCC---------CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          287 -APS---------DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       287 -~~~---------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                       ..+         ..++..-++++.++|.-+|..|++++++++||||....
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence             000         12334567999999999999999999999999998754

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.8e-43  Score=319.53  Aligned_cols=251  Identities=28%  Similarity=0.511  Sum_probs=203.8

Q ss_pred             eecccCCeEEEEEEeccCCcEEEEEEeecccc--HHH---HHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecC
Q 018630           68 VVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESA---RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD  142 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~---~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  142 (353)
                      .||+|+||.||++.+..+++.||+|.+.....  ...   .......+.+++...||+|+.+++.+..+..+++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            47999999999999998999999999865321  111   1222233445556789999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccccc
Q 018630          143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  222 (353)
Q Consensus       143 ~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  222 (353)
                      |++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......  .....|
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVG  157 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCcCC
Confidence            99999999888889999999999999999999998 999999999999999999999999999987553322  234578


Q ss_pred             CCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 018630          223 TYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS  301 (353)
Q Consensus       223 t~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  301 (353)
                      +..|+|||.+.++ .++.++|+||+||++|+|++|..||.......    ........ .... ...+..+++++.+++.
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~----~~~~~~~~-~~~~-~~~~~~~s~~~~~li~  231 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMT-LTMA-VELPDSFSPELRSLLE  231 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc----hHHHHHHh-hccC-CCCCCcCCHHHHHHHH
Confidence            9999999998754 58999999999999999999999997653321    11111111 1111 2233457899999999


Q ss_pred             HhhhhCcCCCC-----CHHHHHcCCcccccC
Q 018630          302 ACVQKEPQQRL-----SAQELMTHPFLKMYG  327 (353)
Q Consensus       302 ~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  327 (353)
                      +||..+|.+||     ++.++++||||+...
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             HHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            99999999999     999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-44  Score=331.30  Aligned_cols=266  Identities=25%  Similarity=0.418  Sum_probs=210.7

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec-----CeEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAIS  135 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~-----~~~~  135 (353)
                      ++|++.+.||+|+||.||++.+..+|+.||+|+++..........+.+|+.+++.++||||+++++++...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            68999999999999999999999999999999986543444556778899999999999999999876543     4589


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +|+||+.+ +|.+++.. ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++........
T Consensus        85 lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          85 IVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             EEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence            99999975 88888754 579999999999999999999998 9999999999999999999999999999876543221


Q ss_pred             ---CCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH--------HHHHHh---
Q 018630          216 ---QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--------LMEAIV---  280 (353)
Q Consensus       216 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~--------~~~~~~---  280 (353)
                         ......|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+....+.....        ....+.   
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR  241 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence               1123568999999998755 4689999999999999999999999976432111110000        000000   


Q ss_pred             -----cCCC-CC-----CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          281 -----DQPP-PS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       281 -----~~~~-~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                           ...+ ..     ......++++.++|.+||+.||++|||+.|+++||||+.+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                 0000 00     0113457889999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.3e-43  Score=315.42  Aligned_cols=253  Identities=30%  Similarity=0.495  Sum_probs=213.3

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|.+.+.||+|+||.||++.++.+|..+|+|.+.... .......+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5888999999999999999999999999999986542 123345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCCCC
Q 018630          141 MDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       141 ~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~  217 (353)
                      +++++|.+++....  .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            99999999987643  47899999999999999999998 9999999999999998886 46999999987765433333


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  297 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.       .+....+....... ....++.++.
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~  231 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQGYFAP-ISPNFSRDLR  231 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhcccCCC-CCCCCCHHHH
Confidence            345688999999999888899999999999999999999999975432       12223333333222 2346788999


Q ss_pred             HHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          298 SFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       298 ~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +++.+||+.+|++|||+.|+++||||
T Consensus       232 ~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         232 SLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHHhccChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-43  Score=318.04  Aligned_cols=254  Identities=25%  Similarity=0.394  Sum_probs=211.5

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCC-----cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTG-----QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      ++..++|.+.+.||+|+||.||++.++..+     ..||+|.+...........+.+|+.+++.++||||+++++.+...
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            355688999999999999999999886543     789999987665555567788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEE
Q 018630          132 GAISIILEYMDGGSLADFLKKVK----------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI  201 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  201 (353)
                      ...++||||+++++|.+++....          .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCCCEEE
Confidence            99999999999999999986532          36778899999999999999998 99999999999999999999999


Q ss_pred             eeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHH
Q 018630          202 TDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA  278 (353)
Q Consensus       202 ~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~  278 (353)
                      +|||+++.......  ......++..|+|||.+.+..++.++|+|||||++||+++ |..||...+.       .+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~~~~~  233 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------EEVLKF  233 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-------HHHHHH
Confidence            99999876543221  1223456788999999988889999999999999999998 9999976432       222333


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          279 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +..... ...+..++.++.+++.+||+.+|++|||+.++++
T Consensus       234 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         234 VIDGGH-LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            333322 2334567999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-46  Score=314.39  Aligned_cols=268  Identities=35%  Similarity=0.613  Sum_probs=229.7

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHH-HhcCCCCceEEEeeEeEecCeEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      .+..++.+-+..||.|+||+|++..++.+|+..|||.++....+....+++.|.+. ++.-++||||++|++...++..+
T Consensus        60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW  139 (361)
T KOG1006|consen   60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW  139 (361)
T ss_pred             ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence            45567777888999999999999999999999999999988776777888888886 45567999999999999999999


Q ss_pred             EEEEecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          136 IILEYMDGGSLADFLK-----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      +.||.|+ .||..+-+     +...+++.-+-.+....++||.||..+..|||||+||+|||++..|.+||||||++..+
T Consensus       140 iCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  140 ICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             eeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            9999997 48876554     34679999999999999999999998889999999999999999999999999999776


Q ss_pred             cccCCCCcccccCCcccCcceecCC--CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      ...- ..+..+|...|||||.+...  .|+.++|+||||++|||+.||.+||.      .|.+..+.+..+..+.+|...
T Consensus       219 v~Si-AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr------~w~svfeql~~Vv~gdpp~l~  291 (361)
T KOG1006|consen  219 VDSI-AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR------KWDSVFEQLCQVVIGDPPILL  291 (361)
T ss_pred             HHHH-HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc------hHHHHHHHHHHHHcCCCCeec
Confidence            5332 23445889999999999653  48999999999999999999999995      477777777777776665432


Q ss_pred             C----CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcC
Q 018630          289 S----DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD  332 (353)
Q Consensus       289 ~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~  332 (353)
                      .    -.++..+..+|..||.+|-++||.+.+++++||++.+.....+
T Consensus       292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~  339 (361)
T KOG1006|consen  292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD  339 (361)
T ss_pred             CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence            2    3478999999999999999999999999999999998766654

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-43  Score=335.17  Aligned_cols=257  Identities=26%  Similarity=0.340  Sum_probs=210.1

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccC-----CcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSF  128 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~  128 (353)
                      ...+..++|.+.+.||+|+||.||++.+...     +..||||+++..........+.+|++++..+. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            3455668899999999999999999987433     34799999976655556678999999999996 99999999999


Q ss_pred             EecCeEEEEEEecCCCCHHHHHHhc-------------------------------------------------------
Q 018630          129 YSNGAISIILEYMDGGSLADFLKKV-------------------------------------------------------  153 (353)
Q Consensus       129 ~~~~~~~lv~e~~~~gsL~~~l~~~-------------------------------------------------------  153 (353)
                      ...+..|+||||+++|+|.+++...                                                       
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            9999999999999999999988642                                                       


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEE
Q 018630          154 -----------------------------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  192 (353)
Q Consensus       154 -----------------------------------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIl  192 (353)
                                                               ..+++..+..++.|++.||+|||+ ++++||||||+||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil  269 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence                                                     136778889999999999999998 99999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCch
Q 018630          193 INHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW  269 (353)
Q Consensus       193 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~  269 (353)
                      ++.++.+||+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......  
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--  347 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--  347 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--
Confidence            99999999999999876532221  1122356788999999988889999999999999999997 999997643211  


Q ss_pred             hhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          270 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                          .....+..... ...+..++.++.+++.+||+.||++|||+.++.+
T Consensus       348 ----~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 ----TFYNKIKSGYR-MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             ----HHHHHHhcCCC-CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence                12223333322 2234578899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.9e-43  Score=326.42  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=208.0

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      +...+|+..+.||+|+||.||++.+..+++    .||+|+++.........++.+|+.+++.++||||+++++.+... .
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            345789999999999999999998766655    48999987655555667888999999999999999999988764 5


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .++++||+++|+|.+++... ..++...+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCCcEEEccccccccccC
Confidence            67999999999999999864 468899999999999999999998 9999999999999999999999999999987643


Q ss_pred             cCCCC--cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          213 TSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       213 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      .....  ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+...       .+....+..... ...+
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~  233 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------SEISSILEKGER-LPQP  233 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHhCCCC-CCCC
Confidence            22211  12234678999999998899999999999999999998 9999976432       122222222222 2223


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ..++.++.+++.+||..||++|||+.+++.+
T Consensus       234 ~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         234 PICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5678899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-43  Score=310.81  Aligned_cols=253  Identities=35%  Similarity=0.566  Sum_probs=218.1

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|++.+.||+|++|.||++.+..+++.||+|.+..... ......+.+|+++++.++|||++++++.+.+++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            57889999999999999999998999999999875532 24557889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      +++++|.+++.....+++..+..++.|++.|+.|||+ .|++||||+|+||+++.++.++|+|||.+.............
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            9999999999888889999999999999999999998 999999999999999999999999999998765444333445


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      .++..|+|||...+..++.++|+||+|+++|+|++|..||...+..       ........... ...+..+++.+.+++
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~~~~i  231 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-------AALFRIVQDDH-PPLPEGISPELKDFL  231 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHhccCC-CCCCCCCCHHHHHHH
Confidence            7889999999998877899999999999999999999999764321       11112222222 223456789999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcc
Q 018630          301 SACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .+||..+|++|||+.++++||||
T Consensus       232 ~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         232 MQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHhCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-44  Score=323.92  Aligned_cols=256  Identities=24%  Similarity=0.463  Sum_probs=208.5

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      |++.+.||.|++|.||++.++.+|+.||+|++..... ......+.+|+++++.++|||++++++.+.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            5678899999999999999999999999999875532 223356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          142 DGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       142 ~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      . ++|.+++....  .+++..+..++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||++............
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            6 59999998765  68999999999999999999998 99999999999999999999999999998765433222333


Q ss_pred             cccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHH--------------------
Q 018630          220 FVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA--------------------  278 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~--------------------  278 (353)
                      ..+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+....   .......                    
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ---LFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            4668899999988664 578999999999999999999999976543211   1111110                    


Q ss_pred             -HhcCC--CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          279 -IVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       279 -~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                       .....  ........+++++.++|.+||+.||.+|||++|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence             00000  0011134577899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-43  Score=315.33  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=212.3

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ..++|++.+.||+|+||.||+|..+.+   ...||+|.++..........+.+|+.+++.++||||+++++.+...+..+
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            346899999999999999999988654   45899999876655666778899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +||||+++++|.+++... ..++...+..++.|++.|+.|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus        82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            999999999999999764 478999999999999999999998 999999999999999999999999999998764222


Q ss_pred             CCCc--ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          215 GQAN--TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       215 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      ....  ...+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....       .+....+......+ .+..
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~  232 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------QDVIKAVEDGYRLP-PPMD  232 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-------HHHHHHHHcCCCCC-CCCC
Confidence            2111  2234678999999998889999999999999999998 9999965322       23334444433222 2356


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +++.+.+++.+||+.+|++||++.+++++
T Consensus       233 ~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         233 CPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            78999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.2e-43  Score=314.03  Aligned_cols=244  Identities=25%  Similarity=0.380  Sum_probs=203.2

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      +.||+|+||.||++.++.+++.+|+|.+...........+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999999999999999887655556667899999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC--cccccC
Q 018630          147 ADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGT  223 (353)
Q Consensus       147 ~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt  223 (353)
                      .+++... ..+++..+..++.|++.||.|||+ +|++||||||.||+++.++.+||+|||++..........  .....+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            9999764 468999999999999999999998 999999999999999999999999999987543211111  111234


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  302 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  302 (353)
                      ..|+|||.+.++.++.++|+|||||++|||++ |..||.....       ......+...... ..+..++..+.+++.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~~li~~  231 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-------QQTREAIEQGVRL-PCPELCPDAVYRLMER  231 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-------HHHHHHHHcCCCC-CCcccCCHHHHHHHHH
Confidence            56999999998889999999999999999998 9999965332       1222233332222 2345678999999999


Q ss_pred             hhhhCcCCCCCHHHHHc
Q 018630          303 CVQKEPQQRLSAQELMT  319 (353)
Q Consensus       303 ~L~~dp~~Rpt~~e~l~  319 (353)
                      ||+.||++|||+.++++
T Consensus       232 ~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         232 CWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.7e-44  Score=320.30  Aligned_cols=247  Identities=32%  Similarity=0.537  Sum_probs=203.0

Q ss_pred             eeeeeecccCCeEEEEEEec----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           64 DTIKVVGKGSGGIVQLVQHK----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ++.+.||.|+||.||+|...    ..+..|+||.++..........+.+|++.+++++||||+++++++...+.+++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            46789999999999999987    34668999999766556668889999999999999999999999998888999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--
Q 018630          140 YMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--  215 (353)
Q Consensus       140 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--  215 (353)
                      |+++|+|.+++...  ..++...+..++.|++.||.|||+ ++++|+||+++||+++.++.+||+|||++........  
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999886  679999999999999999999998 8999999999999999999999999999977622111  


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ......+...|+|||.+....++.++||||||+++|||++ |..||...+       ..+....+.+..... .+..++.
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~  232 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-------NEEIIEKLKQGQRLP-IPDNCPK  232 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-------HHHHHHHHHTTEETT-SBTTSBH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccccccce-eccchhH
Confidence            1222356778999999988889999999999999999999 789987642       234445554444332 3467899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+.++|.+||+.||++|||+.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-45  Score=315.27  Aligned_cols=263  Identities=27%  Similarity=0.448  Sum_probs=221.6

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      ...||+|+|+.|--+....+|..||||++.+. ..-.+.++.+|++++.+++ |+||++++++|+++...|+|||-|.||
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            36899999999999999999999999999766 4566788999999998874 999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC---cEEEeeccccccccccC-------
Q 018630          145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTS-------  214 (353)
Q Consensus       145 sL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~a~~~~~~~-------  214 (353)
                      +|...+.++..+++.++..+..+|+.||.+||. +||.||||||+|||..+.+   -+|||||.+...+...+       
T Consensus       162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence            999999999999999999999999999999998 9999999999999997655   48999999875542211       


Q ss_pred             CCCcccccCCcccCcceec---C--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCC-chh------hH-HHHHHHHhc
Q 018630          215 GQANTFVGTYNYMSPERIS---G--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD-GWT------SF-YELMEAIVD  281 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~------~~-~~~~~~~~~  281 (353)
                      ....+.+|+..|||||+..   +  ..|+.+.|.||||+|+|-|++|.+||.+.=..+ +|.      .- ..+.+.|.+
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE  320 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE  320 (463)
T ss_pred             ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence            1234578999999999762   2  358999999999999999999999997642221 222      22 234556665


Q ss_pred             CCC--CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          282 QPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       282 ~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      +..  |...+..+|.+.+++++.+|..|+..|.++.++++|||++++..++
T Consensus       321 GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek  371 (463)
T KOG0607|consen  321 GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK  371 (463)
T ss_pred             cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence            553  4555678999999999999999999999999999999999987553

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=305.31  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=208.0

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-----cC
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-----NG  132 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-----~~  132 (353)
                      ++-++|.+.+.||+|+|+.||++++..++..||+|++.... .......++|++..++++|||++++++....     ..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            45589999999999999999999999999999999998775 5567889999999999999999999876543     24


Q ss_pred             eEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCcEEEcCCCcEEEeeccc
Q 018630          133 AISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKITDFGV  206 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~~--iiH~Dlkp~NIll~~~~~~kl~DfG~  206 (353)
                      ..|++++|...|||.+.++..    ..+++.++.+|+.++++||++||+ ..  .+||||||.|||+++++.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccC
Confidence            599999999999999998753    468999999999999999999998 77  99999999999999999999999999


Q ss_pred             cccccccCCCC---------cccccCCcccCcceecCC---CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH
Q 018630          207 SAIMASTSGQA---------NTFVGTYNYMSPERISGG---KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE  274 (353)
Q Consensus       207 a~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~  274 (353)
                      ++...-.....         .....|..|+|||++.-+   ..+.++|||||||+||.|+.|..||...-+..+ +    
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-S----  250 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-S----  250 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-e----
Confidence            87653221111         123468999999998644   468999999999999999999999965322111 1    


Q ss_pred             HHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          275 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +.-++..+....+....+|..+.++|..||+.||.+||++.+++.+
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            0111222222222234589999999999999999999999999874

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.6e-43  Score=317.73  Aligned_cols=253  Identities=25%  Similarity=0.379  Sum_probs=209.8

Q ss_pred             CccCceeeeeecccCCeEEEEEEecc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..++|.+.+.||+|++|.||+|.+..     ++..||+|.+...........+.+|+.+++.++|+||+++++.+.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            44789999999999999999999976     6788999988765555556778999999999999999999999998899


Q ss_pred             EEEEEEecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC---cEEEee
Q 018630          134 ISIILEYMDGGSLADFLKKVK-------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITD  203 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~D  203 (353)
                      .++||||++|++|.+++...+       .+++..+..++.|++.|++|||+ ++++||||||+||+++.++   .+||+|
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcceEecc
Confidence            999999999999999997653       48899999999999999999998 9999999999999998755   599999


Q ss_pred             ccccccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHh
Q 018630          204 FGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIV  280 (353)
Q Consensus       204 fG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~  280 (353)
                      ||+++........  ......+..|+|||++.+..++.++|||||||++|||++ |..||...+.       .+....+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-------~~~~~~~~  235 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-------QEVMEFVT  235 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHH
Confidence            9998765322111  112233567999999988889999999999999999997 9999976432       12333333


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .... ...+..++..+.+++.+||+.+|++|||+.++++|
T Consensus       236 ~~~~-~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         236 GGGR-LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3322 22345678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.7e-43  Score=318.52  Aligned_cols=257  Identities=24%  Similarity=0.430  Sum_probs=202.7

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEec--CeEEEEEE
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSN--GAISIILE  139 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~--~~~~lv~e  139 (353)
                      |++++.||+|+||.||++.+..+++.||+|.++............+|+.++..+. |+|++++++.+.++  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            6788999999999999999999999999999875433333334457888887775 99999999999987  89999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      |+.+ +|.+++... ..+++..+..++.|++.||.|||+ .|++||||+|+||+++. +.++|+|||++....... ...
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~~~  156 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-PYT  156 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-CCeEEEecccccccccCC-CcC
Confidence            9975 888888753 578999999999999999999998 99999999999999999 999999999997654332 223


Q ss_pred             ccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH--------HHHHHhcCC-----C
Q 018630          219 TFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--------LMEAIVDQP-----P  284 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~-----~  284 (353)
                      ...++..|+|||.+.. +.++.++|+||+||++|||++|..||...+..+.......        .........     .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            4568899999997654 4578999999999999999999999977543221111100        000000000     0


Q ss_pred             CC-------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          285 PS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       285 ~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +.       .....++.++.++|.+||+.||++|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            00       0012568899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.7e-43  Score=314.63  Aligned_cols=251  Identities=25%  Similarity=0.380  Sum_probs=210.4

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +...+|.+.+.||+|++|.||++.++.+++.||+|.+...  ......+.+|+++++.++||||+++++.+..++.++++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence            4556799999999999999999999989999999998644  23346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |||+++++|.+++...  ..++...+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            9999999999998754  358899999999999999999998 9999999999999999999999999999876543221


Q ss_pred             CC-cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          216 QA-NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       216 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .. ....++..|+|||.+.+..++.++|+|||||++|||++ |..||...+.       .+....+..... ...+..++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~~  231 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKGYR-MERPEGCP  231 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCC-CCCCCCCC
Confidence            11 11233567999999988889999999999999999998 9999976432       223333333322 23346789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +++.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         232 PKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.6e-43  Score=323.72  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=207.9

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcE--EEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF--FALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~  134 (353)
                      +...+|++.+.||+|+||.||+|.++.++..  +|+|.++..........+.+|+.++.++ +||||+++++.+...+.+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            4567899999999999999999998877764  5777776544555667888999999998 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc
Q 018630          135 SIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE  198 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~  198 (353)
                      ++||||+++++|.+++....                .+++..+..++.|++.|++|||+ +|++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecCCCc
Confidence            99999999999999997542                47889999999999999999998 99999999999999999999


Q ss_pred             EEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHH
Q 018630          199 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELME  277 (353)
Q Consensus       199 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~  277 (353)
                      ++|+|||++...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..       +...
T Consensus       163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~  234 (303)
T cd05088         163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE  234 (303)
T ss_pred             EEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-------HHHH
Confidence            999999998643211 11112234667999999988889999999999999999998 99999754321       2222


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+..... ...+..+++++.+|+.+||+.+|++|||+++++.+
T Consensus       235 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         235 KLPQGYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHhcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3322222 22334578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.8e-43  Score=313.23  Aligned_cols=249  Identities=26%  Similarity=0.460  Sum_probs=206.8

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +.++|++.+.||+|+||.||++..+ ++..+|+|.+....  .....+.+|+.+++.++||||+++++.+......++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            3467999999999999999999875 45689999876432  22456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC-
Q 018630          139 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  216 (353)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||+ +|++||||+|+||+++.++.++|+|||.++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999999998753 568999999999999999999998 99999999999999999999999999998765322211 


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .....++..|+|||.+.+..++.++|+||+|+++|||++ |..||...+.       .+....+.....+. .+...+.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~~~~-~~~~~~~~  229 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVEMISRGFRLY-RPKLASMT  229 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCCCC-CCCCCCHH
Confidence            112234568999999988889999999999999999999 9999976432       23344444443322 23456889


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          296 FCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +.+++.+||+.||++|||++++++
T Consensus       230 ~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         230 VYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.3e-43  Score=321.35  Aligned_cols=258  Identities=34%  Similarity=0.616  Sum_probs=215.8

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecC
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD  142 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  142 (353)
                      |+....||+|+||.||++..+.+++.||||.+... .......+.+|+.+++.++|+|++++++.+...+..++||||++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            34456799999999999999999999999987644 23445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccccc
Q 018630          143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  222 (353)
Q Consensus       143 ~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  222 (353)
                      +++|.+++.. ..+++..+..++.|++.|++|||+ .|++|+||+|+||+++.++.++|+|||++..............|
T Consensus       101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  178 (292)
T cd06657         101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG  178 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence            9999998754 568999999999999999999998 99999999999999999999999999988765433333344578


Q ss_pred             CCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHH
Q 018630          223 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSFIS  301 (353)
Q Consensus       223 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~  301 (353)
                      ++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..       +....+....+.. .....+++++.+++.
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNLPPKLKNLHKVSPSLKGFLD  251 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhhCCcccCCcccCCHHHHHHHH
Confidence            89999999998888999999999999999999999999764321       1122222222111 123467899999999


Q ss_pred             HhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          302 ACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       302 ~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      +||+.||.+||++.+++.||||......+
T Consensus       252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         252 RLLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             HHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence            99999999999999999999999887544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-43  Score=330.18  Aligned_cols=268  Identities=25%  Similarity=0.427  Sum_probs=213.3

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeE----ecCeEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFY----SNGAIS  135 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~----~~~~~~  135 (353)
                      ++|++.+.||+|++|.||++.++.+++.||+|++.... .......+.+|+.+++.++||||+++++.+.    ....++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            68999999999999999999999999999999987542 2234566778999999999999999998775    345789


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||+. ++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++........
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            9999996 5999999877789999999999999999999998 9999999999999999999999999999876543222


Q ss_pred             C----CcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH----------------
Q 018630          216 Q----ANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE----------------  274 (353)
Q Consensus       216 ~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----------------  274 (353)
                      .    .....++..|+|||.+.+ ..++.++|+||+||++|||++|..||...+..........                
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence            1    123478899999998865 4589999999999999999999999976543211100000                


Q ss_pred             -HHHHHhcCCCCCC-----CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          275 -LMEAIVDQPPPSA-----PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       275 -~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                       ....+........     .....++++.++|.+||+.||++|||+.+++.||||+......
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence             0000100010000     1134689999999999999999999999999999998765443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=335.93  Aligned_cols=250  Identities=30%  Similarity=0.514  Sum_probs=217.2

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      .++||+|.||+||-++++.+|+.||||++.+. .......+++.|+.|++++.||.||.+...|+.....++|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            37899999999999999999999999998644 3444558899999999999999999999999999999999999976 


Q ss_pred             CHHHHH-H-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC---cEEEeeccccccccccCCCCcc
Q 018630          145 SLADFL-K-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       145 sL~~~l-~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      +..+.+ . ..+++++...+.++.||+.||.|||. ++|+|+||||+|||+.+..   .+||||||+|+...... ...+
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FRrs  725 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FRRS  725 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchhh-hhhh
Confidence            555544 3 34789999999999999999999998 9999999999999997654   69999999999887543 4456


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC--CCCCCCCCCCCHHHH
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--PPPSAPSDQFSPEFC  297 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  297 (353)
                      .+|||.|.|||+++++.|+..-|+||+|+|+|.-++|..||...+         ++.++|...  ..|+.++..+++++.
T Consensus       726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE---------dIndQIQNAaFMyPp~PW~eis~~Ai  796 (888)
T KOG4236|consen  726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE---------DINDQIQNAAFMYPPNPWSEISPEAI  796 (888)
T ss_pred             hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc---------chhHHhhccccccCCCchhhcCHHHH
Confidence            799999999999999999999999999999999999999996532         233344332  345566789999999


Q ss_pred             HHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          298 SFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       298 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +||..+|+..-.+|.|....+.|||+|.+.
T Consensus       797 dlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  797 DLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            999999999999999999999999999763

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.6e-43  Score=318.93  Aligned_cols=253  Identities=30%  Similarity=0.535  Sum_probs=216.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~lv  137 (353)
                      ++|.+.+.||+|++|.||++.+..+++.||+|++....  .......+.+|..+++.+. ||||+++++.+..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47899999999999999999999999999999986532  2334567888999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--  215 (353)
                      |||+++++|.+++.+.+.+++..+..++.|++.||.|||+ .|++|+||+|+||+++.+++++|+|||++........  
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            9999999999999988889999999999999999999998 9999999999999999999999999999876543221  


Q ss_pred             ------------------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH
Q 018630          216 ------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME  277 (353)
Q Consensus       216 ------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~  277 (353)
                                        ......++..|+|||......++.++|+||||++++++++|..||...+..       ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~  232 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-------LTFQ  232 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHH
Confidence                              112345788999999998888999999999999999999999999875421       1222


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCH----HHHHcCCcc
Q 018630          278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA----QELMTHPFL  323 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~e~l~hp~~  323 (353)
                      .+....  ...+..+++.+.+++.+||+.||++|||+    +++++||||
T Consensus       233 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         233 KILKLE--YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHhcC--CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            222221  22335678999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.5e-45  Score=317.97  Aligned_cols=265  Identities=24%  Similarity=0.424  Sum_probs=208.2

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCC----cEEEEEEeeccccHH-HHHHHHHHHHHHhcCCCCceEEEeeEeEe-cCe
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTG----QFFALKVIQMNVEES-ARRQIAQELKINQSSQCPYVVVCYQSFYS-NGA  133 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-~~~  133 (353)
                      +..|+.++.||+|+||.||+|..+.++    +.+|||.++.+.+.. ......+|+.+++.++|||++.+..+|.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            468999999999999999999665443    368999987653322 23456789999999999999999999987 789


Q ss_pred             EEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC----CcEEEeec
Q 018630          134 ISIILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR----GEVKITDF  204 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~----~~~kl~Df  204 (353)
                      +++++||++. +|...++-.     +.++...++.+++||+.|+.|||+ +-|+||||||.|||+..+    |+|||+||
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCeeEeecc
Confidence            9999999986 999988632     578999999999999999999999 889999999999999877    89999999


Q ss_pred             cccccccccCCCC---cccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchh---------h
Q 018630          205 GVSAIMASTSGQA---NTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT---------S  271 (353)
Q Consensus       205 G~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---------~  271 (353)
                      |+++.+...-...   ...+-|.+|+|||++.+.. |+.+.|+||+|||+.||++-.+.|.+.+.....+         .
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999876544322   3356799999999998865 8999999999999999999988886643322111         1


Q ss_pred             HHHHHHHHhcCCCCC----------------CC------------CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          272 FYELMEAIVDQPPPS----------------AP------------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       272 ~~~~~~~~~~~~~~~----------------~~------------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +.+++..-.+...+.                ..            ...-++...+|+.+||++||.+|.|++++++|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            111110000000000                00            01234558899999999999999999999999999


Q ss_pred             ccc
Q 018630          324 KMY  326 (353)
Q Consensus       324 ~~~  326 (353)
                      .+-
T Consensus       341 ~~d  343 (438)
T KOG0666|consen  341 TED  343 (438)
T ss_pred             ccC
Confidence            876

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-42  Score=308.62  Aligned_cols=251  Identities=40%  Similarity=0.725  Sum_probs=214.0

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      +|...+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++|||++++++.+..+...++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            47888999999999999999998999999999876533 45678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          142 DGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       142 ~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      ++++|.+++... ..+++..+..++.|++.|+.+||+ .|++||||+|+||+++.++.++|+|||.+........ ....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~  157 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTM  157 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccce
Confidence            999999999876 679999999999999999999998 9999999999999999999999999999876654322 3445


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSF  299 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  299 (353)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..       ...........+. .....++..+.++
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-------KALFKIATNGPPGLRNPEKWSDEFKDF  230 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHHhcCCCCcCcccccCHHHHHH
Confidence            7889999999998888999999999999999999999999764321       1111222222222 2223348899999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCc
Q 018630          300 ISACVQKEPQQRLSAQELMTHPF  322 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~  322 (353)
                      |.+||+.||++|||+.|++.|||
T Consensus       231 i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         231 LKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHccCChhhCCCHHHHhcCCC
Confidence            99999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.2e-43  Score=353.10  Aligned_cols=253  Identities=26%  Similarity=0.434  Sum_probs=206.4

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++..  .......++.+|+++++.++||||+++++.+.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            6899999999999999999999999999999998754  23345667899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          139 EYMDGGSLADFLKKV-----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       139 e~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                      ||++|++|.+++...           ...+...+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||++
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCCCEEEEecCcc
Confidence            999999999998642           234566788999999999999998 99999999999999999999999999999


Q ss_pred             ccccccC------------------CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch
Q 018630          208 AIMASTS------------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW  269 (353)
Q Consensus       208 ~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  269 (353)
                      +......                  ......+||+.|+|||++.+..++.++||||+||++|||++|..||...+...  
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k--  238 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK--  238 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh--
Confidence            7652110                  01112469999999999999999999999999999999999999997633211  


Q ss_pred             hhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          270 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                          ..................+++.+.+++.+||+.||++||+..+.+.+
T Consensus       239 ----i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        239 ----ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             ----hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                00111111111112234688999999999999999999887665543

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.6e-43  Score=316.51  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=208.2

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      +...+|++++.||+|+||+||++++..+++    .||+|+++..........+.+|+.+++.+.||||+++++.+.. ..
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   82 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST   82 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence            445789999999999999999999877766    4899998766556667788999999999999999999998865 45


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .++++||+++|+|.+++... +.+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            77999999999999999764 568999999999999999999998 9999999999999999999999999999976543


Q ss_pred             cCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          213 TSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       213 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      ....  .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.....       ......+.....+ ..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~  233 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-------REIPDLLEKGERL-PQP  233 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCcC-CCC
Confidence            2211  112234678999999988889999999999999999998 9999965432       1222223332222 224


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..++.++.+++.+||+.||++|||+.+++.
T Consensus       234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         234 PICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.3e-43  Score=324.26  Aligned_cols=259  Identities=25%  Similarity=0.394  Sum_probs=204.2

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC-----
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----  132 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~-----  132 (353)
                      ..++|++.+.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.+++.++||||+++++++....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3478999999999999999999999999999999886442 2222345668999999999999999999876543     


Q ss_pred             ---eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          133 ---AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       133 ---~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                         ..++||||+.+ +|.+++... ..+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence               45999999975 888887654 368999999999999999999998 999999999999999999999999999997


Q ss_pred             cccccCCC----CcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          209 IMASTSGQ----ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       209 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      ........    .....++..|+|||.+.+. .++.++|+||+|+++|||++|..||...+....    ...+..+....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~----~~~~~~~~~~~  243 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ----LTLISQLCGSI  243 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCC
Confidence            65432211    1234578899999988664 378899999999999999999999976543211    11111111100


Q ss_pred             CCC---------------------------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          284 PPS---------------------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       284 ~~~---------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ++.                           ......+..+.+||.+||+.||.+|||++++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            000                           0011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-43  Score=327.85  Aligned_cols=263  Identities=27%  Similarity=0.433  Sum_probs=216.4

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC-----eEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----AIS  135 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~-----~~~  135 (353)
                      +|++.+.||.|++|.||++++..+++.||||.+..... ......+.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            58899999999999999999998899999999875432 444567889999999999999999999887764     789


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  214 (353)
                      ++|||+.+ +|.+++.+...+++..+..++.|++.||+|||+ .|++||||||.||+++.++.++|+|||++....... 
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999974 899999887789999999999999999999998 999999999999999999999999999998765433 


Q ss_pred             --CCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc----------
Q 018630          215 --GQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD----------  281 (353)
Q Consensus       215 --~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~----------  281 (353)
                        .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||...+..+..   ..+......          
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHhhhcc
Confidence              123345688999999999887 7899999999999999999999999765432111   111110000          


Q ss_pred             ----------CCCC-----CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          282 ----------QPPP-----SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       282 ----------~~~~-----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                                ....     ......+++++.++|.+||++||++|||+++++.||||+.+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                      0000     00123468899999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-44  Score=329.64  Aligned_cols=261  Identities=28%  Similarity=0.496  Sum_probs=209.6

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEE-EeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALK-VIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK-~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~  134 (353)
                      .++...|++++.||.|+-+.||+|..... +.||+| +.....+.....-+..|+.+|.+++ |.+|+++|++-..++.+
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            45667899999999999999999998644 445555 4444456777888999999999985 89999999998889999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      |+||||-+- +|..+|++.... +.-.++.+..|++.|+.++|. .||||.||||.|+|+ -.|.+||+|||+|..+...
T Consensus       436 YmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  436 YMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             EEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence            999999864 999999886543 435788899999999999998 999999999999999 5689999999999887644


Q ss_pred             CCC--CcccccCCcccCcceecCCC-----------CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh
Q 018630          214 SGQ--ANTFVGTYNYMSPERISGGK-----------YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV  280 (353)
Q Consensus       214 ~~~--~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~  280 (353)
                      ...  ..+.+||+.||+||++....           .+.++||||||||||+|+-|+.||...      .+....+.++.
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------~n~~aKl~aI~  586 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------INQIAKLHAIT  586 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------HHHHHHHHhhc
Confidence            332  23568999999999985422           467899999999999999999999642      23334445555


Q ss_pred             cCCCCCCCCC-CCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          281 DQPPPSAPSD-QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       281 ~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +..-.-..+. .-..++.+++..||..||.+|||..++|+|||++..+
T Consensus       587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence            4422111111 1123499999999999999999999999999999854

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.3e-43  Score=320.20  Aligned_cols=256  Identities=26%  Similarity=0.388  Sum_probs=210.6

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEe-----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQH-----KWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY  129 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~  129 (353)
                      +.+..++|.+.+.||+|+||.||++.+     ..++..||+|+++..........+.+|+.+++.+ +||||+++++.+.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            345667899999999999999999975     2345689999987665555567789999999999 7999999999999


Q ss_pred             ecCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          130 SNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       130 ~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                      ..+..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCCeEEECCCccc
Confidence            9999999999999999999997643  38999999999999999999998 99999999999999999999999999998


Q ss_pred             ccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018630          208 AIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPP  284 (353)
Q Consensus       208 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  284 (353)
                      ........  ......++..|+|||.+.+..++.++||||+||++|+|++ |..||......+      . .........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~-~~~~~~~~~  261 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------K-FYKLIKEGY  261 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------H-HHHHHHcCC
Confidence            76543221  1112345678999999998889999999999999999998 999997643221      1 112222222


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ....+...++++.+++.+||+.+|++|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         262 RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            22334567899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-44  Score=346.16  Aligned_cols=251  Identities=28%  Similarity=0.400  Sum_probs=209.1

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEe-Ee----
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSF-YS----  130 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~-~~----  130 (353)
                      .+...++++.+.|.+|+|+.||+|++...|..||+|++-.. ++.....+.+|+++|+.|. |+|||.+++.. ..    
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            34556788999999999999999999988899999998766 7788899999999999997 99999999932 21    


Q ss_pred             --cCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCcEEEcCCCcEEEeec
Q 018630          131 --NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKITDF  204 (353)
Q Consensus       131 --~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~--iiH~Dlkp~NIll~~~~~~kl~Df  204 (353)
                        .-.++|+||||.||+|-++++.+  ..|++.++++|++|+|+|+.+||. ..  |||||||-+||||+.+|+.|||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcc
Confidence              13578999999999999999854  569999999999999999999998 77  999999999999999999999999


Q ss_pred             cccccccccCCCCc---------ccccCCcccCccee---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhH
Q 018630          205 GVSAIMASTSGQAN---------TFVGTYNYMSPERI---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF  272 (353)
Q Consensus       205 G~a~~~~~~~~~~~---------~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~  272 (353)
                      |.++..........         ...-|+.|+|||.+   .+.+.+.|+|||||||+||-|+....||+...+       
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------  263 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------  263 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence            99865432221111         12358999999976   567789999999999999999999999986422       


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          273 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                          -+|..+....+....++..+.+||+.||+.||++||++-+++.+
T Consensus       264 ----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  264 ----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             ----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                13333333333346789999999999999999999999999765

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-43  Score=343.71  Aligned_cols=269  Identities=20%  Similarity=0.276  Sum_probs=200.3

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCc-EEEEEEe--------------ec--cccHHHHHHHHHHHHHHhcCCCCceE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQ-FFALKVI--------------QM--NVEESARRQIAQELKINQSSQCPYVV  122 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~--------------~~--~~~~~~~~~~~~e~~~~~~l~hp~iv  122 (353)
                      .++|++++.||+|+||.||++..+.... ..++|.+              ..  .........+.+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4789999999999999999987653322 2222211              00  01223456688999999999999999


Q ss_pred             EEeeEeEecCeEEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC
Q 018630          123 VCYQSFYSNGAISIILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG  197 (353)
Q Consensus       123 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~  197 (353)
                      ++++++..++..|+|++++. ++|.+++...     .......+..++.||+.||.|||+ +||+||||||+|||++.++
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC
Confidence            99999999999999999996 4888776532     233466788899999999999998 9999999999999999999


Q ss_pred             cEEEeeccccccccccCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCC-CCCCccCCchhhHHHH
Q 018630          198 EVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP-YSPPEQQDGWTSFYEL  275 (353)
Q Consensus       198 ~~kl~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P-f~~~~~~~~~~~~~~~  275 (353)
                      .+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..+ |.... ........+.
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~-~~~~~~~~~~  383 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG-GKPGKQLLKI  383 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC-CCHHHHHHHH
Confidence            999999999977643322 22245799999999999998999999999999999999997754 43321 1111111111


Q ss_pred             HHHHh------------------cCCC--------CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          276 MEAIV------------------DQPP--------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       276 ~~~~~------------------~~~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      +..+.                  ....        .......++.++.++|.+||++||.+|||+.|++.||||+....+
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~  463 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEE  463 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCch
Confidence            11110                  0000        000112356778899999999999999999999999999886655


Q ss_pred             Cc
Q 018630          330 NV  331 (353)
Q Consensus       330 ~~  331 (353)
                      ..
T Consensus       464 ~~  465 (501)
T PHA03210        464 EI  465 (501)
T ss_pred             HH
Confidence            44

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.8e-43  Score=312.53  Aligned_cols=251  Identities=26%  Similarity=0.412  Sum_probs=208.8

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      .+..++|++++.||+|++|.||++... +++.||+|.+....  .....+.+|+.+++.++|+||+++++.+...+..++
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            456689999999999999999999875 56789999876542  234678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          137 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +|||+++++|.+++...  ..++...+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            99999999999999753  568889999999999999999998 999999999999999999999999999997654322


Q ss_pred             CC-CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          215 GQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       215 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      .. .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.....       ......+...... .....+
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~  229 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-------SDVMSALQRGYRM-PRMENC  229 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-------HHHHHHHHcCCCC-CCCCCC
Confidence            11 122345678999999988889999999999999999998 9999976432       1233333333222 223568


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +.++.+++.+||+.+|++|||++++++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         230 PDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=323.94  Aligned_cols=264  Identities=28%  Similarity=0.507  Sum_probs=229.6

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~  133 (353)
                      .+...+|.++.+||+|+||.|.++..+.+.+.+|||+++...  +.+...--+.|-+++... +-|.+++++..|+....
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            567789999999999999999999999999999999998652  223333345566666655 45788999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+||||+.||+|-..+++.+.+.+..+..++.+|+.||-+||+ +|||.||||.+|||++.+|++||+|||+++...-.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            99999999999999999999999999999999999999999998 99999999999999999999999999999876656


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .....+.||||.|+|||.+...+|+..+|.||+|++||||+.|++||.+.++.       ++.+.|.+...  ..+..+|
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-------elF~aI~ehnv--syPKslS  574 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQAIMEHNV--SYPKSLS  574 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHHccC--cCccccc
Confidence            66677899999999999999999999999999999999999999999986553       45566655443  3457889


Q ss_pred             HHHHHHHHHhhhhCcCCCCCH-----HHHHcCCcccccCCCC
Q 018630          294 PEFCSFISACVQKEPQQRLSA-----QELMTHPFLKMYGDLN  330 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~~~~~~  330 (353)
                      .++.++....|.+.|.+|..+     +++-.||||+....++
T Consensus       575 kEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  575 KEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             HHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence            999999999999999999955     6899999998765444

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.8e-43  Score=318.95  Aligned_cols=257  Identities=23%  Similarity=0.375  Sum_probs=212.3

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccC-----CcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  128 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~  128 (353)
                      ...+..++|++.+.||+|+||.||++..+..     ...+|+|.+...........+.+|+.++..+ +||||+++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            3456668899999999999999999987643     3689999987654455567788999999999 799999999999


Q ss_pred             EecCeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEE
Q 018630          129 YSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  192 (353)
Q Consensus       129 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIl  192 (353)
                      ..++.++++|||+++++|.++++..                ..+++..+..++.|++.||.|||+ +||+||||||+||+
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil  164 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL  164 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence            9999999999999999999998642                458899999999999999999998 99999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCch
Q 018630          193 INHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW  269 (353)
Q Consensus       193 l~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~  269 (353)
                      ++.++.++|+|||+++........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....    
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  240 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----  240 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----
Confidence            999999999999999765432211  112234568999999988889999999999999999998 9999976432    


Q ss_pred             hhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          270 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                         .+....+.....+ ..+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       241 ---~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         241 ---EELFKLLKEGYRM-EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             ---HHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence               2233333333322 2345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-44  Score=337.56  Aligned_cols=253  Identities=30%  Similarity=0.534  Sum_probs=220.6

Q ss_pred             eeeeeecccCCeEEEEEEeccCCcEEE---EEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC--eEEEEE
Q 018630           64 DTIKVVGKGSGGIVQLVQHKWTGQFFA---LKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIIL  138 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~~va---iK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~--~~~lv~  138 (353)
                      +...+||+|+|-+||+|.|..+|-.||   +|.-..........++..|+.+++.|+||||+++|.+|.+..  .+.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            345689999999999999999999887   443333445666789999999999999999999999998754  588999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCcEEEc-CCCcEEEeeccccccccccCCC
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-KHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~iiH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      |.+..|+|+.|+++.+.++...++.|++||+.||.|||++ -.|||||||.+||+|+ ..|.|||+|+|+|+.+...  .
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--H  200 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc--c
Confidence            9999999999999999999999999999999999999982 2499999999999997 4689999999999887543  3


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....+|||.|||||.+. ..|+..+||||||+++.||+|+.+||..-      .+..++..++..+..|.....--.+++
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC------~n~AQIYKKV~SGiKP~sl~kV~dPev  273 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC------TNPAQIYKKVTSGIKPAALSKVKDPEV  273 (632)
T ss_pred             cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh------CCHHHHHHHHHcCCCHHHhhccCCHHH
Confidence            44579999999999987 68999999999999999999999999753      445567778888887766655568999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      ++||.+||.. .++|||+.|+|+||||...
T Consensus       274 r~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  274 REFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            9999999999 9999999999999999975

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.1e-42  Score=317.08  Aligned_cols=251  Identities=28%  Similarity=0.439  Sum_probs=208.5

Q ss_pred             CccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      +.++|.+.+.||+|+||.||++.+.     .++..+|+|.+... .......+.+|+.+++.++||||+++++.+...+.
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            4578999999999999999999852     34567999988654 33445678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEE
Q 018630          134 ISIILEYMDGGSLADFLKKVK-------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK  200 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  200 (353)
                      +++||||+++++|.+++...+             .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCCcEE
Confidence            999999999999999997543             48999999999999999999998 9999999999999999999999


Q ss_pred             EeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHH
Q 018630          201 ITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELME  277 (353)
Q Consensus       201 l~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~  277 (353)
                      |+|||+++.......  ......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...+.       .....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-------~~~~~  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIE  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH
Confidence            999999876532211  1122345778999999998889999999999999999998 9999976432       22334


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+....... ....+++++.+|+.+||+.||.+|||+.++++
T Consensus       234 ~i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         234 CITQGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            444443322 23567899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=336.73  Aligned_cols=281  Identities=26%  Similarity=0.413  Sum_probs=242.5

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      .++.+.+++.+..||-|+||.|-+++.+.....+|+|++++.  .+......+..|-.+|..+..|.||++|..|.++++
T Consensus       415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky  494 (732)
T KOG0614|consen  415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY  494 (732)
T ss_pred             cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence            356778999999999999999999988766556899988755  455667889999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      .|++||-|-||.|...++..+.+++..++.++..++.|++|||+ +|||.|||||+|++++.+|-+||.|||+|+.+.. 
T Consensus       495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~-  572 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS-  572 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence            99999999999999999999999999999999999999999998 9999999999999999999999999999998774 


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      +...-++||||.|.|||.+.++..+.++|.||||+++|||++|.+||++.++....       ..|.++......+..++
T Consensus       573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY-------n~ILkGid~i~~Pr~I~  645 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY-------NLILKGIDKIEFPRRIT  645 (732)
T ss_pred             CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH-------HHHHhhhhhhhcccccc
Confidence            44567899999999999999999999999999999999999999999998875433       33333333333446788


Q ss_pred             HHHHHHHHHhhhhCcCCCCC-----HHHHHcCCcccccCCCCcCHhHHhhhhCCCcc
Q 018630          294 PEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGDLNVDLSEYFTDAGSPLA  345 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~  345 (353)
                      ....+||+++...+|.+|..     ..||-+|-||..+..+....-..-+-+.++++
T Consensus       646 k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va  702 (732)
T KOG0614|consen  646 KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVA  702 (732)
T ss_pred             hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCC
Confidence            89999999999999999996     68999999999988776644433333344443

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.9e-43  Score=320.21  Aligned_cols=259  Identities=23%  Similarity=0.357  Sum_probs=208.7

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCC----------------cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTG----------------QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV  122 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv  122 (353)
                      ..++|++.+.||+|+||.||++.+...+                ..||+|.+...........+.+|+++++.++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            3478999999999999999999876543                468999988765556678899999999999999999


Q ss_pred             EEeeEeEecCeEEEEEEecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcE
Q 018630          123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  191 (353)
Q Consensus       123 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NI  191 (353)
                      ++++.+..+...+++|||+.+++|.+++....           .+++..++.++.|++.||.|||+ .|++||||||+||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp~Ni  161 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccchhce
Confidence            99999999999999999999999999997765           68999999999999999999998 9999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc--CCCCCCCCccCC
Q 018630          192 LINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT--GQFPYSPPEQQD  267 (353)
Q Consensus       192 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~Pf~~~~~~~  267 (353)
                      +++.++.++|+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|||++  |..||...+..+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            999999999999999876432221  1123356778999999988889999999999999999998  778886543221


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          268 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+.......... ........+..++.++.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         242 VIENAGHFFRDD-GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHhccccc-cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            111111100000 011111223456789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-42  Score=311.21  Aligned_cols=245  Identities=29%  Similarity=0.441  Sum_probs=210.4

Q ss_pred             eeecccCCeEEEEEEeccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||++.+...   +..||+|.++..........+.+|++.++.++|+|++++++++.....+++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            3689999999999999866   8899999998765555578899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          144 GSLADFLKKV---------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       144 gsL~~~l~~~---------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ++|.+++...         ..+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            9999999875         779999999999999999999998 999999999999999999999999999998765432


Q ss_pred             --CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          215 --GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       215 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                        .......+++.|+|||.+....++.++|+||+||++|+|++ |..||...+.       .+....+..... ...+..
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~  231 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLEYLRKGYR-LPKPEY  231 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC-CCCCcc
Confidence              22334467889999999988889999999999999999999 6999977532       233344443322 233456


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +++++.+++.+||+.||.+|||+.|++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            79999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.5e-43  Score=327.20  Aligned_cols=264  Identities=24%  Similarity=0.365  Sum_probs=210.7

Q ss_pred             cCcee-eeeecccCCeEEEEEEeccCCcEEEEEEeeccccHH-------------HHHHHHHHHHHHhcCCCCceEEEee
Q 018630           61 EDIDT-IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES-------------ARRQIAQELKINQSSQCPYVVVCYQ  126 (353)
Q Consensus        61 ~~~~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~~~~l~hp~iv~~~~  126 (353)
                      ++|.. .+.||.|+||+||++.++.+++.||||+++......             ....+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            56654 477999999999999999999999999986542211             0124678999999999999999999


Q ss_pred             EeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccc
Q 018630          127 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  206 (353)
Q Consensus       127 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~  206 (353)
                      ++..+...++||||+. ++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCCCEEECCccc
Confidence            9999999999999997 5999999887889999999999999999999998 9999999999999999999999999999


Q ss_pred             cccccc--------------cCCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhh
Q 018630          207 SAIMAS--------------TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS  271 (353)
Q Consensus       207 a~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  271 (353)
                      +.....              .........+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+... 
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-  244 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG-  244 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence            876541              11112233568899999998764 46899999999999999999999998765432111 


Q ss_pred             HHHHHHHHhcCCCC-------------------C---CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          272 FYELMEAIVDQPPP-------------------S---APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       272 ~~~~~~~~~~~~~~-------------------~---~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                        .+..........                   .   ......+.++.++|.+||+.||++|||++|++.||||+.+...
T Consensus       245 --~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        245 --RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             --HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence              111111100000                   0   0013457889999999999999999999999999999976543

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.4e-43  Score=318.06  Aligned_cols=254  Identities=24%  Similarity=0.373  Sum_probs=211.2

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccC-----CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      +...+|.+.+.||.|+||.||++.+..+     ++.||+|+++..........+.+|+.++..++||||+++++.+....
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            4556789999999999999999987543     57899999876655555677889999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC
Q 018630          133 AISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  196 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~  196 (353)
                      ..++++||+.+++|.+++...                ..++...+..++.|++.||.|||+ +|++||||||.||+++.+
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEecCC
Confidence            999999999999999998532                347888899999999999999998 999999999999999999


Q ss_pred             CcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHH
Q 018630          197 GEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY  273 (353)
Q Consensus       197 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~  273 (353)
                      +.+||+|||+++.......  ......+++.|+|||.+.++.++.++|+|||||++|||++ |..||.+...       .
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~  233 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------Q  233 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------H
Confidence            9999999999876533221  1122345778999999988889999999999999999998 8889876432       2


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          274 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +....+....... .+..++..+.+|+.+||+.+|.+||++++++..
T Consensus       234 ~~~~~i~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         234 DVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHHcCCcCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            3444444444332 346789999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.3e-43  Score=325.30  Aligned_cols=262  Identities=29%  Similarity=0.463  Sum_probs=208.6

Q ss_pred             eeccc--CCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           68 VVGKG--SGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        68 ~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      .||+|  ++|.||++++..+++.||+|+++.. ........+.+|+.+++.++||||+++++++..+...+++|||++++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            34444  5577788888889999999998765 34456678999999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-------
Q 018630          145 SLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-------  215 (353)
Q Consensus       145 sL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-------  215 (353)
                      +|.+++...  ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||.+........       
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            999999764  468999999999999999999998 9999999999999999999999999998865532221       


Q ss_pred             CCcccccCCcccCcceecCC--CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC----------
Q 018630          216 QANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP----------  283 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----------  283 (353)
                      ......++..|+|||.+...  .++.++|+||+||++|||++|..||...+...      ...+.+....          
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ------MLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccCccccccCchh
Confidence            11234567889999998763  58899999999999999999999997643211      1111111000          


Q ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHH
Q 018630          284 ---------------------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY  336 (353)
Q Consensus       284 ---------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~  336 (353)
                                           ........++.++.+|+.+||+.||++|||++++++||||+...+.+.++.+-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~~~~~~  311 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSLLDL  311 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccchhHHHh
Confidence                                 00011122356789999999999999999999999999999888777666543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.7e-43  Score=330.77  Aligned_cols=259  Identities=26%  Similarity=0.356  Sum_probs=211.2

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeE
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQS  127 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~  127 (353)
                      ..+.+..++|.+.+.||+|+||.||++++.     .+++.||+|+++..........+.+|++++..+. ||||+++++.
T Consensus        30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            345677788999999999999999999864     3456899999986644555567889999999997 9999999999


Q ss_pred             eEecCeEEEEEEecCCCCHHHHHHhcC-----------------------------------------------------
Q 018630          128 FYSNGAISIILEYMDGGSLADFLKKVK-----------------------------------------------------  154 (353)
Q Consensus       128 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  154 (353)
                      +..++..++||||+++|+|.++++..+                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999986531                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 018630          155 ---------------------------------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS  189 (353)
Q Consensus       155 ---------------------------------------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~  189 (353)
                                                                   .++...+..++.|++.||.|||+ ++++||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~  268 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAAR  268 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcc
Confidence                                                         25667788899999999999998 99999999999


Q ss_pred             cEEEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccC
Q 018630          190 NLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ  266 (353)
Q Consensus       190 NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~  266 (353)
                      ||+++.++.++|+|||+++.......  ......+++.|+|||.+.+..++.++|+||+||++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999976432211  1122356788999999998889999999999999999998 89999754321


Q ss_pred             CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          267 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                            ......+..... ...+..++.++.+++.+||+.+|.+||++.|+++.
T Consensus       349 ------~~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         349 ------EQFYNAIKRGYR-MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             ------HHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                  112222222222 22345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=352.62  Aligned_cols=253  Identities=26%  Similarity=0.444  Sum_probs=217.8

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCc-----EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ-----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      +..+..+..+.||+|.||.||.+.......     .||||.++...+......|.+|..+|+.++|||||++.+++.+..
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            445678889999999999999988754322     499999988888888999999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecc
Q 018630          133 AISIILEYMDGGSLADFLKKV-------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG  205 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  205 (353)
                      ..+|++|||+||+|..+|+..       ..++....+.++.|+++|++||++ +++|||||..+|+|++....+||+|||
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999999865       458999999999999999999998 999999999999999999999999999


Q ss_pred             ccccccccCC-CCccc-ccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcC
Q 018630          206 VSAIMASTSG-QANTF-VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ  282 (353)
Q Consensus       206 ~a~~~~~~~~-~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  282 (353)
                      +|+.+..... ..... .-...|||||.+..+.++.++|||||||++||++| |..||.+.+.       .+++.-...+
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------~~v~~~~~~g  920 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------FEVLLDVLEG  920 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-------HHHHHHHHhC
Confidence            9984432222 11111 23468999999999999999999999999999999 9999988543       3455544444


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          283 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      . ...++..++..+.++|..||+.+|++||++..+++
T Consensus       921 g-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  921 G-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             C-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            4 34456789999999999999999999999999988

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.6e-42  Score=309.64  Aligned_cols=251  Identities=33%  Similarity=0.548  Sum_probs=215.6

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +|++.+.||+|++|.||++.+..+++.+|+|.+.... .......+.+|+++++.++|+||+++++.+.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5889999999999999999999999999999987542 334456778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          141 MDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       141 ~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++......  .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCCcEEEeeccchhhhccC--C
Confidence            999999999866    3568999999999999999999998 99999999999999999999999999998776543  2


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.       .+....+.....+.. ...++.++
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~  229 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-------QDLRYKVQRGKYPPI-PPIYSQDL  229 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCCCCC-chhhCHHH
Confidence            3335688999999999988899999999999999999999999976432       223333333333322 34788999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .+++.+||+.+|++|||+.++++||++
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         230 QNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-42  Score=317.58  Aligned_cols=250  Identities=28%  Similarity=0.393  Sum_probs=205.9

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCc--EEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQ--FFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      ++|++.+.||+|+||.||++..+.++.  .+++|.++..........+.+|+.++.++ +||||+++++.+...+.++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            679999999999999999999877765  47888887544445567788999999888 799999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEE
Q 018630          138 LEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI  201 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  201 (353)
                      +||+++++|.+++....                .+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCCeEEE
Confidence            99999999999997532                47889999999999999999998 99999999999999999999999


Q ss_pred             eeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHh
Q 018630          202 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIV  280 (353)
Q Consensus       202 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~  280 (353)
                      +|||++........ ......+..|+|||.+.+..++.++|||||||++|||++ |..||.....       .+....+.
T Consensus       161 ~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-------~~~~~~~~  232 (297)
T cd05089         161 ADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-------AELYEKLP  232 (297)
T ss_pred             CCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHh
Confidence            99999864321111 111223557999999988889999999999999999997 9999976432       22333343


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .... ...+..++.++.+|+.+||+.+|.+|||++++++.
T Consensus       233 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         233 QGYR-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             cCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3322 22345688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-42  Score=313.82  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=204.6

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      +..++|++.+.||+|+||+||++....+++    .+++|.+..........++..|+..+..++||||+++++++. ...
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~   82 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS   82 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence            445789999999999999999999877776    477787754433444567788888899999999999999875 455


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .++++||+++|+|.+++... +.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            78899999999999999764 578999999999999999999998 9999999999999999999999999999976532


Q ss_pred             cCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          213 TSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       213 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      ...  ......++..|+|||.+.++.++.++|+|||||++|||++ |..||.+....       .....+..... ...+
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~  233 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGER-LAQP  233 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCc-CCCC
Confidence            221  1223456778999999988889999999999999999998 99999764321       11222222222 2233


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..++.++.+++.+||..||++|||+.|+++
T Consensus       234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         234 QICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            456789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=320.02  Aligned_cols=260  Identities=23%  Similarity=0.404  Sum_probs=205.4

Q ss_pred             CceeeeeecccCCeEEEEEEecc--CCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec--CeEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKW--TGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAIS  135 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~--~~~~  135 (353)
                      +|.+.+.||+|++|.||+|.++.  +++.||+|.+....  .......+.+|+.+++.++||||+++++.+.+.  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48889999999999999999988  78999999987632  122335677899999999999999999999987  8899


Q ss_pred             EEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC----CCcEEEeeccc
Q 018630          136 IILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH----RGEVKITDFGV  206 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~----~~~~kl~DfG~  206 (353)
                      +||||+++ +|.+++...     ..+++..++.++.|++.||.|||+ .+++||||||+||+++.    ++.+||+|||+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            99999975 787777532     368999999999999999999998 99999999999999999    89999999999


Q ss_pred             cccccccCC---CCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCc------hhhHHHHH
Q 018630          207 SAIMASTSG---QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG------WTSFYELM  276 (353)
Q Consensus       207 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~~~~~~  276 (353)
                      +........   ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+....      ......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            876543322   12334678899999988764 578999999999999999999999986544320      00011111


Q ss_pred             HHHhc--------------------CCCCCCCC-----------CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          277 EAIVD--------------------QPPPSAPS-----------DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       277 ~~~~~--------------------~~~~~~~~-----------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ..+..                    ........           ...+.++.+++.+||+.||++|||+.|++.||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            10000                    00000000           1467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.3e-42  Score=319.56  Aligned_cols=256  Identities=23%  Similarity=0.364  Sum_probs=209.6

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEecc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQS  127 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~  127 (353)
                      +.+..++|.+.+.||+|+||.||++++..       +...+|+|.++..........+.+|+.+++.+ +||||+++++.
T Consensus        13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            34556889999999999999999998643       23579999987654455567788899999998 79999999999


Q ss_pred             eEecCeEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcE
Q 018630          128 FYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  191 (353)
Q Consensus       128 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NI  191 (353)
                      +..++..++||||+.+++|.+++....                .++...++.++.|++.||+|||+ +|++||||||+||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Ni  171 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNV  171 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHhe
Confidence            999999999999999999999997642                47888999999999999999998 9999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCc
Q 018630          192 LINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG  268 (353)
Q Consensus       192 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~  268 (353)
                      +++.++.++|+|||+++........  .....+++.|+|||.+.+..++.++|+|||||++|||++ |..||.....   
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---  248 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  248 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---
Confidence            9999999999999998765322111  111234568999999988889999999999999999998 8899865322   


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          269 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                          .+....+..... ...+..++.++.+++.+||..+|++|||+.+++++
T Consensus       249 ----~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         249 ----EELFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             ----HHHHHHHHcCCC-CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                223333333322 23345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.3e-42  Score=311.37  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=209.4

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ..++|++.+.||+|+||.||++.++.++.   .+|+|.++..........+.+|+.+++.++||||+++++.+..++..+
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            34689999999999999999998865443   799999876544555678899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +||||+++++|.+++... ..++...+..++.|++.|+.|||+ +|++||||||+||+++.++.++|+|||++.......
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            999999999999999764 568999999999999999999998 999999999999999999999999999987654322


Q ss_pred             CCC---cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          215 GQA---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       215 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ...   ....++..|+|||.+.+..++.++|+|||||++||+++ |..||...+.       .+....+...... ....
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~  232 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-------QDVIKAIEEGYRL-PAPM  232 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-------HHHHHHHhCCCcC-CCCC
Confidence            211   11223568999999998889999999999999999887 9999976432       1233334433322 2235


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+++++.+++.+||+.+|.+|||+.++++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         233 DCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            67899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.3e-42  Score=309.66  Aligned_cols=242  Identities=24%  Similarity=0.380  Sum_probs=201.0

Q ss_pred             eecccCCeEEEEEEe--ccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           68 VVGKGSGGIVQLVQH--KWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      .||+|+||.||++..  ..+++.+|+|+++... .......+.+|+.+++.+.||||+++++.+. ....++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999864  4567899999986543 3445677899999999999999999999775 45678999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC---Ccccc
Q 018630          145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFV  221 (353)
Q Consensus       145 sL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~---~~~~~  221 (353)
                      +|.+++.....+++..+..++.|++.||+|||+ +|++||||||.||+++.++.++|+|||++.........   .....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            999999887889999999999999999999998 99999999999999999999999999999765433221   11223


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       222 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      ++..|+|||.+....++.++|+|||||++|||++ |..||...+.       ......+.....+ ..+..+++++.++|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~i~~~~~~-~~~~~~~~~l~~li  231 (257)
T cd05116         160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-------NEVTQMIESGERM-ECPQRCPPEMYDLM  231 (257)
T ss_pred             CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence            4578999999988889999999999999999998 9999976432       2333444443332 23457899999999


Q ss_pred             HHhhhhCcCCCCCHHHHHc
Q 018630          301 SACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+||+.||++||+++++..
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         232 KLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHhccCchhCcCHHHHHH
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.5e-42  Score=313.88  Aligned_cols=261  Identities=29%  Similarity=0.520  Sum_probs=215.3

Q ss_pred             CceeeeeecccCCeEEEEEEec---cCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV---EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~  134 (353)
                      +|++.+.||.|+||.||+|.+.   .+|+.||+|+++...   .......+.+|+.++..+ +|+||+.+++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788999999999999999875   478999999987542   223346678899999998 589999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |+|+||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.+++++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            9999999999999999888889999999999999999999998 999999999999999999999999999987653322


Q ss_pred             -CCCcccccCCcccCcceecCC--CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          215 -GQANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       215 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                       .......|+..|+|||.+.+.  .++.++|+||+|+++|+|++|..||......   ....+....+.....+  .+..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~--~~~~  234 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSEPP--YPQE  234 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc---ccHHHHHHHhhccCCC--CCcc
Confidence             112235688999999998753  4688999999999999999999999753322   1222333333333222  2356


Q ss_pred             CCHHHHHHHHHhhhhCcCCCC-----CHHHHHcCCcccccCC
Q 018630          292 FSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGD  328 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~~  328 (353)
                      +++.+.+++.+||+.||++||     ++.+++.||||+....
T Consensus       235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence            889999999999999999997     8999999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.6e-42  Score=309.30  Aligned_cols=250  Identities=25%  Similarity=0.422  Sum_probs=206.6

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +.++|++.+.||+|+||.||.++... +..+|+|.+....  .....+.+|+.+++.++||||+++++++......++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            45789999999999999999998753 4569999886442  22356889999999999999999999999888999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC-
Q 018630          139 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  216 (353)
                      ||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||.||+++.++.+||+|||.++........ 
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            999999999999764 468999999999999999999998 99999999999999999999999999998765332211 


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.       ......+....... .....+..
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~  229 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-------SETVEKVSQGLRLY-RPHLASEK  229 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHhcCCCCC-CCCCCCHH
Confidence            112235568999999988889999999999999999998 9999975432       22333444433322 23456899


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +.+++.+||+.||++|||+.+++.+
T Consensus       230 ~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         230 VYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHh
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1e-42  Score=312.30  Aligned_cols=249  Identities=25%  Similarity=0.385  Sum_probs=210.3

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ..+|.+.+.||.|+||.||++.+.. ++.+|+|++.... ......+.+|+.+++.++||||+++++.+.....+++|||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            3679999999999999999999986 8899999987553 3335568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          140 YMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       140 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |+++++|.+++...  ..++...+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~  161 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS  161 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence            99999999999753  468999999999999999999998 999999999999999999999999999997654332222


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.       .+....+...... ..+..+++++
T Consensus       162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~  233 (261)
T cd05148         162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-------HEVYDQITAGYRM-PCPAKCPQEI  233 (261)
T ss_pred             cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHHhCCcC-CCCCCCCHHH
Confidence            33345678999999988889999999999999999998 8999976432       2233333333222 2345788999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHc
Q 018630          297 CSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+++.+||+.||.+|||+.++++
T Consensus       234 ~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         234 YKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999976

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.8e-42  Score=312.59  Aligned_cols=256  Identities=24%  Similarity=0.372  Sum_probs=203.0

Q ss_pred             cCc-eeeeeecccCCeEEEEEE----eccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--cCe
Q 018630           61 EDI-DTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGA  133 (353)
Q Consensus        61 ~~~-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~~  133 (353)
                      ++| ++++.||+|+||+||++.    ...++..||+|+++..........+.+|+++++.++||||+++++.+..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            345 889999999999998865    3356789999998765444456778899999999999999999998765  346


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      ++++|||+++++|.+++.. ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||+++.....
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            8999999999999999976 459999999999999999999998 99999999999999999999999999998765432


Q ss_pred             CCC---CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc--------hhhHHHHHHHHhcC
Q 018630          214 SGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG--------WTSFYELMEAIVDQ  282 (353)
Q Consensus       214 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--------~~~~~~~~~~~~~~  282 (353)
                      ...   .....++..|+|||.+.+..++.++|+||||+++|||++|..||........        ..............
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            211   1122456679999999888899999999999999999999999865432100        00011111111111


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          283 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .. ...+..++.++.+++.+||+.||++|||++++++
T Consensus       241 ~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         241 MR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11 1224567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.2e-42  Score=318.00  Aligned_cols=254  Identities=22%  Similarity=0.358  Sum_probs=208.6

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEecc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  128 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~  128 (353)
                      .+..++|.+.+.||+|+||.||++++..       ....+|+|.++..........+.+|+.+++.+ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            4556789999999999999999998632       34579999987654555567788999999998 699999999999


Q ss_pred             EecCeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEE
Q 018630          129 YSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  192 (353)
Q Consensus       129 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIl  192 (353)
                      ..++.++++|||+++|+|.+++...                ..++...+..++.|++.||.|||+ +|++||||||+||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Nil  166 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAARNVL  166 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccceeEE
Confidence            9999999999999999999999753                247888999999999999999998 99999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCCCC--cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCch
Q 018630          193 INHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW  269 (353)
Q Consensus       193 l~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~  269 (353)
                      ++.++.+||+|||+++.........  ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.    
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----  242 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----  242 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH----
Confidence            9999999999999997654322111  11234567999999988889999999999999999999 8999966432    


Q ss_pred             hhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          270 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                         .+....+..... ...+..++.++.+++.+||+.||++|||+.++++
T Consensus       243 ---~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         243 ---EELFKLLREGHR-MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             ---HHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence               223333333322 2234567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-42  Score=308.31  Aligned_cols=250  Identities=23%  Similarity=0.369  Sum_probs=207.2

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +..++|++.+.||+|++|.||++.+. +++.||+|.++...  ....++.+|+.+++.++||||+++++.+...+..++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            45678999999999999999999875 45789999987542  2345688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          138 LEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |||+++++|.+++....  .++...+..++.|++.|+.|||+ +|++||||||+||+++.++.++|+|||+++.......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999999997653  68999999999999999999998 9999999999999999999999999999977653221


Q ss_pred             CC-cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          216 QA-NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       216 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .. .....+..|+|||.+.+..++.++|+||||+++|||++ |..||.....       ......+...... ......+
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~  230 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-------AEVLQQVDQGYRM-PCPPGCP  230 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCC-CCCCcCC
Confidence            11 11123457999999988889999999999999999999 9999976432       1233333333222 2335678


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         231 KELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.4e-42  Score=314.28  Aligned_cols=251  Identities=28%  Similarity=0.419  Sum_probs=207.7

Q ss_pred             CccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ...+|.+.+.||+|+||.||++++.     .++..+++|.+... .......+.+|+.+++.++||||+++++.+.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            4567999999999999999999854     34567899987644 23344668899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC
Q 018630          134 ISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG  197 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~  197 (353)
                      .++||||+++++|.+++....                .+++..+..++.|++.|++|||+ +|++||||||+||+++.++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC
Confidence            999999999999999997542                37889999999999999999998 9999999999999999999


Q ss_pred             cEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHH
Q 018630          198 EVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE  274 (353)
Q Consensus       198 ~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~  274 (353)
                      .++|+|||++........  ......++..|+|||.+.+..++.++|+|||||++|||++ |..||...+.       .+
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~  233 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-------TE  233 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HH
Confidence            999999999876543221  1122456788999999998889999999999999999998 9999966432       22


Q ss_pred             HHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          275 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+.+.....+. .....+.++.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         234 VIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            333444433322 33567889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-42  Score=317.75  Aligned_cols=259  Identities=23%  Similarity=0.356  Sum_probs=205.2

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCC--------------cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTG--------------QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVC  124 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~  124 (353)
                      ...+|++.+.||+|+||.||++.+..++              ..||+|.++..........+.+|+++++.++|||++++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            3468999999999999999999875432              35899998766555666789999999999999999999


Q ss_pred             eeEeEecCeEEEEEEecCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEE
Q 018630          125 YQSFYSNGAISIILEYMDGGSLADFLKKVK------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  192 (353)
Q Consensus       125 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIl  192 (353)
                      ++.+...+..++||||+.+++|.+++....            .++...+..++.|++.||.|||+ +|++||||||+||+
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil  161 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChhhEE
Confidence            999999999999999999999999986531            36788899999999999999998 99999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc--CCCCCCCCccCCc
Q 018630          193 INHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT--GQFPYSPPEQQDG  268 (353)
Q Consensus       193 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~Pf~~~~~~~~  268 (353)
                      ++.++.+||+|||++........  ......++..|+|||.+.++.++.++|+|||||++|+|++  |..||...+..+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999876432211  1112344678999999988889999999999999999988  6778876443211


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          269 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .....+...... .......+...++.+.+|+.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQG-RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhcc-ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            111111111111 11111223457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-42  Score=307.37  Aligned_cols=243  Identities=26%  Similarity=0.411  Sum_probs=201.9

Q ss_pred             eeecccCCeEEEEEEeccCC---cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTG---QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||.||++.....+   ..+|+|.+...........+.+|+.+++.+.||||+++++.+. ....++||||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46899999999999876554   7899999876654456678899999999999999999999765 4568999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc---c
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT---F  220 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~---~  220 (353)
                      ++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...........   .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~  158 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG  158 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence            9999999887889999999999999999999998 99999999999999999999999999999866433322111   1


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (353)
                      .++..|+|||.+.+..++.++|+|||||++|++++ |..||...+.       .+....+.... +...+..++..+.++
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~l~~l  230 (257)
T cd05060         159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-------AEVIAMLESGE-RLPRPEECPQEIYSI  230 (257)
T ss_pred             cccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHcCC-cCCCCCCCCHHHHHH
Confidence            23467999999988889999999999999999998 9999976432       12233333332 223345678999999


Q ss_pred             HHHhhhhCcCCCCCHHHHHc
Q 018630          300 ISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +.+||+.+|++|||+.++++
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-42  Score=323.89  Aligned_cols=256  Identities=27%  Similarity=0.409  Sum_probs=206.2

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEe-----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQH-----KWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYS  130 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~  130 (353)
                      .+..++|++.+.||+|+||.||+|.+     ..+++.||||+++..........+.+|+.++..+ +||||+++++.+..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            34567899999999999999999984     3467899999997654455566788999999998 68999999998765


Q ss_pred             c-CeEEEEEEecCCCCHHHHHHhc--------------------------------------------------------
Q 018630          131 N-GAISIILEYMDGGSLADFLKKV--------------------------------------------------------  153 (353)
Q Consensus       131 ~-~~~~lv~e~~~~gsL~~~l~~~--------------------------------------------------------  153 (353)
                      . ...+++|||+++|+|.+++...                                                        
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 5689999999999999998642                                                        


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CCccc
Q 018630          154 -----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTF  220 (353)
Q Consensus       154 -----------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~  220 (353)
                                 ..++...+..++.|++.||+|||+ +||+||||||.||+++.++.+||+|||++........  .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                       136777888999999999999998 9999999999999999999999999999876432211  11123


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (353)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......      ......+...... ..+...++++.++
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~~~  314 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTRM-RAPDYTTPEMYQT  314 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccCCC-CCCCCCCHHHHHH
Confidence            45678999999988889999999999999999997 99999764321      1222233333222 2234578899999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcC
Q 018630          300 ISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +.+||+.||++|||+.|+++|
T Consensus       315 ~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         315 MLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-43  Score=317.59  Aligned_cols=256  Identities=27%  Similarity=0.508  Sum_probs=209.8

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      |++.+.||+|++|.||++.+..+++.+|+|.+.... .......+.+|+.+++.++||||+++++.+..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999999899999999986553 2234567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          142 DGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       142 ~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      ++ +|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.............
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            75 888888763 688999999999999999999998 999999999999999999999999999987765443223335


Q ss_pred             ccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC----------------
Q 018630          221 VGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP----------------  283 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----------------  283 (353)
                      .++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+..+..   ......+....                
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhcccchhhhhhhhh
Confidence            678899999998776 6899999999999999999999999765432211   11111111100                


Q ss_pred             ------CC--CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          284 ------PP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       284 ------~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                            ..  ......++.++.++|.+||+.||.+||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                  00  00123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-42  Score=306.33  Aligned_cols=246  Identities=24%  Similarity=0.414  Sum_probs=208.7

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +..++|++.+.||.|++|.||++...  |+.||+|.++....  ...++.+|+.+++.++|+||+++++.+......++|
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            45678999999999999999999875  78999999875533  467789999999999999999999999989999999


Q ss_pred             EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          138 LEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |||+++++|.+++....  .+++..+..++.|++.|+.|||+ +|++|+||||+||+++.++.++|+|||.++...... 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            99999999999998765  68999999999999999999998 999999999999999999999999999987753221 


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                        .....+..|+|||.+....++.++|+||||+++|++++ |..||.....       ......+...... ..+..+++
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~  226 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPHVEKGYRM-EAPEGCPP  226 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhcCCCC-CCccCCCH
Confidence              12344567999999988889999999999999999997 9999975432       2233333333222 23456789


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ++.++|.+||+.+|++|||+.+++.
T Consensus       227 ~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         227 EVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHH
Confidence            9999999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1e-41  Score=314.56  Aligned_cols=256  Identities=31%  Similarity=0.514  Sum_probs=212.0

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      -|...+.||+|+||.||++++..+++.||+|++....  .......+.+|+.+++.++|||++++++.+.+....++|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            3666788999999999999999999999999986432  23344678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          140 YMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       140 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      |+.+ +|.+++.. ...+++..+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||++....    ...
T Consensus       102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----~~~  175 (313)
T cd06633         102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PAN  175 (313)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCCCEEEeecCCCcccC----CCC
Confidence            9964 88887765 4578999999999999999999998 999999999999999999999999999875432    223


Q ss_pred             ccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          219 TFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ...|+..|+|||.+.   ...++.++|+||+||++|+|++|..||...+..       .....+.....+......++..
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  248 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNDSPTLQSNEWTDS  248 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCCccccCHH
Confidence            457889999999984   356889999999999999999999999764321       1122222233333334567788


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      +.+|+.+||+.+|.+||++.+++.||||+.....+
T Consensus       249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~  283 (313)
T cd06633         249 FRGFVDYCLQKIPQERPASAELLRHDFVRRDRPAR  283 (313)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccCCCchhH
Confidence            99999999999999999999999999999755433

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-42  Score=306.69  Aligned_cols=245  Identities=36%  Similarity=0.607  Sum_probs=211.7

Q ss_pred             ecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           69 VGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      ||.|++|.||.+.+..+++.+|+|++....  .......+..|+.+++.++||||+++++.+..++..++||||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999998889999999987652  223556788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCCcc
Q 018630          147 ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY  226 (353)
Q Consensus       147 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y  226 (353)
                      .+++.....+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||.+..............++..|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            9999988789999999999999999999998 999999999999999999999999999987765433334456788999


Q ss_pred             cCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhh
Q 018630          227 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK  306 (353)
Q Consensus       227 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  306 (353)
                      +|||.+.+..++.++|+||||+++|++++|..||...+.       ......+....  ...+...+.++.+++.+||..
T Consensus       160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILKDP--LRFPEFLSPEARDLISGLLQK  230 (250)
T ss_pred             cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcC
Confidence            999999888889999999999999999999999965432       22233333322  223456689999999999999


Q ss_pred             CcCCCCCH---HHHHcCCcc
Q 018630          307 EPQQRLSA---QELMTHPFL  323 (353)
Q Consensus       307 dp~~Rpt~---~e~l~hp~~  323 (353)
                      ||++|||+   .++++||||
T Consensus       231 ~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         231 DPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CHhhCCCcccHHHHHhCCCC
Confidence            99999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.2e-42  Score=315.28  Aligned_cols=258  Identities=25%  Similarity=0.373  Sum_probs=205.0

Q ss_pred             ccCceeeeeecccCCeEEEEEEecc----------------CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKW----------------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV  123 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~  123 (353)
                      .++|++.+.||+|+||.||++.+..                ++..+|+|++...........+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3679999999999999999986532                344799999876655566678999999999999999999


Q ss_pred             EeeEeEecCeEEEEEEecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEE
Q 018630          124 CYQSFYSNGAISIILEYMDGGSLADFLKKVK-----------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  192 (353)
Q Consensus       124 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIl  192 (353)
                      +++.+..+...++||||+++++|.+++....           .++...+..++.|++.||+|||+ .|++||||||+||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp~Nil  162 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCChheEE
Confidence            9999999999999999999999999987642           36677899999999999999998 99999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc--CCCCCCCCccCCc
Q 018630          193 INHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT--GQFPYSPPEQQDG  268 (353)
Q Consensus       193 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~Pf~~~~~~~~  268 (353)
                      ++.++.++|+|||+++.......  ......+++.|+|||...++.++.++|+|||||++|||++  |..||...+..+.
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            99999999999999876533221  1112234678999999888889999999999999999998  7789976543221


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          269 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ............... ....+..+++.+.+|+.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         243 IENTGEFFRDQGRQV-YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHhhccccc-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            111111111111111 11223457889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.9e-42  Score=313.03  Aligned_cols=249  Identities=24%  Similarity=0.403  Sum_probs=205.4

Q ss_pred             CceeeeeecccCCeEEEEEEecc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      +|++.+.||+|+||.||++.+..     ....+|+|.+...........+.+|+.+++.+.||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47788999999999999998753     2357899988766555556788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEE
Q 018630          137 ILEYMDGGSLADFLKKV------------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  192 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIl  192 (353)
                      ++||+.+++|.+++...                        ..++...+..++.|++.||.|||+ .+++||||||+||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dikp~nil  159 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLAARNVL  159 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhhhheEE
Confidence            99999999999998642                        247888999999999999999998 99999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCch
Q 018630          193 INHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW  269 (353)
Q Consensus       193 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~  269 (353)
                      +++++.++|+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....   
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---  236 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---  236 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence            99999999999999876532221  1122345678999999988889999999999999999998 99999764322   


Q ss_pred             hhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          270 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                          .+......... ...+..++.++.+++.+||+.||++||++.++++
T Consensus       237 ----~~~~~~~~~~~-~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         237 ----RLFNLLKTGYR-MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             ----HHHHHHhCCCC-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                22233333222 2234678899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.8e-42  Score=321.59  Aligned_cols=256  Identities=26%  Similarity=0.462  Sum_probs=203.4

Q ss_pred             eeccc--CCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           68 VVGKG--SGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        68 ~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      .||+|  +||+||++++..+|+.||+|++.... .......+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            45666  99999999999999999999987543 3344577889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC-----
Q 018630          145 SLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-----  217 (353)
Q Consensus       145 sL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-----  217 (353)
                      +|.+++.+.  ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++++||+.+..........     
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD  163 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence            999998864  358999999999999999999998 999999999999999999999999998654332211111     


Q ss_pred             --cccccCCcccCcceecCC--CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-----------
Q 018630          218 --NTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-----------  282 (353)
Q Consensus       218 --~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-----------  282 (353)
                        ....++..|+|||++.+.  .++.++|+||+||++|||++|..||.......      .....+...           
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ------MLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH------HHHHHhcCCCCCCccccccc
Confidence              112345679999999764  47899999999999999999999997643211      111111000           


Q ss_pred             ---------------------------------CCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          283 ---------------------------------PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       283 ---------------------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                                                       .........+++.+.+|+++||+.||++|||+.|+++||||+...+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence                                             00001123456789999999999999999999999999999887665


Q ss_pred             C
Q 018630          330 N  330 (353)
Q Consensus       330 ~  330 (353)
                      .
T Consensus       318 ~  318 (328)
T cd08226         318 T  318 (328)
T ss_pred             c
Confidence            4

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6e-42  Score=314.62  Aligned_cols=256  Identities=21%  Similarity=0.365  Sum_probs=211.4

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEec-------cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHK-------WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQS  127 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~  127 (353)
                      +.+..++|.+.+.||+|+||.||++++.       .++..||+|.+...........+.+|+.+++.+ +||||+++++.
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            3566789999999999999999999753       234579999987554455567889999999998 89999999999


Q ss_pred             eEecCeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcE
Q 018630          128 FYSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  191 (353)
Q Consensus       128 ~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NI  191 (353)
                      +......++||||+.+++|.+++...                ..++...+..++.|++.||.|||+ +|++||||||+||
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~Ni  168 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAARNV  168 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccceE
Confidence            99999999999999999999999763                246778899999999999999998 9999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCc
Q 018630          192 LINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG  268 (353)
Q Consensus       192 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~  268 (353)
                      +++.++.+||+|||+++........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+    
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----  244 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----  244 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence            9999999999999999766432221  122345678999999988889999999999999999998 888886532    


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          269 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                         ..+....+...... ..+..++.++.+++.+||+.+|++|||+.|+++.
T Consensus       245 ---~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         245 ---VEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             ---HHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence               22333444333322 2345788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-42  Score=308.20  Aligned_cols=249  Identities=24%  Similarity=0.434  Sum_probs=204.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ..+|++.+.||+|++|.||++.++ ++..+|+|.+.....  ....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            457889999999999999999886 466899998864322  23457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC-
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-  217 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-  217 (353)
                      |+++++|.+++... ..+++..+..++.|++.|++|||+ .|++||||||+||+++.++.+||+|||+++......... 
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            99999999999753 568999999999999999999998 999999999999999999999999999987654221111 


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..       +....+....... .+..+++++
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~  230 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------EVVESVSAGYRLY-RPKLAPTEV  230 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------HHHHHHHcCCcCC-CCCCCCHHH
Confidence            11123457999999998889999999999999999999 89999754322       2233333332222 234679999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          297 CSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+++.+||+.+|++|||+.|+++.
T Consensus       231 ~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         231 YTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1e-41  Score=307.11  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=209.7

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ...+|+..+.||+|+||.||++.++.+++   .+|+|.++..........+..|+.+++.++|||++++.+.+...+..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            34678899999999999999999876554   799999876644555678899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +||||+++++|.+++... +.+++..+..++.|++.|+.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            999999999999999764 578999999999999999999998 999999999999999999999999999987654322


Q ss_pred             CCCc---ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          215 GQAN---TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       215 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ....   ....++.|+|||.+.+..++.++|+|||||++|||++ |..||...+.       .+....+...... ....
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~~~~i~~~~~~-~~~~  233 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVMKAINDGFRL-PAPM  233 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhcCCCC-CCCC
Confidence            1111   1123457999999988889999999999999999997 9999975432       2333444333322 2234


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .++.++.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         234 DCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            67899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=324.14  Aligned_cols=253  Identities=28%  Similarity=0.457  Sum_probs=201.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC-eEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-AISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~-~~~lv~e  139 (353)
                      ++|.....||+|+||.||++.-. +|+.||||.+....... ..++..|+.++.+++|||+|+++++|.+.+ ..+||+|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE  152 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE  152 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence            56777789999999999999886 45899999887654332 566999999999999999999999999888 5999999


Q ss_pred             ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          140 YMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEK--HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~--~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      ||++|||.+++....  .+++..+.+||.++++||+|||...  .||||||||.|||+|.+.++||+|||+|+.......
T Consensus       153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~  232 (361)
T KOG1187|consen  153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT  232 (361)
T ss_pred             ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence            999999999998654  8999999999999999999999855  399999999999999999999999999965432122


Q ss_pred             CCccc-ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH---------HHHHhcCCCC
Q 018630          216 QANTF-VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL---------MEAIVDQPPP  285 (353)
Q Consensus       216 ~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~---------~~~~~~~~~~  285 (353)
                      ...+. .||.+|+|||.+..+..+.++||||||+++.||+||+.|......... ....+.         ...+.+....
T Consensus       233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~-~~l~~w~~~~~~~~~~~eiiD~~l~  311 (361)
T KOG1187|consen  233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE-LSLVEWAKPLLEEGKLREIVDPRLK  311 (361)
T ss_pred             ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc-ccHHHHHHHHHHCcchhheeCCCcc
Confidence            22222 799999999999989999999999999999999999988765431111 111121         1122222211


Q ss_pred             CCCCCCCC-----HHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          286 SAPSDQFS-----PEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       286 ~~~~~~~~-----~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                         ....+     ..+..+..+|++.+|.+||++.|+++
T Consensus       312 ---~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  312 ---EGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ---CCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence               02222     23667889999999999999999755

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.4e-42  Score=306.59  Aligned_cols=242  Identities=26%  Similarity=0.388  Sum_probs=198.9

Q ss_pred             eecccCCeEEEEEEec--cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCC
Q 018630           68 VVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGS  145 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gs  145 (353)
                      .||+|+||.||++...  ..+..||+|++...........+.+|+.+++.++||||+++++.+. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999998765  3456799999876655556677999999999999999999999875 457899999999999


Q ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC---cccc
Q 018630          146 LADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA---NTFV  221 (353)
Q Consensus       146 L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~---~~~~  221 (353)
                      |.+++.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++..........   ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            9999875 4578999999999999999999998 999999999999999999999999999987543322211   1122


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       222 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      ++..|+|||.+....++.++|+|||||++||+++ |..||.....       ......+.....+ ..+...++++.+++
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~l~~li  231 (257)
T cd05115         160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-------PEVMSFIEQGKRL-DCPAECPPEMYALM  231 (257)
T ss_pred             CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence            3568999999988889999999999999999996 9999976432       1233333333332 23456789999999


Q ss_pred             HHhhhhCcCCCCCHHHHHc
Q 018630          301 SACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+||..||++||++.++.+
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999966

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.5e-42  Score=310.72  Aligned_cols=252  Identities=30%  Similarity=0.442  Sum_probs=207.7

Q ss_pred             CCccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ++..+|...+.||+|+||.||++...     .++..+|+|.+... .......+.+|+++++.++|+||+++++.+....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            34567889999999999999999743     34668999987654 3445567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC
Q 018630          133 AISIILEYMDGGSLADFLKKVK---------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG  197 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~---------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~  197 (353)
                      ..+++|||+++++|.+++...+               .+++..+..++.|++.|++|||+ .|++||||||+||+++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCCC
Confidence            9999999999999999997643               47889999999999999999998 9999999999999999999


Q ss_pred             cEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHH
Q 018630          198 EVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE  274 (353)
Q Consensus       198 ~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~  274 (353)
                      .++|+|||+++.......  ......+++.|+|||.+.+..++.++|+|||||++|||++ |.+||......       +
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~  232 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------E  232 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------H
Confidence            999999999875432211  1112235678999999998889999999999999999998 99999654321       2


Q ss_pred             HHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          275 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ....+...... ..+..+++.+.+++.+||+.||++||+++++++
T Consensus       233 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         233 AIECITQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHHcCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            33334333332 234568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.5e-42  Score=309.54  Aligned_cols=253  Identities=23%  Similarity=0.387  Sum_probs=210.6

Q ss_pred             ccCceeeeeecccCCeEEEEEEecc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .++|+.++.||.|+||.||+++.+.     +.+.+|+|.+...........+.+|+.+++.++||||+++++.+.+....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            4789999999999999999999754     34679999886654444567789999999999999999999999988999


Q ss_pred             EEEEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecc
Q 018630          135 SIILEYMDGGSLADFLKKVK---------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG  205 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  205 (353)
                      ++||||+++++|.+++....         .+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++++|||
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l~~~~  162 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQREVKVSLLS  162 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCCcEEEcccc
Confidence            99999999999999998655         68999999999999999999998 999999999999999999999999999


Q ss_pred             ccccccccC-CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          206 VSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       206 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      ++....... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....       ...........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~~~~  235 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQAGK  235 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHHcCC
Confidence            986543221 12233456778999999988888999999999999999998 8899965432       12233333333


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ........++..+.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            3233345788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-42  Score=313.21  Aligned_cols=256  Identities=29%  Similarity=0.479  Sum_probs=207.0

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec--CeEEEEEE
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILE  139 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e  139 (353)
                      |++.+.||.|++|.||++.+..+++.+|+|.+.... .......+.+|+.+++.++|||++++++.+...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999999899999999997653 233345678899999999999999999999887  89999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CC
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QA  217 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~  217 (353)
                      |+++ +|.+++... ..+++..++.++.|++.||+|||+ .|++|+||+|+||++++++.++|+|||++........ ..
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            9975 999988765 579999999999999999999998 9999999999999999999999999999976654321 12


Q ss_pred             cccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-------------
Q 018630          218 NTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-------------  283 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------------  283 (353)
                      ....++..|+|||.+.+ ..++.++|+||||+++|||++|..||...+......   .+........             
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhccccccchhh
Confidence            23456889999998765 357899999999999999999999997654321111   1111100000             


Q ss_pred             ----CC--------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          284 ----PP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       284 ----~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                          ..        ......+++++.+++.+||+.+|.+|||+++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                00        00011138899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.6e-42  Score=312.24  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=209.3

Q ss_pred             CccCceeeeeecccCCeEEEEEEecc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..++|++.+.||+|+||.||+|.+..     ++..+|+|++...........+.+|+.+++.++||||+++++.+..+..
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            45789999999999999999998753     5779999998766555666789999999999999999999999998899


Q ss_pred             EEEEEEecCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcE
Q 018630          134 ISIILEYMDGGSLADFLKKVK----------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  191 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~----------------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NI  191 (353)
                      .++|+||+++++|.+++....                      .+++..+..++.|++.||.|||+ ++++||||||+||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p~ni  161 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLATRNC  161 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccccHhhe
Confidence            999999999999999997432                      36788889999999999999998 9999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCc
Q 018630          192 LINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG  268 (353)
Q Consensus       192 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~  268 (353)
                      +++.++.++|+|||++........  .......+..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+.   
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~---  238 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH---  238 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence            999999999999999875432211  1122234667999999988889999999999999999997 8889865432   


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          269 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                          .+....+....... .+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       239 ----~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 ----EEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             ----HHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                23334444433322 23567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.5e-41  Score=313.86  Aligned_cols=258  Identities=32%  Similarity=0.528  Sum_probs=215.3

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +.|...+.||+|+||.||++++..++..+|+|++...  ........+.+|+++++.++|||++++++.+..+...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            4578889999999999999999989999999998643  22344567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      ||+.| +|.+.+.. ...+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++.....    .
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~  178 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----A  178 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCCCEEEecCCCccccCC----c
Confidence            99975 88777754 4678999999999999999999998 9999999999999999999999999998765332    2


Q ss_pred             cccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          218 NTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ....|++.|+|||.+.   .+.++.++|+||+||++|+|++|..||...+.       ......+.....+......+++
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  251 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPTLQSNEWSD  251 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhccCCCCCCccccH
Confidence            3346888999999974   35688999999999999999999999976432       1223333333333444456788


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  331 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  331 (353)
                      .+.+++.+||+.+|.+|||+.++++|+|+........
T Consensus       252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  288 (317)
T cd06635         252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV  288 (317)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence            9999999999999999999999999999976655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-42  Score=320.88  Aligned_cols=264  Identities=27%  Similarity=0.443  Sum_probs=210.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC------
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~------  132 (353)
                      .++|++++.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++..+.      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            467999999999999999999999999999999986432 2334566889999999999999999999887543      


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .+++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++.....
T Consensus        94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            468999999 6799988865 579999999999999999999998 9999999999999999999999999999876432


Q ss_pred             cCCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH--------HHHHHH----
Q 018630          213 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--------ELMEAI----  279 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~--------~~~~~~----  279 (353)
                         ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.........        .....+    
T Consensus       171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07880         171 ---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED  247 (343)
T ss_pred             ---CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence               2234567899999999876 358899999999999999999999997643211100000        000000    


Q ss_pred             ----hcCCCC------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          280 ----VDQPPP------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       280 ----~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                          ....+.      ......+++++.++|.+||+.||.+|||+.+++.||||+.+.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence                000000      01124678889999999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-42  Score=307.97  Aligned_cols=249  Identities=23%  Similarity=0.355  Sum_probs=203.4

Q ss_pred             ceeeeeecccCCeEEEEEEeccC---CcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe-----
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-----  133 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~-----  133 (353)
                      |.+.+.||+|+||.||.+....+   +..||+|.++... .......+.+|+..++.++||||+++++.+.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56788999999999999987643   4789999987542 33445678999999999999999999998765443     


Q ss_pred             -EEEEEEecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccc
Q 018630          134 -ISIILEYMDGGSLADFLKKV------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  206 (353)
Q Consensus       134 -~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~  206 (353)
                       .++++||+++++|..++...      ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCCeEEECCccc
Confidence             79999999999999988542      358999999999999999999998 9999999999999999999999999999


Q ss_pred             cccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          207 SAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       207 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      ++........  .....++..|+|||.+.+..++.++|+|||||++|||++ |..||...+.       .+....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~  232 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-------HEIYDYLRHGN  232 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC
Confidence            9765433221  111234678999999988889999999999999999999 8999965332       23344444443


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .. ..+..+++++.+++.+||+.||++|||+.|++++
T Consensus       233 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 RL-KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CC-CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33 2346789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.5e-42  Score=307.36  Aligned_cols=249  Identities=24%  Similarity=0.397  Sum_probs=203.5

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +..++|++.+.||+|+||.||++.+..+ ..||+|+++....  ....+.+|+++++.++||||+++++.+. +...++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV   78 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence            3457899999999999999999988755 4699999875322  2356888999999999999999998764 4568999


Q ss_pred             EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||.++.......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999999999763  457899999999999999999998 9999999999999999999999999999976543221


Q ss_pred             C-CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          216 Q-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       216 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      . .....++..|+|||...+..++.++|+|||||++|+|++ |..||......       +....+...... .....++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~-~~~~~~~  229 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRM-PCPPECP  229 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhcCCCC-CCccccC
Confidence            1 112345678999999988889999999999999999999 88899764321       222333332222 2235678


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+.+++.+||+.||++|||++++++
T Consensus       230 ~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         230 ESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.4e-42  Score=306.77  Aligned_cols=249  Identities=26%  Similarity=0.430  Sum_probs=205.1

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +..++|++++.||+|+||.||+|..+ +++.||+|.+.....  ....+.+|+.+++.++||||+++++.+. ....+++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            45578999999999999999999875 578899999875432  2356888999999999999999998764 5678999


Q ss_pred             EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |||+.+++|.+++...  ..++...+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            9999999999998753  468899999999999999999998 9999999999999999999999999999876542211


Q ss_pred             -CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          216 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       216 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                       ......++..|+|||.+....++.++|+||||+++||+++ |..||.+.+.       .+....+...... ..+...+
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~  229 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-------PEVIQNLERGYRM-PRPDNCP  229 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-------HHHHHHHHcCCCC-CCCCCCC
Confidence             1122345678999999988889999999999999999999 9999976432       1222333333222 2345678


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .++.+++.+||+.+|++|||++++++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         230 EELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHH
Confidence            89999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.1e-42  Score=314.85  Aligned_cols=260  Identities=31%  Similarity=0.505  Sum_probs=216.3

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ..|...+.||.|++|.||+++++.+++.+|+|.+...  .......++.+|+++++.++|+|++++++++..+...++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            4578889999999999999999999999999998643  23344567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      ||+. |+|.+++.. ...+++..+..++.|++.|+.|||+ .+++||||+|.||+++.++.++|+|||++.....    .
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCCcEEECCcccceeecC----c
Confidence            9997 588887754 4568999999999999999999998 9999999999999999999999999999865432    2


Q ss_pred             cccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          218 NTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ....+++.|+|||.+.   ...++.++|||||||++|+|++|..||...+..       .....+.....+......++.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  241 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPALQSGHWSE  241 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHHHHhhcCCCCcCcccccH
Confidence            2346888999999874   345788999999999999999999998764321       222233333333334456888


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCH
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  333 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~  333 (353)
                      .+.+||.+||+.+|++||++.++++|||+......+..+
T Consensus       242 ~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~~~  280 (308)
T cd06634         242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM  280 (308)
T ss_pred             HHHHHHHHHhhCCcccCCCHHHHhhCccccccCChhHHH
Confidence            999999999999999999999999999999877666544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-42  Score=312.46  Aligned_cols=255  Identities=26%  Similarity=0.462  Sum_probs=202.7

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhc---CCCCceEEEeeEeEecCe-----
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQS---SQCPYVVVCYQSFYSNGA-----  133 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~---l~hp~iv~~~~~~~~~~~-----  133 (353)
                      |++.+.||+|++|.||+++++.+++.||+|.++.... ......+.+|+.+++.   ++|||++++++.+.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6788999999999999999998899999999875422 2223445566666554   469999999999987766     


Q ss_pred             EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ++++|||+.+ +|.+++....  .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            9999999975 8999887643  58999999999999999999998 999999999999999999999999999987754


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--------
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--------  283 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------  283 (353)
                      ... ......++..|+|||.+.+..++.++|+||+||++|+|++|.+||...+..+...   ..........        
T Consensus       159 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         159 FEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD---KIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             CCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH---HHHHHcCCCChHhcCCCc
Confidence            322 2233457889999999998889999999999999999999999997654432211   1111111000        


Q ss_pred             ----------CC---CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          284 ----------PP---SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       284 ----------~~---~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                                ..   ......+++.+.++|.+||+.||.+||++.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                      00   00012346788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3e-42  Score=320.60  Aligned_cols=266  Identities=24%  Similarity=0.396  Sum_probs=208.7

Q ss_pred             CceeeeeecccCCeEEEEEEeccC--CcEEEEEEeeccc-cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEe----cCe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWT--GQFFALKVIQMNV-EESARRQIAQELKINQSS-QCPYVVVCYQSFYS----NGA  133 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~----~~~  133 (353)
                      +|++.+.||+|+||.||++.+..+  ++.||+|.+.... .......+.+|+.+++.+ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            488899999999999999999888  8899999986432 223345678899999888 59999999986542    246


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      .+++++|+. ++|.+++.....+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            789999996 5999999888889999999999999999999998 99999999999999999999999999999765422


Q ss_pred             CC----CCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH--------HHHHH--
Q 018630          214 SG----QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--------ELMEA--  278 (353)
Q Consensus       214 ~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~--------~~~~~--  278 (353)
                      ..    ......|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.........        +....  
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            21    1233578999999998765 468999999999999999999999997644211100000        00000  


Q ss_pred             ----------HhcCCC--CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          279 ----------IVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       279 ----------~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                                ......  ........+..+.+|+.+||+.||.+|||+.+++.|||++.+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence                      000000  011123467899999999999999999999999999999988754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.4e-43  Score=325.81  Aligned_cols=265  Identities=25%  Similarity=0.435  Sum_probs=211.6

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe-----
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-----  133 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~-----  133 (353)
                      .++|.+.+.||+|++|.||++++..+++.||+|++.... .......+.+|+.+++.+.|||++++.+.+.....     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            468999999999999999999999999999999986542 23344667789999999999999999987765544     


Q ss_pred             -EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 -ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 -~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                       .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence             89999999 5699998876 579999999999999999999998 9999999999999999999999999999876532


Q ss_pred             cCCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--------HH-----
Q 018630          213 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------EA-----  278 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~--------~~-----  278 (353)
                      .   .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.........+..        ..     
T Consensus       171 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07851         171 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES  247 (343)
T ss_pred             c---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence            2   3345788899999988653 57899999999999999999999997654321111110000        00     


Q ss_pred             ---HhcCCCCC------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          279 ---IVDQPPPS------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       279 ---~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                         ........      .....+++++.++|.+||+.||++|||+.++++||||+.+.+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence               00000000      01124588999999999999999999999999999999876554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-42  Score=321.12  Aligned_cols=264  Identities=24%  Similarity=0.400  Sum_probs=208.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------C
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~  132 (353)
                      .++|.+.+.||+|+||.||++.+..+++.||+|++.... .......+.+|+.++++++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            378999999999999999999999899999999986542 223345678899999999999999999987542      4


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ..+++++++ +++|.++++. ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++.....
T Consensus        96 ~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             cEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            578888887 6799888765 469999999999999999999998 9999999999999999999999999999875432


Q ss_pred             cCCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH-----------------
Q 018630          213 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE-----------------  274 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~-----------------  274 (353)
                         ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+..........                 
T Consensus       173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (345)
T cd07877         173 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  249 (345)
T ss_pred             ---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence               2334578899999998866 4688999999999999999999999976433211100000                 


Q ss_pred             ---HHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          275 ---LMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       275 ---~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                         ..........  ........++++.++|.+||+.||.+|||+.+++.||||+.+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence               0000000000  000112468899999999999999999999999999999976543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.9e-42  Score=314.53  Aligned_cols=259  Identities=28%  Similarity=0.457  Sum_probs=207.0

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC-----
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----  132 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~-----  132 (353)
                      ..++|++.+.||.|+||.||++.++.+++.||+|.++.... ......+.+|+.+++.++|||++++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            45789999999999999999999998999999999875422 223356678999999999999999999887544     


Q ss_pred             -----eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccc
Q 018630          133 -----AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  206 (353)
Q Consensus       133 -----~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~  206 (353)
                           .+++|+||+++ ++.+.+... ..+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++.+||+|||+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                 79999999986 777777653 468999999999999999999998 9999999999999999999999999999


Q ss_pred             cccccccCC-CCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018630          207 SAIMASTSG-QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  284 (353)
Q Consensus       207 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  284 (353)
                      +........ ......++..|+|||.+.+. .++.++|+||+||++|+|++|.+||...+..+    ....+........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~  238 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA----QLELISRLCGSPC  238 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCC
Confidence            876543322 11223567889999988654 47899999999999999999999997643221    1111112111110


Q ss_pred             CC-------------------------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          285 PS-------------------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       285 ~~-------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      +.                         .....+++.+.+++.+||+.||++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            00                         0123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.2e-42  Score=307.68  Aligned_cols=251  Identities=24%  Similarity=0.414  Sum_probs=208.3

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ..+|++.+.||+|+||.||+|..+.+++   .||||++...........+..|+.+++.++||||+++++.+..+...++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            4678999999999999999999887665   6999998765555567789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          137 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      ||||+++++|.+++... +.++...+..++.|++.|+.|||+ +|++|+||||+||+++.++.++|+|||++........
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            99999999999998764 568999999999999999999998 9999999999999999999999999999876533221


Q ss_pred             C--Ccccc---cCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          216 Q--ANTFV---GTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       216 ~--~~~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      .  .....   .+..|+|||.+.+..++.++|+||+||++||+++ |..||...+.       .+....+..... ...+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-------~~~~~~i~~~~~-~~~~  233 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------QDVINAIEQDYR-LPPP  233 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-------HHHHHHHHcCCc-CCCc
Confidence            1  11111   2457999999998889999999999999999886 9999976432       123333332222 2223


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..++.++.+++.+||+.+|++||++++++.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         234 MDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.6e-42  Score=317.83  Aligned_cols=257  Identities=22%  Similarity=0.360  Sum_probs=210.7

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccC-------CcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEee
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT-------GQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQ  126 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~  126 (353)
                      .+.+...+|++.+.||+|+||.||+|.+...       +..||+|.++..........+.+|+.+++++ +||||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            4556667899999999999999999986432       2368999887655555667889999999999 7999999999


Q ss_pred             EeEecCeEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCc
Q 018630          127 SFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  190 (353)
Q Consensus       127 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~N  190 (353)
                      .+..++..++++||+++|+|.+++....                .++...+..++.|++.||.|||+ +|++||||||+|
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N  164 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARN  164 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccce
Confidence            9999999999999999999999997532                36778889999999999999998 999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018630          191 LLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  267 (353)
Q Consensus       191 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~  267 (353)
                      |+++.++.+||+|||+++........  .....++..|+|||.+.+..++.++|+|||||++|||++ |..||...+.  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            99999999999999998765432211  122234567999999998889999999999999999998 8899965332  


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          268 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                           .+....+...... ..+..++.++.+++.+||+.+|++|||+.|++++
T Consensus       243 -----~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         243 -----EELFKLLKEGHRM-DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             -----HHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                 2333333333322 2345678899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-43  Score=315.67  Aligned_cols=259  Identities=28%  Similarity=0.505  Sum_probs=209.6

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      |+..+.||+|++|.||++++..+++.||+|++.... .......+..|+.+++.++|+|++++++.+.+...+++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            567788999999999999999999999999987653 2333466778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          142 DGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       142 ~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      ++ +|.+++... ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.............
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            84 999999876 579999999999999999999998 999999999999999999999999999987765443333444


Q ss_pred             ccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--------HHHh-----cCCCCC
Q 018630          221 VGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------EAIV-----DQPPPS  286 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~  286 (353)
                      .++..|+|||.+.+. .++.++|+|||||++|||++|..||...+..+.........        ..+.     ....+.
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            567889999998776 78999999999999999999999997644321111111000        0000     000000


Q ss_pred             -------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          287 -------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       287 -------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                             ......+.++.++|.+||+.||++||+++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                   1112347889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.2e-42  Score=320.37  Aligned_cols=263  Identities=25%  Similarity=0.418  Sum_probs=205.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec---------
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN---------  131 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~---------  131 (353)
                      .+|.+.+.||.|+||.||++.++.+++.||+|.+..... .....+.+|+++++.++||||+++++.+...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            689999999999999999999999999999999865533 3456788899999999999999999766543         


Q ss_pred             -----CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-CCcEEEeecc
Q 018630          132 -----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFG  205 (353)
Q Consensus       132 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG  205 (353)
                           ...++|+||++ ++|.+++.. ..+++..++.++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                 35899999997 499888865 468999999999999999999998 99999999999999974 5578999999


Q ss_pred             ccccccccCC---CCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH--------
Q 018630          206 VSAIMASTSG---QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--------  273 (353)
Q Consensus       206 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~--------  273 (353)
                      .+........   ......++..|+|||.+.. ..++.++|+|||||++|+|++|..||...+..+......        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876532211   1122357889999998754 457899999999999999999999997654321110000        


Q ss_pred             -------HHH-HHHhcCCC-CC----CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          274 -------ELM-EAIVDQPP-PS----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       274 -------~~~-~~~~~~~~-~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                             ... ........ ..    .....++.++.+||.+||+.||.+|||+.+++.||||+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  307 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS  307 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence                   000 00000000 00    01135788999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-41  Score=304.07  Aligned_cols=248  Identities=28%  Similarity=0.438  Sum_probs=209.2

Q ss_pred             ceeeeeecccCCeEEEEEEeccCC----cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTG----QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +++.+.||.|+||.||++.+..++    ..||+|++...........+.+|+.++..++|+||+++++.+.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356788999999999999998766    8999999976655546778999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          139 EYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||+++++|.+++.....  +++..+..++.|++.|+.+||+ .|++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            99999999999976544  9999999999999999999998 99999999999999999999999999998766533221


Q ss_pred             Cc-ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          217 AN-TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       217 ~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      .. ...+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.       ....+.+....... .+..++.
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~  231 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLEYLKKGYRLP-KPENCPP  231 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCCCCC-CCCcCCH
Confidence            11 1236789999999988889999999999999999998 8888875322       23333444433332 3455899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ++.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      232 EIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.2e-42  Score=308.24  Aligned_cols=252  Identities=34%  Similarity=0.511  Sum_probs=208.8

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc----cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +|.+.+.||+|+||.||++.+...+..+++|+++...    ......++.+|+.+++.++||||+++++.+.++...++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5889999999999999999998777777777765321    222334567889999999999999999999989999999


Q ss_pred             EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          138 LEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +||+++++|.+++..    ...+++..+..++.|++.|+.|||+ .|++|+||+|+||+++. +.++|+|||++......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence            999999999998864    3568999999999999999999998 99999999999999965 67999999998766443


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ........|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+       .......+.....+ ..+..++
T Consensus       159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~  230 (260)
T cd08222         159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVEGPTP-SLPETYS  230 (260)
T ss_pred             cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCCCC-CCcchhc
Confidence            333344568889999999988888999999999999999999999996532       12233333333332 2345778


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .++.++|.+||+.||++||++.++++||||
T Consensus       231 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         231 RQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.5e-42  Score=317.89  Aligned_cols=266  Identities=27%  Similarity=0.454  Sum_probs=212.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-cCeEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISII  137 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-~~~~~lv  137 (353)
                      .++|.+.+.||.|+||.||++.+..+++.||+|++... ........+.+|+.+++.++||||+++++++.. ....+++
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv   88 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV   88 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence            46899999999999999999999999999999987543 223345667889999999999999999998875 5678999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      +||+. ++|.++++. ..+++..+..++.|++.||.|||+ +|++||||+|.||+++.++.++|+|||.+.....   ..
T Consensus        89 ~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~~  162 (328)
T cd07856          89 TELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENCDLKICDFGLARIQDP---QM  162 (328)
T ss_pred             eehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCCCEEeCccccccccCC---Cc
Confidence            99994 699888865 468889999999999999999998 9999999999999999999999999999875432   22


Q ss_pred             cccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH--------------------HH
Q 018630          218 NTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--------------------LM  276 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~--------------------~~  276 (353)
                      ....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.........+                    ..
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd07856         163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV  242 (328)
T ss_pred             CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence            34567889999998866 5689999999999999999999999976543111110000                    00


Q ss_pred             HHHhcCCC--CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCc
Q 018630          277 EAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  331 (353)
Q Consensus       277 ~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  331 (353)
                      ........  .......+++++.++|.+||+.+|++|||+++++.||||+.+.+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~  299 (328)
T cd07856         243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD  299 (328)
T ss_pred             hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcc
Confidence            00000000  00111356789999999999999999999999999999988876654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-42  Score=320.66  Aligned_cols=261  Identities=28%  Similarity=0.447  Sum_probs=207.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------Ce
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GA  133 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~~  133 (353)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.+.||||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            58999999999999999999999899999999986532 233345678999999999999999999988654      35


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +++|+||+.. +|.+++.  ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||+++.... 
T Consensus        95 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-  169 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-  169 (342)
T ss_pred             EEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence            6999999974 7877653  468999999999999999999998 9999999999999999999999999999875432 


Q ss_pred             CCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH--------HHH------
Q 018630          214 SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--------MEA------  278 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~--------~~~------  278 (353)
                        ......+++.|+|||.+.+ ..++.++|+|||||++|||++|..||.+.+...........        ...      
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07879         170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA  247 (342)
T ss_pred             --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence              2234577889999999876 45889999999999999999999999865432111110000        000      


Q ss_pred             --HhcCCC---CC---CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          279 --IVDQPP---PS---APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       279 --~~~~~~---~~---~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                        .....+   ..   ......++++.+||.+||+.||++|||+++++.||||+.+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence              000000   00   001246788999999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-41  Score=305.30  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=204.9

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      .+..++|++.+.||+|++|.||++.+. ++..+|+|.+.....  ....+.+|+.+++.++|||++++++.+. ....++
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence            345678999999999999999999876 566799999875422  2346889999999999999999999775 456889


Q ss_pred             EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          137 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +|||+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            99999999999999753  458999999999999999999998 999999999999999999999999999997654322


Q ss_pred             CC-CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          215 GQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       215 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      .. .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+.       .+....+...... ..+...
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~  228 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------REVLEQVERGYRM-PCPQDC  228 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCC-CCCCcC
Confidence            11 112235568999999988889999999999999999999 8999976432       2333344333222 234567


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +.++.+|+.+||+.||++|||++++..
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-41  Score=304.44  Aligned_cols=246  Identities=25%  Similarity=0.427  Sum_probs=204.3

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeE-ecCeEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAIS  135 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~-~~~~~~  135 (353)
                      .+...+|++.+.||+|+||.||++...  |..+|+|.++..   .....+.+|+.+++.++|+|++++++.+. .++..+
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           2 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             CccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            356678999999999999999999764  788999988643   23456889999999999999999998764 456789


Q ss_pred             EEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          136 IILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +++||+++++|.+++....  .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            9999999999999997643  47899999999999999999998 99999999999999999999999999998754322


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      .   ....++..|+|||++.+..++.++|+|||||++|+|++ |..||...+.       .+....+..... ......+
T Consensus       156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~  224 (256)
T cd05082         156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPRVEKGYK-MDAPDGC  224 (256)
T ss_pred             C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCCC-CCCCCCC
Confidence            2   22345668999999988889999999999999999997 9999975322       233333333322 2334578


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ++.+.+++.+||+.+|++|||+.++++
T Consensus       225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         225 PPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-41  Score=309.92  Aligned_cols=258  Identities=23%  Similarity=0.363  Sum_probs=206.1

Q ss_pred             cCceeeeeecccCCeEEEEEEe----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec--CeE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQH----KWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAI  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~--~~~  134 (353)
                      .-|++++.||+|+||.||+++.    ..++..||+|.++..........+.+|+.+++.+.|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3478899999999999999974    4568899999987665555567899999999999999999999988765  578


Q ss_pred             EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      ++||||++|++|.+++.+. ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++|+|||+++.....
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            9999999999999999764 458999999999999999999998 99999999999999999999999999999765432


Q ss_pred             CCC---CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccC--------CchhhHHHHHHHHhcC
Q 018630          214 SGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ--------DGWTSFYELMEAIVDQ  282 (353)
Q Consensus       214 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~~~~~~~~~~~~  282 (353)
                      ...   .....++..|+|||.+.+..++.++|+|||||++|||+++..|+..+...        ............+...
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG  242 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence            221   12345677899999998888999999999999999999987665332110        0000111122222222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          283 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .. ...+..++.++.+|+.+||+.||++|||+.+++++
T Consensus       243 ~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         243 KR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cc-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            22 22345689999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.3e-42  Score=315.31  Aligned_cols=258  Identities=29%  Similarity=0.470  Sum_probs=202.8

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEec-------
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSN-------  131 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~-------  131 (353)
                      .++|.+.+.||.|++|.||++.++.+++.+|+|++..... ......+.+|+++++.++||||+++++.+...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            5899999999999999999999999999999999865422 22234567899999999999999999877543       


Q ss_pred             -CeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          132 -GAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       132 -~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                       ..+++|+||+.+ +|...+.. ...+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++..
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence             357999999975 77777664 3579999999999999999999998 9999999999999999999999999999976


Q ss_pred             ccccCCC-----------CcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH
Q 018630          210 MASTSGQ-----------ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME  277 (353)
Q Consensus       210 ~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~  277 (353)
                      .......           .....+++.|+|||.+.+. .++.++|+||+||++|||++|.+||.+.+....   ...+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~~~~~~  241 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---LHLIFK  241 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH
Confidence            5322211           1223568889999988654 578999999999999999999999976543211   111111


Q ss_pred             HHhcCC----------------------CCC---CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          278 AIVDQP----------------------PPS---APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       278 ~~~~~~----------------------~~~---~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                       .....                      .+.   ......++++.++|.+||+.||.+|||+.|++.||||
T Consensus       242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 -LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             -HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence             10000                      000   0012345789999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-41  Score=306.89  Aligned_cols=248  Identities=25%  Similarity=0.346  Sum_probs=200.7

Q ss_pred             eeeeeecccCCeEEEEEEeccCCc--EEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------CeE
Q 018630           64 DTIKVVGKGSGGIVQLVQHKWTGQ--FFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAI  134 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~~~  134 (353)
                      .+.+.||+|+||.||++.+..++.  .+|+|.++.. ........+.+|+.+++.++||||+++++.+...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999999877765  6899988754 2344567788999999999999999999876432      357


Q ss_pred             EEEEEecCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          135 SIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      +++|||+.+|+|.+++..      ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCCCEEECCCCccc
Confidence            899999999999998742      1347899999999999999999998 999999999999999999999999999998


Q ss_pred             cccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018630          209 IMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPP  285 (353)
Q Consensus       209 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  285 (353)
                      ........  .....+++.|+|||.+.+..++.++|+|||||++|||++ |..||...+.       .+....+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~  233 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLRQGNRL  233 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcCCCC
Confidence            75432211  122345678999999998889999999999999999999 8999976332       1233334433322


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      . ....++..+.+++.+||+.||++|||+.+++++
T Consensus       234 ~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         234 K-QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             C-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2 235678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-41  Score=307.16  Aligned_cols=256  Identities=28%  Similarity=0.449  Sum_probs=202.8

Q ss_pred             cCceeeeeecccCCeEEEEEE----eccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--cCeE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAI  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~~~  134 (353)
                      .+|++++.||+|+||.||.+.    +..+++.||+|.++.. .......+.+|+++++.++||||+++++++..  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            578999999999999999987    3457889999998754 33445678899999999999999999997653  3578


Q ss_pred             EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      ++|+||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            9999999999999999764 468999999999999999999998 99999999999999999999999999999865432


Q ss_pred             CCCC---cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC---------chhhHHHHHHHHhc
Q 018630          214 SGQA---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD---------GWTSFYELMEAIVD  281 (353)
Q Consensus       214 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------~~~~~~~~~~~~~~  281 (353)
                      ....   ....++..|+|||.+.+..++.++|+|||||++|||++|..|+..+....         ...........+..
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN  241 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence            2111   11223456999999988889999999999999999999877764432210         00011112222222


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      . ........++.++.+|+.+||+.+|++|||+.|+++
T Consensus       242 ~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         242 N-GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             C-CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2 222334568899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.3e-41  Score=309.87  Aligned_cols=261  Identities=30%  Similarity=0.541  Sum_probs=213.3

Q ss_pred             CceeeeeecccCCeEEEEEEec---cCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV---EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~  134 (353)
                      +|.+.+.||+|++|.||++.+.   .+++.||||+++...   .......+.+|+.++..+ +||||+++++.+..+..+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788999999999999999864   467899999987542   123345678899999998 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ++||||+.+++|.+++.....+++..+..++.|++.||.|||+ .+++||||+|.||+++.++.++|+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            9999999999999999877789999999999999999999998 999999999999999999999999999987654332


Q ss_pred             CC-CcccccCCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          215 GQ-ANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       215 ~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      .. .....|+..|+|||.+.+..  .+.++|+||+|+++|+|++|..||.......   ...+....+.....  ..+..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~--~~~~~  234 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKSKP--PFPKT  234 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHHHccCC--CCCcc
Confidence            21 22346889999999987654  7889999999999999999999996533221   12222333333322  22356


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCC---HHHHHcCCcccccCC
Q 018630          292 FSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMYGD  328 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~~~  328 (353)
                      +++++.+++.+||+.||++|||   +.++++||||+....
T Consensus       235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            7899999999999999999998   567799999988754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=304.03  Aligned_cols=251  Identities=26%  Similarity=0.412  Sum_probs=207.9

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      .+..++|.+.+.||+|++|.||++.+. +++.+|||.+.....  ....+.+|+.+++.++||||+++++.+......++
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            355689999999999999999999976 557899999875422  34568899999999999999999999998899999


Q ss_pred             EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          137 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ||||+++++|.+++...  ..++...+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||++.......
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            99999999999999764  368999999999999999999998 999999999999999999999999999987654221


Q ss_pred             CC-CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          215 GQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       215 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      .. .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.       ......+...... ..+...
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~  229 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-------REVLEQVERGYRM-PRPPNC  229 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC-CCCCCC
Confidence            11 112234568999999998889999999999999999998 9999965432       2233344333222 223456


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +.++.+++.+||+.+|++||+++++++
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         230 PEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.5e-42  Score=320.78  Aligned_cols=266  Identities=26%  Similarity=0.436  Sum_probs=210.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEec--CeEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSN--GAIS  135 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~--~~~~  135 (353)
                      .++|++.+.||+|+||.||++.+..+++.+|+|.+... ........+.+|+.+++++ +||||+++++++...  ..++
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            36899999999999999999999988999999987543 2233345677899999999 999999999988643  4689


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||+.+ +|.+++... .+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++........
T Consensus        86 lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          86 LVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            99999974 999998775 78899999999999999999998 9999999999999999999999999999976543321


Q ss_pred             -----CCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH----------------
Q 018630          216 -----QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY----------------  273 (353)
Q Consensus       216 -----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----------------  273 (353)
                           ......|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||......+......                
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                 2223568999999998865 457899999999999999999999997643321100000                


Q ss_pred             ----HHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          274 ----ELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       274 ----~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                          .....+....  ........++.++.++|.+||+.||++|||+.++++|||++.+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                0000000000  011112347889999999999999999999999999999988743

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=359.44  Aligned_cols=261  Identities=32%  Similarity=0.548  Sum_probs=227.1

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++.....||.|.||.||-|.+..+|+..|+|.++... .......+.+|+.++..++|||+|.+|++-.+....+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            4556678999999999999999999999999886552 244557789999999999999999999999888999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC----C
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----Q  216 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~----~  216 (353)
                      |+||+|.++++..+..++.....+..|++.|+.|||+ .|||||||||+||+++.+|.+|++|||.|..+.....    .
T Consensus      1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            9999999999988888888888999999999999998 9999999999999999999999999999987754432    2


Q ss_pred             CcccccCCcccCcceecCCC---CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          217 ANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .....||+-|||||++.+..   ...++|||||||++.||+||+.||...+.      ...++..+..+..|..+ ..++
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy~V~~gh~Pq~P-~~ls 1467 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMYHVAAGHKPQIP-ERLS 1467 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHhHHhccCCCCCc-hhhh
Confidence            23578999999999997743   56789999999999999999999987543      34667777777766554 5599


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      ++..+||.+||+.||.+|.++.|++.|-|-+...+..
T Consensus      1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred             HhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence            9999999999999999999999999999988766543

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-41  Score=305.96  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=209.6

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      +...+|++.+.||+|+||.||++.++.+|+    .+|+|.+...........+.+|+.++..++||||+++++.+.. ..
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            345789999999999999999999876665    6899988766555566788899999999999999999998886 78


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .++|+||+++|+|.+++... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||+++....
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            89999999999999999764 568999999999999999999998 9999999999999999999999999999976543


Q ss_pred             cCCCCc--ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          213 TSGQAN--TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       213 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      ......  ...++..|+|||.+....++.++|+||+||++||+++ |..||.....       .++...+...... ..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~  233 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------VEIPDLLEKGERL-PQP  233 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhCCCCC-CCC
Confidence            222111  1223568999999988889999999999999999998 9999976432       2333344433322 223


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ...+.++.+++.+||..||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         234 PICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            457889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-42  Score=311.72  Aligned_cols=258  Identities=28%  Similarity=0.426  Sum_probs=205.4

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEEEEEec
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      |.+.+.||+|++|.||+|....+++.||||.+.............+|+..++.+. |||++++++.+..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            6778999999999999999998899999999865533333344567888888998 999999999999999999999999


Q ss_pred             CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          142 DGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       142 ~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                       +++|.+++....  .+++..+..++.|++.+|.|||+ +|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcCC
Confidence             679999887754  78999999999999999999998 999999999999999999999999999987654322 2334


Q ss_pred             cccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH---------------HHHHHhcCC
Q 018630          220 FVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------LMEAIVDQP  283 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---------------~~~~~~~~~  283 (353)
                      ..++..|+|||.+.. ..++.++|+||||++++||++|.+||...+..+.......               ....+....
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            568889999998854 4579999999999999999999999976543221111000               000000000


Q ss_pred             C------CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          284 P------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       284 ~------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .      ........+.++.++|.+||+.||++|||+.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0      000011236889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.5e-41  Score=341.82  Aligned_cols=148  Identities=32%  Similarity=0.549  Sum_probs=137.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +++|.+++.||.|+||.||++.+..+++.||||+++..  ........+.+|+.++..++||||++++..+.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            47899999999999999999999999999999998754  2344457788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      |||+.|++|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999888889999999999999999999998 899999999999999999999999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.5e-42  Score=303.81  Aligned_cols=229  Identities=26%  Similarity=0.356  Sum_probs=191.8

Q ss_pred             cCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCHHHHHH
Q 018630           72 GSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK  151 (353)
Q Consensus        72 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  151 (353)
                      |.+|.||+|+++.+++.||+|.+....      ...+|...+....||||+++++.+.+....++||||++|++|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999999999999999987542      12234444455679999999999999999999999999999999998


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCCcccCcce
Q 018630          152 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER  231 (353)
Q Consensus       152 ~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~  231 (353)
                      +...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++++|||.+......   .....++..|+|||.
T Consensus        78 ~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~  153 (237)
T cd05576          78 KFLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEV  153 (237)
T ss_pred             HhcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCcc
Confidence            87789999999999999999999998 99999999999999999999999999987655432   223456778999999


Q ss_pred             ecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCC
Q 018630          232 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR  311 (353)
Q Consensus       232 ~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  311 (353)
                      +.+..++.++|+||+|+++|||++|..||......            +. .......+..+++.+.++|.+||+.||++|
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  220 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------IN-THTTLNIPEWVSEEARSLLQQLLQFNPTER  220 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cc-cccccCCcccCCHHHHHHHHHHccCCHHHh
Confidence            98888999999999999999999999887542110            00 001112235678999999999999999999


Q ss_pred             CCH-----HHHHcCCcc
Q 018630          312 LSA-----QELMTHPFL  323 (353)
Q Consensus       312 pt~-----~e~l~hp~~  323 (353)
                      ||+     +++++||||
T Consensus       221 ~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         221 LGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cCCCccchHHHHcCCCC
Confidence            986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.2e-41  Score=307.00  Aligned_cols=253  Identities=21%  Similarity=0.318  Sum_probs=209.4

Q ss_pred             CCccCceeeeeecccCCeEEEEEEecc----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-cC
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKW----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NG  132 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-~~  132 (353)
                      +..++|.+.+.||+|+||.||++.+..    ++..||+|.+...........+.+|+.+++.++||||+++++.+.. +.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            445789999999999999999999875    3578999998766566667888999999999999999999998765 57


Q ss_pred             eEEEEEEecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeec
Q 018630          133 AISIILEYMDGGSLADFLKKV--------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF  204 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~Df  204 (353)
                      ..++++||+.+++|.+++...        ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+||
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCCcEEECCC
Confidence            789999999999999998753        458899999999999999999998 99999999999999999999999999


Q ss_pred             cccccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhc
Q 018630          205 GVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD  281 (353)
Q Consensus       205 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~  281 (353)
                      |+++.+......  .....++..|+|||++.+..++.++|||||||++||+++ |..||...+.       .+....+..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-------FEMAAYLKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHc
Confidence            999765322211  112345678999999988889999999999999999999 9999976432       122233333


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .... .....+++++.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         235 GYRL-AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCC-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3222 223467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=313.85  Aligned_cols=258  Identities=27%  Similarity=0.432  Sum_probs=209.3

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCC--Cc----eEEEeeEeEecC
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC--PY----VVVCYQSFYSNG  132 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--p~----iv~~~~~~~~~~  132 (353)
                      ...+|+++..+|+|+||.|-.+.+..++..||||+++.-  ...+...+-|+++++++.+  |+    ++++.++|...+
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            357899999999999999999999999999999998632  3444556678888888732  33    778888899999


Q ss_pred             eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC---------------
Q 018630          133 AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---------------  195 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~---------------  195 (353)
                      +.|+|+|.+ |-|+++++..+  .+++...++.+++||+.++++||+ .+++|.||||+|||+.+               
T Consensus       165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCccce
Confidence            999999999 56999999875  568999999999999999999998 99999999999999943               


Q ss_pred             -----CCcEEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchh
Q 018630          196 -----RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT  270 (353)
Q Consensus       196 -----~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~  270 (353)
                           +..++++|||.|+...   ....+.+.|..|+|||++.+-.|++++||||+||||.||++|...|..-+.    .
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen----~  315 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN----L  315 (415)
T ss_pred             eccCCCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc----H
Confidence                 2358999999987643   234667899999999999999999999999999999999999999976542    2


Q ss_pred             hHHHHHHHHhcCCCCCCC-----------------------------------------CCCCCHHHHHHHHHhhhhCcC
Q 018630          271 SFYELMEAIVDQPPPSAP-----------------------------------------SDQFSPEFCSFISACVQKEPQ  309 (353)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~li~~~L~~dp~  309 (353)
                      ....+++.+....+....                                         .+....++.+||++||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            333455555442221000                                         000122488999999999999


Q ss_pred             CCCCHHHHHcCCcccccC
Q 018630          310 QRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       310 ~Rpt~~e~l~hp~~~~~~  327 (353)
                      +|+|+.|++.||||+...
T Consensus       396 ~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  396 RRITLREALSHPFFARLT  413 (415)
T ss_pred             ccccHHHHhcCHHhhcCC
Confidence            999999999999998754

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.4e-41  Score=302.66  Aligned_cols=244  Identities=23%  Similarity=0.364  Sum_probs=202.5

Q ss_pred             eeecccCCeEEEEEEecc-CCc--EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHKW-TGQ--FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|++|.||++.+.. .++  .||||.+...........+.+|+.++++++||||+++++.+.. ..+++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999999865 333  6999998766444566789999999999999999999999888 899999999999


Q ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC---Cc
Q 018630          144 GSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---AN  218 (353)
Q Consensus       144 gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~---~~  218 (353)
                      ++|.+++....  .+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.+||+|||++.........   ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence            99999997754  68999999999999999999998 99999999999999999999999999999776432211   11


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018630          219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  297 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ...++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.       .+....+.........+...+..+.
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~  231 (257)
T cd05040         159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-------SQILKKIDKEGERLERPEACPQDIY  231 (257)
T ss_pred             CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCcCCCCccCCHHHH
Confidence            2456788999999988889999999999999999998 9999965432       2223333322222223456789999


Q ss_pred             HHHHHhhhhCcCCCCCHHHHHc
Q 018630          298 SFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       298 ~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +++.+||+.+|++|||+.++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.1e-41  Score=299.94  Aligned_cols=243  Identities=24%  Similarity=0.377  Sum_probs=201.6

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      +.||+|+||.||++... +++.+|+|.+...........+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36899999999999865 68899999987665555566788999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC-cccccCC
Q 018630          147 ADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-NTFVGTY  224 (353)
Q Consensus       147 ~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~gt~  224 (353)
                      .+++... ..+++..+..++.|++.||.|+|+ +|++||||+|+||+++.++.++|+|||++.......... ....++.
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI  158 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence            9998753 467899999999999999999998 999999999999999999999999999986543221111 1123456


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018630          225 NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  303 (353)
Q Consensus       225 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (353)
                      .|+|||.+....++.++|+||||+++|++++ |..||......       .....+...... ..+..++..+.+++.+|
T Consensus       159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~~li~~~  230 (250)
T cd05085         159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKGYRM-SCPQKCPDDVYKVMQRC  230 (250)
T ss_pred             cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCCCC-CCCCCCCHHHHHHHHHH
Confidence            7999999988889999999999999999998 99999764321       222333333222 23456789999999999


Q ss_pred             hhhCcCCCCCHHHHHc
Q 018630          304 VQKEPQQRLSAQELMT  319 (353)
Q Consensus       304 L~~dp~~Rpt~~e~l~  319 (353)
                      |+.+|++|||+.|+++
T Consensus       231 l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         231 WDYKPENRPKFSELQK  246 (250)
T ss_pred             cccCcccCCCHHHHHH
Confidence            9999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-41  Score=304.94  Aligned_cols=242  Identities=26%  Similarity=0.393  Sum_probs=198.4

Q ss_pred             eecccCCeEEEEEEeccCCc--EEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           68 VVGKGSGGIVQLVQHKWTGQ--FFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      .||+|+||.||++.++.++.  .+|+|.++..........+.+|+.++..+ +||||+++++.+...+.+++||||++++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            58999999999999987776  46888887544455567788999999998 7999999999999999999999999999


Q ss_pred             CHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          145 SLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       145 sL~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      +|.+++....                .++...+..++.|++.|++|||+ +|++||||||+||+++.++.+||+|||++.
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCCeEEECCCCCcc
Confidence            9999997532                47889999999999999999998 999999999999999999999999999985


Q ss_pred             cccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          209 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      ...... .......+..|+|||++....++.++|+|||||++|||++ |..||...+.       ......+...... .
T Consensus       161 ~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~~~~-~  231 (270)
T cd05047         161 GQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYEKLPQGYRL-E  231 (270)
T ss_pred             ccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-------HHHHHHHhCCCCC-C
Confidence            322111 1111233567999999988889999999999999999997 9999965432       1223333332222 2


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+..++.++.+++.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            33467889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.4e-41  Score=302.56  Aligned_cols=249  Identities=25%  Similarity=0.391  Sum_probs=202.9

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +..++|++...||+|++|.||++.+..+ ..+|+|.+....  .....+.+|+.+++.+.|||++++++.+. .+..+++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence            3457899999999999999999988654 469999876442  23356788999999999999999998775 4568899


Q ss_pred             EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |||+.+++|.+++...  ..++...+..++.|++.||.|||+ .|++|+||+|+||++++++.++|+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            9999999999999764  347889999999999999999998 9999999999999999999999999999976533221


Q ss_pred             -CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          216 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       216 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                       ......++..|+|||...+..++.++|+||||+++|+|++ |..||.+....       +....+...... ..+...+
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~-~~~~~~~  229 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------EVLEQVERGYRM-PCPQGCP  229 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCC-CCCcccC
Confidence             1122345678999999988889999999999999999999 99999764321       222333333222 2235678


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+.+++.+||+.||++||+++++++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         230 ESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-41  Score=300.11  Aligned_cols=243  Identities=27%  Similarity=0.381  Sum_probs=202.0

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      +.||.|++|.||++.+.. ++.||+|.+...........+.+|++++++++||||+++++.+......++||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            368999999999999987 9999999987654445567889999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC--cccccC
Q 018630          147 ADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGT  223 (353)
Q Consensus       147 ~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt  223 (353)
                      .+++... ..++...+..++.|++.|+.|||+ ++++||||+|+||+++.++.++|+|||.+..........  ....++
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            9999653 568899999999999999999998 999999999999999999999999999987543211111  112335


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018630          224 YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  302 (353)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  302 (353)
                      ..|+|||.+.++.++.++|+|||||++|||++ |..||......       .....+.... ....+...+.++.+++.+
T Consensus       159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~~~li~~  230 (251)
T cd05041         159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIESGY-RMPAPQLCPEEIYRLMLQ  230 (251)
T ss_pred             eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHhcCC-CCCCCccCCHHHHHHHHH
Confidence            67999999988889999999999999999999 88999764321       2222232222 222345678999999999


Q ss_pred             hhhhCcCCCCCHHHHHc
Q 018630          303 CVQKEPQQRLSAQELMT  319 (353)
Q Consensus       303 ~L~~dp~~Rpt~~e~l~  319 (353)
                      ||+.+|++|||+.|+++
T Consensus       231 ~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         231 CWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.8e-41  Score=303.81  Aligned_cols=248  Identities=22%  Similarity=0.314  Sum_probs=192.9

Q ss_pred             eeecccCCeEEEEEEec--cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           67 KVVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      +.||+|+||.||++...  .++..+|+|.++..........+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            35899999999999764  3456799999876644445567889999999999999999999999889999999999999


Q ss_pred             CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CC
Q 018630          145 SLADFLKKV-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QA  217 (353)
Q Consensus       145 sL~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~  217 (353)
                      +|.+++...     ...+...+..++.|++.|++|||+ .+++||||||+||+++.+++++|+|||++........  ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            999999753     245677888999999999999998 9999999999999999999999999999865432221  11


Q ss_pred             cccccCCcccCcceecCC-------CCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          218 NTFVGTYNYMSPERISGG-------KYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      ....++..|+|||++.+.       .++.++|+||+|+++|||++ |..||......+.   ..............+...
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHhhcccCCCCCCccC
Confidence            234567889999988642       35789999999999999996 9999976443211   001011111111112222


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ...++.+.+++.+|| .+|++|||++|++.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            356788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.9e-41  Score=310.06  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=206.0

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      +..++|+..+.||+|+||.||++.+..++.    .+|+|.+...........+.+|+.+++.++||||+++++.+... .
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            345788999999999999999999877776    57889887654455556788999999999999999999988654 5


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .++++||+++|+|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCCceEEccccccccccC
Confidence            67899999999999998764 368999999999999999999998 9999999999999999999999999999976543


Q ss_pred             cCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          213 TSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       213 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      ...  ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...    ..   ....+..... ...+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~---~~~~~~~~~~-~~~~  233 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----RE---IPDLLEKGER-LPQP  233 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HH---HHHHHHCCCC-CCCC
Confidence            222  1122345678999999988889999999999999999997 9999976432    11   1222222222 2223


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ...+..+.+++.+||..+|++||+++++++.
T Consensus       234 ~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         234 PICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4578899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-42  Score=322.35  Aligned_cols=260  Identities=26%  Similarity=0.414  Sum_probs=218.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .-|..++.||-|+||.|.+++...+...||+|.+.+.  .........+.|.+||...+.+-||++|-.|.+...+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            4577889999999999999999999999999998655  23445677889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc------
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS------  212 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~------  212 (353)
                      +|++||++-.+|-+.+-+.++.++.++.++.+|+++.|. .|+|||||||+|||||.+|++||+|||+++-+.=      
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            999999999999998999999999999999999999998 9999999999999999999999999999965420      


Q ss_pred             --cCC----------------------------------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcC
Q 018630          213 --TSG----------------------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  256 (353)
Q Consensus       213 --~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  256 (353)
                        .+.                                  ..++.+||+.|+|||++....|+..+|.||.|||||||+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence              000                                  02345799999999999999999999999999999999999


Q ss_pred             CCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCC---CHHHHHcCCcccccC
Q 018630          257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKMYG  327 (353)
Q Consensus       257 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~~~  327 (353)
                      ++||-+....+....+..+...     .......+++.++.++|.++ ..++++|.   .++|+-.||||+...
T Consensus       868 ~~pf~~~tp~~tq~kv~nw~~~-----l~~~~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  868 QPPFLADTPGETQYKVINWRNF-----LHIPYQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             CCCccCCCCCcceeeeeehhhc-----cccccccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccc
Confidence            9999887665532222111111     11234568999999999884 56788998   466799999998754

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.1e-41  Score=302.74  Aligned_cols=251  Identities=27%  Similarity=0.504  Sum_probs=207.5

Q ss_pred             CceeeeeecccCCeEEEEEEecc-CCcEEEEEEeecc---------ccHHHHHHHHHHHHHHhc-CCCCceEEEeeEeEe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKW-TGQFFALKVIQMN---------VEESARRQIAQELKINQS-SQCPYVVVCYQSFYS  130 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~~~~~~~e~~~~~~-l~hp~iv~~~~~~~~  130 (353)
                      .|++.+.||+|+||.||++.+.. .++.+|+|.+...         .......++.+|+.++.+ ++||||+++++.+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999987 6789999987532         123344567788887764 799999999999999


Q ss_pred             cCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccc
Q 018630          131 NGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  206 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~  206 (353)
                      ++..+++|||+++++|.+++..    ...+++..++.++.|++.||.|||+..+++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999998743    356899999999999999999999647899999999999999999999999999


Q ss_pred             cccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          207 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      +....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.       ......+......+
T Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~  232 (269)
T cd08528         161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLATKIVEAVYEP  232 (269)
T ss_pred             eeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHHHHhhccCCc
Confidence            87654332 33455789999999999988899999999999999999999999975432       22333333333333


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .....+++++.++|.+||+.||++|||+.|+..+
T Consensus       233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            3334678999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2e-42  Score=343.91  Aligned_cols=255  Identities=30%  Similarity=0.503  Sum_probs=206.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe----------
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS----------  130 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~----------  130 (353)
                      .+|+.++.||+|+||.||+|+++-+|+.||||++...........+.+|+.++.+++|||||++|..|.+          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            5788999999999999999999999999999999877667777889999999999999999999832100          


Q ss_pred             --------------------------------------------------------------------------------
Q 018630          131 --------------------------------------------------------------------------------  130 (353)
Q Consensus       131 --------------------------------------------------------------------------------  130 (353)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ---------------------c--------CeEEEEEEecCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhcCC
Q 018630          131 ---------------------N--------GAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEKH  180 (353)
Q Consensus       131 ---------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~ql~~~l~~LH~~~~  180 (353)
                                           +        -.+||.||||+.-+|.++++++... ..+.++++++||++||.|+|+ +|
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~-~g  717 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD-QG  717 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh-Cc
Confidence                                 0        2378999999986777777765444 478899999999999999998 99


Q ss_pred             ceecCCCCCcEEEcCCCcEEEeecccccccc------------------ccCCCCcccccCCcccCcceecCC---CCCc
Q 018630          181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMA------------------STSGQANTFVGTYNYMSPERISGG---KYGY  239 (353)
Q Consensus       181 iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~---~~~~  239 (353)
                      ||||||||.||++++++.|||+|||+|+...                  ......++.+||.-|+|||++.+.   .|+.
T Consensus       718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999999999999999998721                  111134567899999999999765   4999


Q ss_pred             cccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhhhhCcCCCCCHHHH
Q 018630          240 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQEL  317 (353)
Q Consensus       240 ~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  317 (353)
                      |+|+||||+++.||+-   ||...      ..-..++..+.++..|..  ....--+.-.++|+.||+.||++||||.|+
T Consensus       798 KiDmYSLGIVlFEM~y---PF~Ts------MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL  868 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEMLY---PFGTS------MERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL  868 (1351)
T ss_pred             hhhhHHHHHHHHHHhc---cCCch------HHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence            9999999999999985   57532      111233344444444333  123334567889999999999999999999


Q ss_pred             HcCCcccc
Q 018630          318 MTHPFLKM  325 (353)
Q Consensus       318 l~hp~~~~  325 (353)
                      |++.||..
T Consensus       869 L~s~llpp  876 (1351)
T KOG1035|consen  869 LNSELLPP  876 (1351)
T ss_pred             hhccCCCc
Confidence            99999985

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.4e-41  Score=304.01  Aligned_cols=244  Identities=22%  Similarity=0.370  Sum_probs=192.2

Q ss_pred             eeecccCCeEEEEEEecc--CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           67 KVVGKGSGGIVQLVQHKW--TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      +.||+|+||.||++....  ....+|+|.+...........+.+|+.+++.++||||+++++.+.....+++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999986532  345788998765545555677889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CC
Q 018630          145 SLADFLKKVK-----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QA  217 (353)
Q Consensus       145 sL~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~  217 (353)
                      +|.+++....     ..++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++........  ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            9999997642     24677888999999999999998 9999999999999999999999999999865432211  11


Q ss_pred             cccccCCcccCcceecC-------CCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHH-HhcCC---CC
Q 018630          218 NTFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA-IVDQP---PP  285 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~---~~  285 (353)
                      ....+++.|+|||++..       ..++.++|+|||||++|||++ |..||......       +.... +....   +.
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~  232 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQDIKLPK  232 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhccCccCCC
Confidence            22345678999998743       356889999999999999999 88898764321       11122 11111   12


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +.....+++.+.+++..|| .||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         233 PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            2234467889999999998 59999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.3e-41  Score=300.41  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=196.1

Q ss_pred             eeecccCCeEEEEEEecc---CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeE-ecCeEEEEEEecC
Q 018630           67 KVVGKGSGGIVQLVQHKW---TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAISIILEYMD  142 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~  142 (353)
                      +.||+|+||.||++.+..   .+..+|+|.+...........+.+|+.+++.++||||+++++.+. .++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998653   345799999865444455677889999999999999999999765 4567899999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC----CC
Q 018630          143 GGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----QA  217 (353)
Q Consensus       143 ~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~----~~  217 (353)
                      +++|.+++... ..++...+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.......    ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            99999999764 456778888999999999999998 9999999999999999999999999999875432211    11


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+.       .+....+.....+ ..+..+++.+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~  231 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------FDITVYLLQGRRL-LQPEYCPDPL  231 (262)
T ss_pred             ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHhcCCCC-CCCCcCCHHH
Confidence            12345678999999988889999999999999999999 5667754322       2233333333222 2335678899


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          297 CSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+++.+||+.+|++||++.|+++.
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-40  Score=300.96  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=206.5

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ..++|.+.+.||+|+||.||++.+...   ...||||.............+.+|+.+++.+.||||+++++++.+ ...+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            446788999999999999999987543   346899988766545566788999999999999999999998775 5578


Q ss_pred             EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +||||+++++|.+++... ..++...+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||+++......
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            999999999999999764 358999999999999999999998 999999999999999999999999999987654332


Q ss_pred             CC-CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          215 GQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       215 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      .. .....++..|+|||.+....++.++|+||||+++||+++ |..||...+..       +....+...... ..+..+
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~-~~~~~~  233 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-------DVIGRIENGERL-PMPPNC  233 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCCcC-CCCCCC
Confidence            11 112234567999999988889999999999999999986 99999764322       223333333322 234578


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ++++.+++.+||..+|++|||+.+++..
T Consensus       234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         234 PPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-40  Score=298.35  Aligned_cols=250  Identities=24%  Similarity=0.401  Sum_probs=205.0

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ++..++|++.+.||+|+||.||++... .+..+|+|.++..  ......+.+|+.+++.++|+||+++++.+.+ ...++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            355689999999999999999999865 5667999987644  2345678899999999999999999998877 77899


Q ss_pred             EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          137 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +|||+++++|.+++...  ..++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            99999999999999763  457888899999999999999998 999999999999999999999999999987653222


Q ss_pred             CC-CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          215 GQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       215 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      .. .....++..|+|||.+....++.++|+|||||++|++++ |..||...+.       ......+..... .......
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~  228 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRALERGYR-MPRPENC  228 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCC-CCCcccC
Confidence            11 112345677999999988889999999999999999998 9999976432       122233333322 2233567


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +.++.+++.+||+.+|++||++.++++
T Consensus       229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         229 PEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1e-40  Score=298.48  Aligned_cols=249  Identities=25%  Similarity=0.430  Sum_probs=205.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ..+|++.+.||+|+||.||++.+. ++..+|+|.++....  ....+.+|+++++.++|||++++++.+......++|+|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            468999999999999999999875 477899998865422  23467889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC-C
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-A  217 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~  217 (353)
                      |+++++|.+++... ..+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||.+......... .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            99999999998764 568999999999999999999998 99999999999999999999999999998765332211 1


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....++..|+|||.+.++.++.++|+||+|+++|||++ |..||.....       ....+.+....... .+...+.++
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~  230 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVVETINAGFRLY-KPRLASQSV  230 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHhCCCCCC-CCCCCCHHH
Confidence            12234678999999988889999999999999999998 9999975332       23333443332222 234568999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          297 CSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+|+.+||+.+|++|||+.+++++
T Consensus       231 ~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         231 YELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHHcccChhhCCCHHHHHHh
Confidence            999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8e-41  Score=303.39  Aligned_cols=258  Identities=26%  Similarity=0.402  Sum_probs=207.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEec----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--cCe
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHK----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGA  133 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~~  133 (353)
                      .++|++.+.||+|+||.||++...    .+++.+|+|.++..........+.+|+++++.+.||||+++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            367888999999999999999864    34789999998766444456789999999999999999999998876  568


Q ss_pred             EEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .+++|||+++++|.+++.... .++...+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||.+.....
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            999999999999999997654 58999999999999999999998 9999999999999999999999999999977642


Q ss_pred             cCCCC---cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch--------hhHHHHHHHHhc
Q 018630          213 TSGQA---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW--------TSFYELMEAIVD  281 (353)
Q Consensus       213 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--------~~~~~~~~~~~~  281 (353)
                      .....   ....++..|+|||.+.+..++.++|+|||||++|||++|..||.........        .........+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            22111   1223456799999998888999999999999999999999998654322100        112222222222


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .. ....+..++.++.+++.+||+.+|.+|||+.|++.
T Consensus       242 ~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         242 GE-RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             CC-cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            22 22234567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-40  Score=297.47  Aligned_cols=244  Identities=26%  Similarity=0.456  Sum_probs=202.1

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +..++|++.+.||+|+||.||++.  .+++.||+|.++...   ....+.+|+.+++.++|||++++++.+..+ ..++|
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           3 LNLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             ccHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence            345789999999999999999886  468899999986542   235678899999999999999999988654 47899


Q ss_pred             EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          138 LEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |||+.+++|.+++....  .++...+..++.|++.|+.|||+ .|++||||||+||+++.++.++|+|||++......  
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            99999999999997643  57899999999999999999998 99999999999999999999999999998654321  


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                       ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.       .+....+.....+ .....++.
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~  224 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KEVKECVEKGYRM-EPPEGCPA  224 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HHHHHHHhCCCCC-CCCCcCCH
Confidence             122234568999999988889999999999999999998 9999976432       2233333333222 23457889


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ++.+++.+||+.+|++|||+++++.
T Consensus       225 ~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         225 DVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-42  Score=321.99  Aligned_cols=245  Identities=26%  Similarity=0.399  Sum_probs=209.5

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHH-hcCCCCceEEEeeEeEecCeEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      ..++|++...+|.|+|+.|..+.+..+++..++|++...     ..+..+|+.++ ..-+||||+++.+++.++.+.|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            357899999999999999999999999999999998755     22334555443 345799999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE-cCCCcEEEeeccccccccccCCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI-NHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll-~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||.+.|+.+.+.+....... ..+..|+.+|+.|+.|||+ +|++||||||+|||+ ++.|+++|+|||.++.....   
T Consensus       395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---  469 (612)
T ss_pred             ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence            99999999988887765555 7888999999999999998 999999999999999 68999999999999775543   


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ..+.+-|..|.|||++....|+.++|+||||++||+|++|..||.....+      .++...+....    ....+|.++
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~----~s~~vS~~A  539 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPK----FSECVSDEA  539 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCc----cccccCHHH
Confidence            44567789999999999889999999999999999999999999764432      23444443332    227899999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ++||++||+.||.+||++.++..||||
T Consensus       540 KdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  540 KDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHHhccCChhhCcChhhhccCcch
Confidence            999999999999999999999999999

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.6e-41  Score=300.80  Aligned_cols=243  Identities=25%  Similarity=0.438  Sum_probs=199.2

Q ss_pred             eecccCCeEEEEEEeccCC------cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           68 VVGKGSGGIVQLVQHKWTG------QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      .||+|+||.||+++++...      +.+|+|.+...........+.+|+.+++.++||||+++++++......++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            5899999999999986443      6899998865544455677889999999999999999999999899999999999


Q ss_pred             CCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-----cEEEeecccccc
Q 018630          142 DGGSLADFLKKV-------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-----EVKITDFGVSAI  209 (353)
Q Consensus       142 ~~gsL~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-----~~kl~DfG~a~~  209 (353)
                      ++++|.+++...       ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++     .++|+|||++..
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            999999999642       237888999999999999999998 9999999999999999887     899999999876


Q ss_pred             ccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          210 MASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       210 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      ......  ......++..|+|||.+.++.++.++|+|||||++|+|++ |..||...+.       .+....+...... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~-  232 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-------QEVLQHVTAGGRL-  232 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-------HHHHHHHhcCCcc-
Confidence            532211  1112345678999999998899999999999999999998 9999975432       1222333322222 


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+..++..+.+++.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         233 QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            234567899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.2e-41  Score=301.72  Aligned_cols=237  Identities=20%  Similarity=0.325  Sum_probs=191.0

Q ss_pred             eecccCCeEEEEEEeccCCc-------EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           68 VVGKGSGGIVQLVQHKWTGQ-------FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      .||+|+||.||++.++..+.       .+|+|.+... .......+.+|+.+++.+.|||++++++.+..+...++||||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            68999999999999865443       4888887543 233445778899999999999999999999998999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc--------EEEeecccccccc
Q 018630          141 MDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--------VKITDFGVSAIMA  211 (353)
Q Consensus       141 ~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~--------~kl~DfG~a~~~~  211 (353)
                      +++|+|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.        ++++|||++....
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence            9999999999765 358999999999999999999998 99999999999999987764        6999999886543


Q ss_pred             ccCCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcC-CCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      .    .....+++.|+|||++.+. .++.++|+|||||++|||++| ..||...+..       .... .....  ...+
T Consensus       160 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-------~~~~-~~~~~--~~~~  225 (258)
T cd05078         160 P----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-------KKLQ-FYEDR--HQLP  225 (258)
T ss_pred             C----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-------HHHH-HHHcc--ccCC
Confidence            2    2234678899999999874 579999999999999999998 4666543221       1111 11111  1223


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ...+.++.+++.+||+.||++|||++++++.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         226 APKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            3466899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.5e-40  Score=301.65  Aligned_cols=256  Identities=17%  Similarity=0.211  Sum_probs=194.7

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccC---CcEEEEEEeeccccHHH----------HHHHHHHHHHHhcCCCCceEEEe
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESA----------RRQIAQELKINQSSQCPYVVVCY  125 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~----------~~~~~~e~~~~~~l~hp~iv~~~  125 (353)
                      ..++|.+.+.||+|+||.||++.+..+   +..+|+|+.........          ......+...+..+.|+|++.++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346899999999999999999998877   66788886543321110          01122334455678999999999


Q ss_pred             eEeEecC----eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEE
Q 018630          126 QSFYSNG----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI  201 (353)
Q Consensus       126 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl  201 (353)
                      +.+....    ..+++++++. .++.+.+......++..+..++.|++.||+|||+ ++++||||||+|||++.++.++|
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCcEEE
Confidence            8765432    4477888875 4788887766667888999999999999999998 99999999999999999999999


Q ss_pred             eeccccccccccCC-------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchh--hH
Q 018630          202 TDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT--SF  272 (353)
Q Consensus       202 ~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~  272 (353)
                      +|||+|+.......       ......||+.|+|||++.+..++.++|||||||++|||++|..||..........  ..
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            99999976542211       1223469999999999999999999999999999999999999998753322111  11


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          273 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+....+.....   .....++++.+++..||+.+|++||+++++++
T Consensus       248 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        248 CDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            122233322221   22456889999999999999999999999875

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.6e-40  Score=297.31  Aligned_cols=235  Identities=21%  Similarity=0.319  Sum_probs=192.0

Q ss_pred             eeecccCCeEEEEEEeccCC----------cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           67 KVVGKGSGGIVQLVQHKWTG----------QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      +.||+|+||.||++.+..++          ..+++|.+......  ...+.+|+.+++.++||||+++++.+.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            36899999999999998766          35788876644222  5778899999999999999999998887 77899


Q ss_pred             EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-------cEEEeeccccc
Q 018630          137 ILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-------EVKITDFGVSA  208 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-------~~kl~DfG~a~  208 (353)
                      ||||+++++|.+++.... .++...+..++.|++.||.|||+ +|++||||||+||+++.++       .++|+|||++.
T Consensus        78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            999999999999998765 78999999999999999999998 9999999999999999887       79999999987


Q ss_pred             cccccCCCCcccccCCcccCcceecCC--CCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018630          209 IMASTSGQANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPP  285 (353)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  285 (353)
                      ....    .....++..|+|||++.+.  .++.++|+||+||++|+|++ |..||...+..+       ...........
T Consensus       157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-------~~~~~~~~~~~  225 (259)
T cd05037         157 TVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------KERFYQDQHRL  225 (259)
T ss_pred             cccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-------HHHHHhcCCCC
Confidence            6543    2234567789999999876  78999999999999999999 688886653211       11111111111


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                         +......+.+++.+||+.+|.+|||+.++++
T Consensus       226 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         226 ---PMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ---CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence               1122378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-40  Score=297.90  Aligned_cols=237  Identities=18%  Similarity=0.327  Sum_probs=189.8

Q ss_pred             eecccCCeEEEEEEecc------------CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           68 VVGKGSGGIVQLVQHKW------------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      .||+|+||.||++....            ....+|+|.+... .......+.+|+.+++.++||||+++++++..+...+
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            58999999999997532            2235889987654 2334456788999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc-------EEEeecccc
Q 018630          136 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE-------VKITDFGVS  207 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~-------~kl~DfG~a  207 (353)
                      +||||+++++|..++... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.       ++++|||++
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~  159 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP  159 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence            999999999999988754 568999999999999999999998 99999999999999987664       899999988


Q ss_pred             ccccccCCCCcccccCCcccCcceec-CCCCCccccHHHHHHHHHHHH-cCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERIS-GGKYGYKSDIWSLGLVLLECA-TGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  285 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  285 (353)
                      ......    ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......       +. .........
T Consensus       160 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~-~~~~~~~~~  227 (262)
T cd05077         160 ITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EK-ERFYEGQCM  227 (262)
T ss_pred             ccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HH-HHHHhcCcc
Confidence            654322    2346788999999886 456899999999999999998 588888653321       11 111111111


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                        .....++++.+||.+||+.||++||++.+++.+
T Consensus       228 --~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         228 --LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             --CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence              122346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5e-40  Score=296.48  Aligned_cols=248  Identities=18%  Similarity=0.295  Sum_probs=190.9

Q ss_pred             eeecccCCeEEEEEEeccC--CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           67 KVVGKGSGGIVQLVQHKWT--GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      +.||+|+||.||++.....  ...+++|.+...........+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3689999999999875433  23567787765544455678999999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--CCCc
Q 018630          145 SLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQAN  218 (353)
Q Consensus       145 sL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~  218 (353)
                      +|.+++.+.    ...+...+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            999999753    345677888999999999999998 999999999999999999999999999875432111  1123


Q ss_pred             ccccCCcccCcceecC-------CCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          219 TFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ...++..|+|||++..       ..++.++|+|||||++|||++ |..||...+..+   ...............+....
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhhcccccCCCccCC
Confidence            3567889999998743       245789999999999999997 677886533211   11111111111111222234


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+++.+.+++..|| .+|++|||++++++
T Consensus       237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         237 PYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            57889999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-40  Score=299.89  Aligned_cols=237  Identities=20%  Similarity=0.316  Sum_probs=189.2

Q ss_pred             eecccCCeEEEEEEeccC------------------------CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEE
Q 018630           68 VVGKGSGGIVQLVQHKWT------------------------GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV  123 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~  123 (353)
                      .||+|+||.||++....+                        ...||+|++.... ......+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            589999999999874321                        2358899886542 334466888999999999999999


Q ss_pred             EeeEeEecCeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-----
Q 018630          124 CYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-----  197 (353)
Q Consensus       124 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-----  197 (353)
                      +++++.++...++||||+++++|..++.. .+.+++..+..++.|++.||+|||+ +||+||||||+||+++..+     
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEeccCcccCc
Confidence            99999999999999999999999999875 4678999999999999999999998 9999999999999997643     


Q ss_pred             --cEEEeeccccccccccCCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHH-cCCCCCCCCccCCchhhHH
Q 018630          198 --EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECA-TGQFPYSPPEQQDGWTSFY  273 (353)
Q Consensus       198 --~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~~~~~~~~~  273 (353)
                        .++++|||++......    ....++..|+|||.+.+ ..++.++|+|||||++|||+ +|..||......+      
T Consensus       160 ~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------  229 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE------  229 (274)
T ss_pred             cceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH------
Confidence              4899999987543221    22357788999998865 46899999999999999995 6999997643321      


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          274 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                       ....... ..  ..+...++++.++|.+||+.+|++|||+.+++++
T Consensus       230 -~~~~~~~-~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 -KERFYEK-KH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -HHHHHHh-cc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             1111111 11  1123356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=324.26  Aligned_cols=270  Identities=34%  Similarity=0.602  Sum_probs=228.7

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeE-----ecCeE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY-----SNGAI  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~-----~~~~~  134 (353)
                      +-|++..+||.|.+|.||+++++.+++..|+|+.....+  ...++..|.++++.. +|||++.+|++|.     .++.+
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            568999999999999999999999999999999876533  335667788887765 6999999999886     35789


Q ss_pred             EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      +||||||.|||..|+++..  .++.+..+..|++.++.|+.+||. +.++|||+|-.|||++.++.|||+|||++..+..
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            9999999999999999753  678999999999999999999998 8899999999999999999999999999999888


Q ss_pred             cCCCCcccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      ......+.+|||.|||||++..     ..|+.++|+||||++..||.-|.+|+.++.+..       .+-.+...++|..
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------aLF~IpRNPPPkL  248 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPRNPPPKL  248 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------hhccCCCCCCccc
Confidence            8888888999999999999854     347889999999999999999999999876532       2223334444333


Q ss_pred             -CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhhC
Q 018630          288 -PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAG  341 (353)
Q Consensus       288 -~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~  341 (353)
                       .+...+.++.+||+.||.+|-++||+..+++.|||++.-. ..-.|...+++-.
T Consensus       249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~-~e~qir~~ik~~~  302 (953)
T KOG0587|consen  249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP-NERQVRIQIKDHI  302 (953)
T ss_pred             cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc-cHHHHHHHHHHHH
Confidence             3677889999999999999999999999999999999433 3345555555544

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-43  Score=298.11  Aligned_cols=279  Identities=23%  Similarity=0.368  Sum_probs=218.6

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-------
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYS-------  130 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-------  130 (353)
                      ....|+.+..+|+|.||.||+|+.+.+|+.||+|++-.... +..-....+|++++..+.|+|++.+.+.|..       
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            34678889999999999999999999999999987644322 2223456789999999999999998876642       


Q ss_pred             -cCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          131 -NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       131 -~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                       ...+|+|+.+|+. +|.-++... .+++..++.+++.++..||.|+|+ ..|+|||+||.|+||+.+|.+||+|||+++
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence             3459999999986 999998765 679999999999999999999998 899999999999999999999999999998


Q ss_pred             cccccCC----CCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH---------
Q 018630          209 IMASTSG----QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------  274 (353)
Q Consensus       209 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---------  274 (353)
                      .+.....    ..+..+-|.+|++||.+.+. .|+.+.|+|+.||++.||.+|.+-+.+..+......+..         
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            7653322    23345679999999999875 589999999999999999999998877554432222222         


Q ss_pred             --------HHHHHhcCCCCC---------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHh
Q 018630          275 --------LMEAIVDQPPPS---------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF  337 (353)
Q Consensus       275 --------~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~  337 (353)
                              +.+.+...+.+.         ..+..-.++..+|+.+||..||.+|+++.++++|.||..-..-..++..-+
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqanl~~ml  332 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQANLQDML  332 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchhhHHHHH
Confidence                    222221111100         001122457899999999999999999999999999988776655555554


Q ss_pred             hh
Q 018630          338 TD  339 (353)
Q Consensus       338 ~~  339 (353)
                      ++
T Consensus       333 ~t  334 (376)
T KOG0669|consen  333 ST  334 (376)
T ss_pred             HH
Confidence            44

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=316.11  Aligned_cols=252  Identities=23%  Similarity=0.378  Sum_probs=213.5

Q ss_pred             CCccCceeeeeecccCCeEEEEEEecc--CCc--EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKW--TGQ--FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      +..+.....+.||.|.||.||++....  .|+  -||||..+.....+....|++|+.+++.++||||+++++++.+ ..
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence            334455666889999999999987642  233  5899999887666778899999999999999999999999885 56


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .++|||.++-|.|..+++.+ ..++......+++||+.||.|||+ +.+|||||..+|||+.+...+||+|||+++.+..
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            89999999999999999876 568999999999999999999999 9999999999999999999999999999999876


Q ss_pred             cCCCCcc-cccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          213 TSGQANT-FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       213 ~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ......+ ..-...|||||.+.-..++.++|||.||+++||++. |..||.+....+       ++..+..+...+. ++
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-------VI~~iEnGeRlP~-P~  615 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-------VIGHIENGERLPC-PP  615 (974)
T ss_pred             cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-------eEEEecCCCCCCC-CC
Confidence            6543333 234678999999998999999999999999999988 999998865433       3444455555444 57


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ++|+.+..|+.+||.+||.+||++.++..
T Consensus       616 nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  616 NCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             CCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            89999999999999999999999988754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=324.39  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=226.5

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      +++.....+-++||.|.||.|++++.+..|+   .||||.++....+.+++.|+.|+.||.+.+||||+.+.++....+.
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            5666778899999999999999999887765   6999999999889999999999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ..||+|||++|+|+.+|+.+ ++++..+...+.+.|+.||+||-+ .|.|||||..+|||++.+-.+|++|||+++.+.+
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            99999999999999999865 778888999999999999999987 9999999999999999999999999999998765


Q ss_pred             cCCCCcc-ccc--CCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          213 TSGQANT-FVG--TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       213 ~~~~~~~-~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      ......+ ..|  ..+|.|||.+...+++.++||||+|+++||.++ |..||.+.+.       .+++.++.++...+. 
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-------QdVIkaIe~gyRLPp-  855 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------QDVIKAIEQGYRLPP-  855 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-------HHHHHHHHhccCCCC-
Confidence            4433222 222  468999999999999999999999999999988 9999987543       467777777766544 


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +-.+|..+.+|+..||++|-++||++.||+++
T Consensus       856 PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  856 PMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            35789999999999999999999999999874

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=314.89  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=213.4

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +..+...+.+.||+|.||.|.++.-. .+..||||+++.......+..|.+|+++|.+++||||+.++++|..++.+++|
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            34456788899999999999999875 36899999999887788889999999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||+++|+|.+++..+  ..+.......++.||+.||+||.+ .+++||||.++|+|++.++++||+|||.++.+-+...
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            9999999999999876  233455667799999999999998 9999999999999999999999999999987654433


Q ss_pred             CCc--ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc--CCCCCCCCccCCchhhHHHHHHHHhcCCCC---CCC
Q 018630          216 QAN--TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT--GQFPYSPPEQQDGWTSFYELMEAIVDQPPP---SAP  288 (353)
Q Consensus       216 ~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  288 (353)
                      ...  ..+-..+|||+|.+..++++.++|+|++|+++||+++  ...||+....++    ..+-...+.....+   ...
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~----vven~~~~~~~~~~~~~l~~  768 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ----VVENAGEFFRDQGRQVVLSR  768 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH----HHHhhhhhcCCCCcceeccC
Confidence            221  2355789999999999999999999999999999865  788998755432    11222233322221   233


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +.-++.++.++|.+||+.|-.+|||++++..
T Consensus       769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  769 PPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            5678999999999999999999999999854

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=294.41  Aligned_cols=270  Identities=27%  Similarity=0.518  Sum_probs=227.0

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHh-cCCCCceEEEeeEeEec
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQ-SSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~-~l~hp~iv~~~~~~~~~  131 (353)
                      .+.+.+.+|+++++||+|+|+.|.+++.+.+.+.+|+|++++.  .+.....-...|-.+.. ..+||.+|-+...|..+
T Consensus       244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte  323 (593)
T KOG0695|consen  244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE  323 (593)
T ss_pred             ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence            3456789999999999999999999999999999999999865  23333444555555544 35899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ..+++|.||++||+|--++++++.++++.++.+..+|+-||.|||+ +|||.||||.+|+|++..|++||+|+|.++..-
T Consensus       324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            9999999999999999999999999999999999999999999998 999999999999999999999999999998776


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccC-CchhhHHHHHHHHhcCCCCCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ-DGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ..+....+.||||.|.|||.+++..|...+|.|+||++++||+.|+.||.-.--. ...+....+.+.+.....  ..+.
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--ripr  480 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPR  480 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cccc
Confidence            6666777899999999999999999999999999999999999999999642111 111233334444443332  2245


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCC------CHHHHHcCCcccccC
Q 018630          291 QFSPEFCSFISACVQKEPQQRL------SAQELMTHPFLKMYG  327 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rp------t~~e~l~hp~~~~~~  327 (353)
                      .+|-.+..+++.-|++||.+|.      .++++-.|+||+...
T Consensus       481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            6777889999999999999998      468999999998644

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-41  Score=311.78  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=216.0

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      |+....+..+..+||-|.||.||.+.++...-.||||.++..  .....+|++|+.+|+.+.|||+|+++++|..+..+|
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            445556677889999999999999999988889999998754  455688999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      ||+|||..|+|.++++..  ..++.....+++.||..||+||.. +++|||||..+|+|+..+..+|++|||+++.+...
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            999999999999999865  347777888999999999999997 99999999999999999999999999999998655


Q ss_pred             CCCCccc-ccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          214 SGQANTF-VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       214 ~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      .+..+.. --.+.|.|||-+-...++.++|||+||++|||+.| |-.||.+.+.    ...+.++    ........+..
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----SqVY~LL----EkgyRM~~PeG  490 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYGLL----EKGYRMDGPEG  490 (1157)
T ss_pred             ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----HHHHHHH----hccccccCCCC
Confidence            4333211 12468999999999999999999999999999999 9999987543    3333333    33334445678


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHH
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELM  318 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l  318 (353)
                      +++.+..||++||++.|.+||+++|+-
T Consensus       491 CPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  491 CPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             CCHHHHHHHHHHhcCCcccCccHHHHH
Confidence            999999999999999999999999983

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.3e-39  Score=293.97  Aligned_cols=249  Identities=25%  Similarity=0.361  Sum_probs=199.4

Q ss_pred             ceeeeeecccCCeEEEEEEec---cCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC------
Q 018630           63 IDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------  132 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~------  132 (353)
                      |.+.+.||+|+||.||+|...   .+++.||||+++... ......++.+|+++++.++||||+++++.+....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999864   357899999987542 3445677889999999999999999999876432      


Q ss_pred             eEEEEEEecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccc
Q 018630          133 AISIILEYMDGGSLADFLKKV------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  206 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~  206 (353)
                      ..++++||+.+|+|.+++...      ..++...+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCCCEEECcccc
Confidence            347889999999999887532      247889999999999999999998 9999999999999999999999999999


Q ss_pred             cccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          207 SAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       207 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      ++.......  ......+++.|++||.+....++.++|+|||||++|+|++ |..||...+.       .+....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~  232 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-------SEIYNYLIKGN  232 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-------HHHHHHHHcCC
Confidence            876532211  1122345678999999988889999999999999999999 8999975432       12233333332


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .. ......+..+.+++.+||+.+|++|||+.+++.+
T Consensus       233 ~~-~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 RL-KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             cC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22 2234578899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=303.28  Aligned_cols=264  Identities=29%  Similarity=0.486  Sum_probs=217.6

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc------cHHHHHHHHHHHHHHhcCCCCceEEEeeEeE-e
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV------EESARRQIAQELKINQSSQCPYVVVCYQSFY-S  130 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~-~  130 (353)
                      ...++|.++..||+|+|+.||+|.+....++||||+-..+.      .+.......+|.+|.+.++||.||++|++|. +
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            34578999999999999999999999999999999876553      2334567889999999999999999999987 5


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCceecCCCCCcEEEcC---CCcEEEeeccc
Q 018630          131 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-KHIIHRDLKPSNLLINH---RGEVKITDFGV  206 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~iiH~Dlkp~NIll~~---~~~~kl~DfG~  206 (353)
                      ...+|-|+|||+|.+|.-+++.++.+++.+++.|+.||+.||.||... -.|||-||||.|||+-+   -|.+||+|||+
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            567899999999999999999999999999999999999999999862 35999999999999954   46799999999


Q ss_pred             cccccccCCC-------CcccccCCcccCcceecC----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH
Q 018630          207 SAIMASTSGQ-------ANTFVGTYNYMSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL  275 (353)
Q Consensus       207 a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~  275 (353)
                      ++.+......       .....||.||.+||++.-    .+.+.++||||+|||+|.++.|+.||.......   .+.+-
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---dILqe  696 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---DILQE  696 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---HHHhh
Confidence            9998655443       223579999999999853    347899999999999999999999998643221   11111


Q ss_pred             HHHHhcCC-CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          276 MEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       276 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                       ..|.+.. ...+....+++++++||++||++--++|....++..||||..
T Consensus       697 -NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  697 -NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             -hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence             1222221 122223568999999999999999999999999999999986

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=309.97  Aligned_cols=261  Identities=22%  Similarity=0.325  Sum_probs=219.3

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccC-Cc--EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWT-GQ--FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      .+..++....+.||+|+||+|+++.+... |+  .||||+++.......-..|++|+.+|.+++|||++++|++..+ ..
T Consensus       106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence            34556778889999999999999987653 33  6899999877655577889999999999999999999999887 77


Q ss_pred             EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      +.+|||.+++|||.+.|++.  ..+.......++.||+.||.||.+ +++|||||..+|+++.....|||+|||+.+.+.
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccceeeeecccceeccC
Confidence            88999999999999999873  457888899999999999999998 999999999999999999999999999999887


Q ss_pred             ccCCCCcc---cccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          212 STSGQANT---FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       212 ~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      .....+..   .--...|+|||.++..+++.++|+|++||++|||++ |.-||.+...       ..+++.+.++...+ 
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------~qIL~~iD~~erLp-  335 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------IQILKNIDAGERLP-  335 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------HHHHHhccccccCC-
Confidence            55443321   123568999999999999999999999999999999 9999988533       35555555444333 


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      .+..++.++++++..||..+|.+|||+.+|...-+.++..
T Consensus       336 RPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaq  375 (1039)
T KOG0199|consen  336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQ  375 (1039)
T ss_pred             CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcC
Confidence            3568899999999999999999999999997665555443

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.9e-40  Score=274.73  Aligned_cols=260  Identities=23%  Similarity=0.390  Sum_probs=208.4

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEec--CeEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSN--GAIS  135 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~--~~~~  135 (353)
                      ..++|++++.+|+|.++.||.+.+..+++.++||+++.-    ..+.+.+|++++..+. ||||++++++..++  ....
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            457899999999999999999999999999999999743    5677899999999987 99999999988754  6789


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC-CcEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~~~  214 (353)
                      +|+||+++.+...+-   ..++.-.+..++.|++.||.|+|+ .||+|||+||.|++++.. ..++|+|+|+|...... 
T Consensus       112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-  186 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  186 (338)
T ss_pred             hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCC-
Confidence            999999987766654   358888999999999999999999 999999999999999865 46999999999876543 


Q ss_pred             CCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCC-ccCCchhhHHHHH------HHHhc-----
Q 018630          215 GQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPP-EQQDGWTSFYELM------EAIVD-----  281 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~-~~~~~~~~~~~~~------~~~~~-----  281 (353)
                      ...+..+.+..|-.||++..- .|+..-|+|||||+++.|++.+-||-.. +..+..-.+..++      ..+.+     
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            345566788899999998764 5899999999999999999988887543 3322211111111      00000     


Q ss_pred             ---------CC--------CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          282 ---------QP--------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       282 ---------~~--------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                               ..        ..+....-.++++.+|+.++|.+|..+|+||.|++.||||....
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence                     00        01111233579999999999999999999999999999997643

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.5e-38  Score=280.55  Aligned_cols=243  Identities=39%  Similarity=0.662  Sum_probs=206.2

Q ss_pred             CCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCHHHHHHh
Q 018630           73 SGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK  152 (353)
Q Consensus        73 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  152 (353)
                      +||.||++.+..+++.+|+|++...........+.+|++.++.++|+|++++++.+......++++||+.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999999889999999987654333367889999999999999999999999998999999999999999999987


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCCcccCccee
Q 018630          153 VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI  232 (353)
Q Consensus       153 ~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~  232 (353)
                      ...++...+..++.+++.++.+||+ .+++|+||+|.||+++.++.++|+|||.+....... ......++..|++||.+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHH
Confidence            6668999999999999999999998 899999999999999999999999999987765332 33445788899999999


Q ss_pred             cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC-CCHHHHHHHHHhhhhCcCCC
Q 018630          233 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ-FSPEFCSFISACVQKEPQQR  311 (353)
Q Consensus       233 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R  311 (353)
                      .+..++.++|+||+|++++++++|..||.....      .................... ++.++.+++.+||..+|++|
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  232 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ------LLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR  232 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence            888889999999999999999999999966321      12233333333332222222 88999999999999999999


Q ss_pred             CCHHHHHcCCcc
Q 018630          312 LSAQELMTHPFL  323 (353)
Q Consensus       312 pt~~e~l~hp~~  323 (353)
                      |++.++++||||
T Consensus       233 p~~~~~~~~~~~  244 (244)
T smart00220      233 LTAEEALQHPFF  244 (244)
T ss_pred             cCHHHHhhCCCC
Confidence            999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1e-38  Score=314.35  Aligned_cols=264  Identities=20%  Similarity=0.263  Sum_probs=180.7

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccC----CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeE----
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWT----GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQS----  127 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~----  127 (353)
                      ..+..++|++.+.||+|+||.||++.+..+    +..||+|.+.......  .... + .+ +...+.++..+...    
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--~~~~-e-~l-~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--IWMN-E-RV-RRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--HHHH-H-HH-HhhchhhHHHHHHhhhcc
Confidence            345678999999999999999999999988    8999999876432111  1111 1 11 11112222211111    


Q ss_pred             --eEecCeEEEEEEecCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 018630          128 --FYSNGAISIILEYMDGGSLADFLKKVKT--------------------IPEEYLAAICEQVLKGLLYLHHEKHIIHRD  185 (353)
Q Consensus       128 --~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~ql~~~l~~LH~~~~iiH~D  185 (353)
                        ...+..+++|+||+.+++|.+++.....                    .....+..++.|++.||.|||+ ++|+|||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRD  280 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRD  280 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCc
Confidence              2356789999999999999999875321                    1234466899999999999998 9999999


Q ss_pred             CCCCcEEEcC-CCcEEEeeccccccccccC-CCCcccccCCcccCcceecCC----------------------CCCccc
Q 018630          186 LKPSNLLINH-RGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGG----------------------KYGYKS  241 (353)
Q Consensus       186 lkp~NIll~~-~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~  241 (353)
                      |||+|||++. ++.+||+|||+|+...... ......++++.|+|||.+...                      .++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999985 5799999999997653222 223456889999999966332                      234567


Q ss_pred             cHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHH----------HhcCCCC-C-----CCCCCCCHHHHHHHHHhhh
Q 018630          242 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA----------IVDQPPP-S-----APSDQFSPEFCSFISACVQ  305 (353)
Q Consensus       242 DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~----------~~~~~~~-~-----~~~~~~~~~~~~li~~~L~  305 (353)
                      ||||+||++|||+++..|+...     ...+...+..          ....... .     ...........+||.+||+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            9999999999999977665321     0111111100          0000000 0     0011123345689999999


Q ss_pred             hCcCCCCCHHHHHcCCcccccCCCC
Q 018630          306 KEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       306 ~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      +||++|||+.|+++||||+......
T Consensus       436 ~dP~kR~ta~e~L~Hpff~~~~~~~  460 (566)
T PLN03225        436 FKGRQRISAKAALAHPYFDREGLLG  460 (566)
T ss_pred             CCcccCCCHHHHhCCcCcCCCCccc
Confidence            9999999999999999999876553

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-40  Score=310.64  Aligned_cols=247  Identities=28%  Similarity=0.464  Sum_probs=198.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------CeE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAI  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~~~  134 (353)
                      .-+...+.||+|+||.||+++++.+|+.||||.+........+....+|++++++++|||||+++++-+..      ...
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            45677789999999999999999999999999987765556677888999999999999999999875543      356


Q ss_pred             EEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC--CC--cEEEeecccc
Q 018630          135 SIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH--RG--EVKITDFGVS  207 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~--~~--~~kl~DfG~a  207 (353)
                      .+|||||.||||+..+++.   ..+++...+.+..+++.||.|||. +||+||||||.||++-.  +|  .-||+|||.|
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            8999999999999999753   569999999999999999999998 99999999999999843  34  3799999999


Q ss_pred             ccccccCCCCcccccCCcccCcceec-CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERIS-GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      +...+.. ...+.+||+.|.+||++. .+.|+..+|.||+||++|+++||..||..-...   ++..+++..+...++..
T Consensus       172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p---k~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP---KNNKEIMWHIITKKPSG  247 (732)
T ss_pred             ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc---cccchhhhhhhccCCCc
Confidence            9876544 677889999999999998 478999999999999999999999999653221   22223333332222110


Q ss_pred             -------------------CCCCCCCHH----HHHHHHHhhhhCcCCCC
Q 018630          287 -------------------APSDQFSPE----FCSFISACVQKEPQQRL  312 (353)
Q Consensus       287 -------------------~~~~~~~~~----~~~li~~~L~~dp~~Rp  312 (353)
                                         +.+..+++.    +...+..+|+.+|.+|.
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                               112223332    45778889999999998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=266.58  Aligned_cols=232  Identities=38%  Similarity=0.709  Sum_probs=197.4

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHh-cCCCCceEEEeeEeEecCeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~hp~iv~~~~~~~~~~~~  134 (353)
                      ..+.-++...+..||+|++|.|-+.++..+|+..|+|.+..........++.+|+++.. ...+|.+|.+|+...+++..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            34455677778899999999999999999999999999988877777788889998854 56799999999999999999


Q ss_pred             EEEEEecCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          135 SIILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l----~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      ++.||.|+. ||..+-    ...+.+++..+-+++..++.||.|||++..+||||+||.|||++.+|++|+||||++..+
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            999999974 887654    445789999999999999999999999889999999999999999999999999999877


Q ss_pred             cccCCCCcccccCCcccCcceecC----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          211 ASTSGQANTFVGTYNYMSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      .+.- ..+...|...|||||.+..    ..|+.++||||||+++.||.++++||..      |....+.+.++...+.|.
T Consensus       200 ~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~------w~tpF~qLkqvVeep~P~  272 (282)
T KOG0984|consen  200 VDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES------WGTPFQQLKQVVEEPSPQ  272 (282)
T ss_pred             hhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc------cCCHHHHHHHHhcCCCCC
Confidence            5432 2223578889999998854    3699999999999999999999999954      667777778888877776


Q ss_pred             CCCCCCCHH
Q 018630          287 APSDQFSPE  295 (353)
Q Consensus       287 ~~~~~~~~~  295 (353)
                      .+...+|++
T Consensus       273 Lp~~~FS~e  281 (282)
T KOG0984|consen  273 LPADTFSPE  281 (282)
T ss_pred             CcccccCCC
Confidence            665656543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=284.21  Aligned_cols=261  Identities=26%  Similarity=0.440  Sum_probs=211.9

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------C
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~  132 (353)
                      ..+|.-++.+|.|.- .|..|-+.-.+++||+|.+... ......++..+|..++..++|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            367888899999998 7778889889999999987543 2334457788999999999999999999988632      4


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ..|+|||+|.. +|...+.  -.++-..+..+.+|+++|++|||+ .||+||||||+||++..++.+||.|||+|+....
T Consensus        95 e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchhheeeccchhhcccCc
Confidence            58999999975 9998887  367888999999999999999999 9999999999999999999999999999987543


Q ss_pred             cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHH--------------
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA--------------  278 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~--------------  278 (353)
                      . -..+.++.|..|+|||++.+..|...+||||+||++.||++|..-|.+.+.-+.|....+....              
T Consensus       171 ~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  171 D-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             c-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            3 3456688999999999999988999999999999999999999999987776665544332210              


Q ss_pred             -HhcCCC----------------CCC-C-CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          279 -IVDQPP----------------PSA-P-SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       279 -~~~~~~----------------~~~-~-~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                       .....+                +.. . ...-+..+.+++.+||-.||++|.|++++|+|||++-|
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence             000000                000 0 01123358899999999999999999999999999843

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=4.6e-40  Score=301.82  Aligned_cols=261  Identities=23%  Similarity=0.374  Sum_probs=209.4

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCC------CceEEEeeEeEecC
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC------PYVVVCYQSFYSNG  132 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h------p~iv~~~~~~~~~~  132 (353)
                      .-.+|.+....|+|-||+|..|.+...|..||||++..+  +.....=++|+++|++|+.      -+++.++..|...+
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            346789999999999999999999999999999999754  3444556788999988853      57999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC-CcEEEeeccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSA  208 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~  208 (353)
                      ++|||+|-+. .+|.+++++.+   .|....+..++.||.-||..|.. .||+|.||||.|||++.. ..+||||||.|.
T Consensus       508 HLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  508 HLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             eeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCcccc
Confidence            9999999996 59999998754   47888999999999999999997 999999999999999865 468999999987


Q ss_pred             cccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh--------
Q 018630          209 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--------  280 (353)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~--------  280 (353)
                      ....  ...+.+.-+..|+|||.+.+.+|++..|+||+||+||||+||+..|++....+...-+.++...+.        
T Consensus       586 ~~~e--neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq  663 (752)
T KOG0670|consen  586 FASE--NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ  663 (752)
T ss_pred             cccc--ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence            6543  235566778899999999999999999999999999999999999988665443322222211100        


Q ss_pred             --cCCC---------------------------C--------------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHH
Q 018630          281 --DQPP---------------------------P--------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  317 (353)
Q Consensus       281 --~~~~---------------------------~--------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  317 (353)
                        +...                           |              +......-..+.+|+.+||..||++|.|..++
T Consensus       664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA  743 (752)
T KOG0670|consen  664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA  743 (752)
T ss_pred             hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence              0000                           0              00000112348899999999999999999999


Q ss_pred             HcCCcccc
Q 018630          318 MTHPFLKM  325 (353)
Q Consensus       318 l~hp~~~~  325 (353)
                      |+||||+.
T Consensus       744 L~HpFi~~  751 (752)
T KOG0670|consen  744 LKHPFITE  751 (752)
T ss_pred             hcCCcccC
Confidence            99999984

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.2e-37  Score=296.30  Aligned_cols=266  Identities=21%  Similarity=0.263  Sum_probs=188.3

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEec----------------cCCcEEEEEEeeccccHHHHHH--------------H
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHK----------------WTGQFFALKVIQMNVEESARRQ--------------I  106 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~~~~~~--------------~  106 (353)
                      .+..++|++.+.||+|+||+||++...                ..++.||||.+...... ....              .
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~-~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG-VRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh-hHHHHHhhhhhhhcccchh
Confidence            456789999999999999999998642                34568999998654221 1122              2


Q ss_pred             HHHHHHHhcCCCCce-----EEEeeEeEe--------cCeEEEEEEecCCCCHHHHHHhc--------------------
Q 018630          107 AQELKINQSSQCPYV-----VVCYQSFYS--------NGAISIILEYMDGGSLADFLKKV--------------------  153 (353)
Q Consensus       107 ~~e~~~~~~l~hp~i-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~--------------------  153 (353)
                      ..|+.++..+.|.++     ++++++|..        .+..++|+||+++++|.+++...                    
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            235555555555443     555555432        35689999999999999988642                    


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC-CcccccCCcccC
Q 018630          154 ----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMS  228 (353)
Q Consensus       154 ----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~gt~~y~a  228 (353)
                          ..++...++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......... .....+|+.|+|
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence                123566788999999999999998 99999999999999999999999999998765332211 112234789999


Q ss_pred             cceecCCC--------------------CC--ccccHHHHHHHHHHHHcCCC-CCCCCccCC----chhhHHHHHHHHhc
Q 018630          229 PERISGGK--------------------YG--YKSDIWSLGLVLLECATGQF-PYSPPEQQD----GWTSFYELMEAIVD  281 (353)
Q Consensus       229 PE~~~~~~--------------------~~--~~~DiwslG~il~ell~g~~-Pf~~~~~~~----~~~~~~~~~~~~~~  281 (353)
                      ||.+....                    ++  .+.|+||+||++|+|++|.. ||.......    ..............
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99875432                    11  24699999999999999875 775421110    00111111112222


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhhCc---CCCCCHHHHHcCCccc
Q 018630          282 QPPPSAPSDQFSPEFCSFISACVQKEP---QQRLSAQELMTHPFLK  324 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~L~~dp---~~Rpt~~e~l~hp~~~  324 (353)
                      ...........++...+|+.+||..+|   .+|+|++|+|+||||.
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            222233345678999999999999876   6899999999999995

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=281.89  Aligned_cols=135  Identities=30%  Similarity=0.437  Sum_probs=116.7

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-----C---CceEEEeeEe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----C---PYVVVCYQSF  128 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----h---p~iv~~~~~~  128 (353)
                      .+...+|.+.++||=|.|++||+|.+..+.+.||+|+.+..  .-.......|+++++++.     |   .+||++++.|
T Consensus        74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            45558999999999999999999999999999999998743  333455678899887752     3   4599999998


Q ss_pred             Ee----cCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc
Q 018630          129 YS----NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN  194 (353)
Q Consensus       129 ~~----~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~  194 (353)
                      ..    +.++|||+|++ |.+|..+|...  +.++...+++|++|++.||.|||.+.||||.||||+|||+.
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            74    56899999999 67999999864  56999999999999999999999999999999999999993

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=306.06  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=215.0

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEecc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEee
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQ  126 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~  126 (353)
                      .+++..++..+.+.||+|.||.|+++.-..       ....||||.++..........+..|+++++.+. ||||+.+.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            456666777788899999999999987532       134799999987766678889999999999874 999999999


Q ss_pred             EeEecCeEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCc
Q 018630          127 SFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  190 (353)
Q Consensus       127 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~N  190 (353)
                      .+...+.+++|+||+..|+|.++++..+                .++......+++||+.||+||++ .+++||||..+|
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRN  448 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARN  448 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhh
Confidence            9999999999999999999999998755                38899999999999999999998 899999999999


Q ss_pred             EEEcCCCcEEEeeccccccccccCCCC-cccc--cCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccC
Q 018630          191 LLINHRGEVKITDFGVSAIMASTSGQA-NTFV--GTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ  266 (353)
Q Consensus       191 Ill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~  266 (353)
                      ||+..+..+||+|||+|+......... ....  -...|||||.+....|+.++||||+|++|||+++ |..||.+..  
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~--  526 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP--  526 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence            999999999999999998644332221 1122  2446999999999999999999999999999999 999998622  


Q ss_pred             CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          267 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                          ...++.+.+..+... ..+..+++++.++++.||+.+|++||++.++..
T Consensus       527 ----~~~~l~~~l~~G~r~-~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  527 ----PTEELLEFLKEGNRM-EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             ----cHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence                223444544454443 445677999999999999999999999999976

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=303.96  Aligned_cols=277  Identities=31%  Similarity=0.530  Sum_probs=232.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|+.++.+|.|+||.||+++++.+++..|+|+++... .....-+.+|+-+++.++||||+.+++.+.....+++.|||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            78999999999999999999999999999999998763 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      |.||+|.+.-+-.+++++.++...++..+.|++|||+ .|-+|||||-.||++++.|.+|++|||.+..+...-....+.
T Consensus        94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf  172 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF  172 (829)
T ss_pred             cCCCcccceeeecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence            9999999988877899999999999999999999998 999999999999999999999999999998777666666778


Q ss_pred             ccCCcccCccee---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018630          221 VGTYNYMSPERI---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  297 (353)
Q Consensus       221 ~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      .||+.|||||+-   +.+.|+..+|+|++|++..|+-.-++|..+..+..    ...++.+-.-..+........++.+-
T Consensus       173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr----~l~LmTkS~~qpp~lkDk~kws~~fh  248 (829)
T KOG0576|consen  173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR----ALFLMTKSGFQPPTLKDKTKWSEFFH  248 (829)
T ss_pred             cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH----HHHHhhccCCCCCcccCCccchHHHH
Confidence            999999999975   45679999999999999999999888876654421    12222222222233333456788999


Q ss_pred             HHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhhCCCc
Q 018630          298 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPL  344 (353)
Q Consensus       298 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~  344 (353)
                      +|++.+|.++|.+|||++-+|.|||+..-.+....+ +.++...+|.
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~-eLLdK~n~P~  294 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAI-ELLDKVNNPN  294 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccchhhHHHH-HHHHHccCCC
Confidence            999999999999999999999999998764333322 2345555555

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.3e-36  Score=316.71  Aligned_cols=244  Identities=20%  Similarity=0.299  Sum_probs=188.8

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      .+.....||+|+||.||++++..++..||||.+.....     ...+|++.+++++||||+++++++.++...++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            45566789999999999999998999999998864321     1124578889999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--cCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH--EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       142 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~--~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      ++|+|.++++.   +++..+..++.|++.||+|||.  ..+|+||||||+||+++.++..++. ||.+.....    ...
T Consensus       766 ~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~~  837 (968)
T PLN00113        766 EGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DTK  837 (968)
T ss_pred             CCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----CCC
Confidence            99999999963   8889999999999999999993  1689999999999999998887775 665543221    123


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh---------cCCCCCC--C
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---------DQPPPSA--P  288 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~~--~  288 (353)
                      ..+|+.|+|||++.+..++.++||||+||++|||++|+.||.......  ....+......         +......  .
T Consensus       838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (968)
T PLN00113        838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH--GSIVEWARYCYSDCHLDMWIDPSIRGDVSV  915 (968)
T ss_pred             ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC--CcHHHHHHHhcCccchhheeCccccCCCCc
Confidence            367899999999999899999999999999999999999995422111  11111111111         1111000  0


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ......++.+++.+||+.||++|||+.|+++.
T Consensus       916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            11122357789999999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=271.91  Aligned_cols=263  Identities=24%  Similarity=0.395  Sum_probs=205.7

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec-----CeEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAIS  135 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~-----~~~~  135 (353)
                      +.+-.+.||.|+||+||.+.+..+|+.||+|.+..- ..-..-+++.+|++++...+|.|++..++...-.     ..+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            455567899999999999999999999999987532 2233457788999999999999999887765432     2478


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +++|.|.. +|...+-....++.+.++-+.+||++||+|||+ .+|.||||||.|+|++++..+||||||+++.......
T Consensus       134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            88999975 888888888889999999999999999999999 9999999999999999999999999999987543322


Q ss_pred             -CCcccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH----------------H
Q 018630          216 -QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----------------E  277 (353)
Q Consensus       216 -~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~----------------~  277 (353)
                       ..+..+-|-.|+|||.+.+.. |+.+.||||+|||+.||+..+..|...++-+....+-+++                .
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence             233456788999999998864 8999999999999999999998887654432221111111                1


Q ss_pred             HHhcCCC-CCCC--------CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          278 AIVDQPP-PSAP--------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       278 ~~~~~~~-~~~~--------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      .+..... ++..        +..-..+...++..||..||++|.+.++++.|++..+.
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            1122111 1111        11223468899999999999999999999999998653

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=296.08  Aligned_cols=258  Identities=27%  Similarity=0.355  Sum_probs=197.7

Q ss_pred             eeecccCCeE-EEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           67 KVVGKGSGGI-VQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        67 ~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      +++|.|+.|+ ||++..  .|+.||||.+-.    .......+|+..++.. +|||||++|+.-.+....||..|.|.. 
T Consensus       515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-  587 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY--EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-  587 (903)
T ss_pred             HHcccCCCCcEEEEEee--CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence            5789999875 466654  588999998643    2345677899999887 599999999998999999999999986 


Q ss_pred             CHHHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC---CC--cEEEeeccccccccccCC
Q 018630          145 SLADFLKKV-KT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RG--EVKITDFGVSAIMASTSG  215 (353)
Q Consensus       145 sL~~~l~~~-~~---l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~--~~kl~DfG~a~~~~~~~~  215 (353)
                      +|.+++... ..   ......+.+..|++.||++||+ .+||||||||.||||+.   ++  +++|+|||+++.+.....
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence            999999873 11   1113457889999999999999 99999999999999976   33  699999999998754332


Q ss_pred             ---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCC-CCCCCC
Q 018630          216 ---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSD  290 (353)
Q Consensus       216 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  290 (353)
                         ...+..||-+|+|||++....-+.++||||+||++|+.++ |..||++.-..+         ..|..+.. ......
T Consensus       667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---------~NIl~~~~~L~~L~~  737 (903)
T KOG1027|consen  667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---------ANILTGNYTLVHLEP  737 (903)
T ss_pred             hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---------hhhhcCccceeeecc
Confidence               2334679999999999999888889999999999999999 599998743211         11221111 001111


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhhCCCcc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLA  345 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~  345 (353)
                      ....++.+||.+|+++||..||+|.+++.||||=..++    ...||.|+++.++
T Consensus       738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ek----rL~Fl~dvSDRvE  788 (903)
T KOG1027|consen  738 LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEK----RLSFLRDVSDRVE  788 (903)
T ss_pred             CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHH----HHHHHHhhhhhhh
Confidence            11128999999999999999999999999999954433    3446666665554

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=289.13  Aligned_cols=248  Identities=24%  Similarity=0.355  Sum_probs=210.3

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      ..+..++||+|+||+||++..-..|+    +||||++..........++.+|+-++.+++|||++++++++.... +-||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            34556899999999999988765555    689999877766667788999999999999999999999988655 8899


Q ss_pred             EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          138 LEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ++|+++|+|.++++.+ .++..+..+.|..||++||.|||. ++++||||..+|+|+.+-..+|+.|||+++........
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            9999999999999865 678999999999999999999998 99999999999999999999999999999887655443


Q ss_pred             Cccc--ccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          217 ANTF--VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       217 ~~~~--~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ....  .-.+.|||=|.+....|+.++||||+||++||++| |..|+.+...       .++-.-+.++.. -..+..++
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-------~eI~dlle~geR-LsqPpiCt  926 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-------EEIPDLLEKGER-LSQPPICT  926 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-------HHhhHHHhcccc-CCCCCCcc
Confidence            3332  23568999999999999999999999999999999 9999987533       233333444443 34456789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      -++..++.+||-.|++.||+++++..
T Consensus       927 iDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHHhccCcccCccHHHHHH
Confidence            99999999999999999999998854

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=267.04  Aligned_cols=256  Identities=27%  Similarity=0.418  Sum_probs=194.2

Q ss_pred             CCCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhc--CCCCceEEEeeEeEe
Q 018630           53 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS--SQCPYVVVCYQSFYS  130 (353)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~hp~iv~~~~~~~~  130 (353)
                      ++..-........++.+|+|.||.||+|+..  ++.||||+++..    .+..+..|.+|...  +.|+||+++++.-..
T Consensus       202 ~sspl~~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr  275 (534)
T KOG3653|consen  202 PSSPLLELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKR  275 (534)
T ss_pred             CCcccccCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence            3444556778888999999999999999875  799999998744    45667777777654  689999999987654


Q ss_pred             cC----eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CCceecCCCCCcEEEcCCCc
Q 018630          131 NG----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE--------KHIIHRDLKPSNLLINHRGE  198 (353)
Q Consensus       131 ~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~--------~~iiH~Dlkp~NIll~~~~~  198 (353)
                      ..    .++||++|.+.|||.++|.. ..++.....+++..+++||+|||+.        ..|+|||||..|||+.++++
T Consensus       276 ~t~~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT  354 (534)
T KOG3653|consen  276 GTADRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT  354 (534)
T ss_pred             CCccccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence            44    89999999999999999988 4689999999999999999999972        46999999999999999999


Q ss_pred             EEEeeccccccccccC--CCCcccccCCcccCcceecCCC-CC-----ccccHHHHHHHHHHHHcCCCCC--------CC
Q 018630          199 VKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGK-YG-----YKSDIWSLGLVLLECATGQFPY--------SP  262 (353)
Q Consensus       199 ~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~il~ell~g~~Pf--------~~  262 (353)
                      ..|+|||+|..+....  ++....+||.+|||||++.+.. +.     .+.||||+|.++||+++.-.-+        ..
T Consensus       355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql  434 (534)
T KOG3653|consen  355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL  434 (534)
T ss_pred             EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence            9999999998875332  2344579999999999987642 22     4789999999999999854222        11


Q ss_pred             CccCC--chhhHHHHHHHHhcCCCCCCCC-----CCCCHHHHHHHHHhhhhCcCCCCCHH
Q 018630          263 PEQQD--GWTSFYELMEAIVDQPPPSAPS-----DQFSPEFCSFISACVQKEPQQRLSAQ  315 (353)
Q Consensus       263 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~  315 (353)
                      +=+.+  ..-.+.++...+...+..+..+     ..-...+++.+..||..||+.|.|+.
T Consensus       435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence            11100  0112233333333322222211     12234688999999999999999996

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-35  Score=264.68  Aligned_cols=249  Identities=28%  Similarity=0.427  Sum_probs=192.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhc--CCCCceEEEeeEeEec----CeE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS--SQCPYVVVCYQSFYSN----GAI  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~hp~iv~~~~~~~~~----~~~  134 (353)
                      .+..+.+.||+|.||.||+++.+  |+.||||++...    ..+...+|.+|.+.  ++|+||+.+.+.-..+    .++
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             heeEEEEEecCccccceeecccc--CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            56788999999999999998765  999999998754    23456677777655  7999999998865422    479


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-------CCceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~-------~~iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                      +||++|-+.|||+|+|.+ ..++.+...+++..++.||++||.+       -.|.|||||..|||+.++|..-|+|+|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            999999999999999998 6799999999999999999999962       34999999999999999999999999999


Q ss_pred             ccccccCC----CCcccccCCcccCcceecCCC----C--CccccHHHHHHHHHHHHcC----------CCCCCCCccCC
Q 018630          208 AIMASTSG----QANTFVGTYNYMSPERISGGK----Y--GYKSDIWSLGLVLLECATG----------QFPYSPPEQQD  267 (353)
Q Consensus       208 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwslG~il~ell~g----------~~Pf~~~~~~~  267 (353)
                      -.......    ..+..+||.+|||||++...-    +  -..+||||||.++||+...          ++||.+.-+.+
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence            76543322    234579999999999986532    2  2368999999999999753          37887755444


Q ss_pred             chhhHHHHHHHHhcCCCCC-CCCC-CCC---HHHHHHHHHhhhhCcCCCCCHHHHH
Q 018630          268 GWTSFYELMEAIVDQPPPS-APSD-QFS---PEFCSFISACVQKEPQQRLSAQELM  318 (353)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~-~~~~-~~~---~~~~~li~~~L~~dp~~Rpt~~e~l  318 (353)
                        .++.+...-+......+ .++. .-.   ..+.++|+.||..+|.-|.|+--+-
T Consensus       444 --Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  444 --PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             --CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence              34445444443333222 2221 112   2466889999999999999986553

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=274.85  Aligned_cols=202  Identities=30%  Similarity=0.460  Sum_probs=178.1

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc---HHH----HHHHHHHHHHHhcCC---CCceEEEeeE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---ESA----RRQIAQELKINQSSQ---CPYVVVCYQS  127 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~----~~~~~~e~~~~~~l~---hp~iv~~~~~  127 (353)
                      .++.+|..++.+|.|+||.|++|.++.+...|+||.+.++.-   ...    .-.+-.|++||..++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            456789999999999999999999999999999999876521   111    112457899998887   9999999999


Q ss_pred             eEecCeEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccc
Q 018630          128 FYSNGAISIILEY-MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  206 (353)
Q Consensus       128 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~  206 (353)
                      |++++++|++||- -+|.+|++++.....+++.+++.|+.|++.|+++||+ .||||||||-+|++++.+|.+||+|||.
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCCeEEEeeccc
Confidence            9999999999996 4567999999999999999999999999999999998 9999999999999999999999999998


Q ss_pred             cccccccCCCCcccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCC
Q 018630          207 SAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP  262 (353)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~  262 (353)
                      |....  ++....++||..|.|||++.+.+| ...-|||+||++||.++....||.+
T Consensus       717 aa~~k--sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTK--SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhc--CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            86543  345677899999999999999887 6778999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=5.1e-33  Score=239.21  Aligned_cols=212  Identities=40%  Similarity=0.677  Sum_probs=189.1

Q ss_pred             ecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCHHH
Q 018630           69 VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD  148 (353)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL~~  148 (353)
                      ||+|++|.||++....+++.+++|++...........+.+|++.++.+.|++++++++.+......++++||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999888999999998766443345788999999999999999999999998899999999999899999


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-CCcEEEeeccccccccccCCCCcccccCCcc
Q 018630          149 FLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNY  226 (353)
Q Consensus       149 ~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y  226 (353)
                      ++... ..++...+..++.+++.++.+||+ .|++|+||+|.||+++. ++.++|+|||.+..............+...|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            99875 578999999999999999999998 89999999999999999 8999999999987654432223335678899


Q ss_pred             cCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhh
Q 018630          227 MSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ  305 (353)
Q Consensus       227 ~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  305 (353)
                      ++||..... .++.++|+|++|++++++                                        ..+.+++.+|++
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------HHHHHHHHHHhh
Confidence            999999877 788999999999999999                                        579999999999


Q ss_pred             hCcCCCCCHHHHHcCC
Q 018630          306 KEPQQRLSAQELMTHP  321 (353)
Q Consensus       306 ~dp~~Rpt~~e~l~hp  321 (353)
                      .||++||+++++++|+
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.9e-34  Score=258.60  Aligned_cols=268  Identities=25%  Similarity=0.414  Sum_probs=205.5

Q ss_pred             ccCceeeeeecccCCeEEEEEEecc---CCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKW---TGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~  135 (353)
                      ...|..+..||.|+|++||++.+..   ..+.||+|.+.....   -.++..|++++..+ .+.||+++.+.+..++...
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            3678899999999999999999877   678999998865533   24578899998887 4899999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-CCcEEEeecccccccc---
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMA---  211 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~---  211 (353)
                      +|+||++..+..++...   ++...+..+++.++.||.++|+ +|||||||||.|++.+. .++-.|+|||+|....   
T Consensus       112 ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             EEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            99999999888888764   7788999999999999999998 99999999999999985 4678999999997210   


Q ss_pred             ----ccC-----------C---------------C-----------CcccccCCcccCcceecCC-CCCccccHHHHHHH
Q 018630          212 ----STS-----------G---------------Q-----------ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLV  249 (353)
Q Consensus       212 ----~~~-----------~---------------~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~i  249 (353)
                          ...           .               .           .....||++|+|||++..- ..+.++||||.|+|
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                000           0               0           0014699999999998664 57899999999999


Q ss_pred             HHHHHcCCCCCCCCccC-Cc-------------------------hh-----hHHHHHH--------HHhcCC----CCC
Q 018630          250 LLECATGQFPYSPPEQQ-DG-------------------------WT-----SFYELME--------AIVDQP----PPS  286 (353)
Q Consensus       250 l~ell~g~~Pf~~~~~~-~~-------------------------~~-----~~~~~~~--------~~~~~~----~~~  286 (353)
                      +..++++..||-..... +.                         |.     .+.+...        .+....    ...
T Consensus       268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~  347 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE  347 (418)
T ss_pred             eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence            99999999998543221 10                         00     0001100        000000    011


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHh
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  334 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~  334 (353)
                      ...+..+..+.+|+.+||+.||.+|.|++++|+||||....+-...+.
T Consensus       348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~~~~~  395 (418)
T KOG1167|consen  348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTERGLQ  395 (418)
T ss_pred             cccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhhhhhH
Confidence            112345668999999999999999999999999999997665544444

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=3.6e-31  Score=231.23  Aligned_cols=199  Identities=36%  Similarity=0.592  Sum_probs=175.7

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecC
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD  142 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  142 (353)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+...........+.+|++.++.++|+|++++++.+......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            56778999999999999999988999999998765433356788899999999999999999999988899999999999


Q ss_pred             CCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-CCCccc
Q 018630          143 GGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTF  220 (353)
Q Consensus       143 ~gsL~~~l~~~~~-l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~  220 (353)
                      +++|.+++..... +++..+..++.+++.++.+||+ .+++|+|++|.||+++.++.++|+|||.+....... ......
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            9999999988666 8999999999999999999998 899999999999999999999999999987765332 122345


Q ss_pred             ccCCcccCccee-cCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 018630          221 VGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQFPYSP  262 (353)
Q Consensus       221 ~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~  262 (353)
                      .++..|++||.+ ....++.++|+|++|+++++|++|..||..
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            678899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=4e-32  Score=242.34  Aligned_cols=254  Identities=20%  Similarity=0.263  Sum_probs=208.9

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccC-----CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-  130 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-  130 (353)
                      ++..++++....+.+|+||.||.+..+..     .+.|.+|.++...++.....+..|.-++..+.|||+..+.++..+ 
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            34456777888899999999999966543     234667888777667777888999999999999999999998765 


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEe
Q 018630          131 NGAISIILEYMDGGSLADFLKKV--------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT  202 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~  202 (353)
                      ....++++.++.-|+|..++...        +.++..+...++.|++.|++|||+ .|+||.||..+|.+|++.-++||+
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhheeEEec
Confidence            46778889999999999999732        356777888899999999999998 999999999999999999999999


Q ss_pred             eccccccccccCCCCc--ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHH
Q 018630          203 DFGVSAIMASTSGQAN--TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI  279 (353)
Q Consensus       203 DfG~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~  279 (353)
                      |=.+++.+.....+.-  ..-....||+||.+.+..|+.++|+||||+++|||+| |+.||...++.       +....+
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-------Em~~yl  511 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-------EMEHYL  511 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-------HHHHHH
Confidence            9999987654433211  1123568999999999999999999999999999999 99999876553       333444


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          280 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .++.. -..+.++|+++..++--||..+|++||+++|++.
T Consensus       512 kdGyR-laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  512 KDGYR-LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             hccce-ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            44443 4456789999999999999999999999999976

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-32  Score=235.56  Aligned_cols=256  Identities=21%  Similarity=0.377  Sum_probs=198.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeE-eEecCeEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQS-FYSNGAISII  137 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~-~~~~~~~~lv  137 (353)
                      .+.|.+.+.||+|.||.+-+++++.+++.+++|.++..  ....+.+.+|..---.+ .|.||+.-|++ |+..+.++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            36799999999999999999999999999999998755  34457788888764444 58999988874 6677899999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC--CCcEEEeeccccccccccCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||++.|+|.+-+.. ..+.+...+.++.|++.|+.|+|+ +++||||||.+||||-.  .-++||||||.++..+..-.
T Consensus       101 qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             eccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            999999999987766 348899999999999999999999 99999999999999943  34899999999876543221


Q ss_pred             CCcccccCCcccCcceecC---CC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCC
Q 018630          216 QANTFVGTYNYMSPERISG---GK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAP  288 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~---~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  288 (353)
                         ..--+..|.+||....   +.  .++.+|+|+||++++.++||.+||....-.+  ..+.+.++ .....  ..+..
T Consensus       179 ---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d--~~Y~~~~~-w~~rk~~~~P~~  252 (378)
T KOG1345|consen  179 ---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD--KPYWEWEQ-WLKRKNPALPKK  252 (378)
T ss_pred             ---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC--chHHHHHH-HhcccCccCchh
Confidence               1223557899997643   22  4678999999999999999999997543332  22222222 22222  22233


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCC---CCHHHHHcCCcccc
Q 018630          289 SDQFSPEFCSFISACVQKEPQQR---LSAQELMTHPFLKM  325 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~R---pt~~e~l~hp~~~~  325 (353)
                      ...+++.+..+.++-|..+|++|   -++.......|...
T Consensus       253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            45689999999999999999999   56666666677643

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.5e-32  Score=282.66  Aligned_cols=196  Identities=21%  Similarity=0.238  Sum_probs=145.3

Q ss_pred             CceEEEeeEe-------EecCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCc
Q 018630          119 PYVVVCYQSF-------YSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  190 (353)
Q Consensus       119 p~iv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~N  190 (353)
                      +||+.+++.|       .....++.++||+. ++|.+++... ..+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvHrDlKP~N  110 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS-QGIVVHNVRPSC  110 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh-CCeeeccCCchh
Confidence            4666666655       23346778899884 5999999753 569999999999999999999998 999999999999


Q ss_pred             EEEcCC-------------------CcEEEeeccccccccccCC----------------CCcccccCCcccCcceecCC
Q 018630          191 LLINHR-------------------GEVKITDFGVSAIMASTSG----------------QANTFVGTYNYMSPERISGG  235 (353)
Q Consensus       191 Ill~~~-------------------~~~kl~DfG~a~~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~  235 (353)
                      |||+..                   +.+|++|||+++.......                .....+||++|||||++.+.
T Consensus       111 iLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~  190 (793)
T PLN00181        111 FVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS  190 (793)
T ss_pred             EEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC
Confidence            999653                   4566666666653211000                01124689999999999999


Q ss_pred             CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHH
Q 018630          236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ  315 (353)
Q Consensus       236 ~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  315 (353)
                      .++.++|||||||++|||++|.+|+....     ..    +..+.....++.. ....+...+++.+||++||.+|||+.
T Consensus       191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~----~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~  260 (793)
T PLN00181        191 SSNCASDVYRLGVLLFELFCPVSSREEKS-----RT----MSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMS  260 (793)
T ss_pred             CCCchhhhhhHHHHHHHHhhCCCchhhHH-----HH----HHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChH
Confidence            99999999999999999999988875321     11    1111111111111 12245678999999999999999999


Q ss_pred             HHHcCCccccc
Q 018630          316 ELMTHPFLKMY  326 (353)
Q Consensus       316 e~l~hp~~~~~  326 (353)
                      |+++||||...
T Consensus       261 eil~h~~~~~~  271 (793)
T PLN00181        261 ELLQSEFINEP  271 (793)
T ss_pred             HHhhchhhhhh
Confidence            99999999764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=1.5e-30  Score=219.78  Aligned_cols=166  Identities=29%  Similarity=0.458  Sum_probs=129.7

Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccccc
Q 018630          144 GSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  222 (353)
Q Consensus       144 gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  222 (353)
                      |||.+++... ..+++..++.++.|++.||.|||+ .+      ||+||+++.++.+++  ||++......     ...|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCccceee--ccceEeeccc-----cCCC
Confidence            6899999864 569999999999999999999998 76      999999999999999  9998765432     2268


Q ss_pred             CCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC-CCCCCCCH--HHHHH
Q 018630          223 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSP--EFCSF  299 (353)
Q Consensus       223 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~l  299 (353)
                      |+.|||||++.+..++.++||||+||++|||++|..||.......  ................. .....++.  ++.++
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            999999999999999999999999999999999999997643321  11112221111111100 11122333  69999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          300 ISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      +.+||+.||.+|||+.|++.|+|+..
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999999863

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.7e-31  Score=260.31  Aligned_cols=263  Identities=22%  Similarity=0.361  Sum_probs=207.1

Q ss_pred             eeeeeecccCCeEEEEEEeccCCcEEEEEEee----c-cccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           64 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ----M-NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~----~-~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .....+|.|++|.|+.+......+.++.|.+.    . .........+..|.-+-..+.|||++.......+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999999888887777767666543    1 222223333778888888999999988877766655555559


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC--
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--  216 (353)
                      |||++ +|+.++...+.++...+..++.|++.|++|+|+ .||.|||+||+|+++..+|.+||+|||.+.........  
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence            99999 999999987789999999999999999999998 99999999999999999999999999998776544332  


Q ss_pred             --CcccccCCcccCcceecCCCCCc-cccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          217 --ANTFVGTYNYMSPERISGGKYGY-KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       217 --~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                        ....+|+..|+|||.+.+..|+. ..||||.|++++.|++|+.||..+.+.+.................+......++
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp  558 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP  558 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence              34568999999999999999965 689999999999999999999887665432100011111111122233345678


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      ...+.+|.+||+.||.+|.|+++|++.+||+....
T Consensus       559 ~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  559 RETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             hhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            88999999999999999999999999999997543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-27  Score=219.72  Aligned_cols=252  Identities=23%  Similarity=0.273  Sum_probs=194.2

Q ss_pred             CceeeeeecccCCeEEEEEEeccCC-cEEEEEEeeccccHHHHHHHHHHHHHHhcCC----CCceEEEeeEe-EecCeEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTG-QFFALKVIQMNVEESARRQIAQELKINQSSQ----CPYVVVCYQSF-YSNGAIS  135 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~----hp~iv~~~~~~-~~~~~~~  135 (353)
                      +|.+.+.||+|+||.||.+.+..++ +.+|+|+.......... .+..|..++..+.    .+++..+++.+ ..+..-+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            8999999999999999999998764 67899987654222211 5667777777665    25788888888 4778899


Q ss_pred             EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC-----CcEEEeeccccc
Q 018630          136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-----GEVKITDFGVSA  208 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~-----~~~kl~DfG~a~  208 (353)
                      +||+.+ |.+|.++....  +.++..++..++.|++.+|+++|+ .|++||||||.|+++...     ..+.|.|||+++
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            999988 67999988654  579999999999999999999998 999999999999999865     359999999998


Q ss_pred             --cccccCCC--------CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHH
Q 018630          209 --IMASTSGQ--------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA  278 (353)
Q Consensus       209 --~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~  278 (353)
                        ........        .....||..|.++.++.+...+.+.|+||++.++.|++.|..||...+..............
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence              43222211        12345999999999999999999999999999999999999999775543221111111111


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          279 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .   .... .....+.++.++...+-..+..++|.+..+...
T Consensus       256 ~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  256 L---LTDR-FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             h---cccc-ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            1   1111 234456778888888888999999999887664

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=1.5e-26  Score=211.57  Aligned_cols=258  Identities=34%  Similarity=0.573  Sum_probs=208.5

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHH--HHHHHHHHHHHHhcCCCC-ceEEEeeEeEecCeEEEEEE
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES--ARRQIAQELKINQSSQCP-YVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~l~hp-~iv~~~~~~~~~~~~~lv~e  139 (353)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+.......  ....+.+|+.++..+.|+ +++++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            778899999999999999987   789999987664333  477889999999999988 79999999987778899999


Q ss_pred             ecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCC
Q 018630          140 YMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSG  215 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~  215 (353)
                      ++.++++.+++....   .++......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||.+........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            999999998877664   79999999999999999999998 9999999999999999988 799999999875543332


Q ss_pred             ------CCcccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-
Q 018630          216 ------QANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-  285 (353)
Q Consensus       216 ------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-  285 (353)
                            ......|+..|+|||.+.+   ..++...|+||+|++++++++|..||......   .........+.....+ 
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTPS  234 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCcc
Confidence                  2356789999999999987   57889999999999999999999997664321   0112223333332222 


Q ss_pred             C--CCCCCC----CHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          286 S--APSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       286 ~--~~~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      .  ......    ...+.+++.+++..+|..|.+..+...++|.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence            1  111111    25789999999999999999999999987766544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=8.7e-28  Score=202.34  Aligned_cols=252  Identities=19%  Similarity=0.289  Sum_probs=201.7

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCC-CceEEEeeEeEecCeEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC-PYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-p~iv~~~~~~~~~~~~~l  136 (353)
                      +...+|.+++.||.|+||.+|++....+|+.||||+-+..   ....++.-|.++.+.+++ ..|..+..++.+..+-.+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            4568999999999999999999999999999999986533   334567778888777764 667777777778888899


Q ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC---CcEEEeeccccccccc
Q 018630          137 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMAS  212 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~  212 (353)
                      ||+.+ |.||.++.+-. +.++..+++-++-|++.-++|+|. ++++||||||+|+|..-+   ..+.|+|||+|+.+.+
T Consensus        89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            99999 78999998743 679999999999999999999998 999999999999999743   4699999999988754


Q ss_pred             cCCC-------CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018630          213 TSGQ-------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  285 (353)
Q Consensus       213 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  285 (353)
                      ....       .....||.+|.+-.++.+...+.+.|+-|+|.++.++.-|..||.+..........+.+.+ .....+.
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E-kK~s~~i  245 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE-KKMSTPI  245 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH-hhcCCCH
Confidence            3322       2235799999999998888889999999999999999999999988665443333333322 2223333


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCHH
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQ  315 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  315 (353)
                      ......+|.++.-.+.-|=..--++-|...
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            445678899999999888777777777654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=3.7e-27  Score=218.54  Aligned_cols=167  Identities=18%  Similarity=0.190  Sum_probs=132.6

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEecc-CCcEEEEEEeecc----ccHHHHHHHHHHHHHHhcCCCCceEE-EeeEeEe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKW-TGQFFALKVIQMN----VEESARRQIAQELKINQSSQCPYVVV-CYQSFYS  130 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~hp~iv~-~~~~~~~  130 (353)
                      ....++|.+.+.||+|+||+||+|.++. +++.+|||++...    ........+.+|+++++.++|+|++. ++.    
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----   89 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----   89 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence            3455789999999999999999999876 6788899986532    12344667999999999999999984 443    


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCC-CCCcEEEcCCCcEEEeecccccc
Q 018630          131 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL-KPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dl-kp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      .+..|+||||++|++|... .   ...   ...++.|++.||.|||+ +||+|||| ||+|||++.+++++|+|||+|+.
T Consensus        90 ~~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             cCCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence            2467999999999999732 1   111   14678999999999998 99999999 99999999999999999999987


Q ss_pred             ccccCC--------CCcccccCCcccCcceecCC
Q 018630          210 MASTSG--------QANTFVGTYNYMSPERISGG  235 (353)
Q Consensus       210 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~  235 (353)
                      ....+.        ......+++.|+|||.+...
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            653321        11345688899999998653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-26  Score=202.12  Aligned_cols=249  Identities=21%  Similarity=0.306  Sum_probs=201.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .-.|++.+.||.|+||+.+++++..++++||||.-+..   +...+++.|.+..+.|. .++|...|-+..++.+-.||+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            34799999999999999999999999999999986533   34567778887777664 689999998888888889999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC-----CcEEEeeccccccccc
Q 018630          139 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-----GEVKITDFGVSAIMAS  212 (353)
Q Consensus       139 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~-----~~~kl~DfG~a~~~~~  212 (353)
                      |.+ |.||.|+..-. +.++..++..+|.|++.-++|+|+ +.+|.|||||+|+||..-     ..+.++|||+|+.+.+
T Consensus       104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            998 78999998754 679999999999999999999998 999999999999999743     3599999999988765


Q ss_pred             cCCC-------CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-
Q 018630          213 TSGQ-------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-  284 (353)
Q Consensus       213 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-  284 (353)
                      ....       ..+..||.+||+-..+.+...+.+.|+-|||=++.+++-|..||.+....    +..+..++|.+.+. 
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~----tnK~kYeKIGe~Kr~  257 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD----TNKEKYEKIGETKRS  257 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc----chHHHHHHhcccccc
Confidence            4332       23567999999999999999999999999999999999999999886543    22233344444332 


Q ss_pred             --CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHH
Q 018630          285 --PSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  317 (353)
Q Consensus       285 --~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  317 (353)
                        ......++|.++..-+.-.=+.+-.+-|.++-+
T Consensus       258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl  292 (449)
T KOG1165|consen  258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL  292 (449)
T ss_pred             CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence              233456778888887777777777777766533

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=6.5e-28  Score=227.92  Aligned_cols=242  Identities=30%  Similarity=0.436  Sum_probs=203.3

Q ss_pred             eecccCCeEEEEEEe---ccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEEEEEecC
Q 018630           68 VVGKGSGGIVQLVQH---KWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMD  142 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~  142 (353)
                      ++|.|+||.|++++-   ...|..+|+|+.+.... ...+.....|..++...+ ||.++++.-.++.++.+++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998754   34577899998765421 111224556777777766 9999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccccc
Q 018630          143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  222 (353)
Q Consensus       143 ~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  222 (353)
                      ||.|...+.....+.+.....+...++-+++++|+ .+++|||+|++||+++.+|++++.|||+++........    ||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CG  155 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----cc
Confidence            99999999888889999999999999999999998 99999999999999999999999999999876543322    99


Q ss_pred             CCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018630          223 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  302 (353)
Q Consensus       223 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  302 (353)
                      |..|||||.+.  .....+|.||+|++.+||++|..||..           +.+..|.+....  .+..+++.+.+++..
T Consensus       156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~~~~--~p~~l~~~a~~~~~~  220 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKAELE--MPRELSAEARSLFRQ  220 (612)
T ss_pred             chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhhccC--CchhhhHHHHHHHHH
Confidence            99999999998  567889999999999999999999975           455556554443  246789999999999


Q ss_pred             hhhhCcCCCCCH-----HHHHcCCcccccCCC
Q 018630          303 CVQKEPQQRLSA-----QELMTHPFLKMYGDL  329 (353)
Q Consensus       303 ~L~~dp~~Rpt~-----~e~l~hp~~~~~~~~  329 (353)
                      ++..+|..|.-+     .++.+|+||+...+.
T Consensus       221 l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  221 LFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            999999999955     699999999886644

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=8.6e-27  Score=230.79  Aligned_cols=242  Identities=21%  Similarity=0.224  Sum_probs=183.0

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc---HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ++...+.||++.|=+|.++++. .|. |+||++-....   -....+..+|++ ...+++||++.+..+-..++..|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            6888999999999999999886 344 89998754422   223344445555 56678999999988877788899999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc--ccCC-
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSG-  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~--~~~~-  215 (353)
                      +|... +|+|.+..+.-+..-+.+.|+.||+.|+..+|. .||+|||||.+|||+++-+.+.|+||..-+..-  ..+. 
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            99986 999999988778889999999999999999998 999999999999999999999999998654321  1111 


Q ss_pred             CC----cccccCCcccCcceecCC----------C-CCccccHHHHHHHHHHHHc-CCCCCCCCccCCc----hhhHHHH
Q 018630          216 QA----NTFVGTYNYMSPERISGG----------K-YGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG----WTSFYEL  275 (353)
Q Consensus       216 ~~----~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~----~~~~~~~  275 (353)
                      +.    .+...-.+|.|||.+...          . .+++.||||+||+++||++ |++||.-..--..    .......
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence            11    112234579999987541          2 5678999999999999999 8999953211000    0011111


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          276 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ++.+            -+..++++|..|++.||++|.+|++.|+.
T Consensus       259 Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  259 LEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhC------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            2222            13368999999999999999999999985

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=9.8e-25  Score=195.82  Aligned_cols=273  Identities=17%  Similarity=0.276  Sum_probs=189.2

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCC-----------------------------------cEEEEEEee-cc-
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTG-----------------------------------QFFALKVIQ-MN-   97 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----------------------------------~~vaiK~~~-~~-   97 (353)
                      +..+..++|++.+.||+|--+.||.|+-..+|                                   -+.|||++- .+ 
T Consensus       151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~  230 (598)
T KOG4158|consen  151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH  230 (598)
T ss_pred             hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence            34577899999999999999999998754311                                   134566542 11 


Q ss_pred             --ccHHHHHHHHHHHH-------H----------H-----hcCCCCceEEEeeEeE------------------------
Q 018630           98 --VEESARRQIAQELK-------I----------N-----QSSQCPYVVVCYQSFY------------------------  129 (353)
Q Consensus        98 --~~~~~~~~~~~e~~-------~----------~-----~~l~hp~iv~~~~~~~------------------------  129 (353)
                        .+....+.+-+|..       .          +     +...|||||.++..|.                        
T Consensus       231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~  310 (598)
T KOG4158|consen  231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS  310 (598)
T ss_pred             CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence              11122222222321       0          0     1146999999987653                        


Q ss_pred             ---ecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc--CCC--cEEEe
Q 018630          130 ---SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN--HRG--EVKIT  202 (353)
Q Consensus       130 ---~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~--~~~--~~kl~  202 (353)
                         ++..+|+||.-++. +|.+++-.+ ..+.....-++.|+++|+.|||. +||.|||+|.+|||+.  +++  .+.++
T Consensus       311 g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVva  387 (598)
T KOG4158|consen  311 GAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVA  387 (598)
T ss_pred             ccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEc
Confidence               24569999999976 999999764 46777888899999999999998 9999999999999984  444  58999


Q ss_pred             eccccccccccC------CCCcccccCCcccCcceecCCC------CCccccHHHHHHHHHHHHcCCCCCCCCccCCchh
Q 018630          203 DFGVSAIMASTS------GQANTFVGTYNYMSPERISGGK------YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT  270 (353)
Q Consensus       203 DfG~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~  270 (353)
                      |||++-.....+      .+.....|...-||||+....+      --.++|.|+.|.+.||+++...||...-+..   
T Consensus       388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---  464 (598)
T KOG4158|consen  388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---  464 (598)
T ss_pred             ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---
Confidence            999885543211      1222346788899999886432      1248999999999999999999998632211   


Q ss_pred             hHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHH---Hc------CCcccccCCCC-cCHhHHh
Q 018630          271 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL---MT------HPFLKMYGDLN-VDLSEYF  337 (353)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~---l~------hp~~~~~~~~~-~~~~~~~  337 (353)
                        .+...  ......+..++.+++.+++++..+|+.||++|+++.-+   ++      |.|++...+.+ .+++.|+
T Consensus       465 --L~~r~--Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~~~~~~~~~wL  537 (598)
T KOG4158|consen  465 --LDTRT--YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMMEKCGISQMTWL  537 (598)
T ss_pred             --echhh--hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhcccccHHHHHHH
Confidence              11111  22223344567899999999999999999999987533   32      45555544444 4666665

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=1.5e-24  Score=193.30  Aligned_cols=232  Identities=20%  Similarity=0.280  Sum_probs=149.8

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCC----------CceEEEeeEeE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQC----------PYVVVCYQSFY  129 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h----------p~iv~~~~~~~  129 (353)
                      .+...+.||.|+++.||.+.+..+|+.+|+|+.....  .....+++.+|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4567789999999999999999999999999875442  22334566666644433222          12332222211


Q ss_pred             ---------ec---C-----eEEEEEEecCCCCHHHHHHh---cCCC----CHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 018630          130 ---------SN---G-----AISIILEYMDGGSLADFLKK---VKTI----PEEYLAAICEQVLKGLLYLHHEKHIIHRD  185 (353)
Q Consensus       130 ---------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~l----~~~~~~~i~~ql~~~l~~LH~~~~iiH~D  185 (353)
                               ..   .     ..+++|+-+.+ +|.+++..   ....    .......+..|+++.+++||+ .|++|+|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgd  170 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGD  170 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEecc
Confidence                     11   1     24778898864 99887642   2222    222334556899999999998 9999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCCcccCcceecC--------CCCCccccHHHHHHHHHHHHcCC
Q 018630          186 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG--------GKYGYKSDIWSLGLVLLECATGQ  257 (353)
Q Consensus       186 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~  257 (353)
                      |+|+|++++.+|.++|+||+.....+...   .....+..|.+||....        -.++.+.|.|+||+++|.|.||.
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            99999999999999999998775543322   11334577999997643        24788999999999999999999


Q ss_pred             CCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCC
Q 018630          258 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR  311 (353)
Q Consensus       258 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  311 (353)
                      .||...........             .......+|+.++.||..+|+.||.+|
T Consensus       248 lPf~~~~~~~~~~~-------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW-------------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG-------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc-------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99987544321110             111223789999999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=2.2e-24  Score=184.15  Aligned_cols=140  Identities=17%  Similarity=0.177  Sum_probs=108.9

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeeccccH--H-----------------------HHHHHHHHHHHHhcCCCCc
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE--S-----------------------ARRQIAQELKINQSSQCPY  120 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~-----------------------~~~~~~~e~~~~~~l~hp~  120 (353)
                      ...||+|++|.||+|.+. +|+.||||+++.....  .                       .......|++++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            457999999999999997 8999999999754210  0                       0122345888888887766


Q ss_pred             eEEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCceecCCCCCcEEEcCCCcE
Q 018630          121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL-HHEKHIIHRDLKPSNLLINHRGEV  199 (353)
Q Consensus       121 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~L-H~~~~iiH~Dlkp~NIll~~~~~~  199 (353)
                      +...... ... ..++||||++|+++.........++...+..++.|++.+|.++ |+ .||+||||||+||+++ ++.+
T Consensus        81 v~~p~~~-~~~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          81 IPCPEPI-LLK-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCCCcEE-Eec-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEE-CCcE
Confidence            5332222 222 2389999999887766544457899999999999999999999 66 8999999999999998 5789


Q ss_pred             EEeeccccccc
Q 018630          200 KITDFGVSAIM  210 (353)
Q Consensus       200 kl~DfG~a~~~  210 (353)
                      +|+|||+|...
T Consensus       157 ~LiDFG~a~~~  167 (190)
T cd05147         157 YIIDVSQSVEH  167 (190)
T ss_pred             EEEEccccccC
Confidence            99999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.91  E-value=1.1e-24  Score=215.60  Aligned_cols=223  Identities=35%  Similarity=0.554  Sum_probs=170.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      .+|+.++.+..|+||.||.++++.+.+++|+|+=+.+   ...+.      ++.....|.+|                  
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~---lilRn------ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN---LILRN------ILTFAGNPFVV------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccc---hhhhc------cccccCCccee------------------
Confidence            6899999999999999999999999999999652211   11110      23333334433                  


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-----
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-----  215 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-----  215 (353)
                         |+=...++..+.++.+.        +.+++|||+ .||+|||+||+|.+|+.-|++|++|||+++.......     
T Consensus       136 ---gDc~tllk~~g~lPvdm--------vla~Eylh~-ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e  203 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGPLPVDM--------VLAVEYLHS-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE  203 (1205)
T ss_pred             ---chhhhhcccCCCCcchh--------hHHhHhhcc-CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence               45556666666666544        779999998 9999999999999999999999999999865421100     


Q ss_pred             ----------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh-cCCC
Q 018630          216 ----------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV-DQPP  284 (353)
Q Consensus       216 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~  284 (353)
                                .....+|||.|+|||++....|...+|+|++|+|+||++-|..||.+...+       +++..+. +...
T Consensus       204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-------elfg~visd~i~  276 (1205)
T KOG0606|consen  204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------ELFGQVISDDIE  276 (1205)
T ss_pred             cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-------HHHhhhhhhhcc
Confidence                      112358999999999999999999999999999999999999999885443       3333333 2222


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhhCcCCCC---CHHHHHcCCcccccCCC
Q 018630          285 PSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKMYGDL  329 (353)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~~~~~  329 (353)
                      .+.....+++++++++.++|+.+|..|.   .+-++.+|+||+...+.
T Consensus       277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  277 WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            3333567899999999999999999998   56788999999986654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1e-24  Score=186.97  Aligned_cols=246  Identities=17%  Similarity=0.267  Sum_probs=193.9

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      .++.++..++.+|.....|..|+++..  |..+++|++.... .....+.|..|.-.++-..||||+.+++.+..+..+.
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             CcchhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            355677788889999999999988765  7778888876552 2223467888888899999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCce-ecCCCCCcEEEcCCCcEEE--eeccccccc
Q 018630          136 IILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHII-HRDLKPSNLLINHRGEVKI--TDFGVSAIM  210 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~l~~LH~~~~ii-H~Dlkp~NIll~~~~~~kl--~DfG~a~~~  210 (353)
                      ++..||+.|||+..++....  .+..++.+++.++++|++|||+-..++ ---|....+++|++-+.+|  +|--++.. 
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-  342 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-  342 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence            99999999999999987643  577889999999999999999833344 3468899999998876655  44333211 


Q ss_pred             cccCCCCcccccCCcccCcceecCCCCC---ccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGGKYG---YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                            .......|.||+||.+..++-+   .++|+|||++++|||.|...||.+.++.+       .-.++........
T Consensus       343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-------cgmkialeglrv~  409 (448)
T KOG0195|consen  343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-------CGMKIALEGLRVH  409 (448)
T ss_pred             ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-------hhhhhhhcccccc
Confidence                  1223457899999999876643   57899999999999999999998865543       3334444444455


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHH
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELM  318 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  318 (353)
                      .+..+++.+..|+.-|++.||.+||.+..++
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            5678999999999999999999999987764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=4.1e-24  Score=185.10  Aligned_cols=172  Identities=20%  Similarity=0.274  Sum_probs=132.4

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHH------HHHHHHHHhcCCCCceEEEeeEeEe
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQ------IAQELKINQSSQCPYVVVCYQSFYS  130 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~------~~~e~~~~~~l~hp~iv~~~~~~~~  130 (353)
                      .-++|..++.||.|+||.||++..  ++..+|+|++.....  +.....      +.+|+..+.++.||+|..+...+..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            347899999999999999999766  466899999975422  222222      5789999999999999988887653


Q ss_pred             c--------CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEe
Q 018630          131 N--------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT  202 (353)
Q Consensus       131 ~--------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~  202 (353)
                      .        +..++||||++|.+|.++..    +++    ....+++.++..+|+ .|++|||++|.||+++.+| ++|+
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC-EEEE
Confidence            3        45899999999999988732    333    245699999999998 9999999999999999988 9999


Q ss_pred             eccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHH
Q 018630          203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  254 (353)
Q Consensus       203 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  254 (353)
                      |||.+....... ...           .......|+.++|+||||+++..+.
T Consensus       177 Dfg~~~~~~e~~-a~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        177 DLSGKRCTAQRK-AKD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ECCCcccccchh-hHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            999875432111 000           0233345678999999999998765

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=2.8e-23  Score=177.67  Aligned_cols=142  Identities=18%  Similarity=0.170  Sum_probs=111.7

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeeccccH-------------------------HHHHHHHHHHHHHhcCCCCc
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-------------------------SARRQIAQELKINQSSQCPY  120 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~e~~~~~~l~hp~  120 (353)
                      ...||+|++|.||+|.+. +|+.||||+++.....                         .....+.+|...+..+.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 8999999998754210                         01123457888888888888


Q ss_pred             eEEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEE
Q 018630          121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK  200 (353)
Q Consensus       121 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  200 (353)
                      +.........  ..++||||++|+++.........++...+..++.|++.++.++|+..||+||||||+||+++ ++.++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            7544333322  24899999998765444333467888999999999999999999758999999999999998 89999


Q ss_pred             Eeecccccccc
Q 018630          201 ITDFGVSAIMA  211 (353)
Q Consensus       201 l~DfG~a~~~~  211 (353)
                      |+|||++....
T Consensus       158 liDFG~a~~~~  168 (190)
T cd05145         158 IIDVSQAVELD  168 (190)
T ss_pred             EEEcccceecC
Confidence            99999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.90  E-value=5.7e-25  Score=204.36  Aligned_cols=176  Identities=31%  Similarity=0.498  Sum_probs=140.4

Q ss_pred             EEEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      +|+.|++|...+|.+|+...   ...+....+.++.|++.|++|    ++.+|+|+||.||+...++.+||+|||+.+..
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccchhhhhhhhhheeec
Confidence            78899999999999999754   346778899999999999999    68999999999999999999999999998876


Q ss_pred             cccC------CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          211 ASTS------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       211 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      ....      ......+||.+||+||++.+..|+.++||||||++|+||+. -..+|.          -...+..+.++.
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~r~g~  476 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDIRDGI  476 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhhhcCC
Confidence            5433      12344689999999999999999999999999999999998 333331          123344455555


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                      .|+...... ++-..|+.+||.+.|.+||++.+.--|+|.+
T Consensus       477 ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  477 IPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             CChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            553333333 3456899999999999999888887787754

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=5.1e-22  Score=168.62  Aligned_cols=187  Identities=14%  Similarity=0.074  Sum_probs=138.7

Q ss_pred             eeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc---HHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEEEEE
Q 018630           64 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .....|++|+||+|+++..  .+.+++.+.+....-   ..+...+.+|+++++++. |+++.++++.    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3457899999999997766  577888777665422   222345789999999995 4778888875    34699999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCC-CCCcEEEcCCCcEEEeeccccccccccCCC--
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL-KPSNLLINHRGEVKITDFGVSAIMASTSGQ--  216 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dl-kp~NIll~~~~~~kl~DfG~a~~~~~~~~~--  216 (353)
                      |+.|.+|...+..      . ...++.|++.+|.++|+ +||+|||| ||+|||++.+|.++|+|||+|.........  
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            9999998754321      1 23577899999999998 99999999 799999999999999999999754432210  


Q ss_pred             --C---------cccccCCcccCcceecCC-CCC-ccccHHHHHHHHHHHHcCCCCCCCCc
Q 018630          217 --A---------NTFVGTYNYMSPERISGG-KYG-YKSDIWSLGLVLLECATGQFPYSPPE  264 (353)
Q Consensus       217 --~---------~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~ell~g~~Pf~~~~  264 (353)
                        .         .....++.|++|+...-- ..+ ...+.++.|+-+|.++|+..|+....
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence              0         012256777777754322 233 46688899999999999888765543

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=3e-21  Score=166.48  Aligned_cols=135  Identities=21%  Similarity=0.257  Sum_probs=106.8

Q ss_pred             eeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-----CCCceEEEeeEeEecC---eEE-
Q 018630           65 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-----QCPYVVVCYQSFYSNG---AIS-  135 (353)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~hp~iv~~~~~~~~~~---~~~-  135 (353)
                      -.+.||+|++|.||.  +..++.. +||++..... .....+.+|+++++.+     .||||+++++++.++.   ..+ 
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            346899999999995  7667666 6998865422 2346789999999998     6799999999998763   434 


Q ss_pred             EEEEe--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhcCCceecCCCCCcEEEcC----CCcEEEeecccc
Q 018630          136 IILEY--MDGGSLADFLKKVKTIPEEYLAAICEQVLKGL-LYLHHEKHIIHRDLKPSNLLINH----RGEVKITDFGVS  207 (353)
Q Consensus       136 lv~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l-~~LH~~~~iiH~Dlkp~NIll~~----~~~~kl~DfG~a  207 (353)
                      +|+||  +.+++|.+++++ ..+++.  ..++.|++.++ +|||+ ++|+||||||+||+++.    +++++|+||+-+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            78999  557999999976 346665  35678888777 99998 99999999999999974    337999995433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=5e-22  Score=200.11  Aligned_cols=201  Identities=24%  Similarity=0.289  Sum_probs=161.2

Q ss_pred             CCCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHH--HHHHHHHHHHhcCCCCceEEEeeEeEe
Q 018630           53 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYS  130 (353)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~~~~l~hp~iv~~~~~~~~  130 (353)
                      ....++..+.|.+.+.||+|+||+||+|.+.. |+.||+|+-+.....+..  .+++.-++   ..--+.|..+...+.-
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK---PQMLPSIMHISSAHVF  765 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc---hhhhcchHHHHHHHcc
Confidence            34456777899999999999999999999986 999999987655322211  22222222   1112456666666667


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-------CCcEEEee
Q 018630          131 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-------RGEVKITD  203 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-------~~~~kl~D  203 (353)
                      .+..++|+||.+.|+|.++++..+..++..+..++.|+++.++.||. .+|||+||||+|.||..       .--++|+|
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEEe
Confidence            78889999999999999999988899999999999999999999998 99999999999999952       23599999


Q ss_pred             ccccccccccC--CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCC
Q 018630          204 FGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  258 (353)
Q Consensus       204 fG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  258 (353)
                      ||.+.-+.-..  ......++|-.+-.+|...|.+|++.+|.|+|+.+++.|++|++
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99997664222  23344578889999999999999999999999999999999863

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=5.5e-21  Score=168.60  Aligned_cols=143  Identities=20%  Similarity=0.158  Sum_probs=113.0

Q ss_pred             CceeeeeecccCCeEEEEEE-eccCCcEEEEEEeeccccH-----------------------HHHHHHHHHHHHHhcCC
Q 018630           62 DIDTIKVVGKGSGGIVQLVQ-HKWTGQFFALKVIQMNVEE-----------------------SARRQIAQELKINQSSQ  117 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~-----------------------~~~~~~~~e~~~~~~l~  117 (353)
                      -|.+.+.||+|++|.||+|. +..+|+.||+|+++.....                       .....+.+|+.++..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 6678999999998754210                       01234668999988887


Q ss_pred             CCc--eEEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-ceecCCCCCcEEEc
Q 018630          118 CPY--VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLIN  194 (353)
Q Consensus       118 hp~--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~-iiH~Dlkp~NIll~  194 (353)
                      +..  +.+++.   . ...++||||+.|++|.........+....+..++.|++.++.+||+ .| ++||||||+||+++
T Consensus       109 ~~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeE---e-cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCChhhEEEE
Confidence            532  334443   2 2358999999998887765444556777788999999999999998 89 99999999999998


Q ss_pred             CCCcEEEeeccccccc
Q 018630          195 HRGEVKITDFGVSAIM  210 (353)
Q Consensus       195 ~~~~~kl~DfG~a~~~  210 (353)
                       ++.++|+|||.+...
T Consensus       184 -~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 -DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CCCEEEEEChhhhcc
Confidence             889999999987643

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.5e-20  Score=177.94  Aligned_cols=204  Identities=23%  Similarity=0.366  Sum_probs=160.2

Q ss_pred             HhcCCCCceEEEeeEeEecCeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcE
Q 018630          113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  191 (353)
Q Consensus       113 ~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NI  191 (353)
                      ++.+.|.|+.++++.+.+++..++|.+||..|+|.+.+.. ...++......++++++.||.|||+.....|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            3578999999999999999999999999999999999987 356788888889999999999999844449999999999


Q ss_pred             EEcCCCcEEEeecccccccccc--CCCCcccccCCcccCcceecCCC-------CCccccHHHHHHHHHHHHcCCCCCCC
Q 018630          192 LINHRGEVKITDFGVSAIMAST--SGQANTFVGTYNYMSPERISGGK-------YGYKSDIWSLGLVLLECATGQFPYSP  262 (353)
Q Consensus       192 ll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~g~~Pf~~  262 (353)
                      +++....+||+|||+.......  ........-..-|.|||.+....       .+.+.|+||+|++++|+++..-||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998765321  11122223456799999987631       46789999999999999999999987


Q ss_pred             CccCCchhhHHHHHHHHhcCCC----CCCC-CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          263 PEQQDGWTSFYELMEAIVDQPP----PSAP-SDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .......   .+++..+.+...    |... ....++++..++.+||..+|.+||+++++-.
T Consensus       161 ~~~~~~~---~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDP---DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCCh---HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            5444322   344444444221    1111 1245668999999999999999999998854

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=7.8e-22  Score=194.48  Aligned_cols=261  Identities=27%  Similarity=0.390  Sum_probs=210.0

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCC-cEEEEEEeecc-ccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTG-QFFALKVIQMN-VEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~l  136 (353)
                      ...|...+.||+|+|+.|-.+....+. ..+|.|.+... .......++..|..+...+. |+|++.+++...+....++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            356788888999999999887775443 35677766544 23445566777888888877 9999999999999999999


Q ss_pred             EEEecCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCCceecCCCCCcEEEcCCC-cEEEeeccccccccc
Q 018630          137 ILEYMDGGSLADFL-KKVK-TIPEEYLAAICEQVLKGLLYLH-HEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMAS  212 (353)
Q Consensus       137 v~e~~~~gsL~~~l-~~~~-~l~~~~~~~i~~ql~~~l~~LH-~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~  212 (353)
                      .++|..|+++++-+ .... ..+...+..+..|+..++.|+| . .++.|+|+||+|.+++..+ .++++|||+|.....
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            99999999999988 5544 6778888999999999999999 6 9999999999999999999 999999999987765


Q ss_pred             -cCC--CCccccc-CCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          213 -TSG--QANTFVG-TYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       213 -~~~--~~~~~~g-t~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                       .+.  .....+| ++.|+|||...+.. .....|+||.|+++.-+++|..||..+...+...  ......-  ......
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~--~~~~~~~--~~~~~~  253 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY--SSWKSNK--GRFTQL  253 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--eeecccc--cccccC
Confidence             221  2234678 99999999998854 4678999999999999999999998776544211  1111110  111234


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      .+..++....+++.+++..+|+.|.+.+++..+||+..
T Consensus       254 ~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  254 PWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            45778899999999999999999999999999999998

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.9e-19  Score=156.42  Aligned_cols=135  Identities=22%  Similarity=0.313  Sum_probs=112.9

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeecccc-------HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-------ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      +.||+|++|.||++..  .|..+++|+......       ......+.+|+.++..+.|+++.....++......+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5789999999999987  577899997653211       1123567889999999999988776666667778899999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      |++|++|.+++.....    ....++.+++.+|.++|+ .|++|+|++|.||+++ ++.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999875332    788999999999999998 9999999999999998 78999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=5.4e-19  Score=152.20  Aligned_cols=131  Identities=21%  Similarity=0.308  Sum_probs=105.9

Q ss_pred             eecccCCeEEEEEEeccCCcEEEEEEeeccc-------cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           68 VVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-------EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      .||+|++|.||++..  ++..+++|......       ......++.+|++++..+.|+++....-.+..+...++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            379999999999984  57889999854321       112236678899999999887765544445566677899999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ++|++|.+++.....       .++.|++.+|.+||+ .|++|+|++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999998765321       789999999999998 9999999999999998 89999999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=7e-19  Score=151.51  Aligned_cols=137  Identities=20%  Similarity=0.207  Sum_probs=107.0

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH---------------------HHHHHHHHHHHHHhcCCCCc-
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE---------------------SARRQIAQELKINQSSQCPY-  120 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------~~~~~~~~e~~~~~~l~hp~-  120 (353)
                      |.+.+.||+|+||.||++... +|+.||||++......                     ........|..++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            666788999999999999875 7999999987643210                     01123567888888887764 


Q ss_pred             -eEEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcE
Q 018630          121 -VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV  199 (353)
Q Consensus       121 -iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  199 (353)
                       +...++    ....++||||++|++|.+....      .....++.+++.++.++|+ .|++||||+|+||+++.++.+
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccEEEcCCCcE
Confidence             333333    2455899999999998765431      3456788999999999998 999999999999999999999


Q ss_pred             EEeecccccccc
Q 018630          200 KITDFGVSAIMA  211 (353)
Q Consensus       200 kl~DfG~a~~~~  211 (353)
                      +|+|||.+....
T Consensus       165 ~liDfg~~~~~~  176 (198)
T cd05144         165 YIIDWPQMVSTD  176 (198)
T ss_pred             EEEECCccccCC
Confidence            999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=3.6e-18  Score=168.55  Aligned_cols=136  Identities=20%  Similarity=0.239  Sum_probs=110.1

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEe-ecc-c-----cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI-QMN-V-----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~-~-----~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .|...+.||+|+||.||++...  +..+++|+. ... .     ......++.+|+++++.++|++++.....+..+...
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            4456789999999999998765  334444432 111 1     112345688999999999999998877777777778


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ++||||++|++|.+++.        ....++.|++.+|.+||+ .|++||||||+||++ .++.++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999999885        346789999999999998 999999999999999 678999999999865

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=1.5e-17  Score=141.69  Aligned_cols=138  Identities=21%  Similarity=0.269  Sum_probs=96.3

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeeccccHH--HHH---------------------HHHHHHHHHhcCCCCc--
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES--ARR---------------------QIAQELKINQSSQCPY--  120 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~---------------------~~~~e~~~~~~l~hp~--  120 (353)
                      .+.||+|+||+||+|.+. +++.||||++.......  ...                     ....|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 89999999987542111  011                     0124444444443322  


Q ss_pred             eEEEeeEeEecCeEEEEEEecCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcE
Q 018630          121 VVVCYQSFYSNGAISIILEYMDGGSLAD-FLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV  199 (353)
Q Consensus       121 iv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  199 (353)
                      +.+++..    ...++||||++++++.. .+.... .. ..+..++.+++.++.++|+..|++|+||||+||+++ ++.+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            3333332    24589999999854321 111111 11 667889999999999999658999999999999999 8999


Q ss_pred             EEeecccccccc
Q 018630          200 KITDFGVSAIMA  211 (353)
Q Consensus       200 kl~DfG~a~~~~  211 (353)
                      +|+|||.+....
T Consensus       154 ~liDfg~a~~~~  165 (187)
T cd05119         154 YIIDVPQAVEID  165 (187)
T ss_pred             EEEECccccccc
Confidence            999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.6e-16  Score=140.41  Aligned_cols=135  Identities=20%  Similarity=0.302  Sum_probs=104.0

Q ss_pred             eeec-ccCCeEEEEEEeccCCcEEEEEEeeccc------------cHHHHHHHHHHHHHHhcCCCCce--EEEeeEeEec
Q 018630           67 KVVG-KGSGGIVQLVQHKWTGQFFALKVIQMNV------------EESARRQIAQELKINQSSQCPYV--VVCYQSFYSN  131 (353)
Q Consensus        67 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~~~~l~hp~i--v~~~~~~~~~  131 (353)
                      ..|| .|+.|+||.+...  +..++||.+....            .......+.+|+.++..+.|+++  +..++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4677 7888999888774  7789999875320            11234668889999999988775  5566553322


Q ss_pred             -C---eEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccc
Q 018630          132 -G---AISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  206 (353)
Q Consensus       132 -~---~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~  206 (353)
                       .   ..++|||+++| .+|.+++.. ..+++..    +.|++.++.+||+ +||+||||||.|||++.++.++|+|||.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence             2   23599999997 689988865 4555543    5689999999998 9999999999999999989999999998


Q ss_pred             ccc
Q 018630          207 SAI  209 (353)
Q Consensus       207 a~~  209 (353)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=3.6e-17  Score=155.17  Aligned_cols=255  Identities=23%  Similarity=0.290  Sum_probs=196.0

Q ss_pred             cCceeeeeecc--cCCeEEEEEEe--ccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeE
Q 018630           61 EDIDTIKVVGK--GSGGIVQLVQH--KWTGQFFALKVIQMNVE-ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        61 ~~~~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~  134 (353)
                      ..+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.... ......-.+|+.-.+.+ .|+|.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45667889999  99999999998  88899999997322111 11122233445444444 589999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhcCCceecCCCCCcEEEcCC-CcEEEeeccccc
Q 018630          135 SIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLK----GLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSA  208 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~ql~~----~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~  208 (353)
                      ++-+|++. .+|..+...... +++..++....+...    |+.++|+ .+++|-|+||.||+...+ ...+++|||+..
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~  271 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSCKLTDFGLVS  271 (524)
T ss_pred             eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC-CcccccccchhheecccccceeecCCcceeE
Confidence            99999996 699988876554 888999999999999    9999998 999999999999999999 789999999998


Q ss_pred             cccccCCCCcc-----cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          209 IMASTSGQANT-----FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       209 ~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      .+....-....     ..|...|++||... +.++...|++++|.++.+-.++..+.... ....|..+.       ...
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g-~~~~W~~~r-------~~~  342 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG-KNSSWSQLR-------QGY  342 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC-CCCCccccc-------ccc
Confidence            77654422222     25778899999876 46789999999999999998887655432 112232221       111


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      .+.......+.++...+..|++.+|-.|++++.+++|+++...
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            2333344567778889999999999999999999999999753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=2.2e-16  Score=128.86  Aligned_cols=133  Identities=26%  Similarity=0.301  Sum_probs=110.3

Q ss_pred             eeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCC--CceEEEeeEeEecCeEEEEEEecC
Q 018630           65 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC--PYVVVCYQSFYSNGAISIILEYMD  142 (353)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~  142 (353)
                      +++.||.|.++.||++...  +..+++|.......   ...+.+|+..++.+.+  .++.+++......+..++++||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            3578999999999999985  37899999865533   4567888888888876  488888888777788999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE--KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       143 ~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~--~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      |+++..+       +......++.+++.+++++|..  .+++|+|++|+||+++..+.+++.|||.+..
T Consensus        77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8777654       4566678899999999999972  2699999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=2.3e-17  Score=164.33  Aligned_cols=268  Identities=26%  Similarity=0.372  Sum_probs=208.4

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      ....+.+.+.+-+.+|+++.++.+.-..+|-..++|+.....  .....+.+..+-.+.-.-.+|.++.....+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            356678889999999999999999988888777776543321  111223334444444444567777766666677889


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +++++|+.+++|...++..+..+.+-+..++..+..+.++||+ ..+.|+|++|.|++...+|+.++.|||.........
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccCCcccCcccccccccccc
Confidence            9999999999999999988888888888999999999999998 669999999999999999999999998443221000


Q ss_pred             -------------------------------CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 018630          215 -------------------------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP  263 (353)
Q Consensus       215 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  263 (353)
                                                     .......||+.|.+||...+......+|+|++|++++|.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                           0012346899999999999999999999999999999999999999886


Q ss_pred             ccCCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHH---HHHcCCcccccCCCCcC
Q 018630          264 EQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQ---ELMTHPFLKMYGDLNVD  332 (353)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~---e~l~hp~~~~~~~~~~~  332 (353)
                      ..+       ++.+.+..... .+.-+...++++++++.++|..+|.+|..+.   ++-.||||+.....++.
T Consensus      1039 tpq-------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1039 TPQ-------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred             chh-------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccc
Confidence            554       33344444443 3334567889999999999999999999988   88899999987666653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.63  E-value=1.4e-14  Score=139.19  Aligned_cols=169  Identities=18%  Similarity=0.288  Sum_probs=134.7

Q ss_pred             EEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHH
Q 018630           80 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE  159 (353)
Q Consensus        80 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~  159 (353)
                      +..+.++.+|.|..++.+.. .....+.+.++.++.++||||+++++.+..++.+|+|+|-+.  .|..++++.   +..
T Consensus        31 ~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~  104 (690)
T KOG1243|consen   31 GTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKE  104 (690)
T ss_pred             cceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHH
Confidence            44566788899988876644 444567788889999999999999999999999999999994  788888764   377


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCCcccCcceecCCCCCc
Q 018630          160 YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY  239 (353)
Q Consensus       160 ~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  239 (353)
                      .+..-+.||+.||.+||.+.+++|++|.-..|+++..|..||++|.++......+........--.|..|+.+....  -
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--c
Confidence            78888999999999999779999999999999999999999999998765443332222233333466676554433  3


Q ss_pred             cccHHHHHHHHHHHHcC
Q 018630          240 KSDIWSLGLVLLECATG  256 (353)
Q Consensus       240 ~~DiwslG~il~ell~g  256 (353)
                      ..|.|.|||+++|++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            46999999999999998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.58  E-value=1.7e-15  Score=147.11  Aligned_cols=142  Identities=18%  Similarity=0.306  Sum_probs=95.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH---------------------------------HHHHHHH
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE---------------------------------SARRQIA  107 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------------------~~~~~~~  107 (353)
                      .+|+. +.||+|++|+||.|+.+.+|+.||||+.+.....                                 +....+.
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 7899999999999999877999999999754211                                 1122233


Q ss_pred             HHHHHHhc------C----CCCceEEEeeEeEe-cCeEEEEEEecCCCCHHHHH--HhcC----CCCHHHHHHHHHHHHH
Q 018630          108 QELKINQS------S----QCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFL--KKVK----TIPEEYLAAICEQVLK  170 (353)
Q Consensus       108 ~e~~~~~~------l----~hp~iv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~----~l~~~~~~~i~~ql~~  170 (353)
                      +|++....      +    .+...+.+-.++.+ ....++||||++|+.+.++-  ...+    .+.+..+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence            33433222      2    23333333333332 45667999999999998742  3322    23333334444444  


Q ss_pred             HHHHHHhcCCceecCCCCCcEEEcCCC----cEEEeecccccccc
Q 018630          171 GLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMA  211 (353)
Q Consensus       171 ~l~~LH~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG~a~~~~  211 (353)
                           .. .|++|+|+||.||+++.+|    +++++|||++..+.
T Consensus       277 -----f~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -----FR-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----Hh-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 34 7999999999999999888    99999999987664

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1.4e-14  Score=138.78  Aligned_cols=140  Identities=19%  Similarity=0.290  Sum_probs=96.9

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHH---------------------------------H------HHH
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR---------------------------------R------QIA  107 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---------------------------------~------~~~  107 (353)
                      +.||+|++|+||+|+.+ +|+.||||+.+........                                 .      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999975 7999999998655211110                                 0      122


Q ss_pred             HHHHHHhc----CCCCceEEEeeEeE-ecCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 018630          108 QELKINQS----SQCPYVVVCYQSFY-SNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLK-GLLYLHHEKH  180 (353)
Q Consensus       108 ~e~~~~~~----l~hp~iv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~-~l~~LH~~~~  180 (353)
                      +|+..+..    +.+.+-+.+-.++. ..+..++||||++|++|.++.... ...   ....++.+++. .+..+|. .|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~-~g  277 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR-DG  277 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh-CC
Confidence            33333332    22322233333332 234568999999999998876532 122   23456666666 4788898 99


Q ss_pred             ceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       181 iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ++|+|++|.||+++.+++++++|||++..+.
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999987664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=1.6e-14  Score=127.76  Aligned_cols=210  Identities=23%  Similarity=0.318  Sum_probs=144.5

Q ss_pred             HHhcCCCCceEEEeeEeEec-----CeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhc-CCc
Q 018630          112 INQSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHE-KHI  181 (353)
Q Consensus       112 ~~~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~-~~i  181 (353)
                      -+-++.|.||++++.+|.+.     ....+++||+..|++..+|++.    ..+......+|+-||+.||.|||+. --|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            34456799999999887654     3478999999999999999753    5688888999999999999999983 349


Q ss_pred             eecCCCCCcEEEcCCCcEEEeecccccccc----ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCC
Q 018630          182 IHRDLKPSNLLINHRGEVKITDFGVSAIMA----STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  257 (353)
Q Consensus       182 iH~Dlkp~NIll~~~~~~kl~DfG~a~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  257 (353)
                      +|+++..+.|++..+|-+|++----.....    ..........+-++|.|||.=....-+.++|||++|.+..+|..+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            999999999999988888865211110000    0000111234567899999655455677899999999999998765


Q ss_pred             CCCC-CCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCH
Q 018630          258 FPYS-PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  333 (353)
Q Consensus       258 ~Pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~  333 (353)
                      .--. ..+..    ...+..........        .+--..++.+||+-.|+.||++.+++.||-+-.+...+..+
T Consensus       280 iq~tnseS~~----~~ee~ia~~i~~le--------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslkll~  344 (458)
T KOG1266|consen  280 IQSTNSESKV----EVEENIANVIIGLE--------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLKLLM  344 (458)
T ss_pred             eccCCCccee----ehhhhhhhheeecc--------CccccCcCcccccCCCCCCcchhhhhcCceeeecchHHHHh
Confidence            3211 11111    11111111111110        11234588999999999999999999999987776655433

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.52  E-value=2.3e-13  Score=115.60  Aligned_cols=138  Identities=17%  Similarity=0.143  Sum_probs=97.4

Q ss_pred             eeecccCCeEEEEEEecc------CCcEEEEEEeecccc---------------------HHHH----HHHHHHHHHHhc
Q 018630           67 KVVGKGSGGIVQLVQHKW------TGQFFALKVIQMNVE---------------------ESAR----RQIAQELKINQS  115 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~---------------------~~~~----~~~~~e~~~~~~  115 (353)
                      ..||.|--+.||.|....      .+..+|||+.+.+..                     ...+    ....+|.+.+++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653      357899998853310                     0011    123378888777


Q ss_pred             CCC--CceEEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCceecCCCCCcEE
Q 018630          116 SQC--PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL-HHEKHIIHRDLKPSNLL  192 (353)
Q Consensus       116 l~h--p~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~L-H~~~~iiH~Dlkp~NIl  192 (353)
                      +..  -++..++..    ..-++||||+.++.+....-+...+++..+..+..|++.+|..+ |. .|++|+||++.||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~-~glVHGDLs~~NIL  157 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKE-CNLVHADLSEYNML  157 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEE
Confidence            643  334444443    45688999997654432222223456667778889999999999 77 89999999999999


Q ss_pred             EcCCCcEEEeeccccccc
Q 018630          193 INHRGEVKITDFGVSAIM  210 (353)
Q Consensus       193 l~~~~~~kl~DfG~a~~~  210 (353)
                      ++ ++.+.|+|||.+...
T Consensus       158 ~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             EE-CCcEEEEECCCceeC
Confidence            96 578999999987554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=1.6e-13  Score=114.80  Aligned_cols=127  Identities=18%  Similarity=0.180  Sum_probs=92.4

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCce-EEEeeEeEecCeEEEEEEecCCC
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV-VVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      ++.|+.|.++.||+++..  +..|++|+......  .......|+.+++.+.+.++ .+++...  ....++||||++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence            467899999999999864  78899998754421  12345667777776654443 3444432  33457999999998


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCc-----eecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI-----IHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       145 sL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i-----iH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      ++.+.     .   ......+.+++.+|..||+ .++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        77 ~l~~~-----~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTE-----D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc-----c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            87643     0   1123456789999999998 764     9999999999998 6789999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=5.6e-14  Score=133.65  Aligned_cols=254  Identities=22%  Similarity=0.200  Sum_probs=183.6

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEec-cCCcEEEEEEeeccccH-HHHHHHHHHHHHHhc-CCCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHK-WTGQFFALKVIQMNVEE-SARRQIAQELKINQS-SQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~-l~hp~iv~~~~~~~~~~~  133 (353)
                      .....+|-.+..||.|.|+.|+.+.-+ .++..|++|.+...... .....-..|+-+... ..|.+++..+..|.....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            345578889999999999999887755 56778999987544221 111222334444333 358888888888888888


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC-CcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~  212 (353)
                      .|+-.|||+++++...+.....+++...+.+..|++.++.++|+ +.++|+|++|.||++..+ +..+++|||+.+.+..
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccccccccce
Confidence            88999999999988777655678899999999999999999998 999999999999999876 7889999999865322


Q ss_pred             cCCCCcccccCCcc-cCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          213 TSGQANTFVGTYNY-MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       213 ~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      ...  .....+..| .+++......+..++|++|||..+.+.+++..-=....+          ...+..+..+..  ..
T Consensus       420 ~~~--~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~~p~~--~~  485 (524)
T KOG0601|consen  420 SSG--VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGDTPNL--PG  485 (524)
T ss_pred             ecc--cccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeecccccCC--Cc
Confidence            211  111223334 355555566788999999999999999997632211111          112222222221  23


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      ...++..+...|...|+..||.+.++..|.=|..
T Consensus       486 ~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  486 LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            3478889999999999999999999988865543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=3.6e-12  Score=105.03  Aligned_cols=131  Identities=24%  Similarity=0.306  Sum_probs=97.8

Q ss_pred             eecccCCeEEEEEEeccCCcEEEEEE-eecc------ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           68 VVGKGSGGIVQLVQHKWTGQFFALKV-IQMN------VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~~vaiK~-~~~~------~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      .+++|+-+.++.+...  |..+++|. +++.      ...-...+..+|+.++..+.--.|...+-+..++....|+|||
T Consensus         3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            4688999999888553  55677774 3222      1223356778899998876544444333344566778899999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ++|..|.+.+...       ...++..+-.-+.-||. .||+|+||.++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-------RPDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-------chHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998899888774       24677778888899998 9999999999999996655 99999999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.30  E-value=5.1e-11  Score=97.95  Aligned_cols=142  Identities=23%  Similarity=0.352  Sum_probs=104.1

Q ss_pred             eeeeecccCCeEEEEEEeccCCcEEEEEEe-ecc------ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           65 TIKVVGKGSGGIVQLVQHKWTGQFFALKVI-QMN------VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~------~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      .+..+-+|+-+.|+.+..  .|+.+.||.= .+.      ...-.+.+..+|++++.++.--.|....-++.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            456788899999988776  5888888852 111      1233457788999998876544444333345566666789


Q ss_pred             EEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC---cEEEeecccccc
Q 018630          138 LEYMDG-GSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAI  209 (353)
Q Consensus       138 ~e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~a~~  209 (353)
                      |||++| -++.+++...  ..........++.++-..+.-||. ++++|+||..+||++.+++   .+.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999986 3778887654  223333347899999999999998 9999999999999997665   368999999854

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.28  E-value=1.7e-11  Score=106.96  Aligned_cols=141  Identities=18%  Similarity=0.252  Sum_probs=101.8

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCC--ceEEEeeEeEec---CeEEEEEEec
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP--YVVVCYQSFYSN---GAISIILEYM  141 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp--~iv~~~~~~~~~---~~~~lv~e~~  141 (353)
                      +.|+.|..+.||++... +|+.+++|+............+.+|..++..+.+.  .+.+++......   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            56899999999999875 36889999876542212345678888888877653  345555554443   3678999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 018630          142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH--------------------------------------------  177 (353)
Q Consensus       142 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~--------------------------------------------  177 (353)
                      +|.++.+.+.. ..+++.....++.+++.+|..||+                                            
T Consensus        83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            99888765432 345666666777777777777763                                            


Q ss_pred             -----------cCCceecCCCCCcEEEcC--CCcEEEeecccccc
Q 018630          178 -----------EKHIIHRDLKPSNLLINH--RGEVKITDFGVSAI  209 (353)
Q Consensus       178 -----------~~~iiH~Dlkp~NIll~~--~~~~kl~DfG~a~~  209 (353)
                                 ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       134699999999999988  56789999997743

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.16  E-value=1.1e-09  Score=98.23  Aligned_cols=138  Identities=15%  Similarity=0.074  Sum_probs=93.2

Q ss_pred             eecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHH----------HHHHHHHHHhcC-----CCCceEEEeeEeEe--
Q 018630           68 VVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR----------QIAQELKINQSS-----QCPYVVVCYQSFYS--  130 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~----------~~~~e~~~~~~l-----~hp~iv~~~~~~~~--  130 (353)
                      .+-......|+.+.  ..|+.|.||......-....+          .+.+|...+..+     ..|..|-+......  
T Consensus        29 ~v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         29 VFRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             EEecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            33334444455543  357889999764322111111          356777766554     33444433221111  


Q ss_pred             cCeEEEEEEecCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-------CCcEE
Q 018630          131 NGAISIILEYMDGG-SLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-------RGEVK  200 (353)
Q Consensus       131 ~~~~~lv~e~~~~g-sL~~~l~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-------~~~~k  200 (353)
                      ....++|||++++. +|.+++..  ..+.+......++.+++..+.-||. .||+|+|+++.|||++.       +..+.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEE
Confidence            23578999999875 79998864  2456677788999999999999998 99999999999999975       45799


Q ss_pred             Eeeccccc
Q 018630          201 ITDFGVSA  208 (353)
Q Consensus       201 l~DfG~a~  208 (353)
                      |+||+.+.
T Consensus       186 LIDl~r~~  193 (268)
T PRK15123        186 VIDLHRAQ  193 (268)
T ss_pred             EEECCccc
Confidence            99999774

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.15  E-value=1.6e-11  Score=118.68  Aligned_cols=157  Identities=18%  Similarity=0.308  Sum_probs=117.0

Q ss_pred             HHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-C---Cc-----ccccCCcccCcceecCCCC
Q 018630          167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-Q---AN-----TFVGTYNYMSPERISGGKY  237 (353)
Q Consensus       167 ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~---~~-----~~~gt~~y~aPE~~~~~~~  237 (353)
                      +.++|+.++|.+.++||++|.|++|.++..+..||+.|+.+........ .   ..     ...-...|.|||.+.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            4449999999989999999999999999999999999998754432111 0   00     0123567999999998888


Q ss_pred             CccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHH
Q 018630          238 GYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE  316 (353)
Q Consensus       238 ~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  316 (353)
                      +.++|++|+||++|.+.. |+.-+.......     ..-......+........++++++++=+.+++..++..||++..
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~  261 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL  261 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcc-----hhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence            999999999999999994 555554432211     11111122222223344789999999999999999999999999


Q ss_pred             HHcCCcccccCC
Q 018630          317 LMTHPFLKMYGD  328 (353)
Q Consensus       317 ~l~hp~~~~~~~  328 (353)
                      +..-|||+.-+-
T Consensus       262 l~~~~ff~D~~~  273 (700)
T KOG2137|consen  262 LLSIPFFSDPGL  273 (700)
T ss_pred             hhcccccCCchh
Confidence            999999987653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.14  E-value=9.3e-10  Score=101.10  Aligned_cols=241  Identities=15%  Similarity=0.224  Sum_probs=156.0

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEE--------EeeEeEecCeEEEE
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV--------CYQSFYSNGAISII  137 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~--------~~~~~~~~~~~~lv  137 (353)
                      .+.||+|+-+.+|-+-..   ...+.|++...... ...+...|  +...-.||-+-.        +++. ......-++
T Consensus        16 gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa-~~aqk~a~--la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGfl   88 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPA-AQAQKVAE--LAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFL   88 (637)
T ss_pred             CccccCCccceeeecchh---hchhheeecCCCch-HHHHHHHH--hccCCCCcchhhhhcccHHHhhCC-CccceeEEe
Confidence            467999999999876443   23456887654222 22222222  223334554332        1221 122336788


Q ss_pred             EEecCCCC-HHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          138 LEYMDGGS-LADFLK------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       138 ~e~~~~gs-L~~~l~------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      |..+.|.. +..+.+      .......+.+...++.|+.+.+.||. .|.+-+|+.++|+|+++++.+.|.|-..-.. 
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi-  166 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI-  166 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCceEEEEcccceee-
Confidence            88887642 222221      12346788999999999999999998 9999999999999999999999998653322 


Q ss_pred             cccCCCCcccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcC-CCCCCCCccCCchhhHHH--H-----HH
Q 018630          211 ASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDGWTSFYE--L-----ME  277 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~~~~~~~--~-----~~  277 (353)
                      ...+......+|.+.|.+||.-+     +..-+...|.|.||+++++++.| ..||++.......-.-.+  +     ..
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            23333445568999999999764     33457789999999999999985 999987433221111111  0     00


Q ss_pred             HH-----hcCCCCCCCCCCCCHHHHHHHHHhhhh--CcCCCCCHH
Q 018630          278 AI-----VDQPPPSAPSDQFSPEFCSFISACVQK--EPQQRLSAQ  315 (353)
Q Consensus       278 ~~-----~~~~~~~~~~~~~~~~~~~li~~~L~~--dp~~Rpt~~  315 (353)
                      ..     ....+...+..-+++++..|..+|+..  ++.-|||++
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            01     111122234456789999999999985  367899986

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.14  E-value=4.9e-10  Score=94.85  Aligned_cols=126  Identities=22%  Similarity=0.270  Sum_probs=81.9

Q ss_pred             EEEEEEeccCCcEEEEEEeeccc-------------------------cHHHHHHHHHHHHHHhcCCCC--ceEEEeeEe
Q 018630           76 IVQLVQHKWTGQFFALKVIQMNV-------------------------EESARRQIAQELKINQSSQCP--YVVVCYQSF  128 (353)
Q Consensus        76 ~V~~~~~~~~~~~vaiK~~~~~~-------------------------~~~~~~~~~~e~~~~~~l~hp--~iv~~~~~~  128 (353)
                      .||.|... +|..+|+|+.+...                         .........+|.+.|..+..-  ++.+++.+.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            37888874 68899999884321                         112235577899999888755  355665432


Q ss_pred             EecCeEEEEEEecC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCceecCCCCCcEEEcCCCcEEEeecc
Q 018630          129 YSNGAISIILEYMD--GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL-HHEKHIIHRDLKPSNLLINHRGEVKITDFG  205 (353)
Q Consensus       129 ~~~~~~~lv~e~~~--~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~L-H~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  205 (353)
                          .-++||||++  |..+..+....  ++......++.+++..+..+ |. .|++|+||++.||+++.+ .+.++|||
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-CEEE--GT
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-eEEEEecC
Confidence                2369999998  65555443321  22445677888888866664 66 999999999999999876 99999999


Q ss_pred             ccccc
Q 018630          206 VSAIM  210 (353)
Q Consensus       206 ~a~~~  210 (353)
                      .+...
T Consensus       152 qav~~  156 (188)
T PF01163_consen  152 QAVDS  156 (188)
T ss_dssp             TEEET
T ss_pred             cceec
Confidence            87543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.12  E-value=2e-09  Score=101.19  Aligned_cols=212  Identities=17%  Similarity=0.243  Sum_probs=153.5

Q ss_pred             CeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeE----ecCeEEEEEEecCC-CCHHH
Q 018630           74 GGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY----SNGAISIILEYMDG-GSLAD  148 (353)
Q Consensus        74 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~----~~~~~~lv~e~~~~-gsL~~  148 (353)
                      -.+.|++....+|..|++|+++.... ........-++.++++.|+|+|++.++|.    .+..+++|++|+++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            36789999999999999999953321 11122345577788999999999999887    35679999999985 56776


Q ss_pred             HHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          149 FLK---------------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       149 ~l~---------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +--               .....++..+|.++.||..||.++|+ .|+.-+-|.|.+|+++.+-+++|...|+.......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            542               12346889999999999999999999 99999999999999988888998877766554322


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH-HHHHhcCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL-MEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  292 (353)
                      ..              |-+   .-..+-|.-.||.++.-|.||..-   ....+.   .... ...         ....+
T Consensus       447 ~~--------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n---s~~~d~---~~~s~~~~---------I~~~y  494 (655)
T KOG3741|consen  447 PT--------------EPL---ESQQQNDLRDLGLLLLALATGTEN---SNRTDS---TQSSHLTR---------ITTTY  494 (655)
T ss_pred             CC--------------cch---hHHhhhhHHHHHHHHHHHhhcccc---cccccc---hHHHHHHH---------hhhhh
Confidence            10              111   113457999999999999998521   001110   0011 111         13467


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +.+++++|.-+...++++ -+..+++.|
T Consensus       495 S~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  495 STDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            889999999999999887 678888775

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.99  E-value=4e-09  Score=92.22  Aligned_cols=135  Identities=19%  Similarity=0.236  Sum_probs=98.8

Q ss_pred             eeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-------------------c--HHHHHHHHHHHHHHhcCCCC--c
Q 018630           64 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-------------------E--ESARRQIAQELKINQSSQCP--Y  120 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------------~--~~~~~~~~~e~~~~~~l~hp--~  120 (353)
                      .+...||.|.-|.||.+.+. .|..+|||.=+...                   +  ...+....+|.+.|..+.-.  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            35678999999999999987 78999999653221                   0  11234567888888887644  4


Q ss_pred             eEEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEE
Q 018630          121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK  200 (353)
Q Consensus       121 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  200 (353)
                      +.+.++    .+..++||||++|-.|...-     ++......++..|++-+.-+-. .|++|+|+++-||+++++|.+.
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHH-cCccccCCchheEEEecCCCEE
Confidence            555544    35678999999997666532     2344555566666666666655 8999999999999999999999


Q ss_pred             Eeecccccc
Q 018630          201 ITDFGVSAI  209 (353)
Q Consensus       201 l~DfG~a~~  209 (353)
                      ++||--+..
T Consensus       243 vIDwPQ~v~  251 (304)
T COG0478         243 VIDWPQAVP  251 (304)
T ss_pred             EEeCccccc
Confidence            999976543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.96  E-value=5.5e-09  Score=90.37  Aligned_cols=105  Identities=20%  Similarity=0.240  Sum_probs=79.3

Q ss_pred             HHHHHHHHHHhcC-----CCCceEEEeeEeEe-cCeEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 018630          104 RQIAQELKINQSS-----QCPYVVVCYQSFYS-NGAISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH  176 (353)
Q Consensus       104 ~~~~~e~~~~~~l-----~hp~iv~~~~~~~~-~~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH  176 (353)
                      ....+|...+..+     .-|..+.+...-.. ....++|+|++++ .+|.+++......+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            4456666655443     33444443222111 1345899999987 479999987555778888999999999999999


Q ss_pred             hcCCceecCCCCCcEEEcCCC---cEEEeecccccc
Q 018630          177 HEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAI  209 (353)
Q Consensus       177 ~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~a~~  209 (353)
                      . .||+|+|+++.|||++.++   .+.++||+-++.
T Consensus       136 ~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 D-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             H-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            8 9999999999999999887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.79  E-value=1.5e-07  Score=80.68  Aligned_cols=137  Identities=20%  Similarity=0.323  Sum_probs=88.0

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH-----------HHHHHHHHHHHHHhcCCCCceEEEeeE-
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----------SARRQIAQELKINQSSQCPYVVVCYQS-  127 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~~e~~~~~~l~hp~iv~~~~~-  127 (353)
                      -.+|..++++-......|.+..  .+|+.+++|..+.....           ....++......+..........++.+ 
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            4678888888888877775554  46899999986543211           111122222222222222222232222 


Q ss_pred             ----eEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEee
Q 018630          128 ----FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD  203 (353)
Q Consensus       128 ----~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~D  203 (353)
                          +.-....+++|||++|..|.+...    +++    .++..+..++.-+|+ .|+.|+|..|.|++++.+ .++++|
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~-~i~iID  177 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNN-GIRIID  177 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEECC-cEEEEE
Confidence                222345678999999988876532    333    244567788999998 999999999999999855 499999


Q ss_pred             ccccc
Q 018630          204 FGVSA  208 (353)
Q Consensus       204 fG~a~  208 (353)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            98543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.78  E-value=6.7e-10  Score=106.74  Aligned_cols=249  Identities=19%  Similarity=0.167  Sum_probs=171.1

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCc-eEEEeeEeEecCeEEEEEEec
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~-iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      +.....+++|+++.+++.+...+...+ .+.+...      ....-+++++.+++||| .+..++.+..+....++++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            455667799999999999887665555 7776544      34556788899999999 667777777788899999999


Q ss_pred             CCC-CHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          142 DGG-SLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       142 ~~g-sL~~~l-~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      .++ +-.... ...-.+.+-......+.-+++++++|+ .-=+|+|    ||+.. ++..+..||+....+.... ...+
T Consensus       317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~-~~~t  389 (829)
T KOG0576|consen  317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM-KPRT  389 (829)
T ss_pred             cCCccccccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----ccccc-ccccccccccCCcccCccc-cccc
Confidence            887 222211 111123333444566667789999998 4458888    77764 4789999999887765433 3456


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-CCCCCC-CCCCHHH-
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPS-DQFSPEF-  296 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~-  296 (353)
                      ..+++.++|||+.....+....|.|++|.-..++.-|.+|-..+...-         ..+..++ .+.... ...++.. 
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~---------~~~g~~p~s~~L~~~~aw~~~~~  460 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL---------PMIGNGPNSPMLTDKSAWSPVFH  460 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcccc---------CCCCCCCCccccchhhhcCcccc
Confidence            789999999999999999999999999998888888887765432210         0000000 000000 0011111 


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHh
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  334 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~  334 (353)
                      .++...|+..-|..|++...++.|.+|.+++=.=...+
T Consensus       461 ~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~~aa  498 (829)
T KOG0576|consen  461 RDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIHCAA  498 (829)
T ss_pred             cCCcccccCCCCCCCcchhhHHHHHHhccCcccceecc
Confidence            24777899999999999999999999988764333333

>PRK09902 hypothetical protein; Provisional

Probab=98.74  E-value=1.7e-07  Score=80.10  Aligned_cols=137  Identities=17%  Similarity=0.150  Sum_probs=97.6

Q ss_pred             cccCCeEEEEEEeccCCcEEEEEEeecccc-----HHHHHHHHHHHHHHhcCCCCc--eEEEe--eEeEe--cCeEEEEE
Q 018630           70 GKGSGGIVQLVQHKWTGQFFALKVIQMNVE-----ESARRQIAQELKINQSSQCPY--VVVCY--QSFYS--NGAISIIL  138 (353)
Q Consensus        70 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~~~~l~hp~--iv~~~--~~~~~--~~~~~lv~  138 (353)
                      |+|+-+.|+.....  |+.+-+|.-.....     ......+.+|...+..+..-+  +.++.  +....  .-..+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            56888889887654  45678886531111     224567888888877754322  33333  11111  23468999


Q ss_pred             EecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc--EEEeecccccc
Q 018630          139 EYMDG-GSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAI  209 (353)
Q Consensus       139 e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~--~kl~DfG~a~~  209 (353)
                      |-+.| .+|.+++...  .+.+......++.+++..+.-||+ .|+.|+|+.+.||+++.+|.  ++++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97763 5899988663  456788888999999999999998 99999999999999987777  99999986544

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.74  E-value=8.2e-08  Score=93.17  Aligned_cols=139  Identities=22%  Similarity=0.319  Sum_probs=90.3

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccccHH---------------------------------HHHHHH------
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES---------------------------------ARRQIA------  107 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------------------------~~~~~~------  107 (353)
                      ..|+.+|-|+||.|+-+ +|+.||||+.+++..+.                                 ..+.+.      
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            57889999999999987 59999999986552211                                 111222      


Q ss_pred             HHHHHHhc----C-CCCceEEEeeEeEecCeEEEEEEecCCCCHHHHH--HhcCCCCHHHHHHHHHHHHHH-HHHHHhcC
Q 018630          108 QELKINQS----S-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKG-LLYLHHEK  179 (353)
Q Consensus       108 ~e~~~~~~----l-~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~l~~~~~~~i~~ql~~~-l~~LH~~~  179 (353)
                      +|+..+.+    + +.|++.-..=++.-.+.-.++|||++|..+.+..  +. ...+...   ++..++++ +..+-. .
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~-d  284 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLR-D  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHh-c
Confidence            22222222    1 2344332222233456678999999999898874  33 3344333   33333332 222223 6


Q ss_pred             CceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       180 ~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      |++|.|.+|.||+++.+|++.+.|||+...+.
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            89999999999999999999999999986654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.72  E-value=1.3e-07  Score=82.00  Aligned_cols=139  Identities=19%  Similarity=0.247  Sum_probs=91.4

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHH-----------------------HHHHHHHHHHHhcCC--CCc
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA-----------------------RRQIAQELKINQSSQ--CPY  120 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------------------~~~~~~e~~~~~~l~--hp~  120 (353)
                      ...|++|.-+.||+|.. .++..+|+|+++.....-.                       ..-..+|..-|+++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            45788899999999987 4688999999865421110                       111234555444432  222


Q ss_pred             eEEEeeEeEecCeEEEEEEecCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcE
Q 018630          121 VVVCYQSFYSNGAISIILEYMDGGSLAD-FLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV  199 (353)
Q Consensus       121 iv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  199 (353)
                      +.+.+.+.    .-.+||||+....... .|+. -++....+..+..++++.+.-|-...++||+||+.-|||+. ++.+
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            23333322    2368999996531111 1111 23344467888889999998887668999999999999998 8899


Q ss_pred             EEeecccccccc
Q 018630          200 KITDFGVSAIMA  211 (353)
Q Consensus       200 kl~DfG~a~~~~  211 (353)
                      .++|||-|....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999875543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.66  E-value=2.8e-07  Score=94.50  Aligned_cols=210  Identities=23%  Similarity=0.308  Sum_probs=148.7

Q ss_pred             HHHHHHHHHHHhcCCCCceEEEeeEeEecC----eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 018630          103 RRQIAQELKINQSSQCPYVVVCYQSFYSNG----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE  178 (353)
Q Consensus       103 ~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~  178 (353)
                      +....-|+..+....|+|++.++.+.....    ...+..+++...++...++....++...++.+..++..|+.|+|+ 
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH-
Confidence            344455666777889999999888765432    233557889999999999998999999999999999999999998 


Q ss_pred             CCceecCCCCC---cEEEcCCCcEEEe--eccccccccccCCCCcccccCCcccCcceecCCCCC--ccccHHHHHHHHH
Q 018630          179 KHIIHRDLKPS---NLLINHRGEVKIT--DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG--YKSDIWSLGLVLL  251 (353)
Q Consensus       179 ~~iiH~Dlkp~---NIll~~~~~~kl~--DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~DiwslG~il~  251 (353)
                      ....|.-+...   +--.+..+.+.++  ||+.+........ ..+...+..+.|||......++  ...|+|.+|..+.
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            65555544444   3333445566666  8887766543332 2334456678889988766554  4479999999999


Q ss_pred             HHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCc
Q 018630          252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  331 (353)
Q Consensus       252 ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  331 (353)
                      .+..|..+-...          .....+        ..........+...+|+.-++++|+++.+++.|||.+..++...
T Consensus       384 ~~~~~~~i~~~~----------~~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~  445 (1351)
T KOG1035|consen  384 QLSQGEDISEKS----------AVPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES  445 (1351)
T ss_pred             hhhhcCcccccc----------cchhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence            998876432211          111111        11112227888999999999999999999999999998776554


Q ss_pred             C
Q 018630          332 D  332 (353)
Q Consensus       332 ~  332 (353)
                      +
T Consensus       446 ~  446 (1351)
T KOG1035|consen  446 S  446 (1351)
T ss_pred             c
Confidence            3

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.52  E-value=3e-06  Score=74.12  Aligned_cols=78  Identities=21%  Similarity=0.174  Sum_probs=53.7

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCC--ceEEEeeE---eEecCeEEEEEEe
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP--YVVVCYQS---FYSNGAISIILEY  140 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp--~iv~~~~~---~~~~~~~~lv~e~  140 (353)
                      ++.|+.|..+.||.+....  ..+++|.....   .....+.+|..+++.+...  .+.+++..   .......+++|++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            5789999999999999864  58999986543   3455666777776655322  23444442   2344568999999


Q ss_pred             cCCCCHHH
Q 018630          141 MDGGSLAD  148 (353)
Q Consensus       141 ~~~gsL~~  148 (353)
                      ++|.++..
T Consensus        77 i~g~~~~~   84 (239)
T PF01636_consen   77 IPGRPLDD   84 (239)
T ss_dssp             ESSEEHHH
T ss_pred             eccccccc
Confidence            99987777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.51  E-value=1.8e-06  Score=75.72  Aligned_cols=134  Identities=15%  Similarity=0.229  Sum_probs=79.6

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCc--eEEEeeEeEecCeEEEEEEecCCC
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY--VVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~--iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      ..||.|..+.||+.    .+..+++|..+...   ....+.+|.++++.+..-.  +.+.+.+....+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            56799999999974    24467889876543   2234577888877654322  345566666677788999999986


Q ss_pred             C-HHHHH--------------Hh----c-----CCCCHHHH-HHHHHHH----------HH-HHHHHH---hcCCceecC
Q 018630          145 S-LADFL--------------KK----V-----KTIPEEYL-AAICEQV----------LK-GLLYLH---HEKHIIHRD  185 (353)
Q Consensus       145 s-L~~~l--------------~~----~-----~~l~~~~~-~~i~~ql----------~~-~l~~LH---~~~~iiH~D  185 (353)
                      + +...+              .+    -     ...+.... ..+..++          .. ...+|.   ....++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 21111              00    0     00111100 0110000          01 111221   123478999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccc
Q 018630          186 LKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       186 lkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      +.|.||+++.++ +.++||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.34  E-value=4.2e-06  Score=81.26  Aligned_cols=138  Identities=21%  Similarity=0.308  Sum_probs=88.0

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccccHH------------------------------HHHHHHHHHHH----
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES------------------------------ARRQIAQELKI----  112 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------~~~~~~~e~~~----  112 (353)
                      +.||.-+.|.|++|+-+. |+.||||+-+......                              ....+..|++.    
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            578999999999999985 9999999976542211                              11122222221    


Q ss_pred             ------HhcCCCCc------eEEEeeEeEecCeEEEEEEecCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 018630          113 ------NQSSQCPY------VVVCYQSFYSNGAISIILEYMDGGSLADF--LKKVKTIPEEYLAAICEQVLKGLLYLHHE  178 (353)
Q Consensus       113 ------~~~l~hp~------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~~l~~~~~~~i~~ql~~~l~~LH~~  178 (353)
                            .+.+.|-+      |.++|-.  ....-.|+||||+|..+.|.  +.+ ..++...+...+.+...-+-+  . 
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~qIf--~-  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQIF--K-  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHHHH--h-
Confidence                  12233433      3333332  23567899999999877654  333 345555444333333222222  2 


Q ss_pred             CCceecCCCCCcEEEcC----CCcEEEeecccccccc
Q 018630          179 KHIIHRDLKPSNLLINH----RGEVKITDFGVSAIMA  211 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~----~~~~kl~DfG~a~~~~  211 (353)
                      .|++|+|-+|.||++..    ++.+.+.|||+.....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            68999999999999984    5689999999987654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.34  E-value=6.5e-06  Score=73.03  Aligned_cols=75  Identities=15%  Similarity=0.052  Sum_probs=49.0

Q ss_pred             ecccCC-eEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           69 VGKGSG-GIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        69 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      |..|.. ..||++...  +..+++|+.....    ...+.+|+++++.+. +--+.+++.....++..++|||+++|.+|
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            444555 788998764  4678889865432    234556777666553 23344666666656678999999999877


Q ss_pred             HHH
Q 018630          147 ADF  149 (353)
Q Consensus       147 ~~~  149 (353)
                      ...
T Consensus        80 ~~~   82 (244)
T cd05150          80 AAL   82 (244)
T ss_pred             hHh
Confidence            643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.33  E-value=6.4e-06  Score=85.73  Aligned_cols=81  Identities=16%  Similarity=0.217  Sum_probs=56.3

Q ss_pred             eeeeecccCCeEEEEEEeccCC--cEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCce--EEEeeEeEec---CeEEE
Q 018630           65 TIKVVGKGSGGIVQLVQHKWTG--QFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYV--VVCYQSFYSN---GAISI  136 (353)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~i--v~~~~~~~~~---~~~~l  136 (353)
                      .++.++.|....+|++.....+  ..+++|+............+.+|.++++.+. |+++  .+++..+.+.   +..|+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            3577899999999998765432  4677887654322222346788999988875 6654  5666666543   56789


Q ss_pred             EEEecCCCC
Q 018630          137 ILEYMDGGS  145 (353)
Q Consensus       137 v~e~~~~gs  145 (353)
                      ||||++|..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.13  E-value=1.6e-05  Score=65.66  Aligned_cols=130  Identities=28%  Similarity=0.296  Sum_probs=88.8

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceE-EEeeEeEecCeEEEEEEec
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV-VCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv-~~~~~~~~~~~~~lv~e~~  141 (353)
                      ....+.|++|++|.||++...  |..+|+|+-+.   ++.+..+..|++++..+.-.++. ++|.+..    -++.|||+
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~---ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i   94 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR---DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI   94 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecC---CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence            445678999999999999865  77999997543   35567888999998887755543 3444322    24559999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCC-CCcEEEcCCCcEEEeecccccc
Q 018630          142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK-PSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       142 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlk-p~NIll~~~~~~kl~DfG~a~~  209 (353)
                      .|.+|.++-...   +..++    ..++..---|- ..||-|..|. |...++..++.+.|+||..|+.
T Consensus        95 ~G~~L~~~~~~~---~rk~l----~~vlE~a~~LD-~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          95 DGRPLGKLEIGG---DRKHL----LRVLEKAYKLD-RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cCcchhhhhhcc---cHHHH----HHHHHHHHHHH-HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            998888765431   22232    23444433343 4889888885 5555555666999999998863

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.13  E-value=9.2e-05  Score=62.99  Aligned_cols=126  Identities=25%  Similarity=0.373  Sum_probs=88.3

Q ss_pred             cCceeeeeecccCC-eEEEEEEeccCCcEEEEEEeec---cc--------c--H-------HHHHHHHHHHHH---HhcC
Q 018630           61 EDIDTIKVVGKGSG-GIVQLVQHKWTGQFFALKVIQM---NV--------E--E-------SARRQIAQELKI---NQSS  116 (353)
Q Consensus        61 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~---~~--------~--~-------~~~~~~~~e~~~---~~~l  116 (353)
                      .+++.++.||.|.- |.||+++..  |+.||+|+++.   ..        .  .       .....+..|.+.   ++..
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 999999874  88999999321   10        0  0       112345555554   4445


Q ss_pred             CCCce--EEEeeEeEe------------------cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 018630          117 QCPYV--VVCYQSFYS------------------NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH  176 (353)
Q Consensus       117 ~hp~i--v~~~~~~~~------------------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH  176 (353)
                      .+.++  ++++++..-                  .....||-||++...         .++    ..-+.++.+-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence            56666  888887531                  123578888887643         122    234557888899999


Q ss_pred             hcCCceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       177 ~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                      . .||+-+|+++.|..     .-+|+|||.+
T Consensus       182 k-~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 K-LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             H-CCeeeccCcccccc-----CCEEEecccC
Confidence            8 99999999999987     2478999854

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.11  E-value=3.8e-07  Score=95.64  Aligned_cols=254  Identities=11%  Similarity=-0.011  Sum_probs=162.0

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc----cHHHHHHHHHHHHHHhcCCCCceEEEeeEeE--ecCe
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----EESARRQIAQELKINQSSQCPYVVVCYQSFY--SNGA  133 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~--~~~~  133 (353)
                      .+.+++.-.+|.|..+.--..+.+.++  +.+|+.+...    .+..++-...|.+..+...|+++...+.-..  ....
T Consensus      1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred             hhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence            345555545555554433222222122  3455554321    1222233445555566678998876665433  3456


Q ss_pred             EEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCC----ceecCCCCCcEEEcCCCcEEEeecc
Q 018630          134 ISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKH----IIHRDLKPSNLLINHRGEVKITDFG  205 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~~----iiH~Dlkp~NIll~~~~~~kl~DfG  205 (353)
                      .+.+++|+.+|.+++.+-+.    ..+...-+.....+.+.+..-+|+..+    .+|+++|+.|.+|..+-+++++++|
T Consensus      1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred             HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence            78899999999999988653    344555555555555666666665322    6899999999999999999999999


Q ss_pred             ccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018630          206 VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  285 (353)
Q Consensus       206 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  285 (353)
                      +.+............++++.|++|++...-.++.++|+|..|+.+|++.-|..+|-.        .....+..+.+...-
T Consensus      1386 LdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~--------flq~~Lkgiidn~tf 1457 (2724)
T KOG1826|consen 1386 LDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF--------FLQPALKGIIDNHTF 1457 (2724)
T ss_pred             cccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH--------HHHHHHcCccccccc
Confidence            998444333334456788899999998888899999999999999999888877732        111112222222222


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      ...+.-.|.+.......+|-+.-..||.-...+.-+.+
T Consensus      1458 ~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1458 FSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred             ccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence            22222334555566666777777889988888776665

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.99  E-value=7.1e-05  Score=66.02  Aligned_cols=30  Identities=33%  Similarity=0.522  Sum_probs=25.5

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          179 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      .+++|+|+.|.||+++.++...|+||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            458999999999999876666799999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.97  E-value=0.00021  Score=61.15  Aligned_cols=128  Identities=22%  Similarity=0.335  Sum_probs=86.6

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccc---------------cHHHHHHHHHHHHHHhcC------CCCceEEEe
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---------------EESARRQIAQELKINQSS------QCPYVVVCY  125 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~e~~~~~~l------~hp~iv~~~  125 (353)
                      ..||+|+.-.||.-  . .....+||+.....               ......+..+|+.-...+      .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46899999988653  3 34457789886554               012234555555544433      378899999


Q ss_pred             eEeEecCeEEEEEEecCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC--
Q 018630          126 QSFYSNGAISIILEYMDG------GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG--  197 (353)
Q Consensus       126 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~--  197 (353)
                      +..+.+...-+|+|.+.+      .+|.+++.. +.+++ ....   .+-+-..||-. .+|+.+|++|.||++...+  
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~-~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLD-HHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHH-cCCeecCCCcccEEEEecCCC
Confidence            999988888999997653      368888855 44655 3333   33344556666 7899999999999996432  


Q ss_pred             --cEEEee
Q 018630          198 --EVKITD  203 (353)
Q Consensus       198 --~~kl~D  203 (353)
                        .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              477776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.92  E-value=8e-05  Score=68.40  Aligned_cols=140  Identities=16%  Similarity=0.233  Sum_probs=93.4

Q ss_pred             eeeeecccCCeEEEEEEeccCCcEEEEEEeeccc----c---------------------HHHHHHHHHHHHHHhcCCCC
Q 018630           65 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----E---------------------ESARRQIAQELKINQSSQCP  119 (353)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~---------------------~~~~~~~~~e~~~~~~l~hp  119 (353)
                      +-..|..|.-+.||.|... +|..+|||+++.+.    +                     ...+.-..+|++-+.+++..
T Consensus       148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3357888999999999875 78889999985431    0                     11112234455555554433


Q ss_pred             ceEEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcE
Q 018630          120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV  199 (353)
Q Consensus       120 ~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  199 (353)
                      .|.-. ....- ....|||+|+....-..-.-+.-.++...+..+-.|++.-|.-|-+..++||.||+--|+|+ .+|.+
T Consensus       227 GIP~P-ePIlL-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  227 GIPCP-EPILL-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCCCC-Cceee-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence            32211 00000 22468999996432222222234678888999999999999988777899999999999999 56889


Q ss_pred             EEeeccccc
Q 018630          200 KITDFGVSA  208 (353)
Q Consensus       200 kl~DfG~a~  208 (353)
                      .++|.+-+.
T Consensus       304 yiIDVSQSV  312 (520)
T KOG2270|consen  304 YIIDVSQSV  312 (520)
T ss_pred             EEEEccccc
Confidence            999988664

>PRK10593 hypothetical protein; Provisional

Probab=97.86  E-value=0.00041  Score=63.50  Aligned_cols=80  Identities=13%  Similarity=0.051  Sum_probs=52.4

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCC---CceEEEeeEeEe---cCeEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC---PYVVVCYQSFYS---NGAIS  135 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h---p~iv~~~~~~~~---~~~~~  135 (353)
                      ...-.+.||.|..+.||.+... ++ .+++|..+..   .....+..|...++.+.-   -.+.++++.+..   .+..+
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~   89 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDS-QG-NPMPLMARSF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV   89 (297)
T ss_pred             hhheeeecCCccceeEEEEEcC-CC-CEEEEEeccc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence            3445678999999999999754 23 4677875421   112356677777665532   245566665543   46789


Q ss_pred             EEEEecCCCCH
Q 018630          136 IILEYMDGGSL  146 (353)
Q Consensus       136 lv~e~~~~gsL  146 (353)
                      +|||+++|+++
T Consensus        90 LVmE~i~G~~~  100 (297)
T PRK10593         90 LLLERLRGVSV  100 (297)
T ss_pred             EEEeccCCEec
Confidence            99999998764

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.79  E-value=8.8e-05  Score=63.01  Aligned_cols=99  Identities=26%  Similarity=0.219  Sum_probs=76.6

Q ss_pred             HHHHHHhcCCC-CceEEEeeEeEecCeEEEEEEecCCCCHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCc
Q 018630          108 QELKINQSSQC-PYVVVCYQSFYSNGAISIILEYMDGGSLAD---FLKKVKTIPEEYLAAICEQVLKGLLYLHHE--KHI  181 (353)
Q Consensus       108 ~e~~~~~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~~gsL~~---~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~--~~i  181 (353)
                      .|.-+++.+++ +++.+++|+|-+    ++++||...+++..   .+......++..+.++|.++++.++++++.  ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            46667777765 689999998743    56889998766642   122223468899999999999999999861  237


Q ss_pred             eecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          182 IHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       182 iH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      .-.|++|+|+-++++|++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            88999999999999999999999876443

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.77  E-value=0.00051  Score=62.68  Aligned_cols=139  Identities=14%  Similarity=0.155  Sum_probs=78.4

Q ss_pred             eeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCc--eEEEee------EeEecCeEE
Q 018630           64 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY--VVVCYQ------SFYSNGAIS  135 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~--iv~~~~------~~~~~~~~~  135 (353)
                      .-++.+..|....+|++...  +..+++|+.... .   ...+..|+.++..+.+.+  +.+++.      ....++..+
T Consensus        17 ~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~-~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          17 LSFEGISAGIENTNYFVTTD--SGRYVLTLFEKV-S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             hheecccCccccceEEEEeC--CCcEEEEEcCCC-C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            33567788888899988653  456889987642 1   233445555554442211  333332      112345678


Q ss_pred             EEEEecCCCCHHH----H-------H---Hhc-CCCC--------HHHHHH------------HHHHHHHHHHHHHh---
Q 018630          136 IILEYMDGGSLAD----F-------L---KKV-KTIP--------EEYLAA------------ICEQVLKGLLYLHH---  177 (353)
Q Consensus       136 lv~e~~~~gsL~~----~-------l---~~~-~~l~--------~~~~~~------------i~~ql~~~l~~LH~---  177 (353)
                      +|++|++|.++..    .       +   +.. ..+.        ......            ....+..++.++.+   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999866421    1       1   100 0000        000000            01112233344332   


Q ss_pred             ---cCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          178 ---EKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       178 ---~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                         ..+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence               2479999999999999987778999999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.75  E-value=0.00028  Score=62.08  Aligned_cols=75  Identities=20%  Similarity=0.212  Sum_probs=45.0

Q ss_pred             eeeecccCCeEEEEEEecc-CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCc-eEEEeeEeEecCeEEEEEEecCC
Q 018630           66 IKVVGKGSGGIVQLVQHKW-TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~-iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      ++.|..|-...+|++.... .++.|++|+......  ......+|+.+++.+...+ ..+++..+.  +  .++|||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence            4678888889999997643 356788997654321  1122235666666553222 234443322  2  379999998


Q ss_pred             CCH
Q 018630          144 GSL  146 (353)
Q Consensus       144 gsL  146 (353)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK05231 homoserine kinase; Provisional

Probab=97.71  E-value=0.0015  Score=60.27  Aligned_cols=30  Identities=27%  Similarity=0.362  Sum_probs=25.9

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          179 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      .+++|+|+.|.||+++.+....++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            589999999999999866556899999764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.67  E-value=0.00098  Score=61.28  Aligned_cols=142  Identities=19%  Similarity=0.252  Sum_probs=78.2

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-----CCCceEEEee---EeEecCe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-----QCPYVVVCYQ---SFYSNGA  133 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~hp~iv~~~~---~~~~~~~  133 (353)
                      ....++.++.|....+|++...  +..+++|+........   .+..|..++..+     ..|.++.-.+   .....+.
T Consensus        23 ~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~~~---~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~   97 (307)
T TIGR00938        23 ELLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVKAE---ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK   97 (307)
T ss_pred             CceeccccCCccccceEEEEeC--CCcEEEEEecCCCCHH---HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence            3445677888888899998753  3357789875432222   233344444333     2333332211   1112466


Q ss_pred             EEEEEEecCCCCHH-----H------HH---Hhc-CCC--------CHHH-----HH----------HHHHHHHHHHHHH
Q 018630          134 ISIILEYMDGGSLA-----D------FL---KKV-KTI--------PEEY-----LA----------AICEQVLKGLLYL  175 (353)
Q Consensus       134 ~~lv~e~~~~gsL~-----~------~l---~~~-~~l--------~~~~-----~~----------~i~~ql~~~l~~L  175 (353)
                      .+++++|++|.++.     .      .+   +.. ..+        ....     ..          .....+...++++
T Consensus        98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l  177 (307)
T TIGR00938        98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL  177 (307)
T ss_pred             EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence            78999999985431     1      11   110 000        0000     00          0011123344444


Q ss_pred             Hh------cCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          176 HH------EKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       176 H~------~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      ..      ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            32      2689999999999999988877899999763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.66  E-value=0.0016  Score=61.68  Aligned_cols=78  Identities=15%  Similarity=0.103  Sum_probs=51.1

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeeccc----c--HHHHHHHHHHHHHHhcC---CCCceEEEeeEeEecCeEEE
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----E--ESARRQIAQELKINQSS---QCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~--~~~~~~~~~e~~~~~~l---~hp~iv~~~~~~~~~~~~~l  136 (353)
                      .+.||.|.+..||++.....++.++||.-....    .  .....+...|.+.++.+   ...++.+++.+  ++...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            467999999999999986433589999743110    1  11234555666666553   22456667665  4456789


Q ss_pred             EEEecCCCC
Q 018630          137 ILEYMDGGS  145 (353)
Q Consensus       137 v~e~~~~gs  145 (353)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.51  E-value=0.00034  Score=62.54  Aligned_cols=134  Identities=15%  Similarity=0.169  Sum_probs=72.3

Q ss_pred             eecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCce-EEEeeEeEecCeEEEEEEecCCCCH
Q 018630           68 VVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV-VVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      .+..|-...+|++..  +++.+++|........- .....+|..+++.+....+ .+++...  +  -++|+||++|..+
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~   75 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI   75 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence            345677888998873  46788899754331111 0123556666665543222 2233222  2  2689999998665


Q ss_pred             HH--------------HHHh---c----CCCCHH-HHHHHHHHH---------HHHHHHHHh-------cCCceecCCCC
Q 018630          147 AD--------------FLKK---V----KTIPEE-YLAAICEQV---------LKGLLYLHH-------EKHIIHRDLKP  188 (353)
Q Consensus       147 ~~--------------~l~~---~----~~l~~~-~~~~i~~ql---------~~~l~~LH~-------~~~iiH~Dlkp  188 (353)
                      ..              .+.+   .    .+++.. .+..+..++         ...+..+-.       ...++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            32              1111   0    011111 112222111         111222211       12589999999


Q ss_pred             CcEEEcCCCcEEEeecccccc
Q 018630          189 SNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       189 ~NIll~~~~~~kl~DfG~a~~  209 (353)
                      .||+++.++ +.|+||..+..
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcEEEeCCC-CEEEeccccCc
Confidence            999998877 78999997743

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.47  E-value=8.2e-05  Score=67.25  Aligned_cols=134  Identities=16%  Similarity=0.219  Sum_probs=90.2

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-------------------HH--HHHHHHHHHHHHhcCCC--C
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-------------------ES--ARRQIAQELKINQSSQC--P  119 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~--~~~~~~~e~~~~~~l~h--p  119 (353)
                      +.+.++||-|.-+.||++-+. .|+..++|.-+....                   ..  .+-...+|...++.+.-  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            346688999999999999885 688899985422200                   00  11234466666666532  1


Q ss_pred             ceEEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcE
Q 018630          120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV  199 (353)
Q Consensus       120 ~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  199 (353)
                      -+.+.+    +.+..++|||++.|..|....+-      ..+-.+...+..-+.-|.. .|+||+|..--||++.+++.+
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLAN-HGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHH-cCceecccchheeEEecCCCE
Confidence            122333    34567899999999877654321      1223344555556666766 899999999999999999999


Q ss_pred             EEeeccccc
Q 018630          200 KITDFGVSA  208 (353)
Q Consensus       200 kl~DfG~a~  208 (353)
                      +++||--..
T Consensus       242 ~vIDFPQmv  250 (465)
T KOG2268|consen  242 VVIDFPQMV  250 (465)
T ss_pred             EEeechHhh
Confidence            999997553

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.30  E-value=0.0017  Score=59.48  Aligned_cols=76  Identities=20%  Similarity=0.113  Sum_probs=44.1

Q ss_pred             eeeecccCCeEEEEEEecc------CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCc-eEEEeeEeEecCeEEEEE
Q 018630           66 IKVVGKGSGGIVQLVQHKW------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~-iv~~~~~~~~~~~~~lv~  138 (353)
                      ++.+..|-...+|++....      .++.+++|+......  ......+|..++..+.... ..+++..+. +   .+|+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~   76 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE   76 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence            4566777778899887643      257899999654321  1233455655555543222 223444332 2   2579


Q ss_pred             EecCCCCHH
Q 018630          139 EYMDGGSLA  147 (353)
Q Consensus       139 e~~~~gsL~  147 (353)
                      ||++|.++.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            999886653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.09  E-value=0.0041  Score=57.00  Aligned_cols=30  Identities=23%  Similarity=0.578  Sum_probs=27.4

Q ss_pred             CceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          180 HIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       180 ~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      .++|+|+++.|++++.++-+-+.||+.+..
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            489999999999999999999999998865

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.04  E-value=0.0054  Score=55.45  Aligned_cols=30  Identities=23%  Similarity=0.574  Sum_probs=25.0

Q ss_pred             CceecCCCCCcEEEcCCCc-EEEeecccccc
Q 018630          180 HIIHRDLKPSNLLINHRGE-VKITDFGVSAI  209 (353)
Q Consensus       180 ~iiH~Dlkp~NIll~~~~~-~kl~DfG~a~~  209 (353)
                      .++|+|++|.||+++.+++ .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987555 57999997743

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.92  E-value=0.0052  Score=56.72  Aligned_cols=104  Identities=21%  Similarity=0.259  Sum_probs=70.2

Q ss_pred             cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          131 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      +.+.|++|++- |++|...    ..-..+++..++++.+..+.-+...-..-|||+...||+|+ +|++.|+||-+++.-
T Consensus       298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            34667778866 5555432    23345678888888888888887666789999999999999 999999999999843


Q ss_pred             cccCCCCcccccCCcccCcceecCCCCCccccHHHH
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL  246 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  246 (353)
                      ..++.     +..-..--|-.+.| .-+..-+||-+
T Consensus       372 ~~q~~-----isy~rldhp~lF~G-~dd~QFeIYrl  401 (488)
T COG5072         372 YSQGI-----ISYNRLDHPDLFNG-VDDYQFEIYRL  401 (488)
T ss_pred             cCCce-----eeccccCchhhhcC-ccceeeeHHHH
Confidence            22221     11122334444553 33666677764

>PLN02236 choline kinase

Probab=96.84  E-value=0.01  Score=55.53  Aligned_cols=138  Identities=14%  Similarity=0.154  Sum_probs=74.3

Q ss_pred             eeeeecccCCeEEEEEEecc----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceE-EEeeEeEecCeEEEEEE
Q 018630           65 TIKVVGKGSGGIVQLVQHKW----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV-VCYQSFYSNGAISIILE  139 (353)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv-~~~~~~~~~~~~~lv~e  139 (353)
                      -++.|..|-.-.+|++....    .++.|++|+...... .. -.-.+|..+++.+..-++. ++++.+. ++   .|.+
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~-idR~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~e  113 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LF-FDRDDEIRTFECMSRHGQGPRLLGRFP-NG---RVEE  113 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-ee-echHHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEE
Confidence            34556668888999987432    246899998754421 11 1124566655554332222 3344442 22   4789


Q ss_pred             ecCCCCHHHH-------H-------H---hcC-C----C-CHHHHHHHHHHH-----------------HHHHHHH----
Q 018630          140 YMDGGSLADF-------L-------K---KVK-T----I-PEEYLAAICEQV-----------------LKGLLYL----  175 (353)
Q Consensus       140 ~~~~gsL~~~-------l-------~---~~~-~----l-~~~~~~~i~~ql-----------------~~~l~~L----  175 (353)
                      |+++.+|...       +       .   +.. +    . ....+..+..++                 ...+..|    
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            9987665311       1       1   000 0    1 112222232111                 1111111    


Q ss_pred             Hh---cCCceecCCCCCcEEEcC-CCcEEEeeccccc
Q 018630          176 HH---EKHIIHRDLKPSNLLINH-RGEVKITDFGVSA  208 (353)
Q Consensus       176 H~---~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~  208 (353)
                      ..   ...++|+|+++.||+++. ++.+.++||..+.
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            11   135899999999999986 4689999998764

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.74  E-value=0.043  Score=52.13  Aligned_cols=75  Identities=20%  Similarity=0.164  Sum_probs=46.8

Q ss_pred             eeeeecccCCeEEEEEEeccCCcEEEEEEeecccc---H---HHHHHHHHHHHHHhcCC---CCceEEEeeEeEecCeEE
Q 018630           65 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---E---SARRQIAQELKINQSSQ---CPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~---~~~~~~~~e~~~~~~l~---hp~iv~~~~~~~~~~~~~  135 (353)
                      ..+.||.|.--.||++.+.  +..++||.-.....   .   ....+...|...++...   ...+.+++.++.  ...+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            4678899999999999874  45688997541110   0   01223333444444332   246677777655  4567


Q ss_pred             EEEEecCC
Q 018630          136 IILEYMDG  143 (353)
Q Consensus       136 lv~e~~~~  143 (353)
                      ++|||+++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.66  E-value=0.078  Score=48.57  Aligned_cols=29  Identities=28%  Similarity=0.501  Sum_probs=25.4

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          179 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678999999653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.65  E-value=0.012  Score=54.76  Aligned_cols=29  Identities=31%  Similarity=0.580  Sum_probs=25.1

Q ss_pred             ceecCCCCCcEEEcC-CCcEEEeecccccc
Q 018630          181 IIHRDLKPSNLLINH-RGEVKITDFGVSAI  209 (353)
Q Consensus       181 iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~  209 (353)
                      ++|.|+.+.||++++ ++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975 57899999998743

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.62  E-value=0.014  Score=53.07  Aligned_cols=76  Identities=17%  Similarity=0.084  Sum_probs=42.9

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC---CCCceEEEeeEeEecCeEEEEEE
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS---QCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l---~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .+-.+.++.|....+|.+.  .+++.+.||+-....    ...+..|..-++.+   .--.+.+.+......+..++|+|
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle   92 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE   92 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChhh----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence            4456788989999999887  468889999866321    22344444444443   34456677777776677799999


Q ss_pred             ecCCC
Q 018630          140 YMDGG  144 (353)
Q Consensus       140 ~~~~g  144 (353)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99875

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.60  E-value=0.043  Score=51.19  Aligned_cols=74  Identities=15%  Similarity=0.041  Sum_probs=44.5

Q ss_pred             eecccCCeEEEEEEeccCCcEEEEEEeeccc------cHHHHHHHHHHHHHHhcCC--CC-ceEEEeeEeEecCeEEEEE
Q 018630           68 VVGKGSGGIVQLVQHKWTGQFFALKVIQMNV------EESARRQIAQELKINQSSQ--CP-YVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~e~~~~~~l~--hp-~iv~~~~~~~~~~~~~lv~  138 (353)
                      .||.|....||++.+...++.++||.-..-.      -.....+..-|...++...  .| .+.++|.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            4788999999999986434689999642110      0112233445555554432  24 45555543  456667999


Q ss_pred             EecCC
Q 018630          139 EYMDG  143 (353)
Q Consensus       139 e~~~~  143 (353)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99964

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.56  E-value=0.044  Score=50.39  Aligned_cols=31  Identities=16%  Similarity=0.276  Sum_probs=27.7

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      .+++|+|+.++|++++.++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4799999999999999999999999987643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.31  E-value=0.0092  Score=57.46  Aligned_cols=166  Identities=20%  Similarity=0.228  Sum_probs=98.7

Q ss_pred             HHHHHHHHHHhcCCCCceEEEeeEeEe-cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCce
Q 018630          104 RQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII  182 (353)
Q Consensus       104 ~~~~~e~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~ii  182 (353)
                      .++.-....++.+.|+|......+-.. .....+|+|++. .||.+.+..+. +-.....              . +++.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~--------------~-~~~~   89 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL--------------A-HGVL   89 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc--------------c-cccc
Confidence            456666778889999999888775542 345789999995 59999987643 2111111              1 2233


Q ss_pred             ecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 018630          183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  262 (353)
Q Consensus       183 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  262 (353)
                      |-.     |       ++.+| -++..    .   .+..                .+++||||+|.++.++.-|..-+..
T Consensus        90 ~~~-----~-------~~~td-~~~t~----~---~~~~----------------~pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   90 HLN-----I-------IYITD-HFLTK----Y---PSPI----------------GPKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             eeh-----h-------hhccc-ccccc----C---CCCC----------------CcchhhhhHHHHHHHHHHhhHHHHH
Confidence            321     1       22223 11100    0   1111                1389999999999999998766543


Q ss_pred             CccCCchhhHHHHHHHHhcCCCCC-------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          263 PEQQDGWTSFYELMEAIVDQPPPS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      ....    ...+.+.+........       .....++....++..+|+...|..||...++.+++-|...
T Consensus       134 ~~~s----~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  134 LTES----EYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHH----HHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            2211    1111111111111000       0012345567889999999999999999999999988764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.24  E-value=0.021  Score=49.33  Aligned_cols=103  Identities=17%  Similarity=0.163  Sum_probs=64.2

Q ss_pred             EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHH
Q 018630           88 FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ  167 (353)
Q Consensus        88 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~q  167 (353)
                      +..+|.+....-.-...-+..+.+++.++  -.|+++..-  +.-.+-++.|+|-....             .-..++..
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~~N~i~a  149 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKI-------------NFSNFITA  149 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCccc-------------chhHHHHH
Confidence            34455554332111223345566666654  357777643  33456788999864211             11122333


Q ss_pred             HHHHHHHHHh-cCCceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          168 VLKGLLYLHH-EKHIIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       168 l~~~l~~LH~-~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                      =+.+|.-.|+ ..+.+|+|..|+||+.|+.|.+||.|=+..
T Consensus       150 gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  150 GIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             hHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            3567778884 467999999999999999999999998753

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.97  E-value=0.023  Score=53.42  Aligned_cols=62  Identities=26%  Similarity=0.438  Sum_probs=46.2

Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH  195 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~  195 (353)
                      ...++-+|..|.++..+++.. ..++..+.+++.-.++|+--+---.+++|.|+.|.||++-.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            345677789999999888763 45566777777767777655443468999999999999953

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.85  E-value=0.45  Score=44.10  Aligned_cols=28  Identities=21%  Similarity=0.304  Sum_probs=23.7

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          179 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      .+++|+|+.+.||+++ + .+.++||+-+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            5789999999999995 4 57899999763

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.84  E-value=0.05  Score=51.45  Aligned_cols=76  Identities=18%  Similarity=0.131  Sum_probs=47.1

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeecc----cc-HHHHHHHHHHHHHHhcCC--CC-ceEEEeeEeEecCeEEEE
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN----VE-ESARRQIAQELKINQSSQ--CP-YVVVCYQSFYSNGAISII  137 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~-~~~~~~~~~e~~~~~~l~--hp-~iv~~~~~~~~~~~~~lv  137 (353)
                      .+.||.|.-..||++.+...++.++||.-..-    .+ .....+..-|...++...  .| .+.++|.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            67889999999999998534567999964211    01 112344455555555432  23 45556653  45566788


Q ss_pred             EEecCC
Q 018630          138 LEYMDG  143 (353)
Q Consensus       138 ~e~~~~  143 (353)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998864

>PRK06148 hypothetical protein; Provisional

Probab=95.72  E-value=0.24  Score=53.14  Aligned_cols=31  Identities=26%  Similarity=0.536  Sum_probs=26.0

Q ss_pred             CCceecCCCCCcEEEcCCC--cE-EEeecccccc
Q 018630          179 KHIIHRDLKPSNLLINHRG--EV-KITDFGVSAI  209 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~~--~~-kl~DfG~a~~  209 (353)
                      .++||+|+.+.||+++.++  ++ -|+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999998775  45 4999998754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.72  E-value=0.28  Score=45.50  Aligned_cols=28  Identities=36%  Similarity=0.640  Sum_probs=25.4

Q ss_pred             ceecCCCCCcEEEcCCCc-EEEeeccccc
Q 018630          181 IIHRDLKPSNLLINHRGE-VKITDFGVSA  208 (353)
Q Consensus       181 iiH~Dlkp~NIll~~~~~-~kl~DfG~a~  208 (353)
                      +||+|+.|.||+++.+.. +.+.|||-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999998885 9999999764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.31  E-value=0.14  Score=44.51  Aligned_cols=71  Identities=21%  Similarity=0.128  Sum_probs=44.1

Q ss_pred             CCeEEEEEEeccCC-cEEEEEEeeccccHHHHHHHHHHHHHHhcC---CCCceEEEeeEeEecCeEEEEEEecCCCCHH
Q 018630           73 SGGIVQLVQHKWTG-QFFALKVIQMNVEESARRQIAQELKINQSS---QCPYVVVCYQSFYSNGAISIILEYMDGGSLA  147 (353)
Q Consensus        73 ~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l---~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL~  147 (353)
                      +.|.|..+....+| .++.+|+=..    ....-+..|+.-+..+   +.-.+.+.+.+..+.++.|+|+||++-+.+.
T Consensus        25 ~gG~inea~~v~dg~~~~FvK~n~~----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          25 SGGDINEAWRLRDGTDPFFVKCNQR----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             CCccccceeEeecCCcceEEEecch----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            33444444443344 4788886332    2334455555554443   3345667788888899999999999976654

>PTZ00384 choline kinase; Provisional

Probab=94.91  E-value=0.25  Score=46.81  Aligned_cols=29  Identities=24%  Similarity=0.264  Sum_probs=23.8

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          179 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      ...+|.|+-+.||+.+ ++.+.++||-.|.
T Consensus       227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEec-CCCEEEEEecccc
Confidence            4579999999999875 4569999998763

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=94.50  E-value=0.098  Score=47.84  Aligned_cols=84  Identities=24%  Similarity=0.274  Sum_probs=63.3

Q ss_pred             CCCCceEEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC
Q 018630          116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH  195 (353)
Q Consensus       116 l~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~  195 (353)
                      +.+|-+|.+..       ..+||.|+...-+..---+.-.++.++....-.|+..+|.-|-...-+||.|++--|+|...
T Consensus       347 lpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~  419 (531)
T KOG2269|consen  347 LPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWTP  419 (531)
T ss_pred             CCCCceeeeec-------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheecC
Confidence            46788877654       46899998543333221222458888989889999999998866688999999999999976


Q ss_pred             CCcEEEeecccc
Q 018630          196 RGEVKITDFGVS  207 (353)
Q Consensus       196 ~~~~kl~DfG~a  207 (353)
                      + .+.++|..-+
T Consensus       420 g-Kvw~IDVsQs  430 (531)
T KOG2269|consen  420 G-KVWVIDVSQS  430 (531)
T ss_pred             C-ceEEEechhc
Confidence            5 8999997654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	353
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-63
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-61
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-61
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-59
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-59
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-59
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-59
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-59
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-59
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-58
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-46
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-45
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-42
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-42
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-41
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-38
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-38
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-37
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-37
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-37
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-37
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-36
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-36
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-36
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-34
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-34
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-34
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-34
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-34
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-34
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-34
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-33
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-33
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-32
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-31
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-31
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-31
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-31
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-31
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-31
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-31
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-31
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-31
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-31
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-31
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-30
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-30
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-30
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-30
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-30
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-29
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-29
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-29
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-29
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-28
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-28
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-28
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-28
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-27
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-27
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-27
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-27
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-27
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-26
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-26
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-25
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-25
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-25
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-25
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-25
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-25
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-25
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-25
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-25
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-25
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-24
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-24
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-24
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-24
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-24
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-24
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-24
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-24
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-24
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-24
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-24
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-24
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-24
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-24
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-24
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-24
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-24
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-24
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-24
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-24
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-24
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-24
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-24
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-24
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-24
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-24
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-24
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-24
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-24
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-24
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-24
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-24
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-24
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-24
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-24
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-24
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-24
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-24
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-24
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-23
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-23
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-23
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-23
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-23
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-23
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-23
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-23
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-23
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-23
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-23
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-23
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-23
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-23
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-23
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-23
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-23
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-23
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-23
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-23
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-23
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-23
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-23
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-23
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-23
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-23
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-23
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-23
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-23
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-23
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-23
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-23
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-23
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-23
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-23
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-23
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-23
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-23
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-23
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-23
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-23
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-23
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-23
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-23
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-23
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-23
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-23
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-22
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-22
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-22
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-22
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-22
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-22
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-22
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-22
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-22
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-22
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-22
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-22
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-22
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-22
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-22
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-22
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-22
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-22
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-22
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-22
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-22
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-22
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-22
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-22
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-22
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-22
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-22
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-22
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-22
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-22
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-22
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-22
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-22
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-22
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-22
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-22
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-22
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-22
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-22
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-22
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-22
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-22
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-22
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-22
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-22
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-22
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-22
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-22
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-22
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-22
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-22
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-22
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-22
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-22
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-22
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-22
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-22
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-22
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-22
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-22
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-22
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-22
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-22
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-22
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-22
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-22
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-22
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-21
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-21
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-21
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-21
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-21
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-21
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-21
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-21
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-21
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-21
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-21
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-21
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-21
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-21
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-21
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-21
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-21
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-21
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-21
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-21
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-21
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-21
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-21
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-21
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-21
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-21
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-21
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-21
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-20
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-20
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-20
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-20
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-20
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-20
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-20
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-20
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-20
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-20
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-20
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-20
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-20
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-20
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-20
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-20
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-20
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-20
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-20
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-20
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-20
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-20
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-20
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-20
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-20
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-20
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-20
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-20
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-20
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-20
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-20
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-20
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-20
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-20
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-20
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-20
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-20
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-20
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-20
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-20
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-20
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-20
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-19
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-19
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-19
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-19
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-19
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-19
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-19
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-19
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-19
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-19
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-19
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-19
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-19
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-19
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-19
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-19
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-19
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-19
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-19
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-19
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-19
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-19
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-19
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-19
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-19
3soa_A	444	Full-Length Human Camkii Length = 444		7e-19
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-19
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-19
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-19
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-18
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-18
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-18
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-18
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-18
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-18
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-18
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-18
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-18
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-18
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-18
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-18
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-18
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-18
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-18
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-18
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-18
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-18
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-18
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-18
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-18
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-18
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-18
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-18
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-18
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-18
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-18
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-18
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-18
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-18
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-18
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-18
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-18
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-18
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-18
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-18
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-18
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-18
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-18
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-18
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-17
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-17
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-17
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-17
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-17
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-17
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-17
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-17
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-17
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-17
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-17
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-17
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-17
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-17
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-17
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-17
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-17
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-17
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-17
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-17
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		8e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-17
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-16
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-16
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-16
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-16
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-16
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-16
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-16
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-16
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-16
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-16
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-16
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-16
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-15
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-15
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-15
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-15
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-15
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-15
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-15
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-15
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-15
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-15
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-15
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-15
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-15
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-15
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-15
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-15
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-15
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-15
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-15
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-15
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-15
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-15
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-15
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-15
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-14
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-14
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-14
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-14
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-14
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-14
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-14
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-14
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-14
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-14
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-14
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-14
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-14
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-14
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-14
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-14
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-14
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-14
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-14
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-14
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-14
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-14
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-14
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-14
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-14
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-14
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-14
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-13
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-13
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-13
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-12
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-12
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-12
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-10
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-10
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-10
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		4e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-10

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  237 bits (605), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 115/261 (44%), Positives = 167/261 (63%), Gaps = 5/261 (1%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 145 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 260 YSPPEQQDGW---TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
             PP+ ++      + +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++
Sbjct: 203 IPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 262
Query: 317 LMTHPFLKMYGDLNVDLSEYF 337
           LM H F+K      VD + + 
Sbjct: 263 LMVHAFIKRSDAEEVDFAGWL 283

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  233 bits (593), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 114/258 (44%), Positives = 163/258 (63%), Gaps = 5/258 (1%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 44  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 103
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 104 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 163
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 164 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221
Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
                   G  + +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM 
Sbjct: 222 IG---SGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 278
Query: 320 HPFLKMYGDLNVDLSEYF 337
           H F+K      VD + + 
Sbjct: 279 HAFIKRSDAEEVDFAGWL 296

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  231 bits (588), Expect = 6e-61,   Method: Compositional matrix adjust.
 Identities = 114/258 (44%), Positives = 161/258 (62%), Gaps = 9/258 (3%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 28  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 87
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 88  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 147
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFGVS  +      AN FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 148 KLCDFGVSGQLIDE--MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205
Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
             P        + +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM 
Sbjct: 206 RPP-------MAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMV 258
Query: 320 HPFLKMYGDLNVDLSEYF 337
           H F+K      VD + + 
Sbjct: 259 HAFIKRSDAEEVDFAGWL 276

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  225 bits (573), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 117/293 (39%), Positives = 168/293 (57%), Gaps = 37/293 (12%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 87  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 146
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 147 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 206
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 207 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264
Query: 260 YSPPEQQD------------------------------GWTS-----FYELMEAIVDQPP 284
             PP+ ++                              G  S      +EL++ IV++PP
Sbjct: 265 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 324
Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 337
           P  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 325 PKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 377

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  225 bits (573), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 117/293 (39%), Positives = 168/293 (57%), Gaps = 37/293 (12%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 52  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 171
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 172 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
Query: 260 YSPPEQQD------------------------------GWTS-----FYELMEAIVDQPP 284
             PP+ ++                              G  S      +EL++ IV++PP
Sbjct: 230 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 337
           P  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 290 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 342

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  224 bits (572), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 117/293 (39%), Positives = 168/293 (57%), Gaps = 37/293 (12%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 145 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 260 YSPPEQQD------------------------------GWTS-----FYELMEAIVDQPP 284
             PP+ ++                              G  S      +EL++ IV++PP
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 337
           P  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 315

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  224 bits (572), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 117/293 (39%), Positives = 168/293 (57%), Gaps = 37/293 (12%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 145 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 260 YSPPEQQD------------------------------GWTS-----FYELMEAIVDQPP 284
             PP+ ++                              G  S      +EL++ IV++PP
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 337
           P  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 315

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  224 bits (572), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 117/293 (39%), Positives = 168/293 (57%), Gaps = 37/293 (12%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 145 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 260 YSPPEQQD------------------------------GWTS-----FYELMEAIVDQPP 284
             PP+ ++                              G  S      +EL++ IV++PP
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 337
           P  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 315

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  224 bits (572), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 117/293 (39%), Positives = 168/293 (57%), Gaps = 37/293 (12%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 145 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 260 YSPPEQQD------------------------------GWTS-----FYELMEAIVDQPP 284
             PP+ ++                              G  S      +EL++ IV++PP
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 337
           P  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 315

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  223 bits (568), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 114/297 (38%), Positives = 169/297 (56%), Gaps = 41/297 (13%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           VQH+ +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 35  VQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 94
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +MDGGSL   LK+ K IPEE L  +   VL+GL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 95  HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEI 154
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFGVS  +  +   AN+FVGT +YM+PER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 155 KLCDFGVSGQLIDS--MANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212
Query: 260 YSPPEQQ-----------DG----------------------------WTSFYELMEAIV 280
             PP+ +           DG                              + +EL++ IV
Sbjct: 213 IPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIV 272
Query: 281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 337
           ++PPP  P+  F+P+F  F++ C+ K P +R   + L  H F+K      VD + + 
Sbjct: 273 NEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLTNHTFIKRSEVEEVDFAGWL 329

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  180 bits (457), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 95/266 (35%), Positives = 155/266 (58%), Gaps = 17/266 (6%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIIL 138
           ++H  +GQ  A+K I+  V    ++++  +L I+ ++  CP+ V  Y + +  G + I +
Sbjct: 70  MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 129
Query: 139 EYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           E MD  SL  F K+V    +TIPE+ L  I   ++K L +LH +  +IHRD+KPSN+LIN
Sbjct: 130 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 188
Query: 195 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVL 250
             G+VK+ DFG+S  +  +  +     G   YM+PERI    +   Y  KSDIWSLG+ +
Sbjct: 189 ALGQVKMCDFGISGYLVDSVAK-TIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 247
Query: 251 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 310
           +E A  +FPY      D W + ++ ++ +V++P P  P+D+FS EF  F S C++K  ++
Sbjct: 248 IELAILRFPY------DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKE 301
Query: 311 RLSAQELMTHPFLKMYGDLNVDLSEY 336
           R +  ELM HPF  ++     D++ +
Sbjct: 302 RPTYPELMQHPFFTLHESKGTDVASF 327

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 95/266 (35%), Positives = 155/266 (58%), Gaps = 17/266 (6%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIIL 138
           ++H  +GQ  A+K I+  V    ++++  +L I+ ++  CP+ V  Y + +  G + I +
Sbjct: 26  MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85
Query: 139 EYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           E MD  SL  F K+V    +TIPE+ L  I   ++K L +LH +  +IHRD+KPSN+LIN
Sbjct: 86  ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 144
Query: 195 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVL 250
             G+VK+ DFG+S  +     + +   G   YM+PERI    +   Y  KSDIWSLG+ +
Sbjct: 145 ALGQVKMCDFGISGYLVDDVAK-DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 203
Query: 251 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 310
           +E A  +FPY      D W + ++ ++ +V++P P  P+D+FS EF  F S C++K  ++
Sbjct: 204 IELAILRFPY------DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKE 257
Query: 311 RLSAQELMTHPFLKMYGDLNVDLSEY 336
           R +  ELM HPF  ++     D++ +
Sbjct: 258 RPTYPELMQHPFFTLHESKGTDVASF 283

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 97/268 (36%), Positives = 149/268 (55%), Gaps = 21/268 (7%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEY 140
           HK +GQ  A+K I+  V+E  ++Q+  +L +  +SS CPY+V  Y + +  G   I +E 
Sbjct: 43  HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102
Query: 141 MDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           M   S   F K V       IPEE L  I    +K L +L     IIHRD+KPSN+L++ 
Sbjct: 103 M-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR 161
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI--SGGKYGY--KSDIWSLGLVLL 251
            G +K+ DFG+S  +  +  +     G   YM+PERI  S  + GY  +SD+WSLG+ L 
Sbjct: 162 SGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP---SAPSDQFSPEFCSFISACVQKEP 308
           E ATG+FPY        W S ++ +  +V   PP   ++   +FSP F +F++ C+ K+ 
Sbjct: 221 ELATGRFPYP------KWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDE 274
Query: 309 QQRLSAQELMTHPFLKMYGDLNVDLSEY 336
            +R   +EL+ HPF+ MY +  V+++ Y
Sbjct: 275 SKRPKYKELLKHPFILMYEERAVEVACY 302

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 92/265 (34%), Positives = 148/265 (55%), Gaps = 17/265 (6%)
Query: 81  QHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILE 139
           +H  +GQ  A+K I+  V    ++++  +L I+ ++  CP+ V  Y + +  G + I  E
Sbjct: 54  RHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXE 113
Query: 140 YMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
             D  SL  F K+V    +TIPE+ L  I   ++K L +LH +  +IHRD+KPSN+LIN 
Sbjct: 114 LXDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 172
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVLL 251
            G+VK  DFG+S  +     + +   G   Y +PERI    +   Y  KSDIWSLG+  +
Sbjct: 173 LGQVKXCDFGISGYLVDDVAK-DIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXI 231
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E A  +FPY      D W + ++ ++ +V++P P  P+D+FS EF  F S C++K  ++R
Sbjct: 232 ELAILRFPY------DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKER 285
Query: 312 LSAQELMTHPFLKMYGDLNVDLSEY 336
            +  EL  HPF  ++     D++ +
Sbjct: 286 PTYPELXQHPFFTLHESKGTDVASF 310

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 153/269 (56%), Gaps = 18/269 (6%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIIL 138
           ++ + TG   A+K ++ +  +   ++I  +L +  +S  CPY+V C+ +F +N  + I +
Sbjct: 44  MRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103
Query: 139 EYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           E M  G+ A+ LKK     IPE  L  +   ++K L YL  +  +IHRD+KPSN+L++ R
Sbjct: 104 ELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLL 251
           G++K+ DFG+S  +     +  +  G   YM+PERI     +   Y  ++D+WSLG+ L+
Sbjct: 162 GQIKLCDFGISGRLVDDKAKDRS-AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV 220
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ-FSPEFCSFISACVQKEPQQ 310
           E ATGQFPY          + +E++  ++ + PP  P    FS +F SF+  C+ K+ ++
Sbjct: 221 ELATGQFPYK------NCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRK 274
Query: 311 RLSAQELMTHPFLKMYGDLNVDLSEYFTD 339
           R    +L+ H F+K Y  L VD++ +F D
Sbjct: 275 RPKYNKLLEHSFIKRYETLEVDVASWFKD 303

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 89/248 (35%), Positives = 138/248 (55%), Gaps = 19/248 (7%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           HK TGQ  A+K + +   ES  ++I +E+ I Q    P+VV  Y S++ N  + I++EY 
Sbjct: 50  HKETGQIVAIKQVPV---ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106
Query: 142 DGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 200
             GS++D ++ + KT+ E+ +A I +  LKGL YLH  + I HRD+K  N+L+N  G  K
Sbjct: 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI-HRDIKAGNILLNTEGHAK 165
Query: 201 ITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 260
           + DFGV+  +     + N  +GT  +M+PE I    Y   +DIWSLG+  +E A G+ PY
Sbjct: 166 LADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
Query: 261 SPPEQQDGWTSFYELMEAIV---DQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           +              M AI      PPP+    + +S  F  F+  C+ K P+QR +A +
Sbjct: 226 AD----------IHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
Query: 317 LMTHPFLK 324
           L+ HPF++
Sbjct: 276 LLQHPFVR 283

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 139/253 (54%), Gaps = 14/253 (5%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           T +  A+K+I +   E     I QE+ +      PY+   + S+  +  + II+EY+ GG
Sbjct: 43  TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGG 102
Query: 145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           S  D LK    + E Y+A I  ++LKGL YLH E+ I HRD+K +N+L++ +G+VK+ DF
Sbjct: 103 SALDLLKP-GPLEETYIATILREILKGLDYLHSERKI-HRDIKAANVLLSEQGDVKLADF 160
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 264
           GV+  +  T  + N FVGT  +M+PE I    Y +K+DIWSLG+  +E A G+    PP 
Sbjct: 161 GVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE----PP- 215
Query: 265 QQDGWTSFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
                 S    M  +   P  S P+   Q S  F  F+ AC+ K+P+ R +A+EL+ H F
Sbjct: 216 -----NSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKF 270
Query: 323 LKMYGDLNVDLSE 335
           +  Y      L+E
Sbjct: 271 ITRYTKKTSFLTE 283

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 89/239 (37%), Positives = 133/239 (55%), Gaps = 10/239 (4%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           T +  A+K+I +   E     I QE+ +      PYV   Y S+  +  + II+EY+ GG
Sbjct: 51  TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 110
Query: 145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           S  D L+    + E  +A I  ++LKGL YLH EK I HRD+K +N+L++  GEVK+ DF
Sbjct: 111 SALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADF 168
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 264
           GV+  +  T  + NTFVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P+S   
Sbjct: 169 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 228
Query: 265 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
                    +++  I    PP+   + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 229 PM-------KVLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 89/239 (37%), Positives = 133/239 (55%), Gaps = 10/239 (4%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           T +  A+K+I +   E     I QE+ +      PYV   Y S+  +  + II+EY+ GG
Sbjct: 31  TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 90
Query: 145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           S  D L+    + E  +A I  ++LKGL YLH EK I HRD+K +N+L++  GEVK+ DF
Sbjct: 91  SALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADF 148
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 264
           GV+  +  T  + NTFVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P+S   
Sbjct: 149 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 208
Query: 265 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
                    +++  I    PP+   + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 209 PM-------KVLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 143/261 (54%), Gaps = 30/261 (11%)
Query: 81  QHKWTGQFFALKVIQMNVEESARRQIAQELK-INQSSQCPYVVVCYQSFYS------NGA 133
           +H  TGQ  A+KV  M+V      +I QE+  + + S    +   Y +F        +  
Sbjct: 44  RHVKTGQLAAIKV--MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101
Query: 134 ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           + +++E+   GS+ D +K  K  T+ EE++A IC ++L+GL +LH  K +IHRD+K  N+
Sbjct: 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNV 160
Query: 192 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSL 246
           L+    EVK+ DFGVSA +  T G+ NTF+GT  +M+PE I+        Y +KSD+WSL
Sbjct: 161 LLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 220
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEA---IVDQPPPSAPSDQFSPEFCSFISAC 303
           G+  +E A G    +PP            M A   I   P P   S ++S +F SFI +C
Sbjct: 221 GITAIEMAEG----APP------LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESC 270
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K   QR + ++LM HPF++
Sbjct: 271 LVKNHSQRPATEQLMKHPFIR 291

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 89/239 (37%), Positives = 131/239 (54%), Gaps = 10/239 (4%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           T Q  A+K+I +   E     I QE+ +       YV   Y S+     + II+EY+ GG
Sbjct: 47  TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGG 106
Query: 145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           S  D L+      E  +A + +++LKGL YLH EK I HRD+K +N+L++ +G+VK+ DF
Sbjct: 107 SALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKI-HRDIKAANVLLSEQGDVKLADF 164
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 264
           GV+  +  T  + NTFVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P S   
Sbjct: 165 GVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 224
Query: 265 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
                     ++  I    PP+   D F+  F  FI AC+ K+P  R +A+EL+ H F+
Sbjct: 225 PM-------RVLFLIPKNNPPTLVGD-FTKSFKEFIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 88/239 (36%), Positives = 132/239 (55%), Gaps = 10/239 (4%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           T +  A+K+I +   E     I QE+ +      PYV   Y S+  +  + II+EY+ GG
Sbjct: 46  TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105
Query: 145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           S  D L+    + E  +A I  ++LKGL YLH EK I HRD+K +N+L++  GEVK+ DF
Sbjct: 106 SALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADF 163
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 264
           GV+  +  T  + N FVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P+S   
Sbjct: 164 GVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223
Query: 265 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
                    +++  I    PP+   + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 224 PM-------KVLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 88/239 (36%), Positives = 132/239 (55%), Gaps = 10/239 (4%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           T +  A+K+I +   E     I QE+ +      PYV   Y S+  +  + II+EY+ GG
Sbjct: 31  TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 90
Query: 145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           S  D L+    + E  +A I  ++LKGL YLH EK I HRD+K +N+L++  GEVK+ DF
Sbjct: 91  SALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADF 148
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 264
           GV+  +  T  + N FVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P+S   
Sbjct: 149 GVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 208
Query: 265 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
                    +++  I    PP+   + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 209 PM-------KVLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  147 bits (371), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 144/251 (57%), Gaps = 13/251 (5%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISII 137
           L + K +G+  A+K+  M++ +  RR++   E+ I +  Q   VV  Y+S+     + ++
Sbjct: 63  LAREKHSGRQVAVKM--MDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           +E++ GG+L D + +V+ + EE +A +CE VL+ L YLH +  +IHRD+K  ++L+   G
Sbjct: 121 MEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQG-VIHRDIKSDSILLTLDG 178
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ 257
            VK++DFG  A ++    +    VGT  +M+PE IS   Y  + DIWSLG++++E   G+
Sbjct: 179 RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
Query: 258 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAP-SDQFSPEFCSFISACVQKEPQQRLSAQE 316
            PY          S  + M+ + D PPP    S + SP    F+   + ++PQ+R +AQE
Sbjct: 239 PPYFS-------DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291
Query: 317 LMTHPFLKMYG 327
           L+ HPFL   G
Sbjct: 292 LLDHPFLLQTG 302

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 85/249 (34%), Positives = 138/249 (55%), Gaps = 17/249 (6%)
Query: 83  KWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           K TG+  A+K  +M++ +  RR++   E+ I +      VV  Y S+     + +++E++
Sbjct: 67  KHTGKQVAVK--KMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFL 124
Query: 142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
           +GG+L D +   + + EE +A +C  VL+ L YLH++  +IHRD+K  ++L+   G +K+
Sbjct: 125 EGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQG-VIHRDIKSDSILLTSDGRIKL 182
Query: 202 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY- 260
           +DFG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY 
Sbjct: 183 SDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 242
Query: 261 -SPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELM 318
             PP Q          M  I D  PP      + S     F+   + +EP QR +AQEL+
Sbjct: 243 NEPPLQA---------MRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELL 293
Query: 319 THPFLKMYG 327
            HPFLK+ G
Sbjct: 294 GHPFLKLAG 302

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 138/247 (55%), Gaps = 17/247 (6%)
Query: 85  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           +G+  A+K  +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++G
Sbjct: 44  SGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           G+L D +   + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++D
Sbjct: 102 GALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSD 159
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--S 261
           FG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   
Sbjct: 160 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219
Query: 262 PPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
           PP          + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ H
Sbjct: 220 PP---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270
Query: 321 PFLKMYG 327
           PFL   G
Sbjct: 271 PFLAKAG 277

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 138/247 (55%), Gaps = 17/247 (6%)
Query: 85  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           +G+  A+K  +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++G
Sbjct: 53  SGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 110
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           G+L D +   + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++D
Sbjct: 111 GALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSD 168
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--S 261
           FG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   
Sbjct: 169 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 228
Query: 262 PPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
           PP          + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ H
Sbjct: 229 PP---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 279
Query: 321 PFLKMYG 327
           PFL   G
Sbjct: 280 PFLAKAG 286

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 138/247 (55%), Gaps = 17/247 (6%)
Query: 85  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           +G+  A+K  +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++G
Sbjct: 48  SGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 105
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           G+L D +   + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++D
Sbjct: 106 GALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSD 163
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--S 261
           FG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   
Sbjct: 164 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 223
Query: 262 PPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
           PP          + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ H
Sbjct: 224 PP---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 274
Query: 321 PFLKMYG 327
           PFL   G
Sbjct: 275 PFLAKAG 281

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 138/247 (55%), Gaps = 17/247 (6%)
Query: 85  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           +G+  A+K  +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++G
Sbjct: 55  SGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 112
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           G+L D +   + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++D
Sbjct: 113 GALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSD 170
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--S 261
           FG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   
Sbjct: 171 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 230
Query: 262 PPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
           PP          + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ H
Sbjct: 231 PP---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 281
Query: 321 PFLKMYG 327
           PFL   G
Sbjct: 282 PFLAKAG 288

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 83/249 (33%), Positives = 139/249 (55%), Gaps = 17/249 (6%)
Query: 83  KWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           + +G+  A+K  +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E++
Sbjct: 96  RSSGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153
Query: 142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
           +GG+L D +   + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK+
Sbjct: 154 EGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKL 211
Query: 202 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY- 260
           +DFG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY 
Sbjct: 212 SDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 271
Query: 261 -SPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELM 318
             PP          + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+
Sbjct: 272 NEPP---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 322
Query: 319 THPFLKMYG 327
            HPFL   G
Sbjct: 323 KHPFLAKAG 331

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 138/247 (55%), Gaps = 17/247 (6%)
Query: 85  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           +G+  A+K  +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++G
Sbjct: 175 SGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           G+L D +   + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++D
Sbjct: 233 GALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSD 290
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--S 261
           FG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   
Sbjct: 291 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350
Query: 262 PPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
           PP          + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ H
Sbjct: 351 PP---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401
Query: 321 PFLKMYG 327
           PFL   G
Sbjct: 402 PFLAKAG 408

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 84/249 (33%), Positives = 135/249 (54%), Gaps = 14/249 (5%)
Query: 81  QHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 140
           ++K TG   A KVI+   EE     I  E++I  +   PY+V    ++Y +G + I++E+
Sbjct: 31  KNKETGALAAAKVIETKSEEELEDYIV-EIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 89
Query: 141 MDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
             GG++ A  L+  + + E  +  +C Q+L+ L +LH  K IIHRDLK  N+L+   G++
Sbjct: 90  CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEGDI 148
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECA 254
           ++ DFGVSA    T  + ++F+GT  +M+PE +         Y YK+DIWSLG+ L+E A
Sbjct: 149 RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 208
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
                  PP  +        L++     PP      ++S EF  F+   + K P+ R SA
Sbjct: 209 Q----IEPPHHE--LNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSA 262
Query: 315 QELMTHPFL 323
            +L+ HPF+
Sbjct: 263 AQLLEHPFV 271

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 84/249 (33%), Positives = 135/249 (54%), Gaps = 14/249 (5%)
Query: 81  QHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 140
           ++K TG   A KVI+   EE     I  E++I  +   PY+V    ++Y +G + I++E+
Sbjct: 39  KNKETGALAAAKVIETKSEEELEDYIV-EIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97
Query: 141 MDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
             GG++ A  L+  + + E  +  +C Q+L+ L +LH  K IIHRDLK  N+L+   G++
Sbjct: 98  CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEGDI 156
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECA 254
           ++ DFGVSA    T  + ++F+GT  +M+PE +         Y YK+DIWSLG+ L+E A
Sbjct: 157 RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
                  PP  +        L++     PP      ++S EF  F+   + K P+ R SA
Sbjct: 217 Q----IEPPHHE--LNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSA 270
Query: 315 QELMTHPFL 323
            +L+ HPF+
Sbjct: 271 AQLLEHPFV 279

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 77/242 (31%), Positives = 137/242 (56%), Gaps = 11/242 (4%)
Query: 85  TGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ G
Sbjct: 44  TGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           GSL D + +   + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TD
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTD 159
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 263
           FG  A +     + +T VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY   
Sbjct: 160 FGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-- 217
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
             ++   + Y +     +  P     ++ S  F  F++ C+  + ++R SA+EL+ H FL
Sbjct: 218 -NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
Query: 324 KM 325
           K+
Sbjct: 274 KI 275

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 137/242 (56%), Gaps = 11/242 (4%)
Query: 85  TGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ G
Sbjct: 44  TGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           GSL D + +   + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TD
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTD 159
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 263
           FG  A +     + +  VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY   
Sbjct: 160 FGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-- 217
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
             ++   + Y +     +  P     ++ S  F  F++ C++ + ++R SA+EL+ H FL
Sbjct: 218 -NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273
Query: 324 KM 325
           K+
Sbjct: 274 KI 275

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 135/268 (50%), Gaps = 16/268 (5%)
Query: 81  QHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 140
           Q+K T    A KVI    EE     +  E+ I  S   P +V    +FY    + I++E+
Sbjct: 57  QNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAFYYENNLWILIEF 115
Query: 141 MDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
             GG++ A  L+  + + E  +  +C+Q L  L YLH  K IIHRDLK  N+L    G++
Sbjct: 116 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDI 174
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECA 254
           K+ DFGVSA    T  + ++F+GT  +M+PE +         Y YK+D+WSLG+ L+E A
Sbjct: 175 KLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
                  PP  +        L++    +PP  A   ++S  F  F+  C++K    R + 
Sbjct: 235 E----IEPPHHE--LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTT 288
Query: 315 QELMTHPFLKMYGDLNVDLSEYFTDAGS 342
            +L+ HPF+ +  D N  + E   +A +
Sbjct: 289 SQLLQHPFVTV--DSNKPIRELIAEAKA 314

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 138/242 (57%), Gaps = 11/242 (4%)
Query: 85  TGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ G
Sbjct: 45  TGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 102
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           GSL D + +   + E  +AA+C + L+ L +LH    +IHR++K  N+L+   G VK+TD
Sbjct: 103 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRNIKSDNILLGMDGSVKLTD 160
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 263
           FG  A +     + +T VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY   
Sbjct: 161 FGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-- 218
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
             ++   + Y +     +  P     ++ S  F  F++ C++ + ++R SA+EL+ H FL
Sbjct: 219 -NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFL 274
Query: 324 KM 325
           K+
Sbjct: 275 KI 276

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 137/242 (56%), Gaps = 11/242 (4%)
Query: 85  TGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ G
Sbjct: 45  TGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 102
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           GSL D + +   + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TD
Sbjct: 103 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTD 160
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 263
           FG  A +     + +  VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY   
Sbjct: 161 FGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-- 218
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
             ++   + Y +     +  P     ++ S  F  F++ C++ + ++R SA+EL+ H FL
Sbjct: 219 -NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFL 274
Query: 324 KM 325
           K+
Sbjct: 275 KI 276

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 136/255 (53%), Gaps = 22/255 (8%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAIS 135
           LV+ K TG+++A+K+++  V   A+ ++A  L   ++ Q+S+ P++     SF ++  + 
Sbjct: 169 LVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 227
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY +GG L   L + +   E+       +++  L YLH EK++++RDLK  NL+++ 
Sbjct: 228 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 287
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KITDFG+            TF GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 288 DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 347
Query: 256 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
           G+ P+   + +      +E  LME I  + P +       PE  S +S  ++K+P+QRL 
Sbjct: 348 GRLPFYNQDHE----KLFELILMEEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLG 396
Query: 314 -----AQELMTHPFL 323
                A+E+M H F 
Sbjct: 397 GGSEDAKEIMQHRFF 411

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 135/255 (52%), Gaps = 22/255 (8%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN---QSSQCPYVVVCYQSFYSNGAIS 135
           LV+ K TG+++A+K+++  V   A+ ++A  L  N   Q+S+ P++     SF ++  + 
Sbjct: 166 LVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY +GG L   L + +   E+       +++  L YLH EK++++RDLK  NL+++ 
Sbjct: 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 284
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KITDFG+            TF GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 285 DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344
Query: 256 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
           G+ P+   + +      +E  LME I  + P +       PE  S +S  ++K+P+QRL 
Sbjct: 345 GRLPFYNQDHE----KLFELILMEEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLG 393
Query: 314 -----AQELMTHPFL 323
                A+E+M H F 
Sbjct: 394 GGSEDAKEIMQHRFF 408

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 136/242 (56%), Gaps = 11/242 (4%)
Query: 85  TGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ G
Sbjct: 44  TGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           GSL D + +   + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TD
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTD 159
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 263
           FG  A +     + +  VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY   
Sbjct: 160 FGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-- 217
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
             ++   + Y +     +  P     ++ S  F  F++ C+  + ++R SA+EL+ H FL
Sbjct: 218 -NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
Query: 324 KM 325
           K+
Sbjct: 274 KI 275

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 134/268 (50%), Gaps = 16/268 (5%)
Query: 81  QHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 140
           Q+K T    A KVI    EE     +  E+ I  S   P +V    +FY    + I++E+
Sbjct: 57  QNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAFYYENNLWILIEF 115
Query: 141 MDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
             GG++ A  L+  + + E  +  +C+Q L  L YLH  K IIHRDLK  N+L    G++
Sbjct: 116 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDI 174
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECA 254
           K+ DFGVSA       + ++F+GT  +M+PE +         Y YK+D+WSLG+ L+E A
Sbjct: 175 KLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
                  PP  +        L++    +PP  A   ++S  F  F+  C++K    R + 
Sbjct: 235 E----IEPPHHE--LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTT 288
Query: 315 QELMTHPFLKMYGDLNVDLSEYFTDAGS 342
            +L+ HPF+ +  D N  + E   +A +
Sbjct: 289 SQLLQHPFVTV--DSNKPIRELIAEAKA 314

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 134/253 (52%), Gaps = 18/253 (7%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAIS 135
           LV+ K TG+++A+K+++  V   A+ ++A  L   ++ Q+S+ P++     SF ++  + 
Sbjct: 28  LVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 86
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY +GG L   L + +   E+       +++  L YLH EK++++RDLK  NL+++ 
Sbjct: 87  FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 146
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KITDFG+             F GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 147 DGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 206
Query: 256 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-- 313
           G+ P+   + +  +     LME I  + P +       PE  S +S  ++K+P+QRL   
Sbjct: 207 GRLPFYNQDHEKLFELI--LMEEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGG 257
Query: 314 ---AQELMTHPFL 323
              A+E+M H F 
Sbjct: 258 SEDAKEIMQHRFF 270

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 134/253 (52%), Gaps = 18/253 (7%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAIS 135
           LV+ K TG+++A+K+++  V   A+ ++A  L   ++ Q+S+ P++     SF ++  + 
Sbjct: 26  LVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 84
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY +GG L   L + +   E+       +++  L YLH EK++++RDLK  NL+++ 
Sbjct: 85  FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 144
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KITDFG+             F GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 145 DGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 204
Query: 256 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-- 313
           G+ P+   + +  +     LME I  + P +       PE  S +S  ++K+P+QRL   
Sbjct: 205 GRLPFYNQDHEKLFELI--LMEEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGG 255
Query: 314 ---AQELMTHPFL 323
              A+E+M H F 
Sbjct: 256 SEDAKEIMQHRFF 268

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 134/253 (52%), Gaps = 18/253 (7%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAIS 135
           LV+ K TG+++A+K+++  V   A+ ++A  L   ++ Q+S+ P++     SF ++  + 
Sbjct: 27  LVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 85
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY +GG L   L + +   E+       +++  L YLH EK++++RDLK  NL+++ 
Sbjct: 86  FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 145
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KITDFG+             F GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 146 DGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 205
Query: 256 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-- 313
           G+ P+   + +  +     LME I  + P +       PE  S +S  ++K+P+QRL   
Sbjct: 206 GRLPFYNQDHEKLFELI--LMEEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGG 256
Query: 314 ---AQELMTHPFL 323
              A+E+M H F 
Sbjct: 257 SEDAKEIMQHRFF 269

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 133/268 (49%), Gaps = 16/268 (5%)
Query: 81  QHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 140
           Q+K T    A KVI    EE     +  E+ I  S   P +V    +FY    + I++E+
Sbjct: 57  QNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAFYYENNLWILIEF 115
Query: 141 MDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
             GG++ A  L+  + + E  +  +C+Q L  L YLH  K IIHRDLK  N+L    G++
Sbjct: 116 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDI 174
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECA 254
           K+ DFGVSA       + + F+GT  +M+PE +         Y YK+D+WSLG+ L+E A
Sbjct: 175 KLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
                  PP  +        L++    +PP  A   ++S  F  F+  C++K    R + 
Sbjct: 235 E----IEPPHHE--LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTT 288
Query: 315 QELMTHPFLKMYGDLNVDLSEYFTDAGS 342
            +L+ HPF+ +  D N  + E   +A +
Sbjct: 289 SQLLQHPFVTV--DSNKPIRELIAEAKA 314

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 120/228 (52%), Gaps = 12/228 (5%)
Query: 90  ALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 147
           ALK +Q+   ++  AR    +E+ + +    P V+  Y SF  +  ++I+LE  D G L+
Sbjct: 61  ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 148 DFLKKVKT----IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
             +K  K     IPE  +     Q+   L ++H  + ++HRD+KP+N+ I   G VK+ D
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATGVVKLGD 179
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 263
            G+    +S +  A++ VGT  YMSPERI    Y +KSDIWSLG +L E A  Q P+   
Sbjct: 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
           +      + Y L + I     P  PSD +S E    ++ C+  +P++R
Sbjct: 240 K-----MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 85/259 (32%), Positives = 132/259 (50%), Gaps = 34/259 (13%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K I +   +++  ++ +E++       P +V  Y SF     + ++++ + GGS+ D 
Sbjct: 44  AIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDI 103
Query: 150 LK--------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
           +K        K   + E  +A I  +VL+GL YLH    I HRD+K  N+L+   G V+I
Sbjct: 104 IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI-HRDVKAGNILLGEDGSVQI 162
Query: 202 TDFGVSAIMASTSGQ------ANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECA 254
            DFGVSA +A T G         TFVGT  +M+PE +   + Y +K+DIWS G+  +E A
Sbjct: 163 ADFGVSAFLA-TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221
Query: 255 TGQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQ-------FSPEFCSFISACVQ 305
           TG  PY   PP +         LM  + + PP      Q       +   F   IS C+Q
Sbjct: 222 TGAAPYHKYPPMKV--------LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQ 273
Query: 306 KEPQQRLSAQELMTHPFLK 324
           K+P++R +A EL+ H F +
Sbjct: 274 KDPEKRPTAAELLRHKFFQ 292

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 85/259 (32%), Positives = 132/259 (50%), Gaps = 34/259 (13%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K I +   +++  ++ +E++       P +V  Y SF     + ++++ + GGS+ D 
Sbjct: 39  AIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDI 98
Query: 150 LK--------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
           +K        K   + E  +A I  +VL+GL YLH    I HRD+K  N+L+   G V+I
Sbjct: 99  IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI-HRDVKAGNILLGEDGSVQI 157
Query: 202 TDFGVSAIMASTSGQ------ANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECA 254
            DFGVSA +A T G         TFVGT  +M+PE +   + Y +K+DIWS G+  +E A
Sbjct: 158 ADFGVSAFLA-TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 216
Query: 255 TGQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQ-------FSPEFCSFISACVQ 305
           TG  PY   PP +         LM  + + PP      Q       +   F   IS C+Q
Sbjct: 217 TGAAPYHKYPPMKV--------LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQ 268
Query: 306 KEPQQRLSAQELMTHPFLK 324
           K+P++R +A EL+ H F +
Sbjct: 269 KDPEKRPTAAELLRHKFFQ 287

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 136/255 (53%), Gaps = 23/255 (9%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAIS 135
           LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++     +F ++  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY +GG L   L + +   EE       +++  L YLH  + +++RD+K  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDK 140
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KITDFG+     S      TF GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 256 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
           G+ P+   + +      +E  LME I  + P +      SPE  S ++  ++K+P+QRL 
Sbjct: 201 GRLPFYNQDHE----RLFELILMEEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLG 249
Query: 314 -----AQELMTHPFL 323
                A+E+M H F 
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 136/255 (53%), Gaps = 23/255 (9%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAIS 135
           LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++     +F ++  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY +GG L   L + +   EE       +++  L YLH  + +++RD+K  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDK 140
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KITDFG+     S      TF GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 256 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL- 312
           G+ P+   + +      +E  LME I  + P +      SPE  S ++  ++K+P+QRL 
Sbjct: 201 GRLPFYNQDHE----RLFELILMEEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLG 249
Query: 313 ----SAQELMTHPFL 323
                A+E+M H F 
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 136/255 (53%), Gaps = 23/255 (9%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAIS 135
           LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++     +F ++  + 
Sbjct: 26  LVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 84
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY +GG L   L + +   EE       +++  L YLH  + +++RD+K  NL+++ 
Sbjct: 85  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDK 143
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KITDFG+     S      TF GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 144 DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 203
Query: 256 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL- 312
           G+ P+   + +      +E  LME I  + P +      SPE  S ++  ++K+P+QRL 
Sbjct: 204 GRLPFYNQDHE----RLFELILMEEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLG 252
Query: 313 ----SAQELMTHPFL 323
                A+E+M H F 
Sbjct: 253 GGPSDAKEVMEHRFF 267

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 141/279 (50%), Gaps = 23/279 (8%)
Query: 55  DNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELK 111
           D ++ + D D              LV+ K TG+++A+K+++  V   A+ ++A    E +
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESR 62
Query: 112 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 171
           + Q+++ P++     +F ++  +  ++EY +GG L   L + +   EE       +++  
Sbjct: 63  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 122
Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           L YLH  + +++RD+K  NL+++  G +KITDFG+     S       F GT  Y++PE 
Sbjct: 123 LEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV 181
Query: 232 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPS 289
           +    YG   D W LG+V+ E   G+ P+   + +      +E  LME I  + P +   
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEI--RFPRT--- 232
Query: 290 DQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 323
              SPE  S ++  ++K+P+QRL      A+E+M H F 
Sbjct: 233 --LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 135/255 (52%), Gaps = 23/255 (9%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAIS 135
           LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++     +F ++  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY +GG L   L + +   EE       +++  L YLH  + +++RD+K  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDK 140
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KITDFG+     S       F GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 256 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL- 312
           G+ P+   + +      +E  LME I  + P +      SPE  S ++  ++K+P+QRL 
Sbjct: 201 GRLPFYNQDHE----RLFELILMEEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLG 249
Query: 313 ----SAQELMTHPFL 323
                A+E+M H F 
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 135/255 (52%), Gaps = 23/255 (9%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAIS 135
           LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++     +F ++  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY +GG L   L + +   EE       +++  L YLH  + +++RD+K  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDK 140
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KITDFG+     S       F GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 256 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL- 312
           G+ P+   + +      +E  LME I  + P +      SPE  S ++  ++K+P+QRL 
Sbjct: 201 GRLPFYNQDHE----RLFELILMEEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLG 249
Query: 313 ----SAQELMTHPFL 323
                A+E+M H F 
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 135/255 (52%), Gaps = 23/255 (9%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAIS 135
           LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++     +F ++  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY +GG L   L + +   EE       +++  L YLH  + +++RD+K  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDK 140
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KITDFG+     S       F GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 256 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL- 312
           G+ P+   + +      +E  LME I  + P +      SPE  S ++  ++K+P+QRL 
Sbjct: 201 GRLPFYNQDHE----RLFELILMEEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLG 249
Query: 313 ----SAQELMTHPFL 323
                A+E+M H F 
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 142/290 (48%), Gaps = 27/290 (9%)
Query: 58  LNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQ 114
           L L+D D              LV+ K T + +A++V++   +N +E       ++    Q
Sbjct: 49  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 174
           +S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L Y
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           LH E+ II+RDLK  N+L++  G +K+TD+G+           +TF GT NY++PE + G
Sbjct: 169 LH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 235 GKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSAP 288
             YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P     
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 283
Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQ------ELMTHPFLKMYGDLNVD 332
               S +  S + + + K+P++RL         ++  HPF +     NVD
Sbjct: 284 --SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR-----NVD 326

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 138/282 (48%), Gaps = 22/282 (7%)
Query: 58  LNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQ 114
           L L+D D              LV+ K T + +A+KV++   +N +E       ++    Q
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 174
           +S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L Y
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           LH E+ II+RDLK  N+L++  G +K+TD+G+           + F GT NY++PE + G
Sbjct: 126 LH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 235 GKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSAP 288
             YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P     
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 240
Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQ------ELMTHPFLK 324
               S +  S + + + K+P++RL         ++  HPF +
Sbjct: 241 --SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 138/282 (48%), Gaps = 22/282 (7%)
Query: 58  LNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQ 114
           L L+D D              LV+ K T + +A+KV++   +N +E       ++    Q
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 174
           +S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L Y
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           LH E+ II+RDLK  N+L++  G +K+TD+G+           + F GT NY++PE + G
Sbjct: 122 LH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 235 GKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSAP 288
             YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P     
Sbjct: 181 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 236
Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQ------ELMTHPFLK 324
               S +  S + + + K+P++RL         ++  HPF +
Sbjct: 237 --SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 276

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 124/234 (52%), Gaps = 29/234 (12%)
Query: 106 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP----EEYL 161
           + +E+ +++  +   +V    SF  NG I I +E + GGSL+  L+  K  P    E+ +
Sbjct: 66  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTI 124
Query: 162 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTF 220
               +Q+L+GL YL H+  I+HRD+K  N+LIN + G +KI+DFG S  +A  +    TF
Sbjct: 125 GFYTKQILEGLKYL-HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 183
Query: 221 VGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 278
            GT  YM+PE I  G   YG  +DIWSLG  ++E ATG+    PP        FYEL E 
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PP--------FYELGEP 231
Query: 279 IVD-------QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 325
                     +  P  P +  S E  +FI  C + +P +R  A +L+   FLK+
Sbjct: 232 QAAMFKVGMFKVHPEIP-ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 141/290 (48%), Gaps = 27/290 (9%)
Query: 58  LNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQ 114
           L L+D D              LV+ K T + +A+KV++   +N +E       ++    Q
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 174
           +S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L Y
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           LH E+ II+RDLK  N+L++  G +K+TD+G+           + F GT NY++PE + G
Sbjct: 137 LH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 235 GKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSAP 288
             YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P     
Sbjct: 196 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 251
Query: 289 SDQFSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMYGDLNVD 332
               S +  S + + + K+P++RL         ++  HPF +     NVD
Sbjct: 252 --SMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFR-----NVD 294

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/233 (36%), Positives = 123/233 (52%), Gaps = 29/233 (12%)
Query: 106 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP----EEYL 161
           + +E+ +++  +   +V    SF  NG I I +E + GGSL+  L+  K  P    E+ +
Sbjct: 52  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTI 110
Query: 162 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTF 220
               +Q+L+GL YL H+  I+HRD+K  N+LIN + G +KI+DFG S  +A  +    TF
Sbjct: 111 GFYTKQILEGLKYL-HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 169
Query: 221 VGTYNYMSPERISGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 278
            GT  YM+PE I  G  GY   +DIWSLG  ++E ATG+    PP        FYEL E 
Sbjct: 170 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PP--------FYELGEP 217
Query: 279 IVD-------QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                     +  P  P +  S E  +FI  C + +P +R  A +L+   FLK
Sbjct: 218 QAAMFKVGMFKVHPEIP-ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 22/247 (8%)
Query: 85  TGQFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           +G  +A+KV++   + V +  R ++ ++  I      P+VV  + +F + G + +IL+++
Sbjct: 55  SGHLYAMKVLKKATLKVRDRVRTKMERD--ILADVNHPFVVKLHYAFQTEGKLYLILDFL 112
Query: 142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
            GG L   L K     EE +     ++  GL +LH    II+RDLKP N+L++  G +K+
Sbjct: 113 RGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH-SLGIIYRDLKPENILLDEEGHIKL 171
Query: 202 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS 261
           TDFG+S        +A +F GT  YM+PE ++   + + +D WS G+++ E  TG  P+ 
Sbjct: 172 TDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQ 231
Query: 262 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRL-----SAQ 315
             ++++  T    +++A +  P       QF S E  S + A  ++ P  RL      A+
Sbjct: 232 GKDRKETMTL---ILKAKLGMP-------QFLSTEAQSLLRALFKRNPANRLGSGPDGAE 281
Query: 316 ELMTHPF 322
           E+  H F
Sbjct: 282 EIKRHVF 288

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 131/279 (46%), Gaps = 26/279 (9%)
Query: 54  SDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESA--RRQIAQELK 111
           S  Q  LED D              L + + +    ALKV+     E A    Q+ +E++
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVE 64
Query: 112 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 171
           I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S + +T  GT +Y+ PE 
Sbjct: 125 LSYCH-SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEM 181
Query: 232 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 291
           I G  +  K D+WSLG++  E   G     PP +   +   Y  +  +           +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGM----PPFEAHTYQETYRRISRV-----------E 226
Query: 292 FS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFLK 324
           F+ P+F +      IS  ++    QRL+  E++ HP++K
Sbjct: 227 FTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 26/279 (9%)
Query: 54  SDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESA--RRQIAQELK 111
           S  Q  LED D              L + + +    ALKV+     E A    Q+ +E++
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVE 64
Query: 112 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 171
           I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE 
Sbjct: 125 LSYCH-SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 181
Query: 232 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 291
           I G  +  K D+WSLG++  E   G     PP +   +   Y  +  +           +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGM----PPFEAHTYQETYRRISRV-----------E 226
Query: 292 FS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFLK 324
           F+ P+F +      IS  ++    QRL+  E++ HP++K
Sbjct: 227 FTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 128/246 (52%), Gaps = 22/246 (8%)
Query: 87  QFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           Q +A+KV++   + V +  R ++ +++ +  +   P++V  + +F + G + +IL+++ G
Sbjct: 53  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNH--PFIVKLHYAFQTEGKLYLILDFLRG 110
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           G L   L K     EE +     ++   L +LH    II+RDLKP N+L++  G +K+TD
Sbjct: 111 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTD 169
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 263
           FG+S        +A +F GT  YM+PE ++   +   +D WS G+++ E  TG  P+   
Sbjct: 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRLSA-----QEL 317
           ++++  T    +++A +  P       QF SPE  S +    ++ P  RL A     +E+
Sbjct: 230 DRKETMTM---ILKAKLGMP-------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279
Query: 318 MTHPFL 323
             H F 
Sbjct: 280 KRHSFF 285

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 128/246 (52%), Gaps = 22/246 (8%)
Query: 87  QFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           Q +A+KV++   + V +  R ++ +++ +  +   P++V  + +F + G + +IL+++ G
Sbjct: 54  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNH--PFIVKLHYAFQTEGKLYLILDFLRG 111
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           G L   L K     EE +     ++   L +LH    II+RDLKP N+L++  G +K+TD
Sbjct: 112 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTD 170
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 263
           FG+S        +A +F GT  YM+PE ++   +   +D WS G+++ E  TG  P+   
Sbjct: 171 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 230
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRLSA-----QEL 317
           ++++  T    +++A +  P       QF SPE  S +    ++ P  RL A     +E+
Sbjct: 231 DRKETMTM---ILKAKLGMP-------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 280
Query: 318 MTHPFL 323
             H F 
Sbjct: 281 KRHSFF 286

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 128/246 (52%), Gaps = 22/246 (8%)
Query: 87  QFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           Q +A+KV++   + V +  R ++ +++ +  +   P++V  + +F + G + +IL+++ G
Sbjct: 53  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNH--PFIVKLHYAFQTEGKLYLILDFLRG 110
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
           G L   L K     EE +     ++   L +LH    II+RDLKP N+L++  G +K+TD
Sbjct: 111 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTD 169
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 263
           FG+S        +A +F GT  YM+PE ++   +   +D WS G+++ E  TG  P+   
Sbjct: 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRLSA-----QEL 317
           ++++  T    +++A +  P       QF SPE  S +    ++ P  RL A     +E+
Sbjct: 230 DRKETMTM---ILKAKLGMP-------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279
Query: 318 MTHPFL 323
             H F 
Sbjct: 280 KRHSFF 285

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 127/277 (45%), Gaps = 26/277 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKI 112
            +  ++D D              L + K      ALKV+   Q+  +E    Q+ +E++I
Sbjct: 9   RKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEI 67
Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 172
               + P ++  Y  F+    I ++LE+   G L   L+K     E+  A   E++   L
Sbjct: 68  QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 232
            Y H E+ +IHRD+KP NLL+ ++GE+KI DFG S  + + S +     GT +Y+ PE I
Sbjct: 128 HYCH-ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMI 184
Query: 233 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
            G  +  K D+W  G++  E   G  P+  P       S  E    IV+        D  
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-------SHTETHRRIVN-------VDLK 230
Query: 293 SPEFCS-----FISACVQKEPQQRLSAQELMTHPFLK 324
            P F S      IS  ++  P QRL  + +M HP++K
Sbjct: 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 54  SDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELK 111
           S  Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 64
Query: 112 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 171
           I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 124
Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE 
Sbjct: 125 LSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 181
Query: 232 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 291
           I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------E 226
Query: 292 FS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
           F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 127/277 (45%), Gaps = 26/277 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKI 112
            +  ++D D              L + K      ALKV+   Q+  +E    Q+ +E++I
Sbjct: 10  RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEI 68
Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 172
               + P ++  Y  F+    I ++LE+   G L   L+K     E+  A   E++   L
Sbjct: 69  QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 128
Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 232
            Y H E+ +IHRD+KP NLL+ ++GE+KI DFG S  + + S +     GT +Y+ PE I
Sbjct: 129 HYCH-ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMI 185
Query: 233 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
            G  +  K D+W  G++  E   G  P+  P       S  E    IV+        D  
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-------SHTETHRRIVN-------VDLK 231
Query: 293 SPEFCS-----FISACVQKEPQQRLSAQELMTHPFLK 324
            P F S      IS  ++  P QRL  + +M HP++K
Sbjct: 232 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 268

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 8   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE I 
Sbjct: 128 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEXIE 184
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 185 GRXHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 229
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 129/261 (49%), Gaps = 19/261 (7%)
Query: 79  LVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +VQ   T + +A+K +  Q  VE +  R + +EL+I Q  + P++V  + SF     + +
Sbjct: 33  IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAA-ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +++ + GG L   L++     EE +   ICE V+  L YL +++ IIHRD+KP N+L++ 
Sbjct: 93  VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM-ALDYLQNQR-IIHRDMKPDNILLDE 150
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLE 252
            G V ITDF ++A++   + Q  T  GT  YM+PE  S   G  Y +  D WSLG+   E
Sbjct: 151 HGHVHITDFNIAAMLPRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209
Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 312
              G+ PY            +     +V  P        +S E  S +   ++  P QR 
Sbjct: 210 LLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA------WSQEMVSLLKKLLEPNPDQRF 263
Query: 313 SA-QELMTHPFLKMYGDLNVD 332
           S   ++   P++    D+N D
Sbjct: 264 SQLSDVQNFPYM---NDINWD 281

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 135/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 4   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S + +T  GT +Y+ PE I 
Sbjct: 124 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIE 180
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 225
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 136/281 (48%), Gaps = 26/281 (9%)
Query: 51  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 108
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 168
           E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
              L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ 
Sbjct: 121 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLP 177
Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 224
Query: 289 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 2   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 61
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE I 
Sbjct: 122 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 178
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 179 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 223
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 224 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE I 
Sbjct: 123 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 179
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 224
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 26/281 (9%)
Query: 51  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 108
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 168
           E++I    + P ++  Y  F+    + +ILEY   G +   L+K+    E+  A    ++
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
              L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ 
Sbjct: 123 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLP 179
Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 226
Query: 289 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 29  RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 88
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE I 
Sbjct: 149 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 205
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 250
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 251 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 136/281 (48%), Gaps = 26/281 (9%)
Query: 51  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 108
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 168
           E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
              L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ 
Sbjct: 121 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLP 177
Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 224
Query: 289 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 136/281 (48%), Gaps = 26/281 (9%)
Query: 51  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 108
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 168
           E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
              L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ 
Sbjct: 123 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLP 179
Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 226
Query: 289 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 54  SDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELK 111
           +  Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 112 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 171
           I    + P ++  Y  F+ +  + +ILEY   G++   L+K+    E+  A    ++   
Sbjct: 61  IQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           L Y H +K +IHRD+KP NLL+   GE+KI DFG S + A +S +A    GT +Y+ PE 
Sbjct: 121 LSYCHSKK-VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRA-ALCGTLDYLPPEM 177
Query: 232 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 291
           I G  +  K D+WSLG++  E   G+ P+     QD +     +               +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV---------------E 222
Query: 292 FS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
           F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 223 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 20  RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 79
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE I 
Sbjct: 140 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 196
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 197 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 241
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 242 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 133/275 (48%), Gaps = 26/275 (9%)
Query: 57  QLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKINQ 114
           Q  LED +              L + K      ALKV+ +  +E++    Q+ +E++I  
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 174
             + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L Y
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 120
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
            H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE I G
Sbjct: 121 CH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 177
Query: 235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS- 293
             +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+ 
Sbjct: 178 RMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFTF 222
Query: 294 PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
           P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 223 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 85  TGQFFALKVIQ-----MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           TG+ FA+KV++      N +++A  +   E  I +  + P++V    +F + G + +ILE
Sbjct: 44  TGKIFAMKVLKKAMIVRNAKDTAHTK--AERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           Y+ GG L   L++     E+       ++   L +LH +K II+RDLKP N+++NH+G V
Sbjct: 102 YLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH-QKGIIYRDLKPENIMLNHQGHV 160
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+TDFG+           +TF GT  YM+PE +    +    D WSLG ++ +  TG  P
Sbjct: 161 KLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----A 314
           ++   ++    +  ++++  ++ PP        + E    +   +++    RL      A
Sbjct: 221 FTGENRK---KTIDKILKCKLNLPP------YLTQEARDLLKKLLKRNAASRLGAGPGDA 271
Query: 315 QELMTHPFLK 324
            E+  HPF +
Sbjct: 272 GEVQAHPFFR 281

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 6   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S + +   GT +Y+ PE I 
Sbjct: 126 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIE 182
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 227
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 4   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S    + S +  T  GT +Y+ PE I 
Sbjct: 124 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWSC--HAPSSRRTTLSGTLDYLPPEMIE 180
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 225
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 136/278 (48%), Gaps = 26/278 (9%)
Query: 54  SDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELK 111
           +  Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 112 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 171
           I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           L Y H  K +IHRD+KP NLL+   GE+KI DFG S + A +S +A    GT +Y+ PE 
Sbjct: 121 LSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRA-ALCGTLDYLPPEM 177
Query: 232 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 291
           I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------E 222
Query: 292 FS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
           F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 223 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 136/281 (48%), Gaps = 26/281 (9%)
Query: 51  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 108
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 168
           E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
              L Y H  K +IHRD+KP NLL+   GE+KI +FG S  + + S +  T  GT +Y+ 
Sbjct: 121 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLP 177
Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 224
Query: 289 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 29  RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 88
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S + +   GT +Y+ PE I 
Sbjct: 149 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIE 205
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 250
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 251 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 118/222 (53%), Gaps = 17/222 (7%)
Query: 106 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAI 164
           I +E++  Q  + P  +     +       +++EY   GS +D L+   K + E  +AA+
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAV 159
Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 224
               L+GL YLH   ++IHRD+K  N+L++  G VK+ DFG ++IMA     AN FVGT 
Sbjct: 160 THGALQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVGTP 214
Query: 225 NYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 281
            +M+PE I     G+Y  K D+WSLG+  +E A  + P       +  ++ Y     I  
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYH----IAQ 267
Query: 282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
              P+  S  +S  F +F+ +C+QK PQ R +++ L+ H F+
Sbjct: 268 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 118/222 (53%), Gaps = 17/222 (7%)
Query: 106 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAI 164
           I +E++  Q  + P  +     +       +++EY   GS +D L+   K + E  +AA+
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAV 120
Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 224
               L+GL YLH   ++IHRD+K  N+L++  G VK+ DFG ++IMA     AN FVGT 
Sbjct: 121 THGALQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVGTP 175
Query: 225 NYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 281
            +M+PE I     G+Y  K D+WSLG+  +E A  + P       +  ++ Y     I  
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYH----IAQ 228
Query: 282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
              P+  S  +S  F +F+ +C+QK PQ R +++ L+ H F+
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 123 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEMIE 179
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 224
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 135/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 6   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S + A +S +A    GT +Y+ PE I 
Sbjct: 126 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRA-ALCGTLDYLPPEMIE 182
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 227
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 20/251 (7%)
Query: 85  TGQFFALKV-----IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           TG+ +A+K      I+M   E+        L +  +  CP++V    +F++   +S IL+
Sbjct: 213 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
            M+GG L   L +     E  +     +++ GL ++H+ + +++RDLKP+N+L++  G V
Sbjct: 273 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHV 331
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 258
           +I+D G++   +     A+  VGT+ YM+PE +  G  Y   +D +SLG +L +   G  
Sbjct: 332 RISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
Query: 259 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----S 313
           P+   + +D        +   V+ P      D FSPE  S +   +Q++  +RL      
Sbjct: 390 PFRQHKTKDKHEIDRMTLTMAVELP------DSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 314 AQELMTHPFLK 324
           AQE+   PF +
Sbjct: 444 AQEVKESPFFR 454

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 20/251 (7%)
Query: 85  TGQFFALKV-----IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           TG+ +A+K      I+M   E+        L +  +  CP++V    +F++   +S IL+
Sbjct: 213 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
            M+GG L   L +     E  +     +++ GL ++H+ + +++RDLKP+N+L++  G V
Sbjct: 273 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHV 331
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 258
           +I+D G++   +     A+  VGT+ YM+PE +  G  Y   +D +SLG +L +   G  
Sbjct: 332 RISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
Query: 259 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----S 313
           P+   + +D        +   V+ P      D FSPE  S +   +Q++  +RL      
Sbjct: 390 PFRQHKTKDKHEIDRMTLTMAVELP------DSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 314 AQELMTHPFLK 324
           AQE+   PF +
Sbjct: 444 AQEVKESPFFR 454

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 5   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 64
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI +FG S  + + S +  T  GT +Y+ PE I 
Sbjct: 125 YCH-SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 181
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 226
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 123 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEMIE 179
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 224
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 20/251 (7%)
Query: 85  TGQFFALKV-----IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           TG+ +A+K      I+M   E+        L +  +  CP++V    +F++   +S IL+
Sbjct: 212 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 271
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
            M+GG L   L +     E  +     +++ GL ++H+ + +++RDLKP+N+L++  G V
Sbjct: 272 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHV 330
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 258
           +I+D G++   +     A+  VGT+ YM+PE +  G  Y   +D +SLG +L +   G  
Sbjct: 331 RISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 388
Query: 259 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----S 313
           P+   + +D        +   V+ P      D FSPE  S +   +Q++  +RL      
Sbjct: 389 PFRQHKTKDKHEIDRMTLTMAVELP------DSFSPELRSLLEGLLQRDVNRRLGCLGRG 442
Query: 314 AQELMTHPFLK 324
           AQE+   PF +
Sbjct: 443 AQEVKESPFFR 453

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 128/251 (50%), Gaps = 22/251 (8%)
Query: 81  QHKWTGQFFALKVIQ------MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI 134
           +H+ TG   A+K++       ++V    RR+I Q LK+ +    P+++  YQ   +   I
Sbjct: 36  KHELTGHKVAVKILNRQKIRSLDVVGKIRREI-QNLKLFRH---PHIIKLYQVISTPSDI 91
Query: 135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
            +++EY+ GG L D++ K   + E+    + +Q+L G+ Y H    ++HRDLKP N+L++
Sbjct: 92  FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM-VVHRDLKPENVLLD 150
Query: 195 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 253
                KI DFG+S +M+       +  G+ NY +PE ISG  Y G + DIWS G++L   
Sbjct: 151 AHMNAKIADFGLSNMMSDGEFLRXS-CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYAL 209
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
             G  P+   +     T F ++ + I   P         +P   S +   +Q +P +R +
Sbjct: 210 LCGTLPF---DDDHVPTLFKKICDGIFYTP------QYLNPSVISLLKHMLQVDPMKRAT 260
Query: 314 AQELMTHPFLK 324
            +++  H + K
Sbjct: 261 IKDIREHEWFK 271

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 8   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 128 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIE 184
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 229
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 123 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIE 179
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 224
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 20/251 (7%)
Query: 85  TGQFFALKV-----IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           TG+ +A+K      I+M   E+        L +  +  CP++V    +F++   +S IL+
Sbjct: 213 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
            M+GG L   L +     E  +     +++ GL ++H+ + +++RDLKP+N+L++  G V
Sbjct: 273 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHV 331
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 258
           +I+D G++   +     A+  VGT+ YM+PE +  G  Y   +D +SLG +L +   G  
Sbjct: 332 RISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
Query: 259 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----S 313
           P+   + +D        +   V+ P      D FSPE  S +   +Q++  +RL      
Sbjct: 390 PFRQHKTKDKHEIDRMTLTMAVELP------DSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 314 AQELMTHPFLK 324
           AQE+   PF +
Sbjct: 444 AQEVKESPFFR 454

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 123 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIE 179
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 224
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 132/264 (50%), Gaps = 23/264 (8%)
Query: 78  QLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           +L  H  T Q  ALK I  Q+  +     ++ +E+   +  + P+++  Y    +   I 
Sbjct: 26  KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +++EY  GG L D++ + K + E+      +Q++  + Y H  K I+HRDLKP NLL++ 
Sbjct: 86  MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK-IVHRDLKPENLLLDD 143
Query: 196 RGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 253
              VKI DFG+S IM  T G    T  G+ NY +PE I+G  Y G + D+WS G+VL   
Sbjct: 144 NLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVM 201
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
             G+ P+      +   + ++ + + V   P     D  SP   S I   +  +P QR++
Sbjct: 202 LVGRLPFD----DEFIPNLFKKVNSCVYVMP-----DFLSPGAQSLIRRMIVADPMQRIT 252
Query: 314 AQELMTHPFLKMYGDLNVDLSEYF 337
            QE+   P+       NV+L +Y 
Sbjct: 253 IQEIRRDPW------FNVNLPDYL 270

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 123 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIE 179
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 224
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 135/281 (48%), Gaps = 26/281 (9%)
Query: 51  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 108
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 168
           E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
              L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ 
Sbjct: 121 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLP 177
Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 224
Query: 289 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 4   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 124 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIE 180
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 225
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 134/281 (47%), Gaps = 26/281 (9%)
Query: 51  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 108
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 168
           E++I    + P ++  Y  F+    + +ILEY   G +   L+K+    E+  A    ++
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
              L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ 
Sbjct: 123 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLP 179
Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 226
Query: 289 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 113
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 5   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 64
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 125 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIE 181
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 226
Query: 294 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 323
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 125/250 (50%), Gaps = 22/250 (8%)
Query: 85  TGQFFALKVIQ-----MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           TG+ FA+KV++      N +++A  +   E  I +  + P++V    +F + G + +ILE
Sbjct: 44  TGKIFAMKVLKKAMIVRNAKDTAHTK--AERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           Y+ GG L   L++     E+       ++   L +LH +K II+RDLKP N+++NH+G V
Sbjct: 102 YLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH-QKGIIYRDLKPENIMLNHQGHV 160
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+TDFG+           + F GT  YM+PE +    +    D WSLG ++ +  TG  P
Sbjct: 161 KLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----A 314
           ++   ++    +  ++++  ++ PP        + E    +   +++    RL      A
Sbjct: 221 FTGENRK---KTIDKILKCKLNLPP------YLTQEARDLLKKLLKRNAASRLGAGPGDA 271
Query: 315 QELMTHPFLK 324
            E+  HPF +
Sbjct: 272 GEVQAHPFFR 281

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 30  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 90  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 148
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 208 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 254
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 255 LVKDPKKRMTIQDSLQHPWIK 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 12/275 (4%)
Query: 57  QLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQ 114
           Q+  ED D             QLV+HK + + +A+K++     ++ S      +E  I  
Sbjct: 71  QMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 174
            +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +V+  L  
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDA 189
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERIS 233
           +H    +IHRD+KP N+L++  G +K+ DFG    M  T     +T VGT +Y+SPE + 
Sbjct: 190 IH-SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLK 248
Query: 234 G----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 289
                G YG + D WS+G+ L E   G  P+        ++   +   ++   P  +  S
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLC-FPEDAEIS 307
Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                  C+F++   ++    R   +E+  HPF K
Sbjct: 308 KHAKNLICAFLTD--REVRLGRNGVEEIKQHPFFK 340

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 30  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 90  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 148
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 208 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 254
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 255 LVKDPKKRMTIQDSLQHPWIK 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPAFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 54  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 173
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G   T  GT  Y++PE
Sbjct: 174 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGATWTLCGTPEYLAPE 229
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 129/272 (47%), Gaps = 14/272 (5%)
Query: 57  QLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKIN 113
           +L +ED +              L + K T QFFA+K ++ +V   ++     + ++  ++
Sbjct: 14  KLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 73
Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
            + + P++   + +F +   +  ++EY++GG L   ++               +++ GL 
Sbjct: 74  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           +LH  K I++RDLK  N+L++  G +KI DFG+         + N F GT +Y++PE + 
Sbjct: 134 FLH-SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILL 192
Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G KY +  D WS G++L E   GQ P+   ++++ + S        +    P  P     
Sbjct: 193 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS--------IRMDNPFYPR-WLE 243
Query: 294 PEFCSFISACVQKEPQQRLSAQ-ELMTHPFLK 324
            E    +     +EP++RL  + ++  HP  +
Sbjct: 244 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 275

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 131/257 (50%), Gaps = 28/257 (10%)
Query: 85  TGQFFALKVIQ-------MNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           TG+ +A+KV++           E  R  RQ+ + ++     Q P++V  + +F +   + 
Sbjct: 81  TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLHYAFQTETKLH 135
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +IL+Y++GG L   L + +   E  +     +++  L +LH +  II+RD+K  N+L++ 
Sbjct: 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILLDS 194
Query: 196 RGEVKITDFGVSA-IMASTSGQANTFVGTYNYMSPERISGGKYGYKS--DIWSLGLVLLE 252
            G V +TDFG+S   +A  + +A  F GT  YM+P+ + GG  G+    D WSLG+++ E
Sbjct: 195 NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 312
             TG  P++   +++   S  E+   I+   PP     + S      I   + K+P++RL
Sbjct: 255 LLTGASPFTVDGEKN---SQAEISRRILKSEPPY--PQEMSALAKDLIQRLLMKDPKKRL 309
Query: 313 S-----AQELMTHPFLK 324
                 A E+  H F +
Sbjct: 310 GCGPRDADEIKEHLFFQ 326

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 135/268 (50%), Gaps = 32/268 (11%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG+ +A K I+     S+RR     +I +E+ I +  + P ++  +  F +   + 
Sbjct: 25  RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ E+      +Q+L G+ YL H K I H DLKP N+++  
Sbjct: 85  LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL-HSKRIAHFDLKPENIMLLD 143
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           +      +K+ DFG++  + + +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 144 KNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 202
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+  T+              SA +  F  E+ S        FI   
Sbjct: 203 ILLSGASPFLGETKQETLTNI-------------SAVNYDFDEEYFSNTSELAKDFIRRL 249
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGDLNV 331
           + K+P++R++  + + H ++K     NV
Sbjct: 250 LVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+HK TG  FA+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+HK TG  FA+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+HK TG  FA+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 114/242 (47%), Gaps = 13/242 (5%)
Query: 85  TGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           TG   A+K+I       A   +++  E+KI+   + P ++  Y  F  +  + ++LE   
Sbjct: 35  TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH 94
Query: 143 GGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
            G +  +LK +VK   E        Q++ G+LYLH    I+HRDL  SNLL+     +KI
Sbjct: 95  NGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-ILHRDLTLSNLLLTRNMNIKI 153
Query: 202 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS 261
            DFG++  +     +  T  GT NY+SPE  +   +G +SD+WSLG +      G+ P+ 
Sbjct: 154 ADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213
Query: 262 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 321
               ++           + D   PS      S E    I   +++ P  RLS   ++ HP
Sbjct: 214 TDTVKNTLNKV-----VLADYEMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264
Query: 322 FL 323
           F+
Sbjct: 265 FM 266

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 123/250 (49%), Gaps = 14/250 (5%)
Query: 79  LVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           L + K T QFFA+K ++ +V   ++     + ++  ++ + + P++   + +F +   + 
Sbjct: 35  LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY++GG L   ++               +++ GL +LH  K I++RDLK  N+L++ 
Sbjct: 95  FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDK 153
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KI DFG+         + N F GT +Y++PE + G KY +  D WS G++L E   
Sbjct: 154 DGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213
Query: 256 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 315
           GQ P+   ++++ + S        +    P  P      E    +     +EP++RL  +
Sbjct: 214 GQSPFHGQDEEELFHS--------IRMDNPFYPR-WLEKEAKDLLVKLFVREPEKRLGVR 264
Query: 316 -ELMTHPFLK 324
            ++  HP  +
Sbjct: 265 GDIRQHPLFR 274

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 129/257 (50%), Gaps = 19/257 (7%)
Query: 78  QLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCYQSF--YSNGAI 134
           Q ++ K  G+    K +   ++ E+ ++ +  E+ + +  + P +V  Y      +N  +
Sbjct: 23  QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 135 SIILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLHHEKH----IIHRDL 186
            I++EY +GG LA  +    K+ + + EE++  +  Q+   L   H        ++HRDL
Sbjct: 83  YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 187 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 246
           KP+N+ ++ +  VK+ DFG++ I+   +  A TFVGT  YMSPE+++   Y  KSDIWSL
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G +L E      P++   Q+       EL   I +      P  ++S E    I+  +  
Sbjct: 203 GCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRIPY-RYSDELNEIITRMLNL 254
Query: 307 EPQQRLSAQELMTHPFL 323
           +   R S +E++ +P +
Sbjct: 255 KDYHRPSVEEILENPLI 271

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLAGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 34/277 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           +K TG + ALK ++++ EE       +E+ + +  +   +V  Y   ++   ++++ E+M
Sbjct: 26  NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85
Query: 142 DGGSLADFL--KKVKTIPEEYLAAICE----QVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           D   L  ++  + V   P      + +    Q+L+GL + H  K I+HRDLKP NLLIN 
Sbjct: 86  DN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-ILHRDLKPQNLLINK 143
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECA 254
           RG++K+ DFG++          ++ V T  Y +P+ + G + Y    DIWS G +L E  
Sbjct: 144 RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 255 TGQ--FPYSPPEQQ-------------DGWTSFYEL--MEAIVDQPPPSAPSDQFSPE-- 295
           TG+  FP +  E+Q               W S  +L      + Q PP        P   
Sbjct: 204 TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTK 263
Query: 296 ------FCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
                    F+   +Q  P  RLSA++ + HP+   Y
Sbjct: 264 EPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 6/214 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 264
            I    Y    D W+LG+++ E A G  P+   E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADE 242

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 78/248 (31%), Positives = 125/248 (50%), Gaps = 14/248 (5%)
Query: 79  LVQHKWTGQFFALKVI-QMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L + K +    ALKV+ +  +E E    Q+ +E++I      P ++  Y  FY    I +
Sbjct: 41  LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYL 100
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ILEY   G L   L+K  T  E+  A I E++   L+Y H +K +IHRD+KP NLL+  +
Sbjct: 101 ILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK-VIHRDIKPENLLLGLK 159
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
           GE+KI DFG S  + + S +  T  GT +Y+ PE I G  +  K D+W +G++  E   G
Sbjct: 160 GELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
               +PP +       Y  +  +  + P S P+          IS  ++  P +RL   +
Sbjct: 218 ----NPPFESASHNETYRRIVKVDLKFPASVPTGA-----QDLISKLLRHNPSERLPLAQ 268
Query: 317 LMTHPFLK 324
           +  HP+++
Sbjct: 269 VSAHPWVR 276

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 134/268 (50%), Gaps = 32/268 (11%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG+ +A K I+     S+RR     +I +E+ I +  + P ++  +  F +   + 
Sbjct: 46  RQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 105
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ E+      +Q+L G+ YL H K I H DLKP N+++  
Sbjct: 106 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL-HSKRIAHFDLKPENIMLLD 164
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           +      +K+ DFG++  + + +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 165 KNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 223
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+  T+              SA +  F  E+ S        FI   
Sbjct: 224 ILLSGASPFLGETKQETLTNI-------------SAVNYDFDEEYFSNTSELAKDFIRRL 270
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGDLNV 331
           + K+P++R+   + + H ++K     NV
Sbjct: 271 LVKDPKRRMXIAQSLEHSWIKAIRRRNV 298

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 20  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 79
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 80  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 139
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 140 TFEYLH-SLDLIYRDLKPENLLIDEQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 195
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 196 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 110 GLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN+FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLV 228
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 229 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 279
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 280 EEMEGYGPLKAHPFFE 295

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLXGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + ++LEY  GG +   L+++    E +      Q++ 
Sbjct: 94  RIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +K+ DFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 34  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 54  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 173
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 174 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 229
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 28  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 87
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 88  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 147
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 148 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 203
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 204 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 51  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 110
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 111 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 169
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN+FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 170 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 229
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 230 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 280
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 281 EEMEGYGPLKAHPFFE 296

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 47  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 106
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 107 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 165
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN+FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 166 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 225
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 226 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 276
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 277 EEMEGYGPLKAHPFFE 292

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 48  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 108 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 166
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 227 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 277
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 278 EEMEGYGPLKAHPFFE 293

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 48  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 108 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 166
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 227 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 277
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 278 EEMEGYGPLKAHPFFE 293

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           +L  H  TGQ  ALK+I   V   +  Q  I +E+   +  + P+++  Y    S   I 
Sbjct: 25  KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 84
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +++EY  G  L D++ +   + E+      +Q++  + Y H  K I+HRDLKP NLL++ 
Sbjct: 85  MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDE 142
Query: 196 RGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 253
              VKI DFG+S IM  T G    T  G+ NY +PE ISG  Y G + D+WS G++L   
Sbjct: 143 HLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 200
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
              + P+   + +     F  +   +   P         SP     I   +   P  R+S
Sbjct: 201 LCRRLPF---DDESIPVLFKNISNGVYTLP------KFLSPGAAGLIKRMLIVNPLNRIS 251
Query: 314 AQELMTHPFLKMYGDLNVDLSEYF 337
             E+M   + K      VDL EY 
Sbjct: 252 IHEIMQDDWFK------VDLPEYL 269

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 28  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 87
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 88  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 146
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 147 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 206
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 207 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 257
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 258 EEMEGYGPLKAHPFFE 273

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 229 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 279
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 280 EEMEGYGPLKAHPFFE 295

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 145
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 146 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 201
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 124/266 (46%), Gaps = 23/266 (8%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           +L  H  TGQ  ALK+I   V   +  Q  I +E+   +  + P+++  Y    S   I 
Sbjct: 31  KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +++EY  G  L D++ +   + E+      +Q++  + Y H  K I+HRDLKP NLL++ 
Sbjct: 91  MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDE 148
Query: 196 RGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 253
              VKI DFG+S IM  T G    T  G+ NY +PE ISG  Y G + D+WS G++L   
Sbjct: 149 HLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 206
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
              + P+   + +     F  +   +   P         SP     I   +   P  R+S
Sbjct: 207 LCRRLPF---DDESIPVLFKNISNGVYTLP------KFLSPGAAGLIKRMLIVNPLNRIS 257
Query: 314 AQELMTHPFLKMYGDLNVDLSEYFTD 339
             E+M   + K      VDL EY  +
Sbjct: 258 IHEIMQDDWFK------VDLPEYLLE 277

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 25  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 84
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 85  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 143
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 144 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 203
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 204 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 254
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 255 EEMEGYGPLKAHPFFE 270

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 48  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 108 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 166
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 227 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 277
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 278 EEMEGYGPLKAHPFFE 293

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 229 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 279
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 280 EEMEGYGPLKAHPFFE 295

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 26  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 86  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 144
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 145 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 205 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 255
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 256 EEMEGYGPLKAHPFFE 271

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 48  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 108 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 166
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 227 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 277
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 278 EEMEGYGPLKAHPFFE 293

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           +L  H  TGQ  ALK+I   V   +  Q  I +E+   +  + P+++  Y    S   I 
Sbjct: 21  KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 80
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +++EY  G  L D++ +   + E+      +Q++  + Y H  K I+HRDLKP NLL++ 
Sbjct: 81  MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDE 138
Query: 196 RGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 253
              VKI DFG+S IM  T G    T  G+ NY +PE ISG  Y G + D+WS G++L   
Sbjct: 139 HLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 196
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
              + P+   + +     F  +   +   P         SP     I   +   P  R+S
Sbjct: 197 LCRRLPF---DDESIPVLFKNISNGVYTLP------KFLSPGAAGLIKRMLIVNPLNRIS 247
Query: 314 AQELMTHPFLKMYGDLNVDLSEYF 337
             E+M   + K      VDL EY 
Sbjct: 248 IHEIMQDDWFK------VDLPEYL 265

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 124/254 (48%), Gaps = 20/254 (7%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
            L++ +  G+++A+KV++  +    ++      E  +      P+++  + +F     I 
Sbjct: 23  HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +I++Y++GG L   L+K +  P         +V   L YLH  K II+RDLKP N+L++ 
Sbjct: 83  MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH-SKDIIYRDLKPENILLDK 141
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KITDFG +  +   +       GT +Y++PE +S   Y    D WS G+++ E   
Sbjct: 142 NGHIKITDFGFAKYVPDVT---YXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
Query: 256 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL--- 312
           G   Y+P    +   ++ +++ A +  PP       F+ +    +S  + ++  QRL   
Sbjct: 199 G---YTPFYDSNTMKTYEKILNAELRFPP------FFNEDVKDLLSRLITRDLSQRLGNL 249
Query: 313 --SAQELMTHPFLK 324
               +++  HP+ K
Sbjct: 250 QNGTEDVKNHPWFK 263

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           +L  H  TGQ  ALK+I   V   +  Q  I +E+   +  + P+++  Y    S   I 
Sbjct: 30  KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +++EY  G  L D++ +   + E+      +Q++  + Y H  K I+HRDLKP NLL++ 
Sbjct: 90  MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDE 147
Query: 196 RGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 253
              VKI DFG+S IM  T G    T  G+ NY +PE ISG  Y G + D+WS G++L   
Sbjct: 148 HLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 205
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
              + P+   + +     F  +   +   P         SP     I   +   P  R+S
Sbjct: 206 LCRRLPF---DDESIPVLFKNISNGVYTLP------KFLSPGAAGLIKRMLIVNPLNRIS 256
Query: 314 AQELMTHPFLKMYGDLNVDLSEYF 337
             E+M   + K      VDL EY 
Sbjct: 257 IHEIMQDDWFK------VDLPEYL 274

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NL+I+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLIIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 132/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG+ +A K I+     S+RR     +I +E+ I +  + P ++  +  F +   + 
Sbjct: 32  RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 91
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ E+      +Q+L G+ YL H K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL-HSKRIAHFDLKPENIMLLD 150
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           +      +K+ DFG++  + + +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+  T+              SA +  F  E+ S        FI   
Sbjct: 210 ILLSGASPFLGETKQETLTNI-------------SAVNYDFDEEYFSNTSELAKDFIRRL 256
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R+   + + H ++K
Sbjct: 257 LVKDPKRRMXIAQSLEHSWIK 277

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 145
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 146 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 201
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 27  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 86
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 87  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 145
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 146 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 205
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 206 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 256
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 257 EEMEGYGPLKAHPFFE 272

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 54  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 173
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 174 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 229
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 51  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 110
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 111 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 169
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 170 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 229
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 230 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 280
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 281 EEMEGYGPLKAHPFFE 296

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 229 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 279
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 280 EEMEGYGPLKAHPFFE 295

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 126/255 (49%), Gaps = 18/255 (7%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII 137
            LV+ + +G    +K I  +  +    QI  E+++ +S   P ++  ++ F     + I+
Sbjct: 39  HLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98
Query: 138 LEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           +E  +GG L + +     + K + E Y+A + +Q++  L Y H  +H++H+DLKP N+L 
Sbjct: 99  METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-SQHVVHKDLKPENILF 157
Query: 194 NH---RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 250
                   +KI DFG++ +  S     N   GT  YM+PE +      +K DIWS G+V+
Sbjct: 158 QDTSPHSPIKIIDFGLAELFKSDEHSTNA-AGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
Query: 251 LECATGQFPYSPPEQQDGWTSFYELME-AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
               TG  P++        TS  E+ + A   +P  +      +P+    +   + K+P+
Sbjct: 216 YFLLTGCLPFT-------GTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPE 268
Query: 310 QRLSAQELMTHPFLK 324
           +R SA +++ H + K
Sbjct: 269 RRPSAAQVLHHEWFK 283

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 19  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 78
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 79  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 138
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+  T  GT  Y++PE
Sbjct: 139 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEYLAPE 194
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 195 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 47  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 106
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 107 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 165
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 166 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 225
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 226 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 276
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 277 EEMEGYGPLKAHPFFE 292

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 32  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 91
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 92  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 150
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 151 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 210
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 211 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 261
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 262 EEMEGYGPLKAHPFFE 277

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 132/261 (50%), Gaps = 32/261 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +I E + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 304 VQKEPQQRLSAQELMTHPFLK 324
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 128/257 (49%), Gaps = 19/257 (7%)
Query: 78  QLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCYQSF--YSNGAI 134
           Q ++ K  G+    K +   ++ E+ ++ +  E+ + +  + P +V  Y      +N  +
Sbjct: 23  QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 135 SIILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLHHEKH----IIHRDL 186
            I++EY +GG LA  +    K+ + + EE++  +  Q+   L   H        ++HRDL
Sbjct: 83  YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 187 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 246
           KP+N+ ++ +  VK+ DFG++ I+   +  A  FVGT  YMSPE+++   Y  KSDIWSL
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G +L E      P++   Q+       EL   I +      P  ++S E    I+  +  
Sbjct: 203 GCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRIPY-RYSDELNEIITRMLNL 254
Query: 307 EPQQRLSAQELMTHPFL 323
           +   R S +E++ +P +
Sbjct: 255 KDYHRPSVEEILENPLI 271

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 132/284 (46%), Gaps = 25/284 (8%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L + K TG   A+K+I+ +     S    +  E+ + +    P ++  Y+ F       +
Sbjct: 22  LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYL 81
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++E   GG L D +   +   E   A I +QVL G  YL H+ +I+HRDLKP NLL+  +
Sbjct: 82  VMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL-HKHNIVHRDLKPENLLLESK 140
Query: 197 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+SA      G+    +GT  Y++PE +   KY  K D+WS G++L   
Sbjct: 141 SRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYIL 198
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQR 311
             G  P+     Q       E+++ +        P D  Q S E    +   +  EP +R
Sbjct: 199 LCGYPPFGGQTDQ-------EILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKR 251
Query: 312 LSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLAT--LSNLSGF 353
           +SA+E + HP++  +       S+  TD G    T  L N+  F
Sbjct: 252 ISAEEALNHPWIVKF------CSQKHTDVGKHALTGALGNMKKF 289

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+  T  GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEYLAPE 209
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ + A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 130/260 (50%), Gaps = 32/260 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+     ++RR     +I +E+ I +    P ++  +  + +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE   +  +Q+L G+ YLH +K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           +      +K+ DFG++  +       N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              +A S  F  EF S        FI   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TAVSYDFDEEFFSQTSELAKDFIRKL 256
Query: 304 VQKEPQQRLSAQELMTHPFL 323
           + KE ++RL+ QE + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 133/282 (47%), Gaps = 23/282 (8%)
Query: 54  SDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNV---EESARRQIAQEL 110
           S N+L +++ +              L + K TG  +A+KV++ +V   ++     + ++ 
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
            ++ +   P++   +  F +   +  ++E+++GG L   ++K +   E        +++ 
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
            L++LH +K II+RDLK  N+L++H G  K+ DFG+            TF GT +Y++PE
Sbjct: 136 ALMFLH-DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAP 288
            +    YG   D W++G++L E   G  P+    + D       L EAI++     P+  
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVVYPTWL 247
Query: 289 SDQFSPEFCSFISACVQKEPQQRLSA------QELMTHPFLK 324
            +  +    SF++    K P  RL +        ++ HPF K
Sbjct: 248 HEDATGILKSFMT----KNPTMRLGSLTQGGEHAILRHPFFK 285

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EYM GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +K+ DFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EYM GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +K+ DFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 124/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y  F  +  +  
Sbjct: 55  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYF 114
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 115 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 173
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 174 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 233
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 234 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 284
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 285 EEMEGYGPLKAHPFFE 300

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 118/241 (48%), Gaps = 12/241 (4%)
Query: 85  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T + FA KV+   M ++   + +++ E+ I++S   P+VV  +  F  +  + ++LE   
Sbjct: 66  TKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICR 125
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
             SL +  K+ K + E        Q ++G+ YLH+ + +IHRDLK  NL +N   +VKI 
Sbjct: 126 RRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIG 184
Query: 203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
           DFG++  +     +  T  GT NY++PE +    + ++ DIWSLG +L     G+ P+  
Sbjct: 185 DFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE- 243
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
                  TS  +     + +   S P    +P   + I   +  +P  R S  EL+T  F
Sbjct: 244 -------TSCLKETYIRIKKNEYSVPR-HINPVASALIRRMLHADPTLRPSVAELLTDEF 295
Query: 323 L 323
Sbjct: 296 F 296

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 127/260 (48%), Gaps = 27/260 (10%)
Query: 82  HKWTGQFFALKVIQMNVE-------ESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGA 133
           H+ TG  FA+K++++  E       E  R    +E  I  Q +  P+++    S+ S+  
Sbjct: 115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + ++ + M  G L D+L +   + E+   +I   +L+ + +LH   +I+HRDLKP N+L+
Sbjct: 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH-ANNIVHRDLKPENILL 233
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK------YGYKSDIWSLG 247
           +   +++++DFG S  +     +     GT  Y++PE +          YG + D+W+ G
Sbjct: 234 DDNMQIRLSDFGFSCHL-EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
Query: 248 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPS-DQFSPEFCSFISACV 304
           ++L     G  P+        W     LM  ++   Q   S+P  D  S      IS  +
Sbjct: 293 VILFTLLAGSPPF--------WHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLL 344
Query: 305 QKEPQQRLSAQELMTHPFLK 324
           Q +P+ RL+A++ + HPF +
Sbjct: 345 QVDPEARLTAEQALQHPFFE 364

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 124/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLV 228
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +      F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 229 AGLPPFRAGNEG---LIFAKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 279
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 280 EEMEGYGPLKAHPFFE 295

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 112/223 (50%), Gaps = 14/223 (6%)
Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICE 166
           E +I +     +VV    ++ +  A+ ++L  M+GG L   +  +     PE        
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 226
           ++  GL  LH E+ I++RDLKP N+L++  G ++I+D G+ A+           VGT  Y
Sbjct: 294 EICCGLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTIKGRVGTVGY 351
Query: 227 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 286
           M+PE +   +Y +  D W+LG +L E   GQ P+    QQ       E +E +V + P  
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF----QQRKKKIKREEVERLVKEVPEE 407
Query: 287 APSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
             S++FSP+  S  S  + K+P +RL     SA+E+  HP  K
Sbjct: 408 Y-SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++P 
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPA 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 127/257 (49%), Gaps = 19/257 (7%)
Query: 78  QLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCYQSF--YSNGAI 134
           Q ++ K  G+    K +   ++ E+ ++ +  E+ + +  + P +V  Y      +N  +
Sbjct: 23  QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 135 SIILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLHHEKH----IIHRDL 186
            I++EY +GG LA  +    K+ + + EE++  +  Q+   L   H        ++HRDL
Sbjct: 83  YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 187 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 246
           KP+N+ ++ +  VK+ DFG++ I+      A  FVGT  YMSPE+++   Y  KSDIWSL
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G +L E      P++   Q+       EL   I +      P  ++S E    I+  +  
Sbjct: 203 GCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRIPY-RYSDELNEIITRMLNL 254
Query: 307 EPQQRLSAQELMTHPFL 323
           +   R S +E++ +P +
Sbjct: 255 KDYHRPSVEEILENPLI 271

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 123/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 53  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 112
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 113 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 171
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 172 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 231
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +   +  F ++++   D P        F P+    +   +  +  +RL  
Sbjct: 232 AGLPPFRAGNE---YLIFQKIIKLEYDFPA------AFFPKARDLVEKLLVLDATKRLGC 282
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 283 EEMEGYGPLKAHPFFE 298

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 124/256 (48%), Gaps = 20/256 (7%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 197 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G  P+    +      F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 229 AGLPPFRAGNEG---LIFAKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 279
Query: 315 QE------LMTHPFLK 324
           +E      L  HPF +
Sbjct: 280 EEMEGYGPLKAHPFFE 295

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NL+I+ +G +K+TDFG++       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGLA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH 177
           +VV    ++ +  A+ ++L  M+GG L   +  +     PE        ++  GL  LH 
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 237
           E+ I++RDLKP N+L++  G ++I+D G+ A+           VGT  YM+PE +   +Y
Sbjct: 305 ER-IVYRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362
Query: 238 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 297
            +  D W+LG +L E   GQ P+    QQ       E +E +V + P    S++FSP+  
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSPF----QQRKKKIKREEVERLVKEVPEEY-SERFSPQAR 417
Query: 298 SFISACVQKEPQQRL-----SAQELMTHPFLK 324
           S  S  + K+P +RL     SA+E+  HP  K
Sbjct: 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT   ++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEALAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 104/185 (56%), Gaps = 4/185 (2%)
Query: 78  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +L +H  TG+  A+K+I +  +  ++ +++ +E++I +    P +V  ++   +   + +
Sbjct: 29  KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 88
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           I+EY  GG + D+L     + E+   +   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 89  IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH-QKRIVHRDLKAENLLLDAD 147
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 255
             +KI DFG S    +  G+ +TF G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 148 MNIKIADFGFSNEF-TVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 206
Query: 256 GQFPY 260
           G  P+
Sbjct: 207 GSLPF 211

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 29/271 (10%)
Query: 83  KWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           K T    ALK I++  EE A     +E+ + +  +   +V  +   ++  +++++ EY+D
Sbjct: 24  KLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83
Query: 143 GGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
              L  +L     I   + +     Q+L+GL Y H +K ++HRDLKP NLLIN RGE+K+
Sbjct: 84  K-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK-VLHRDLKPQNLLINERGELKL 141
Query: 202 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--F 258
            DFG++   +  +   +  V T  Y  P+ + G   Y  + D+W +G +  E ATG+  F
Sbjct: 142 ADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201
Query: 259 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ-----------------FSPEFCS--- 298
           P S  E+Q  +   + ++    ++  P   S++                  +P   S   
Sbjct: 202 PGSTVEEQLHF--IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA 259
Query: 299 -FISACVQKEPQQRLSAQELMTHPFLKMYGD 328
             ++  +Q E + R+SA++ M HPF    G+
Sbjct: 260 DLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 117/241 (48%), Gaps = 12/241 (4%)
Query: 85  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T + FA KV+   M ++   + +++ E+ I++S   P+VV  +  F  +  + ++LE   
Sbjct: 50  TKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICR 109
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
             SL +  K+ K + E        Q ++G+ YLH+ + +IHRDLK  NL +N   +VKI 
Sbjct: 110 RRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIG 168
Query: 203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
           DFG++  +     +     GT NY++PE +    + ++ DIWSLG +L     G+ P+  
Sbjct: 169 DFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE- 227
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
                  TS  +     + +   S P    +P   + I   +  +P  R S  EL+T  F
Sbjct: 228 -------TSCLKETYIRIKKNEYSVPR-HINPVASALIRRMLHADPTLRPSVAELLTDEF 279
Query: 323 L 323
Sbjct: 280 F 280

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 153
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 123/248 (49%), Gaps = 9/248 (3%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           HK + Q FA+K+I   +E + +++I   LK+ +    P +V  ++ F+      +++E +
Sbjct: 32  HKKSNQAFAVKIISKRMEANTQKEITA-LKLCEGH--PNIVKLHEVFHDQLHTFLVMELL 88
Query: 142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGE 198
           +GG L + +KK K   E   + I  +++  + ++H +  ++HRDLKP NLL    N   E
Sbjct: 89  NGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH-DVGVVHRDLKPENLLFTDENDNLE 147
Query: 199 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 258
           +KI DFG + +    +    T   T +Y +PE ++   Y    D+WSLG++L    +GQ 
Sbjct: 148 IKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQV 207
Query: 259 PYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           P+   ++    TS  E+M+ I   D           S E    I   +  +P +RL    
Sbjct: 208 PFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSG 267
Query: 317 LMTHPFLK 324
           L  + +L+
Sbjct: 268 LRYNEWLQ 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 129/260 (49%), Gaps = 32/260 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+     ++RR     +I +E+ I +      V+  +  + +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE   +  +Q+L G+ YLH +K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           +      +K+ DFG++  +       N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              +A S  F  EF S        FI   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TAVSYDFDEEFFSQTSELAKDFIRKL 256
Query: 304 VQKEPQQRLSAQELMTHPFL 323
           + KE ++RL+ QE + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 117/241 (48%), Gaps = 12/241 (4%)
Query: 85  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T + FA KV+   M ++   + +++ E+ I++S   P+VV  +  F  +  + ++LE   
Sbjct: 66  TKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICR 125
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
             SL +  K+ K + E        Q ++G+ YLH+ + +IHRDLK  NL +N   +VKI 
Sbjct: 126 RRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIG 184
Query: 203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
           DFG++  +     +     GT NY++PE +    + ++ DIWSLG +L     G+ P+  
Sbjct: 185 DFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE- 243
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
                  TS  +     + +   S P    +P   + I   +  +P  R S  EL+T  F
Sbjct: 244 -------TSCLKETYIRIKKNEYSVPR-HINPVASALIRRMLHADPTLRPSVAELLTDEF 295
Query: 323 L 323
Sbjct: 296 F 296

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 129/260 (49%), Gaps = 32/260 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+     ++RR     +I +E+ I +      V+  +  + +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE   +  +Q+L G+ YLH +K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           +      +K+ DFG++  +       N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              +A S  F  EF S        FI   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TAVSYDFDEEFFSQTSELAKDFIRKL 256
Query: 304 VQKEPQQRLSAQELMTHPFL 323
           + KE ++RL+ QE + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NLLI+ +G +K+ DFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 126/257 (49%), Gaps = 24/257 (9%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC-----PYVVVCYQSFYSNGAISI 136
           ++ TGQ FA+K++ +    S+     ++LK  ++S C     P++V   +++ S+G + +
Sbjct: 45  NRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIVELLETYSSDGMLYM 103
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAIC----EQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + E+MDG  L   + K       Y  A+      Q+L+ L Y H + +IIHRD+KP N+L
Sbjct: 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPENVL 162
Query: 193 INHR---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 249
           +  +     VK+ DFGV+  +  +   A   VGT ++M+PE +    YG   D+W  G++
Sbjct: 163 LASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 250 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKE 307
           L    +G  P+   +++        L E I+       P      S      +   +  +
Sbjct: 223 LFILLSGCLPFYGTKER--------LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLD 274
Query: 308 PQQRLSAQELMTHPFLK 324
           P +R++  E + HP+LK
Sbjct: 275 PAERITVYEALNHPWLK 291

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 117/241 (48%), Gaps = 12/241 (4%)
Query: 85  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T + FA KV+   M ++   + +++ E+ I++S   P+VV  +  F  +  + ++LE   
Sbjct: 66  TKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICR 125
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
             SL +  K+ K + E        Q ++G+ YLH+ + +IHRDLK  NL +N   +VKI 
Sbjct: 126 RRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIG 184
Query: 203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
           DFG++  +     +     GT NY++PE +    + ++ DIWSLG +L     G+ P+  
Sbjct: 185 DFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE- 243
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
                  TS  +     + +   S P    +P   + I   +  +P  R S  EL+T  F
Sbjct: 244 -------TSCLKETYIRIKKNEYSVPR-HINPVASALIRRMLHADPTLRPSVAELLTDEF 295
Query: 323 L 323
Sbjct: 296 F 296

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 55/295 (18%)
Query: 86  GQFFALKVIQMNVEESARR----------------QIAQELKINQSSQCPYVVVCYQSFY 129
            +F+ALK  + ++ E  R                     EL+I    +  Y + C     
Sbjct: 54  NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113
Query: 130 SNGAISIILEYMDGGSLADF------LKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHI 181
           +   + II EYM+  S+  F      L K  T  IP + +  I + VL    Y+H+EK+I
Sbjct: 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI 173
Query: 182 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG--GKYGY 239
            HRD+KPSN+L++  G VK++DFG S  M     + +   GTY +M PE  S      G 
Sbjct: 174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--GTYEFMPPEFFSNESSYNGA 231
Query: 240 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI----VDQP------------ 283
           K DIWSLG+ L        P+S         S  EL   I    ++ P            
Sbjct: 232 KVDIWSLGICLYVMFYNVVPFSLK------ISLVELFNNIRTKNIEYPLDRNHFLYPLTN 285
Query: 284 PPSAPSDQF-SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV-DLSEY 336
             S  S+ F S E   F+   ++K P +R+++++ + H +L    D N+ DL E+
Sbjct: 286 KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL---ADTNIEDLREF 337

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 121/252 (48%), Gaps = 17/252 (6%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L + K TG   A+K+I+ +     S    +  E+ + +    P ++  Y+ F       +
Sbjct: 39  LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYL 98
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++E   GG L D +   +   E   A I +QVL G  YL H+ +I+HRDLKP NLL+  +
Sbjct: 99  VMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL-HKHNIVHRDLKPENLLLESK 157
Query: 197 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+SA      G+    +GT  Y++PE +   KY  K D+WS G++L   
Sbjct: 158 SRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYIL 215
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQR 311
             G  P+     Q       E+++ +        P D  Q S E    +   +  EP +R
Sbjct: 216 LCGYPPFGGQTDQ-------EILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKR 268
Query: 312 LSAQELMTHPFL 323
           +SA+E + HP++
Sbjct: 269 ISAEEALNHPWI 280

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NL+I+ +G +++TDFG++       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLMIDQQGYIQVTDFGLA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 104/186 (55%), Gaps = 4/186 (2%)
Query: 78  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +L +H  TG+  A+K+I +  +  ++ +++ +E++I +    P +V  ++   +   + +
Sbjct: 32  KLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K+I+HRDLK  NLL++  
Sbjct: 92  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKYIVHRDLKAENLLLDGD 150
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 255
             +KI DFG S    +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 151 MNIKIADFGFSNEF-TVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 256 GQFPYS 261
           G  P+ 
Sbjct: 210 GSLPFD 215

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 32/260 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+     ++RR     +I +E+ I +      V+  +  + +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE   +  +Q+L G+ YLH +K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           +      +K+ DFG++  +       N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              ++ S  F  EF S        FI   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TSVSYDFDEEFFSHTSELAKDFIRKL 256
Query: 304 VQKEPQQRLSAQELMTHPFL 323
           + KE ++RL+ QE + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++     SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++     SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NL+I+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLMIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 103/185 (55%), Gaps = 4/185 (2%)
Query: 78  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +L +H  TG+  A+K+I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 255
             +KI DFG S    +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 150 MNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 256 GQFPY 260
           G  P+
Sbjct: 209 GSLPF 213

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 32/260 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+     ++RR     +I +E+ I +      V+  +  + +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE   +  +Q+L G+ YLH +K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           +      +K+ DFG++  +       N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              ++ S  F  EF S        FI   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TSVSYDFDEEFFSHTSELAKDFIRKL 256
Query: 304 VQKEPQQRLSAQELMTHPFL 323
           + KE ++RL+ QE + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 9/216 (4%)
Query: 52  KPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQM--NVEESARRQIAQE 109
           K  D ++  ED +             QLV+HK T + +A+K++     ++ S      +E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 110 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 169
             I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +V+
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVV 183
Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMS 228
             L  +H     IHRD+KP N+L++  G +K+ DFG    M      + +T VGT +Y+S
Sbjct: 184 LALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 242
Query: 229 PERISG----GKYGYKSDIWSLGLVLLECATGQFPY 260
           PE +      G YG + D WS+G+ L E   G  P+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 125/248 (50%), Gaps = 12/248 (4%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQ-ELKINQSSQCPYVVVCYQSFYSNGAISII 137
           LV+    G+ + +K I ++   S  R+ ++ E+ +  + + P +V   +SF  NG++ I+
Sbjct: 42  LVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101
Query: 138 LEYMDGGSLADFLKKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           ++Y +GG L   +   K +   E+ +     Q+   L ++H  K I+HRD+K  N+ +  
Sbjct: 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK-ILHRDIKSQNIFLTK 160
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G V++ DFG++ ++ ST   A   +GT  Y+SPE      Y  KSDIW+LG VL E  T
Sbjct: 161 DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220
Query: 256 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 315
            +  +     ++       +++ I    PP   S  +S +  S +S   ++ P+ R S  
Sbjct: 221 LKHAFEAGSMKN------LVLKIISGSFPPV--SLHYSYDLRSLVSQLFKRNPRDRPSVN 272
Query: 316 ELMTHPFL 323
            ++   F+
Sbjct: 273 SILEKGFI 280

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 9/216 (4%)
Query: 52  KPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQM--NVEESARRQIAQE 109
           K  D ++  ED +             QLV+HK T + +A+K++     ++ S      +E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 110 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 169
             I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +V+
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVV 178
Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMS 228
             L  +H     IHRD+KP N+L++  G +K+ DFG    M      + +T VGT +Y+S
Sbjct: 179 LALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 229 PERISG----GKYGYKSDIWSLGLVLLECATGQFPY 260
           PE +      G YG + D WS+G+ L E   G  P+
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 103/185 (55%), Gaps = 4/185 (2%)
Query: 78  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +L +H  TG+  A+K+I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 255
             +KI DFG S    +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 150 MNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 256 GQFPY 260
           G  P+
Sbjct: 209 GSLPF 213

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 6/210 (2%)
Query: 53  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 110
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I Q+   P++     SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 153
Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
              YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPY 260
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 9/216 (4%)
Query: 52  KPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQM--NVEESARRQIAQE 109
           K  D ++  ED +             QLV+HK T + +A+K++     ++ S      +E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 110 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 169
             I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +V+
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVV 183
Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMS 228
             L  +H     IHRD+KP N+L++  G +K+ DFG    M      + +T VGT +Y+S
Sbjct: 184 LALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 242
Query: 229 PERISG----GKYGYKSDIWSLGLVLLECATGQFPY 260
           PE +      G YG + D WS+G+ L E   G  P+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 32/260 (12%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           + K TG  +A K I+     ++RR     +I +E+ I +      V+  +  + +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +ILE + GG L DFL + +++ EE   +  +Q+L G+ YLH +K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 196 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           +      +K+ DFG++  +       N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 303
              +G  P+    +Q+   +              ++ S  F  EF S        FI   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TSVSYDFDEEFFSHTSELAKDFIRKL 256
Query: 304 VQKEPQQRLSAQELMTHPFL 323
           + KE ++RL+ QE + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 100 ESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVKT 155
           +S R++  +E +  +  Q P +V  Y S+ S       I ++ E    G+L  +LK+ K 
Sbjct: 66  KSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKV 125
Query: 156 IPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINH-RGEVKITDFGVSAIMAST 213
              + L + C Q+LKGL +LH     IIHRDLK  N+ I    G VKI D G++ +  ++
Sbjct: 126 XKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185
Query: 214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 273
             +A   +GT  + +PE     KY    D+++ G   LE AT ++PYS  E Q+    + 
Sbjct: 186 FAKA--VIGTPEFXAPEXYE-EKYDESVDVYAFGXCXLEXATSEYPYS--ECQNAAQIYR 240
Query: 274 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
            +   +     P++      PE    I  C+++   +R S ++L+ H F +
Sbjct: 241 RVTSGV----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 116/241 (48%), Gaps = 12/241 (4%)
Query: 85  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T + FA K++   + ++   R +++ E+ I++S    +VV  +  F  N  + ++LE   
Sbjct: 41  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 100
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
             SL +  K+ K + E        Q++ G  YLH  + +IHRDLK  NL +N   EVKI 
Sbjct: 101 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIG 159
Query: 203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
           DFG++  +     +  T  GT NY++PE +S   + ++ D+WS+G ++     G+ P+  
Sbjct: 160 DFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE- 218
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
                  TS  +     + +   S P    +P   S I   +Q +P  R +  EL+   F
Sbjct: 219 -------TSCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEF 270
Query: 323 L 323
Sbjct: 271 F 271

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 116/241 (48%), Gaps = 12/241 (4%)
Query: 85  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T + FA K++   + ++   R +++ E+ I++S    +VV  +  F  N  + ++LE   
Sbjct: 41  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 100
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
             SL +  K+ K + E        Q++ G  YLH  + +IHRDLK  NL +N   EVKI 
Sbjct: 101 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIG 159
Query: 203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
           DFG++  +     +  T  GT NY++PE +S   + ++ D+WS+G ++     G+ P+  
Sbjct: 160 DFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE- 218
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
                  TS  +     + +   S P    +P   S I   +Q +P  R +  EL+   F
Sbjct: 219 -------TSCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEF 270
Query: 323 L 323
Sbjct: 271 F 271

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 125/251 (49%), Gaps = 14/251 (5%)
Query: 79  LVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII 137
           L + K T    A+K+I + +V  S+  ++ +E+ + +    P ++  Y  F       ++
Sbjct: 55  LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114
Query: 138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHR 196
           +E   GG L D +       E   A I +QVL G+ YLH  KH I+HRDLKP NLL+  +
Sbjct: 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESK 172
Query: 197 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
            +   +KI DFG+SA+  +   +    +GT  Y++PE +   KY  K D+WS+G++L   
Sbjct: 173 EKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFIL 230
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
             G  P+     Q+      E  +   D P     S+         I   +Q + Q+R+S
Sbjct: 231 LAGYPPFGGQTDQEILRKV-EKGKYTFDSPEWKNVSEGAK----DLIKQMLQFDSQRRIS 285
Query: 314 AQELMTHPFLK 324
           AQ+ + HP++K
Sbjct: 286 AQQALEHPWIK 296

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 103/185 (55%), Gaps = 4/185 (2%)
Query: 78  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +L +H  TG+  A+++I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 31  KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 255
             +KI DFG S    +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 150 MNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 256 GQFPY 260
           G  P+
Sbjct: 209 GSLPF 213

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 103/185 (55%), Gaps = 4/185 (2%)
Query: 78  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +L +H  TG+  A+K+I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 24  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 83
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 84  VMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 142
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 255
             +KI DFG S    +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 143 MNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 201
Query: 256 GQFPY 260
           G  P+
Sbjct: 202 GSLPF 206

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 102/185 (55%), Gaps = 4/185 (2%)
Query: 78  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +L +H  TG+  A+K+I +  +  ++ +++ +E++I +    P +V  ++   +   + +
Sbjct: 32  KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           I+EY  GG + D+L     + E+   +   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 92  IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH-QKRIVHRDLKAENLLLDAD 150
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 255
             +KI DFG S    +  G+ + F G   Y +PE   G KY G + D+WSLG++L    +
Sbjct: 151 MNIKIADFGFSNEF-TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 256 GQFPY 260
           G  P+
Sbjct: 210 GSLPF 214

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 116/241 (48%), Gaps = 12/241 (4%)
Query: 85  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T + FA K++   + ++   R +++ E+ I++S    +VV  +  F  N  + ++LE   
Sbjct: 45  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 104
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
             SL +  K+ K + E        Q++ G  YLH  + +IHRDLK  NL +N   EVKI 
Sbjct: 105 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIG 163
Query: 203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
           DFG++  +     +  T  GT NY++PE +S   + ++ D+WS+G ++     G+ P+  
Sbjct: 164 DFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE- 222
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
                  TS  +     + +   S P    +P   S I   +Q +P  R +  EL+   F
Sbjct: 223 -------TSCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEF 274
Query: 323 L 323
Sbjct: 275 F 275

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 115/247 (46%), Gaps = 21/247 (8%)
Query: 103 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTI-P 157
           RR+      +N     P +V  Y +  +         I++EY+DG +L D +     + P
Sbjct: 60  RREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-- 215
           +  +  I +      L   H+  IIHRD+KP+N+LI+    VK+ DFG++  +A +    
Sbjct: 116 KRAIEVIADACQA--LNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSV 173
Query: 216 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 274
            Q    +GT  Y+SPE+  G     +SD++SLG VL E  TG+ P++      G +    
Sbjct: 174 XQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSV 227
Query: 275 LMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             + + + P PPSA  +  S +  + +   + K P+ R      M    ++++     + 
Sbjct: 228 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEA 287
Query: 334 SEYFTDA 340
            +  TDA
Sbjct: 288 PKVLTDA 294

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 129/275 (46%), Gaps = 35/275 (12%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 138
           + + KW  +  A+K I+    ES R+    EL+       P +V  Y +  +   + +++
Sbjct: 25  VCKAKWRAKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 79
Query: 139 EYMDGGSLADFLKKVKTIP---EEYLAAICEQVLKGLLYLH--HEKHIIHRDLKPSNLLI 193
           EY +GGSL + L   + +P     +  + C Q  +G+ YLH    K +IHRDLKP NLL+
Sbjct: 80  EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 139
Query: 194 NHRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
              G V KI DFG +  + +         G+  +M+PE   G  Y  K D++S G++L E
Sbjct: 140 VAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWE 196
Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 312
             T + P+     + G  +F  +M A+ +   P    +   P   S ++ C  K+P QR 
Sbjct: 197 VITRRKPFD----EIGGPAF-RIMWAVHNGTRPPLIKNLPKP-IESLMTRCWSKDPSQRP 250
Query: 313 SAQE---LMTHPFLKMYGDLNVDLSEYFTDAGSPL 344
           S +E   +MTH            L  YF  A  PL
Sbjct: 251 SMEEIVKIMTH------------LMRYFPGADEPL 273

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 115/247 (46%), Gaps = 21/247 (8%)
Query: 103 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTI-P 157
           RR+      +N     P +V  Y +  +         I++EY+DG +L D +     + P
Sbjct: 60  RREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-- 215
           +  +  I +      L   H+  IIHRD+KP+N++I+    VK+ DFG++  +A +    
Sbjct: 116 KRAIEVIADACQA--LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 216 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 274
            Q    +GT  Y+SPE+  G     +SD++SLG VL E  TG+ P++      G +    
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSV 227
Query: 275 LMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             + + + P PPSA  +  S +  + +   + K P+ R      M    ++++     + 
Sbjct: 228 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEA 287
Query: 334 SEYFTDA 340
            +  TDA
Sbjct: 288 PKVLTDA 294

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 130/276 (47%), Gaps = 37/276 (13%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 138
           + + KW  +  A+K I+    ES R+    EL+       P +V  Y +  +   + +++
Sbjct: 24  VCKAKWRAKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78
Query: 139 EYMDGGSLADFLKKVKTIPEEYLAA----ICEQVLKGLLYLH--HEKHIIHRDLKPSNLL 192
           EY +GGSL + L   + +P  Y AA     C Q  +G+ YLH    K +IHRDLKP NLL
Sbjct: 79  EYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137
Query: 193 INHRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           +   G V KI DFG +  + +         G+  +M+PE   G  Y  K D++S G++L 
Sbjct: 138 LVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194
Query: 252 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E  T + P+     + G  +F  +M A+ +   P    +   P   S ++ C  K+P QR
Sbjct: 195 EVITRRKPFD----EIGGPAF-RIMWAVHNGTRPPLIKNLPKP-IESLMTRCWSKDPSQR 248
Query: 312 LSAQE---LMTHPFLKMYGDLNVDLSEYFTDAGSPL 344
            S +E   +MTH            L  YF  A  PL
Sbjct: 249 PSMEEIVKIMTH------------LMRYFPGADEPL 272

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 115/241 (47%), Gaps = 12/241 (4%)
Query: 85  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T + FA K++   + ++   R +++ E+ I++S    +VV  +  F  N  + ++LE   
Sbjct: 63  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 122
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
             SL +  K+ K + E        Q++ G  YLH  + +IHRDLK  NL +N   EVKI 
Sbjct: 123 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIG 181
Query: 203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
           DFG++  +     +     GT NY++PE +S   + ++ D+WS+G ++     G+ P+  
Sbjct: 182 DFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE- 240
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
                  TS  +     + +   S P    +P   S I   +Q +P  R +  EL+   F
Sbjct: 241 -------TSCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEF 292
Query: 323 L 323
Sbjct: 293 F 293

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 115/247 (46%), Gaps = 21/247 (8%)
Query: 103 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTI-P 157
           RR+      +N     P +V  Y +  +         I++EY+DG +L D +     + P
Sbjct: 60  RREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-- 215
           +  +  I +      L   H+  IIHRD+KP+N++I+    VK+ DFG++  +A +    
Sbjct: 116 KRAIEVIADACQA--LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 216 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 274
            Q    +GT  Y+SPE+  G     +SD++SLG VL E  TG+ P++      G +    
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSV 227
Query: 275 LMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             + + + P PPSA  +  S +  + +   + K P+ R      M    ++++     + 
Sbjct: 228 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEA 287
Query: 334 SEYFTDA 340
            +  TDA
Sbjct: 288 PKVLTDA 294

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 101/185 (54%), Gaps = 4/185 (2%)
Query: 78  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +L +H  TG+  A+K+I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 255
             +KI DFG S    +   + + F G   Y +PE   G KY G + D+WSLG++L    +
Sbjct: 150 MNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 256 GQFPY 260
           G  P+
Sbjct: 209 GSLPF 213

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 13/247 (5%)
Query: 82  HKWTGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           HK TG  FA K+I    + SAR  +++ +E +I +  Q P +V  + S        ++ +
Sbjct: 50  HKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE- 198
            + GG L + +   +   E   +   +Q+L+ + Y H    I+HR+LKP NLL+  + + 
Sbjct: 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKG 167
Query: 199 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
             VK+ DFG+ AI  + S   + F GT  Y+SPE +    Y    DIW+ G++L     G
Sbjct: 168 AAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
              Y P   +D    + ++     D P P    D  +PE  S I + +   P++R++A +
Sbjct: 227 ---YPPFWDEDQHRLYAQIKAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQ 281
Query: 317 LMTHPFL 323
            +  P++
Sbjct: 282 ALKVPWI 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 115/241 (47%), Gaps = 12/241 (4%)
Query: 85  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T + FA K++   + ++   R +++ E+ I++S    +VV  +  F  N  + ++LE   
Sbjct: 65  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
             SL +  K+ K + E        Q++ G  YLH  + +IHRDLK  NL +N   EVKI 
Sbjct: 125 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIG 183
Query: 203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
           DFG++  +     +     GT NY++PE +S   + ++ D+WS+G ++     G+ P+  
Sbjct: 184 DFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE- 242
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
                  TS  +     + +   S P    +P   S I   +Q +P  R +  EL+   F
Sbjct: 243 -------TSCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEF 294
Query: 323 L 323
Sbjct: 295 F 295

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 103 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTI-P 157
           RR+      +N     P +V  Y +  +         I++EY+DG +L D +     + P
Sbjct: 60  RREAQNAAALNH----PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 158 E---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 214
           +   E +A  C+      L   H+  IIHRD+KP+N++I+    VK+ DFG++  +A + 
Sbjct: 116 KRAIEVIADACQA-----LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 215 G---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 271
               Q    +GT  Y+SPE+  G     +SD++SLG VL E  TG+ P++      G + 
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSP 224
Query: 272 FYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 330
                + + + P PPSA  +  S +  + +   + K P+ R      M    ++++    
Sbjct: 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284
Query: 331 VDLSEYFTDA 340
            +  +  TDA
Sbjct: 285 PEAPKVLTDA 294

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 125/252 (49%), Gaps = 16/252 (6%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 138
           + +W G   A+K++ M  +  A R  +  +E+ I +  + P +V+   +      +SI+ 
Sbjct: 55  RAEWHGSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113
Query: 139 EYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLIN 194
           EY+  GSL   L K    + + E    ++   V KG+ YLH+    I+HR+LK  NLL++
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD 173
Query: 195 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
            +  VK+ DFG+S + AST   + +  GT  +M+PE +       KSD++S G++L E A
Sbjct: 174 KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
           T Q P+       G  +  +++ A+  +          +P+  + I  C   EP +R S 
Sbjct: 234 TLQQPW-------GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSF 286
Query: 315 QELMT--HPFLK 324
             +M    P +K
Sbjct: 287 ATIMDLLRPLIK 298

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 125/251 (49%), Gaps = 22/251 (8%)
Query: 81  QHKWTGQFFALKVIQ------MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI 134
           +H+ TG   A+K++       ++V    +R+I Q LK+ +    P+++  YQ   +    
Sbjct: 31  EHQLTGHKVAVKILNRQKIRSLDVVGKIKREI-QNLKLFRH---PHIIKLYQVISTPTDF 86
Query: 135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
            +++EY+ GG L D++ K   + E     + +Q+L  + Y H    ++HRDLKP N+L++
Sbjct: 87  FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLD 145
Query: 195 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 253
                KI DFG+S +M S      T  G+ NY +PE ISG  Y G + DIWS G++L   
Sbjct: 146 AHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
             G  P+   + +   T F ++   +   P      +  +    + +   +Q +P +R +
Sbjct: 205 LCGTLPF---DDEHVPTLFKKIRGGVFYIP------EYLNRSVATLLMHMLQVDPLKRAT 255
Query: 314 AQELMTHPFLK 324
            +++  H + K
Sbjct: 256 IKDIREHEWFK 266

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 129/283 (45%), Gaps = 20/283 (7%)
Query: 52  KPSDN--QLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNV---EESARRQI 106
           +PS+N  ++ L D +              L   K T + +A+K+++ +V   ++     +
Sbjct: 8   QPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTM 67
Query: 107 AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE 166
            ++  +    + P++   +  F +   +  ++EY++GG L   +++V    E        
Sbjct: 68  VEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA 127
Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 226
           ++  GL +LH ++ II+RDLK  N++++  G +KI DFG+             F GT +Y
Sbjct: 128 EISIGLFFLH-KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDY 186
Query: 227 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 286
           ++PE I+   YG   D W+ G++L E   GQ P+   + +D    F  +ME  V  P   
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF---DGEDEDELFQSIMEHNVSYP--- 240
Query: 287 APSDQFSPEFCSFISACVQKEPQQRLSA-----QELMTHPFLK 324
                 S E  S     + K P +RL       +++  H F +
Sbjct: 241 ---KSLSKEAVSICKGLMTKHPAKRLGCGPEGERDVREHAFFR 280

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 122/266 (45%), Gaps = 25/266 (9%)
Query: 89  FALKVIQMNVEESA------RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IIL 138
            A+KV++ ++          RR+      +N     P +V  Y +  +         I++
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVM 95
Query: 139 EYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           EY+DG +L D +     + P+  +  I +      L   H+  IIHRD+KP+N++I+   
Sbjct: 96  EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA--LNFSHQNGIIHRDVKPANIMISATN 153
Query: 198 EVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
            VK+ DFG++  +A +     Q    +GT  Y+SPE+  G     +SD++SLG VL E  
Sbjct: 154 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
           TG+ P++         ++  + E   D  PPSA  +  S +  + +   + K P+ R   
Sbjct: 214 TGEPPFT--GDSPDSVAYQHVRE---DPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 268
Query: 315 QELMTHPFLKMYGDLNVDLSEYFTDA 340
              M    ++++     +  +  TDA
Sbjct: 269 AAEMRADLVRVHNGEPPEAPKVLTDA 294

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 115/241 (47%), Gaps = 12/241 (4%)
Query: 85  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T + FA K++   + ++   R +++ E+ I++S    +VV  +  F  N  + ++LE   
Sbjct: 39  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
             SL +  K+ K + E        Q++ G  YLH  + +IHRDLK  NL +N   EVKI 
Sbjct: 99  RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIG 157
Query: 203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 262
           DFG++  +     +     GT NY++PE +S   + ++ D+WS+G ++     G+ P+  
Sbjct: 158 DFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE- 216
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
                  TS  +     + +   S P    +P   S I   +Q +P  R +  EL+   F
Sbjct: 217 -------TSCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEF 268
Query: 323 L 323
Sbjct: 269 F 269

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 125/254 (49%), Gaps = 17/254 (6%)
Query: 78  QLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           +L++ K T +  A+K I+    ++E+ +R+I      ++S + P +V   +   +   ++
Sbjct: 37  RLMRDKLTKELVAVKYIERGAAIDENVQREIIN----HRSLRHPNIVRFKEVILTPTHLA 92
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           II+EY  GG L + +       E+      +Q+L G+ Y  H   I HRDLK  N L++ 
Sbjct: 93  IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC-HSMQICHRDLKLENTLLDG 151
Query: 196 R--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLE 252
                +KI DFG S   +    Q  + VGT  Y++PE +   +Y G  +D+WS G+ L  
Sbjct: 152 SPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYV 210
Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD-QFSPEFCSFISACVQKEPQQR 311
              G +P+  PE+   +    + + ++      S P D + SPE C  IS     +P  R
Sbjct: 211 MLVGAYPFEDPEEPRDYRKTIQRILSV----KYSIPDDIRISPECCHLISRIFVADPATR 266
Query: 312 LSAQELMTHP-FLK 324
           +S  E+ TH  FLK
Sbjct: 267 ISIPEIKTHSWFLK 280

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 123/253 (48%), Gaps = 13/253 (5%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L + K TGQ  A+KVI      +++ +  + +E+++ +    P ++  Y+ F   G   +
Sbjct: 44  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           + E   GG L D +   K   E   A I  QVL G+ Y+H  K I+HRDLKP NLL+  +
Sbjct: 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESK 162
Query: 197 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
            +   ++I DFG+S    ++    +  +GT  Y++PE +  G Y  K D+WS G++L   
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYIL 220
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
            +G  P++   + D      E  +   + P     S+         I   +   P  R+S
Sbjct: 221 LSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESAK----DLIRKMLTYVPSMRIS 275
Query: 314 AQELMTHPFLKMY 326
           A++ + H +++ Y
Sbjct: 276 ARDALDHEWIQTY 288

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 13/247 (5%)
Query: 82  HKWTGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           HK TG  FA K+I    + SAR  +++ +E +I +  Q P +V  + S        ++ +
Sbjct: 27  HKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE- 198
            + GG L + +   +   E   +   +Q+L+ + Y H    I+HR+LKP NLL+  + + 
Sbjct: 86  LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKG 144
Query: 199 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
             VK+ DFG+ AI  + S   + F GT  Y+SPE +    Y    DIW+ G++L     G
Sbjct: 145 AAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
              Y P   +D    + ++     D P P    D  +PE  S I + +   P++R++A +
Sbjct: 204 ---YPPFWDEDQHRLYAQIKAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQ 258
Query: 317 LMTHPFL 323
            +  P++
Sbjct: 259 ALKVPWI 265

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 13/247 (5%)
Query: 82  HKWTGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           HK TG  FA K+I    + SAR  +++ +E +I +  Q P +V  + S        ++ +
Sbjct: 27  HKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE- 198
            + GG L + +   +   E   +   +Q+L+ + Y H    I+HR+LKP NLL+  + + 
Sbjct: 86  LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKG 144
Query: 199 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
             VK+ DFG+ AI  + S   + F GT  Y+SPE +    Y    DIW+ G++L     G
Sbjct: 145 AAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
              Y P   +D    + ++     D P P    D  +PE  S I + +   P++R++A +
Sbjct: 204 ---YPPFWDEDQHRLYAQIKAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQ 258
Query: 317 LMTHPFL 323
            +  P++
Sbjct: 259 ALKVPWI 265

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 102/185 (55%), Gaps = 4/185 (2%)
Query: 78  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +L +H  TG+  A+++I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 31  KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 255
             +KI DFG S    +   + + F G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 150 MNIKIADFGFSNEF-TFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 256 GQFPY 260
           G  P+
Sbjct: 209 GSLPF 213

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 13/247 (5%)
Query: 82  HKWTGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           HK TG  FA K+I    + SAR  +++ +E +I +  Q P +V  + S        ++ +
Sbjct: 26  HKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 84
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE- 198
            + GG L + +   +   E   +   +Q+L+ + Y H    I+HR+LKP NLL+  + + 
Sbjct: 85  LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKG 143
Query: 199 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
             VK+ DFG+ AI  + S   + F GT  Y+SPE +    Y    DIW+ G++L     G
Sbjct: 144 AAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
              Y P   +D    + ++     D P P    D  +PE  S I + +   P++R++A +
Sbjct: 203 ---YPPFWDEDQHRLYAQIKAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQ 257
Query: 317 LMTHPFL 323
            +  P++
Sbjct: 258 ALKVPWI 264

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 124/254 (48%), Gaps = 17/254 (6%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAIS 135
           L +HK    F+A+KV+Q    +++   + I  E  +  ++ + P++V  + SF +   + 
Sbjct: 56  LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            +L+Y++GG L   L++ +   E        ++   L YLH   +I++RDLKP N+L++ 
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH-SLNIVYRDLKPENILLDS 174
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
           +G + +TDFG+       +   +TF GT  Y++PE +    Y    D W LG VL E   
Sbjct: 175 QGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234
Query: 256 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 315
           G  P+             E+ + I+++P    P+   S      +   +QK+  +RL A+
Sbjct: 235 GLPPFYSRNTA-------EMYDNILNKPLQLKPNITNSAR--HLLEGLLQKDRTKRLGAK 285
Query: 316 ----ELMTHPFLKM 325
               E+ +H F  +
Sbjct: 286 DDFMEIKSHVFFSL 299

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 128/254 (50%), Gaps = 22/254 (8%)
Query: 78  QLVQHKWTGQFFALKVIQ------MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN 131
           ++ +H+ TG   A+K++       ++V    +R+I Q LK+ +    P+++  YQ   + 
Sbjct: 28  KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI-QNLKLFRH---PHIIKLYQVISTP 83
Query: 132 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
               +++EY+ GG L D++ K   + E     + +Q+L  + Y H    ++HRDLKP N+
Sbjct: 84  TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM-VVHRDLKPENV 142
Query: 192 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVL 250
           L++     KI DFG+S +M+      ++  G+ NY +PE ISG  Y G + DIWS G++L
Sbjct: 143 LLDAHMNAKIADFGLSNMMSDGEFLRDS-CGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201
Query: 251 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 310
                G  P+   + +   T F ++   +   P      +  +    + +   +Q +P +
Sbjct: 202 YALLCGTLPF---DDEHVPTLFKKIRGGVFYIP------EYLNRSVATLLMHMLQVDPLK 252
Query: 311 RLSAQELMTHPFLK 324
           R + +++  H + K
Sbjct: 253 RATIKDIREHEWFK 266

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 123/253 (48%), Gaps = 13/253 (5%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L + K TGQ  A+KVI      +++ +  + +E+++ +    P ++  Y+ F   G   +
Sbjct: 67  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 126
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           + E   GG L D +   K   E   A I  QVL G+ Y+H  K I+HRDLKP NLL+  +
Sbjct: 127 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESK 185
Query: 197 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
            +   ++I DFG+S    ++    +  +GT  Y++PE +  G Y  K D+WS G++L   
Sbjct: 186 SKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYIL 243
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
            +G  P++   + D      E  +   + P     S+         I   +   P  R+S
Sbjct: 244 LSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESAK----DLIRKMLTYVPSMRIS 298
Query: 314 AQELMTHPFLKMY 326
           A++ + H +++ Y
Sbjct: 299 ARDALDHEWIQTY 311

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 123/253 (48%), Gaps = 13/253 (5%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L + K TGQ  A+KVI      +++ +  + +E+++ +    P ++  Y+ F   G   +
Sbjct: 68  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 127
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           + E   GG L D +   K   E   A I  QVL G+ Y+H  K I+HRDLKP NLL+  +
Sbjct: 128 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESK 186
Query: 197 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
            +   ++I DFG+S    ++    +  +GT  Y++PE +  G Y  K D+WS G++L   
Sbjct: 187 SKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYIL 244
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
            +G  P++   + D      E  +   + P     S+         I   +   P  R+S
Sbjct: 245 LSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESAK----DLIRKMLTYVPSMRIS 299
Query: 314 AQELMTHPFLKMY 326
           A++ + H +++ Y
Sbjct: 300 ARDALDHEWIQTY 312

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 125/277 (45%), Gaps = 18/277 (6%)
Query: 56  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKI 112
           +++ L D +              L + K T + +A+K+++ +V   ++     + ++  +
Sbjct: 15  DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 74
Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 172
               + P++   +  F +   +  ++EY++GG L   +++V    E +      ++  GL
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 232
            +L   K II+RDLK  N++++  G +KI DFG+             F GT +Y++PE I
Sbjct: 135 FFLQ-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII 193
Query: 233 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
           +   YG   D W+ G++L E   GQ P+   E +D    F  +ME  V  P         
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPF---EGEDEDELFQSIMEHNVAYP------KSM 244
Query: 293 SPEFCSFISACVQKEPQQRLSA-----QELMTHPFLK 324
           S E  +     + K P +RL       +++  H F +
Sbjct: 245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 123/252 (48%), Gaps = 16/252 (6%)
Query: 81  QHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 138
           + +W G   A+K++ M  +  A R  +  +E+ I +  + P +V+   +      +SI+ 
Sbjct: 55  RAEWHGSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113
Query: 139 EYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLIN 194
           EY+  GSL   L K    + + E    ++   V KG+ YLH+    I+HRDLK  NLL++
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVD 173
Query: 195 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
            +  VK+ DFG+S + AS    +    GT  +M+PE +       KSD++S G++L E A
Sbjct: 174 KKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
           T Q P+       G  +  +++ A+  +          +P+  + I  C   EP +R S 
Sbjct: 234 TLQQPW-------GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSF 286
Query: 315 QELMT--HPFLK 324
             +M    P +K
Sbjct: 287 ATIMDLLRPLIK 298

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 99/185 (53%), Gaps = 4/185 (2%)
Query: 78  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +L +H  TG+  A+K+I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYL 90
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           + EY  GG + D+L       E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 91  VXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 255
             +KI DFG S    +   + + F G   Y +PE   G KY G + D+WSLG++L    +
Sbjct: 150 XNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 256 GQFPY 260
           G  P+
Sbjct: 209 GSLPF 213

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 117/243 (48%), Gaps = 22/243 (9%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 164
            +  E++I +    P  ++  ++F+      I+LE M+GG L D +   K + E      
Sbjct: 200 NVETEIEILKKLNHP-CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 258
Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFV 221
             Q+L  + YLH E  IIHRDLKP N+L++ + E   +KITDFG S I+  TS    T  
Sbjct: 259 FYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLC 316
Query: 222 GTYNYMSPE-RISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 278
           GT  Y++PE  +S G  GY    D WSLG++L  C +G  P+S    Q        L + 
Sbjct: 317 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQ 370
Query: 279 IVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY 336
           I        P    + S +    +   +  +P+ R + +E + HP+L+     + D+   
Sbjct: 371 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRK 425
Query: 337 FTD 339
           F D
Sbjct: 426 FQD 428

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 123/253 (48%), Gaps = 13/253 (5%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L + K TGQ  A+KVI      +++ +  + +E+++ +    P ++  Y+ F   G   +
Sbjct: 50  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 109
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           + E   GG L D +   K   E   A I  QVL G+ Y+H  K I+HRDLKP NLL+  +
Sbjct: 110 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESK 168
Query: 197 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
            +   ++I DFG+S    ++    +  +GT  Y++PE +  G Y  K D+WS G++L   
Sbjct: 169 SKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYIL 226
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
            +G  P++   + D      E  +   + P     S+         I   +   P  R+S
Sbjct: 227 LSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESAK----DLIRKMLTYVPSMRIS 281
Query: 314 AQELMTHPFLKMY 326
           A++ + H +++ Y
Sbjct: 282 ARDALDHEWIQTY 294

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 117/243 (48%), Gaps = 22/243 (9%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 164
            +  E++I +    P  ++  ++F+      I+LE M+GG L D +   K + E      
Sbjct: 186 NVETEIEILKKLNHP-CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 244
Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFV 221
             Q+L  + YLH E  IIHRDLKP N+L++ + E   +KITDFG S I+  TS    T  
Sbjct: 245 FYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLC 302
Query: 222 GTYNYMSPE-RISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 278
           GT  Y++PE  +S G  GY    D WSLG++L  C +G  P+S    Q        L + 
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQ 356
Query: 279 IVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY 336
           I        P    + S +    +   +  +P+ R + +E + HP+L+     + D+   
Sbjct: 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRK 411
Query: 337 FTD 339
           F D
Sbjct: 412 FQD 414

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 135
Query: 182 IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 237
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 194
Query: 238 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 293
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 248
Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 339
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 289

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 129/263 (49%), Gaps = 22/263 (8%)
Query: 79  LVQHKWTGQFFALKVIQMN---VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           LV+ + TG+ FALK I+ +    + S   +IA   KI   +    +V     + S     
Sbjct: 27  LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN----IVTLEDIYESTTHYY 82
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI-- 193
           ++++ + GG L D + +     E+  + + +QVL  + YLH E  I+HRDLKP NLL   
Sbjct: 83  LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH-ENGIVHRDLKPENLLYLT 141
Query: 194 -NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--L 250
                ++ ITDFG+S +    +G  +T  GT  Y++PE ++   Y    D WS+G++  +
Sbjct: 142 PEENSKIMITDFGLSKM--EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYI 199
Query: 251 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 310
           L C      Y P  ++     F ++ E   +   P    D  S     FI   ++K+P +
Sbjct: 200 LLCG-----YPPFYEETESKLFEKIKEGYYEFESPFW--DDISESAKDFICHLLEKDPNE 252
Query: 311 RLSAQELMTHPFLKMYGDLNVDL 333
           R + ++ ++HP++     L+ D+
Sbjct: 253 RYTCEKALSHPWIDGNTALHRDI 275

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 135
Query: 182 IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 237
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 194
Query: 238 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 293
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 248
Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 339
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 289

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 76  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 134
Query: 182 IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 237
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 135 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 193
Query: 238 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 293
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 194 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 247
Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 339
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 248 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 288

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 135
Query: 182 IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 237
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 194
Query: 238 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 293
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 248
Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 339
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 289

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 164
           E KI       ++V    +F +   + +++  M+GG +   +  V        E      
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 224
             Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 225 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 284
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + +++Q  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVLEQ-- 408
Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
                D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 119/244 (48%), Gaps = 12/244 (4%)
Query: 85  TGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
            GQ +A K+I    + SAR  +++ +E +I +  + P +V  + S    G   +I + + 
Sbjct: 46  AGQEYAAKIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 104
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEV 199
           GG L + +   +   E   +   +Q+L+ +L+ H +  ++HRDLKP NLL+  +     V
Sbjct: 105 GGELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRDLKPENLLLASKLKGAAV 163
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFG++  +         F GT  Y+SPE +    YG   D+W+ G++L     G   
Sbjct: 164 KLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG--- 220
Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           Y P   +D    + ++     D P P    D  +PE    I+  +   P +R++A E + 
Sbjct: 221 YPPFWDEDQHRLYQQIKAGAYDFPSPEW--DTVTPEAKDLINKMLTINPSKRITAAEALK 278
Query: 320 HPFL 323
           HP++
Sbjct: 279 HPWI 282

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 83  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 141
Query: 182 IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 237
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 142 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 200
Query: 238 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 293
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 201 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 254
Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 339
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 255 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 295

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 125/259 (48%), Gaps = 16/259 (6%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 138
           L + K T +  A+K I     E     +  E+ +    + P +V     + S G + +I+
Sbjct: 36  LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL---INH 195
           + + GG L D + +     E   + +  QVL  + YL H+  I+HRDLKP NLL   ++ 
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDE 154
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLEC 253
             ++ I+DFG+S  M       +T  GT  Y++PE ++   Y    D WS+G++  +L C
Sbjct: 155 DSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
                 Y P   ++    F ++++A  +   P    D  S     FI   ++K+P++R +
Sbjct: 214 G-----YPPFYDENDAKLFEQILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFT 266
Query: 314 AQELMTHPFLKMYGDLNVD 332
            ++ + HP++   GD  +D
Sbjct: 267 CEQALQHPWIA--GDTALD 283

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 164
           E KI       ++V    +F +   + +++  M+GG +   +  V        E      
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 224
             Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 225 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 284
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + +++Q  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVLEQ-- 408
Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
                D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 164
           E KI       ++V    +F +   + +++  M+GG +   +  V        E      
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 224
             Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 225 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 284
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + +++Q  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVLEQ-- 408
Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
                D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 119/254 (46%), Gaps = 18/254 (7%)
Query: 79  LVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           L + K T + +A+K+++ +V   ++     + ++  +    + P++   +  F +   + 
Sbjct: 359 LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            ++EY++GG L   +++V    E +      ++  GL +L   K II+RDLK  N++++ 
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ-SKGIIYRDLKLDNVMLDS 477
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G +KI DFG+             F GT +Y++PE I+   YG   D W+ G++L E   
Sbjct: 478 EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537
Query: 256 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA- 314
           GQ P+   E +D    F  +ME  V  P         S E  +     + K P +RL   
Sbjct: 538 GQAPF---EGEDEDELFQSIMEHNVAYP------KSMSKEAVAICKGLMTKHPGKRLGCG 588
Query: 315 ----QELMTHPFLK 324
               +++  H F +
Sbjct: 589 PEGERDIKEHAFFR 602

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 110/233 (47%), Gaps = 21/233 (9%)
Query: 103 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTI-P 157
           RR+      +N     P +V  Y +  +         I++EY+DG +L D +     + P
Sbjct: 77  RREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 132
Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-- 215
           +  +  I +      L   H+  IIHRD+KP+N++I+    VK+ DFG++  +A +    
Sbjct: 133 KRAIEVIADACQA--LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 190
Query: 216 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 274
            Q    +GT  Y+SPE+  G     +SD++SLG VL E  TG+ P++      G +    
Sbjct: 191 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSV 244
Query: 275 LMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
             + + + P PPSA  +  S +  + +   + K P+ R      M    ++++
Sbjct: 245 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 297

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 125/259 (48%), Gaps = 16/259 (6%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 138
           L + K T +  A+K I     E     +  E+ +    + P +V     + S G + +I+
Sbjct: 36  LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL---INH 195
           + + GG L D + +     E   + +  QVL  + YL H+  I+HRDLKP NLL   ++ 
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDE 154
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLEC 253
             ++ I+DFG+S  M       +T  GT  Y++PE ++   Y    D WS+G++  +L C
Sbjct: 155 DSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
                 Y P   ++    F ++++A  +   P    D  S     FI   ++K+P++R +
Sbjct: 214 G-----YPPFYDENDAKLFEQILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFT 266
Query: 314 AQELMTHPFLKMYGDLNVD 332
            ++ + HP++   GD  +D
Sbjct: 267 CEQALQHPWIA--GDTALD 283

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 121/250 (48%), Gaps = 12/250 (4%)
Query: 81  QHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           + + T Q +A+KVI + + +      I +E+++ +    P ++  ++    + +  I+ E
Sbjct: 42  KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-- 197
              GG L D + K K   E   A I +QV  G+ Y+ H+ +I+HRDLKP N+L+  +   
Sbjct: 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM-HKHNIVHRDLKPENILLESKEKD 160
Query: 198 -EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
            ++KI DFG+S      +   +  +GT  Y++PE +  G Y  K D+WS G++L    +G
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDR-IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
             P+    + D      E  +   D P     SD         I   +   P  R++A +
Sbjct: 219 TPPFYGKNEYDILKRV-ETGKYAFDLPQWRTISDDAK----DLIRKMLTFHPSLRITATQ 273
Query: 317 LMTHPFLKMY 326
            + HP+++ Y
Sbjct: 274 CLEHPWIQKY 283

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 109 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 164
           E KI       ++V    +F +   + +++  M+GG +   +  V        E      
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 224
             Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 225 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 284
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + +++Q  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVLEQ-- 408
Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
                D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 125/259 (48%), Gaps = 16/259 (6%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 138
           L + K T +  A+K I     E     +  E+ +    + P +V     + S G + +I+
Sbjct: 36  LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL---INH 195
           + + GG L D + +     E   + +  QVL  + YL H+  I+HRDLKP NLL   ++ 
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDE 154
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLEC 253
             ++ I+DFG+S  M       +T  GT  Y++PE ++   Y    D WS+G++  +L C
Sbjct: 155 DSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
                 Y P   ++    F ++++A  +   P    D  S     FI   ++K+P++R +
Sbjct: 214 G-----YPPFYDENDAKLFEQILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFT 266
Query: 314 AQELMTHPFLKMYGDLNVD 332
            ++ + HP++   GD  +D
Sbjct: 267 CEQALQHPWIA--GDTALD 283

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 121/265 (45%), Gaps = 27/265 (10%)
Query: 85  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           TGQ  A+K    + ++   ++IA +E+++ +  + P +V   + F     + ++ EY D 
Sbjct: 27  TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
             L +  +  + +PE  + +I  Q L+ + + H + + IHRD+KP N+LI     +K+ D
Sbjct: 87  TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-KHNCIHRDVKPENILITKHSVIKLCD 145
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSP 262
           FG + ++   S   +  V T  Y SPE + G  +YG   D+W++G V  E  +G  P  P
Sbjct: 146 FGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWP 204
Query: 263 -------------------PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF----CSF 299
                              P  Q  +++        +  P    P +   P         
Sbjct: 205 GKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGL 264
Query: 300 ISACVQKEPQQRLSAQELMTHPFLK 324
           +  C+  +P +RL+ ++L+ HP+ +
Sbjct: 265 LKGCLHMDPTERLTCEQLLHHPYFE 289

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 125/259 (48%), Gaps = 16/259 (6%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 138
           L + K T +  A+K I     E     +  E+ +    + P +V     + S G + +I+
Sbjct: 36  LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL---INH 195
           + + GG L D + +     E   + +  QVL  + YL H+  I+HRDLKP NLL   ++ 
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDE 154
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLEC 253
             ++ I+DFG+S  M       +T  GT  Y++PE ++   Y    D WS+G++  +L C
Sbjct: 155 DSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
                 Y P   ++    F ++++A  +   P    D  S     FI   ++K+P++R +
Sbjct: 214 G-----YPPFYDENDAKLFEQILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFT 266
Query: 314 AQELMTHPFLKMYGDLNVD 332
            ++ + HP++   GD  +D
Sbjct: 267 CEQALQHPWIA--GDTALD 283

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 124/257 (48%), Gaps = 24/257 (9%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC-----PYVVVCYQSFYSNGAISI 136
           ++ TGQ FA+K++ +    S+     ++LK  ++S C     P++V   +++ S+G + +
Sbjct: 47  NRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIVELLETYSSDGMLYM 105
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAIC----EQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + E+MDG  L   + K       Y  A+      Q+L+ L Y H + +IIHRD+KP  +L
Sbjct: 106 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPHCVL 164
Query: 193 INHR---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 249
           +  +     VK+  FGV+  +  +   A   VGT ++M+PE +    YG   D+W  G++
Sbjct: 165 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 224
Query: 250 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKE 307
           L    +G  P+   +++        L E I+       P      S      +   +  +
Sbjct: 225 LFILLSGCLPFYGTKER--------LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLD 276
Query: 308 PQQRLSAQELMTHPFLK 324
           P +R++  E + HP+LK
Sbjct: 277 PAERITVYEALNHPWLK 293

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 121/253 (47%), Gaps = 13/253 (5%)
Query: 79  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           L + K TGQ  A+KVI      +++ +  + +E+++ +    P +   Y+ F   G   +
Sbjct: 44  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYL 103
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           + E   GG L D +   K   E   A I  QVL G+ Y H  K I+HRDLKP NLL+  +
Sbjct: 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK-IVHRDLKPENLLLESK 162
Query: 197 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
            +   ++I DFG+S    ++    +  +GT  Y++PE +  G Y  K D+WS G++L   
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKXKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYIL 220
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
            +G  P++   + D      E  +   + P     S+         I   +   P  R+S
Sbjct: 221 LSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESAK----DLIRKXLTYVPSXRIS 275
Query: 314 AQELMTHPFLKMY 326
           A++ + H +++ Y
Sbjct: 276 ARDALDHEWIQTY 288

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 84  WTGQFFALKVIQMNVEESARRQI---AQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 140
           W G   A+K  + + +E   + I    QE K+    + P ++           + +++E+
Sbjct: 28  WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87
Query: 141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK--HIIHRDLKPSNLLINHRGE 198
             GG L   L   K IP + L     Q+ +G+ YLH E    IIHRDLK SN+LI  + E
Sbjct: 88  ARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146
Query: 199 --------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 250
                   +KITDFG++     T+  +    G Y +M+PE I    +   SD+WS G++L
Sbjct: 147 NGDLSNKILKITDFGLAREWHRTTKMSAA--GAYAWMAPEVIRASMFSKGSDVWSYGVLL 204
Query: 251 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKEPQ 309
            E  TG+ P+      DG    Y +    +  P PS       PE F   +  C   +P 
Sbjct: 205 WELLTGEVPF---RGIDGLAVAYGVAMNKLALPIPST-----CPEPFAKLMEDCWNPDPH 256
Query: 310 QRLSAQELM 318
            R S   ++
Sbjct: 257 SRPSFTNIL 265

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 124/257 (48%), Gaps = 24/257 (9%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC-----PYVVVCYQSFYSNGAISI 136
           ++ TGQ FA+K++ +    S+     ++LK  ++S C     P++V   +++ S+G + +
Sbjct: 45  NRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIVELLETYSSDGMLYM 103
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAIC----EQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + E+MDG  L   + K       Y  A+      Q+L+ L Y H + +IIHRD+KP  +L
Sbjct: 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPHCVL 162
Query: 193 INHR---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 249
           +  +     VK+  FGV+  +  +   A   VGT ++M+PE +    YG   D+W  G++
Sbjct: 163 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 250 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKE 307
           L    +G  P+   +++        L E I+       P      S      +   +  +
Sbjct: 223 LFILLSGCLPFYGTKER--------LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLD 274
Query: 308 PQQRLSAQELMTHPFLK 324
           P +R++  E + HP+LK
Sbjct: 275 PAERITVYEALNHPWLK 291

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 119/246 (48%), Gaps = 12/246 (4%)
Query: 85  TGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           T Q +A+KVI + + +      I +E+++ +    P ++  ++    + +  I+ E   G
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVK 200
           G L D + K K   E   A I +QV  G+ Y+ H+ +I+HRDLKP N+L+  +    ++K
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYM-HKHNIVHRDLKPENILLESKEKDCDIK 164
Query: 201 ITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 260
           I DFG+S      +   +  +GT  Y++PE +  G Y  K D+WS G++L    +G  P+
Sbjct: 165 IIDFGLSTCFQQNTKMKDR-IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222
Query: 261 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
               + D      E  +   D P     SD         I   +   P  R++A + + H
Sbjct: 223 YGKNEYDILKRV-ETGKYAFDLPQWRTISDDAK----DLIRKMLTFHPSLRITATQCLEH 277
Query: 321 PFLKMY 326
           P+++ Y
Sbjct: 278 PWIQKY 283

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 119/246 (48%), Gaps = 12/246 (4%)
Query: 85  TGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 143
           T Q +A+KVI + + +      I +E+++ +    P ++  ++    + +  I+ E   G
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVK 200
           G L D + K K   E   A I +QV  G+ Y+ H+ +I+HRDLKP N+L+  +    ++K
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYM-HKHNIVHRDLKPENILLESKEKDCDIK 164
Query: 201 ITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 260
           I DFG+S      +   +  +GT  Y++PE +  G Y  K D+WS G++L    +G  P+
Sbjct: 165 IIDFGLSTCFQQNTKMKDR-IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222
Query: 261 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
               + D      E  +   D P     SD         I   +   P  R++A + + H
Sbjct: 223 YGKNEYDILKRV-ETGKYAFDLPQWRTISDDAK----DLIRKMLTFHPSLRITATQCLEH 277
Query: 321 PFLKMY 326
           P+++ Y
Sbjct: 278 PWIQKY 283

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 125/263 (47%), Gaps = 28/263 (10%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELK---------INQSSQCPYVVVCYQSFYSNG 132
           HK T + +A+K+I +    S   +  QEL+         + + S  P ++    ++ +N 
Sbjct: 38  HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97
Query: 133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
              ++ + M  G L D+L +  T+ E+    I   +L+ +  LH + +I+HRDLKP N+L
Sbjct: 98  FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENIL 156
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG------KYGYKSDIWSL 246
           ++    +K+TDFG S  +     +  +  GT +Y++PE I          YG + D+WS 
Sbjct: 157 LDDDMNIKLTDFGFSCQL-DPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---DQPPPSAPSDQFSPEFCSFISAC 303
           G+++     G  P+        W     LM  ++   +    S   D +S      +S  
Sbjct: 216 GVIMYTLLAGSPPF--------WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 267
Query: 304 VQKEPQQRLSAQELMTHPFLKMY 326
           +  +PQ+R +A+E + HPF + Y
Sbjct: 268 LVVQPQKRYTAEEALAHPFFQQY 290

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 122/263 (46%), Gaps = 26/263 (9%)
Query: 86  GQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           G+  ALK I+++ E+      A +E+ + +    P +V      +S   ++++ E+M+  
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103
Query: 145 SLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
            L   L + KT + +  +     Q+L+G+ + H  + I+HRDLKP NLLIN  G +K+ D
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLAD 162
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPY 260
           FG++             V T  Y +P+ + G  KY    DIWS+G +  E  TG+  FP 
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 261 SPPEQQ-------------DGWTSFYEL------MEAIVDQPPPSAPSDQFSPEFCSFIS 301
              + Q               W    EL         + ++ P S+    F  E    +S
Sbjct: 223 VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLS 282
Query: 302 ACVQKEPQQRLSAQELMTHPFLK 324
             +  +P +R+SA++ M HP+ K
Sbjct: 283 NMLCFDPNKRISARDAMNHPYFK 305

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 122/263 (46%), Gaps = 26/263 (9%)
Query: 86  GQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           G+  ALK I+++ E+      A +E+ + +    P +V      +S   ++++ E+M+  
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103
Query: 145 SLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 203
            L   L + KT + +  +     Q+L+G+ + H  + I+HRDLKP NLLIN  G +K+ D
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLAD 162
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPY 260
           FG++             V T  Y +P+ + G  KY    DIWS+G +  E  TG+  FP 
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 261 SPPEQQ-------------DGWTSFYEL------MEAIVDQPPPSAPSDQFSPEFCSFIS 301
              + Q               W    EL         + ++ P S+    F  E    +S
Sbjct: 223 VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLS 282
Query: 302 ACVQKEPQQRLSAQELMTHPFLK 324
             +  +P +R+SA++ M HP+ K
Sbjct: 283 NMLCFDPNKRISARDAMNHPYFK 305

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 122
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQP 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 124/262 (47%), Gaps = 14/262 (5%)
Query: 79  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 138
           L + K TG+ FA+K I     +     I  E+ + +  +   +V     + S   + +++
Sbjct: 40  LAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVM 99
Query: 139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NH 195
           + + GG L D + +     E+  + +  QVL  + YLH    I+HRDLKP NLL    + 
Sbjct: 100 QLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHR-MGIVHRDLKPENLLYYSQDE 158
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLEC 253
             ++ I+DFG+S  M       +T  GT  Y++PE ++   Y    D WS+G++  +L C
Sbjct: 159 ESKIMISDFGLSK-MEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 217
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
                 Y P   ++    F ++++A  +   P    D  S     FI   ++K+P +R +
Sbjct: 218 G-----YPPFYDENDSKLFEQILKAEYEFDSPYW--DDISDSAKDFIRNLMEKDPNKRYT 270
Query: 314 AQELMTHPFLKMYGDLNVDLSE 335
            ++   HP++     LN ++ E
Sbjct: 271 CEQAARHPWIAGDTALNKNIHE 292

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 28/263 (10%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELK---------INQSSQCPYVVVCYQSFYSNG 132
           HK T + +A+K+I +    S   +  QEL+         + + S  P ++    ++ +N 
Sbjct: 25  HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 84
Query: 133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
              ++ + M  G L D+L +  T+ E+    I   +L+ +  LH + +I+HRDLKP N+L
Sbjct: 85  FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENIL 143
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK------YGYKSDIWSL 246
           ++    +K+TDFG S  +     +     GT +Y++PE I          YG + D+WS 
Sbjct: 144 LDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 202
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---DQPPPSAPSDQFSPEFCSFISAC 303
           G+++     G  P+        W     LM  ++   +    S   D +S      +S  
Sbjct: 203 GVIMYTLLAGSPPF--------WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 254
Query: 304 VQKEPQQRLSAQELMTHPFLKMY 326
           +  +PQ+R +A+E + HPF + Y
Sbjct: 255 LVVQPQKRYTAEEALAHPFFQQY 277

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 131/251 (52%), Gaps = 14/251 (5%)
Query: 83  KWTGQFFALKVIQMNVE-ESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNGAISIILEY 140
           K TGQ +A K ++     +  R +I  E+ + + +  CP V+  ++ + +   I +ILEY
Sbjct: 51  KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEY 110
Query: 141 MDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH--- 195
             GG +      +  + + E  +  + +Q+L+G+ YLH + +I+H DLKP N+L++    
Sbjct: 111 AAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH-QNNIVHLDLKPQNILLSSIYP 169
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
            G++KI DFG+S  +   + +    +GT  Y++PE ++       +D+W++G++     T
Sbjct: 170 LGDIKIVDFGMSRKIGH-ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228
Query: 256 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 315
              P+   + Q+   ++  + +  VD    +  S   S     FI + + K P++R +A+
Sbjct: 229 HTSPFVGEDNQE---TYLNISQVNVDYSEETFSS--VSQLATDFIQSLLVKNPEKRPTAE 283
Query: 316 ELMTHPFLKMY 326
             ++H +L+ +
Sbjct: 284 ICLSHSWLQQW 294

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 28/263 (10%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELK---------INQSSQCPYVVVCYQSFYSNG 132
           HK T + +A+K+I +    S   +  QEL+         + + S  P ++    ++ +N 
Sbjct: 38  HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97
Query: 133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
              ++ + M  G L D+L +  T+ E+    I   +L+ +  LH + +I+HRDLKP N+L
Sbjct: 98  FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENIL 156
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK------YGYKSDIWSL 246
           ++    +K+TDFG S  +     +     GT +Y++PE I          YG + D+WS 
Sbjct: 157 LDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---DQPPPSAPSDQFSPEFCSFISAC 303
           G+++     G  P+        W     LM  ++   +    S   D +S      +S  
Sbjct: 216 GVIMYTLLAGSPPF--------WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 267
Query: 304 VQKEPQQRLSAQELMTHPFLKMY 326
           +  +PQ+R +A+E + HPF + Y
Sbjct: 268 LVVQPQKRYTAEEALAHPFFQQY 290

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 119/244 (48%), Gaps = 12/244 (4%)
Query: 85  TGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           TGQ +A K+I    + SAR  +++ +E +I +  + P +V  + S    G   ++ + + 
Sbjct: 28  TGQEYAAKIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVT 86
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---V 199
           GG L + +   +   E   +   +Q+L+ + + H    I+HRDLKP NLL+  + +   V
Sbjct: 87  GGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG-IVHRDLKPENLLLASKSKGAAV 145
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFG++  +         F GT  Y+SPE +    YG   D+W+ G++L     G   
Sbjct: 146 KLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG--- 202
Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           Y P   +D    + ++     D P P    D  +PE    I+  +   P +R++A E + 
Sbjct: 203 YPPFWDEDQHRLYQQIKAGAYDFPSPEW--DTVTPEAKDLINKMLTINPAKRITASEALK 260
Query: 320 HPFL 323
           HP++
Sbjct: 261 HPWI 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 119/244 (48%), Gaps = 12/244 (4%)
Query: 85  TGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           TGQ +A K+I    + SAR  +++ +E +I +  + P +V  + S    G   ++ + + 
Sbjct: 28  TGQEYAAKIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVT 86
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---V 199
           GG L + +   +   E   +   +Q+L+ + + H    I+HRDLKP NLL+  + +   V
Sbjct: 87  GGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG-IVHRDLKPENLLLASKSKGAAV 145
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFG++  +         F GT  Y+SPE +    YG   D+W+ G++L     G   
Sbjct: 146 KLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG--- 202
Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           Y P   +D    + ++     D P P    D  +PE    I+  +   P +R++A E + 
Sbjct: 203 YPPFWDEDQHRLYQQIKAGAYDFPSPEW--DTVTPEAKDLINKMLTINPAKRITASEALK 260
Query: 320 HPFL 323
           HP++
Sbjct: 261 HPWI 264

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 124/256 (48%), Gaps = 19/256 (7%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEY 140
           HK T   FA+K+I     + ++R   +E++I  +  Q P ++     +     + ++ E 
Sbjct: 43  HKATNMEFAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97
Query: 141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL-INHRGE- 198
           M GG L D + + K   E   +A+   + K + YLH +  ++HRDLKPSN+L ++  G  
Sbjct: 98  MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG-VVHRDLKPSNILYVDESGNP 156
Query: 199 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
             ++I DFG +  + + +G   T   T N+++PE +    Y    DIWSLG++L    TG
Sbjct: 157 ESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS---DQFSPEFCSFISACVQKEPQQRLS 313
             P++     +G     E + A +     S      +  S      +S  +  +P QRL+
Sbjct: 217 YTPFA-----NGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT 271
Query: 314 AQELMTHPFLKMYGDL 329
           A  ++ HP++  +  L
Sbjct: 272 AALVLRHPWIVHWDQL 287

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 4/207 (1%)
Query: 60  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 238 GYKS-DIWSLGLVLLECATGQFPYSPP 263
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 114/256 (44%), Gaps = 29/256 (11%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V H+ TG+   +K + +  +E  +R   +E+K+ +  + P V+      Y +  ++ I E
Sbjct: 29  VTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87
Query: 140 YMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE 198
           Y+ GG+L   +K + +  P     +  + +  G+ YLH   +IIHRDL   N L+     
Sbjct: 88  YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH-SMNIIHRDLNSHNCLVRENKN 146
Query: 199 VKITDFGVSAIMASTSGQAN--------------TFVGTYNYMSPERISGGKYGYKSDIW 244
           V + DFG++ +M     Q                T VG   +M+PE I+G  Y  K D++
Sbjct: 147 VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVF 206
Query: 245 SLGLVLLECATGQFPYSP---PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 301
           S G+VL E   G+    P   P   D   +    ++      PP+ P     P F     
Sbjct: 207 SFGIVLCE-IIGRVNADPDYLPRTMDFGLNVRGFLDRYC---PPNCP-----PSFFPITV 257
Query: 302 ACVQKEPQQRLSAQEL 317
            C   +P++R S  +L
Sbjct: 258 RCCDLDPEKRPSFVKL 273

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 119/244 (48%), Gaps = 12/244 (4%)
Query: 85  TGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           TG  +A K+I    + SAR  +++ +E +I +  +   +V  + S    G   ++ + + 
Sbjct: 28  TGHEYAAKIINTK-KLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVT 86
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEV 199
           GG L + +   +   E   +   +Q+L+ +L+ H +  ++HRDLKP NLL+  +     V
Sbjct: 87  GGELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRDLKPENLLLASKCKGAAV 145
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFG++  +         F GT  Y+SPE +    YG   DIW+ G++L     G   
Sbjct: 146 KLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG--- 202
Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           Y P   +D    + ++     D P P    D  +PE  + I+  +   P +R++A E + 
Sbjct: 203 YPPFWDEDQHKLYQQIKAGAYDFPSPE--WDTVTPEAKNLINQMLTINPAKRITAHEALK 260
Query: 320 HPFL 323
           HP++
Sbjct: 261 HPWV 264

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 118/244 (48%), Gaps = 12/244 (4%)
Query: 85  TGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
            GQ +A  +I    + SAR  +++ +E +I +  + P +V  + S    G   +I + + 
Sbjct: 35  AGQEYAAMIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 93
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEV 199
           GG L + +   +   E   +   +Q+L+ +L+ H +  ++HR+LKP NLL+  +     V
Sbjct: 94  GGELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRNLKPENLLLASKLKGAAV 152
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           K+ DFG++  +         F GT  Y+SPE +    YG   D+W+ G++L     G   
Sbjct: 153 KLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG--- 209
Query: 260 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
           Y P   +D    + ++     D P P    D  +PE    I+  +   P +R++A E + 
Sbjct: 210 YPPFWDEDQHRLYQQIKAGAYDFPSPEW--DTVTPEAKDLINKMLTINPSKRITAAEALK 267
Query: 320 HPFL 323
           HP++
Sbjct: 268 HPWI 271

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 25  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 84
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L DF+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 85  FL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 142
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 143 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 203 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 262
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 263 RSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 121/266 (45%), Gaps = 33/266 (12%)
Query: 86  GQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           G+ FALK I++  E E       +E+ I +  +   +V  Y   ++   + ++ E++D  
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85
Query: 145 SLADFLKKVKTIPEEYLAAICE-----QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
                LKK+  + E  L ++       Q+L G+ Y H ++ ++HRDLKP NLLIN  GE+
Sbjct: 86  -----LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGEL 139
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 258
           KI DFG++        +    V T  Y +P+ + G  KY    DIWS+G +  E   G  
Sbjct: 140 KIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
Query: 259 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSF------------------ 299
            +    + D     + ++     +  P+     ++ P F  +                  
Sbjct: 200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259
Query: 300 -ISACVQKEPQQRLSAQELMTHPFLK 324
            +S  ++ +P QR++A++ + H + K
Sbjct: 260 LLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L DF+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 86  FL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 143
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 204 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 263
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 264 RSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 121/266 (45%), Gaps = 33/266 (12%)
Query: 86  GQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           G+ FALK I++  E E       +E+ I +  +   +V  Y   ++   + ++ E++D  
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85
Query: 145 SLADFLKKVKTIPEEYLAAICE-----QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
                LKK+  + E  L ++       Q+L G+ Y H ++ ++HRDLKP NLLIN  GE+
Sbjct: 86  -----LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGEL 139
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 258
           KI DFG++        +    V T  Y +P+ + G  KY    DIWS+G +  E   G  
Sbjct: 140 KIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAP 199
Query: 259 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSF------------------ 299
            +    + D     + ++     +  P+     ++ P F  +                  
Sbjct: 200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259
Query: 300 -ISACVQKEPQQRLSAQELMTHPFLK 324
            +S  ++ +P QR++A++ + H + K
Sbjct: 260 LLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L DF+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEG 140
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 121/266 (45%), Gaps = 33/266 (12%)
Query: 86  GQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           G+ FALK I++  E E       +E+ I +  +   +V  Y   ++   + ++ E++D  
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85
Query: 145 SLADFLKKVKTIPEEYLAAICE-----QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
                LKK+  + E  L ++       Q+L G+ Y H ++ ++HRDLKP NLLIN  GE+
Sbjct: 86  -----LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGEL 139
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 258
           KI DFG++        +    + T  Y +P+ + G  KY    DIWS+G +  E   G  
Sbjct: 140 KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
Query: 259 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSF------------------ 299
            +    + D     + ++     +  P+     ++ P F  +                  
Sbjct: 200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259
Query: 300 -ISACVQKEPQQRLSAQELMTHPFLK 324
            +S  ++ +P QR++A++ + H + K
Sbjct: 260 LLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 123/256 (48%), Gaps = 19/256 (7%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEY 140
           HK T   FA+K+I     + ++R   +E++I  +  Q P ++     +     + ++ E 
Sbjct: 43  HKATNXEFAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97
Query: 141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL-INHRGE- 198
             GG L D + + K   E   +A+   + K + YLH +  ++HRDLKPSN+L ++  G  
Sbjct: 98  XKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG-VVHRDLKPSNILYVDESGNP 156
Query: 199 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
             ++I DFG +  + + +G   T   T N+++PE +    Y    DIWSLG++L    TG
Sbjct: 157 ESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS---DQFSPEFCSFISACVQKEPQQRLS 313
             P++     +G     E + A +     S      +  S      +S  +  +P QRL+
Sbjct: 217 YTPFA-----NGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLT 271
Query: 314 AQELMTHPFLKMYGDL 329
           A  ++ HP++  +  L
Sbjct: 272 AALVLRHPWIVHWDQL 287

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 118/242 (48%), Gaps = 12/242 (4%)
Query: 87  QFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           Q +A K+I    + SAR  +++ +E +I +  + P +V  + S    G   ++ + + GG
Sbjct: 57  QEYAAKIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 115
Query: 145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKI 201
            L + +   +   E   +    Q+L+ + ++H +  I+HRDLKP NLL+  +     VK+
Sbjct: 116 ELFEDIVAREYYSEADASHCIHQILESVNHIH-QHDIVHRDLKPENLLLASKCKGAAVKL 174
Query: 202 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS 261
            DFG++  +         F GT  Y+SPE +    YG   DIW+ G++L     G   Y 
Sbjct: 175 ADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG---YP 231
Query: 262 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 321
           P   +D    + ++     D P P    D  +PE  + I+  +   P +R++A + + HP
Sbjct: 232 PFWDEDQHKLYQQIKAGAYDFPSPEW--DTVTPEAKNLINQMLTINPAKRITADQALKHP 289
Query: 322 FL 323
           ++
Sbjct: 290 WV 291

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 128/258 (49%), Gaps = 40/258 (15%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF-------YSNG 132
            +H+  G+ + +K ++ N  E A R++    K++  +   Y   C+  F         N 
Sbjct: 30  AKHRIDGKTYVIKRVKYN-NEKAEREVKALAKLDHVNIVHYNG-CWDGFDYDPETSSKNS 87
Query: 133 AIS------IILEYMDGGSLADFLKKVKTIPEEYLAAI--CEQVLKGLLYLHHEKHIIHR 184
           + S      I +E+ D G+L  +++K +    + + A+   EQ+ KG+ Y+H +K +I+R
Sbjct: 88  SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK-LINR 146
Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 244
           DLKPSN+ +    +VKI DFG+   + +  G+     GT  YMSPE+IS   YG + D++
Sbjct: 147 DLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRXRSKGTLRYMSPEQISSQDYGKEVDLY 205
Query: 245 SLGLVLLE----CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           +LGL+L E    C T  F  S          F +L + I+        SD F  +  + +
Sbjct: 206 ALGLILAELLHVCDTA-FETSK--------FFTDLRDGII--------SDIFDKKEKTLL 248
Query: 301 SACVQKEPQQRLSAQELM 318
              + K+P+ R +  E++
Sbjct: 249 QKLLSKKPEDRPNTSEIL 266

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 119/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++D   L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 86  HVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 143
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 296
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 204 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 263
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 264 RSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 42  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 98
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 99  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 157
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 158 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 212
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 213 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 268
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 269 MTECWNNNVNQRPSFRDL 286

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 56  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 112
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 113 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 171
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 226
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 227 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 282
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 283 MTECWNNNVNQRPSFRDL 300

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 38  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 94
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 153
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 208
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 264
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 265 MTECWNNNVNQRPSFRDL 282

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 69  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 125
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 184
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 185 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 239
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 295
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 296 MTECWNNNVNQRPSFRDL 313

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 45  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 101
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 102 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 160
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 161 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 215
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 216 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 271
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 272 MTECWNNNVNQRPSFRDL 289

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 44  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 100
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 101 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 159
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 160 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 214
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 215 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 270
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 271 MTECWNNNVNQRPSFRDL 288

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 56  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 112
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 113 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 171
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 226
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 227 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 282
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 283 MTECWNNNVNQRPSFRDL 300

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 36  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 92
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 93  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 151
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 152 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 206
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 207 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 262
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 263 MTECWNNNVNQRPSFRDL 280

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 37  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 93
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 94  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 152
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 153 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 207
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 208 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 263
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 264 MTECWNNNVNQRPSFRDL 281

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 41  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 97
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 98  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 156
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 211
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 267
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 268 MTECWNNNVNQRPSFRDL 285

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 38  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 94
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 153
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 208
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 264
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 265 MTECWNNNVNQRPSFRDL 282

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 43  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 99
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 100 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 158
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 159 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 213
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 214 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 269
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 270 MTECWNNNVNQRPSFRDL 287

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 38  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 94
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 153
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 208
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 264
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 265 MTECWNNNVNQRPSFRDL 282

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 116/233 (49%), Gaps = 14/233 (6%)
Query: 39  IVSQTETEAPPLIKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQ--- 95
           I+   E   P   K    +L+ ED +              +V+ K   + FA+K++    
Sbjct: 52  ILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE 111
Query: 96  -MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 154
            +   E+A  +  +++ +N  S+  ++   + +F  +  + ++++Y  GG L   L K +
Sbjct: 112 MLKRAETACFREERDVLVNGDSK--WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE 169
Query: 155 -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMAS 212
             +PEE       +++  +  +H + H +HRD+KP N+L++  G +++ DFG    +M  
Sbjct: 170 DRLPEEMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228
Query: 213 TSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPY 260
            + Q++  VGT +Y+SPE +       G+YG + D WSLG+ + E   G+ P+
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTR 200
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 140 Y--MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           +  MD     D    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 86  FLSMDLKKFMD-ASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEG 143
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 204 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 263
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 264 RSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 140 Y--MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           +  MD     D    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 84  FLSMDLKKFMD-ASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEG 141
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 142 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 202 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 261
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 262 RSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 30  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 89
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 90  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 147
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 148 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTR 207
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 296
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 208 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 267
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 268 RSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 27  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 86
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 87  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 144
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 145 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 204
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 205 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 264
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 265 RSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 84  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 141
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 142 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 202 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 261
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 262 RSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 109/216 (50%), Gaps = 16/216 (7%)
Query: 57  QLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQ----IAQELKI 112
           QL+ ED +              +V+ K T + +A+K+  +N  E  +R       +E  +
Sbjct: 70  QLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKI--LNKWEMLKRAETACFREERDV 127
Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKG 171
             +  C ++   + +F     + ++++Y  GG L   L K +  +PE+       +++  
Sbjct: 128 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 187
Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSP 229
           +  +H + H +HRD+KP N+L++  G +++ DFG S +  +  G  Q++  VGT +Y+SP
Sbjct: 188 IDSIH-QLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 245
Query: 230 ERISG-----GKYGYKSDIWSLGLVLLECATGQFPY 260
           E +       GKYG + D WSLG+ + E   G+ P+
Sbjct: 246 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 82  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 139
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 140 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 260 RSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 30  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 89
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 90  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 147
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 148 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 207
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 296
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 208 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 267
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 268 RSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 82  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 139
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 140 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 260 RSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 101/189 (53%), Gaps = 25/189 (13%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAI--CEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           I +E+ D G+L  +++K +    + + A+   EQ+ KG+ Y+H +K +IHRDLKPSN+ +
Sbjct: 111 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK-LIHRDLKPSNIFL 169
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE- 252
               +VKI DFG+   + +  G+     GT  YMSPE+IS   YG + D+++LGL+L E 
Sbjct: 170 VDTKQVKIGDFGLVTSLKN-DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228
Query: 253 ---CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
              C T  F  S          F +L + I+        SD F  +  + +   + K+P+
Sbjct: 229 LHVCDTA-FETSK--------FFTDLRDGII--------SDIFDKKEKTLLQKLLSKKPE 271
Query: 310 QRLSAQELM 318
            R +  E++
Sbjct: 272 DRPNTSEIL 280

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 109/216 (50%), Gaps = 16/216 (7%)
Query: 57  QLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQ----IAQELKI 112
           QL+ ED +              +V+ K T + +A+K+  +N  E  +R       +E  +
Sbjct: 86  QLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKI--LNKWEMLKRAETACFREERDV 143
Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKG 171
             +  C ++   + +F     + ++++Y  GG L   L K +  +PE+       +++  
Sbjct: 144 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 203
Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSP 229
           +  +H + H +HRD+KP N+L++  G +++ DFG S +  +  G  Q++  VGT +Y+SP
Sbjct: 204 IDSIH-QLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 261
Query: 230 ERISG-----GKYGYKSDIWSLGLVLLECATGQFPY 260
           E +       GKYG + D WSLG+ + E   G+ P+
Sbjct: 262 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 114/250 (45%), Gaps = 31/250 (12%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++ K TG   A+K +++ V        A+EL        P +V  Y +      ++I +E
Sbjct: 112 MEDKQTGFQCAVKKVRLEVFR------AEELMACAGLTSPRIVPLYGAVREGPWVNIFME 165
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-E 198
            ++GGSL   +K+   +PE+       Q L+GL YL H + I+H D+K  N+L++  G  
Sbjct: 166 LLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYL-HSRRILHGDVKADNVLLSSDGSH 224
Query: 199 VKITDFGVSAIMASTSGQANTFV------GTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
             + DFG  A+     G   + +      GT  +M+PE + G     K D+WS   ++L 
Sbjct: 225 AALCDFG-HAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLH 283
Query: 253 CATGQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSA---PSDQFSPEFCSFISACVQKE 307
              G  P         WT F+   L   I  +PPP     PS   +P     I   ++KE
Sbjct: 284 MLNGCHP---------WTQFFRGPLCLKIASEPPPVREIPPS--CAPLTAQAIQEGLRKE 332
Query: 308 PQQRLSAQEL 317
           P  R+SA EL
Sbjct: 333 PIHRVSAAEL 342

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 84  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 141
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 142 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 202 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 261
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 262 RSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 84  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEG 141
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 142 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 202 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 261
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 262 RSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 27  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 86
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 87  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 144
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 145 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 204
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 205 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 264
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 265 RSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 86  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 143
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 204 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 263
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 264 RSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 25  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 84
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 85  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 142
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 143 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 203 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 262
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 263 RSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 82  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 139
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 140 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 260 RSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L   +T  E + L  I  Q  +G+ YLH  K 
Sbjct: 70  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKS 128
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 295
            Y ++SD+++ G+VL E  TGQ PYS    +D      E++      P  S         
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSLSPDLSKVRSNCPKR 245
Query: 296 FCSFISACVQKEPQQRLS 313
               ++ C++K+  +R S
Sbjct: 246 MKRLMAECLKKKRDERPS 263

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 14/247 (5%)
Query: 81  QHKWTGQFFALKVIQMNVEES-ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           + K T + +ALKV++  V++   R +I   L+++     P ++   + F +   IS++LE
Sbjct: 73  KQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH----PNIIKLKEIFETPTEISLVLE 128
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---R 196
            + GG L D + +     E   A   +Q+L+ + YLH E  I+HRDLKP NLL       
Sbjct: 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH-ENGIVHRDLKPENLLYATPAPD 187
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
             +KI DFG+S I+        T  GT  Y +PE + G  YG + D+WS+G++      G
Sbjct: 188 APLKIADFGLSKIVEHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
             P+   E+ D +  F  ++        P    D+ S      +   +  +P++RL+  +
Sbjct: 247 FEPFY-DERGDQFM-FRRILNCEYYFISPWW--DEVSLNAKDLVRKLIVLDPKKRLTTFQ 302
Query: 317 LMTHPFL 323
            + HP++
Sbjct: 303 ALQHPWV 309

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 25  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 84
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 85  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEG 142
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 143 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 203 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 262
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 263 RSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 123/250 (49%), Gaps = 19/250 (7%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEY 140
           HK T   +A+KVI     + ++R  ++E++I  +  Q P ++     +     + ++ E 
Sbjct: 48  HKATNMEYAVKVI-----DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTEL 102
Query: 141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL-INHRGE- 198
           M GG L D + + K   E   + +   + K + YLH +  ++HRDLKPSN+L ++  G  
Sbjct: 103 MRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG-VVHRDLKPSNILYVDESGNP 161
Query: 199 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
             ++I DFG +  + + +G   T   T N+++PE +    Y    DIWSLG++L     G
Sbjct: 162 ECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLS 313
             P++     +G +   E +   +     +     +   S      +S  +  +P QRL+
Sbjct: 222 YTPFA-----NGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLT 276
Query: 314 AQELMTHPFL 323
           A++++ HP++
Sbjct: 277 AKQVLQHPWV 286

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 123/251 (49%), Gaps = 21/251 (8%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEY 140
           HK T   +A+KVI     + ++R  ++E++I  +  Q P ++     +     + ++ E 
Sbjct: 48  HKATNMEYAVKVI-----DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTEL 102
Query: 141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL-INHRGE- 198
           M GG L D + + K   E   + +   + K + YLH +  ++HRDLKPSN+L ++  G  
Sbjct: 103 MRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG-VVHRDLKPSNILYVDESGNP 161
Query: 199 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
             ++I DFG +  + + +G   T   T N+++PE +    Y    DIWSLG++L     G
Sbjct: 162 ECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221
Query: 257 QFPYS--PPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRL 312
             P++  P +  +      E++  I            +  S      +S  +  +P QRL
Sbjct: 222 YTPFANGPSDTPE------EILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRL 275
Query: 313 SAQELMTHPFL 323
           +A++++ HP++
Sbjct: 276 TAKQVLQHPWV 286

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 86  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 143
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 296
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 204 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 263
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 264 RSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 25  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 84
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 85  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 142
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 143 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 203 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 262
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 263 RSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 84  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 141
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 142 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 202 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 261
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 262 RSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 86  FLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 143
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 204 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 263
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 264 RSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 82  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 139
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 140 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 260 RSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 38/274 (13%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 140 --------YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
                   +MD  +L         IP   + +   Q+L+GL + H  + ++HRDLKP NL
Sbjct: 82  HVHQDLKTFMDASALTG-------IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNL 133
Query: 192 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVL 250
           LIN  G +K+ DFG++             V T  Y +PE + G K Y    DIWSLG + 
Sbjct: 134 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193
Query: 251 LECATGQFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP--- 294
            E  T +  +    + D     +  +            ++ D  P  P      FS    
Sbjct: 194 AEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVP 253
Query: 295 ----EFCSFISACVQKEPQQRLSAQELMTHPFLK 324
               +  S +S  +  +P +R+SA+  + HPF +
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 14/224 (6%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 162
           Q+ QE+ I +    P VV   +     +   + ++ E ++ G + + +  +K + E+   
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQAR 140
Query: 163 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 222
              + ++KG+ YLH++K IIHRD+KPSNLL+   G +KI DFGVS     +    +  VG
Sbjct: 141 FYFQDLIKGIEYLHYQK-IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG 199
Query: 223 TYNYMSPERISGGKY---GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 279
           T  +M+PE +S  +    G   D+W++G+ L     GQ P+         +         
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF 259
Query: 280 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
            DQP         + +    I+  + K P+ R+   E+  HP++
Sbjct: 260 PDQP-------DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 17/226 (7%)
Query: 80  VQHKWTGQFFALKVIQMNVEESAR----RQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
            + K T Q  A+K I++     A+    R   +E+K+ Q    P ++    +F     IS
Sbjct: 29  ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           ++ ++M+             +   ++ A     L+GL YLH +  I+HRDLKP+NLL++ 
Sbjct: 89  LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLDE 147
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECA 254
            G +K+ DFG++    S +      V T  Y +PE + G + YG   D+W++G +L E  
Sbjct: 148 NGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207
Query: 255 TGQFPYSPPEQQ-DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 299
             + P+ P +   D  T  +E +           P+++  P+ CS 
Sbjct: 208 L-RVPFLPGDSDLDQLTRIFETL---------GTPTEEQWPDMCSL 243

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 112/249 (44%), Gaps = 29/249 (11%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++ K TG   A+K +++ V        A+EL        P +V  Y +      ++I +E
Sbjct: 93  MEDKQTGFQCAVKKVRLEVFR------AEELMACAGLTSPRIVPLYGAVREGPWVNIFME 146
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-E 198
            ++GGSL   +K+   +PE+       Q L+GL YL H + I+H D+K  N+L++  G  
Sbjct: 147 LLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYL-HSRRILHGDVKADNVLLSSDGSH 205
Query: 199 VKITDFGVSAIMASTSGQANTFVGTY-----NYMSPERISGGKYGYKSDIWSLGLVLLEC 253
             + DFG +  +       +   G Y      +M+PE + G     K D+WS   ++L  
Sbjct: 206 AALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHM 265
Query: 254 ATGQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSA---PSDQFSPEFCSFISACVQKEP 308
             G  P         WT F+   L   I  +PPP     PS   +P     I   ++KEP
Sbjct: 266 LNGCHP---------WTQFFRGPLCLKIASEPPPVREIPPS--CAPLTAQAIQEGLRKEP 314
Query: 309 QQRLSAQEL 317
             R+SA EL
Sbjct: 315 IHRVSAAEL 323

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 39  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 95
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HR+L   N+L+ +   V
Sbjct: 96  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRNLATRNILVENENRV 154
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 155 KIGDFGLTKVLPQDKEYYKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 209
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 210 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 265
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 266 MTECWNNNVNQRPSFRDL 283

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 11/247 (4%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V  + TG  FA K + M   ES +  + +E++     + P +V  + +F  +  + +I E
Sbjct: 70  VTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 128
Query: 140 YMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-- 196
           +M GG L + +  +   + E+       QV KGL ++H E + +H DLKP N++   +  
Sbjct: 129 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRS 187
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
            E+K+ DFG++A +        T  GT  + +PE   G   GY +D+WS+G++     +G
Sbjct: 188 NELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
             P+   E  D      +  +  +D    S      S +   FI   +  +P  R++  +
Sbjct: 247 LSPFG-GENDDETLRNVKSCDWNMDDSAFSG----ISEDGKDFIRKLLLADPNTRMTIHQ 301
Query: 317 LMTHPFL 323
            + HP+L
Sbjct: 302 ALEHPWL 308

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 78  QLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           +L++ K   +  A+K I+    ++E+ +R+I      ++S + P +V   +   +   ++
Sbjct: 36  RLMRDKQANELVAVKYIERGEKIDENVKREIIN----HRSLRHPNIVRFKEVILTPTHLA 91
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           I++EY  GG L + +       E+      +Q++ G+ Y  H   + HRDLK  N L++ 
Sbjct: 92  IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYA-HAMQVAHRDLKLENTLLDG 150
Query: 196 R--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLE 252
                +KI DFG S      S Q  + VGT  Y++PE +   +Y G  +D+WS G+ L  
Sbjct: 151 SPAPRLKIADFGYSKASVLHS-QPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 312
              G +P+  PE+     +F + +  I++           SPE    IS     +P +R+
Sbjct: 210 MLVGAYPFEDPEEP---KNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRI 266
Query: 313 SAQELMTHP-FLK 324
           S  E+  H  FLK
Sbjct: 267 SIPEIRNHEWFLK 279

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 122/253 (48%), Gaps = 15/253 (5%)
Query: 78  QLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           +L++ K + +  A+K I+    ++E+ +R+I      ++S + P +V   +   +   ++
Sbjct: 35  RLMRDKQSNELVAVKYIERGEKIDENVKREIIN----HRSLRHPNIVRFKEVILTPTHLA 90
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           I++EY  GG L + +       E+      +Q++ G+ Y  H   + HRDLK  N L++ 
Sbjct: 91  IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDG 149
Query: 196 R--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLE 252
                +KI DFG S   +    Q  + VGT  Y++PE +   +Y G  +D+WS G+ L  
Sbjct: 150 SPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 208
Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 312
              G +P+  PE+     +F + +  I++           SPE    IS     +P +R+
Sbjct: 209 MLVGAYPFEDPEEP---KNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRI 265
Query: 313 SAQELMTHP-FLK 324
           S  E+  H  FLK
Sbjct: 266 SIPEIRNHEWFLK 278

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 123/258 (47%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 41  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 97
Query: 141 MDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+   + I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 98  LPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 156
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 211
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 267
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 268 MTECWNNNVNQRPSFRDL 285

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 112/238 (47%), Gaps = 13/238 (5%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A K+ +  VE+  R    QE++I +S   P ++  Y++F  N  I +++E   GG L + 
Sbjct: 39  AKKIPKYFVEDVDR--FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFER 96
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGV 206
           +   +   E   A I + VL  + Y  H+ ++ HRDLKP N L    +    +K+ DFG+
Sbjct: 97  VVHKRVFRESDAARIMKDVLSAVAYC-HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGL 155
Query: 207 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 266
           +A          T VGT  Y+SP+ +  G YG + D WS G+++     G  P+S P   
Sbjct: 156 AARF-KPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDX 213
Query: 267 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
           +      E          P       SP+  S I   + K P+QR+++ + + H + +
Sbjct: 214 EVMLKIREGTFTF-----PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 11/247 (4%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           V  + TG  FA K + M   ES +  + +E++     + P +V  + +F  +  + +I E
Sbjct: 176 VTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 140 YMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-- 196
           +M GG L + +  +   + E+       QV KGL ++H E + +H DLKP N++   +  
Sbjct: 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRS 293
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
            E+K+ DFG++A +        T  GT  + +PE   G   GY +D+WS+G++     +G
Sbjct: 294 NELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
             P+   E  D      +  +  +D    S      S +   FI   +  +P  R++  +
Sbjct: 353 LSPFG-GENDDETLRNVKSCDWNMDDSAFSG----ISEDGKDFIRKLLLADPNTRMTIHQ 407
Query: 317 LMTHPFL 323
            + HP+L
Sbjct: 408 ALEHPWL 414

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 112/238 (47%), Gaps = 13/238 (5%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A K+ +  VE+  R    QE++I +S   P ++  Y++F  N  I +++E   GG L + 
Sbjct: 56  AKKIPKYFVEDVDR--FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFER 113
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGV 206
           +   +   E   A I + VL  + Y  H+ ++ HRDLKP N L    +    +K+ DFG+
Sbjct: 114 VVHKRVFRESDAARIMKDVLSAVAYC-HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGL 172
Query: 207 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 266
           +A          T VGT  Y+SP+ +  G YG + D WS G+++     G  P+S P   
Sbjct: 173 AARF-KPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDX 230
Query: 267 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
           +      E          P       SP+  S I   + K P+QR+++ + + H + +
Sbjct: 231 EVMLKIREGTFTF-----PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 123/259 (47%), Gaps = 20/259 (7%)
Query: 100 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 159
           E    +I  E+ + +S   P ++  +  F       ++ E+ +GG L + +       E 
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 160 YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQ 216
             A I +Q+L G+ YL H+ +I+HRD+KP N+L+ ++     +KI DFG+S+   S   +
Sbjct: 147 DAANIMKQILSGICYL-HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYK 204
Query: 217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 276
               +GT  Y++PE +   KY  K D+WS G+++     G  P+     QD       ++
Sbjct: 205 LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------II 256
Query: 277 EAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS 334
           + +         +D    S E    I   +  +  +R +A+E +   ++K Y + N++ S
Sbjct: 257 KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN-NINKS 315
Query: 335 EYFTDAGSPLATLSNLSGF 353
           +  T  G+    LSN+  F
Sbjct: 316 DQKTLCGA----LSNMRKF 330

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  AL  I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 26/268 (9%)
Query: 81  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  AL  I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 22  RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 140 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 197
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 82  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 139
Query: 198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 256
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 140 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 257 QFPYSPPEQQDGWTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EF 296
           +  +    + D     +  +            ++ D  P  P      FS        + 
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 260 RSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 113/226 (50%), Gaps = 29/226 (12%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+KV++   E++   ++ +E +I      PY+V    VC        A+ +++E   GG 
Sbjct: 41  AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----ALMLVMEMAGGGP 95
Query: 146 LADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L  FL  K + IP   +A +  QV  G+ YL  EK+ +HRDL   N+L+ +R   KI+DF
Sbjct: 96  LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRHYAKISDF 154
Query: 205 GVS-AIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G+S A+ A  S       G +   + +PE I+  K+  +SD+WS G+ + E  + GQ PY
Sbjct: 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214
Query: 261 SP---PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
                PE      +F E  + +  + PP  P     PE  + +S C
Sbjct: 215 KKMKGPEV----MAFIEQGKRM--ECPPECP-----PELYALMSDC 249

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+E+
Sbjct: 41  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEF 97
Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL ++L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 98  LPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 156
Query: 200 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 211
Query: 252 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 299
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 267
Query: 300 ISACVQKEPQQRLSAQEL 317
           ++ C      QR S ++L
Sbjct: 268 MTECWNNNVNQRPSFRDL 285

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 83  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 137
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 196
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 197 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 255
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 256 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 306
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR++  E M HP++
Sbjct: 307 KTEPTQRMTITEFMNHPWI 325

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 39  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 93
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 94  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 152
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 153 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 211
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 212 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 262
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR++  E M HP++
Sbjct: 263 KTEPTQRMTITEFMNHPWI 281

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 89  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 143
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 144 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 202
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 203 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 261
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 262 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 312
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR++  E M HP++
Sbjct: 313 KTEPTQRMTITEFMNHPWI 331

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 38  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 92
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 93  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 151
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 152 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 210
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 211 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 261
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR++  E M HP++
Sbjct: 262 KTEPTQRMTITEFMNHPWI 280

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 37  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 91
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 92  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 150
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 151 KRPNAILKLTDFGFAKETTSHNSLTEPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 209
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 210 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 260
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR++  E M HP++
Sbjct: 261 KTEPTQRMTITEFMNHPWI 279

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 37  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 91
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 92  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 150
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 151 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 209
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 210 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 260
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR++  E M HP++
Sbjct: 261 KTEPTQRMTITEFMNHPWI 279

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 39  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 93
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 94  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 152
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 153 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 211
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 212 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 262
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR++  E M HP++
Sbjct: 263 KTEPTQRMTITEFMNHPWI 281

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 44  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 98
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 99  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 157
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 158 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 216
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 217 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 267
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR++  E M HP++
Sbjct: 268 KTEPTQRMTITEFMNHPWI 286

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 43  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 97
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 98  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 156
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 157 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 215
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 216 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 266
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR++  E M HP++
Sbjct: 267 KTEPTQRMTITEFMNHPWI 285

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 101/189 (53%), Gaps = 13/189 (6%)
Query: 99  EESARRQIAQELKINQSSQCPY--VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 156
           EE+ +R    E +++ SSQ  +  +V        +    +++EY++G +L+++++    +
Sbjct: 52  EETLKRF---EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL 108
Query: 157 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-G 215
             +       Q+L G+ + H +  I+HRD+KP N+LI+    +KI DFG++  ++ TS  
Sbjct: 109 SVDTAINFTNQILDGIKHAH-DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167
Query: 216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 275
           Q N  +GT  Y SPE+  G      +DI+S+G+VL E   G+ P+      +G T+    
Sbjct: 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF------NGETAVSIA 221
Query: 276 MEAIVDQPP 284
           ++ I D  P
Sbjct: 222 IKHIQDSVP 230

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 45  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 99
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 100 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 158
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 159 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 217
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 218 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 268
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR++  E M HP++
Sbjct: 269 KTEPTQRMTITEFMNHPWI 287

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L   +T  E + L  I  Q  +G+ YLH  K 
Sbjct: 82  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKS 140
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 295
            Y ++SD+++ G+VL E  TGQ PYS    +D      E++      P  S         
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 296 FCSFISACVQKEPQQRLS 313
               ++ C++K+  +R S
Sbjct: 258 MKRLMAECLKKKRDERPS 275

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 53  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 107
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 108 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 166
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 167 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 225
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 226 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 276
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR++  E M HP++
Sbjct: 277 KTEPTQRMTITEFMNHPWI 295

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 119/251 (47%), Gaps = 11/251 (4%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII 137
           +L++ K + +  A+K I+    E     + +E+  ++S + P +V   +   +   ++I+
Sbjct: 36  RLMRDKQSNELVAVKYIERG--EKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIV 93
Query: 138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR- 196
           +EY  GG L + +       E+      +Q++ G+ Y  H   + HRDLK  N L++   
Sbjct: 94  MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSP 152
Query: 197 -GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECA 254
              +KI DFG S   +    Q  + VGT  Y++PE +   +Y G  +D+WS G+ L    
Sbjct: 153 APRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
            G +P+  PE+     +F + +  I++           SPE    IS     +P +R+S 
Sbjct: 212 VGAYPFEDPEEP---KNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISI 268
Query: 315 QELMTHP-FLK 324
            E+  H  FLK
Sbjct: 269 PEIRNHEWFLK 279

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 121/276 (43%), Gaps = 42/276 (15%)
Query: 80  VQHKWTGQFFALKVIQMN-----VEESARRQIA--QELKINQSSQCPYVVVCYQSFYSNG 132
            +++ T +  ALK ++++     V  SA R+I   +ELK         +V  +   +S+ 
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN------IVRLHDVLHSDK 74
Query: 133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
            ++++ E+ D      F      +  E + +   Q+LKGL + H  ++++HRDLKP NLL
Sbjct: 75  KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLL 133
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLL 251
           IN  GE+K+ DFG++          +  V T  Y  P+ + G K Y    D+WS G +  
Sbjct: 134 INRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193
Query: 252 ECATGQFPYSPPEQQDG----------------WTSFYELMEAIVDQPPPSAPSD----- 290
           E A    P  P    D                 W S  +L +    +P P  P+      
Sbjct: 194 ELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY---KPYPMYPATTSLVN 250
Query: 291 ---QFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
              + +      +   ++  P QR+SA+E + HP+ 
Sbjct: 251 VVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L   +T  E + L  I  Q  +G+ YLH  K 
Sbjct: 82  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKS 140
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 295
            Y ++SD+++ G+VL E  TGQ PYS    +D      E++      P  S         
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 296 FCSFISACVQKEPQQRLS 313
               ++ C++K+  +R S
Sbjct: 258 MKRLMAECLKKKRDERPS 275

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 115/242 (47%), Gaps = 11/242 (4%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           TG   A K+I+    +  + ++  E+ +        ++  Y +F S   I +++EY+DGG
Sbjct: 113 TGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 145 SLAD-FLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG--EVKI 201
            L D  + +   + E       +Q+ +G+ ++ H+ +I+H DLKP N+L  +R   ++KI
Sbjct: 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHM-HQMYILHLDLKPENILCVNRDAKQIKI 230
Query: 202 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS 261
            DFG++            F GT  +++PE ++     + +D+WS+G++     +G  P+ 
Sbjct: 231 IDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289
Query: 262 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 321
                +   +       + D+          S E   FIS  + KE   R+SA E + HP
Sbjct: 290 GDNDAETLNNILACRWDLEDE-----EFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344
Query: 322 FL 323
           +L
Sbjct: 345 WL 346

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 66  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 124
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 267
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 93  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 151
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 267
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 243

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 68  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 126
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 267
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 218

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 94  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 152
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 267
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 244

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 71  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 129
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 267
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 221

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 71  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 129
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 267
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 221

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 111/223 (49%), Gaps = 23/223 (10%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+KV++   E++   ++ +E +I      PY+V    VC        A+ +++E   GG 
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----ALMLVMEMAGGGP 421
Query: 146 LADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L  FL  K + IP   +A +  QV  G+ YL  EK+ +HR+L   N+L+ +R   KI+DF
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRNLAARNVLLVNRHYAKISDF 480
Query: 205 GVS-AIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G+S A+ A  S       G +   + +PE I+  K+  +SD+WS G+ + E  + GQ PY
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
Query: 261 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
              ++  G      + +    + PP  P     PE  + +S C
Sbjct: 541 ---KKMKGPEVMAFIEQGKRMECPPECP-----PELYALMSDC 575

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY------QSFYSNGAIS 135
           H+ TG+  A+K  +  +    R +   E++I +    P VV         Q    N    
Sbjct: 36  HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 95
Query: 136 IILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + +EY +GG L  +L + +    + E  +  +   +   L YLH E  IIHRDLKP N++
Sbjct: 96  LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIV 154
Query: 193 IN---HRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGGKYGYKSDIWSLGL 248
           +     R   KI D G +  +    G+  T FVGT  Y++PE +   KY    D WS G 
Sbjct: 155 LQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 212
Query: 249 VLLECATGQFPYSPPEQQDGW 269
           +  EC TG  P+ P  Q   W
Sbjct: 213 LAFECITGFRPFLPNWQPVQW 233

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVC------YQSFYSNGAIS 135
           H+ TG+  A+K  +  +    R +   E++I +    P VV         Q    N    
Sbjct: 35  HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94
Query: 136 IILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + +EY +GG L  +L + +    + E  +  +   +   L YLH E  IIHRDLKP N++
Sbjct: 95  LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIV 153
Query: 193 IN---HRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGGKYGYKSDIWSLGL 248
           +     R   KI D G +  +    G+  T FVGT  Y++PE +   KY    D WS G 
Sbjct: 154 LQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 249 VLLECATGQFPYSPPEQQDGW 269
           +  EC TG  P+ P  Q   W
Sbjct: 212 LAFECITGFRPFLPNWQPVQW 232

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 66  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 124
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 267
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 78  QLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           +L++ K + +  A+K I+    ++E+ +R+I      ++S + P +V   +   +   ++
Sbjct: 36  RLMRDKQSNELVAVKYIERGEKIDENVKREIIN----HRSLRHPNIVRFKEVILTPTHLA 91
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           I++EY  GG L + +       E+      +Q++ G+ Y  H   + HRDLK  N L++ 
Sbjct: 92  IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDG 150
Query: 196 R--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLE 252
                +KI  FG S   +    Q  + VGT  Y++PE +   +Y G  +D+WS G+ L  
Sbjct: 151 SPAPRLKICAFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 312
              G +P+  PE+     +F + +  I++           SPE    IS     +P +R+
Sbjct: 210 MLVGAYPFEDPEEP---KNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRI 266
Query: 313 SAQELMTHP-FLK 324
           S  E+  H  FLK
Sbjct: 267 SIPEIRNHEWFLK 279

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 27/194 (13%)
Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 217
           EE +  +  Q+LKGL Y+H    ++HRDLKP NL +N   E+KI DFG++        + 
Sbjct: 125 EEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEM 180
Query: 218 NTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--- 273
             +V T  Y +PE I S   Y    DIWS+G ++ E  TG+  +   +  D  T      
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240
Query: 274 -----ELMEAIVD-------QPPPSAPSDQF-------SPEFCSFISACVQKEPQQRLSA 314
                E ++ + D       Q  P  P   F       SP+    +   ++ +  +RL+A
Sbjct: 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 300
Query: 315 QELMTHPFLKMYGD 328
            + +THPF + + D
Sbjct: 301 AQALTHPFFEPFRD 314

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L   +T  + + L  I  Q  +G+ YLH  K+
Sbjct: 94  ILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH-AKN 152
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS---GG 235
           IIHRD+K +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 295
            + ++SD++S G+VL E  TG+ PYS    +D       ++      P  S         
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELPYSHINNRD---QIIFMVGRGYASPDLSKLYKNCPKA 269
Query: 296 FCSFISACVQKEPQQR------LSAQELMTHPFLKM 325
               ++ CV+K  ++R      LS+ EL+ H   K+
Sbjct: 270 MKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKI 305

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 27/194 (13%)
Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 217
           EE +  +  Q+LKGL Y+H    ++HRDLKP NL +N   E+KI DFG++        + 
Sbjct: 143 EEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEM 198
Query: 218 NTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--- 273
             +V T  Y +PE I S   Y    DIWS+G ++ E  TG+  +   +  D  T      
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258
Query: 274 -----ELMEAIVD-------QPPPSAPSDQF-------SPEFCSFISACVQKEPQQRLSA 314
                E ++ + D       Q  P  P   F       SP+    +   ++ +  +RL+A
Sbjct: 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 318
Query: 315 QELMTHPFLKMYGD 328
            + +THPF + + D
Sbjct: 319 AQALTHPFFEPFRD 332

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 83  KWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           K TG+ F  K I        +  +  E+ I      P ++  + +F     + +ILE++ 
Sbjct: 73  KATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 143 GGSLADFLKKVKTIPEEYLAAICE------QVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           GG L D     +   E+Y  +  E      Q  +GL ++H E  I+H D+KP N++   +
Sbjct: 132 GGELFD-----RIAAEDYKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETK 185
Query: 197 --GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
               VKI DFG+ A   +          T  + +PE +     G+ +D+W++G++     
Sbjct: 186 KASSVKIIDFGL-ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
           +G  P++    +D   +   +     D           SPE   FI   +QKEP++RL+ 
Sbjct: 245 SGLSPFA---GEDDLETLQNVKRC--DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 299
Query: 315 QELMTHPFLK-------------MYGDLNVDLSEYFTDAGSPLATLSNLSGF 353
            + + HP+LK              Y  +   + E + D  +P   +  ++ F
Sbjct: 300 HDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANF 351

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 78  QLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           +L++ K + +  A+K I+    ++E+ +R+I      ++S + P +V   +   +   ++
Sbjct: 36  RLMRDKQSNELVAVKYIERGEKIDENVKREIIN----HRSLRHPNIVRFKEVILTPTHLA 91
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           I++EY  GG L + +       E+      +Q++ G+ Y  H   + HRDLK  N L++ 
Sbjct: 92  IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDG 150
Query: 196 R--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLE 252
                +KI  FG S      S   +T VGT  Y++PE +   +Y G  +D+WS G+ L  
Sbjct: 151 SPAPRLKICAFGYSKSSVLHSQPKDT-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 312
              G +P+  PE+     +F + +  I++           SPE    IS     +P +R+
Sbjct: 210 MLVGAYPFEDPEEP---KNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRI 266
Query: 313 SAQELMTHP-FLK 324
           S  E+  H  FLK
Sbjct: 267 SIPEIRNHEWFLK 279

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 121/276 (43%), Gaps = 42/276 (15%)
Query: 80  VQHKWTGQFFALKVIQMN-----VEESARRQIA--QELKINQSSQCPYVVVCYQSFYSNG 132
            +++ T +  ALK ++++     V  SA R+I   +ELK         +V  +   +S+ 
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN------IVRLHDVLHSDK 74
Query: 133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
            ++++ E+ D      F      +  E + +   Q+LKGL + H  ++++HRDLKP NLL
Sbjct: 75  KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLL 133
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLL 251
           IN  GE+K+ +FG++          +  V T  Y  P+ + G K Y    D+WS G +  
Sbjct: 134 INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193
Query: 252 ECATGQFPYSPPEQQDG----------------WTSFYELMEAIVDQPPPSAPSD----- 290
           E A    P  P    D                 W S  +L +    +P P  P+      
Sbjct: 194 ELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY---KPYPMYPATTSLVN 250
Query: 291 ---QFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
              + +      +   ++  P QR+SA+E + HP+ 
Sbjct: 251 VVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/327 (23%), Positives = 139/327 (42%), Gaps = 59/327 (18%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARRQIA---QELKINQSSQCPYVVVCYQSFYSNGAI 134
            L ++K TG++  ++  ++N+E  +   +     EL +++    P +V    +F ++  +
Sbjct: 28  NLARYKPTGEYVTVR--RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 85
Query: 135 SIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
            ++  +M  GS  D +    +  + E  +A I + VLK L Y+HH  ++ HR +K S++L
Sbjct: 86  WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV-HRSVKASHIL 144
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYN--------YMSPERISGGKYGY--KSD 242
           I+  G+V ++    +  M S  GQ    V  +         ++SPE +     GY  KSD
Sbjct: 145 ISVDGKVYLSGLRSNLSMIS-HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 203
Query: 243 IWSLGLVLLECATGQFPYS--------------------------------PPEQQDGWT 270
           I+S+G+   E A G  P+                                  P +    +
Sbjct: 204 IYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANS 263
Query: 271 SFYELMEAIVDQP----PPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 325
              + +     +P     PS P  + FSP F  F+  C+Q+ P  R SA  L+ H F K 
Sbjct: 264 GLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK- 322
Query: 326 YGDLNVDLSEYFTDAGSPLATLSNLSG 352
              +    SE   +   P+  ++N  G
Sbjct: 323 --QIKRRASEALPELLRPVTPITNFEG 347

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 87  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 53  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 108
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 109 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGML 165
Query: 200 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 246
           K+ DFG++  M   +TS   ++ VGT NYM PE I       ++           D+WSL
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 226 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 279
Query: 307 EPQQRLSAQELMTHPFLKM 325
           +P+QR+S  EL+ HP++++
Sbjct: 280 DPKQRISIPELLAHPYVQI 298

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/327 (23%), Positives = 139/327 (42%), Gaps = 59/327 (18%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARRQIA---QELKINQSSQCPYVVVCYQSFYSNGAI 134
            L ++K TG++  ++  ++N+E  +   +     EL +++    P +V    +F ++  +
Sbjct: 44  NLARYKPTGEYVTVR--RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101
Query: 135 SIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
            ++  +M  GS  D +    +  + E  +A I + VLK L Y+HH  ++ HR +K S++L
Sbjct: 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV-HRSVKASHIL 160
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYN--------YMSPERISGGKYGY--KSD 242
           I+  G+V ++    +  M S  GQ    V  +         ++SPE +     GY  KSD
Sbjct: 161 ISVDGKVYLSGLRSNLSMIS-HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 219
Query: 243 IWSLGLVLLECATGQFPYS--------------------------------PPEQQDGWT 270
           I+S+G+   E A G  P+                                  P +    +
Sbjct: 220 IYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANS 279
Query: 271 SFYELMEAIVDQP----PPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 325
              + +     +P     PS P  + FSP F  F+  C+Q+ P  R SA  L+ H F K 
Sbjct: 280 GLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK- 338
Query: 326 YGDLNVDLSEYFTDAGSPLATLSNLSG 352
              +    SE   +   P+  ++N  G
Sbjct: 339 --QIKRRASEALPELLRPVTPITNFEG 363

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 87  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 81  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 136
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 137 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GML 193
Query: 200 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 246
           K+ DFG++  M   +TS   ++ VGT NYM PE I       ++           D+WSL
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 254 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 307
Query: 307 EPQQRLSAQELMTHPFLKM 325
           +P+QR+S  EL+ HP++++
Sbjct: 308 DPKQRISIPELLAHPYVQI 326

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 87  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 33  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 88
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 89  -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GML 145
Query: 200 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 246
           K+ DFG++  M   +TS   ++ VGT NYM PE I       ++           D+WSL
Sbjct: 146 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 205
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 206 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 259
Query: 307 EPQQRLSAQELMTHPFLKM 325
           +P+QR+S  EL+ HP++++
Sbjct: 260 DPKQRISIPELLAHPYVQI 278

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 87  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 37  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 92
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 93  -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GML 149
Query: 200 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 246
           K+ DFG++  M   +TS   ++ VGT NYM PE I       ++           D+WSL
Sbjct: 150 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 209
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 210 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 263
Query: 307 EPQQRLSAQELMTHPFLKM 325
           +P+QR+S  EL+ HP++++
Sbjct: 264 DPKQRISIPELLAHPYVQI 282

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 87  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 34  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 89
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 90  -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGML 146
Query: 200 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 246
           K+ DFG++  M   +TS   ++ VGT NYM PE I       ++           D+WSL
Sbjct: 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 207 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 260
Query: 307 EPQQRLSAQELMTHPFLKM 325
           +P+QR+S  EL+ HP++++
Sbjct: 261 DPKQRISIPELLAHPYVQI 279

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 129/287 (44%), Gaps = 44/287 (15%)
Query: 80  VQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVV---------VCYQSF 128
            + + TGQ  A+K I    +V  +A+R + +ELKI +  +   ++         V Y  F
Sbjct: 73  ARRRLTGQQVAIKKIPNAFDVVTNAKRTL-RELKILKHFKHDNIIAIKDILRPTVPYGEF 131
Query: 129 YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
            S   + ++L+ M+   L   +   + +  E++     Q+L+GL Y+H    +IHRDLKP
Sbjct: 132 KS---VYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH-SAQVIHRDLKP 186
Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQANTF----VGTYNYMSPE-RISGGKYGYKSDI 243
           SNLL+N   E+KI DFG++  + ++  +   F    V T  Y +PE  +S  +Y    D+
Sbjct: 187 SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 246
Query: 244 WSLGLVLLECATGQ--FP--------------YSPPEQQDGWTSFYELMEAIVDQPPPS- 286
           WS+G +  E    +  FP                 P          E + A +   PP  
Sbjct: 247 WSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQ 306
Query: 287 -APSDQFSP----EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
             P +   P    +  S +   ++ EP  R+SA   + HPFL  Y D
Sbjct: 307 PVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 7/152 (4%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 86  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 144
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 267
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 236

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 7/152 (4%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 66  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 124
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 267
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 7/152 (4%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 180
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 94  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 152
Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 235
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 267
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 244

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 87  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 81  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 136
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 137 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GML 193
Query: 200 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 246
           K+ DFG++  M   +TS   ++ VGT NYM PE I       ++           D+WSL
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 254 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 307
Query: 307 EPQQRLSAQELMTHPFLKM 325
           +P+QR+S  EL+ HP++++
Sbjct: 308 DPKQRISIPELLAHPYVQI 326

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 76  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 128
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 236
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 129 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 188
Query: 237 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 189 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 239
Query: 293 SPEFCSFISACVQKEPQQR 311
             E    +  C ++ P+ R
Sbjct: 240 --ELYQLMRLCWKERPEDR 256

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 74  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 236
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 237 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 237
Query: 293 SPEFCSFISACVQKEPQQR 311
             E    +  C ++ P+ R
Sbjct: 238 --ELYQLMRLCWKERPEDR 254

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL  +   +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYL-SDMGFVHRDLAARNILINSNLVCKVSDFGL 193
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 75  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 127
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 236
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 128 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 187
Query: 237 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 238
Query: 293 SPEFCSFISACVQKEPQQR 311
             E    +  C ++ P+ R
Sbjct: 239 --ELYQLMRLCWKERPEDR 255

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 56/293 (19%)
Query: 80  VQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVV---------VCYQSF 128
            + + TGQ  A+K I    +V  +A+R + +ELKI +  +   ++         V Y  F
Sbjct: 74  ARRRLTGQQVAIKKIPNAFDVVTNAKRTL-RELKILKHFKHDNIIAIKDILRPTVPYGEF 132
Query: 129 YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
            S   + ++L+ M+   L   +   + +  E++     Q+L+GL Y+H    +IHRDLKP
Sbjct: 133 KS---VYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH-SAQVIHRDLKP 187
Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQANTF----VGTYNYMSPE-RISGGKYGYKSDI 243
           SNLL+N   E+KI DFG++  + ++  +   F    V T  Y +PE  +S  +Y    D+
Sbjct: 188 SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 247
Query: 244 WSLGLVLLECATGQ--FPYSPPEQQDGWTSFYELMEAIVDQPPP---------------- 285
           WS+G +  E    +  FP         +    +L+  ++  P P                
Sbjct: 248 WSVGCIFGEMLARRQLFP------GKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQ 301
Query: 286 SAPSDQFSP----------EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
           S P  Q  P          +  S +   ++ EP  R+SA   + HPFL  Y D
Sbjct: 302 SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 354

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 77/145 (53%), Gaps = 11/145 (7%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 83  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 135
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 236
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 136 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 195
Query: 237 YGYKSDIWSLGLVLLECAT-GQFPY 260
           +  KSD+WS G++L E  T G+ PY
Sbjct: 196 FTIKSDVWSFGILLTEIVTHGRIPY 220

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 80  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 132
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 236
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 192
Query: 237 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 243
Query: 293 SPEFCSFISACVQKEPQQR 311
             E    +  C ++ P+ R
Sbjct: 244 --ELYQLMRLCWKERPEDR 260

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 74  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 236
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGT 186
Query: 237 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 237
Query: 293 SPEFCSFISACVQKEPQQR 311
             E    +  C ++ P+ R
Sbjct: 238 --ELYQLMRLCWKERPEDR 254

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 69  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 121
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 234
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 122 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 179
Query: 235 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 232
Query: 291 QFSPEFCSFISACVQKEPQQR 311
               E    +  C ++ P+ R
Sbjct: 233 ----ELYQLMRLCWKERPEDR 249

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 74  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 236
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 237 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 237
Query: 293 SPEFCSFISACVQKEPQQR 311
             E    +  C ++ P+ R
Sbjct: 238 --ELYQLMRLCWKERPEDR 254

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 77/145 (53%), Gaps = 11/145 (7%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 82  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 134
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 236
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 135 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 194
Query: 237 YGYKSDIWSLGLVLLECAT-GQFPY 260
           +  KSD+WS G++L E  T G+ PY
Sbjct: 195 FTIKSDVWSFGILLTEIVTHGRIPY 219

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 193
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 74  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 234
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 184
Query: 235 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 237
Query: 291 QFSPEFCSFISACVQKEPQQR 311
               E    +  C ++ P+ R
Sbjct: 238 ----ELYQLMRLCWKERPEDR 254

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 132/294 (44%), Gaps = 54/294 (18%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ-----SFYSNGAISI 136
           HK TG+  A+K I+   +     +  +E+KI +  +   ++  +      SF +   + I
Sbjct: 32  HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91
Query: 137 ILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           I E M      D  + + T  + ++++     Q L+ +  LH   ++IHRDLKPSNLLIN
Sbjct: 92  IQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH-GSNVIHRDLKPSNLLIN 146
Query: 195 HRGEVKITDFGVSAIM-------ASTSGQAN---TFVGTYNYMSPE-RISGGKYGYKSDI 243
              ++K+ DFG++ I+       +  +GQ +    FV T  Y +PE  ++  KY    D+
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP------------------- 284
           WS G +L E     F   P      +     L+  I+  P                    
Sbjct: 207 WSCGCILAEL----FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262
Query: 285 ----PSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 330
               P+AP ++     +P+    +   +  +P +R++A+E + HP+L+ Y D N
Sbjct: 263 LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 193
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 193
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 80  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 132
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 234
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 190
Query: 235 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 243
Query: 291 QFSPEFCSFISACVQKEPQQR 311
               E    +  C ++ P+ R
Sbjct: 244 ----ELYQLMRLCWKERPEDR 260

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 75  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 134
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 135 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 191
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 192 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 251
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 252 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 300

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 193
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 79  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 131
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 234
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 132 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 189
Query: 235 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 242
Query: 291 QFSPEFCSFISACVQKEPQQR 311
               E    +  C ++ P+ R
Sbjct: 243 ----ELYQLMRLCWKERPEDR 259

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 40/221 (18%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 133 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 190
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 191 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247
Query: 256 GQ--FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK------- 306
           G+  FP +     D      ++M  +   PP S  S   S E  ++I++  Q        
Sbjct: 248 GRTLFPGT-----DHINQLQQIMR-LTGTPPASVISRMPSHEARNYINSLPQMPKRNFAD 301
Query: 307 -------------------EPQQRLSAQELMTHPFLKMYGD 328
                              +  +R++A E + HP+   Y D
Sbjct: 302 VFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHD 342

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 65  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 124
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 125 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 181
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 182 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 241
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 242 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 290

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 84  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 136
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 234
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 137 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 194
Query: 235 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 195 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 247
Query: 291 QFSPEFCSFISACVQKEPQQR 311
               E    +  C ++ P+ R
Sbjct: 248 ----ELYQLMRLCWKERPEDR 264

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 48  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 107
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 108 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 164
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 165 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 224
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 225 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 273

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 10/176 (5%)
Query: 92  KVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           KV    + E A  +    +E ++      P +V  Y        I ++ E+M+ G L+D+
Sbjct: 33  KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 150 LKKVKTI-PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  + +   E L  +C  V +G+ YL  E  +IHRDL   N L+     +K++DFG++ 
Sbjct: 93  LRTQRGLFAAETLLGMCLDVCEGMAYLE-EASVIHRDLAARNCLVGENQVIKVSDFGMTR 151
Query: 209 IMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
            +      ++T  GT     + SPE  S  +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 152 FVLDDQYTSST--GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 111/252 (44%), Gaps = 33/252 (13%)
Query: 103 RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG---SLADFLKKV 153
           +R   +EL+I +  + P VV     FYSNG       ++++LEY+      +   + K  
Sbjct: 76  KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK 135
Query: 154 KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMAS 212
           +T+P   +     Q+L+ L Y+H    I HRD+KP NLL++   G +K+ DFG + I+ +
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 213 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 259
                +     Y Y +PE I G   Y    DIWS G V+ E   GQ  FP          
Sbjct: 195 GEPNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253
Query: 260 ----YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS----PEFCSFISACVQKEPQQR 311
                  P ++   T     ME    Q  P   S  F     P+    IS  ++  P  R
Sbjct: 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313
Query: 312 LSAQELMTHPFL 323
           L+A E + HPF 
Sbjct: 314 LTAIEALCHPFF 325

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 34/232 (14%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLA 162
           QI ++LK ++  Q  Y VV  +  Y      I+ EYM+ GSL DFLK  + + +    L 
Sbjct: 56  QIMKKLKHDKLVQL-YAVVSEEPIY------IVTEYMNKGSLLDFLKDGEGRALKLPNLV 108
Query: 163 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANT 219
            +  QV  G+ Y+    +I HRDL+ +N+L+ +    KI DFG++ ++     T+ Q   
Sbjct: 109 DMAAQVAAGMAYIERMNYI-HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAK 167
Query: 220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP----------------YSP 262
           F     + +PE    G++  KSD+WS G++L E  T G+ P                Y  
Sbjct: 168 F--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 225
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--FISACVQKEPQQRL 312
           P  QD   S +ELM     + P   P+ ++   F    F +   Q +P + L
Sbjct: 226 PCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPGENL 277

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 95/184 (51%), Gaps = 11/184 (5%)
Query: 83  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 29  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 86
Query: 142 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 200
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 87  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 145
Query: 201 ITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 256
           ++DFG+S  +     TS + + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 146 VSDFGLSRYVLDDEYTSSRGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 203
Query: 257 QFPY 260
           + PY
Sbjct: 204 KMPY 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 177
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 118
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISG 234
           E  +IHRDL   N L+     +K++DFG++  +      ++T  GT     + SPE  S 
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 176
Query: 235 GKYGYKSDIWSLGLVLLEC-ATGQFPY 260
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPY 203

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 88  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 147
             A+K ++    ESAR+   +E ++    Q  ++V  +        + ++ EYM  G L 
Sbjct: 50  LVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 108
Query: 148 DFLK------KVKTIPEEY---------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
            FL+      K+    E+          L A+  QV  G++YL    H +HRDL   N L
Sbjct: 109 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCL 167
Query: 193 INHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 250
           +     VKI DFG+S  + ST         +    +M PE I   K+  +SD+WS G+VL
Sbjct: 168 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 227
Query: 251 LECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
            E  T G+ P+   S  E  D  T   EL      + P + P     PE  + +  C Q+
Sbjct: 228 WEIFTYGKQPWYQLSNTEAIDCITQGREL------ERPRACP-----PEVYAIMRGCWQR 276
Query: 307 EPQQRLSAQEL 317
           EPQQR S +++
Sbjct: 277 EPQQRHSIKDV 287

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 177
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 62  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 120
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISG 234
           E  +IHRDL   N L+     +K++DFG++  +      ++T  GT     + SPE  S 
Sbjct: 121 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 178
Query: 235 GKYGYKSDIWSLGLVLLEC-ATGQFPY 260
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 193
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           + ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 ARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 10/176 (5%)
Query: 92  KVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           KV    + E A  +    +E ++      P +V  Y        I ++ E+M+ G L+D+
Sbjct: 36  KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 95
Query: 150 LKKVKTI-PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  + +   E L  +C  V +G+ YL  E  +IHRDL   N L+     +K++DFG++ 
Sbjct: 96  LRTQRGLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQVIKVSDFGMTR 154
Query: 209 IMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
            +      ++T  GT     + SPE  S  +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 155 FVLDDQYTSST--GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 208

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 88  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 147
             A+K ++    ESAR+   +E ++    Q  ++V  +        + ++ EYM  G L 
Sbjct: 44  LVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 102
Query: 148 DFLK------KVKTIPEEY---------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
            FL+      K+    E+          L A+  QV  G++YL    H +HRDL   N L
Sbjct: 103 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCL 161
Query: 193 INHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 250
           +     VKI DFG+S  + ST         +    +M PE I   K+  +SD+WS G+VL
Sbjct: 162 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 221
Query: 251 LECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
            E  T G+ P+   S  E  D  T   EL      + P + P     PE  + +  C Q+
Sbjct: 222 WEIFTYGKQPWYQLSNTEAIDCITQGREL------ERPRACP-----PEVYAIMRGCWQR 270
Query: 307 EPQQRLSAQEL 317
           EPQQR S +++
Sbjct: 271 EPQQRHSIKDV 281

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 177
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 82  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 140
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 234
           E  +IHRDL   N L+     +K++DFG++  +     TS     F     + SPE  S 
Sbjct: 141 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSF 198
Query: 235 GKYGYKSDIWSLGLVLLEC-ATGQFPY 260
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGKIPY 225

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 33/263 (12%)
Query: 84  WTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           W G+  A+K+     E+S  R+  +   + +   +   ++     S +S+  + +I  Y 
Sbjct: 29  WQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88
Query: 142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLIN 194
           + GSL D+L+ + T+       I   +  GL +LH E         I HRDLK  N+L+ 
Sbjct: 89  EMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147
Query: 195 HRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPE------RISGGKYGYKSDIW 244
             G+  I D G++ + + ++ Q     N  VGT  YM+PE      ++       + DIW
Sbjct: 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIW 207
Query: 245 SLGLVLLECATGQFP------YSPP--EQQDGWTSFYELMEAI-VDQPPPSAPSDQFS-P 294
           + GLVL E A           Y PP  +      SF ++ + + VDQ  P+ P+  FS P
Sbjct: 208 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP 267
Query: 295 EFCS---FISACVQKEPQQRLSA 314
              S    +  C  + P  RL+A
Sbjct: 268 TLTSLAKLMKECWYQNPSARLTA 290

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 97  LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 155
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 156 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 214 EEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
Query: 324 K 324
           +
Sbjct: 259 Q 259

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 33/263 (12%)
Query: 84  WTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           W G+  A+K+     E+S  R+  +   + +   +   ++     S +S+  + +I  Y 
Sbjct: 29  WQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88
Query: 142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLIN 194
           + GSL D+L+ + T+       I   +  GL +LH E         I HRDLK  N+L+ 
Sbjct: 89  EMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147
Query: 195 HRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPE------RISGGKYGYKSDIW 244
             G+  I D G++ + + ++ Q     N  VGT  YM+PE      ++       + DIW
Sbjct: 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIW 207
Query: 245 SLGLVLLECATGQFP------YSPP--EQQDGWTSFYELMEAI-VDQPPPSAPSDQFS-P 294
           + GLVL E A           Y PP  +      SF ++ + + VDQ  P+ P+  FS P
Sbjct: 208 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP 267
Query: 295 EFCS---FISACVQKEPQQRLSA 314
              S    +  C  + P  RL+A
Sbjct: 268 TLTSLAKLMKECWYQNPSARLTA 290

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 33/263 (12%)
Query: 84  WTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           W G+  A+K+     E+S  R+  +   + +   +   ++     S +S+  + +I  Y 
Sbjct: 58  WQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 117
Query: 142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLIN 194
           + GSL D+L+ + T+       I   +  GL +LH E         I HRDLK  N+L+ 
Sbjct: 118 EMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 176
Query: 195 HRGEVKITDFGVSAIMASTSGQ----ANTFVGTYNYMSPE------RISGGKYGYKSDIW 244
             G+  I D G++ + + ++ Q     N  VGT  YM+PE      ++       + DIW
Sbjct: 177 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIW 236
Query: 245 SLGLVLLECATGQFP------YSPP--EQQDGWTSFYELMEAI-VDQPPPSAPSDQFS-P 294
           + GLVL E A           Y PP  +      SF ++ + + VDQ  P+ P+  FS P
Sbjct: 237 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP 296
Query: 295 EFCS---FISACVQKEPQQRLSA 314
              S    +  C  + P  RL+A
Sbjct: 297 TLTSLAKLMKECWYQNPSARLTA 319

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 123/259 (47%), Gaps = 33/259 (12%)
Query: 87  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 81  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 136
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 137 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GML 193
Query: 200 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 246
           K+ DFG++  M   +TS   ++ VG  NYM PE I       ++           D+WSL
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 254 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 307
Query: 307 EPQQRLSAQELMTHPFLKM 325
           +P+QR+S  EL+ HP++++
Sbjct: 308 DPKQRISIPELLAHPYVQI 326

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 187
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 246 EEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290
Query: 324 K 324
           +
Sbjct: 291 Q 291

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 54/294 (18%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ-----SFYSNGAISI 136
           HK TG+  A+K I+   +     +  +E+KI +  +   ++  +      SF +   + I
Sbjct: 32  HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91
Query: 137 ILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           I E M      D  + + T  + ++++     Q L+ +  LH   ++IHRDLKPSNLLIN
Sbjct: 92  IQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH-GSNVIHRDLKPSNLLIN 146
Query: 195 HRGEVKITDFGVSAIM-------ASTSGQAN---TFVGTYNYMSPE-RISGGKYGYKSDI 243
              ++K+ DFG++ I+       +  +GQ +    +V T  Y +PE  ++  KY    D+
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP------------------- 284
           WS G +L E     F   P      +     L+  I+  P                    
Sbjct: 207 WSCGCILAEL----FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262
Query: 285 ----PSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 330
               P+AP ++     +P+    +   +  +P +R++A+E + HP+L+ Y D N
Sbjct: 263 LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 193
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
             ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 187
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 246 EEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290
Query: 324 K 324
           +
Sbjct: 291 Q 291

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 88  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 147
             A+K ++    ESAR+   +E ++    Q  ++V  +        + ++ EYM  G L 
Sbjct: 73  LVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 148 DFLK------KVKTIPEEY---------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
            FL+      K+    E+          L A+  QV  G++YL    H +HRDL   N L
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCL 190
Query: 193 INHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 250
           +     VKI DFG+S  + ST         +    +M PE I   K+  +SD+WS G+VL
Sbjct: 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250
Query: 251 LECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
            E  T G+ P+   S  E  D  T   EL      + P + P     PE  + +  C Q+
Sbjct: 251 WEIFTYGKQPWYQLSNTEAIDCITQGREL------ERPRACP-----PEVYAIMRGCWQR 299
Query: 307 EPQQRLSAQEL 317
           EPQQR S +++
Sbjct: 300 EPQQRHSIKDV 310

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 188
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 247 EEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291
Query: 324 K 324
           +
Sbjct: 292 Q 292

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 187
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 246 EEIIGGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 290
Query: 324 K 324
           +
Sbjct: 291 Q 291

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 188
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 247 EEIIGGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291
Query: 324 K 324
           +
Sbjct: 292 Q 292

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 188
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 247 EEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291
Query: 324 K 324
           +
Sbjct: 292 Q 292

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 188
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 247 EEIIGGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291
Query: 324 K 324
           +
Sbjct: 292 Q 292

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 177
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 121
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISG 234
           E  +IHRDL   N L+     +K++DFG++  +      ++T  GT     + SPE  S 
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 179
Query: 235 GKYGYKSDIWSLGLVLLEC-ATGQFPY 260
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 177
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 70  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 122
Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 234
           E++ IHR+L+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 123 ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 180
Query: 235 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 233
Query: 291 QFSPEFCSFISACVQKEPQQR 311
               E    +  C ++ P+ R
Sbjct: 234 ----ELYQLMRLCWKERPEDR 250

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 110/251 (43%), Gaps = 40/251 (15%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K+++ N   S  R +  E  + +    P+V+  Y +   +G + +I+EY   GSL  F
Sbjct: 57  AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 150 LKKVKTIPEEYLA------------------------AICEQVLKGLLYLHHEKHIIHRD 185
           L++ + +   YL                         +   Q+ +G+ YL  E  ++HRD
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRD 175
Query: 186 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDI 243
           L   N+L+    ++KI+DFG+S  +           G     +M+ E +    Y  +SD+
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 244 WSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           WS G++L E  T G  PY   PPE+       + L++       P    D  S E    +
Sbjct: 236 WSFGVLLWEIVTLGGNPYPGIPPER------LFNLLKTGHRMERP----DNCSEEMYRLM 285
Query: 301 SACVQKEPQQR 311
             C ++EP +R
Sbjct: 286 LQCWKQEPDKR 296

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 83  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 24  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81
Query: 142 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 200
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 82  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 140
Query: 201 ITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 256
           ++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 141 VSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 198
Query: 257 QFPY 260
           + PY
Sbjct: 199 KMPY 202

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 110/251 (43%), Gaps = 40/251 (15%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K+++ N   S  R +  E  + +    P+V+  Y +   +G + +I+EY   GSL  F
Sbjct: 57  AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 150 LKKVKTIPEEYLA------------------------AICEQVLKGLLYLHHEKHIIHRD 185
           L++ + +   YL                         +   Q+ +G+ YL  E  ++HRD
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMSLVHRD 175
Query: 186 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDI 243
           L   N+L+    ++KI+DFG+S  +           G     +M+ E +    Y  +SD+
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 244 WSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           WS G++L E  T G  PY   PPE+       + L++       P    D  S E    +
Sbjct: 236 WSFGVLLWEIVTLGGNPYPGIPPER------LFNLLKTGHRMERP----DNCSEEMYRLM 285
Query: 301 SACVQKEPQQR 311
             C ++EP +R
Sbjct: 286 LQCWKQEPDKR 296

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 83  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 44  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101
Query: 142 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 200
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 160
Query: 201 ITDFGVSAIM---ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 256
           ++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 161 VSDFGLSRYVLDDEETSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218
Query: 257 QFPY 260
           + PY
Sbjct: 219 KMPY 222

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           ++ I+ EYM+   LA+ L++   + EE+      Q+L+GL Y+H   +++HRDLKP+NL 
Sbjct: 96  SVYIVQEYMET-DLANVLEQGPLL-EEHARLFMYQLLRGLKYIH-SANVLHRDLKPANLF 152
Query: 193 INHRGEV-KITDFGVSAIMA---STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLG 247
           IN    V KI DFG++ IM    S  G  +  + T  Y SP   +S   Y    D+W+ G
Sbjct: 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212
Query: 248 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIV-----------------DQPPPSAPSD 290
            +  E  TG+  ++   + +      E +  +                  D   P  P  
Sbjct: 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLT 272
Query: 291 QFSP----EFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           Q  P    E   F+   +   P  RL+A+E ++HP++ +Y
Sbjct: 273 QLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 87  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 53  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 108
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 109 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGML 165
Query: 200 KITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 246
           K+ DFG++  M         ++ VGT NYM PE I       ++           D+WSL
Sbjct: 166 KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225
Query: 247 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 306
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 226 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 279
Query: 307 EPQQRLSAQELMTHPFLKM 325
           +P+QR+S  EL+ HP++++
Sbjct: 280 DPKQRISIPELLAHPYVQI 298

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 110/251 (43%), Gaps = 40/251 (15%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K+++ N   S  R +  E  + +    P+V+  Y +   +G + +I+EY   GSL  F
Sbjct: 57  AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 150 LKKVKTIPEEYLA------------------------AICEQVLKGLLYLHHEKHIIHRD 185
           L++ + +   YL                         +   Q+ +G+ YL  E  ++HRD
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRD 175
Query: 186 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDI 243
           L   N+L+    ++KI+DFG+S  +           G     +M+ E +    Y  +SD+
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 244 WSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           WS G++L E  T G  PY   PPE+       + L++       P    D  S E    +
Sbjct: 236 WSFGVLLWEIVTLGGNPYPGIPPER------LFNLLKTGHRMERP----DNCSEEMYRLM 285
Query: 301 SACVQKEPQQR 311
             C ++EP +R
Sbjct: 286 LQCWKQEPDKR 296

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 83  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 28  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 85
Query: 142 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 200
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 86  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 144
Query: 201 ITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 256
           ++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 145 VSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 202
Query: 257 QFPY 260
           + PY
Sbjct: 203 KMPY 206

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 83  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 29  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 86
Query: 142 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 200
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 87  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 145
Query: 201 ITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 256
           ++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 146 VSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 203
Query: 257 QFPY 260
           + PY
Sbjct: 204 KMPY 207

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 83  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 44  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101
Query: 142 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 200
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 160
Query: 201 ITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 256
           ++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 161 VSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218
Query: 257 QFPY 260
           + PY
Sbjct: 219 KMPY 222

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 44/231 (19%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + +++E MD    A+  + +   +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 102 VYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 156
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  AST+     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 157 VKSDCTLKILDFGL-ARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 215
Query: 253 CATGQFPYSPPEQQDGW--------TSFYELMEAIVDQPP--------PSAPSDQFSPEF 296
              G   +   +  D W        T   E M A+  QP         P+ P   F   F
Sbjct: 216 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL--QPTVRNYVENRPAYPGIAFEELF 273
Query: 297 CSFI-------------------SACVQKEPQQRLSAQELMTHPFLKMYGD 328
             +I                   S  +  +P +R+S  E + HP++ ++ D
Sbjct: 274 PDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 324

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 121 VVVCYQSFYSNGAISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
           V+     F    +  +ILE M+    L DF+ +   + EE   +   QVL+ + + H+  
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 134
Query: 180 HIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY- 237
            ++HRD+K  N+LI+ +RGE+K+ DFG  A++  T      F GT  Y  PE I   +Y 
Sbjct: 135 -VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYH 191
Query: 238 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 297
           G  + +WSLG++L +   G  P+   E+      F+                 + S E  
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------------QRVSSECQ 236
Query: 298 SFISACVQKEPQQRLSAQELMTHPFLK 324
             I  C+   P  R + +E+  HP+++
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPWMQ 263

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 83  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 35  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 92
Query: 142 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 200
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 93  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 151
Query: 201 ITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 256
           ++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 152 VSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 209
Query: 257 QFPY 260
           + PY
Sbjct: 210 KMPY 213

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 116/259 (44%), Gaps = 33/259 (12%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK +Q   +  ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 83  NKRTQEKFALKXLQDCPK--ARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 137
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 138 XECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH-SINIAHRDVKPENLLYTS 196
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +    S +         Y Y++PE +   KY    D WSLG++   
Sbjct: 197 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDXWSLGVIXYI 255
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 256 LLCGYPPFYSNHGLAISPGXKTRIRXGQYEF---------PNPEWSEVSEEVKXLIRNLL 306
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR +  E   HP++
Sbjct: 307 KTEPTQRXTITEFXNHPWI 325

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 49  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 103
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 104 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 162
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 163 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV      S   I I+ EYM  GSL DFLK    K   +P+  
Sbjct: 55  QVMKKLRHEKLVQL-YAVV------SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQ-- 105
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 106 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 164
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 165 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 218
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +KEP++R
Sbjct: 219 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEER 249

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 14/176 (7%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLVGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G+++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 49  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGX 103
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 104 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 162
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 163 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 105
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 106 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 26/265 (9%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
            G+ +A+K+I+     S  R   +   + Q      ++   + F  +    ++ E + GG
Sbjct: 37  NGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGG 96
Query: 145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKI 201
           S+   ++K K   E   + +   V   L +L H K I HRDLKP N+L     +   VKI
Sbjct: 97  SILAHIQKQKHFNEREASRVVRDVAAALDFL-HTKGIAHRDLKPENILCESPEKVSPVKI 155
Query: 202 TDFGVSAIMA-------STSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLV 249
            DF + + M         T+ +  T  G+  YM+PE +         Y  + D+WSLG+V
Sbjct: 156 CDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVV 215
Query: 250 LLECATGQFPYSPPEQQD-GW-------TSFYELMEAIVDQPP--PSAPSDQFSPEFCSF 299
           L    +G  P+      D GW           +L E+I +     P       S E    
Sbjct: 216 LYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDL 275
Query: 300 ISACVQKEPQQRLSAQELMTHPFLK 324
           IS  + ++ +QRLSA +++ HP+++
Sbjct: 276 ISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 102
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM+ GSL DFLK    K   +P+  
Sbjct: 62  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMNKGSLLDFLKGETGKYLRLPQ-- 112
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 113 LVDMSAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQG 171
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 172 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 225
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +KEP++R
Sbjct: 226 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEER 256

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 52  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 106
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 107 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 165
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 166 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 117/257 (45%), Gaps = 44/257 (17%)
Query: 88  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 147
             A+K ++ +  ++AR+   +E ++  + Q  ++V  Y        + ++ EYM  G L 
Sbjct: 45  LVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 103
Query: 148 DFLKKVKTIPEEYLAA---------------ICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
            FL+     P+  L A               I +Q+  G++YL   +H +HRDL   N L
Sbjct: 104 KFLRAHG--PDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCL 160
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTY-----NYMSPERISGGKYGYKSDIWSLG 247
           +     VKI DFG+S  + ST       VG +      +M PE I   K+  +SD+WSLG
Sbjct: 161 VGENLLVKIGDFGMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 217
Query: 248 LVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFCSFISA 302
           +VL E  T G+ P+          S  E++E I    V Q P + P + +       +  
Sbjct: 218 VVLWEIFTYGKQPWYQ-------LSNNEVIECITQGRVLQRPRTCPQEVY-----ELMLG 265
Query: 303 CVQKEPQQRLSAQELMT 319
           C Q+EP  R + + + T
Sbjct: 266 CWQREPHMRKNIKGIHT 282

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM+ GSL DFLK    K   +P+  
Sbjct: 62  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMNKGSLLDFLKGETGKYLRLPQ-- 112
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 113 LVDMSAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 171
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 172 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 225
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +KEP++R
Sbjct: 226 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEER 256

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 117/267 (43%), Gaps = 39/267 (14%)
Query: 83  KWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 140
           KW G+  A+KV     E S  R+  I Q + +   +   ++    +   S   + +I +Y
Sbjct: 57  KWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116
Query: 141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLI 193
            + GSL D+LK   T+  + +  +    + GL +LH E         I HRDLK  N+L+
Sbjct: 117 HENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 194 NHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERI--SGGKYGYKS----DI 243
              G   I D G++    S + +     NT VGT  YM PE +  S  +  ++S    D+
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 244 WSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAP--- 288
           +S GL+L E    C +G      Q PY      D     YE M  IV   +  PS P   
Sbjct: 236 YSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD---PSYEDMREIVCIKKLRPSFPNRW 292
Query: 289 -SDQFSPEFCSFISACVQKEPQQRLSA 314
            SD+   +    ++ C    P  RL+A
Sbjct: 293 SSDECLRQMGKLMTECWAHNPASRLTA 319

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 131/294 (44%), Gaps = 54/294 (18%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ-----SFYSNGAISI 136
           HK TG+  A+K I+   +     +  +E+KI +  +   ++  +      SF +   + I
Sbjct: 32  HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91
Query: 137 ILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           I E M      D  + + T  + ++++     Q L+ +  LH   ++IHRDLKPSNLLIN
Sbjct: 92  IQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH-GSNVIHRDLKPSNLLIN 146
Query: 195 HRGEVKITDFGVSAIM-------ASTSGQANTF---VGTYNYMSPE-RISGGKYGYKSDI 243
              ++K+ DFG++ I+       +  +GQ +     V T  Y +PE  ++  KY    D+
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP------------------- 284
           WS G +L E     F   P      +     L+  I+  P                    
Sbjct: 207 WSCGCILAEL----FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262
Query: 285 ----PSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 330
               P+AP ++     +P+    +   +  +P +R++A+E + HP+L+ Y D N
Sbjct: 263 LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 14/176 (7%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLVGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G+++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 104
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 164 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 54  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTF 113
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           LKK     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 114 LKKNDGQFTVIQ--LVGMLRGISAGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 170
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY  
Sbjct: 171 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWE 230
Query: 263 PEQQD 267
              QD
Sbjct: 231 MTNQD 235

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 55  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 109
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 110 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 169 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 97/183 (53%), Gaps = 24/183 (13%)
Query: 86  GQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVV----VCYQSFYSN-GAIS 135
           G+F ALK +++   E     S  R++A  L+  ++ + P VV    VC  S       ++
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 136 IILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           ++ E++D   L  +L KV    +P E +  +  Q+L+GL +LH  + ++HRDLKP N+L+
Sbjct: 96  LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILV 153
Query: 194 NHRGEVKITDFGVSAI----MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 249
              G++K+ DFG++ I    MA TS      V T  Y +PE +    Y    D+WS+G +
Sbjct: 154 TSSGQIKLADFGLARIYSFQMALTS-----VVVTLWYRAPEVLLQSSYATPVDLWSVGCI 208
Query: 250 LLE 252
             E
Sbjct: 209 FAE 211

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 231 QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRLPQ-- 281
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 282 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 341 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 394
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           E     P PP  P           +  C +KEP++R + + L    FL+ Y
Sbjct: 395 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEERPTFEYL--QAFLEDY 438

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 127/273 (46%), Gaps = 42/273 (15%)
Query: 86  GQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVV----VCYQSFYSN-GAIS 135
           G+F ALK +++   E     S  R++A  L+  ++ + P VV    VC  S       ++
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 136 IILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           ++ E++D   L  +L KV    +P E +  +  Q+L+GL +LH  + ++HRDLKP N+L+
Sbjct: 96  LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILV 153
Query: 194 NHRGEVKITDFGVSAI----MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 249
              G++K+ DFG++ I    MA TS      V T  Y +PE +    Y    D+WS+G +
Sbjct: 154 TSSGQIKLADFGLARIYSFQMALTS-----VVVTLWYRAPEVLLQSSYATPVDLWSVGCI 208
Query: 250 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--------------SAPSDQFSPE 295
             E    +  +      D      +++    ++  P              + P ++F  +
Sbjct: 209 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 268
Query: 296 F----CSFISACVQKEPQQRLSAQELMTHPFLK 324
                   +  C+   P +R+SA   ++HP+ +
Sbjct: 269 IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 58  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRLPQ-- 108
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 109 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 167
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 168 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 221
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +KEP++R
Sbjct: 222 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEER 252

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 231 QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRLPQ-- 281
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 282 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 341 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 394
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           E     P PP  P           +  C +KEP++R + + L    FL+ Y
Sbjct: 395 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEERPTFEYL--QAFLEDY 438

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ E M+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 193
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ E M+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL  +   +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLS-DMGAVHRDLAARNILINSNLVCKVSDFGL 193
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I++EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVIEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 174
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 203
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXG-VLHRDIKDENILIDLNRGELKLID 154
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 262
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 155 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 213 DEEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 257
Query: 323 LK 324
           ++
Sbjct: 258 MQ 259

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 127/273 (46%), Gaps = 42/273 (15%)
Query: 86  GQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVV----VCYQSFYSN-GAIS 135
           G+F ALK +++   E     S  R++A  L+  ++ + P VV    VC  S       ++
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 136 IILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           ++ E++D   L  +L KV    +P E +  +  Q+L+GL +LH  + ++HRDLKP N+L+
Sbjct: 96  LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILV 153
Query: 194 NHRGEVKITDFGVSAI----MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 249
              G++K+ DFG++ I    MA TS      V T  Y +PE +    Y    D+WS+G +
Sbjct: 154 TSSGQIKLADFGLARIYSFQMALTS-----VVVTLWYRAPEVLLQSSYATPVDLWSVGCI 208
Query: 250 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--------------SAPSDQFSPE 295
             E    +  +      D      +++    ++  P              + P ++F  +
Sbjct: 209 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 268
Query: 296 F----CSFISACVQKEPQQRLSAQELMTHPFLK 324
                   +  C+   P +R+SA   ++HP+ +
Sbjct: 269 IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 13/161 (8%)
Query: 108 QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAA 163
           +E  + ++ Q   +V  Y        I II EYM  GSL DFLK  +     +P+  L  
Sbjct: 57  EEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK--LID 114
Query: 164 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTF 220
              Q+ +G+ Y+   K+ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F
Sbjct: 115 FSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF 173
Query: 221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
                + +PE I+ G +  KSD+WS G++L E  T G+ PY
Sbjct: 174 --PIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 21/223 (9%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY-MDGGSLADFLKKVKTIPEEYLAA 163
           ++A   K+      P V+     F +     ++LE  +    L D++ +   + E     
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 164 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVG 222
              QV+  + + H  + ++HRD+K  N+LI+  RG  K+ DFG  A++         F G
Sbjct: 144 FFGQVVAAIQHCH-SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDFDG 200
Query: 223 TYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 281
           T  Y  PE IS  +Y    + +WSLG++L +   G  P+    ++D      E++EA + 
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF----ERD-----QEILEAELH 251
Query: 282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
            P         SP+ C+ I  C+  +P  R S +E++  P+++
Sbjct: 252 FP------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I++EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVIEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 107/235 (45%), Gaps = 26/235 (11%)
Query: 91  LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           LK   M VEE  +   + +E+K     Q   V      FY      II+E+M  G+L D+
Sbjct: 44  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IIIEFMTYGNLLDY 97
Query: 150 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 98  LRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 156
Query: 208 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PP 263
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY    P
Sbjct: 157 RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDP 216
Query: 264 EQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
            Q       YEL+E     + P   P   +       + AC Q  P  R S  E+
Sbjct: 217 SQ------VYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEI 260

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 18/237 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P ++        +  + I+ E M+ GSL  F
Sbjct: 48  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 107
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+
Sbjct: 108 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 164
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 165 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 224
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 225 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 273

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 314 QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRLPQ-- 364
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 365 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 424 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 477
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           E     P PP  P           +  C +KEP++R + + L    FL+ Y
Sbjct: 478 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEERPTFEYLQA--FLEDY 521

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 41/205 (20%)
Query: 89  FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------------ISI 136
           +A+K I++   E AR ++ +E+K     + P +V  + ++                 + I
Sbjct: 33  YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYI 92
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICE----QVLKGLLYLHHEKHIIHRDLKPSNLL 192
            ++     +L D++    TI EE   ++C     Q+ + + +LH  K ++HRDLKPSN+ 
Sbjct: 93  QMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLH-SKGLMHRDLKPSNIF 150
Query: 193 INHRGEVKITDFGVSAIM----------------ASTSGQANTFVGTYNYMSPERISGGK 236
                 VK+ DFG+   M                A  +GQ    VGT  YMSPE+I G  
Sbjct: 151 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ----VGTKLYMSPEQIHGNS 206
Query: 237 YGYKSDIWSLGLVLLECATGQFPYS 261
           Y +K DI+SLGL+L E     +P+S
Sbjct: 207 YSHKVDIFSLGLILFELL---YPFS 228

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 34/297 (11%)
Query: 48  PPLIKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQ-- 105
           P +++  + +L  +D +              +V+ K TGQ +A+K+  MN  +  +R   
Sbjct: 48  PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEV 105
Query: 106 --IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLA 162
               +E  +  +    ++   + +F     + +++EY  GG L   L K  + IP E   
Sbjct: 106 SCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR 165
Query: 163 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-- 220
               +++  +  +H   ++ HRD+KP N+L++  G +++ DFG S +     G   +   
Sbjct: 166 FYLAEIVMAIDSVHRLGYV-HRDIKPDNILLDRCGHIRLADFG-SCLKLRADGTVRSLVA 223
Query: 221 VGTYNYMSPERISGGKYGY-------KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 273
           VGT +Y+SPE +     G        + D W+LG+   E   GQ P+      + +    
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283
Query: 274 ELME----AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFL 323
              E     +VD+  P    D      C          P+ RL    A +  THPF 
Sbjct: 284 HYKEHLSLPLVDEGVPEEARDFIQRLLCP---------PETRLGRGGAGDFRTHPFF 331

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 42/230 (18%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + +++E MD  +L   +     +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A T+     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGEL 218
Query: 254 ATGQFPYSPPEQQDGW--------TSFYELMEAIVDQPP--------PSAPSDQFSPEFC 297
             G   +   +  D W        T   E M A+  QP         P  P  +F   F 
Sbjct: 219 VKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL--QPTVRNYVENRPKYPGIKFEELFP 276
Query: 298 SFI-------------------SACVQKEPQQRLSAQELMTHPFLKMYGD 328
            +I                   S  +  +P +R+S  E + HP++ ++ D
Sbjct: 277 DWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 326

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 20/232 (8%)
Query: 91  LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           LK   M VEE  +   + +E+K     Q   V      FY      II+E+M  G+L D+
Sbjct: 47  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IIIEFMTYGNLLDY 100
Query: 150 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 101 LRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 159
Query: 208 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 265
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 160 RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 219
Query: 266 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
               +  YEL+E       P    ++        + AC Q  P  R S  E+
Sbjct: 220 ----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDRPSFAEI 263

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 87/305 (28%), Positives = 135/305 (44%), Gaps = 51/305 (16%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS---- 135
            Q   +G+ +ALK +  N EE  R  I +   + + S  P +V     F S  +I     
Sbjct: 47  AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV----QFCSAASIGKEES 102
Query: 136 -------IILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKH-IIHR 184
                  ++L  +  G L +FLKK+++   +  + +  I  Q  + + ++H +K  IIHR
Sbjct: 103 DTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHR 162
Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMA-----STSGQANTFV-------GTYNYMSPERI 232
           DLK  NLL++++G +K+ DFG +  ++     S S Q    V        T  Y +PE I
Sbjct: 163 DLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222
Query: 233 ---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 289
              S    G K DIW+LG +L      Q P+     +DG          IV+      P 
Sbjct: 223 DLYSNFPIGEKQDIWALGCILYLLCFRQHPF-----EDGAKL------RIVNGKYSIPPH 271
Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD-----AGSPL 344
           D     F S I A +Q  P++RLS  E++ H   ++    NV+     T+      G   
Sbjct: 272 DTQYTVFHSLIRAMLQVNPEERLSIAEVV-HQLQEIAAARNVNPKSPITELLEQNGGYGS 330
Query: 345 ATLSN 349
           ATLS 
Sbjct: 331 ATLSR 335

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 52  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 106
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 107 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 165
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G + ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 166 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 104
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G + ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 164 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 73  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 127
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 128 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 186
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 187 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 245

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 102
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 231 QVMKKLRHEKLVQL-YAVVSEEPIY------IVGEYMSKGSLLDFLKGETGKYLRLPQ-- 281
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 282 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 341 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 394
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           E     P PP  P           +  C +KEP++R + + L    FL+ Y
Sbjct: 395 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEERPTFEYL--QAFLEDY 438

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGX 102
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 102
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 105
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 106 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 58  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 112
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 113 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 171
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 172 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 230

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLVGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 54  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 108
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 109 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 167
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 168 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 226

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 42  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 96
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 97  LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 155
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 104
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G + ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 164 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 91/187 (48%), Gaps = 15/187 (8%)
Query: 136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           II+E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 253 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 310
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 255
Query: 311 RLSAQEL 317
           R S  E+
Sbjct: 256 RPSFAEI 262

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 105
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 106 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 105
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 106 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 104
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 164 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 55  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 109
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 110 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 169 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 97  LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 155
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 156 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 214 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
Query: 324 K 324
           +
Sbjct: 259 Q 259

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  K + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVKXQK-LTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 XELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 91/187 (48%), Gaps = 15/187 (8%)
Query: 136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           II+E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 253 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 310
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 255
Query: 311 RLSAQEL 317
           R S  E+
Sbjct: 256 RPSFAEI 262

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           II+E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 91  IIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 149
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 150 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 253 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 210 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 261
Query: 312 LSAQEL 317
            S  E+
Sbjct: 262 PSFAEI 267

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 55  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 109
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 110 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 169 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 9/145 (6%)
Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEK 179
           +V   +  +   I II E+M  GSL DFLK  +    P   L     Q+ +G+ ++  ++
Sbjct: 72  LVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QR 130
Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGK 236
           + IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ G 
Sbjct: 131 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGS 188
Query: 237 YGYKSDIWSLGLVLLECAT-GQFPY 260
           +  KSD+WS G++L+E  T G+ PY
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGRIPY 213

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 203
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 157
Query: 204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 262
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 158 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 215
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 216 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 260
Query: 323 LK 324
           ++
Sbjct: 261 MQ 262

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 27/248 (10%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++ K TG   A+K +++ V         +EL        P +V  Y +      ++I +E
Sbjct: 77  MKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-E 198
            ++GGSL   +K++  +PE+       Q L+GL YL H + I+H D+K  N+L++  G  
Sbjct: 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL-HTRRILHGDVKADNVLLSSDGSR 189
Query: 199 VKITDFGVSAIMASTSGQANTFV------GTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
             + DFG  A+     G   + +      GT  +M+PE + G     K DIWS   ++L 
Sbjct: 190 AALCDFG-HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
Query: 253 CATGQFPYSPPEQQDGWTSFYE---LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
              G  P         WT ++     ++   + PP        +P     I   ++KEP 
Sbjct: 249 MLNGCHP---------WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 299
Query: 310 QRLSAQEL 317
            R SA EL
Sbjct: 300 HRASAMEL 307

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 161 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 219 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263
Query: 324 K 324
           +
Sbjct: 264 Q 264

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 18/182 (9%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 142
           TG   A+K +Q +  +  +R   +E++I ++    ++V      Y  G  ++ +++EY+ 
Sbjct: 38  TGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 96
Query: 143 GGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
            G L DFL++ +  +    L     Q+ KG+ YL   +  +HRDL   N+L+     VKI
Sbjct: 97  SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKI 155
Query: 202 TDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
            DFG++ ++            GQ+  F     + +PE +S   +  +SD+WS G+VL E 
Sbjct: 156 ADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYEL 210
Query: 254 AT 255
            T
Sbjct: 211 FT 212

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 56  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 106
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 107 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 165
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 166 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 219
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +K+P++R
Sbjct: 220 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 250

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 101 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 159
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 160 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 217
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 218 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 262
Query: 324 K 324
           +
Sbjct: 263 Q 263

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 54  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 104
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 105 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 163
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 164 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 217
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +K+P++R
Sbjct: 218 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 248

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 160
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 161 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 219 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263
Query: 324 K 324
           +
Sbjct: 264 Q 264

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 202
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 203 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 261 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305
Query: 324 K 324
           +
Sbjct: 306 Q 306

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 18/182 (9%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 142
           TG   A+K +Q +  +  +R   +E++I ++    ++V      Y  G  ++ +++EY+ 
Sbjct: 39  TGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 97
Query: 143 GGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
            G L DFL++ +  +    L     Q+ KG+ YL   +  +HRDL   N+L+     VKI
Sbjct: 98  SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKI 156
Query: 202 TDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
            DFG++ ++            GQ+  F     + +PE +S   +  +SD+WS G+VL E 
Sbjct: 157 ADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYEL 211
Query: 254 AT 255
            T
Sbjct: 212 FT 213

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 110/243 (45%), Gaps = 42/243 (17%)
Query: 101 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-------- 152
           +AR+   +E ++  + Q  ++V  Y        + ++ EYM  G L  FL+         
Sbjct: 59  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118
Query: 153 VKTIPEEY--------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           V   P +         +  I  Q+  G++YL   +H +HRDL   N L+     VKI DF
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGANLLVKIGDF 177
Query: 205 GVSAIMASTSGQANTFVGTY-----NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 258
           G+S  + ST       VG +      +M PE I   K+  +SD+WS G++L E  T G+ 
Sbjct: 178 GMSRDVYSTD---YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 259 PYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
           P+          S  E++E I    V + P   P + +       +  C Q+EPQQRL+ 
Sbjct: 235 PWFQ-------LSNTEVIECITQGRVLERPRVCPKEVY-----DVMLGCWQREPQQRLNI 282
Query: 315 QEL 317
           +E+
Sbjct: 283 KEI 285

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 187
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 246 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290
Query: 324 K 324
           +
Sbjct: 291 Q 291

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   FV T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 108 QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEYLAA 163
           QE ++ +  +   +V  Y +  S   I I+ EYM  GSL DFLK    K   +P+  L  
Sbjct: 62  QEAQVMKKIRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ--LVD 118
Query: 164 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTF 220
           +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q   F
Sbjct: 119 MAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 177
Query: 221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI 279
                + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +E  
Sbjct: 178 --PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERG 231
Query: 280 VDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
              P PP  P           +  C +K+P++R
Sbjct: 232 YRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   FV T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 202
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 203 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 261 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305
Query: 324 K 324
           +
Sbjct: 306 Q 306

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVCEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 102
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 106/235 (45%), Gaps = 26/235 (11%)
Query: 91  LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 44  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 97
Query: 150 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 98  LRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 156
Query: 208 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PP 263
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY    P
Sbjct: 157 RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDP 216
Query: 264 EQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
            Q       YEL+E     + P   P   +       + AC Q  P  R S  E+
Sbjct: 217 SQ------VYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEI 260

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  K + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVKXQK-LTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 110 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 167
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 168 SELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 225 GRTLFP 230

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 27/248 (10%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++ K TG   A+K +++ V         +EL        P +V  Y +      ++I +E
Sbjct: 91  MKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 144
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-E 198
            ++GGSL   +K++  +PE+       Q L+GL YL H + I+H D+K  N+L++  G  
Sbjct: 145 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL-HTRRILHGDVKADNVLLSSDGSR 203
Query: 199 VKITDFGVSAIMASTSGQANTFV------GTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
             + DFG  A+     G   + +      GT  +M+PE + G     K DIWS   ++L 
Sbjct: 204 AALCDFG-HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 262
Query: 253 CATGQFPYSPPEQQDGWTSFYE---LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
              G  P         WT ++     ++   + PP        +P     I   ++KEP 
Sbjct: 263 MLNGCHP---------WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 313
Query: 310 QRLSAQEL 317
            R SA EL
Sbjct: 314 HRASAMEL 321

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 106 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 163
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 164 SELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 221 GRTLFP 226

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 27/248 (10%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++ K TG   A+K +++ V         +EL        P +V  Y +      ++I +E
Sbjct: 93  MKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 146
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-E 198
            ++GGSL   +K++  +PE+       Q L+GL YL H + I+H D+K  N+L++  G  
Sbjct: 147 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL-HTRRILHGDVKADNVLLSSDGSR 205
Query: 199 VKITDFGVSAIMASTSGQANTFV------GTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
             + DFG  A+     G   + +      GT  +M+PE + G     K DIWS   ++L 
Sbjct: 206 AALCDFG-HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 264
Query: 253 CATGQFPYSPPEQQDGWTSFYE---LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
              G  P         WT ++     ++   + PP        +P     I   ++KEP 
Sbjct: 265 MLNGCHP---------WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 315
Query: 310 QRLSAQEL 317
            R SA EL
Sbjct: 316 HRASAMEL 323

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 161 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 219 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263
Query: 324 K 324
           +
Sbjct: 264 Q 264

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  K + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVKSQK-LTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG   +   T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 SELKILDFG---LCRHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 202
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 203 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 261 EEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 305
Query: 324 K 324
           +
Sbjct: 306 Q 306

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 136 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 194
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 195 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 253 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297
Query: 324 K 324
           +
Sbjct: 298 Q 298

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 124 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 182
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 183 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 240
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 241 EEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 285
Query: 324 K 324
           +
Sbjct: 286 Q 286

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI--ILEYMD 142
           TG+  A+K ++ +     R    QE+ I ++    +++         GA S+  ++EY+ 
Sbjct: 59  TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
            GSL D+L +  +I    L    +Q+ +G+ YLH  +H IHRDL   N+L+++   VKI 
Sbjct: 119 LGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLH-AQHYIHRDLAARNVLLDNDRLVKIG 176
Query: 203 DFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE-- 252
           DFG++  +            G +  F     + +PE +   K+ Y SD+WS G+ L E  
Sbjct: 177 DFGLAKAVPEGHEXYRVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLYELL 231
Query: 253 --CATGQFPYSPPEQQDGWTSFYELM 276
             C + Q   SPP      T F EL+
Sbjct: 232 THCDSSQ---SPP------TKFLELI 248

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 18/182 (9%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 142
           TG   A+K +Q +  +  +R   +E++I ++    ++V      Y  G  ++ +++EY+ 
Sbjct: 51  TGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 109
Query: 143 GGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
            G L DFL++ +  +    L     Q+ KG+ YL   +  +HRDL   N+L+     VKI
Sbjct: 110 SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKI 168
Query: 202 TDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
            DFG++ ++            GQ+  F     + +PE +S   +  +SD+WS G+VL E 
Sbjct: 169 ADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYEL 223
Query: 254 AT 255
            T
Sbjct: 224 FT 225

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 116 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 174
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 175 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 233 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 277
Query: 324 K 324
           +
Sbjct: 278 Q 278

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 74/126 (58%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 111 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 168
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T+ +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 169 CELKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 226 GRTLFP 231

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 94/187 (50%), Gaps = 18/187 (9%)
Query: 86  GQFFALKVIQMNVEES----ARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISII 137
           G+   + V  M + E+    A ++I  E  +  S   P+V     +C  S      + +I
Sbjct: 74  GEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLI 128
Query: 138 LEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            + M  G L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+   
Sbjct: 129 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTP 187
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECA 254
             VKITDFG++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  
Sbjct: 188 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 247
Query: 255 T-GQFPY 260
           T G  PY
Sbjct: 248 TFGSKPY 254

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 74/126 (58%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 111 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 168
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T+ +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 169 CELKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 226 GRTLFP 231

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 116 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 174
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 175 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 233 EEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 277
Query: 324 K 324
           +
Sbjct: 278 Q 278

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 105/232 (45%), Gaps = 20/232 (8%)
Query: 91  LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 51  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 104
Query: 150 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 105 LRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 163
Query: 208 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 265
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 164 RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 223
Query: 266 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
               +  YEL+E       P    ++        + AC Q  P  R S  E+
Sbjct: 224 ----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDRPSFAEI 267

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 74/126 (58%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 111 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 168
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T+ +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 169 CELKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 226 GRTLFP 231

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 149 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 207
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 208 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 265
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 266 EEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 310
Query: 324 K 324
           +
Sbjct: 311 Q 311

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 175
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 176 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 234 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 278
Query: 324 K 324
           +
Sbjct: 279 Q 279

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 100 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 157
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   FV T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 158 CELKILDFGLA---RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 215 GRTLFP 220

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 32/231 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 232 QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 282
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG+  ++     T+ Q 
Sbjct: 283 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQG 341
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 342 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 395
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           E     P PP  P           +  C +K+P++R + + L    FL+ Y
Sbjct: 396 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEERPTFEYL--QAFLEDY 439

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  K + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 100 LVTHLMGADLNNIVKCAK-LTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 157
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 158 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 215 GRTLFP 220

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 175
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 176 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 234 EEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWM 278
Query: 324 K 324
           +
Sbjct: 279 Q 279

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 93/180 (51%), Gaps = 16/180 (8%)
Query: 85  TGQFFALKVIQM-NVEE----SARRQIAQELKINQSSQCPYVV----VCYQSFYSNG-AI 134
           +G F ALK +++ N EE    S  R++A  L+  ++ + P VV    VC  S       +
Sbjct: 28  SGHFVALKSVRVPNGEEGLPISTVREVAL-LRRLEAFEHPNVVRLMDVCATSRTDREIKV 86
Query: 135 SIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           +++ E++D   L  +L K     +P E +  +  Q L+GL +LH    I+HRDLKP N+L
Sbjct: 87  TLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENIL 144
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +   G VK+ DFG++ I +     A   V T  Y +PE +    Y    D+WS+G +  E
Sbjct: 145 VTSGGTVKLADFGLARIYSYQMALAPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAE 203

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 117/248 (47%), Gaps = 17/248 (6%)
Query: 80  VQHKWTGQFFALK--VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII 137
           V+ K  G+ +A+K  +      +   R++A+     +  Q P  V   Q++   G + + 
Sbjct: 76  VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135
Query: 138 LEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
            E + G SL    +    ++PE  +       L  L +LH +  ++H D+KP+N+ +  R
Sbjct: 136 TE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG-LVHLDVKPANIFLGPR 193
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
           G  K+ DFG+  +   T+G      G   YM+PE +  G YG  +D++SLGL +LE A  
Sbjct: 194 GRCKLGDFGL-LVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACN 251
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
                 P   +GW    +L +  +   PP   +   S E  S +   ++ +P+ R +A+ 
Sbjct: 252 ---MELPHGGEGWQ---QLRQGYL---PPEFTAG-LSSELRSVLVMMLEPDPKLRATAEA 301
Query: 317 LMTHPFLK 324
           L+  P L+
Sbjct: 302 LLALPVLR 309

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 88/180 (48%), Gaps = 14/180 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K++       A  +   E  I  S   P++V    VC         I ++ + M  G 
Sbjct: 48  AIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----TIQLVTQLMPHGC 102
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L +++ + K  I  + L   C Q+ KG++YL  E+ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNVLVKSPNHVKITDF 161
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 261
           G++ ++     + N   G     +M+ E I   K+ ++SD+WS G+ + E  T G  PY 
Sbjct: 162 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 146 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 204
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 175
Query: 205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 263
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 176 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 234 EEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 278
Query: 324 K 324
           +
Sbjct: 279 Q 279

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA--ISIILEYMD 142
           TG   A+K +Q +  +  +R   +E++I ++    ++V      Y  G   + +++EY+ 
Sbjct: 35  TGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLP 93
Query: 143 GGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
            G L DFL++ +  +    L     Q+ KG+ YL   +  +HRDL   N+L+     VKI
Sbjct: 94  SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKI 152
Query: 202 TDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
            DFG++ ++            GQ+  F     + +PE +S   +  +SD+WS G+VL E 
Sbjct: 153 ADFGLAKLLPLDKDXXVVREPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYEL 207
Query: 254 AT 255
            T
Sbjct: 208 FT 209

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I++EYM  G L DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVMEYMSKGCLLDFLKGEMGKYLRLPQ-- 115
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 109 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 166
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 167 XELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 224 GRTLFP 229

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 85/163 (52%), Gaps = 9/163 (5%)
Query: 100 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPE 158
           E  ++Q  QE+K+    Q   +V     F S+G  + ++  YM  GSL D L  +   P 
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELL-GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 159 ---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--ST 213
                   I +    G+ +LH E H IHRD+K +N+L++     KI+DFG++      + 
Sbjct: 130 LSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
           +   +  VGT  YM+PE +  G+   KSDI+S G+VLLE  TG
Sbjct: 189 TVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 230

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 109 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 166
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 167 XELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 224 GRTLFP 229

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 102
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G + ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 162 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 93/187 (49%), Gaps = 23/187 (12%)
Query: 134 ISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           I II E+M  GSL DFLK  +    P   L     Q+ +G+ ++  +++ IHRDL+ +N+
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANI 315
Query: 192 LINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
           L++     KI DFG++ ++     T+ +   F     + +PE I+ G +  KSD+WS G+
Sbjct: 316 LVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSDVWSFGI 373
Query: 249 VLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
           +L+E  T G+ PY   S PE        Y +        P + P      E  + +  C 
Sbjct: 374 LLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR------PENCPE-----ELYNIMMRCW 422
Query: 305 QKEPQQR 311
           +  P++R
Sbjct: 423 KNRPEER 429

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 104
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G + ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 164 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 124/274 (45%), Gaps = 31/274 (11%)
Query: 81  QHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILE 139
           ++K TG+  A+K    + ++   ++IA +E+K+ +  +   +V   +         ++ E
Sbjct: 45  RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104
Query: 140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           ++D   L D       +  + +     Q++ G+ + H   +IIHRD+KP N+L++  G V
Sbjct: 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH-SHNIIHRDIKPENILVSQSGVV 163
Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 258
           K+ DFG +  +A+     +  V T  Y +PE + G  KYG   D+W++G ++ E   G+ 
Sbjct: 164 KLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE- 222
Query: 259 PYSPPEQQDGWTSFYELM----------EAIVDQPPPSA-----------PSDQFSPEFC 297
           P  P +        Y +M          + + ++ P  A           P ++  P+  
Sbjct: 223 PLFPGDSD--IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLS 280
Query: 298 SFI----SACVQKEPQQRLSAQELMTHPFLKMYG 327
             +      C+  +P +R    EL+ H F +M G
Sbjct: 281 EVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 106/235 (45%), Gaps = 26/235 (11%)
Query: 91  LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 44  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 97
Query: 150 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 98  LRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 156
Query: 208 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PP 263
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY    P
Sbjct: 157 RLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDP 216
Query: 264 EQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
            Q       YEL+E     + P   P   +       + AC Q  P  R S  E+
Sbjct: 217 SQ------VYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEI 260

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 91  LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 51  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 104
Query: 150 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 105 LRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 163
Query: 208 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 265
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 164 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 223
Query: 266 QDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
               +  YEL+E     + P   P   +       + AC Q  P  R S  E+
Sbjct: 224 ----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEI 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 15/187 (8%)
Query: 136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 253 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 310
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 255
Query: 311 RLSAQEL 317
           R S  E+
Sbjct: 256 RPSFAEI 262

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 115 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 172
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 173 XELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 230 GRTLFP 235

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 105/232 (45%), Gaps = 20/232 (8%)
Query: 91  LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 51  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 104
Query: 150 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 105 LRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 163
Query: 208 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 265
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 164 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 223
Query: 266 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
               +  YEL+E       P    ++        + AC Q  P  R S  E+
Sbjct: 224 ----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDRPSFAEI 267

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 111 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 168
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 169 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 226 GRTLFP 231

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 114 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 171
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 172 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 229 GRTLFP 234

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 105/232 (45%), Gaps = 20/232 (8%)
Query: 91  LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 50  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 103
Query: 150 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 104 LRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 162
Query: 208 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 265
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222
Query: 266 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
               +  YEL+E       P    ++        + AC Q  P  R S  E+
Sbjct: 223 ----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDRPSFAEI 266

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 109 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 166
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 167 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 224 GRTLFP 229

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 109 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 166
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 167 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 224 GRTLFP 229

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 106 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 163
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 164 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 221 GRTLFP 226

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 103 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 160
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 161 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 218 GRTLFP 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 106 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 163
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 164 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 221 GRTLFP 226

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 55  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 109
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 110 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G + ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 169 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 15/187 (8%)
Query: 136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 253 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 310
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 255
Query: 311 RLSAQEL 317
           R S  E+
Sbjct: 256 RPSFAEI 262

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 15/187 (8%)
Query: 136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 253 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 310
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 255
Query: 311 RLSAQEL 317
           R S  E+
Sbjct: 256 RPSFAEI 262

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 253 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 256
Query: 312 LSAQEL 317
            S  E+
Sbjct: 257 PSFAEI 262

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 116 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 173
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 174 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 231 GRTLFP 236

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 116 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 173
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 174 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 231 GRTLFP 236

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 91  LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 51  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 104
Query: 150 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 105 LRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 163
Query: 208 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 265
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 164 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 223
Query: 266 QDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
               +  YEL+E     + P   P   +       + AC Q  P  R S  E+
Sbjct: 224 ----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEI 267

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 101 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 158
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 159 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 216 GRTLFP 221

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 106 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 163
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 164 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 221 GRTLFP 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 116 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 173
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 174 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 231 GRTLFP 236

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 115/259 (44%), Gaps = 54/259 (20%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 137
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 39  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 93
Query: 138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 94  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 152
Query: 196 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +K+TDFG +                      +  +G KY    D+WSLG+++  
Sbjct: 153 KRPNAILKLTDFGFA----------------------KETTGEKYDKSCDMWSLGVIMYI 190
Query: 253 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 191 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 241
Query: 305 QKEPQQRLSAQELMTHPFL 323
           + EP QR++  E M HP++
Sbjct: 242 KTEPTQRMTITEFMNHPWI 260

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 115 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 172
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 173 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 230 GRTLFP 235

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 6/175 (3%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K++       A  +   E  I  S   P++V       S   I ++ + M  G L ++
Sbjct: 71  AIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEY 129
Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           + + K  I  + L   C Q+ KG++YL  E+ ++HRDL   N+L+     VKITDFG++ 
Sbjct: 130 VHEHKDNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 188
Query: 209 IMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           ++     + N   G     +M+ E I   K+ ++SD+WS G+ + E  T G  PY
Sbjct: 189 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 243

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 146
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 147 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 206
Query: 253 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 207 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 258
Query: 312 LSAQEL 317
            S  E+
Sbjct: 259 PSFAEI 264

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 110 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 167
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 168 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 225 GRTLFP 230

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL  +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 84/163 (51%), Gaps = 9/163 (5%)
Query: 100 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPE 158
           E  ++Q  QE+K+    Q   +V     F S+G  + ++  YM  GSL D L  +   P 
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELL-GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 159 ---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--ST 213
                   I +    G+ +LH E H IHRD+K +N+L++     KI+DFG++      + 
Sbjct: 130 LSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
           +      VGT  YM+PE +  G+   KSDI+S G+VLLE  TG
Sbjct: 189 TVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 230

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 110 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 167
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 168 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 225 GRTLFP 230

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 99  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 157
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 158 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 217
Query: 253 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 218 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 269
Query: 312 LSAQEL 317
            S  E+
Sbjct: 270 PSFAEI 275

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 127 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 184
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 185 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 242 GRTLFP 247

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 110 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 167
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 168 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 225 GRTLFP 230

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 146
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 147 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 206
Query: 253 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 207 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 258
Query: 312 LSAQEL 317
            S  E+
Sbjct: 259 PSFAEI 264

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 101 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 158
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 159 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 216 GRTLFP 221

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 100 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 157
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 158 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 215 GRTLFP 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 100 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 157
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 158 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 215 GRTLFP 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 124 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 181
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 182 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 239 GRTLFP 244

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 124 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 181
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 182 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 239 GRTLFP 244

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 123 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 180
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 181 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 238 GRTLFP 243

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 45  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 99
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D++++ K  I  +YL   C Q+ +G+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 100 LLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 158
Query: 205 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 159 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 217

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 127 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 184
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 185 CELKILDFGLA---RHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 242 GRTLFP 247

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 123 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 180
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 181 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 238 GRTLFP 243

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 102 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 159
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 160 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 217 GRTLFP 222

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 93/180 (51%), Gaps = 16/180 (8%)
Query: 85  TGQFFALKVIQM-NVEE----SARRQIAQELKINQSSQCPYVV----VCYQSFYSNG-AI 134
           +G F ALK +++ N EE    S  R++A  L+  ++ + P VV    VC  S       +
Sbjct: 28  SGHFVALKSVRVPNGEEGLPISTVREVAL-LRRLEAFEHPNVVRLMDVCATSRTDREIKV 86
Query: 135 SIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           +++ E++D   L  +L K     +P E +  +  Q L+GL +LH    I+HRDLKP N+L
Sbjct: 87  TLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENIL 144
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +   G VK+ DFG++ I  S     +  V T  Y +PE +    Y    D+WS+G +  E
Sbjct: 145 VTSGGTVKLADFGLARIY-SYQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 203

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 83/163 (50%), Gaps = 9/163 (5%)
Query: 100 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPE 158
           E  ++Q  QE+K+    Q   +V     F S+G  + ++  YM  GSL D L  +   P 
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELL-GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 123
Query: 159 ---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 215
                   I +    G+ +LH E H IHRD+K +N+L++     KI+DFG++      + 
Sbjct: 124 LSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 216 QA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
                  VGT  YM+PE +  G+   KSDI+S G+VLLE  TG
Sbjct: 183 XVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 224

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
              G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 113 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 171
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 172 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 231
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        PEQ+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 232 LDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 291
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 292 LTFNPHKRIEVEQALAHPYLEQYYD 316

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 160
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  G L DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGCLLDFLKGEMGKYLRLPQ-- 115
Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 217
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 277 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 311
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K ++    +  RR    E  I      P ++           + II EYM+ GSL  F
Sbjct: 61  AIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF 120
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL  +   +HRDL   N+L+N     K++DFG+
Sbjct: 121 LRKNDGRFTVIQ--LVGMLRGIGSGMKYLS-DMSAVHRDLAARNILVNSNLVCKVSDFGM 177
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY  
Sbjct: 178 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 237
Query: 263 PEQQDGWTSFYELMEAIVDQPPP 285
              QD      + +E     PPP
Sbjct: 238 MSNQD----VIKAIEEGYRLPPP 256

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 18/236 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +++   E  RR    E  I      P VV           + I++E+M+ G+L  F
Sbjct: 75  AIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAF 134
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    ++ HRDL   N+L+N     K++DFG+
Sbjct: 135 LRKHDGQFTVIQ--LVGMLRGIAAGMRYLADMGYV-HRDLAARNILVNSNLVCKVSDFGL 191
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++        T  G      + +PE I   K+   SD+WS G+V+ E  + G+ PY  
Sbjct: 192 SRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 251
Query: 263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
              QD       +++AI +     AP D         +  C QKE  +R   ++++
Sbjct: 252 MSNQD-------VIKAIEEGYRLPAPMD-CPAGLHQLMLDCWQKERAERPKFEQIV 299

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K ++    +  RR    E  I      P ++           + II EYM+ GSL  F
Sbjct: 40  AIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF 99
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    ++ HRDL   N+L+N     K++DFG+
Sbjct: 100 LRKNDGRFTVIQ--LVGMLRGIGSGMKYLSDMSYV-HRDLAARNILVNSNLVCKVSDFGM 156
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY  
Sbjct: 157 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 216
Query: 263 PEQQDGWTSFYELMEAIVDQPPP 285
              QD      + +E     PPP
Sbjct: 217 MSNQD----VIKAIEEGYRLPPP 235

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K ++    +  RR    E  I      P ++           + II EYM+ GSL  F
Sbjct: 46  AIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF 105
Query: 150 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 206
           L+K     T+ +  L  +   +  G+ YL    ++ HRDL   N+L+N     K++DFG+
Sbjct: 106 LRKNDGRFTVIQ--LVGMLRGIGSGMKYLSDMSYV-HRDLAARNILVNSNLVCKVSDFGM 162
Query: 207 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 262
           S ++      A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY  
Sbjct: 163 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 222
Query: 263 PEQQDGWTSFYELMEAIVDQPPP 285
              QD      + +E     PPP
Sbjct: 223 MSNQD----VIKAIEEGYRLPPP 241

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI D+G++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDYGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 13/161 (8%)
Query: 108 QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAA 163
           +E  + ++ Q   +V  Y        I II E+M  GSL DFLK  +     +P+  L  
Sbjct: 56  EEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPK--LID 113
Query: 164 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTF 220
              Q+ +G+ Y+   K+ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F
Sbjct: 114 FSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF 172
Query: 221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
                + +PE I+ G +  KS++WS G++L E  T G+ PY
Sbjct: 173 --PIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 45/130 (34%), Positives = 72/130 (55%), Gaps = 13/130 (10%)
Query: 134 ISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           I II E+M  GSL DFLK  +    P   L     Q+ +G+ ++  +++ IHRDL+ +N+
Sbjct: 251 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANI 309
Query: 192 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
           L++     KI DFG++ + A              + +PE I+ G +  KSD+WS G++L+
Sbjct: 310 LVSASLVCKIADFGLARVGAKFP---------IKWTAPEAINFGSFTIKSDVWSFGILLM 360
Query: 252 ECAT-GQFPY 260
           E  T G+ PY
Sbjct: 361 EIVTYGRIPY 370

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 111/245 (45%), Gaps = 25/245 (10%)
Query: 91  LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           LK   M VEE  +   + +E+K     Q   V      FY      I+ EYM  G+L D+
Sbjct: 65  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFY------IVTEYMPYGNLLDY 118
Query: 150 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 119 LRECNREEVTAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHVVKVADFGLS 177
Query: 208 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 265
            +M   +  A+        + +PE ++   +  KSD+W+ G++L E AT G  PY   + 
Sbjct: 178 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 237
Query: 266 QDGWTSFYELME-AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH-PFL 323
               +  Y+L+E     + P   P     P+    + AC +  P  R S  E  TH  F 
Sbjct: 238 ----SQVYDLLEKGYRMEQPEGCP-----PKVYELMRACWKWSPADRPSFAE--THQAFE 286
Query: 324 KMYGD 328
            M+ D
Sbjct: 287 TMFHD 291

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 143 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 174
Query: 187 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQS 231
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 232 DVWSFGVLLWEIFSLGASPY-PGVKID-----EEFCRRLKEGTRMRAP-DYTTPEMYQTM 284
Query: 301 SACVQKEPQQRLSAQELMTH 320
             C   EP QR +  EL+ H
Sbjct: 285 LDCWHGEPSQRPTFSELVEH 304

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 147 ADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           AD  K +KT  +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DF
Sbjct: 130 ADLYKLLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDF 188
Query: 205 GVSAIM---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--F 258
           G++ +       +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  F
Sbjct: 189 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248
Query: 259 P--------------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS---- 298
           P                 P Q+D       +    ++  P  +  P ++  P   S    
Sbjct: 249 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 308
Query: 299 FISACVQKEPQQRLSAQELMTHPFLKMYGD 328
            +   +   P +R+  ++ + HP+L+ Y D
Sbjct: 309 LLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 136 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 87  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 145
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
                VK+ DFG+S +M   +  A         + +PE ++  K+  KSD+W+ G++L E
Sbjct: 146 GENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 205
Query: 253 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 206 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 257
Query: 312 LSAQEL 317
            S  E+
Sbjct: 258 PSFAEI 263

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 16/182 (8%)
Query: 136 IILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           II EYM+ G+L  FL+ K        L  +   +  G+ YL +  ++ HRDL   N+L+N
Sbjct: 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV-HRDLAARNILVN 181
Query: 195 HRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLL 251
                K++DFG+S ++        T  G      + +PE IS  K+   SD+WS G+V+ 
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 241
Query: 252 ECAT-GQFPYSPPEQQDGWT-SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 309
           E  T G+ PY        W  S +E+M+AI D      P D  S  +   +  C Q+E  
Sbjct: 242 EVMTYGERPY--------WELSNHEVMKAINDGFRLPTPMDCPSAIY-QLMMQCWQQERA 292
Query: 310 QR 311
           +R
Sbjct: 293 RR 294

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 117/255 (45%), Gaps = 26/255 (10%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISI 136
           H+ TGQ  ALK++  +    AR+++       Q+S  P++V C    Y N       + I
Sbjct: 50  HRRTGQKCALKLLYDS--PKARQEVDHHW---QASGGPHIV-CILDVYENMHHGKRCLLI 103
Query: 137 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           I+E M+GG L   +++   +   E   A I   +   + +LH   +I HRD+KP NLL  
Sbjct: 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH-SHNIAHRDVKPENLLYT 162
Query: 195 HRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
            + +   +K+TDFG +    +T     T   T  Y++PE +   KY    D+WSLG+++ 
Sbjct: 163 SKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220
Query: 252 ECATGQFPYSPPEQQD---GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 308
               G  P+     Q    G      L +     P  S    + S +    I   ++ +P
Sbjct: 221 ILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS----EVSEDAKQLIRLLLKTDP 276
Query: 309 QQRLSAQELMTHPFL 323
            +RL+  + M HP++
Sbjct: 277 TERLTITQFMNHPWI 291

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 119/256 (46%), Gaps = 28/256 (10%)
Query: 82  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISI 136
           H+ TGQ  ALK++  +    AR+++       Q+S  P++V C    Y N       + I
Sbjct: 31  HRRTGQKCALKLLYDS--PKARQEVDHHW---QASGGPHIV-CILDVYENMHHGKRCLLI 84
Query: 137 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           I+E M+GG L   +++   +   E   A I   +   + +LH   +I HRD+KP NLL  
Sbjct: 85  IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH-SHNIAHRDVKPENLLYT 143
Query: 195 HRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 251
            + +   +K+TDFG +    +T     T   T  Y++PE +   KY    D+WSLG+++ 
Sbjct: 144 SKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 201
Query: 252 ECATGQFP--YSPPEQ--QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 307
               G FP  YS   Q    G      L +     P  S    + S +    I   ++ +
Sbjct: 202 ILLCG-FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS----EVSEDAKQLIRLLLKTD 256
Query: 308 PQQRLSAQELMTHPFL 323
           P +RL+  + M HP++
Sbjct: 257 PTERLTITQFMNHPWI 272

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 20/232 (8%)
Query: 91  LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 48  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 101
Query: 150 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 102 LRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 160
Query: 208 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 265
            +M   +  A         + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 161 RLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 220
Query: 266 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
               +  YEL+E       P    ++        + AC Q  P  R S  E+
Sbjct: 221 ----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDRPSFAEI 264

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           ++ E M GGS+   + K +   E   + + + V   L +LH+ K I HRDLKP N+L  H
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEH 146
Query: 196 RGE---VKITDFGVSAIMA-------STSGQANTFVGTYNYMSPERI-----SGGKYGYK 240
             +   VKI DFG+ + +         ++ +  T  G+  YM+PE +         Y  +
Sbjct: 147 PNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 241 SDIWSLGLVLLECATGQFPYSPPEQQD-GWT------SFYELMEAIVDQPPPSAPSDQFS 293
            D+WSLG++L    +G  P+      D GW       +   ++   + +     P   ++
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWA 266
Query: 294 PEFCS---FISACVQKEPQQRLSAQELMTHPFLK 324
              C+    IS  + ++ +QRLSA +++ HP+++
Sbjct: 267 HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 106
Query: 143 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 107 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 165
Query: 187 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQS 222
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 223 DVWSFGVLLWEIFSLGASPY-PGVKID-----EEFCRRLKEGTRMRAP-DYTTPEMYQTM 275
Query: 301 SACVQKEPQQRLSAQELMTH 320
             C   EP QR +  EL+ H
Sbjct: 276 LDCWHGEPSQRPTFSELVEH 295

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +    V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 106 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 160
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     FV T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 161 VKSDCTLKILDFGL-ARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 219
Query: 253 CATGQFPYSPPEQQDGWTSFYE 274
              G   +   +  D W    E
Sbjct: 220 MIKGGVLFPGTDHIDQWNKVIE 241

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 94/182 (51%), Gaps = 20/182 (10%)
Query: 85  TGQFFALKVIQM-NVEE----SARRQIAQELKINQSSQCPYVV----VCYQSFYSNG-AI 134
           +G F ALK +++ N EE    S  R++A  L+  ++ + P VV    VC  S       +
Sbjct: 28  SGHFVALKSVRVPNGEEGLPISTVREVAL-LRRLEAFEHPNVVRLMDVCATSRTDREIKV 86
Query: 135 SIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           +++ E++D   L  +L K     +P E +  +  Q L+GL +LH    I+HRDLKP N+L
Sbjct: 87  TLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENIL 144
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTF--VGTYNYMSPERISGGKYGYKSDIWSLGLVL 250
           +   G VK+ DFG++ I    S Q   F  V T  Y +PE +    Y    D+WS+G + 
Sbjct: 145 VTSGGTVKLADFGLARIY---SYQMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 201
Query: 251 LE 252
            E
Sbjct: 202 AE 203

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 31/256 (12%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 56  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 143 GGSLADFLKKVKT------------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN 190
            G+L+ +L+  +             +  E+L     QV KG+ +L   K  IHRDL   N
Sbjct: 116 FGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRK-XIHRDLAARN 174
Query: 191 LLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWS 245
           +L++ +  VKI DFG++  +         G A        +M+PE I    Y  +SD+WS
Sbjct: 175 ILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWS 231
Query: 246 LGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
            G++L E  + G  PY P  + D      E    + +     AP D  +PE    +  C 
Sbjct: 232 FGVLLWEIFSLGASPY-PGVKIDE-----EFXRRLKEGTRMRAP-DYTTPEMYQTMLDCW 284
Query: 305 QKEPQQRLSAQELMTH 320
             EP QR +  EL+ H
Sbjct: 285 HGEPSQRPTFSELVEH 300

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 120/278 (43%), Gaps = 27/278 (9%)
Query: 51  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQEL 110
           + P+ ++  +E  D             ++ +  W      + V  +  +     +  +E 
Sbjct: 208 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 267
Query: 111 KINQSSQCPYVV----VCYQS--FYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLA 162
            + +  + P +V    VC +   FY      II E+M  G+L D+L++   + +    L 
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDYLRECNRQEVSAVVLL 321
Query: 163 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 222
            +  Q+   + YL  +K+ IHR+L   N L+     VK+ DFG+S +M   +  A+    
Sbjct: 322 YMATQISSAMEYLE-KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 380
Query: 223 -TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIV 280
               + +PE ++  K+  KSD+W+ G++L E AT G  PY   +     +  YEL+E   
Sbjct: 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELLEKDY 436
Query: 281 D-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
             + P   P   +       + AC Q  P  R S  E+
Sbjct: 437 RMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEI 469

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 93  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 152
Query: 143 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 153 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 211
Query: 187 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQS 268
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 269 DVWSFGVLLWEIFSLGASPY-PGVKID-----EEFCRRLKEGTRMRAP-DYTTPEMYQTM 321
Query: 301 SACVQKEPQQRLSAQELMTH 320
             C   EP QR +  EL+ H
Sbjct: 322 LDCWHGEPSQRPTFSELVEH 341

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLLIN   ++KI DFG++ I
Sbjct: 135 LLKSQQLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLINTTCDLKICDFGLARI 193
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G     V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 194 ADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 253
Query: 260 ----------YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF-------CSFISA 302
                        P Q+D       +      Q  PS     ++  F          +  
Sbjct: 254 LDQLNHILGILGSPSQED-LNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDR 312
Query: 303 CVQKEPQQRLSAQELMTHPFLKMYGD 328
            +   P +R++ +E + HP+L+ Y D
Sbjct: 313 MLTFNPNKRITVEEALAHPYLEQYYD 338

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 113/259 (43%), Gaps = 34/259 (13%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 57  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 116
Query: 143 GGSLADFLKKVKT------IPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDLK 187
            G+L+ +L+  +        PE         E+L     QV KG+ +L   K  IHRDL 
Sbjct: 117 FGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLA 175
Query: 188 PSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSD 242
             N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +SD
Sbjct: 176 ARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQSD 232
Query: 243 IWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 301
           +WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    + 
Sbjct: 233 VWSFGVLLWEIFSLGASPY-PGVKID-----EEFCRRLKEGTRMRAP-DYTTPEMYQTML 285
Query: 302 ACVQKEPQQRLSAQELMTH 320
            C   EP QR +  EL+ H
Sbjct: 286 DCWHGEPSQRPTFSELVEH 304

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 37/220 (16%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +++ +M G  L   +K  K + E+ +  +  Q+LKGL Y+H    IIHRDLKP NL +N 
Sbjct: 107 LVMPFM-GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNE 163
Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECA 254
             E+KI DFG++        +    V T  Y +PE I +  +Y    DIWS+G ++ E  
Sbjct: 164 DCELKILDFGLA---RQADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPP-------------------PSAPSDQF--- 292
           TG+  +   +  D      E+M+ +   PP                   P      F   
Sbjct: 221 TGKTLFKGSDHLD---QLKEIMK-VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 276
Query: 293 ----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
               SP   + +   +  + +QR++A E + HP+ +   D
Sbjct: 277 LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 113/258 (43%), Gaps = 33/258 (12%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 58  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 117
Query: 143 GGSLADFLKK-----VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
            G+L+ +L+      V   PE         E+L     QV KG+ +L   K  IHRDL  
Sbjct: 118 FGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRK-XIHRDLAA 176
Query: 189 SNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +SD+
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQSDV 233
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
           WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +  
Sbjct: 234 WSFGVLLWEIFSLGASPY-PGVKID-----EEFCRRLKEGTRMRAP-DYTTPEMYQTMLD 286
Query: 303 CVQKEPQQRLSAQELMTH 320
           C   EP QR +  EL+ H
Sbjct: 287 CWHGEPSQRPTFSELVEH 304

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 143 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 174
Query: 187 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQS 231
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 232 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 284
Query: 301 SACVQKEPQQRLSAQELMTH 320
             C   EP QR +  EL+ H
Sbjct: 285 LDCWHGEPSQRPTFSELVEH 304

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 143 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 174
Query: 187 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQS 231
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 232 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 284
Query: 301 SACVQKEPQQRLSAQELMTH 320
             C   EP QR +  EL+ H
Sbjct: 285 LDCWHGEPSQRPTFSELVEH 304

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 253 CATGQFPYSPPEQQDGWTSFYE 274
              G   +   +  D W    E
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 31/256 (12%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 56  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 143 GGSLADFLKKVKT------------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN 190
            G+L+ +L+  +             +  E+L     QV KG+ +L   K  IHRDL   N
Sbjct: 116 FGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRK-XIHRDLAARN 174
Query: 191 LLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWS 245
           +L++ +  VKI DFG++  +         G A        +M+PE I    Y  +SD+WS
Sbjct: 175 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWS 231
Query: 246 LGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 304
            G++L E  + G  PY P  + D      E    + +     AP D  +PE    +  C 
Sbjct: 232 FGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTMLDCW 284
Query: 305 QKEPQQRLSAQELMTH 320
             EP QR +  EL+ H
Sbjct: 285 HGEPSQRPTFSELVEH 300

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 91  LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 292 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 345
Query: 150 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           L++   + +    L  +  Q+   + YL  +K+ IHR+L   N L+     VK+ DFG+S
Sbjct: 346 LRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLVGENHLVKVADFGLS 404
Query: 208 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 265
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 405 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 464
Query: 266 QDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
               +  YEL+E     + P   P   +       + AC Q  P  R S  E+
Sbjct: 465 ----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEI 508

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 124 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 181
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DFG++     T  +    V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 182 CELKILDFGLA---RHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 239 GRTLFP 244

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 105 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 159
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 160 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
Query: 253 CATGQFPYSPPEQQDGWTSFYE 274
              G   +   +  D W    E
Sbjct: 219 MIKGGVLFPGTDHIDQWNKVIE 240

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 112/260 (43%), Gaps = 35/260 (13%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I E+  
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCK 106
Query: 143 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 107 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 165
Query: 187 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQS 222
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 223 DVWSFGVLLWEIFSLGASPY-PGVKID-----EEFCRRLKEGTRMRAP-DYTTPEMYQTM 275
Query: 301 SACVQKEPQQRLSAQELMTH 320
             C   EP QR +  EL+ H
Sbjct: 276 LDCWHGEPSQRPTFSELVEH 295

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 19/228 (8%)
Query: 98  VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE-YMDGGSLADFLKKVKTI 156
           +E+    ++  E+ I    +   ++     F + G   +++E +  G  L  F+ +   +
Sbjct: 68  IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL 127
Query: 157 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 216
            E   + I  Q++  + YL   K IIHRD+K  N++I     +K+ DFG SA        
Sbjct: 128 DEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDFTIKLIDFG-SAAYLERGKL 185
Query: 217 ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 275
             TF GT  Y +PE + G  Y G + ++WSLG+ L      + P+   E         E 
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE---------ET 236
Query: 276 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           +EA +       P    S E  S +S  +Q  P++R + ++L+T P++
Sbjct: 237 VEAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKIXDFGLARV 173
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 142
           TG+  A+K ++ +     R    QE+ I ++    +++         G  ++ +++EY+ 
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
            GSL D+L +  +I    L    +Q+ +G+ YLH  +H IHR+L   N+L+++   VKI 
Sbjct: 102 LGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLH-SQHYIHRNLAARNVLLDNDRLVKIG 159
Query: 203 DFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE-- 252
           DFG++  +            G +  F     + +PE +   K+ Y SD+WS G+ L E  
Sbjct: 160 DFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 253 --CATGQFPYSPPEQQDGWTSFYELM 276
             C + Q   SPP      T F EL+
Sbjct: 215 THCDSSQ---SPP------TKFLELI 231

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 173
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 14/179 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+KV++ N    A ++I  E  +      PYV     +C  S      + ++ + M  G 
Sbjct: 50  AIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTS-----TVQLVTQLMPYGC 104
Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L D +++ +  +  + L   C Q+ KG+ YL  +  ++HRDL   N+L+     VKITDF
Sbjct: 105 LLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE-DVRLVHRDLAARNVLVKSPNHVKITDF 163
Query: 205 GVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G++ ++    T   A+       +M+ E I   ++ ++SD+WS G+ + E  T G  PY
Sbjct: 164 GLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPY 222

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 173
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 58  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 117
Query: 143 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 118 FGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 176
Query: 187 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 177 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQS 233
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 234 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 286
Query: 301 SACVQKEPQQRLSAQELMTH 320
             C   EP QR +  EL+ H
Sbjct: 287 LDCWHGEPSQRPTFSELVEH 306

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 177
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 142
           TG+  A+K ++ +     R    QE+ I ++    +++         G  ++ +++EY+ 
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
            GSL D+L +  +I    L    +Q+ +G+ YLH  +H IHR+L   N+L+++   VKI 
Sbjct: 102 LGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLH-AQHYIHRNLAARNVLLDNDRLVKIG 159
Query: 203 DFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE-- 252
           DFG++  +            G +  F     + +PE +   K+ Y SD+WS G+ L E  
Sbjct: 160 DFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 253 --CATGQFPYSPPEQQDGWTSFYELM 276
             C + Q   SPP      T F EL+
Sbjct: 215 THCDSSQ---SPP------TKFLELI 231

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 177
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 173
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 112/260 (43%), Gaps = 35/260 (13%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I E+  
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCK 106
Query: 143 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 107 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 165
Query: 187 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQS 222
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 223 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 275
Query: 301 SACVQKEPQQRLSAQELMTH 320
             C   EP QR +  EL+ H
Sbjct: 276 LDCWHGEPSQRPTFSELVEH 295

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 100/235 (42%), Gaps = 24/235 (10%)
Query: 88  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 147
           F A+K ++    E  RR    E  I      P V+        +  + II E+M+ GSL 
Sbjct: 63  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 122
Query: 148 DFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
            FL++     T+ +  L  +   +  G+ YL  + + +HRDL   N+L+N     K++DF
Sbjct: 123 SFLRQNDGQFTVIQ--LVGMLRGIAAGMKYL-ADMNYVHRDLAARNILVNSNLVCKVSDF 179
Query: 205 GVSAIMASTSGQANTFVGTY------NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 257
           G+S  +   +    T+           + +PE I   K+   SD+WS G+V+ E  + G+
Sbjct: 180 GLSRFLEDDTSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 238
Query: 258 FPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQR 311
            PY     QD        +E     PPP   PS          +  C QK+   R
Sbjct: 239 RPYWDMTNQD----VINAIEQDYRLPPPMDCPS-----ALHQLMLDCWQKDRNHR 284

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 123 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 181
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 182 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 241
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 242 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 301
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 302 LTFNPHKRIEVEQALAHPYLEQYYD 326

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 173
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 117 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 175
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 236 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 295
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 296 LTFNPHKRIEVEQALAHPYLEQYYD 320

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 120 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 178
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 179 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 238
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 239 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 298
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 299 LTFNPHKRIEVEQALAHPYLEQYYD 323

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 121 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 179
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 180 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 239
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 240 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 299
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 300 LTFNPHKRIEVEQALAHPYLEQYYD 324

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 112 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 170
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 171 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 230
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 231 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 290
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 291 LTFNPHKRIEVEQALAHPYLEQYYD 315

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 122/267 (45%), Gaps = 41/267 (15%)
Query: 87  QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-------------SNGA 133
           +++A+K I+   E+ +   I  E+ +  S    YVV  Y ++                  
Sbjct: 32  RYYAIKKIRHTEEKLS--TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89
Query: 134 ISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           + I +EY + G+L D +  + +    +EY   +  Q+L+ L Y+H +  IIHRDLKP N+
Sbjct: 90  LFIQMEYCENGTLYDLIHSENLNQQRDEYWR-LFRQILEALSYIHSQG-IIHRDLKPMNI 147
Query: 192 LINHRGEVKITDFGV--------------SAIMASTSGQANTFVGTYNYMSPERISG-GK 236
            I+    VKI DFG+              S  +  +S    + +GT  Y++ E + G G 
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH 207
Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 296
           Y  K D++SLG++  E     +P+S   ++    +  + + ++  + PP    ++   E 
Sbjct: 208 YNEKIDMYSLGIIFFEMI---YPFSTGMER---VNILKKLRSVSIEFPPDFDDNKMKVE- 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFL 323
              I   +  +P +R  A+ L+   +L
Sbjct: 261 KKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 113 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 171
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 172 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 231
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 232 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 291
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 292 LTFNPHKRIEVEQALAHPYLEQYYD 316

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 112/260 (43%), Gaps = 35/260 (13%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I E+  
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCK 106
Query: 143 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 107 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 165
Query: 187 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQS 222
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 223 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 275
Query: 301 SACVQKEPQQRLSAQELMTH 320
             C   EP QR +  EL+ H
Sbjct: 276 LDCWHGEPSQRPTFSELVEH 295

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 117 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTSDLKICDFGLARV 175
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235
Query: 260 ----------YSPPEQQDGWTSF-YELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 236 LDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 295
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L  Y D
Sbjct: 296 LTFNPHKRIEVEQALAHPYLAQYYD 320

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI  FG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILGFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 135 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 193
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 194 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 253
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 254 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 313
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 314 LTFNPHKRIEVEQALAHPYLEQYYD 338

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKCQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 37/205 (18%)
Query: 152 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 211
           K + + +E++  +  Q+L+GL Y+H    IIHRDLKPSN+ +N   E++I DFG++    
Sbjct: 124 KCQALSDEHVQFLVYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDSELRILDFGLA---R 179
Query: 212 STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDG 268
               +   +V T  Y +PE  ++   Y    DIWS+G ++ E   G+  FP S     D 
Sbjct: 180 QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGS-----DY 234
Query: 269 WTSFYELMEAIVDQPP------------------PSAPSDQFS-------PEFCSFISAC 303
                 +ME +    P                  P  P    S       P     +   
Sbjct: 235 IDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRM 294
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +  +  QR+SA E + H +   Y D
Sbjct: 295 LVLDSDQRVSAAEALAHAYFSQYHD 319

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
           G  L + +K  + + +E++  +  Q+L+GL Y+H    IIHRDLKPSN+ +N   E++I 
Sbjct: 116 GADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDSELRIL 173
Query: 203 DFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FP 259
           DFG++        +   +V T  Y +PE  ++   Y    DIWS+G ++ E   G+  FP
Sbjct: 174 DFGLA---RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFP 230
Query: 260 YSPPEQQDGWTSFYELMEAIVDQPP------------------PSAPSDQFS-------P 294
            S     D       +ME +    P                  P  P    S       P
Sbjct: 231 GS-----DYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANP 285
Query: 295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
                +   +  +  QR+SA E + H +   Y D
Sbjct: 286 LAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHD 319

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI D G++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDAGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI D G++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDRGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI DF ++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFYLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 117 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 175
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 236 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 295
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L  Y D
Sbjct: 296 LTFNPHKRIEVEQALAHPYLAQYYD 320

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 12/212 (5%)
Query: 103 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 162
           R +  +E +     Q P+VV  +     +G + +    ++G  LA  L++   +      
Sbjct: 78  RTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAV 137
Query: 163 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV-SAIMASTSGQANTFV 221
           AI  Q+    L   H     HRD+KP N+L++      + DFG+ SA       Q    V
Sbjct: 138 AIVRQI-GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV 196
Query: 222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 281
           GT  Y +PER S     Y++DI++L  VL EC TG    SPP Q D  +    +  A ++
Sbjct: 197 GTLYYXAPERFSESHATYRADIYALTCVLYECLTG----SPPYQGDQLS----VXGAHIN 248
Query: 282 Q--PPPSAPSDQFSPEFCSFISACVQKEPQQR 311
           Q  P PS         F + I+    K P+ R
Sbjct: 249 QAIPRPSTVRPGIPVAFDAVIARGXAKNPEDR 280

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH---------HEKHIIHRDL 186
           +I  + + GSL+DFLK    +    L  I E + +GL YLH         H+  I HRD+
Sbjct: 99  LITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDI 157
Query: 187 KPSNLLINHRGEVKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGG-----KYGY 239
           K  N+L+ +     I DFG++       ++G  +  VGT  YM+PE + G          
Sbjct: 158 KSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 240 KSDIWSLGLVLLE----CATGQFPYS----PPEQQDGWT-SFYELMEAIVDQPPPSAPSD 290
           + D++++GLVL E    C     P      P E++ G   S  ++ E +V +       D
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD 277
Query: 291 QFSPE-----FCSFISACVQKEPQQRLSA 314
            +         C  I  C   + + RLSA
Sbjct: 278 YWQKHAGMAMLCETIEECWDHDAEARLSA 306

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 255
            E+KI D G++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDGGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 256 GQ--FP 259
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 115/265 (43%), Gaps = 34/265 (12%)
Query: 87  QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL 146
           Q  A+K ++   E   R +   E  +    Q P VV        +  +S+I  Y   G L
Sbjct: 57  QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 116
Query: 147 ADFL---------------KKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 189
            +FL               + VK+   P +++  +  Q+  G+ YL    H++H+DL   
Sbjct: 117 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA-QIAAGMEYLS-SHHVVHKDLATR 174
Query: 190 NLLINHRGEVKITDFGV--SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 247
           N+L+  +  VKI+D G+      A         +    +M+PE I  GK+   SDIWS G
Sbjct: 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 234
Query: 248 LVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC-SFISACVQ 305
           +VL E  + G  PY     QD       ++E I ++     P D   P +  + +  C  
Sbjct: 235 VVLWEVFSYGLQPYCGYSNQD-------VVEMIRNRQVLPCPDD--CPAWVYALMIECWN 285
Query: 306 KEPQQRLSAQELMTHPFLKMYGDLN 330
           + P +R   +++  H  L+ +G+L+
Sbjct: 286 EFPSRRPRFKDI--HSRLRAWGNLS 308

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 37/205 (18%)
Query: 152 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 211
           K + + +E++  +  Q+L+GL Y+H    IIHRDLKPSN+ +N   E++I DFG++    
Sbjct: 116 KCQALSDEHVQFLVYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDCELRILDFGLA---R 171
Query: 212 STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDG 268
               +   +V T  Y +PE  ++   Y    DIWS+G ++ E   G+  FP S     D 
Sbjct: 172 QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGS-----DY 226
Query: 269 WTSFYELMEAIVDQPP------------------PSAPSDQFS-------PEFCSFISAC 303
                 +ME +    P                  P  P    S       P     +   
Sbjct: 227 IDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRM 286
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +  +  QR+SA E + H +   Y D
Sbjct: 287 LVLDSDQRVSAAEALAHAYFSQYHD 311

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLXGIKHLH-SAGIIHRDLKPSNIV 158
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 253 CATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA---------- 287
               +  +   +  D W            E M+ +       V+  P  A          
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 288 ---PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 328
              P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 326

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLXGIKHLH-SAGIIHRDLKPSNIV 158
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 253 CATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA---------- 287
               +  +   +  D W            E M+ +       V+  P  A          
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 288 ---PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 328
              P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 326

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 30/236 (12%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K ++    E  RR+   E  I    + P ++       ++  + I+ E+M+ G+L  F
Sbjct: 48  AIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSF 107
Query: 150 LK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 205
           L+    +   I    L  +   +  G+ YL  E   +HRDL   N+L+N     K++DFG
Sbjct: 108 LRLNDGQFTVI---QLVGMLRGIASGMRYLA-EMSYVHRDLAARNILVNSNLVCKVSDFG 163
Query: 206 VSAIMASTSG---QANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP 259
           +S  +   S    + ++  G     + +PE I+  K+   SD WS G+V+ E  + G+ P
Sbjct: 164 LSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223
Query: 260 YSPPEQQDGWTSFYELMEAIVDQ----PPPSAPSDQFSPEFCSFISACVQKEPQQR 311
           Y     QD       ++ AI       PPP  P+          +  C QK+   R
Sbjct: 224 YWDMSNQD-------VINAIEQDYRLPPPPDCPTS-----LHQLMLDCWQKDRNAR 267

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 97  VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLXGIKHLH-SAGIIHRDLKPSNIV 151
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 152 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 253 CATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA---------- 287
               +  +   +  D W            E M+ +       V+  P  A          
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270
Query: 288 ---PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 328
              P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL-EYMDGGSLAD 148
           A+K ++    E  RR    E  I      P ++   +   + G +++I+ EYM+ GSL  
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDT 139
Query: 149 FLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 205
           FL+      TI +  L  +   V  G+ YL    ++ HRDL   N+L++     K++DFG
Sbjct: 140 FLRTHDGQFTIMQ--LVGMLRGVGAGMRYLSDLGYV-HRDLAARNVLVDSNLVCKVSDFG 196
Query: 206 VSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
           +S ++      A T  G      + +PE I+   +   SD+WS G+V+ E  A G+ PY
Sbjct: 197 LSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 114/255 (44%), Gaps = 32/255 (12%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 142
           TG+  A+K ++       R    +E++I ++    ++V         G  ++ +++EY+ 
Sbjct: 36  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 95
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
            GSL D+L +   +    L    +Q+ +G+ YLH  +H IHR L   N+L+++   VKI 
Sbjct: 96  LGSLRDYLPR-HCVGLAQLLLFAQQICEGMAYLH-AQHYIHRALAARNVLLDNDRLVKIG 153
Query: 203 DFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE-- 252
           DFG++  +            G +  F     + +PE +   K+ Y SD+WS G+ L E  
Sbjct: 154 DFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKECKFYYASDVWSFGVTLYELL 208
Query: 253 --CATGQFPYSPPEQQDGWT-------SFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
             C + Q P++   +  G T          EL+E     P P    D+   E    +  C
Sbjct: 209 TYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRP----DRCPCEIYHLMKNC 264
Query: 304 VQKEPQQRLSAQELM 318
            + E   R + Q L+
Sbjct: 265 WETEASFRPTFQNLV 279

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 114/255 (44%), Gaps = 32/255 (12%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 142
           TG+  A+K ++       R    +E++I ++    ++V         G  ++ +++EY+ 
Sbjct: 37  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 96
Query: 143 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 202
            GSL D+L +   +    L    +Q+ +G+ YLH  +H IHR L   N+L+++   VKI 
Sbjct: 97  LGSLRDYLPR-HCVGLAQLLLFAQQICEGMAYLH-AQHYIHRALAARNVLLDNDRLVKIG 154
Query: 203 DFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE-- 252
           DFG++  +            G +  F     + +PE +   K+ Y SD+WS G+ L E  
Sbjct: 155 DFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKECKFYYASDVWSFGVTLYELL 209
Query: 253 --CATGQFPYSPPEQQDGWT-------SFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
             C + Q P++   +  G T          EL+E     P P    D+   E    +  C
Sbjct: 210 TYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRP----DRCPCEIYHLMKNC 265
Query: 304 VQKEPQQRLSAQELM 318
            + E   R + Q L+
Sbjct: 266 WETEASFRPTFQNLV 280

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           ++ E M GGS+   + K +   E   + + + V   L +LH+ K I HRDLKP N+L  H
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEH 146
Query: 196 RGE---VKITDFGVSAIMA-------STSGQANTFVGTYNYMSPERI-----SGGKYGYK 240
             +   VKI DF + + +         ++ +  T  G+  YM+PE +         Y  +
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 241 SDIWSLGLVLLECATGQFPYSPPEQQD-GWT------SFYELMEAIVDQPPPSAPSDQFS 293
            D+WSLG++L    +G  P+      D GW       +   ++   + +     P   ++
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWA 266
Query: 294 PEFCS---FISACVQKEPQQRLSAQELMTHPFLK 324
              C+    IS  + ++ +QRLSA +++ HP+++
Sbjct: 267 HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 97/187 (51%), Gaps = 17/187 (9%)
Query: 83  KWTGQF-FALKVIQM-NVEESARRQIAQEL-KINQSSQCPYVVVCYQSFYSNGAISIILE 139
           KW GQ+  A+K+I+  ++ E    Q AQ + K++      +  VC + +     I I+ E
Sbjct: 28  KWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY----PIYIVTE 83
Query: 140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRG 197
           Y+  G L ++L+   K +    L  +C  V +G+ +L  E H  IHRDL   N L++   
Sbjct: 84  YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL--ESHQFIHRDLAARNCLVDRDL 141
Query: 198 EVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLEC- 253
            VK++DFG++  +     Q  + VGT     + +PE     KY  KSD+W+ G+++ E  
Sbjct: 142 CVKVSDFGMTRYVLDD--QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199
Query: 254 ATGQFPY 260
           + G+ PY
Sbjct: 200 SLGKMPY 206

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 73/142 (51%), Gaps = 7/142 (4%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS      V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 253 CATGQFPYSPPEQQDGWTSFYE 274
              G   +   +  D W    E
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 253 CATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA---------- 287
               +  +   +  D W            E M+ +       V+  P  A          
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 288 ---PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 328
              P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 326

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 32/237 (13%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K ++    E  RR+   E  I    + P ++       ++  + I+ E+M+ G+L  F
Sbjct: 46  AIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSF 105
Query: 150 LK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 205
           L+    +   I    L  +   +  G+ YL  E   +HRDL   N+L+N     K++DFG
Sbjct: 106 LRLNDGQFTVI---QLVGMLRGIASGMRYLA-EMSYVHRDLAARNILVNSNLVCKVSDFG 161
Query: 206 VSAIMASTSGQANTFVGTY------NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 258
           +S  +   S    T+  +        + +PE I+  K+   SD WS G+V+ E  + G+ 
Sbjct: 162 LSRFLEENSSDP-TYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGER 220
Query: 259 PYSPPEQQDGWTSFYELMEAIVDQ----PPPSAPSDQFSPEFCSFISACVQKEPQQR 311
           PY     QD       ++ AI       PPP  P+          +  C QK+   R
Sbjct: 221 PYWDMSNQD-------VINAIEQDYRLPPPPDCPTS-----LHQLMLDCWQKDRNAR 265

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL-EYMDGGSLAD 148
           A+K ++    E  RR    E  I      P ++   +   + G +++I+ EYM+ GSL  
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDT 139
Query: 149 FLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 205
           FL+      TI +  L  +   V  G+ YL    ++ HRDL   N+L++     K++DFG
Sbjct: 140 FLRTHDGQFTIMQ--LVGMLRGVGAGMRYLSDLGYV-HRDLAARNVLVDSNLVCKVSDFG 196
Query: 206 VSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
           +S ++      A T  G      + +PE I+   +   SD+WS G+V+ E  A G+ PY
Sbjct: 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 85  TGQFFALKVIQM--------NVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNG 132
           +G F ALK +++         +  S  R++A  L+  ++ + P VV    VC  S     
Sbjct: 33  SGHFVALKSVRVPNGGGGGGGLPISTVREVAL-LRRLEAFEHPNVVRLMDVCATSRTDRE 91
Query: 133 -AISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 189
             ++++ E++D   L  +L K     +P E +  +  Q L+GL +LH    I+HRDLKP 
Sbjct: 92  IKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPE 149
Query: 190 NLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 249
           N+L+   G VK+ DFG++ I +         V T  Y +PE +    Y    D+WS+G +
Sbjct: 150 NILVTSGGTVKLADFGLARIYSYQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCI 208
Query: 250 LLE 252
             E
Sbjct: 209 FAE 211

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 253 CATGQFPYSPPEQQDGWTSFYE 274
               +  +   +  D W    E
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIE 239

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 254 ATGQFPYSPPEQQDGWTSFYE 274
              +  +   +  D W    E
Sbjct: 219 VRHKILFPGRDYIDQWNKVIE 239

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 109/238 (45%), Gaps = 27/238 (11%)
Query: 97  NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 156
           N E + +++I    ++   +    V V Y        + +++EY     +    + + ++
Sbjct: 48  NGEANVKKEIQLLRRLRHKNVIQLVDVLYNE--EKQKMYMVMEY----CVCGMQEMLDSV 101
Query: 157 PEEYLAAICE------QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 210
           PE+    +C+      Q++ GL YLH +  I+H+D+KP NLL+   G +KI+  GV+  +
Sbjct: 102 PEKRFP-VCQAHGYFCQLIDGLEYLHSQG-IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
Query: 211 A--STSGQANTFVGTYNYMSPERISGGKY--GYKSDIWSLGLVLLECATGQFPYSPPEQQ 266
              +      T  G+  +  PE  +G     G+K DIWS G+ L    TG +P+      
Sbjct: 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE----- 214
Query: 267 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
               + Y+L E I  +   + P D   P     +   ++ EP +R S +++  H + +
Sbjct: 215 --GDNIYKLFENI-GKGSYAIPGD-CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 254 ATGQFPYSPPEQQDGWTSFYE 274
              +  +   +  D W    E
Sbjct: 219 VRHKILFPGRDYIDQWNKVIE 239

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 82/163 (50%), Gaps = 9/163 (5%)
Query: 100 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPE 158
           E  ++Q  QE+K+    Q   +V     F S+G  + ++  Y   GSL D L  +   P 
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELL-GFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP 120
Query: 159 ---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 215
                   I +    G+ +LH E H IHRD+K +N+L++     KI+DFG++      + 
Sbjct: 121 LSWHXRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 216 QA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 256
               +  VGT  Y +PE +  G+   KSDI+S G+VLLE  TG
Sbjct: 180 XVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITG 221

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 142 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 196
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 197 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
Query: 253 CATGQFPYSPPEQQDGWTSFYE 274
               +  +   +  D W    E
Sbjct: 256 MVRHKILFPGRDYIDQWNKVIE 277

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G     V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 150 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 120 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 178
Query: 210 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 259
                  +G     V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 179 ADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 238
Query: 260 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 303
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 239 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 298
Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 299 LTFNPHKRIEVEQALAHPYLEQYYD 323

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 105 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 160
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 161 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 254 ATGQFPYSPPEQQDGWTSFYE 274
              +  +   +  D W    E
Sbjct: 220 VRHKILFPGRDYIDQWNKVIE 240

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 98  VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 153
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 154 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 212
Query: 254 ATGQFPYSPPEQQDGWTSFYE 274
              +  +   +  D W    E
Sbjct: 213 VRHKILFPGRDYIDQWNKVIE 233

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 105 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 160
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 161 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 254 ATGQFPYSPPEQQDGWTSFYE 274
              +  +   +  D W    E
Sbjct: 220 VRHKILFPGRDYIDQWNKVIE 240

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 97  VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 152
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 153 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 254 ATGQFPYSPPEQQDGWTSFYE 274
              +  +   +  D W    E
Sbjct: 212 VRHKILFPGRDYIDQWNKVIE 232

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 98  VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 153
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 154 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 212
Query: 254 ATGQFPYSPPEQQDGWTSFYE 274
              +  +   +  D W    E
Sbjct: 213 VRHKILFPGRDYIDQWNKVIE 233

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 103 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 158
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 159 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 217
Query: 254 ATGQFPYSPPEQQDGWTSFYE 274
              +  +   +  D W    E
Sbjct: 218 VRHKILFPGRDYIDQWNKVIE 238

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 134 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 109 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 163
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    D+WS+G ++ E
Sbjct: 164 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGE 222
Query: 253 CATGQFPYSPPEQQDGWTSFYE 274
               +  +   +  D W    E
Sbjct: 223 MVCHKILFPGRDYIDQWNKVIE 244

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + I++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 98  VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 153
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    D+WS+G ++ E 
Sbjct: 154 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEM 212
Query: 254 ATGQFPYSPPEQQDGWTSFYE 274
              +  +   +  D W    E
Sbjct: 213 VCHKILFPGRDYIDQWNKVIE 233

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 142 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 197
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 198 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
Query: 254 ATGQFPYSPPEQQDGWTSFYE 274
              +  +   +  D W    E
Sbjct: 257 VRHKILFPGRDYIDQWNKVIE 277

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 113/263 (42%), Gaps = 34/263 (12%)
Query: 87  QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL 146
           Q  A+K ++   E   R +   E  +    Q P VV        +  +S+I  Y   G L
Sbjct: 40  QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 99
Query: 147 ADFL---------------KKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 189
            +FL               + VK+   P +++  +  Q+  G+ YL    H++H+DL   
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA-QIAAGMEYLS-SHHVVHKDLATR 157
Query: 190 NLLINHRGEVKITDFGV--SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 247
           N+L+  +  VKI+D G+      A         +    +M+PE I  GK+   SDIWS G
Sbjct: 158 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 217
Query: 248 LVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC-SFISACVQ 305
           +VL E  + G  PY     QD       ++E I ++     P D   P +  + +  C  
Sbjct: 218 VVLWEVFSYGLQPYCGYSNQD-------VVEMIRNRQVLPCPDD--CPAWVYALMIECWN 268
Query: 306 KEPQQRLSAQELMTHPFLKMYGD 328
           + P +R   +++  H  L+ +G+
Sbjct: 269 EFPSRRPRFKDI--HSRLRAWGN 289

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 100/241 (41%), Gaps = 50/241 (20%)
Query: 131 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           NG   +++  + G +L   +KK   + IP  Y+  I +Q+L GL Y+H    IIH D+KP
Sbjct: 101 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 160
Query: 189 SNLLIN------HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
            N+L+       +  ++KI D G +             + T  Y SPE + G  +G  +D
Sbjct: 161 ENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGAD 217
Query: 243 IWSLGLVLLECATGQFPYSPPE------QQDGWTSFYELMEAIVD--------------- 281
           IWS   ++ E  TG F + P E        D      EL+  +                 
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277
Query: 282 ------------QPPPSAPSDQF------SPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
                        P     ++++      + E   F+S  +Q +P++R  A  L+ HP+L
Sbjct: 278 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
Query: 324 K 324
           K
Sbjct: 338 K 338

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 100/241 (41%), Gaps = 50/241 (20%)
Query: 131 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           NG   +++  + G +L   +KK   + IP  Y+  I +Q+L GL Y+H    IIH D+KP
Sbjct: 101 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 160
Query: 189 SNLLIN------HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
            N+L+       +  ++KI D G +             + T  Y SPE + G  +G  +D
Sbjct: 161 ENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGAD 217
Query: 243 IWSLGLVLLECATGQFPYSPPE------QQDGWTSFYELMEAIVD--------------- 281
           IWS   ++ E  TG F + P E        D      EL+  +                 
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277
Query: 282 ------------QPPPSAPSDQF------SPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
                        P     ++++      + E   F+S  +Q +P++R  A  L+ HP+L
Sbjct: 278 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
Query: 324 K 324
           K
Sbjct: 338 K 338

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 21/193 (10%)
Query: 80  VQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVV----VCY--QSFYSN- 131
            +H+ TGQ  ALK + M  E+      A +E+KI Q  +   VV    +C    S Y+  
Sbjct: 37  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 96
Query: 132 -GAISIILEYMD---GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 187
            G+I ++ ++ +    G L++ L K  T+ E  +  + + +L GL Y+H  K I+HRD+K
Sbjct: 97  KGSIYLVFDFCEHDLAGLLSNVLVKF-TLSE--IKRVMQMLLNGLYYIHRNK-ILHRDMK 152
Query: 188 PSNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERISGGK-YGYKSD 242
            +N+LI   G +K+ DFG++ A   + + Q N +   V T  Y  PE + G + YG   D
Sbjct: 153 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPID 212
Query: 243 IWSLGLVLLECAT 255
           +W  G ++ E  T
Sbjct: 213 LWGAGCIMAEMWT 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 121/267 (45%), Gaps = 41/267 (15%)
Query: 87  QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-------------SNGA 133
           +++A+K I+   E+ +   I  E+ +  S    YVV  Y ++                  
Sbjct: 32  RYYAIKKIRHTEEKLS--TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89
Query: 134 ISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           + I +EY +  +L D +  + +    +EY   +  Q+L+ L Y+H +  IIHRDLKP N+
Sbjct: 90  LFIQMEYCENRTLYDLIHSENLNQQRDEYWR-LFRQILEALSYIHSQG-IIHRDLKPMNI 147
Query: 192 LINHRGEVKITDFGV--------------SAIMASTSGQANTFVGTYNYMSPERISG-GK 236
            I+    VKI DFG+              S  +  +S    + +GT  Y++ E + G G 
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH 207
Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 296
           Y  K D++SLG++  E     +P+S   ++    +  + + ++  + PP    ++   E 
Sbjct: 208 YNEKIDMYSLGIIFFEMI---YPFSTGMER---VNILKKLRSVSIEFPPDFDDNKMKVE- 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFL 323
              I   +  +P +R  A+ L+   +L
Sbjct: 261 KKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 24/235 (10%)
Query: 88  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 147
           F A+K ++    E  RR    E  I      P V+        +  + II E+M+ GSL 
Sbjct: 37  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 96
Query: 148 DFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
            FL++     T+ +  L  +   +  G+ YL  + + +HR L   N+L+N     K++DF
Sbjct: 97  SFLRQNDGQFTVIQ--LVGMLRGIAAGMKYL-ADMNYVHRALAARNILVNSNLVCKVSDF 153
Query: 205 GVSAIMASTSGQANTFVGTY------NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 257
           G+S  +   +    T+           + +PE I   K+   SD+WS G+V+ E  + G+
Sbjct: 154 GLSRFLEDDTSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 212
Query: 258 FPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQR 311
            PY     QD        +E     PPP   PS          +  C QK+   R
Sbjct: 213 RPYWDMTNQD----VINAIEQDYRLPPPMDCPS-----ALHQLMLDCWQKDRNHR 258

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +     NT  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEAL 231
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 21/192 (10%)
Query: 81  QHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVV----VCY--QSFYSN-- 131
           +H+ TGQ  ALK + M  E+      A +E+KI Q  +   VV    +C    S Y+   
Sbjct: 37  RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96
Query: 132 GAISIILEYMD---GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           G+I ++ ++ +    G L++ L K  T+ E  +  + + +L GL Y+H  K I+HRD+K 
Sbjct: 97  GSIYLVFDFCEHDLAGLLSNVLVKF-TLSE--IKRVMQMLLNGLYYIHRNK-ILHRDMKA 152
Query: 189 SNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERISGGK-YGYKSDI 243
           +N+LI   G +K+ DFG++ A   + + Q N +   V T  Y  PE + G + YG   D+
Sbjct: 153 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDL 212
Query: 244 WSLGLVLLECAT 255
           W  G ++ E  T
Sbjct: 213 WGAGCIMAEMWT 224

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 21/192 (10%)
Query: 81  QHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVV----VCY--QSFYSN-- 131
           +H+ TGQ  ALK + M  E+      A +E+KI Q  +   VV    +C    S Y+   
Sbjct: 38  RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 97
Query: 132 GAISIILEYMD---GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           G+I ++ ++ +    G L++ L K  T+ E  +  + + +L GL Y+H  K I+HRD+K 
Sbjct: 98  GSIYLVFDFCEHDLAGLLSNVLVKF-TLSE--IKRVMQMLLNGLYYIHRNK-ILHRDMKA 153
Query: 189 SNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERISGGK-YGYKSDI 243
           +N+LI   G +K+ DFG++ A   + + Q N +   V T  Y  PE + G + YG   D+
Sbjct: 154 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDL 213
Query: 244 WSLGLVLLECAT 255
           W  G ++ E  T
Sbjct: 214 WGAGCIMAEMWT 225

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 13/162 (8%)
Query: 170 KGLLYLHH--EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV-GTYNY 226
           +GL YLH   +  IIHRD+K +N+L++   E  + DFG++ +M          V GT  +
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 227 MSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQD-----GWTSFY---ELM 276
           ++PE +S GK   K+D++  G++LLE  TGQ  F  +     D      W       + +
Sbjct: 210 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 269
Query: 277 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
           EA+VD        D+   +       C Q  P +R    E++
Sbjct: 270 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 311

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 72/141 (51%), Gaps = 5/141 (3%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + I++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS      V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 254 ATGQFPYSPPEQQDGWTSFYE 274
              +  +   +  D W    E
Sbjct: 219 VCHKILFPGRDYIDQWNKVIE 239

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 11/139 (7%)
Query: 136 IILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           +I +YM+ G+L   L        ++  E    IC    +GL YLH  + IIHRD+K  N+
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINI 170
Query: 192 LINHRGEVKITDFGVSAIMASTSGQAN---TFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
           L++     KITDFG+S    +  GQ +      GT  Y+ PE    G+   KSD++S G+
Sbjct: 171 LLDENFVPKITDFGISK-KGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 249 VLLE--CATGQFPYSPPEQ 265
           VL E  CA      S P +
Sbjct: 230 VLFEVLCARSAIVQSLPRE 248

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 148
           A+K+++   + S R  +  ELK+  Q      +V    +   +G I +I EY   G L +
Sbjct: 79  AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 149 FLKK-----------------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
           +L+                        +  +  E L     QV KG+ +L   K  +HRD
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 197
Query: 186 LKPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYK 240
           L   N+L+ H   VKI DFG++  + S S     G A   V    +M+PE +  G Y  K
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV---KWMAPESLFEGIYTIK 254
Query: 241 SDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEA--IVDQP 283
           SD+WS G++L E  + G  PY P    D   +FY+L++    +DQP
Sbjct: 255 SDVWSYGILLWEIFSLGVNPY-PGIPVDA--NFYKLIQNGFKMDQP 297

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEAL 231
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 52/98 (53%), Gaps = 13/98 (13%)
Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF------ 220
           Q+ + + +LH  K ++HRDLKPSN+       VK+ DFG+   M     +          
Sbjct: 172 QIAEAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 221 ------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
                 VGT  YMSPE+I G  Y +K DI+SLGL+L E
Sbjct: 231 ATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEAL 231
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 81  QHKWTGQFFALKVIQ----MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +HK TG  FA+KV      +   +   R+     K+N  +      +  ++   +  +  
Sbjct: 29  RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL-- 86
Query: 137 ILEYMDGGSLADFLKK---VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL- 192
           I+E+   GSL   L++      +PE     +   V+ G+ +L  E  I+HR++KP N++ 
Sbjct: 87  IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMR 145
Query: 193 -INHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG--------KYGYKS 241
            I   G+   K+TDFG +  +     Q  +  GT  Y+ P+             KYG   
Sbjct: 146 VIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204
Query: 242 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 289
           D+WS+G+     ATG  P+ P E   G     E+M  I+   P  A S
Sbjct: 205 DLWSIGVTFYHAATGSLPFRPFE---GPRRNKEVMYKIITGKPSGAIS 249

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 98/192 (51%), Gaps = 21/192 (10%)
Query: 81  QHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVV----VCY--QSFYSNGA 133
           +H+ TGQ  ALK + M  E+      A +E+KI Q  +   VV    +C    S Y+   
Sbjct: 38  RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 97
Query: 134 ISIIL-----EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
            SI L     E+   G L++ L K  T+ E  +  + + +L GL Y+H  K I+HRD+K 
Sbjct: 98  ASIYLVFDFCEHDLAGLLSNVLVKF-TLSE--IKRVMQMLLNGLYYIHRNK-ILHRDMKA 153
Query: 189 SNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERISGGK-YGYKSDI 243
           +N+LI   G +K+ DFG++ A   + + Q N +   V T  Y  PE + G + YG   D+
Sbjct: 154 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDL 213
Query: 244 WSLGLVLLECAT 255
           W  G ++ E  T
Sbjct: 214 WGAGCIMAEMWT 225

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 53  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 112
Query: 150 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 113 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 171
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 172 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 231
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 232 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 283
Query: 317 LMT 319
           +++
Sbjct: 284 IIS 286

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 87  QFFALKVIQMNVEESARRQIAQELKI------NQSSQCPYVVVCYQSFYSNGAISIILEY 140
           Q  ALK+++   E+   RQ A+E++I              V+   ++F     I +  E 
Sbjct: 123 QHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180
Query: 141 MDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           +   +L + +KK K    ++P   +      +L+ L  LH  + IIH DLKP N+L+  +
Sbjct: 181 LSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQ 236
Query: 197 GE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
           G   +K+ DFG S        +  T + +  Y +PE I G +YG   D+WSLG +L E  
Sbjct: 237 GRSGIKVIDFGSSCY---EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 255 TGQFPYSPPEQQ 266
           TG +P  P E +
Sbjct: 294 TG-YPLLPGEDE 304

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 87  QFFALKVIQMNVEESARRQIAQELKI------NQSSQCPYVVVCYQSFYSNGAISIILEY 140
           Q  ALK+++   E+   RQ A+E++I              V+   ++F     I +  E 
Sbjct: 123 QHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180
Query: 141 MDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           +   +L + +KK K    ++P   +      +L+ L  LH  + IIH DLKP N+L+  +
Sbjct: 181 LSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQ 236
Query: 197 GE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
           G   +K+ DFG S        +  T + +  Y +PE I G +YG   D+WSLG +L E  
Sbjct: 237 GRSGIKVIDFGSSCY---EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 255 TGQFPYSPPEQQ 266
           TG +P  P E +
Sbjct: 294 TG-YPLLPGEDE 304

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 48  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 107
Query: 150 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   V
Sbjct: 108 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTV 166
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 167 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 226
Query: 257 QFPY 260
           + PY
Sbjct: 227 EQPY 230

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 150 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTV 169
Query: 200 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 170 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 257 QFPY 260
           + PY
Sbjct: 230 EQPY 233

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 26/228 (11%)
Query: 81  QHKWTGQFFALKVIQ----MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 136
           +HK TG  FA+KV      +   +   R+     K+N  +      +  ++   +  +  
Sbjct: 29  RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL-- 86
Query: 137 ILEYMDGGSLADFLKK---VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL- 192
           I+E+   GSL   L++      +PE     +   V+ G+ +L  E  I+HR++KP N++ 
Sbjct: 87  IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMR 145
Query: 193 -INHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG--------KYGYKS 241
            I   G+   K+TDFG +  +     Q     GT  Y+ P+             KYG   
Sbjct: 146 VIGEDGQSVYKLTDFGAARELEDDE-QFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204
Query: 242 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 289
           D+WS+G+     ATG  P+ P E   G     E+M  I+   P  A S
Sbjct: 205 DLWSIGVTFYHAATGSLPFRPFE---GPRRNKEVMYKIITGKPSGAIS 249

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 88  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 147
             A+K  +  +    + +  QE +I +    P +V           I I++E + GG   
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 148 DFLK------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
            FL+      +VKT     L  +      G+ YL   K  IHRDL   N L+  +  +KI
Sbjct: 201 TFLRTEGARLRVKT-----LLQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKNVLKI 254
Query: 202 TDFGVS-----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-AT 255
           +DFG+S      + A++ G     V    + +PE ++ G+Y  +SD+WS G++L E  + 
Sbjct: 255 SDFGMSREEADGVXAASGGLRQVPV---KWTAPEALNYGRYSSESDVWSFGILLWETFSL 311
Query: 256 GQFPY 260
           G  PY
Sbjct: 312 GASPY 316

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 21/191 (10%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 148
           A+K+++ +  E     +  E+++ +   +   ++    +   +G + +I+EY   G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 149 FLK-----------KVKTIPEEY-----LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           +L+            +  +PEE      L +   Q+ +G+ YL  +K  IHRDL   N+L
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 189
Query: 193 INHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVL 250
           +     +KI DFG++  + +      T  G     +M+PE +    Y ++SD+WS G+++
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 251 LECAT-GQFPY 260
            E  T G  PY
Sbjct: 250 WEIFTLGGSPY 260

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 72/141 (51%), Gaps = 5/141 (3%)
Query: 134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           + I++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
                +KI DFG+ A  A TS      V T  Y +PE I G  Y    D+WS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEM 218
Query: 254 ATGQFPYSPPEQQDGWTSFYE 274
              +  +   +  D W    E
Sbjct: 219 VCHKILFPGRDYIDQWNKVIE 239

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 150 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTV 169
Query: 200 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 170 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 257 QFPY 260
           + PY
Sbjct: 230 EQPY 233

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 88  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 147
             A+K  +  +    + +  QE +I +    P +V           I I++E + GG   
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 148 DFLK------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
            FL+      +VKT     L  +      G+ YL   K  IHRDL   N L+  +  +KI
Sbjct: 201 TFLRTEGARLRVKT-----LLQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKNVLKI 254
Query: 202 TDFGVS-----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-AT 255
           +DFG+S      + A++ G     V    + +PE ++ G+Y  +SD+WS G++L E  + 
Sbjct: 255 SDFGMSREEADGVYAASGGLRQVPV---KWTAPEALNYGRYSSESDVWSFGILLWETFSL 311
Query: 256 GQFPY 260
           G  PY
Sbjct: 312 GASPY 316

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 219 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 277
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 278 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 44  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 103
Query: 150 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 104 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 162
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 163 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 222
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           + PY     +      + +   ++D+P      D         +  C Q  P+ R S  E
Sbjct: 223 EQPYQGLSNEQ--VLRFVMEGGLLDKP------DNCPDMLLELMRMCWQYNPKMRPSFLE 274
Query: 317 LMT 319
           +++
Sbjct: 275 IIS 277

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 109/268 (40%), Gaps = 38/268 (14%)
Query: 84  WTGQ----FFALKVIQMNVEES--ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII 137
           W  Q    F A+K+  +  ++S  + R+I     +   +   ++    +       + +I
Sbjct: 32  WKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLI 91
Query: 138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH----------HEKHIIHRDLK 187
             + D GSL D+LK    I    L  + E + +GL YLH          H+  I HRD K
Sbjct: 92  TAFHDKGSLTDYLKG-NIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFK 150
Query: 188 PSNLLINHRGEVKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGG-----KYGYK 240
             N+L+       + DFG++         G  +  VGT  YM+PE + G          +
Sbjct: 151 SKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR 210
Query: 241 SDIWSLGLVLLE----CATGQFPYS----PPEQQDGWT-SFYELMEAIVDQPPPSAPSDQ 291
            D++++GLVL E    C     P      P E++ G   S  EL E +V +       D 
Sbjct: 211 IDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEVVVHKKMRPTIKDH 270
Query: 292 F-----SPEFCSFISACVQKEPQQRLSA 314
           +       + C  I  C   + + RLSA
Sbjct: 271 WLKHPGLAQLCVTIEECWDHDAEARLSA 298

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 100 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 159
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 160 LASQK-CIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 218
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 219 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 13/162 (8%)
Query: 170 KGLLYLHH--EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV-GTYNY 226
           +GL YLH   +  IIHRD+K +N+L++   E  + DFG++ +M          V G   +
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 227 MSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQD-----GWTSFY---ELM 276
           ++PE +S GK   K+D++  G++LLE  TGQ  F  +     D      W       + +
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261
Query: 277 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
           EA+VD        D+   +       C Q  P +R    E++
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 105 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 164
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 165 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 223
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 224 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 252

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 102 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 161
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 162 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 220
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 221 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 148
           A+K+++       +  +  ELKI +   Q   +V    +    G + +I EY   G L +
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 149 FLKKVK-----------TIPEEYLAA-----ICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           FL++ +             PEE L++        QV +G+ +L   K+ IHRD+   N+L
Sbjct: 140 FLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVL 198
Query: 193 INHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 247
           + +    KI DFG++  + + S     G A   V    +M+PE I    Y  +SD+WS G
Sbjct: 199 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYG 255
Query: 248 LVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQ 305
           ++L E  + G  PY         + FY+L++       P+     F+P+   S + AC  
Sbjct: 256 ILLWEIFSLGLNPYPGILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWA 307
Query: 306 KEPQQRLSAQELMT 319
            EP  R + Q++ +
Sbjct: 308 LEPTHRPTFQQICS 321

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 115/285 (40%), Gaps = 56/285 (19%)
Query: 92  KVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 151
           K+ Q+N ++  R  I  E+++ +    P +   Y+ +     I +++E   GG L D L 
Sbjct: 63  KIRQINPKDVER--IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 152 ---------------KVKTIP-------------------------EEYLAAICEQVLKG 171
                          K +  P                         E+ ++ I  Q+   
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 172 LLYLHHEKHIIHRDLKPSNLLI--NHRGEVKITDFGVSA-IMASTSGQ---ANTFVGTYN 225
           L YLH++  I HRD+KP N L   N   E+K+ DFG+S       +G+     T  GT  
Sbjct: 181 LHYLHNQG-ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 226 YMSPERI--SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP 283
           +++PE +  +   YG K D WS G++L     G  P+  P   D  T    L + +  + 
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF--PGVNDADTISQVLNKKLCFEN 297
Query: 284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
           P     +  SP     +S  + +   +R  A   + HP++  + D
Sbjct: 298 P---NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 7/133 (5%)
Query: 131 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAA 317
Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
            N+L++     K++DFG++   +ST       V    + +PE +   K+  KSD+WS G+
Sbjct: 318 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGI 374
Query: 249 VLLECAT-GQFPY 260
           +L E  + G+ PY
Sbjct: 375 LLWEIYSFGRVPY 387

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 7/133 (5%)
Query: 131 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAA 130
Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
            N+L++     K++DFG++   +ST       V    + +PE +   K+  KSD+WS G+
Sbjct: 131 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGI 187
Query: 249 VLLECAT-GQFPY 260
           +L E  + G+ PY
Sbjct: 188 LLWEIYSFGRVPY 200

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 111/263 (42%), Gaps = 33/263 (12%)
Query: 84  WTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 141
           W G+  A+K+     E+S  R+  I   + +   +   ++     S  S+  + +I  Y 
Sbjct: 29  WHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYH 88
Query: 142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLIN 194
           + GSL DFL++ +T+       +      GL +LH E         I HRD K  N+L+ 
Sbjct: 89  EHGSLYDFLQR-QTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVK 147
Query: 195 HRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERI-----SGGKYGYK-SDIW 244
              +  I D G++ + +  S       N  VGT  YM+PE +     +     YK +DIW
Sbjct: 148 SNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIW 207
Query: 245 SLGLVLLECATGQF------PYSPP--EQQDGWTSFYELMEAI-VDQPPPSAP----SDQ 291
           + GLVL E A           Y PP  +      SF ++ + + VDQ  P+ P    +D 
Sbjct: 208 AFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADP 267
Query: 292 FSPEFCSFISACVQKEPQQRLSA 314
                   +  C    P  RL+A
Sbjct: 268 VLSGLAQMMRECWYPNPSARLTA 290

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 7/133 (5%)
Query: 131 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 87  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAA 145
Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
            N+L++     K++DFG++   +ST       V    + +PE +   K+  KSD+WS G+
Sbjct: 146 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGI 202
Query: 249 VLLECAT-GQFPY 260
           +L E  + G+ PY
Sbjct: 203 LLWEIYSFGRVPY 215

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 67/138 (48%), Gaps = 9/138 (6%)
Query: 136 IILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           +I +YM+ G+L   L        ++  E    IC    +GL YLH  + IIHRD+K  N+
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINI 170
Query: 192 LINHRGEVKITDFGVS--AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 249
           L++     KITDFG+S        +       GT  Y+ PE    G+   KSD++S G+V
Sbjct: 171 LLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVV 230
Query: 250 LLE--CATGQFPYSPPEQ 265
           L E  CA      S P +
Sbjct: 231 LFEVLCARSAIVQSLPRE 248

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 46  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 105
Query: 150 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 106 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 164
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 165 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 224
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 225 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 276
Query: 317 LMT 319
           +++
Sbjct: 277 IIS 279

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 50  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 109
Query: 150 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 110 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 168
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 169 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 228
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 229 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 280
Query: 317 LMT 319
           +++
Sbjct: 281 IIS 283

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 52  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 111
Query: 150 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 112 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 170
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 230
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 231 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 282
Query: 317 LMT 319
           +++
Sbjct: 283 IIS 285

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 53  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 112
Query: 150 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 113 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 171
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 172 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 231
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 232 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 283
Query: 317 LMT 319
           +++
Sbjct: 284 IIS 286

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 119/267 (44%), Gaps = 41/267 (15%)
Query: 87  QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-------------SNGA 133
           +++A+K I+   E+ +   I  E+ +  S    YVV  Y ++                  
Sbjct: 32  RYYAIKKIRHTEEKLS--TILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKST 89
Query: 134 ISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           + I  EY +  +L D +  + +    +EY   +  Q+L+ L Y+H +  IIHR+LKP N+
Sbjct: 90  LFIQXEYCENRTLYDLIHSENLNQQRDEYWR-LFRQILEALSYIHSQG-IIHRNLKPXNI 147
Query: 192 LINHRGEVKITDFGV--------------SAIMASTSGQANTFVGTYNYMSPERISG-GK 236
            I+    VKI DFG+              S  +  +S    + +GT  Y++ E + G G 
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGH 207
Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 296
           Y  K D +SLG++  E     +P+S   ++    +  + + ++  + PP    ++   E 
Sbjct: 208 YNEKIDXYSLGIIFFEXI---YPFSTGXER---VNILKKLRSVSIEFPPDFDDNKXKVE- 260
Query: 297 CSFISACVQKEPQQRLSAQELMTHPFL 323
              I   +  +P +R  A+ L+   +L
Sbjct: 261 KKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 82/184 (44%), Gaps = 14/184 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 150 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTV 169
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T+       G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 170 KIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 257 QFPY 260
           + PY
Sbjct: 230 EQPY 233

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 81  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 140
Query: 150 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 141 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 199
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 200 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 259
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 260 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 311
Query: 317 LMT 319
           +++
Sbjct: 312 IIS 314

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     ++I DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 52  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 111
Query: 150 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 112 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 170
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 230
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 231 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 282
Query: 317 LMT 319
           +++
Sbjct: 283 IIS 285

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 59  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118
Query: 150 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 119 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 177
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 238 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 289
Query: 317 LMT 319
           +++
Sbjct: 290 IIS 292

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 22/192 (11%)
Query: 87  QFFALKVIQMNVEESARRQIAQELKI------NQSSQCPYVVVCYQSFYSNGAISIILEY 140
           Q  ALK+++   E+   RQ A+E++I              V+   ++F     I +  E 
Sbjct: 123 QHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180
Query: 141 MDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 196
           +   +L + +KK K    ++P   +      +L+ L  LH  + IIH DLKP N+L+  +
Sbjct: 181 LSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQ 236
Query: 197 GE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
           G   +K+ DFG S        +    + +  Y +PE I G +YG   D+WSLG +L E  
Sbjct: 237 GRSGIKVIDFGSSCY---EHQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 255 TGQFPYSPPEQQ 266
           TG +P  P E +
Sbjct: 294 TG-YPLLPGEDE 304

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 46/259 (17%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-----NQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           A+K+++ +   + R  +  ELK+     N  +    +  C       G   +I EY   G
Sbjct: 57  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG----GPTLVITEYCCYG 112
Query: 145 SLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            L +FL++        KT P            E L +   QV KG+ +L   K+ IHRDL
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDL 171
Query: 187 KPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L+ H    KI DFG++  + + S     G A   V    +M+PE I    Y ++S
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFES 228
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPSAPSDQFSPEFCSF 299
           D+WS G+ L E  + G  PY P    D  + FY+++ E      P  AP++ +       
Sbjct: 229 DVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEHAPAEMY-----DI 280
Query: 300 ISACVQKEPQQRLSAQELM 318
           +  C   +P +R + ++++
Sbjct: 281 MKTCWDADPLKRPTFKQIV 299

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 148
           A+K+++       +  +  ELKI +   Q   +V    +    G + +I EY   G L +
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 149 FLKKVK--------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           FL++                T+    L     QV +G+ +L   K+ IHRD+   N+L+ 
Sbjct: 140 FLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLT 198
Query: 195 HRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 249
           +    KI DFG++  + + S     G A   V    +M+PE I    Y  +SD+WS G++
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 250 LLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKE 307
           L E  + G  PY         + FY+L++       P+     F+P+   S + AC   E
Sbjct: 256 LWEIFSLGLNPYPGILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALE 307
Query: 308 PQQRLSAQELMT 319
           P  R + Q++ +
Sbjct: 308 PTHRPTFQQICS 319

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 150 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTV 169
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 170 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 257 QFPY 260
           + PY
Sbjct: 230 EQPY 233

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 29/204 (14%)
Query: 89  FALKVIQ-MNVEESARRQIA--QELKINQSSQCPYVVVCYQSFYSNG--AISIILEYM-- 141
           +ALK I+   +  SA R+IA  +ELK       P V+   + F S+    + ++ +Y   
Sbjct: 51  YALKQIEGTGISMSACREIALLRELK------HPNVISLQKVFLSHADRKVWLLFDYAEH 104
Query: 142 DGGSLADFLKKVKT------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI-- 193
           D   +  F +  K       +P   + ++  Q+L G+ YLH    ++HRDLKP+N+L+  
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMG 163
Query: 194 --NHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKS-DIWSLG 247
               RG VKI D G + +  S        +  V T+ Y +PE + G ++  K+ DIW++G
Sbjct: 164 EGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG 223
Query: 248 LVLLECATGQFPYSPPEQQDGWTS 271
            +  E  T + P     Q+D  TS
Sbjct: 224 CIFAELLTSE-PIFHCRQEDIKTS 246

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 148
           A+K+++       +  +  ELKI +   Q   +V    +    G + +I EY   G L +
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 149 FLKKVKTIPE--------------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           FL++   + E                L     QV +G+ +L   K+ IHRD+   N+L+ 
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLT 198
Query: 195 HRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 249
           +    KI DFG++  + + S     G A   V    +M+PE I    Y  +SD+WS G++
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 250 LLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKE 307
           L E  + G  PY         + FY+L++       P+     F+P+   S + AC   E
Sbjct: 256 LWEIFSLGLNPYPGILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALE 307
Query: 308 PQQRLSAQELMT 319
           P  R + Q++ +
Sbjct: 308 PTHRPTFQQICS 319

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 46/259 (17%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-----NQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           A+K+++ +   + R  +  ELK+     N  +    +  C       G   +I EY   G
Sbjct: 80  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVITEYCCYG 135
Query: 145 SLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            L +FL++        KT P            E L +   QV KG+ +L   K+ IHRDL
Sbjct: 136 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDL 194
Query: 187 KPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L+ H    KI DFG++  + + S     G A   V    +M+PE I    Y ++S
Sbjct: 195 AARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFES 251
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPSAPSDQFSPEFCSF 299
           D+WS G+ L E  + G  PY P    D  + FY+++ E      P  AP++ +       
Sbjct: 252 DVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEHAPAEMY-----DI 303
Query: 300 ISACVQKEPQQRLSAQELM 318
           +  C   +P +R + ++++
Sbjct: 304 MKTCWDADPLKRPTFKQIV 322

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 46/259 (17%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-----NQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           A+K+++ +   + R  +  ELK+     N  +    +  C       G   +I EY   G
Sbjct: 73  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVITEYCCYG 128
Query: 145 SLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            L +FL++        KT P            E L +   QV KG+ +L   K+ IHRDL
Sbjct: 129 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDL 187
Query: 187 KPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L+ H    KI DFG++  + + S     G A   V    +M+PE I    Y ++S
Sbjct: 188 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFES 244
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPSAPSDQFSPEFCSF 299
           D+WS G+ L E  + G  PY P    D  + FY+++ E      P  AP++ +       
Sbjct: 245 DVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEHAPAEMY-----DI 296
Query: 300 ISACVQKEPQQRLSAQELM 318
           +  C   +P +R + ++++
Sbjct: 297 MKTCWDADPLKRPTFKQIV 315

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 46/259 (17%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-----NQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           A+K+++ +   + R  +  ELK+     N  +    +  C       G   +I EY   G
Sbjct: 80  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVITEYCCYG 135
Query: 145 SLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            L +FL++        KT P            E L +   QV KG+ +L   K+ IHRDL
Sbjct: 136 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDL 194
Query: 187 KPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L+ H    KI DFG++  + + S     G A   V    +M+PE I    Y ++S
Sbjct: 195 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFES 251
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPSAPSDQFSPEFCSF 299
           D+WS G+ L E  + G  PY P    D  + FY+++ E      P  AP++ +       
Sbjct: 252 DVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEHAPAEMY-----DI 303
Query: 300 ISACVQKEPQQRLSAQELM 318
           +  C   +P +R + ++++
Sbjct: 304 MKTCWDADPLKRPTFKQIV 322

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 50  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 109
Query: 150 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   V
Sbjct: 110 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTV 168
Query: 200 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 169 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 228
Query: 257 QFPY 260
           + PY
Sbjct: 229 EQPY 232

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 46/259 (17%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-----NQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 144
           A+K+++ +   + R  +  ELK+     N  +    +  C       G   +I EY   G
Sbjct: 75  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVITEYCCYG 130
Query: 145 SLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            L +FL++        KT P            E L +   QV KG+ +L   K+ IHRDL
Sbjct: 131 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDL 189
Query: 187 KPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKS 241
              N+L+ H    KI DFG++  + + S     G A   V    +M+PE I    Y ++S
Sbjct: 190 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFES 246
Query: 242 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPSAPSDQFSPEFCSF 299
           D+WS G+ L E  + G  PY P    D  + FY+++ E      P  AP++ +       
Sbjct: 247 DVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEHAPAEMY-----DI 298
Query: 300 ISACVQKEPQQRLSAQELM 318
           +  C   +P +R + ++++
Sbjct: 299 MKTCWDADPLKRPTFKQIV 317

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 111 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 169
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 170 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 229
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 230 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 277
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 278 IMTQCWQHQPEDR 290

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 111 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 169
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 170 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 229
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 230 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 277
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 278 IMTQCWQHQPEDR 290

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLKKVKTI-----------PEEYLAA-----ICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+  +             PEE L++        QV +G+ Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 166 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEAL 224
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G++L E  T G  PY
Sbjct: 225 FDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 30/248 (12%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 148
           A+K+++       +  +  ELKI +   Q   +V    +    G + +I EY   G L +
Sbjct: 72  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 131
Query: 149 FLKKV----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE 198
           FL++           + +    L     QV +G+ +L   K+ IHRD+   N+L+ +   
Sbjct: 132 FLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNGHV 190
Query: 199 VKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
            KI DFG++  + + S     G A   V    +M+PE I    Y  +SD+WS G++L E 
Sbjct: 191 AKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEI 247
Query: 254 -ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKEPQQR 311
            + G  PY         + FY+L++       P+     F+P+   S + AC   EP  R
Sbjct: 248 FSLGLNPYPGILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALEPTHR 299
Query: 312 LSAQELMT 319
            + Q++ +
Sbjct: 300 PTFQQICS 307

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 110
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 217
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 111 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK 169
Query: 218 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 127 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 185
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 186 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 245
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 246 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 293
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 294 IMTQCWQHQPEDR 306

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 110 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 168
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 228
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 229 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 276
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 277 IMTQCWQHQPEDR 289

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 111 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 169
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 170 RNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 229
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 230 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 277
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 278 IMTQCWQHQPEDR 290

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 30/248 (12%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 148
           A+K+++       +  +  ELKI +   Q   +V    +    G + +I EY   G L +
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 149 FLKKV----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE 198
           FL++           + +    L     QV +G+ +L   K+ IHRD+   N+L+ +   
Sbjct: 140 FLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNGHV 198
Query: 199 VKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
            KI DFG++  + + S     G A   V    +M+PE I    Y  +SD+WS G++L E 
Sbjct: 199 AKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEI 255
Query: 254 -ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKEPQQR 311
            + G  PY         + FY+L++       P+     F+P+   S + AC   EP  R
Sbjct: 256 FSLGLNPYPGILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALEPTHR 307
Query: 312 LSAQELMT 319
            + Q++ +
Sbjct: 308 PTFQQICS 315

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 137 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 195
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 196 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 255
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 256 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 303
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 304 IMTQCWQHQPEDR 316

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 117 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 175
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 176 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 235
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 236 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 283
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 284 IMTQCWQHQPEDR 296

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 102 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 160
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 161 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 220
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 221 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 268
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 269 IMTQCWQHQPEDR 281

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 131 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 78  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAA 136
Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
            N+L++     K++DFG++   +ST       V    + +PE +    +  KSD+WS G+
Sbjct: 137 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREAAFSTKSDVWSFGI 193
Query: 249 VLLECAT-GQFPY 260
           +L E  + G+ PY
Sbjct: 194 LLWEIYSFGRVPY 206

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 126
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 217
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 127 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 218 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 126
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 217
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 127 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 218 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 125 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 183
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 184 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 243
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 244 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 291
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 292 IMTQCWQHQPEDR 304

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 100/243 (41%), Gaps = 22/243 (9%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 49  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 108
Query: 150 LKKVK-------TIPEEYLAAICE---QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++        +    L+ + +   ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 109 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 167
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 168 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 227
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 228 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 279
Query: 317 LMT 319
           +++
Sbjct: 280 IIS 282

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 125 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 183
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 184 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 243
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 244 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 291
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 292 IMTQCWQHQPEDR 304

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 70  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 124
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 217
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 125 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 183
Query: 218 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 184 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 414 KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 468
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 217
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 469 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527
Query: 218 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 117/283 (41%), Gaps = 44/283 (15%)
Query: 85  TGQFFALK-VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISII 137
           +G+  A+K V+Q    ++   QI ++L       C  V + Y  FYS+G       ++++
Sbjct: 44  SGELVAIKKVLQGKAFKNRELQIMRKL-----DHCNIVRLRY-FFYSSGEKKDEVYLNLV 97
Query: 138 LEYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           L+Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++
Sbjct: 98  LDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLD 156
Query: 195 HRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 252
               V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E
Sbjct: 157 PDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 253 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 290
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--AFPQIKAHPWTKVFRP 273
Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 274 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 100/243 (41%), Gaps = 22/243 (9%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 59  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118
Query: 150 LKKVK-------TIPEEYLAAICE---QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++        +    L+ + +   ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 177
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 238 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 289
Query: 317 LMT 319
           +++
Sbjct: 290 IIS 292

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+ Y   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 46/284 (16%)
Query: 85  TGQFFALK-VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISII 137
           +G+  A+K V+Q    ++   QI ++L       C  V + Y  FYS+G       ++++
Sbjct: 44  SGELVAIKKVLQGKAFKNRELQIMRKL-----DHCNIVRLRY-FFYSSGEKKDEVYLNLV 97
Query: 138 LEYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           L+Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLD 156
Query: 195 HRGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLL 251
               V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL 
Sbjct: 157 PDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 252 ECATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPS 289
           E   GQ  FP                +P  +Q       +T F      I   P      
Sbjct: 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--AFPQIKAHPWTKVFR 272
Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
            +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 50  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 104
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 217
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 105 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 163
Query: 218 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 164 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 209

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 32/205 (15%)
Query: 78  QLVQHKWTGQFFALKVIQMNVE---ESARR--QIAQELKINQSSQCPYVVVCYQSFYSNG 132
           + + HK  G+  A+K+++ NV+   E+AR   Q+ + L     +     V   + F  +G
Sbjct: 32  ECIDHKAGGRHVAVKIVK-NVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90
Query: 133 AISIILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN 190
            I I+ E + G S  DF+K+   +P   +++  +  Q+ K + +LH  K + H DLKP N
Sbjct: 91  HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK-LTHTDLKPEN 148
Query: 191 LLI---------------NHRG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           +L                + R     ++K+ DFG +          +T V T +Y +PE 
Sbjct: 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY---DDEHHSTLVSTRHYRAPEV 205
Query: 232 ISGGKYGYKSDIWSLGLVLLECATG 256
           I    +    D+WS+G +L+E   G
Sbjct: 206 ILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 116
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 217
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 117 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 218 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 415 KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 469
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 217
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 470 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 528
Query: 218 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 529 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 106
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 217
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 107 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165
Query: 218 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 110
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 217
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 111 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 169
Query: 218 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 260
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I++E M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 168
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 228
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 229 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 276
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 277 IMTQCWQHQPEDR 289

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 131 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 91  DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 151 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 209
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 289
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 210 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 263
Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELM 318
           +    E    +  C    P QR + ++L+
Sbjct: 264 N----ELYMMMRDCWHAVPSQRPTFKQLV 288

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 37/271 (13%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           ++ + KW G+  A+K+     E S  R+  I Q + +   +   ++    +   +   + 
Sbjct: 57  EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKP 188
           ++ +Y + GSL D+L +  T+  E +  +      GL +LH E         I HRDLK 
Sbjct: 117 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175
Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG------KYG 238
            N+L+   G   I D G++    S +       N  VGT  YM+PE +         +  
Sbjct: 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235
Query: 239 YKSDIWSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIVDQP-PPSA 287
            ++DI+++GLV  E    C+ G      Q PY      D   S  E+ + + +Q   P+ 
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNI 293
Query: 288 PSDQFSPE----FCSFISACVQKEPQQRLSA 314
           P+   S E        +  C       RL+A
Sbjct: 294 PNRWQSCEALRVMAKIMRECWYANGAARLTA 324

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 46/284 (16%)
Query: 85  TGQFFALK-VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISII 137
           +G+  A+K V+Q    ++   QI ++L       C  V + Y  FYS+G       ++++
Sbjct: 44  SGELVAIKKVLQGKAFKNRELQIMRKL-----DHCNIVRLRY-FFYSSGEKKDEVYLNLV 97
Query: 138 LEYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
           L+Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLD 156
Query: 195 HRGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLL 251
               V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL 
Sbjct: 157 PDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 252 ECATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPS 289
           E   GQ  FP                +P  +Q       +T F      I   P      
Sbjct: 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFR 272
Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
            +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 131 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 99  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 158
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 159 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 217
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 289
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 218 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 271
Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELM 318
           +    E    +  C    P QR + ++L+
Sbjct: 272 N----ELYMMMRDCWHAVPSQRPTFKQLV 296

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 131 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 207 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 265
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 289
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 266 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 319
Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELM 318
           +    E    +  C    P QR + ++L+
Sbjct: 320 N----ELYMMMRDCWHAVPSQRPTFKQLV 344

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----T 213
           E+L     QV KG+ +L   K  IHRDL   N+L++ +  VKI DFG++  +        
Sbjct: 191 EHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 249
Query: 214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 272
            G A        +M+PE I    Y  +SD+WS G++L E  + G  PY P  + D     
Sbjct: 250 KGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKID----- 300
Query: 273 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
            E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 301 EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 131 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 95  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 154
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 155 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 213
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 289
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 214 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 267
Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELM 318
           +    E    +  C    P QR + ++L+
Sbjct: 268 N----ELYMMMRDCWHAVPSQRPTFKQLV 292

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 37/271 (13%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           ++ + KW G+  A+K+     E S  R+  I Q + +   +   ++    +   +   + 
Sbjct: 44  EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 103
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKP 188
           ++ +Y + GSL D+L +  T+  E +  +      GL +LH E         I HRDLK 
Sbjct: 104 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 162
Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG------KYG 238
            N+L+   G   I D G++    S +       N  VGT  YM+PE +         +  
Sbjct: 163 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 222
Query: 239 YKSDIWSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIVDQP-PPSA 287
            ++DI+++GLV  E    C+ G      Q PY      D   S  E+ + + +Q   P+ 
Sbjct: 223 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNI 280
Query: 288 PSDQFSPE----FCSFISACVQKEPQQRLSA 314
           P+   S E        +  C       RL+A
Sbjct: 281 PNRWQSCEALRVMAKIMRECWYANGAARLTA 311

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I++E M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 125 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 183
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 184 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 243
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 244 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 291
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 292 IMTQCWQHQPEDR 304

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 174
           +G + +I+ Y   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 131 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 98  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 157
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 158 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 216
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 289
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 217 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 270
Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELM 318
           +    E    +  C    P QR + ++L+
Sbjct: 271 N----ELYMMMRDCWHAVPSQRPTFKQLV 295

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 20/149 (13%)
Query: 131 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 166 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 224
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
               Y ++SD+WS G++L E  T G  PY
Sbjct: 225 FDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 131 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 166 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 224
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 289
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 225 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 278
Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELM 318
           +    E    +  C    P QR + ++L+
Sbjct: 279 N----ELYMMMRDCWHAVPSQRPTFKQLV 303

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 17/168 (10%)
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----T 213
           E+L     QV KG+ +L   K  IHRDL   N+L++ +  VKI DFG++  +        
Sbjct: 200 EHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 258
Query: 214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 272
            G A        +M+PE I    Y  +SD+WS G++L E  + G  PY       G    
Sbjct: 259 KGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKID 309
Query: 273 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
            E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 310 EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 356

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 17/168 (10%)
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----T 213
           E+L     QV KG+ +L   K  IHRDL   N+L++ +  VKI DFG++  +        
Sbjct: 198 EHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 256
Query: 214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 272
            G A        +M+PE I    Y  +SD+WS G++L E  + G  PY       G    
Sbjct: 257 KGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKID 307
Query: 273 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
            E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 308 EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 354

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----T 213
           E+L     QV KG+ +L   K  IHRDL   N+L++ +  VKI DFG++  +        
Sbjct: 193 EHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251
Query: 214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 272
            G A        +M+PE I    Y  +SD+WS G++L E  + G  PY P  + D     
Sbjct: 252 KGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKID----- 302
Query: 273 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
            E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 303 EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 97/243 (39%), Gaps = 22/243 (9%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 46  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 105
Query: 150 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N  +     V
Sbjct: 106 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCXVAEDFTV 164
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 165 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 224
Query: 257 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
           + PY     +      + +   ++D+P      D         +  C Q  P+ R S  E
Sbjct: 225 EQPYQGLSNEQ--VLRFVMEGGLLDKP------DNCPDMLLELMRMCWQYNPKMRPSFLE 276
Query: 317 LMT 319
           +++
Sbjct: 277 IIS 279

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 150 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HR+L   N ++ H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRNLAARNCMVAHDFTV 169
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 170 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 257 QFPY 260
           + PY
Sbjct: 230 EQPY 233

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 37/271 (13%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           ++ + KW G+  A+K+     E S  R+  I Q + +   +   ++    +   +   + 
Sbjct: 21  EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 80
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKP 188
           ++ +Y + GSL D+L +  T+  E +  +      GL +LH E         I HRDLK 
Sbjct: 81  LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 139
Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG------KYG 238
            N+L+   G   I D G++    S +       N  VGT  YM+PE +         +  
Sbjct: 140 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 199
Query: 239 YKSDIWSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIVDQP-PPSA 287
            ++DI+++GLV  E    C+ G      Q PY      D   S  E+ + + +Q   P+ 
Sbjct: 200 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNI 257
Query: 288 PSDQFSPE----FCSFISACVQKEPQQRLSA 314
           P+   S E        +  C       RL+A
Sbjct: 258 PNRWQSCEALRVMAKIMRECWYANGAARLTA 288

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 52  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 111
Query: 150 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HR+L   N ++ H   V
Sbjct: 112 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRNLAARNCMVAHDFTV 170
Query: 200 KITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 256
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 230
Query: 257 QFPY 260
           + PY
Sbjct: 231 EQPY 234

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 37/266 (13%)
Query: 83  KWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 140
           KW G+  A+K+     E S  R+  I Q + +   +   ++    +   +   + ++ +Y
Sbjct: 23  KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82
Query: 141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLI 193
            + GSL D+L +  T+  E +  +      GL +LH E         I HRDLK  N+L+
Sbjct: 83  HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 141
Query: 194 NHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG------KYGYKSDI 243
              G   I D G++    S +       N  VGT  YM+PE +         +   ++DI
Sbjct: 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201
Query: 244 WSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQF 292
           +++GLV  E    C+ G      Q PY      D   S  E+ + + +Q   P+ P+   
Sbjct: 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNIPNRWQ 259
Query: 293 SPE----FCSFISACVQKEPQQRLSA 314
           S E        +  C       RL+A
Sbjct: 260 SCEALRVMAKIMRECWYANGAARLTA 285

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 37/266 (13%)
Query: 83  KWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 140
           KW G+  A+K+     E S  R+  I Q + +   +   ++    +   +   + ++ +Y
Sbjct: 24  KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 83
Query: 141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLI 193
            + GSL D+L +  T+  E +  +      GL +LH E         I HRDLK  N+L+
Sbjct: 84  HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 142
Query: 194 NHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG------KYGYKSDI 243
              G   I D G++    S +       N  VGT  YM+PE +         +   ++DI
Sbjct: 143 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 202
Query: 244 WSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQF 292
           +++GLV  E    C+ G      Q PY      D   S  E+ + + +Q   P+ P+   
Sbjct: 203 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNIPNRWQ 260
Query: 293 SPE----FCSFISACVQKEPQQRLSA 314
           S E        +  C       RL+A
Sbjct: 261 SCEALRVMAKIMRECWYANGAARLTA 286

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 37/271 (13%)
Query: 78  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           ++ + KW G+  A+K+     E S  R+  I Q + +   +   ++    +   +   + 
Sbjct: 24  EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 83
Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKP 188
           ++ +Y + GSL D+L +  T+  E +  +      GL +LH E         I HRDLK 
Sbjct: 84  LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 142
Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG------KYG 238
            N+L+   G   I D G++    S +       N  VGT  YM+PE +         +  
Sbjct: 143 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 202
Query: 239 YKSDIWSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIVDQP-PPSA 287
            ++DI+++GLV  E    C+ G      Q PY      D   S  E+ + + +Q   P+ 
Sbjct: 203 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNI 260
Query: 288 PSDQFSPE----FCSFISACVQKEPQQRLSA 314
           P+   S E        +  C       RL+A
Sbjct: 261 PNRWQSCEALRVMAKIMRECWYANGAARLTA 291

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 82/193 (42%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 209
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  A    +    +    +M PE    G +  K+D 
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 269
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 270 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 317
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 318 IMTQCWQHQPEDR 330

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 82/193 (42%), Gaps = 30/193 (15%)
Query: 136 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 128 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 186
Query: 189 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
            N L+   G     KI DFG++  +  A    +    +    +M PE    G +  K+D 
Sbjct: 187 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 246
Query: 244 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 298
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 247 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 294
Query: 299 FISACVQKEPQQR 311
            ++ C Q +P+ R
Sbjct: 295 IMTQCWQHQPEDR 307

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 57  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 111
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 112 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 170
Query: 196 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLE 252
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 171 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 228
Query: 253 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 290
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 229 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 286
Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 287 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 329

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 44  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 99  DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 157
Query: 196 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 252
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 158 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 253 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 290
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 273
Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 274 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH 177
           Y+V   + F     + ++ E M   +L D L+    + +         +Q+   LL+L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 178 -EKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
            E  IIH DLKP N+L+ +  R  +KI DFG S  +     Q    + +  Y SPE + G
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVLLG 232
Query: 235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----EAIVDQPPPS 286
             Y    D+WSLG +L+E  TG+  +S   + D      E++      I+DQ P +
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 42  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 100
Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 101 LQVRKFSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 209 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 266
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 160 YMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219
Query: 267 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 220 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLH 176
           Y  +C +       I +I+E++  GSL ++L K K    + ++   A+  Q+ KG+ YL 
Sbjct: 76  YKGICTED--GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYLG 131
Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN----YMSPERI 232
             +++ HRDL   N+L+    +VKI DFG++  +  T  +  T     +    + +PE +
Sbjct: 132 SRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 233 SGGKYGYKSDIWSLGLVLLE----CATGQFPYS-------PPEQQDGWTSFYELMEAIVD 281
              K+   SD+WS G+ L E    C +   P +       P   Q   T     ++    
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 249
Query: 282 QP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
            P PP+ P + +       +  C + +P  R S Q L+
Sbjct: 250 LPCPPNCPDEVY-----QLMRKCWEFQPSNRTSFQNLI 282

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 49  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 103
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 104 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 162
Query: 196 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 252
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 163 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 220
Query: 253 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 290
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 221 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 278
Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 279 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 321

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 75/136 (55%), Gaps = 11/136 (8%)
Query: 133 AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           ++ ++ +Y+  GSL D +++ +  +  + L     Q+ KG+ YL  E  ++HR+L   N+
Sbjct: 106 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-EHGMVHRNLAARNV 164
Query: 192 LINHRGEVKITDFGVSAIMASTSGQ-----ANTFVGTYNYMSPERISGGKYGYKSDIWSL 246
           L+    +V++ DFGV+ ++     Q     A T +    +M+ E I  GKY ++SD+WS 
Sbjct: 165 LLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESIHFGKYTHQSDVWSY 221
Query: 247 GLVLLECAT-GQFPYS 261
           G+ + E  T G  PY+
Sbjct: 222 GVTVWELMTFGAEPYA 237

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLH 176
           Y  +C +       I +I+E++  GSL ++L K K    + ++   A+  Q+ KG+ YL 
Sbjct: 88  YKGICTED--GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYLG 143
Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN----YMSPERI 232
             +++ HRDL   N+L+    +VKI DFG++  +  T  +  T     +    + +PE +
Sbjct: 144 SRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 233 SGGKYGYKSDIWSLGLVLLE----CATGQFPYS-------PPEQQDGWTSFYELMEAIVD 281
              K+   SD+WS G+ L E    C +   P +       P   Q   T     ++    
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 261
Query: 282 QP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
            P PP+ P + +       +  C + +P  R S Q L+
Sbjct: 262 LPCPPNCPDEVY-----QLMRKCWEFQPSNRTSFQNLI 294

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 72  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 126
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 127 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 185
Query: 196 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLE 252
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 186 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 243
Query: 253 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 290
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 244 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 301
Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 302 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 344

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH 177
           Y+V   + F     + ++ E M   +L D L+    + +         +Q+   LL+L  
Sbjct: 98  YIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 156
Query: 178 -EKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
            E  IIH DLKP N+L+ +  R  +KI DFG S  +     Q    + +  Y SPE + G
Sbjct: 157 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVLLG 213
Query: 235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----EAIVDQPPPS 286
             Y    D+WSLG +L+E  TG+  +S   + D      E++      I+DQ P +
Sbjct: 214 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 269

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 131 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 174
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 232
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 166 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 224
Query: 233 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 289
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 225 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 278
Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELM 318
           +    E    +  C    P QR + ++L+
Sbjct: 279 N----ELYMMMRDCWHAVPSQRPTFKQLV 303

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 75/136 (55%), Gaps = 11/136 (8%)
Query: 133 AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           ++ ++ +Y+  GSL D +++ +  +  + L     Q+ KG+ YL  E  ++HR+L   N+
Sbjct: 88  SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-EHGMVHRNLAARNV 146
Query: 192 LINHRGEVKITDFGVSAIMASTSGQ-----ANTFVGTYNYMSPERISGGKYGYKSDIWSL 246
           L+    +V++ DFGV+ ++     Q     A T +    +M+ E I  GKY ++SD+WS 
Sbjct: 147 LLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESIHFGKYTHQSDVWSY 203
Query: 247 GLVLLECAT-GQFPYS 261
           G+ + E  T G  PY+
Sbjct: 204 GVTVWELMTFGAEPYA 219

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 78  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 133 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 191
Query: 196 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 252
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 192 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249
Query: 253 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 290
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 250 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 307
Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 350

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH 177
           Y+V   + F     + ++ E M   +L D L+    + +         +Q+   LL+L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 178 -EKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
            E  IIH DLKP N+L+ +  R  +KI DFG S  +     Q    + +  Y SPE + G
Sbjct: 176 PELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVLLG 232
Query: 235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----EAIVDQPPPS 286
             Y    D+WSLG +L+E  TG+  +S   + D      E++      I+DQ P +
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 70/137 (51%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 102 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 160
Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQA-NTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M      + +   G      +M+ E +   K+  KSD+W
Sbjct: 161 RNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 220
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 221 SFGVLLWELMTRGAPPY 237

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 123 SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 177
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 178 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 236
Query: 196 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 252
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 237 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 294
Query: 253 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 290
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 295 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 352
Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 353 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 395

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 80  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 134
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 135 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 193
Query: 196 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 252
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 194 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 251
Query: 253 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 290
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 252 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 309
Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 310 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 352

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 45  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 99
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 100 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 158
Query: 196 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 253
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 159 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 217
Query: 254 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 291
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 218 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 275
Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 276 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 317

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 44  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 99  DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 157
Query: 196 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 253
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 216
Query: 254 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 291
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 274
Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 275 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 82  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 136
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 137 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 195
Query: 196 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLE 252
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 196 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 253
Query: 253 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 290
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 254 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 311
Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 312 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 354

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 52  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 106
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 107 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 165
Query: 196 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLEC 253
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 166 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 224
Query: 254 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 291
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 225 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 282
Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 283 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 324

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 44  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVL 98
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 99  DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 157
Query: 196 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 253
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 216
Query: 254 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 291
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 274
Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 275 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 44  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 99  DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 157
Query: 196 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 253
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 216
Query: 254 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 291
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 274
Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 275 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 56  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 110
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 111 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 169
Query: 196 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLEC 253
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 170 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 228
Query: 254 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 291
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 229 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 286
Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 287 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 328

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 56  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 110
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 111 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 169
Query: 196 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 253
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 170 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 228
Query: 254 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 291
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 229 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 286
Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 287 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 328

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 63  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 117
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 118 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 176
Query: 196 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLEC 253
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 177 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 235
Query: 254 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 291
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 236 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 293
Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 294 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 335

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 48  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 102
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 103 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 161
Query: 196 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 253
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 162 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 220
Query: 254 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 291
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 221 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 278
Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 279 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 320

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 138
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 78  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 139 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 133 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 191
Query: 196 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 253
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 192 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 250
Query: 254 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 291
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 251 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 308
Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 333
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 309 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 350

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 103 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 161
Query: 189 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 162 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 221
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 222 SFGVLLWELMTRGAPPY 238

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 122 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 180
Query: 189 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 181 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 240
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 241 SFGVLLWELMTRGAPPY 257

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 79  LVQHKWTGQFFALKVI---QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 135
           LV+    G F+ALK I   +    E A+R+       N  +    V  C +   +     
Sbjct: 47  LVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106
Query: 136 IILEYMDGGSLADFLKKVKT----IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 191
           ++L +   G+L + ++++K     + E+ +  +   + +GL  +H  K   HRDLKP+N+
Sbjct: 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-AKGYAHRDLKPTNI 165
Query: 192 LINHRGEVKITDFGV---SAIMASTSGQANTFVG------TYNYMSPERISGGKYGY--- 239
           L+   G+  + D G    + I    S QA T         T +Y +PE  S   +     
Sbjct: 166 LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE 225
Query: 240 KSDIWSLGLVLLECATGQFPY 260
           ++D+WSLG VL     G+ PY
Sbjct: 226 RTDVWSLGCVLYAMMFGEGPY 246

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 42  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 100
Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 101 LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 209 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 266
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 160 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219
Query: 267 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 220 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 90/229 (39%), Gaps = 65/229 (28%)
Query: 164 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT---- 219
           +  Q++K + YLH    ++HRD+KPSN+L+N    VK+ DFG+S    +     N     
Sbjct: 114 VVYQLIKVIKYLH-SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 220 -----------------FVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP 259
                            +V T  Y +PE + G  KY    D+WSLG +L E   G+  FP
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232
Query: 260 YSP--------------PEQQD--------GWTSFYELMEAIVDQPPPSAPSDQFSP--- 294
            S               P  +D          T    L E +  +   S   D F+    
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV--EIRQSNKRDIFTKWKN 290
Query: 295 -------------EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 330
                        E    +   +Q  P +R+SA + + HPF+ ++ + N
Sbjct: 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 100 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 158
Query: 189 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 159 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 218
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 219 SFGVLLWELMTRGAPPY 235

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 39  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 97
Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 98  LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156
Query: 209 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 266
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216
Query: 267 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 217 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 259

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 70  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 128
Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 129 LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 187
Query: 209 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 266
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 188 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 247
Query: 267 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 248 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 290

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 95  SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 153
Query: 189 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 154 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 213
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 214 SFGVLLWELMTRGAPPY 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 98  SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 156
Query: 189 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 157 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 216
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 217 SFGVLLWELMTRGAPPY 233

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 42  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 100
Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 101 LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 209 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 266
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 160 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219
Query: 267 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 220 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 121 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 179
Query: 189 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 180 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 239
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 240 SFGVLLWELMTRGAPPY 256

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 101 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 159
Query: 189 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 160 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 219
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 220 SFGVLLWELMTRGAPPY 236

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 103 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 161
Query: 189 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 162 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 221
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 222 SFGVLLWELMTRGAPPY 238

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 32/205 (15%)
Query: 78  QLVQHKWTGQFFALKVIQMNVE---ESARR--QIAQELKINQSSQCPYVVVCYQSFYSNG 132
           + + HK  G+  A+K+++ NV+   E+AR   Q+ + L     +     V   + F  +G
Sbjct: 32  ECIDHKAGGRHVAVKIVK-NVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90
Query: 133 AISIILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN 190
            I I+ E + G S  DF+K+   +P   +++  +  Q+ K + +LH  K + H DLKP N
Sbjct: 91  HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK-LTHTDLKPEN 148
Query: 191 LLI---------------NHRG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           +L                + R     ++K+ DFG +          +T V   +Y +PE 
Sbjct: 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY---DDEHHSTLVXXRHYRAPEV 205
Query: 232 ISGGKYGYKSDIWSLGLVLLECATG 256
           I    +    D+WS+G +L+E   G
Sbjct: 206 ILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 480
Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 481 LQVRKFSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
Query: 209 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 266
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 267 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 600 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 102 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 160
Query: 189 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 161 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 220
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 221 SFGVLLWELMTRGAPPY 237

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 47  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 105
Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 106 LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164
Query: 209 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 266
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224
Query: 267 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 225 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 267

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 45  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 103
Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 104 LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 162
Query: 209 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 266
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 163 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 222
Query: 267 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 223 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 265

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 42  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 100
Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 101 LQVRKFSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSATDCVKLGDFGLSR 159
Query: 209 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 266
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 160 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219
Query: 267 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 220 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 44  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 102
Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 103 LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 161
Query: 209 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 266
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 162 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 221
Query: 267 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 222 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 264

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ +L  +K  +HRDL  
Sbjct: 104 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAA 162
Query: 189 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 163 RNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 222
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 223 SFGVLLWELMTRGAPPY 239

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 480
Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 481 LQVRKFSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSATDCVKLGDFGLSR 539
Query: 209 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 266
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 267 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 600 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 118/281 (41%), Gaps = 47/281 (16%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 148
           A+K ++    +   R  A EL++  +    P ++    +    G + + +EY   G+L D
Sbjct: 56  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115
Query: 149 FLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           FL+K +                T+  + L      V +G+ YL  +K  IHRDL   N+L
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNIL 174
Query: 193 INHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
           +      KI DFG+S      +  T G+         +M+ E ++   Y   SD+WS G+
Sbjct: 175 VGENYVAKIADFGLSRGQEVYVKKTMGRLPV-----RWMAIESLNYSVYTTNSDVWSYGV 229
Query: 249 VLLECAT-GQFPYSPPEQQDGWT--SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 305
           +L E  + G  PY       G T    YE +        P    D    E    +  C +
Sbjct: 230 LLWEIVSLGGTPYC------GMTCAELYEKLPQGYRLEKPLNCDD----EVYDLMRQCWR 279
Query: 306 KEPQQRLS-AQELMTHPFL----KMYGDLNVDLSEYFTDAG 341
           ++P +R S AQ L++   +    K Y  +N  L E FT AG
Sbjct: 280 EKPYERPSFAQILVSLNRMLEERKTY--VNTTLYEKFTYAG 318

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ +L  +K  +HRDL  
Sbjct: 101 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAA 159
Query: 189 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 160 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 219
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 220 SFGVLLWELMTRGAPPY 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 118/281 (41%), Gaps = 47/281 (16%)
Query: 90  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 148
           A+K ++    +   R  A EL++  +    P ++    +    G + + +EY   G+L D
Sbjct: 46  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 105
Query: 149 FLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 192
           FL+K +                T+  + L      V +G+ YL  +K  IHRDL   N+L
Sbjct: 106 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNIL 164
Query: 193 INHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 248
           +      KI DFG+S      +  T G+         +M+ E ++   Y   SD+WS G+
Sbjct: 165 VGENYVAKIADFGLSRGQEVYVKKTMGRLPV-----RWMAIESLNYSVYTTNSDVWSYGV 219
Query: 249 VLLECAT-GQFPYSPPEQQDGWT--SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 305
           +L E  + G  PY       G T    YE +        P    D    E    +  C +
Sbjct: 220 LLWEIVSLGGTPYC------GMTCAELYEKLPQGYRLEKPLNCDD----EVYDLMRQCWR 269
Query: 306 KEPQQRLS-AQELMTHPFL----KMYGDLNVDLSEYFTDAG 341
           ++P +R S AQ L++   +    K Y  +N  L E FT AG
Sbjct: 270 EKPYERPSFAQILVSLNRMLEERKTY--VNTTLYEKFTYAG 308

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 130 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
           S G+  ++L YM  G L +F++     P  + L     QV KG+ +L  +K  +HRDL  
Sbjct: 108 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAA 166
Query: 189 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 244
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 167 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 226
Query: 245 SLGLVLLECAT-GQFPY 260
           S G++L E  T G  PY
Sbjct: 227 SFGVLLWELMTRGAPPY 243
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	353
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-145
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-142
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-141
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-138
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-136
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-90
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-89
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-86
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-85
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-85
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-85
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-85
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-84
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-84
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-84
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-83
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-81
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-81
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-80
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-80
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-79
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-77
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-77
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-77
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-75
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-75
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-75
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-74
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-67
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-65
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-65
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-65
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-63
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-63
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-62
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-62
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-59
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-58
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-58
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-58
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-57
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-57
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-56
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-55
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-55
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-55
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-55
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-55
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-54
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-54
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-54
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-54
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-54
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-54
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-54
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-54
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-54
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-54
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-54
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-54
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-53
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-53
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-53
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-53
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-53
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-53
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-53
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-53
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-53
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-53
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-53
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-53
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-52
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-52
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-52
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-52
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-52
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-52
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-52
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-51
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-51
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-51
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-51
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-51
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-51
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-51
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-51
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-50
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-50
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-50
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-50
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-50
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-49
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-49
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-49
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-49
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-49
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-49
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-49
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-49
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-48
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-48
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-48
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-48
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-48
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-48
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-47
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-47
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-47
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-47
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-47
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-47
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-47
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-46
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-46
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-46
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-46
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-45
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-45
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-45
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-45
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-44
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-44
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-44
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-44
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-43
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-43
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-43
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-40
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-40
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-40
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-39
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-38
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-38
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-38
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-37
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-37
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-36
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-36
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-36
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-36
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-36
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-35
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-34
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-33
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-33
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-32
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-32
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-32
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-31
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-31
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-31
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-31
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-30
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-30
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-30
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-30
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-29
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-29
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-29
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-29
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-29
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-29
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-29
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-28
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-28
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-28
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-28
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-28
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-28
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-28
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-27
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-27
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-27
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-27
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-27
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-27
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-27
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-27
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-27
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-27
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-27
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-26
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-26
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-24
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-23
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-23
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-23
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-23
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-23
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-15
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-12
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	7e-04

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  415 bits (1067), Expect = e-145
 Identities = 124/325 (38%), Positives = 182/325 (56%), Gaps = 37/325 (11%)

Query: 51  IKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQEL 110
            K    +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL
Sbjct: 23  QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 82

Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           ++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+K
Sbjct: 83  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 142

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
           GL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPE
Sbjct: 143 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPE 200

Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----------------------- 267
           R+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++                       
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260

Query: 268 ------------GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 315
                          + +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   +
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320

Query: 316 ELMTHPFLKMYGDLNVDLSEYFTDA 340
           +LM H F+K      VD + +    
Sbjct: 321 QLMVHAFIKRSDAEEVDFAGWLCST 345

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  404 bits (1040), Expect = e-142
 Identities = 100/292 (34%), Positives = 169/292 (57%), Gaps = 17/292 (5%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QS 115
           ++  +D++ I  +G+G+ G+V+ ++H  +GQ  A+K I+  V    ++++  +L I+ ++
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT 62

Query: 116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKG 171
             CP+ V  Y + +  G + I +E MD  SL  F K+V    +TIPE+ L  I   ++K 
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           L +LH +  +IHRD+KPSN+LIN  G+VK+ DFG+S  +       +   G   YM+PER
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD-DVAKDIDAGCKPYMAPER 180

Query: 232 ISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 287
           I+       Y  KSDIWSLG+ ++E A  +FPY        W + ++ ++ +V++P P  
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDS------WGTPFQQLKQVVEEPSPQL 234

Query: 288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 339
           P+D+FS EF  F S C++K  ++R +  ELM HPF  ++     D++ +   
Sbjct: 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKL 286

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  394 bits (1013), Expect = e-138
 Identities = 92/296 (31%), Positives = 161/296 (54%), Gaps = 14/296 (4%)

Query: 51  IKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQEL 110
           I     Q  + D++ +  +G G+ G V  ++ + TG   A+K ++ +  +   ++I  +L
Sbjct: 15  IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL 74

Query: 111 KIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 169
            +  +S  CPY+V C+ +F +N  + I +E M   +     +    IPE  L  +   ++
Sbjct: 75  DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV 134

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 229
           K L YL  +  +IHRD+KPSN+L++ RG++K+ DFG+S  +     + +   G   YM+P
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCAAYMAP 193

Query: 230 ERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 284
           ERI     +   Y  ++D+WSLG+ L+E ATGQFPY          + +E++  ++ + P
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN------CKTDFEVLTKVLQEEP 247

Query: 285 PSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 339
           P  P    FS +F SF+  C+ K+ ++R    +L+ H F+K Y  L VD++ +F D
Sbjct: 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKD 303

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  389 bits (1002), Expect = e-136
 Identities = 101/296 (34%), Positives = 157/296 (53%), Gaps = 21/296 (7%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQS 115
               ED+  +  +G+G+ G V  + HK +GQ  A+K I+  V+E  ++Q+  +L +  +S
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS 77

Query: 116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----TIPEEYLAAICEQVLK 170
           S CPY+V  Y + +  G   I +E M   S   F K V       IPEE L  I    +K
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVK 136

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
            L +L     IIHRD+KPSN+L++  G +K+ DFG+S  +  +  +     G   YM+PE
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 195

Query: 231 RISGGK----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 286
           RI        Y  +SD+WSLG+ L E ATG+FPY        W S ++ +  +V   PP 
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK------WNSVFDQLTQVVKGDPPQ 249

Query: 287 APSD---QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 339
             +    +FSP F +F++ C+ K+  +R   +EL+ HPF+ MY +  V+++ Y   
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCK 305

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  271 bits (696), Expect = 4e-90
 Identities = 83/291 (28%), Positives = 134/291 (46%), Gaps = 12/291 (4%)

Query: 41  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--V 98
              + +    ++P      L +    K +G+G    V        G   ALK +Q+   +
Sbjct: 12  PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71

Query: 99  EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---- 154
           +  AR    +E+ + +    P V+  Y SF  +  ++I+LE  D G L+  +K  K    
Sbjct: 72  DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131

Query: 155 TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 214
            IPE  +     Q+   L ++H  + ++HRD+KP+N+ I   G VK+ D G+    +S +
Sbjct: 132 LIPERTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190

Query: 215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 274
             A++ VGT  YMSPERI    Y +KSDIWSLG +L E A  Q P+          + Y 
Sbjct: 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYS 245

Query: 275 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 325
           L + I     P  PSD +S E    ++ C+  +P++R     +        
Sbjct: 246 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  271 bits (696), Expect = 2e-89
 Identities = 71/271 (26%), Positives = 131/271 (48%), Gaps = 12/271 (4%)

Query: 59  NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQ 117
           ++E    ++ +G+GS G   LV+    G+ + +K I +  +    R +  +E+ +  + +
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK 81

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYL 175
            P +V   +SF  NG++ I+++Y +GG L   +   K     E+ +     Q+   L ++
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 235
           H ++ I+HRD+K  N+ +   G V++ DFG++ ++ ST   A   +GT  Y+SPE     
Sbjct: 142 H-DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200

Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 295
            Y  KSDIW+LG VL E  T +  +          S   L+  I+    P      +S +
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFE-------AGSMKNLVLKIISGSFPPVSL-HYSYD 252

Query: 296 FCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
             S +S   ++ P+ R S   ++   F+   
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  261 bits (668), Expect = 6e-86
 Identities = 98/269 (36%), Positives = 142/269 (52%), Gaps = 20/269 (7%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
           E    ++ +GKGS G V       T +  A+K+I +   E     I QE+ +      PY
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
           V   Y S+  +  + II+EY+ GGS  D L+    + E  +A I  ++LKGL YLH EK 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK- 139

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 240
            IHRD+K +N+L++  GEVK+ DFGV+  +  T  + NTFVGT  +M+PE I    Y  K
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199

Query: 241 SDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA---IVDQPPPSAPSDQFSPE 295
           +DIWSLG+  +E A G+ P+S   P            M+    I    PP+     +S  
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHP------------MKVLFLIPKNNPPTL-EGNYSKP 246

Query: 296 FCSFISACVQKEPQQRLSAQELMTHPFLK 324
              F+ AC+ KEP  R +A+EL+ H F+ 
Sbjct: 247 LKEFVEACLNKEPSFRPTAKELLKHKFIL 275

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  259 bits (665), Expect = 1e-85
 Identities = 84/275 (30%), Positives = 146/275 (53%), Gaps = 23/275 (8%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVV 122
              + +G+G+ G V       TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
               S+     + +++EY+ GGSL D + +   + E  +AA+C + L+ L +LH    +I
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH-SNQVI 138

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           HRD+K  N+L+   G VK+TDFG  A +     + +T VGT  +M+PE ++   YG K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198

Query: 243 IWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA---IVDQPPPS-APSDQFSPEF 296
           IWSLG++ +E   G+ PY    P            + A   I     P     ++ S  F
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENP------------LRALYLIATNGTPELQNPEKLSAIF 246

Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 331
             F++ C++ + ++R SA+EL+ H FLK+   L+ 
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSS 281

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  259 bits (664), Expect = 3e-85
 Identities = 95/273 (34%), Positives = 149/273 (54%), Gaps = 23/273 (8%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
           ++ +G+GS G V    HK TGQ  A+K + +  +     +I +E+ I Q    P+VV  Y
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ---EIIKEISIMQQCDSPHVVKYY 90

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 184
            S++ N  + I++EY   GS++D ++   KT+ E+ +A I +  LKGL YLH     IHR
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH-FMRKIHR 149

Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 244
           D+K  N+L+N  G  K+ DFGV+  +  T  + NT +GT  +M+PE I    Y   +DIW
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIW 209

Query: 245 SLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA---IVDQPPPS-APSDQFSPEFCS 298
           SLG+  +E A G+ PY+   P            M A   I   PPP+    + +S  F  
Sbjct: 210 SLGITAIEMAEGKPPYADIHP------------MRAIFMIPTNPPPTFRKPELWSDNFTD 257

Query: 299 FISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 331
           F+  C+ K P+QR +A +L+ HPF++    +++
Sbjct: 258 FVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  259 bits (664), Expect = 4e-85
 Identities = 97/282 (34%), Positives = 149/282 (52%), Gaps = 34/282 (12%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVC 124
           +++VG G+ G V   +H  TGQ  A+KV  M+V      +I QE+ +  + S    +   
Sbjct: 29  VELVGNGTYGQVYKGRHVKTGQLAAIKV--MDVTGDEEEEIKQEINMLKKYSHHRNIATY 86

Query: 125 YQSFYSNGAIS------IILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLH 176
           Y +F             +++E+   GS+ D +K  K  T+ EE++A IC ++L+GL +LH
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI---- 232
            +  +IHRD+K  N+L+    EVK+ DFGVSA +  T G+ NTF+GT  +M+PE I    
Sbjct: 147 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 205

Query: 233 -SGGKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA---IVDQPPPS 286
                Y +KSD+WSLG+  +E A G  P     P            M A   I   P P 
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------------MRALFLIPRNPAPR 253

Query: 287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
             S ++S +F SFI +C+ K   QR + ++LM HPF++   +
Sbjct: 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  259 bits (663), Expect = 4e-85
 Identities = 92/273 (33%), Positives = 152/273 (55%), Gaps = 23/273 (8%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVV 122
           D+   +G+GS GIV L + K +G+  A+K   M++ +  RR+ +  E+ I +  Q   VV
Sbjct: 48  DSYVKIGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVV 105

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
             Y+S+     + +++E++ GG+L D + +   + EE +A +CE VL+ L YLH  + +I
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLH-AQGVI 163

Query: 183 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           HRD+K  ++L+   G VK++DFG  A ++    +  + VGT  +M+PE IS   Y  + D
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVD 223

Query: 243 IWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA---IVDQPPPS-APSDQFSPEF 296
           IWSLG++++E   G+ PY    P            ++A   + D PPP    S + SP  
Sbjct: 224 IWSLGIMVIEMVDGEPPYFSDSP------------VQAMKRLRDSPPPKLKNSHKVSPVL 271

Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 329
             F+   + ++PQ+R +AQEL+ HPFL   G  
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFLLQTGLP 304

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  257 bits (659), Expect = 1e-84
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 18/288 (6%)

Query: 41  SQTETEAPPLIKPSDNQ-LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NV 98
             +ET   P   PS  +    +    +  +G GS G V  V+ K  G+ +A+K       
Sbjct: 36  EASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR 95

Query: 99  EESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTI 156
               R +   E+  ++   Q P  V   Q++   G + +  E   G SL    +    ++
Sbjct: 96  GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASL 154

Query: 157 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 216
           PE  +       L  L +LH  + ++H D+KP+N+ +  RG  K+ DFG+   +  T+G 
Sbjct: 155 PEAQVWGYLRDTLLALAHLH-SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGA 212

Query: 217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 276
                G   YM+PE + G  YG  +D++SLGL +LE A        P   +GW    +L 
Sbjct: 213 GEVQEGDPRYMAPELLQGS-YGTAADVFSLGLTILEVACN---MELPHGGEGW---QQLR 265

Query: 277 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
           +  +            S E  S +   ++ +P+ R +A+ L+  P L+
Sbjct: 266 QGYLPPEFT----AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  256 bits (655), Expect = 4e-84
 Identities = 87/297 (29%), Positives = 148/297 (49%), Gaps = 27/297 (9%)

Query: 48  PPLIKPSDNQLNLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQI 106
               +     L+  ++ + +  +G G+ G V   ++K TG   A KVI+   EE      
Sbjct: 5   SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDY 63

Query: 107 AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAIC 165
             E++I  +   PY+V    ++Y +G + I++E+  GG++   + ++ + + E  +  +C
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVC 123

Query: 166 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN 225
            Q+L+ L +LH  K IIHRDLK  N+L+   G++++ DFGVSA    T  + ++F+GT  
Sbjct: 124 RQMLEALNFLH-SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 182

Query: 226 YMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA 278
           +M+PE +         Y YK+DIWSLG+ L+E A  + P+    P            M  
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------------MRV 230

Query: 279 ---IVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 331
              I    PP+     ++S EF  F+   + K P+ R SA +L+ HPF+        
Sbjct: 231 LLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  254 bits (652), Expect = 7e-84
 Identities = 77/278 (27%), Positives = 136/278 (48%), Gaps = 19/278 (6%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQC 118
            ED + +  +G GS G  Q ++ K  G+    K +   ++ E+ ++ +  E+ + +  + 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 119 PYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGL 172
           P +V  Y      +N  + I++EY +GG LA  + K       + EE++  +  Q+   L
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 173 LYLHHEK----HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
              H        ++HRDLKP+N+ ++ +  VK+ DFG++ I+   +  A TFVGT  YMS
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184

Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           PE+++   Y  KSDIWSLG +L E      P++         S  EL   I +      P
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------AFSQKELAGKIREGKFRRIP 237

Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
             ++S E    I+  +  +   R S +E++ +P +  +
Sbjct: 238 Y-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  252 bits (646), Expect = 6e-83
 Identities = 65/287 (22%), Positives = 122/287 (42%), Gaps = 38/287 (13%)

Query: 56  NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS 115
           ++    D   I+++G G  G V   +H+  G+ + +K ++ N       +  +E+K    
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAK 60

Query: 116 SQCPYVVVCYQSFYSNGAIS----------------IILEYMDGGSLADFLKKVK--TIP 157
                +V     +                       I +E+ D G+L  +++K +   + 
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120

Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 217
           +     + EQ+ KG+ Y+H  K +I+RDLKPSN+ +    +VKI DFG+   + +   + 
Sbjct: 121 KVLALELFEQITKGVDYIH-SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-KR 178

Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 277
               GT  YMSPE+IS   YG + D+++LGL+L E           E         +   
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETS-------KFFT 229

Query: 278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
            + D        D F  +  + +   + K+P+ R +  E++    + 
Sbjct: 230 DLRDGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  250 bits (639), Expect = 3e-81
 Identities = 78/303 (25%), Positives = 129/303 (42%), Gaps = 31/303 (10%)

Query: 38  RIVSQTETEAPPLIKPSDNQLNLEDIDTIK------VVGKGSGGIVQLVQHKWTGQFFAL 91
           R+  +TE     L+      ++ E  + +        VG+GS G V  ++ K TG   A+
Sbjct: 29  RLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAV 88

Query: 92  KVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 151
           K +++ V         +EL        P +V  Y +      ++I +E ++GGSL   +K
Sbjct: 89  KKVRLEVFRV------EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK 142

Query: 152 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIM 210
           ++  +PE+       Q L+GL YL H + I+H D+K  N+L++  G    + DFG +  +
Sbjct: 143 QMGCLPEDRALYYLGQALEGLEYL-HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201

Query: 211 AS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQ 265
                  +    +   GT  +M+PE + G     K DIWS   ++L    G      P  
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC----HP-- 255

Query: 266 QDGWTSFYEL--MEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
              WT ++       I  +PPP        +P     I   ++KEP  R SA EL     
Sbjct: 256 ---WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312

Query: 323 LKM 325
             +
Sbjct: 313 KAL 315

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  248 bits (635), Expect = 5e-81
 Identities = 89/301 (29%), Positives = 146/301 (48%), Gaps = 40/301 (13%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
           +N +D +  +V+G G+  +VQ        +  A+K I +   +++  ++ +E++      
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--------KVKTIPEEYLAAICEQVL 169
            P +V  Y SF     + ++++ + GGS+ D +K        K   + E  +A I  +VL
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-----NTFVGTY 224
           +GL YLH     IHRD+K  N+L+   G V+I DFGVSA +A+           TFVGT 
Sbjct: 132 EGLEYLHKNGQ-IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 225 NYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA--- 278
            +M+PE +   + Y +K+DIWS G+  +E ATG  PY   PP            M+    
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP------------MKVLML 238

Query: 279 IVDQPPPS--------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 330
            +   PPS            ++   F   IS C+QK+P++R +A EL+ H F +   +  
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

Query: 331 V 331
            
Sbjct: 299 F 299

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  246 bits (630), Expect = 2e-80
 Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 22/268 (8%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCY 125
             +G+GS   V       T    A   +Q   + +S R++  +E ++ +  Q P +V  Y
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 126 QSFY----SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH-HEKH 180
            S+         I ++ E M  G+L  +LK+ K +  + L + C Q+LKGL +LH     
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151

Query: 181 IIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
           IIHRDLK  N+ I    G VKI D G++ +  ++   A   +GT  +M+PE      Y  
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEEK-YDE 208

Query: 240 KSDIWSLGLVLLECATGQFPYS---PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 296
             D+++ G+ +LE AT ++PYS      Q         +   +     P++      PE 
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQ---------IYRRVTSGVKPASFDKVAIPEV 259

Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
              I  C+++   +R S ++L+ H F +
Sbjct: 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  247 bits (632), Expect = 4e-80
 Identities = 85/304 (27%), Positives = 138/304 (45%), Gaps = 30/304 (9%)

Query: 38  RIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN 97
           R  S  + +   L    D +    D+  I   G GS G V   +     +  A+K +  +
Sbjct: 34  RAGSLKDPDVAELFFKDDPEKLFSDLREI---GHGSFGAVYFARDVRNSEVVAIKKMSYS 90

Query: 98  VEESA--RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 155
            ++S    + I +E++  Q  + P  +     +       +++EY  G +        K 
Sbjct: 91  GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP 150

Query: 156 IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 215
           + E  +AA+    L+GL YL H  ++IHRD+K  N+L++  G VK+ DFG ++IMA    
Sbjct: 151 LQEVEIAAVTHGALQGLAYL-HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---- 205

Query: 216 QANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWT 270
            AN+FVGT  +M+PE I       Y  K D+WSLG+  +E A  + P             
Sbjct: 206 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------- 258

Query: 271 SFYELMEA---IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 327
                M A   I     P+  S  +S  F +F+ +C+QK PQ R +++ L+ H F+    
Sbjct: 259 -----MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313

Query: 328 DLNV 331
              V
Sbjct: 314 PPTV 317

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  243 bits (623), Expect = 2e-79
 Identities = 90/294 (30%), Positives = 143/294 (48%), Gaps = 22/294 (7%)

Query: 41  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE 100
            ++  E        +     ++     V+GKG+ GIV   +        A+K I      
Sbjct: 2   MRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR 61

Query: 101 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TIP 157
            ++  + +E+ +++  +   +V    SF  NG I I +E + GGSL+  L+         
Sbjct: 62  YSQ-PLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120

Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQ 216
           E+ +    +Q+L+GL YLH +  I+HRD+K  N+LIN + G +KI+DFG S  +A  +  
Sbjct: 121 EQTIGFYTKQILEGLKYLH-DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179

Query: 217 ANTFVGTYNYMSPERISGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 274
             TF GT  YM+PE I  G  GY   +DIWSLG  ++E ATG+    PP     +    E
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PP-----FYELGE 230

Query: 275 LMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
              A+    + +  P  P +  S E  +FI  C + +P +R  A +L+   FLK
Sbjct: 231 PQAAMFKVGMFKVHPEIP-ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  238 bits (610), Expect = 2e-77
 Identities = 64/285 (22%), Positives = 111/285 (38%), Gaps = 42/285 (14%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQS-SQCPYVVV 123
           ++ +G G  G V     +  G  +A+K  +         +   +E+  +    Q  +VV 
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEK 179
            + ++  +  + I  EY +GGSLAD + +         E  L  +  QV +GL Y+H   
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-SM 134

Query: 180 HIIHRDLKPSNLLINHRGE-------------------VKITDFGVSAIMASTSGQANTF 220
            ++H D+KPSN+ I+                        KI D G    ++S        
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVE 190

Query: 221 VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 279
            G   +++ E +     +  K+DI++L L ++  A  +     P   D W         I
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE---PLPRNGDQW-------HEI 240

Query: 280 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                P  P    S EF   +   +  +P++R SA  L+ H  L 
Sbjct: 241 RQGRLPRIP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  239 bits (611), Expect = 2e-77
 Identities = 68/292 (23%), Positives = 118/292 (40%), Gaps = 38/292 (13%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           L D + I+ +G+G  G+V   ++K     +A+K I++   E AR ++ +E+K     + P
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63

Query: 120 YVVVCYQSFYSNGAIS------------IILEYMDGGSLADFLKKVKT---IPEEYLAAI 164
            +V  + ++                   I ++     +L D++    T           I
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---- 220
             Q+ + + +LH  K ++HRDLKPSN+       VK+ DFG+   M     +        
Sbjct: 124 FLQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 221 --------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 272
                   VGT  YMSPE+I G  Y +K DI+SLGL+L E         P          
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFS---TQMER 233

Query: 273 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
              +  + +   P   + Q  P     +   +   P +R  A  ++ +   +
Sbjct: 234 VRTLTDVRNLKFPPLFT-QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  238 bits (610), Expect = 3e-77
 Identities = 67/298 (22%), Positives = 118/298 (39%), Gaps = 43/298 (14%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
             D + I V+G+G+ G V   ++    +++A+K I+    E     I  E+ +  S    
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQ 62

Query: 120 YVVVCYQSFYSNGAIS-------------IILEYMDGGSLADFLKKVKTIPEEYLAA-IC 165
           YVV  Y ++                    I +EY + G+L D +       +      + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 166 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST------------ 213
            Q+L+ L Y+H  + IIHRDLKP N+ I+    VKI DFG++  +  +            
Sbjct: 123 RQILEALSYIH-SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 214 --SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 270
             S    + +GT  Y++ E + G G Y  K D++SLG++  E                  
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM--------- 232

Query: 271 SFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
               +++ +       P    D         I   +  +P +R  A+ L+   +L + 
Sbjct: 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  235 bits (602), Expect = 1e-75
 Identities = 70/286 (24%), Positives = 126/286 (44%), Gaps = 26/286 (9%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKI--N 113
            +       +K +G G    V  V ++   Q +A+K + +   +         E+     
Sbjct: 5   SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63

Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
                  ++  Y    ++  I +++E      L  +LKK K+I      +  + +L+ + 
Sbjct: 64  LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQANTFVGTYNYMSPER 231
            +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   ++ VGT NYM PE 
Sbjct: 123 TIH-QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 232 ISG-----------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 280
           I              K   KSD+WSLG +L     G+ P+          +    + AI+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------QQIINQISKLHAII 234

Query: 281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           D        D    +    +  C++++P+QR+S  EL+ HP++++ 
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  234 bits (599), Expect = 2e-75
 Identities = 70/286 (24%), Positives = 126/286 (44%), Gaps = 26/286 (9%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKI--N 113
            +       +K +G G    V  V ++   Q +A+K + +   +         E+     
Sbjct: 24  SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 82

Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
                  ++  Y    ++  I +++E      L  +LKK K+I      +  + +L+ + 
Sbjct: 83  LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 141

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQANTFVGTYNYMSPER 231
            +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   ++ VGT NYM PE 
Sbjct: 142 TIH-QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 232 ISG-----------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 280
           I              K   KSD+WSLG +L     G+ P+          +    + AI+
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------QQIINQISKLHAII 253

Query: 281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           D        D    +    +  C++++P+QR+S  EL+ HP++++ 
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  235 bits (601), Expect = 6e-75
 Identities = 75/319 (23%), Positives = 125/319 (39%), Gaps = 52/319 (16%)

Query: 66  IKVVGKGSG--GIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVV 122
           + V+GKG      V L ++K TG++  ++ I +          +  EL +++    P +V
Sbjct: 30  LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
               +F ++  + ++  +M  GS  D +    +  + E  +A I + VLK L Y+HH  +
Sbjct: 90  PYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY 149

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-------FVGTYNYMSPERIS 233
           + HR +K S++LI+  G+V ++    +  M S   +           V    ++SPE + 
Sbjct: 150 V-HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208

Query: 234 GGKYGY--KSDIWSLGLVLLECATGQFPYS---------------PPEQQDGWTSFYE-- 274
               GY  KSDI+S+G+   E A G  P+                 P   D  T   E  
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEEL 268

Query: 275 --------------------LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
                                        P       FSP F  F+  C+Q+ P  R SA
Sbjct: 269 TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328

Query: 315 QELMTHPFLKMYGDLNVDL 333
             L+ H F K       + 
Sbjct: 329 STLLNHSFFKQIKRRASEA 347

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  234 bits (598), Expect = 2e-74
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 26/286 (9%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKI--N 113
            +       +K +G G    V  V ++   Q +A+K + +   +         E+     
Sbjct: 52  SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110

Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
                  ++  Y    ++  I +++E      L  +LKK K+I      +  + +L+ + 
Sbjct: 111 LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQANTFVGTYNYMSPER 231
            +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   ++ VG  NYM PE 
Sbjct: 170 TIH-QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227

Query: 232 ISG-----------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 280
           I              K   KSD+WSLG +L     G+ P+          +    + AI+
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------QQIINQISKLHAII 281

Query: 281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           D        D    +    +  C++++P+QR+S  EL+ HP++++ 
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  212 bits (542), Expect = 6e-67
 Identities = 61/285 (21%), Positives = 117/285 (41%), Gaps = 28/285 (9%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
            ++ +    I+ +G+G    V LV+    G F+ALK I  + E+  R +  +E  +++  
Sbjct: 25  IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLF 83

Query: 117 QCPYVVVCYQSFY----SNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAICEQV 168
             P ++           +     ++L +   G+L + ++++K     + E+ +  +   +
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM---------ASTSGQANT 219
            +GL  +H  K   HRDLKP+N+L+   G+  + D G              A T      
Sbjct: 144 CRGLEAIH-AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 220 FVGTYNYMSPERISGGKY---GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 276
              T +Y +PE  S   +     ++D+WSLG VL     G+ PY      D      + +
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------DMVFQKGDSV 256

Query: 277 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 321
              V        S + S      +++ +  +P QR     L++  
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  207 bits (529), Expect = 2e-65
 Identities = 81/276 (29%), Positives = 131/276 (47%), Gaps = 22/276 (7%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI------QMNVEESARRQIAQEL 110
           Q  LED +  + +GKG  G V L + K +    ALKV+      +  VE     Q+ +E+
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH----QLRREV 60

Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
           +I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++  
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
            L Y H  K +IHRD+KP NLL+   GE+KI DFG S    + S +     GT +Y+ PE
Sbjct: 121 ALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCGTLDYLPPE 177

Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
            I G  +  K D+WSLG++  E   G     PP + + +   Y+ +  +    P      
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVG----KPPFEANTYQETYKRISRVEFTFPDF---- 229

Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
             +      IS  ++  P QR   +E++ HP++   
Sbjct: 230 -VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  208 bits (531), Expect = 6e-65
 Identities = 78/332 (23%), Positives = 127/332 (38%), Gaps = 53/332 (15%)

Query: 39  IVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI---- 94
           I+S             +    + D   I+ + +G    + L +     +F+ALK      
Sbjct: 9   ILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSL 66

Query: 95  ------------QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 142
                            +S       EL+I    +  Y + C     +   + II EYM+
Sbjct: 67  LEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYME 126

Query: 143 GGSLADFLKK--------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 194
             S+  F +            IP + +  I + VL    Y+H+EK+I HRD+KPSN+L++
Sbjct: 127 NDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186

Query: 195 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLE 252
             G VK++DFG S  M     +     GTY +M PE  S      G K DIWSLG+ L  
Sbjct: 187 KNGRVKLSDFGESEYM--VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244

Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIV-----------------DQPPPSAPSDQFSPE 295
                 P+          S  EL   I                       +  ++  S E
Sbjct: 245 MFYNVVPF------SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNE 298

Query: 296 FCSFISACVQKEPQQRLSAQELMTHPFLKMYG 327
              F+   ++K P +R+++++ + H +L    
Sbjct: 299 DIDFLKLFLRKNPAERITSEDALKHEWLADTN 330

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  206 bits (526), Expect = 7e-65
 Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 22/281 (7%)

Query: 52  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI------QMNVEESARRQ 105
           +    +  ++D D  + +GKG  G V L + K      ALKV+      +  VE     Q
Sbjct: 5   EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH----Q 60

Query: 106 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 165
           + +E++I    + P ++  Y  F+    I ++LE+   G L   L+K     E+  A   
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120

Query: 166 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN 225
           E++   L Y H E+ +IHRD+KP NLL+ ++GE+KI DFG S    + S +  T  GT +
Sbjct: 121 EELADALHYCH-ERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMCGTLD 177

Query: 226 YMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP 285
           Y+ PE I G  +  K D+W  G++  E   G     PP      T  +  +  +  + PP
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG----MPPFDSPSHTETHRRIVNVDLKFPP 233

Query: 286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
                  S      IS  ++  P QRL  + +M HP++K  
Sbjct: 234 F-----LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  204 bits (522), Expect = 4e-63
 Identities = 84/288 (29%), Positives = 138/288 (47%), Gaps = 26/288 (9%)

Query: 49  PLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQI 106
           P +   +  +N +  + ++ +GKGS G V +VQ   T + +A+K +  Q  VE +  R +
Sbjct: 3   PPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV 62

Query: 107 AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLA 162
            +EL+I Q  + P++V  + SF     + ++++ + GG L   L++     EE    +  
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF-- 120

Query: 163 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 222
            ICE V+  L YL   + IIHRD+KP N+L++  G V ITDF ++A++     Q  T  G
Sbjct: 121 -ICELVM-ALDYLQ-NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMAG 176

Query: 223 TYNYMSPE---RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 279
           T  YM+PE      G  Y +  D WSLG+   E   G+ PY             E++   
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHTF 232

Query: 280 VDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRL-SAQELMTHPFLK 324
                  PSA    +S E  S +   ++  P QR     ++   P++ 
Sbjct: 233 ETTVVTYPSA----WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  201 bits (513), Expect = 8e-63
 Identities = 69/281 (24%), Positives = 125/281 (44%), Gaps = 15/281 (5%)

Query: 46  EAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESAR 103
           E P ++    +  +       + +GKG       +    T + FA K++   + ++   R
Sbjct: 3   EIPEVLV---DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR 59

Query: 104 RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAA 163
            +++ E+ I++S    +VV  +  F  N  + ++LE     SL +  K+ K + E     
Sbjct: 60  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 119

Query: 164 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT 223
              Q++ G  YLH    +IHRDLK  NL +N   EVKI DFG++  +     +     GT
Sbjct: 120 YLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 178

Query: 224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP 283
            NY++PE +S   + ++ D+WS+G ++     G+ P+   E      ++  + +     P
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEYSIP 235

Query: 284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                    +P   S I   +Q +P  R +  EL+   F  
Sbjct: 236 K------HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  200 bits (511), Expect = 5e-62
 Identities = 69/287 (24%), Positives = 126/287 (43%), Gaps = 17/287 (5%)

Query: 41  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI---QMN 97
           +    E P ++    +  +       + +GKG       +    T + FA K++    + 
Sbjct: 24  APPAKEIPEVLV---DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL- 79

Query: 98  VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 157
           ++   R +++ E+ I++S    +VV  +  F  N  + ++LE     SL +  K+ K + 
Sbjct: 80  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 139

Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 217
           E        Q++ G  YLH    +IHRDLK  NL +N   EVKI DFG++  +     + 
Sbjct: 140 EPEARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198

Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 277
               GT NY++PE +S   + ++ D+WS+G ++     G+ P+   E      ++  + +
Sbjct: 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKK 255

Query: 278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                P         +P   S I   +Q +P  R +  EL+   F  
Sbjct: 256 NEYSIPK------HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  198 bits (505), Expect = 8e-62
 Identities = 76/277 (27%), Positives = 124/277 (44%), Gaps = 13/277 (4%)

Query: 53  PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQEL 110
            +     +ED     ++GKGS   V   +   TG   A+K+I      +    +++  E+
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62

Query: 111 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVL 169
           KI+   + P ++  Y  F  +  + ++LE    G +  +LK +VK   E        Q++
Sbjct: 63  KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 229
            G+LYLH    I+HRDL  SNLL+     +KI DFG++  +     +  T  GT NY+SP
Sbjct: 123 TGMLYLH-SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISP 181

Query: 230 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 289
           E  +   +G +SD+WSLG +      G     PP   D   +    +     + P     
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIG----RPPFDTDTVKNTLNKVVLADYEMPSF--- 234

Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
              S E    I   +++ P  RLS   ++ HPF+   
Sbjct: 235 --LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  195 bits (498), Expect = 5e-59
 Identities = 61/277 (22%), Positives = 112/277 (40%), Gaps = 27/277 (9%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPY 120
                 V+G G+ G + + +  +  +  A+K I       A R    E+++  +S + P 
Sbjct: 25  SFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPN 79

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
           V+  + +        I +E     +L +++ +K           + +Q   GL +L H  
Sbjct: 80  VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL-HSL 137

Query: 180 HIIHRDLKPSNLLINHRGE-----VKITDFGVSAIMA---STSGQANTFVGTYNYMSPER 231
           +I+HRDLKP N+LI+           I+DFG+   +A    +  + +   GT  +++PE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 232 ISG---GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 287
           +S        Y  DI+S G V     + G  P+    Q+        ++           
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----ANILLGACSLDCLH- 251

Query: 288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
           P           I   +  +PQ+R SA+ ++ HPF  
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  190 bits (484), Expect = 3e-58
 Identities = 60/298 (20%), Positives = 111/298 (37%), Gaps = 45/298 (15%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 123
               ++G+G+   V   +HK TG  FA+KV              +E ++ +      +V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 124 CYQSF--YSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHE 178
            +      +     +I+E+   GSL   L++      +PE     +   V+ G+ +L  E
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL-RE 130

Query: 179 KHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
             I+HR++KP N++     + +   K+TDFG +  +     Q  +  GT  Y+ P+    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYER 189

Query: 235 G--------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV------ 280
                    KYG   D+WS+G+     ATG  P+ P E         E+M  I+      
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKEVMYKIITGKPSG 246

Query: 281 -----------------DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 321
                            D P   + S          ++  ++ + ++     +     
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  189 bits (482), Expect = 5e-58
 Identities = 77/302 (25%), Positives = 132/302 (43%), Gaps = 36/302 (11%)

Query: 41  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--V 98
               +       P   +   ED    K++G+GS   V L +   T + +A+K+++    +
Sbjct: 10  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII 69

Query: 99  EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
           +E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  E
Sbjct: 70  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE 129

Query: 159 E----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS--AIMAS 212
                Y A    +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG +      S
Sbjct: 130 TCTRFYTA----EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184

Query: 213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP-YSPPEQQDGWTS 271
              +AN+FVGT  Y+SPE ++       SD+W+LG ++ +   G  P  +  E       
Sbjct: 185 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------- 237

Query: 272 FYELMEAIVDQP---PPSAPSDQFSPEFCSFISACVQKEPQQRL------SAQELMTHPF 322
            Y + + I+      P       F P+    +   +  +  +RL          L  HPF
Sbjct: 238 -YLIFQKIIKLEYDFPEK-----FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

Query: 323 LK 324
            +
Sbjct: 292 FE 293

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  189 bits (481), Expect = 9e-58
 Identities = 52/240 (21%), Positives = 97/240 (40%), Gaps = 26/240 (10%)

Query: 100 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI--- 156
            S     + +++          V   Q       + I ++     +L D++ +  ++   
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 157 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 216
                  I  Q+ + + +LH  K ++HRDLKPSN+       VK+ DFG+   M     +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220

Query: 217 ANTF------------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 264
                           VGT  YMSPE+I G  Y +K DI+SLGL+L E     + +S   
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQM 277

Query: 265 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
           ++        ++  + +   P   + Q  P+    +   +   P +R  A +++ +   +
Sbjct: 278 ER------VRIITDVRNLKFPLLFT-QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  188 bits (479), Expect = 5e-57
 Identities = 82/309 (26%), Positives = 149/309 (48%), Gaps = 31/309 (10%)

Query: 36  GVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQH---KWTGQFFALK 92
           G ++++         +     ++ +E+ + +KV+G G+ G V LV+      TG+ +A+K
Sbjct: 29  GEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK 88

Query: 93  VIQMNVEESARRQIAQ---ELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 148
           V++        +       E ++     Q P++V  + +F +   + +IL+Y++GG L  
Sbjct: 89  VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT 148

Query: 149 FLKKVKTIPEE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
            L + +   E     Y+     +++  L +LH +  II+RD+K  N+L++  G V +TDF
Sbjct: 149 HLSQRERFTEHEVQIYVG----EIVLALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDF 203

Query: 205 GVS-AIMASTSGQANTFVGTYNYMSPERISGGKYGY-KS-DIWSLGLVLLECATGQFP-Y 260
           G+S   +A  + +A  F GT  YM+P+ + GG  G+ K+ D WSLG+++ E  TG  P  
Sbjct: 204 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263

Query: 261 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQ 315
              E+        E+   I+   PP       S      I   + K+P++RL      A 
Sbjct: 264 VDGEKNSQ----AEISRRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDAD 317

Query: 316 ELMTHPFLK 324
           E+  H F +
Sbjct: 318 EIKEHLFFQ 326

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  186 bits (475), Expect = 9e-57
 Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 13/270 (4%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 126
           K +G+GS  I +   HK + Q FA+K+I   +E + +++I   LK       P +V  ++
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEI-TALK--LCEGHPNIVKLHE 73

Query: 127 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            F+      +++E ++GG L + +KK K   E   + I  +++  + ++H +  ++HRDL
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH-DVGVVHRDL 132

Query: 187 KPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           KP NLL     +   +KI DFG + +    +    T   T +Y +PE ++   Y    D+
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDL 192

Query: 244 WSLGLVL--LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSF 299
           WSLG++L  +    GQ P+   ++    TS  E+M+ I               S E    
Sbjct: 193 WSLGVILYTMLS--GQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250

Query: 300 ISACVQKEPQQRLSAQELMTHPFLKMYGDL 329
           I   +  +P +RL    L  + +L+    L
Sbjct: 251 IQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  189 bits (483), Expect = 1e-56
 Identities = 83/295 (28%), Positives = 152/295 (51%), Gaps = 24/295 (8%)

Query: 41  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNV 98
           +    E    +    +++ + + + +K++GKG+ G V LV+ K TG+++A+K+++  + V
Sbjct: 128 NSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV 187

Query: 99  EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
            +        E ++ Q+S+ P++     SF ++  +  ++EY +GG L   L + +   E
Sbjct: 188 AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE 247

Query: 159 E----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 214
           +    Y A    +++  L YLH EK++++RDLK  NL+++  G +KITDFG+        
Sbjct: 248 DRARFYGA----EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303

Query: 215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 274
               TF GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +       +
Sbjct: 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K 356

Query: 275 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
           L E I+ +      +    PE  S +S  ++K+P+QRL      A+E+M H F  
Sbjct: 357 LFELILMEEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  183 bits (468), Expect = 1e-55
 Identities = 84/302 (27%), Positives = 135/302 (44%), Gaps = 37/302 (12%)

Query: 41  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQH---KWTGQFFALKVIQ-M 96
           S  E      +K    + +    + +KV+G+GS G V LV+        Q +A+KV++  
Sbjct: 4   SIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA 63

Query: 97  NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 156
            ++   R +   E  I      P++V  + +F + G + +IL+++ GG L   L K    
Sbjct: 64  TLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 123

Query: 157 PEE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 212
            EE    YLA    ++   L +LH    II+RDLKP N+L++  G +K+TDFG+S     
Sbjct: 124 TEEDVKFYLA----ELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178

Query: 213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 272
              +A +F GT  YM+PE ++   +   +D WS G+++ E  TG      P        F
Sbjct: 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT----LP--------F 226

Query: 273 Y-----ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPF 322
                 E M  I+            SPE  S +    ++ P  RL       +E+  H F
Sbjct: 227 QGKDRKETMTMILKAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

Query: 323 LK 324
             
Sbjct: 285 FS 286

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  192 bits (488), Expect = 1e-55
 Identities = 76/289 (26%), Positives = 136/289 (47%), Gaps = 34/289 (11%)

Query: 54  SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKV------IQMNVEESAR--RQ 105
            +  L + D    +++G+G  G V   +   TG+ +A+K            E  A   R 
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241

Query: 106 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YL 161
           +   L +  +  CP++V    +F++   +S IL+ M+GG L   L +     E     Y 
Sbjct: 242 M---LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298

Query: 162 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV 221
           A    +++ GL ++H  + +++RDLKP+N+L++  G V+I+D G++     +  + +  V
Sbjct: 299 A----EIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV 351

Query: 222 GTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 280
           GT+ YM+PE +  G  Y   +D +SLG +L +   G      P +Q      +E+    +
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH----SPFRQHKTKDKHEIDRMTL 407

Query: 281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
                    D FSPE  S +   +Q++  +RL      AQE+   PF +
Sbjct: 408 TMAVEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  184 bits (470), Expect = 2e-55
 Identities = 82/298 (27%), Positives = 141/298 (47%), Gaps = 35/298 (11%)

Query: 43  TETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEE 100
             ++   L   S+      D   +KV+GKGS G V L +HK    F+A+KV+Q    +++
Sbjct: 20  APSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK 79

Query: 101 SARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 159
              + I  E  +  ++ + P++V  + SF +   +  +L+Y++GG L   L++ +   E 
Sbjct: 80  KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP 139

Query: 160 ----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 215
               Y A    ++   L YLH   +I++RDLKP N+L++ +G + +TDFG+       + 
Sbjct: 140 RARFYAA----EIASALGYLH-SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194

Query: 216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-- 273
             +TF GT  Y++PE +    Y    D W LG VL E   G     PP        FY  
Sbjct: 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL----PP--------FYSR 242

Query: 274 ---ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL----SAQELMTHPFLK 324
              E+ + I+++P    P+   +      +   +QK+  +RL       E+ +H F  
Sbjct: 243 NTAEMYDNILNKPLQLKPN--ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  183 bits (466), Expect = 2e-55
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 39/294 (13%)

Query: 51  IKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQH---KWTGQFFALKVIQMNVEESARRQIA 107
           +     ++  E  + ++V+GKG  G V  V+      TG+ FA+KV++  +     +  A
Sbjct: 7   VNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA 66

Query: 108 Q---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----Y 160
               E  I +  + P++V    +F + G + +ILEY+ GG L   L++     E+    Y
Sbjct: 67  HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126

Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 220
           LA    ++   L +LH +K II+RDLKP N+++NH+G VK+TDFG+           +TF
Sbjct: 127 LA----EISMALGHLH-QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF 181

Query: 221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----EL 275
            GT  YM+PE +    +    D WSLG ++ +  TG     PP        F      + 
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA----PP--------FTGENRKKT 229

Query: 276 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
           ++ I+       P    + E    +   +++    RL      A E+  HPF +
Sbjct: 230 IDKILKCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  182 bits (463), Expect = 8e-55
 Identities = 80/279 (28%), Positives = 147/279 (52%), Gaps = 25/279 (8%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEESARRQIAQELKINQ 114
           ++ + D D +K++GKG+ G V LV+ K TG+++A+K+++  + + +        E ++ Q
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLK 170
           +++ P++     +F ++  +  ++EY +GG L   L + +   EE    Y A    +++ 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA----EIVS 116

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
            L YLH  + +++RD+K  NL+++  G +KITDFG+     S      TF GT  Y++PE
Sbjct: 117 ALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
            +    YG   D W LG+V+ E   G+ P+   + +        L E I+ +      + 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEIRFPRT- 227

Query: 291 QFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
             SPE  S ++  ++K+P+QRL      A+E+M H F  
Sbjct: 228 -LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  182 bits (463), Expect = 1e-54
 Identities = 42/307 (13%), Positives = 84/307 (27%), Gaps = 41/307 (13%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVC 124
           + +  G   +V LV+     + FALKV  M  E S     ++ +                
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 125 YQSF--------------------------YSNGAISIILEYMDG------GSLADFLKK 152
                                         Y+     +++            +L      
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 153 VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 212
                   L  +  Q+++    L   K ++H    P NL I   G + + D      + +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS-KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 213 TSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 270
                        Y   E ++     + +  + W LGL +        P+         +
Sbjct: 247 RG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303

Query: 271 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP-FLKMYGDL 329
                +                     + I   +  + ++RL   E M  P FL++  ++
Sbjct: 304 WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEI 363

Query: 330 NVDLSEY 336
           +  LS  
Sbjct: 364 SSSLSTG 370

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  185 bits (471), Expect = 2e-54
 Identities = 83/302 (27%), Positives = 143/302 (47%), Gaps = 21/302 (6%)

Query: 59  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSS 116
           +L ++   +K +G G+ G V L + K T    A+K+I+  +V  S+  ++ +E+ + +  
Sbjct: 34  HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             P ++  Y  F       +++E   GG L D +       E   A I +QVL G+ YL 
Sbjct: 94  DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL- 152

Query: 177 HEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           H+ +I+HRDLKP NLL+  + +   +KI DFG+SA+  +   +    +GT  Y++PE + 
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEVLR 211

Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQ 291
             KY  K D+WS+G++L     G  P+     Q       E++  +        S     
Sbjct: 212 -KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------EILRKVEKGKYTFDSPEWKN 263

Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLS 351
            S      I   +Q + Q+R+SAQ+ + HP++K          E   +  S    + N+ 
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC----SKKESGIELPSLANAIENMR 319

Query: 352 GF 353
            F
Sbjct: 320 KF 321

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  182 bits (464), Expect = 2e-54
 Identities = 60/297 (20%), Positives = 111/297 (37%), Gaps = 45/297 (15%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 123
               ++G+G+   V   +HK TG  FA+KV              +E ++ +      +V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 124 CYQSF--YSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHE 178
            +      +     +I+E+   GSL   L++      +PE     +   V+ G+ +L  E
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL-RE 130

Query: 179 KHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
             I+HR++KP N++     + +   K+TDFG +  +     Q  +  GT  Y+ P+    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYER 189

Query: 235 G--------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV------ 280
                    KYG   D+WS+G+     ATG  P+ P E         E+M  I+      
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKEVMYKIITGKPSG 246

Query: 281 -----------------DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
                            D P   + S          ++  ++ + ++     +    
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  186 bits (473), Expect = 2e-54
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 33/288 (11%)

Query: 56  NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKV------IQMNVEESARRQIAQE 109
             +  +     +V+G+G  G V   Q K TG+ +A K        +    + A      E
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM----VE 235

Query: 110 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL----ADFLKKVKTIPEE----YL 161
            KI       ++V    +F +   + +++  M+GG +     +  +      E     Y 
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 162 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV 221
           A    Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + 
Sbjct: 296 A----QIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA 350

Query: 222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 281
           GT  +M+PE + G +Y +  D ++LG+ L E    +    P   +       EL + +++
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR---GPFRARGEKVENKELKQRVLE 407

Query: 282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
           Q       D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 408 QAVTY--PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  179 bits (457), Expect = 2e-54
 Identities = 75/285 (26%), Positives = 121/285 (42%), Gaps = 41/285 (14%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
               D+   +V+GKG  G    V H+ TG+   +K + +  +E  +R   +E+K+ +  +
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLE 65

Query: 118 CPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGL 172
            P V+    V Y+       ++ I EY+ GG+L   +K + +  P     +  + +  G+
Sbjct: 66  HPNVLKFIGVLYKD----KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN-------------- 218
            YLH   +IIHRDL   N L+     V + DFG++ +M     Q                
Sbjct: 122 AYLH-SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQD---GWTSFY 273
           T VG   +M+PE I+G  Y  K D++S G+VL E        P   P   D       F 
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240

Query: 274 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
           +         PP+ P     P F      C   +P++R S  +L 
Sbjct: 241 DR------YCPPNCP-----PSFFPITVRCCDLDPEKRPSFVKLE 274

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  180 bits (460), Expect = 3e-54
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 44/303 (14%)

Query: 41  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--V 98
              E        PS N   L+  D IK +G GS G V LV+HK +G  +A+K++     V
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80

Query: 99  EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
           +         E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140

Query: 159 E----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 214
                Y A    Q++    YLH    +I+RDLKP NLLI+ +G +++TDFG +  +    
Sbjct: 141 PHARFYAA----QIVLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---K 192

Query: 215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY- 273
           G+  T  GT   ++PE I    Y    D W+LG+++ E A G     PP        F+ 
Sbjct: 193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY----PP--------FFA 240

Query: 274 ----ELMEAIVDQP---PPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHP 321
               ++ E IV      P       FS +    +   +Q +  +R         ++  H 
Sbjct: 241 DQPIQIYEKIVSGKVRFPSH-----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295

Query: 322 FLK 324
           +  
Sbjct: 296 WFA 298

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  180 bits (460), Expect = 3e-54
 Identities = 79/297 (26%), Positives = 132/297 (44%), Gaps = 42/297 (14%)

Query: 46  EAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKV------IQMNVE 99
           E          +L +ED    K++GKGS G V L + K T QFFA+K       +  +  
Sbjct: 2   ELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV 61

Query: 100 ESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 157
           E     +++        + + P++   + +F +   +  ++EY++GG L   ++      
Sbjct: 62  ECTMVEKRVLS-----LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD 116

Query: 158 EE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 213
                 Y A    +++ GL +LH  K I++RDLK  N+L++  G +KI DFG+       
Sbjct: 117 LSRATFYAA----EIILGLQFLH-SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171

Query: 214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 273
             + NTF GT +Y++PE + G KY +  D WS G++L E   GQ     P        F+
Sbjct: 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ----SP--------FH 219

Query: 274 -----ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-SAQELMTHPFLK 324
                EL  +I    P          E    +     +EP++RL    ++  HP  +
Sbjct: 220 GQDEEELFHSIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  180 bits (460), Expect = 3e-54
 Identities = 81/286 (28%), Positives = 151/286 (52%), Gaps = 22/286 (7%)

Query: 54  SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEESARRQIAQELK 111
           + + L L+D D ++V+G+GS   V LV+ K T + +A+KV++  +  ++     +  E  
Sbjct: 2   AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61

Query: 112 I-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICE 166
           +  Q+S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE    Y A    
Sbjct: 62  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA---- 117

Query: 167 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 226
           ++   L YLH E+ II+RDLK  N+L++  G +K+TD+G+           +TF GT NY
Sbjct: 118 EISLALNYLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 176

Query: 227 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW--TSFYELMEAIVDQPP 284
           ++PE + G  YG+  D W+LG+++ E   G+ P+      D     +   L + I+++  
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236

Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRL------SAQELMTHPFLK 324
               S   S +  S + + + K+P++RL         ++  HPF +
Sbjct: 237 RIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  179 bits (456), Expect = 3e-54
 Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 30/277 (10%)

Query: 54  SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN 113
           S + ++ ++I+  +VVG+G+ G+V     KW  +  A+K I+    ES R+    EL+  
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIE---SESERKAFIVELRQL 55

Query: 114 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFL---KKVKTIPEEYLAAICE 166
                P +V     C           +++EY +GGSL + L   + +      +  + C 
Sbjct: 56  SRVNHPNIVKLYGACLNPVC------LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109

Query: 167 QVLKGLLYLHHEK--HIIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTSGQANTFVGT 223
           Q  +G+ YLH  +   +IHRDLKP NLL+   G V KI DFG +  + +         G+
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGS 166

Query: 224 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP 283
             +M+PE   G  Y  K D++S G++L E  T + P+      +     + +M A+ +  
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVHNGT 221

Query: 284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
            P    +       S ++ C  K+P QR S +E++  
Sbjct: 222 RPPLIKN-LPKPIESLMTRCWSKDPSQRPSMEEIVKI 257

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  180 bits (459), Expect = 5e-54
 Identities = 77/299 (25%), Positives = 136/299 (45%), Gaps = 36/299 (12%)

Query: 43  TETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEE 100
           T T +      + +++ L D + + V+GKGS G V L + K T + +A+K++   + +++
Sbjct: 2   TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61

Query: 101 SARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 159
                   E ++     + P++   +  F +   +  ++EY++GG L   +++V    E 
Sbjct: 62  DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 121

Query: 160 ----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 215
               Y A I      GL +L   K II+RDLK  N++++  G +KI DFG+         
Sbjct: 122 HAVFYAAEIAI----GLFFLQ-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176

Query: 216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-- 273
              TF GT +Y++PE I+   YG   D W+ G++L E   GQ     P        F   
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ----AP--------FEGE 224

Query: 274 ---ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
              EL ++I++       S   S E  +     + K P +RL       +++  H F +
Sbjct: 225 DEDELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  182 bits (464), Expect = 5e-54
 Identities = 65/292 (22%), Positives = 118/292 (40%), Gaps = 46/292 (15%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCY 125
           K++G GS G V   Q  + G+  A+K + ++  + A      E+K+  +S   P V+  Y
Sbjct: 21  KILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESDDHPNVIRYY 75

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKK-------VKTIPEEYLAAICEQVLKGLLYLHHE 178
            S  ++  + I LE     +L D ++        +K   E    ++  Q+  G+ +LH  
Sbjct: 76  CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-S 133

Query: 179 KHIIHRDLKPSNLLINHRGE-------------VKITDFGVSAIM----ASTSGQANTFV 221
             IIHRDLKP N+L++                 + I+DFG+   +    +S     N   
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 222 GTYNYMSPERISGG-------KYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY 273
           GT  + +PE +          +     DI+S+G V     + G+ P+     ++      
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-----S 248

Query: 274 ELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
            ++  I                E    IS  +  +P +R +A +++ HP   
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  181 bits (461), Expect = 8e-54
 Identities = 80/308 (25%), Positives = 138/308 (44%), Gaps = 46/308 (14%)

Query: 44  ETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR 103
           +   P +++  + +L  +D + +KV+G+G+   V +V+ K TGQ +A+K++    +   R
Sbjct: 44  QWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW-DMLKR 102

Query: 104 RQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEE 159
            +++    E  +  +    ++   + +F     + +++EY  GG L   L K  + IP E
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE 162

Query: 160 ----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTS 214
               YLA   E V+  +  + H    +HRD+KP N+L++  G +++ DFG    + A  +
Sbjct: 163 MARFYLA---EIVM-AIDSV-HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217

Query: 215 GQANTFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 267
            ++   VGT +Y+SPE +         G YG + D W+LG+   E   GQ     P    
Sbjct: 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ----TP---- 269

Query: 268 GWTSFY-----ELMEAIVDQP---PPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQE 316
               FY     E    IV            +    E   FI   +   P+ RL    A +
Sbjct: 270 ----FYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCP-PETRLGRGGAGD 324

Query: 317 LMTHPFLK 324
             THPF  
Sbjct: 325 FRTHPFFF 332

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  186 bits (473), Expect = 1e-53
 Identities = 68/292 (23%), Positives = 113/292 (38%), Gaps = 29/292 (9%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 123
           +  + +G G  G V    H+ TG+  A+K  +  +    R +   E++I +    P VV 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 124 CYQ------SFYSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLY 174
             +          N    + +EY +GG L  +L + +    + E  +  +   +   L Y
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136

Query: 175 LHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           LH E  IIHRDLKP N+++     R   KI D G +  +         FVGT  Y++PE 
Sbjct: 137 LH-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPEL 194

Query: 232 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------LM 276
           +   KY    D WS G +  EC TG  P+ P  Q   W                     +
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254

Query: 277 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
           +     P P+  S   + +   ++   +    +QR +  +       +    
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  177 bits (451), Expect = 2e-53
 Identities = 74/285 (25%), Positives = 132/285 (46%), Gaps = 28/285 (9%)

Query: 39  IVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVI-Q 95
           I +         +   D  +   D++  + +G GS G V    H+  W G   A+K++ +
Sbjct: 15  IPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTV----HRAEWHGSDVAVKILME 70

Query: 96  MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--- 152
            +       +  +E+ I +  + P +V+   +      +SI+ EY+  GSL   L K   
Sbjct: 71  QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130

Query: 153 VKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMA 211
            + + E    ++   V KG+ YLH+    I+HR+LK  NLL++ +  VK+ DFG+S + A
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190

Query: 212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 271
           ST   + +  GT  +M+PE +       KSD++S G++L E AT Q P+          +
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-------NLN 243

Query: 272 FYELMEAIVDQ-----PPPSAPSDQFSPEFCSFISACVQKEPQQR 311
             +++ A+  +      P +       P+  + I  C   EP +R
Sbjct: 244 PAQVVAAVGFKCKRLEIPRNLN-----PQVAAIIEGCWTNEPWKR 283

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  181 bits (462), Expect = 3e-53
 Identities = 79/303 (26%), Positives = 140/303 (46%), Gaps = 23/303 (7%)

Query: 59  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQS 115
              D     +V+GKGS G V L + K TGQ  A+KVI      +++ +  + +E+++ + 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82

Query: 116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL 175
              P ++  Y+ F   G   ++ E   GG L D +   K   E   A I  QVL G+ Y+
Sbjct: 83  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 142

Query: 176 HHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 232
            H+  I+HRDLKP NLL+  + +   ++I DFG+S    ++  +    +GT  Y++PE +
Sbjct: 143 -HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKIGTAYYIAPEVL 200

Query: 233 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSD 290
             G Y  K D+WS G++L    +G  P++   +        ++++ +             
Sbjct: 201 H-GTYDEKCDVWSTGVILYILLSGCPPFNGANEY-------DILKKVEKGKYTFELPQWK 252

Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNL 350
           + S      I   +   P  R+SA++ + H +++ Y    +       D  S    + N+
Sbjct: 253 KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS-----VDVPSLDNAILNI 307

Query: 351 SGF 353
             F
Sbjct: 308 RQF 310

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  177 bits (451), Expect = 3e-53
 Identities = 77/287 (26%), Positives = 136/287 (47%), Gaps = 44/287 (15%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA---QELKIN 113
           + +L+D   ++ +G GS G V L++ +  G+++A+KV++  +     +Q+     E  + 
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLML 60

Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVL 169
                P+++  + +F     I +I++Y++GG L   L+K +  P      Y A    +V 
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA----EVC 116

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 229
             L YLH  K II+RDLKP N+L++  G +KITDFG +  +        T  GT +Y++P
Sbjct: 117 LALEYLH-SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAP 172

Query: 230 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP 284
           E +S   Y    D WS G+++ E   G      P        FY     +  E I++   
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGY----TP--------FYDSNTMKTYEKILNAEL 220

Query: 285 --PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
             P      F+ +    +S  + ++  QRL       +++  HP+ K
Sbjct: 221 RFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  179 bits (456), Expect = 3e-53
 Identities = 83/307 (27%), Positives = 155/307 (50%), Gaps = 22/307 (7%)

Query: 33  NKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALK 92
              G  I  + E         + + L L+D D ++V+G+GS   V LV+ K T + +A++
Sbjct: 24  GAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMR 83

Query: 93  VIQ--MNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 149
           V++  +  ++     +  E  +  Q+S  P++V  +  F +   +  ++EY++GG L   
Sbjct: 84  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 143

Query: 150 LKKVKTIPEE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 205
           +++ + +PEE    Y A    ++   L YLH E+ II+RDLK  N+L++  G +K+TD+G
Sbjct: 144 MQRQRKLPEEHARFYSA----EISLALNYLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYG 198

Query: 206 VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQ 265
           +           +TF GT NY++PE + G  YG+  D W+LG+++ E   G+ P+     
Sbjct: 199 MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258

Query: 266 QDGWT--SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL------SAQEL 317
            D     +   L + I+++      S   S +  S + + + K+P++RL         ++
Sbjct: 259 SDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADI 316

Query: 318 MTHPFLK 324
             HPF +
Sbjct: 317 QGHPFFR 323

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  176 bits (449), Expect = 5e-53
 Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 39/292 (13%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
             +  ++V  +G  G V   Q     ++ A+K+  +  ++S + +   E+      +   
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNE--YEVYSLPGMKHEN 79

Query: 121 VV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
           ++       +    +  + +I  + + GSL+DFLK    +    L  I E + +GL YLH
Sbjct: 80  ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLH 138

Query: 177 HEKH---------IIHRDLKPSNLLINHRGEVKITDFGVSAIM--ASTSGQANTFVGTYN 225
            +           I HRD+K  N+L+ +     I DFG++       ++G  +  VGT  
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198

Query: 226 YMSPERISGG-----KYGYKSDIWSLGLVLLECATGQFPYS--------PPEQQDGWTSF 272
           YM+PE + G          + D++++GLVL E A+              P E++ G    
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258

Query: 273 YELMEAIVDQ------PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
            E M+ +V                      C  I  C   + + RLSA  + 
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  177 bits (450), Expect = 5e-53
 Identities = 81/321 (25%), Positives = 135/321 (42%), Gaps = 42/321 (13%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS- 115
           +L    +   +V+ +G    V   Q   +G+ +ALK +  N EE   R I QE+   +  
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKL 82

Query: 116 SQCPYVVVCYQSFY-------SNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAIC 165
           S  P +V    +         +  A  ++L  +  G L +FLKK+++   +  + +  I 
Sbjct: 83  SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142

Query: 166 EQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN------ 218
            Q  + + ++H +K  IIHRDLK  NLL++++G +K+ DFG +  ++     +       
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 219 ------TFVGTYNYMSPERI---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 269
                 T   T  Y +PE I   S    G K DIW+LG +L      Q P          
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP---------- 252

Query: 270 TSFYE-LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
             F +     IV+      P D     F S I A +Q  P++RLS  E++     ++   
Sbjct: 253 --FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ-EIAAA 309

Query: 329 LNVDLSEYFTDAGSPLATLSN 349
            NV+     T+         +
Sbjct: 310 RNVNPKSPITELLEQNGGYGS 330

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  177 bits (452), Expect = 5e-53
 Identities = 77/297 (25%), Positives = 143/297 (48%), Gaps = 27/297 (9%)

Query: 41  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNV 98
            ++  E   +   S N+L +++ + I+V+GKGS G V L + K TG  +A+KV++  + +
Sbjct: 3   KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62

Query: 99  EESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 157
           ++        E +I + +   P++   +  F +   +  ++E+++GG L   ++K +   
Sbjct: 63  QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122

Query: 158 EE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 213
           E     Y A    +++  L++L H+K II+RDLK  N+L++H G  K+ DFG+       
Sbjct: 123 EARARFYAA----EIISALMFL-HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177

Query: 214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 273
                TF GT +Y++PE +    YG   D W++G++L E   G  P+    +        
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------- 230

Query: 274 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL------SAQELMTHPFLK 324
           +L EAI++             +    + + + K P  RL          ++ HPF K
Sbjct: 231 DLFEAILNDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  177 bits (450), Expect = 7e-53
 Identities = 73/306 (23%), Positives = 134/306 (43%), Gaps = 35/306 (11%)

Query: 43  TETEAPPLIKPSDNQLNLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNV 98
                  ++  +D+ +  ED+ +  +V+GKG   +V+   ++ TGQ FA+K++   +   
Sbjct: 5   ISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTS 64

Query: 99  EESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 157
                 + + +E  I    + P++V   +++ S+G + ++ E+MDG  L   + K     
Sbjct: 65  SPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124

Query: 158 EEYL----AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIM 210
             Y     +    Q+L+ L Y H + +IIHRD+KP  +L+  +     VK+  FGV+  +
Sbjct: 125 FVYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183

Query: 211 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDG 268
             +   A   VGT ++M+PE +    YG   D+W  G++L  L           P     
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG------CLP----- 232

Query: 269 WTSFY----ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
              FY     L E I+              S      +   +  +P +R++  E + HP+
Sbjct: 233 ---FYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPW 289

Query: 323 LKMYGD 328
           LK    
Sbjct: 290 LKERDR 295

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  179 bits (455), Expect = 8e-53
 Identities = 89/336 (26%), Positives = 142/336 (42%), Gaps = 49/336 (14%)

Query: 23  GTFMDGDLLVN------KDGVRI----------VSQTETEAPPLIKPSDNQLNLEDI-DT 65
           GTF++ +L+         +   I          V    T     + P      L D    
Sbjct: 84  GTFVNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKA----LRDEYIM 139

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVI-------QMNVEESARRQIAQELKINQSSQC 118
            K +G G+ G V+L   + T +  A+++I           E      +  E++I +    
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
           P ++     F+      I+LE M+GG L D +   K + E        Q+L  + YL HE
Sbjct: 200 PCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL-HE 257

Query: 179 KHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG- 234
             IIHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE +   
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSV 316

Query: 235 --GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI----VDQPPPSAP 288
               Y    D WSLG++L  C +G  P+S    Q        L + I     +  P    
Sbjct: 317 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPE--V 368

Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
             + S +    +   +  +P+ R + +E + HP+L+
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  182 bits (464), Expect = 8e-53
 Identities = 82/291 (28%), Positives = 135/291 (46%), Gaps = 33/291 (11%)

Query: 52  KPSDNQ-LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKV------IQMNVEESARR 104
           K  + Q +        +V+GKG  G V   Q + TG+ +A K        +   E  A  
Sbjct: 174 KWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL- 232

Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI--PEE--- 159
               E +I +     +VV    ++ +  A+ ++L  M+GG L   +  +     PE    
Sbjct: 233 ---NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289

Query: 160 -YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 218
            Y A    ++  GL  LH  + I++RDLKP N+L++  G ++I+D G++  +        
Sbjct: 290 FYAA----EICCGLEDLH-RERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIK 343

Query: 219 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 278
             VGT  YM+PE +   +Y +  D W+LG +L E   GQ   SP +Q+       E+   
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ---SPFQQRKKKIKREEVERL 400

Query: 279 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
           + + P     S++FSP+  S  S  + K+P +RL     SA+E+  HP  K
Sbjct: 401 VKEVPEEY--SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  176 bits (449), Expect = 8e-53
 Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 21/272 (7%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 126
           + +G GS  + +   HK T   FA+K+I  + +     +I     + +  Q P ++    
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-KRDPTEEIE---ILLRYGQHPNIITLKD 83

Query: 127 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            +     + ++ E M GG L D + + K   E   +A+   + K + YLH  + ++HRDL
Sbjct: 84  VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH-AQGVVHRDL 142

Query: 187 KPSNLLINHRGE----VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           KPSN+L          ++I DFG +  + + +G   T   T N+++PE +    Y    D
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACD 202

Query: 243 IWSLGLVLLECATGQFP-YSPPEQQDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFC 297
           IWSLG++L    TG  P  + P+         E++  I              +  S    
Sbjct: 203 IWSLGVLLYTMLTGYTPFANGPDDTP-----EEILARIGSGKFSLSGG--YWNSVSDTAK 255

Query: 298 SFISACVQKEPQQRLSAQELMTHPFLKMYGDL 329
             +S  +  +P QRL+A  ++ HP++  +  L
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  176 bits (448), Expect = 1e-52
 Identities = 67/353 (18%), Positives = 126/353 (35%), Gaps = 73/353 (20%)

Query: 42  QTETEAPPLIKPSDNQLNLEDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVI----QM 96
              +    L     + L L+    +   +G+GS G+V++     T    A+K++      
Sbjct: 6   HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65

Query: 97  NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 156
            +      +I  E+++ +    P +   Y+ +     I +++E   GG L D L      
Sbjct: 66  QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125

Query: 157 P----------------------------------------EEYLAAICEQVLKGLLYLH 176
                                                    E+ ++ I  Q+   L YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185

Query: 177 HEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTS----GQANTFVGTYNYMSPE 230
             + I HRD+KP N L +      +K+ DFG+S      +        T  GT  +++PE
Sbjct: 186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244

Query: 231 --RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQP 283
               +   YG K D WS G++L     G    + P        F      + +  ++++ 
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMG----AVP--------FPGVNDADTISQVLNKK 292

Query: 284 P--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS 334
               +   +  SP     +S  + +   +R  A   + HP++  + D    +S
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKMS 345

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  174 bits (444), Expect = 1e-52
 Identities = 70/273 (25%), Positives = 128/273 (46%), Gaps = 33/273 (12%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKINQSSQCPYVVV 123
           + +GKG+  +V+   HK TG  FA K+I   +++  +  +  + +E +I +  Q P +V 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK--LEREARICRKLQHPNIVR 69

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            + S        ++ + + GG L + +   +   E   +   +Q+L+ + Y H    I+H
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVH 128

Query: 184 RDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 240
           R+LKP NLL+  + +   VK+ DFG++  + + S   + F GT  Y+SPE +    Y   
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187

Query: 241 SDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP--PSAPSDQ 291
            DIW+ G++L  L                G+  F+      L   I       PS   D 
Sbjct: 188 VDIWACGVILYILLV--------------GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 233

Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
            +PE  S I + +   P++R++A + +  P++ 
Sbjct: 234 VTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  179 bits (457), Expect = 2e-52
 Identities = 72/302 (23%), Positives = 141/302 (46%), Gaps = 21/302 (6%)

Query: 59  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSS 116
              +  + + ++GKGS G V   + + T Q +A+KVI   + +      I +E+++ +  
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             P ++  ++    + +  I+ E   GG L D + K K   E   A I +QV  G+ Y+ 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM- 137

Query: 177 HEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 233
           H+ +I+HRDLKP N+L+  + +   +KI DFG+S      + +    +GT  Y++PE + 
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLR 196

Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQ 291
            G Y  K D+WS G++L    +G  P+    +        ++++ +              
Sbjct: 197 -GTYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYAFDLPQWRT 248

Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLS 351
            S +    I   +   P  R++A + + HP+++ Y      +S+  +      + ++N+ 
Sbjct: 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE----SAMTNIR 304

Query: 352 GF 353
            F
Sbjct: 305 QF 306

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  173 bits (442), Expect = 2e-52
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 26/272 (9%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKINQSSQCPYVVV 123
             +G+GS G V++   K T    A K I    +   +  ++    E++I +S   P ++ 
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ----EIEIMKSLDHPNIIR 70

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
            Y++F  N  I +++E   GG L + +   +   E   A I + VL  + Y  H+ ++ H
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC-HKLNVAH 129

Query: 184 RDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 240
           RDLKP N L         +K+ DFG++A          T VGT  Y+SP+ +  G YG +
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMRTKVGTPYYVSPQVLE-GLYGPE 187

Query: 241 SDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEF 296
            D WS G+++  L C  G  P+S P          E+M  I +     P       SP+ 
Sbjct: 188 CDEWSAGVMMYVLLC--GYPPFSAPTDS-------EVMLKIREGTFTFPEKDWLNVSPQA 238

Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
            S I   + K P+QR+++ + + H + +    
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  178 bits (453), Expect = 2e-52
 Identities = 81/306 (26%), Positives = 140/306 (45%), Gaps = 44/306 (14%)

Query: 44  ETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR 103
           E   P   K    +L+ ED + +KV+G+G+ G V +V+ K   + FA+K++    E   R
Sbjct: 57  EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW-EMLKR 115

Query: 104 RQIA---QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEE 159
            + A   +E  +  +    ++   + +F  +  + ++++Y  GG L   L K +   PEE
Sbjct: 116 AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE 175

Query: 160 ----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTS 214
               YLA   E V+  +  +H + H +HRD+KP N+L++  G +++ DFG    +M   +
Sbjct: 176 MARFYLA---EMVI-AIDSVH-QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230

Query: 215 GQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 269
            Q++  VGT +Y+SPE +       G+YG + D WSLG+ + E   G+     P      
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE----TP------ 280

Query: 270 TSFY-----ELMEAIVDQPPP-SAPSD--QFSPEFCSFISACVQKEPQQRL---SAQELM 318
             FY     E    I++       P+     S      I   +    + RL     ++  
Sbjct: 281 --FYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICS-REHRLGQNGIEDFK 337

Query: 319 THPFLK 324
            HPF  
Sbjct: 338 KHPFFS 343

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  174 bits (444), Expect = 2e-52
 Identities = 75/292 (25%), Positives = 116/292 (39%), Gaps = 39/292 (13%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
            DI  ++ VGKG  G V      W G+  A+K+     E+S  R+   EL      +   
Sbjct: 8   RDITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHEN 63

Query: 121 VV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
           ++        S +S+  + +I  Y + GSL D+L+   T+       I   +  GL +LH
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLH 122

Query: 177 HEKH-------IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYN 225
            E         I HRDLK  N+L+   G+  I D G++ + + ++ Q     N  VGT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 226 YMSPERISG------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ----DGWT----S 271
           YM+PE +             + DIW+ GLVL E A         E              S
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 272 FYELMEAIVDQ---P--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
           F ++ + +      P  P    SD         +  C  + P  RL+A  + 
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  177 bits (450), Expect = 3e-52
 Identities = 86/308 (27%), Positives = 141/308 (45%), Gaps = 42/308 (13%)

Query: 39  IVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV 98
           I +        + K  D ++  ED + +KV+G+G+ G VQLV+HK T + +A+K++    
Sbjct: 47  IDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF- 105

Query: 99  EESARRQIA---QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 155
           E   R   A   +E  I   +  P+VV  + +F  +  + +++EYM GG L + +     
Sbjct: 106 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD- 164

Query: 156 IPEE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IM 210
           +PE+    Y A    +V+  L  + H    IHRD+KP N+L++  G +K+ DFG    + 
Sbjct: 165 VPEKWARFYTA----EVVLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219

Query: 211 ASTSGQANTFVGTYNYMSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 266
                + +T VGT +Y+SPE +      G YG + D WS+G+ L E   G      P   
Sbjct: 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD----TP--- 272

Query: 267 DGWTSFY-----ELMEAIVD--QPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQE 316
                FY          I++          +  S E  + I A    + + RL     +E
Sbjct: 273 -----FYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVRLGRNGVEE 326

Query: 317 LMTHPFLK 324
           +  H F K
Sbjct: 327 IKRHLFFK 334

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  175 bits (444), Expect = 8e-52
 Identities = 43/304 (14%), Positives = 86/304 (28%), Gaps = 64/304 (21%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI------QMNVEESARRQIAQ------------ 108
            V+G+           + TG+ F + V         N  +  + ++ +            
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 109 ---------ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD--------GGSLADFLK 151
                       + +  Q   ++           +S    Y          G  L     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 152 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 211
             K++       +  QV++ L  LHH   ++H  L+P +++++ RG V +T F       
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLTGFEH----L 253

Query: 212 STSGQANTFVGTYNYMSPERIS-----------GGKYGYKSDIWSLGLVLLECATGQFPY 260
              G       +  +  PE  +                +  D W+LGLV+        P 
Sbjct: 254 VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313

Query: 261 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
           +               E I                  + +   ++   + RL   + M  
Sbjct: 314 TKDAA-------LGGSEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360

Query: 321 PFLK 324
           P  +
Sbjct: 361 PEYE 364

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  180 bits (459), Expect = 1e-51
 Identities = 75/296 (25%), Positives = 137/296 (46%), Gaps = 26/296 (8%)

Query: 41  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNV 98
               T +      + +++ L D + + V+GKGS G V L + K T + +A+K++   + +
Sbjct: 321 KTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI 380

Query: 99  EESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 157
           ++        E ++     + P++   +  F +   +  ++EY++GG L   +++V    
Sbjct: 381 QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK 440

Query: 158 EE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 213
           E     Y A I      GL +L   K II+RDLK  N++++  G +KI DFG+       
Sbjct: 441 EPHAVFYAAEIAI----GLFFLQ-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495

Query: 214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 273
                TF GT +Y++PE I+   YG   D W+ G++L E   GQ P+   ++        
Sbjct: 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------- 548

Query: 274 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
           EL ++I++       S   S E  +     + K P +RL       +++  H F +
Sbjct: 549 ELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  172 bits (439), Expect = 2e-51
 Identities = 77/315 (24%), Positives = 129/315 (40%), Gaps = 40/315 (12%)

Query: 39  IVSQTETEAPPLIKPSDNQ-LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN 97
           ++ Q+++       P   Q    + I  +K +GKG  G V +   KW G+  A+KV    
Sbjct: 14  LIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTT 71

Query: 98  VEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKV 153
            E S  R+   E+      +   ++       +   S   + +I +Y + GSL D+LK  
Sbjct: 72  EEASWFRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS- 128

Query: 154 KTIPEEYLAAICEQVLKGLLYLHHEKH-------IIHRDLKPSNLLINHRGEVKITDFGV 206
            T+  + +  +    + GL +LH E         I HRDLK  N+L+   G   I D G+
Sbjct: 129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188

Query: 207 SAIMASTSGQA----NTFVGTYNYMSPERISGG------KYGYKSDIWSLGLVLLECATG 256
           +    S + +     NT VGT  YM PE +         +    +D++S GL+L E A  
Sbjct: 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

Query: 257 QFPYSP-PEQQDGWT-------SFYELMEAIVDQ---P--PPSAPSDQFSPEFCSFISAC 303
                   E Q  +        S+ ++ E +  +   P  P    SD+   +    ++ C
Sbjct: 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308

Query: 304 VQKEPQQRLSAQELM 318
               P  RL+A  + 
Sbjct: 309 WAHNPASRLTALRVK 323

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  171 bits (436), Expect = 2e-51
 Identities = 69/266 (25%), Positives = 128/266 (48%), Gaps = 16/266 (6%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVCY 125
            ++GKGS G V   + + T Q +A+KVI   + +      I +E+++ +    P ++  +
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
           +    + +  I+ E   GG L D + K K   E   A I +QV  G+ Y+ H+ +I+HRD
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM-HKHNIVHRD 146

Query: 186 LKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           LKP N+L+  + +   +KI DFG+S      + +    +GT  Y++PE +  G Y  K D
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPE-VLRGTYDEKCD 204

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFI 300
           +WS G++L    +G  P+    +        ++++ +               S +    I
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYAFDLPQWRTISDDAKDLI 257

Query: 301 SACVQKEPQQRLSAQELMTHPFLKMY 326
              +   P  R++A + + HP+++ Y
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQKY 283

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  173 bits (441), Expect = 2e-51
 Identities = 73/300 (24%), Positives = 131/300 (43%), Gaps = 37/300 (12%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVCY 125
           + +GKG+  +V+   HK TG  FA K+I    +     +++ +E +I +  Q P +V  +
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
            S        ++ + + GG L + +   +   E   +   +Q+L+ + Y H    I+HR+
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRN 153

Query: 186 LKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           LKP NLL+  + +   VK+ DFG++  +  +    + F GT  Y+SPE +    Y    D
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVD 212

Query: 243 IWSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP--PSAPSDQFS 293
           IW+ G++L  L                G+  F+      L   I       PS   D  +
Sbjct: 213 IWACGVILYILLV--------------GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258

Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF 353
           PE  S I + +   P++R++A + +  P++     +          A     T+  L  F
Sbjct: 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV--------ASAIHRQDTVDCLKKF 310

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  171 bits (435), Expect = 4e-51
 Identities = 72/283 (25%), Positives = 132/283 (46%), Gaps = 36/283 (12%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI--------QMNVEESARRQIAQELKINQS-SQ 117
           +++G+G   +V+   HK T + +A+K+I             +  R    +E+ I +  S 
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
            P ++    ++ +N    ++ + M  G L D+L +  T+ E+    I   +L+ +  LH 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH- 141

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-- 235
           + +I+HRDLKP N+L++    +K+TDFG S  +     +     GT +Y++PE I     
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMN 200

Query: 236 ----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP-- 284
                YG + D+WS G+++     G    SPP        F+      ++  I+      
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAG----SPP--------FWHRKQMLMLRMIMSGNYQF 248

Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 327
            S   D +S      +S  +  +PQ+R +A+E + HPF + Y 
Sbjct: 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  170 bits (434), Expect = 4e-51
 Identities = 57/294 (19%), Positives = 113/294 (38%), Gaps = 39/294 (13%)

Query: 49  PLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM------NVEESA 102
              K     L   +I+  K +GKG  G+V   +        A+K + +            
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66

Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIP 157
            ++  +E+ I  +   P +V    + +          +++E++  G L   L  K   I 
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLDKAHPIK 120

Query: 158 EEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE-----VKITDFGVSAIMA 211
                 +   +  G+ Y+ ++   I+HRDL+  N+ +    E      K+ DFG+S    
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180

Query: 212 STSGQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQD 267
            +       +G + +M+PE I      Y  K+D +S  ++L    TG+ P+      +  
Sbjct: 181 HSVS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-- 235

Query: 268 GWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
                 + +  I ++   P+ P D   P   + I  C   +P++R     ++  
Sbjct: 236 -----IKFINMIREEGLRPTIPED-CPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  176 bits (448), Expect = 5e-51
 Identities = 71/314 (22%), Positives = 134/314 (42%), Gaps = 35/314 (11%)

Query: 59  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI------------QMNVEESARRQ 105
            + +    ++ +G G+ G V L + K      A+KVI                 E    +
Sbjct: 33  KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92

Query: 106 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 165
           I  E+ + +S   P ++  +  F       ++ E+ +GG L + +       E   A I 
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152

Query: 166 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVG 222
           +Q+L G+ YL H+ +I+HRD+KP N+L+ ++     +KI DFG+S+  +    +    +G
Sbjct: 153 KQILSGICYL-HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLG 210

Query: 223 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP-YSPPEQQDGWTSFYELMEAIVD 281
           T  Y++PE +   KY  K D+WS G+++     G  P     +Q        ++++ +  
Sbjct: 211 TAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DIIKKVEK 261

Query: 282 QPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 339
                        S E    I   +  +  +R +A+E +   ++K Y +         +D
Sbjct: 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK-----SD 316

Query: 340 AGSPLATLSNLSGF 353
             +    LSN+  F
Sbjct: 317 QKTLCGALSNMRKF 330

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  171 bits (435), Expect = 6e-51
 Identities = 80/275 (29%), Positives = 126/275 (45%), Gaps = 28/275 (10%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI-------QMNVEESARRQIAQELKINQSSQCP 119
           K +G G+ G V+L   + T +  A+K+I           E      +  E++I +    P
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            ++     F +     I+LE M+GG L D +   K + E        Q+L  + YLH E 
Sbjct: 76  CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-EN 133

Query: 180 HIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-- 234
            IIHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE +    
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVG 192

Query: 235 -GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI----VDQPPPSAPS 289
              Y    D WSLG++L  C +G  P+S    Q        L + I     +  P     
Sbjct: 193 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPE--VW 244

Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
            + S +    +   +  +P+ R + +E + HP+L+
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  174 bits (442), Expect = 9e-51
 Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 28/275 (10%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVCY 125
           + +GKG+  +V+       GQ +A  +I    +     +++ +E +I +  + P +V  +
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
            S    G   +I + + GG L + +   +   E   +   +Q+L+ +L+ H +  ++HR+
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRN 135

Query: 186 LKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           LKP NLL+  + +   VK+ DFG++  +         F GT  Y+SPE +    YG   D
Sbjct: 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVD 195

Query: 243 IWSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP--PSAPSDQFS 293
           +W+ G++L  L    G   Y P         F+      L + I       PS   D  +
Sbjct: 196 LWACGVILYILLV--G---YPP---------FWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241

Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
           PE    I+  +   P +R++A E + HP++     
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRST 276

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  168 bits (428), Expect = 2e-50
 Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 39/282 (13%)

Query: 59  NLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEE---SARRQIAQELKIN 113
           +  ++   +++G G  G V    ++  W G   A+K  + + +E        + QE K+ 
Sbjct: 5   DFAELTLEEIIGIGGFGKV----YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 114 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 169
              + P ++    VC +       + +++E+  GG L   L   K IP + L     Q+ 
Sbjct: 61  AMLKHPNIIALRGVCLKE----PNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIA 115

Query: 170 KGLLYLHHEK--HIIHRDLKPSNLLINHRGE--------VKITDFGVSAIMASTSGQANT 219
           +G+ YLH E    IIHRDLK SN+LI  + E        +KITDFG++     T+    +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMS 173

Query: 220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 279
             G Y +M+PE I    +   SD+WS G++L E  TG+ P+       G      +   +
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF------RGID-GLAVAYGV 226

Query: 280 VDQ-PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
                    PS      F   +  C   +P  R S   ++  
Sbjct: 227 AMNKLALPIPST-CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  169 bits (430), Expect = 2e-50
 Identities = 79/283 (27%), Positives = 134/283 (47%), Gaps = 34/283 (12%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 126
           +V+G G+   V LV+ + TG+ FALK I+ +        +  E+ + +  +   +V    
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR-DSSLENEIAVLKKIKHENIVTLED 73

Query: 127 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            + S     ++++ + GG L D + +     E+  + + +QVL  + YLH E  I+HRDL
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH-ENGIVHRDL 132

Query: 187 KPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           KP NLL     E   + ITDFG+S +  +  G  +T  GT  Y++PE ++   Y    D 
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDC 190

Query: 244 WSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----ELMEAI----VDQPPPSAPSDQF 292
           WS+G++   L C  G   Y P         FY     +L E I     +   P    D  
Sbjct: 191 WSIGVITYILLC--G---YPP---------FYEETESKLFEKIKEGYYEFESP--FWDDI 234

Query: 293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE 335
           S     FI   ++K+P +R + ++ ++HP++     L+ D+  
Sbjct: 235 SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYP 277

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  169 bits (431), Expect = 3e-50
 Identities = 68/263 (25%), Positives = 128/263 (48%), Gaps = 15/263 (5%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVCY 125
           K +GKG+   V+L +H  TG+  A+K+I    +  ++ +++ +E++I +    P +V  +
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
           +   +   + +I+EY  GG + D+L     + E+   +   Q++  + Y H +K I+HRD
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH-QKRIVHRD 139

Query: 186 LKPSNLLINHRGEVKITDFGVSAIMASTSGQA-NTFVGTYNYMSPERISGGKY-GYKSDI 243
           LK  NLL++    +KI DFG S     T G   + F G   Y +PE   G KY G + D+
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDV 197

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
           WSLG++L    +G  P+   + Q+       ++      P         S +  + +   
Sbjct: 198 WSLGVILYTLVSGSLPF---DGQNLKELRERVLRGKYRIPF------YMSTDCENLLKRF 248

Query: 304 VQKEPQQRLSAQELMTHPFLKMY 326
           +   P +R + +++M   ++   
Sbjct: 249 LVLNPIKRGTLEQIMKDRWINAG 271

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  169 bits (429), Expect = 4e-50
 Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 36/277 (12%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI---------QMNVEESARRQIAQELKINQSSQ 117
            ++GKG  G V            A+KVI          ++   +   ++A   K+     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 118 CPYVVVCYQSFYSNGAISIILEY-MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
            P V+     F +     ++LE  +    L D++ +   + E        QV+  + + H
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156

Query: 177 HEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 235
             + ++HRD+K  N+LI+  RG  K+ DFG  A++         F GT  Y  PE IS  
Sbjct: 157 S-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFDGTRVYSPPEWISRH 213

Query: 236 KY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY---ELMEAIVDQPPPSAPSDQ 291
           +Y    + +WSLG++L +   G  P            F    E++EA +  P        
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIP------------FERDQEILEAELHFPA------H 255

Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
            SP+ C+ I  C+  +P  R S +E++  P+++   +
Sbjct: 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  168 bits (427), Expect = 7e-50
 Identities = 74/289 (25%), Positives = 123/289 (42%), Gaps = 38/289 (13%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKI-NQSSQCPYVV 122
            V+G+G+   VQ   +  T Q +A+K+I     ++     R    E+++  Q      V+
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR----EVEMLYQCQGHRNVL 74

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
              + F       ++ E M GGS+   + K +   E   + + + V   L +LH  K I 
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH-NKGIA 133

Query: 183 HRDLKPSNLLINHRGE---VKITDFGVSAIM-------ASTSGQANTFVGTYNYMSPE-- 230
           HRDLKP N+L  H  +   VKI DF + + +         ++ +  T  G+  YM+PE  
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193

Query: 231 ---RISGGKYGYKSDIWSLGLVL--LECATGQFP-YSPPEQQDGWTSFY-------ELME 277
                    Y  + D+WSLG++L  L    G  P         GW            L E
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLS--GYPPFVGRCGSDCGWDRGEACPACQNMLFE 251

Query: 278 AIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
           +I +     P       S      IS  + ++ +QRLSA +++ HP+++
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  167 bits (425), Expect = 1e-49
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 39/289 (13%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVI-------------------------QMNVEE 100
              +GKGS G+V+L  ++    ++A+KV+                               
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 101 SARRQIAQELKINQSSQCPYVVVCYQ--SFYSNGAISIILEYMDGGSLADFLKKVKTIPE 158
               Q+ QE+ I +    P VV   +     +   + ++ E ++ G + +       + E
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSE 136

Query: 159 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 218
           +      + ++KG+ YLH+ + IIHRD+KPSNLL+   G +KI DFGVS     +    +
Sbjct: 137 DQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195

Query: 219 TFVGTYNYMSPERISGGKYGY---KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 275
             VGT  +M+PE +S  +  +     D+W++G+ L     GQ P+      D       L
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF-----MD--ERIMCL 248

Query: 276 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
              I  Q          + +    I+  + K P+ R+   E+  HP++ 
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  168 bits (428), Expect = 1e-49
 Identities = 74/278 (26%), Positives = 122/278 (43%), Gaps = 30/278 (10%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCY 125
           +V+G G  G V    H+ TGQ  ALK++          +  QE+    Q+S  P++V   
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLL------YDSPKARQEVDHHWQASGGPHIVCIL 88

Query: 126 QSF----YSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
             +    +    + II+E M+GG L   +  +  +   E   A I   +   + +LH   
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH-SH 147

Query: 180 HIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
           +I HRD+KP NLL   + +   +K+TDFG +     T     T   T  Y++PE +   K
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPCYTPYYVAPEVLGPEK 205

Query: 237 YGYKSDIWSLGLVL--LECATGQFP-YSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQ 291
           Y    D+WSLG+++  L C  G  P YS   Q         +   I       P+    +
Sbjct: 206 YDKSCDMWSLGVIMYILLC--GFPPFYSNTGQA----ISPGMKRRIRLGQYGFPNPEWSE 259

Query: 292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 329
            S +    I   ++ +P +RL+  + M HP++     +
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  168 bits (427), Expect = 1e-49
 Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 34/293 (11%)

Query: 64  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI-------QMNVEESARRQIAQELKINQSS 116
            T+  +G G+ G V     K   +   +K I          +E+    ++  E+ I    
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 117 QCPYVVVCYQSFYSNGAISIILE-YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL 175
           +   ++     F + G   +++E +  G  L  F+ +   + E   + I  Q++  + YL
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-NTFVGTYNYMSPERISG 234
              K IIHRD+K  N++I     +K+ DFG +A +    G+   TF GT  Y +PE + G
Sbjct: 147 R-LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGTIEYCAPEVLMG 203

Query: 235 GKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL---MEAIVDQPPPSAPSD 290
             Y G + ++WSLG+ L      + P            F EL   +EA +  P       
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENP------------FCELEETVEAAIHPPYL----- 246

Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSP 343
             S E  S +S  +Q  P++R + ++L+T P++    +L     E       P
Sbjct: 247 -VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKP 298

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  167 bits (426), Expect = 4e-49
 Identities = 71/281 (25%), Positives = 133/281 (47%), Gaps = 39/281 (13%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI-------QMNVEESARRQIAQELKINQS-SQC 118
            V+G+G   +V+   H+ TG  FA+K++            E  R    +E  I +  +  
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
           P+++    S+ S+  + ++ + M  G L D+L +   + E+   +I   +L+ + +LH  
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH-A 218

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG--- 235
            +I+HRDLKP N+L++   +++++DFG S  +     +     GT  Y++PE +      
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDE 277

Query: 236 ---KYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP- 284
               YG + D+W+ G++L  L    G    SPP        F+      ++  I++    
Sbjct: 278 THPGYGKEVDLWACGVILFTLLA--G----SPP--------FWHRRQILMLRMIMEGQYQ 323

Query: 285 -PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
             S   D  S      IS  +Q +P+ RL+A++ + HPF +
Sbjct: 324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  165 bits (419), Expect = 4e-49
 Identities = 64/263 (24%), Positives = 119/263 (45%), Gaps = 10/263 (3%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
           ++ +G+G+ G VQL  ++ T +  A+K++ M         I +E+ IN+      VV  Y
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
                     + LEY  GG L D ++    +PE        Q++ G++YLH    I HRD
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 130

Query: 186 LKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY-GYKSD 242
           +KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++     D
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
           +WS G+VL     G+ P+      D  +   +      ++     P  +      + +  
Sbjct: 191 VWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244

Query: 303 CVQKEPQQRLSAQELMTHPFLKM 325
            + + P  R++  ++    +   
Sbjct: 245 ILVENPSARITIPDIKKDRWYNK 267

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  167 bits (424), Expect = 4e-49
 Identities = 67/293 (22%), Positives = 113/293 (38%), Gaps = 39/293 (13%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
              I   + +GKG  G V     KW G+  A+K+     E S  R+   E+      +  
Sbjct: 41  ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHE 96

Query: 120 YVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL 175
            ++       +   +   + ++ +Y + GSL D+L +  T+  E +  +      GL +L
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHL 155

Query: 176 HHEKH-------IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTY 224
           H E         I HRDLK  N+L+   G   I D G++    S +       N  VGT 
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 225 NYMSPERISG------GKYGYKSDIWSLGLVLLECATGQFPYS-PPEQQDGW-------T 270
            YM+PE +         +   ++DI+++GLV  E A          + Q  +        
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275

Query: 271 SFYELMEAIVDQ---P--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
           S  E+ + + +Q   P  P    S +        +  C       RL+A  + 
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  165 bits (420), Expect = 5e-49
 Identities = 68/269 (25%), Positives = 129/269 (47%), Gaps = 24/269 (8%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 126
           + +G G+ G V LV+ + +G    +K I  +  +    QI  E+++ +S   P ++  ++
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 127 SFYSNGAISIILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
            F     + I++E  +GG L + +     + K + E Y+A + +Q++  L Y  H +H++
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF-HSQHVV 146

Query: 183 HRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
           H+DLKP N+L         +KI DFG++ +  S    +    GT  YM+PE        +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAAGTALYMAPEVFK-RDVTF 204

Query: 240 KSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPE 295
           K DIWS G+V+  L    G  P++    +       E+ +    + P          +P+
Sbjct: 205 KCDIWSAGVVMYFLLT--GCLPFTGTSLE-------EVQQKATYKEPNYAVECRP-LTPQ 254

Query: 296 FCSFISACVQKEPQQRLSAQELMTHPFLK 324
               +   + K+P++R SA +++ H + K
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  166 bits (422), Expect = 7e-49
 Identities = 70/283 (24%), Positives = 132/283 (46%), Gaps = 34/283 (12%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKI-NQSSQCPYVVVC 124
           K +G+G   +V+    K TGQ +A K ++     +  R +I  E+ +   +  CP V+  
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 125 YQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
           ++ + +   I +ILEY  GG +      +  + + E  +  + +Q+L+G+ YLH + +I+
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH-QNNIV 153

Query: 183 HRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
           H DLKP N+L++       +KI DFG+S  +   + +    +GT  Y++PE ++      
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMGTPEYLAPEILNYDPITT 212

Query: 240 KSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP--PSAPS 289
            +D+W++G+   +LL   T     SP         F      E    I            
Sbjct: 213 ATDMWNIGIIAYMLL---TH---TSP---------FVGEDNQETYLNISQVNVDYSEETF 257

Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 332
              S     FI + + K P++R +A+  ++H +L+ +   N+ 
Sbjct: 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  165 bits (420), Expect = 1e-48
 Identities = 70/302 (23%), Positives = 123/302 (40%), Gaps = 28/302 (9%)

Query: 35  DGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI 94
            G  +    +  A  L    + +          ++G G  G V            A+K +
Sbjct: 17  RGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV 76

Query: 95  -----QMNVEESARRQIAQELKINQ--SSQCPYVVVCYQSFYSNGAISIILEYMDG-GSL 146
                    E     ++  E+ + +  SS    V+     F    +  +ILE  +    L
Sbjct: 77  EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL 136

Query: 147 ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFG 205
            DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DFG
Sbjct: 137 FDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFG 195

Query: 206 VSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPE 264
             A++         F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   E
Sbjct: 196 SGALL--KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---E 250

Query: 265 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
             +      E++   V          + S E    I  C+   P  R + +E+  HP+++
Sbjct: 251 HDE------EIIRGQVFFRQ------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298

Query: 325 MY 326
             
Sbjct: 299 DV 300

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  164 bits (417), Expect = 1e-48
 Identities = 66/279 (23%), Positives = 122/279 (43%), Gaps = 35/279 (12%)

Query: 59  NLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVIQM-NVEESARRQIAQELKINQS 115
               I   + +G GS G V    +K  W G   A+K++ +        +    E+ + + 
Sbjct: 22  PDGQITVGQRIGSGSFGTV----YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK 76

Query: 116 SQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLK 170
           ++   ++           +   ++I+ ++ +G SL   L   +T    + L  I  Q  +
Sbjct: 77  TRHVNILLFMGYS-----TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST--SGQANTFVGTYNYMS 228
           G+ YLH  K IIHRDLK +N+ ++    VKI DFG++   +    S Q     G+  +M+
Sbjct: 132 GMDYLH-AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190

Query: 229 PERI---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--- 282
           PE I       Y ++SD+++ G+VL E  TGQ PYS         +  +++E +      
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIEMVGRGSLS 244

Query: 283 -PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
                  S+         ++ C++K+  +R S   ++  
Sbjct: 245 PDLSKVRSN-CPKRMKRLMAECLKKKRDERPSFPRILAE 282

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  164 bits (418), Expect = 4e-48
 Identities = 75/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 126
             +G+G+  IV   + K T + +ALKV++  V++     +  E+ +      P ++   +
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI---VRTEIGVLLRLSHPNIIKLKE 115

Query: 127 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 186
            F +   IS++LE + GG L D + +     E   A   +Q+L+ + YLH E  I+HRDL
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH-ENGIVHRDL 174

Query: 187 KPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 243
           KP NLL         +KI DFG+S I+        T  GT  Y +PE + G  YG + D+
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDM 233

Query: 244 WSLGLVL--LECATGQFP-YSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCS 298
           WS+G++   L C  G  P Y     Q        +   I++      S   D+ S     
Sbjct: 234 WSVGIITYILLC--GFEPFYDERGDQ-------FMFRRILNCEYYFISPWWDEVSLNAKD 284

Query: 299 FISACVQKEPQQRLSAQELMTHPFLK 324
            +   +  +P++RL+  + + HP++ 
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWVT 310

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  162 bits (412), Expect = 6e-48
 Identities = 73/293 (24%), Positives = 137/293 (46%), Gaps = 37/293 (12%)

Query: 59  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESA--RRQIAQELKI 112
            +ED  +  + +G G   IV+  + K TG+ +A K I   +++       R +I +E+ I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 172
            +  + P ++  +  F +   + +ILE + GG L DFL + +++ E+      +Q+L G+
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQANTFVGTYNYMS 228
            YL H K I H DLKP N+++  +      +K+ DFG++  +     +     GT  +++
Sbjct: 122 HYL-HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFKNIFGTPEFVA 179

Query: 229 PERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIV 280
           PE ++    G ++D+WS+G+   +LL   +G    SP         F      E +  I 
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILL---SG---ASP---------FLGETKQETLTNIS 224

Query: 281 DQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 331
                         S     FI   + K+P++R++  + + H ++K     NV
Sbjct: 225 AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  163 bits (414), Expect = 8e-48
 Identities = 60/284 (21%), Positives = 119/284 (41%), Gaps = 33/284 (11%)

Query: 59  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
            L +     + +G+G  GIV       + + +  K +   V+ + +  + +E+ I   ++
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIAR 59

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADF-LKKVKTIPEEYLAAICEQVLKGLLYLH 176
              ++  ++SF S   + +I E++ G  + +        + E  + +   QV + L +LH
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 177 HEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
              +I H D++P N++   R    +KI +FG +  +               Y +PE    
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVHQH 177

Query: 235 GKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP-- 284
                 +D+WSLG    VLL   +G    +P         F      +++E I++     
Sbjct: 178 DVVSTATDMWSLGTLVYVLL---SG---INP---------FLAETNQQIIENIMNAEYTF 222

Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
                 + S E   F+   + KE + R++A E + HP+LK   +
Sbjct: 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  164 bits (416), Expect = 1e-47
 Identities = 74/279 (26%), Positives = 131/279 (46%), Gaps = 40/279 (14%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI-----QMNVEESARRQIAQELKINQSSQCPYV 121
           + +G G   IV+  + K TG  +A K I     + +     R +I +E+ I +    P +
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
           +  +  + +   + +ILE + GG L DFL + +++ EE   +  +Q+L G+ YL H K I
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL-HTKKI 136

Query: 182 IHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 237
            H DLKP N+++  +      +K+ DFG++  +     +     GT  +++PE ++    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPEFVAPEIVNYEPL 195

Query: 238 GYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAI----VDQPPP 285
           G ++D+WS+G+   +LL   +G    SP         F      E +  I     D    
Sbjct: 196 GLEADMWSIGVITYILL---SG---ASP---------FLGDTKQETLANITAVSYDFDEE 240

Query: 286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                Q S     FI   + KE ++RL+ QE + HP++ 
Sbjct: 241 --FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  162 bits (413), Expect = 1e-47
 Identities = 64/263 (24%), Positives = 119/263 (45%), Gaps = 10/263 (3%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
           ++ +G+G+ G VQL  ++ T +  A+K++ M         I +E+ IN+      VV  Y
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
                     + LEY  GG L D ++    +PE        Q++ G++YLH    I HRD
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 130

Query: 186 LKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY-GYKSD 242
           +KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++     D
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
           +WS G+VL     G+ P+      D  +   +      ++     P  +      + +  
Sbjct: 191 VWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244

Query: 303 CVQKEPQQRLSAQELMTHPFLKM 325
            + + P  R++  ++    +   
Sbjct: 245 ILVENPSARITIPDIKKDRWYNK 267

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  162 bits (412), Expect = 1e-47
 Identities = 73/283 (25%), Positives = 131/283 (46%), Gaps = 40/283 (14%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI-----QMNVEESARRQIAQELKINQSSQCPYV 121
           + +G G   IV+  + K TG  +A K I     + +    +R +I +E+ I +      V
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
           +  +  + +   + +ILE + GG L DFL + +++ EE   +  +Q+L G+ YL H K I
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL-HTKKI 136

Query: 182 IHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 237
            H DLKP N+++  +      +K+ DFG++  +     +     GT  +++PE ++    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPEFVAPEIVNYEPL 195

Query: 238 GYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAI----VDQPPP 285
           G ++D+WS+G+   +LL   +G    SP         F      E +  I     D    
Sbjct: 196 GLEADMWSIGVITYILL---SG---ASP---------FLGDTKQETLANITSVSYDFDEE 240

Query: 286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
                  S     FI   + KE ++RL+ QE + HP++    +
Sbjct: 241 --FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  162 bits (413), Expect = 2e-47
 Identities = 76/295 (25%), Positives = 136/295 (46%), Gaps = 41/295 (13%)

Query: 59  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESA--RRQIAQELKI 112
           N++D  DT + +G G   +V+  + K TG  +A K I   +         R  I +E+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 172
            +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE      +Q+L G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQANTFVGTYNYMS 228
            YL H   I H DLKP N+++  R      +KI DFG++  +     +     GT  +++
Sbjct: 128 YYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEFVA 185

Query: 229 PERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAI- 279
           PE ++    G ++D+WS+G+   +LL   +G    SP         F      E +  + 
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILL---SG---ASP---------FLGDTKQETLANVS 230

Query: 280 ---VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 331
               +           S     FI   + K+P++R++ Q+ + HP++K       
Sbjct: 231 AVNYEFEDE--YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  161 bits (410), Expect = 3e-47
 Identities = 60/282 (21%), Positives = 119/282 (42%), Gaps = 36/282 (12%)

Query: 59  NLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVIQM-NVEESARRQIAQELKINQS 115
             E ++  +++GKG  G V    +   W G+  A+++I +    E   +   +E+   + 
Sbjct: 31  PFEQLEIGELIGKGRFGQV----YHGRWHGEV-AIRLIDIERDNEDQLKAFKREVMAYRQ 85

Query: 116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLY 174
           ++   VV+   +  S   ++II     G +L   ++  K  +       I ++++KG+ Y
Sbjct: 86  TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-----SGQANTFVGTYNYMSP 229
           LH  K I+H+DLK  N+  ++ G+V ITDFG+ +I           +     G   +++P
Sbjct: 146 LH-AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 230 ERISGGK---------YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA 278
           E I             +   SD+++LG +  E    ++P+   P E          ++  
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---------IIWQ 254

Query: 279 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
           +     P+        E    +  C   E ++R +  +LM  
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  163 bits (413), Expect = 6e-47
 Identities = 47/321 (14%), Positives = 92/321 (28%), Gaps = 56/321 (17%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI------------QMNVEESARRQIAQELKINQ 114
            V+G+           + TG+ F + V             QM  E    R +       Q
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 115 SSQCPYVVVCYQSFYSNGAISII-------------------LEYMDGGSLADFLKKV-- 153
           +      +  +          +I                       +  +  + L     
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 154 --KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM- 210
             K++       +  QV++ L  LHH   ++H  L+P +++++ RG V +T F       
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 211 ASTSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQ 265
           AS               +   +           +  D W+LGL +        P +    
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD-- 320

Query: 266 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP-FLK 324
                +     E I                  + +   ++   + RL   + M  P + +
Sbjct: 321 -----AALGGSEWIFRSCKN------IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

Query: 325 MYGDLNVDLSEYFTDAGSPLA 345
           +  +L+  L  Y TD      
Sbjct: 370 LRTELSAALPLYQTDGEPTRE 390

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  162 bits (413), Expect = 6e-47
 Identities = 71/284 (25%), Positives = 126/284 (44%), Gaps = 32/284 (11%)

Query: 59  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
           ++ D  D ++ +G G+ G+V     K TG+ F  K I        +  +  E+ I     
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLH 106

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLH 176
            P ++  + +F     + +ILE++ GG L D +  +   + E  +     Q  +GL ++H
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166

Query: 177 HEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
            E  I+H D+KP N++   +    VKI DFG++  + +          T  + +PE +  
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVDR 224

Query: 235 GKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP-- 284
              G+ +D+W++G+   VLL   +G    SP         F      E ++ +       
Sbjct: 225 EPVGFYTDMWAIGVLGYVLL---SG---LSP---------FAGEDDLETLQNVKRCDWEF 269

Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
                   SPE   FI   +QKEP++RL+  + + HP+LK    
Sbjct: 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  161 bits (410), Expect = 2e-46
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 25/276 (9%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 126
           +V+G G  G V  + +K T + FALK++Q      ARR++    +    SQCP++V    
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRA---SQCPHIVRIVD 122

Query: 127 SF----YSNGAISIILEYMDGGSLAD--FLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
            +         + I++E +DGG L      +  +   E   + I + + + + YLH   +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SIN 181

Query: 181 IIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 237
           I HRD+KP NLL   +     +K+TDFG +    ++     T   T  Y++PE +   KY
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPYYVAPEVLGPEKY 240

Query: 238 GYKSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFS 293
               D+WSLG+++  L C  G   Y P     G      +   I       P+    + S
Sbjct: 241 DKSCDMWSLGVIMYILLC--G---YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295

Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 329
            E    I   ++ EP QR++  E M HP++     +
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  165 bits (418), Expect = 2e-46
 Identities = 69/308 (22%), Positives = 129/308 (41%), Gaps = 35/308 (11%)

Query: 42  QTETEAPPLIKPSDNQLNLEDI----DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN 97
               +      P   ++  + +    D  + +G G+ G+V  V  + TG  FA K +   
Sbjct: 134 NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 193

Query: 98  VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTI 156
            E   +  + +E++     + P +V  + +F  +  + +I E+M GG L + +  +   +
Sbjct: 194 HESD-KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM 252

Query: 157 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTS 214
            E+       QV KGL ++H E + +H DLKP N++   +    +K+ DFG++A +    
Sbjct: 253 SEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPK 310

Query: 215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTS 271
                  GT  + +PE   G   GY +D+WS+G+   +LL   +G    SP         
Sbjct: 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL---SG---LSP--------- 355

Query: 272 FY-----ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
           F      E +  +         +     S +   FI   +  +P  R++  + + HP+L 
Sbjct: 356 FGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415

Query: 325 MYGDLNVD 332
                  D
Sbjct: 416 PGNAPGRD 423

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  158 bits (401), Expect = 2e-46
 Identities = 70/262 (26%), Positives = 129/262 (49%), Gaps = 14/262 (5%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVC 124
             +G G+ G V++ +H+ TG   A+K++  Q         +I +E++  +  + P+++  
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 184
           YQ   +     +++EY+ GG L D++ K   + E     + +Q+L  + Y H    ++HR
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR-HMVVHR 135

Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDI 243
           DLKP N+L++     KI DFG+S +M S      T  G+ NY +PE ISG  Y G + DI
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDI 194

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
           WS G++L     G  P+   + +   T F ++   +   P         +    + +   
Sbjct: 195 WSCGVILYALLCGTLPF---DDEHVPTLFKKIRGGVFYIPE------YLNRSVATLLMHM 245

Query: 304 VQKEPQQRLSAQELMTHPFLKM 325
           +Q +P +R + +++  H + K 
Sbjct: 246 LQVDPLKRATIKDIREHEWFKQ 267

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  157 bits (398), Expect = 5e-46
 Identities = 44/266 (16%), Positives = 100/266 (37%), Gaps = 31/266 (11%)

Query: 59  NLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVIQM-NVEESARRQIAQELKINQS 115
           + + ++ +  + +   G +     K  W G    +KV+++ +      R   +E    + 
Sbjct: 8   DFKQLNFLTKLNENHSGEL----WKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRI 63

Query: 116 SQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVL 169
              P V+     C      +   ++I  +M  GSL + L       + +         + 
Sbjct: 64  FSHPNVLPVLGACQSPPAPH--PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121

Query: 170 KGLLYLH-HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 228
           +G+ +LH  E  I    L   +++I+     +I+   V     S        +    +++
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-----MYAPAWVA 176

Query: 229 PERISGGKYGY---KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP 285
           PE +           +D+WS  ++L E  T + P++        ++    M+  ++   P
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA------DLSNMEIGMKVALEGLRP 230

Query: 286 SAPSDQFSPEFCSFISACVQKEPQQR 311
           + P    SP     +  C+ ++P +R
Sbjct: 231 TIPPG-ISPHVSKLMKICMNEDPAKR 255

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  159 bits (403), Expect = 1e-45
 Identities = 69/279 (24%), Positives = 126/279 (45%), Gaps = 31/279 (11%)

Query: 62  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV 121
            +   +++G G  G V   +   TG   A K+I+    +  + ++  E+ +        +
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHANL 148

Query: 122 VVCYQSFYSNGAISIILEYMDGGSLAD-FLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 180
           +  Y +F S   I +++EY+DGG L D  + +   + E       +Q+ +G+ ++H + +
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH-QMY 207

Query: 181 IIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 238
           I+H DLKP N+L  +R    +KI DFG++        +     GT  +++PE ++     
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKLKVNFGTPEFLAPEVVNYDFVS 266

Query: 239 YKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP--PSAP 288
           + +D+WS+G+   +LL   +G    SP         F      E +  I+          
Sbjct: 267 FPTDMWSVGVIAYMLL---SG---LSP---------FLGDNDAETLNNILACRWDLEDEE 311

Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 327
               S E   FIS  + KE   R+SA E + HP+L  + 
Sbjct: 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  157 bits (399), Expect = 2e-45
 Identities = 64/319 (20%), Positives = 114/319 (35%), Gaps = 62/319 (19%)

Query: 51  IKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQ 108
              S+  L+L+++  ++++G+G  G V    +K     +  A+KV       + R+    
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAV----YKGSLDERPVAVKVF----SFANRQNFIN 54

Query: 109 ELKINQSS--QCPYVVVCY-----QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 161
           E  I +    +   +          +        +++EY   GSL  +L    T      
Sbjct: 55  EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSS 113

Query: 162 AAICEQVLKGLLYLHHEKH--------IIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 213
             +   V +GL YLH E          I HRDL   N+L+ + G   I+DFG+S  +   
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 214 --------SGQANTFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECATG-- 256
                      A + VGT  YM+PE + G            + D+++LGL+  E      
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 257 -----------QFPYSPPEQQDGWTSFYELMEAIVDQ------PPPSAPSDQFSPEFCSF 299
                      Q  +          +F ++   +  +      P     +          
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHP--TFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291

Query: 300 ISACVQKEPQQRLSAQELM 318
           I  C  ++ + RL+AQ   
Sbjct: 292 IEDCWDQDAEARLTAQXAE 310

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  158 bits (401), Expect = 2e-45
 Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 10/263 (3%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
           +K +G G+ G+ +L++ K T +  A+K I      +    + +E+  ++S + P +V   
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFK 82

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
           +   +   ++II+EY  GG L + +       E+      +Q+L G+ Y H    I HRD
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS-MQICHRD 141

Query: 186 LKPSNLLI--NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSD 242
           LK  N L+  +    +KI DFG S        Q  + VGT  Y++PE +   +Y G  +D
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIAD 200

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 302
           +WS G+ L     G +P+   E  +    + + ++ I+          + SPE C  IS 
Sbjct: 201 VWSCGVTLYVMLVGAYPF---EDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257

Query: 303 CVQKEPQQRLSAQELMTHPFLKM 325
               +P  R+S  E+ TH +   
Sbjct: 258 IFVADPATRISIPEIKTHSWFLK 280

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  155 bits (395), Expect = 3e-45
 Identities = 56/188 (29%), Positives = 84/188 (44%), Gaps = 15/188 (7%)

Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           + +  ++G  LA  L++   +      AI  Q+   L   H      HRD+KP N+L++ 
Sbjct: 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH-AAGATHRDVKPENILVSA 169

Query: 196 RGEVKITDFG-VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 254
                + DFG  SA       Q    VGT  YM+PER S     Y++DI++L  VL EC 
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229

Query: 255 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD---QFSPEFCSFISACVQKEPQQR 311
           TG  PY       G      +M A ++Q  P  PS         F + I+  + K P+ R
Sbjct: 230 TGSPPY------QGDQ--LSVMGAHINQAIPR-PSTVRPGIPVAFDAVIARGMAKNPEDR 280

Query: 312 -LSAQELM 318
            ++  +L 
Sbjct: 281 YVTCGDLS 288

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  154 bits (391), Expect = 3e-44
 Identities = 78/263 (29%), Positives = 131/263 (49%), Gaps = 15/263 (5%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVC 124
           + +G+GS G V+L  H  T Q  ALK I  Q+  +     ++ +E+   +  + P+++  
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 184
           Y    +   I +++EY  GG L D++ + K + E+      +Q++  + Y H    I+HR
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR-HKIVHR 132

Query: 185 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDI 243
           DLKP NLL++    VKI DFG+S IM +      T  G+ NY +PE I+G  Y G + D+
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDV 191

Query: 244 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
           WS G+VL     G+ P+   + +     F ++   +   P         SP   S I   
Sbjct: 192 WSCGIVLYVMLVGRLPF---DDEFIPNLFKKVNSCVYVMPD------FLSPGAQSLIRRM 242

Query: 304 VQKEPQQRLSAQELMTHPFLKMY 326
           +  +P QR++ QE+   P+  + 
Sbjct: 243 IVADPMQRITIQEIRRDPWFNVN 265

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  153 bits (388), Expect = 3e-44
 Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 21/209 (10%)

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
             +V        +    +++EY++G +L+++++    +  +       Q+L G+ +  H+
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH-AHD 129

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFG-VSAIMASTSGQANTFVGTYNYMSPERISGGKY 237
             I+HRD+KP N+LI+    +KI DFG   A+  ++  Q N  +GT  Y SPE+  G   
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 238 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSD--- 290
              +DI+S+G+VL E   G+ P+      +G T+      +I    +    P+  +D   
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPF------NGETAV-----SIAIKHIQDSVPNVTTDVRK 238

Query: 291 QFSPEFCSFISACVQKEPQQR-LSAQELM 318
                  + I    +K+   R  + QE+ 
Sbjct: 239 DIPQSLSNVILRATEKDKANRYKTIQEMK 267

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  153 bits (388), Expect = 3e-44
 Identities = 64/274 (23%), Positives = 121/274 (44%), Gaps = 28/274 (10%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKINQSSQCPYVVV 123
            ++G+GS G V+ V    T    A+K++   ++    +    + +E+++ +  +   V+ 
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 124 CYQ--SFYSNGAISIILEYMDGGS--LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
                       + +++EY   G   + D + + K  P         Q++ GL YLH  +
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHS-Q 128

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGK- 236
            I+H+D+KP NLL+   G +KI+  GV+  +   +      T  G+  +  PE  +G   
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT 188

Query: 237 Y-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD---QPPPSAPSDQF 292
           + G+K DIWS G+ L    TG +P+      +G  + Y+L E I       P        
Sbjct: 189 FSGFKVDIWSAGVTLYNITTGLYPF------EG-DNIYKLFENIGKGSYAIPGD-----C 236

Query: 293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
            P     +   ++ EP +R S +++  H + +  
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  156 bits (395), Expect = 1e-43
 Identities = 76/278 (27%), Positives = 138/278 (49%), Gaps = 14/278 (5%)

Query: 52  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQE 109
           +  D ++ +        +G G+ G V++ +H+ TG   A+K++  Q         +I +E
Sbjct: 7   QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66

Query: 110 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 169
           ++  +  + P+++  YQ   +   I +++EY+ GG L D++ K   + E+    + +Q+L
Sbjct: 67  IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 229
            G+ Y H    ++HRDLKP N+L++     KI DFG+S +M S      T  G+ NY +P
Sbjct: 127 SGVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAP 184

Query: 230 ERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           E ISG  Y G + DIWS G++L     G  P+   +     T F ++ + I   P     
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPF---DDDHVPTLFKKICDGIFYTPQ---- 237

Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
               +P   S +   +Q +P +R + +++  H + K  
Sbjct: 238 --YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  152 bits (386), Expect = 2e-43
 Identities = 46/302 (15%), Positives = 97/302 (32%), Gaps = 40/302 (13%)

Query: 48  PPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVI-QMNVEES 101
           P +   ++ QL  + +    ++G+G+   V              Q F LKV    N  E 
Sbjct: 52  PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE- 110

Query: 102 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----TI 156
                 Q ++  + S     +  Y +        ++ E    G+L + +   K      +
Sbjct: 111 -FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169

Query: 157 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-----------GEVKITDFG 205
           P+  + +   ++L  +  +H +  IIH D+KP N ++ +              + + D G
Sbjct: 170 PQGLVISFAMRMLYMIEQVH-DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228

Query: 206 VSAIMAS--TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 263
            S  M              T  +   E +S   + Y+ D + +   +     G +     
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM--KV 286

Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
           + + G      L   +      +            F    +       L + +L+     
Sbjct: 287 KNEGGECKPEGLFRRLPHLDMWN-----------EFFHVMLNIPDCHHLPSLDLLRQKLK 335

Query: 324 KM 325
           K+
Sbjct: 336 KV 337

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  149 bits (379), Expect = 8e-43
 Identities = 54/188 (28%), Positives = 95/188 (50%), Gaps = 12/188 (6%)

Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           I++EY+DG +L D +     +  +    +     + L +  H+  IIHRD+KP+N++I+ 
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF-SHQNGIIHRDVKPANIMISA 151

Query: 196 RGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 252
              VK+ DFG++  +A +     Q    +GT  Y+SPE+  G     +SD++SLG VL E
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211

Query: 253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQR 311
             TG+ P+       G +      + + + P  PSA  +  S +  + +   + K P+ R
Sbjct: 212 VLTGEPPF------TGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

Query: 312 -LSAQELM 318
             +A E+ 
Sbjct: 266 YQTAAEMR 273

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  144 bits (365), Expect = 1e-40
 Identities = 69/318 (21%), Positives = 134/318 (42%), Gaps = 34/318 (10%)

Query: 40  VSQTETEAPPLIKPSDNQLNLEDID---TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM 96
           +          +      L  + ++    + +VG+GS G+V   ++K TG+  A+K    
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE 60

Query: 97  NVEESARRQIAQ-ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 155
           + ++   ++IA  E+K+ +  +   +V   +         ++ E++D  ++ D L+    
Sbjct: 61  SDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN 119

Query: 156 -IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 214
            +  + +     Q++ G+ + H   +IIHRD+KP N+L++  G VK+ DFG +  +A+  
Sbjct: 120 GLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178

Query: 215 GQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP--------Y--- 260
              +  V T  Y +PE + G   YG   D+W++G ++ E   G+  FP        Y   
Sbjct: 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238

Query: 261 ----SPPEQQDGWTSFYELMEAI-VDQPPPSAPSD------QFSPEFCSFISACVQKEPQ 309
               +   +      F +      V  P             + S         C+  +P 
Sbjct: 239 MCLGNLIPRH--QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD 296

Query: 310 QRLSAQELMTHPFLKMYG 327
           +R    EL+ H F +M G
Sbjct: 297 KRPFCAELLHHDFFQMDG 314

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  142 bits (360), Expect = 5e-40
 Identities = 71/292 (24%), Positives = 132/292 (45%), Gaps = 31/292 (10%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ-ELKINQSSQC 118
           +E  + I  +G+GS G+V   +++ TGQ  A+K    + ++   ++IA  E+++ +  + 
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHH 177
           P +V   + F     + ++ EY D  ++   L + +  +PE  + +I  Q L+ + + H 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH- 119

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK- 236
           + + IHRD+KP N+LI     +K+ DFG + ++   S   +  V T  Y SPE + G   
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179

Query: 237 YGYKSDIWSLGLVLLECATGQ--FP--------Y-------SPPEQQDGWTSFYELMEAI 279
           YG   D+W++G V  E  +G   +P        Y           +      F       
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH--QQVFSTNQYFS 237

Query: 280 -VDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
            V  P P             S      +  C+  +P +RL+ ++L+ HP+ +
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  143 bits (362), Expect = 9e-40
 Identities = 69/322 (21%), Positives = 123/322 (38%), Gaps = 70/322 (21%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-----------NQ 114
           ++ +G G    V L +        A+K+++ +  +        E+K+             
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKED 81

Query: 115 SSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKK--VKTIPEEYLAAICEQV 168
           S    +++     F   G       ++ E + G +L   +KK   + IP  Y+  I +Q+
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINH------RGEVKITDFGVSAIMASTSGQANTFVG 222
           L GL Y+H    IIH D+KP N+L+          ++KI D G +             + 
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQ 197

Query: 223 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---LMEAI 279
           T  Y SPE + G  +G  +DIWS   ++ E  TG F +  P++   +T   +    +  +
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF-EPDEGHSYTKDDDHIAQIIEL 256

Query: 280 VDQPPPS-------------------------------------APSDQFSPEFCSFISA 302
           + + P                                         S   + E   F+S 
Sbjct: 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316

Query: 303 CVQKEPQQRLSAQELMTHPFLK 324
            +Q +P++R  A  L+ HP+LK
Sbjct: 317 MLQLDPRKRADAGGLVNHPWLK 338

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  140 bits (354), Expect = 3e-39
 Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 47/285 (16%)

Query: 59  NLEDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
            ++D     +V+G G  G V  + +K T + FALK++       ARR++    +    SQ
Sbjct: 15  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--QDCPKARREVELHWRA---SQ 69

Query: 118 CPYVVVCYQSF----YSNGAISIILEYMDGGSLAD--FLKKVKTIPEEYLAAICEQVLKG 171
           CP++V     +         + I++E +DGG L      +  +   E   + I + + + 
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMS 228
           + YLH   +I HRD+KP NLL   +     +K+TDFG                      +
Sbjct: 130 IQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------FA 167

Query: 229 PERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-- 284
            E  +G KY    D+WSLG+++  L C  G   Y P     G      +   I       
Sbjct: 168 KE-TTGEKYDKSCDMWSLGVIMYILLC--G---YPPFYSNHGLAISPGMKTRIRMGQYEF 221

Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 329
           P+    + S E    I   ++ EP QR++  E M HP++     +
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  138 bits (350), Expect = 1e-38
 Identities = 69/297 (23%), Positives = 114/297 (38%), Gaps = 47/297 (15%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE--------SARRQIA--QELKINQS 115
           +  +G G+ G V   +   +G F ALK +++            S  R++A  + L+   +
Sbjct: 14  VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE---A 70

Query: 116 SQCPYVV-----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQV 168
            + P VV                ++++ E++D   L  +L K     +P E +  +  Q 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 129

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGTYN 225
           L+GL +LH    I+HRDLKP N+L+   G VK+ DFG    +A            V T  
Sbjct: 130 LRGLDFLHA-NCIVHRDLKPENILVTSGGTVKLADFG----LARIYSYQMALTPVVVTLW 184

Query: 226 YMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWT 270
           Y +PE +    Y    D+WS+G +  E    +  F   S  +Q            +D W 
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244

Query: 271 SFYELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
               L         P                 +   +   P +R+SA   + H +L 
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  138 bits (350), Expect = 2e-38
 Identities = 80/319 (25%), Positives = 136/319 (42%), Gaps = 55/319 (17%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE----SARRQIAQELKINQS 115
           +E    +  +G+G+   V   + K T    ALK I++  EE    +A R    E+ + + 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKD 56

Query: 116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLY 174
            +   +V  +   ++  +++++ EY+D   L  +L      I    +     Q+L+GL Y
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-STSGQANTF---VGTYNYMSPE 230
            H  + ++HRDLKP NLLIN RGE+K+ DFG    +A + S    T+   V T  Y  P+
Sbjct: 116 CHR-QKVLHRDLKPQNLLINERGELKLADFG----LARAKSIPTKTYDNEVVTLWYRPPD 170

Query: 231 RISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWTSFYE 274
            + G   Y  + D+W +G +  E ATG+  FP  +  EQ            ++ W     
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230

Query: 275 LMEAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
             E      P            +   +    ++  +Q E + R+SA++ M HP       
Sbjct: 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP------- 283

Query: 329 LNVDLSEYFTDAGSPLATL 347
                  +F   G  +  L
Sbjct: 284 -------FFLSLGERIHKL 295

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  143 bits (363), Expect = 3e-38
 Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 34/215 (15%)

Query: 136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
           I++EY+ G SL     +   +P     A   ++L  L YLH    +++ DLKP N+++  
Sbjct: 161 IVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLH-SIGLVYNDLKPENIMLTE 217

Query: 196 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 255
              +K+ D G      S         GT  + +PE +  G     +DI+++G  L     
Sbjct: 218 EQ-LKLIDLGA----VSRINSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTL 271

Query: 256 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR-LSA 314
                      +G           VD  P   P  +    +   +   +  +P+QR  +A
Sbjct: 272 DLPTR------NG---------RYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTA 316

Query: 315 QELMTHPFLKMYGDLNVDLSEYFT-DAGSPLATLS 348
           +E        M   L   L E    D G P   LS
Sbjct: 317 EE--------MSAQLTGVLREVVAQDTGVPRPGLS 343

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  134 bits (340), Expect = 5e-37
 Identities = 79/297 (26%), Positives = 133/297 (44%), Gaps = 43/297 (14%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQ 114
           +E    ++ VG+G+ G+V   +    G+  ALK I+++ E+     +A R    E+ + +
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIR----EISLLK 74

Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLL 173
               P +V      +S   ++++ E+M+   L   L + KT + +  +     Q+L+G+ 
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTF---VGTYNYMSP 229
           + H    I+HRDLKP NLLIN  G +K+ DFG    +A   G    ++   V T  Y +P
Sbjct: 134 HCHQ-HRILHRDLKPQNLLINSDGALKLADFG----LARAFGIPVRSYTHEVVTLWYRAP 188

Query: 230 ERISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWTSFY 273
           + + G K Y    DIWS+G +  E  TG+  FP  +  +Q               W    
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248

Query: 274 ELMEAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
           EL                      F  E    +S  +  +P +R+SA++ M HP+ K
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  133 bits (337), Expect = 2e-36
 Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 45/295 (15%)

Query: 66  IKVVGKGSGGIVQLVQH-KWTGQFFALKVIQMNVEE-----SARRQIA--QELKINQSSQ 117
           +  +G+G+ G V   +  K  G+F ALK +++   E     S  R++A  + L+   + +
Sbjct: 16  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE---TFE 72

Query: 118 CPYVV-----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLK 170
            P VV                ++++ E++D   L  +L KV    +P E +  +  Q+L+
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 131

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGTYNYM 227
           GL +LH    ++HRDLKP N+L+   G++K+ DFG    +A            V T  Y 
Sbjct: 132 GLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFG----LARIYSFQMALTSVVVTLWYR 186

Query: 228 SPERISGGKYGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWTSF 272
           +PE +    Y    D+WS+G +  E    +  F   S  +Q            ++ W   
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246

Query: 273 YELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
             L                           +  C+   P +R+SA   ++HP+ +
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  131 bits (333), Expect = 3e-36
 Identities = 71/299 (23%), Positives = 136/299 (45%), Gaps = 46/299 (15%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQ 114
           ++  + ++ +G+G+ G V   +++ T +  ALK ++++ ++     SA R    E+ + +
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLK 56

Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLL 173
             +   +V  +   +S+  ++++ E+ D   L  +       +  E + +   Q+LKGL 
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTF---VGTYNYMSP 229
           + H  ++++HRDLKP NLLIN  GE+K+ +FG    +A   G     +   V T  Y  P
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINRNGELKLANFG----LARAFGIPVRCYSAEVVTLWYRPP 170

Query: 230 ERISGGK-YGYKSDIWSLGLVLLECATGQFPY------------------SPPEQQDGWT 270
           + + G K Y    D+WS G +  E A    P                   +P E+Q  W 
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ--WP 228

Query: 271 SFYELMEAIV--DQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
           S  +L +       P  ++  +     +      +   ++  P QR+SA+E + HP+  
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  131 bits (332), Expect = 3e-36
 Identities = 76/302 (25%), Positives = 132/302 (43%), Gaps = 45/302 (14%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQ 114
           +E    ++ +G+G+ G+V   Q+   G+ FALK I++  E+     +  R    E+ I +
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR----EISILK 55

Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLL 173
             +   +V  Y   ++   + ++ E++D   L   L   +  +      +   Q+L G+ 
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTF---VGTYNYMSP 229
           Y H  + ++HRDLKP NLLIN  GE+KI DFG    +A   G     +   + T  Y +P
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINREGELKIADFG----LARAFGIPVRKYTHEIVTLWYRAP 169

Query: 230 ERISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWTSFY 273
           + + G K Y    DIWS+G +  E   G   FP  S  +Q               W +  
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229

Query: 274 ELMEAIVDQP--PPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
           EL +   +     P                 +S  ++ +P QR++A++ + H + K   +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK---E 286

Query: 329 LN 330
            N
Sbjct: 287 NN 288

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  131 bits (333), Expect = 5e-36
 Identities = 81/299 (27%), Positives = 133/299 (44%), Gaps = 50/299 (16%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE----SARRQIAQELKINQSSQCPYV 121
           ++ +G G+   V    +K TG + ALK ++++ EE    +A R    E+ + +  +   +
Sbjct: 10  LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENI 65

Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT------IPEEYLAAICEQVLKGLLYL 175
           V  Y   ++   ++++ E+MD   L  ++           +    +     Q+L+GL + 
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTF---VGTYNYMSPER 231
           H    I+HRDLKP NLLIN RG++K+ DFG    +A   G   NTF   V T  Y +P+ 
Sbjct: 125 HE-NKILHRDLKPQNLLINKRGQLKLGDFG----LARAFGIPVNTFSSEVVTLWYRAPDV 179

Query: 232 ISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWTSFYEL 275
           + G + Y    DIWS G +L E  TG+  FP  +  EQ            +  W S  +L
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 276 MEAIVDQP--PPSAPSDQFSPEFCSFISA--------CVQKEPQQRLSAQELMTHPFLK 324
            +   +    PP        P     +           +Q  P  RLSA++ + HP+  
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  133 bits (337), Expect = 8e-36
 Identities = 82/338 (24%), Positives = 133/338 (39%), Gaps = 48/338 (14%)

Query: 35  DGVRIVSQTETEAPPLIKPSDNQLNLEDIDT----IKVVGKGSGGIVQLVQHKWTGQFFA 90
             +++    +      +  +  Q      +      KV+G GS G+V   +   +G+  A
Sbjct: 24  GSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVA 83

Query: 91  LKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDG- 143
           +K +  +     R     EL+I +      +V     FYS+G       ++++L+Y+   
Sbjct: 84  IKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET 138

Query: 144 --GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVK 200
                  + +  +T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++     +K
Sbjct: 139 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLK 197

Query: 201 ITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ- 257
           + DFG SA      G+ N  ++ +  Y +PE I G   Y    D+WS G VL E   GQ 
Sbjct: 198 LCDFG-SA-KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

Query: 258 -FPY---------------SPPEQQ-DGWTSFYELMEAIVDQPPPSAPSDQF----SPEF 296
            FP                +P  +Q       Y   E    Q      +  F     PE 
Sbjct: 256 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY--TEFKFPQIKAHPWTKVFRPRTPPEA 313

Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS 334
            +  S  ++  P  RL+  E   H F     D NV L 
Sbjct: 314 IALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 351

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  131 bits (331), Expect = 1e-35
 Identities = 68/320 (21%), Positives = 125/320 (39%), Gaps = 46/320 (14%)

Query: 41  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE 100
           +QT+      +  + +  +++    I  +G+G+ G V       T +  A+K I++  EE
Sbjct: 14  AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE 73

Query: 101 -----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 155
                +A R    E+ + +  Q   ++      + N  + +I EY +   L  ++ K   
Sbjct: 74  EGVPGTAIR----EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD 128

Query: 156 IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-----HRGEVKITDFGVSAIM 210
           +    + +   Q++ G+ + H  +  +HRDLKP NLL++         +KI DFG    +
Sbjct: 129 VSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG----L 183

Query: 211 ASTSG-QANTF---VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FPYSPP 263
           A   G     F   + T  Y  PE + G + Y    DIWS+  +  E       FP    
Sbjct: 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243

Query: 264 EQQ-------------DGWTSFYELMEAIVDQPPPSAPS------DQFSPEFCSFISACV 304
             Q               W     L +     P     +           E    ++A +
Sbjct: 244 IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAML 303

Query: 305 QKEPQQRLSAQELMTHPFLK 324
           + +P +R+SA+  + HP+  
Sbjct: 304 EMDPVKRISAKNALEHPYFS 323

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  128 bits (325), Expect = 2e-34
 Identities = 69/312 (22%), Positives = 124/312 (39%), Gaps = 55/312 (17%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
            ++ G+G+ G VQL + K TG   A+K +  +      R++ Q ++       P +V   
Sbjct: 28  ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNREL-QIMQDLAVLHHPNIVQLQ 85

Query: 126 QSFYSNGA-------ISIILEYMDGGSLADFLKKV--------KTIPEEYLAAICEQVLK 170
             FY+ G        +++++EY+        L +            P   +     Q+++
Sbjct: 86  SYFYTLGERDRRDIYLNVVMEYVP----DT-LHRCCRNYYRRQVAPPPILIKVFLFQLIR 140

Query: 171 GLLYLHHEKH-IIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANT-FVGTYNYM 227
            +  LH     + HRD+KP N+L+N   G +K+ DFG SA    +  + N  ++ +  Y 
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-SA-KKLSPSEPNVAYICSRYYR 198

Query: 228 SPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQQ-DG 268
           +PE I G + Y    DIWS+G +  E   G+  F                  P  +    
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258

Query: 269 WTSFYELMEAIVDQPPPSAPSDQF-------SPEFCSFISACVQKEPQQRLSAQELMTHP 321
               +   +  +        S+ F       + E    +SA +Q  P++R+   E + HP
Sbjct: 259 LNPSH--TDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316

Query: 322 FLKMYGDLNVDL 333
           +     D    L
Sbjct: 317 YFDELHDPATKL 328

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  126 bits (320), Expect = 6e-34
 Identities = 72/301 (23%), Positives = 127/301 (42%), Gaps = 43/301 (14%)

Query: 55  DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE--------SARRQI 106
           D +   +  + +  +G+G    V   + K T Q  A+K I++            +A R  
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-- 61

Query: 107 AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAIC 165
             E+K+ Q    P ++    +F     IS++ ++M+   L   +K     +   ++ A  
Sbjct: 62  --EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM 118

Query: 166 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN-TF---V 221
              L+GL YLH +  I+HRDLKP+NLL++  G +K+ DFG    +A + G  N  +   V
Sbjct: 119 LMTLQGLEYLH-QHWILHRDLKPNNLLLDENGVLKLADFG----LAKSFGSPNRAYTHQV 173

Query: 222 GTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------ 265
            T  Y +PE + G + YG   D+W++G +L E        P  S  +Q            
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 233

Query: 266 QDGWTSFYELMEAIVDQPPPSAP-SDQF---SPEFCSFISACVQKEPQQRLSAQELMTHP 321
           ++ W     L + +  +  P  P    F     +    I       P  R++A + +   
Sbjct: 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293

Query: 322 F 322
           +
Sbjct: 294 Y 294

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  126 bits (319), Expect = 2e-33
 Identities = 68/297 (22%), Positives = 118/297 (39%), Gaps = 31/297 (10%)

Query: 33  NKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALK 92
            +    +  ++       +      LN ED+   + +G+G+ G V   + +      A+K
Sbjct: 88  TQQP--LTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145

Query: 93  VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 148
             +  +    + +  QE +I +    P +V    VC Q       I I++E + GG    
Sbjct: 146 SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK----QPIYIVMELVQGGDFLT 201

Query: 149 FLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           FL+     +  + L  +      G+ YL   K  IHRDL   N L+  +  +KI+DFG+S
Sbjct: 202 FLRTEGARLRVKTLLQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKNVLKISDFGMS 260

Query: 208 AIMASTSGQANTFVGTYNY--MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPE 264
              A     A+  +        +PE ++ G+Y  +SD+WS G++L E  + G  PY    
Sbjct: 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY---- 316

Query: 265 QQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
                ++  +  E +        P   P           +  C   EP QR S   +
Sbjct: 317 --PNLSN-QQTREFVEKGGRLPCPELCP-----DAVFRLMEQCWAYEPGQRPSFSTI 365

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  126 bits (318), Expect = 3e-33
 Identities = 91/320 (28%), Positives = 136/320 (42%), Gaps = 50/320 (15%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
            KV+G GS G+V   +   + +  A+K +  +     R     EL+I +  + P VV   
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNR-----ELQIMRIVKHPNVVDLK 98

Query: 126 QSFYSNGA------ISIILEYMDG---GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             FYSNG       ++++LEY+      +   + K  +T+P   +     Q+L+ L Y+H
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158

Query: 177 HEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISG 234
               I HRD+KP NLL++   G +K+ DFG SA     +G+ N  ++ +  Y +PE I G
Sbjct: 159 -SIGICHRDIKPQNLLLDPPSGVLKLIDFG-SA-KILIAGEPNVSYICSRYYRAPELIFG 215

Query: 235 GK-YGYKSDIWSLGLVLLECATGQ--FPY---------------SPPEQQ-DGWTSFYEL 275
              Y    DIWS G V+ E   GQ  FP                +P  +Q       Y  
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY-- 273

Query: 276 MEAIVDQPPPSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 331
           ME    Q  P   S  F     P+    IS  ++  P  RL+A E + HPF         
Sbjct: 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333

Query: 332 DLSEYFTDAGSPLATLSNLS 351
            +       G  L  L N +
Sbjct: 334 RMP-----NGRELPPLFNWT 348

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  124 bits (313), Expect = 1e-32
 Identities = 72/359 (20%), Positives = 123/359 (34%), Gaps = 104/359 (28%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQ----CP 119
           I+ +G G    V L       +F A+KV++      E+A  +I     +  S        
Sbjct: 42  IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 120 YVVVCYQSFYSNGA----ISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLL 173
            VV     F  +G     I ++ E + G  L  ++ K   + +P   +  I +QVL+GL 
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160

Query: 174 YLHHEKHIIHRDLKPSNLLIN--------------------------------------- 194
           YLH +  IIH D+KP N+L++                                       
Sbjct: 161 YLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220

Query: 195 ----------HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 244
                      + +VKI D G +             + T  Y S E + G  Y   +DIW
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277

Query: 245 SLGLVLLECATGQFPYSPPEQQDGWTSFYEL--MEAIVDQPPP-----SAPSDQF----- 292
           S   +  E ATG + + P   ++       +  +  ++ + P         S +F     
Sbjct: 278 STACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337

Query: 293 ---------------------------SPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                                      +  F  F+   ++  P++R +A E + HP+L 
Sbjct: 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  123 bits (310), Expect = 2e-32
 Identities = 69/314 (21%), Positives = 120/314 (38%), Gaps = 60/314 (19%)

Query: 59  NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKIN 113
            +   + +  +G+G+ G V   +H+ TGQ  ALK + M  E+     +A R+I    KI 
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI----KIL 70

Query: 114 QSSQCPYVV----VCY----QSFYSNGAISIILEYMDGGSLADFLKKV-----KTIPEEY 160
           Q  +   VV    +C           G+I ++ ++ +     D L  +            
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HD-LAGLLSNVLVKFTLSE 125

Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANT 219
           +  + + +L GL Y+H    I+HRD+K +N+LI   G +K+ DFG++ A   + + Q N 
Sbjct: 126 IKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 220 F---VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FPY------------- 260
           +   V T  Y  PE + G + YG   D+W  G ++ E  T                    
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244

Query: 261 --SPPEQQDGWTSFYELMEAIVDQPPPSAPSD--------QFSPEFCSFISACVQKEPQQ 310
             S   +   W +          +                   P     I   +  +P Q
Sbjct: 245 CGSITPEV--WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302

Query: 311 RLSAQELMTHPFLK 324
           R+ + + + H F  
Sbjct: 303 RIDSDDALNHDFFW 316

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  121 bits (306), Expect = 4e-32
 Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 42/298 (14%)

Query: 52  KPSDNQLNL---EDIDTIKVVGKGSGGIVQLVQHKWTGQFF------ALKVIQMNVEESA 102
            P+   L +    +   IKV+G G+ G V   +  W  +        A+K ++      A
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTV--YKGLWIPEGEKVKIPVAIKELREATSPKA 60

Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIP 157
            ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  I 
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIG 115

Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 217
            +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   + 
Sbjct: 116 SQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 218 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE 274
           +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY      DG  +  E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY------DGIPA-SE 227

Query: 275 LMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
           +   +        PP         +    +  C   +   R   +EL+   F KM  D
Sbjct: 228 ISSILEKGERLPQPPICT-----IDVYMIMRKCWMIDADSRPKFRELIIE-FSKMARD 279

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  120 bits (304), Expect = 5e-32
 Identities = 67/297 (22%), Positives = 121/297 (40%), Gaps = 32/297 (10%)

Query: 45  TEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQL----VQHKWTGQFFALKVIQMNVEE 100
           +E  P  +          +  I+ +G+G  G V+L     +   TG+  A+K ++     
Sbjct: 5   SEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG 64

Query: 101 SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 155
           +    + +E++I ++     +V    +C +   +   I +I+E++  GSL ++L K K  
Sbjct: 65  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG--IKLIMEFLPSGSLKEYLPKNKNK 122

Query: 156 IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 215
           I  +       Q+ KG+ YL   +  +HRDL   N+L+    +VKI DFG++  + +   
Sbjct: 123 INLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181

Query: 216 QANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS 271
                        + +PE +   K+   SD+WS G+ L E  T      SP         
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241

Query: 272 FY-------ELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
                     L+  + +      PP+ P      E    +  C + +P  R S Q L
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCP-----DEVYQLMRKCWEFQPSNRTSFQNL 293

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  122 bits (307), Expect = 2e-31
 Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 35/297 (11%)

Query: 26  MDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT 85
            D D L  +     V +    A      S   LN++++  ++ +GKG  G V  +   + 
Sbjct: 158 TDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDV--MLGDYR 215

Query: 86  GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYM 141
           G   A+K I+    ++  +    E  +    +   +V    V  +     G + I+ EYM
Sbjct: 216 GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYIVTEYM 269

Query: 142 DGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
             GSL D+L+      +  + L      V + + YL    + +HRDL   N+L++     
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDNVA 328

Query: 200 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 258
           K++DFG++   +ST       V    + +PE +   K+  KSD+WS G++L E  + G+ 
Sbjct: 329 KVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 385

Query: 259 PYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
           PY             +++  +        P   P     P     +  C   +   R
Sbjct: 386 PY------PRIPL-KDVVPRVEKGYKMDAPDGCP-----PAVYDVMKNCWHLDAATR 430

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  119 bits (301), Expect = 2e-31
 Identities = 59/298 (19%), Positives = 121/298 (40%), Gaps = 45/298 (15%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS-SQCPYVVVC 124
           ++ +G+G    V    +    +   +K+++   ++  +R    E+KI ++    P ++  
Sbjct: 41  VRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITL 96

Query: 125 YQSFY--SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 182
                   +   +++ E+++     DF +  +T+ +  +     ++LK L Y H    I+
Sbjct: 97  ADIVKDPVSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIM 152

Query: 183 HRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYK 240
           HRD+KP N++I+H   ++++ D+G+ A       + N  V +  +  PE +   + Y Y 
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 211

Query: 241 SDIWSLGLVLLECATGQFPYSP-----------------PEQQDGWTSFYELMEA--IVD 281
            D+WSLG +L      + P+                    +  D +   Y +       D
Sbjct: 212 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD-YIDKYNIELDPRFND 270

Query: 282 QPP-----------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
                          S      SPE   F+   ++ + Q RL+A+E M HP+      
Sbjct: 271 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  118 bits (297), Expect = 6e-31
 Identities = 70/289 (24%), Positives = 123/289 (42%), Gaps = 34/289 (11%)

Query: 61  EDIDTIKVVGKGSGGIVQL----VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
             +  I+ +G+G  G V L      +  TG+  A+K ++ +     R    QE+ I ++ 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 117 QCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 172
              +++     C  +  ++  + +++EY+  GSL D+L +  +I    L    +Q+ +G+
Sbjct: 91  YHEHIIKYKGCCEDAGAAS--LQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGM 147

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN---YMSP 229
            YLH  +H IHRDL   N+L+++   VKI DFG++  +              +   + +P
Sbjct: 148 AYLH-AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

Query: 230 ERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT-------SFYELMEAIVD 281
           E +   K+ Y SD+WS G+ L E  T      SPP +            +   L E +  
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266

Query: 282 ----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
                 P   P      E    +  C + E   R + + L   P LK  
Sbjct: 267 GERLPRPDKCP-----AEVYHLMKNCWETEASFRPTFENL--IPILKTV 308

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  118 bits (297), Expect = 8e-31
 Identities = 69/330 (20%), Positives = 126/330 (38%), Gaps = 68/330 (20%)

Query: 52  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARR 104
            P + ++  E I   + +G+GS G+V   +    G          A+K +        R 
Sbjct: 16  VPDEWEVAREKITMSRELGQGSFGMV--YEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73

Query: 105 QIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY 160
           +   E  + +   C +VV    V  Q         +I+E M  G L  +L+ ++      
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPAMANN 129

Query: 161 ----------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 210
                     +  +  ++  G+ YL+     +HRDL   N ++     VKI DFG++  +
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188

Query: 211 ASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 257
             T          Y Y            MSPE +  G +   SD+WS G+VL E AT  +
Sbjct: 189 YETD---------Y-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238

Query: 258 FPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
            PY       G ++  +++  +++      P + P           +  C Q  P+ R S
Sbjct: 239 QPYQ------GLSNE-QVLRFVMEGGLLDKPDNCP-----DMLFELMRMCWQYNPKMRPS 286

Query: 314 AQELMTHPFLKMYGDLNVDLSEYFTDAGSP 343
             E+++    +       ++S Y+++    
Sbjct: 287 FLEIISS-IKEEMEPGFREVSFYYSEENKL 315

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  119 bits (300), Expect = 8e-31
 Identities = 65/326 (19%), Positives = 119/326 (36%), Gaps = 72/326 (22%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI------NQSSQCP 119
             ++GKGS G V     +   ++ A+K+I+ N + +   Q   E+++      + +    
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKK-AFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHH 177
           Y+V   + F     + ++ E +   +L D L+      +         +Q+   LL+L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175

Query: 178 EK-HIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
            +  IIH DLKP N+L+ +  R  +KI DFG S+       +   ++ +  Y SPE + G
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLG--QRIYQYIQSRFYRSPEVLLG 232

Query: 235 GKYGYKSDIWSLGLVLLECATGQ--FP--------------------------------- 259
             Y    D+WSLG +L+E  TG+  F                                  
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFF 292

Query: 260 -------YSPPEQQDG-----WTSFYELMEAIVDQPPPSAPSDQFSPE--------FCSF 299
                  ++  + +DG          +L   +  +                     F   
Sbjct: 293 EKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 352

Query: 300 ISACVQKEPQQRLSAQELMTHPFLKM 325
           I   +  +P+ R+     + H F K 
Sbjct: 353 ILRMLDYDPKTRIQPYYALQHSFFKK 378

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  117 bits (295), Expect = 2e-30
 Identities = 70/331 (21%), Positives = 119/331 (35%), Gaps = 51/331 (15%)

Query: 40  VSQTETEAPPLIKPSDN-QLNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQ 95
                 E P     S   ++    I   K++G G  G V   +L          A+K ++
Sbjct: 27  AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK 86

Query: 96  MNVEESARRQIAQELKINQSSQCPYVV----VCYQS--FYSNGAISIILEYMDGGSLADF 149
               E  RR    E  I      P ++    V  +           I+ EYM+ GSL  F
Sbjct: 87  AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM------IVTEYMENGSLDTF 140

Query: 150 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
           L+          L  +   V  G+ YL  +   +HRDL   N+L++     K++DFG+S 
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGMRYLS-DLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199

Query: 209 IMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPE 264
           ++      A T  G      + +PE I+   +   SD+WS G+V+ E    G+ PY    
Sbjct: 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY---- 255

Query: 265 QQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
                T+  +++ ++ +      P   P           +  C  K+  QR    ++++ 
Sbjct: 256 --WNMTN-RDVISSVEEGYRLPAPMGCP-----HALHQLMLDCWHKDRAQRPRFSQIVSV 307

Query: 321 PFLKMYGDLNVDLSEYFTDAGSPLATLSNLS 351
                       L          L   + +S
Sbjct: 308 ------------LDALIRSP-ESLRATATVS 325

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  117 bits (296), Expect = 3e-30
 Identities = 77/312 (24%), Positives = 128/312 (41%), Gaps = 45/312 (14%)

Query: 57  QLNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN 113
           +L+  +I   KVVG G  G V   +L          A+K +++   E  RR    E  I 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100

Query: 114 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQV 168
                P ++    V  +S      + I+ EYM+ GSL  FL+K         L  +   +
Sbjct: 101 GQFDHPNIIRLEGVVTKS----KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YN 225
             G+ YL  +   +HRDL   N+LIN     K++DFG+  ++      A T  G      
Sbjct: 157 ASGMKYLS-DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215

Query: 226 YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD--- 281
           + SPE I+  K+   SD+WS G+VL E  + G+ PY         ++  ++++A+ +   
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------WEMSN-QDVIKAVDEGYR 268

Query: 282 -QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 340
             PP   P           +  C QK+   R   +++++             L +   + 
Sbjct: 269 LPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSI------------LDKLIRNP 311

Query: 341 GSPLATLSNLSG 352
           GS     S  + 
Sbjct: 312 GSLKIITSAAAR 323

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  115 bits (290), Expect = 3e-30
 Identities = 60/266 (22%), Positives = 111/266 (41%), Gaps = 35/266 (13%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
            LN++++  ++ +GKG  G V  +   + G   A+K I+    ++  +    E  +    
Sbjct: 17  ALNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIK---NDATAQAFLAEASVMTQL 71

Query: 117 QCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLK 170
           +   +V    V  +     G + I+ EYM  GSL D+L+      +  + L      V +
Sbjct: 72  RHSNLVQLLGVIVEE---KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 230
            + YL    + +HRDL   N+L++     K++DFG++   +ST       V    + +PE
Sbjct: 129 AMEYLE-GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPE 184

Query: 231 RISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPP 285
            +   K+  KSD+WS G++L E  + G+ PY             +++  +        P 
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPY------PRIPL-KDVVPRVEKGYKMDAPD 237

Query: 286 SAPSDQFSPEFCSFISACVQKEPQQR 311
             P     P     +  C   +   R
Sbjct: 238 GCP-----PAVYEVMKNCWHLDAAMR 258

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  116 bits (292), Expect = 4e-30
 Identities = 72/290 (24%), Positives = 121/290 (41%), Gaps = 35/290 (12%)

Query: 61  EDIDTIKVVGKGSGGIVQL----VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
             +  I  +GKG+ G V+L         TG   A+K +Q +  +  +R   +E++I ++ 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKAL 81

Query: 117 QCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKG 171
              ++V    V Y     +  + +++EY+  G L DFL++ +  +    L     Q+ KG
Sbjct: 82  HSDFIVKYRGVSYGPGRQS--LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMS 228
           + YL   +  +HRDL   N+L+     VKI DFG++ ++                  + +
Sbjct: 140 MEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198

Query: 229 PERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY-------ELMEAIV 280
           PE +S   +  +SD+WS G+VL E  T      SP  +                L+E + 
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258

Query: 281 D----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           +      PP+ P      E    +  C    PQ R S   L   P L M 
Sbjct: 259 EGQRLPAPPACP-----AEVHELMKLCWAPSPQDRPSFSAL--GPQLDML 301

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  117 bits (294), Expect = 4e-30
 Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 49/282 (17%)

Query: 61  EDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
             +   +V+G+G  G V    L+ +       A+K +    +     Q   E  I +   
Sbjct: 89  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 148

Query: 118 CPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGL 172
            P V+    +C +S    G+  ++L YM  G L +F++        + L     QV KG+
Sbjct: 149 HPNVLSLLGICLRS---EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 205

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY------ 226
            +L   K  +HRDL   N +++ +  VK+ DFG++  M              +       
Sbjct: 206 KFLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE--------FDSVHNKTGA 256

Query: 227 ------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI 279
                 M+ E +   K+  KSD+WS G++L E  T G  PY          +F ++   +
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP------DVNTF-DITVYL 309

Query: 280 VD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           +       P   P           +  C   + + R S  EL
Sbjct: 310 LQGRRLLQPEYCP-----DPLYEVMLKCWHPKAEMRPSFSEL 346

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  116 bits (293), Expect = 4e-30
 Identities = 69/330 (20%), Positives = 124/330 (37%), Gaps = 84/330 (25%)

Query: 66  IKVVGKGS-GGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI------NQSSQC 118
           +  +G+G+ G +V+ + HK  G+  A+K+++ NV+         E+++         +  
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-NVD-RYCEAARSEIQVLEHLNTTDPNST 76

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLH 176
              V   + F  +G I I+ E + G S  DF+K+        +++  +  Q+ K + +LH
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH 135

Query: 177 HEKHIIHRDLKPSNLLINH-------------------RGEVKITDFGVSAIMASTSGQA 217
               + H DLKP N+L                        ++K+ DFG SA         
Sbjct: 136 -SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATYDDE--HH 191

Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FP-YSPPEQQDGWTSFYE 274
           +T V T +Y +PE I    +    D+WS+G +L+E   G   FP +   E          
Sbjct: 192 STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH-------LA 244

Query: 275 LMEAIVDQPPPS---------------------------------------APSDQFSPE 295
           +ME I+   P                                            D     
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304

Query: 296 FCSFISACVQKEPQQRLSAQELMTHPFLKM 325
               I   ++ +P +R++ +E + HPF  +
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPFFDL 334

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  116 bits (292), Expect = 5e-30
 Identities = 68/271 (25%), Positives = 111/271 (40%), Gaps = 34/271 (12%)

Query: 58  LNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKIN 113
           ++   +   KV+G G  G V    L       +   A+K ++    E  R     E  I 
Sbjct: 41  IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 100

Query: 114 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQV 168
                  ++    V  +       + II EYM+ G+L  FL++         L  +   +
Sbjct: 101 GQFSHHNIIRLEGVISKY----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 156

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YN 225
             G+ YL    + +HRDL   N+L+N     K++DFG+S ++        T  G      
Sbjct: 157 AAGMKYLA-NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215

Query: 226 YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD--- 281
           + +PE IS  K+   SD+WS G+V+ E  T G+ PY         ++ +E+M+AI D   
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY------WELSN-HEVMKAINDGFR 268

Query: 282 -QPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
              P   P           +  C Q+E  +R
Sbjct: 269 LPTPMDCP-----SAIYQLMMQCWQQERARR 294

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  114 bits (288), Expect = 8e-30
 Identities = 60/279 (21%), Positives = 122/279 (43%), Gaps = 38/279 (13%)

Query: 51  IKPSDNQLNLEDID-TIKVVGKGSGGIVQLVQHKWTGQFF----ALKVIQMNV-EESARR 104
           I+P +  L+ + +    K +G G+ G V+  +  +  +      A+K+++    + + + 
Sbjct: 6   IRPKEVYLDRKLLTLEDKELGSGNFGTVK--KGYYQMKKVVKTVAVKILKNEANDPALKD 63

Query: 105 QIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY 160
           ++  E  + Q    PY+V    +C        +  +++E  + G L  +L++ + + ++ 
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGICEAE-----SWMLVMEMAELGPLNKYLQQNRHVKDKN 118

Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 220
           +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S  + +        
Sbjct: 119 IIELVHQVSMGMKYL-EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177

Query: 221 VGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
                   + +PE I+  K+  KSD+WS G+++ E  + GQ PY       G     E+ 
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY------RGMKG-SEVT 230

Query: 277 EAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
             +        P   P      E    ++ C   + + R
Sbjct: 231 AMLEKGERMGCPAGCP-----REMYDLMNLCWTYDVENR 264

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  115 bits (291), Expect = 9e-30
 Identities = 65/322 (20%), Positives = 110/322 (34%), Gaps = 70/322 (21%)

Query: 66  IKVVGKGS-GGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI------NQSSQC 118
           +  +G+G+ G +V+ + H       ALK+I+ NV    R     E+ +            
Sbjct: 24  VGNLGEGTFGKVVECLDHARGKSQVALKIIR-NVG-KYREAARLEINVLKKIKEKDKENK 81

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLH 176
              V+    F  +G + I  E + G +  +FLK+   +  P  ++  +  Q+   L +LH
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140

Query: 177 HEKHIIHRDLKPSNLLINH-------------------RGEVKITDFGVSAIMASTSGQA 217
             + + H DLKP N+L  +                      +++ DFG SA         
Sbjct: 141 ENQ-LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFDHE--HH 196

Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYS-------------- 261
            T V T +Y  PE I    +    D+WS+G +L E   G   F                 
Sbjct: 197 TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 256

Query: 262 -PPEQ-----------QDGWTSFYELMEAIVDQPPPSAPSDQ-------FSPEFCSFISA 302
             P               G   + E             P             +    +  
Sbjct: 257 PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR 316

Query: 303 CVQKEPQQRLSAQELMTHPFLK 324
            ++ +P QR++  E + HPF  
Sbjct: 317 MLEFDPAQRITLAEALLHPFFA 338

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  114 bits (288), Expect = 1e-29
 Identities = 67/285 (23%), Positives = 115/285 (40%), Gaps = 38/285 (13%)

Query: 50  LIKPSDNQLNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQI 106
           +I PS   ++       +V+G+G  G V    L+ +       A+K +    +     Q 
Sbjct: 19  VIGPSSLIVHFN-----EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 73

Query: 107 AQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYL 161
             E  I +    P V+    +C +S    G+  ++L YM  G L +F++        + L
Sbjct: 74  LTEGIIMKDFSHPNVLSLLGICLRS---EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 130

Query: 162 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTF 220
                QV KG+ YL   K  +HRDL   N +++ +  VK+ DFG++  +        +  
Sbjct: 131 IGFGLQVAKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189

Query: 221 VGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 276
            G      +M+ E +   K+  KSD+WS G++L E  T G  PY          +F ++ 
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP------DVNTF-DIT 242

Query: 277 EAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
             ++       P   P           +  C   + + R S  EL
Sbjct: 243 VYLLQGRRLLQPEYCP-----DPLYEVMLKCWHPKAEMRPSFSEL 282

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  117 bits (294), Expect = 2e-29
 Identities = 67/284 (23%), Positives = 113/284 (39%), Gaps = 35/284 (12%)

Query: 42  QTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES 101
              T           ++   DI     +G G  G V     K      A+K   +  +  
Sbjct: 201 NKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTM 258

Query: 102 ARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKV--KT 155
              +  +E  + +  + P +V    VC +         II E+M  G+L D+L++   + 
Sbjct: 259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE----PPFYIITEFMTYGNLLDYLRECNRQE 314

Query: 156 IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS--- 212
           +    L  +  Q+   + YL  +K+ IHR+L   N L+     VK+ DFG+S +M     
Sbjct: 315 VSAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373

Query: 213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS 271
           T+     F     + +PE ++  K+  KSD+W+ G++L E AT G  PY       G   
Sbjct: 374 TAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------PGIDL 425

Query: 272 FYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
             ++ E +      + P   P      +    + AC Q  P  R
Sbjct: 426 -SQVYELLEKDYRMERPEGCP-----EKVYELMRACWQWNPSDR 463

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  116 bits (293), Expect = 2e-29
 Identities = 78/319 (24%), Positives = 134/319 (42%), Gaps = 48/319 (15%)

Query: 17  FSRTKSGTFMDGDLLV-----NKDGV--RIVSQTETEAPPLIKPSDN--QLNLEDIDTIK 67
           F  T    F     LV     + DG+  R+ +   T  P     + +  ++  E +    
Sbjct: 131 FYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEV 190

Query: 68  VVGKGSGGIVQLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQSSQCPYVV---- 122
            +G+G  G V      W G    A+K ++      +     QE ++ +  +   +V    
Sbjct: 191 KLGQGCFGEV--WMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKH 180
           V  +       I I+ EYM  GSL DFLK    K +    L  +  Q+  G+ Y+    +
Sbjct: 247 VVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-RMN 300

Query: 181 IIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKY 237
            +HRDL+ +N+L+      K+ DFG++ ++     T+ Q   F     + +PE    G++
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRF 358

Query: 238 GYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQF 292
             KSD+WS G++L E  T G+ PY       G  +  E+++ +        PP  P    
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYP------GMVN-REVLDQVERGYRMPCPPECP---- 407

Query: 293 SPEFCSFISACVQKEPQQR 311
                  +  C +KEP++R
Sbjct: 408 -ESLHDLMCQCWRKEPEER 425

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  115 bits (289), Expect = 2e-29
 Identities = 68/313 (21%), Positives = 110/313 (35%), Gaps = 63/313 (20%)

Query: 41  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGS-----GGIVQLVQHKWTGQFFALKVIQ 95
                           ++  ++I  I+ +G G+      G V  + +  +    A+K + 
Sbjct: 51  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 110

Query: 96  MNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLK 151
               E        E  I        +V    V  QS        I+LE M GG L  FL+
Sbjct: 111 EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLR 166

Query: 152 KVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKI 201
           + +  P +        L  +   +  G  YL  E H IHRD+   N L+   G     KI
Sbjct: 167 ETRPRPSQPSSLAMLDLLHVARDIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKI 225

Query: 202 TDFGVSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLV 249
            DFG++  +             Y Y            M PE    G +  K+D WS G++
Sbjct: 226 GDFGMARDIYRAG---------Y-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 275

Query: 250 LLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACV 304
           L E  + G  PY         ++  E++E +       PP + P           ++ C 
Sbjct: 276 LWEIFSLGYMPYP------SKSN-QEVLEFVTSGGRMDPPKNCP-----GPVYRIMTQCW 323

Query: 305 QKEPQQRLSAQEL 317
           Q +P+ R +   +
Sbjct: 324 QHQPEDRPNFAII 336

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  113 bits (285), Expect = 2e-29
 Identities = 62/275 (22%), Positives = 109/275 (39%), Gaps = 41/275 (14%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-----ALKVIQMNV--EESARRQIAQEL 110
           +  +D+  ++ +G GS G+V+  + +W          A+K ++ +V  +  A     +E+
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVR--RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 72

Query: 111 KINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAIC 165
               S     ++    V          + ++ E    GSL D L+K +       L+   
Sbjct: 73  NAMHSLDHRNLIRLYGVVLTP-----PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127

Query: 166 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT-- 223
            QV +G+ YL   K  IHRDL   NLL+  R  VKI DFG+   +               
Sbjct: 128 VQVAEGMGYLE-SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 224 -YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD 281
            + + +PE +    + + SD W  G+ L E  T GQ P+       G     +++  I  
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW------IGLNG-SQILHKIDK 239

Query: 282 Q-----PPPSAPSDQFSPEFCSFISACVQKEPQQR 311
           +      P   P      +  + +  C   +P+ R
Sbjct: 240 EGERLPRPEDCP-----QDIYNVMVQCWAHKPEDR 269

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  114 bits (287), Expect = 3e-29
 Identities = 79/321 (24%), Positives = 134/321 (41%), Gaps = 46/321 (14%)

Query: 52  KPSDNQLNL---EDIDTIKVVGKGSGGIVQLVQHKWTGQFF------ALKVIQMNVEESA 102
            P+   L +    +   IKV+G G+ G V   +  W  +        A+K ++      A
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTV--YKGLWIPEGEKVKIPVAIKELREATSPKA 60

Query: 103 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIP 157
            ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  I 
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIG 115

Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 217
            +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   + 
Sbjct: 116 SQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 218 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE 274
           +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY      DG  +  E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY------DGIPA-SE 227

Query: 275 LMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 330
           +   +        PP         +    +  C   +   R   +EL+   F KM     
Sbjct: 228 ISSILEKGERLPQPPICT-----IDVYMIMVKCWMIDADSRPKFRELIIE-FSKMA---- 277

Query: 331 VDLSEYFTDAGSPLATLSNLS 351
            D   Y    G     L + +
Sbjct: 278 RDPQRYLVIQGDERMHLPSPT 298

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  112 bits (283), Expect = 4e-29
 Identities = 57/282 (20%), Positives = 107/282 (37%), Gaps = 54/282 (19%)

Query: 61  EDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
           ED+   +++G+G  G V       HK      A+K  + +     + +   E  I ++  
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 118 CPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGL 172
            P++V    +            II+E    G L  +L++ K ++    L     Q+ K +
Sbjct: 72  HPHIVKLIGII-----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY------ 226
            YL    + +HRD+   N+L+     VK+ DFG+S  +              +Y      
Sbjct: 127 AYLE-SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----------DYYKASVT 174

Query: 227 ------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI 279
                 MSPE I+  ++   SD+W   + + E  + G+ P+          +  +++  +
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF------FWLEN-KDVIGVL 227

Query: 280 VD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
                   P   P     P   + ++ C   +P  R    EL
Sbjct: 228 EKGDRLPKPDLCP-----PVLYTLMTRCWDYDPSDRPRFTEL 264

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  115 bits (289), Expect = 5e-29
 Identities = 78/324 (24%), Positives = 127/324 (39%), Gaps = 77/324 (23%)

Query: 66  IKVVGKGS-GGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI------NQSSQC 118
           +KV+GKGS G +V+   HK   Q  ALK+++ N +    RQ A+E++I            
Sbjct: 102 LKVIGKGSFGQVVKAYDHK-VHQHVALKMVR-NEK-RFHRQAAEEIRILEHLRKQDKDNT 158

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLH 176
             V+   ++F     I +  E +   +L + +KK K        +      +L+ L  LH
Sbjct: 159 MNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217

Query: 177 HEKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTY----NYMSPE 230
             + IIH DLKP N+L+    R  +K+ DFG       +S   +  V TY     Y +PE
Sbjct: 218 KNR-IIHCDLKPENILLKQQGRSGIKVIDFG-------SSCYEHQRVYTYIQSRFYRAPE 269

Query: 231 RISGGKYGYKSDIWSLGLVLLECATGQ--FPYS---------------PP---------- 263
            I G +YG   D+WSLG +L E  TG    P                 P           
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA 329

Query: 264 ------EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS-----------------FI 300
                 +    + +   L +  V      +   +      S                 F+
Sbjct: 330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL 389

Query: 301 SACVQKEPQQRLSAQELMTHPFLK 324
             C++ +P  R++  + + HP+L+
Sbjct: 390 KQCLEWDPAVRMTPGQALRHPWLR 413

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  114 bits (286), Expect = 7e-29
 Identities = 71/329 (21%), Positives = 121/329 (36%), Gaps = 76/329 (23%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
            K +G GS GIV  V    +G+ FALK     V +  R +  +EL I +      ++   
Sbjct: 12  GKTLGTGSFGIVCEVFDIESGKRFALK----KVLQDPRYKN-RELDIMKVLDHVNIIKLV 66

Query: 126 QSFYSNGA--------------------------------------ISIILEYMDG---G 144
             FY+ G                                       +++I+EY+      
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 145 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 203
            L  F++  ++IP   ++    Q+ + + ++H    I HRD+KP NLL+N     +K+ D
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCD 185

Query: 204 FGVSAIMASTSGQANT-FVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP 259
           FG SA       + +  ++ +  Y +PE + G  +Y    D+WS+G V  E   G+  F 
Sbjct: 186 FG-SA-KKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243

Query: 260 ---Y------------SPPEQQ-DGWTSFYELMEAIVDQPPPSAPSDQFS----PEFCSF 299
                           +P ++Q       Y   E                          
Sbjct: 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHY--TEVRFPTLKAKDWRKILPEGTPSLAIDL 301

Query: 300 ISACVQKEPQQRLSAQELMTHPFLKMYGD 328
           +   ++ EP  R++  E M HPF     +
Sbjct: 302 LEQILRYEPDLRINPYEAMAHPFFDHLRN 330

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  113 bits (285), Expect = 7e-29
 Identities = 73/307 (23%), Positives = 133/307 (43%), Gaps = 48/307 (15%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVC 124
             ++G+G+ G+V    HK TG+  A+K I+  +    A R   +E+KI +  +   ++  
Sbjct: 16  KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-TLREIKILKHFKHENIITI 74

Query: 125 YQSFYSNGA-----ISIILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYLHH 177
           +     +       + II E M      D  + + T    ++++     Q L+ +  LH 
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH- 129

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM---------- 227
             ++IHRDLKPSNLLIN   ++K+ DFG++ I+  ++   +   G  + M          
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189

Query: 228 SPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQQDGW 269
           +PE + +  KY    D+WS G +L E    +  FP   Y            +P    D  
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249

Query: 270 TSFYELMEAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
                     +   P    +       + +P+    +   +  +P +R++A+E + HP+L
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

Query: 324 KMYGDLN 330
           + Y D N
Sbjct: 310 QTYHDPN 316

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  115 bits (290), Expect = 8e-29
 Identities = 72/298 (24%), Positives = 125/298 (41%), Gaps = 43/298 (14%)

Query: 33  NKDGV----RIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF 88
           + DG+      V  T       +     ++  E +     +G+G  G V      W G  
Sbjct: 235 HADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEV--WMGTWNGTT 292

Query: 89  F-ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDG 143
             A+K ++      +     QE ++ +  +   +V    V  +       I I+ EYM  
Sbjct: 293 RVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-----PIYIVTEYMSK 345

Query: 144 GSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 201
           GSL DFLK    K +    L  +  Q+  G+ Y+    + +HRDL+ +N+L+      K+
Sbjct: 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENLVCKV 404

Query: 202 TDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 257
            DFG++ ++     T+ Q   F     + +PE    G++  KSD+WS G++L E  T G+
Sbjct: 405 ADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462

Query: 258 FPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
            PY       G  +  E+++ +        PP  P           +  C +KEP++R
Sbjct: 463 VPYP------GMVN-REVLDQVERGYRMPCPPECP-----ESLHDLMCQCWRKEPEER 508

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  111 bits (280), Expect = 9e-29
 Identities = 70/292 (23%), Positives = 134/292 (45%), Gaps = 37/292 (12%)

Query: 40  VSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-ALKVIQMNV 98
           +      +   +     +++ +D+  +K +G G  G+V     KW GQ+  A+K+I+   
Sbjct: 3   LGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGS 60

Query: 99  EESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK 154
              +  +  +E K+  +     +V    VC +       I II EYM  G L ++L++++
Sbjct: 61  --MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ----RPIFIITEYMANGCLLNYLREMR 114

Query: 155 -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 213
                + L  +C+ V + + YL   K  +HRDL   N L+N +G VK++DFG+S  +   
Sbjct: 115 HRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

Query: 214 SGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 269
              ++   G+     +  PE +   K+  KSDIW+ G+++ E  + G+ PY      + +
Sbjct: 174 EYTSSV--GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY------ERF 225

Query: 270 TSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           T+  E  E I        P  A       +  + + +C  ++  +R + + L
Sbjct: 226 TN-SETAEHIAQGLRLYRPHLAS-----EKVYTIMYSCWHEKADERPTFKIL 271

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  112 bits (282), Expect = 1e-28
 Identities = 62/307 (20%), Positives = 110/307 (35%), Gaps = 55/307 (17%)

Query: 43  TETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQM-NV 98
                    K  D  ++   +   K++G+G  G V    L Q   T    A+K +++ N 
Sbjct: 16  PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75

Query: 99  EESARRQIAQELKINQSSQCPYVV----VCYQS-FYSNGAISIILEYMDGGSLADFLKKV 153
            +    +   E    +    P V+    VC +          +IL +M  G L  +L   
Sbjct: 76  SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135

Query: 154 KTIPEEY------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
           +            L      +  G+ YL   ++ +HRDL   N ++     V + DFG+S
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLS-NRNFLHRDLAARNCMLRDDMTVCVADFGLS 194

Query: 208 AIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT 255
             + S           Y Y            ++ E ++   Y  KSD+W+ G+ + E AT
Sbjct: 195 KKIYSGD---------Y-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

Query: 256 -GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQ 310
            G  PY       G  +  E+ + ++     + P          E    + +C + +P  
Sbjct: 245 RGMTPYP------GVQNH-EMYDYLLHGHRLKQPEDCL-----DELYEIMYSCWRTDPLD 292

Query: 311 RLSAQEL 317
           R +   L
Sbjct: 293 RPTFSVL 299

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  112 bits (282), Expect = 1e-28
 Identities = 67/301 (22%), Positives = 111/301 (36%), Gaps = 63/301 (20%)

Query: 53  PSDNQLNLEDIDTIKVVGKGS-----GGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA 107
               ++  ++I  I+ +G G+      G V  + +  +    A+K +     E       
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 81

Query: 108 QELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--- 160
            E  I        +V    V  Q    +    I++E M GG L  FL++ +  P +    
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQ----SLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137

Query: 161 ----LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMAST 213
               L  +   +  G  YL  E H IHRD+   N L+   G     KI DFG++  +   
Sbjct: 138 AMLDLLHVARDIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196

Query: 214 SGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           S         Y Y            M PE    G +  K+D WS G++L E  + G  PY
Sbjct: 197 S---------Y-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

Query: 261 SPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
                    ++  E++E +       PP + P           ++ C Q +P+ R +   
Sbjct: 247 P------SKSN-QEVLEFVTSGGRMDPPKNCP-----GPVYRIMTQCWQHQPEDRPNFAI 294

Query: 317 L 317
           +
Sbjct: 295 I 295

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  115 bits (290), Expect = 1e-28
 Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 36/289 (12%)

Query: 40  VSQTETEAPPLIKPSDNQLNLEDIDTIKVV-GKGSGGIV---QLVQHKWTGQFFALKVIQ 95
           V ++    P  +K     L  +++    +  G G+ G V        K      A+KV++
Sbjct: 314 VFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV-AIKVLK 372

Query: 96  MNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLK 151
              E++   ++ +E +I      PY+V    VC        A+ +++E   GG L  FL 
Sbjct: 373 QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-----QAEALMLVMEMAGGGPLHKFLV 427

Query: 152 KVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 210
             +  IP   +A +  QV  G+ YL  EK+ +HR+L   N+L+ +R   KI+DFG+S  +
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486

Query: 211 ASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 266
            +                + +PE I+  K+  +SD+WS G+ + E  + GQ PY      
Sbjct: 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY------ 540

Query: 267 DGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
                  E+M  I      + PP  P     PE  + +S C   + + R
Sbjct: 541 KKMKG-PEVMAFIEQGKRMECPPECP-----PELYALMSDCWIYKWEDR 583

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  112 bits (281), Expect = 1e-28
 Identities = 64/294 (21%), Positives = 112/294 (38%), Gaps = 58/294 (19%)

Query: 61  EDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSS 116
           +     +++GKG  G V   QL Q   +    A+K+++ ++   S   +  +E    +  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 117 QCPYVV----VCYQS--FYSNGAISIILEYMDGGSLADFLKKVK------TIPEEYLAAI 164
             P+V     V  +S          +IL +M  G L  FL   +       +P + L   
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 224
              +  G+ YL   ++ IHRDL   N ++     V + DFG+S  + S            
Sbjct: 143 MVDIACGMEYLS-SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----------- 190

Query: 225 NY-------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT 270
           +Y             ++ E ++   Y   SD+W+ G+ + E  T GQ PY+      G  
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA------GIE 244

Query: 271 SFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
           +  E+   ++     + PP         E    +  C   +P+QR S   L   
Sbjct: 245 NA-EIYNYLIGGNRLKQPPECM-----EEVYDLMYQCWSADPKQRPSFTCLRME 292

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  112 bits (283), Expect = 1e-28
 Identities = 76/334 (22%), Positives = 121/334 (36%), Gaps = 88/334 (26%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-----NQSSQCPY 120
           I+ +G G+ G V L QH    +++A+KV++ N++    R    E  I     N       
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIK-KYTRSAKIEADILKKIQNDDINNNN 97

Query: 121 VVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHE 178
           +V  +  F     + +I E + G SL + + +        E +   C ++LK L YL  +
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR-K 155

Query: 179 KHIIHRDLKPSNLLINH-------------------------RGEVKITDFGVSAIMAST 213
             + H DLKP N+L++                             +K+ DFG  A   S 
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CATFKSD 214

Query: 214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDGWTS 271
                + + T  Y +PE I    +   SD+WS G VL E  TG   F      +      
Sbjct: 215 --YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH----- 267

Query: 272 FYELMEAIVDQPPP---------------------------------------SAPSDQF 292
              +ME+I+   P                                          P  + 
Sbjct: 268 -LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326

Query: 293 S--PEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                FC F+ + +Q +P  R S  EL+ H FL+
Sbjct: 327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  110 bits (278), Expect = 2e-28
 Identities = 28/252 (11%), Positives = 62/252 (24%), Gaps = 34/252 (13%)

Query: 68  VVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCY 125
             G                +  AL  +  Q  + +   ++             P V    
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
              ++     ++ E++ GGSL +      +          + +       H    +    
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG--AIRAMQSLAAAADAAH-RAGVALSI 154

Query: 186 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWS 245
             PS + ++  G+V +                         M            + DI  
Sbjct: 155 DHPSRVRVSIDGDVVLAYPA--------------------TMPDA-------NPQDDIRG 187

Query: 246 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 305
           +G  L      ++P      + G                P+        +  +  +  VQ
Sbjct: 188 IGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP--IEPADIDRDIPFQISAVAARSVQ 245

Query: 306 KEPQQRLSAQEL 317
            +   R ++  L
Sbjct: 246 GDGGIRSASTLL 257

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  110 bits (278), Expect = 2e-28
 Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 34/282 (12%)

Query: 61  EDIDTIKVVGKGSGGIVQL----VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
             +  ++ +GKG+ G V++         TG+  A+K +Q + E    R   +E++I +S 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSL 68

Query: 117 QCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKG 171
           Q   +V    VCY +      + +I+EY+  GSL D+L+K K  I    L     Q+ KG
Sbjct: 69  QHDNIVKYKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMS 228
           + YL   K  IHRDL   N+L+ +   VKI DFG++ ++                  + +
Sbjct: 127 MEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185

Query: 229 PERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT--------SFYELMEAI 279
           PE ++  K+   SD+WS G+VL E  T  +   SPP +               + L+E +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 280 VD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
            +      P   P      E    ++ C      QR S ++L
Sbjct: 246 KNNGRLPRPDGCP-----DEIYMIMTECWNNNVNQRPSFRDL 282

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  110 bits (278), Expect = 2e-28
 Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 31/235 (13%)

Query: 90  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 145
           A+KV++   E++   ++ +E +I      PY+V    VC        A+ +++E   GG 
Sbjct: 41  AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----ALMLVMEMAGGGP 95

Query: 146 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 204
           L  FL   +  IP   +A +  QV  G+ YL  EK+ +HRDL   N+L+ +R   KI+DF
Sbjct: 96  LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRHYAKISDF 154

Query: 205 GVSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
           G+S  + +                + +PE I+  K+  +SD+WS G+ + E  + GQ PY
Sbjct: 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214

Query: 261 SPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
                        E+M  I      + PP  P     PE  + +S C   + + R
Sbjct: 215 ------KKMKG-PEVMAFIEQGKRMECPPECP-----PELYALMSDCWIYKWEDR 257

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  110 bits (277), Expect = 3e-28
 Identities = 65/286 (22%), Positives = 114/286 (39%), Gaps = 54/286 (18%)

Query: 57  QLNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN 113
           ++  E I+  + +G+G  G V     +  +      A+K  +    +S R +  QE    
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70

Query: 114 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQV 168
           +    P++V    V  ++      + II+E    G L  FL+  K ++    L     Q+
Sbjct: 71  RQFDHPHIVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY-- 226
              L YL   K  +HRD+   N+L++    VK+ DFG+S  M  +            Y  
Sbjct: 126 STALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----------TYYK 173

Query: 227 ----------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYEL 275
                     M+PE I+  ++   SD+W  G+ + E    G  P+       G  +  ++
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF------QGVKN-NDV 226

Query: 276 MEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           +  I +      PP+ P     P   S ++ C   +P +R    EL
Sbjct: 227 IGRIENGERLPMPPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 267

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 5e-28
 Identities = 78/314 (24%), Positives = 134/314 (42%), Gaps = 38/314 (12%)

Query: 33  NKDGVRIVSQTETEAPPLIKPSDNQ----LNLEDIDTIKVVGKGSGGIVQL----VQHKW 84
           + D     ++       +    +++         +  ++ +GKG+ G V++         
Sbjct: 9   HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68

Query: 85  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 140
           TG+  A+K +Q + E    R   +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 69  TGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 125

Query: 141 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 199
           +  GSL D+L+K K  I    L     Q+ KG+ YL   K  IHRDL   N+L+ +   V
Sbjct: 126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRV 184

Query: 200 KITDFGVSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT- 255
           KI DFG++ ++                  + +PE ++  K+   SD+WS G+VL E  T 
Sbjct: 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244

Query: 256 GQFPYSPPEQQDGWT--------SFYELMEAIVD----QPPPSAPSDQFSPEFCSFISAC 303
            +   SPP +               + L+E + +      P   P      E    ++ C
Sbjct: 245 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCP-----DEIYMIMTEC 299

Query: 304 VQKEPQQRLSAQEL 317
                 QR S ++L
Sbjct: 300 WNNNVNQRPSFRDL 313

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  112 bits (282), Expect = 5e-28
 Identities = 67/269 (24%), Positives = 118/269 (43%), Gaps = 39/269 (14%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQSS 116
           +  E +   K +G G  G V      +      A+K +       +      E  + ++ 
Sbjct: 185 IPRESLKLEKKLGAGQFGEV--WMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTL 240

Query: 117 QCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLK 170
           Q   +V    V  +       I II E+M  GSL DFLK  +    P   L     Q+ +
Sbjct: 241 QHDKLVKLHAVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYM 227
           G+ ++  +++ IHRDL+ +N+L++     KI DFG++ ++      A    G      + 
Sbjct: 296 GMAFIE-QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWT 352

Query: 228 SPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----Q 282
           +PE I+ G +  KSD+WS G++L+E  T G+ PY       G ++  E++ A+       
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP------GMSN-PEVIRALERGYRMP 405

Query: 283 PPPSAPSDQFSPEFCSFISACVQKEPQQR 311
            P + P      E  + +  C +  P++R
Sbjct: 406 RPENCP-----EELYNIMMRCWKNRPEER 429

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  109 bits (275), Expect = 8e-28
 Identities = 58/282 (20%), Positives = 104/282 (36%), Gaps = 49/282 (17%)

Query: 61  EDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
               + +V+GKG  G+V   + +         A+K +    E        +E  + +   
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 118 CPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGL 172
            P V+    +        G   ++L YM  G L  F++  +     + L +   QV +G+
Sbjct: 81  HPNVLALIGIMLPP---EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY------ 226
            YL  E+  +HRDL   N +++    VK+ DFG++  +             Y+       
Sbjct: 138 EYLA-EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--------YYSVQQHRHA 188

Query: 227 ------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI 279
                  + E +   ++  KSD+WS G++L E  T G  PY           F +L   +
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR------HIDPF-DLTHFL 241

Query: 280 VD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
                   P   P           +  C + +P  R + + L
Sbjct: 242 AQGRRLPQPEYCP-----DSLYQVMQQCWEADPAVRPTFRVL 278

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  109 bits (274), Expect = 9e-28
 Identities = 67/314 (21%), Positives = 121/314 (38%), Gaps = 71/314 (22%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARRQIAQE 109
           +++L  +  ++ +G+   G V   +    G          A+K ++   E   R +   E
Sbjct: 5   EISLSAVRFMEELGEDRFGKV--YKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62

Query: 110 LKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY----- 160
             +    Q P VV    V  +       +S+I  Y   G L +FL       +       
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKD----QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118

Query: 161 -----------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
                         +  Q+  G+ YL    H++H+DL   N+L+  +  VKI+D G+   
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLS-SHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177

Query: 210 MASTSGQANTFVGTYN----------YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 258
           + +           Y           +M+PE I  GK+   SDIWS G+VL E  + G  
Sbjct: 178 VYAAD--------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229

Query: 259 PYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 314
           PY       G+++  +++E I +      P   P         + +  C  + P +R   
Sbjct: 230 PYC------GYSN-QDVVEMIRNRQVLPCPDDCP-----AWVYALMIECWNEFPSRRPRF 277

Query: 315 QELMTHPFLKMYGD 328
           +++  H  L+ +G+
Sbjct: 278 KDI--HSRLRAWGN 289

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  108 bits (271), Expect = 1e-27
 Identities = 69/277 (24%), Positives = 124/277 (44%), Gaps = 37/277 (13%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQS 115
           +L  E+I  +K +G G  G+V     KW GQ+  A+K   +     +  +  QE +    
Sbjct: 4   ELKREEITLLKELGSGQFGVV--KLGKWKGQYDVAVK--MIKEGSMSEDEFFQEAQTMMK 59

Query: 116 SQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLK 170
              P +V    VC +       I I+ EY+  G L ++L+     +    L  +C  V +
Sbjct: 60  LSHPKLVKFYGVCSKE----YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCE 115

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYM 227
           G+ +L      IHRDL   N L++    VK++DFG++  +      ++   GT     + 
Sbjct: 116 GMAFLE-SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--GTKFPVKWS 172

Query: 228 SPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----Q 282
           +PE     KY  KSD+W+ G+++ E  + G+ PY      D +T+  E++  +       
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY------DLYTN-SEVVLKVSQGHRLY 225

Query: 283 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
            P  A            + +C  + P++R + Q+L++
Sbjct: 226 RPHLAS-----DTIYQIMYSCWHELPEKRPTFQQLLS 257

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  108 bits (271), Expect = 1e-27
 Identities = 66/275 (24%), Positives = 123/275 (44%), Gaps = 37/275 (13%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQS 115
            ++  ++  ++ +G G  G+V      W  +   A+K I+      +     +E ++   
Sbjct: 4   VIDPSELTFVQEIGSGQFGLV--HLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMK 59

Query: 116 SQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLK 170
              P +V    VC +       I ++ E+M+ G L+D+L+  +     E L  +C  V +
Sbjct: 60  LSHPKLVQLYGVCLEQ----APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYM 227
           G+ YL  E  +IHRDL   N L+     +K++DFG++  +      ++T  GT     + 
Sbjct: 116 GMAYLE-EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWA 172

Query: 228 SPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----Q 282
           SPE  S  +Y  KSD+WS G+++ E  + G+ PY      +  ++  E++E I       
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY------ENRSN-SEVVEDISTGFRLY 225

Query: 283 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
            P  A            ++ C ++ P+ R +   L
Sbjct: 226 KPRLAS-----THVYQIMNHCWRERPEDRPAFSRL 255

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  108 bits (273), Expect = 2e-27
 Identities = 58/269 (21%), Positives = 111/269 (41%), Gaps = 38/269 (14%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF------ALKVIQMNVEESARRQIAQELKINQ 114
            ++  +KV+G G  G V   +  W  +         +KVI+      + + +   +    
Sbjct: 13  TELRKLKVLGSGVFGTV--HKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70

Query: 115 SSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVL 169
           S    ++V    +C  S     ++ ++ +Y+  GSL D +++ +  +  + L     Q+ 
Sbjct: 71  SLDHAHIVRLLGLCPGS-----SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYM 227
           KG+ YL  E  ++HR+L   N+L+    +V++ DFGV+ ++     Q           +M
Sbjct: 126 KGMYYLE-EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184

Query: 228 SPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----Q 282
           + E I  GKY ++SD+WS G+ + E  T G  PY       G     E+ + +       
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY------AGLRL-AEVPDLLEKGERLA 237

Query: 283 PPPSAPSDQFSPEFCSFISACVQKEPQQR 311
            P          +    +  C   +   R
Sbjct: 238 QPQICT-----IDVYMVMVKCWMIDENIR 261

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  108 bits (273), Expect = 2e-27
 Identities = 72/315 (22%), Positives = 117/315 (37%), Gaps = 68/315 (21%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-------N----- 113
           +K +G G  G+V         +  A+K I +   +S +    +E+KI       N     
Sbjct: 16  LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH-ALREIKIIRRLDHDNIVKVF 74

Query: 114 --QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQV 168
                    +     S     ++ I+ EYM+     D L  V     + EE+      Q+
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LANVLEQGPLLEEHARLFMYQL 129

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANT---FVGTY 224
           L+GL Y+H   +++HRDLKP+NL IN     +KI DFG++ IM             + T 
Sbjct: 130 LRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 225 NYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQQ 266
            Y SP  + S   Y    D+W+ G +  E  TG+  F                    E  
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE-- 246

Query: 267 DGWTSFYELMEAI-------VDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLS 313
                  E  + +       +                  S E   F+   +   P  RL+
Sbjct: 247 -------EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299

Query: 314 AQELMTHPFLKMYGD 328
           A+E ++HP++ +Y  
Sbjct: 300 AEEALSHPYMSIYSF 314

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  108 bits (272), Expect = 2e-27
 Identities = 52/190 (27%), Positives = 79/190 (41%), Gaps = 25/190 (13%)

Query: 139 EYMDGGSLADFL---KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 195
            YM  GSL D L        +       I +    G+ +LH E H IHRD+K +N+L++ 
Sbjct: 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDE 168

Query: 196 RGEVKITDFGVSAIMASTSGQANT--FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 253
               KI+DFG++      +    T   VGT  YM+PE +  G+   KSDI+S G+VLLE 
Sbjct: 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEI 227

Query: 254 ATGQFPYSPPEQQD---GWTSFY----ELMEAIVDQPPPSAPS-DQFSPE----FCSFIS 301
            TG        +               + +E  +D         +           S  S
Sbjct: 228 ITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYID------KKMNDADSTSVEAMYSVAS 281

Query: 302 ACVQKEPQQR 311
            C+ ++  +R
Sbjct: 282 QCLHEKKNKR 291

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  111 bits (280), Expect = 3e-27
 Identities = 67/292 (22%), Positives = 118/292 (40%), Gaps = 40/292 (13%)

Query: 45  TEAPPLIKPSDNQ--LNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVE 99
            E      PS     +  E I+  + +G+G  G V     +  +      A+K  +    
Sbjct: 372 DEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS 431

Query: 100 ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 154
           +S R +  QE    +    P++V    V  ++      + II+E    G L  FL+  K 
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRKF 486

Query: 155 TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-- 212
           ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M    
Sbjct: 487 SLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545

Query: 213 --TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 269
              + +    +    +M+PE I+  ++   SD+W  G+ + E    G  P+       G 
Sbjct: 546 YYKASKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF------QGV 596

Query: 270 TSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
            +  +++  I +      PP+ P     P   S ++ C   +P +R    EL
Sbjct: 597 KN-NDVIGRIENGERLPMPPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 642

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  109 bits (274), Expect = 3e-27
 Identities = 77/298 (25%), Positives = 129/298 (43%), Gaps = 47/298 (15%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVV 122
              VG G+ G V     K +G+  A+K +       E  A+R   +EL + +  Q   V+
Sbjct: 29  PTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKR-AYRELLLLKHMQHENVI 86

Query: 123 VCYQSFYSNGAIS------IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLY 174
                F    ++       +++ +M      D L+K+      EE +  +  Q+LKGL Y
Sbjct: 87  GLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEKIQYLVYQMLKGLKY 141

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERI- 232
           +H    ++HRDLKP NL +N   E+KI DFG    +A  +    T +V T  Y +PE I 
Sbjct: 142 IH-SAGVVHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTRWYRAPEVIL 196

Query: 233 SGGKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWTSFYELM 276
           S   Y    DIWS+G ++ E  TG+  F                  P  +       +  
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256

Query: 277 EAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
           ++ +   P +   D      + SP+    +   ++ +  +RL+A + +THPF + + D
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  109 bits (274), Expect = 3e-27
 Identities = 78/325 (24%), Positives = 132/325 (40%), Gaps = 54/325 (16%)

Query: 47  APPLIKPSDNQLNLEDID--------TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV 98
           +PP  +    +  +             ++ VG G+ G V       TG   A+K +    
Sbjct: 3   SPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRP 61

Query: 99  ---EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS------IILEYMDGGSLADF 149
              E  A+R   +EL++ +  +   V+     F  +  +       +++ +M      D 
Sbjct: 62  FQSELFAKR-AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TDL 116

Query: 150 LKKVKTIP--EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 207
            K +K     E+ +  +  Q+LKGL Y+H    IIHRDLKP NL +N   E+KI DFG  
Sbjct: 117 GKLMKHEKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDCELKILDFG-- 173

Query: 208 AIMASTSGQANT-FVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FPYS-- 261
             +A  +    T +V T  Y +PE I +  +Y    DIWS+G ++ E  TG+  F  S  
Sbjct: 174 --LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231

Query: 262 ------------PPEQQDGWTSFYELMEAIVDQPPPSAPSD------QFSPEFCSFISAC 303
                        P  +       +  +  +   P     D        SP   + +   
Sbjct: 232 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 291

Query: 304 VQKEPQQRLSAQELMTHPFLKMYGD 328
           +  + +QR++A E + HP+ +   D
Sbjct: 292 LVLDAEQRVTAGEALAHPYFESLHD 316

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  107 bits (269), Expect = 4e-27
 Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 39/270 (14%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQS 115
           ++  E +  ++ +G G  G V      + G    A+K +       +      E  + + 
Sbjct: 9   EVPRETLKLVERLGAGQFGEV--WMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQ 64

Query: 116 SQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVL 169
            Q   +V    V      +   I II EYM+ GSL DFLK      +    L  +  Q+ 
Sbjct: 65  LQHQRLVRLYAVV-----TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNY 226
           +G+ ++  E++ IHRDL+ +N+L++     KI DFG++ ++      A    G      +
Sbjct: 120 EGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKW 176

Query: 227 MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD---- 281
            +PE I+ G +  KSD+WS G++L E  T G+ PY       G T+  E+++ +      
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY------PGMTN-PEVIQNLERGYRM 229

Query: 282 QPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
             P + P      E    +  C ++ P+ R
Sbjct: 230 VRPDNCP-----EELYQLMRLCWKERPEDR 254

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  108 bits (273), Expect = 4e-27
 Identities = 69/296 (23%), Positives = 121/296 (40%), Gaps = 42/296 (14%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES--ARRQIAQELKINQSSQCPYVVV 123
           +  VG G+ G V       TG   A+K +    +    A+R   +EL++ +  +   V+ 
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIG 92

Query: 124 CYQSFYSNGAIS------IILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYL 175
               F    ++       ++   M     AD    VK     ++++  +  Q+L+GL Y+
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 148

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SG 234
           H    IIHRDLKPSNL +N   E+KI DFG++     T+ +   +V T  Y +PE + + 
Sbjct: 149 H-SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIMLNW 204

Query: 235 GKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWTSFYELMEA 278
             Y    DIWS+G ++ E  TG+  FP +               P  +       E    
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264

Query: 279 IVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
            +         +        +P     +   +  +  +R++A + + H +   Y D
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  107 bits (269), Expect = 5e-27
 Identities = 67/275 (24%), Positives = 116/275 (42%), Gaps = 37/275 (13%)

Query: 53  PSDNQ--LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQEL 110
           P+ ++  +   DI     +G G  G V   +  W      + V  +  +     +  +E 
Sbjct: 3   PNYDKWEMERTDITMKHKLGGGQYGEV--YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 60

Query: 111 KINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAI 164
            + +  + P +V    VC +         II E+M  G+L D+L++   + +    L  +
Sbjct: 61  AVMKEIKHPNLVQLLGVCTRE----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116

Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT- 223
             Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S +M   +  A+   G  
Sbjct: 117 ATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAK 173

Query: 224 --YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIV 280
               + +PE ++  K+  KSD+W+ G++L E AT G  PY       G     ++ E + 
Sbjct: 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------PGIDL-SQVYELLE 226

Query: 281 D----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 311
                + P   P      +    + AC Q  P  R
Sbjct: 227 KDYRMERPEGCP-----EKVYELMRACWQWNPSDR 256

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  108 bits (272), Expect = 6e-27
 Identities = 76/308 (24%), Positives = 128/308 (41%), Gaps = 55/308 (17%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVV 122
           +K +G G+ GIV         +  A+K +       +  A+R   +EL + +      ++
Sbjct: 30  LKPIGSGAQGIVCAAYDAILERNVAIKKL-SRPFQNQTHAKR-AYRELVLMKCVNHKNII 87

Query: 123 VCYQSFYSNGAIS------IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLY 174
                F    ++       I++E MD    A+ L +V    +  E ++ +  Q+L G+ +
Sbjct: 88  GLLNVFTPQKSLEEFQDVYIVMELMD----AN-LCQVIQMELDHERMSYLLYQMLCGIKH 142

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           LH    IIHRDLKPSN+++     +KI DFG+ A  A TS     +V T  Y +PE I G
Sbjct: 143 LH-SAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILG 200

Query: 235 GKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWT-------- 270
             Y    DIWS+G ++ E   G   FP +               P  +            
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260

Query: 271 ----------SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
                     SF +L    V  P  S  +   + +    +S  +  +  +R+S  E + H
Sbjct: 261 VENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319

Query: 321 PFLKMYGD 328
           P++ ++ D
Sbjct: 320 PYINVWYD 327

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  108 bits (271), Expect = 6e-27
 Identities = 64/298 (21%), Positives = 120/298 (40%), Gaps = 42/298 (14%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVC 124
           +  +G+G+ G+V            A+K I     +   +R   +E+KI    +   ++  
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR-TLREIKILLRFRHENIIGI 90

Query: 125 YQSFYSNGA-----ISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLH 176
                +        + I+ + M+     D L K+   + +  +++     Q+L+GL Y+H
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLME----TD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH 145

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT---FVGTYNYMSPERI- 232
              +++HRDLKPSNLL+N   ++KI DFG++ +             +V T  Y +PE + 
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204

Query: 233 SGGKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWTSFYELM 276
           +   Y    DIWS+G +L E  + +  FP                 P Q+D         
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264

Query: 277 EAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
              +   P                +    +   +   P +R+  ++ + HP+L+ Y D
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  107 bits (269), Expect = 7e-27
 Identities = 56/196 (28%), Positives = 86/196 (43%), Gaps = 29/196 (14%)

Query: 139 EYMDGGSLADFLKKVKTIPEEYL-----AAICEQVLKGLLYLHHEK--HIIHRDLKPSNL 191
            YM  GS+A  L++ +   +  L       I     +GL YLH      IIHRD+K +N+
Sbjct: 107 PYMANGSVASCLRE-RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165

Query: 192 LINHRGEVKITDFGVSAIMASTSGQANTFV-GTYNYMSPERISGGKYGYKSDIWSLGLVL 250
           L++   E  + DFG++ +M        T V GT  +++PE +S GK   K+D++  G++L
Sbjct: 166 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 225

Query: 251 LECATGQFPY---SPPEQQDG----WTSFYELME-----AIVDQPPPSAPSDQFSPEFCS 298
           LE  TGQ  +         D     W     L++     A+VD        +    E   
Sbjct: 226 LELITGQRAFDLARLANDDDVMLLDWV--KGLLKEKKLEALVD---VDLQGNYKDEEVEQ 280

Query: 299 FI---SACVQKEPQQR 311
            I     C Q  P +R
Sbjct: 281 LIQVALLCTQSSPMER 296

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  109 bits (274), Expect = 8e-27
 Identities = 72/308 (23%), Positives = 127/308 (41%), Gaps = 55/308 (17%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES---ARRQIAQELKINQSSQCPYVV 122
           +K +G G+ GIV         +  A+K +     ++   A+R   +EL + +      ++
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKR-AYRELVLMKCVNHKNII 124

Query: 123 VCYQSFYSNGAIS------IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLY 174
                F     +       +++E MD    A+ L +V    +  E ++ +  Q+L G+ +
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMD----AN-LCQVIQMELDHERMSYLLYQMLCGIKH 179

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           LH    IIHRDLKPSN+++     +KI DFG+ A  A TS     +V T  Y +PE I G
Sbjct: 180 LH-SAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILG 237

Query: 235 GKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWT-------- 270
             Y    DIWS+G ++ E    +  FP                 P  +            
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297

Query: 271 ----------SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
                     +F +L       P  S  +   + +    +S  +  +P +R+S  + + H
Sbjct: 298 VENRPKYAGLTFPKLFPD-SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356

Query: 321 PFLKMYGD 328
           P++ ++ D
Sbjct: 357 PYINVWYD 364

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  106 bits (267), Expect = 1e-26
 Identities = 86/340 (25%), Positives = 133/340 (39%), Gaps = 75/340 (22%)

Query: 23  GTFMDGDLLVNKDGVRIVSQTET-EAPPLIKPSDN-QLNLEDIDTIKVVGKGSGGIVQLV 80
           G    G  L   +G     Q    E P     +    +   DI     +G+G+ G V   
Sbjct: 1   GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKV--F 58

Query: 81  QHKWTGQFF-------ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFY 129
             +             A+K ++    ESAR+   +E ++    Q  ++V    VC +   
Sbjct: 59  LAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-- 115

Query: 130 SNGAISIILEYMDGGSLADFLKK---------------VKTIPEEYLAAICEQVLKGLLY 174
               + ++ EYM  G L  FL+                   +    L A+  QV  G++Y
Sbjct: 116 --RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY-------- 226
           L    H +HRDL   N L+     VKI DFG+S  + ST          Y Y        
Sbjct: 174 LA-GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---------Y-YRVGGRTML 222

Query: 227 ----MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD 281
               M PE I   K+  +SD+WS G+VL E  T G+ P+         ++  E ++ I  
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY------QLSN-TEAIDCITQ 275

Query: 282 ----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
               + P + P     PE  + +  C Q+EPQQR S +++
Sbjct: 276 GRELERPRACP-----PEVYAIMRGCWQREPQQRHSIKDV 310

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  107 bits (268), Expect = 2e-26
 Identities = 57/316 (18%), Positives = 109/316 (34%), Gaps = 70/316 (22%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ----------ELKINQS 115
            + +  GS G V        G   A+K +   V +     I            E+++   
Sbjct: 27  QRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85

Query: 116 SQCPYV-----VVCYQSFYSNGAISIILEYMDGGSLADFLKKV-----KTIPEEYLAAIC 165
              P +     +  +    +   + ++ E M      D L +V       I  +++    
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TD-LAQVIHDQRIVISPQHIQYFM 140

Query: 166 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN 225
             +L GL  LH E  ++HRDL P N+L+    ++ I DF + A   +       +V    
Sbjct: 141 YHILLGLHVLH-EAGVVHRDLHPGNILLADNNDITICDFNL-AREDTADANKTHYVTHRW 198

Query: 226 YMSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQQD 267
           Y +PE +     +    D+WS G V+ E    +  F    +            +P     
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI--- 255

Query: 268 GWTSFYELMEAI--------VDQPPPSAPSDQF-------SPEFCSFISACVQKEPQQRL 312
                 E +           +     + P+  +        P     I+  ++  PQ+R+
Sbjct: 256 ------EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309

Query: 313 SAQELMTHPFLKMYGD 328
           S ++ + HP+ +   D
Sbjct: 310 STEQALRHPYFESLFD 325

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  107 bits (269), Expect = 2e-26
 Identities = 65/317 (20%), Positives = 121/317 (38%), Gaps = 68/317 (21%)

Query: 69  VGKGSGGIVQLVQHK--WTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVV--- 122
           VG+G+ G V   + K     + +ALK I+   +  SA R+I     + +  + P V+   
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREI----ALLRELKHPNVISLQ 84

Query: 123 -VCYQSFYSNGAISIILEY--------MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
            V      ++  + ++ +Y        +     +   KK   +P   + ++  Q+L G+ 
Sbjct: 85  KVFLSH--ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 174 YLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVS---AIMASTSGQANTFVGTYNY 226
           YLH    ++HRDLKP+N+L+      RG VKI D G +             +  V T+ Y
Sbjct: 143 YLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201

Query: 227 MSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP-------YSPPEQQD--------- 267
            +PE + G + Y    DIW++G +  E  T +  F         S P   D         
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261

Query: 268 ---------GWTS---FYELMEAIVDQPPPSAPSDQFSPEFCSFISA--------CVQKE 307
                              LM+        +    ++  +      +         +  +
Sbjct: 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321

Query: 308 PQQRLSAQELMTHPFLK 324
           P +R+++++ M  P+  
Sbjct: 322 PIKRITSEQAMQDPYFL 338

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  105 bits (264), Expect = 3e-26
 Identities = 57/197 (28%), Positives = 83/197 (42%), Gaps = 35/197 (17%)

Query: 139 EYMDGGSLADFLKKVKTIPEEYLA-----AICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 193
           +YM+ G+L   L     +P   ++      IC    +GL YLH  + IIHRD+K  N+L+
Sbjct: 115 KYMENGNLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINILL 172

Query: 194 NHRGEVKITDFGVSAIMASTSGQANTFV-----GTYNYMSPERISGGKYGYKSDIWSLGL 248
           +     KITDFG+S           T +     GT  Y+ PE    G+   KSD++S G+
Sbjct: 173 DENFVPKITDFGISKKGTELD---QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229

Query: 249 VLLECATGQFP--YSPPEQQDG---WTSFY---ELMEAIVDQPPPSAPS--DQFSPE--- 295
           VL E    +     S P +      W         +E IVD      P+  D+  PE   
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD------PNLADKIRPESLR 283

Query: 296 -FCSFISACVQKEPQQR 311
            F      C+    + R
Sbjct: 284 KFGDTAVKCLALSSEDR 300

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  103 bits (260), Expect = 1e-25
 Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 74/301 (24%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARRQIAQELKIN 113
            DI   + +G+G+ G V     +             A+K ++ +   +AR+   +E ++ 
Sbjct: 15  RDIVLKRELGEGAFGKV--FLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELL 71

Query: 114 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK----------------V 153
            + Q  ++V    VC         + ++ EYM  G L  FL+                  
Sbjct: 72  TNLQHEHIVKFYGVCGDG----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 154 KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 213
             +    +  I  Q+  G++YL   +H +HRDL   N L+     VKI DFG+S  + ST
Sbjct: 128 GELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186

Query: 214 SGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 260
                     Y Y            M PE I   K+  +SD+WS G++L E  T G+ P+
Sbjct: 187 D---------Y-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236

Query: 261 SPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 316
                    ++  E++E I      + P   P      E    +  C Q+EPQQRL+ +E
Sbjct: 237 F------QLSN-TEVIECITQGRVLERPRVCP-----KEVYDVMLGCWQREPQQRLNIKE 284

Query: 317 L 317
           +
Sbjct: 285 I 285

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  103 bits (260), Expect = 1e-25
 Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 57/226 (25%)

Query: 123 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--------------LAAICEQV 168
            C       G + +I EY   G L +FL++   + E                L     QV
Sbjct: 118 ACTH----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY-- 226
            +G+ +L   K+ IHRD+   N+L+ +    KI DFG++  + + S          NY  
Sbjct: 174 AQGMAFLA-SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS----------NYIV 222

Query: 227 ----------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYEL 275
                     M+PE I    Y  +SD+WS G++L E  + G  PY       G     + 
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP------GILVNSKF 276

Query: 276 MEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
            + + D      P  AP         S + AC   EP  R + Q++
Sbjct: 277 YKLVKDGYQMAQPAFAP-----KNIYSIMQACWALEPTHRPTFQQI 317

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  103 bits (258), Expect = 4e-25
 Identities = 73/326 (22%), Positives = 115/326 (35%), Gaps = 83/326 (25%)

Query: 46  EAPPLIKPSDNQ--LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQM 96
             P L+ P          +I+ ++ +G+G+ G V   Q +  G          A+K+++ 
Sbjct: 30  RMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRV--FQARAPGLLPYEPFTMVAVKMLKE 87

Query: 97  NVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK 152
                 +    +E  +      P +V    VC         + ++ EYM  G L +FL+ 
Sbjct: 88  EASADMQADFQREAALMAEFDNPNIVKLLGVCAVG----KPMCLLFEYMAYGDLNEFLRS 143

Query: 153 ------------------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 188
                                      +       I  QV  G+ YL  E+  +HRDL  
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHRDLAT 202

Query: 189 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY------------MSPERISGGK 236
            N L+     VKI DFG+S  + S           Y Y            M PE I   +
Sbjct: 203 RNCLVGENMVVKIADFGLSRNIYSAD---------Y-YKADGNDAIPIRWMPPESIFYNR 252

Query: 237 YGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQ 291
           Y  +SD+W+ G+VL E  + G  PY       G     E++  + D      P + P   
Sbjct: 253 YTTESDVWAYGVVLWEIFSYGLQPYY------GMAH-EEVIYYVRDGNILACPENCP--- 302

Query: 292 FSPEFCSFISACVQKEPQQRLSAQEL 317
              E  + +  C  K P  R S   +
Sbjct: 303 --LELYNLMRLCWSKLPADRPSFCSI 326

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  101 bits (253), Expect = 1e-24
 Identities = 71/302 (23%), Positives = 116/302 (38%), Gaps = 72/302 (23%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARRQIAQELKIN 113
           + +   K +G+G+ G V  ++    G          A+K+++     S  R +  ELKI 
Sbjct: 27  DRLKLGKPLGRGAFGQV--IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84

Query: 114 QSSQC-PYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK---------------- 152
                   VV     C +     G + +I+E+   G+L+ +L+                 
Sbjct: 85  IHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141

Query: 153 VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 212
              +  E+L     QV KG+ +L   +  IHRDL   N+L++ +  VKI DFG++  +  
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 213 TSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP 259
                       +Y            M+PE I    Y  +SD+WS G++L E  + G  P
Sbjct: 201 DP----------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

Query: 260 YSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 315
           Y       G     E    + +    + P         PE    +  C   EP QR +  
Sbjct: 251 YP------GVKIDEEFCRRLKEGTRMRAPDYTT-----PEMYQTMLDCWHGEPSQRPTFS 299

Query: 316 EL 317
           EL
Sbjct: 300 EL 301

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  100 bits (251), Expect = 2e-24
 Identities = 71/304 (23%), Positives = 116/304 (38%), Gaps = 75/304 (24%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARRQIAQELKI- 112
             +   K +G G+ G V  V+    G          A+K+++ +   + R  +  ELK+ 
Sbjct: 23  NRLSFGKTLGAGAFGKV--VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80

Query: 113 NQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK---------------- 152
           +       +V     C       G   +I EY   G L +FL++                
Sbjct: 81  SYLGNHMNIVNLLGACTI----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 153 --VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 210
                +  E L +   QV KG+ +L   K+ IHRDL   N+L+ H    KI DFG++  +
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 211 ASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 257
            + S          NY            M+PE I    Y ++SD+WS G+ L E  + G 
Sbjct: 196 KNDS----------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245

Query: 258 FPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
            PY       G     +  + I +      P  AP      E    +  C   +P +R +
Sbjct: 246 SPYP------GMPVDSKFYKMIKEGFRMLSPEHAP-----AEMYDIMKTCWDADPLKRPT 294

Query: 314 AQEL 317
            +++
Sbjct: 295 FKQI 298

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  100 bits (251), Expect = 5e-24
 Identities = 72/334 (21%), Positives = 129/334 (38%), Gaps = 77/334 (23%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKI-NQSSQCPYV 121
           +K +GKG+ GIV     + TG+  A+K I  +       A+R   +E+ I  + S    +
Sbjct: 14  VKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQR-TFREIMILTELSGHENI 71

Query: 122 VVCYQSFYSNG--AISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLH 176
           V       ++    + ++ +YM+     D L  V     +   +   +  Q++K + YLH
Sbjct: 72  VNLLNVLRADNDRDVYLVFDYME----TD-LHAVIRANILEPVHKQYVVYQLIKVIKYLH 126

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN----------- 225
               ++HRD+KPSN+L+N    VK+ DFG+S    +     N    + N           
Sbjct: 127 -SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185

Query: 226 ----------YMSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FPYS----------- 261
                     Y +PE +    KY    D+WSLG +L E   G+  FP S           
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245

Query: 262 -------------------------PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 296
                                      + +   ++  ++     +      P    + E 
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305

Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 330
              +   +Q  P +R+SA + + HPF+ ++ + N
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 64/304 (21%), Positives = 118/304 (38%), Gaps = 76/304 (25%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF---------ALKVIQMNVEESARRQIAQELK 111
           + +   K +G+G  G V  V  +  G            A+K+++ +  E     +  E++
Sbjct: 81  DKLTLGKPLGEGCFGQV--VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 138

Query: 112 INQSSQC-PYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY------ 160
           + +       ++     C Q    +G + +I+EY   G+L ++L+  +    EY      
Sbjct: 139 MMKMIGKHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194

Query: 161 ----------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 210
                     L +   Q+ +G+ YL   +  IHRDL   N+L+     +KI DFG++  +
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253

Query: 211 ASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 257
            +             Y            M+PE +    Y ++SD+WS G+++ E  T G 
Sbjct: 254 NNID----------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303

Query: 258 FPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 313
            PY       G     EL + + +      P +        E    +  C    P QR +
Sbjct: 304 SPYP------GIPV-EELFKLLKEGHRMDKPANCT-----NELYMMMRDCWHAVPSQRPT 351

Query: 314 AQEL 317
            ++L
Sbjct: 352 FKQL 355

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 68/327 (20%), Positives = 128/327 (39%), Gaps = 79/327 (24%)

Query: 61  EDIDTIKVVGKGSGGIV------QLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKIN 113
           + +   K +G+G+ G V       + + K       A+K+++ +  E     +  E+++ 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 114 QSSQC-PYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-------- 160
           +       ++     C Q    +G + +I+EY   G+L ++L+  +    EY        
Sbjct: 95  KMIGKHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 161 --------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 212
                   L +   Q+ +G+ YL   +  IHRDL   N+L+     +KI DFG++  + +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 213 TSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP 259
                        Y            M+PE +    Y ++SD+WS G+++ E  T G  P
Sbjct: 210 ID----------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

Query: 260 YSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 315
           Y       G     EL + + +      P +        E    +  C    P QR + +
Sbjct: 260 YP------GIPV-EELFKLLKEGHRMDKPANCT-----NELYMMMRDCWHAVPSQRPTFK 307

Query: 316 EL-------MTHPFLKMYGDLNVDLSE 335
           +L       +T    + Y DL+  L +
Sbjct: 308 QLVEDLDRILTLTTNEEYLDLSQPLEQ 334

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.0 bits (242), Expect = 3e-23
 Identities = 50/297 (16%), Positives = 100/297 (33%), Gaps = 66/297 (22%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--------EESARRQIAQ 108
           ++  ED+   + +G+G+   +   +          ++ +  V          +      +
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIF--KGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61

Query: 109 ELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAA 163
              +       ++V    VC           ++ E++  GSL  +LKK K  I   +   
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCG----DENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117

Query: 164 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--------VKITDFGVSAIMASTSG 215
           + +Q+   + +L  E  +IH ++   N+L+    +        +K++D G+S  +     
Sbjct: 118 VAKQLAAAMHFL-EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176

Query: 216 QANTFVGTYNY------MSPERIS-GGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD 267
                            + PE I         +D WS G  L E  + G  P S      
Sbjct: 177 ----------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS------ 220

Query: 268 GWTSFYELMEAIVD-----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 319
              S    ++   D      P           E  + I+ C+  EP  R S + ++ 
Sbjct: 221 ALDS-QRKLQFYEDRHQLPAPKA--------AELANLINNCMDYEPDHRPSFRAIIR 268

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 97.3 bits (243), Expect = 3e-23
 Identities = 67/309 (21%), Positives = 119/309 (38%), Gaps = 81/309 (26%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARRQIAQELKIN 113
           +++   K +G+G  G V  V+               A+K+++ N   S  R +  E  + 
Sbjct: 23  KNLVLGKTLGEGEFGKV--VKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVL 80

Query: 114 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--------- 160
           +    P+V+     C Q    +G + +I+EY   GSL  FL++ + +   Y         
Sbjct: 81  KQVNHPHVIKLYGACSQ----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136

Query: 161 ---------------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 205
                          L +   Q+ +G+ YL  E  ++HRDL   N+L+    ++KI+DFG
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNILVAEGRKMKISDFG 195

Query: 206 VSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLEC 253
           +S  +              +Y            M+ E +    Y  +SD+WS G++L E 
Sbjct: 196 LSRDVYEED----------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

Query: 254 AT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEP 308
            T G  PY       G      L   +      + P +        E    +  C ++EP
Sbjct: 246 VTLGGNPYP------GIPP-ERLFNLLKTGHRMERPDNCS-----EEMYRLMLQCWKQEP 293

Query: 309 QQRLSAQEL 317
            +R    ++
Sbjct: 294 DKRPVFADI 302

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 74/360 (20%), Positives = 133/360 (36%), Gaps = 87/360 (24%)

Query: 16  NFSRTKSGTFMDGDLLVN---KDGVRIVSQTETEAPPLIKPSDNQLNL--------EDID 64
           +   T++  F       +    D     ++       L   S+ +L          + + 
Sbjct: 13  DIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLV 72

Query: 65  TIKVVGKGSGGIV------QLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQSSQ 117
             K +G+G+ G V       L + K       A+K+++ +  E     +  E+++ +   
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 118 C-PYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY------------ 160
               ++     C Q    +G + +I+EY   G+L ++L+  +    EY            
Sbjct: 133 KHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 161 ----LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 216
               L +   QV +G+ YL   K  IHRDL   N+L+     +KI DFG++  +      
Sbjct: 189 SSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-- 245

Query: 217 ANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS-- 261
                    Y            M+PE +    Y ++SD+WS G++L E  T G  PY   
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297

Query: 262 PPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           P E         EL + + +      P +        E    +  C    P QR + ++L
Sbjct: 298 PVE---------ELFKLLKEGHRMDKPSNCT-----NELYMMMRDCWHAVPSQRPTFKQL 343

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 97.3 bits (243), Expect = 3e-23
 Identities = 71/310 (22%), Positives = 120/310 (38%), Gaps = 63/310 (20%)

Query: 45  TEAPPLIKPSDN-QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF----ALKVIQMNVE 99
                   P+    L+  DI    V+G+G+ G V  ++ +          A+K ++    
Sbjct: 8   HHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQV--LKARIKKDGLRMDAAIKRMKEYAS 65

Query: 100 ESARRQIAQELKI-NQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK-- 152
           +   R  A EL++  +    P ++     C       G + + +EY   G+L DFL+K  
Sbjct: 66  KDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGYLYLAIEYAPHGNLLDFLRKSR 121

Query: 153 --------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE 198
                           T+  + L      V +G+ YL  +K  IHRDL   N+L+     
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYV 180

Query: 199 VKITDFGVSAIMASTSGQANTFVGTYN------YMSPERISGGKYGYKSDIWSLGLVLLE 252
            KI DFG+S            +V          +M+ E ++   Y   SD+WS G++L E
Sbjct: 181 AKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 233

Query: 253 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKE 307
             + G  PY       G T   EL E +      + P +        E    +  C +++
Sbjct: 234 IVSLGGTPYC------GMTC-AELYEKLPQGYRLEKPLNCD-----DEVYDLMRQCWREK 281

Query: 308 PQQRLSAQEL 317
           P +R S  ++
Sbjct: 282 PYERPSFAQI 291

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 98.3 bits (245), Expect = 5e-23
 Identities = 71/346 (20%), Positives = 115/346 (33%), Gaps = 85/346 (24%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVV 122
             ++G+GS G V L   K T +  A+K +   +       +R I +E+ I    +  Y++
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDLIDCKR-ILREITILNRLKSDYII 88

Query: 123 VCYQSFYSNGAIS-----IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
             Y     +  +      I+LE  D   L    K    + EE++  I   +L G  ++H 
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIH- 146

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN------------ 225
           E  IIHRDLKP+N L+N    VK+ DFG++  + S            N            
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206

Query: 226 ----------YMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQD-----GW 269
                     Y +PE I   + Y    DIWS G +  E       +            G 
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266

Query: 270 TSFYELMEAIVDQPPPSAPSDQF----------SPEFCSFI-SACVQK------------ 306
           + F    +    +    +  DQ           + +    I    V K            
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326

Query: 307 ----------------------EPQQRLSAQELMTHPFLKMYGDLN 330
                                  P +R++  + + HP+LK      
Sbjct: 327 LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 98.7 bits (246), Expect = 5e-23
 Identities = 67/354 (18%), Positives = 110/354 (31%), Gaps = 93/354 (26%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES---ARRQIAQELKINQSSQCPYV- 121
             ++G GS G V     K   +  A+K I   V E     +R I +E+ I       +V 
Sbjct: 58  RHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKR-ILREIAILNRLNHDHVV 115

Query: 122 ----VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
               +V  +       + ++LE  D        +    + E ++  +   +L G+ Y+H 
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH- 173

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN------------ 225
              I+HRDLKP+N L+N    VK+ DFG++  +       +    +              
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233

Query: 226 ---------------YMSPERI-SGGKYGYKSDIWSLGLVLLECATGQ------------ 257
                          Y +PE I     Y    D+WS+G +  E                 
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293

Query: 258 -FP----YSPPEQQDGWTSFYELMEAIVDQ----------P------------------- 283
            FP    +     Q     F        DQ          P                   
Sbjct: 294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI 353

Query: 284 -PPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 330
            P    +D        S +    +   +   P +R++  E + HPF K      
Sbjct: 354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 96.6 bits (241), Expect = 8e-23
 Identities = 76/309 (24%), Positives = 118/309 (38%), Gaps = 80/309 (25%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARRQIAQELKI- 112
           E+++  KV+G G+ G V  +     G          A+K+++   + S R  +  ELK+ 
Sbjct: 45  ENLEFGKVLGSGAFGKV--MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 102

Query: 113 NQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK---------------- 152
            Q      +V     C      +G I +I EY   G L ++L+                 
Sbjct: 103 TQLGSHENIVNLLGACTL----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158

Query: 153 -------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 205
                  +  +  E L     QV KG+ +L   K  +HRDL   N+L+ H   VKI DFG
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLVTHGKVVKICDFG 217

Query: 206 VSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLEC 253
           ++  + S S          NY            M+PE +  G Y  KSD+WS G++L E 
Sbjct: 218 LARDIMSDS----------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

Query: 254 AT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEP 308
            + G  PY       G        + I +      P  A       E    + +C   + 
Sbjct: 268 FSLGVNPYP------GIPVDANFYKLIQNGFKMDQPFYAT-----EEIYIIMQSCWAFDS 316

Query: 309 QQRLSAQEL 317
           ++R S   L
Sbjct: 317 RKRPSFPNL 325

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 52/270 (19%), Positives = 92/270 (34%), Gaps = 38/270 (14%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
            K +G G  G++ L       +  A  V+   VE      +  ELK  Q       +  +
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVV--KVEYQENGPLFSELKFYQRVAKKDCIKKW 99

Query: 126 QSFYSNGAISIILEY----------------MD--GGSLADFLKKVKTIPEEYLAAICEQ 167
                   + I L Y                M+  G  L     +  T  +  +  +  +
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIR 159

Query: 168 VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT--DFGVSAIMASTS-------GQAN 218
           +L  L Y+H E   +H D+K +NLL+ ++   ++   D+G+S                  
Sbjct: 160 MLDVLEYIH-ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK 218

Query: 219 TFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFY 273
              GT  + S   +    G     +SD+  LG  +L    G+ P+     +     T+  
Sbjct: 219 GHNGTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKT 275

Query: 274 ELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
            L++ +       APS     E   F+   
Sbjct: 276 NLLDELPQSVLKWAPSGSSCCEIAQFLVCA 305

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 29/213 (13%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVC 124
            + +G+GS G++    +    Q  A   I+     S   Q+  E +     + C  +   
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHE 178
           Y          ++++ + G SL D L        VKT+     A   +Q+L  +  +H E
Sbjct: 72  YYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTV-----AMAAKQMLARVQSIH-E 124

Query: 179 KHIIHRDLKPSNLLI-----NHRGEVKITDFGVSA--IMASTSG-----QANTFVGTYNY 226
           K +++RD+KP N LI      +   + + DFG+        T       +     GT  Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

Query: 227 MSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           MS     G +   + D+ +LG V +    G  P
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 27/168 (16%)

Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 220
           L     QV KG+ +L   +  IHRDL   N+L++ +  VKI DFG    +A    +   +
Sbjct: 195 LICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFG----LARDIYKDPDY 249

Query: 221 VGTYN------YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY 273
           V   +      +M+PE I    Y  +SD+WS G++L E  + G  PY       G     
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDE 303

Query: 274 ELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 317
           E    + +    + P         PE    +  C   EP QR +  EL
Sbjct: 304 EFCRRLKEGTRMRAPDYTT-----PEMYQTMLDCWHGEPSQRPTFSEL 346

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 76.3 bits (188), Expect = 8e-16
 Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 27/212 (12%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
            K +G G+ G ++L ++ +T ++ A+K+  M           +  K   S     +   Y
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS--GDGIPQVY 71

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHEK 179
                    +++LE + G SL D          +KT+       I  Q++  + Y+H  K
Sbjct: 72  YFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTV-----LMIAIQLISRMEYVH-SK 124

Query: 180 HIIHRDLKPSNLLI-----NHRGEVKITDFGVSA--IMASTS-----GQANTFVGTYNYM 227
           ++I+RD+KP N LI       +  + I DF ++   I   T       +  +  GT  YM
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184

Query: 228 SPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
           S     G +   + D+ +LG + +    G  P
Sbjct: 185 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 75.9 bits (187), Expect = 9e-16
 Identities = 51/211 (24%), Positives = 83/211 (39%), Gaps = 27/211 (12%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVC 124
            + +G GS G + L      G+  A   I++   ++   Q+  E KI         +   
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVA---IKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHE 178
                      +++E + G SL D          +KT+       + +Q++  + Y+H  
Sbjct: 71  RWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTV-----LLLADQMISRIEYIH-S 123

Query: 179 KHIIHRDLKPSNLLI---NHRGEVKITDFGVSA--IMASTSG-----QANTFVGTYNYMS 228
           K+ IHRD+KP N L+        V I DFG++     A T       +     GT  Y S
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFP 259
                G +   + D+ SLG VL+    G  P
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 74.1 bits (181), Expect = 4e-15
 Identities = 48/337 (14%), Positives = 90/337 (26%), Gaps = 76/337 (22%)

Query: 51  IKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN------------- 97
             P  + L  E +   + +G+G  G V   Q        A+K+I +              
Sbjct: 10  PVPFSHCLPTEKLQRCEKIGEGVFGEV--FQTIADHTPVAIKIIAIEGPDLVNGSHQKTF 67

Query: 98  ---VEESARRQIAQELKINQSSQCPYVVVCY----------------------------- 125
              + E    +    L     ++    +                                
Sbjct: 68  EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127

Query: 126 -QSFYSNGAISIILEYMDGG-SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
              F+ +  + I+LE+  GG  L     K+ ++      +I  Q+   L          H
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAEASLRFEH 185

Query: 184 RDLKPSNLLINHRGEVKITD-----------FGVSAIMASTSGQANTFVGTYNYMSPER- 231
           RDL   N+L+      K+              G+   +   +       G   +      
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMD 245

Query: 232 --ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF---YELMEAIVDQPPPS 286
             +  G   Y+ DI+ L         G++    P     W  +     L +        +
Sbjct: 246 EDLFTGDGDYQFDIYRLMKKENNNRWGEY---HPYSNVLWLHYLTDKMLKQMTFKTKCNT 302

Query: 287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
               Q   +   F    +        SA +L+    L
Sbjct: 303 PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 47/211 (22%), Positives = 85/211 (40%), Gaps = 27/211 (12%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVC 124
            + +G GS G + L  +  T +  A+K+  +  +     Q+  E KI         +   
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKIYRILQGGTGIPNV 68

Query: 125 YQSFYSNGAISIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHE 178
                      ++++ + G SL D          +KT+       + +Q++  + ++H  
Sbjct: 69  RWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTV-----LMLADQMINRVEFVH-S 121

Query: 179 KHIIHRDLKPSNLLI---NHRGEVKITDFGVSAI-MASTSGQ------ANTFVGTYNYMS 228
           K  +HRD+KP N L+       +V I DFG++     +++ Q           GT  Y S
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181

Query: 229 PERISGGKYGYKSDIWSLGLVLLECATGQFP 259
                G +   + D+ SLG VL+    G  P
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 39/228 (17%), Positives = 79/228 (34%), Gaps = 41/228 (17%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQF--------FALKVIQMNVEESARRQIAQELKINQSSQ 117
                + + GI+       T           F+LK+      ++   ++  E    Q + 
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL------DAKDGRLFNEQNFFQRAA 100

Query: 118 CPYVVVCYQSFYSNGAISIILEY-------------MD--GGSLADFLKKV--KTIPEEY 160
            P  V  ++  YS   ++I                 +   G SL   L       + E  
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERS 160

Query: 161 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI--NHRGEVKITDFGVSAIMASTS---- 214
           +  +  ++L  L +LH E   +H ++   N+ +    + +V +  +G +     +     
Sbjct: 161 VLQVACRLLDALEFLH-ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219

Query: 215 ---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 259
              G  +   G   ++S +   G     +SD+ SLG  +L+   G  P
Sbjct: 220 YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 47/272 (17%), Positives = 96/272 (35%), Gaps = 39/272 (14%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR-RQIAQELKINQSSQCPYVVVC 124
              +G+G  G + L     + +        +   E +    +  ELK  Q +  P  +  
Sbjct: 40  GLPIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98

Query: 125 YQSFYSNGAISI------------ILEY----MD--GGSLADFLKKV-KTIPEEYLAAIC 165
           +        + +               Y    MD  G  L    +   K    + +  + 
Sbjct: 99  WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLS 158

Query: 166 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT--DFGVSAIMASTSGQA------ 217
            ++L  L Y+H E   +H D+K SNLL+N++   ++   D+G++                
Sbjct: 159 LRILDILEYIH-EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217

Query: 218 -NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY-----SPPEQQDGWTS 271
                GT  + S +  +G     + D+  LG  +++  TG  P+      P   +D    
Sbjct: 218 KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIR 277

Query: 272 FYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 303
           + E + +++D+     P+     E   ++   
Sbjct: 278 YRENIASLMDK---CFPAANAPGEIAKYMETV 306

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 39.7 bits (92), Expect = 7e-04
 Identities = 14/89 (15%), Positives = 30/89 (33%), Gaps = 7/89 (7%)

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             P              + +     D       ++  + + E  +  I   V++ +  L+
Sbjct: 133 SVPQPYTYM-----KNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLY 187

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFG 205
            E  ++H DL   N++     +V   D G
Sbjct: 188 QEAELVHADLSEYNIMYID--KVYFIDMG 214

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	353
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.25
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.9
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.71
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.7
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.52
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.35
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.28
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.26
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.05
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.95
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.74
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.7
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.48
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.37
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.28
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.23
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.13
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.03
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.98
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.8
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.41
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.32
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.92
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.86
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.4
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	84.09
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	81.95
3ls8_A	614	Phosphatidylinositol 3-kinase catalytic subunit ty	81.71

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9e-67  Score=475.09  Aligned_cols=264  Identities=28%  Similarity=0.476  Sum_probs=233.2

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ...++|++++.||+|+||+||+|+++.+|+.||||++....  .......+.+|+++++.++|||||+++++|.+++.+|
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            45688999999999999999999999999999999997542  2234567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  214 (353)
                      +|||||+||+|.+++++.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+.+.... 
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            999999999999999998999999999999999999999999 999999999999999999999999999998765332 


Q ss_pred             -CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          215 -GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       215 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                       ....+.+||+.|||||++.+..|+.++||||+||++|||++|.+||.+.+.       .++...+......  .+..+|
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~~~--~p~~~s  258 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------GLIFAKIIKLEYD--FPEKFF  258 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC--CCTTCC
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCC--CCcccC
Confidence             234567999999999999999999999999999999999999999976432       3455555554432  346789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHH------HHcCCcccccCCCCc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQE------LMTHPFLKMYGDLNV  331 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e------~l~hp~~~~~~~~~~  331 (353)
                      +++++||.+||++||++|||++|      +++||||+.....++
T Consensus       259 ~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          259 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             HHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             HHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence            99999999999999999999987      589999998765554

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.3e-66  Score=479.91  Aligned_cols=260  Identities=27%  Similarity=0.473  Sum_probs=224.7

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++... ........+.+|+++++.++|||||++++++.+++.+|+|
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            458999999999999999999999999999999999765 3445567899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      ||||+||+|.+++...  ..+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+|+.......
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            9999999999999754  457999999999999999999999 9999999999999999999999999999987654433


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ...+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+       ..+++..+.....++ .+..+|++
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~~~~~~-~~~~~s~~  252 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNLVLKIISGSFPP-VSLHYSYD  252 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCC-CCTTSCHH
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcCCCCC-CCccCCHH
Confidence            3455789999999999999999999999999999999999999998743       334555666555443 34678999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +.+||.+||++||++|||++|+++||||+...
T Consensus       253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            99999999999999999999999999998643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.9e-66  Score=476.43  Aligned_cols=258  Identities=33%  Similarity=0.607  Sum_probs=228.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +.|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+++.++|||||+++++|.+++.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            569999999999999999999999999999999975532 2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      |+||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+|+..........+.
T Consensus       153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~  230 (346)
T 4fih_A          153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  230 (346)
T ss_dssp             CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence            999999999976 679999999999999999999999 999999999999999999999999999998876655556778


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-CCCCCCCCHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSF  299 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  299 (353)
                      +||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.       .+.+..+.....+ ...+..+|+++.+|
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~~~~~~~~~~~s~~~~dl  303 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNLPPRLKNLHKVSPSLKGF  303 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence            999999999999999999999999999999999999999976432       2344444444332 23345789999999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          300 ISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      |.+||++||++|||++|+++||||+....
T Consensus       304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          304 LDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            99999999999999999999999987653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-64  Score=457.46  Aligned_cols=255  Identities=29%  Similarity=0.494  Sum_probs=221.8

Q ss_pred             cCc-eeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe----cCeE
Q 018630           61 EDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAI  134 (353)
Q Consensus        61 ~~~-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~----~~~~  134 (353)
                      ++| ++.+.||+|+||+||+|.++.++..||+|++... ........+.+|++++++++|||||+++++|.+    ++.+
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            344 6778899999999999999999999999998754 345556789999999999999999999999875    3568


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCcEEEcC-CCcEEEeecccccccc
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINH-RGEVKITDFGVSAIMA  211 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~  211 (353)
                      |+|||||+||+|.+++.+.+.+++..+..++.||+.||+|||+ +|  |+||||||+|||++. +|.+||+|||+|+...
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999999999998999999999999999999999998 78  999999999999985 7899999999997543


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      .  ....+.+||+.|||||++.+ .|+.++|||||||++|||+||..||.+.+      ....+...+.....+...+..
T Consensus       184 ~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~------~~~~~~~~i~~~~~~~~~~~~  254 (290)
T 3fpq_A          184 A--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGVKPASFDKV  254 (290)
T ss_dssp             T--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTTCCCGGGGGC
T ss_pred             C--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC------cHHHHHHHHHcCCCCCCCCcc
Confidence            2  33456799999999999875 69999999999999999999999997542      233455566666555555667


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      .++++.+||.+||+.||++|||++|+++||||+.
T Consensus       255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            8999999999999999999999999999999985

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5e-65  Score=457.25  Aligned_cols=254  Identities=31%  Similarity=0.522  Sum_probs=210.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++...  .......+.+|+++++.++||||+++++++.+++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999997552  233456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |||+ +|+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++++||+|||+|+..... ...
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~  168 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFL  168 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCCCEEEeecCCCeecCCC-Ccc
Confidence            9999 57999999998999999999999999999999999 99999999999999999999999999999875433 334


Q ss_pred             cccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .+.+||+.|||||++.+..| +.++||||+||++|+|++|..||.+.+       ...+...+......  .+..+|+++
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-------~~~~~~~i~~~~~~--~p~~~s~~~  239 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-------IPVLFKNISNGVYT--LPKFLSPGA  239 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCC--CCTTSCHHH
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCC--CCCCCCHHH
Confidence            56799999999999998876 589999999999999999999997643       23445555554432  346789999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      .+||.+||+.||++|||++|+++||||+.
T Consensus       240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          240 AGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            99999999999999999999999999974

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-65  Score=466.75  Aligned_cols=260  Identities=30%  Similarity=0.483  Sum_probs=220.6

Q ss_pred             CCccCceeeeeecccCCeEEEEEEec---cCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ...++|++++.||+|+||+||+|++.   .+++.||||+++... ......++.+|++++++++|||||++++++.+++.
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            45578999999999999999999874   467899999996542 11223467889999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+|+.....
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            99999999999999999998999999999999999999999999 99999999999999999999999999999876555


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .....+.+||+.|||||++.+..|+.++||||+||++|||+||..||.+.+.       .++...+.....+  .+..+|
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~~--~p~~~s  250 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------KETMTMILKAKLG--MPQFLS  250 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTTSC
T ss_pred             CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-------HHHHHHHHcCCCC--CCCcCC
Confidence            5556678999999999999999999999999999999999999999987433       3445555554432  346789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCH-----HHHHcCCcccccC
Q 018630          294 PEFCSFISACVQKEPQQRLSA-----QELMTHPFLKMYG  327 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~~~  327 (353)
                      +++.+||.+||++||++|||+     +|+++||||+...
T Consensus       251 ~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence            999999999999999999984     7999999998653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.5e-64  Score=478.07  Aligned_cols=258  Identities=33%  Similarity=0.596  Sum_probs=229.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +.|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+|+.+++.++|||||+++++|.+++.+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            569999999999999999999999999999999975532 2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      |+||+|.++++. +.+++..+..++.||+.||+|||+ +|||||||||+|||++.+|.+||+|||+|+..........+.
T Consensus       230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred             CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence            999999999976 579999999999999999999999 999999999999999999999999999998876655566778


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSF  299 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  299 (353)
                      +||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.       .+.+..+..... .......+|+++.+|
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~~~~~~~~~~~s~~~~dl  380 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNLPPRLKNLHKVSPSLKGF  380 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence            999999999999999999999999999999999999999976432       334444544433 233456789999999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          300 ISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      |.+||+.||++|||++|+++||||+....
T Consensus       381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          381 LDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            99999999999999999999999997653

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-63  Score=458.82  Aligned_cols=258  Identities=28%  Similarity=0.434  Sum_probs=222.3

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ..+.|++.+.||+|+||+||+|+++.+|+.||||+++....      ..+|+.+++.++|||||++++++.+++.+||||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45679999999999999999999999999999999975422      246999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCC--
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSG--  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~--  215 (353)
                      |||+||+|.+++++.+.+++..+..++.||+.||+|||+ +||+||||||+|||++.+| ++||+|||+|+.......  
T Consensus       130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            999999999999998999999999999999999999998 9999999999999999887 699999999987653321  


Q ss_pred             ---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-CCCCCC
Q 018630          216 ---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQ  291 (353)
Q Consensus       216 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  291 (353)
                         .....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+.       ...+....++ ...+..
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~~~~~~~~~~~  281 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-------CLKIASEPPPIREIPPS  281 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-------HHHHHHSCCGGGGSCTT
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHHcCCCCchhcCcc
Confidence               12335899999999999999999999999999999999999999987655432       2233333322 234568


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHH-------------HcCCcccccCCCC
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQEL-------------MTHPFLKMYGDLN  330 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~-------------l~hp~~~~~~~~~  330 (353)
                      +++++.+||.+||++||.+|||+.|+             ++|||++.+.+.+
T Consensus       282 ~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence            99999999999999999999999997             5799999887654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1e-61  Score=442.51  Aligned_cols=256  Identities=27%  Similarity=0.408  Sum_probs=206.7

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC--------
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--------  132 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~--------  132 (353)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++..........+.+|+++++.++|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            579999999999999999999999999999999987666667788999999999999999999999987544        


Q ss_pred             ----eEEEEEEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecc
Q 018630          133 ----AISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG  205 (353)
Q Consensus       133 ----~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  205 (353)
                          .+|+|||||+||+|.+++.....   .+...++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCCcEEEccCc
Confidence                47999999999999999987644   4556788999999999999999 999999999999999999999999999


Q ss_pred             ccccccccCC------------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH
Q 018630          206 VSAIMASTSG------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY  273 (353)
Q Consensus       206 ~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~  273 (353)
                      +|+.......            ...+.+||+.|||||++.+..|+.++|||||||++|||++   ||....      ...
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------~~~  234 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ERV  234 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------HHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------HHH
Confidence            9987643221            1234589999999999999999999999999999999996   775421      122


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          274 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ..+..+.....++ .....++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus       235 ~~~~~~~~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          235 RTLTDVRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHHTTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHHhcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            2333343333322 1234567789999999999999999999999999998653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-60  Score=450.24  Aligned_cols=266  Identities=26%  Similarity=0.426  Sum_probs=218.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe------cCe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS------NGA  133 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~------~~~  133 (353)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++.. .......++.+|+++++.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999999999999999999754 234456778899999999999999999998753      367


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            999999996 5899999988999999999999999999999999 99999999999999999999999999999876432


Q ss_pred             ----CCCCcccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH------------
Q 018630          214 ----SGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM------------  276 (353)
Q Consensus       214 ----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~------------  276 (353)
                          .....+.+||+.|||||++.+.. |+.++||||+||++|||++|.+||.+.+..+....+....            
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                22345679999999999988754 6999999999999999999999998755432111111100            


Q ss_pred             ----HHHhcCCCCCC------CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          277 ----EAIVDQPPPSA------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       277 ----~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                          .......++..      ....+++++.+||.+||++||++|||++|+|+||||+.+.+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                00000000000      01357899999999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.8e-60  Score=433.81  Aligned_cols=257  Identities=27%  Similarity=0.427  Sum_probs=219.0

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      .+..++|.+.+.||+|+||+||+|++.     .+++.||||+++.. ......++.+|++++++++|||||++++++.++
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            456688999999999999999999864     35789999999755 345567899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc
Q 018630          132 GAISIILEYMDGGSLADFLKKV-------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE  198 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~  198 (353)
                      +.+|+|||||++|+|.++++..             ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.+++
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCCCc
Confidence            9999999999999999999764             369999999999999999999998 99999999999999999999


Q ss_pred             EEEeeccccccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHH
Q 018630          199 VKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYEL  275 (353)
Q Consensus       199 ~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~  275 (353)
                      +||+|||+|+........  ....+||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+.       .++
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~  239 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEV  239 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence            999999999865433221  223468999999999999999999999999999999999 9999987432       345


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          276 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      ...+..+..+. .+..+|+++.+||.+||+.||++|||++|++  +|++.
T Consensus       240 ~~~i~~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          240 IECITQGRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             HHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             HHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence            55666555433 3467899999999999999999999999994  46653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1e-59  Score=430.59  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=219.9

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      ++..+++++++.||+|+||+||++...     .+++.||||+++.........++.+|+.++++++|||||++++++.++
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            466788999999999999999999853     467899999997665556667899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC
Q 018630          132 GAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH  195 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~  195 (353)
                      +.+++|||||++|+|.+++...                ..+++..+..++.|++.||+|||+ ++||||||||+|||+++
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEECC
Confidence            9999999999999999999642                358999999999999999999999 99999999999999999


Q ss_pred             CCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhH
Q 018630          196 RGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSF  272 (353)
Q Consensus       196 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~  272 (353)
                      ++++||+|||+|+.......  .....+||+.|||||++.++.|+.++|||||||++|||+| |..||.+.+.       
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------  253 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------  253 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------
Confidence            99999999999987643322  2344689999999999999999999999999999999998 8999987432       


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          273 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .++...+..+..++ .+..+|+++.+|+.+||+.||++|||+.|++++
T Consensus       254 ~~~~~~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          254 QDVVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            34556666555443 356789999999999999999999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4e-59  Score=430.47  Aligned_cols=255  Identities=29%  Similarity=0.424  Sum_probs=213.0

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS  130 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~  130 (353)
                      ..+..++|.+.+.||+|+||+||+|+.+     .+++.||||+++.. ......++.+|++++++++|||||++++++.+
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~  114 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTE  114 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            3466788999999999999999999864     46889999999754 45566789999999999999999999999999


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC
Q 018630          131 NGAISIILEYMDGGSLADFLKKV---------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH  195 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~  195 (353)
                      ++.+|+|||||++|+|.++++..               .++++..+..++.|++.||+|||+ ++|+||||||+|||++.
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECC
Confidence            99999999999999999999753               358999999999999999999998 99999999999999999


Q ss_pred             CCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhH
Q 018630          196 RGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSF  272 (353)
Q Consensus       196 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~  272 (353)
                      ++++||+|||+|+.......  .....+||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+.       
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------  266 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------  266 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------
Confidence            99999999999987643322  2234579999999999999999999999999999999999 9999987432       


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          273 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+++..+..+..+. .+..+++++.+|+.+||+.||++|||++|++++
T Consensus       267 ~~~~~~i~~g~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          267 TEAIDCITQGRELE-RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCCC-CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            34455555554433 346789999999999999999999999999874

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-59  Score=426.72  Aligned_cols=254  Identities=23%  Similarity=0.368  Sum_probs=209.3

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      .|++..+++++.+.||+|+||+||+++.+   ..||||+++.. ........+.+|+.++++++|||||++++++. ++.
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~  105 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDN  105 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCe
Confidence            46788899999999999999999999864   35999998754 34556788999999999999999999999775 456


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      +++|||||+||+|.+++... .++++..+..++.|++.||+|||+ ++||||||||+|||++.++++||+|||+|+....
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            89999999999999999764 679999999999999999999999 9999999999999999999999999999987543


Q ss_pred             cC--CCCcccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC---
Q 018630          213 TS--GQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP---  284 (353)
Q Consensus       213 ~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---  284 (353)
                      ..  ......+||+.|||||++.+   ++|+.++|||||||++|||+||..||.+.+..      ..+...+.....   
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~~p~  258 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYASPD  258 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCCCCC
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCCCC
Confidence            22  22345689999999999864   45899999999999999999999999764321      222333333322   


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ....+..+++++.+||.+||+.||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            22345678999999999999999999999998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.1e-59  Score=462.22  Aligned_cols=262  Identities=27%  Similarity=0.504  Sum_probs=225.7

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-----cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-----EESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      .+.+++|++++.||+|+||+||+|+++.+|+.||||++....     ..........++.+++.++|||||+++++|.++
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            466789999999999999999999999999999999996541     122233344557778889999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      +.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||+ +|||||||||+|||++.+|++||+|||+|+...
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999999999999999999998999999999999999999999998 999999999999999999999999999998764


Q ss_pred             ccCCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ..  ...+.+||+.|||||++.. ..|+.++|+|||||++|||++|.+||.+.+..+    ..++...+.....  ..+.
T Consensus       344 ~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~----~~~i~~~i~~~~~--~~p~  415 (689)
T 3v5w_A          344 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLTMAV--ELPD  415 (689)
T ss_dssp             SC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC----HHHHHHHHHHCCC--CCCT
T ss_pred             CC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhhcCCCC--CCCc
Confidence            32  3456799999999999975 579999999999999999999999997654332    2234444444433  2346


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCC-----HHHHHcCCcccccC
Q 018630          291 QFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  327 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~~  327 (353)
                      .+|+++++||.+||+.||++|++     ++|+++||||+...
T Consensus       416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            79999999999999999999998     79999999998754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1e-58  Score=433.44  Aligned_cols=259  Identities=23%  Similarity=0.361  Sum_probs=207.2

Q ss_pred             cCceeeeeecccCCeEEEEEEec---cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ++|++.+.||+|+||+||+|+++   .+++.||||.+.....   ..++.+|+++++.+ +||||++++++|.+++++|+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            67999999999999999999875   3578999999865432   34578899999887 69999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC-CcEEEeeccccccccccC-
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTS-  214 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~~~-  214 (353)
                      ||||++||+|.++++   .+++..++.++.||+.||+|||+ +||+||||||+|||++.+ +.+||+|||+|+...... 
T Consensus        98 vmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A           98 AMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             EEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred             EEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence            999999999999984   59999999999999999999999 999999999999999876 799999999997543221 


Q ss_pred             ---------------------------CCCcccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccC
Q 018630          215 ---------------------------GQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQ  266 (353)
Q Consensus       215 ---------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~  266 (353)
                                                 ....+.+||+.|||||++.+.. |+.++||||+||++|||++|..||...+..
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~  253 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD  253 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence                                       1123458999999999998764 899999999999999999999999654321


Q ss_pred             -CchhhHH-------------------------------HHHHHHhc--------------CCCCCCCCCCCCHHHHHHH
Q 018630          267 -DGWTSFY-------------------------------ELMEAIVD--------------QPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       267 -~~~~~~~-------------------------------~~~~~~~~--------------~~~~~~~~~~~~~~~~~li  300 (353)
                       +....+.                               ...+.+..              ..........+|+++.+||
T Consensus       254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl  333 (361)
T 4f9c_A          254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL  333 (361)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence             1000000                               00000000              0001122356899999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      .+||++||++|||++|+++||||+..
T Consensus       334 ~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          334 DKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHCcCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999853

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7e-59  Score=432.29  Aligned_cols=258  Identities=26%  Similarity=0.385  Sum_probs=220.3

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccC-----CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCC-CceEEEeeEe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESARRQIAQELKINQSSQC-PYVVVCYQSF  128 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-p~iv~~~~~~  128 (353)
                      .+++..++|++.+.||+|+||+||+|.+..+     ++.||||+++..........+.+|++++.++.| ||||+++++|
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            4567889999999999999999999997654     368999999877666677889999999999865 8999999998


Q ss_pred             Eec-CeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcE
Q 018630          129 YSN-GAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  191 (353)
Q Consensus       129 ~~~-~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NI  191 (353)
                      .++ +.+++|||||++|+|.++++..                ..+++..+..++.|++.||+|||+ ++||||||||+||
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NI  216 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI  216 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccce
Confidence            764 5789999999999999999753                348999999999999999999999 9999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCc
Q 018630          192 LINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG  268 (353)
Q Consensus       192 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~  268 (353)
                      |++.++.+||+|||+|+.......  .....+||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..  
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--  294 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--  294 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999999987643322  2234579999999999999999999999999999999998 99999875432  


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          269 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                          ..+...+..+..+ ..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       295 ----~~~~~~i~~g~~~-~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          295 ----EEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             ----HHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----HHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                1233344444333 3346789999999999999999999999999987

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.4e-57  Score=449.74  Aligned_cols=259  Identities=25%  Similarity=0.440  Sum_probs=227.8

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .+++|++++.||+|+||.||+|+++.+|+.||+|++.... ......+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            3578999999999999999999999999999999987653 344577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC--CcEEEeeccccccccccCC
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~--~~~kl~DfG~a~~~~~~~~  215 (353)
                      |||+||+|.+++.. .+.+++..+..++.||+.||+|||+ +||+||||||+|||++.+  +.+||+|||+|+.+... .
T Consensus       234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~  311 (573)
T 3uto_A          234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-Q  311 (573)
T ss_dssp             ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-S
T ss_pred             eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-C
Confidence            99999999999864 4679999999999999999999999 999999999999999854  89999999999876533 3


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCCCCCCC
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFS  293 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  293 (353)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.       .+.+..+.....  +......+|
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s  384 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWNMDDSAFSGIS  384 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCCCCCSGGGTTSC
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHhCCCCCCcccccCCC
Confidence            34567899999999999999999999999999999999999999987543       344555554432  233346789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +++++||.+||+.||++|||+.|+++||||+...
T Consensus       385 ~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          385 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            9999999999999999999999999999999754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-54  Score=401.18  Aligned_cols=261  Identities=26%  Similarity=0.479  Sum_probs=229.6

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      +...++|++++.||+|+||.||+|.+..+|+.||||++... ........+.+|+++++.++||||+++++++..++.+|
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            44568999999999999999999999999999999998755 34455677899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||+++++|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++...... .
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~  168 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-G  168 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-C
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-C
Confidence            999999999999999988899999999999999999999998 99999999999999999999999999999765433 3


Q ss_pred             CCcccccCCcccCcceecCCCCC-ccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          216 QANTFVGTYNYMSPERISGGKYG-YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      .....+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+       ..+....+......  .+..+++
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~--~p~~~s~  239 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKELRERVLRGKYR--IPFYMST  239 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCC--CCTTSCH
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCC--CCCCCCH
Confidence            34567899999999999988775 89999999999999999999998743       23444455544332  2356899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      ++.+||.+||+.||.+|||++|+++||||+...+
T Consensus       240 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            9999999999999999999999999999987543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-54  Score=403.34  Aligned_cols=259  Identities=31%  Similarity=0.573  Sum_probs=228.1

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      +..++|++++.||+|+||.||+|+++.+|+.||+|+++...  .......+.+|+.+++.++||||+++++++...+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            45689999999999999999999999999999999997542  2233467889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+++.......
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            999999999999999988899999999999999999999998 9999999999999999999999999999986544444


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .....+||+.|+|||++.+..++.++|+|||||++|||++|..||...+.       ......+.....  ..+..++++
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~--~~p~~~s~~  231 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEI--RFPRTLSPE  231 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--CCCTTSCHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHH
Confidence            55667899999999999999999999999999999999999999976432       233344444332  234578999


Q ss_pred             HHHHHHHhhhhCcCCCC-----CHHHHHcCCccccc
Q 018630          296 FCSFISACVQKEPQQRL-----SAQELMTHPFLKMY  326 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  326 (353)
                      +.+||.+||+.||++||     +++|+++||||+..
T Consensus       232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            99999999999999999     99999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.7e-55  Score=409.22  Aligned_cols=262  Identities=28%  Similarity=0.535  Sum_probs=221.2

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEec
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSN  131 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~  131 (353)
                      ...+..++|++++.||+|+||.||+|+++.+++.||||+++...  .......+.+|..+++.+ +||||+++++++.+.
T Consensus        17 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~   96 (353)
T 3txo_A           17 SNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP   96 (353)
T ss_dssp             ------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             cCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence            34567789999999999999999999999999999999997542  223346678899999887 799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      +.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+++...
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999999999988999999999999999999999998 999999999999999999999999999998655


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      .........+||+.|+|||++.+..++.++|+|||||++|||++|..||...+.       .+....+......  .+..
T Consensus       176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~  246 (353)
T 3txo_A          176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDEVV--YPTW  246 (353)
T ss_dssp             C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTT
T ss_pred             cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCC--CCCC
Confidence            444455667899999999999988899999999999999999999999987543       3444555554432  2456


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCH------HHHHcCCccccc
Q 018630          292 FSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMY  326 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~------~e~l~hp~~~~~  326 (353)
                      +++++.+||.+||+.||.+||++      +|+++||||+..
T Consensus       247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            89999999999999999999999      899999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.1e-55  Score=413.54  Aligned_cols=268  Identities=28%  Similarity=0.543  Sum_probs=226.8

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecC
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNG  132 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~  132 (353)
                      ..+..++|++++.||+|+||.||+|+++.+++.||+|+++...  .......+.+|..++.++ +||||+++++++.+++
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            3567789999999999999999999999999999999997652  233345677888888775 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+++....
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            999999999999999999988899999999999999999999998 9999999999999999999999999999986544


Q ss_pred             cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC--chhhHHHHHHHHhcCCCCCCCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD--GWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ......+.+||+.|+|||++.+..++.++|+|||||++|||++|..||......+  .......+.+.+......  .+.
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p~  283 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPR  283 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--CCT
T ss_pred             CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--CCC
Confidence            4455667799999999999999999999999999999999999999996543221  111223344444444332  345


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCH------HHHHcCCccccc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMY  326 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~------~e~l~hp~~~~~  326 (353)
                      .+++++.+||.+||+.||.+||++      +|+++||||+..
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            789999999999999999999995      799999999865

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.6e-54  Score=391.58  Aligned_cols=260  Identities=30%  Similarity=0.565  Sum_probs=225.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++..++.+++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            4789999999999999999999999999999999875532 224568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      |++|++|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++............
T Consensus        98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  175 (297)
T 3fxz_A           98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (297)
T ss_dssp             CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             CCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence            9999999999976 469999999999999999999999 99999999999999999999999999999876655545556


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (353)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..      ................+..+++.+.+|
T Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l  249 (297)
T 3fxz_A          176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPELQNPEKLSAIFRDF  249 (297)
T ss_dssp             CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred             ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCCCCccccCHHHHHH
Confidence            78999999999999999999999999999999999999999764332      111222222333333456789999999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          300 ISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      |.+||+.||++|||++|+++||||+....
T Consensus       250 i~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          250 LNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHccCChhHCcCHHHHhhChhhcccCc
Confidence            99999999999999999999999997654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-54  Score=396.00  Aligned_cols=254  Identities=23%  Similarity=0.295  Sum_probs=197.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC----eEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----AISI  136 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~----~~~l  136 (353)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++....  .......|+..+..++|||||++++++.+++    .+|+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            4688999999999999999986  589999999875422  2223345666677899999999999998653    6899


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--------CceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK--------HIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--------~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      |||||++|+|.++++. ..+++..+..++.|++.||+|||+ +        +|+||||||+|||++.++++||+|||+|+
T Consensus        79 V~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999999986 569999999999999999999997 5        89999999999999999999999999998


Q ss_pred             cccccCC----CCcccccCCcccCcceecCC------CCCccccHHHHHHHHHHHHcCCCCCCCCccCC--------chh
Q 018630          209 IMASTSG----QANTFVGTYNYMSPERISGG------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD--------GWT  270 (353)
Q Consensus       209 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~  270 (353)
                      .......    .....+||+.|||||++.+.      .++.++|||||||++|||+||.+||.......        ...
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            7654332    12345899999999999764      36789999999999999999987765432211        011


Q ss_pred             hHHHHHHHHhcCCCCCCCCC-----CCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          271 SFYELMEAIVDQPPPSAPSD-----QFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ........+......+..+.     ..+..+.+|+.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            23344444444333222221     123578899999999999999999999873

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.4e-53  Score=397.49  Aligned_cols=268  Identities=28%  Similarity=0.537  Sum_probs=228.9

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~  133 (353)
                      .+..++|++++.||+|+||.||+|+++.+++.||+|+++..  ........+.+|..++..+ +||||+++++++.+++.
T Consensus         5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            35678999999999999999999999999999999999765  2345567788999999887 89999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+||+++.+|++||+|||+++.....
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999999999988899999999999999999999998 99999999999999999999999999999865444


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC--chhhHHHHHHHHhcCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD--GWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      .......+||+.|+|||++.+..++.++|+|||||++|||++|..||......+  ...........+......  .+..
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p~~  241 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRS  241 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--CCTT
T ss_pred             CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--CCCC
Confidence            444566789999999999999999999999999999999999999996532211  111222333444443322  3457


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCH------HHHHcCCcccccC
Q 018630          292 FSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMYG  327 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~------~e~l~hp~~~~~~  327 (353)
                      +++++.+||.+||+.||.+||++      +|+++||||+...
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            89999999999999999999995      8999999998643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.6e-54  Score=399.42  Aligned_cols=261  Identities=29%  Similarity=0.517  Sum_probs=225.8

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~  133 (353)
                      .+..++|++.+.||+|+||.||+|+++.+|+.||||+++...  .......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            466789999999999999999999999999999999997542  122345677888888765 89999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+||||++||+|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+||+++.+|++||+|||+++.....
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            99999999999999999988899999999999999999999999 99999999999999999999999999999865444


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .......+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+.       .+....+.....  ..+..++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~--~~p~~~s  242 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDNP--FYPRWLE  242 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--CCCTTSC
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCCC--CCCcccC
Confidence            4445667899999999999999999999999999999999999999986443       234444444433  2345789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHH-HHHcCCcccccC
Q 018630          294 PEFCSFISACVQKEPQQRLSAQ-ELMTHPFLKMYG  327 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~-e~l~hp~~~~~~  327 (353)
                      +++.+||.+||+.||++||++. ++++||||+...
T Consensus       243 ~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          243 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            9999999999999999999998 999999998753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.3e-53  Score=397.12  Aligned_cols=259  Identities=27%  Similarity=0.435  Sum_probs=225.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH-----HHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|+++.....     .....+.+|+.+++.++||||+++++++.+.+.+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            36799999999999999999999999999999999765321     1346788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC----cEEEeeccccccc
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIM  210 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG~a~~~  210 (353)
                      ++||||++||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++.++    .+||+|||++...
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            9999999999999999888899999999999999999999998 9999999999999998777    7999999999876


Q ss_pred             cccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CC
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--AP  288 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  288 (353)
                      ... ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.       .+....+.......  ..
T Consensus       170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~  241 (361)
T 2yab_A          170 EDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITAVSYDFDEEF  241 (361)
T ss_dssp             CTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCCCCCHHH
T ss_pred             CCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCCchh
Confidence            533 234556899999999999998999999999999999999999999977432       23444454443322  12


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            357899999999999999999999999999999998643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-53  Score=389.47  Aligned_cols=256  Identities=28%  Similarity=0.543  Sum_probs=225.3

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      +..++|++++.||+|+||.||+|+++.+|+.||+|+++....  ......+.+|..+++.++||||+++++++.+...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            456899999999999999999999999999999999975421  123466788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||++||+|.+++.....+++..++.++.|++.||.|||+ +||+||||||+||+++.+|.+||+|||+++....   
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---  158 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---  158 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence            999999999999999988899999999999999999999998 9999999999999999999999999999976543   


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .....+||+.|+|||++.+..++.++|+|||||++|||++|..||...+.       ......+......  .+..++++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~--~p~~~~~~  229 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAELR--FPPFFNED  229 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCCCC--CCTTSCHH
T ss_pred             ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC--CCCCCCHH
Confidence            23456899999999999999999999999999999999999999976432       2334444444332  24578999


Q ss_pred             HHHHHHHhhhhCcCCCC-----CHHHHHcCCccccc
Q 018630          296 FCSFISACVQKEPQQRL-----SAQELMTHPFLKMY  326 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  326 (353)
                      +.++|.+||+.||.+||     +++|+++||||+..
T Consensus       230 ~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            99999999999999999     99999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.7e-53  Score=395.61  Aligned_cols=260  Identities=27%  Similarity=0.501  Sum_probs=225.8

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~  133 (353)
                      .+..++|++++.||+|+||.||+|+++.+++.||||+++...  .......+..|..++..+ +||||+++++++.+.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            456789999999999999999999999999999999997542  122346678899999887 79999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+||||++||+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|++||+|||+++.....
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            99999999999999999988899999999999999999999999 99999999999999999999999999999865444


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .......+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+.       .++...+......  .+..++
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~s  245 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHNVA--YPKSMS  245 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTTSC
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhCCCC--CCCCCC
Confidence            4445667899999999999999999999999999999999999999986433       2344455444332  345789


Q ss_pred             HHHHHHHHHhhhhCcCCCCC-----HHHHHcCCccccc
Q 018630          294 PEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMY  326 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~  326 (353)
                      +++.+||.+||+.||.+||+     ++|+++||||+..
T Consensus       246 ~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          246 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            99999999999999999995     6999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.4e-53  Score=405.71  Aligned_cols=259  Identities=26%  Similarity=0.434  Sum_probs=225.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            368999999999999999999999999999999987653 3445677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc---CCCcEEEeeccccccccccCC
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN---HRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      ||+.||+|.+.+.....+++..+..++.||+.||.|||+ +||+||||||+|||++   .++.+||+|||++........
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            999999999999988899999999999999999999999 9999999999999998   457899999999987665544


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCCCCCCC
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFS  293 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  293 (353)
                      .....+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.       .+....+.....  +......++
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s  241 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------HRLYQQIKAGAYDFPSPEWDTVT  241 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhCCCCCCccccccCC
Confidence            44567899999999999998999999999999999999999999977443       233444444332  233345789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      +++.+||.+||+.||++|||+.|+++||||+..
T Consensus       242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          242 PEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            999999999999999999999999999999753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.8e-53  Score=382.77  Aligned_cols=264  Identities=23%  Similarity=0.418  Sum_probs=216.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +++|++++.||+|+||+||+|+++.+++.||+|++.... .......+.+|+.+++.++||||+++++++.+++.+++||
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            368999999999999999999999999999999997553 3344577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      ||+++ +|.+.+. ..+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.........
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence            99986 6665554 45789999999999999999999999 999999999999999999999999999998765544445


Q ss_pred             cccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC------------
Q 018630          218 NTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP------------  284 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------------  284 (353)
                      ....||+.|+|||++.+.. ++.++||||+||++|+|++|..||.......  .....+.........            
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcccccc
Confidence            5668999999999998766 8999999999999999999887754322111  111111111111000            


Q ss_pred             -----------CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          285 -----------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       285 -----------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                                 .......+++++.+||.+||+.||++|||++|+++||||+.++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                       0011235789999999999999999999999999999999765

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-52  Score=391.66  Aligned_cols=257  Identities=28%  Similarity=0.491  Sum_probs=227.1

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      ....++|++++.||+|+||.||+|+++.+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+++.+
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            456789999999999999999999999999999999987542  122346788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++....  
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--  193 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence            9999999999999999988899999999999999999999998 9999999999999999999999999999986543  


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                       .....+||+.|+|||++.+..++.++|+|||||++|||++|..||...+.       .+....+......  .+..+++
T Consensus       194 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~~~  263 (350)
T 1rdq_E          194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGKVR--FPSHFSS  263 (350)
T ss_dssp             -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTTCCH
T ss_pred             -CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HHHHHHHHcCCCC--CCCCCCH
Confidence             23456899999999999999999999999999999999999999976432       2344455544332  3457899


Q ss_pred             HHHHHHHHhhhhCcCCCCC-----HHHHHcCCccccc
Q 018630          295 EFCSFISACVQKEPQQRLS-----AQELMTHPFLKMY  326 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~  326 (353)
                      ++.+||.+||+.||.+||+     ++|+++||||+..
T Consensus       264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            9999999999999999998     9999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.6e-53  Score=392.21  Aligned_cols=262  Identities=26%  Similarity=0.452  Sum_probs=222.0

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .++|++++.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            47899999999999999999999999999999999766444555778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--CCC
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQA  217 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  217 (353)
                      |+++++|.+++.....+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++......  ...
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            99999999999887889999999999999999999998 999999999999999999999999999997654222  223


Q ss_pred             cccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...      ..................+++++
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  238 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAP  238 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS------HHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHHhcccccCCccccCCHHH
Confidence            45689999999999988775 789999999999999999999998754432      11222233333333346789999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      .+||.+||+.||++|||++|+++||||+....
T Consensus       239 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          239 LALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence            99999999999999999999999999987543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-52  Score=394.33  Aligned_cols=260  Identities=29%  Similarity=0.503  Sum_probs=219.6

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHH-HhcCCCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~-~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ....++|++++.||+|+||.||+|+++.+++.||||+++...  .......+.+|..+ ++.++||||+++++++.+.+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            466789999999999999999999999999999999997653  23344566677776 567899999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+++.....
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            99999999999999999988899999999999999999999998 99999999999999999999999999999875544


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .......+||+.|+|||++.+..++.++|+|||||++|||++|..||...+.       .+....+.....  ..+..++
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~~--~~~~~~~  263 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNKPL--QLKPNIT  263 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------HHHHHHHHHSCC--CCCSSSC
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhccc--CCCCCCC
Confidence            4556677999999999999999999999999999999999999999977443       234444444432  2345789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCH----HHHHcCCccccc
Q 018630          294 PEFCSFISACVQKEPQQRLSA----QELMTHPFLKMY  326 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~----~e~l~hp~~~~~  326 (353)
                      +++.+||.+||+.||.+||++    .++++||||+..
T Consensus       264 ~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            999999999999999999987    699999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.9e-53  Score=388.28  Aligned_cols=268  Identities=26%  Similarity=0.449  Sum_probs=218.4

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..+...++|++++.||+|+||+||+|++. +++.||+|++.... .......+.+|+.+++.++||||+++++++.+++.
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC   93 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence            33455689999999999999999999996 58999999987542 22335678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      +++||||+++ +|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            9999999985 888887654 459999999999999999999998 9999999999999999999999999999987654


Q ss_pred             cCCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC-----
Q 018630          213 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-----  286 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----  286 (353)
                      .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+...   .+........+..     
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSGGGT
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhhhhh
Confidence            4444555688999999999876 568999999999999999999999998765543222   2222111111100     


Q ss_pred             -------------------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          287 -------------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       287 -------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                                         .....+++++.+||.+||+.||++|||++|+++||||+....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                               011346889999999999999999999999999999997643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.1e-52  Score=393.83  Aligned_cols=264  Identities=28%  Similarity=0.463  Sum_probs=216.2

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ....++|++++.||+|+||+||+++++.+++.||||++.....  ....+.+|+.+++.++||||+++++++.+++.+++
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            3456899999999999999999999999999999999875422  22557899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc--EEEeeccccccccccC
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTS  214 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~~~  214 (353)
                      ||||+++|+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++.  +||+|||+++..... 
T Consensus        94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-  171 (361)
T 3uc3_A           94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  171 (361)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence            99999999999999888899999999999999999999998 99999999999999987765  999999998754322 


Q ss_pred             CCCcccccCCcccCcceecCCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYK-SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....   .......+............++
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHHHTTCCCCCTTSCCC
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcCCCCCCCcCCCC
Confidence            23345689999999999988887655 8999999999999999999987655432   3344455555444444445789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +++.+||.+||+.||++|||+.|+++||||+...
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            9999999999999999999999999999997653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-52  Score=395.52  Aligned_cols=265  Identities=28%  Similarity=0.519  Sum_probs=228.7

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ...+..++|++++.||+|+||.||+|+++.+++.||+|++....  .......+.+|+.+++.++||||+++++++.+.+
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            44677899999999999999999999999999999999987542  2223467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .+|+||||+.||+|.+++.....+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++.....
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999999999988899999999999999999999998 9999999999999999999999999999987543


Q ss_pred             cCCCCcccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                       .......+||+.|+|||++.+   ..++.++|+|||||++|||++|..||...+...    ..+....+.....  ..+
T Consensus       168 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~~~~~~~~--~~p  240 (384)
T 4fr4_A          168 -ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHTFETTVV--TYP  240 (384)
T ss_dssp             -TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----HHHHHHHHHHCCC--CCC
T ss_pred             -CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhhccc--CCC
Confidence             234456789999999999864   458999999999999999999999997654322    2333344433332  234


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCC-HHHHHcCCcccccC
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLS-AQELMTHPFLKMYG  327 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt-~~e~l~hp~~~~~~  327 (353)
                      ..+++++.+||.+||+.||.+||+ ++++++||||+...
T Consensus       241 ~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          241 SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            578999999999999999999998 89999999998653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.5e-52  Score=395.08  Aligned_cols=291  Identities=25%  Similarity=0.408  Sum_probs=226.7

Q ss_pred             CCCccCceeeeeeccc--CCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKG--SGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ....++|++++.||+|  +||.||+|+++.+|+.||||++.... .......+.+|+.+++.++||||+++++++.+++.
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            3456899999999999  99999999999999999999997653 34556778899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      +++||||+++++|.+++...  ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||.+....
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999999999875  679999999999999999999999 999999999999999999999999999886543


Q ss_pred             ccC-------CCCcccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH-HHHHHh-
Q 018630          212 STS-------GQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE-LMEAIV-  280 (353)
Q Consensus       212 ~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~-~~~~~~-  280 (353)
                      ...       ......+||+.|+|||++.+  ..++.++|||||||++|||++|..||.+.+..+....... ....+. 
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            221       11223478999999999987  5799999999999999999999999987554332111000 000000 


Q ss_pred             -----------------------------------cCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          281 -----------------------------------DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       281 -----------------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                                                         ...........+++++.+||.+||+.||++|||++|+++||||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence                                               000011123567899999999999999999999999999999998


Q ss_pred             cCCCCcCHhHHhhhhCCCcccccccC
Q 018630          326 YGDLNVDLSEYFTDAGSPLATLSNLS  351 (353)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (353)
                      .......-   +....+|+.++.++.
T Consensus       340 ~~~~~~~~---~~~~~~~~~~~~~~~  362 (389)
T 3gni_B          340 IKRRASEA---LPELLRPVTPITNFE  362 (389)
T ss_dssp             C---CCSS---HHHHTTTCCCCC---
T ss_pred             Hhhcchhh---hhhhhcCCCcccccc
Confidence            76544321   233444555554443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.9e-53  Score=394.33  Aligned_cols=281  Identities=44%  Similarity=0.803  Sum_probs=242.7

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      .+..++|++.+.||+|+||.||++.+..+++.||+|++...........+.+|+.+++.++||||+++++++..++.+++
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            45668999999999999999999999999999999999877666777889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+..||+||||||+||+++.++.+||+|||++......  .
T Consensus       109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  186 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M  186 (360)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C
T ss_pred             EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--c
Confidence            99999999999999988899999999999999999999998338999999999999999999999999998765432  2


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc----------------------------
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG----------------------------  268 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------------------------  268 (353)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.                            
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            3446899999999999999999999999999999999999999976442110                            


Q ss_pred             -------hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhh
Q 018630          269 -------WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD  339 (353)
Q Consensus       269 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~  339 (353)
                             .....+....+.....+......+++++.+||.+||+.||++|||++|+++||||+.......+...++..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~  344 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCS  344 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCCCHHHHHHH
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhhhHHHHHhh
Confidence                   01122334445555555555567899999999999999999999999999999999999888888888743

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.5e-53  Score=385.19  Aligned_cols=260  Identities=27%  Similarity=0.480  Sum_probs=216.6

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-------------------------HHHHHHHHHHHH
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-------------------------ESARRQIAQELK  111 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------------~~~~~~~~~e~~  111 (353)
                      .+..++|++.+.||+|+||.||+|.+..+++.||||++.....                         ......+.+|++
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            3556899999999999999999999999999999999865421                         112356889999


Q ss_pred             HHhcCCCCceEEEeeEeEe--cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 018630          112 INQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS  189 (353)
Q Consensus       112 ~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~  189 (353)
                      +++.++||||+++++++.+  ...+++||||+++++|.+++. ...+++..+..++.|++.||.|||+ +||+||||||+
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~  166 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPS  166 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGG
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHH
Confidence            9999999999999999886  578999999999999988654 3679999999999999999999998 99999999999


Q ss_pred             cEEEcCCCcEEEeeccccccccccCCCCcccccCCcccCcceecCCC---CCccccHHHHHHHHHHHHcCCCCCCCCccC
Q 018630          190 NLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYSPPEQQ  266 (353)
Q Consensus       190 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf~~~~~~  266 (353)
                      ||+++.++.+||+|||+++.............||+.|+|||++.+..   ++.++|||||||++|+|++|..||...+. 
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-  245 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI-  245 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred             HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH-
Confidence            99999999999999999987654433344568999999999998765   47889999999999999999999976432 


Q ss_pred             CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          267 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                            ......+............+++++.+||.+||+.||++|||+.|+++||||++
T Consensus       246 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          246 ------MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             ------HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             ------HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence                  23334444444333334578999999999999999999999999999999963

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.4e-52  Score=386.32  Aligned_cols=261  Identities=29%  Similarity=0.481  Sum_probs=215.5

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEec---cCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhcCCCCceEEEeeEeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVVCYQSFY  129 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~  129 (353)
                      ..+..++|++.+.||+|+||.||+|++.   .+++.||+|+++...   .......+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            3466789999999999999999999985   689999999987542   2234466789999999999999999999999


Q ss_pred             ecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          130 SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       130 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      .++.+|+||||++|++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999999999999999999988899999999999999999999998 9999999999999999999999999999976


Q ss_pred             ccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          210 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      ...........+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.       ......+.....  ..+
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~--~~p  241 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------KKTIDKILKCKL--NLP  241 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCC--CCC
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCC--CCC
Confidence            54444444556899999999999998999999999999999999999999987543       233344444332  223


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCC-----CHHHHHcCCccccc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMY  326 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  326 (353)
                      ..+++++.+||.+||+.||.+||     +++|+++||||+..
T Consensus       242 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          242 PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            56899999999999999999999     88999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.1e-52  Score=404.70  Aligned_cols=263  Identities=30%  Similarity=0.561  Sum_probs=218.6

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..+..++|++++.||+|+||.||+|+++.+|+.||||+++..  ........+.+|+.+++.++||||+++++++...+.
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            345678999999999999999999999999999999999754  233445677899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +++||||+++|+|.+++...+.+++..+..++.||+.||+|||+.+||+||||||+|||++.++.+||+|||+++.....
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999999999988899999999999999999999995479999999999999999999999999999865544


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.       ......+......  .+..++
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~~  373 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEIR--FPRTLG  373 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTTSC
T ss_pred             CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHHhCCCC--CCccCC
Confidence            4455667899999999999999999999999999999999999999976432       2333444433332  345689


Q ss_pred             HHHHHHHHHhhhhCcCCCC-----CHHHHHcCCcccccC
Q 018630          294 PEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  327 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  327 (353)
                      +++.+||.+||+.||.+||     |++|+++||||+...
T Consensus       374 ~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence            9999999999999999999     999999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.5e-53  Score=401.53  Aligned_cols=263  Identities=29%  Similarity=0.488  Sum_probs=222.1

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      ....++|++++.||+|+||.||+|+++.+++.||+|+++....  ......+.+|+.+++.++||||+++++++.++..+
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            4566899999999999999999999999999999999875311  11123477899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |+||||++||+|.++++. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+++......
T Consensus       145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence            999999999999999976 579999999999999999999999 999999999999999999999999999997754332


Q ss_pred             C-CCcccccCCcccCcceecCCC----CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCC
Q 018630          215 G-QANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSA  287 (353)
Q Consensus       215 ~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~  287 (353)
                      . ...+.+||+.|+|||++.+..    ++.++|+|||||++|||++|..||.+.+..       .....+....  ....
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~p  295 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHKNSLTFP  295 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHHHCCCC
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------hHHHHHHhccccccCC
Confidence            1 234578999999999997755    789999999999999999999999875432       2233333211  1122


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCC--CCCHHHHHcCCcccccCC
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~~~  328 (353)
                      ....+++++.+||.+||+.+|.+  ||+++|+++||||+....
T Consensus       296 ~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w  338 (410)
T 3v8s_A          296 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  338 (410)
T ss_dssp             TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred             CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence            23578999999999999999988  999999999999997543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-52  Score=392.04  Aligned_cols=258  Identities=26%  Similarity=0.448  Sum_probs=220.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc----HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE----ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      .++|++.+.||+|+||.||+|.++.+++.||||++.....    ......+.+|+.+++.++||||+++++++.+++.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            4689999999999999999999999999999999864321    113467899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc---EEEeeccccc
Q 018630          136 IILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSA  208 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~---~kl~DfG~a~  208 (353)
                      +||||++|++|.+++...    ..+++..+..++.||+.||.|||+ +||+||||||+||+++.++.   +||+|||++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            999999999999887643    358999999999999999999998 99999999999999987654   9999999998


Q ss_pred             cccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--
Q 018630          209 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--  286 (353)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--  286 (353)
                      ............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..        ......+.......  
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~i~~~~~~~~~  253 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFEGIIKGKYKMNP  253 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HHHHHHHHHTCCCCCH
T ss_pred             EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HHHHHHHHcCCCCCCc
Confidence            76654444455689999999999999899999999999999999999999997632        13333444333221  


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      .....+++++.+||.+||+.||++|||+.|+++||||+..
T Consensus       254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            1225689999999999999999999999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.1e-52  Score=385.00  Aligned_cols=265  Identities=25%  Similarity=0.458  Sum_probs=207.0

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .++|++++.||+|+||.||+|.++.+|+.||+|+++..........+.+|+.+++.++||||+++++++..++.+++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            46899999999999999999999999999999999765444444678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          140 YMDGGSLADFLKKV------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       140 ~~~~gsL~~~l~~~------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      |++ ++|.+++...      ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            998 5999998754      358999999999999999999998 99999999999999999999999999999876544


Q ss_pred             CCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--------
Q 018630          214 SGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--------  284 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------  284 (353)
                      ........||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+..   ..+.........        
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCGGGGG
T ss_pred             cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhhhhhh
Confidence            4444556899999999999764 6899999999999999999999999875432211   111111110000        


Q ss_pred             --------------------CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          285 --------------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       285 --------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                                          .......+++++.+||.+||+.||++|||++|+++||||+.+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                001123578899999999999999999999999999999987554

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.4e-52  Score=391.61  Aligned_cols=257  Identities=27%  Similarity=0.445  Sum_probs=223.8

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            368999999999999999999999999999999997542 3445677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC---cEEEeeccccccccccCC
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSG  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~a~~~~~~~~  215 (353)
                      ||++||+|.+++.....+++..+..++.||+.||.|||+ +||+||||||+||+++.++   .+||+|||++...... .
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~  185 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-E  185 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-C
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-c
Confidence            999999999999888889999999999999999999999 9999999999999998654   5999999999776533 2


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCCCCCCC
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFS  293 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  293 (353)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       ......+.....  +......++
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~  258 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGAYDYPSPEWDTVT  258 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCCCTTGGGGSC
T ss_pred             ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCCCcccccCCC
Confidence            34456899999999999998999999999999999999999999977433       233344443332  222335689


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      +++.+||.+||+.||++|||+.|+++||||+.
T Consensus       259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          259 PEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            99999999999999999999999999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-52  Score=387.96  Aligned_cols=263  Identities=27%  Similarity=0.399  Sum_probs=204.6

Q ss_pred             cCceee---eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEE
Q 018630           61 EDIDTI---KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        61 ~~~~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~l  136 (353)
                      ++|++.   +.||+|+||.||+|.++.+++.||||++...    ....+.+|+.+++.+. ||||+++++++.++...|+
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            456654   7899999999999999999999999998754    2356678999999887 9999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC---cEEEeecccccccccc
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMAST  213 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~a~~~~~~  213 (353)
                      ||||+++|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++   .+||+|||+++.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           84 VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             EECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             EEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            99999999999999998899999999999999999999998 9999999999999998766   8999999999876555


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC--CCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP--SDQ  291 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  291 (353)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.........+....+.........  ...
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (325)
T 3kn6_A          163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN  242 (325)
T ss_dssp             ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred             CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccC
Confidence            445556789999999999999999999999999999999999999998765543334455666666665543221  135


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      +++++.+||.+||+.||++|||++|+++||||+....
T Consensus       243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             SCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             CCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            8999999999999999999999999999999987543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9e-53  Score=390.38  Aligned_cols=256  Identities=30%  Similarity=0.481  Sum_probs=220.5

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.++||||+++++++..++.+++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            45789999999999999999999999999999999875421  1223578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||||+ +|+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...... ..
T Consensus        87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~  163 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NF  163 (336)
T ss_dssp             EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BT
T ss_pred             EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-cc
Confidence            99999 67999999888899999999999999999999998 99999999999999999999999999999765433 33


Q ss_pred             CcccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          217 ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+........       .+..  .....+..++++
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------~i~~--~~~~~p~~~s~~  234 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------KVNS--CVYVMPDFLSPG  234 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------CCCS--SCCCCCTTSCHH
T ss_pred             cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHc--CCCCCcccCCHH
Confidence            455689999999999988776 789999999999999999999997654332111       1111  112334678999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      +.+||.+||+.||.+|||++|+++||||+..
T Consensus       235 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999999999853

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-52  Score=386.60  Aligned_cols=256  Identities=21%  Similarity=0.361  Sum_probs=222.8

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .++|++.+.||+|+||.||++.++.+++.||+|++...  ......+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            37899999999999999999999999999999998754  3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC--CCcEEEeeccccccccccCCC
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      |++|++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.  ++.+||+|||++...... ..
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~  159 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN  159 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-Cc
Confidence            99999999999765 479999999999999999999998 99999999999999987  789999999999876432 22


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC--CCCCCCH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSP  294 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  294 (353)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.       .+....+........  ....+++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~  232 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEYTFDEEAFKEISI  232 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHcCCCCCChhhhccCCH
Confidence            3456799999999999988899999999999999999999999976432       234444444433221  2347899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      ++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            99999999999999999999999999999865

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-52  Score=384.73  Aligned_cols=258  Identities=27%  Similarity=0.459  Sum_probs=222.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH-----HHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++......     .....+.+|+.+++.++||||+++++++.+...++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            6799999999999999999999999999999998754221     13567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC----cEEEeecccccccc
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMA  211 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG~a~~~~  211 (353)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++    .+||+|||+++...
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            999999999999999888889999999999999999999998 9999999999999998877    89999999998764


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPS  289 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  289 (353)
                      .. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...       .+....+.....  +....
T Consensus       170 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~  241 (326)
T 2y0a_A          170 FG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVNYEFEDEYF  241 (326)
T ss_dssp             TT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHTCCCCCHHHH
T ss_pred             CC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHHhcCCCcCcccc
Confidence            32 234456899999999999988999999999999999999999999976432       222333332222  11123


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ..+++.+.+||.+||+.||++|||++|+++||||+...
T Consensus       242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            56789999999999999999999999999999998653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-52  Score=400.89  Aligned_cols=269  Identities=24%  Similarity=0.440  Sum_probs=223.1

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .+..++|++++.||+|+||+||+++++.+++.||+|+++....  ......+.+|..++..++||||+++++++.+++.+
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            3556899999999999999999999999999999999875311  11223478899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          135 SIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      |+||||++||+|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            999999999999999987 4789999999999999999999998 99999999999999999999999999999765433


Q ss_pred             CC-CCcccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          214 SG-QANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       214 ~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      .. .....+||+.|+|||++.     ...++.++|||||||++|||++|..||.+.+..+.   ...+......... +.
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~~-p~  304 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNHKERFQF-PT  304 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHCCC-CS
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhhhhccccccC-Cc
Confidence            22 223468999999999987     56789999999999999999999999987543221   1111111111111 22


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCC--CCCHHHHHcCCcccccCCCC
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      ....+++++.+||.+||+.+|++  |++++|+++||||+......
T Consensus       305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~  349 (437)
T 4aw2_A          305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN  349 (437)
T ss_dssp             SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred             ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence            23568999999999999998888  99999999999998765443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-52  Score=396.83  Aligned_cols=264  Identities=26%  Similarity=0.436  Sum_probs=220.3

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .+..++|++++.||+|+||.||+|+++.+|+.||||+++...  .......+.+|..++..++||||+++++++.+++.+
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            456689999999999999999999999999999999987532  112234578899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      |+||||++||+|.+++.+. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.+|++||+|||+++.....
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            9999999999999999875 479999999999999999999998 99999999999999999999999999999876433


Q ss_pred             CC-CCcccccCCcccCcceec-------CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC---
Q 018630          214 SG-QANTFVGTYNYMSPERIS-------GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ---  282 (353)
Q Consensus       214 ~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---  282 (353)
                      .. .....+||+.|+|||++.       ...++.++|+|||||++|||++|..||...+..       +....+...   
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~~  288 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-------ETYGKIVHYKEH  288 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHHH
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcccC
Confidence            22 223468999999999987       356899999999999999999999999875432       222222221   


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCcCCC---CCHHHHHcCCcccccCCC
Q 018630          283 PPPSAPSDQFSPEFCSFISACVQKEPQQR---LSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R---pt~~e~l~hp~~~~~~~~  329 (353)
                      ...+.....+++++.+||.+||+ +|.+|   |+++|+++||||+.....
T Consensus       289 ~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~  337 (412)
T 2vd5_A          289 LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD  337 (412)
T ss_dssp             CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred             cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            11122235789999999999999 99998   599999999999876443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.5e-52  Score=379.13  Aligned_cols=260  Identities=25%  Similarity=0.451  Sum_probs=211.3

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +++|++++.||+|+||.||+|++ .+++.||+|++..... ......+.+|+.+++.++||||+++++++..++.+++||
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            36899999999999999999998 5789999999865432 223466789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      ||+++ +|.+++... +.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.........
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            99986 999998764 679999999999999999999998 999999999999999999999999999998765443344


Q ss_pred             cccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-----------
Q 018630          218 NTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-----------  285 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------  285 (353)
                      ....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+   ...............           
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhccccc
Confidence            456789999999999764 58999999999999999999999998754321   111221111111000           


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          286 ------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       286 ------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                                  ......+++++.+||.+||+.||++|||++|+++||||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                        0112457899999999999999999999999999999985

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-51  Score=378.72  Aligned_cols=267  Identities=25%  Similarity=0.460  Sum_probs=215.8

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            478999999999999999999999999999999886553 3445677889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...........
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            999999999999888889999999999999999999998 9999999999999999999999999999987654444445


Q ss_pred             ccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc----------------
Q 018630          219 TFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD----------------  281 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~----------------  281 (353)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...   ........                
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY---LIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhcccccccccccccccccc
Confidence            5689999999999976 568999999999999999999999998754432111   11111100                


Q ss_pred             C-CCCCC--------CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          282 Q-PPPSA--------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       282 ~-~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      . ..+..        ....+++++.+||.+||+.||++|||++|+++||||+...+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            0 00000        0135788999999999999999999999999999999876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.3e-52  Score=388.83  Aligned_cols=258  Identities=26%  Similarity=0.413  Sum_probs=220.8

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .++|++.+.||+|+||.||+|.++.+++.||||++.....     ...+|++++..+ +||||+++++++.+++.+|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4789999999999999999999999999999999975532     234577777666 7999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC----CcEEEeeccccccccccC
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR----GEVKITDFGVSAIMASTS  214 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~----~~~kl~DfG~a~~~~~~~  214 (353)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||++..+    +.+||+|||++.......
T Consensus        96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            999999999999988889999999999999999999999 999999999999998543    359999999998766555


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCCCCC
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQF  292 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  292 (353)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....    ....++...+......  ...+..+
T Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD----DTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT----SCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc----CCHHHHHHHHccCCcccCccccccC
Confidence            555667899999999999887899999999999999999999999976432    1233445555544432  2234678


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ++++.+||.+||+.||++|||+.|+++||||..+.
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence            99999999999999999999999999999997754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.5e-52  Score=384.66  Aligned_cols=266  Identities=26%  Similarity=0.458  Sum_probs=211.9

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      +++|++++.||+|+||.||+|++..+++.||+|++...........+.+|+.+++.++||||+++++++..++.+++|||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            36899999999999999999999999999999998765443333456689999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      |+++ +|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence            9985 999988765 458999999999999999999998 9999999999999999999999999999987654444445


Q ss_pred             ccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC----------
Q 018630          219 TFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA----------  287 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  287 (353)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+    ....+...........          
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHhchhhhcchhh
Confidence            5688999999999876 568999999999999999999999998754322    1111112111111100          


Q ss_pred             ---------------CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCc
Q 018630          288 ---------------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  331 (353)
Q Consensus       288 ---------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  331 (353)
                                     ....+++++.+||.+||+.||.+|||++|+++||||+...+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  293 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH  293 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence                           11357889999999999999999999999999999998766543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.5e-51  Score=377.65  Aligned_cols=256  Identities=35%  Similarity=0.644  Sum_probs=221.9

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEec
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  141 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~  141 (353)
                      .|+..+.||+|+||.||+|+++.+|+.||||++..... .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  124 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL  124 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence            47788899999999999999999999999999875532 23466889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccc
Q 018630          142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV  221 (353)
Q Consensus       142 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  221 (353)
                      ++++|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..............
T Consensus       125 ~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  202 (321)
T 2c30_A          125 QGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  202 (321)
T ss_dssp             CSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence            99999999875 579999999999999999999998 9999999999999999999999999999987655444445678


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHHH
Q 018630          222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSFI  300 (353)
Q Consensus       222 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li  300 (353)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||...+.       ......+.....+. .....+++++.++|
T Consensus       203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li  275 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRDSPPPKLKNSHKVSPVLRDFL  275 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSSCCCCTTGGGSCHHHHHHH
T ss_pred             CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCCCCcCccccCCHHHHHHH
Confidence            99999999999998999999999999999999999999976432       22333343333322 23346899999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      .+||+.||++|||+.|+++||||+...
T Consensus       276 ~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          276 ERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999999998654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.9e-51  Score=370.22  Aligned_cols=262  Identities=30%  Similarity=0.459  Sum_probs=223.9

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      ++..++|++.+.||+|+||.||++.+..+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            5677999999999999999999999999999999999865422  22246788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++...... 
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            9999999999999999988899999999999999999999998 99999999999999999999999999988654322 


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                       ......||+.|+|||.+.+..++.++||||||+++|+|++|..||...+.       .+....+.....  ..+..+++
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~--~~~~~~~~  232 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVEF--TFPDFVTE  232 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCC--CCCTTSCH
T ss_pred             -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-------HHHHHHHHhCCC--CCCCcCCH
Confidence             23445789999999999998999999999999999999999999976432       223333333322  22456899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      ++.+||.+||+.||.+|||+.|+++||||+......
T Consensus       233 ~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~  268 (279)
T 3fdn_A          233 GARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP  268 (279)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred             HHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence            999999999999999999999999999998766443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1e-51  Score=382.42  Aligned_cols=266  Identities=22%  Similarity=0.367  Sum_probs=209.9

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ....++|++++.||+|+||.||+|.+..+++.||||+++... .......+.+|+.+++.++||||+++++++.+++.++
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            345689999999999999999999999999999999997553 2334566789999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc-----CCCcEEEeeccccccc
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-----HRGEVKITDFGVSAIM  210 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~-----~~~~~kl~DfG~a~~~  210 (353)
                      +||||+++ +|.+++.....+++..++.++.||+.||.|||+ +||+||||||+||+++     .++.+||+|||+++..
T Consensus       110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99999985 999999988889999999999999999999999 9999999999999995     4456999999999876


Q ss_pred             cccCCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC--
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--  287 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--  287 (353)
                      ..........+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+   .................  
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSTT
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCchhhhhh
Confidence            5444445556789999999999875 48999999999999999999999998754322   11222222111110000  


Q ss_pred             ----------------------CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          288 ----------------------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       288 ----------------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                                            ....+++++.+||.+||+.||++|||++|+++||||+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence                                  0011678999999999999999999999999999998653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.4e-51  Score=368.13  Aligned_cols=262  Identities=27%  Similarity=0.436  Sum_probs=226.0

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++.... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999999999999999987553 4455677889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc---EEEeeccccccccccCC
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~---~kl~DfG~a~~~~~~~~  215 (353)
                      ||+++++|.+.+.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.   +||+|||++...... .
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-~  162 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-E  162 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-C
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-c
Confidence            999999999999888899999999999999999999998 99999999999999987665   999999999765433 2


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCC
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFS  293 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  293 (353)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+.       ......+....  .+......++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGAYDYPSPEWDTVT  235 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-------hHHHHHHHhccccCCchhhcccC
Confidence            33456799999999999999999999999999999999999999976433       22333333322  2223345789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      +++.+||.+||+.||++|||++|+++||||+...+..
T Consensus       236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (284)
T 3kk8_A          236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA  272 (284)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence            9999999999999999999999999999998755433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-51  Score=389.40  Aligned_cols=262  Identities=26%  Similarity=0.447  Sum_probs=207.2

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEec--CeEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSN--GAIS  135 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~--~~~~  135 (353)
                      .++|++++.||+|+||.||+|.++.+|+.||||++... ........+.+|+.+++.+. ||||+++++++..+  ..+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            47899999999999999999999999999999998644 33455677889999999997 99999999999754  3799


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc--
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST--  213 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--  213 (353)
                      +||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            9999998 599999876 579999999999999999999999 99999999999999999999999999999765321  


Q ss_pred             -------------------CCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH
Q 018630          214 -------------------SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY  273 (353)
Q Consensus       214 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~  273 (353)
                                         .......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+...   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---  241 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE---  241 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence                               112234689999999999987 578999999999999999999999998754432111   


Q ss_pred             HHHHHHhcCCC--------------------------C----------------CCCCCCCCHHHHHHHHHhhhhCcCCC
Q 018630          274 ELMEAIVDQPP--------------------------P----------------SAPSDQFSPEFCSFISACVQKEPQQR  311 (353)
Q Consensus       274 ~~~~~~~~~~~--------------------------~----------------~~~~~~~~~~~~~li~~~L~~dp~~R  311 (353)
                      .+...+ ..+.                          .                ......+++++.+||.+||+.||++|
T Consensus       242 ~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          242 RIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            111111 0000                          0                00123678999999999999999999


Q ss_pred             CCHHHHHcCCcccccCC
Q 018630          312 LSAQELMTHPFLKMYGD  328 (353)
Q Consensus       312 pt~~e~l~hp~~~~~~~  328 (353)
                      ||++|+++||||+.+.+
T Consensus       321 ~t~~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          321 ISANDALKHPFVSIFHN  337 (388)
T ss_dssp             CCHHHHTTSTTTTTTCC
T ss_pred             CCHHHHhCCHHHHHhcC
Confidence            99999999999987653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.2e-51  Score=382.21  Aligned_cols=264  Identities=27%  Similarity=0.406  Sum_probs=211.4

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      ...++|++.+.||+|+||.||+|++..+++.||||+++...   ....+.+|+.+++.++||||+++++++...+.+++|
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            34577999999999999999999999999999999987542   345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC---CCcEEEeeccccccccccC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~~~~  214 (353)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.   ++.+||+|||+++..... 
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-  204 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-  204 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence            9999999999999888889999999999999999999998 99999999999999975   889999999999765432 


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCCCCC
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQF  292 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  292 (353)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|..||......      ......+......  ......+
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~~~~~~~~~~~  278 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEYYFISPWWDEV  278 (349)
T ss_dssp             --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCCCCCTTTTTTS
T ss_pred             cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCCccCCchhhhC
Confidence            2234567999999999999989999999999999999999999999764321      2233344433322  2234578


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcC
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD  332 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~  332 (353)
                      ++++.+||.+||+.||++|||+.|+++||||+........
T Consensus       279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~  318 (349)
T 2w4o_A          279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVH  318 (349)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchhh
Confidence            9999999999999999999999999999999987655443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-51  Score=398.79  Aligned_cols=261  Identities=28%  Similarity=0.476  Sum_probs=227.5

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ...+..++|.+.+.||+|+||.||+|++..+|+.||||++.....  ......+.+|+.+++.++||||+++++++...+
T Consensus        10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS   89 (476)
T ss_dssp             CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            345667899999999999999999999999999999999975421  123467899999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999999999999888889999999999999999999998 9999999999999999999999999999987543


Q ss_pred             cCCCCcccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      . ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.       ......+......  .+..
T Consensus       169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~  238 (476)
T 2y94_A          169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PTLFKKICDGIFY--TPQY  238 (476)
T ss_dssp             T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HHHHHHHHTTCCC--CCTT
T ss_pred             c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCCcC--CCcc
Confidence            2 33455689999999999988775 7899999999999999999999976432       2334445444332  3456


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      +++++.+||.+||+.||++|||++|+++||||+..
T Consensus       239 ~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          239 LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            89999999999999999999999999999999763

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-51  Score=381.07  Aligned_cols=255  Identities=26%  Similarity=0.400  Sum_probs=212.8

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC-------
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-------  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~-------  132 (353)
                      .++|++++.||+|+||.||+|+++.+|+.||||+++..........+.+|+.+++.++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            3689999999999999999999999999999999986655566788999999999999999999999886543       


Q ss_pred             --------------------------------------------------eEEEEEEecCCCCHHHHHHhcC---CCCHH
Q 018630          133 --------------------------------------------------AISIILEYMDGGSLADFLKKVK---TIPEE  159 (353)
Q Consensus       133 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~---~l~~~  159 (353)
                                                                        .+++||||+++++|.+++....   ..+..
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              3899999999999999998753   35666


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC------------CCCcccccCCccc
Q 018630          160 YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS------------GQANTFVGTYNYM  227 (353)
Q Consensus       160 ~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~------------~~~~~~~gt~~y~  227 (353)
                      .++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++......            ......+||+.|+
T Consensus       165 ~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            789999999999999998 999999999999999999999999999998765432            1223457999999


Q ss_pred             CcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhC
Q 018630          228 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE  307 (353)
Q Consensus       228 aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  307 (353)
                      |||++.+..++.++|||||||++|||++|..|+.         ..............+. .....++++.+||.+||+.|
T Consensus       244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---------~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~  313 (332)
T 3qd2_B          244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---------ERVRIITDVRNLKFPL-LFTQKYPQEHMMVQDMLSPS  313 (332)
T ss_dssp             CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---------HHHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHHCSS
T ss_pred             ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---------HHHHHHHHhhccCCCc-ccccCChhHHHHHHHHccCC
Confidence            9999999999999999999999999999876652         2222333333332221 22345788999999999999


Q ss_pred             cCCCCCHHHHHcCCcccc
Q 018630          308 PQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       308 p~~Rpt~~e~l~hp~~~~  325 (353)
                      |++|||++|+++||||+.
T Consensus       314 p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          314 PTERPEATDIIENAIFEN  331 (332)
T ss_dssp             GGGSCCHHHHHHSTTCCC
T ss_pred             CCcCCCHHHHhhchhhhc
Confidence            999999999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.9e-51  Score=369.11  Aligned_cols=263  Identities=25%  Similarity=0.448  Sum_probs=225.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++...........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            36899999999999999999999999999999999766545566788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--CCC
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQA  217 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  217 (353)
                      |+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.......  ...
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            99999999999877789999999999999999999998 999999999999999999999999999997654222  223


Q ss_pred             cccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....||+.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+...      .....+............+++++
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  238 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAP  238 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS------HHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHhhhcccccCchhhcCHHH
Confidence            45678999999999987765 789999999999999999999998754432      11222233222223345689999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      .+||.+||+.||++|||++|+++||||+.....
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          239 LALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             HHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence            999999999999999999999999999876544

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.2e-51  Score=369.50  Aligned_cols=255  Identities=27%  Similarity=0.504  Sum_probs=213.4

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|.+.+.||+|+||.||+|.++.+++.+|+|++...........+.+|+++++.++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            78999999999999999999999999999999987665444567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE---cCCCcEEEeecccccccccc
Q 018630          141 MDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       141 ~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +++++|.+++...    ..+++..++.++.|++.||.|||+ +||+||||||+||++   +.++.+||+|||++......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD  180 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence            9999999988543    679999999999999999999998 999999999999999   45678999999999765432


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc-CCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQF  292 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  292 (353)
                       .......||+.|+|||++. ..++.++|||||||++|+|++|..||...+.       .+....... ..........+
T Consensus       181 -~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~  251 (285)
T 3is5_A          181 -EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-------EEVQQKATYKEPNYAVECRPL  251 (285)
T ss_dssp             -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCC--CCC
T ss_pred             -ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-------HHHHhhhccCCcccccccCcC
Confidence             2334567999999999886 5689999999999999999999999986432       222222222 22222233457


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      ++++.+||.+||+.||++|||++|+++||||+.
T Consensus       252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-50  Score=383.55  Aligned_cols=258  Identities=25%  Similarity=0.436  Sum_probs=222.5

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .++|++++.||+|+||.||+|.++.+++.||+|++.... ......+.+|+.+++.++||||+++++++.+...+++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            478999999999999999999999999999999987653 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC--CCcEEEeeccccccccccCCC
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      |++||+|.+++... ..+++..+..++.||+.||+|||+ +||+||||||+|||++.  ++.+||+|||+++..... ..
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~  206 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI  206 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEecccceecCCC-cc
Confidence            99999999998765 479999999999999999999998 99999999999999974  467999999999876432 22


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCCH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSP  294 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  294 (353)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       .+....+....  .+......+++
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~  279 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDWEFDEDAFSSVSP  279 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCccccccCCH
Confidence            3445799999999999998999999999999999999999999987432       22333333322  22333457899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ++.+||.+||+.||++|||+.|+++||||+...
T Consensus       280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            999999999999999999999999999998754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.5e-51  Score=371.18  Aligned_cols=275  Identities=36%  Similarity=0.659  Sum_probs=218.3

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHH-HHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA-RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ++..++|++++.||+|+||.||+|++..+|+.||+|+++....... ...+.++...++.++||||+++++++.+++..+
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            4567899999999999999999999999999999999976533333 344555555688899999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          136 IILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~-~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      +||||+++ +|.+++..    ...+++..++.++.|++.||.|||+ + |++||||||+||+++.++.+||+|||++...
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999985 88887754    4679999999999999999999998 7 9999999999999999999999999999765


Q ss_pred             cccCCCCcccccCCcccCccee----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          211 ASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      .... ......||+.|+|||++    .+..++.++||||+||++|+|++|..||.....      .............+.
T Consensus       161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~  233 (290)
T 3fme_A          161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------PFQQLKQVVEEPSPQ  233 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------HHHHHHHHHHSCCCC
T ss_pred             cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------hHHHHHHHhccCCCC
Confidence            4332 23345799999999996    455789999999999999999999999975321      122233334444444


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhh
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  340 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~  340 (353)
                      .....+++++.+||.+||+.||++|||++|+++||||+.......+...+++..
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~  287 (290)
T 3fme_A          234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKLI  287 (290)
T ss_dssp             CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCHHHHHHHH
T ss_pred             cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcccccCHHHHHHHh
Confidence            455678999999999999999999999999999999999888888888777543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.8e-51  Score=411.01  Aligned_cols=260  Identities=27%  Similarity=0.502  Sum_probs=228.1

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~  133 (353)
                      .+..++|++++.||+|+||.||+|+++.+++.||||+++...  .......+..|..++..+ +||+|+.++.++.+.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            456789999999999999999999999999999999997542  223345677888888876 79999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+++.....
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            99999999999999999988899999999999999999999999 99999999999999999999999999999865544


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .......+||+.|+|||++.+..|+.++|+|||||++|||++|..||.+.+.       .++...+......  .+..++
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~s  566 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHNVA--YPKSMS  566 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHSSCCC--CCTTSC
T ss_pred             CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhCCCC--CCccCC
Confidence            4455667999999999999999999999999999999999999999987433       3455566655433  345789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCH-----HHHHcCCccccc
Q 018630          294 PEFCSFISACVQKEPQQRLSA-----QELMTHPFLKMY  326 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~~  326 (353)
                      +++.+||.+||+.||++||++     +|+++||||+..
T Consensus       567 ~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            999999999999999999998     999999999865

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-51  Score=402.64  Aligned_cols=262  Identities=28%  Similarity=0.487  Sum_probs=225.2

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      +..++|++.+.||+|+||.||+|+++.+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            56688999999999999999999999999999999987542  1223456789999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          136 IILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +||||++||+|.+++...+  .+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++.....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            9999999999999998654  39999999999999999999999 99999999999999999999999999999875432


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  293 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                       ......+||+.|+|||++.+..++.++|+|||||++|||++|..||...+.....   ..+...+.....  ..+..++
T Consensus       340 -~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~~~~--~~p~~~s  413 (576)
T 2acx_A          340 -QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVPE--EYSERFS  413 (576)
T ss_dssp             -CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHHCCC--CCCTTSC
T ss_pred             -ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhcccc--cCCccCC
Confidence             2334568999999999999989999999999999999999999999875543222   223333333322  2346789


Q ss_pred             HHHHHHHHHhhhhCcCCCC-----CHHHHHcCCccccc
Q 018630          294 PEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMY  326 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  326 (353)
                      +++.+||.+||+.||.+||     +++|+++||||+..
T Consensus       414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            9999999999999999999     89999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-51  Score=376.02  Aligned_cols=264  Identities=23%  Similarity=0.409  Sum_probs=208.0

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc----HHHHHHHHHHHHHHhcC---CCCceEEEeeEeEe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE----ESARRQIAQELKINQSS---QCPYVVVCYQSFYS  130 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l---~hp~iv~~~~~~~~  130 (353)
                      +..++|++++.||+|+||+||+|++..+++.||||++.....    ......+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            345799999999999999999999999999999999864321    11123445566655544   59999999999887


Q ss_pred             cC-----eEEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEee
Q 018630          131 NG-----AISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD  203 (353)
Q Consensus       131 ~~-----~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~D  203 (353)
                      ..     .+++||||+. ++|.+++.....  +++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEEee
Confidence            54     5899999997 599999987644  9999999999999999999999 9999999999999999999999999


Q ss_pred             ccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       204 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      ||+++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+   ....+........
T Consensus       164 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~  239 (308)
T 3g33_A          164 FGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPP  239 (308)
T ss_dssp             CSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHCCCC
T ss_pred             CccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence            9999765432 23455689999999999999999999999999999999999999998754322   1112222221111


Q ss_pred             CCC---------------------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          284 PPS---------------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       284 ~~~---------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ...                     .....+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            000                     00135789999999999999999999999999999998653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.2e-51  Score=398.87  Aligned_cols=264  Identities=27%  Similarity=0.459  Sum_probs=227.5

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .+..++|++++.||+|+||.||+|+++.+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+...+
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            3566899999999999999999999999999999999975421  12346788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      |+||||++||+|.+++...    ..+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+++..
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999999999999764    369999999999999999999998 99999999999999999999999999999876


Q ss_pred             cccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ..........+||+.|+|||++.+..++.++|+|||||++|||++|..||...+...   ...++...+.....  ..+.
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~---~~~~~~~~i~~~~~--~~p~  414 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRVLEQAV--TYPD  414 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC---CHHHHHHHHHHCCC--CCCT
T ss_pred             cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch---hHHHHHHHHhhccc--CCCc
Confidence            544444455689999999999999999999999999999999999999998754332   22334444444433  2346


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCC-----HHHHHcCCccccc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMY  326 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~  326 (353)
                      .+++++.+||.+||+.||++||+     ++++++||||+..
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            78999999999999999999996     5899999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.5e-50  Score=366.06  Aligned_cols=257  Identities=29%  Similarity=0.488  Sum_probs=221.3

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe----cCe
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGA  133 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~----~~~  133 (353)
                      ....|++.+.||+|+||.||+|.+..++..||+|++... ........+.+|+.+++.++||||+++++++..    ...
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            445689999999999999999999999999999998754 345567788999999999999999999998875    466


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCcEEEc-CCCcEEEeeccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLIN-HRGEVKITDFGVSAIM  210 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--iiH~Dlkp~NIll~-~~~~~kl~DfG~a~~~  210 (353)
                      +++||||+++++|.+++.....+++..++.++.|++.||.|||+ +|  ++||||||+||+++ .++.+||+|||++...
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            89999999999999999988899999999999999999999998 88  99999999999997 7889999999998654


Q ss_pred             cccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ...  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.....      .......+.....+.....
T Consensus       183 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~  253 (290)
T 1t4h_A          183 RAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFDK  253 (290)
T ss_dssp             CTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGGGGG
T ss_pred             ccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc------HHHHHHHHhccCCccccCC
Confidence            322  2344579999999998874 589999999999999999999999976432      2344455555555544556


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      ..++++.+||.+||+.||.+|||++|+++||||+.
T Consensus       254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            77899999999999999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.3e-50  Score=386.81  Aligned_cols=269  Identities=25%  Similarity=0.357  Sum_probs=213.5

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec-----Ce
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GA  133 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~-----~~  133 (353)
                      .++|++.+.||+|+||.||+|.++.+++.||||++... .......++.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            47899999999999999999999999999999999754 3345567899999999999999999999998766     67


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+||||+. ++|.+++.....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            999999997 5999999988889999999999999999999999 99999999999999999999999999999876433


Q ss_pred             CC----------------------CCcccccCCcccCccee-cCCCCCccccHHHHHHHHHHHHcCCCC-----------
Q 018630          214 SG----------------------QANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQFP-----------  259 (353)
Q Consensus       214 ~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~P-----------  259 (353)
                      ..                      .....+||++|+|||++ ....++.++|||||||++|||++|..|           
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            21                      23557899999999986 455699999999999999999985444           


Q ss_pred             CCCCccCC----------chhhHHHH------------------------HHHHhcCCCCCC-----CCCCCCHHHHHHH
Q 018630          260 YSPPEQQD----------GWTSFYEL------------------------MEAIVDQPPPSA-----PSDQFSPEFCSFI  300 (353)
Q Consensus       260 f~~~~~~~----------~~~~~~~~------------------------~~~~~~~~~~~~-----~~~~~~~~~~~li  300 (353)
                      |.+.+...          ........                        ...+........     ....+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            43322100          00000000                        111111111000     0145799999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      .+||+.||.+|||++|+++||||+.+.+..
T Consensus       343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          343 ESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            999999999999999999999999876554

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.9e-51  Score=375.40  Aligned_cols=259  Identities=27%  Similarity=0.424  Sum_probs=223.9

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH-----HHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++......     .....+.+|+.+++.+.||||+++++++.+.+.+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            46899999999999999999999999999999998754221     1356788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC----cEEEeeccccccc
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIM  210 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG~a~~~  210 (353)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++    .+||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            9999999999999999988889999999999999999999998 9999999999999999888    7999999999776


Q ss_pred             cccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CC
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--AP  288 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  288 (353)
                      ... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.       .+....+.......  ..
T Consensus       170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~  241 (321)
T 2a2a_A          170 EDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITSVSYDFDEEF  241 (321)
T ss_dssp             CTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCCCCCHHH
T ss_pred             Ccc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcccccChhh
Confidence            533 233456799999999999998999999999999999999999999976432       23333444333221  11


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ...+++.+.+||.+||+.||++|||++|+++||||+...
T Consensus       242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            246789999999999999999999999999999998654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.7e-51  Score=366.73  Aligned_cols=259  Identities=28%  Similarity=0.471  Sum_probs=198.3

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ..++|++.+.||+|+||.||++++..+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            35789999999999999999999999999999999865421  1224678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          137 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      ||||+++++|.+++... ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++........
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            99999999999999865 679999999999999999999998 9999999999999999999999999999987654433


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ......||+.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+       ....+....  ...+..++++
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~--~~~~~~~~~~  238 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-------TLNKVVLAD--YEMPSFLSIE  238 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSSC--CCCCTTSCHH
T ss_pred             cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-------HHHHHhhcc--cCCccccCHH
Confidence            3445679999999999998889999999999999999999999997654322       111221111  1234568999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +.++|.+||+.||++|||++++++||||+...
T Consensus       239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            99999999999999999999999999998654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.4e-51  Score=394.09  Aligned_cols=267  Identities=22%  Similarity=0.313  Sum_probs=201.3

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-----cCe
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS-----NGA  133 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-----~~~  133 (353)
                      .++|++++.||+|+||+||+|.++.+++.||||++... .......++.+|+.+++.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            47899999999999999999999999999999998654 344556789999999999999999999999853     357


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+||||+. ++|.+++.....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            999999985 6999999988889999999999999999999999 99999999999999999999999999999875422


Q ss_pred             C---------------------------CCCcccccCCcccCccee-cCCCCCccccHHHHHHHHHHHHc----------
Q 018630          214 S---------------------------GQANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECAT----------  255 (353)
Q Consensus       214 ~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~----------  255 (353)
                      .                           ......+||++|+|||++ .+..++.++|||||||++|||++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                           123346789999999986 45669999999999999999999          


Q ss_pred             -CCCCCCCCccCCc-----------h--hhHHHHHHHH---h--------------------cCCCC------CCCCCCC
Q 018630          256 -GQFPYSPPEQQDG-----------W--TSFYELMEAI---V--------------------DQPPP------SAPSDQF  292 (353)
Q Consensus       256 -g~~Pf~~~~~~~~-----------~--~~~~~~~~~~---~--------------------~~~~~------~~~~~~~  292 (353)
                       |.++|.+.+....           +  ......+..+   .                    ...+.      .......
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             6677765431000           0  0000111111   0                    00000      0112456


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      ++++.+||.+||+.||++|||++|+++||||+.+..
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            899999999999999999999999999999998753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.2e-50  Score=370.37  Aligned_cols=269  Identities=35%  Similarity=0.571  Sum_probs=232.9

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .+.|++++.||+|+||.||++.+..+++.||||++...........+.+|+.+++.++||||+++++++..+..+++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            36799999999999999999999999999999999766544556788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      |+++++|.+++.. +.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++............
T Consensus       101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence            9999999999875 679999999999999999999998 99999999999999999999999999999876554444455


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (353)
                      ..||+.|+|||.+.+..++.++|+|||||++|+|++|..||...+.       ......+..... ......+++++.+|
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~l~~l  250 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNNP-PTLEGNYSKPLKEF  250 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCC-CCCCSSCCHHHHHH
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-------HHHHHHhhcCCC-CCCccccCHHHHHH
Confidence            6899999999999998999999999999999999999999976432       122233333333 23446789999999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhh
Q 018630          300 ISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFT  338 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~  338 (353)
                      |.+||+.||.+|||+.|+++||||.......-.+.+.++
T Consensus       251 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~  289 (303)
T 3a7i_A          251 VEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELID  289 (303)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTCHHHHHHCCCGGGGHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHhhChhhhcCCCccHHHHHHHH
Confidence            999999999999999999999999887776655555443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.1e-51  Score=397.11  Aligned_cols=261  Identities=27%  Similarity=0.483  Sum_probs=223.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .++|++++.||+|+||+||+|+++.+++.||||++.... .......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999999999999999986431 1223567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc---CCCcEEEeeccccccccccCC
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN---HRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      ||+.+++|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++   .++.+||+|||+++..... .
T Consensus       101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~  178 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-T  178 (486)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-C
Confidence            999999999999888899999999999999999999998 9999999999999995   4567999999999765433 2


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCCCCCC
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFS  293 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  293 (353)
                      .....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.       .+....+......  ...+..++
T Consensus       179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s  250 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYAFDLPQWRTIS  250 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCSCSGGGGGSC
T ss_pred             ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCCcccCCCC
Confidence            3445689999999999876 599999999999999999999999987533       2344444444332  22335689


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      +++.+||.+||+.||.+|||+.|+++||||+.+....
T Consensus       251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence            9999999999999999999999999999999877655

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.1e-50  Score=366.12  Aligned_cols=259  Identities=26%  Similarity=0.374  Sum_probs=227.6

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|++...  ........+.+|+.+++.+.||||+++++++.+++..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            457899999999999999999999999999999998755  234566788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.........
T Consensus        93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            99999999999999888899999999999999999999998 99999999999999999999999999999876544444


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .....||+.|+|||++.+..++.++|+||||+++|+|++|..||.....       .+....+.....  ..+..+++++
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~--~~~~~~~~~~  242 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKKNEY--SIPKHINPVA  242 (294)
T ss_dssp             BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCC--CCCTTSCHHH
T ss_pred             cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhhccC--CCccccCHHH
Confidence            4556899999999999988899999999999999999999999976432       222333333322  2345789999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      .++|.+||+.||++|||++|+++||||+...
T Consensus       243 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          243 ASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence            9999999999999999999999999998654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=371.28  Aligned_cols=253  Identities=26%  Similarity=0.397  Sum_probs=207.5

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHH-hcCCCCceEEEeeEeEecCeEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~-~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ..++|++++.||+|+||+||+|++..+|+.||||++.... ..........|+..+ +...||||+++++++.+.+.+++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            3468999999999999999999999999999999986542 233334444444444 44599999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          137 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      ||||+ +++|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++...... .
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~  211 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-G  211 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEccceeeeecccC-C
Confidence            99999 56999988764 469999999999999999999998 99999999999999999999999999998775433 2


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ......||+.|+|||++.+ .++.++|||||||++|||++|..||...+          ....+.....+......++++
T Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~  280 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYLPPEFTAGLSSE  280 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCCCHHHHTTSCHH
T ss_pred             CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCCCcccccCCCHH
Confidence            3344579999999999876 78999999999999999999976664421          123333333333334578999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      +.+||.+||+.||++|||++|+++||||+.
T Consensus       281 l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            999999999999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-50  Score=396.20  Aligned_cols=261  Identities=25%  Similarity=0.419  Sum_probs=222.9

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH------------HHHHHHHHHHHHHhcCCCCceEEEeeE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE------------SARRQIAQELKINQSSQCPYVVVCYQS  127 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~e~~~~~~l~hp~iv~~~~~  127 (353)
                      .++|.+++.||+|+||+||+|.++.+++.||+|++......            .....+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            47899999999999999999999999999999998754211            234678899999999999999999999


Q ss_pred             eEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC---cEEEeec
Q 018630          128 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDF  204 (353)
Q Consensus       128 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~Df  204 (353)
                      +.+...+++||||++||+|.+++.....+++..+..++.||+.||.|||+ +||+||||||+||+++.++   .+||+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            99999999999999999999999888899999999999999999999998 9999999999999998776   6999999


Q ss_pred             cccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018630          205 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  284 (353)
Q Consensus       205 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  284 (353)
                      |++...... ......+||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+.       .+....+.....
T Consensus       194 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~  264 (504)
T 3q5i_A          194 GLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-------QDIIKKVEKGKY  264 (504)
T ss_dssp             TTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC
T ss_pred             CCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC
Confidence            999876433 3345568999999999987 4699999999999999999999999987533       344445544443


Q ss_pred             CCC--CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          285 PSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       285 ~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      ...  .+..+++++.+||.+||+.||.+|||++|+++||||+.+....
T Consensus       265 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~  312 (504)
T 3q5i_A          265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNI  312 (504)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCC
T ss_pred             CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcc
Confidence            221  2257899999999999999999999999999999999876543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.9e-51  Score=394.64  Aligned_cols=263  Identities=24%  Similarity=0.429  Sum_probs=209.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------C
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~  132 (353)
                      .++|++++.||+|+||.||+|.+..+++.||||++... .......++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            47899999999999999999999999999999998754 2445567889999999999999999999998654      4


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .+|+||||+++ +|.+.+..  .+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            67999999986 67777653  59999999999999999999999 9999999999999999999999999999987543


Q ss_pred             cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH---------------HH
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL---------------ME  277 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~---------------~~  277 (353)
                      . ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..+.+.               ..
T Consensus       217 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          217 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             C-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence            2 2345578999999999999999999999999999999999999999876543322221111               01


Q ss_pred             HHhcCCCCCCC-------CCC-----------CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          278 AIVDQPPPSAP-------SDQ-----------FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       278 ~~~~~~~~~~~-------~~~-----------~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ......+....       +..           .++++.+||.+||+.||++|||++|+++||||+.+.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence            11111110000       000           156799999999999999999999999999998754

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-50  Score=384.74  Aligned_cols=260  Identities=27%  Similarity=0.438  Sum_probs=208.1

Q ss_pred             CccCceee-eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHH-hcCCCCceEEEeeEeEe----cC
Q 018630           59 NLEDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYS----NG  132 (353)
Q Consensus        59 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~hp~iv~~~~~~~~----~~  132 (353)
                      ..++|.+. +.||+|+||+||++.++.+++.||||+++..      ..+.+|+.++ +..+||||+++++++..    ..
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            35678887 7899999999999999999999999998643      2455677775 45689999999998875    67


Q ss_pred             eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC---CCcEEEeecccc
Q 018630          133 AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVS  207 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a  207 (353)
                      .+|+||||++||+|.+++...  ..+++..+..++.||+.||.|||+ +||+||||||+|||++.   ++.+||+|||++
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            899999999999999999864  359999999999999999999998 99999999999999997   789999999999


Q ss_pred             ccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      +..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+...........+. ......+..
T Consensus       212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~-~~~~~~~~~  289 (400)
T 1nxk_A          212 KETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-MGQYEFPNP  289 (400)
T ss_dssp             EECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH-HTCCCCCTT
T ss_pred             cccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH-cCcccCCCc
Confidence            865432 234456899999999999999999999999999999999999999987544322111111111 112222223


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ....+++++.+||.+||+.||++|||+.|+++||||....
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            3457899999999999999999999999999999997643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.6e-50  Score=368.52  Aligned_cols=261  Identities=27%  Similarity=0.440  Sum_probs=222.9

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .++|.+.+.||+|+||.||++++..+|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            368999999999999999999999999999999997542 2234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE---cCCCcEEEeeccccccccccCCC
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+ +|++||||||+||++   +.++.++|+|||++.....  ..
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--~~  163 (304)
T 2jam_A           87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GI  163 (304)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--BT
T ss_pred             cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--Cc
Confidence            99999999999888899999999999999999999998 999999999999999   7788999999999875432  22


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCCCCCCCH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSP  294 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  294 (353)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.       ......+.....  +......+++
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~  236 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------SKLFEKIKEGYYEFESPFWDDISE  236 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCCCccccccCCH
Confidence            3345799999999999998999999999999999999999999976432       233344443332  2233467899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  331 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  331 (353)
                      ++.+||.+||+.||++|||++|+++||||+.......
T Consensus       237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (304)
T 2jam_A          237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHR  273 (304)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSCCC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcccc
Confidence            9999999999999999999999999999987655443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-50  Score=365.74  Aligned_cols=256  Identities=29%  Similarity=0.419  Sum_probs=221.0

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|++.+.||+|+||.||++.+..++..+|+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            679999999999999999999999999999999875532 2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE---cCCCcEEEeeccccccccccCCCC
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      +++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||++   +.++.++|+|||++...... ...
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~~  165 (277)
T 3f3z_A           88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMM  165 (277)
T ss_dssp             CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-SCB
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-cch
Confidence            9999999999888889999999999999999999998 999999999999999   78889999999999765433 234


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC--CCCCCCHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPE  295 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  295 (353)
                      ....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.       .+....+........  ....++++
T Consensus       166 ~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~  237 (277)
T 3f3z_A          166 RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD-------SEVMLKIREGTFTFPEKDWLNVSPQ  237 (277)
T ss_dssp             CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred             hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCCCchhhhcCCHH
Confidence            45689999999999875 489999999999999999999999987543       233344444333221  12368999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +.+||.+||+.||.+|||+.|+++||||+...
T Consensus       238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            99999999999999999999999999998643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.5e-50  Score=364.98  Aligned_cols=260  Identities=31%  Similarity=0.490  Sum_probs=225.7

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .+..++|++.+.||+|+||.||++++..+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            4667899999999999999999999999999999999865421  22246788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++...... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            9999999999999999988899999999999999999999998 99999999999999999999999999998665432 


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                       ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.       ......+.....  ..+..+++
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~--~~~~~~~~  237 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-------TETHRRIVNVDL--KFPPFLSD  237 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCC--CCCTTSCH
T ss_pred             -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-------hHHHHHHhcccc--CCCCcCCH
Confidence             23456799999999999998999999999999999999999999976433       223333433332  23356899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      ++.++|.+||+.||.+|||+.|+++||||+....
T Consensus       238 ~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            9999999999999999999999999999986543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-51  Score=381.14  Aligned_cols=265  Identities=25%  Similarity=0.424  Sum_probs=216.8

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ...++|++++.||+|+||.||+|++..+|+.||||++... ........+.+|+.+++.++||||+++++++.+.+..++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            4568999999999999999999999999999999998655 334456678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.........
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            99999999999888877889999999999999999999999 99999999999999999999999999999876554444


Q ss_pred             CcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh---------------
Q 018630          217 ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---------------  280 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~---------------  280 (353)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+.   .........               
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ---LYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhhhHhhhccc
Confidence            4556899999999999875 689999999999999999999999987543221   111111100               


Q ss_pred             -cCC-CCC--------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          281 -DQP-PPS--------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       281 -~~~-~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                       ... .+.        .....+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence             000 000        0013578999999999999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.4e-50  Score=370.12  Aligned_cols=256  Identities=28%  Similarity=0.430  Sum_probs=209.9

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ....+..++|++.+.||+|+||.||++++  +|+.||||++.... .......+.+|+.++++++||||+++++++...+
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            34456778999999999999999999987  58899999986553 3455678899999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          133 AISIILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~~l~~LH~~~~--iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                      .+++||||+++++|.+++....   .+++..+..++.|++.||+|||+ +|  |+||||||+||+++.++.+||+|||++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            9999999999999999998654   39999999999999999999998 89  999999999999999999999999999


Q ss_pred             ccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      +.............||+.|+|||++.+..++.++|||||||++|+|++|..||...+.       .+....+........
T Consensus       187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~~~~~  259 (309)
T 3p86_A          187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-------AQVVAAVGFKCKRLE  259 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHHHHHSCCCCC
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCC
Confidence            7655444344556899999999999999999999999999999999999999976533       233333333333344


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+..+++++.+||.+||+.||.+|||++++++
T Consensus       260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            45788999999999999999999999999988

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-51  Score=380.84  Aligned_cols=265  Identities=24%  Similarity=0.434  Sum_probs=218.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc----cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....    .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            368999999999999999999999999999999986542    2344578899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 018630          136 IILEYMDGGSLADFLKKV----------------------------------------KTIPEEYLAAICEQVLKGLLYL  175 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~ql~~~l~~L  175 (353)
                      +||||++||+|.+++...                                        ..+++..++.++.|++.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999988521                                        1236778889999999999999


Q ss_pred             HhcCCceecCCCCCcEEEcCCC--cEEEeeccccccccccCC----CCcccccCCcccCcceecC--CCCCccccHHHHH
Q 018630          176 HHEKHIIHRDLKPSNLLINHRG--EVKITDFGVSAIMASTSG----QANTFVGTYNYMSPERISG--GKYGYKSDIWSLG  247 (353)
Q Consensus       176 H~~~~iiH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG  247 (353)
                      |+ +||+||||||+||+++.++  .+||+|||++........    ......||+.|+|||++.+  ..++.++||||||
T Consensus       185 H~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          185 HN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             HH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             HH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence            99 9999999999999998776  899999999986543221    2345679999999999975  5789999999999


Q ss_pred             HHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          248 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       248 ~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      |++|||++|..||...+..       +....+.......  .....+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus       264 ~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~  336 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ  336 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHCCCCCCCCChH-------HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence            9999999999999775432       2333333333222  222357999999999999999999999999999999998


Q ss_pred             cCCCCcC
Q 018630          326 YGDLNVD  332 (353)
Q Consensus       326 ~~~~~~~  332 (353)
                      +.+.-..
T Consensus       337 ~~~~~~~  343 (345)
T 3hko_A          337 FSDKIYK  343 (345)
T ss_dssp             TSSCSSC
T ss_pred             ChHhhEe
Confidence            8766544

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.8e-51  Score=398.79  Aligned_cols=262  Identities=29%  Similarity=0.493  Sum_probs=226.2

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ...++|++.+.||+|+||.||+|+++.+|+.||||++....  .......+.+|+.+++.++||||+++++++.+.+.++
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34578999999999999999999999999999999986542  2334577899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE---cCCCcEEEeeccccccccc
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~  212 (353)
                      +||||+.+++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||++   +.++.+||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            999999999999999988899999999999999999999999 999999999999999   4678999999999976543


Q ss_pred             cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSD  290 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  290 (353)
                      . ......+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+.       .+....+.......  ..+.
T Consensus       182 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~  252 (484)
T 3nyv_A          182 S-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------YDILKKVEKGKYTFELPQWK  252 (484)
T ss_dssp             C-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCSGGGG
T ss_pred             c-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCCCCcccc
Confidence            3 23345689999999999876 699999999999999999999999987543       23444454443322  2235


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      .+++++.+||.+||+.||.+|||+.|+++||||+.+...
T Consensus       253 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          253 KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE  291 (484)
T ss_dssp             GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence            689999999999999999999999999999999987653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-50  Score=379.71  Aligned_cols=259  Identities=28%  Similarity=0.444  Sum_probs=213.7

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-----CCceEEEeeEeE
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----CPYVVVCYQSFY  129 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----hp~iv~~~~~~~  129 (353)
                      ...+..++|++++.||+|+||.||+|++..+++.||||+++..  .........|+.+++.+.     ||||+++++++.
T Consensus        29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            3445568999999999999999999999999999999998743  344556777888888876     999999999999


Q ss_pred             ecCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC------------
Q 018630          130 SNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH------------  195 (353)
Q Consensus       130 ~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~------------  195 (353)
                      ..+..++||||+ +++|.+++....  .+++..++.++.||+.||+|||+ +||+||||||+|||++.            
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhc
Confidence            999999999999 889999998754  59999999999999999999998 99999999999999975            


Q ss_pred             -------------CCcEEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 018630          196 -------------RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  262 (353)
Q Consensus       196 -------------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  262 (353)
                                   ++.+||+|||+++....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                         78999999999976432   23456899999999999999999999999999999999999999987


Q ss_pred             CccCCchhhHHHHHHHHhcCCCC-------------------------C----------------CCCCCCCHHHHHHHH
Q 018630          263 PEQQDGWTSFYELMEAIVDQPPP-------------------------S----------------APSDQFSPEFCSFIS  301 (353)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~-------------------------~----------------~~~~~~~~~~~~li~  301 (353)
                      .+..+    ....+.......+.                         .                ......++.+.+||.
T Consensus       262 ~~~~~----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  337 (360)
T 3llt_A          262 HEHME----HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY  337 (360)
T ss_dssp             SSHHH----HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred             CcHHH----HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence            54321    11111111111100                         0                000112477889999


Q ss_pred             HhhhhCcCCCCCHHHHHcCCccc
Q 018630          302 ACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       302 ~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                      +||+.||.+|||++|+++||||+
T Consensus       338 ~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          338 SILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHhcCChhhCCCHHHHhcCcccC
Confidence            99999999999999999999996

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.3e-51  Score=373.56  Aligned_cols=266  Identities=27%  Similarity=0.420  Sum_probs=213.2

Q ss_pred             cCceee-eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhc-CCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~-l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +.|++. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++.+ .+||||+++++++.+++.+++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            678885 78999999999999999999999999987552 2334678899999888 57999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc---EEEeeccccccccccC-
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTS-  214 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~---~kl~DfG~a~~~~~~~-  214 (353)
                      ||+++++|.+++.....+++..+..++.|++.||+|||+ +||+||||||+||+++.++.   +||+|||++....... 
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            999999999999988899999999999999999999999 99999999999999988776   9999999987653221 


Q ss_pred             ------CCCcccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCC-chh-------hHHHH
Q 018630          215 ------GQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD-GWT-------SFYEL  275 (353)
Q Consensus       215 ------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~-------~~~~~  275 (353)
                            ......+||+.|+|||++.+     ..++.++|||||||++|+|++|..||......+ .|.       .....
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  249 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML  249 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence                  11223569999999999875     458899999999999999999999998754322 111       11223


Q ss_pred             HHHHhcCCCCCC--CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          276 MEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       276 ~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      ...+........  ....+++++.+||.+||+.||.+|||++|+++||||+....
T Consensus       250 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             HHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            344444332211  12468899999999999999999999999999999997643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.5e-50  Score=394.52  Aligned_cols=257  Identities=30%  Similarity=0.477  Sum_probs=218.2

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .++|++++.||+|+||+||+|+++.++..||+|++.... .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            367999999999999999999999999999999987542 2223567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC---CcEEEeeccccccccccCC
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~~~~  215 (353)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||+ +||+||||||+||+++..   +.+||+|||++...... .
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~  193 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-K  193 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-B
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-c
Confidence            999999999999888899999999999999999999998 999999999999999764   45999999999876533 2


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCCCCCC
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFS  293 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  293 (353)
                      .....+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.       .+....+......  ...+..++
T Consensus       194 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s  265 (494)
T 3lij_A          194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------QEILRKVEKGKYTFDSPEWKNVS  265 (494)
T ss_dssp             CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCCCSGGGTTSC
T ss_pred             cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCchhcccCC
Confidence            345568999999999986 5699999999999999999999999987543       2344444444332  22335789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      +++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            999999999999999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.9e-50  Score=372.71  Aligned_cols=259  Identities=26%  Similarity=0.377  Sum_probs=227.1

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ...++|.+.+.||+|+||.||++.+..+++.||+|++...  ........+.+|+.+++.++||||+++++++.+.+.++
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            3457899999999999999999999999999999998754  23456678899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++........
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            999999999999999988899999999999999999999998 9999999999999999999999999999987654444


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....       .+....+.....  ..+..++++
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~--~~~~~~~~~  267 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKKNEY--SIPKHINPV  267 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCC--CCCTTSCHH
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHhcCCC--CCCccCCHH
Confidence            45556899999999999988899999999999999999999999976432       122233333222  234578999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      +.+||.+||+.||++|||++|+++||||+..
T Consensus       268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          268 AASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=373.40  Aligned_cols=264  Identities=34%  Similarity=0.612  Sum_probs=216.1

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEe-----
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYS-----  130 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~-----  130 (353)
                      ....++|++.+.||+|+||.||+|++..+++.||||++.....  ....+.+|+.+++.+ +||||+++++++..     
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3456889999999999999999999999999999999875432  235678899999888 79999999999886     


Q ss_pred             -cCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          131 -NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       131 -~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                       .+.+++||||+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence             56899999999999999999864  579999999999999999999998 99999999999999999999999999999


Q ss_pred             ccccccCCCCcccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ  282 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~  282 (353)
                      ..............||+.|+|||++.     +..++.++|||||||++|+|++|..||...+..       .....+...
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~  249 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLIPRN  249 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcC
Confidence            77654433344567999999999987     456899999999999999999999999764321       222333444


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          283 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      ..+......+++.+.+||.+||+.||.+|||++++++||||+......
T Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~  297 (326)
T 2x7f_A          250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER  297 (326)
T ss_dssp             CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHH
T ss_pred             ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcccc
Confidence            444444567899999999999999999999999999999999766543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-50  Score=375.30  Aligned_cols=261  Identities=26%  Similarity=0.445  Sum_probs=215.9

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCC--CceEEEeeEeEecCeE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQC--PYVVVCYQSFYSNGAI  134 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h--p~iv~~~~~~~~~~~~  134 (353)
                      +..++|++++.||+|+||.||++.+. +++.||||++... ........+.+|+.+++.+.|  |||+++++++..++.+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            45578999999999999999999985 6899999998755 344556788999999999976  9999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ++|||+ .+++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+|||++ ++.+||+|||+++......
T Consensus        85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999995 577999999998899999999999999999999998 9999999999999996 6889999999998764332


Q ss_pred             C--CCcccccCCcccCcceecC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc
Q 018630          215 G--QANTFVGTYNYMSPERISG-----------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD  281 (353)
Q Consensus       215 ~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~  281 (353)
                      .  .....+||+.|+|||++.+           ..++.++|||||||++|||++|..||.....      .......+..
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~  235 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAIID  235 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------HHHHHHHHhc
Confidence            2  1234679999999999864           5689999999999999999999999975322      1223344444


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      .......+...++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            44444455667889999999999999999999999999999986543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-50  Score=379.32  Aligned_cols=263  Identities=27%  Similarity=0.423  Sum_probs=211.6

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------C
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~  132 (353)
                      .++|++++.||+|+||.||+|.+..+|+.||||++... .......++.+|+.+++.++||||+++++++...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            36899999999999999999999999999999998544 3445567889999999999999999999998765      3


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .+|+||||+ +++|.++++. ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            469999999 7799999987 679999999999999999999998 9999999999999999999999999999986542


Q ss_pred             cCCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH----------------
Q 018630          213 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL----------------  275 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~----------------  275 (353)
                         .....++|+.|+|||++.+ ..++.++||||+||++|||++|..||.+.+..+....+...                
T Consensus       181 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  257 (367)
T 1cm8_A          181 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  257 (367)
T ss_dssp             ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             ---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence               2445689999999999987 67999999999999999999999999875543221111110                


Q ss_pred             ----HHHHhcCCC--CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          276 ----MEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       276 ----~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                          +..+.....  ........++++.+||.+||+.||++|||++|+++||||+.+.+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                000000000  01122467899999999999999999999999999999998654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.5e-50  Score=374.97  Aligned_cols=257  Identities=31%  Similarity=0.513  Sum_probs=221.3

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +.|..++.||+|+||.||+|++..+++.||||++....  .......+.+|+++++.++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45999999999999999999999999999999987542  3445577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      ||+. |+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....    .
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----C
Confidence            9997 588888754 4679999999999999999999999 9999999999999999999999999999876542    2


Q ss_pred             cccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          218 NTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ...+||+.|+|||++.   ...++.++|||||||++|||++|..||...+.       ......+.....+......+++
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  280 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPALQSGHWSE  280 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCCCTTSCH
T ss_pred             CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCCCCCCCH
Confidence            3468999999999984   46789999999999999999999999976432       2223344444444445567899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      .+.+||.+||+.||++|||++++++||||.......
T Consensus       281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~  316 (348)
T 1u5q_A          281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  316 (348)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcc
Confidence            999999999999999999999999999998765443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.5e-50  Score=363.34  Aligned_cols=263  Identities=27%  Similarity=0.468  Sum_probs=223.0

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--------cHHHHHHHHHHHHHHhcCC-CCceEEEeeEeE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--------EESARRQIAQELKINQSSQ-CPYVVVCYQSFY  129 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~  129 (353)
                      ..++|++.+.||+|+||.||++.++.+|+.||||++....        .......+.+|+.+++.+. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4589999999999999999999999999999999986542        1234567889999999985 999999999999


Q ss_pred             ecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          130 SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       130 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      .++..++||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++..
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence            999999999999999999999988899999999999999999999998 9999999999999999999999999999976


Q ss_pred             ccccCCCCcccccCCcccCcceec------CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          210 MASTSGQANTFVGTYNYMSPERIS------GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      .... .......|++.|+|||++.      ...++.++||||||+++|+|++|..||...+.       ......+....
T Consensus       174 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~  245 (298)
T 1phk_A          174 LDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMIMSGN  245 (298)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC
T ss_pred             cCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------HHHHHHHhcCC
Confidence            5432 2344567999999999885      45689999999999999999999999976432       22333333332


Q ss_pred             CC--CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          284 PP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       284 ~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      ..  ......+++++.+||.+||+.||.+|||+.|+++||||+....+.
T Consensus       246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (298)
T 1phk_A          246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE  294 (298)
T ss_dssp             CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred             cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence            22  222346899999999999999999999999999999999765543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=379.74  Aligned_cols=252  Identities=25%  Similarity=0.412  Sum_probs=211.8

Q ss_pred             eeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCCC
Q 018630           65 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      ..+.||+|+||.||+|.+..+|+.||+|+++... ......+.+|+.+++.++||||+++++++...+.+++||||++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            3678999999999999999999999999997653 344577899999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE--cCCCcEEEeeccccccccccCCCCcccc
Q 018630          145 SLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI--NHRGEVKITDFGVSAIMASTSGQANTFV  221 (353)
Q Consensus       145 sL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll--~~~~~~kl~DfG~a~~~~~~~~~~~~~~  221 (353)
                      +|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||+  +.++.+||+|||+++...... .....+
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~  249 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVNF  249 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCCCC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cccccc
Confidence            999988654 569999999999999999999998 999999999999999  567789999999998765332 334557


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCCCCCCCHHHHHH
Q 018630          222 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSF  299 (353)
Q Consensus       222 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  299 (353)
                      ||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.       .+....+.....  +......+++++.+|
T Consensus       250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  322 (373)
T 2x4f_A          250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-------AETLNNILACRWDLEDEEFQDISEEAKEF  322 (373)
T ss_dssp             SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred             CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence            99999999999988999999999999999999999999987543       223333333322  222235789999999


Q ss_pred             HHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          300 ISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      |.+||+.||.+|||+.|+++||||+..
T Consensus       323 i~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          323 ISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            999999999999999999999999865

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.6e-50  Score=375.54  Aligned_cols=256  Identities=27%  Similarity=0.520  Sum_probs=219.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-------HHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecC
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-------ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNG  132 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~  132 (353)
                      ++|++.+.||+|+||.||+|.++.+|+.||||++.....       ......+.+|+.+++.+ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            579999999999999999999998999999999875421       23356788999999998 7999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ..++||||++|++|.+++.....+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            999999999999999999988889999999999999999999998 9999999999999999999999999999977653


Q ss_pred             cCCCCcccccCCcccCcceecC------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISG------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      . ......+||+.|+|||++.+      ..++.++|||||||++|+|++|..||...+.       ......+.......
T Consensus       253 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~  324 (365)
T 2y7j_A          253 G-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-------ILMLRMIMEGQYQF  324 (365)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCC
T ss_pred             C-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCC
Confidence            3 23445689999999999853      3588999999999999999999999976432       22333333333221


Q ss_pred             C--CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          287 A--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       287 ~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      .  ....+++++.+||.+||+.||++|||++|+++||||+.
T Consensus       325 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          325 SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            1  22467899999999999999999999999999999974

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.3e-50  Score=361.63  Aligned_cols=260  Identities=26%  Similarity=0.444  Sum_probs=215.4

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..+..++|.+.+.||+|+||.||++.+..+|+.||||++....  .......+.+|+.+++.++||||+++++++...+.
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            3456789999999999999999999999999999999987542  12234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      .++||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999999999999988889999999999999999999998 99999999999999999999999999998765432


Q ss_pred             CCCCcccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                       .......|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.       ......+......  .+..+
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~--~~~~~  234 (276)
T 2h6d_A          165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFKKIRGGVFY--IPEYL  234 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTTS
T ss_pred             -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhcCccc--Cchhc
Confidence             22334578999999999988765 6899999999999999999999976432       2333344333322  24567


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      ++++.++|.+||+.||++|||++|+++||||+..
T Consensus       235 ~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            9999999999999999999999999999999754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9e-51  Score=377.09  Aligned_cols=251  Identities=25%  Similarity=0.422  Sum_probs=218.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-------HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-------ESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      .++|++.+.||+|+||.||+|.++.+++.||||+++....       ......+.+|+.+++.++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            3689999999999999999999999999999999875421       113345778999999999999999999999999


Q ss_pred             eEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          133 AISIILEYMDGG-SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      .+++||||+.+| +|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            999999999766 999999988899999999999999999999999 999999999999999999999999999998764


Q ss_pred             ccCCCCcccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      .. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......             ...  ....+.
T Consensus       182 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~~~--~~~~~~  245 (335)
T 3dls_A          182 RG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------VEA--AIHPPY  245 (335)
T ss_dssp             TT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------TTT--CCCCSS
T ss_pred             CC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------Hhh--ccCCCc
Confidence            33 23445679999999999988876 88999999999999999999999763321             111  112345


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      .+++++.+||.+||+.||++|||++|+++||||+...
T Consensus       246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            6899999999999999999999999999999998643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1e-49  Score=360.51  Aligned_cols=252  Identities=24%  Similarity=0.337  Sum_probs=212.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++... ........+.+|+..+..+ +||||+++++++.+++.+++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            36899999999999999999999999999999998754 2334556788899888888 999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC-----------------
Q 018630          138 LEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-----------------  196 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~-----------------  196 (353)
                      |||+++++|.+++...    ..+++..++.++.|++.||.|||+ +||+||||||+||+++.+                 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            9999999999999765    679999999999999999999999 999999999999999844                 


Q ss_pred             --CcEEEeeccccccccccCCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH
Q 018630          197 --GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY  273 (353)
Q Consensus       197 --~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~  273 (353)
                        ..+||+|||.+......    ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+...+         
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------  235 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------  235 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---------
T ss_pred             CceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---------
Confidence              47999999998765432    234689999999999876 56789999999999999999988775421         


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          274 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                       ....+.....+ ..+..+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       236 -~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          236 -QWHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             -HHHHHHTTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             -HHHHHHcCCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence             12233333332 33467899999999999999999999999999999998643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.7e-50  Score=379.18  Aligned_cols=261  Identities=26%  Similarity=0.440  Sum_probs=216.0

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCC--CCceEEEeeEeEecCeE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQ--CPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~--hp~iv~~~~~~~~~~~~  134 (353)
                      +...+|++++.||+|+||.||++.+.. ++.||||++... ........+.+|+.+++.+.  ||||+++++++..++.+
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            344679999999999999999999874 899999998755 34556678999999999986  59999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |+||| +.+++|.+++.....+++..+..++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||+++......
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            99999 5578999999988899999999999999999999998 9999999999999995 6899999999998764332


Q ss_pred             C--CCcccccCCcccCcceecC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc
Q 018630          215 G--QANTFVGTYNYMSPERISG-----------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD  281 (353)
Q Consensus       215 ~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~  281 (353)
                      .  .....+||+.|+|||++.+           ..++.++|||||||++|||++|..||.....      .......+..
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~~~~~  282 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAIID  282 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------HHHHHHHHhC
Confidence            2  2235689999999999865           3689999999999999999999999975322      1223344444


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          282 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      .......+...++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus       283 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            44433445566899999999999999999999999999999986543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-50  Score=377.58  Aligned_cols=267  Identities=28%  Similarity=0.508  Sum_probs=222.3

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEec---cCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhcC-CCCceEEEeeE
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV---EESARRQIAQELKINQSS-QCPYVVVCYQS  127 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~  127 (353)
                      ...+..++|++.+.||+|+||.||++++.   .+++.||||+++...   .......+.+|+.+++.+ +||||++++++
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  127 (355)
T 1vzo_A           48 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA  127 (355)
T ss_dssp             CCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             cccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence            34566789999999999999999999984   579999999986432   122334567788888888 69999999999


Q ss_pred             eEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          128 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       128 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                      +..++.+++||||+++++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          128 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999999999988899999999999999999999998 99999999999999999999999999999


Q ss_pred             ccccccC-CCCcccccCCcccCcceecCC--CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018630          208 AIMASTS-GQANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  284 (353)
Q Consensus       208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  284 (353)
                      +...... ......+||+.|+|||++.+.  .++.++|||||||++|||++|..||........   ...+...+....+
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~  283 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKSEP  283 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHHHHCCC
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---HHHHHHHHhccCC
Confidence            7653222 223346899999999999863  478999999999999999999999976544322   2233334433332


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhhCcCCCC-----CHHHHHcCCcccccC
Q 018630          285 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  327 (353)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  327 (353)
                        ..+..+++.+.+||.+||+.||++||     |++|+++||||+...
T Consensus       284 --~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          284 --PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             --CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence              23457899999999999999999999     999999999998653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-50  Score=376.03  Aligned_cols=264  Identities=23%  Similarity=0.377  Sum_probs=212.8

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH----HHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      ..++|++.+.||+|+||.||++.+..+|+.||||++......    .....+.+|+.+++.++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            347899999999999999999999999999999998754221    1234678999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      ++||||+++ +|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.....
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            999999986 899888764 468999999999999999999998 99999999999999999999999999999876555


Q ss_pred             CCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC------
Q 018630          214 SGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS------  286 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------  286 (353)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+   ....+...........      
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChhhhhhhcc
Confidence            4445567899999999999764 48999999999999999999999998754321   1222222221111000      


Q ss_pred             ----------------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          287 ----------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       287 ----------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                                      .....+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                            00145678999999999999999999999999999998654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.9e-50  Score=386.01  Aligned_cols=258  Identities=29%  Similarity=0.452  Sum_probs=207.8

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-------cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-------EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      .++|.+.+.||+|+||.||+|.++.+++.||||++....       .......+.+|+.++++++||||+++++++. .+
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            468999999999999999999999999999999987542       1222345789999999999999999999875 55


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC---cEEEeecccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAI  209 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl~DfG~a~~  209 (353)
                      .+++||||+++|+|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+|||++.++   .+||+|||+++.
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            689999999999999999888889999999999999999999998 9999999999999997554   599999999987


Q ss_pred             ccccCCCCcccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          210 MASTSGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      .... ......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||........      ....+.......
T Consensus       292 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~------~~~~i~~~~~~~  364 (419)
T 3i6u_A          292 LGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQITSGKYNF  364 (419)
T ss_dssp             CC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC------HHHHHHTTCCCC
T ss_pred             cCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH------HHHHHhcCCCCC
Confidence            6432 23445689999999999864   5688999999999999999999999976543321      122233332221


Q ss_pred             --CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          287 --APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       287 --~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                        .....+++++.+||.+||+.||++|||++|+++||||+..
T Consensus       365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence              1224689999999999999999999999999999999853

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.6e-50  Score=363.43  Aligned_cols=261  Identities=25%  Similarity=0.444  Sum_probs=220.4

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH-----HHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ++|++.+.||+|+||.||++.+..+++.||+|+++.....     .....+.+|+.+++.++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            6799999999999999999999999999999998754211     13567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC----cEEEeecccccccc
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMA  211 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG~a~~~~  211 (353)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++    .+||+|||++....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            999999999999999888899999999999999999999998 9999999999999998877    89999999997654


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APS  289 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  289 (353)
                      ... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.       .+....+.......  ...
T Consensus       164 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~  235 (283)
T 3bhy_A          164 AGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------QETLTNISAVNYDFDEEYF  235 (283)
T ss_dssp             ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCCCCHHHH
T ss_pred             CCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------HHHHHHhHhcccCCcchhc
Confidence            322 23445789999999999988999999999999999999999999976432       22333333322211  122


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      ..+++.+.+|+.+||+.||++|||+.|+++||||+......
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            46789999999999999999999999999999999765443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-49  Score=362.31  Aligned_cols=264  Identities=23%  Similarity=0.385  Sum_probs=217.9

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      +..++|++++.||+|+||.||++++..+++.||+|++...  ........+.+|+.+++.++||||+++++++..++.++
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            3457899999999999999999999999999999998543  34556678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||++|++|.+++...+++++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++........
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            999999999999999988899999999999999999999998 9999999999999999999999999999976543322


Q ss_pred             -CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCCCCC
Q 018630          216 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQF  292 (353)
Q Consensus       216 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  292 (353)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..      ......+....+.  ......+
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSVPNVTTDVRKDI  240 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCCCCHHHHSCTTS
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccCCCcchhcccCC
Confidence             223457999999999999999999999999999999999999999764321      1222222222221  1234568


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      ++.+.++|.+||+.||.+||+..+.+.++|.+...+
T Consensus       241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            999999999999999999997777777777655443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.3e-49  Score=371.53  Aligned_cols=265  Identities=22%  Similarity=0.388  Sum_probs=218.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec-----CeEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAIS  135 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~-----~~~~  135 (353)
                      ++|++++.||+|+||.||+|.+..+++.||||++...........+.+|+++++.++||||+++++++...     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            68999999999999999999999999999999998665566678899999999999999999999998754     4789


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||+.+ +|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++........
T Consensus       107 iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  183 (364)
T 3qyz_A          107 IVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  183 (364)
T ss_dssp             EEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence            99999975 99999876 569999999999999999999998 9999999999999999999999999999987643322


Q ss_pred             ---CCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH---------------
Q 018630          216 ---QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM---------------  276 (353)
Q Consensus       216 ---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~---------------  276 (353)
                         .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....               
T Consensus       184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  263 (364)
T 3qyz_A          184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  263 (364)
T ss_dssp             BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence               12445899999999987654 58999999999999999999999998765443222111100               


Q ss_pred             --HHHhcCCCCC-----CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          277 --EAIVDQPPPS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       277 --~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                        ..........     .....+++++.+||.+||+.||++|||++|+++||||+.+.+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence              0000000000     011457899999999999999999999999999999998643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.9e-50  Score=373.58  Aligned_cols=264  Identities=25%  Similarity=0.393  Sum_probs=213.9

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-------
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYS-------  130 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-------  130 (353)
                      ..++|++++.||+|+||.||+|+++.+|+.||||++.... .......+.+|+.+++.++||||+++++++..       
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            4589999999999999999999999999999999986542 22234567789999999999999999999876       


Q ss_pred             -cCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          131 -NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       131 -~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                       .+.+++||||+++ +|.+.+... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence             4578999999986 777777653 679999999999999999999998 999999999999999999999999999997


Q ss_pred             ccccc----CCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          209 IMAST----SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       209 ~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      .....    ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+    ....+.......
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~  248 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQLCGSI  248 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCC
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCC
Confidence            65422    122344578999999999876 458999999999999999999999998754322    112222222222


Q ss_pred             CCCCCCC---------------------------CCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          284 PPSAPSD---------------------------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       284 ~~~~~~~---------------------------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      .+...+.                           ..++++.+||.+||+.||++|||++|+++||||+....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            2111110                           02678999999999999999999999999999987543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.2e-50  Score=366.38  Aligned_cols=262  Identities=32%  Similarity=0.560  Sum_probs=217.4

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++..++.+++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            3478999999999999999999999999999999986542 233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++..........
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            99999999998875 4679999999999999999999998 999999999999999999999999999876543322233


Q ss_pred             cccccCCcccCccee-----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-CCCCCCCC
Q 018630          218 NTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQ  291 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  291 (353)
                      ....||+.|+|||++     .+..++.++|||||||++|+|++|..||...+..       .....+.... +....+..
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~  247 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSDPPTLLTPSK  247 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCCSSGGG
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHHHhccCCcccCCccc
Confidence            446799999999998     3567899999999999999999999999764321       2222333332 22233467


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      ++.++.++|.+||+.||++|||+.++++||||+.....
T Consensus       248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence            89999999999999999999999999999999987654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-50  Score=372.30  Aligned_cols=261  Identities=25%  Similarity=0.421  Sum_probs=215.3

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC----
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----  132 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~----  132 (353)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++..  ........+.+|+.+++.++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            347899999999999999999999999999999999765  24455678899999999999999999999887653    


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ..|+||||++|++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            359999999999999999988899999999999999999999998 9999999999999999999999999999976543


Q ss_pred             cCC---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh-cCCCC-CC
Q 018630          213 TSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV-DQPPP-SA  287 (353)
Q Consensus       213 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~-~~  287 (353)
                      ...   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..       ....... ....+ ..
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~  241 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIPPSA  241 (311)
T ss_dssp             -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCCHHH
T ss_pred             cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCCCCccc
Confidence            322   223357899999999999999999999999999999999999999764321       2222222 22221 12


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ....+++++.++|.+||+.||++||++.+++.|+|++...
T Consensus       242 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            2356899999999999999999999999999999998654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-49  Score=363.98  Aligned_cols=261  Identities=36%  Similarity=0.615  Sum_probs=218.6

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      ..++|++.+.||+|+||.||++.+..+|+.||+|++....   ....+.+|+.+++.++||||+++++++..++.+++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            3478999999999999999999999999999999987543   2356788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          139 EYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       139 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      ||+++++|.+++. ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||++..........
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR  182 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence            9999999999997 44679999999999999999999998 999999999999999999999999999998765544444


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-CCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-PPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  296 (353)
                      ....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..       .....+... ......+..+++++
T Consensus       183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l  255 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAIFMIPTNPPPTFRKPELWSDNF  255 (314)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCCcccCCcccCCHHH
Confidence            5568999999999999989999999999999999999999999764321       111222222 22222345678999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      .+||.+||+.||.+|||+.++++||||+......
T Consensus       256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~  289 (314)
T 3com_A          256 TDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS  289 (314)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred             HHHHHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence            9999999999999999999999999999765443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.7e-50  Score=378.84  Aligned_cols=282  Identities=25%  Similarity=0.400  Sum_probs=214.7

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--------
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--------  130 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--------  130 (353)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||++....     ....+|+.+++.++||||+++++++..        
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4578999999999999999999999999999999986542     123479999999999999999998843        


Q ss_pred             ------------------------------cCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Q 018630          131 ------------------------------NGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLH  176 (353)
Q Consensus       131 ------------------------------~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH  176 (353)
                                                    ...+++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                          3458999999985 88777653    467999999999999999999999


Q ss_pred             hcCCceecCCCCCcEEEc-CCCcEEEeeccccccccccCCCCcccccCCcccCcceecCCC-CCccccHHHHHHHHHHHH
Q 018630          177 HEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECA  254 (353)
Q Consensus       177 ~~~~iiH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell  254 (353)
                      + +||+||||||+||+++ .++.+||+|||+++..... .......||+.|+|||++.+.. ++.++||||+||++|||+
T Consensus       159 ~-~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          159 S-LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             T-TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             H-CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence            8 9999999999999998 6889999999999876433 3344568899999999988754 899999999999999999


Q ss_pred             cCCCCCCCCccCCchhhHHHHHHHHhcC---------------CCCC--------CCCCCCCHHHHHHHHHhhhhCcCCC
Q 018630          255 TGQFPYSPPEQQDGWTSFYELMEAIVDQ---------------PPPS--------APSDQFSPEFCSFISACVQKEPQQR  311 (353)
Q Consensus       255 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------~~~~--------~~~~~~~~~~~~li~~~L~~dp~~R  311 (353)
                      +|..||.+.+..+...   .+.......               ..+.        ..+..+++++.+||.+||+.||++|
T Consensus       237 ~g~~pf~~~~~~~~~~---~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          237 LGKPLFSGETSIDQLV---RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HSSCSSCCSSHHHHHH---HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             hCCCCCCCCChHHHHH---HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            9999998754332111   111111000               0000        0234578999999999999999999


Q ss_pred             CCHHHHHcCCcccccCCCCc----CHhHHhhhhCCCcccccccC
Q 018630          312 LSAQELMTHPFLKMYGDLNV----DLSEYFTDAGSPLATLSNLS  351 (353)
Q Consensus       312 pt~~e~l~hp~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  351 (353)
                      ||+.|+++||||+...+...    .-..+-+....+++.+++++
T Consensus       314 ~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (383)
T 3eb0_A          314 INPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFS  357 (383)
T ss_dssp             CCHHHHHTSGGGHHHHHC------------------CCCCSCCC
T ss_pred             CCHHHHhcCHHHHHHHhhccccccccccCCCcccCCCCCCCCCC
Confidence            99999999999987643211    11111122235566677765

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.3e-49  Score=372.51  Aligned_cols=256  Identities=21%  Similarity=0.377  Sum_probs=219.1

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEec-------cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHK-------WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQS  127 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~  127 (353)
                      ..+..++|++.+.||+|+||.||+|++.       .++..||||+++..........+.+|+.+++.+ +||||++++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            4566789999999999999999999874       345689999998776666778899999999999 89999999999


Q ss_pred             eEecCeEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcE
Q 018630          128 FYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  191 (353)
Q Consensus       128 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NI  191 (353)
                      +...+.+|+||||+++|+|.+++....                .++...+..++.||+.||.|||+ +||+||||||+||
T Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NI  234 (370)
T 2psq_A          156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNV  234 (370)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGE
T ss_pred             EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchhhE
Confidence            999999999999999999999998653                47899999999999999999998 9999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCc
Q 018630          192 LINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG  268 (353)
Q Consensus       192 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~  268 (353)
                      |++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..  
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--  312 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--  312 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence            999999999999999986543322  2233467889999999999999999999999999999999 99999875432  


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          269 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                           +....+..... ...+..+++++.++|.+||+.||.+|||+.|++++
T Consensus       313 -----~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          313 -----ELFKLLKEGHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             -----GHHHHHHTTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----HHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                 22333333333 23346789999999999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2e-50  Score=368.28  Aligned_cols=267  Identities=32%  Similarity=0.573  Sum_probs=196.7

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      +.+..++|++.+.||+|+||.||++.+..+++.||||++...........+.+|+.+++.++||||+++++++...+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            34667899999999999999999999998999999999876544455677889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          136 IILEYMDGGSLADFLKK--------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~--------~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                      +||||+++++|.+++..        ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            99999999999999874        3568999999999999999999998 99999999999999999999999999998


Q ss_pred             ccccccCC-----CCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc
Q 018630          208 AIMASTSG-----QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD  281 (353)
Q Consensus       208 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~  281 (353)
                      ........     ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......      ........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~  242 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQN  242 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHTS
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhcc
Confidence            76543211     1234578999999999875 468999999999999999999999998754322      11111111


Q ss_pred             CCC-------CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          282 QPP-------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       282 ~~~-------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      ...       .......+++++.++|.+||+.||.+|||+.|+++||||+...+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            111       112235678999999999999999999999999999999976554

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.7e-50  Score=360.54  Aligned_cols=260  Identities=29%  Similarity=0.497  Sum_probs=220.4

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--cCeEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAIS  135 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~~~~  135 (353)
                      ..++|++.+.||+|+||.||++.++.+++.||+|++.... .......+.+|+.+++.++||||+++++++.+  ++.++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            3578999999999999999999999999999999997553 44566789999999999999999999998754  57899


Q ss_pred             EEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCC-----ceecCCCCCcEEEcCCCcEEEeeccc
Q 018630          136 IILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKH-----IIHRDLKPSNLLINHRGEVKITDFGV  206 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~~-----iiH~Dlkp~NIll~~~~~~kl~DfG~  206 (353)
                      +||||+++++|.+++...    ..+++..++.++.|++.||.|||+ .|     ++||||||+||+++.++.+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            999999999999999754    349999999999999999999998 88     99999999999999999999999999


Q ss_pred             cccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          207 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      ++.............||+.|+|||++.+..++.++||||||+++|+|++|..||...+.       ......+.....+ 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~~~-  234 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFR-  234 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC-
T ss_pred             heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHHHHhhcccc-
Confidence            87654332223345789999999999998999999999999999999999999986532       2334444444433 


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ..+..+++++.++|.+||+.||++|||+.|+++|+|+..-.
T Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            23457899999999999999999999999999999998654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.3e-50  Score=376.38  Aligned_cols=262  Identities=25%  Similarity=0.404  Sum_probs=198.9

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------Ce
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GA  133 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~~  133 (353)
                      ++|++++.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            7899999999999999999999999999999998654 3345567888999999999999999999998653      56


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+|+|++ +++|.+++.. ..+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||+++.... 
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-  184 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-  184 (367)
T ss_dssp             CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred             EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence            89999999 6799998876 679999999999999999999998 9999999999999999999999999999976542 


Q ss_pred             CCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH----------------
Q 018630          214 SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----------------  276 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~----------------  276 (353)
                        .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+....                
T Consensus       185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  262 (367)
T 2fst_X          185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  262 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred             --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence              2345689999999999987 678999999999999999999999998765432211111110                


Q ss_pred             HHHhcCCCC--C----CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          277 EAIVDQPPP--S----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       277 ~~~~~~~~~--~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      .........  .    ......++++.+||.+||+.||++|||++|+++||||+.+.+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence            000000000  0    011356889999999999999999999999999999998654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.6e-50  Score=369.14  Aligned_cols=262  Identities=26%  Similarity=0.452  Sum_probs=217.4

Q ss_pred             cCceee-eeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEE
Q 018630           61 EDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        61 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      ++|.+. +.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.+ .||||+++++++.+.+.+++|
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            567776 89999999999999999999999999987542 223356788999999888 469999999999999999999


Q ss_pred             EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC---CCcEEEeeccccccccc
Q 018630          138 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMAS  212 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~~  212 (353)
                      |||+++|+|.+++...  ..+++..++.++.|++.||+|||+ +||+||||||+||+++.   ++.+||+|||+++....
T Consensus       108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            9999999999998543  679999999999999999999998 99999999999999987   78999999999987643


Q ss_pred             cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc--CCCCCCCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD--QPPPSAPSD  290 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  290 (353)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..       +....+..  ...+.....
T Consensus       187 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~  258 (327)
T 3lm5_A          187 AC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------ETYLNISQVNVDYSEETFS  258 (327)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCCCTTTTT
T ss_pred             cc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHHHhcccccCchhhc
Confidence            32 234468999999999999999999999999999999999999999774432       22222222  222333346


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  331 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  331 (353)
                      .+++.+.+||.+||+.||.+|||++|+++||||+.+.....
T Consensus       259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence            78999999999999999999999999999999998765543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-50  Score=368.27  Aligned_cols=259  Identities=22%  Similarity=0.363  Sum_probs=214.2

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC--eEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISI  136 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~--~~~l  136 (353)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++..........+.+|+++++.++||||+++++++....  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            34789999999999999999999999999999999976544444567789999999999999999999988654  8899


Q ss_pred             EEEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE----cCCCcEEEeecccccc
Q 018630          137 ILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAI  209 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll----~~~~~~kl~DfG~a~~  209 (353)
                      ||||+++++|.+++.....   +++..++.++.|++.||.|||+ +||+||||||+||++    +.++.+||+|||+++.
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999999986533   9999999999999999999999 999999999999999    7778899999999987


Q ss_pred             ccccCCCCcccccCCcccCcceec--------CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc
Q 018630          210 MASTSGQANTFVGTYNYMSPERIS--------GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD  281 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~  281 (353)
                      ..... ......||+.|+|||++.        +..++.++|||||||++|||++|..||.......   ...+.+..+..
T Consensus       166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~  241 (319)
T 4euu_A          166 LEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKEVMYKIIT  241 (319)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG---GCHHHHHHHHH
T ss_pred             cCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc---hhHHHHHHHhc
Confidence            65432 334567999999999886        5678999999999999999999999997543322   12233333333


Q ss_pred             CCCCC-----------------------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCc
Q 018630          282 QPPPS-----------------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  322 (353)
Q Consensus       282 ~~~~~-----------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  322 (353)
                      ..+..                       .....+++.+.+||.+||+.||++|||++|+++||=
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            22211                       111234567899999999999999999999999974

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=361.33  Aligned_cols=266  Identities=32%  Similarity=0.505  Sum_probs=215.2

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ....++|.....||+|+||.||++.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus        18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   96 (295)
T 2clq_A           18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI   96 (295)
T ss_dssp             EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence            344566667779999999999999999999999999987653 3445678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-CCcEEEeeccccccccc
Q 018630          137 ILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMAS  212 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~  212 (353)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.....
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            99999999999999865   246788999999999999999998 99999999999999987 89999999999987654


Q ss_pred             cCCCCcccccCCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      .........||+.|+|||++.+..  ++.++||||||+++|+|++|..||.......     .......... .....+.
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-~~~~~~~  249 (295)
T 2clq_A          176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFK-VHPEIPE  249 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHC-CCCCCCT
T ss_pred             CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhcccc-ccccccc
Confidence            443345568999999999987643  8899999999999999999999996532211     1111111111 2223346


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                      .+++++.+||.+||+.||++|||++|+++||||+...+.+
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  289 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK  289 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-----
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccC
Confidence            7899999999999999999999999999999998765443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.5e-50  Score=370.68  Aligned_cols=277  Identities=36%  Similarity=0.668  Sum_probs=209.3

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHH-HHhcCCCCceEEEeeEeEecCe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK-INQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      .+.+..++|++++.||+|+||.||++.++.+|+.||||+++.........++.+|+. +++.++||||+++++++..++.
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD   95 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence            345667899999999999999999999999999999999987655555556666666 7788899999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          134 ISIILEYMDGGSLADFLKK-----VKTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~-~iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                      .++||||+.+ +|.+++..     ...+++..+..++.|++.||.|||+ + |++||||||+||+++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            9999999985 88888764     4679999999999999999999998 7 9999999999999999999999999999


Q ss_pred             ccccccCCCCcccccCCcccCccee----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      +...... ......||+.|+|||++    .+..++.++|||||||++|+|++|..||...+..      .+....+....
T Consensus       174 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~  246 (327)
T 3aln_A          174 GQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV------FDQLTQVVKGD  246 (327)
T ss_dssp             CC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSC
T ss_pred             eeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH------HHHHHHHhcCC
Confidence            7654332 23334799999999998    4566899999999999999999999999764321      11111222222


Q ss_pred             CCC---CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhh
Q 018630          284 PPS---APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  340 (353)
Q Consensus       284 ~~~---~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~  340 (353)
                      .+.   .....+++++.+||.+||+.||++|||+.|+++||||....+...+....++..
T Consensus       247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~  306 (327)
T 3aln_A          247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKI  306 (327)
T ss_dssp             CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCHHHHHHHH
T ss_pred             CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHHHHHHHHHHH
Confidence            221   122468999999999999999999999999999999999888887777766554

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.3e-49  Score=378.56  Aligned_cols=262  Identities=27%  Similarity=0.408  Sum_probs=210.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------Ce
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GA  133 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~~  133 (353)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....     ....+|+++++.++||||+++++++...      ..
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            357999999999999999999999999999999986542     2234799999999999999999988542      34


Q ss_pred             EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC-CcEEEeeccccc
Q 018630          134 ISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSA  208 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~-~~~kl~DfG~a~  208 (353)
                      +++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+ +.+||+|||+++
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            7899999986 77766643    4679999999999999999999998 999999999999999965 578999999998


Q ss_pred             cccccCCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHH--------
Q 018630          209 IMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI--------  279 (353)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~--------  279 (353)
                      ..... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.   ..+++..+        
T Consensus       206 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~---l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHHHH
T ss_pred             hcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHH
Confidence            75433 234456899999999999765 689999999999999999999999987543221   12222111        


Q ss_pred             ---hcC----CCCCC--------CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcC
Q 018630          280 ---VDQ----PPPSA--------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD  332 (353)
Q Consensus       280 ---~~~----~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~  332 (353)
                         ...    ..+..        ....+++++.+||.+||+.||.+|||+.|+++||||+...+....
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  349 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK  349 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCC
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccccc
Confidence               000    00000        123568999999999999999999999999999999987655443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-49  Score=374.27  Aligned_cols=263  Identities=25%  Similarity=0.423  Sum_probs=204.6

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC------
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~------  132 (353)
                      .++|++++.||+|+||.||+|.+..+++.||||++... ........+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            47899999999999999999999999999999998754 33455677889999999999999999999987654      


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .+|+||||+++ +|.+++.  ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus       104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            78999999975 8888886  469999999999999999999998 9999999999999999999999999999976543


Q ss_pred             cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH---------------HHH
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------LME  277 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---------------~~~  277 (353)
                      . ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..               ...
T Consensus       180 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          180 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             c-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            2 223456899999999999998999999999999999999999999987543221111100               000


Q ss_pred             HHhcCCCCCCC------------C------CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          278 AIVDQPPPSAP------------S------DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       278 ~~~~~~~~~~~------------~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ......+....            +      ...++++.+||.+||+.||++|||++|+++||||+.+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence            00000000000            0      01156799999999999999999999999999998654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2e-50  Score=379.71  Aligned_cols=260  Identities=14%  Similarity=0.157  Sum_probs=196.3

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHH---HHHhcCCCCceEEEe-------eE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQEL---KINQSSQCPYVVVCY-------QS  127 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~---~~~~~l~hp~iv~~~-------~~  127 (353)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++....  .......+.+|+   .+++. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            356999999999999999999999999999999998753  344556677774   45555 799988755       34


Q ss_pred             eEec-----------------CeEEEEEEecCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhcCCcee
Q 018630          128 FYSN-----------------GAISIILEYMDGGSLADFLKKV-KTIPEEYL------AAICEQVLKGLLYLHHEKHIIH  183 (353)
Q Consensus       128 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~------~~i~~ql~~~l~~LH~~~~iiH  183 (353)
                      +..+                 ..+|+||||++ ++|.+++... ..++...+      ..++.||+.||+|||+ +||+|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~ivH  217 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS-KGLVH  217 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEEE
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCcc
Confidence            4333                 34899999998 7999999864 34455555      6777999999999998 99999


Q ss_pred             cCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCC
Q 018630          184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYS  261 (353)
Q Consensus       184 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~  261 (353)
                      |||||+|||++.++.+||+|||+++.....   .....+|+.|+|||++.+  ..++.++|||||||++|||++|..||.
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999999865422   224567799999999987  679999999999999999999999998


Q ss_pred             CCccCCc--hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          262 PPEQQDG--WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       262 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      .......  +...  .................+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       295 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          295 LVTPGIKGSWKRP--SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             BCCTTCTTCCCBC--CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             CcCcccccchhhh--hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            7533211  0000  00000011112222357899999999999999999999999999999998654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.4e-49  Score=367.58  Aligned_cols=264  Identities=27%  Similarity=0.422  Sum_probs=217.2

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec-----CeE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAI  134 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~-----~~~  134 (353)
                      .++|++.+.||+|+||.||++.+..+|+.||||++...........+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            478999999999999999999999999999999997665566677889999999999999999999987654     789


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ++||||+. ++|.+++.. +.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            99999997 599999876 579999999999999999999998 999999999999999999999999999998654221


Q ss_pred             C----------CCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-
Q 018630          215 G----------QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-  282 (353)
Q Consensus       215 ~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-  282 (353)
                      .          .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.    ...+...... 
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~  242 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ----LLLIFGIIGTP  242 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCC
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhCCC
Confidence            1          1223578999999998765 6789999999999999999999999987543211    1111111100 


Q ss_pred             --------------------CCC-C-----CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCC
Q 018630          283 --------------------PPP-S-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  330 (353)
Q Consensus       283 --------------------~~~-~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  330 (353)
                                          .+. .     .....+++++.+||.+||+.||++|||++|+++||||+.+....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence                                000 0     01246789999999999999999999999999999999876544

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.7e-49  Score=377.38  Aligned_cols=261  Identities=29%  Similarity=0.469  Sum_probs=210.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC------CCCceEEEeeEeEecCe
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS------QCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~hp~iv~~~~~~~~~~~  133 (353)
                      ..+|++++.||+|+||.||+|.+..+++.||||+++..  ......+.+|+.+++.+      +|+||+.+++.+...+.
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            46899999999999999999999999999999998754  33345566777766654      67899999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc--EEEeecccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAI  209 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~--~kl~DfG~a~~  209 (353)
                      +++||||+. ++|.+++....  .+++..++.++.||+.||.|||+ +||+||||||+|||++.++.  +||+|||+++.
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            999999996 59999998653  49999999999999999999998 89999999999999999887  99999999976


Q ss_pred             ccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH-------------
Q 018630          210 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM-------------  276 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~-------------  276 (353)
                      ...   .....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+.+..             
T Consensus       252 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~  328 (429)
T 3kvw_A          252 EHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR  328 (429)
T ss_dssp             TTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred             cCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence            432   3345689999999999999999999999999999999999999998765432211111110             


Q ss_pred             -HHHhcCC-CC----------------------------C-------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          277 -EAIVDQP-PP----------------------------S-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       277 -~~~~~~~-~~----------------------------~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                       ....... .+                            .       ......++++.+||.+||++||++|||++|+++
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence             0000000 00                            0       001234788999999999999999999999999


Q ss_pred             CCcccccC
Q 018630          320 HPFLKMYG  327 (353)
Q Consensus       320 hp~~~~~~  327 (353)
                      ||||+...
T Consensus       409 Hpw~~~~~  416 (429)
T 3kvw_A          409 HPWLRRRL  416 (429)
T ss_dssp             STTTC---
T ss_pred             ChhhccCC
Confidence            99999754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.8e-49  Score=374.92  Aligned_cols=263  Identities=29%  Similarity=0.440  Sum_probs=208.2

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC------
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------  132 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~------  132 (353)
                      ...+|++.+.||+|+||+||+|++..+++ +|+|++....     ....+|+++++.++||||+++++++...+      
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            34689999999999999999999986666 8888765431     11236999999999999999999986544      


Q ss_pred             eEEEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc-CCCcEEEeecccc
Q 018630          133 AISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVS  207 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~-~~~~~kl~DfG~a  207 (353)
                      .+++||||+++ ++.+.+.    ....+++..++.++.|++.||+|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus       112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            38999999987 5544433    24679999999999999999999998 9999999999999999 7999999999999


Q ss_pred             ccccccCCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh------
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV------  280 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~------  280 (353)
                      +..... .......||+.|+|||++.+. .++.++||||+||++|||++|..||.+.+..+..   ..+.....      
T Consensus       190 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          190 KILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL---VEIIKVLGTPSREQ  265 (394)
T ss_dssp             EECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCHHH
T ss_pred             ccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHH
Confidence            876433 234456889999999999765 5899999999999999999999999875433211   11111100      


Q ss_pred             ---------cCCCCC--------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCH
Q 018630          281 ---------DQPPPS--------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  333 (353)
Q Consensus       281 ---------~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~  333 (353)
                               ....+.        .....+++++.+||.+||+.||.+|||+.|+++||||+...+....+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~  335 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARM  335 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCC
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccC
Confidence                     000000        01234789999999999999999999999999999999877655443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.7e-51  Score=383.44  Aligned_cols=249  Identities=17%  Similarity=0.214  Sum_probs=203.6

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHH---HHHhcCCCCceEEEe-------eE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQEL---KINQSSQCPYVVVCY-------QS  127 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~---~~~~~l~hp~iv~~~-------~~  127 (353)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++...  ........+.+|+   ++++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            47899999999999999999999989999999998743  2334567788999   555666899999998       55


Q ss_pred             eEecC-----------------eEEEEEEecCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhcCCcee
Q 018630          128 FYSNG-----------------AISIILEYMDGGSLADFLKKVKTIPE-------EYLAAICEQVLKGLLYLHHEKHIIH  183 (353)
Q Consensus       128 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~l~~-------~~~~~i~~ql~~~l~~LH~~~~iiH  183 (353)
                      +..++                 ..|+||||+ +|+|.+++...+.+++       ..+..++.|++.||+|||+ +||+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH  229 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVH  229 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence            55443                 389999999 5799999987655655       7888899999999999999 99999


Q ss_pred             cCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCCcccCcceecCC-----------CCCccccHHHHHHHHHH
Q 018630          184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-----------KYGYKSDIWSLGLVLLE  252 (353)
Q Consensus       184 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~e  252 (353)
                      |||||+|||++.++.+||+|||+++....   .....+| +.|+|||++.+.           .++.++|||||||++||
T Consensus       230 rDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            99999999999999999999999976332   2345577 999999999877           79999999999999999


Q ss_pred             HHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          253 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       253 ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      |++|..||...+......       .+.      .....+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       306 lltg~~Pf~~~~~~~~~~-------~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          306 IWCADLPITKDAALGGSE-------WIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHSSCCC------CCSG-------GGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HHHCCCCCcccccccchh-------hhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            999999997654432211       111      11257899999999999999999999999999999998643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3e-49  Score=358.55  Aligned_cols=259  Identities=27%  Similarity=0.492  Sum_probs=221.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+++++.++||||+++++++...+.+++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            468999999999999999999999999999999986542 2234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC---CcEEEeeccccccccccCC
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~~~~  215 (353)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.+   +.+||+|||++...... .
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~-~  178 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-T  178 (287)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-S
T ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-C
Confidence            999999999999888899999999999999999999998 999999999999999754   46999999998765433 2


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CCCCCCC
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFS  293 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  293 (353)
                      ......||+.|+|||.+.+ .++.++|+||||+++|+|++|..||...+.       ......+.......  .....++
T Consensus       179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYAFDLPQWRTIS  250 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCSGGGTTSC
T ss_pred             ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCCchhhhhcC
Confidence            2344578999999999875 489999999999999999999999987432       23334444433222  2235789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      +++.++|.+||+.||++|||+.|+++||||+.+.+
T Consensus       251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence            99999999999999999999999999999997654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.9e-49  Score=359.01  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=216.0

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      +..++|.+.+.||+|+||.||++.+..+++.||+|++... .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            4568999999999999999999999999999999988543 456677899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          138 LEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      |||+++++|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++........
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999999999987 4679999999999999999999999 99999999999999999999999999999775432221


Q ss_pred             C--------------cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc--hhhHHHHHHHHh
Q 018630          217 A--------------NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG--WTSFYELMEAIV  280 (353)
Q Consensus       217 ~--------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~  280 (353)
                      .              ...+||+.|+|||++.+..++.++|||||||++|||++|..||........  ..........  
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--  242 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR--  242 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence            1              145799999999999999999999999999999999999999876433221  1111111111  


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                            ..+..+++++.+++.+||+.||++|||+.++++  |++
T Consensus       243 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~  278 (310)
T 3s95_A          243 ------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE  278 (310)
T ss_dssp             ------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred             ------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence                  113467889999999999999999999999987  444

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.2e-49  Score=361.05  Aligned_cols=276  Identities=33%  Similarity=0.658  Sum_probs=214.6

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHH-HHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA-RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ....++|++++.||+|+||.||+|.++.+|+.||||++........ ...+.++..+++.++||||+++++++..++.++
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            4567899999999999999999999999999999999976644333 344455556788889999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          136 IILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~-~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +||||+ ++.+..+... ...+++..+..++.|++.||.|||+ + |++||||||+||+++.++.+||+|||++......
T Consensus       101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            999999 5567666654 4679999999999999999999998 5 9999999999999999999999999998765432


Q ss_pred             CCCCcccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC-C
Q 018630          214 SGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-A  287 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~  287 (353)
                      . ......||+.|+|||++.     ...++.++|||||||++|+|++|..||.....      ..+....+.....+. .
T Consensus       179 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~  251 (318)
T 2dyl_A          179 K-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------DFEVLTKVLQEEPPLLP  251 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHHSCCCCCC
T ss_pred             c-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc------cHHHHHHHhccCCCCCC
Confidence            2 233457899999999984     45688999999999999999999999976322      123333333333322 2


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhhC
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAG  341 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~  341 (353)
                      ....+++++.+||.+||+.||.+|||++++++||||+.+.....++..|+.+..
T Consensus       252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~  305 (318)
T 2dyl_A          252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVM  305 (318)
T ss_dssp             SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSCCCHHHHHHHHH
T ss_pred             ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccccchhHHHhhccc
Confidence            234689999999999999999999999999999999999999999999997754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.2e-49  Score=360.93  Aligned_cols=259  Identities=24%  Similarity=0.379  Sum_probs=221.1

Q ss_pred             CCCCCCCccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeE
Q 018630           53 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQS  127 (353)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~  127 (353)
                      .....+..++|.+.+.||+|+||.||+|.+.     .+++.||+|+++..........+.+|+.+++.++||||++++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            3455677799999999999999999999883     45689999999876666777889999999999999999999999


Q ss_pred             eEecCeEEEEEEecCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCCcee
Q 018630          128 FYSNGAISIILEYMDGGSLADFLKKVKT------------------------IPEEYLAAICEQVLKGLLYLHHEKHIIH  183 (353)
Q Consensus       128 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------l~~~~~~~i~~ql~~~l~~LH~~~~iiH  183 (353)
                      +...+..++||||+++++|.+++.....                        +++..++.++.|++.||.|||+ +||+|
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH  173 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVH  173 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCcc
Confidence            9999999999999999999999986543                        8999999999999999999998 99999


Q ss_pred             cCCCCCcEEEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCC
Q 018630          184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY  260 (353)
Q Consensus       184 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf  260 (353)
                      |||||+||+++.++.+||+|||+++.......  ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999976543322  1223457889999999998889999999999999999999 99999


Q ss_pred             CCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          261 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ...+...       ....+.... ....+..+++++.++|.+||+.||++|||+.|++++
T Consensus       254 ~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          254 PGIPPER-------LFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TTCCGGG-------HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHH-------HHHHhhcCC-cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8754422       223333333 233446789999999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.4e-49  Score=362.66  Aligned_cols=255  Identities=23%  Similarity=0.367  Sum_probs=217.7

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ..+..++|++.+.||+|+||.||++.+..+++   .||||+++..........+.+|+.+++.++||||+++++++.+++
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            45677899999999999999999999986554   599999987666677788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            999999999999999999754 679999999999999999999998 999999999999999999999999999998764


Q ss_pred             ccCCC---CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          212 STSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       212 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      .....   .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.....       .+....+...... .
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~~~~~~~~~~~~~-~  274 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-------RDVISSVEEGYRL-P  274 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTTCCC-C
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHcCCCC-C
Confidence            33221   122346778999999998899999999999999999999 9999976432       2344444444332 2


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+..+++++.+||.+||+.||++|||+.++++
T Consensus       275 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          275 APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            34678999999999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.7e-49  Score=364.68  Aligned_cols=261  Identities=22%  Similarity=0.371  Sum_probs=212.4

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEe--cCeEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYS--NGAIS  135 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~--~~~~~  135 (353)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++...    ...+.+|+.+++.+. ||||+++++++.+  ....+
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            3478999999999999999999999999999999987542    356889999999997 9999999999987  67899


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-cEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  214 (353)
                      +||||+.+++|.++++   .+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||+++..... 
T Consensus       110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-  184 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-  184 (330)
T ss_dssp             EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-
T ss_pred             EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-
Confidence            9999999999999875   48999999999999999999998 9999999999999999777 8999999999765433 


Q ss_pred             CCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCC-chhhH------HHHHHHHhcCCC--
Q 018630          215 GQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD-GWTSF------YELMEAIVDQPP--  284 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~------~~~~~~~~~~~~--  284 (353)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .....      ......+.....  
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence            23445689999999999987 568999999999999999999999995432211 00000      000011111100  


Q ss_pred             --------------------CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          285 --------------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       285 --------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                                          .......+++++.+||.+||+.||.+|||++|+++||||+...+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                                01112237999999999999999999999999999999997654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.6e-49  Score=366.24  Aligned_cols=258  Identities=30%  Similarity=0.473  Sum_probs=212.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-------cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-------EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....       .......+.+|+.+++.++||||+++++++..+. 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            68999999999999999999999999999999986542       1223346889999999999999999999887554 


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc---EEEeeccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIM  210 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~---~kl~DfG~a~~~  210 (353)
                      +++||||+++++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.   +||+|||++...
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence            89999999999999999888899999999999999999999998 99999999999999987664   999999999765


Q ss_pred             cccCCCCcccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--
Q 018630          211 ASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--  285 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--  285 (353)
                      .... ......||+.|+|||++.   ...++.++|||||||++|+|++|..||........      ....+......  
T Consensus       168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~  240 (322)
T 2ycf_A          168 GETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQITSGKYNFI  240 (322)
T ss_dssp             CCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC------HHHHHHHTCCCCC
T ss_pred             cccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH------HHHHHHhCccccC
Confidence            4221 123457899999999974   45689999999999999999999999976544321      11222222221  


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +.....+++++.+||.+||+.||++|||++++++||||+...
T Consensus       241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence            112246789999999999999999999999999999998653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=372.62  Aligned_cols=259  Identities=24%  Similarity=0.364  Sum_probs=219.6

Q ss_pred             CCCccCceeeeeecccCCeEEEEEE-----eccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQ-----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      .+..++|++++.||+|+||.||+|+     +..+++.||||+++..........+.+|+.+++.++||||+++++++...
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4566899999999999999999999     45577899999997665666677899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC---cEEE
Q 018630          132 GAISIILEYMDGGSLADFLKKVK-------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKI  201 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~---~~kl  201 (353)
                      ...++||||+++|+|.+++....       .+++..++.++.|++.||.|||+ +||+||||||+|||++.++   .+||
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCceEEE
Confidence            99999999999999999998653       48999999999999999999999 9999999999999999555   5999


Q ss_pred             eeccccccccccC--CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHH
Q 018630          202 TDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA  278 (353)
Q Consensus       202 ~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~  278 (353)
                      +|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++ |..||...+.       .+....
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------~~~~~~  298 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEF  298 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHH
Confidence            9999997653222  22334568999999999998899999999999999999998 9999976432       344445


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          279 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                      +...... ..+..+++++.+||.+||+.||++|||+.++++|.++-
T Consensus       299 i~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          299 VTSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCC-CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            5444433 33467899999999999999999999999999987664

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.9e-49  Score=372.72  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=219.9

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..+.+..++|++.+.||+|+||.||++.++.+++.||||+++..........+.+|+++++.++||||+++++++..++.
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence            34567788999999999999999999999989999999999866556666788999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      +++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ +|++||||||+|||++.++.+||+|||+++....
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            99999999999999999865 469999999999999999999999 9999999999999999999999999999976432


Q ss_pred             cCCCC--cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          213 TSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       213 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      .....  ....+++.|+|||++.+..++.++|||||||++|||++ |..||...+.       .+....+...... ..+
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~  337 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-------QQTREFVEKGGRL-PCP  337 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-------HHHHHHHHTTCCC-CCC
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC-CCC
Confidence            21111  12235778999999998889999999999999999998 9999977432       2333334443332 334


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+++++.+||.+||+.||++|||++++++
T Consensus       338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            678999999999999999999999999976

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1e-48  Score=357.65  Aligned_cols=257  Identities=25%  Similarity=0.435  Sum_probs=214.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc---HHHHHHHHHHHHHHhcCCCCceEEEeeEeE--ecCeE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---ESARRQIAQELKINQSSQCPYVVVCYQSFY--SNGAI  134 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~--~~~~~  134 (353)
                      .++|++.+.||+|+||.||++.+..+++.||+|+++....   ......+.+|+.+++.++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            4789999999999999999999999999999999875421   234577899999999999999999999984  45689


Q ss_pred             EEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          135 SIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ++||||+.++ |.+++..  ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            9999999875 8787765  3579999999999999999999998 9999999999999999999999999999976542


Q ss_pred             cC--CCCcccccCCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          213 TS--GQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       213 ~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      ..  .......||+.|+|||++.+..  ++.++|||||||++|+|++|..||...+.       .+....+.....  ..
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~~--~~  232 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YKLFENIGKGSY--AI  232 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCC--CC
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHHHHhcCCC--CC
Confidence            22  1223457899999999997654  47899999999999999999999976432       233444444332  23


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +..+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       233 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          233 PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence            457899999999999999999999999999999998754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-49  Score=371.98  Aligned_cols=258  Identities=27%  Similarity=0.413  Sum_probs=217.3

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEE-----eccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQ-----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  128 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~  128 (353)
                      .+.+..++|++.+.||+|+||.||+|+     +..+++.||||+++..........+.+|++++..+ +||||+++++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            445677899999999999999999999     55677899999998766666678899999999999 789999999998


Q ss_pred             EecC-eEEEEEEecCCCCHHHHHHhcCC----------------------------------------------------
Q 018630          129 YSNG-AISIILEYMDGGSLADFLKKVKT----------------------------------------------------  155 (353)
Q Consensus       129 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------  155 (353)
                      ...+ .+++||||+++|+|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            8754 58999999999999999976432                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CCcc
Q 018630          156 --------------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANT  219 (353)
Q Consensus       156 --------------l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~  219 (353)
                                    +++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.......  ....
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence                          8999999999999999999999 9999999999999999999999999999976543222  2234


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018630          220 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  298 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ..||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+      .....+..... ...+..+++++.+
T Consensus       255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~-~~~~~~~~~~l~~  327 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTR-MRAPDYTTPEMYQ  327 (359)
T ss_dssp             CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCC-CCCCTTCCHHHHH
T ss_pred             cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCC-CCCCCCCCHHHHH
Confidence            568899999999998899999999999999999998 999997754321      22222333222 2334678999999


Q ss_pred             HHHHhhhhCcCCCCCHHHHHcC
Q 018630          299 FISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       299 li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ++.+||+.||.+|||++|+++|
T Consensus       328 li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHHH
Confidence            9999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-48  Score=361.44  Aligned_cols=260  Identities=23%  Similarity=0.420  Sum_probs=212.2

Q ss_pred             CCccCceeeeeecccCCeEEEEEEe-ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCC------ceEEEeeEeEe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQH-KWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP------YVVVCYQSFYS  130 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp------~iv~~~~~~~~  130 (353)
                      ...++|++.+.||+|+||.||+|.+ ..+++.||||+++..  ......+.+|+.+++.++|+      +++++++++..
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            3347999999999999999999998 567899999998754  33456677888887776554      59999999999


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-------------
Q 018630          131 NGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-------------  195 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-------------  195 (353)
                      .+.+++||||+ +++|.+++...+  .+++..+..++.|++.||+|||+ +||+||||||+||+++.             
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999999 789999998764  68999999999999999999998 99999999999999987             


Q ss_pred             ------CCcEEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch
Q 018630          196 ------RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW  269 (353)
Q Consensus       196 ------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  269 (353)
                            ++.+||+|||+++....   ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+  
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE--  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH--
T ss_pred             ccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH--
Confidence                  66899999999976432   2345689999999999999899999999999999999999999998754322  


Q ss_pred             hhHHHHHHHHhcCCCC---------------------------------------CCCCCCCCHHHHHHHHHhhhhCcCC
Q 018630          270 TSFYELMEAIVDQPPP---------------------------------------SAPSDQFSPEFCSFISACVQKEPQQ  310 (353)
Q Consensus       270 ~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~li~~~L~~dp~~  310 (353)
                        ....+..+....+.                                       .......++++.+||.+||+.||.+
T Consensus       242 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          242 --HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             --HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             --HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence              11112222111100                                       0011223577999999999999999


Q ss_pred             CCCHHHHHcCCcccccCC
Q 018630          311 RLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       311 Rpt~~e~l~hp~~~~~~~  328 (353)
                      |||+.|+++||||+...+
T Consensus       320 Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          320 RITLREALKHPFFDLLKK  337 (339)
T ss_dssp             SCCHHHHTTSGGGGGGGC
T ss_pred             ccCHHHHhcCHHHHHHhc
Confidence            999999999999997654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.3e-49  Score=373.67  Aligned_cols=259  Identities=27%  Similarity=0.415  Sum_probs=209.2

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC--------CCceEEEeeEeE-
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ--------CPYVVVCYQSFY-  129 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--------hp~iv~~~~~~~-  129 (353)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++..  ......+.+|+.+++.+.        |+||+++++.+. 
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            347899999999999999999999999999999998744  344567888999888774        788999999987 


Q ss_pred             ---ecCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCcEEEcCCC------
Q 018630          130 ---SNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINHRG------  197 (353)
Q Consensus       130 ---~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~-~iiH~Dlkp~NIll~~~~------  197 (353)
                         ....+++||||+ +++|.+++...  ..+++..++.++.||+.||.|||+ + ||+||||||+|||++.++      
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhh
Confidence               456899999999 55777776554  569999999999999999999998 7 999999999999998775      


Q ss_pred             -------------------------------------------cEEEeeccccccccccCCCCcccccCCcccCcceecC
Q 018630          198 -------------------------------------------EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG  234 (353)
Q Consensus       198 -------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  234 (353)
                                                                 .+||+|||+++.....   ....+||+.|+|||++.+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHT
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcC
Confidence                                                       7999999999765432   344589999999999999


Q ss_pred             CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH--HHHHhcCCCC---------------------------
Q 018630          235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--MEAIVDQPPP---------------------------  285 (353)
Q Consensus       235 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~---------------------------  285 (353)
                      ..++.++|||||||++|||++|..||...+..+........  +.......+.                           
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            89999999999999999999999999875544322221111  1111111000                           


Q ss_pred             ----------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          286 ----------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       286 ----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                                .......++++.+||.+||+.||++|||++|+++||||+
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                      000122346788999999999999999999999999997

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-48  Score=365.98  Aligned_cols=258  Identities=23%  Similarity=0.372  Sum_probs=221.8

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccC-------CcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEe
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT-------GQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCY  125 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~  125 (353)
                      ..+.+..++|.+.+.||+|+||.||+|++..+       +..||||+++..........+.+|+++++.+ +||||++++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            34567778999999999999999999997543       3579999998776667778899999999999 899999999


Q ss_pred             eEeEecCeEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCC
Q 018630          126 QSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS  189 (353)
Q Consensus       126 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~  189 (353)
                      +++..++..++||||+++|+|.+++....                .+++..++.++.|++.||.|||+ +||+||||||+
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~  220 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAAR  220 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGG
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCcc
Confidence            99999999999999999999999998753                48999999999999999999998 99999999999


Q ss_pred             cEEEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccC
Q 018630          190 NLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ  266 (353)
Q Consensus       190 NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~  266 (353)
                      ||+++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+. 
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-  299 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-  299 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence            99999999999999999986643322  2233467889999999999999999999999999999999 9999976432 


Q ss_pred             CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          267 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                            .+....+...... ..+..+++++.+||.+||+.||++|||+.|++++
T Consensus       300 ------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          300 ------EELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             ------HHHHHHHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------HHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                  2344444444333 3346789999999999999999999999999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.6e-48  Score=359.49  Aligned_cols=264  Identities=22%  Similarity=0.342  Sum_probs=198.9

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCc---EEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      ..+..++|++.+.||+|+||.||+|.+..++.   .||||+++... .......+.+|+.+++.++||||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            34566899999999999999999999887765   89999987542 344567899999999999999999999998876


Q ss_pred             CeE------EEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcE
Q 018630          132 GAI------SIILEYMDGGSLADFLKKVK------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV  199 (353)
Q Consensus       132 ~~~------~lv~e~~~~gsL~~~l~~~~------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~  199 (353)
                      ...      ++||||+.+++|.+++....      .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCE
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCCCE
Confidence            554      99999999999999997543      59999999999999999999999 999999999999999999999


Q ss_pred             EEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHH
Q 018630          200 KITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM  276 (353)
Q Consensus       200 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~  276 (353)
                      ||+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+       ..
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~  249 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------IY  249 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HH
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-------HH
Confidence            9999999976543322  1223456788999999998899999999999999999999 999998755432       23


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCC-------HHHHHcCCcccccCC
Q 018630          277 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-------AQELMTHPFLKMYGD  328 (353)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-------~~e~l~hp~~~~~~~  328 (353)
                      ..+..... ...+..+++++.+|+.+||+.||++|||       +++++.|||+.....
T Consensus       250 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          250 NYLIGGNR-LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             HHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             HHHhcCCC-CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence            33333332 2334678999999999999999999999       788899999986543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.6e-49  Score=368.38  Aligned_cols=261  Identities=26%  Similarity=0.432  Sum_probs=210.7

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE-----
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI-----  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~-----  134 (353)
                      ++|.+.+.||+|+||.||+|.++.+|+.||||++... ........+.+|+.+++.++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            6899999999999999999999999999999998754 3445567889999999999999999999999876654     


Q ss_pred             -EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          135 -SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       135 -~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                       ++||||+. ++|.+++.  ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.... 
T Consensus       122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-  196 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-  196 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred             EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence             99999997 58988874  459999999999999999999999 9999999999999999999999999999976532 


Q ss_pred             CCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH------------------
Q 018630          214 SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE------------------  274 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~------------------  274 (353)
                        .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.......                  
T Consensus       197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  274 (371)
T 4exu_A          197 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  274 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred             --CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence              2345678999999999987 6789999999999999999999999987543221111100                  


Q ss_pred             --HHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          275 --LMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       275 --~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                        ....+......  ......+++++.+||.+||+.||++|||++|+++||||+.+.+
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence              00000000000  0012357899999999999999999999999999999987643

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.3e-49  Score=361.98  Aligned_cols=272  Identities=24%  Similarity=0.423  Sum_probs=214.5

Q ss_pred             ccCceeeeeecccCCeEEEEEEec-cCCcEEEEEEeeccccH-HHHHHHHHHHHHHhcC---CCCceEEEeeEeE-----
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHK-WTGQFFALKVIQMNVEE-SARRQIAQELKINQSS---QCPYVVVCYQSFY-----  129 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l---~hp~iv~~~~~~~-----  129 (353)
                      .++|++.+.||+|+||.||+|++. .+++.||+|+++..... .....+.+|+.+++.+   .||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            478999999999999999999995 67889999998654221 1122345566665544   8999999999987     


Q ss_pred             ecCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          130 SNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       130 ~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                      ....+++||||+. ++|.+++....  .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCCCEEEecCccc
Confidence            5578999999998 59999998753  48999999999999999999998 99999999999999999999999999999


Q ss_pred             ccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC----
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP----  283 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----  283 (353)
                      +...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+   ....+........    
T Consensus       168 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          168 RIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGGGS
T ss_pred             ccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCcccC
Confidence            7654322 2345678999999999999899999999999999999999999998754321   1112221111000    


Q ss_pred             -----------------CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHh
Q 018630          284 -----------------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF  337 (353)
Q Consensus       284 -----------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~  337 (353)
                                       ........+++++.+||.+||+.||.+|||+.|+++||||+.......++...+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~  314 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSHL  314 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCCC-----
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhhhhccCC
Confidence                             001123468899999999999999999999999999999998876665555443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-48  Score=362.16  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=219.0

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      .+..++|++++.||+|+||.||++++.     .+++.||||+++..........+.+|+.+++.++||||+++++++..+
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            456789999999999999999999987     345899999998766666778899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCC
Q 018630          132 GAISIILEYMDGGSLADFLKKV------------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK  187 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlk  187 (353)
                      +.+++||||+++++|.+++...                        ..+++..++.++.|++.||.|||+ +||+|||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlk  201 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLA  201 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCS
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCC
Confidence            9999999999999999999763                        568999999999999999999998 999999999


Q ss_pred             CCcEEEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCc
Q 018630          188 PSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPE  264 (353)
Q Consensus       188 p~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~  264 (353)
                      |+||+++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999976543221  2234567899999999998889999999999999999999 999997643


Q ss_pred             cCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          265 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .       .+....+.....+ ..+..+++++.++|.+||+.||++|||+.++++
T Consensus       282 ~-------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          282 H-------EEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             H-------HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             h-------HHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            2       3344445444433 334678999999999999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.7e-49  Score=367.38  Aligned_cols=261  Identities=30%  Similarity=0.502  Sum_probs=219.8

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH----------------HHHHHHHHHHHHHhcCCCCc
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE----------------SARRQIAQELKINQSSQCPY  120 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~e~~~~~~l~hp~  120 (353)
                      ....++|++.+.||+|+||.||+|.+  +++.||||++......                .....+.+|+.+++.++|||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            34468999999999999999999998  8999999998744211                11267899999999999999


Q ss_pred             eEEEeeEeEecCeEEEEEEecCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEE
Q 018630          121 VVVCYQSFYSNGAISIILEYMDGGSLADF------LKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  192 (353)
Q Consensus       121 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIl  192 (353)
                      |+++++++.+++..++||||+++++|.++      +..  ...+++..++.++.|++.||.|||+.+|++||||||+||+
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999999999999999999999999998      655  5779999999999999999999996479999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCCCCcccccCCcccCcceecCC-CCCc-cccHHHHHHHHHHHHcCCCCCCCCccCCchh
Q 018630          193 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGY-KSDIWSLGLVLLECATGQFPYSPPEQQDGWT  270 (353)
Q Consensus       193 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~~  270 (353)
                      ++.++.+||+|||++......  ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||......    
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            999999999999999775433  33456799999999999887 5666 999999999999999999999865432    


Q ss_pred             hHHHHHHHHhcCCCCCCC-----------------CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          271 SFYELMEAIVDQPPPSAP-----------------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                        .+....+.........                 ...+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       259 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          259 --VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             --HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             --HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence              2334444444322211                 156899999999999999999999999999999998654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.5e-48  Score=352.67  Aligned_cols=258  Identities=31%  Similarity=0.529  Sum_probs=209.3

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      ....++|++.+.||+|+||.||++.+..+|+.||||+++..  ........+.+|+.+++.++||||+++++.+...+.+
T Consensus        28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            34568999999999999999999999999999999998753  3455677899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          135 SIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      ++||||+++++|.+++..    ...+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++...
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999999999864    3568999999999999999999998 99999999999999999999999999999776


Q ss_pred             cccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ...........|++.|+|||++.+..++.++||||||+++|+|++|..||.+...     ........+.....+.....
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~  261 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPSD  261 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHHHHTTCSCCCCTT
T ss_pred             cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHHhhcccCCCCccc
Confidence            5444444456799999999999998999999999999999999999999976432     22334445555544444456


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+++++.++|.+||+.||++|||+.+++++
T Consensus       262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          262 HYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            789999999999999999999999999873

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.4e-48  Score=352.37  Aligned_cols=254  Identities=27%  Similarity=0.462  Sum_probs=207.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe----------
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS----------  130 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~----------  130 (353)
                      ++|++++.||+|+||.||+|++..+++.||||++...  ......+.+|+.+++.++||||+++++++.+          
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            6799999999999999999999999999999998643  4456788999999999999999999998764          


Q ss_pred             ---cCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccc
Q 018630          131 ---NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  206 (353)
Q Consensus       131 ---~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~  206 (353)
                         .+.+++||||+++++|.+++... ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence               46789999999999999999854 457889999999999999999998 9999999999999999999999999999


Q ss_pred             ccccccc--------------CCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhh
Q 018630          207 SAIMAST--------------SGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS  271 (353)
Q Consensus       207 a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  271 (353)
                      +......              ........||+.|+|||++.+. .++.++|||||||++|+|++   ||...      ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~------~~  233 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG------ME  233 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH------HH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc------hh
Confidence            9765421              1122345789999999999864 68999999999999999998   55431      11


Q ss_pred             HHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          272 FYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       272 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      .......+....  .+.......++.+.++|.+||+.||++|||++++++||||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            223333333322  2333445678889999999999999999999999999999754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.8e-48  Score=353.41  Aligned_cols=260  Identities=28%  Similarity=0.443  Sum_probs=212.1

Q ss_pred             CCCccCceeeeeecccCCeEEEEEE----eccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--  130 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--  130 (353)
                      ++..++|++++.||+|+||.||+++    +..+++.||||++... .......+.+|+.+++.++||||+++++++..  
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            4567899999999999999999998    5678999999998755 34556789999999999999999999998864  


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          131 NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ...+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++++||+|||++..
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            35689999999999999999875 459999999999999999999998 9999999999999999999999999999987


Q ss_pred             ccccCC---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccC---------CchhhHHHHHH
Q 018630          210 MASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ---------DGWTSFYELME  277 (353)
Q Consensus       210 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---------~~~~~~~~~~~  277 (353)
                      ......   ......+++.|+|||.+.+..++.++|||||||++|+|++|..||......         ...........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            643321   122345778899999999889999999999999999999999998653211         11111223333


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+..... ...+..+++++.++|.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          244 LLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3433333 3335678999999999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=357.97  Aligned_cols=261  Identities=27%  Similarity=0.446  Sum_probs=207.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeE----------
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY----------  129 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~----------  129 (353)
                      .++|++++.||+|+||.||++.+..+++.||+|++... .......+.+|+.+++.++||||+++++++.          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            37899999999999999999999999999999998755 3455678899999999999999999998763          


Q ss_pred             ----ecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc-CCCcEEEeec
Q 018630          130 ----SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF  204 (353)
Q Consensus       130 ----~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~-~~~~~kl~Df  204 (353)
                          +.+..++||||+. |+|.+++.. +.+++..++.++.|++.||+|||+ +||+||||||+||+++ .++.+||+||
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEccC
Confidence                4478999999998 599999875 679999999999999999999998 9999999999999997 5679999999


Q ss_pred             cccccccccC---CCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHH-
Q 018630          205 GVSAIMASTS---GQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI-  279 (353)
Q Consensus       205 G~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-  279 (353)
                      |+++......   .......+|+.|+|||.+.+ ..++.++|||||||++|||++|..||...+..+.   ...+.... 
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~  242 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLILESIP  242 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHSC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcC
Confidence            9998654221   12334567999999998865 6789999999999999999999999987543211   11111100 


Q ss_pred             ----------hc---------CCCC----CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          280 ----------VD---------QPPP----SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       280 ----------~~---------~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                                ..         ...+    ......+++++.+||.+||+.||++|||++|+++||||+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence                      00         0000    011246899999999999999999999999999999998654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.6e-48  Score=356.11  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=218.7

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEe-----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQH-----KWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  128 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~  128 (353)
                      .+.+..++|++.+.||+|+||.||++.+     ..+++.||+|+++..........+.+|+.+++.+ +||||+++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            4456778999999999999999999985     4567899999998766666678899999999999 999999999999


Q ss_pred             EecCeEEEEEEecCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCc
Q 018630          129 YSNGAISIILEYMDGGSLADFLKKVK------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  190 (353)
Q Consensus       129 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~N  190 (353)
                      ..++..++||||+++|+|.+++....                  .+++..++.++.|++.||.|||+ +|++||||||+|
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~N  175 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN  175 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccce
Confidence            99999999999999999999998653                  48999999999999999999999 999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018630          191 LLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  267 (353)
Q Consensus       191 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~  267 (353)
                      |+++.++.+||+|||++.........  .....+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            99999999999999999776543221  223457889999999988899999999999999999999 999997754321


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          268 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                         .   ....+... .....+..+++++.++|.+||+.||.+|||+.|++++
T Consensus       256 ---~---~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          256 ---K---FYKMIKEG-FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             ---H---HHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---H---HHHHhccC-CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence               1   11222222 2223346789999999999999999999999999985

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.1e-48  Score=347.09  Aligned_cols=253  Identities=24%  Similarity=0.433  Sum_probs=216.0

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      +.+..++|++.+.||+|+||.||++.+. +++.||+|++......  ...+.+|+.+++.++||||+++++++.+++..+
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            4567789999999999999999999987 5778999998765332  256889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +||||+++++|.+++... ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            999999999999999754 568999999999999999999998 999999999999999999999999999997653222


Q ss_pred             -CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          215 -GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       215 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                       .......+|+.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.       .+....+...... ..+..+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~  232 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFRL-YKPRLA  232 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCC-CCCTTS
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhcCccC-CCCCcC
Confidence             12233456788999999998899999999999999999999 9999976432       3344445444332 334567


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ++++.+++.+||+.||++|||+.++++|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          233 STHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-48  Score=361.91  Aligned_cols=258  Identities=26%  Similarity=0.368  Sum_probs=214.1

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  128 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~  128 (353)
                      .+.+..++|++.+.||+|+||.||+|.+.     .++..||+|+++..........+.+|+.+++.+ .||||+++++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            35667789999999999999999999973     356789999997655555667899999999999 899999999999


Q ss_pred             EecCeEEEEEEecCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecC
Q 018630          129 YSNGAISIILEYMDGGSLADFLKKVK-----------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRD  185 (353)
Q Consensus       129 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~D  185 (353)
                      ...+.+++||||+++|+|.+++....                       .+++..+..++.|++.||.|||+ +||+|||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D  197 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD  197 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence            99999999999999999999997643                       37999999999999999999999 9999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCC
Q 018630          186 LKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP  262 (353)
Q Consensus       186 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~  262 (353)
                      |||+||+++.++.+||+|||++.........  .....||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            9999999999999999999999766433221  223467889999999988899999999999999999998 9999977


Q ss_pred             CccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          263 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .....      .....+.. ......+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       278 ~~~~~------~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          278 IPVDA------NFYKLIQN-GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             CCCSH------HHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcHH------HHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            54321      11222222 22333446789999999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2e-48  Score=361.40  Aligned_cols=259  Identities=27%  Similarity=0.400  Sum_probs=186.1

Q ss_pred             CccCceeee-eecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe----cCe
Q 018630           59 NLEDIDTIK-VVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGA  133 (353)
Q Consensus        59 ~~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~----~~~  133 (353)
                      ..++|.+.+ .||+|+||.||+|.++.+++.||||++...  .....   +....++.+.||||+++++++..    ...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            457899965 699999999999999999999999998654  22222   22233556799999999999876    456


Q ss_pred             EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC---CCcEEEeeccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSA  208 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~  208 (353)
                      +++||||++||+|.+++....  .+++..++.++.|++.||.|||+ +||+||||||+||+++.   ++.+||+|||++.
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            899999999999999998753  69999999999999999999999 99999999999999986   4459999999997


Q ss_pred             cccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          209 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||................. ......+...
T Consensus       180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~  256 (336)
T 3fhr_A          180 ETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR-LGQYGFPNPE  256 (336)
T ss_dssp             EC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCCTTT
T ss_pred             ecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh-ccccccCchh
Confidence            65432  23456789999999999888899999999999999999999999976543321111111111 1111122233


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      ...+++++.+||.+||+.||++|||++|+++||||+..
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            45789999999999999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7e-48  Score=351.65  Aligned_cols=262  Identities=23%  Similarity=0.356  Sum_probs=214.5

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEE----eccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      ..+...+|++++.||+|+||.||+|+    +..+++.||+|+++..........+.+|+.+++.++||||+++++++..+
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            34556789999999999999999999    56789999999997654444557789999999999999999999999876


Q ss_pred             --CeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          132 --GAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       132 --~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                        ..+++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCCCEEECcccccc
Confidence              678999999999999999954 4679999999999999999999998 999999999999999999999999999998


Q ss_pred             cccccCC---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCcc--------CCchhhHHHHHH
Q 018630          209 IMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQ--------QDGWTSFYELME  277 (353)
Q Consensus       209 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~~~~~~~  277 (353)
                      .......   ......||..|+|||++.+..++.++|+|||||++|+|++|..|+..+..        ............
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            7653322   22345688889999999988899999999999999999999998754211        111122333344


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+..... ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       255 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          255 TLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            4444433 3345678999999999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.7e-48  Score=364.46  Aligned_cols=261  Identities=26%  Similarity=0.439  Sum_probs=207.5

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CC-----ceEEEeeEeEecC
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CP-----YVVVCYQSFYSNG  132 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp-----~iv~~~~~~~~~~  132 (353)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++..  .....++.+|+.+++.+. |+     +|+.+++.+...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            357999999999999999999999999999999998744  334456677777776654 44     5999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-cCCceecCCCCCcEEEc--CCCcEEEeecccc
Q 018630          133 AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH-EKHIIHRDLKPSNLLIN--HRGEVKITDFGVS  207 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~-~~~iiH~Dlkp~NIll~--~~~~~kl~DfG~a  207 (353)
                      .+++||||+.+ +|.+++...  ..+++..+..++.|++.||.|||+ ..||+||||||+|||++  .++.+||+|||++
T Consensus       130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            99999999975 999999865  469999999999999999999994 37999999999999995  4778999999999


Q ss_pred             ccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC----
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP----  283 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----  283 (353)
                      +....   .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+...   .+........    
T Consensus       209 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~---~i~~~~~~~~~~~~  282 (382)
T 2vx3_A          209 CQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN---KIVEVLGIPPAHIL  282 (382)
T ss_dssp             EETTC---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCSCCHHHH
T ss_pred             eeccc---ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHHH
Confidence            77543   2345689999999999999999999999999999999999999998754432111   1111110000    


Q ss_pred             -------------CC--------------CCCCC-----------------------C----CCHHHHHHHHHhhhhCcC
Q 018630          284 -------------PP--------------SAPSD-----------------------Q----FSPEFCSFISACVQKEPQ  309 (353)
Q Consensus       284 -------------~~--------------~~~~~-----------------------~----~~~~~~~li~~~L~~dp~  309 (353)
                                   +.              ...+.                       .    .++++.+||.+||+.||+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  362 (382)
T 2vx3_A          283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK  362 (382)
T ss_dssp             TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred             HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence                         00              00000                       0    014789999999999999


Q ss_pred             CCCCHHHHHcCCcccccCC
Q 018630          310 QRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       310 ~Rpt~~e~l~hp~~~~~~~  328 (353)
                      +|||++|+++||||+...+
T Consensus       363 ~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          363 TRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             TSCCHHHHTTSGGGCC---
T ss_pred             hCCCHHHHhcCcccccCCC
Confidence            9999999999999987654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5e-48  Score=354.80  Aligned_cols=267  Identities=26%  Similarity=0.434  Sum_probs=213.9

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCC--CCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQ--CPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~--hp~iv~~~~~~~~~~~  133 (353)
                      .+..++|++++.||+|+||.||++.+. +++.||||++... ........+.+|+.+++.+.  ||||+++++++..++.
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            455678999999999999999999986 5889999998754 34456678899999999987  5999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +++||| +.+++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++ ++.+||+|||++......
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred             EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence            999999 5577999999988899999999999999999999998 9999999999999995 589999999999765433


Q ss_pred             CC--CCcccccCCcccCcceecC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh
Q 018630          214 SG--QANTFVGTYNYMSPERISG-----------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV  280 (353)
Q Consensus       214 ~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~  280 (353)
                      ..  ......||+.|+|||.+.+           ..++.++|||||||++|+|++|..||.....      .......+.
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~  253 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAII  253 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHH
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------HHHHHHHHH
Confidence            22  1234578999999999875           4688999999999999999999999975422      112233344


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCH
Q 018630          281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  333 (353)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~  333 (353)
                      ........+...++++.++|.+||+.||.+|||+.|+++||||+........+
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~~  306 (313)
T 3cek_A          254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM  306 (313)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-------
T ss_pred             hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchhhh
Confidence            44333344556789999999999999999999999999999999765544443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.4e-48  Score=362.04  Aligned_cols=261  Identities=26%  Similarity=0.427  Sum_probs=210.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe------
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------  133 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~------  133 (353)
                      ++|.+.+.||+|+||.||+|.++.+|+.||||++... ........+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            6899999999999999999999999999999998654 334556788999999999999999999999886643      


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +++||||+. ++|.+++.  ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.... 
T Consensus       104 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-  178 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-  178 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred             EEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCCcEEEeecccccCCCC-
Confidence            599999997 58888774  359999999999999999999998 9999999999999999999999999999976432 


Q ss_pred             CCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH-----------------
Q 018630          214 SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL-----------------  275 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~-----------------  275 (353)
                        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...                 
T Consensus       179 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  256 (353)
T 3coi_A          179 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  256 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred             --CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence              2344678999999999887 67899999999999999999999999875432211111100                 


Q ss_pred             ---HHHHhcCCC--CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          276 ---MEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       276 ---~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                         ...+.....  .......+++++.+||.+||+.||++|||++|+++||||+.+.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence               000000000  11123467999999999999999999999999999999987653

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.2e-49  Score=366.36  Aligned_cols=266  Identities=24%  Similarity=0.394  Sum_probs=201.0

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe----
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA----  133 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~----  133 (353)
                      ...++|++.+.||+|+||.||+++++.+|+.||||++....  .......++++.+..++||||+++++++...+.    
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            45689999999999999999999999999999999886442  122345667777888899999999999876433    


Q ss_pred             ---EEEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hcCCceecCCCCCcEEEcC-CCcEEEee
Q 018630          134 ---ISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGLLYLH--HEKHIIHRDLKPSNLLINH-RGEVKITD  203 (353)
Q Consensus       134 ---~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~ql~~~l~~LH--~~~~iiH~Dlkp~NIll~~-~~~~kl~D  203 (353)
                         +++||||+.+ +|.+.+.    ....+++..+..++.|++.||.|||  + +||+||||||+||+++. ++.+||+|
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEee
Confidence               8999999986 6555443    4567899999999999999999999  8 99999999999999996 89999999


Q ss_pred             ccccccccccCCCCcccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC
Q 018630          204 FGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ  282 (353)
Q Consensus       204 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~  282 (353)
                      ||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+..   ..+.......
T Consensus       176 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~  251 (360)
T 3e3p_A          176 FGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL---HEIVRVLGCP  251 (360)
T ss_dssp             CTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCC
T ss_pred             CCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH---HHHHHHcCCC
Confidence            99998765332 334567899999999987654 899999999999999999999999875432211   1111111000


Q ss_pred             -----------CC---------------CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCc
Q 018630          283 -----------PP---------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  331 (353)
Q Consensus       283 -----------~~---------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~  331 (353)
                                 ..               ........++++.+||.+||+.||.+|||+.|+++||||+...+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence                       00               00112235789999999999999999999999999999998765544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.6e-48  Score=349.20  Aligned_cols=255  Identities=24%  Similarity=0.402  Sum_probs=214.6

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..+.+..++|++++.||+|+||.||++.+. ++..||+|+++.....  ...+.+|+++++.++||||+++++++.+++.
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            455677899999999999999999999886 6778999999765322  2568899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      +++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            9999999999999999976 4679999999999999999999998 9999999999999999999999999999976543


Q ss_pred             cCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          213 TSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       213 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ... ......+|+.|+|||++.+..++.++|+||||+++|+|++ |..||...+.       ......+..... ...+.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~  244 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLR-LYRPH  244 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTCC-CCCCT
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-------hHHHHHHhcccC-CCCCC
Confidence            221 1223456788999999998889999999999999999998 9999976432       233444444433 23346


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ..++.+.++|.+||+.||.+|||+.++++|
T Consensus       245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          245 LASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            779999999999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.1e-47  Score=353.74  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=221.6

Q ss_pred             CCCCCCCCccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEee
Q 018630           52 KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ  126 (353)
Q Consensus        52 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~  126 (353)
                      .+.++++..++|++.+.||+|+||.||+|.++     .+++.||+|++...........+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            34556777789999999999999999999886     4578999999986655666778999999999999999999999


Q ss_pred             EeEecCeEEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC
Q 018630          127 SFYSNGAISIILEYMDGGSLADFLKKV----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  196 (353)
Q Consensus       127 ~~~~~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~  196 (353)
                      ++.+.+..++||||+++++|.+++...          ..+++..+..++.|++.||.|||+ +||+||||||+||+++.+
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTT
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcCC
Confidence            999999999999999999999999753          356999999999999999999999 999999999999999999


Q ss_pred             CcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHH
Q 018630          197 GEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY  273 (353)
Q Consensus       197 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~  273 (353)
                      +.+||+|||++........  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.       .
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~  247 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------E  247 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------H
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-------H
Confidence            9999999999976543321  1223467889999999998889999999999999999999 8999976432       2


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          274 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +....+...... ..+..+++++.++|.+||+.||++|||+.|+++|
T Consensus       248 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          248 QVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            334444444332 2346789999999999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.5e-48  Score=349.77  Aligned_cols=256  Identities=24%  Similarity=0.354  Sum_probs=206.5

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      +..+..++|++.+.||+|+||.||++.+..+   +..||+|+++..........+.+|+.+++.++||||+++++++. +
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            3456678999999999999999999998653   45799999876656667788999999999999999999999874 5


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      +..++||||+++++|.+++.... .+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++..
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCCCEEECcccccccc
Confidence            67899999999999999998653 69999999999999999999999 99999999999999999999999999999776


Q ss_pred             cccCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          211 ASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       211 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      ..... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+       ....+...... ..
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-------~~~~i~~~~~~-~~  238 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERL-PM  238 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCC-CC
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-------HHHHHHcCCCC-CC
Confidence            43322 1223456789999999988889999999999999999997 999998754322       23334333332 23


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +..+++++.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            46789999999999999999999999999874

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=8.3e-48  Score=345.37  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=214.3

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      .++..++|++.+.||+|+||.||++.++ ++..||+|+++.....  ...+.+|+.+++.++||||+++++++.+++..+
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            3566789999999999999999999876 5778999998765322  356889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++.......
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            999999999999999875 459999999999999999999998 999999999999999999999999999997654322


Q ss_pred             C-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          215 G-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       215 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      . ......+|+.|+|||++.+..++.++|+||||+++|+|++ |..||...+.       ......+..... ...+...
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~  230 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-------SEVVLKVSQGHR-LYRPHLA  230 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTCC-CCCCTTS
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-------HHHHHHHHcCCC-CCCCCcC
Confidence            1 1223456778999999988889999999999999999999 9999976432       233334444333 2334567


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ++++.+++.+||+.||++|||+.|++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999985

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-47  Score=343.34  Aligned_cols=249  Identities=15%  Similarity=0.270  Sum_probs=212.8

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec--C
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--G  132 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~--~  132 (353)
                      ..+..++|++.+.||+|+||.||++++.  ++.||||+++... .......+.+|+.+++.++||||+++++++.++  +
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence            4567789999999999999999999985  8899999987653 445567899999999999999999999999876  7


Q ss_pred             eEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~--iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      .+++||||+++|+|.+++....  .+++..+..++.|++.||.|||+ +|  ++||||||+||+++.++.++|+|||++.
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCcceeEEecccee
Confidence            8999999999999999998765  48999999999999999999998 89  9999999999999999999999999875


Q ss_pred             cccccCCCCcccccCCcccCcceecCCCCCc---cccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018630          209 IMASTSGQANTFVGTYNYMSPERISGGKYGY---KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  285 (353)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  285 (353)
                      ...     .....||+.|+|||++.+..++.   ++|||||||++|||++|..||...+.       ......+......
T Consensus       162 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~  229 (271)
T 3kmu_A          162 SFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-------MEIGMKVALEGLR  229 (271)
T ss_dssp             TTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-------HHHHHHHHHSCCC
T ss_pred             eec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-------HHHHHHHHhcCCC
Confidence            422     23457899999999998765544   79999999999999999999976432       2233333433333


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ...+..+++++.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            4455788999999999999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.3e-48  Score=368.06  Aligned_cols=263  Identities=22%  Similarity=0.383  Sum_probs=193.9

Q ss_pred             cCcee-eeeecccCCeEEEEEEec--cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--cCeEE
Q 018630           61 EDIDT-IKVVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAIS  135 (353)
Q Consensus        61 ~~~~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~~~~  135 (353)
                      +.|++ .+.||+|+||.||+|+++  .+++.||||++.....   ...+.+|+.+++.++||||+++++++..  ...++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            44666 457999999999999965  5688999999875422   2357789999999999999999999964  67899


Q ss_pred             EEEEecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE----cCCCcEEEe
Q 018630          136 IILEYMDGGSLADFLKKV---------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKIT  202 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~---------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll----~~~~~~kl~  202 (353)
                      +||||+.+ +|.+++...         ..+++..++.++.||+.||.|||+ +||+||||||+|||+    +.++.+||+
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99999975 888887632         249999999999999999999999 999999999999999    677899999


Q ss_pred             eccccccccccC---CCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCc------hhhH
Q 018630          203 DFGVSAIMASTS---GQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG------WTSF  272 (353)
Q Consensus       203 DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~~  272 (353)
                      |||+++......   ......+||+.|+|||++.+. .++.++|||||||++|||++|..||........      ....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            999998764322   223446899999999999874 589999999999999999999999976543210      0111


Q ss_pred             HHHHHHHhcCCCCC---------------------------------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          273 YELMEAIVDQPPPS---------------------------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       273 ~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+...+. .....                                 ......++++.+||.+||+.||.+|||++|+++
T Consensus       255 ~~i~~~~g-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          255 DRIFNVMG-FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHC-CCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhC-CCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111111 00000                                 001123778999999999999999999999999


Q ss_pred             CCcccccCCC
Q 018630          320 HPFLKMYGDL  329 (353)
Q Consensus       320 hp~~~~~~~~  329 (353)
                      ||||+.....
T Consensus       334 hp~f~~~~~~  343 (405)
T 3rgf_A          334 DPYFLEDPLP  343 (405)
T ss_dssp             SGGGTSSSCC
T ss_pred             ChhhccCCCC
Confidence            9999876543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.3e-48  Score=357.77  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=205.5

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcE----EEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF----FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      .+..++|++.+.||+|+||.||+|++..+++.    ||+|.+...........+.+|+.+++.++||||+++++++..+.
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            35568999999999999999999999877765    57787765544455678999999999999999999999988654


Q ss_pred             eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                       .++|+||+.+|+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence             78899999999999999864 679999999999999999999998 999999999999999999999999999998764


Q ss_pred             ccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          212 STSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       212 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      .....  .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..+       ....+.... ....
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~-~~~~  240 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE-RLPQ  240 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTC-CCCC
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HHHHHHcCC-CCCC
Confidence            33222  223456889999999999999999999999999999999 999998754321       222333332 2233


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +..++.++.+++.+||+.||.+|||+.+++++
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            46789999999999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-48  Score=365.38  Aligned_cols=264  Identities=27%  Similarity=0.430  Sum_probs=208.3

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-----------CCceEEEe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----------CPYVVVCY  125 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----------hp~iv~~~  125 (353)
                      .+..++|++.+.||+|+||.||+|++..+++.||||++...  ......+.+|+.+++.+.           ||||++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            34567999999999999999999999999999999998744  334566778888887765           89999999


Q ss_pred             eEeEecC----eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC-CceecCCCCCcEEEcC---
Q 018630          126 QSFYSNG----AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINH---  195 (353)
Q Consensus       126 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~-~iiH~Dlkp~NIll~~---  195 (353)
                      +++...+    .+++||||+ +++|.+++...  ..+++..+..++.||+.||.|||+ + ||+||||||+||+++.   
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEET
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCC
Confidence            9988654    789999999 78999999863  459999999999999999999998 7 9999999999999953   


Q ss_pred             ---CCcEEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhH
Q 018630          196 ---RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF  272 (353)
Q Consensus       196 ---~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~  272 (353)
                         .+.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|||++|..||...+........
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence               347999999999765432   33457899999999999999999999999999999999999999865432211111


Q ss_pred             ---HHHHHHHhcCCC------------------------------------CCCCCCCCCHHHHHHHHHhhhhCcCCCCC
Q 018630          273 ---YELMEAIVDQPP------------------------------------PSAPSDQFSPEFCSFISACVQKEPQQRLS  313 (353)
Q Consensus       273 ---~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt  313 (353)
                         ..+...+...+.                                    ....+..+++++.+||.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence               111111100000                                    00111234578899999999999999999


Q ss_pred             HHHHHcCCcccccC
Q 018630          314 AQELMTHPFLKMYG  327 (353)
Q Consensus       314 ~~e~l~hp~~~~~~  327 (353)
                      ++|+++||||+...
T Consensus       328 ~~ell~hp~f~~~~  341 (373)
T 1q8y_A          328 AGGLVNHPWLKDTL  341 (373)
T ss_dssp             HHHHHTCGGGTTCT
T ss_pred             HHHHhhChhhhccc
Confidence            99999999999754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.6e-47  Score=354.77  Aligned_cols=257  Identities=21%  Similarity=0.370  Sum_probs=217.7

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEec-------cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEee
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHK-------WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQ  126 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~  126 (353)
                      .+.+..++|++.+.||+|+||.||+|++.       .++..||||+++..........+.+|+.+++.+ +||||+++++
T Consensus        29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            34567799999999999999999999975       457789999998766666778899999999999 8999999999


Q ss_pred             EeEecCeEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCc
Q 018630          127 SFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  190 (353)
Q Consensus       127 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~N  190 (353)
                      ++...+.+++||||+++++|.+++....                .+++..++.++.|++.||.|||+ +||+||||||+|
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~N  187 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN  187 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGG
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCccce
Confidence            9999999999999999999999998653                38999999999999999999998 999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018630          191 LLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  267 (353)
Q Consensus       191 Ill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~  267 (353)
                      |+++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.  
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--  265 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  265 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--
Confidence            9999999999999999976543321  1223457889999999988889999999999999999999 9999976432  


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          268 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                           .+....+...... ..+..+++++.++|.+||+.||.+|||+.|++++
T Consensus       266 -----~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          266 -----EELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             -----HHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----HHHHHHHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                 2333344333322 2346789999999999999999999999999884

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.4e-47  Score=355.40  Aligned_cols=261  Identities=24%  Similarity=0.379  Sum_probs=210.9

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCC-cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCc------eEEEeeEeEe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTG-QFFALKVIQMNVEESARRQIAQELKINQSSQCPY------VVVCYQSFYS  130 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~------iv~~~~~~~~  130 (353)
                      +..++|++.+.||+|+||.||+|.+..++ +.||+|+++..  ......+.+|+.+++.+.|++      ++.+++.+..
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            34579999999999999999999998777 68999998754  344566778888888776655      8999999999


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE---------------
Q 018630          131 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---------------  193 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll---------------  193 (353)
                      .+.+++||||+ +++|.+++...  ..+++..+..++.||+.||.|||+ +||+||||||+||++               
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecccccccccccccc
Confidence            99999999999 56887777654  469999999999999999999998 999999999999999               


Q ss_pred             ----cCCCcEEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch
Q 018630          194 ----NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW  269 (353)
Q Consensus       194 ----~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  269 (353)
                          +.++.+||+|||+++....   ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+  
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE--  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred             cccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence                5678999999999976432   2345689999999999999999999999999999999999999998654321  


Q ss_pred             hhHHHHHHHHhcCCCC---------------------------------------CCCCCCCCHHHHHHHHHhhhhCcCC
Q 018630          270 TSFYELMEAIVDQPPP---------------------------------------SAPSDQFSPEFCSFISACVQKEPQQ  310 (353)
Q Consensus       270 ~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~li~~~L~~dp~~  310 (353)
                        ....+..+....+.                                       .......++++.+||.+||+.||++
T Consensus       247 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          247 --HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             --HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             --HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence              11112222111100                                       0011122457899999999999999


Q ss_pred             CCCHHHHHcCCcccccCCC
Q 018630          311 RLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       311 Rpt~~e~l~hp~~~~~~~~  329 (353)
                      |||++|+++||||+.....
T Consensus       325 Rpt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          325 RITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             SCCHHHHTTSGGGGGCCHH
T ss_pred             CcCHHHHhcChhhcCCChh
Confidence            9999999999999986543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.2e-48  Score=363.64  Aligned_cols=256  Identities=26%  Similarity=0.397  Sum_probs=207.1

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEec---cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      ...+..++|++.+.||+|+||.||+++++   .++..||||+++..........+.+|+.++++++||||+++++++...
T Consensus        39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            34567789999999999999999999987   457789999998766666778899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      +.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++..
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            9999999999999999999865 469999999999999999999998 99999999999999999999999999999876


Q ss_pred             cccCCCC---cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          211 ASTSGQA---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       211 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      .......   ....+++.|+|||++.+..++.++|||||||++|||++ |..||...+.       .+....+...... 
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------~~~~~~i~~~~~~-  269 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------QDVIKAVDEGYRL-  269 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------HHHHHHHHTTEEC-
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC-
Confidence            4332211   12345778999999998899999999999999999998 9999976432       2333444433222 


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+..+++++.+++.+||+.||++|||+.++++
T Consensus       270 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            234578999999999999999999999999876

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.9e-48  Score=345.93  Aligned_cols=251  Identities=25%  Similarity=0.457  Sum_probs=203.5

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc---HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ++..++|++.+.||+|+||.||++.+.  ++.||||+++....   ......+.+|+++++.++||||+++++++..++.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            355689999999999999999999975  88999999865422   2234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---ceecCCCCCcEEEcC--------CCcEEEe
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH---IIHRDLKPSNLLINH--------RGEVKIT  202 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~---iiH~Dlkp~NIll~~--------~~~~kl~  202 (353)
                      .++||||+++++|.+++.. +.+++..+..++.|++.||.|||+ +|   ++||||||+||+++.        ++.+||+
T Consensus        81 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             eEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            9999999999999999864 679999999999999999999998 88   899999999999985        7789999


Q ss_pred             eccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC
Q 018630          203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ  282 (353)
Q Consensus       203 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~  282 (353)
                      |||++.......  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+.       ..........
T Consensus       159 Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~  229 (271)
T 3dtc_A          159 DFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-------LAVAYGVAMN  229 (271)
T ss_dssp             CCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHHHHTS
T ss_pred             cCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHhhhcC
Confidence            999997654332  2345789999999999988899999999999999999999999976432       2333344444


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          283 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ......+..+++++.+++.+||+.||.+|||+.|+++|
T Consensus       230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            44444567889999999999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-47  Score=349.15  Aligned_cols=257  Identities=19%  Similarity=0.264  Sum_probs=213.5

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~l  136 (353)
                      +..++|++.+.||+|+||.||++.+..+++.||||++....   ....+.+|+.+++.+ +|+|++.+++++......++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            34578999999999999999999999999999999986442   224577888888888 79999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc-----EEEeeccccccc
Q 018630          137 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE-----VKITDFGVSAIM  210 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~-----~kl~DfG~a~~~  210 (353)
                      ||||+ +++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.     +||+|||+++..
T Consensus        84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99999 88999999875 459999999999999999999998 99999999999999987765     999999999876


Q ss_pred             cccCC-------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          211 ASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       211 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      .....       ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..........+........
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            54322       12345799999999999999999999999999999999999999987654333222222222222221


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                       .......+++++.+++.+||+.||++|||++++++.
T Consensus       242 -~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          242 -LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             -HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             -HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence             112234689999999999999999999999999873

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.8e-47  Score=345.27  Aligned_cols=252  Identities=21%  Similarity=0.377  Sum_probs=210.7

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc---HHHH---HHHHHHHHHHhcCCCCceEEEeeEeEe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---ESAR---RQIAQELKINQSSQCPYVVVCYQSFYS  130 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~---~~~~~e~~~~~~l~hp~iv~~~~~~~~  130 (353)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|++.....   ....   ..+.+|+.+++.++||||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            4566899999999999999999999999999999999865421   1111   678899999999999999999998876


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCcEEEcCCCc-----EEEe
Q 018630          131 NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGE-----VKIT  202 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~--iiH~Dlkp~NIll~~~~~-----~kl~  202 (353)
                      ..  ++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|  ++||||||+||+++.++.     +||+
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            55  6899999999999888654 579999999999999999999998 89  999999999999988776     9999


Q ss_pred             eccccccccccCCCCcccccCCcccCcceec--CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh
Q 018630          203 DFGVSAIMASTSGQANTFVGTYNYMSPERIS--GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV  280 (353)
Q Consensus       203 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~  280 (353)
                      |||+++....   ......||+.|+|||++.  ...++.++|||||||++|+|++|..||...+...     ......+.
T Consensus       172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~  243 (287)
T 4f0f_A          172 DFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIR  243 (287)
T ss_dssp             CCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-----HHHHHHHH
T ss_pred             CCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-----HHHHHHHh
Confidence            9999875432   234467999999999984  4557899999999999999999999997654321     22233333


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ........+..+++++.++|.+||+.||.+|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            444444456788999999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.6e-47  Score=348.05  Aligned_cols=254  Identities=26%  Similarity=0.384  Sum_probs=205.9

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ...++|++.+.||+|+||.||++.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++..++.++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            34589999999999999999999999999999999987542  3445678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  214 (353)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....... 
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence            999999999999999988889999999999999999999998 999999999999999999999999999987654322 


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-CCCCCCCCC
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFS  293 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  293 (353)
                      .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.       ......+..... +......++
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  262 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIPRPSTVRPGIP  262 (309)
T ss_dssp             -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCCCGGGTSTTCC
T ss_pred             ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCCCccccCCCCC
Confidence            122345789999999999988999999999999999999999999976432       122222332222 223456789


Q ss_pred             HHHHHHHHHhhhhCcCCCC-CHHHHHc
Q 018630          294 PEFCSFISACVQKEPQQRL-SAQELMT  319 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rp-t~~e~l~  319 (353)
                      +++.++|.+||+.||++|| |++++++
T Consensus       263 ~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          263 VAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             THHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            9999999999999999999 7887765

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=8e-48  Score=356.24  Aligned_cols=253  Identities=20%  Similarity=0.313  Sum_probs=209.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .++|++.+.||+|+||.||++++..+++.||||++.....   ...+.+|+.+++.+ +||||+++++++.+++..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            4789999999999999999999999999999999875422   23578899999999 9999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc-----EEEeeccccccccc
Q 018630          139 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE-----VKITDFGVSAIMAS  212 (353)
Q Consensus       139 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~-----~kl~DfG~a~~~~~  212 (353)
                      ||+ +++|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.     +||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            999 88999999863 689999999999999999999998 99999999999999998887     99999999987643


Q ss_pred             cCCC-------CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018630          213 TSGQ-------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  285 (353)
Q Consensus       213 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  285 (353)
                      ....       ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.......+....... +.
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~  241 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT-PI  241 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS-CH
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC-CH
Confidence            3221       245689999999999999999999999999999999999999998765433222222221111111 11


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ......++ ++.+++.+||+.||.+||++.++++
T Consensus       242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11122344 9999999999999999999998876

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.7e-48  Score=355.70  Aligned_cols=259  Identities=24%  Similarity=0.351  Sum_probs=208.2

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC--
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--  132 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~--  132 (353)
                      ...+..++|++.+.||+|+||.||++++.  ++.||||+++...  .......+|+.+++.++||||+++++++....  
T Consensus        18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            34567789999999999999999999875  8999999987542  33445667999999999999999999998743  


Q ss_pred             --eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC----------CceecCCCCCcEEEcCCCcEE
Q 018630          133 --AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK----------HIIHRDLKPSNLLINHRGEVK  200 (353)
Q Consensus       133 --~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~----------~iiH~Dlkp~NIll~~~~~~k  200 (353)
                        .+++||||+++|+|.++++. ..+++..+..++.|++.||.|||+ .          ||+||||||+||+++.++.+|
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence              47999999999999999977 569999999999999999999998 8          999999999999999999999


Q ss_pred             EeeccccccccccCC--CCcccccCCcccCcceecCC-----CCCccccHHHHHHHHHHHHcCCCCCCCCccCCch----
Q 018630          201 ITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGG-----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW----  269 (353)
Q Consensus       201 l~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----  269 (353)
                      |+|||+++.......  ......||+.|+|||++.+.     .++.++|||||||++|||++|..||.+.......    
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999977643322  23346799999999999863     4667899999999999999999999775443211    


Q ss_pred             -----hhHHHHHHHHhcCCCCCCCCC-----CCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          270 -----TSFYELMEAIVDQPPPSAPSD-----QFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       270 -----~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                           ................+....     ..++++.+||.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                 122233333333332222111     22456999999999999999999999987

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.1e-48  Score=363.31  Aligned_cols=264  Identities=19%  Similarity=0.309  Sum_probs=204.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc----------cHHHHHHHHHHHHHHhcCCCCceEEEeeEeE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----------EESARRQIAQELKINQSSQCPYVVVCYQSFY  129 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~  129 (353)
                      .++|.+.+.||+|+||.||++.+.. |+.||||++....          .......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            4789999999999999999999864 9999999985431          2334578999999999999999999999985


Q ss_pred             e-----cCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEee
Q 018630          130 S-----NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD  203 (353)
Q Consensus       130 ~-----~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~D  203 (353)
                      .     ...+++||||+. |+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCCCEEEEe
Confidence            4     347899999998 5888888654 479999999999999999999999 9999999999999999999999999


Q ss_pred             ccccccccccCCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH------
Q 018630          204 FGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM------  276 (353)
Q Consensus       204 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~------  276 (353)
                      ||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.........      
T Consensus       178 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (362)
T 3pg1_A          178 FNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE  256 (362)
T ss_dssp             TTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence            9999754432 23344678999999999877 678999999999999999999999998754322111111000      


Q ss_pred             ----------HHHhcCCCCC-------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          277 ----------EAIVDQPPPS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       277 ----------~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                                ..........       ......++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence                      0000000000       01235688999999999999999999999999999999763

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-47  Score=355.10  Aligned_cols=257  Identities=26%  Similarity=0.366  Sum_probs=217.2

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCc-----EEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ-----FFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  128 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~  128 (353)
                      ...+..++|++.+.||+|+||.||++.+..+++     .||+|++...........+.+|+.+++.+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            456777899999999999999999999876654     79999998766666678899999999999 899999999999


Q ss_pred             EecCeEEEEEEecCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc
Q 018630          129 YSNGAISIILEYMDGGSLADFLKKV--------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN  194 (353)
Q Consensus       129 ~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~  194 (353)
                      ..++.+++||||+++|+|.+++...              ..+++..+..++.|++.||.|||+ +||+||||||+||+++
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLT  198 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEEE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEEC
Confidence            9999999999999999999999753              357999999999999999999998 9999999999999999


Q ss_pred             CCCcEEEeeccccccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhh
Q 018630          195 HRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS  271 (353)
Q Consensus       195 ~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~  271 (353)
                      .++.+||+|||++.........  .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......   .
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~  275 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---K  275 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---H
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---H
Confidence            9999999999999865433221  223457889999999988899999999999999999998 999997654321   1


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          272 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .   ...... ......+...++++.++|.+||+.||.+|||+.|+++
T Consensus       276 ~---~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          276 F---YKLVKD-GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             H---HHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H---HHHHhc-CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            1   111222 2222334567999999999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.6e-48  Score=357.18  Aligned_cols=254  Identities=25%  Similarity=0.379  Sum_probs=215.7

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH-----HHHHHHHHHHHHHhcCC--CCceEEEeeEeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQ--CPYVVVCYQSFY  129 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~--hp~iv~~~~~~~  129 (353)
                      ....++|++.+.||+|+||.||+|.+..+++.||||++......     .....+.+|+.+++.+.  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34557899999999999999999999999999999998754211     12245667888888875  599999999999


Q ss_pred             ecCeEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc-CCCcEEEeecccc
Q 018630          130 SNGAISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVS  207 (353)
Q Consensus       130 ~~~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~-~~~~~kl~DfG~a  207 (353)
                      .++..++|+|++.+ ++|.+++.....+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            99999999999986 8999999988899999999999999999999998 9999999999999999 7889999999999


Q ss_pred             ccccccCCCCcccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      +.....  ......||+.|+|||++.+..+ +.++|||||||++|||++|..||...+             .+....  .
T Consensus       198 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~~~~~~--~  260 (320)
T 3a99_A          198 ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQ--V  260 (320)
T ss_dssp             EECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCC--C
T ss_pred             cccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------------hhhccc--c
Confidence            776432  2344679999999999877665 688999999999999999999996521             111111  1


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      .....+++++.+||.+||+.||++|||++|+++||||+....
T Consensus       261 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence            234578999999999999999999999999999999987643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-47  Score=347.95  Aligned_cols=254  Identities=24%  Similarity=0.364  Sum_probs=218.1

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .+.+..++|++.+.||+|+||.||++.++.+++.||+|++....  .....+.+|+.+++.++||||+++++++.+++.+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            45677889999999999999999999999999999999987543  3456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++.....
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            9999999999999999864  458999999999999999999998 9999999999999999999999999999976543


Q ss_pred             cCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          213 TSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       213 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+...       ....+.... ....+.
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-------~~~~~~~~~-~~~~~~  235 (288)
T 3kfa_A          164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDY-RMERPE  235 (288)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTC-CCCCCT
T ss_pred             CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhccC-CCCCCC
Confidence            322 1223456889999999998899999999999999999999 999998754321       222233322 233446


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+++++.+|+.+||+.||.+|||++++++
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            78999999999999999999999999987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-47  Score=353.55  Aligned_cols=254  Identities=26%  Similarity=0.391  Sum_probs=213.1

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEE--EEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF--ALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~  133 (353)
                      .+..++|++.+.||+|+||.||+|++..++..+  |+|.++..........+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            356689999999999999999999999888865  999987655555667889999999999 89999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC
Q 018630          134 ISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG  197 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~  197 (353)
                      +++||||+++++|.+++....                .+++..++.++.|++.||.|||+ +||+||||||+||+++.++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGG
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEcCCC
Confidence            999999999999999997653                69999999999999999999998 9999999999999999999


Q ss_pred             cEEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHH
Q 018630          198 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM  276 (353)
Q Consensus       198 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~  276 (353)
                      .+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.       .+..
T Consensus       180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~  251 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELY  251 (327)
T ss_dssp             CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHH
T ss_pred             eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HHHH
Confidence            9999999998754322 12233467889999999988889999999999999999998 9999976432       2344


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          277 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ..+...... ..+..+++++.+||.+||+.||.+|||++|++++
T Consensus       252 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          252 EKLPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHGGGTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            444444332 3346789999999999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.6e-47  Score=345.51  Aligned_cols=258  Identities=21%  Similarity=0.346  Sum_probs=213.1

Q ss_pred             CCCCCCCCccCceeee-eecccCCeEEEEEE--eccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeE
Q 018630           52 KPSDNQLNLEDIDTIK-VVGKGSGGIVQLVQ--HKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQS  127 (353)
Q Consensus        52 ~~~~~~~~~~~~~~~~-~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~  127 (353)
                      .+.+..+..++|++.+ .||+|+||.||++.  +..+++.||||+++... .......+.+|+.+++.++||||++++++
T Consensus         7 ~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   86 (291)
T 1xbb_A            7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI   86 (291)
T ss_dssp             ----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3445566778999998 99999999999994  45667899999987552 33446789999999999999999999998


Q ss_pred             eEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          128 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       128 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                      + ..+.+++||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++
T Consensus        87 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           87 C-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             E-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             E-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence            8 667889999999999999999988889999999999999999999999 99999999999999999999999999999


Q ss_pred             ccccccCCC---CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          208 AIMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       208 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      .........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.       .+....+....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~  237 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGE  237 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTC
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC
Confidence            765433221   122346788999999988889999999999999999999 9999976432       23334444443


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+ ..+..+++++.++|.+||+.||.+|||+.++++
T Consensus       238 ~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          238 RM-GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            32 334678999999999999999999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-47  Score=354.14  Aligned_cols=259  Identities=23%  Similarity=0.351  Sum_probs=214.8

Q ss_pred             CCCccCceeeeeecccCCeEEEEEE-----eccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQ-----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      .+..++|++.+.||+|+||.||+++     +..+++.||||++..........++.+|+.+++.++||||+++++++...
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            4566899999999999999999999     55678899999997665566677899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC---CCcEEE
Q 018630          132 GAISIILEYMDGGSLADFLKKVK-------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKI  201 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl  201 (353)
                      ...++||||+++++|.+++....       .+++..++.++.|++.||.|||+ +||+||||||+||+++.   +..+||
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999998753       48999999999999999999998 99999999999999984   446999


Q ss_pred             eeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHH
Q 018630          202 TDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA  278 (353)
Q Consensus       202 ~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~  278 (353)
                      +|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...+.       .+....
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~  257 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEF  257 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------HHHHHH
Confidence            99999875533221  2233567899999999988899999999999999999998 9999976432       233444


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          279 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                      +...... ..+..+++.+.++|.+||+.||.+|||+.++++|.|.-
T Consensus       258 ~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          258 VTSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            4444332 33467899999999999999999999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-47  Score=344.00  Aligned_cols=255  Identities=25%  Similarity=0.382  Sum_probs=216.0

Q ss_pred             CCCCccCceeee-eecccCCeEEEEEEec--cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           56 NQLNLEDIDTIK-VVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        56 ~~~~~~~~~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ..+..++|.+.. .||+|+||.||++.+.  .++..||+|+++..........+.+|+.+++.++||||+++++++ ..+
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            345668888887 9999999999999854  467889999998766667778899999999999999999999998 566


Q ss_pred             eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            799999999999999999654 569999999999999999999998 999999999999999999999999999998764


Q ss_pred             ccCC---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          212 STSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       212 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      ....   ......+|+.|+|||++.+..++.++|+|||||++|+|++ |..||...+.       .+....+.....+ .
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~i~~~~~~-~  233 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVMAFIEQGKRM-E  233 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HHHHHHHHTTCCC-C
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHhcCCcC-C
Confidence            3322   1223456889999999988889999999999999999998 9999976543       2333444444332 3


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+..+++++.++|.+||+.||++|||+.++++|
T Consensus       234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            346789999999999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.5e-48  Score=357.98  Aligned_cols=254  Identities=22%  Similarity=0.341  Sum_probs=209.8

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcE----EEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF----FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      .+..++|++++.||+|+||.||+|.+..+++.    ||+|.+...........+.+|+.+++.++||||+++++++. ++
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            45668999999999999999999999888775    77777654433333456778999999999999999999876 56


Q ss_pred             eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ..++||||+.+|+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++...
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            789999999999999999764 579999999999999999999998 999999999999999999999999999998764


Q ss_pred             ccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          212 STSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       212 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||......       +....+..... ...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~  238 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-------EVPDLLEKGER-LAQ  238 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-------HHHHHHHTTCB-CCC
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCCC-CCC
Confidence            3322  2234567889999999998899999999999999999999 99999875432       22333333322 233


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +..+++++.+++.+||+.||.+|||+.++++|
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          239 PQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            45678899999999999999999999999886

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-47  Score=352.25  Aligned_cols=257  Identities=27%  Similarity=0.412  Sum_probs=216.4

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEe-----ccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQH-----KWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY  129 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~  129 (353)
                      +.+..++|++.+.||+|+||.||+|.+     ..+++.||||+++..........+.+|+.++..+ +||||+++++++.
T Consensus        22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            356678999999999999999999985     3567899999998766666677899999999998 7899999999987


Q ss_pred             ec-CeEEEEEEecCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEE
Q 018630          130 SN-GAISIILEYMDGGSLADFLKKVKT----------------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  192 (353)
Q Consensus       130 ~~-~~~~lv~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIl  192 (353)
                      .. ..+++||||+++++|.+++.....                +++..+..++.|++.||.|||+ +||+||||||+||+
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil  180 (316)
T 2xir_A          102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  180 (316)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence            65 459999999999999999987543                8999999999999999999999 99999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCch
Q 018630          193 INHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW  269 (353)
Q Consensus       193 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~  269 (353)
                      ++.++.+||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||......+  
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--  258 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--  258 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--
Confidence            99999999999999976543222  1223567889999999998899999999999999999998 999997654321  


Q ss_pred             hhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          270 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                          .....+..... ...+..+++++.++|.+||+.||.+|||+.|+++|
T Consensus       259 ----~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 ----EFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             ----HHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----HHHHHhccCcc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                22233333322 22345689999999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7e-47  Score=364.48  Aligned_cols=248  Identities=24%  Similarity=0.413  Sum_probs=211.3

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC-e
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-A  133 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~-~  133 (353)
                      .+.+..++|++.+.||+|+||.||++...  ++.||||+++...   ....+.+|+.++++++||||+++++++.... .
T Consensus       187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            45677899999999999999999999875  7899999997543   3467889999999999999999999987654 7


Q ss_pred             EEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      +++||||+++|+|.+++...+.  +++..+..++.|++.||+|||+ +|++||||||+|||++.++.+||+|||+++...
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            9999999999999999987643  7999999999999999999999 999999999999999999999999999997543


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ..   .....+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+       ....+..+... ..+.
T Consensus       341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~-~~p~  409 (450)
T 1k9a_A          341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKM-DAPD  409 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------HHHHHHTTCCC-CCCT
T ss_pred             cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC-CCCC
Confidence            22   223367889999999999999999999999999999998 999998754432       23334443332 3356


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+++++.+||.+||+.||++|||+.+++.
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            78999999999999999999999999976

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.3e-47  Score=344.23  Aligned_cols=255  Identities=25%  Similarity=0.413  Sum_probs=200.6

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ...++..++|++.+.||+|+||.||++++.   ..||+|+++... .......+.+|+.+++.++||||++++++ ....
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~   92 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAP   92 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECSS
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccCC
Confidence            345677789999999999999999999864   359999987553 44556789999999999999999999995 4566


Q ss_pred             eEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          133 AISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCCCEEEccceeccccc
Confidence            78999999999999999964 3579999999999999999999998 999999999999999999999999999997654


Q ss_pred             cc--CCCCcccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC---
Q 018630          212 ST--SGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP---  283 (353)
Q Consensus       212 ~~--~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---  283 (353)
                      ..  ........||+.|+|||++.   +..++.++|||||||++|+|++|..||......      ......+....   
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~  245 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLSP  245 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCCC
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccCc
Confidence            22  12233457999999999986   567899999999999999999999999764332      12222222222   


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ........+++++.+||.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            222334578999999999999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-47  Score=349.69  Aligned_cols=256  Identities=25%  Similarity=0.353  Sum_probs=212.1

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCC----cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTG----QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      ..+..++|.+.+.||+|+||.||+|.++.++    ..||||+++..........+.+|+.+++.++||||+++++++...
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            4567789999999999999999999987543    369999998766666677899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      +..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++..
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            9999999999999999999764 679999999999999999999998 99999999999999999999999999999876


Q ss_pred             cccCCC---CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          211 ASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       211 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      ......   .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...+.       .+....+.......
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~~~~  270 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRLP  270 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCCC
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHCCCcCC
Confidence            433211   122346788999999998899999999999999999999 9999976432       23444454443322


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                       .+..+++++.+++.+||+.||++|||+.+++++
T Consensus       271 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          271 -TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             -CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             345789999999999999999999999999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.1e-47  Score=339.74  Aligned_cols=253  Identities=24%  Similarity=0.429  Sum_probs=215.6

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      +.+..++|++.+.||+|+||.||++.+. +++.||+|++......  ...+.+|+.+++.++||||+++++++.+++..+
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            4566789999999999999999999986 6788999999765332  356889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      +||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.......
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            999999999999999865 568999999999999999999998 999999999999999999999999999987653221


Q ss_pred             -CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          215 -GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       215 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                       .......+++.|+|||++.+..++.++|+||||+++|+|++ |..||...+.       .+....+...... ..+..+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~i~~~~~~-~~~~~~  230 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFRL-YKPRLA  230 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCC-CCCTTS
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HHHHHHHhcCCcC-CCCccC
Confidence             12233467889999999988889999999999999999999 8999976432       2344444444332 234567


Q ss_pred             CHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          293 SPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ++++.+++.+||+.||++|||+.+++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4e-47  Score=351.00  Aligned_cols=261  Identities=25%  Similarity=0.420  Sum_probs=217.1

Q ss_pred             CCCccCceeeeeecccCCeEEEEEE----eccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeE--e
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY--S  130 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~--~  130 (353)
                      .+..++|++++.||+|+||.||+++    +..+++.||||++... .......+.+|+++++.++||||+++++++.  +
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            4667899999999999999999999    5678999999998765 3455677899999999999999999999886  4


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          131 NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ...+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCCCEEEccccccee
Confidence            56799999999999999999863 569999999999999999999998 9999999999999999999999999999986


Q ss_pred             ccccCC---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccC--------CchhhHHHHHHH
Q 018630          210 MASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ--------DGWTSFYELMEA  278 (353)
Q Consensus       210 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~~~~~~~~  278 (353)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......        ............
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            543222   123346788899999999888999999999999999999999998654321        011122233334


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          279 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +..... ...+..+++++.+||.+||+.||++|||+.|++++
T Consensus       257 ~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          257 LEEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            444333 33456789999999999999999999999999764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=352.05  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=205.3

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH-----HHHHHHHHHHHHHhcC----CCCceEEEeeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSS----QCPYVVVCYQS  127 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l----~hp~iv~~~~~  127 (353)
                      ....++|++.+.||+|+||.||++.+..+++.||||+++.....     .....+.+|+.++..+    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34457899999999999999999999999999999998654221     2234456788888777    89999999999


Q ss_pred             eEecCeEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc-CCCcEEEeecc
Q 018630          128 FYSNGAISIILEY-MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFG  205 (353)
Q Consensus       128 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~-~~~~~kl~DfG  205 (353)
                      +...+..++|+|+ +.+++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~dfg  185 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFG  185 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence            9999999999999 7889999999988889999999999999999999998 9999999999999999 88999999999


Q ss_pred             ccccccccCCCCcccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018630          206 VSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  284 (353)
Q Consensus       206 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  284 (353)
                      ++......  ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....         +    +.... 
T Consensus       186 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~----~~~~~-  249 (312)
T 2iwi_A          186 SGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------E----ILEAE-  249 (312)
T ss_dssp             SCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H----HHHTC-
T ss_pred             hhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------H----Hhhhc-
Confidence            99876432  2345679999999999877666 458999999999999999999996521         1    11111 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                       ...+..+++++.++|.+||+.||++|||++|+++||||+...+
T Consensus       250 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          250 -LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             -cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence             1233578999999999999999999999999999999997654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.3e-47  Score=370.88  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=217.2

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      .+++..++|++.+.||+|+||.||++.++.++..||||+++....  ....+.+|+.+++.++||||+++++++..+..+
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            356677899999999999999999999998899999999875532  246789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            9999999999999999864  458999999999999999999999 9999999999999999999999999999987543


Q ss_pred             cCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          213 TSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       213 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+       +...+.... ....+.
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~-~~~~~~  442 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDY-RMERPE  442 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTC-CCCCCT
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC-CCCCCC
Confidence            221 1223356788999999998889999999999999999999 999998754321       222333332 223356


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+++++.+||.+||+.||++|||+.++++
T Consensus       443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          443 GCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            78999999999999999999999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.5e-47  Score=342.49  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=211.0

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEecc---CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKW---TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ..+..++|++.+.||+|+||.||++.+..   ++..||+|++...........+.+|+.+++.++||||+++++++.+ +
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   85 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E   85 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence            35567899999999999999999998653   3446999999876556667889999999999999999999998764 4


Q ss_pred             eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            568999999999999999765 459999999999999999999998 999999999999999999999999999997654


Q ss_pred             ccCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          212 STSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      .... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+       ....+...... ..+
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-------~~~~~~~~~~~-~~~  236 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------VIGVLEKGDRL-PKP  236 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-------HHHHHHHTCCC-CCC
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-------HHHHHhcCCCC-CCC
Confidence            3322 1223457889999999988889999999999999999998 999997654322       12222222222 234


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ..+++.+.++|.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            5689999999999999999999999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=351.84  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=205.7

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEE----EEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF----ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      +..++|++++.||+|+||.||+|.+..+++.+    |+|.+...........+.+|+.+++.++||||+++++++..+. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            55689999999999999999999998887754    6776654444445678899999999999999999999988654 


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .++|++|+.+|+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            78899999999999999764 679999999999999999999998 9999999999999999999999999999987643


Q ss_pred             cCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          213 TSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       213 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      ...  ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..+       ....+.... ....+
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~-~~~~~  241 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE-RLPQP  241 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTC-CCCCC
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCC-CCCCC
Confidence            322  1223456789999999999999999999999999999999 999998754432       222333332 22334


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+++++.++|.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          242 PICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            678999999999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.7e-47  Score=346.85  Aligned_cols=248  Identities=20%  Similarity=0.326  Sum_probs=207.3

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCC-------cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTG-------QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY  129 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~  129 (353)
                      ++..++|++.+.||+|+||.||++.+..++       ..||+|++... .......+.+|+.+++.++||||+++++++.
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            456689999999999999999999998877       47999998654 2334567899999999999999999999999


Q ss_pred             ecCeEEEEEEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc--------EE
Q 018630          130 SNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--------VK  200 (353)
Q Consensus       130 ~~~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~--------~k  200 (353)
                      +++..++||||+++++|.+++..... +++..+..++.|++.||.|||+ +||+||||||+||+++.++.        +|
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999999987644 9999999999999999999998 99999999999999998887        99


Q ss_pred             EeeccccccccccCCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcC-CCCCCCCccCCchhhHHHHHHH
Q 018630          201 ITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDGWTSFYELMEA  278 (353)
Q Consensus       201 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~~~~~~~~~~~  278 (353)
                      |+|||++.....    .....||+.|+|||++.+ ..++.++|||||||++|||++| .+||...+.       ......
T Consensus       162 l~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~~~~~~  230 (289)
T 4fvq_A          162 LSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------QRKLQF  230 (289)
T ss_dssp             ECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHH
T ss_pred             eccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-------HHHHHH
Confidence            999999865432    223468899999999987 6789999999999999999995 555544322       111122


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          279 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ....   ...+...++++.+|+.+||+.||++|||+.|+++|
T Consensus       231 ~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          231 YEDR---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHTT---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhcc---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2221   12234557889999999999999999999999985

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-46  Score=363.38  Aligned_cols=254  Identities=24%  Similarity=0.386  Sum_probs=214.3

Q ss_pred             CCCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           53 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ...+.+..++|++.+.||+|+||.||++.+. ++..||||+++....  ....+.+|+.+++.++||||+++++++. ..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            3456778899999999999999999999986 577899999976532  3567899999999999999999999876 66


Q ss_pred             eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      .+++||||+++|+|.+++...  ..++...+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            789999999999999999754  478999999999999999999999 99999999999999999999999999999875


Q ss_pred             cccCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          211 ASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       211 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      ..... ......+++.|+|||++....++.++|||||||++|||++ |..||.+.+.       .+....+......+ .
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~~~-~  406 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRALERGYRMP-R  406 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHHTCCCC-C
T ss_pred             CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCC-C
Confidence            43211 1223356788999999998899999999999999999999 9999976432       23344444433322 3


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +..+++++.+||.+||+.||++|||+++++.
T Consensus       407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          407 PENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            4678999999999999999999999999976

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.7e-47  Score=350.34  Aligned_cols=260  Identities=23%  Similarity=0.294  Sum_probs=212.3

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      ...++|++.+.||+|+||.||++.++ +++.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  113 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI  113 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred             HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            34578999999999999999999975 68999999986553 33456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          138 LEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      |||+++|+|.+++....    .+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++.....
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999986542    58999999999999999999998 99999999999999999999999999999764322


Q ss_pred             CC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-------
Q 018630          214 SG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-------  284 (353)
Q Consensus       214 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------  284 (353)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|..||......+.................       
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN  272 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred             cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence            21  223356899999999998889999999999999999999999999875544332222111111111111       


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          285 -PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       285 -~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                       ........+..+.+++.+||+.||++|||+.|++++
T Consensus       273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             111122345678999999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.4e-47  Score=343.84  Aligned_cols=252  Identities=26%  Similarity=0.395  Sum_probs=199.2

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhc--CCCCceEEEeeEeEe----c
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS--SQCPYVVVCYQSFYS----N  131 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~hp~iv~~~~~~~~----~  131 (353)
                      ...++|++.+.||+|+||.||++++  +++.||||++....    ...+.+|.+++..  ++||||+++++.+..    .
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            3457999999999999999999987  68999999987542    2334455555544  899999999998654    3


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCceecCCCCCcEEEcCCCcEEEee
Q 018630          132 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH--------HEKHIIHRDLKPSNLLINHRGEVKITD  203 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH--------~~~~iiH~Dlkp~NIll~~~~~~kl~D  203 (353)
                      ..+++||||+++|+|.++++. ..+++..+..++.|++.||.|||        + +||+||||||+||+++.++.+||+|
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTSCEEECC
T ss_pred             ceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCCCEEEee
Confidence            568999999999999999965 57999999999999999999999        7 8999999999999999999999999


Q ss_pred             ccccccccccCCC----CcccccCCcccCcceecCC------CCCccccHHHHHHHHHHHHcC----------CCCCCCC
Q 018630          204 FGVSAIMASTSGQ----ANTFVGTYNYMSPERISGG------KYGYKSDIWSLGLVLLECATG----------QFPYSPP  263 (353)
Q Consensus       204 fG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~Pf~~~  263 (353)
                      ||+++........    .....||+.|+|||++.+.      .++.++|||||||++|||++|          ..||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            9999765433221    2334799999999999876      455799999999999999999          8888764


Q ss_pred             ccCCchhhHHHHHHHHhcCCCCCCCC-----CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          264 EQQDGWTSFYELMEAIVDQPPPSAPS-----DQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .....  ..................+     ...++++.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          237 VPNDP--SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             SCSSC--CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCc--chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            43321  1222222222222211111     224578999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.3e-47  Score=347.73  Aligned_cols=260  Identities=25%  Similarity=0.385  Sum_probs=212.8

Q ss_pred             CCCccCc-eeeeeecccCCeEEEEEE----eccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-
Q 018630           57 QLNLEDI-DTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-  130 (353)
Q Consensus        57 ~~~~~~~-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-  130 (353)
                      .+..++| ++++.||+|+||.||++.    +..+++.||||+++..........+.+|+.+++.++||||+++++++.+ 
T Consensus        26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            3333455 999999999999998775    4457889999999877666677889999999999999999999999987 


Q ss_pred             -cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          131 -NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       131 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                       ...+++||||+++++|.+++... .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCCCEEECCcccccc
Confidence             46899999999999999999764 59999999999999999999999 9999999999999999999999999999987


Q ss_pred             ccccCC---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccC--------CchhhHHHHHHH
Q 018630          210 MASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ--------DGWTSFYELMEA  278 (353)
Q Consensus       210 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~~~~~~~~  278 (353)
                      ......   ......+|+.|+|||++.+..++.++|||||||++|+|++|..||......        ............
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            653322   122346788899999999888999999999999999999999999753221        011112223333


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          279 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +.... ....+..+++++.+||.+||+.||++|||+.|+++
T Consensus       264 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          264 LERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Hhccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            33333 33345678999999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-46  Score=340.28  Aligned_cols=245  Identities=27%  Similarity=0.432  Sum_probs=210.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe----------
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS----------  130 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~----------  130 (353)
                      .+|++.+.||+|+||.||++.+..+++.||+|+++...     ..+.+|+++++.++||||+++++++..          
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            67999999999999999999999999999999987653     246689999999999999999998754          


Q ss_pred             ------cCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEe
Q 018630          131 ------NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT  202 (353)
Q Consensus       131 ------~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~  202 (353)
                            ...+++||||+++++|.+++...  ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~  164 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTKQVKIG  164 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEEC
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCCCEEEC
Confidence                  45689999999999999999754  679999999999999999999998 999999999999999999999999


Q ss_pred             eccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC
Q 018630          203 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ  282 (353)
Q Consensus       203 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~  282 (353)
                      |||++....... ......||+.|+|||.+.+..++.++|+||||+++|+|++|..||...         ......+...
T Consensus       165 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~~~~~~  234 (284)
T 2a19_B          165 DFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFTDLRDG  234 (284)
T ss_dssp             CCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHHHHHTT
T ss_pred             cchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHHHhhcc
Confidence            999997765432 234457999999999999989999999999999999999999887421         1223333332


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          283 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      .    .+..+++++.++|.+||+.||.+|||+.|+++|.+.-.
T Consensus       235 ~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          235 I----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             c----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            2    23567899999999999999999999999999877643

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.3e-46  Score=341.82  Aligned_cols=253  Identities=21%  Similarity=0.317  Sum_probs=207.0

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEe-EecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF-YSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~-~~~~~~~lv~e  139 (353)
                      ++|++.+.||+|+||.||++++..+++.||||++...   .....+.+|+.+++.+.|++++..+..+ ......++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc---ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            6899999999999999999999999999999987543   2234577899999999888766666554 56788999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE---cCCCcEEEeeccccccccccCC
Q 018630          140 YMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       140 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |+ +++|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||++   +.++.+||+|||+++.......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence            99 8899999985 4679999999999999999999998 999999999999999   7889999999999987654322


Q ss_pred             -------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          216 -------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       216 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                             ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.................... ...
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~  242 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EVL  242 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HHH
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-hhh
Confidence                   123457999999999999999999999999999999999999999876554433333333333222221 112


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ...+++++.++|.+||+.||++|||++++++
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            2567899999999999999999999999987

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=348.21  Aligned_cols=255  Identities=23%  Similarity=0.348  Sum_probs=207.7

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe----cCe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGA  133 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~----~~~  133 (353)
                      +..++|++.+.||+|+||.||++++..+++.||||++... .......+.+|+.+++.++||||+++++++..    ...
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            4557899999999999999999999999999999998654 34556788999999999999999999998873    357


Q ss_pred             EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          134 ISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      .++||||+.+++|.+++..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            8999999999999999976    3679999999999999999999999 9999999999999999999999999998876


Q ss_pred             ccccCCC---------CcccccCCcccCcceecCCC---CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH
Q 018630          210 MASTSGQ---------ANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME  277 (353)
Q Consensus       210 ~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~  277 (353)
                      .......         .....||+.|+|||++.+..   ++.++|||||||++|+|++|..||........  .   ...
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~---~~~  258 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--S---VAL  258 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--C---HHH
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--h---hhH
Confidence            4321111         11245799999999987654   68999999999999999999999964221110  1   111


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+.. .........+++++.++|.+||+.||.+|||+.+++++
T Consensus       259 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          259 AVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHC-C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hhhc-cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            2222 22222345789999999999999999999999999985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.9e-46  Score=338.94  Aligned_cols=254  Identities=21%  Similarity=0.310  Sum_probs=209.0

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEe-EecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF-YSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~-~~~~~~~lv~  138 (353)
                      .++|++.+.||+|+||.||++++..+++.||||++.....   ...+.+|+.+++.+.|++++..+..+ ......++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            3789999999999999999999999999999999865432   23578899999999988866555544 5678889999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE---cCCCcEEEeeccccccccccC
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ||+ +++|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||++   +.++.+||+|||++.......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            999 8899999974 4679999999999999999999998 999999999999999   488899999999998765433


Q ss_pred             C-------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          215 G-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       215 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      .       ......||+.|+|||.+.+..++.++|||||||++|+|++|..||...+..........+......... ..
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~  241 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EV  241 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HH
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-HH
Confidence            2       123457999999999999999999999999999999999999999875544333333333333222211 11


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ....+++++.+++.+||+.||++|||++++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            23567899999999999999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.3e-47  Score=354.58  Aligned_cols=257  Identities=17%  Similarity=0.232  Sum_probs=203.5

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccC-----CcEEEEEEeeccccHHH----------HHHHHHHHHHHhcCCCCceE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESA----------RRQIAQELKINQSSQCPYVV  122 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~----------~~~~~~e~~~~~~l~hp~iv  122 (353)
                      ...++|++.+.||+|+||.||+|.+..+     ++.||||++........          .....+|+..+..+.||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3456899999999999999999998764     57899999875532110          12234566677888999999


Q ss_pred             EEeeEeEec----CeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc--C
Q 018630          123 VCYQSFYSN----GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN--H  195 (353)
Q Consensus       123 ~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~--~  195 (353)
                      ++++++...    ...++||||+ |++|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++  .
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence            999998764    5689999999 89999999876 679999999999999999999999 9999999999999999  8


Q ss_pred             CCcEEEeeccccccccccCCC-------CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc
Q 018630          196 RGEVKITDFGVSAIMASTSGQ-------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG  268 (353)
Q Consensus       196 ~~~~kl~DfG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~  268 (353)
                      ++.+||+|||+++........       ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+......
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            899999999999776433221       1334599999999999999999999999999999999999999985332211


Q ss_pred             hhhHH-----HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          269 WTSFY-----ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       269 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .....     .....+.....   ....+++++.+++..||+.||++|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            11000     00111111111   12567899999999999999999999999976

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-46  Score=339.41  Aligned_cols=249  Identities=21%  Similarity=0.317  Sum_probs=207.9

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE-EEE
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI-SII  137 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~-~lv  137 (353)
                      .|...+.||+|+||.||+|.+..+++   .||+|++...........+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46677999999999999999765544   79999998766666778899999999999999999999999866554 999


Q ss_pred             EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--
Q 018630          138 LEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--  214 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--  214 (353)
                      |||+.+++|.+++.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++......  
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            999999999999976 4678999999999999999999998 999999999999999999999999999997653321  


Q ss_pred             --CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcC-CCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          215 --GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       215 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                        .......+++.|+|||.+.+..++.++|||||||++|+|++| .+||...+..       .....+..... ...+..
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~  252 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-------DLTHFLAQGRR-LPQPEY  252 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-------GHHHHHHTTCC-CCCCTT
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-------HHHHHhhcCCC-CCCCcc
Confidence              222345678999999999999999999999999999999995 4555443322       22233333332 333467


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +++++.+++.+||+.||.+|||+.++++
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            8999999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-47  Score=354.27  Aligned_cols=265  Identities=22%  Similarity=0.332  Sum_probs=209.9

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ....++|.+.+.||+|+||.||++++. +++.||||++...........+.+|+.+++.++||||+++++++..++..++
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred             HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence            455689999999999999999999864 6899999998765433334468899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          137 ILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEK---HIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~ql~~~l~~LH~~~---~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ||||+.+|+|.+++....    .+++..+..++.|++.||.|||+ +   ||+||||||+||+++.++.+||+|||++..
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~  183 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL  183 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence            999999999999998643    48999999999999999999998 8   999999999999999999999999999986


Q ss_pred             ccccCCC-CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc-hhhHHHHHHHHhcCCC---
Q 018630          210 MASTSGQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG-WTSFYELMEAIVDQPP---  284 (353)
Q Consensus       210 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~---  284 (353)
                      ....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ................   
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             CCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             cCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            5433222 2335699999999999888899999999999999999999999963211110 0111111111111110   


Q ss_pred             ------CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          285 ------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       285 ------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                            ........++.+.+++.+||+.||.+|||+.|+++|-.-
T Consensus       264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                  011112234679999999999999999999999997543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.2e-47  Score=354.52  Aligned_cols=258  Identities=19%  Similarity=0.241  Sum_probs=203.8

Q ss_pred             CCccCceeeeeecccCCeEEEEEEecc---CCcEEEEEEeeccccHH----------HHHHHHHHHHHHhcCCCCceEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKW---TGQFFALKVIQMNVEES----------ARRQIAQELKINQSSQCPYVVVC  124 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~----------~~~~~~~e~~~~~~l~hp~iv~~  124 (353)
                      +..++|++.+.||+|+||.||+|.+..   ++..+|+|++.......          ....+.+|+..++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            445789999999999999999999987   78899999987553211          11346678888999999999999


Q ss_pred             eeEeEe----cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC--c
Q 018630          125 YQSFYS----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG--E  198 (353)
Q Consensus       125 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~--~  198 (353)
                      ++++..    ....++||||+ +++|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESSSTTS
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccCCCCc
Confidence            999987    78899999999 89999999887789999999999999999999998 9999999999999999877  9


Q ss_pred             EEEeeccccccccccCC-------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhh
Q 018630          199 VKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS  271 (353)
Q Consensus       199 ~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  271 (353)
                      +||+|||+++.......       ......||+.|+|||++.+..++.++|||||||++|||++|..||......  ...
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~  269 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD--PVA  269 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC--HHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc--cHH
Confidence            99999999977643221       113457999999999999989999999999999999999999999642221  111


Q ss_pred             HHHHHHHHhcCCCC----CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          272 FYELMEAIVDQPPP----SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       272 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ............+.    ......+++++.++|.+||+.||++|||++++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            22222222222111    0112368999999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.3e-46  Score=343.63  Aligned_cols=256  Identities=21%  Similarity=0.324  Sum_probs=204.3

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEecc---CCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKW---TGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      ..+..++|.+.+.||+|+||.||+|.+..   +++.||+|+++.. ........+.+|+.+++.++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            34567899999999999999999998765   4558999998755 2345567789999999999999999999998765


Q ss_pred             C-----eEEEEEEecCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEE
Q 018630          132 G-----AISIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK  200 (353)
Q Consensus       132 ~-----~~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~k  200 (353)
                      .     ..++||||+++++|.+++..      ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+|
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECTTSCEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCcEE
Confidence            4     45999999999999999843      3569999999999999999999998 9999999999999999999999


Q ss_pred             EeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHH
Q 018630          201 ITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELME  277 (353)
Q Consensus       201 l~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~  277 (353)
                      |+|||++........  ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+       ...
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~  260 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------MYD  260 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHH
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------HHH
Confidence            999999976543321  1223457889999999999899999999999999999999 999997754322       223


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+..... ...+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       261 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          261 YLLHGHR-LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHHTTCC-CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCC-CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3333332 23346789999999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=362.79  Aligned_cols=256  Identities=23%  Similarity=0.370  Sum_probs=210.4

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC--eEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISI  136 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~--~~~l  136 (353)
                      ..++|.+.+.||+|+||.||+|++..+|+.||||++...........+.+|+++++.++||||+++++++...+  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            34789999999999999999999999999999999976544444567789999999999999999999988654  7899


Q ss_pred             EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE----cCCCcEEEeecccccc
Q 018630          137 ILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAI  209 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll----~~~~~~kl~DfG~a~~  209 (353)
                      ||||+++|+|.+++....   .+++..++.++.|++.||+|||+ +||+||||||+||++    +.++.+||+|||+++.
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            999999999999997643   39999999999999999999999 999999999999999    7777899999999987


Q ss_pred             ccccCCCCcccccCCcccCcceecC--------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc
Q 018630          210 MASTSGQANTFVGTYNYMSPERISG--------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD  281 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~  281 (353)
                      ..... ......||+.|+|||++.+        ..++.++|||||||++|||++|..||.......   ...+.+..+..
T Consensus       166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~---~~~~~~~~~~~  241 (396)
T 4eut_A          166 LEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKEVMYKIIT  241 (396)
T ss_dssp             CCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT---TCHHHHHHHHH
T ss_pred             ccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc---chHHHHHHHhc
Confidence            64332 3345679999999999864        457889999999999999999999997543322   12233444444


Q ss_pred             CCCCCC-----------------------CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          282 QPPPSA-----------------------PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       282 ~~~~~~-----------------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..++..                       ....+++.+.++|.+||+.||++|||+.|+++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            332210                       11224567889999999999999999999854

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.8e-46  Score=338.57  Aligned_cols=250  Identities=25%  Similarity=0.420  Sum_probs=204.3

Q ss_pred             CCCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec-
Q 018630           53 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-  131 (353)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~-  131 (353)
                      ...+.+..++|++.+.||+|+||.||++++.  |+.||||+++...   ....+.+|+.+++.++||||+++++++... 
T Consensus        13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (278)
T 1byg_A           13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   87 (278)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             hccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3455677899999999999999999999874  8899999987542   446788999999999999999999986544 


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      +..++||||+++++|.+++.....  +++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++..
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  166 (278)
T 1byg_A           88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  166 (278)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCCcEEEeecccccc
Confidence            578999999999999999976543  8999999999999999999998 9999999999999999999999999999876


Q ss_pred             ccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          210 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      ....   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..       +....+..... ...
T Consensus       167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~~~~~~~~~~~-~~~  235 (278)
T 1byg_A          167 ASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKGYK-MDA  235 (278)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GHHHHHTTTCC-CCC
T ss_pred             cccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhcCCC-CCC
Confidence            4432   223467889999999988889999999999999999998 99999765432       22333333322 334


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +..+++++.++|.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            5678999999999999999999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4e-46  Score=339.54  Aligned_cols=250  Identities=24%  Similarity=0.322  Sum_probs=207.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeE-ecCeEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAISI  136 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~-~~~~~~l  136 (353)
                      .+|++.+.||+|+||.||+|.+..+   ...+|+|.+...........+.+|+.+++.++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            5799999999999999999997543   33689999887666667788999999999999999999999854 5678899


Q ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          137 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++.......
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            99999999999999753 568999999999999999999998 9999999999999999999999999999976543221


Q ss_pred             ----CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          216 ----QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       216 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                          ......+|+.|+|||.+.+..++.++|+|||||++|+|++ |.+||...+..+       ....+..... ...+.
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-------~~~~~~~~~~-~~~~~  255 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRR-LLQPE  255 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-------HHHHHHTTCC-CCCCT
T ss_pred             hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhcCCC-CCCCc
Confidence                1233467889999999998899999999999999999999 667776654332       2223333332 23346


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+++++.+++.+||+.||++|||+.|+++
T Consensus       256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          256 YCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            78999999999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6e-46  Score=335.21  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=212.8

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      .++.+..++|++.+.||+|+||.||++.+. +++.||+|+++....  ....+.+|+++++.++||||+++++++. .+.
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   81 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP   81 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCC
Confidence            345677799999999999999999999976 577899999875532  2457889999999999999999999876 456


Q ss_pred             EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++....
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            89999999999999999754  379999999999999999999998 999999999999999999999999999997754


Q ss_pred             ccCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          212 STSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      .... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.       .+....+..... ...+
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~  232 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYR-MVRP  232 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC-CCCC
T ss_pred             CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HHHHHHHhcccC-CCCc
Confidence            3221 1223456789999999988889999999999999999999 9999976432       233444444332 2334


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+++++.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            678999999999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.1e-46  Score=372.02  Aligned_cols=252  Identities=21%  Similarity=0.339  Sum_probs=207.3

Q ss_pred             CccCceee-eeecccCCeEEEEEEe--ccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           59 NLEDIDTI-KVVGKGSGGIVQLVQH--KWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        59 ~~~~~~~~-~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      ..+.+.+. +.||+|+||.||++.+  +.+++.||||+++... .......+.+|+++++.++||||+++++++. ...+
T Consensus       366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~  444 (635)
T 4fl3_A          366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESW  444 (635)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSE
T ss_pred             cchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCE
Confidence            33344443 4899999999999954  4567899999997642 3344678999999999999999999999886 4568


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ++||||+++|+|.+++.....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus       445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            8999999999999999988889999999999999999999998 999999999999999999999999999998764332


Q ss_pred             C---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          215 G---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       215 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      .   ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.       .++...+...... ..+.
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------~~~~~~i~~~~~~-~~p~  595 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGERM-GCPA  595 (635)
T ss_dssp             -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCC-CCCT
T ss_pred             cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC-CCCC
Confidence            2   1222356788999999998899999999999999999998 9999977433       2344445444433 3346


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+++++.+||.+||+.||++|||++++++.
T Consensus       596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~  625 (635)
T 4fl3_A          596 GCPREMYDLMNLCWTYDVENRPGFAAVELR  625 (635)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            789999999999999999999999999873

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.7e-46  Score=358.88  Aligned_cols=253  Identities=24%  Similarity=0.379  Sum_probs=208.9

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..+.+..++|++.+.||+|+||.||++.+.. +..||||+++....  ....+.+|+.+++.++||||+++++++.+ +.
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            4456778899999999999999999999874 56799999876532  23578999999999999999999998865 67


Q ss_pred             EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++...
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            89999999999999999743  569999999999999999999998 999999999999999999999999999998654


Q ss_pred             ccCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          212 STSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      .... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+...       .+....+......+ .+
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~~~-~~  403 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMP-CP  403 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCC-CC
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCC-CC
Confidence            3221 1223456789999999998899999999999999999999 9999976432       23444444443322 34


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+++++.+||.+||+.||++|||++++++
T Consensus       404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          404 PECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            578999999999999999999999999987

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-46  Score=343.68  Aligned_cols=252  Identities=27%  Similarity=0.423  Sum_probs=198.4

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhc--CCCCceEEEeeEeEec----C
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS--SQCPYVVVCYQSFYSN----G  132 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~hp~iv~~~~~~~~~----~  132 (353)
                      ..++|++.+.||+|+||.||++++.  ++.||||++....    .....+|.+++..  ++||||+++++++...    .
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            3478999999999999999999875  8999999986442    2233444455444  5999999999999877    7


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--------CceecCCCCCcEEEcCCCcEEEeec
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK--------HIIHRDLKPSNLLINHRGEVKITDF  204 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--------~iiH~Dlkp~NIll~~~~~~kl~Df  204 (353)
                      .+++||||+++|+|.++++. ..+++..+..++.|++.||.|||+ +        ||+||||||+||+++.++.+||+||
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            89999999999999999976 479999999999999999999998 7        9999999999999999999999999


Q ss_pred             cccccccccCCC----CcccccCCcccCcceecCCCCCcc------ccHHHHHHHHHHHHcC----------CCCCCCCc
Q 018630          205 GVSAIMASTSGQ----ANTFVGTYNYMSPERISGGKYGYK------SDIWSLGLVLLECATG----------QFPYSPPE  264 (353)
Q Consensus       205 G~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~ell~g----------~~Pf~~~~  264 (353)
                      |++.........    .....||+.|+|||++.+..++..      +|||||||++|||++|          ..||....
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence            999765433222    124579999999999987766554      9999999999999999          67776543


Q ss_pred             cCCchhhHHHHHHHHhcCCCCCCCC-----CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          265 QQDGWTSFYELMEAIVDQPPPSAPS-----DQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ....  ..................+     ..+++++.+||.+||+.||.+|||+.|+++|
T Consensus       267 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          267 PSDP--SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CSSC--CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCC--chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            3321  2222222332222222221     2456779999999999999999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-46  Score=352.34  Aligned_cols=251  Identities=24%  Similarity=0.318  Sum_probs=201.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCC---cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeE-ecCeEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTG---QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAISI  136 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~-~~~~~~l  136 (353)
                      ..|.+.+.||+|+||.||++.+..++   ..||+|.++..........+.+|+.+++.++||||+++++++. .++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            45788999999999999999876443   3689999876655667788999999999999999999999865 4568899


Q ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          137 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      ||||+++|+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.......
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            99999999999999764 458999999999999999999998 9999999999999999999999999999976543221


Q ss_pred             ----CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          216 ----QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       216 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                          ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+       ....+..... ...+.
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-------~~~~~~~~~~-~~~p~  319 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRR-LLQPE  319 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-------HHHHHHTTCC-CCCCT
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-------HHHHHHcCCC-CCCCC
Confidence                1123457789999999998899999999999999999999 788887755432       2223333332 23346


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+++++.++|.+||+.||++|||+.|++++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-46  Score=343.81  Aligned_cols=261  Identities=28%  Similarity=0.441  Sum_probs=213.1

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEE----eccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      ..+..++|++++.||+|+||.||+++    +..+++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            34566889999999999999999998    4668999999998765 345567899999999999999999999988654


Q ss_pred             --CeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          132 --GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       132 --~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                        ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence              3789999999999999999875 469999999999999999999998 999999999999999999999999999998


Q ss_pred             cccccCCC---CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccC---------CchhhHHHHH
Q 018630          209 IMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ---------DGWTSFYELM  276 (353)
Q Consensus       209 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---------~~~~~~~~~~  276 (353)
                      ........   .....++..|+|||.+.+..++.++|||||||++|+|++|..||......         ........+.
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            76433221   22345778899999998888999999999999999999999998643110         0011112233


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          277 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+...... ..+..+++++.++|.+||+.||++|||+.|+++
T Consensus       274 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          274 ELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            333333322 335678999999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=345.36  Aligned_cols=251  Identities=29%  Similarity=0.404  Sum_probs=192.2

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeE------
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFY------  129 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~------  129 (353)
                      .+...+|++.+.||+|+||.||++++..+++.||||++... .......+.+|+.+++.+. ||||+++++++.      
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            34556899999999999999999999999999999998654 3445567889999999985 999999999884      


Q ss_pred             --ecCeEEEEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCcEEEcCCCcEEEe
Q 018630          130 --SNGAISIILEYMDGGSLADFLKK---VKTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKIT  202 (353)
Q Consensus       130 --~~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~~--iiH~Dlkp~NIll~~~~~~kl~  202 (353)
                        ....+++||||+. |+|.+++..   .+.+++..++.++.|++.||.|||+ .|  |+||||||+||+++.++.+||+
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCCCEEEe
Confidence              3456899999996 699998865   4579999999999999999999998 88  9999999999999999999999


Q ss_pred             eccccccccccCCC------------CcccccCCcccCccee---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC
Q 018630          203 DFGVSAIMASTSGQ------------ANTFVGTYNYMSPERI---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD  267 (353)
Q Consensus       203 DfG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~  267 (353)
                      |||++.........            .....||+.|+|||++   .+..++.++|||||||++|+|++|..||...... 
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-  259 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-  259 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-
Confidence            99999775432211            1134689999999998   5567899999999999999999999999754321 


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCC
Q 018630          268 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP  321 (353)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  321 (353)
                                .+.............++.+.+||.+||+.||.+|||+.|+++|-
T Consensus       260 ----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          260 ----------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             ----------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence                      11122222233456788899999999999999999999999973

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=348.65  Aligned_cols=250  Identities=17%  Similarity=0.240  Sum_probs=205.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEecc--------CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEE--------
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKW--------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV--------  123 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~--------  123 (353)
                      .++|++.+.||+|+||.||+|++..        .++.||+|++...      ..+.+|+++++.++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            4789999999999999999999987        4889999998754      35778999999999999887        


Q ss_pred             -------EeeEeEe-cCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE
Q 018630          124 -------CYQSFYS-NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI  193 (353)
Q Consensus       124 -------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll  193 (353)
                             +++++.. ++.+++||||+ +++|.+++...  ..+++..+..++.|++.||.|||+ +||+||||||+||++
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFV  192 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEE
Confidence                   5666665 68899999999 89999999875  789999999999999999999999 999999999999999


Q ss_pred             cCCC--cEEEeeccccccccccCC-------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Q 018630          194 NHRG--EVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE  264 (353)
Q Consensus       194 ~~~~--~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  264 (353)
                      +.++  .+||+|||+++.......       ......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9988  899999999976643322       1233579999999999999899999999999999999999999997643


Q ss_pred             cCCchhhHHHHHHHHhcCCCCC----CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          265 QQDGWTSFYELMEAIVDQPPPS----APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..  ..........+.......    .....+++++.+||.+||+.||++|||++++++
T Consensus       273 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          273 PN--TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TC--HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cC--HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            21  122233333333222211    112357899999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.6e-46  Score=338.39  Aligned_cols=254  Identities=24%  Similarity=0.365  Sum_probs=205.0

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEecc-CCc--EEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKW-TGQ--FFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      .+..++|++.+.||+|+||.||++++.. +++  .||+|+++...  .......+.+|+.+++.++||||+++++++..+
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            4566899999999999999999998643 333  68999987542  334567889999999999999999999988765


Q ss_pred             CeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      . .++|+||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++...
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            5 88999999999999999764 579999999999999999999998 99999999999999999999999999999776


Q ss_pred             cccCC---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          211 ASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       211 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      .....   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.       .+....+.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~  244 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEGERL  244 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSCCCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------HHHHHHHHccCCCC
Confidence            43322   1223467888999999988889999999999999999999 9999976432       24445555544444


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+..+++++.++|.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          245 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            455688999999999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.1e-46  Score=359.52  Aligned_cols=253  Identities=25%  Similarity=0.374  Sum_probs=192.0

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      +.|...+.||+|+||+||.+ ...+|+.||||++....    ...+.+|+.+++.+ +||||+++++.+.+++.+|+|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            44566789999999999865 45689999999986542    24567899998875 89999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC-------------CcE
Q 018630          140 YMDGGSLADFLKKVKTI-------PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-------------GEV  199 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l-------~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~-------------~~~  199 (353)
                      |+. |+|.+++......       ++..+..++.|++.||+|||+ +||+||||||+|||++.+             +.+
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            996 5999999865432       223456799999999999998 999999999999999754             489


Q ss_pred             EEeeccccccccccCC----CCcccccCCcccCcceecC-------CCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018630          200 KITDFGVSAIMASTSG----QANTFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  267 (353)
Q Consensus       200 kl~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~  267 (353)
                      ||+|||+++.......    .....+||+.|+|||++.+       ..++.++|||||||++|||++ |..||...... 
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-  246 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-  246 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence            9999999987654322    1234579999999999975       568999999999999999999 99999754221 


Q ss_pred             chhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          268 GWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       268 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                          ...+......... .......+++++.+||.+||+.||.+|||+.|+++||||..
T Consensus       247 ----~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          247 ----ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             ----HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             ----HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence                1111111111111 11111234578999999999999999999999999999964

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=366.29  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=207.9

Q ss_pred             CCccCceeee-eecccCCeEEEEEEecc--CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           58 LNLEDIDTIK-VVGKGSGGIVQLVQHKW--TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        58 ~~~~~~~~~~-~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      +..+++.+.+ .||+|+||.||++.++.  ++..||||+++..........+.+|+++++.++||||+++++++.. +.+
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            3445666666 89999999999998753  4567999999876545556789999999999999999999999875 569


Q ss_pred             EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      ++||||+.+|+|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            9999999999999999754 569999999999999999999998 99999999999999999999999999999875432


Q ss_pred             CCCC---cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          214 SGQA---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       214 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      ....   ....+++.|+|||++.+..++.++|||||||++|||++ |..||...+.       .++...+..+... ..+
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------~~~~~~i~~~~~~-~~p  561 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVMAFIEQGKRM-ECP  561 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-------HHHHHHHHTTCCC-CCC
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHcCCCC-CCC
Confidence            2211   12345689999999998899999999999999999998 9999987543       2344455544433 334


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+++++.+||.+||+.||++|||+.++++
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            678999999999999999999999999976

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=344.42  Aligned_cols=258  Identities=22%  Similarity=0.324  Sum_probs=194.3

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-----
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-----  130 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-----  130 (353)
                      ..+..++|++.+.||+|+||.||+++.  +++.||||++.......  .....++..+..++||||+++++.+..     
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~--~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN--FINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh--HHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            456779999999999999999999976  68999999987542211  122344444556899999999975542     


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---------CceecCCCCCcEEEcCCCcEEE
Q 018630          131 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK---------HIIHRDLKPSNLLINHRGEVKI  201 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---------~iiH~Dlkp~NIll~~~~~~kl  201 (353)
                      ...+++||||+++|+|.+++... ..++..+..++.|++.||.|||+ .         ||+||||||+|||++.++.+||
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             CceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCCcEEE
Confidence            34679999999999999999764 45899999999999999999998 8         9999999999999999999999


Q ss_pred             eeccccccccccC--------CCCcccccCCcccCcceecC-------CCCCccccHHHHHHHHHHHHcCCCCCCCCccC
Q 018630          202 TDFGVSAIMASTS--------GQANTFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ  266 (353)
Q Consensus       202 ~DfG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~  266 (353)
                      +|||+++......        ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            9999997654221        12234579999999999987       35677999999999999999997666443221


Q ss_pred             Cch-----------hhHHHHHHHHhcCCCCCCCCCC------CCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          267 DGW-----------TSFYELMEAIVDQPPPSAPSDQ------FSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       267 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ...           ...................+..      +++++.+||.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            111           1111222222222222222222      3457999999999999999999999955

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=338.55  Aligned_cols=248  Identities=29%  Similarity=0.511  Sum_probs=201.5

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      .+..++|++.+.||+|+||.||++++.  ++.||+|++...   .....+.+|+.+++.++||||+++++++.  +..++
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~l   76 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCL   76 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEE
Confidence            356789999999999999999999875  789999998643   34567889999999999999999999876  34789


Q ss_pred             EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCceecCCCCCcEEEcCCCc-EEEeeccccccc
Q 018630          137 ILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHE--KHIIHRDLKPSNLLINHRGE-VKITDFGVSAIM  210 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~~l~~LH~~--~~iiH~Dlkp~NIll~~~~~-~kl~DfG~a~~~  210 (353)
                      ||||+++++|.+++....   .++...+..++.|++.||.|||+.  +||+||||||+||+++.++. +||+|||++...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999999999999998654   478999999999999999999973  58999999999999998886 799999998765


Q ss_pred             cccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          211 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ...   .....||+.|+|||++.+..++.++|||||||++|||++|..||......     .............+ ....
T Consensus       157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~-~~~~  227 (307)
T 2eva_A          157 QTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----AFRIMWAVHNGTRP-PLIK  227 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----HHHHHHHHHTTCCC-CCBT
T ss_pred             ccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----HHHHHHHHhcCCCC-Cccc
Confidence            322   23457899999999999989999999999999999999999999754321     12223333333332 3346


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+++.+.+++.+||+.||.+|||+++++++
T Consensus       228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            789999999999999999999999999873

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=349.45  Aligned_cols=249  Identities=16%  Similarity=0.194  Sum_probs=200.0

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEE-----EeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC---CCceEEEe
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLV-----QHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ---CPYVVVCY  125 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---hp~iv~~~  125 (353)
                      ...++..++|.+.+.||+|+||.||+|     .+..+++.||||+++...    ...+.+|+.++..+.   |+||+.++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            344566788999999999999999999     467789999999987553    234555666655555   99999999


Q ss_pred             eEeEecCeEEEEEEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-----
Q 018630          126 QSFYSNGAISIILEYMDGGSLADFLKK-----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-----  195 (353)
Q Consensus       126 ~~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-----  195 (353)
                      +.+..++..++||||+++|+|.+++..     ...+++..++.++.|++.||+|||+ +||+||||||+|||++.     
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCc
Confidence            999999999999999999999999974     4569999999999999999999998 99999999999999998     


Q ss_pred             ------CCcEEEeeccccccccc--cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC
Q 018630          196 ------RGEVKITDFGVSAIMAS--TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD  267 (353)
Q Consensus       196 ------~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~  267 (353)
                            ++.+||+|||+|+....  ........+||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999976532  2223345689999999999999999999999999999999999999996543221


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          268 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                       +.         ....   ......++.+.+++.+||+.+|.+|++..+.+.+
T Consensus       293 -~~---------~~~~---~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          293 -CK---------PEGL---FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             -EE---------ECSC---CTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             -ee---------echh---ccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence             10         0011   1112346789999999999999999765554443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=357.44  Aligned_cols=254  Identities=23%  Similarity=0.340  Sum_probs=196.7

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~l  136 (353)
                      +...+|.+.+.||+|+||+|+ +....+++.||||++.....    ..+.+|+.+++.+ +||||+++++++.+....|+
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~-~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEE-EEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             EccEEEecCCeeecCcCEEEE-EEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            344579999999999999976 35556899999999865422    2345789999888 79999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC---C--CcEEEeeccccccc
Q 018630          137 ILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---R--GEVKITDFGVSAIM  210 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~---~--~~~kl~DfG~a~~~  210 (353)
                      ||||+. |+|.+++.... ..++..+..++.|++.||.|||+ +||+||||||+||+++.   +  ..+||+|||+++..
T Consensus        96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            999997 59999997653 45566778999999999999999 99999999999999953   2  35889999999876


Q ss_pred             cccC---CCCcccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018630          211 ASTS---GQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQP  283 (353)
Q Consensus       211 ~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
                      ....   ......+||+.|+|||++.+   ..++.++|||||||++|||++ |..||.....        ..........
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~  245 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--------RQANILLGAC  245 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--------HHHHHHTTCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--------HHHHHHhccC
Confidence            4322   12334679999999999974   567889999999999999999 9999965322        1111222221


Q ss_pred             CCC--CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          284 PPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       284 ~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      ...  ......+..+.+||.+||+.||.+|||++|+++||||...
T Consensus       246 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            111  1123345668999999999999999999999999999754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.5e-45  Score=333.19  Aligned_cols=237  Identities=28%  Similarity=0.465  Sum_probs=191.2

Q ss_pred             CccCceee-eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHH-hcCCCCceEEEeeEeEe----cC
Q 018630           59 NLEDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYS----NG  132 (353)
Q Consensus        59 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~hp~iv~~~~~~~~----~~  132 (353)
                      ..++|.+. +.||+|+||.||++.++.+++.||+|+++..      ..+.+|+.++ +..+||||+++++++..    ..
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            34778887 7899999999999999999999999998643      3456777776 66799999999999887    77


Q ss_pred             eEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC---CCcEEEeecccc
Q 018630          133 AISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVS  207 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a  207 (353)
                      .+++||||+++++|.+++....  .+++..+..++.|++.||.|||+ +||+||||||+||+++.   ++.+||+|||++
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            8999999999999999998754  69999999999999999999998 99999999999999998   788999999988


Q ss_pred             ccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--C
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--P  285 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~  285 (353)
                      ....                      +..++.++|||||||++|||++|..||...+.......   ....+.....  +
T Consensus       168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~  222 (299)
T 3m2w_A          168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYEFP  222 (299)
T ss_dssp             EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC---SCCSSCTTCCSSC
T ss_pred             cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH---HHHHHhhccccCC
Confidence            5432                      24578899999999999999999999976432210000   0000000000  0


Q ss_pred             CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          286 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       286 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ......+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            001146799999999999999999999999999999998654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.2e-47  Score=375.73  Aligned_cols=266  Identities=26%  Similarity=0.408  Sum_probs=211.3

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe------cC
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS------NG  132 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~------~~  132 (353)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||+++..........+.+|+.+++.++||||+++++++..      ++
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            347899999999999999999999999999999998776566677889999999999999999999998654      67


Q ss_pred             eEEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc---EEEeeccc
Q 018630          133 AISIILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGV  206 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~---~kl~DfG~  206 (353)
                      ..++||||++||+|.+++....   .+++..++.++.|++.||+|||+ .||+||||||+||+++.++.   +||+|||+
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            8899999999999999998653   58999999999999999999998 99999999999999997765   99999999


Q ss_pred             cccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhH--HHHHHHHh----
Q 018630          207 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF--YELMEAIV----  280 (353)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~~----  280 (353)
                      +...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........|...  ........    
T Consensus       171 a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          171 AKELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             CCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred             ccccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence            9876433 2344568999999999999999999999999999999999999999653211100000  00000000    


Q ss_pred             -cC--------CCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          281 -DQ--------PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       281 -~~--------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                       .+        ..+......+++.+.+||.+||+.||++|||++|+++||||+..
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence             00        00111223367889999999999999999999999999999764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4e-45  Score=359.35  Aligned_cols=253  Identities=24%  Similarity=0.379  Sum_probs=213.3

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..+.+..++|++.+.||+|+||.||++.+.. +..||||+++....  ....+.+|+++++.++||||+++++++.+ +.
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            4456778899999999999999999999874 56799999976532  23578999999999999999999998865 67


Q ss_pred             EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      +++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++...
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            89999999999999999753  569999999999999999999998 999999999999999999999999999997654


Q ss_pred             ccCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          212 STSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      .... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+...       .++...+....... .+
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~~~-~~  486 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMP-CP  486 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHHHHHTTCCCC-CC
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCC-CC
Confidence            2211 1223356789999999998899999999999999999999 9999976432       23444444443322 34


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ..+++++.+||.+||+.||++|||++++++
T Consensus       487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          487 PECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            578999999999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=342.92  Aligned_cols=267  Identities=22%  Similarity=0.350  Sum_probs=211.9

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ..+.+..++|++.+.||+|+||.||++.+..   .+|+|+++... .......+.+|+.+++.++||||+++++++.+++
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            3456778999999999999999999998853   49999986542 2223355778999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      .+++||||+++++|.+++...+ .+++..+..++.|++.||.|||+ +|++||||||+||+++ ++.+||+|||+++...
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            9999999999999999998654 69999999999999999999998 9999999999999997 6899999999986543


Q ss_pred             cc-----CCCCcccccCCcccCcceecC---------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH
Q 018630          212 ST-----SGQANTFVGTYNYMSPERISG---------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME  277 (353)
Q Consensus       212 ~~-----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~  277 (353)
                      ..     ........||+.|+|||++.+         ..++.++|||||||++|||++|..||.....       .....
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~  253 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-------EAIIW  253 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-------HHHHH
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence            11     112233468999999999864         3578999999999999999999999976432       23444


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHh
Q 018630          278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  334 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~  334 (353)
                      .+.....+......+++++.+++.+||+.||++|||+.++++  .++...+....++
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~~~~~~  308 (319)
T 2y4i_B          254 QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRRLS  308 (319)
T ss_dssp             HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC--------
T ss_pred             HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHhhccCC
Confidence            555555555555578899999999999999999999999998  5555555444433

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.1e-45  Score=334.27  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=205.0

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc---ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN---VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      |...+.||+|+||.||++.+  +++.||+|++...   ........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44568999999999999986  5889999998653   234456789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          140 YMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       140 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      |+++++|.+++...   ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.........
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            99999999999743   468999999999999999999998 99999999999999999999999999998765432221


Q ss_pred             --CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH-------HHhcCCCCCC
Q 018630          217 --ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME-------AIVDQPPPSA  287 (353)
Q Consensus       217 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~-------~~~~~~~~~~  287 (353)
                        .....||+.|+|||.+.+ .++.++|+|||||++|+|++|..||.................       ....... ..
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  267 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-ND  267 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC-SC
T ss_pred             ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc-cc
Confidence              233578999999998865 589999999999999999999999987655433222221111       1111111 11


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .....++.+.+++.+||+.||.+|||+.+++++
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            123345779999999999999999999999873

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4e-45  Score=339.15  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=203.5

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhc--CCCCceEEEeeEeEecC----e
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS--SQCPYVVVCYQSFYSNG----A  133 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~hp~iv~~~~~~~~~~----~  133 (353)
                      .++|++.+.||+|+||.||++++  +++.||||++....    ...+.+|.+++..  ++||||+++++++....    .
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            36899999999999999999987  48999999986442    3456677887766  79999999999998765    8


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCceecCCCCCcEEEcCCCcEEEeecc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH--------HEKHIIHRDLKPSNLLINHRGEVKITDFG  205 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH--------~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  205 (353)
                      +++||||+++|+|.+++.. ..+++..++.++.|++.||.|||        + .||+||||||+||+++.++++||+|||
T Consensus       115 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCCCEEEEECC
Confidence            9999999999999999976 57999999999999999999999        7 899999999999999999999999999


Q ss_pred             ccccccccCC----CCcccccCCcccCcceecCC------CCCccccHHHHHHHHHHHHcC----------CCCCCCCcc
Q 018630          206 VSAIMASTSG----QANTFVGTYNYMSPERISGG------KYGYKSDIWSLGLVLLECATG----------QFPYSPPEQ  265 (353)
Q Consensus       206 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~Pf~~~~~  265 (353)
                      ++........    ......||+.|+|||++.+.      .++.++|||||||++|||++|          ..||.....
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~  272 (342)
T 1b6c_B          193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  272 (342)
T ss_dssp             TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence            9977654332    12345799999999999775      234789999999999999999          788876543


Q ss_pred             CCchhhHHHHHHHHhcCCCCCCCC-----CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          266 QDGWTSFYELMEAIVDQPPPSAPS-----DQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+  .........+.........+     ...++.+.+|+.+||+.||++|||++++++|
T Consensus       273 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          273 SD--PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SS--CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             Cc--ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            22  12233334443333222222     1334679999999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.4e-45  Score=351.84  Aligned_cols=254  Identities=22%  Similarity=0.299  Sum_probs=208.4

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCC-CceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC-PYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-p~iv~~~~~~~~~~~~~lv~  138 (353)
                      .++|++.+.||+|+||.||++.+..+++.||||++.....   ..++.+|+++++.+.| +++..+..++......++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            3789999999999999999999999999999998865422   2347789999998887 55556666667788999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEE---cCCCcEEEeeccccccccccC
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      ||+ +++|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+   +.++.+||+|||+++......
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            999 8899999985 4679999999999999999999998 999999999999999   588999999999998765433


Q ss_pred             CC-------CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          215 GQ-------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       215 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      ..       .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+..+......... ..
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~  239 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI-EA  239 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH-HH
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH-HH
Confidence            21       22567999999999999999999999999999999999999999876554433333333332222211 11


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ....+++++.+||.+||+.||++||++.++++
T Consensus       240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            12467899999999999999999999998865

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.8e-44  Score=362.08  Aligned_cols=255  Identities=24%  Similarity=0.341  Sum_probs=212.9

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      ...+..++|++.+.||+|+||.||++.+..+   +..||+|.++..........+.+|+.+++.++||||+++++++. +
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            3456678899999999999999999998643   45799999876656667788999999999999999999999875 5


Q ss_pred             CeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          132 GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      +..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            6789999999999999999865 368999999999999999999999 99999999999999999999999999999876


Q ss_pred             cccCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          211 ASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       211 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      ..... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.       .+....+....... .
T Consensus       542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~~~-~  613 (656)
T 2j0j_A          542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGERLP-M  613 (656)
T ss_dssp             CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHHTCCCC-C
T ss_pred             CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHcCCCCC-C
Confidence            43322 1223456789999999988899999999999999999997 9999976433       23344444443332 3


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +..+++++.+||.+||+.||++|||+.++++
T Consensus       614 ~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4678999999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-45  Score=349.41  Aligned_cols=250  Identities=18%  Similarity=0.211  Sum_probs=196.9

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH--HHHHHHHHHHHHHhcCCC-Cce---------------
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE--SARRQIAQELKINQSSQC-PYV---------------  121 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h-p~i---------------  121 (353)
                      ...|...+.||+|+||.||+|.+..+|+.||||++......  .....+.+|+.+++.+.| +|.               
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            35688899999999999999999999999999998744222  235678899999998877 211               


Q ss_pred             EE------EeeEeEe-----cCeEEEEEEecCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcee
Q 018630          122 VV------CYQSFYS-----NGAISIILEYMDGGSLADFLKK-------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIH  183 (353)
Q Consensus       122 v~------~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~-------~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH  183 (353)
                      +.      +...+..     ...++++|+++ +++|.++++.       ...+++..+..++.|++.||+|||+ +||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiH  234 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVH  234 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence            11      1111111     23467888877 4699998852       2347788899999999999999998 99999


Q ss_pred             cCCCCCcEEEcCCCcEEEeeccccccccccCCCCcccccCCcccCccee----------cCCCCCccccHHHHHHHHHHH
Q 018630          184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI----------SGGKYGYKSDIWSLGLVLLEC  253 (353)
Q Consensus       184 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~il~el  253 (353)
                      |||||+|||++.++.+||+|||+++.....   ....+| +.|+|||++          ....++.++|||||||++|||
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            999999999999999999999998765433   345577 999999999          555689999999999999999


Q ss_pred             HcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          254 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       254 l~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      ++|..||...+..+....       +..      ....+++++.+||.+||+.||++|||+.++++||||+...+
T Consensus       311 ltg~~Pf~~~~~~~~~~~-------~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~  372 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEW-------IFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  372 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGG-------GGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             HHCCCCCCCcchhhhHHH-------HHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence            999999987654332211       111      12367899999999999999999999999999999987654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.6e-45  Score=340.21  Aligned_cols=246  Identities=21%  Similarity=0.254  Sum_probs=191.9

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-------cHHHHHHHHHHHHHHhcCC---------CCce
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-------EESARRQIAQELKINQSSQ---------CPYV  121 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~---------hp~i  121 (353)
                      +..++|++.+.||+|+||+||+|++  +|+.||||+++...       .......+.+|+.+++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            4568899999999999999999998  68999999997552       1222356777777777664         6666


Q ss_pred             EEEeeEe-----------------Ee-------------cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 018630          122 VVCYQSF-----------------YS-------------NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG  171 (353)
Q Consensus       122 v~~~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~  171 (353)
                      +++.+++                 .+             .+.+|+||||+++|++.+.+.+ +.+++..++.++.||+.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            6665543                 32             6899999999999976666644 678999999999999999


Q ss_pred             HHHHH-hcCCceecCCCCCcEEEcCCC--------------------cEEEeeccccccccccCCCCcccccCCcccCcc
Q 018630          172 LLYLH-HEKHIIHRDLKPSNLLINHRG--------------------EVKITDFGVSAIMASTSGQANTFVGTYNYMSPE  230 (353)
Q Consensus       172 l~~LH-~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE  230 (353)
                      |.||| + +||+||||||+|||++.++                    .+||+|||+|+....     ...+||+.|+|||
T Consensus       174 L~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE  247 (336)
T 2vuw_A          174 LAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSG
T ss_pred             HHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccChh
Confidence            99999 8 9999999999999999887                    899999999987643     2358999999999


Q ss_pred             eecCCCCCccccHHHHHHH-HHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-C----CCCCCCCCHHHHHHHHHhh
Q 018630          231 RISGGKYGYKSDIWSLGLV-LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-P----SAPSDQFSPEFCSFISACV  304 (353)
Q Consensus       231 ~~~~~~~~~~~DiwslG~i-l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~li~~~L  304 (353)
                      ++.+.. +.++||||++++ .+++++|..||.+..    |  .......+..... .    ......+++++.+||.+||
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----W--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----H--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcchh----h--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHh
Confidence            998766 899999998777 777888999984310    0  0112223321111 1    1112346789999999999


Q ss_pred             hhCcCCCCCHHHHH-cCCccc
Q 018630          305 QKEPQQRLSAQELM-THPFLK  324 (353)
Q Consensus       305 ~~dp~~Rpt~~e~l-~hp~~~  324 (353)
                      +.|     |++|++ +||||+
T Consensus       321 ~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          321 NFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             GSS-----SHHHHHHHCGGGC
T ss_pred             ccC-----CHHHHHhcCCCcC
Confidence            987     999999 999996

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-44  Score=362.95  Aligned_cols=244  Identities=20%  Similarity=0.298  Sum_probs=204.5

Q ss_pred             CCccCceeeeeecccCCeEEEEEEecc-CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe---
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKW-TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA---  133 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~---  133 (353)
                      +..++|++.+.||+|+||.||++.+.. +++.||||++...........+.+|+.++..++||||+++++++...+.   
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            344899999999999999999999976 7899999998766556667788999999999999999999999987655   


Q ss_pred             --EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          134 --ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 --~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                        .|+||||++|++|.+++..  .+++..+..++.||+.||.|||+ +||+||||||+|||++.+ .+||+|||+++...
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence              7999999999999988765  79999999999999999999998 999999999999999875 89999999997654


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      ..    ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.....               .+.......
T Consensus       233 ~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------~~~~~~~~~  292 (681)
T 2pzi_A          233 SF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------LPEDDPVLK  292 (681)
T ss_dssp             CC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------CCTTCHHHH
T ss_pred             cC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc---------------ccccccccc
Confidence            32    445799999999998765 4899999999999999999999887532211               000011112


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      .++.+.+||.+||+.||.+||+..+.+.|+|+..
T Consensus       293 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            4678999999999999999999999999988764

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-41  Score=308.60  Aligned_cols=227  Identities=13%  Similarity=0.091  Sum_probs=188.9

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      +..++|++.+.||+|+||.||++.+..+++.||||++....  .......+.+|+.++..++||||+++++++..++..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44478999999999999999999999999999999997653  3456678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||++|++|.++++.  ......+..++.|++.||+|||+ +||+||||||+||+++.+|.+||+++|          
T Consensus       108 lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            99999999999999965  24666789999999999999998 999999999999999999999998543          


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCCCCCC
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFS  293 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  293 (353)
                                |++       .++.++|||||||++|||++|..||.+.+..+......    .......+  ......++
T Consensus       175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  233 (286)
T 3uqc_A          175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----RDTAGQPIEPADIDRDIP  233 (286)
T ss_dssp             ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----BCTTSCBCCHHHHCTTSC
T ss_pred             ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----HHhccCCCChhhcccCCC
Confidence                      333       37899999999999999999999998765432110000    00011111  11235689


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +++.++|.+||+.||++| |+.|+++
T Consensus       234 ~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          234 FQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHHHHHHHcccCCccC-CHHHHHH
Confidence            999999999999999999 9999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.9e-37  Score=304.73  Aligned_cols=187  Identities=15%  Similarity=0.181  Sum_probs=139.9

Q ss_pred             eecccCCeEEEEEEeccCCcEEEEEEeecc---------ccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeEEEE
Q 018630           68 VVGKGSGGIVQLVQHKWTGQFFALKVIQMN---------VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~~lv  137 (353)
                      ..+.|++|.+..++....|+.||+|++...         ..+...+++.+|+++++++ .|+||+++++++++++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            467788888888888889999999998643         1234457799999999998 699999999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |||++|++|.+++...+++++.   .|+.||+.||+|+|+ +|||||||||+|||++.+|++||+|||+|+.........
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            9999999999999998888865   488999999999999 999999999999999999999999999998876655556


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCC
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  259 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P  259 (353)
                      .+.+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       397 ~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            67899999999999975 467789999999999888766443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=9.4e-30  Score=249.72  Aligned_cols=184  Identities=18%  Similarity=0.208  Sum_probs=143.9

Q ss_pred             eeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-------cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           64 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-------EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ...+.||+|+||.||++.  ..++.+|+|......       ......++.+|+++++.++||||+++..++..+...|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            345689999999999994  458889999864321       12234668999999999999999965555557777899


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||||++|++|.+++..        +..++.|++.||.|||+ +||+||||||+|||++.  ++||+|||+++........
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            9999999999999876        56899999999999998 99999999999999988  9999999999876533211


Q ss_pred             -------CcccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCC
Q 018630          217 -------ANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPY  260 (353)
Q Consensus       217 -------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf  260 (353)
                             ....+||+.|||||++..  ..|+..+|+|+..+-..+-+.++.+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                   135689999999999976  56888899999988888877766555

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.8e-26  Score=208.35  Aligned_cols=143  Identities=19%  Similarity=0.177  Sum_probs=115.4

Q ss_pred             eeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH-----------------HHHHHHHHHHHHHhcCCCCceEEEee
Q 018630           64 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----------------SARRQIAQELKINQSSQCPYVVVCYQ  126 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~~e~~~~~~l~hp~iv~~~~  126 (353)
                      .+.+.||+|+||.||+|.+ .+|+.||||+++.....                 .....+.+|+.+++.++  | +++.+
T Consensus        93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            3449999999999999999 78999999998643211                 24567899999999998  4 55555


Q ss_pred             EeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccc
Q 018630          127 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  206 (353)
Q Consensus       127 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~  206 (353)
                      .+.. +..|+||||++|++|.+ +.      ......++.|++.||.|||+ +||+||||||+|||++ ++.+||+|||+
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            4443 55699999999999987 32      12355799999999999998 9999999999999999 99999999999


Q ss_pred             cccccccCCCCcccccCCcccCcceec
Q 018630          207 SAIMASTSGQANTFVGTYNYMSPERIS  233 (353)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aPE~~~  233 (353)
                      |+.             +..++|||.+.
T Consensus       239 a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          239 SVE-------------VGEEGWREILE  252 (282)
T ss_dssp             CEE-------------TTSTTHHHHHH
T ss_pred             CeE-------------CCCCCHHHHHH
Confidence            853             33478888774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=2.6e-22  Score=178.83  Aligned_cols=138  Identities=17%  Similarity=0.248  Sum_probs=108.0

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcE--EEEEEeecccc-----------------------HHHHHHHHHHHHHHhcCC
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQF--FALKVIQMNVE-----------------------ESARRQIAQELKINQSSQ  117 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~-----------------------~~~~~~~~~e~~~~~~l~  117 (353)
                      |.+.+.||+|+||.||+|.+..+|+.  ||||+++....                       ......+.+|+.++..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999999778999  99999754311                       112246788999998887


Q ss_pred             CCce--EEEeeEeEecCeEEEEEEecCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCCceecCCCCC
Q 018630          118 CPYV--VVCYQSFYSNGAISIILEYMDG-G----SLADFLKKVKTIPEEYLAAICEQVLKGLLYLH-HEKHIIHRDLKPS  189 (353)
Q Consensus       118 hp~i--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH-~~~~iiH~Dlkp~  189 (353)
                      |+++  ..++..    +..++||||+.+ |    +|.++...   .++..+..++.|++.||.||| + .||+||||||+
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~-~givHrDlkp~  200 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQE-AELVHADLSEY  200 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHT-SCEECSSCSTT
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHH
Confidence            7754  233321    356899999942 3    77776433   235567899999999999999 7 99999999999


Q ss_pred             cEEEcCCCcEEEeeccccccc
Q 018630          190 NLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       190 NIll~~~~~~kl~DfG~a~~~  210 (353)
                      |||++.  .++|+|||+|...
T Consensus       201 NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS--SEEECCCTTCEET
T ss_pred             HEEEcC--cEEEEECcccccC
Confidence            999988  9999999998653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=6e-19  Score=164.14  Aligned_cols=137  Identities=15%  Similarity=0.169  Sum_probs=97.8

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc----------------H-----HHHHHHHHHHHHHhcCCCCce
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE----------------E-----SARRQIAQELKINQSSQCPYV  121 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------------~-----~~~~~~~~e~~~~~~l~hp~i  121 (353)
                      |.+.+.||+|++|.||+|.+. +|+.||||+++....                .     ..+....+|...+..+.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            789999999999999999985 799999999753210                0     011112345555655544333


Q ss_pred             EEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC----
Q 018630          122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----  197 (353)
Q Consensus       122 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~----  197 (353)
                      . +...+... ..++||||++|++|.++..      ...+..++.|++.+|.+||+ .|||||||||.|||++.+|    
T Consensus       176 ~-vp~p~~~~-~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          176 P-VPEPIAQS-RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             S-CCCEEEEE-TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEEEEECSSC
T ss_pred             C-CCeeeecc-CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeCCCCccc
Confidence            2 11111112 2369999999988865421      22456788999999999998 9999999999999998776    


Q ss_pred             ------cEEEeecccccc
Q 018630          198 ------EVKITDFGVSAI  209 (353)
Q Consensus       198 ------~~kl~DfG~a~~  209 (353)
                            .+.|+||+-+..
T Consensus       247 ~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TTSEEEEEEECCCTTCEE
T ss_pred             ccccccceEEEEeCCccc
Confidence                  389999997644

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=6.6e-13  Score=117.79  Aligned_cols=140  Identities=16%  Similarity=0.109  Sum_probs=108.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      +.|.+...++.|+.+.||++...  ++.+++|+...... .....+.+|+.+++.+. +..+.+++..+...+..|+|||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            56888889999999999999754  67899999865311 11235778888887764 5667788888888889999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-----------------------------------------  178 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~-----------------------------------------  178 (353)
                      |++|.+|.+.+.     +......++.+++.++..||+-                                         
T Consensus        91 ~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             ecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            999999887531     1223447788999999999970                                         


Q ss_pred             -----------------CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          179 -----------------KHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       179 -----------------~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                                       ..++|+|++|.||+++.++.+.|+||+.+.
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                             348999999999999876566799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=5.7e-12  Score=111.14  Aligned_cols=134  Identities=13%  Similarity=0.039  Sum_probs=95.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCc--eEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY--VVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~--iv~~~~~~~~~~~~~lv~  138 (353)
                      ..+.+....+.|+.+.||++.. .+|+.+++|+....    ....+.+|+.+++.+.+.+  +.+++.....++..++||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            4555544445667799999965 46778999987543    1234667777776664333  456777777778899999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH--------------------------------------  180 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--------------------------------------  180 (353)
                      ||++|.+|.  .   ...+   ...++.+++..+..||+ ..                                      
T Consensus        95 e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           95 GEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHT-LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             ECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTT-SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             EecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            999998884  1   1122   23566777777888876 32                                      


Q ss_pred             --------------------ceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          181 --------------------IIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       181 --------------------iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                                          ++|+|++|.||+++.++.+.|+|||.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                9999999999999876667799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.25  E-value=1.3e-11  Score=114.64  Aligned_cols=142  Identities=16%  Similarity=0.240  Sum_probs=104.1

Q ss_pred             eeeeeecccCCeEEEEEEeccCCcEEEEEEee--ccccHHHHHHHHHHHHHHhcCCC--CceEEEeeEeEec---CeEEE
Q 018630           64 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEESARRQIAQELKINQSSQC--PYVVVCYQSFYSN---GAISI  136 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~e~~~~~~l~h--p~iv~~~~~~~~~---~~~~l  136 (353)
                      ..++.|+.|.++.||++...  +..+++|+..  ..........+.+|..+++.+..  ..+.+++..+.+.   +..|+
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            34678899999999999864  4678899876  33222234567788888887763  4466777777665   45899


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE--------------------------------------  178 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~--------------------------------------  178 (353)
                      ||||++|.++.+.  ....++......++.+++..|..||+.                                      
T Consensus       119 vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          119 IMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999999777431  123467888889999999999999961                                      


Q ss_pred             -------------------CCceecCCCCCcEEEcCCCc--EEEeecccccc
Q 018630          179 -------------------KHIIHRDLKPSNLLINHRGE--VKITDFGVSAI  209 (353)
Q Consensus       179 -------------------~~iiH~Dlkp~NIll~~~~~--~kl~DfG~a~~  209 (353)
                                         ..++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               46899999999999987753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=2e-10  Score=104.13  Aligned_cols=184  Identities=17%  Similarity=0.235  Sum_probs=118.1

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCc--eEEEeeEeEecC---eEEEEEE
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPY--VVVCYQSFYSNG---AISIILE  139 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~--iv~~~~~~~~~~---~~~lv~e  139 (353)
                      ++.++.|....||++.     ..+++|+....   .....+.+|..+++.+ .+..  +..++.......   ..|+||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            3458999999999874     45889985432   3456788888888765 3322  233333332222   4588999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-----------------------------------------  178 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~-----------------------------------------  178 (353)
                      +++|.+|.+...  ..++......++.|++..+..||+.                                         
T Consensus        97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            999988865332  3577778888888888888888850                                         


Q ss_pred             ----------------CCceecCCCCCcEEEcC--CCcEEEeeccccccccccCCCCcccccCCcccCcceecC-----C
Q 018630          179 ----------------KHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-----G  235 (353)
Q Consensus       179 ----------------~~iiH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~  235 (353)
                                      ..++|+|++|.||+++.  ++.+.|+||+.+.... ...+.........-..|+....     +
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~-~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD-PDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC-TTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC-hHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            23799999999999988  4568899999875431 1110000000000012221110     0


Q ss_pred             C---------CCccccHHHHHHHHHHHHcCCCCC
Q 018630          236 K---------YGYKSDIWSLGLVLLECATGQFPY  260 (353)
Q Consensus       236 ~---------~~~~~DiwslG~il~ell~g~~Pf  260 (353)
                      .         .....+.|+++.++|.+.+|..+|
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0         112358999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.71  E-value=1.8e-07  Score=84.73  Aligned_cols=134  Identities=19%  Similarity=0.228  Sum_probs=90.6

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCC---ceEEEeeEeE-ecCeEEEEEEec
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP---YVVVCYQSFY-SNGAISIILEYM  141 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp---~iv~~~~~~~-~~~~~~lv~e~~  141 (353)
                      ++.++.|....||++     +..+++|+-.   .......+.+|..+++.+.+.   .+.+.+.... ..+..++||||+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            456788999999988     4568888843   233456788999998887642   2344444443 345678999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 018630          142 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH--------------------------------------------  177 (353)
Q Consensus       142 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~--------------------------------------------  177 (353)
                      +|.++.+..-  ..++......++.++...|..||+                                            
T Consensus        96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            9988765321  233444455555555555555553                                            


Q ss_pred             ---------------cCCceecCCCCCcEEEcC---CCc-EEEeecccccc
Q 018630          178 ---------------EKHIIHRDLKPSNLLINH---RGE-VKITDFGVSAI  209 (353)
Q Consensus       178 ---------------~~~iiH~Dlkp~NIll~~---~~~-~kl~DfG~a~~  209 (353)
                                     ...++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           124599999999999987   455 58999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.70  E-value=3.1e-07  Score=81.22  Aligned_cols=133  Identities=14%  Similarity=0.075  Sum_probs=92.9

Q ss_pred             ecccCC-eEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEEEEEecCCCCH
Q 018630           69 VGKGSG-GIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSL  146 (353)
Q Consensus        69 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~gsL  146 (353)
                      +..|.. +.||++.....+..+++|+-+..    ....+.+|...++.+. +--+.+++.++.+++..++|||+++|.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            344544 47999988777788999986543    3455777888776553 22255677777888899999999999888


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 018630          147 ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE------------------------------------------------  178 (353)
Q Consensus       147 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~------------------------------------------------  178 (353)
                      .+.....    ......++.++...|..||+-                                                
T Consensus       108 ~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  183 (272)
T 4gkh_A          108 FQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM  183 (272)
T ss_dssp             HHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred             cccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence            7765431    122334555566666666630                                                


Q ss_pred             ---------CCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          179 ---------KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       179 ---------~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                               ..++|+|+.|.||+++.++.+-|+||+.+..
T Consensus       184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                     0268999999999998877778999997643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.35  E-value=8.5e-07  Score=83.13  Aligned_cols=78  Identities=14%  Similarity=0.068  Sum_probs=47.4

Q ss_pred             eeeeecccCCeEEEEEEeccCCcEEEEEEeecccc---H---HHHHHHHHHHHHHhcCCC--C-ceEEEeeEeEecCeEE
Q 018630           65 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---E---SARRQIAQELKINQSSQC--P-YVVVCYQSFYSNGAIS  135 (353)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~---~~~~~~~~e~~~~~~l~h--p-~iv~~~~~~~~~~~~~  135 (353)
                      ..+.||.|..+.||++....+++.++||.......   .   ....++..|.++++.+..  | .+.+++..  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            35789999999999998766678899998653211   0   012345667777665421  2 33355543  344568


Q ss_pred             EEEEecCCC
Q 018630          136 IILEYMDGG  144 (353)
Q Consensus       136 lv~e~~~~g  144 (353)
                      +||||++|.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999863

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.28  E-value=1.4e-05  Score=72.85  Aligned_cols=30  Identities=17%  Similarity=0.381  Sum_probs=27.3

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          179 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      ..++|+|+++.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            689999999999999888899999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=3.6e-06  Score=77.52  Aligned_cols=83  Identities=11%  Similarity=0.128  Sum_probs=48.8

Q ss_pred             eeeeee-cccCCeEEEEEEecc------CCcEEEEEEeecccc--HHHHHHHHHHHHHHhcCC-C--CceEEEeeEeEec
Q 018630           64 DTIKVV-GKGSGGIVQLVQHKW------TGQFFALKVIQMNVE--ESARRQIAQELKINQSSQ-C--PYVVVCYQSFYSN  131 (353)
Q Consensus        64 ~~~~~l-g~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~-h--p~iv~~~~~~~~~  131 (353)
                      ...+.| +.|....+|++....      ++..+++|+......  ......+.+|..+++.+. +  -.+.+++....+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345678 888889999887541      256789998654320  000123455555554432 1  2344555554443


Q ss_pred             ---CeEEEEEEecCCCCH
Q 018630          132 ---GAISIILEYMDGGSL  146 (353)
Q Consensus       132 ---~~~~lv~e~~~~gsL  146 (353)
                         +..++||||++|.++
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               456899999998654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.05  E-value=7e-05  Score=63.30  Aligned_cols=136  Identities=18%  Similarity=0.183  Sum_probs=92.9

Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccccc
Q 018630          144 GSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  222 (353)
Q Consensus       144 gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  222 (353)
                      -||.+.|+.. .++++++++.++.|.+.+|.-+-..+.-..+=+.|..|++..+|.|-+.+ +.+.            ..
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~   99 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG   99 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence            4799998754 78999999999999999988772212222444567999999999988764 2110            11


Q ss_pred             CCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018630          223 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  302 (353)
Q Consensus       223 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  302 (353)
                      ...+.|||... ...+.+.=|||||+++|.-+--..|                          ......+|+.+.+||..
T Consensus       100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~--------------------------e~eE~eLS~~LE~LL~~  152 (229)
T 2yle_A          100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK--------------------------ENEERELSPPLEQLIDH  152 (229)
T ss_dssp             -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC--------------------------TTEEECCCHHHHHHHHH
T ss_pred             ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC--------------------------cccchhhCHHHHHHHHH
Confidence            22466888763 3456788999999999998862221                          12235789999999999


Q ss_pred             hhhh-------------------------CcCCCCCHHHHHc
Q 018630          303 CVQK-------------------------EPQQRLSAQELMT  319 (353)
Q Consensus       303 ~L~~-------------------------dp~~Rpt~~e~l~  319 (353)
                      |.+-                         .+..|++.+++++
T Consensus       153 Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          153 MANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             HTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             HHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence            9866                         2468889998875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.95  E-value=3.1e-05  Score=73.08  Aligned_cols=76  Identities=13%  Similarity=0.180  Sum_probs=44.3

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccccc--CCcccCcceecCC---CCCccccHHHHHHHHHHH
Q 018630          179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG--TYNYMSPERISGG---KYGYKSDIWSLGLVLLEC  253 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DiwslG~il~el  253 (353)
                      ..++|+|++|.|||++.++ ++++||+.+.... ...+......  ...|.+|+.....   ......++.+....+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~-p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP-MGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEEC-HHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCc-hHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            6799999999999998776 9999999875432 1111111010  1235555444211   112234445667777766


Q ss_pred             HcC
Q 018630          254 ATG  256 (353)
Q Consensus       254 l~g  256 (353)
                      +.+
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.74  E-value=0.00012  Score=66.12  Aligned_cols=77  Identities=16%  Similarity=0.069  Sum_probs=56.2

Q ss_pred             eeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC---CCceEEEeeEeEecCeEEEEEEe
Q 018630           64 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ---CPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      .-.+.|+.|....+|++..  ++..+++|+....    ....+..|...++.+.   ...+.+++......+..++||||
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            3457789999999999986  4678889987543    2345667777666552   24566777767677889999999


Q ss_pred             cCCCCH
Q 018630          141 MDGGSL  146 (353)
Q Consensus       141 ~~~gsL  146 (353)
                      ++|.++
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.70  E-value=7e-05  Score=67.21  Aligned_cols=29  Identities=24%  Similarity=0.260  Sum_probs=24.8

Q ss_pred             CceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          180 HIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       180 ~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      .++|+|+.|.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 5677889999997754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.48  E-value=0.00042  Score=62.53  Aligned_cols=143  Identities=16%  Similarity=0.210  Sum_probs=75.8

Q ss_pred             CceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-----CCCceEEEe-e--EeEecCe
Q 018630           62 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-----QCPYVVVCY-Q--SFYSNGA  133 (353)
Q Consensus        62 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~hp~iv~~~-~--~~~~~~~  133 (353)
                      ...-++.|+.|....+|++... +| .+++|+......   ...+..|..++..+     ..|.++... +  .....+.
T Consensus        23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~   97 (322)
T 2ppq_A           23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR   97 (322)
T ss_dssp             CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred             cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence            3345677888888999998764 33 688998765211   12233444444332     234444221 1  1123467


Q ss_pred             EEEEEEecCCCCHH-----H------H---HHhc-CC--------CCHHHHHH---------------HHHHHHHHHHHH
Q 018630          134 ISIILEYMDGGSLA-----D------F---LKKV-KT--------IPEEYLAA---------------ICEQVLKGLLYL  175 (353)
Q Consensus       134 ~~lv~e~~~~gsL~-----~------~---l~~~-~~--------l~~~~~~~---------------i~~ql~~~l~~L  175 (353)
                      .+++++|++|..+.     .      .   ++.. ..        .....-..               +...+...+..+
T Consensus        98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l  177 (322)
T 2ppq_A           98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL  177 (322)
T ss_dssp             EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence            78999999985431     1      1   1111 01        01100000               001133344455


Q ss_pred             Hh------cCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          176 HH------EKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       176 H~------~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ..      ..+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            42      14699999999999998776668999997643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.37  E-value=0.00048  Score=61.24  Aligned_cols=79  Identities=10%  Similarity=0.024  Sum_probs=50.5

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCC---CceEEEeeEeEecCeEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC---PYVVVCYQSFYSNGAISII  137 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h---p~iv~~~~~~~~~~~~~lv  137 (353)
                      .+..-++.+|.|..+.||++... +|+.|++|+...... .....+..|...++.+.-   --+.+++..  +  .-++|
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEE
Confidence            34566788999999999999864 789999998653321 112235667776665421   113333332  2  23688


Q ss_pred             EEecCCCC
Q 018630          138 LEYMDGGS  145 (353)
Q Consensus       138 ~e~~~~gs  145 (353)
                      |||++++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.28  E-value=0.00041  Score=63.01  Aligned_cols=31  Identities=29%  Similarity=0.458  Sum_probs=27.0

Q ss_pred             CCceecCCCCCcEEEcCC----CcEEEeecccccc
Q 018630          179 KHIIHRDLKPSNLLINHR----GEVKITDFGVSAI  209 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~----~~~kl~DfG~a~~  209 (353)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            579999999999999874    6899999998754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.23  E-value=0.0022  Score=57.87  Aligned_cols=75  Identities=13%  Similarity=0.068  Sum_probs=42.8

Q ss_pred             eeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-----CCceEEEee--EeEecCeEEEEEE
Q 018630           67 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----CPYVVVCYQ--SFYSNGAISIILE  139 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----hp~iv~~~~--~~~~~~~~~lv~e  139 (353)
                      ..++ |....||++... +|+.+++|+......  ....+..|..+++.+.     .|.++..-+  ....++..+++++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            4566 778899988653 466799999863311  1223444555544332     233332211  1223567789999


Q ss_pred             ecCCCC
Q 018630          140 YMDGGS  145 (353)
Q Consensus       140 ~~~~gs  145 (353)
                      |++|.+
T Consensus       108 ~i~G~~  113 (328)
T 1zyl_A          108 SVGGRQ  113 (328)
T ss_dssp             CCCCEE
T ss_pred             ecCCCC
Confidence            998743

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.13  E-value=0.001  Score=62.77  Aligned_cols=74  Identities=16%  Similarity=0.117  Sum_probs=45.1

Q ss_pred             eeeeecccCCeEEEEEEecc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCce-EEEeeEeEecCeEEE
Q 018630           65 TIKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV-VVCYQSFYSNGAISI  136 (353)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~i-v~~~~~~~~~~~~~l  136 (353)
                      .++.|+.|....+|++....       .+..+++|+......   ...+.+|..+++.+...++ .++++.+.  +  .+
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~  149 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  149 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence            45678889899999998642       257899998743211   1233356666655432222 34555433  2  28


Q ss_pred             EEEecCCCC
Q 018630          137 ILEYMDGGS  145 (353)
Q Consensus       137 v~e~~~~gs  145 (353)
                      |+||++|.+
T Consensus       150 v~e~l~G~~  158 (429)
T 1nw1_A          150 LEEYIPSRP  158 (429)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEeCCcc
Confidence            899998633

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.03  E-value=0.00071  Score=62.77  Aligned_cols=138  Identities=13%  Similarity=0.103  Sum_probs=76.0

Q ss_pred             eeeecccCCeEEEEEEecc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCc-eEEEeeEeEecCeEEEE
Q 018630           66 IKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAISII  137 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~-iv~~~~~~~~~~~~~lv  137 (353)
                      ++.|..|....+|++....       +++.+++|+.....  .....+.+|..+++.+.-.+ ..+++..+.+    .+|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            3567778888999998642       35789999863321  11234456777765543111 2344544432    289


Q ss_pred             EEecCCCCHH--------------HHHHh---c-----CCCC--HHHHHHHHHHHHH-------------------HHHH
Q 018630          138 LEYMDGGSLA--------------DFLKK---V-----KTIP--EEYLAAICEQVLK-------------------GLLY  174 (353)
Q Consensus       138 ~e~~~~gsL~--------------~~l~~---~-----~~l~--~~~~~~i~~ql~~-------------------~l~~  174 (353)
                      |||++|.+|.              +.+.+   .     +...  ...+..+..++-.                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            9999985442              11111   1     0111  2345555544322                   1233


Q ss_pred             HH----h---cCCceecCCCCCcEEEcCC----CcEEEeecccccc
Q 018630          175 LH----H---EKHIIHRDLKPSNLLINHR----GEVKITDFGVSAI  209 (353)
Q Consensus       175 LH----~---~~~iiH~Dlkp~NIll~~~----~~~kl~DfG~a~~  209 (353)
                      |.    .   ...++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            32    1   1358999999999999876    7899999997743

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.98  E-value=0.0065  Score=55.33  Aligned_cols=31  Identities=19%  Similarity=0.428  Sum_probs=27.4

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999987654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.80  E-value=0.0018  Score=59.68  Aligned_cols=30  Identities=23%  Similarity=0.466  Sum_probs=24.5

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ..++|+|+.+.|||++.++ +.|+||..+..
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            3589999999999997554 89999987743

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.41  E-value=0.013  Score=55.75  Aligned_cols=76  Identities=20%  Similarity=0.218  Sum_probs=44.6

Q ss_pred             eeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCce-EEEeeEeEecCeEEEEEEecCC
Q 018630           65 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV-VVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      .++.|+.|-...+|++.....+..+++|+.......  .....+|..+++.+...++ .++++.+.  +.  +|+||++|
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G  185 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDG  185 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCS
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCC
Confidence            456788898999999987543578899987433111  0011456666666543333 35555552  22  49999987


Q ss_pred             CCH
Q 018630          144 GSL  146 (353)
Q Consensus       144 gsL  146 (353)
                      .+|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.92  E-value=0.029  Score=52.69  Aligned_cols=29  Identities=34%  Similarity=0.624  Sum_probs=25.6

Q ss_pred             CceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          180 HIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       180 ~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      .++|+|+.+.||+ +.++.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4899999999999 7888999999998753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.86  E-value=2.2  Score=35.77  Aligned_cols=112  Identities=12%  Similarity=0.160  Sum_probs=76.0

Q ss_pred             CCCceEEEeeEeEecCeEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhcCCceecCCCCCcEEEc
Q 018630          117 QCPYVVVCYQSFYSNGAISIILEYMDGG-SLADFLKKVKTIPEEYLAAICEQVLKGLL-YLHHEKHIIHRDLKPSNLLIN  194 (353)
Q Consensus       117 ~hp~iv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~ql~~~l~-~LH~~~~iiH~Dlkp~NIll~  194 (353)
                      .||++  -...-.+++.+.+.++--+++ +.. .+   ..++....++++..|+.... +++.   -+|--|+|+||+++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i---~~~~~~eKlrll~nl~~L~~~~~~~---r~tf~l~P~NL~f~  118 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI---RKTTLLSRIRAAIHLVSKVKHHSAR---RLIFIVCPENLMFN  118 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH---HTSCHHHHHHHHHHHHHHHSSCCSS---SEECCCCGGGEEEC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH---HhcCHHHHHHHHHHHHHHHHHhhhC---ceeEEEeCceEEEe
Confidence            57887  333335667777776655333 333 33   45788899999999988777 5543   68899999999999


Q ss_pred             CCCcEEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHH-HHHHHHHHHHcCCCCC
Q 018630          195 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW-SLGLVLLECATGQFPY  260 (353)
Q Consensus       195 ~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw-slG~il~ell~g~~Pf  260 (353)
                      .++.+++.=.|+-..                 ++|..     .+. .|.| +.=|++..++.++..|
T Consensus       119 ~~~~p~i~hRGi~~~-----------------lpP~e-----~~e-e~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          119 RALEPFFLHVGVKES-----------------LPPDE-----WDD-ERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             TTCCEEESCCEETTT-----------------BSSCS-----CCH-HHHHHHHHHHHHHHTTCSSCH
T ss_pred             CCCcEEEEEcCCccc-----------------CCCCC-----CCH-HHHHHHHHHHHHHHHcCCCCH
Confidence            999999987775322                 22221     121 2333 6678888888887766

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.40  E-value=1.6  Score=36.53  Aligned_cols=116  Identities=10%  Similarity=0.087  Sum_probs=77.7

Q ss_pred             CCCceEEEeeEeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC
Q 018630          117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  196 (353)
Q Consensus       117 ~hp~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~  196 (353)
                      .||+++.. .+-..++.+.+.++.-+  +...+-. -...+....+.++.+|+....++++   -+|--|+|+||+++.+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-ik~~~~~eKlr~l~ni~~l~~~~~~---r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-IKSFTKNEKLRYLLNIKNLEEVNRT---RYTFVLAPDELFFTRD  115 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-GGGSCHHHHHHHHHHGGGGGGGGGS---SEECCCSGGGEEECTT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-HHhcCHHHHHHHHHHHHHHHHHhcC---ceEEEEecceEEEcCC
Confidence            67888866 44555566655555433  2222222 2457888999999999988866654   5889999999999999


Q ss_pred             CcEEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 018630          197 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  261 (353)
Q Consensus       197 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  261 (353)
                      +.+++.=-|+-..+                 +|.     .++...=.-..=|++..+++++..|.
T Consensus       116 ~~p~i~~RGik~~l-----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          116 GLPIAKTRGLQNVV-----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             SCEEESCCEETTTB-----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCEEEEEccCccCC-----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999877753221                 221     12222223366788999999988874

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=84.09  E-value=6.6  Score=38.91  Aligned_cols=45  Identities=24%  Similarity=0.328  Sum_probs=32.9

Q ss_pred             HHHHHHHHHHH--HHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          159 EYLAAICEQVL--KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       159 ~~~~~i~~ql~--~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      .....++.+++  ..+.|+=.   |  +|-.++|||++.+|++.-+|||.+-
T Consensus       529 ~ar~nF~~SlA~~Svv~YILG---l--GDRH~~NILid~tG~v~HIDFG~~f  575 (696)
T 2x6h_A          529 EVMDTYIKSCAGYCVITYLLG---V--GDRHLDNLLLTTNGKLFHIDFGYIL  575 (696)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---C--CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred             HHHHHHHHHHHHHHHHHHHcc---C--CCCCCcceEEeCCCCEEEEeehhhh
Confidence            34455665553  34556533   3  6999999999999999999999863

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=81.95  E-value=0.65  Score=42.97  Aligned_cols=29  Identities=24%  Similarity=0.500  Sum_probs=24.6

Q ss_pred             ceecCCCCCcEEE------cCCCcEEEeecccccc
Q 018630          181 IIHRDLKPSNLLI------NHRGEVKITDFGVSAI  209 (353)
Q Consensus       181 iiH~Dlkp~NIll------~~~~~~kl~DfG~a~~  209 (353)
                      ++|+|+.+.|||+      +.++.+.++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      3456799999998754

>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A

Probab=81.71  E-value=14  Score=35.90  Aligned_cols=45  Identities=22%  Similarity=0.330  Sum_probs=33.2

Q ss_pred             HHHHHHHHHHH--HHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          159 EYLAAICEQVL--KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       159 ~~~~~i~~ql~--~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      .....++..++  ..+.|+=   ||  +|=.++|||++.+|++.=+|||.+-
T Consensus       455 ~a~~nF~~S~A~ySvv~YIL---Gi--gDRH~~NILld~tG~v~HIDFG~~f  501 (614)
T 3ls8_A          455 EVMDTYVKSCAGYCVITYIL---GV--GDRHLDNLLLTKTGKLFHIDFGYIL  501 (614)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH---TC--CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred             HHHHHHHHHHHHHhHhheee---ec--cCCCCcceeEcCCCCEeeeehHHhh
Confidence            34455665544  3456663   33  6999999999999999999999873

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	353
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-95
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-80
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-78
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-78
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-78
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-77
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-77
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-75
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-72
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-72
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-72
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-71
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-70
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-69
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-67
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-66
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-66
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-66
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-65
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-65
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-63
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-63
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-63
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-60
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-60
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-58
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-58
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-57
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-57
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-57
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-56
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-56
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-56
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-54
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-53
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-51
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-51
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-50
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-49
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-45
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-42
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  283 bits (725), Expect = 7e-95
 Identities = 123/318 (38%), Positives = 181/318 (56%), Gaps = 37/318 (11%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
           +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL++    
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+KGL YL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 179

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQD----------------------------- 267
           Y  +SDIWS+GL L+E A G++P  PP+ ++                             
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 268 ------GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 321
                    + +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299

Query: 322 FLKMYGDLNVDLSEYFTD 339
           F+K      VD + +   
Sbjct: 300 FIKRSDAEEVDFAGWLCS 317

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (622), Expect = 4e-80
 Identities = 76/274 (27%), Positives = 136/274 (49%), Gaps = 19/274 (6%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCP 119
           ED + +  +G GS G  Q ++ K  G+    K +   ++ E+ ++ +  E+ + +  + P
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 120 YVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLL 173
            +V  Y      +N  + I++EY +GG LA  + K     + + EE++  +  Q+   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 174 YLH----HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 229
             H        ++HRDLKP+N+ ++ +  VK+ DFG++ I+   +  A  FVGT  YMSP
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 230 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 289
           E+++   Y  KSDIWSLG +L E      P++   Q+       EL   I +      P 
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRIP- 235

Query: 290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 323
            ++S E    I+  +  +   R S +E++ +P +
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (612), Expect = 2e-78
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 10/268 (3%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           +ED D ++ +G+G+ G VQL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 122

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKY 237
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 238 -GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 296
                D+WS G+VL     G+ P+      D  +   +      ++     P  +     
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236

Query: 297 CSFISACVQKEPQQRLSAQELMTHPFLK 324
            + +   + + P  R++  ++    +  
Sbjct: 237 LALLHKILVENPSARITIPDIKKDRWYN 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (609), Expect = 4e-78
 Identities = 80/270 (29%), Positives = 129/270 (47%), Gaps = 14/270 (5%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQ 114
           Q  LED +  + +GKG  G V L + K +    ALKV+      +     Q+ +E++I  
Sbjct: 2   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 174
             + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L Y
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
            H  K +IHRD+KP NLL+   GE+KI DFG S    S+  +  T  GT +Y+ PE I G
Sbjct: 122 CH-SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEG 178

Query: 235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 294
             +  K D+WSLG++  E   G+ P+          ++ E  + I          D  + 
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEAN-------TYQETYKRISRVEFT--FPDFVTE 229

Query: 295 EFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                IS  ++  P QR   +E++ HP++ 
Sbjct: 230 GARDLISRLLKHNPSQRPMLREVLEHPWIT 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (611), Expect = 4e-78
 Identities = 87/278 (31%), Positives = 139/278 (50%), Gaps = 15/278 (5%)

Query: 58  LNLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 116
           LN ED  + I  +G G+ G V   Q+K T    A KVI    EE        E+ I  S 
Sbjct: 8   LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMVEIDILASC 66

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYL 175
             P +V    +FY    + I++E+  GG++   + +  + + E  +  +C+Q L  L YL
Sbjct: 67  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI--- 232
           H +  IIHRDLK  N+L    G++K+ DFGVSA    T  + ++F+GT  +M+PE +   
Sbjct: 127 H-DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185

Query: 233 --SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
                 Y YK+D+WSLG+ L+E A  + P+              L++    +PP  A   
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPH------HELNPMRVLLKIAKSEPPTLAQPS 239

Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
           ++S  F  F+  C++K    R +  +L+ HPF+ +  +
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (605), Expect = 3e-77
 Identities = 79/265 (29%), Positives = 139/265 (52%), Gaps = 9/265 (3%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
            + +G+G+ G V       TGQ  A++ + +  ++  +  I  E+ + + ++ P +V   
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL 83

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
            S+     + +++EY+ GGSL D + +   + E  +AA+C + L+ L +LH    +IHRD
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH-SNQVIHRD 141

Query: 186 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWS 245
           +K  N+L+   G VK+TDFG  A +     + +T VGT  +M+PE ++   YG K DIWS
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201

Query: 246 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 305
           LG++ +E   G+ PY              L     +  P     ++ S  F  F++ C+ 
Sbjct: 202 LGIMAIEMIEGEPPY------LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 306 KEPQQRLSAQELMTHPFLKMYGDLN 330
            + ++R SA+EL+ H FLK+   L+
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLS 280

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  237 bits (606), Expect = 4e-77
 Identities = 76/264 (28%), Positives = 130/264 (49%), Gaps = 17/264 (6%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES--ARRQIAQELKINQSSQCPYVVV 123
           ++ +G GS G V   +     +  A+K +  + ++S    + I +E++  Q  + P  + 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 124 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 183
               +       +++EY  G +        K + E  +AA+    L+GL YL H  ++IH
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL-HSHNMIH 138

Query: 184 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGYK 240
           RD+K  N+L++  G VK+ DFG ++IMA      N+FVGT  +M+PE I     G+Y  K
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 241 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 300
            D+WSLG+  +E A  + P                +  I     P+  S  +S  F +F+
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPALQSGHWSEYFRNFV 247

Query: 301 SACVQKEPQQRLSAQELMTHPFLK 324
            +C+QK PQ R +++ L+ H F+ 
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVL 271

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 1e-75
 Identities = 75/265 (28%), Positives = 128/265 (48%), Gaps = 16/265 (6%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCY 125
             +G+GS   V       T    A   +Q   + +S R++  +E ++ +  Q P +V  Y
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 126 QSFYS----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH- 180
            S+ S       I ++ E M  G+L  +LK+ K +  + L + C Q+LKGL +LH     
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134

Query: 181 IIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 239
           IIHRDLK  N+ I    G VKI D G++ +  ++   A   +GT  +M+PE     KY  
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDE 191

Query: 240 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 299
             D+++ G+ +LE AT ++PYS         +  ++   +     P++      PE    
Sbjct: 192 SVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245

Query: 300 ISACVQKEPQQRLSAQELMTHPFLK 324
           I  C+++   +R S ++L+ H F +
Sbjct: 246 IEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  224 bits (571), Expect = 6e-72
 Identities = 74/287 (25%), Positives = 134/287 (46%), Gaps = 15/287 (5%)

Query: 59  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
           ++ DI D   V+G G+   V L + K T +  A+K I     E     +  E+ +    +
Sbjct: 6   DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
            P +V     + S G + +I++ + GG L D + +     E   + +  QVL  + YL H
Sbjct: 66  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL-H 124

Query: 178 EKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           +  I+HRDLKP NLL    +   ++ I+DFG+S +    S   +T  GT  Y++PE ++ 
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-VLSTACGTPGYVAPEVLAQ 183

Query: 235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQF 292
             Y    D WS+G++      G  P+             +L E I+  +    S   D  
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLFEQILKAEYEFDSPYWDDI 236

Query: 293 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 339
           S     FI   ++K+P++R + ++ + HP++     L+ ++ +  ++
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSE 283

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 8e-72
 Identities = 73/274 (26%), Positives = 133/274 (48%), Gaps = 20/274 (7%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQC 118
           ED    K++G+GS   V L +   T + +A+K+++    ++E+    + +E  +      
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
           P+ V  Y +F  +  +   L Y   G L  +++K+ +  E        +++  L YL H 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL-HG 126

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGK 236
           K IIHRDLKP N+L+N    ++ITDFG + +++  S   +AN+FVGT  Y+SPE ++   
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 296
               SD+W+LG ++ +   G  P+    +       Y + + I+         ++F P+ 
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKLEYD--FPEKFFPKA 237

Query: 297 CSFISACVQKEPQQRLSAQE------LMTHPFLK 324
              +   +  +  +RL  +E      L  HPF +
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  225 bits (574), Expect = 9e-72
 Identities = 68/272 (25%), Positives = 125/272 (45%), Gaps = 15/272 (5%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
           L+  D  + +G G+ G+V  V  + TG  FA K + M   ES +  + +E++     + P
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHP 83

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHE 178
            +V  + +F  +  + +I E+M GG L + +  +   + E+       QV KGL ++H E
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-E 142

Query: 179 KHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
            + +H DLKP N++   +   E+K+ DFG++A +           GT  + +PE   G  
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEGKP 201

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQFSP 294
            GY +D+WS+G++     +G  P+             E +  +   D     +     S 
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDWNMDDSAFSGISE 254

Query: 295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           +   FI   +  +P  R++  + + HP+L   
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  221 bits (563), Expect = 4e-71
 Identities = 71/283 (25%), Positives = 136/283 (48%), Gaps = 26/283 (9%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--------ESARRQIAQELKI 112
           E+ +  +++G+G   +V+   HK T + +A+K+I +           +  R    +E+ I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 113 NQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 171
            +  S  P ++    ++ +N    ++ + M  G L D+L +  T+ E+    I   +L+ 
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 231
           +  L H+ +I+HRDLKP N+L++    +K+TDFG S  +     +     GT +Y++PE 
Sbjct: 123 ICAL-HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEI 180

Query: 232 ISGG------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQP 283
           I          YG + D+WS G+++     G  P+   +Q         ++  I+  +  
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIMSGNYQ 233

Query: 284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
             S   D +S      +S  +  +PQ+R +A+E + HPF + Y
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 6e-70
 Identities = 74/269 (27%), Positives = 134/269 (49%), Gaps = 14/269 (5%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSS 116
           +ED    K++GKGS G V L + K T QFFA+K ++ +V   ++     + ++  ++ + 
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
           + P++   + +F +   +  ++EY++GG L   ++               +++ GL +LH
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
             K I++RDLK  N+L++  G +KI DFG+         + NTF GT +Y++PE + G K
Sbjct: 121 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 296
           Y +  D WS G++L E   GQ P+   +++       EL  +I    P          E 
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDNPF--YPRWLEKEA 230

Query: 297 CSFISACVQKEPQQRLSA-QELMTHPFLK 324
              +     +EP++RL    ++  HP  +
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFR 259

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  217 bits (554), Expect = 9e-69
 Identities = 66/270 (24%), Positives = 123/270 (45%), Gaps = 15/270 (5%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 119
            +  D ++ +G G+ G+V     K TG+ F  K I        +  +  E+ I      P
Sbjct: 28  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHP 86

Query: 120 YVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHE 178
            ++  + +F     + +ILE++ GG L D +  +   + E  +     Q  +GL ++H E
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH-E 145

Query: 179 KHIIHRDLKPSNLLI--NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
             I+H D+KP N++        VKI DFG++  + +          T  + +PE +    
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVDREP 204

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQFSP 294
            G+ +D+W++G++     +G  P++  +         E ++ +   D           SP
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCDWEFDEDAFSSVSP 257

Query: 295 EFCSFISACVQKEPQQRLSAQELMTHPFLK 324
           E   FI   +QKEP++RL+  + + HP+LK
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 6e-67
 Identities = 56/264 (21%), Positives = 116/264 (43%), Gaps = 16/264 (6%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
            + +G+G  GIV       + + +  K +   V+ + +  + +E+ I   ++   ++  +
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHR 184
           +SF S   + +I E++ G  + + +      + E  + +   QV + L +LH   +I H 
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH-SHNIGHF 126

Query: 185 DLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 242
           D++P N++   R    +KI +FG +  +               Y +PE          +D
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185

Query: 243 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--PPPSAPSDQFSPEFCSFI 300
           +WSLG ++    +G  P+     Q       +++E I++           + S E   F+
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 301 SACVQKEPQQRLSAQELMTHPFLK 324
              + KE + R++A E + HP+LK
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLK 262

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  211 bits (539), Expect = 2e-66
 Identities = 73/278 (26%), Positives = 136/278 (48%), Gaps = 20/278 (7%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ-----MNVEESARRQIAQELKI 112
           L + D    +++G+G  G V   +   TG+ +A+K +      M   E+        L +
Sbjct: 1   LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60

Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 172
             +  CP++V    +F++   +S IL+ M+GG L   L +     E  +     +++ GL
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 232
            ++ H + +++RDLKP+N+L++  G V+I+D G++     +  + +  VGT+ YM+PE +
Sbjct: 121 EHM-HNRFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHASVGTHGYMAPEVL 177

Query: 233 SGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 291
             G  Y   +D +SLG +L +   G  P+   + +D     +E+    +         D 
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLTMAVE--LPDS 231

Query: 292 FSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLK 324
           FSPE  S +   +Q++  +RL      AQE+   PF +
Sbjct: 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 3e-66
 Identities = 64/270 (23%), Positives = 122/270 (45%), Gaps = 15/270 (5%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSS 116
           +    I   + +G GS G V   +        A+K++ +        +    E+ + + +
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 117 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYL 175
           +   +++    + +   ++I+ ++ +G SL   L  ++T      L  I  Q  +G+ YL
Sbjct: 62  RHVNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS 233
           H  K IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I 
Sbjct: 121 HA-KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 234 G---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
                 Y ++SD+++ G+VL E  TGQ PYS    +D       ++      P  S    
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMVGRGYLSPDLSKVRS 236

Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTH 320
                    ++ C++K+  +R    +++  
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 6e-66
 Identities = 78/274 (28%), Positives = 141/274 (51%), Gaps = 17/274 (6%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQS 115
           + + D D +K++GKG+ G V LV+ K TG+++A+K+++  V   +        E ++ Q+
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL 175
           ++ P++     +F ++  +  ++EY +GG L   L + +   EE       +++  L Y 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY- 120

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 235
            H + +++RD+K  NL+++  G +KITDFG+     S      TF GT  Y++PE +   
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 295
            YG   D W LG+V+ E   G+ P+   + +        L E I+ +          SPE
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEIR--FPRTLSPE 231

Query: 296 FCSFISACVQKEPQQRLS-----AQELMTHPFLK 324
             S ++  ++K+P+QRL      A+E+M H F  
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 6e-65
 Identities = 61/266 (22%), Positives = 112/266 (42%), Gaps = 19/266 (7%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
           LN++++  ++ +GKG  G V L  ++  G   A+K I+    ++  +    E  +    +
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK---NDATAQAFLAEASVMTQLR 58

Query: 118 CPYVVVCYQSFY-SNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLY 174
              +V          G + I+ EYM  GSL D+L  +    +  + L      V + + Y
Sbjct: 59  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           L    + +HRDL   N+L++     K++DFG++   +ST    +T      + +PE +  
Sbjct: 119 LEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALRE 174

Query: 235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 294
            K+  KSD+WS G++L E  +      P           +++  +       AP D   P
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVVPRVEKGYKMDAP-DGCPP 227

Query: 295 EFCSFISACVQKEPQQRLSAQELMTH 320
                +  C   +   R S  +L   
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 6e-65
 Identities = 72/267 (26%), Positives = 123/267 (46%), Gaps = 17/267 (6%)

Query: 67  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 126
           +V+G G  G V  + +K T + FALK++Q      ARR++    +    SQCP++V    
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRA---SQCPHIVRIVD 72

Query: 127 SFYS----NGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKH 180
            + +       + I++E +DGG L   ++    +   E   + I + + + + YLH   +
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SIN 131

Query: 181 IIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 237
           I HRD+KP NLL   +     +K+TDFG  A   ++     T   T  Y++PE +   KY
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190

Query: 238 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 297
               D+WSLG+++     G  P+               +  +     P+    + S E  
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-MGQYEFPNPEWSEVSEEVK 249

Query: 298 SFISACVQKEPQQRLSAQELMTHPFLK 324
             I   ++ EP QR++  E M HP++ 
Sbjct: 250 MLIRNLLKTEPTQRMTITEFMNHPWIM 276

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  203 bits (517), Expect = 1e-63
 Identities = 72/272 (26%), Positives = 128/272 (47%), Gaps = 20/272 (7%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQ 117
           L+D   ++ +G GS G V L++ +  G+++A+KV++    V          E  +     
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
            P+++  + +F     I +I++Y++GG L   L+K +  P         +V   L YLH 
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH- 121

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 237
            K II+RDLKP N+L++  G +KITDFG +  +   +    T  GT +Y++PE +S   Y
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKPY 178

Query: 238 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 297
               D WS G+++ E   G  P+             +  E I++          F+ +  
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNAELR--FPPFFNEDVK 229

Query: 298 SFISACVQKEPQQRL-----SAQELMTHPFLK 324
             +S  + ++  QRL       +++  HP+ K
Sbjct: 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 4e-63
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 21/281 (7%)

Query: 56  NQLNLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI-----QMNVEESARRQIAQE 109
            Q N++D  DT + +G G   +V+  + K TG  +A K I     + +    +R  I +E
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 110 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 169
           + I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE      +Q+L
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQANTFVGTYN 225
            G+ Y  H   I H DLKP N+++  R      +KI DFG++  +   + +     GT  
Sbjct: 124 NGVYY-LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPE 181

Query: 226 YMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI--VDQP 283
           +++PE ++    G ++D+WS+G++     +G  P+    +Q       E +  +  V+  
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNYE 234

Query: 284 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                    S     FI   + K+P++R++ Q+ + HP++K
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  200 bits (509), Expect = 4e-63
 Identities = 67/272 (24%), Positives = 127/272 (46%), Gaps = 19/272 (6%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVV 123
            +++G G    V L +     +  A+KV++ ++  + S   +  +E +   +   P +V 
Sbjct: 12  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71

Query: 124 CYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 179
            Y +  +         I++EY+DG +L D +     +  +    +     + L + H + 
Sbjct: 72  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH-QN 130

Query: 180 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMA---STSGQANTFVGTYNYMSPERISGGK 236
            IIHRD+KP+N++I+    VK+ DFG++  +A   ++  Q    +GT  Y+SPE+  G  
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190

Query: 237 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQFSP 294
              +SD++SLG VL E  TG+ P++         S   +    V  D  PPSA  +  S 
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEPPFT-------GDSPVSVAYQHVREDPIPPSARHEGLSA 243

Query: 295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
           +  + +   + K P+ R      M    ++++
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 2e-61
 Identities = 63/285 (22%), Positives = 113/285 (39%), Gaps = 25/285 (8%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN----VEESARRQIAQELKINQSSQCPYV 121
           +  +G+G    V   + K T Q  A+K I++      ++   R   +E+K+ Q    P +
Sbjct: 3   LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62

Query: 122 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
           +    +F     IS++ ++M+             +   ++ A     L+GL YLH +  I
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-QHWI 121

Query: 182 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYK 240
           +HRDLKP+NLL++  G +K+ DFG++    S +      V T  Y +PE + G + YG  
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 241 SDIWSLGLVLLECATGQFPYSPPEQQD---------------GWTSFYELMEAIVDQPPP 285
            D+W++G +L E              D                W     L + +  +  P
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241

Query: 286 SAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 326
             P          +    I       P  R++A + +   +    
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 7e-61
 Identities = 58/280 (20%), Positives = 120/280 (42%), Gaps = 24/280 (8%)

Query: 56  NQLNLEDIDTIKVVGKGSGGIVQLVQH--KWTGQFFALKVIQMNV-EESARRQIAQELKI 112
             L LED    K +G G+ G V+   +  K   +  A+K+++    + + + ++  E  +
Sbjct: 6   KLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 61

Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 172
            Q    PY+V       +   + +++E  + G L  +L++ + + ++ +  +  QV  G+
Sbjct: 62  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT---FVGTYNYMSP 229
            YL    + +HRDL   N+L+  +   KI+DFG+S  + +                + +P
Sbjct: 121 KYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

Query: 230 ERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           E I+  K+  KSD+WS G+++ E  + GQ PY   +         E+   +        P
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMGCP 232

Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQELMT---HPFLKM 325
           +     E    ++ C   + + R     +     + +  +
Sbjct: 233 AG-CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 1e-60
 Identities = 64/266 (24%), Positives = 123/266 (46%), Gaps = 15/266 (5%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
           ++ +D+  +K +G G  G+V+  + +      A+K+I       +  +  +E K+  +  
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLS 57

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLH 176
              +V  Y        I II EYM  G L ++L+        + L  +C+ V + + YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGG 235
             K  +HRDL   N L+N +G VK++DFG+S  +      ++        +  PE +   
Sbjct: 118 S-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 236 KYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 294
           K+  KSDIW+ G+++ E  + G+ PY      + +T+  E  E I        P    S 
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPY------ERFTN-SETAEHIAQGLRLYRPHL-ASE 228

Query: 295 EFCSFISACVQKEPQQRLSAQELMTH 320
           +  + + +C  ++  +R + + L+++
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSN 254

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 6e-60
 Identities = 68/269 (25%), Positives = 117/269 (43%), Gaps = 28/269 (10%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-----EESARRQIAQELKINQ--SSQC 118
             ++G G  G V            A+K ++ +      E     ++  E+ + +  SS  
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGS-LADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 177
             V+     F    +  +ILE  +    L DF+ +   + EE   +   QVL+ + + H 
Sbjct: 69  SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 127

Query: 178 EKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 236
              ++HRD+K  N+LI+ +RGE+K+ DFG  A++  T      F GT  Y  PE I   +
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHR 185

Query: 237 Y-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 295
           Y G  + +WSLG++L +   G  P+   E         E++   V          + S E
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFFRQ------RVSSE 230

Query: 296 FCSFISACVQKEPQQRLSAQELMTHPFLK 324
               I  C+   P  R + +E+  HP+++
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  194 bits (494), Expect = 6e-60
 Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 20/280 (7%)

Query: 52  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQE 109
            PS N   L+  D IK +G GS G V LV+HK +G  +A+K++  Q  V+         E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 110 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 169
            +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 229
               YLH    +I+RDLKP NLLI+ +G +++TDFG +  +    G+  T  GT   ++P
Sbjct: 152 LTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWTLCGTPEALAP 207

Query: 230 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 289
           E I    Y    D W+LG+++ E A G  P+   +         ++ E IV         
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGKVR--FP 258

Query: 290 DQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 324
             FS +    +   +Q +  +R         ++  H +  
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 6e-60
 Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 24/280 (8%)

Query: 56  NQLNLEDIDTIKVVGKGSGGIVQLVQHKWT--GQFFALKVIQMNVEESARRQIAQELKIN 113
           + L + DI     +G G+ G V+   ++        A+KV++   E++   ++ +E +I 
Sbjct: 8   DNLLIADI----ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 63

Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGL 172
                PY+V       +   + +++E   GG L  FL  K + IP   +A +  QV  G+
Sbjct: 64  HQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN---TFVGTYNYMSP 229
            YL   K+ +HRDL   N+L+ +R   KI+DFG+S  + +                + +P
Sbjct: 123 KYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181

Query: 230 ERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 288
           E I+  K+  +SD+WS G+ + E  + GQ PY             E+M  I        P
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-------KMKGPEVMAFIEQGKRMECP 234

Query: 289 SDQFSPEFCSFISACVQKEPQQRLSAQEL---MTHPFLKM 325
            +   PE  + +S C   + + R     +   M   +  +
Sbjct: 235 PE-CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (490), Expect = 7e-60
 Identities = 64/276 (23%), Positives = 109/276 (39%), Gaps = 19/276 (6%)

Query: 55  DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELK 111
             ++++  +   +V+G G  G V     K  G+   F A+K ++    E  RR    E  
Sbjct: 20  AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS 79

Query: 112 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF-LKKVKTIPEEYLAAICEQVLK 170
           I      P V+        +  + II E+M+ GSL  F  +         L  +   +  
Sbjct: 80  IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-----FVGTYN 225
           G+ YL    + +HRDL   N+L+N     K++DFG+S  +   +                
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198

Query: 226 YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPP 284
           + +PE I   K+   SD+WS G+V+ E  + G+ PY     Q       +++ AI     
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-------DVINAIEQDYR 251

Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
              P D         +  C QK+   R    +++  
Sbjct: 252 LPPPMD-CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-59
 Identities = 65/271 (23%), Positives = 116/271 (42%), Gaps = 17/271 (6%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
           +  E +  ++ +G G  G V +  +       A+K +       +      E  + +  Q
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQ 66

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYL 175
              +V  Y +  +   I II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++
Sbjct: 67  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISG 234
             E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ 
Sbjct: 126 E-ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 294
           G +  KSD+WS G++L E  T      P        +  E+++ +        P D    
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRP-DNCPE 237

Query: 295 EFCSFISACVQKEPQQRLSAQEL--MTHPFL 323
           E    +  C ++ P+ R +   L  +   F 
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 3e-59
 Identities = 59/265 (22%), Positives = 108/265 (40%), Gaps = 13/265 (4%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
           ++  ++  ++ +G G  G+V L          A+K I       +     +E ++     
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI--REGAMSEEDFIEEAEVMMKLS 58

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADF-LKKVKTIPEEYLAAICEQVLKGLLYLH 176
            P +V  Y        I ++ E+M+ G L+D+   +      E L  +C  V +G+ YL 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 177 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-TSGQANTFVGTYNYMSPERISGG 235
            E  +IHRDL   N L+     +K++DFG++  +       +        + SPE  S  
Sbjct: 119 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 295
           +Y  KSD+WS G+++ E  +               S  E++E I        P    S  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIP------YENRSNSEVVEDISTGFRLYKPRL-ASTH 230

Query: 296 FCSFISACVQKEPQQRLSAQELMTH 320
               ++ C ++ P+ R +   L+  
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 6e-59
 Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 31/307 (10%)

Query: 57  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF--ALKVIQMNVEESARRQIAQELKI-N 113
            L+  DI    V+G+G+ G V   + K  G     A+K ++    +   R  A EL++  
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65

Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK----------------VKTIP 157
           +    P ++    +    G + + +EY   G+L DFL+K                  T+ 
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 158 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 217
            + L      V +G+ YL  +K  IHRDL   N+L+      KI DFG+S        + 
Sbjct: 126 SQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVKK 183

Query: 218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 277
                   +M+ E ++   Y   SD+WS G++L E  +               +  EL E
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELYE 237

Query: 278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH--PFLKMYGD-LNVDLS 334
            +        P +    E    +  C +++P +R S  +++      L+     +N  L 
Sbjct: 238 KLPQGYRLEKPLN-CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 296

Query: 335 EYFTDAG 341
           E FT AG
Sbjct: 297 EKFTYAG 303

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  188 bits (479), Expect = 2e-58
 Identities = 64/274 (23%), Positives = 108/274 (39%), Gaps = 13/274 (4%)

Query: 48  PPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA 107
           P        ++   DI     +G G  G V     K      A+K ++ +  E    +  
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFL 61

Query: 108 QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAIC 165
           +E  + +  + P +V             II E+M  G+L D+L     + +    L  + 
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121

Query: 166 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV-GTY 224
            Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S +M   +  A+       
Sbjct: 122 TQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 225 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 284
            + +PE ++  K+  KSD+W+ G++L E AT      P           ++ E +     
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYR 234

Query: 285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
              P      +    + AC Q  P  R S  E+ 
Sbjct: 235 MERPEG-CPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 3e-58
 Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 40/295 (13%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF-----FALKVIQMNVEESARRQIAQELKI 112
              E+++  KV+G G+ G V         +       A+K+++   + S R  +  ELK+
Sbjct: 34  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 113 -NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK------------------- 152
             Q      +V    +   +G I +I EY   G L ++L+                    
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 153 ----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 208
               +  +  E L     QV KG+ +L   K  +HRDL   N+L+ H   VKI DFG++ 
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 209 IMASTSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 265
            + S S             +M+PE +  G Y  KSD+WS G++L E  + G  PY     
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272

Query: 266 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
                        ++            + E    + +C   + ++R S   L + 
Sbjct: 273 D-------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 3e-58
 Identities = 71/288 (24%), Positives = 125/288 (43%), Gaps = 24/288 (8%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQC 118
           +E+   ++ +G+G+ G+V   ++K TG+  ALK I+++ E E       +E+ + +    
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHH 177
           P +V      ++   + ++ E++             T IP   + +   Q+L+GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119

Query: 178 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 237
              ++HRDLKP NLLIN  G +K+ DFG++             V T  Y +PE + G KY
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 238 -GYKSDIWSLGLVLLECATGQFPYSPPEQQD---------------GWTSFYELMEAIVD 281
                DIWSLG +  E  T +  +    + D                W     + +    
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 282 QP-----PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
            P       S        +  S +S  +  +P +R+SA+  + HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (476), Expect = 7e-58
 Identities = 59/289 (20%), Positives = 103/289 (35%), Gaps = 39/289 (13%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQS 115
            +I+ ++ +G+G+ G V   +             A+K+++       +    +E  +   
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 116 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---------------------- 153
              P +V           + ++ EYM  G L +FL+ +                      
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 154 --KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 211
               +       I  QV  G+ YL   K  +HRDL   N L+     VKI DFG+S  + 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERK-FVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 212 STSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 269
           S               +M PE I   +Y  +SD+W+ G+VL E  +           +  
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-- 249

Query: 270 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
               E++  + D    + P +    E  + +  C  K P  R S   + 
Sbjct: 250 ----EVIYYVRDGNILACP-ENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 1e-57
 Identities = 77/284 (27%), Positives = 142/284 (50%), Gaps = 21/284 (7%)

Query: 56  NQLNLEDIDTIKVVGKGSGGIVQLVQH---KWTGQFFALKVI---QMNVEESARRQIAQE 109
            ++ +E+ + +KV+G G+ G V LV+      TG+ +A+KV+    +  +         E
Sbjct: 19  EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78

Query: 110 LKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 168
            ++     Q P++V  + +F +   + +IL+Y++GG L   L + +   E  +     ++
Sbjct: 79  RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 138

Query: 169 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYM 227
           +  L +  H+  II+RD+K  N+L++  G V +TDFG+S    +   + A  F GT  YM
Sbjct: 139 VLALEH-LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 228 SPERISGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP 285
           +P+ + GG  G+    D WSLG+++ E  TG  P++   +++   S  E+   I+   PP
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPP 254

Query: 286 SAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLK 324
                + S      I   + K+P++RL      A E+  H F +
Sbjct: 255 --YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-57
 Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 16/270 (5%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKV----IQMNVEESARRQIAQELKIN 113
           L   +   IKV+G G+ G V        G+   + V    ++      A ++I  E  + 
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 114 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 173
            S   P+V        ++    I      G  L    +    I  +YL   C Q+ KG+ 
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT--FVGTYNYMSPER 231
           YL   + ++HRDL   N+L+     VKITDFG++ ++ +   + +         +M+ E 
Sbjct: 126 YLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 232 ISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 290
           I    Y ++SD+WS G+ + E  T G  PY      DG  +  E+   +        P  
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPY------DGIPA-SEISSILEKGERLPQPPI 237

Query: 291 QFSPEFCSFISACVQKEPQQRLSAQELMTH 320
             + +    +  C   +   R   +EL+  
Sbjct: 238 -CTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 2e-57
 Identities = 66/292 (22%), Positives = 131/292 (44%), Gaps = 24/292 (8%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQC 118
           ++  + ++ +G+G+ G V   +++ T +  ALK +++ + +E       +E+ + +  + 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
             +V  +   +S+  ++++ E+ D      F      +  E + +   Q+LKGL + H  
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS- 119

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-Y 237
           ++++HRDLKP NLLIN  GE+K+ +FG++          +  V T  Y  P+ + G K Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 238 GYKSDIWSLGLVLLECATGQFPYSPPE----------------QQDGWTSFYELMEAIVD 281
               D+WS G +  E A    P  P                   ++ W S  +L +    
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 282 QPPPSAPS-----DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
              P+  S      + +      +   ++  P QR+SA+E + HP+   +  
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-57
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 17/272 (6%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 117
           +  E +     +G+G  G V +     T +  A+K +       +     QE ++ +  +
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL--KPGTMSPEAFLQEAQVMKKLR 70

Query: 118 CPYVVVCYQSFYSNGAISIILEYMDGGSLADF--LKKVKTIPEEYLAAICEQVLKGLLYL 175
              +V  Y +  S   I I+ EYM  GSL DF   +  K +    L  +  Q+  G+ Y+
Sbjct: 71  HEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 176 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISG 234
               + +HRDL+ +N+L+      K+ DFG++ ++      A         + +PE    
Sbjct: 130 ER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 294
           G++  KSD+WS G++L E  T      P           E+++ +        P +    
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGM------VNREVLDQVERGYRMPCPPE-CPE 241

Query: 295 EFCSFISACVQKEPQQRLSAQEL--MTHPFLK 324
                +  C +KEP++R + + L      +  
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  185 bits (471), Expect = 3e-57
 Identities = 68/287 (23%), Positives = 125/287 (43%), Gaps = 24/287 (8%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQC 118
           +E    ++ +G+G+ G+V   Q+   G+ FALK I++  E E       +E+ I +  + 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 119 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
             +V  Y   ++   + ++ E++D             +      +   Q+L G+ Y H +
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-D 118

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKY 237
           + ++HRDLKP NLLIN  GE+KI DFG++        +    + T  Y +P+ + G  KY
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 238 GYKSDIWSLGLVLLECATGQFPYSPPEQQD---------------GWTSFYELMEAIVDQ 282
               DIWS+G +  E   G   +    + D                W +  EL +   + 
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 283 P-----PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                 P  +            +S  ++ +P QR++A++ + H + K
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 6e-57
 Identities = 63/271 (23%), Positives = 105/271 (38%), Gaps = 16/271 (5%)

Query: 56  NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELK 111
            +++   +   KV+G G  G V     K +        A+K ++    E  R     E  
Sbjct: 2   TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 61

Query: 112 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF-LKKVKTIPEEYLAAICEQVLK 170
           I        ++           + II EYM+ G+L  F  +K        L  +   +  
Sbjct: 62  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGTYNYM 227
           G+ Y     + +HRDL   N+L+N     K++DFG+S ++        T         + 
Sbjct: 122 GMKY-LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 228 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 287
           +PE IS  K+   SD+WS G+V+ E  T               S +E+M+AI D      
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERP------YWELSNHEVMKAINDGFRLPT 234

Query: 288 PSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
           P D         +  C Q+E  +R    +++
Sbjct: 235 PMD-CPSAIYQLMMQCWQQERARRPKFADIV 264

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-56
 Identities = 66/302 (21%), Positives = 117/302 (38%), Gaps = 38/302 (12%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQC 118
           +   + +  +G+G+ G V   +H+ TGQ  ALK + M N +E       +E+KI Q  + 
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68

Query: 119 PYVVVCYQSFYS--------NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 170
             VV   +   +         G+I ++ ++ +          +       +  + + +L 
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 171 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM----ASTSGQANTFVGTYNY 226
           GL Y+H    I+HRD+K +N+LI   G +K+ DFG++        S   +    V T  Y
Sbjct: 129 GLYYIH-RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 227 MSPERISGGK-YGYKSDIWSLGLVLLECATGQFPY-----------------SPPEQQDG 268
             PE + G + YG   D+W  G ++ E  T                      S   +   
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247

Query: 269 WTSFYELMEAIV------DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 322
               YEL E +        +      +    P     I   +  +P QR+ + + + H F
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307

Query: 323 LK 324
             
Sbjct: 308 FW 309

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-56
 Identities = 62/293 (21%), Positives = 118/293 (40%), Gaps = 31/293 (10%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQH-KWTGQFFALKVIQM-NVEESARRQIAQELKINQ---S 115
           +  + +  +G+G+ G V   +  K  G+F ALK +++   EE       +E+ + +   +
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 116 SQCPYVVVCYQSFYS-----NGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVL 169
            + P VV  +             ++++ E++D        K     +P E +  +  Q+L
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 170 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 229
           +GL +LH    ++HRDLKP N+L+   G++K+ DFG++ I  S      + V T  Y +P
Sbjct: 127 RGLDFLH-SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAP 184

Query: 230 ERISGGKYGYKSDIWSLGLVLLECATGQFPYS------------------PPEQQDGWTS 271
           E +    Y    D+WS+G +  E    +  +                     E      +
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 272 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 324
                       P               +  C+   P +R+SA   ++HP+ +
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 6e-56
 Identities = 60/293 (20%), Positives = 121/293 (41%), Gaps = 32/293 (10%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV--- 122
           +  +G+G+ G+V            A+K I     ++  ++  +E+KI    +   ++   
Sbjct: 13  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72

Query: 123 -VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 181
            +             ++ ++ G  L   LK  + +  +++     Q+L+GL Y+ H  ++
Sbjct: 73  DIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYI-HSANV 130

Query: 182 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISGG-KY 237
           +HRDLKPSNLL+N   ++KI DFG++ +             +V T  Y +PE +     Y
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190

Query: 238 GYKSDIWSLGLVLLECATGQFPY-----------------SPPEQQDGWTSFYELMEAIV 280
               DIWS+G +L E  + +  +                 SP ++        +    ++
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250

Query: 281 DQP-----PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
             P     P +        +    +   +   P +R+  ++ + HP+L+ Y D
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  181 bits (460), Expect = 1e-55
 Identities = 53/275 (19%), Positives = 104/275 (37%), Gaps = 19/275 (6%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
            + +G GS G + L      G+  A+K+  +   ++   Q+  E KI +  Q    +   
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV---KTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 126 QSFYSNG-AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 184
           +   + G    +++E +       F    +    + +  + +Q++  + Y+H  K+ IHR
Sbjct: 69  RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-SKNFIHR 127

Query: 185 DLKPSNLLINHRG---EVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISG 234
           D+KP N L+        V I DFG++               +     GT  Y S     G
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187

Query: 235 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 294
            +   + D+ SLG VL+    G  P+   +       +  + E  +  P        +  
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG-YPS 246

Query: 295 EFCSFISACVQKEPQQRLSAQ---ELMTHPFLKMY 326
           EF ++++ C       +       +L  + F +  
Sbjct: 247 EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 5e-55
 Identities = 60/268 (22%), Positives = 106/268 (39%), Gaps = 14/268 (5%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNVEESARRQIAQELKINQ 114
           +  E I+  + +G+G  G V    +          A+K  +    +S R +  QE    +
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63

Query: 115 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLL 173
               P++V       +   + II+E    G L  FL  +  ++    L     Q+   L 
Sbjct: 64  QFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122

Query: 174 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM-ASTSGQANTFVGTYNYMSPERI 232
           YL   K  +HRD+   N+L++    VK+ DFG+S  M  ST  +A+       +M+PE I
Sbjct: 123 YLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 233 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 292
           +  ++   SD+W  G+ + E                     +++  I +      P +  
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQ------GVKNNDVIGRIENGERLPMPPN-C 234

Query: 293 SPEFCSFISACVQKEPQQRLSAQELMTH 320
            P   S ++ C   +P +R    EL   
Sbjct: 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 7e-55
 Identities = 61/295 (20%), Positives = 111/295 (37%), Gaps = 33/295 (11%)

Query: 50  LIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQ-----HKWTGQFFALKVIQMNVEESARR 104
           L      +     +   K +G G+ G V                 A+K+++ +   + R 
Sbjct: 12  LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE 71

Query: 105 QIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--------- 154
            +  ELK+ +       +V    +    G   +I EY   G L +FL++ +         
Sbjct: 72  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131

Query: 155 ---------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 205
                     +  E L +   QV KG+ +L   K+ IHRDL   N+L+ H    KI DFG
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFG 190

Query: 206 VSAIMASTSGQANT--FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 263
           ++  + + S             +M+PE I    Y ++SD+WS G+ L E  +      P 
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
              D           ++ +       +    E    +  C   +P +R + ++++
Sbjct: 251 MPVD------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 7e-55
 Identities = 59/271 (21%), Positives = 106/271 (39%), Gaps = 19/271 (7%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNV--EESARRQIAQELKI 112
           +  +D+  ++ +G GS G+V+  +           A+K ++ +V  +  A     +E+  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 113 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKG 171
             S     ++  Y        + ++ E    GSL D L K         L+    QV +G
Sbjct: 65  MHSLDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMS 228
           + YL   K  IHRDL   NLL+  R  VKI DFG+   +                + + +
Sbjct: 124 MGYLE-SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 229 PERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 287
           PE +    + + SD W  G+ L E  T GQ P+          +  +++  I  +     
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-------GLNGSQILHKIDKEGERLP 235

Query: 288 PSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
             +    +  + +  C   +P+ R +   L 
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 2e-54
 Identities = 63/317 (19%), Positives = 120/317 (37%), Gaps = 38/317 (11%)

Query: 46  EAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEE 100
            A  +  P + ++  E I   + +G+GS G+V     K           A+K +      
Sbjct: 5   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 64

Query: 101 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK------ 154
             R +   E  + +   C +VV             +I+E M  G L  +L+ ++      
Sbjct: 65  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 124

Query: 155 ----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 210
                     +  +  ++  G+ YL+     +HRDL   N ++     VKI DFG++  +
Sbjct: 125 PVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 183

Query: 211 --ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 268
                  +    +    +MSPE +  G +   SD+WS G+VL E AT           + 
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE- 242

Query: 269 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT------HPF 322
                +++  +++      P D         +  C Q  P+ R S  E+++       P 
Sbjct: 243 -----QVLRFVMEGGLLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296

Query: 323 LKMYGDLNVDLSEYFTD 339
            +       ++S Y+++
Sbjct: 297 FR-------EVSFYYSE 306

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 4e-54
 Identities = 72/316 (22%), Positives = 118/316 (37%), Gaps = 41/316 (12%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
            KV+G GS G+V   +   +G+  A+K +  +     +R   +EL+I +      +V   
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLR 79

Query: 126 QSFYSNGA------ISIILEYMDGGSLA---DFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
             FYS+G       ++++L+Y+          + +  +T+P  Y+     Q+ + L Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139

Query: 177 HEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 235
               I HRD+KP NLL++    V K+ DFG +  +       +     Y           
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198

Query: 236 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA----------------- 278
            Y    D+WS G VL E   GQ  +      D      +++                   
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258

Query: 279 ---IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE 335
              I   P       +  PE  +  S  ++  P  RL+  E   H F     D NV L  
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPN 318

Query: 336 YFTDAGSPLATLSNLS 351
                G     L N +
Sbjct: 319 -----GRDTPALFNFT 329

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-53
 Identities = 63/288 (21%), Positives = 120/288 (41%), Gaps = 36/288 (12%)

Query: 58  LNLEDIDTIKVVGKGSGGIVQLVQHKWT-------GQFFALKVIQMNVEESARRQIAQEL 110
           L  + +   K +G+G+ G V L +               A+K+++ +  E     +  E+
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69

Query: 111 KI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----------------KV 153
           ++     +   ++    +   +G + +I+EY   G+L ++L+                  
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 154 KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 213
           + +  + L +   QV +G+ YL   K  IHRDL   N+L+     +KI DFG++  +   
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 214 SGQANTFV--GTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT 270
                T        +M+PE +    Y ++SD+WS G++L E  T G  PY          
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-------GV 241

Query: 271 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
              EL + + +      PS+  + E    +  C    P QR + ++L+
Sbjct: 242 PVEELFKLLKEGHRMDKPSN-CTNELYMMMRDCWHAVPSQRPTFKQLV 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-53
 Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 32/293 (10%)

Query: 53  PSDNQLNLEDIDTIKVVGKGSGGIV-----QLVQHKWTGQFFALKVIQMNVEESARRQIA 107
            S  +   + +   K +G+G+ G V       +    T +  A+K+++     S  R + 
Sbjct: 5   ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 64

Query: 108 QELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKVK----------- 154
            ELKI         VV          G + +I+E+   G+L+ +L+  +           
Sbjct: 65  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124

Query: 155 -----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 209
                 +  E+L     QV KG+ +L   +  IHRDL   N+L++ +  VKI DFG++  
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 210 MAS--TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 267
           +       +         +M+PE I    Y  +SD+WS G++L E  +      P  + D
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243

Query: 268 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
                      + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 244 EE-----FCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-53
 Identities = 65/292 (22%), Positives = 109/292 (37%), Gaps = 39/292 (13%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 120
             I   + +GKG  G V     KW G+  A+K+     E S  R+   E+      +   
Sbjct: 3   RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREA--EIYQTVMLRHEN 58

Query: 121 VV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 176
           ++       +   +   + ++ +Y + GSL D+L +  T+  E +  +      GL +LH
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLH 117

Query: 177 -------HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS----TSGQANTFVGTYN 225
                   +  I HRDLK  N+L+   G   I D G++    S         N  VGT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 226 YMSPERISG------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD--------GWTS 271
           YM+PE +         +   ++DI+++GLV  E A         E              S
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 272 FYELMEAIVDQ-----PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 318
             E+ + + +Q      P    S +        +  C       RL+A  + 
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  174 bits (443), Expect = 5e-53
 Identities = 51/284 (17%), Positives = 97/284 (34%), Gaps = 17/284 (5%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 125
            + +G+GS G++    +    Q  A+K      +    R   +  K+   + C  +   Y
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL--LAGCTGIPNVY 67

Query: 126 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 185
                     ++++ +            +    + +A   +Q+L  +  +H EK +++RD
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-EKSLVYRD 126

Query: 186 LKPSNLLIN-----HRGEVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERIS 233
           +KP N LI      +   + + DFG+                +     GT  YMS     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 234 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 293
           G +   + D+ +LG V +    G  P+   +       +  + E     P     +  F 
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG-FP 245

Query: 294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 337
            EF  ++                L    F K+   LN    E F
Sbjct: 246 EEFYKYMHYARNLAFDATPDYDYLQ-GLFSKVLERLNTTEDENF 288

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-51
 Identities = 62/280 (22%), Positives = 109/280 (38%), Gaps = 22/280 (7%)

Query: 50  LIKPSDNQLNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQI 106
           +I PS   ++       +V+G+G  G V    L+ +       A+K +    +     Q 
Sbjct: 21  VIGPSSLIVHFN-----EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75

Query: 107 AQELKINQSSQCPYVVVCYQSFY-SNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAI 164
             E  I +    P V+        S G+  ++L YM  G L +F++     P    L   
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135

Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---- 220
             QV KG+      K  +HRDL   N +++ +  VK+ DFG++  M      +       
Sbjct: 136 GLQVAKGM-KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194

Query: 221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 280
                +M+ E +   K+  KSD+WS G++L E  T   P  P        + +++   ++
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLL 248

Query: 281 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 320
                  P           +  C   + + R S  EL++ 
Sbjct: 249 QGRRLLQPEY-CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  170 bits (432), Expect = 6e-51
 Identities = 59/325 (18%), Positives = 129/325 (39%), Gaps = 47/325 (14%)

Query: 38  RIVSQTETEAPPLIKPSDNQL----NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKV 93
           R+ +   T  P      ++ +    N +D   ++ +G+G    V    +    +   +K+
Sbjct: 8   RVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI 67

Query: 94  IQMNVEESARRQIAQELKINQS-SQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFL 150
           ++       +++I +E+KI ++    P ++          +   +++ E+++        
Sbjct: 68  LK----PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 123

Query: 151 KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAI 209
           +    + +  +     ++LK L Y H    I+HRD+KP N++I+H   ++++ D+G++  
Sbjct: 124 QT---LTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179

Query: 210 MASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSP------ 262
                 + N  V +  +  PE +   + Y Y  D+WSLG +L      + P+        
Sbjct: 180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238

Query: 263 ----------PEQQDGWTSFYELMEAI-------------VDQPPPSAPSDQFSPEFCSF 299
                      E    +   Y +                  ++   S      SPE   F
Sbjct: 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298

Query: 300 ISACVQKEPQQRLSAQELMTHPFLK 324
           +   ++ + Q RL+A+E M HP+  
Sbjct: 299 LDKLLRYDHQSRLTAREAMEHPYFY 323

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 3e-50
 Identities = 71/293 (24%), Positives = 127/293 (43%), Gaps = 36/293 (12%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVC 124
           ++ VG G+ G V       TG   A+K +    + E   ++  +EL++ +  +   V+  
Sbjct: 23  LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 82

Query: 125 YQSFYSNGAIS------IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 178
              F  +  +       +++ +M  G+    L K + + E+ +  +  Q+LKGL Y+H  
Sbjct: 83  LDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH-A 139

Query: 179 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KY 237
             IIHRDLKP NL +N   E+KI DFG++        +   +V T  Y +PE I    +Y
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPEVILNWMRY 196

Query: 238 GYKSDIWSLGLVLLECATGQFPY-----------------SPPEQQDGWTSFYELMEAIV 280
               DIWS+G ++ E  TG+  +                 +PP +        E    + 
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256

Query: 281 DQP-----PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 328
             P       ++     SP   + +   +  + +QR++A E + HP+ +   D
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 4e-49
 Identities = 62/309 (20%), Positives = 121/309 (39%), Gaps = 45/309 (14%)

Query: 60  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQC 118
           L+    +K +G G+ GIV         +  A+K +    + ++  ++  +EL + +    
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 119 PYVVVCYQSFYSNGA------ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 172
             ++     F           + +++E MD         +   +  E ++ +  Q+L G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 132

Query: 173 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 232
            +LH    IIHRDLKPSN+++     +KI DFG++     TS     +V T  Y +PE I
Sbjct: 133 KHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVI 190

Query: 233 SGGKYGYKSDIWSLGLVLLECATGQFPY-------------------SPPEQQDGWTSFY 273
            G  Y    DIWS+G ++ E    +  +                    P   +    +  
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 274 ELMEAIVDQPPPSAPS--------------DQFSPEFCSFISACVQKEPQQRLSAQELMT 319
             +E        + P                  + +    +S  +  +P +R+S  + + 
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

Query: 320 HPFLKMYGD 328
           HP++ ++ D
Sbjct: 311 HPYINVWYD 319

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-45
 Identities = 64/299 (21%), Positives = 122/299 (40%), Gaps = 34/299 (11%)

Query: 61  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCP 119
           E    +  VG G+ G V       TG   A+K +    +     ++  +EL++ +  +  
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 120 YVVVCYQSFYSNGAIS-----IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 174
            V+     F    ++       ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136

Query: 175 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 234
           +H    IIHRDLKPSNL +N   E+KI DFG++        +   +V T  Y +PE +  
Sbjct: 137 IH-SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLN 192

Query: 235 GK-YGYKSDIWSLGLVLLECATGQFPY-----------------SPPEQQDGWTSFYELM 276
              Y    DIWS+G ++ E  TG+  +                 +P  +     S     
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252

Query: 277 EAIVDQP-----PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 330
             I           +      +P     +   +  +  +R++A + + H +   Y D +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 71/318 (22%), Positives = 122/318 (38%), Gaps = 62/318 (19%)

Query: 66  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQ-------SS 116
           ++ +G G    V L +        A+K+++ +    E+A  +I    ++N        S 
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 117 QCPYVVVCYQSFY---SNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKG 171
              +++     F     NG   +++  + G +L   +KK +   IP  Y+  I +Q+L G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 172 LLYLHHEKHIIHRDLKPSNLLINHRG------EVKITDFGVSAIMASTSGQANTFVGTYN 225
           L Y+H    IIH D+KP N+L+          ++KI D G +             + T  
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYTNSIQTRE 194

Query: 226 YMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP 285
           Y SPE + G  +G  +DIWS   ++ E  TG F + P E          + + I      
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 286 SAP---------------------------------------SDQFSPEFCSFISACVQK 306
            +                                        S   + E   F+S  +Q 
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 307 EPQQRLSAQELMTHPFLK 324
           +P++R  A  L+ HP+LK
Sbjct: 315 DPRKRADAGGLVNHPWLK 332

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.2 bits (210), Expect = 2e-20
 Identities = 36/211 (17%), Positives = 71/211 (33%), Gaps = 41/211 (19%)

Query: 63  IDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVI-----------------QMNVEESARR 104
           +D I K++G+G    V     +       +K                    ++    A R
Sbjct: 1   VDAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 105 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 164
               E +  Q  Q   V   Y    +    ++++E +D         ++  +  E    +
Sbjct: 60  SARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAK-------ELYRVRVENPDEV 108

Query: 165 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 224
            + +L+ +   +H + I+H DL   N+L++  G + I DF  S  +     +        
Sbjct: 109 LDMILEEVAKFYH-RGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR------EI 160

Query: 225 NYMSPERIS---GGKYGYKSDIWSLGLVLLE 252
                  I       Y  + DI S    +L+
Sbjct: 161 LERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	353
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.53
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.01
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.98
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.5
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.94
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.1

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-66  Score=473.72  Aligned_cols=282  Identities=44%  Similarity=0.801  Sum_probs=243.9

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ++..++|++++.||+|+||+||+|+++.+|+.||+|+++.........++.+|+.+++.++||||++++++|.+++.+|+
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34568999999999999999999999999999999999876556667789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||||++||+|.+++.+.+.+++..++.++.|++.||.|||+++||+||||||+|||++.+|++||+|||+|+.....  .
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~  159 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M  159 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--T
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--c
Confidence            99999999999999988899999999999999999999997358999999999999999999999999999876432  2


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc----------------------------
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG----------------------------  268 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------------------------  268 (353)
                      ..+.+||+.|+|||++.+..|+.++||||+||++|||++|..||.+.+..+.                            
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            3457999999999999999999999999999999999999999976543210                            


Q ss_pred             -------hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHhHHhhhh
Q 018630          269 -------WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  340 (353)
Q Consensus       269 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~  340 (353)
                             .....+....+....++......+|+++.+||.+||+.||++|||++|+++||||+.......++..|++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~d~~~~~~~~  318 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCST  318 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCCCHHHHHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcccccHHHHHHHH
Confidence                   011122333344444444444567899999999999999999999999999999999999999999998654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-65  Score=457.30  Aligned_cols=262  Identities=26%  Similarity=0.452  Sum_probs=224.2

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++..........+.+|++++++++||||+++++++.+++.+|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            46899999999999999999999999999999999766544555678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--CCC
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQA  217 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  217 (353)
                      |++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++++||+|||+|+......  ...
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            99999999999888889999999999999999999998 999999999999999999999999999998764332  223


Q ss_pred             cccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          218 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ...+||+.|||||++.+..+ +.++||||+||++|||++|..||...+...      ..................+++++
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~s~~~  236 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAP  236 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS------HHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCCCCCCccccCCHHH
Confidence            45689999999999988876 578999999999999999999997654322      12223333333334456789999


Q ss_pred             HHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          297 CSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      .+||.+||+.||++|||++|+++||||+...+
T Consensus       237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~  268 (271)
T d1nvra_         237 LALLHKILVENPSARITIPDIKKDRWYNKPLK  268 (271)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence            99999999999999999999999999986544

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-64  Score=448.98  Aligned_cols=256  Identities=31%  Similarity=0.479  Sum_probs=227.4

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      +.+++|++++.||+|+||+||+|+++.+++.||+|++....  .......+.+|+++++.++||||+++++++.+++.+|
T Consensus         3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            45789999999999999999999999999999999987542  2233567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||+++|+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            999999999999999988899999999999999999999998 99999999999999999999999999999765432  


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .....+||+.|||||++.+..++.++|||||||++|||++|..||.+.+.       .+....+......  .+..+|++
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~s~~  230 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVEFT--FPDFVTEG  230 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCC--CCTTSCHH
T ss_pred             cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCC--CCccCCHH
Confidence            34456899999999999999999999999999999999999999976432       3444555544432  34678999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      +.+||.+||+.||++|||++|+++||||+.
T Consensus       231 ~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         231 ARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-63  Score=451.52  Aligned_cols=257  Identities=30%  Similarity=0.574  Sum_probs=225.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++..... ....+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            5799999999999999999999999999999998765322 346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCccc
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  220 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  220 (353)
                      |+||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+|+............
T Consensus        99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence            999999998776 579999999999999999999998 999999999999999999999999999998876555555667


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  300 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  300 (353)
                      +||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.+..      ...........+....+..+++++++||
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~~~s~~~~~li  250 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPELQNPEKLSAIFRDFL  250 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred             ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence            8999999999999999999999999999999999999999764321      1222222233333344567899999999


Q ss_pred             HHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          301 SACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       301 ~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      .+||+.||++|||++|+++||||+..
T Consensus       251 ~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         251 NRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999854

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-63  Score=442.10  Aligned_cols=255  Identities=29%  Similarity=0.516  Sum_probs=211.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--cCeEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISI  136 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--~~~~~l  136 (353)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.... .+.....+.+|++++++++||||+++++++.+  ++.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            478999999999999999999999999999999987653 45556778999999999999999999999864  567899


Q ss_pred             EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC-----ceecCCCCCcEEEcCCCcEEEeecccc
Q 018630          137 ILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKH-----IIHRDLKPSNLLINHRGEVKITDFGVS  207 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~-----iiH~Dlkp~NIll~~~~~~kl~DfG~a  207 (353)
                      |||||+||+|.+++.+    ...+++..++.++.|++.||+|||+ +|     |+||||||+|||++.++.+||+|||+|
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            9999999999999864    3579999999999999999999998 55     999999999999999999999999999


Q ss_pred             ccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          208 AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      +............+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.       .++...+.....+. 
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~~~i~~~~~~~-  233 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFRR-  233 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCCC-
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCCC-
Confidence            8876554445567899999999999999999999999999999999999999976432       34445555554433 


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcc
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  323 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  323 (353)
                      .+..+|+++.+||.+||+.||++|||++|+++|||+
T Consensus       234 ~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            346789999999999999999999999999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-62  Score=447.98  Aligned_cols=265  Identities=27%  Similarity=0.425  Sum_probs=212.9

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++...........+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            66999999999999999999999999999999998665445556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc---CCCcEEEeeccccccccccCCCC
Q 018630          141 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN---HRGEVKITDFGVSAIMASTSGQA  217 (353)
Q Consensus       141 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~~~~~~~  217 (353)
                      |+||+|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+||++.   .++.+||+|||+|+..... ...
T Consensus        89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~~~  166 (307)
T d1a06a_          89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVL  166 (307)
T ss_dssp             CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred             cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEeccceeEEccCC-Cee
Confidence            9999999999988899999999999999999999998 9999999999999995   4789999999999865432 334


Q ss_pred             cccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCCCCCCHH
Q 018630          218 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSPE  295 (353)
Q Consensus       218 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  295 (353)
                      .+.+||+.|||||++.+..|+.++||||+||++|||++|..||.+.+.       .+....+......  ......+|++
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~~  239 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-------AKLFEQILKAEYEFDSPYWDDISDS  239 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHhccCCCCCCccccCCCHH
Confidence            557899999999999999999999999999999999999999976432       3344455544332  2334678999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHh
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  334 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~  334 (353)
                      +.+||.+||++||++|||++|+++||||+.......++.
T Consensus       240 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~  278 (307)
T d1a06a_         240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIH  278 (307)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCCCCCH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccccccc
Confidence            999999999999999999999999999987554444333

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-62  Score=435.72  Aligned_cols=252  Identities=30%  Similarity=0.502  Sum_probs=219.7

Q ss_pred             ceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe----cCeEEEE
Q 018630           63 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISII  137 (353)
Q Consensus        63 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~----~~~~~lv  137 (353)
                      |++.+.||+|+||+||+|.++.+++.||+|++.... .......+.+|++++++++||||+++++++.+    +..+|+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            467788999999999999999999999999987553 44556789999999999999999999999875    4568999


Q ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ceecCCCCCcEEEc-CCCcEEEeeccccccccccC
Q 018630          138 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       138 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--iiH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |||+++|+|.+++.+...+++..+..++.||+.||+|||+ ++  |+||||||+|||++ .++.+||+|||+|+....  
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--  167 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--  167 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence            9999999999999988899999999999999999999998 78  99999999999996 478999999999976432  


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ....+.+||+.|||||++.+ .++.++||||+||++|||++|..||....      ....+...+.....+...+...++
T Consensus       168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~------~~~~~~~~i~~~~~~~~~~~~~~~  240 (270)
T d1t4ha_         168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGVKPASFDKVAIP  240 (270)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc------cHHHHHHHHHcCCCCcccCccCCH
Confidence            23445789999999999875 59999999999999999999999997542      223455566665555555567899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                      ++.+||.+||++||++|||++|+++|||||
T Consensus       241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999999997

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-62  Score=444.26  Aligned_cols=263  Identities=28%  Similarity=0.498  Sum_probs=227.0

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      ..++|++++.||+|+||+||+|+++.+|+.||||+++...  .......+.+|+++++.++||||+++++++.+++.+|+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            4578999999999999999999999999999999997542  22344678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--  214 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--  214 (353)
                      ||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+......  
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            99999999999999998999999999999999999999999 999999999999999999999999999998764332  


Q ss_pred             CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018630          215 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  294 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ....+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.       .++...+......  .+..+++
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~s~  235 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKLEYD--FPEKFFP  235 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCCC--CCTTCCH
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-------HHHHHHHHcCCCC--CCccCCH
Confidence            233456899999999999999999999999999999999999999986432       3444555554432  3467899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHH------HHcCCcccccCCCCc
Q 018630          295 EFCSFISACVQKEPQQRLSAQE------LMTHPFLKMYGDLNV  331 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e------~l~hp~~~~~~~~~~  331 (353)
                      ++.+||.+||+.||++|||++|      +++||||+.....++
T Consensus       236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence            9999999999999999999987      588999987654443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-63  Score=445.64  Aligned_cols=257  Identities=32%  Similarity=0.557  Sum_probs=222.7

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  140 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~  140 (353)
                      +.|++++.||+|+||+||+|+++.+|+.||||+++... ......+.+|++++++++||||+++++++.+++.+++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            46899999999999999999999999999999997653 23356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          141 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       141 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      |+||+|.+++.+ .+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++++||+|||+|+..........+
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            999999999765 4679999999999999999999998 99999999999999999999999999999776544333456


Q ss_pred             cccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-CCCCCCCCC
Q 018630          220 FVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFS  293 (353)
Q Consensus       220 ~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  293 (353)
                      .+||+.|+|||++.     +..|+.++||||+||++|||++|..||.+.+..+       .+..+..... ....+..+|
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~s  242 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTLAQPSRWS  242 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHHSCCCCCSSGGGSC
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCCCCCccccCC
Confidence            78999999999984     4568999999999999999999999998755432       2333333332 233446789


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      +++.+||.+||+.||++|||++|+++||||+..
T Consensus       243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999853

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-62  Score=448.72  Aligned_cols=259  Identities=31%  Similarity=0.573  Sum_probs=231.7

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      +.+++|++++.||+|+||+||+|+++.+|+.||||+++...  ......++.+|+.+++.++||||+++++++.+++.+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            46789999999999999999999999999999999997542  2233567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+.......
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            999999999999999999999999999999999999999999 9999999999999999999999999999987665555


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .....+||+.|+|||++.+..|+.++|+|||||++|||++|.+||.+.+.       .++...+.....  ..+..+|++
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~~i~~~~~--~~p~~~s~~  231 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEI--RFPRTLSPE  231 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--CCCTTSCHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-------HHHHHHHhcCCC--CCCccCCHH
Confidence            56678999999999999999999999999999999999999999987543       334455554443  234679999


Q ss_pred             HHHHHHHhhhhCcCCCCC-----HHHHHcCCccccc
Q 018630          296 FCSFISACVQKEPQQRLS-----AQELMTHPFLKMY  326 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~  326 (353)
                      +.+||.+||++||.+|++     ++|+++||||+..
T Consensus       232 ~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence            999999999999999994     8999999999764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-61  Score=441.45  Aligned_cols=257  Identities=30%  Similarity=0.489  Sum_probs=226.0

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +.|+.++.||+|+||+||+|+++.+|+.||||+++...  .......+.+|++++++++||||+++++++.+++.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35999999999999999999999999999999997653  3445677999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      |||.+|+|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++++||+|||+|+....    ..
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~  169 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----AN  169 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BC
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCCCEEEeecccccccCC----CC
Confidence            999999998888877899999999999999999999998 9999999999999999999999999999976542    34


Q ss_pred             ccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          219 TFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ..+||+.|||||++.+   +.|+.++|||||||++|||++|..||.+.+.       .+....+.....+......+|++
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~s~~  242 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPALQSGHWSEY  242 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCSCTTSCHH
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCCCCCCCCCHH
Confidence            5689999999999864   4589999999999999999999999976432       23444555555555556678999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCC
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  329 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  329 (353)
                      +.+||.+||+.||++|||++|+++||||+.....
T Consensus       243 ~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~  276 (309)
T d1u5ra_         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             HHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence            9999999999999999999999999999865443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-60  Score=436.85  Aligned_cols=256  Identities=28%  Similarity=0.544  Sum_probs=227.5

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      .+++|++++.||+|+||+||+|+++.+|+.||||+++...  .......+.+|+.+++.++||||+++++++.+++.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            4678999999999999999999999999999999997542  22335678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||||++||+|..++.....+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+.....   
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence            99999999999999999999999999999999999999998 99999999999999999999999999999876432   


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ..+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.       .+....+......  .+..+++++
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~s~~~  228 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAELR--FPPFFNEDV  228 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCCCC--CCTTSCHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------HHHHHHHHcCCCC--CCCCCCHHH
Confidence            3457899999999999999999999999999999999999999987433       3444555554432  345789999


Q ss_pred             HHHHHHhhhhCcCCCC-----CHHHHHcCCcccccC
Q 018630          297 CSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  327 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~~  327 (353)
                      .++|.+||++||.+|+     |++|+++||||+...
T Consensus       229 ~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         229 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             HHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence            9999999999999996     999999999998753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-60  Score=441.45  Aligned_cols=259  Identities=25%  Similarity=0.437  Sum_probs=225.6

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      .+++|++++.||+|+||.||+|+++.+|+.||||++.... ......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3579999999999999999999999999999999997653 344577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC--CCcEEEeeccccccccccCC
Q 018630          139 EYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       139 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |||+||+|.+++. ..+.+++..+..++.||+.||+|||+ +||+||||||+|||++.  ++.+||+|||+|+..... .
T Consensus       103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~  180 (350)
T d1koaa2         103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-Q  180 (350)
T ss_dssp             CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-S
T ss_pred             EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheecccc-c
Confidence            9999999999985 44679999999999999999999999 99999999999999964  578999999999876533 3


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCCCCCCC
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFS  293 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  293 (353)
                      .....+||+.|||||++.+..++.++|||||||++|||++|..||.+.+.       .+....+.....  +......+|
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s  253 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWNMDDSAFSGIS  253 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCSCCGGGGGCC
T ss_pred             ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCcccccCCC
Confidence            34457899999999999999999999999999999999999999986533       234444443332  223335689


Q ss_pred             HHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          294 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       294 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      +++.+||.+||+.||++|||++|+++||||+...
T Consensus       254 ~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999998754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3e-60  Score=440.15  Aligned_cols=257  Identities=25%  Similarity=0.439  Sum_probs=225.3

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++... ......+.+|+.+++.++||||++++++|.+++.+|+|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            478999999999999999999999999999999987653 3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEc--CCCcEEEeeccccccccccCCC
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN--HRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~--~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||+||+|.+++... .++++..++.++.||+.||+|||+ +||+||||||+|||++  .++.+||+|||+|+..... ..
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~  184 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI  184 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccceecCCC-Cc
Confidence            99999999887654 469999999999999999999998 9999999999999998  5789999999999876533 33


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCCCCCCCH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSP  294 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  294 (353)
                      .....||+.|+|||++.+..|+.++|||||||++|||+||..||.+.+.       .+....+.....  +......+|+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~  257 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDWEFDEDAFSSVSP  257 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred             eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCcccccCCCH
Confidence            4556899999999999999999999999999999999999999987433       234444444332  3334467999


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      ++.+||.+||++||.+|||++|+++||||+..
T Consensus       258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-60  Score=432.00  Aligned_cols=258  Identities=27%  Similarity=0.452  Sum_probs=224.4

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-----HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-----ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++....     ......+.+|+.++++++||||+++++++.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            679999999999999999999999999999999865421     223577899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC----cEEEeecccccccc
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMA  211 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG~a~~~~  211 (353)
                      +|||||+||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++    .+||+|||+|....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            999999999999999988899999999999999999999998 9999999999999998776    59999999998764


Q ss_pred             ccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APS  289 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  289 (353)
                      .. ....+..||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.       .+....+.......  ...
T Consensus       169 ~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~  240 (293)
T d1jksa_         169 FG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVNYEFEDEYF  240 (293)
T ss_dssp             TS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCCCCCHHHH
T ss_pred             CC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcCCCCCchhc
Confidence            33 334556899999999999999999999999999999999999999987433       23444444443322  223


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ..+|+++.+||.+||+.||++|||++|+++||||+...
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            57899999999999999999999999999999998643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.7e-60  Score=437.28  Aligned_cols=256  Identities=28%  Similarity=0.493  Sum_probs=227.2

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  135 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~  135 (353)
                      ..+++|++++.||+|+||.||+|+++.+|+.||||+++...  .......+.+|+++++.++||||+++++++.+...++
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence            34689999999999999999999999999999999987542  2233467889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      +||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+....   
T Consensus       118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---  193 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---  193 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred             cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence            999999999999999988999999999999999999999998 9999999999999999999999999999987643   


Q ss_pred             CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          216 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ...+.+||+.|||||++.+..++.++|||||||++|||++|..||.+.+.       ......+......  .+..++++
T Consensus       194 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~s~~  264 (350)
T d1rdqe_         194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGKVR--FPSHFSSD  264 (350)
T ss_dssp             CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTTCCHH
T ss_pred             ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------HHHHHHHhcCCCC--CCccCCHH
Confidence            23456899999999999999999999999999999999999999976432       3444555555433  34678999


Q ss_pred             HHHHHHHhhhhCcCCCC-----CHHHHHcCCccccc
Q 018630          296 FCSFISACVQKEPQQRL-----SAQELMTHPFLKMY  326 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  326 (353)
                      +.+||.+||+.||.+|+     |++|+++||||+..
T Consensus       265 ~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            99999999999999995     99999999999865

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-59  Score=422.78  Aligned_cols=258  Identities=27%  Similarity=0.488  Sum_probs=224.6

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--------cHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEe
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--------EESARRQIAQELKINQSSQ-CPYVVVCYQSFYS  130 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~  130 (353)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++...        .......+.+|+.+++++. ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999999999999999987542        1234567889999999997 9999999999999


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          131 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      ++.+|+||||++||+|.++++..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCCCeEEccchheeEc
Confidence            99999999999999999999988999999999999999999999998 99999999999999999999999999999876


Q ss_pred             cccCCCCcccccCCcccCcceecC------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018630          211 ASTSGQANTFVGTYNYMSPERISG------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  284 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  284 (353)
                      ... ......+||+.|+|||.+.+      ..++.++||||+||++|||++|..||.+.+.       ......+.....
T Consensus       161 ~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-------~~~~~~i~~~~~  232 (277)
T d1phka_         161 DPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMIMSGNY  232 (277)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCC
T ss_pred             cCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-------HHHHHHHHhCCC
Confidence            543 33455789999999998853      3578899999999999999999999987543       233344443332


Q ss_pred             --CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          285 --PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       285 --~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                        +......+|+++.+||.+||+.||++|||++|+++||||+.+
T Consensus       233 ~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         233 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence              233345799999999999999999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.9e-59  Score=436.90  Aligned_cols=259  Identities=27%  Similarity=0.503  Sum_probs=220.8

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-----cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      .+++|++++.||+|+||.||+|+++.+|+.||||++....     .........+++.+++.++||||+++++++.+++.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            4689999999999999999999999999999999986432     11222333455778888999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+||||++||+|.+++.+...+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            99999999999999999998999999999999999999999998 99999999999999999999999999999876433


Q ss_pred             CCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018630          214 SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  292 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                        .....+||+.|+|||++.. ..|+.++|||||||++|||++|..||...+..+    ...+......  .+...+..+
T Consensus       161 --~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~~~~~~~--~~~~~~~~~  232 (364)
T d1omwa3         161 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLT--MAVELPDSF  232 (364)
T ss_dssp             --CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----HHHHHHHSSS--CCCCCCSSS
T ss_pred             --cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccc--CCCCCCCCC
Confidence              3445689999999999975 468999999999999999999999998754432    2222222222  223345679


Q ss_pred             CHHHHHHHHHhhhhCcCCCCC-----HHHHHcCCccccc
Q 018630          293 SPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMY  326 (353)
Q Consensus       293 ~~~~~~li~~~L~~dp~~Rpt-----~~e~l~hp~~~~~  326 (353)
                      |+++.+||.+||+.||++|||     ++|+++||||+..
T Consensus       233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            999999999999999999999     7999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-60  Score=432.82  Aligned_cols=257  Identities=29%  Similarity=0.512  Sum_probs=224.8

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHH-hcCCCCceEEEeeEeEecCeEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~-~~l~hp~iv~~~~~~~~~~~~~l  136 (353)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++...  .......+..|..++ +.++||||+++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            378999999999999999999999999999999997542  122234555666655 47899999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||||++||+|.+++.....+++..++.++.||+.||+|||+ +||+||||||+|||++.++++||+|||+++........
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence            99999999999999998999999999999999999999998 99999999999999999999999999999876655555


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  296 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....+||+.|+|||++.+..|+.++||||+||++|||++|..||.+.+.       .++...+....+  ..+..+|+++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~--~~p~~~s~~~  230 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDNP--FYPRWLEKEA  230 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--CCCTTSCHHH
T ss_pred             ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC--CCCccCCHHH
Confidence            6667899999999999999999999999999999999999999987433       344455554433  3346789999


Q ss_pred             HHHHHHhhhhCcCCCCCHH-HHHcCCccccc
Q 018630          297 CSFISACVQKEPQQRLSAQ-ELMTHPFLKMY  326 (353)
Q Consensus       297 ~~li~~~L~~dp~~Rpt~~-e~l~hp~~~~~  326 (353)
                      .+||.+||+.||++|||+. |+++||||+..
T Consensus       231 ~dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         231 KDLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            9999999999999999995 89999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=427.22  Aligned_cols=260  Identities=24%  Similarity=0.374  Sum_probs=213.6

Q ss_pred             eeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccH----HHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           64 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      +.++.||+|+||+||+|+++.+|+.||||+++.....    .....+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            3578999999999999999999999999998654221    223568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCcc
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  219 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  219 (353)
                      |+.++++..+......+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+...........
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence            99988777777667789999999999999999999999 99999999999999999999999999999877665555566


Q ss_pred             cccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC---C----------
Q 018630          220 FVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP---P----------  285 (353)
Q Consensus       220 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~----------  285 (353)
                      .+||+.|+|||++... .|+.++||||+||++|||++|.+||.+.+..+...   .+.........   +          
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~---~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH---HHHHhcCCCChhhccchhccchhhh
Confidence            7899999999998755 57999999999999999999999998754432111   11111110000   0          


Q ss_pred             -----C----CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          286 -----S----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       286 -----~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                           .    .....+++++.+||.+||+.||++|||++|+++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence                 0    00135688999999999999999999999999999998654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-59  Score=427.57  Aligned_cols=256  Identities=21%  Similarity=0.369  Sum_probs=222.7

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      +++|++++.||+|+||+||+|.++.+|+.||||+++...  .....+.+|+++++.++||||++++++|.+++.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            578999999999999999999999999999999997653  234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCC--CcEEEeeccccccccccCCC
Q 018630          140 YMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~--~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||+||+|.+++...+ .+++..++.++.||+.||+|||+ +||+||||||+|||++.+  +.+||+|||+++..... ..
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~  159 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN  159 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhccccC-Cc
Confidence            999999999998654 79999999999999999999998 999999999999999854  48999999999875432 23


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CCCCCCCH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFSP  294 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  294 (353)
                      ....++|+.|+|||.+.+..|+.++||||+||++|+|++|..||...+.       .+....+.......  .....+|+
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~  232 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEYTFDEEAFKEISI  232 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCChhhccCCCH
Confidence            4456899999999999999999999999999999999999999987543       23444554443322  22246899


Q ss_pred             HHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          295 EFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       295 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      ++.+||.+||++||++|||++|+++||||+..
T Consensus       233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999999999754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=420.14  Aligned_cols=264  Identities=26%  Similarity=0.486  Sum_probs=216.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-HHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +++|++++.||+|+||+||+|+++.+|+.||||+++.... .....++.+|++++++++||||+++++++.+++.+|+||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            3789999999999999999999999999999999975532 233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 018630          139 EYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  216 (353)
                      ||+.+ ++.+++..  ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+........
T Consensus        81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            99976 55555533  3569999999999999999999998 99999999999999999999999999999887655555


Q ss_pred             CcccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC----------
Q 018630          217 ANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP----------  285 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------  285 (353)
                      .....||+.|+|||.+.... ++.++|+||+||++|+|++|..||.+.+..+.   ..............          
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCCchhhccccccccc
Confidence            66678999999999987766 58899999999999999999999987543221   11111111110000          


Q ss_pred             ------C-------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          286 ------S-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       286 ------~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                            .       .....+++++.+||.+||+.||++|||++|+++||||+...+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                  0       001356789999999999999999999999999999986543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-58  Score=427.31  Aligned_cols=257  Identities=28%  Similarity=0.435  Sum_probs=211.7

Q ss_pred             ccCceeee-eecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHh-cCCCCceEEEeeEeEe----cCe
Q 018630           60 LEDIDTIK-VVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ-SSQCPYVVVCYQSFYS----NGA  133 (353)
Q Consensus        60 ~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~hp~iv~~~~~~~~----~~~  133 (353)
                      .++|++++ .||+|+||+||+|+++.+++.||||+++..      ..+.+|+.++. ..+||||++++++|.+    +..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            47899875 699999999999999999999999998743      34667888754 5689999999999875    467


Q ss_pred             EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC---CCcEEEeeccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSA  208 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~  208 (353)
                      +|+|||||+||+|.+++.+.  ..+++..++.++.||+.||+|||+ +||+||||||+|||++.   .+.+||+|||+|+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceee
Confidence            99999999999999999864  469999999999999999999998 99999999999999985   4579999999998


Q ss_pred             cccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CC
Q 018630          209 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PS  286 (353)
Q Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  286 (353)
                      ..... ......+||+.|+|||++.+..|+.++|||||||++|+|+||.+||.+.+.....   ..+...+.....  +.
T Consensus       163 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         163 ETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             ECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSSCCT
T ss_pred             eccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCCCCCCC
Confidence            76543 3345678999999999999989999999999999999999999999765433211   111122221111  11


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      .....+|+++.+||.+||+.||++|||++|+++||||+...
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            12235899999999999999999999999999999997544

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-57  Score=412.22  Aligned_cols=261  Identities=23%  Similarity=0.331  Sum_probs=220.6

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ..+++..++|++.+.||+|+||+||+|.++.+++.||||+++....  ...++.+|++++++++||||+++++++.+++.
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            3467788999999999999999999999999999999999875533  24578999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      +++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+...
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCCcEEEccccceeecC
Confidence            99999999999999999754  578999999999999999999998 999999999999999999999999999998764


Q ss_pred             ccCCC-CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          212 STSGQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       212 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ..... .....|++.|+|||++.+..|+.++||||+||++|||++|..||....      ....+...+..... ...+.
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~------~~~~~~~~i~~~~~-~~~~~  239 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEKDYR-MERPE  239 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHHHTTCC-CCCCT
T ss_pred             CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc------hHHHHHHHHhcCCC-CCCCc
Confidence            43222 223458899999999999999999999999999999999666554321      12233344444333 33456


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      .+++++.+||.+||+.||++|||++|+++  +|+..
T Consensus       240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         240 GCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence            78999999999999999999999999976  55543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=418.97  Aligned_cols=257  Identities=26%  Similarity=0.365  Sum_probs=215.1

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCc-----EEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ-----FFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY  129 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~  129 (353)
                      +++..++|++.+.||+|+||+||+|++..+++     .||+|.+...........+.+|+.++.++ +|||||++++++.
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            45677899999999999999999999876543     69999987665556667889999999887 8999999999999


Q ss_pred             ecCeEEEEEEecCCCCHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCC
Q 018630          130 SNGAISIILEYMDGGSLADFLKKV-----------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL  186 (353)
Q Consensus       130 ~~~~~~lv~e~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dl  186 (353)
                      +++.+++|||||++|+|.++++..                       ..+++..++.++.|++.||+|||+ +||+||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRDl  190 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDL  190 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETTC
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccC
Confidence            999999999999999999999754                       248999999999999999999998 99999999


Q ss_pred             CCCcEEEcCCCcEEEeeccccccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 018630          187 KPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPP  263 (353)
Q Consensus       187 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~  263 (353)
                      ||+||+++.++++||+|||+|+........  ..+..||+.|||||++.+..++.++|||||||++|||+| |..||.+.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876544332  234568999999999999999999999999999999998 89999875


Q ss_pred             ccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          264 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +...       .+..+.........+..+|+++.+||.+||+.||++|||++|+++|
T Consensus       271 ~~~~-------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         271 PVDA-------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCSH-------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHH-------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4321       2223333333334456889999999999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-58  Score=411.46  Aligned_cols=248  Identities=26%  Similarity=0.399  Sum_probs=212.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-----HHHHHHHHHHHHHHhcCC--CCceEEEeeEeEecCe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-----ESARRQIAQELKINQSSQ--CPYVVVCYQSFYSNGA  133 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~~~~l~--hp~iv~~~~~~~~~~~  133 (353)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++....     .....++.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            579999999999999999999999999999999865421     112234668999998876  8999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-CCcEEEeecccccccc
Q 018630          134 ISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 ~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~  211 (353)
                      .++||||+.+ +++.+++.....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEECccccceecc
Confidence            9999999976 6888999888899999999999999999999999 99999999999999985 4799999999997654


Q ss_pred             ccCCCCcccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          212 STSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ..  ...+.+||+.|+|||++.+..+ +.++||||+||++|||++|..||...+             .+.....  ..+.
T Consensus       163 ~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~~--~~~~  225 (273)
T d1xwsa_         163 DT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQV--FFRQ  225 (273)
T ss_dssp             SS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCCC--CCSS
T ss_pred             cc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhccc--CCCC
Confidence            32  3455789999999999987665 677999999999999999999997521             1222222  2345


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccccc
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  326 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  326 (353)
                      .+|+++.+||.+||+.||++|||++|+++||||+..
T Consensus       226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            789999999999999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-57  Score=409.06  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=209.0

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ++++..++|++.+.||+|+||+||+|+.+   ..||||+++.. ........+.+|+.++++++||||+++++++. ++.
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~   77 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ   77 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence            45677889999999999999999999754   35999998754 23455678999999999999999999999764 567


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      +++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+....
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            89999999999999999754 569999999999999999999998 9999999999999999999999999999977643


Q ss_pred             cC--CCCcccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC---
Q 018630          213 TS--GQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP---  284 (353)
Q Consensus       213 ~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---  284 (353)
                      ..  .......||+.|||||++.+   ..|+.++|||||||++|||+||..||.+.+..      ......+.....   
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~~p~  230 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRGYLSPD  230 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHTSCCCC
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCCCc
Confidence            22  22345689999999999864   35899999999999999999999999865432      122222332222   


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          285 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ....+..+++++.+||.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            223456789999999999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.5e-58  Score=412.70  Aligned_cols=261  Identities=25%  Similarity=0.419  Sum_probs=213.9

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +++|++++.||+|+||+||+|+++ +|+.||||+++... ......++.+|+.++++++||||+++++.+.+++..++++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            478999999999999999999986 78999999997653 2333567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      ||+.++.+..+....+.+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||.|...........
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            999987777777777889999999999999999999998 9999999999999999999999999999987765555555


Q ss_pred             ccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--------------
Q 018630          219 TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--------------  283 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------------  283 (353)
                      ...|++.|+|||.+.+. .++.++|+||+||++|||++|..||.+.+..+..   ...........              
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH---HHHHHhhCCCChhhccchhhhhhcc
Confidence            66899999999998765 4699999999999999999999999875432211   11111111100              


Q ss_pred             ---------CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          284 ---------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       284 ---------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                               +.......+++++.+||.+||++||++|||++|+++||||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                     001113457889999999999999999999999999999984

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.8e-57  Score=409.10  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=209.6

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCCc---EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      ++..++|++.+.||+|+||+||+|+++.+++   .||||.+...........+.+|++++++++|||||++++++..++.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            3556889999999999999999999987665   6899998776666777889999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      +++|||||++|+|.+++... +.+++..+..++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+....
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999999988764 579999999999999999999998 9999999999999999999999999999987643


Q ss_pred             cCCC-----CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          213 TSGQ-----ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       213 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      ....     .....||+.|||||.+.++.++.++|||||||++|||+| |..||.+.+.       .++...+.....++
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-------~~~~~~i~~~~~~~  253 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-------QDVINAIEQDYRLP  253 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCC
Confidence            3221     112457899999999999999999999999999999998 8999976432       34455555544333


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                       .+..+++++.+||.+||+.||++|||+.|++++
T Consensus       254 -~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 -PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence             346789999999999999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=405.00  Aligned_cols=258  Identities=26%  Similarity=0.407  Sum_probs=218.6

Q ss_pred             CCccCceeeee-ecccCCeEEEEEEecc--CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           58 LNLEDIDTIKV-VGKGSGGIVQLVQHKW--TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        58 ~~~~~~~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      +..++|.+... ||+|+||+||+|.++.  ++..||||+++.........++.+|++++++++||||+++++++.. +.+
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence            44577888885 9999999999998754  4558999999877666777889999999999999999999998864 568


Q ss_pred             EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      |+||||+++|+|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+|+.....
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            9999999999999998653 679999999999999999999999 99999999999999999999999999999876543


Q ss_pred             CC---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          214 SG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       214 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      ..   ......||+.|+|||++.++.++.++|||||||++|||+| |..||.+.+.       .++...+..+..+. .+
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-------~~~~~~i~~~~~~~-~p  234 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVMAFIEQGKRME-CP  234 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HHHHHHHHTTCCCC-CC
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCC-CC
Confidence            22   2234568999999999998899999999999999999998 9999986532       23445555555443 34


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHH---HcCCcccc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQEL---MTHPFLKM  325 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~---l~hp~~~~  325 (353)
                      ..+|+++.+||.+||+.||++|||+.++   |+|+|+..
T Consensus       235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            6799999999999999999999999888   56777653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-57  Score=404.87  Aligned_cols=248  Identities=21%  Similarity=0.349  Sum_probs=207.5

Q ss_pred             eeecccCCeEEEEEEec--cCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEEEecCC
Q 018630           67 KVVGKGSGGIVQLVQHK--WTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG  143 (353)
Q Consensus        67 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  143 (353)
                      +.||+|+||+||+|.++  .+++.||||+++.. .......++.+|++++++++||||+++++++.. +.+++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            57999999999999764  45678999998654 334456789999999999999999999998864 567899999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC---Cccc
Q 018630          144 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTF  220 (353)
Q Consensus       144 gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~---~~~~  220 (353)
                      |+|.+++.....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+........   ....
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            9999999998899999999999999999999998 99999999999999999999999999999876433221   2235


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018630          221 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  299 (353)
Q Consensus       221 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (353)
                      .||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+.       .++...+..+..+. .+..+|+++.+|
T Consensus       171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~~~-~p~~~~~~~~~l  242 (277)
T d1xbba_         171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGERMG-CPAGCPREMYDL  242 (277)
T ss_dssp             CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCC-CCTTCCHHHHHH
T ss_pred             CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HHHHHHHHcCCCCC-CCcccCHHHHHH
Confidence            78999999999999999999999999999999998 8999987432       24445555544433 346789999999


Q ss_pred             HHHhhhhCcCCCCCHHHHH---cCCccc
Q 018630          300 ISACVQKEPQQRLSAQELM---THPFLK  324 (353)
Q Consensus       300 i~~~L~~dp~~Rpt~~e~l---~hp~~~  324 (353)
                      |.+||+.||++|||+++++   +|+|++
T Consensus       243 i~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         243 MNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            9999999999999999984   565554

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-57  Score=412.64  Aligned_cols=263  Identities=23%  Similarity=0.398  Sum_probs=209.3

Q ss_pred             cCceeeeeecccCCeEEEEEEeccC-CcEEEEEEeecccc-HHHHHHHHHHHHHHhc---CCCCceEEEeeEeEe-----
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWT-GQFFALKVIQMNVE-ESARRQIAQELKINQS---SQCPYVVVCYQSFYS-----  130 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~---l~hp~iv~~~~~~~~-----  130 (353)
                      ++|++++.||+|+||+||+|++..+ ++.||||+++.... ......+.+|+.+++.   .+||||++++++|..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            6899999999999999999999765 67899999865422 2222344566666554   589999999998853     


Q ss_pred             cCeEEEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          131 NGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ...++++|||+.++++..... ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            357899999999876654443 33668999999999999999999998 9999999999999999999999999999876


Q ss_pred             ccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC------
Q 018630          210 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP------  283 (353)
Q Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~------  283 (353)
                      .... ......+||+.|+|||++.+..|+.++||||+||++|||++|.+||.+.+..+...   .+........      
T Consensus       166 ~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         166 YSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLPGEEDWPR  241 (305)
T ss_dssp             CCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCGGGSCT
T ss_pred             hccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH---HHHHhhCCCchhcccc
Confidence            5432 33456789999999999999999999999999999999999999998755432111   1111111000      


Q ss_pred             ---------------CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          284 ---------------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       284 ---------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                                     ........+++++.+||.+||++||++|||++|+++||||+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence                           001123467899999999999999999999999999999997643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=399.80  Aligned_cols=250  Identities=24%  Similarity=0.434  Sum_probs=204.5

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +.++|++++.||+|+||+||+|+++ +++.||||+++....  ...++.+|++++++++||||+++++++..++.+++||
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            4578999999999999999999986 677899999875432  2357899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC-
Q 018630          139 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  216 (353)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++++||+|||+|+........ 
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999999998754 568999999999999999999998 99999999999999999999999999999876543322 


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+       ..++...+.....+. .+..++++
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~~~~~-~p~~~~~~  230 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRLY-KPRLASTH  230 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHHHHHHHHTCCCC-CCTTSCHH
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHhcCCCC-CccccCHH
Confidence            234578999999999999999999999999999999999 566665432       234444554444333 34678999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +.+||.+||+.||++|||++|+++|
T Consensus       231 l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         231 VYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.9e-56  Score=402.25  Aligned_cols=256  Identities=25%  Similarity=0.424  Sum_probs=211.3

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc--cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC----eE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----AI  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~----~~  134 (353)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...  .......+.+|+++++.++||||+++++++...+    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            67999999999999999999999999999999997652  3455678999999999999999999999988653    48


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 018630          135 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  214 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  214 (353)
                      |+||||++|++|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+|||++.++..+++|||.+.......
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            9999999999999999988999999999999999999999998 999999999999999999999999999987653322


Q ss_pred             ---CCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-C-CCCCC
Q 018630          215 ---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-P-PSAPS  289 (353)
Q Consensus       215 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~  289 (353)
                         ......+||+.|+|||++.+..++.++||||+||++|||+||.+||.+.+.       .+....+.... . +....
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCCCCGGGTS
T ss_pred             ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-------HHHHHHHHhcCCCCCchhc
Confidence               233456899999999999999999999999999999999999999976432       22333333332 2 22345


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCccc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  324 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  324 (353)
                      ..+|+++.+||.+||++||++||+..+.+.|+|.+
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            67899999999999999999999555555677765

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=401.34  Aligned_cols=258  Identities=24%  Similarity=0.395  Sum_probs=216.8

Q ss_pred             CCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCe
Q 018630           54 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  133 (353)
Q Consensus        54 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~  133 (353)
                      .++++..++|++.+.||+|+||.||+|.++ +++.||||+++....  ....+.+|++++++++||||+++++++. ++.
T Consensus         6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~   81 (272)
T d1qpca_           6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP   81 (272)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeec-cCC
Confidence            456677899999999999999999999986 678899999875432  2357899999999999999999999775 456


Q ss_pred             EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      +++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeecccceeeccccceEEcc
Confidence            78999999999999977543  469999999999999999999998 999999999999999999999999999998765


Q ss_pred             ccCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCC-CCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          212 STSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ-FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      .... ......||+.|+|||++.++.++.++|||||||++|||+||. +||...       ...+....+.....+. .+
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-------~~~~~~~~i~~~~~~~-~p  232 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-------TNPEVIQNLERGYRMV-RP  232 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHHTTCCCC-CC
T ss_pred             CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHhcCCCC-Cc
Confidence            3322 233457899999999999889999999999999999999954 555442       2234455555554433 35


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc--CCccc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT--HPFLK  324 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~  324 (353)
                      ..+++++.+|+.+||+.||++|||++|+++  |+||.
T Consensus       233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            679999999999999999999999999998  67765

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-56  Score=401.60  Aligned_cols=265  Identities=23%  Similarity=0.395  Sum_probs=224.2

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +++|++++.||+|+||+||+|+++.+++.||||+++... ......++.+|+.+++.++||||+++++++.+...+++|+
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            368999999999999999999999999999999997553 3445678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCc
Q 018630          139 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  218 (353)
Q Consensus       139 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  218 (353)
                      +++.+++|..++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||.|+..........
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            999999999998888899999999999999999999998 9999999999999999999999999999988765555555


Q ss_pred             ccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--------------
Q 018630          219 TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--------------  283 (353)
Q Consensus       219 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------------  283 (353)
                      ...+++.|+|||.+.+.. ++.++||||+||++|||++|..||...+..   ......+.......              
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH---HHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH---HHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            667889999999987765 699999999999999999999997543221   11111111111110              


Q ss_pred             ----------CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          284 ----------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       284 ----------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                                ........+++++.+||.+||+.||++|||++|+++||||+.+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                      011122457889999999999999999999999999999997754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-56  Score=394.65  Aligned_cols=250  Identities=25%  Similarity=0.408  Sum_probs=217.6

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeEEEEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  138 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~~lv~  138 (353)
                      +.++|++++.||+|+||+||+++++ +++.||||+++....  ....+.+|+.++++++||||+++++++.+++.+++||
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            4578999999999999999999985 788999999986533  2357899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-C
Q 018630          139 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-Q  216 (353)
Q Consensus       139 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~  216 (353)
                      ||+++|+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++....... .
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            99999999998764 4679999999999999999999998 9999999999999999999999999999986654332 2


Q ss_pred             CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          217 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .....||+.|+|||.+.+..++.++|||||||++|||+| |..||...+.       .++...+.....+ ..+...+++
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------~~~~~~i~~~~~~-~~p~~~~~~  229 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLRL-YRPHLASEK  229 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTTCCC-CCCTTCCHH
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-------HHHHHHHHhCCCC-CCcccccHH
Confidence            234678999999999999999999999999999999998 8999976432       3455556555443 345688999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +.+||.+||+.||++|||++++++|
T Consensus       230 l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         230 VYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=398.07  Aligned_cols=255  Identities=24%  Similarity=0.306  Sum_probs=209.6

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEeccCC----cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTG----QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ++..+.|++.+.||+|+||.||+|..+.++    ..||||+++.........++.+|++++++++|||||++++++.+.+
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            345578999999999999999999987654    4799999987766666778999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      .+++||||+.++++.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999999999988654 679999999999999999999999 999999999999999999999999999998764


Q ss_pred             ccCC---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          212 STSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       212 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                      ....   ......||+.|+|||++.++.++.++|||||||++|||++|..||....      ...++...+..+..++ .
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~------~~~~~~~~i~~~~~~~-~  234 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL------SNHEVMKAINDGFRLP-T  234 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTTCCCC-C
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC------CHHHHHHHHhccCCCC-C
Confidence            3322   1223468999999999999999999999999999999999655543321      2234455555554433 3


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      +..+++++.+||.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         235 PMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            4678999999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=396.01  Aligned_cols=255  Identities=23%  Similarity=0.340  Sum_probs=208.9

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccC---CcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      +++..++|++.+.||+|+||.||+|++..+   +..||||.++..........+.+|+.++++++||||+++++++. ++
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            466778999999999999999999998654   34689999876666777788999999999999999999999885 56


Q ss_pred             eEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          133 AISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      .+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++.+||+|||+|+...
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCCcEEEccchhheecc
Confidence            78999999999999998765 4579999999999999999999999 999999999999999999999999999998765


Q ss_pred             ccCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          212 STSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       212 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..       ++...+..+..+ ..+
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-------~~~~~i~~~~~~-~~~  231 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERL-PMP  231 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------GHHHHHHTTCCC-CCC
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC-CCC
Confidence            3322 2334578999999999999999999999999999999998 89999875543       234444444433 345


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ..+|+++.+||.+||+.||++|||++|+++|
T Consensus       232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            6899999999999999999999999999885

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=409.76  Aligned_cols=267  Identities=26%  Similarity=0.381  Sum_probs=211.2

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec------CeE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAI  134 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~------~~~  134 (353)
                      -+|+.+++||+|+||+||+|+++.+|+.||||++.....     ...+|++++++++||||++++++|...      .++
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            369999999999999999999999999999999875421     234799999999999999999998542      458


Q ss_pred             EEEEEecCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-cEEEeeccccccc
Q 018630          135 SIILEYMDGGSLADFL---KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIM  210 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~  210 (353)
                      ++||||++++.+..+.   .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999999865333332   334679999999999999999999998 9999999999999999775 8999999999876


Q ss_pred             cccCCCCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH--------HHHHh-
Q 018630          211 ASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--------MEAIV-  280 (353)
Q Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~--------~~~~~-  280 (353)
                      ... ....+.+||+.|+|||.+.+ ..++.++||||+||++|||++|..||...+..+....+...        ..... 
T Consensus       174 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         174 VRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             cCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            533 33456789999999998875 46899999999999999999999999775433211111100        00000 


Q ss_pred             ---cCCCC--------CCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCCCCcCHh
Q 018630          281 ---DQPPP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  334 (353)
Q Consensus       281 ---~~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~~~  334 (353)
                         ....+        .......++++.+||.+||++||++|||++|+++||||+...+.+..+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~  317 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP  317 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCT
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCC
Confidence               00000        0112457899999999999999999999999999999998876665443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=408.49  Aligned_cols=262  Identities=26%  Similarity=0.419  Sum_probs=210.1

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC------
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------  132 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~------  132 (353)
                      .++|++++.||+|+||+||+|.++.+|+.||||+++.. .......++.+|+++++.++||||++++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            47899999999999999999999999999999999754 34455678899999999999999999999987654      


Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          133 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      .+|+||||+ +.+|..+.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+|++|||+|+....
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhcccccccccccccceeccCC
Confidence            579999999 5688887765 679999999999999999999998 9999999999999999999999999999987543


Q ss_pred             cCCCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH----------------
Q 018630          213 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL----------------  275 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~----------------  275 (353)
                         .....+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+........                
T Consensus       174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T d1cm8a_         174 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  250 (346)
T ss_dssp             ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             ---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence               34556899999999998764 5689999999999999999999999876433211111100                


Q ss_pred             ----HHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          276 ----MEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       276 ----~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                          ........  ........+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                00000000  01112356789999999999999999999999999999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-55  Score=400.45  Aligned_cols=261  Identities=24%  Similarity=0.372  Sum_probs=209.3

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe--------
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYS--------  130 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~--------  130 (353)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.... ......++.+|+++++.++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            589999999999999999999999999999999986542 23345678899999999999999999998754        


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          131 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      ++.+|+||||+.++.+.........+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCCcEEeeecceeeec
Confidence            45689999999887666666666789999999999999999999998 99999999999999999999999999999765


Q ss_pred             cccC----CCCcccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018630          211 ASTS----GQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  285 (353)
Q Consensus       211 ~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  285 (353)
                      ....    ....+.+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+.    ...+........+
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~  243 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ----LALISQLCGSITP  243 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCT
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH----HHHHHHhcCCCCh
Confidence            4221    223346799999999998765 689999999999999999999999976543221    1122222211111


Q ss_pred             CCCC---------------------------CCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccc
Q 018630          286 SAPS---------------------------DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  325 (353)
Q Consensus       286 ~~~~---------------------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  325 (353)
                      ....                           ...++++.+||.+||++||++|||++|+++||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            1000                           013678899999999999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-55  Score=402.12  Aligned_cols=263  Identities=28%  Similarity=0.513  Sum_probs=222.1

Q ss_pred             CCccCceeeeeecccCCeEEEEEEe---ccCCcEEEEEEeeccc---cHHHHHHHHHHHHHHhcCCC-CceEEEeeEeEe
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQH---KWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQC-PYVVVCYQSFYS  130 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h-p~iv~~~~~~~~  130 (353)
                      +.+++|++++.||+|+||+||+|++   +.+|+.||||+++...   .......+.+|++++++++| |||+++++.+.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            4568999999999999999999987   4468999999986431   22334668899999999976 899999999999


Q ss_pred             cCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          131 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       131 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      ...++++|||+.+|+|.+++...+.+++..+..++.||+.||+|+|+ +||+||||||+||+++.+|.+||+|||+++..
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            99999999999999999999999999999999999999999999998 99999999999999999999999999999765


Q ss_pred             ccc-CCCCcccccCCcccCcceecCC--CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          211 AST-SGQANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       211 ~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      ... .....+..|++.|+|||.+.+.  .++.++|||||||++|||++|..||...+..+..   ..+........+  .
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~~~~~--~  254 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSEP--P  254 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHCCC--C
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcccCCC--C
Confidence            432 2234456899999999999765  3688999999999999999999999877655433   233333333322  2


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCC-----CHHHHHcCCccccc
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMY  326 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  326 (353)
                      .+..+++++.+||.+||++||++||     |++|+++||||+..
T Consensus       255 ~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            2357899999999999999999999     58999999999854

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=405.12  Aligned_cols=265  Identities=22%  Similarity=0.372  Sum_probs=211.4

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC-----eEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----AIS  135 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~-----~~~  135 (353)
                      ++|++++.||+|+||+||+|.++.+|+.||||++..........++.+|+.+++.++||||+++++++....     .++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            579999999999999999999999999999999976656666778999999999999999999999987543     345


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  215 (353)
                      + ++|+.+|+|.+++.. +.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.......
T Consensus        88 l-~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          88 L-VTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             E-EEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             E-EEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            5 456668999999976 579999999999999999999998 9999999999999999999999999999976543322


Q ss_pred             ---CCcccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH----------------
Q 018630          216 ---QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL----------------  275 (353)
Q Consensus       216 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~----------------  275 (353)
                         .....+||+.|+|||++.. ..++.++||||+||++|+|++|..||...+..+........                
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence               2344679999999999855 45789999999999999999999999875432211111100                


Q ss_pred             -HHHHhcCCCCC-----CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          276 -MEAIVDQPPPS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       276 -~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                       ...........     .....+++++.+||.+||+.||.+|||++|+++||||+...+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence             00000000000     112467889999999999999999999999999999986543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=390.63  Aligned_cols=262  Identities=22%  Similarity=0.331  Sum_probs=213.3

Q ss_pred             CCCCCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           53 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      ..++++..++|++.+.||+|+||.||+|+++. ++.||||+++....  ....+.+|+.++++++|||||++++++. ++
T Consensus         9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~   84 (285)
T d1fmka3           9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE   84 (285)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             CcceEcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEe-cC
Confidence            34567788999999999999999999999874 46799999975533  2357899999999999999999999885 45


Q ss_pred             eEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 018630          133 AISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  210 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~  210 (353)
                      .+++||||+++|+|..++..  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++++||+|||+|+..
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCCcEEEcccchhhhc
Confidence            67899999999999998864  3579999999999999999999998 99999999999999999999999999999875


Q ss_pred             cccCC-CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018630          211 ASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  289 (353)
Q Consensus       211 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
                      ..... ......||+.|+|||++.++.++.++||||+||++|||++|..||...      ....+....+.....++ .+
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~------~~~~~~~~~i~~~~~~~-~~  236 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG------MVNREVLDQVERGYRMP-CP  236 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT------CCHHHHHHHHHTTCCCC-CC
T ss_pred             cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC------CCHHHHHHHHHhcCCCC-CC
Confidence            43322 233457899999999999999999999999999999999965554332      12234455555544333 45


Q ss_pred             CCCCHHHHHHHHHhhhhCcCCCCCHHHHHc--CCccccc
Q 018630          290 DQFSPEFCSFISACVQKEPQQRLSAQELMT--HPFLKMY  326 (353)
Q Consensus       290 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~~  326 (353)
                      ..+++++.+||.+||+.||++|||++++++  ++||...
T Consensus       237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            678999999999999999999999999988  7888654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-55  Score=398.31  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=206.9

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCc----EEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecCeE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~~~  134 (353)
                      +.++|++++.||+|+||+||+|.+..+|+    .||+|.++........+++.+|+.++++++||||+++++++.++ ..
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            34679999999999999999999987776    58888886554445567899999999999999999999998764 56


Q ss_pred             EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      ++++||+.+|+|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+.....
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            7888999999999887754 679999999999999999999999 99999999999999999999999999999876543


Q ss_pred             CCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018630          214 SGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  290 (353)
Q Consensus       214 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ...  .....||+.|+|||++.++.++.++|||||||++|||+| |.+||.+.+..       ++...+..+..+ ..+.
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-------~~~~~i~~~~~~-~~p~  236 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKGERL-PQPP  236 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-------GHHHHHHHTCCC-CCCT
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCCCC-CCCc
Confidence            322  223468999999999999999999999999999999998 89999775432       223333333333 3346


Q ss_pred             CCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          291 QFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       291 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+++++.+|+.+||+.||++|||+.|+++|
T Consensus       237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         237 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-55  Score=396.02  Aligned_cols=258  Identities=26%  Similarity=0.385  Sum_probs=205.1

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEecc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  128 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~  128 (353)
                      .+++..++|++.+.||+|+||.||+|.+..     +++.||||+++..........+.+|..++.++ +|+||+.+++++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            345667899999999999999999999754     45689999998665566667777787777665 689999999987


Q ss_pred             Eec-CeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcE
Q 018630          129 YSN-GAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  191 (353)
Q Consensus       129 ~~~-~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NI  191 (353)
                      ..+ ..+++|||||++|+|.+++...                ..+++..+..++.|++.||+|||+ +||+||||||+||
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NI  165 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI  165 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGE
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccce
Confidence            654 5789999999999999999753                248899999999999999999998 9999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcC-CCCCCCCccCCc
Q 018630          192 LINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDG  268 (353)
Q Consensus       192 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~  268 (353)
                      |++.++++||+|||+|+.......  ......||+.|+|||.+.+..++.++||||+||++|||++| .+||.+.+..+ 
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-  244 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  244 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999986543332  23345799999999999999999999999999999999986 56787644321 


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          269 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                           .....+..+..+ ..+..+++++.+||.+||+.||++|||++|+++|
T Consensus       245 -----~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         245 -----EFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             -----HHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----HHHHHHhcCCCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                 223333333333 3456789999999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.4e-54  Score=396.05  Aligned_cols=259  Identities=21%  Similarity=0.370  Sum_probs=210.9

Q ss_pred             CccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEe--cCeEE
Q 018630           59 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYS--NGAIS  135 (353)
Q Consensus        59 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~--~~~~~  135 (353)
                      ..++|++++.||+|+||+||+|+++.+|+.||||+++...    ..++.+|+.+++.+. ||||++++++|..  ...++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            3478999999999999999999999999999999987542    356788999999985 9999999999874  46799


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC-cEEEeeccccccccccC
Q 018630          136 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTS  214 (353)
Q Consensus       136 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  214 (353)
                      +||||+.+++|..+.   +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+..... 
T Consensus       109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-  183 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-  183 (328)
T ss_dssp             EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred             EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence            999999999987653   569999999999999999999998 9999999999999998655 6999999999875433 


Q ss_pred             CCCcccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHH---------h---c
Q 018630          215 GQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI---------V---D  281 (353)
Q Consensus       215 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~---------~---~  281 (353)
                      ......++|+.|+|||.+.+.. ++.++||||+||++|||++|..||.......  .....+....         .   .
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhhhhhhhccc
Confidence            3345668999999999987754 7999999999999999999999997643321  1111111000         0   0


Q ss_pred             C-------------------CCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          282 Q-------------------PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       282 ~-------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      .                   .........+++++.+||.+||++||++|||++|+|+||||+...+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            0                   0011122347899999999999999999999999999999997654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-54  Score=389.80  Aligned_cols=254  Identities=23%  Similarity=0.347  Sum_probs=218.1

Q ss_pred             CCCccCceeeeeecccCCeEEEEEEecc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEec
Q 018630           57 QLNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  131 (353)
Q Consensus        57 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~  131 (353)
                      ++..++|++++.||+|+||+||+|+.+.     +++.||||+++.........++.+|+.++++++||||+++++++...
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            4455789999999999999999999753     56789999998776666778899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCC
Q 018630          132 GAISIILEYMDGGSLADFLKKVK------------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK  187 (353)
Q Consensus       132 ~~~~lv~e~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlk  187 (353)
                      +..+++|||+++|+|.+++....                        .++...+..++.|++.||+|||+ ++++|||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrDlK  167 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLA  167 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCS
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeEEc
Confidence            99999999999999999996532                        48899999999999999999998 999999999


Q ss_pred             CCcEEEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCC-CCCCCCc
Q 018630          188 PSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ-FPYSPPE  264 (353)
Q Consensus       188 p~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~Pf~~~~  264 (353)
                      |+|||++.++.+||+|||+|+.......  ...+..||+.|+|||.+.+..|+.++|||||||++|||++|. +||...+
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            9999999999999999999986643332  223467899999999999999999999999999999999985 6787643


Q ss_pred             cCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          265 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .       .++...+..+..+. .+..+++++.+||.+||+.||++|||+.|+++
T Consensus       248 ~-------~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         248 H-------EEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             H-------HHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H-------HHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            2       34556666665443 35678999999999999999999999999965

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-54  Score=386.03  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=205.0

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccC-C--cEEEEEEeecc--ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWT-G--QFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  132 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~  132 (353)
                      +..++|++++.||+|+||.||+|+...+ +  ..||||+++..  .......++.+|+.++++++||||+++++++.+ +
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            4557899999999999999999986533 3  36899998654  234456789999999999999999999999965 4


Q ss_pred             eEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 018630          133 AISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  211 (353)
Q Consensus       133 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  211 (353)
                      ..++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            67899999999999987765 4679999999999999999999999 999999999999999999999999999998764


Q ss_pred             ccCC---CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018630          212 STSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  287 (353)
Q Consensus       212 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (353)
                      ....   ......|+..|+|||++.+..++.++|||||||++|||+| |..||.+.+.       .+....+........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-------~~~~~~i~~~~~~~~  235 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEGERLP  235 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSCCCCC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-------HHHHHHHHhCCCCCC
Confidence            3322   1223467889999999999999999999999999999998 8999976433       345566665555455


Q ss_pred             CCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          288 PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       288 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .+..+|+++.+||.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            56789999999999999999999999999964

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=391.40  Aligned_cols=253  Identities=26%  Similarity=0.377  Sum_probs=213.3

Q ss_pred             CCccCceeeeeecccCCeEEEEEEeccCCcE--EEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEeEecCeE
Q 018630           58 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF--FALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAI  134 (353)
Q Consensus        58 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~~~~~~~  134 (353)
                      ++.++|++.+.||+|+||+||+|.++.+|..  ||||.++..........+.+|+++++++ +||||+++++++.+++.+
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            5678999999999999999999999988874  6778776554555667899999999998 799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCc
Q 018630          135 SIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE  198 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~  198 (353)
                      ++||||+++|+|.++++..                ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGGC
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcCCCc
Confidence            9999999999999999643                568999999999999999999999 99999999999999999999


Q ss_pred             EEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCC-CCCCCCccCCchhhHHHHHH
Q 018630          199 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ-FPYSPPEQQDGWTSFYELME  277 (353)
Q Consensus       199 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~Pf~~~~~~~~~~~~~~~~~  277 (353)
                      +||+|||+|+...... ......||+.|+|||.+.++.++.++|||||||++|||++|. +||.+.+       ..++..
T Consensus       166 ~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~~  237 (309)
T d1fvra_         166 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYE  237 (309)
T ss_dssp             EEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHH
T ss_pred             eEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHHH
Confidence            9999999997654332 234457899999999999999999999999999999999964 6776543       334555


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          278 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      .+..+..+. .+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       238 ~i~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         238 KLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HGGGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            665554433 356789999999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-54  Score=383.37  Aligned_cols=248  Identities=25%  Similarity=0.426  Sum_probs=205.3

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-cCeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAI  134 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-~~~~  134 (353)
                      +.+..++|++++.||+|+||.||+|+.+  |+.||||+++..   ...+.+.+|++++++++||||+++++++.+ ++.+
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            5678899999999999999999999984  789999999754   234678899999999999999999998854 4678


Q ss_pred             EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 018630          135 SIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  212 (353)
Q Consensus       135 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  212 (353)
                      ++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCCCEeecccccceecCC
Confidence            9999999999999999654  358999999999999999999998 9999999999999999999999999999976543


Q ss_pred             cCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018630          213 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  291 (353)
Q Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      .   .....+|+.|+|||.+.++.++.++|||||||++|||+| |.+||...+..       ++...+..+..++ .+..
T Consensus       156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-------~~~~~i~~~~~~~-~~~~  224 (262)
T d1byga_         156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKGYKMD-APDG  224 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GHHHHHTTTCCCC-CCTT
T ss_pred             C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCCCCC-CCcc
Confidence            2   334578999999999998999999999999999999998 78888765432       2334444444443 3467


Q ss_pred             CCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          292 FSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       292 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +++++.+||.+||+.||.+|||+.+++++
T Consensus       225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            89999999999999999999999999873

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=386.84  Aligned_cols=255  Identities=24%  Similarity=0.378  Sum_probs=215.0

Q ss_pred             CCCCccCceeeeeecccCCeEEEEEEeccCC-------cEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeE
Q 018630           56 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTG-------QFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQS  127 (353)
Q Consensus        56 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~  127 (353)
                      +.+..++|++++.||+|+||.||+|++..++       ..||||+++.........++.+|...+.++ +||||++++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            5677899999999999999999999976554       479999998776666778888888888777 79999999999


Q ss_pred             eEecCeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcE
Q 018630          128 FYSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  191 (353)
Q Consensus       128 ~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NI  191 (353)
                      +.+++..++||||+++|+|.+++...                ..+++..+..++.||+.||+|||+ ++|+||||||+||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~Ni  166 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNV  166 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccce
Confidence            99999999999999999999999754                358999999999999999999999 9999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCc
Q 018630          192 LINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG  268 (353)
Q Consensus       192 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~  268 (353)
                      |++.++.+||+|||+++.......  ......||+.|+|||.+.++.|+.++|||||||++|||++ |.+||.+.+.   
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---  243 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  243 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence            999999999999999987654332  2334678999999999999999999999999999999998 7999976432   


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          269 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                          ..+...+..+..+ ..+..+++++.+||.+||+.||++|||+.|+++
T Consensus       244 ----~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         244 ----EELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             ----HHHHHHHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----HHHHHHHHcCCCC-CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence                3444455554443 345678999999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=386.61  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=222.2

Q ss_pred             CCCCCCCccCceeeeeecccCCeEEEEEEecc-----CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeE
Q 018630           53 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQS  127 (353)
Q Consensus        53 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~  127 (353)
                      +.++++..++|++.+.||+|+||+||+|.++.     +++.||||+++..........+.+|++++++++||||++++++
T Consensus        12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            44677888999999999999999999998853     3578999999876666667789999999999999999999999


Q ss_pred             eEecCeEEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC
Q 018630          128 FYSNGAISIILEYMDGGSLADFLKKV----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG  197 (353)
Q Consensus       128 ~~~~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~  197 (353)
                      +..++..++||||+++|+|.+++...          ..++...+..++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecCCc
Confidence            99999999999999999999998643          246889999999999999999998 9999999999999999999


Q ss_pred             cEEEeeccccccccccCC--CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcC-CCCCCCCccCCchhhHHH
Q 018630          198 EVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDGWTSFYE  274 (353)
Q Consensus       198 ~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~~~~~~~  274 (353)
                      ++||+|||+|+.......  ......||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+       ..+
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-------~~~  243 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQ  243 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-------HHH
Confidence            999999999987654332  22334689999999999999999999999999999999997 57886643       334


Q ss_pred             HHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          275 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      ....+.++..+. .+..+++.+.++|.+||+.||++|||++++++
T Consensus       244 ~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         244 VLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             HHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            555555555433 34678999999999999999999999999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-54  Score=397.15  Aligned_cols=264  Identities=24%  Similarity=0.368  Sum_probs=210.2

Q ss_pred             ccCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccc-cHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-----cCe
Q 018630           60 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYS-----NGA  133 (353)
Q Consensus        60 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-----~~~  133 (353)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++... ......++.+|+++++.++||||+++++++..     +..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            378999999999999999999999999999999997553 34455678999999999999999999998863     234


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      .+++++|+.||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+|++|||++..... 
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-  173 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  173 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccccccccccchhcccCc-
Confidence            4566777889999999865 579999999999999999999998 9999999999999999999999999999876432 


Q ss_pred             CCCCcccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH----------------
Q 018630          214 SGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----------------  276 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~----------------  276 (353)
                        ...+..||+.|+|||.+.+.. ++.++||||+||++|+|++|.+||.+.+.......+....                
T Consensus       174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence              234568999999999877754 6899999999999999999999998754322111111000                


Q ss_pred             HHHhcCCCCC------CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccCC
Q 018630          277 EAIVDQPPPS------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  328 (353)
Q Consensus       277 ~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  328 (353)
                      ..........      .....+++++.+||.+||+.||++|||++|+++||||+.+.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence            0000000000      012357899999999999999999999999999999997654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=397.27  Aligned_cols=262  Identities=24%  Similarity=0.409  Sum_probs=202.3

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeecc-ccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe------cCe
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS------NGA  133 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~------~~~  133 (353)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++.. .......++.+|+.++++++||||++++++|..      .+.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6899999999999999999999999999999999755 334556788999999999999999999999863      478


Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 018630          134 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  213 (353)
Q Consensus       134 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  213 (353)
                      +|+||||+.+ ++.+.+.  ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++.++++|||+++.... 
T Consensus        97 ~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~-  171 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-  171 (355)
T ss_dssp             EEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCccccccccccceeeechhhhhcccc-
Confidence            9999999976 5555443  579999999999999999999999 9999999999999999999999999999876543 


Q ss_pred             CCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH---------------HHHHH
Q 018630          214 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY---------------ELMEA  278 (353)
Q Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---------------~~~~~  278 (353)
                      .......++|+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+.......+.               .....
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred             ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence            334455689999999999999999999999999999999999999998754322111110               00011


Q ss_pred             HhcCCCCCCC------------------CCCCCHHHHHHHHHhhhhCcCCCCCHHHHHcCCcccccC
Q 018630          279 IVDQPPPSAP------------------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  327 (353)
Q Consensus       279 ~~~~~~~~~~------------------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  327 (353)
                      ..........                  ....++++.+||++||+.||++||||+|+|+||||+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            1111110000                  011356789999999999999999999999999998743

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-53  Score=384.96  Aligned_cols=257  Identities=24%  Similarity=0.359  Sum_probs=218.0

Q ss_pred             CCCCCccCceeeeeecccCCeEEEEEEec-----cCCcEEEEEEeeccccHHHHHHHHHHHHHHhcC-CCCceEEEeeEe
Q 018630           55 DNQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  128 (353)
Q Consensus        55 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~iv~~~~~~  128 (353)
                      .+++..++|++.+.||+|+||.||+|+..     .+++.||||+++..........+.+|+.+++.+ +||||+++++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            45677799999999999999999999863     456799999998776666777899999999988 699999999999


Q ss_pred             EecCeEEEEEEecCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCc
Q 018630          129 YSNGAISIILEYMDGGSLADFLKKVK------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  190 (353)
Q Consensus       129 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~N  190 (353)
                      .++..+++|||||++|+|.+++....                  .+++..+..++.||+.||+|||+ +|++||||||+|
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~N  175 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN  175 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccccc
Confidence            99999999999999999999997543                  58999999999999999999999 999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccccCCC--CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018630          191 LLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  267 (353)
Q Consensus       191 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~  267 (353)
                      |+++.++.+|++|||+++........  ....+||+.|+|||.+.++.++.++|||||||++|||+| |.+||...+.. 
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-  254 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-  254 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-
Confidence            99999999999999999876543322  233578999999999999999999999999999999999 66666554332 


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          268 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                            .....+.........+..+++++.+||.+||+.||++|||++|+++
T Consensus       255 ------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         255 ------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             ------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                  1122222223333445678999999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=374.56  Aligned_cols=248  Identities=23%  Similarity=0.309  Sum_probs=206.7

Q ss_pred             eeeeecccCCeEEEEEEeccCC---cEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEe-cCeEEEEEEe
Q 018630           65 TIKVVGKGSGGIVQLVQHKWTG---QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEY  140 (353)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~  140 (353)
                      +.++||+|+||+||+|++..++   ..||||+++.........++.+|++++++++||||+++++++.+ ++.+++||||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            3578999999999999986543   36999999766667777889999999999999999999999875 5689999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC---
Q 018630          141 MDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---  216 (353)
Q Consensus       141 ~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~---  216 (353)
                      |++|+|.+++... ..++...+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........   
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence            9999999998754 467888999999999999999998 99999999999999999999999999999876433221   


Q ss_pred             -CcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018630          217 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  295 (353)
Q Consensus       217 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                       .....||+.|+|||.+....++.++||||||+++|||+||..||.....      ..+....+..+..+. .+..++++
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~------~~~~~~~i~~g~~~~-~p~~~~~~  262 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDITVYLLQGRRLL-QPEYCPDP  262 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCCCC-CCTTCCHH
T ss_pred             ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC------HHHHHHHHHcCCCCC-CcccCcHH
Confidence             2235689999999999999999999999999999999997777754321      123344445554433 45678999


Q ss_pred             HHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          296 FCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       296 ~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      +.+||.+||+.||++|||+.|+++|
T Consensus       263 l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         263 LYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-51  Score=370.28  Aligned_cols=259  Identities=21%  Similarity=0.303  Sum_probs=204.3

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceE-EEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV-VCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv-~~~~~~~~~~~~~lv~e  139 (353)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.....   ..++.+|+++++.++|++++ .+...+.+++..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            479999999999999999999999999999999875422   23577899999999876654 55566677889999999


Q ss_pred             ecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC---CCcEEEeeccccccccccCC
Q 018630          140 YMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMASTSG  215 (353)
Q Consensus       140 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~~~~~  215 (353)
                      |+. ++|.+.+. ..+.+++..+..++.|++.||+|||+ +||+||||||+|||++.   +..++|+|||+|+.......
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          84 LLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            995 57766655 45689999999999999999999999 99999999999999864   45799999999987653322


Q ss_pred             -------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018630          216 -------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  288 (353)
Q Consensus       216 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
                             .....+||+.|||||++.+..++.++|||||||++|||++|..||....................... ....
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  240 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IEVL  240 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-HHHH
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-hhHh
Confidence                   22345799999999999999999999999999999999999999987655433332222222222221 1222


Q ss_pred             CCCCCHHHHHHHHHhhhhCcCCCCCHHH---HHcCCcccc
Q 018630          289 SDQFSPEFCSFISACVQKEPQQRLSAQE---LMTHPFLKM  325 (353)
Q Consensus       289 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e---~l~hp~~~~  325 (353)
                      ...+|+++.+||.+||+.||++||++++   +++|+|.+.
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            3578999999999999999999999874   567777654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=365.28  Aligned_cols=255  Identities=23%  Similarity=0.290  Sum_probs=197.3

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCceEEEeeEeEecC----eEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----AISI  136 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~iv~~~~~~~~~~----~~~l  136 (353)
                      .+|.+.+.||+|+||.||+|+.  +|+.||||+++.....  ......|+..+..++||||+++++++.+++    .+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            5788999999999999999986  5899999998754221  222234555666789999999999988653    6899


Q ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------cCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 018630          137 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH-------EKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  209 (353)
Q Consensus       137 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~-------~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~~  209 (353)
                      ||||+++|+|.+++++ ..+++..+..++.|++.||.|||+       .+||+||||||+|||++.++.+||+|||+++.
T Consensus        79 v~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            9999999999999987 469999999999999999999996       26999999999999999999999999999987


Q ss_pred             ccccCC----CCcccccCCcccCcceecCCC------CCccccHHHHHHHHHHHHcCCCCCCCCccCC--------chhh
Q 018630          210 MASTSG----QANTFVGTYNYMSPERISGGK------YGYKSDIWSLGLVLLECATGQFPYSPPEQQD--------GWTS  271 (353)
Q Consensus       210 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~  271 (353)
                      ......    .....+||+.|+|||++.+..      ++.++|||||||++|||+||..||.......        ....
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            654332    233468999999999987642      5778999999999999999988875432211        1112


Q ss_pred             HHHHHHHHhcCCCCCCCCC-----CCCHHHHHHHHHhhhhCcCCCCCHHHHHcC
Q 018630          272 FYELMEAIVDQPPPSAPSD-----QFSPEFCSFISACVQKEPQQRLSAQELMTH  320 (353)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  320 (353)
                      ..............+..+.     ..+.++.+|+.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            3333444443333222111     123458999999999999999999999874

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.4e-50  Score=361.44  Aligned_cols=253  Identities=19%  Similarity=0.261  Sum_probs=208.1

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCC-CceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC-PYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-p~iv~~~~~~~~~~~~~lv~e  139 (353)
                      ++|++++.||+|+||+||+|++..+|+.||||+++....   ...+.+|+++++.+.| +|++.+++++..+...++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            689999999999999999999999999999999865422   2346677888877765 899999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcC-----CCcEEEeecccccccccc
Q 018630          140 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-----RGEVKITDFGVSAIMAST  213 (353)
Q Consensus       140 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~-----~~~~kl~DfG~a~~~~~~  213 (353)
                      |+ +++|.+++... ..++...+..++.|++.||+|||+ +||+||||||+|||++.     ++.+||+|||+|+.....
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            99 67999998765 479999999999999999999998 99999999999999974     578999999999876432


Q ss_pred             CC-------CCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018630          214 SG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  286 (353)
Q Consensus       214 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (353)
                      ..       .....+||+.|||||++.+..++.++|||||||++|||++|..||.+.+..........+...... .+..
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~  238 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-TPLR  238 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-SCHH
T ss_pred             ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC-CChH
Confidence            21       233467999999999999999999999999999999999999999876554333322222222221 1122


Q ss_pred             CCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          287 APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       287 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                      .....+|+++.+++..|+..+|++||+++.+.+
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            223568899999999999999999999887755

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.2e-48  Score=359.32  Aligned_cols=262  Identities=25%  Similarity=0.391  Sum_probs=196.8

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-----------CCceEEEeeEeE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----------CPYVVVCYQSFY  129 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----------hp~iv~~~~~~~  129 (353)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++..  ......+.+|+++++.++           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            5799999999999999999999999999999998754  233456677787776654           578999998876


Q ss_pred             e--cCeEEEEEEecCCCCH-HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCC------c
Q 018630          130 S--NGAISIILEYMDGGSL-ADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG------E  198 (353)
Q Consensus       130 ~--~~~~~lv~e~~~~gsL-~~~l~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~------~  198 (353)
                      .  ....+++++++..+.. .....  ....+++..++.++.|++.||+|||+..||+||||||+|||++.++      .
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence            4  4567777777665443 33222  3367899999999999999999999768999999999999998665      3


Q ss_pred             EEEeeccccccccccCCCCcccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--
Q 018630          199 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--  276 (353)
Q Consensus       199 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~--  276 (353)
                      ++++|||.|.....   .....+||+.|+|||++.+..++.++|+||+||++++|++|+.||...+............  
T Consensus       171 ~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~  247 (362)
T d1q8ya_         171 IKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  247 (362)
T ss_dssp             EEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             eeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence            99999999876442   2345689999999999999999999999999999999999999997654322111111111  


Q ss_pred             -HHHh-----------------cCC------C-------------CCCCCCCCCHHHHHHHHHhhhhCcCCCCCHHHHHc
Q 018630          277 -EAIV-----------------DQP------P-------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  319 (353)
Q Consensus       277 -~~~~-----------------~~~------~-------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  319 (353)
                       ..+.                 ...      .             ........++++.+||.+||++||.+|||++|+|+
T Consensus       248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             0000                 000      0             00011234578999999999999999999999999


Q ss_pred             CCcccccC
Q 018630          320 HPFLKMYG  327 (353)
Q Consensus       320 hp~~~~~~  327 (353)
                      ||||+...
T Consensus       328 Hp~f~~~~  335 (362)
T d1q8ya_         328 HPWLKDTL  335 (362)
T ss_dssp             CGGGTTCT
T ss_pred             CcccCCCC
Confidence            99999653

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=3.8e-26  Score=192.37  Aligned_cols=165  Identities=19%  Similarity=0.172  Sum_probs=120.9

Q ss_pred             eeeeeecccCCeEEEEEEeccCCcEEEEEEeecccc-----------------HHHHHHHHHHHHHHhcCCCCceEEEee
Q 018630           64 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-----------------ESARRQIAQELKINQSSQCPYVVVCYQ  126 (353)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------~~~~~~~~~e~~~~~~l~hp~iv~~~~  126 (353)
                      .+.+.||+|+||+||+|.+. +|+.||||+++....                 ........+|...+..+.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            46789999999999999985 789999998753211                 122344567888899999999988776


Q ss_pred             EeEecCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCceecCCCCCcEEEcCCCcEEEeeccc
Q 018630          127 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  206 (353)
Q Consensus       127 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~iiH~Dlkp~NIll~~~~~~kl~DfG~  206 (353)
                      ...    .+++|||+++..+.       .++...+..++.|++.++.|||+ +||+||||||+|||++++ .++|+|||.
T Consensus        82 ~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          82 WEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             ecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCC-CEEEEECCC
Confidence            422    27899999986542       35556678899999999999998 999999999999999865 589999999


Q ss_pred             cccccccCCCCcccccCCcccCc--c---eecCCCCCccccHHHHHHHH
Q 018630          207 SAIMASTSGQANTFVGTYNYMSP--E---RISGGKYGYKSDIWSLGLVL  250 (353)
Q Consensus       207 a~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~DiwslG~il  250 (353)
                      |.....+..  .      .|...  +   .+....|+.++|+||+.--+
T Consensus       149 a~~~~~~~~--~------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         149 SVEVGEEGW--R------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CEETTSTTH--H------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             cccCCCCCc--H------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            866432211  1      11110  0   01235688899999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.53  E-value=1.6e-07  Score=80.50  Aligned_cols=140  Identities=16%  Similarity=0.108  Sum_probs=87.6

Q ss_pred             cCceeeeeecccCCeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-CCceEEEeeEeEecCeEEEEEE
Q 018630           61 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILE  139 (353)
Q Consensus        61 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e  139 (353)
                      +.|+..+..+-++.+.||++..  +++.+++|+....... ....+.+|...+..+. +--+.+++....+++..++||+
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~   90 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence            5666666655566689998864  4667788987544211 1223556666654432 2224455666677889999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 018630          140 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH------------------------------------------  177 (353)
Q Consensus       140 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~~l~~LH~------------------------------------------  177 (353)
                      +++|.++.+.....     .....++.++...+..||+                                          
T Consensus        91 ~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T d1j7la_          91 EADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred             eccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence            99998876543211     1112233334444444441                                          


Q ss_pred             ----------------cCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          178 ----------------EKHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       178 ----------------~~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                                      ...++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                            0127899999999999877667799999764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.01  E-value=1.1e-05  Score=68.36  Aligned_cols=74  Identities=11%  Similarity=0.005  Sum_probs=46.6

Q ss_pred             eecccC-CeEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCC--CceEEEeeEeEecCeEEEEEEecCCC
Q 018630           68 VVGKGS-GGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC--PYVVVCYQSFYSNGAISIILEYMDGG  144 (353)
Q Consensus        68 ~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~g  144 (353)
                      .+..|. .+.||++... ++..+++|.......    ..+..|...++.+..  -.+.+++....+++..++||++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            334444 4688988864 566788998654422    224445554443321  22556667677788899999999986


Q ss_pred             CH
Q 018630          145 SL  146 (353)
Q Consensus       145 sL  146 (353)
                      ++
T Consensus        92 ~~   93 (255)
T d1nd4a_          92 DL   93 (255)
T ss_dssp             ET
T ss_pred             cc
Confidence            54

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.98  E-value=9.6e-06  Score=73.69  Aligned_cols=78  Identities=10%  Similarity=0.001  Sum_probs=45.7

Q ss_pred             eeeecccCCeEEEEEEeccCCcEEEEEEeecccc------HHHHHHHHHHHHHHhcC---CCCceEEEeeEeEecCeEEE
Q 018630           66 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE------ESARRQIAQELKINQSS---QCPYVVVCYQSFYSNGAISI  136 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~~~~l---~hp~iv~~~~~~~~~~~~~l  136 (353)
                      .+.||.|..-.||++.+..+++.+++|.-.....      .....+...|...++.+   -...+.+++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            5678999999999999887788899997532100      01112344555555433   12334555543  4555678


Q ss_pred             EEEecCCCC
Q 018630          137 ILEYMDGGS  145 (353)
Q Consensus       137 v~e~~~~gs  145 (353)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.50  E-value=8.8e-05  Score=65.25  Aligned_cols=66  Identities=15%  Similarity=0.095  Sum_probs=41.1

Q ss_pred             eEEEEEEeccCCcEEEEEEeeccccHHHHHHHHHHHHHHhcCC-----CCceEEEe--eEeEecCeEEEEEEecCC
Q 018630           75 GIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----CPYVVVCY--QSFYSNGAISIILEYMDG  143 (353)
Q Consensus        75 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----hp~iv~~~--~~~~~~~~~~lv~e~~~~  143 (353)
                      =.||++... +|+.|++|+.+....  ...++..|...+..+.     .+..+..-  ..+..++..+.+++++.|
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            589999874 788899999875421  2344566666654432     12222211  123456788999999987

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.94  E-value=0.0026  Score=55.00  Aligned_cols=30  Identities=23%  Similarity=0.293  Sum_probs=27.0

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 018630          179 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  208 (353)
Q Consensus       179 ~~iiH~Dlkp~NIll~~~~~~kl~DfG~a~  208 (353)
                      .|+||+|+.++||+++.+...-+.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            579999999999999988778999999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.10  E-value=0.013  Score=52.33  Aligned_cols=74  Identities=18%  Similarity=0.109  Sum_probs=45.2

Q ss_pred             eeeecccCCeEEEEEEecc-------CCcEEEEEEeeccccHHHHHHHHHHHHHHhcCCCCc-eEEEeeEeEecCeEEEE
Q 018630           66 IKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAISII  137 (353)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~-iv~~~~~~~~~~~~~lv  137 (353)
                      ++.|+.|-.=.+|++....       ..+.|.+++.... ...  ....+|..+++.+.-.+ ..++++.+.+    .+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~--idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETE--SHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCH--HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chh--hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            4678888888999998653       2456778876522 211  23446666666543223 3356665532    578


Q ss_pred             EEecCCCCH
Q 018630          138 LEYMDGGSL  146 (353)
Q Consensus       138 ~e~~~~gsL  146 (353)
                      +||++|.+|
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987443